Citrus Sinensis ID: 017627

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------37
Protein Sequence
MAFFSKLFRIKNLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQKDPSRL
Secondary Structure (PSIPRED)
cEEHHHHHHHHHHHccccccccccccccccccccccccccccccccccEEHHHHHHHHHccccccccccccEEEEEEEccccccEEEEEEcccccccHHHHHHHHHHHHHccccccccccEEEEcccccEEEEEEccccccHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccHHHHHHccccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccEEcHHHHHHHHcccHHcccccccccEEEcEcccccEEEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEHcccccccccccccccccccEEEEEEEEEEcccccHHHHHcccEcccccHHHHHEEEEEEHcccccccccccccHHHHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHcccccccccccccccccccc
Coil and Loop (DISEMBL)
MAFFSKLFRIKnlrrtrkpidqvdvvvdqdqdqyhdhddgidgrsvkkyswDDVERFTQNFSQvigsggfsNVYLARLIndststngaikIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGycddrdegvllfeyvpngtlqeklhgtprssklpwrNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHlncklcdfgsakmgfssavlppspspspsrsriTKQVMmigspgytdphylrtgmastktdvYSFGVILLELVTgmeafcpenGQLLTSLAGSMLNDIADceatkvnelvdprlagdfdLDEARAMLSIAALClrqspilrpsaTQILHTIKHQIssisflfspqkdpsrl
Flexible Loop (DISEMBL)
maffsklfriknlrrtrkpidqvdvvvdqdqdqyhdhddgidgrsVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVpngtlqeklhgtprssklpwRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSavlppspspspsrSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIssisflfspqkdpsrl
Low Complexity Region (SEG)
MAFFSKLFRIKNLRRTRKPIdqvdvvvdqdqdqyhdhddGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLppspspspsrsrITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQKDPSRL
Disordered region (IsUnstruct)
***FSKLFRIKNLRRTRKPIDQVDVVVDQ****YH*HDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG*****KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM*************************MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF*********
Disordered Region (DISOPRED)
MAFFSKLFRI**************************************YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG**RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP********RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH******************
Disordered Region (DISEMBL)
MAFFSKLFRIKNLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA**************ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL**********
Disordered Region (DISPRO)
MAFFSKLFRIKNLRR****************************RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS******PS****RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS****FS********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAFFSKLFRIKNLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQKDPSRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	368	2.2.26 [Sep-21-2011]
B3LFC0	349	Probable receptor-like pr	yes	no	0.845	0.891	0.570	1e-100
Q9SV83	342	Probable receptor-like pr	no	no	0.831	0.894	0.563	1e-96
Q9FZB1	872	Probable LRR receptor-lik	no	no	0.769	0.324	0.351	1e-48
C0LGT5	866	Probable LRR receptor-lik	no	no	0.777	0.330	0.354	2e-47
C0LGL4	880	Probable LRR receptor-lik	no	no	0.766	0.320	0.350	6e-47
C0LGG4	890	Probable LRR receptor-lik	no	no	0.75	0.310	0.352	1e-46
C0LGR6	913	Probable LRR receptor-lik	no	no	0.779	0.314	0.340	4e-46
C0LGD8	864	Probable LRR receptor-lik	no	no	0.766	0.326	0.346	2e-45
Q9LIG2	899	Receptor-like protein kin	no	no	0.777	0.318	0.327	2e-45
Q9SI06	892	Putative leucine-rich rep	no	no	0.777	0.320	0.319	3e-45

>sp|B3LFC0|Y1332_ARATH Probable receptor-like protein kinase At1g33260 OS=Arabidopsis thaliana GN=At1g33260 PE=2 SV=1

 Score =  364 bits (935), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 187/328 (57%), Positives = 241/328 (73%), Gaps = 17/328 (5%)

Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQE 105
           V  Y+WDDVE  T NFS++IG+GG+S++YLAR+   S S N A+K+HV S RL QVF+ E
Sbjct: 30  VTCYTWDDVESLTSNFSRLIGTGGYSSIYLARV---SGSINAALKVHVSSHRLYQVFRSE 86

Query: 106 LDILLHLSHDNIVKLIGYCDDRDE-GVLLFEYVPNGTLQEKLHGTPRSSK--LPWRNRMA 162
           L+ILL L H +IVKL+GY DD +E G LL EY+P G LQEKL+   R+SK  LPWRNR A
Sbjct: 87  LEILLRLQHPHIVKLLGYFDDSEESGALLLEYLPQGNLQEKLN---RNSKQVLPWRNRTA 143

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           IAFQ+AQAIE++HE+C+  IVHGDIK+SNILL++H N KLCDFGSAK+GFSS V  PS +
Sbjct: 144 IAFQVAQAIEHIHEKCSPQIVHGDIKSSNILLDKHFNSKLCDFGSAKVGFSSMV-QPSKT 202

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
            S    R +KQVMMIGSPGYTDPHYLRTG+AS K D+Y FGV++LELV+G EA   E G+
Sbjct: 203 TSTMSPR-SKQVMMIGSPGYTDPHYLRTGIASKKMDMYGFGVVVLELVSGKEAVSSERGE 261

Query: 283 LLTSLAGSMLNDIADCEA----TKVNELVDPRLA--GDFDLDEARAMLSIAALCLRQSPI 336
           +L     S++++I D        KV + +DPRL+  G  DL+E + ML +AA CLR  P 
Sbjct: 262 MLVHSTASLIHEILDSNGDIGEEKVRQFLDPRLSRDGSIDLEEVKTMLRVAAFCLRSPPS 321

Query: 337 LRPSATQILHTIKHQISSISFLFSPQKD 364
           LRPSA+Q++ T+  +I S+SFL   +K+
Sbjct: 322 LRPSASQVVQTLNKKIPSLSFLGCGKKE 349

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SV83|Y4103_ARATH Probable receptor-like protein kinase At4g10390 OS=Arabidopsis thaliana GN=At4g10390 PE=2 SV=1

 Score =  353 bits (906), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 182/323 (56%), Positives = 231/323 (71%), Gaps = 17/323 (5%)

Query: 43  GRSVKKY-SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV 101
           G  V  Y SWDDVE  T NFS++IGSGG+S++Y+AR    S S   A+K+HV S RL QV
Sbjct: 24  GSGVTCYNSWDDVETLTSNFSRLIGSGGYSSIYMARF---SGSDKAALKVHVSSHRLYQV 80

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDE-GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
           F+ ELDILL L H NIVKL+GY DD +E G LL EY+P G LQEKL    +   L WRNR
Sbjct: 81  FRLELDILLRLQHPNIVKLLGYFDDSEENGALLLEYLPQGNLQEKLQSNSKQV-LQWRNR 139

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           +AIA QL QAIE++HE+C+  IVHGDIK+SN+LL+++ +CKLCDFGSAK+GFSS V PP+
Sbjct: 140 VAIALQLVQAIEHIHEKCSPQIVHGDIKSSNVLLDKNFDCKLCDFGSAKVGFSSMVQPPT 199

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            SP   RSR   QV M+GSPGYTDPHYLRTG+AS K D+Y FGV++LELV+G EAF  E 
Sbjct: 200 MSP---RSR---QVKMVGSPGYTDPHYLRTGIASKKMDMYGFGVVVLELVSGKEAFSAER 253

Query: 281 GQLLTSLAGSMLNDI----ADCEATKVNELVDPRLAGD-FDLDEARAMLSIAALCLRQSP 335
           G++L  +A  ++N+I     D    KV + +DPRL  D  D+DE + MLS+AA+C+    
Sbjct: 254 GEMLVHIAAPLMNEILDSSVDISEDKVRQFLDPRLLRDSLDIDEVKTMLSVAAVCISSKL 313

Query: 336 ILRPSATQILHTIKHQISSISFL 358
            LRPSA Q+  T+  +I S+SFL
Sbjct: 314 SLRPSAAQVADTLIKEIPSLSFL 336

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1

 Score =  194 bits (492), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 109/310 (35%), Positives = 166/310 (53%), Gaps = 27/310 (8%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQ 104
           ++ ++ +V + T NF +V+G GGF  VY   L      T  A+K+  H  +    + FK 
Sbjct: 554 RRITYPEVLKMTNNFERVLGKGGFGTVYHGNL----EDTQVAVKMLSHSSAQGYKE-FKA 608

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+++LL + H N+V L+GYCDD D   L++EY+ NG L+E + G    + L W NRM IA
Sbjct: 609 EVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGKRGGNVLTWENRMQIA 668

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
            + AQ +EYLH  CT  +VH D+K +NILL E    KL DFG ++             P 
Sbjct: 669 VEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSR-----------SFPV 717

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL- 283
              S ++   ++ G+PGY DP Y RT   S K+DVYSFGV+LLE+VT          +  
Sbjct: 718 DGESHVS--TVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTRERTH 775

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
           +    GSML          +  ++DP+L GD+D + A  ++ +A  C+  S   RP+   
Sbjct: 776 INEWVGSMLT------KGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAH 829

Query: 344 ILHTIKHQIS 353
           ++  +   ++
Sbjct: 830 VVTELNECVA 839

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT5|Y5169_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g16900 OS=Arabidopsis thaliana GN=At5g16900 PE=2 SV=1

 Score =  190 bits (482), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 110/310 (35%), Positives = 169/310 (54%), Gaps = 24/310 (7%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI-HVGSDRLSQVFKQE 105
           ++ ++ ++   T NF +VIG GGF  VY   L NDS     A+K+    S +  + FK E
Sbjct: 561 RRITYSEILLMTNNFERVIGEGGFGVVYHGYL-NDSEQV--AVKVLSPSSSQGYKEFKAE 617

Query: 106 LDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
           +++LL + H N+V L+GYCD++    L++EY+ NG L+  L G      L W NR++IA 
Sbjct: 618 VELLLRVHHINLVSLVGYCDEQAHLALIYEYMANGDLKSHLSGKHGDCVLKWENRLSIAV 677

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
           + A  +EYLH  C   +VH D+K+ NILL+EH   KL DFG ++  FS            
Sbjct: 678 ETALGLEYLHSGCKPLMVHRDVKSMNILLDEHFQAKLADFGLSR-SFSVG---------- 726

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN-GQLL 284
             S ++  V  +G+PGY DP Y RT   + K+DVYSFG++LLE++T        N  + +
Sbjct: 727 EESHVSTGV--VGTPGYLDPEYYRTYRLTEKSDVYSFGIVLLEIITNQPVLEQANENRHI 784

Query: 285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI 344
                +ML        + ++ +VDP L G++D    R  L +A  C+  SP+ RP  + +
Sbjct: 785 AERVRTMLT------RSDISTIVDPNLIGEYDSGSVRKALKLAMSCVDPSPVARPDMSHV 838

Query: 345 LHTIKHQISS 354
           +  +K  I S
Sbjct: 839 VQELKQCIKS 848

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGL4|Y2289_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g28960 OS=Arabidopsis thaliana GN=At2g28960 PE=2 SV=1

 Score =  188 bits (478), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 110/314 (35%), Positives = 162/314 (51%), Gaps = 32/314 (10%)

Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV---- 101
            K++++ +VE  T NF +V+G GGF  VY   L       NG   I V     S V    
Sbjct: 560 TKRFTYSEVEALTDNFERVLGEGGFGVVYHGIL-------NGTQPIAVKLLSQSSVQGYK 612

Query: 102 -FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
            FK E+++LL + H N+V L+GYCD+     LL+EY PNG L++ L G    S L W +R
Sbjct: 613 EFKAEVELLLRVHHVNLVSLVGYCDEESNLALLYEYAPNGDLKQHLSGERGGSPLKWSSR 672

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           + I  + AQ +EYLH  C   +VH D+K +NILL+EH   KL DFG ++           
Sbjct: 673 LKIVVETAQGLEYLHTGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRS---------- 722

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
             P    + ++  V   G+PGY DP Y RT   + K+DVYSFG++LLE++T         
Sbjct: 723 -FPVGGETHVSTAVA--GTPGYLDPEYYRTNRLNEKSDVYSFGIVLLEIITSRPVIQQTR 779

Query: 281 GQL-LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
            +  + +  G ML          +  +VDPRL  D++       L IA  C+  S   RP
Sbjct: 780 EKPHIAAWVGYMLT------KGDIENVVDPRLNRDYEPTSVWKALEIAMSCVNPSSEKRP 833

Query: 340 SATQILHTIKHQIS 353
           + +Q+ + +K  ++
Sbjct: 834 TMSQVTNELKQCLT 847

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2

 Score =  187 bits (475), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 106/301 (35%), Positives = 156/301 (51%), Gaps = 25/301 (8%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQEL 106
           +K ++ +V + T NF +V+G GGF  VY   L  D       +  H  +    + FK E+
Sbjct: 572 RKITYPEVLKMTNNFERVLGKGGFGTVYHGNL--DGAEVAVKMLSHSSAQGYKE-FKAEV 628

Query: 107 DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           ++LL + H ++V L+GYCDD D   L++EY+ NG L+E + G    + L W NRM IA +
Sbjct: 629 ELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVE 688

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
            AQ +EYLH  C   +VH D+K +NILL E    KL DFG ++               P 
Sbjct: 689 AAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSR-------------SFPI 735

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
                   ++ G+PGY DP Y RT   S K+DVYSFGV+LLE+VT          +    
Sbjct: 736 DGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRER---- 791

Query: 287 LAGSMLNDIADCEATK--VNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI 344
                +ND      TK  +  +VDP+L GD+D + A  ++ +A  C+  S   RP+   +
Sbjct: 792 ---PHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHV 848

Query: 345 L 345
           +
Sbjct: 849 V 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGR6|Y4291_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g29180 OS=Arabidopsis thaliana GN=At4g29180 PE=2 SV=2

 Score =  185 bits (470), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 110/323 (34%), Positives = 171/323 (52%), Gaps = 36/323 (11%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLA----------RLINDSTSTNGAIKIHVGSD 96
           +++++ +V   T NF++VIG GGF  VYL           ++INDS+           S 
Sbjct: 555 RRFTYSEVSSITNNFNKVIGKGGFGIVYLGSLEDGTEIAVKMINDSSFGKSKGSSSSSSS 614

Query: 97  -RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL 155
            ++S+ F+ E ++LL + H N+   +GYCDD     L++EY+ NG LQ+ L  +  +  L
Sbjct: 615 SQVSKEFQVEAELLLTVHHRNLASFVGYCDDGRSMALIYEYMANGNLQDYL-SSENAEDL 673

Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
            W  R+ IA   AQ +EYLH  C   IVH D+K +NILL ++L  K+ DFG +K+     
Sbjct: 674 SWEKRLHIAIDSAQGLEYLHHGCRPPIVHRDVKTANILLNDNLEAKIADFGLSKV----- 728

Query: 216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                  P    S +   VM  G+PGY DP Y  T   + K+DVYSFG++LLEL+TG  +
Sbjct: 729 ------FPEDDLSHVVTAVM--GTPGYVDPEYYNTFKLNEKSDVYSFGIVLLELITGKRS 780

Query: 276 FCPENGQLLTSLAGSMLNDIADCEA----TKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
                  ++ +  G  +N +   E       ++ +VDPRL GDF  + A   + +A  C+
Sbjct: 781 -------IMKTDDGEKMNVVHYVEPFLKMGDIDGVVDPRLHGDFSSNSAWKFVEVAMSCV 833

Query: 332 RQSPILRPSATQILHTIKHQISS 354
           R     RP+  QI+  +K  +++
Sbjct: 834 RDRGTNRPNTNQIVSDLKQCLAA 856

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD8|Y1755_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07550 OS=Arabidopsis thaliana GN=At1g07550 PE=2 SV=1

 Score =  183 bits (465), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 108/312 (34%), Positives = 171/312 (54%), Gaps = 30/312 (9%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQ 104
           +++++ DV + T NF  VIG GGF  VY   L N+      AIK+  H  +    + FK 
Sbjct: 548 RRFTYSDVNKMTNNFQVVIGKGGFGVVYQGCLNNEQ----AAIKVLSHSSAQGYKE-FKT 602

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+++LL + H+ +V LIGYCDD +   L++E +  G L+E L G P  S L W  R+ IA
Sbjct: 603 EVELLLRVHHEKLVSLIGYCDDDNGLALIYELMGKGNLKEHLSGKPGCSVLSWPIRLKIA 662

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
            + A  IEYLH  C   IVH D+K++NILL E    K+ DFG ++    S ++     P+
Sbjct: 663 LESAIGIEYLHTGCKPKIVHRDVKSTNILLSEEFEAKIADFGLSR----SFLIGNEAQPT 718

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA--FCPENGQ 282
                     ++ G+ GY DP Y +T + S K+DVYSFGV+LLE+++G +      EN  
Sbjct: 719 ----------VVAGTFGYLDPEYHKTSLLSMKSDVYSFGVVLLEIISGQDVIDLSRENCN 768

Query: 283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
           ++   +  + N   D E+     +VDP L  D+D   A  ++ +A  C+ ++   RP+ +
Sbjct: 769 IVEWTSFILEN--GDIES-----IVDPNLHQDYDTSSAWKVVELAMSCVNRTSKERPNMS 821

Query: 343 QILHTIKHQISS 354
           Q++H +   + +
Sbjct: 822 QVVHVLNECLET 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1

 Score =  183 bits (464), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 160/308 (51%), Gaps = 22/308 (7%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQEL 106
           +++++ +V   T NF +V+G GGF  VY    +N++      +  H  S    + FK E+
Sbjct: 580 RRFTYSEVVTMTNNFERVLGKGGFGMVYHGT-VNNTEQVAVKMLSHSSSQGYKE-FKAEV 637

Query: 107 DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           ++LL + H N+V L+GYCD+ +   L++EY+ NG L+E + G    S L W  R+ I  +
Sbjct: 638 ELLLRVHHKNLVGLVGYCDEGENLALIYEYMANGDLREHMSGKRGGSILNWETRLKIVVE 697

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
            AQ +EYLH  C   +VH D+K +NILL EHL+ KL DFG ++               P 
Sbjct: 698 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSR-------------SFPI 744

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL-LT 285
                   ++ G+PGY DP Y RT   + K+DVYSFG++LLE++T          +  + 
Sbjct: 745 EGETHVSTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSREKPHIA 804

Query: 286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
              G ML          +  ++DP+L GD+D       + +A  CL  S   RP+ +Q++
Sbjct: 805 EWVGLMLTK------GDIQNIMDPKLYGDYDSGSVWRAVELAMSCLNPSSARRPTMSQVV 858

Query: 346 HTIKHQIS 353
             +   +S
Sbjct: 859 IELNECLS 866

Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SI06|Y5573_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g04300 OS=Arabidopsis thaliana GN=At2g04300 PE=3 SV=2

 Score =  182 bits (463), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/310 (31%), Positives = 167/310 (53%), Gaps = 24/310 (7%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQE 105
           +++++ +V + T NF +++G GGF  VY    +ND+     A+K +   S +  + FK E
Sbjct: 570 RRFTYSEVVKMTNNFEKILGKGGFGMVYHGT-VNDAEQV--AVKMLSPSSSQGYKEFKAE 626

Query: 106 LDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
           +++LL + H N+V L+GYCD+ +   L++EY+  G L+E + G    S L W+ R+ I  
Sbjct: 627 VELLLRVHHKNLVGLVGYCDEGENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVA 686

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
           + AQ +EYLH  C   +VH D+K +NILL+EH   KL DFG ++             P  
Sbjct: 687 ESAQGLEYLHNGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSR-----------SFPLE 735

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL-L 284
             +R+    ++ G+PGY DP Y RT   + K+DVYSFG++LLE++T          +  +
Sbjct: 736 GETRV--DTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQHVINQSREKPHI 793

Query: 285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI 344
               G ML          +  ++DP+ +GD+D       + +A  C+  S   RP+ +Q+
Sbjct: 794 AEWVGVMLT------KGDIKSIIDPKFSGDYDAGSVWRAVELAMSCVNPSSTGRPTMSQV 847

Query: 345 LHTIKHQISS 354
           +  +   ++S
Sbjct: 848 VIELNECLAS 857

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	368
255555871	543	receptor protein kinase, putative [Ricin	0.913	0.618	0.652	1e-127
225426466	661	PREDICTED: wall-associated receptor kina	0.823	0.458	0.665	1e-115
224056719	365	predicted protein [Populus trichocarpa]	0.937	0.945	0.596	1e-114
224117692	310	predicted protein [Populus trichocarpa]	0.807	0.958	0.659	1e-114
297742498	436	unnamed protein product [Vitis vinifera]	0.714	0.603	0.687	1e-104
449456301	352	PREDICTED: probable receptor-like protei	0.913	0.954	0.554	1e-103
449518701	324	PREDICTED: probable receptor-like protei	0.828	0.941	0.605	1e-102
224100363	287	predicted protein [Populus trichocarpa]	0.741	0.951	0.658	1e-101
42571731	348	protein kinase domain-containing protein	0.845	0.893	0.568	7e-99
42562481	349	protein kinase domain-containing protein	0.845	0.891	0.570	3e-98

>gi|255555871|ref|XP_002518971.1| receptor protein kinase, putative [Ricinus communis] gi|223541958|gb|EEF43504.1| receptor protein kinase, putative [Ricinus communis]

 Score =  460 bits (1183), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 231/354 (65%), Positives = 274/354 (77%), Gaps = 18/354 (5%)

Query: 1   MAFFSKLFRIKNLRRTRKPIDQVDVVVD-QDQDQYHDHDDGIDGRSV-KKYSWDDVERFT 58
           M    + FR+K +  TR+PI QV VVV  +D   +H  +   D     KKYSW+D+ER T
Sbjct: 1   MGCLPRFFRLKPI--TRRPISQVGVVVAARDDIGFHVKEKDFDDDCCEKKYSWNDIERLT 58

Query: 59  QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIV 118
            NF++V+GSGGFS V+LARL    + T GA+KIH  SD L+++FKQELDILL L HDNIV
Sbjct: 59  MNFARVVGSGGFSTVFLARL---PSLTLGAVKIHGNSDHLNRLFKQELDILLQLRHDNIV 115

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL+G+CDD+D G L+ EYVPNG+LQ+KLHG   +  L W+ RMAIAFQLAQA+EYLH++C
Sbjct: 116 KLLGHCDDQDRGALVLEYVPNGSLQDKLHGAA-TEILSWKRRMAIAFQLAQALEYLHDKC 174

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
           TL IVHGDIKASNILL+EHLNCKLCDFGSAKMGFSS V+P S          TKQVMM G
Sbjct: 175 TLQIVHGDIKASNILLDEHLNCKLCDFGSAKMGFSSMVMPSSR---------TKQVMM-G 224

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           SPGYTDPHYLRTGMAS K D+YS+GVI+LELVTGMEAFC E GQLLTS+ G ML +  DC
Sbjct: 225 SPGYTDPHYLRTGMASKKNDIYSYGVIILELVTGMEAFCEERGQLLTSMMGPMLRNARDC 284

Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI 352
           EATK+ E+VDPRLAGDFDL EARAMLS++ALCL QSP+LRPSA QIL  I+  +
Sbjct: 285 EATKMAEMVDPRLAGDFDLKEARAMLSLSALCLGQSPVLRPSAAQILQEIRQNV 338

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426466|ref|XP_002270815.1| PREDICTED: wall-associated receptor kinase-like 10-like [Vitis vinifera]

 Score =  422 bits (1085), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 215/323 (66%), Positives = 252/323 (78%), Gaps = 20/323 (6%)

Query: 45  SVKKYSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           SVK++S +++ER T NFSQ  VIGSGGFS VYLA       ST  A+KIH G +RL++VF
Sbjct: 149 SVKRFSREEIERVTMNFSQTRVIGSGGFSTVYLAHF---PGSTMAAVKIHNGGERLNRVF 205

Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH---GTPRSSKLPWRN 159
           KQEL+ILLHL HDNIVKL+GY DDR+EGVL+FE+VP G+LQE LH   G   +S L W+N
Sbjct: 206 KQELEILLHLDHDNIVKLLGYGDDREEGVLVFEHVPKGSLQEMLHDSTGAKENSPLSWKN 265

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
           RMAIAFQLA+AIEYLHE+C L IVHGDIKASNILL+EHLNCKLCDFGSAKMGFSS VLPP
Sbjct: 266 RMAIAFQLAEAIEYLHEKCALPIVHGDIKASNILLDEHLNCKLCDFGSAKMGFSSTVLPP 325

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
           S S          QVMM+GSPGY DPHYLRTG+ S K D+YSFGVILLEL+TGM+AFC E
Sbjct: 326 SSSR-------MNQVMMMGSPGYVDPHYLRTGIPSKKNDIYSFGVILLELLTGMDAFCSE 378

Query: 280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
             Q LTS+AG +L D     A++V ++VDP L G FDL+EA+ M S+A LCL  SP LRP
Sbjct: 379 REQPLTSIAGPILRD-----ASQVGKVVDPGLGGYFDLEEAKVMASMAGLCLGPSPTLRP 433

Query: 340 SATQILHTIKHQISSISFLFSPQ 362
           SA+ IL T+KH+ISSISFLFSP 
Sbjct: 434 SASDILQTMKHKISSISFLFSPH 456

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224056719|ref|XP_002298989.1| predicted protein [Populus trichocarpa] gi|222846247|gb|EEE83794.1| predicted protein [Populus trichocarpa]

 Score =  419 bits (1077), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 222/372 (59%), Positives = 264/372 (70%), Gaps = 27/372 (7%)

Query: 8   FRIKNLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGS 67
            R ++ R  +K     +   D D  +  D D G  G  V+KY+W ++E+ + NFSQ++GS
Sbjct: 7   LRFRHKRLAKKVDAASNGSNDLDPKKEKDSDHGTHG-CVRKYNWSEIEKLSMNFSQIVGS 65

Query: 68  GGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR 127
           GGFS VYL  L     S  GAIKIH  SD L++VFKQELDILL L HDNIVKL+GYCD +
Sbjct: 66  GGFSTVYLGHL---PGSNLGAIKIHCPSDYLNRVFKQELDILLQLQHDNIVKLLGYCDVQ 122

Query: 128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLP-------WRNRMAIAFQLAQAIEYLHERCTL 180
           DEG L+FEYV NGTLQ+KLHG  R  K         WRNRM IA+QLAQA+EYLHE+C L
Sbjct: 123 DEGALVFEYVSNGTLQDKLHGGEREIKKSSSSSVISWRNRMEIAYQLAQALEYLHEKCPL 182

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            IVHGDIK SNILL+E LNCKLCDFG AKMGFSS ++          S   KQVMM GSP
Sbjct: 183 QIVHGDIKPSNILLDEQLNCKLCDFGFAKMGFSSTIMT---------SNNRKQVMM-GSP 232

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP--ENGQLLTSLAGSMLNDIA-- 296
           GYTDPHYLRTG+AS K DVYS+GVI+LELVTGMEAFC   E GQLL+S+ G +L DI   
Sbjct: 233 GYTDPHYLRTGIASKKNDVYSYGVIILELVTGMEAFCEEREQGQLLSSIMGPILKDIIAS 292

Query: 297 --DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS 354
             +C+A K  E+VDPRL  DF++ E + MLS+AALCL QSP LRPSATQILHTIK  I+S
Sbjct: 293 DNECKAMKEAEMVDPRLGEDFEVKEVKVMLSLAALCLGQSPSLRPSATQILHTIKENIAS 352

Query: 355 ISFLFSPQKDPS 366
           ISF+ + +KD S
Sbjct: 353 ISFISTQKKDLS 364

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224117692|ref|XP_002317644.1| predicted protein [Populus trichocarpa] gi|222860709|gb|EEE98256.1| predicted protein [Populus trichocarpa]

 Score =  417 bits (1073), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 213/323 (65%), Positives = 247/323 (76%), Gaps = 26/323 (8%)

Query: 49  YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDI 108
           YSW ++ER + NFSQ++GSGGFS VYLA L   S    GAIKIH  SD L++VFKQELDI
Sbjct: 1   YSWSEIERLSMNFSQIVGSGGFSTVYLAHLPGSSI---GAIKIHCPSDYLNRVFKQELDI 57

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-------TPRSSKLPWRNRM 161
           LL L HDNIVKL+GYCD++DEG L+FEYV NGTLQ+KLHG       + RS+ L WR RM
Sbjct: 58  LLQLQHDNIVKLLGYCDNQDEGALVFEYVSNGTLQDKLHGAGREIRESSRSTVLSWRKRM 117

Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP 221
           AIA+QLAQA+EYLHE+C L IVHGDIK SNILL+E LNCKLCDFG AKMGFSS V+    
Sbjct: 118 AIAYQLAQALEYLHEKCPLQIVHGDIKPSNILLDEQLNCKLCDFGFAKMGFSSTVM---- 173

Query: 222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE-- 279
               S +R  KQVMM GSPGYTDPHYLRTG+AS K DVYS+GVI+LELVTGMEAFC E  
Sbjct: 174 ---SSNNR--KQVMM-GSPGYTDPHYLRTGIASKKNDVYSYGVIILELVTGMEAFCEERG 227

Query: 280 NGQLLTSLAGSMLNDIA----DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
            GQLLTS+ G +L  I     +C  TKV E+VDP+L GDF++ E  AM+S+AALCL QSP
Sbjct: 228 QGQLLTSMIGPILKSIIASGDECNPTKVAEMVDPKLGGDFEVKEVMAMISLAALCLGQSP 287

Query: 336 ILRPSATQILHTIKHQISSISFL 358
            LRPSA QILHTIK  ++SIS L
Sbjct: 288 SLRPSAAQILHTIKENVASISLL 310

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742498|emb|CBI34647.3| unnamed protein product [Vitis vinifera]

 Score =  384 bits (985), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 191/278 (68%), Positives = 224/278 (80%), Gaps = 15/278 (5%)

Query: 88  AIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH 147
           A+KIH G +RL++VFKQEL+ILLHL HDNIVKL+GY DDR+EGVL+FE+VP G+LQE LH
Sbjct: 3   AVKIHNGGERLNRVFKQELEILLHLDHDNIVKLLGYGDDREEGVLVFEHVPKGSLQEMLH 62

Query: 148 ---GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD 204
              G   +S L W+NRMAIAFQLA+AIEYLHE+C L IVHGDIKASNILL+EHLNCKLCD
Sbjct: 63  DSTGAKENSPLSWKNRMAIAFQLAEAIEYLHEKCALPIVHGDIKASNILLDEHLNCKLCD 122

Query: 205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGV 264
           FGSAKMGFSS VLP      PS SR+  QVMM+GSPGY DPHYLRTG+ S K D+YSFGV
Sbjct: 123 FGSAKMGFSSTVLP------PSSSRM-NQVMMMGSPGYVDPHYLRTGIPSKKNDIYSFGV 175

Query: 265 ILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAML 324
           ILLEL+TGM+AFC E  Q LTS+AG +L D     A++V ++VDP L G FDL+EA+ M 
Sbjct: 176 ILLELLTGMDAFCSEREQPLTSIAGPILRD-----ASQVGKVVDPGLGGYFDLEEAKVMA 230

Query: 325 SIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ 362
           S+A LCL  SP LRPSA+ IL T+KH+ISSISFLFSP 
Sbjct: 231 SMAGLCLGPSPTLRPSASDILQTMKHKISSISFLFSPH 268

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449456301|ref|XP_004145888.1| PREDICTED: probable receptor-like protein kinase At1g33260-like [Cucumis sativus]

 Score =  381 bits (979), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 194/350 (55%), Positives = 248/350 (70%), Gaps = 14/350 (4%)

Query: 7   LFRIKNLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIG 66
           L R   ++R  K  D+  ++  Q Q  +             ++ W ++E  T+NFS ++G
Sbjct: 3   LLRFFRVKRKSKVADKKTILDAQIQQSFF----------ATRFRWTEIESLTKNFSTLVG 52

Query: 67  SGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD 126
           SGGFSNVYLAR    +     A+KI   S+RL+++F+QELDILL L H NIV  +GYCD+
Sbjct: 53  SGGFSNVYLAR---TAPGMAAAVKILGASERLNRMFRQELDILLKLRHRNIVNFVGYCDE 109

Query: 127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGD 186
           RDEG L+FEYVPNG LQEKLH  P +S LPW+ R+ IAFQLAQAIEYLHE+C+L IVHGD
Sbjct: 110 RDEGALVFEYVPNGNLQEKLHRRPAASVLPWKIRLLIAFQLAQAIEYLHEKCSLQIVHGD 169

Query: 187 IKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPH 246
           IK+SNILL+E LNCKLCDFGSAKMGFSSAV  PS S SPS     KQ+MM GSPGYTDP 
Sbjct: 170 IKSSNILLDEQLNCKLCDFGSAKMGFSSAVGNPSSSSSPSSPFRAKQLMM-GSPGYTDPQ 228

Query: 247 YLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNEL 306
           YLRTG+AS K DVYSFGV+LLELVTG EAFC E GQ+LTS+    + D    +A++V EL
Sbjct: 229 YLRTGIASKKNDVYSFGVVLLELVTGKEAFCSEKGQILTSILPPAVRDGGGIKASEVLEL 288

Query: 307 VDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS 356
           VDP+L G+ ++DEA A++ IAA C+RQ P  RP   +++  ++ ++ S+ 
Sbjct: 289 VDPKLWGELEVDEAGALIGIAAECVRQPPAPRPRIGEVVEMMREKMGSVG 338

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449518701|ref|XP_004166375.1| PREDICTED: probable receptor-like protein kinase At1g33260-like, partial [Cucumis sativus]

 Score =  379 bits (972), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 187/309 (60%), Positives = 235/309 (76%), Gaps = 4/309 (1%)

Query: 48  KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELD 107
           ++ W ++E  T+NFS ++GSGGFSNVYLAR    +     A+KI   S+RL+++F+QELD
Sbjct: 6   RFRWTEIESLTKNFSTLVGSGGFSNVYLAR---TAPGMAAAVKILGASERLNRMFRQELD 62

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           ILL L H NIV  +GYCD+RDEG L+FEYVPNG LQEKLH  P +S LPW+ R+ IAFQL
Sbjct: 63  ILLKLRHRNIVNFVGYCDERDEGALVFEYVPNGNLQEKLHRRPAASVLPWKIRLLIAFQL 122

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           AQAIEYLHE+C+L IVHGDIK+SNILL+E LNCKLCDFGSAKMGFSSAV  PS S SPS 
Sbjct: 123 AQAIEYLHEKCSLQIVHGDIKSSNILLDEQLNCKLCDFGSAKMGFSSAVGNPSSSSSPSS 182

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
               KQ+MM GSPGYTDP YLRTG+AS K DVYSFGV+LLELVTG EAFC E GQ+LTS+
Sbjct: 183 PFRAKQLMM-GSPGYTDPQYLRTGIASKKNDVYSFGVVLLELVTGKEAFCSEKGQILTSI 241

Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
               + D    +A++V ELVDP+L G+ ++DEA A++ IAA C+RQ P  RP   +++  
Sbjct: 242 LPPAVRDGGGIKASEVLELVDPKLWGELEVDEAGALIGIAAECVRQPPAPRPRIGEVVEM 301

Query: 348 IKHQISSIS 356
           ++ ++ S+ 
Sbjct: 302 MREKMGSVG 310

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224100363|ref|XP_002334383.1| predicted protein [Populus trichocarpa] gi|222871023|gb|EEF08154.1| predicted protein [Populus trichocarpa]

 Score =  374 bits (960), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 195/296 (65%), Positives = 225/296 (76%), Gaps = 23/296 (7%)

Query: 84  STNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQ 143
           S  GAIKIH  SD L++VFKQELDILL L HDNIVKL+GYCD +DEG L+FEYV NGTLQ
Sbjct: 1   SNLGAIKIHCPSDYLNRVFKQELDILLQLQHDNIVKLLGYCDVQDEGALVFEYVSNGTLQ 60

Query: 144 EKLHGTPRSSKLP-------WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE 196
           +KLHG  R  K         WRNRM IA+QLAQA+EYLHE+C L IVHGDIK SNILL+E
Sbjct: 61  DKLHGGEREIKKSSSSSVISWRNRMEIAYQLAQALEYLHEKCPLQIVHGDIKPSNILLDE 120

Query: 197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK 256
            LNCKLCDFG AKMGFSS ++        S +R  KQVMM GSPGYTDPHYLRTG+AS K
Sbjct: 121 QLNCKLCDFGFAKMGFSSTIM-------TSNNR--KQVMM-GSPGYTDPHYLRTGIASKK 170

Query: 257 TDVYSFGVILLELVTGMEAFCP--ENGQLLTSLAGSMLNDIA----DCEATKVNELVDPR 310
            DVYS+GVI+LELVTGMEAFC   E GQLL+S+ G +L DI     +C+A K  E+VDPR
Sbjct: 171 NDVYSYGVIILELVTGMEAFCEEREQGQLLSSIMGPILKDIIASDNECKAMKEAEMVDPR 230

Query: 311 LAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQKDPS 366
           L  DF++ E + MLS+AALCL QSP LRPSATQILHTIK  I+SISF+ + +KD S
Sbjct: 231 LGEDFEVKEVKVMLSLAALCLGQSPSLRPSATQILHTIKENIASISFISTQKKDLS 286

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42571731|ref|NP_973956.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|110743277|dbj|BAE99529.1| hypothetical protein [Arabidopsis thaliana] gi|332193455|gb|AEE31576.1| protein kinase domain-containing protein [Arabidopsis thaliana]

 Score =  367 bits (941), Expect = 7e-99,   Method: Compositional matrix adjust.
 Identities = 186/327 (56%), Positives = 240/327 (73%), Gaps = 16/327 (4%)

Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQE 105
           V  Y+WDDVE  T NFS++IG+GG+S++YLAR+   S S N A+K+HV S RL QVF+ E
Sbjct: 30  VTCYTWDDVESLTSNFSRLIGTGGYSSIYLARV---SGSINAALKVHVSSHRLYQVFRSE 86

Query: 106 LDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK--LPWRNRMAI 163
           L+ILL L H +IVKL+GY DD + G LL EY+P G LQEKL+   R+SK  LPWRNR AI
Sbjct: 87  LEILLRLQHPHIVKLLGYFDDSESGALLLEYLPQGNLQEKLN---RNSKQVLPWRNRTAI 143

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           AFQ+AQAIE++HE+C+  IVHGDIK+SNILL++H N KLCDFGSAK+GFSS V  PS + 
Sbjct: 144 AFQVAQAIEHIHEKCSPQIVHGDIKSSNILLDKHFNSKLCDFGSAKVGFSSMV-QPSKTT 202

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
           S    R +KQVMMIGSPGYTDPHYLRTG+AS K D+Y FGV++LELV+G EA   E G++
Sbjct: 203 STMSPR-SKQVMMIGSPGYTDPHYLRTGIASKKMDMYGFGVVVLELVSGKEAVSSERGEM 261

Query: 284 LTSLAGSMLNDIADCEA----TKVNELVDPRLA--GDFDLDEARAMLSIAALCLRQSPIL 337
           L     S++++I D        KV + +DPRL+  G  DL+E + ML +AA CLR  P L
Sbjct: 262 LVHSTASLIHEILDSNGDIGEEKVRQFLDPRLSRDGSIDLEEVKTMLRVAAFCLRSPPSL 321

Query: 338 RPSATQILHTIKHQISSISFLFSPQKD 364
           RPSA+Q++ T+  +I S+SFL   +K+
Sbjct: 322 RPSASQVVQTLNKKIPSLSFLGCGKKE 348

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42562481|ref|NP_564421.3| protein kinase domain-containing protein [Arabidopsis thaliana] gi|313471760|sp|B3LFC0.1|Y1332_ARATH RecName: Full=Probable receptor-like protein kinase At1g33260 gi|193211501|gb|ACF16170.1| At1g33260 [Arabidopsis thaliana] gi|332193454|gb|AEE31575.1| protein kinase domain-containing protein [Arabidopsis thaliana]

 Score =  364 bits (935), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 187/328 (57%), Positives = 241/328 (73%), Gaps = 17/328 (5%)

Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQE 105
           V  Y+WDDVE  T NFS++IG+GG+S++YLAR+   S S N A+K+HV S RL QVF+ E
Sbjct: 30  VTCYTWDDVESLTSNFSRLIGTGGYSSIYLARV---SGSINAALKVHVSSHRLYQVFRSE 86

Query: 106 LDILLHLSHDNIVKLIGYCDDRDE-GVLLFEYVPNGTLQEKLHGTPRSSK--LPWRNRMA 162
           L+ILL L H +IVKL+GY DD +E G LL EY+P G LQEKL+   R+SK  LPWRNR A
Sbjct: 87  LEILLRLQHPHIVKLLGYFDDSEESGALLLEYLPQGNLQEKLN---RNSKQVLPWRNRTA 143

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           IAFQ+AQAIE++HE+C+  IVHGDIK+SNILL++H N KLCDFGSAK+GFSS V  PS +
Sbjct: 144 IAFQVAQAIEHIHEKCSPQIVHGDIKSSNILLDKHFNSKLCDFGSAKVGFSSMV-QPSKT 202

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
            S    R +KQVMMIGSPGYTDPHYLRTG+AS K D+Y FGV++LELV+G EA   E G+
Sbjct: 203 TSTMSPR-SKQVMMIGSPGYTDPHYLRTGIASKKMDMYGFGVVVLELVSGKEAVSSERGE 261

Query: 283 LLTSLAGSMLNDIADCEA----TKVNELVDPRLA--GDFDLDEARAMLSIAALCLRQSPI 336
           +L     S++++I D        KV + +DPRL+  G  DL+E + ML +AA CLR  P 
Sbjct: 262 MLVHSTASLIHEILDSNGDIGEEKVRQFLDPRLSRDGSIDLEEVKTMLRVAAFCLRSPPS 321

Query: 337 LRPSATQILHTIKHQISSISFLFSPQKD 364
           LRPSA+Q++ T+  +I S+SFL   +K+
Sbjct: 322 LRPSASQVVQTLNKKIPSLSFLGCGKKE 349

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	368
TAIR|locus:2196680	349	AT1G33260 [Arabidopsis thalian	0.836	0.882	0.56	6.5e-90
TAIR|locus:2122834	342	AT4G10390 [Arabidopsis thalian	0.831	0.894	0.541	1.4e-85
TAIR|locus:2118344	863	AT4G29450 [Arabidopsis thalian	0.788	0.336	0.354	1e-43
TAIR|locus:2125692	731	PERK14 "proline-rich extensin-	0.782	0.393	0.353	1.2e-41
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.777	0.402	0.346	1.3e-40
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.766	0.414	0.346	1.6e-40
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.796	0.775	0.344	3.3e-40
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.763	0.702	0.340	4.2e-40
TAIR|locus:2179857	456	PBS1 "avrPphB susceptible 1" [	0.788	0.635	0.338	8.7e-40
TAIR|locus:2075517	558	AT3G02810 [Arabidopsis thalian	0.771	0.508	0.341	1.4e-39

TAIR|locus:2196680 AT1G33260 [Arabidopsis thaliana (taxid:3702)]

 Score = 897 (320.8 bits), Expect = 6.5e-90, P = 6.5e-90
 Identities = 182/325 (56%), Positives = 235/325 (72%)

Query:    49 YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDI 108
             Y+WDDVE  T NFS++IG+GG+S++YLAR+   S S N A+K+HV S RL QVF+ EL+I
Sbjct:    33 YTWDDVESLTSNFSRLIGTGGYSSIYLARV---SGSINAALKVHVSSHRLYQVFRSELEI 89

Query:   109 LLHLSHDNIVKLIGYCDDRDE-GVLLFEYVPNGTLQEKLHGTPRSSK--LPWRNRMAIAF 165
             LL L H +IVKL+GY DD +E G LL EY+P G LQEKL+   R+SK  LPWRNR AIAF
Sbjct:    90 LLRLQHPHIVKLLGYFDDSEESGALLLEYLPQGNLQEKLN---RNSKQVLPWRNRTAIAF 146

Query:   166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
             Q+AQAIE++HE+C+  IVHGDIK+SNILL++H N KLCDFGSAK+GFSS V         
Sbjct:   147 QVAQAIEHIHEKCSPQIVHGDIKSSNILLDKHFNSKLCDFGSAKVGFSSMVQPSKTTSTM 206

Query:   226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT 285
                  +KQVMMIGSPGYTDPHYLRTG+AS K D+Y FGV++LELV+G EA   E G++L 
Sbjct:   207 SPR--SKQVMMIGSPGYTDPHYLRTGIASKKMDMYGFGVVVLELVSGKEAVSSERGEMLV 264

Query:   286 SLAGSMLNDIADCEAT----KVNELVDPRLA--GDFDLDEARAMLSIAALCLRQSPILRP 339
                 S++++I D        KV + +DPRL+  G  DL+E + ML +AA CLR  P LRP
Sbjct:   265 HSTASLIHEILDSNGDIGEEKVRQFLDPRLSRDGSIDLEEVKTMLRVAAFCLRSPPSLRP 324

Query:   340 SATQILHTIKHQISSISFLFSPQKD 364
             SA+Q++ T+  +I S+SFL   +K+
Sbjct:   325 SASQVVQTLNKKIPSLSFLGCGKKE 349

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2122834 AT4G10390 [Arabidopsis thaliana (taxid:3702)]

 Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
 Identities = 175/323 (54%), Positives = 225/323 (69%)

Query:    43 GRSVKKY-SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV 101
             G  V  Y SWDDVE  T NFS++IGSGG+S++Y+AR    S S   A+K+HV S RL QV
Sbjct:    24 GSGVTCYNSWDDVETLTSNFSRLIGSGGYSSIYMARF---SGSDKAALKVHVSSHRLYQV 80

Query:   102 FKQELDILLHLSHDNIVKLIGYCDDRDE-GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
             F+ ELDILL L H NIVKL+GY DD +E G LL EY+P G LQEKL    +   L WRNR
Sbjct:    81 FRLELDILLRLQHPNIVKLLGYFDDSEENGALLLEYLPQGNLQEKLQSNSKQV-LQWRNR 139

Query:   161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
             +AIA QL QAIE++HE+C+  IVHGDIK+SN+LL+++ +CKLCDFGSAK+GFSS V    
Sbjct:   140 VAIALQLVQAIEHIHEKCSPQIVHGDIKSSNVLLDKNFDCKLCDFGSAKVGFSSMVQPPT 199

Query:   221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                       ++QV M+GSPGYTDPHYLRTG+AS K D+Y FGV++LELV+G EAF  E 
Sbjct:   200 MSPR------SRQVKMVGSPGYTDPHYLRTGIASKKMDMYGFGVVVLELVSGKEAFSAER 253

Query:   281 GQLLTSLAGSMLNDIADCEAT----KVNELVDPRLAGD-FDLDEARAMLSIAALCLRQSP 335
             G++L  +A  ++N+I D        KV + +DPRL  D  D+DE + MLS+AA+C+    
Sbjct:   254 GEMLVHIAAPLMNEILDSSVDISEDKVRQFLDPRLLRDSLDIDEVKTMLSVAAVCISSKL 313

Query:   336 ILRPSATQILHTIKHQISSISFL 358
              LRPSA Q+  T+  +I S+SFL
Sbjct:   314 SLRPSAAQVADTLIKEIPSLSFL 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=IEP;RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

TAIR|locus:2118344 AT4G29450 [Arabidopsis thaliana (taxid:3702)]

 Score = 469 (170.2 bits), Expect = 1.0e-43, P = 1.0e-43
 Identities = 113/319 (35%), Positives = 170/319 (53%)

Query:    47 KKYSWDDVERFTQNFSQVIGSGGFSNVYLA----------RLINDSTSTNGAIKIHVGSD 96
             +++++++V   T NF++VIG GGF  VYL           ++INDS+             
Sbjct:   554 RRFTYNEVSSITNNFNKVIGKGGFGIVYLGSLEDGTKIAVKMINDSSLAKPKGTSSSSLS 613

Query:    97 RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
             R S  F+ E ++LL + H N+   +GYCDD     L++EY+ NG LQ  L  +  +  L 
Sbjct:   614 RASNQFQVEAELLLTVHHRNLASFVGYCDDDRSMALIYEYMANGNLQAYL-SSENAEDLS 672

Query:   157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
             W  R+ IA   AQ +EYLH+ C   IVH D+K +NIL+ ++L  K+ DFG +K+ F    
Sbjct:   673 WEKRLHIAIDSAQGLEYLHDGCRPAIVHRDVKTANILINDNLEAKIADFGLSKV-FPEDD 731

Query:   217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             L            +   VM  G+PGY DP Y RT + + K+DVYSFGV+LLEL+TG  A 
Sbjct:   732 LSH----------VVTTVM--GTPGYVDPEYYRTFVLNEKSDVYSFGVVLLELITGQRAI 779

Query:   277 CP-ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
                E G  ++ +           EA +++ +VDP L GDF  D A   + +A  C+R   
Sbjct:   780 IKTEEGDNISVIHYVW----PFFEARELDGVVDPLLRGDFSQDSAWKFVDVAMSCVRDKG 835

Query:   336 ILRPSATQILHTIKHQISS 354
               RP+  QI+  +K  +++
Sbjct:   836 SNRPTMNQIVAELKQCLAA 854

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 447 (162.4 bits), Expect = 1.2e-41, P = 1.2e-41
 Identities = 110/311 (35%), Positives = 175/311 (56%)

Query:    49 YSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQE 105
             +S++++ + T  FS+  ++G GGF  V+   L N    T  A+K + +GS +  + F+ E
Sbjct:   377 FSYEELSKATGGFSEENLLGEGGFGYVHKGVLKN---GTEVAVKQLKIGSYQGEREFQAE 433

Query:   106 LDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
             +D +  + H ++V L+GYC + D+ +L++E+VP  TL+  LH   R S L W  R+ IA 
Sbjct:   434 VDTISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHEN-RGSVLEWEMRLRIAV 492

Query:   166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
               A+ + YLHE C+  I+H DIKA+NILL+     K+ DFG AK  FS            
Sbjct:   493 GAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKF-FSDT--------NS 543

Query:   226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA-FCPENG--Q 282
                 I+ +V  +G+ GY  P Y  +G  + K+DVYSFGV+LLEL+TG  + F  ++   Q
Sbjct:   544 SFTHISTRV--VGTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDSSTNQ 601

Query:   283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
              L   A  +L      E+   + LVD RL  ++D  +   M + AA C+RQS  LRP  +
Sbjct:   602 SLVDWARPLLTKAISGES--FDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMS 659

Query:   343 QILHTIKHQIS 353
             Q++  ++ +++
Sbjct:   660 QVVRALEGEVA 670

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 437 (158.9 bits), Expect = 1.3e-40, P = 1.3e-40
 Identities = 108/312 (34%), Positives = 172/312 (55%)

Query:    43 GRSVKKYSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLS 99
             G     ++++++   T+ FS+  ++G GGF  VY  +L ND      A+K + VGS +  
Sbjct:   335 GSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKL-NDGKLV--AVKQLKVGSGQGD 391

Query:   100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             + FK E++I+  + H ++V L+GYC    E +L++EYVPN TL+  LHG  R   L W  
Sbjct:   392 REFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPV-LEWAR 450

Query:   160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
             R+ IA   A+ + YLHE C   I+H DIK++NILL++    ++ DFG AK+  S+     
Sbjct:   451 RVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQT--- 507

Query:   220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG---MEAF 276
                       ++ +VM  G+ GY  P Y ++G  + ++DV+SFGV+LLEL+TG   ++ +
Sbjct:   508 ---------HVSTRVM--GTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQY 556

Query:   277 CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI 336
              P   + L   A  +L+     E    +ELVD RL   +  +E   M+  AA C+R S  
Sbjct:   557 QPLGEESLVEWARPLLHKAI--ETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGP 614

Query:   337 LRPSATQILHTI 348
              RP   Q++  +
Sbjct:   615 KRPRMVQVVRAL 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 1.6e-40, P = 1.6e-40
 Identities = 106/306 (34%), Positives = 163/306 (53%)

Query:    49 YSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQE 105
             +S+D++ + T  FS+  ++G GGF  VY   +++D      A+K + +G  +  + FK E
Sbjct:   327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKG-VLSDGREV--AVKQLKIGGSQGEREFKAE 383

Query:   106 LDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
             ++I+  + H ++V L+GYC      +L+++YVPN TL   LH  P    + W  R+ +A 
Sbjct:   384 VEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA-PGRPVMTWETRVRVAA 442

Query:   166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
               A+ I YLHE C   I+H DIK+SNILL+      + DFG AK+               
Sbjct:   443 GAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIA----------QELD 492

Query:   226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG---MEAFCPENGQ 282
                 ++ +VM  G+ GY  P Y  +G  S K DVYS+GVILLEL+TG   ++   P   +
Sbjct:   493 LNTHVSTRVM--GTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDE 550

Query:   283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
              L   A  +L    + E  + +ELVDPRL  +F   E   M+  AA C+R S   RP  +
Sbjct:   551 SLVEWARPLLGQAIENE--EFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMS 608

Query:   343 QILHTI 348
             Q++  +
Sbjct:   609 QVVRAL 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 428 (155.7 bits), Expect = 3.3e-40, P = 3.3e-40
 Identities = 111/322 (34%), Positives = 171/322 (53%)

Query:    40 GIDGRSVKKYSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIKI--HVGS 95
             G D    + +++ ++   T+NF +  +IG GGF  VY   L   STS   AIK   H G 
Sbjct:    52 GSDHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLA--STSQTAAIKQLDHNGL 109

Query:    96 DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSK 154
                ++ F  E+ +L  L H N+V LIGYC D D+ +L++EY+P G+L++ LH  +P    
Sbjct:   110 QG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQP 168

Query:   155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
             L W  RM IA   A+ +EYLH++    +++ D+K SNILL++    KL DFG AK+G   
Sbjct:   169 LDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLG--- 225

Query:   215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
                            ++ +VM  G+ GY  P Y  TG  + K+DVYSFGV+LLE++TG +
Sbjct:   226 --------PVGDKSHVSTRVM--GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 275

Query:   275 AFCPENG---QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
             A         Q L + A  +  D       K +++ DP L G +        L++AA+C+
Sbjct:   276 AIDSSRSTGEQNLVAWARPLFKD-----RRKFSQMADPMLQGQYPPRGLYQALAVAAMCV 330

Query:   332 RQSPILRPSATQILHTIKHQIS 353
             ++ P LRP    ++  + +  S
Sbjct:   331 QEQPNLRPLIADVVTALSYLAS 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 427 (155.4 bits), Expect = 4.2e-40, P = 4.2e-40
 Identities = 105/308 (34%), Positives = 167/308 (54%)

Query:    49 YSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQ 104
             +++  +   T  FS+  V+G+GGF  VY   ++ND      AIK+  H G     + FK 
Sbjct:    75 FTFKQLHSATGGFSKSNVVGNGGFGLVYRG-VLNDGRKV--AIKLMDHAGKQG-EEEFKM 130

Query:   105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP----WRNR 160
             E+++L  L    ++ L+GYC D    +L++E++ NG LQE L+   RS  +P    W  R
Sbjct:   131 EVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDWETR 190

Query:   161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
             M IA + A+ +EYLHE+ +  ++H D K+SNILL+ + N K+ DFG AK+G   A     
Sbjct:   191 MRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGSDKA----- 245

Query:   221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                      ++ +V+  G+ GY  P Y  TG  +TK+DVYS+GV+LLEL+TG      + 
Sbjct:   246 ------GGHVSTRVL--GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKR 297

Query:   281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS 340
                   L    L  +AD +  KV +++DP L G +   E   + +IAA+C++     RP 
Sbjct:   298 ATGEGVLVSWALPQLADRD--KVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPL 355

Query:   341 ATQILHTI 348
                ++ ++
Sbjct:   356 MADVVQSL 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 424 (154.3 bits), Expect = 8.7e-40, P = 8.7e-40
 Identities = 108/319 (33%), Positives = 170/319 (53%)

Query:    40 GIDGRSVKKYSWDDVERFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR 97
             G+   +   +++ ++   T NF     +G GGF  VY  RL  DST    A+K  +  + 
Sbjct:    65 GLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRL--DSTGQVVAVK-QLDRNG 121

Query:    98 L--SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK- 154
             L  ++ F  E+ +L  L H N+V LIGYC D D+ +L++E++P G+L++ LH  P   + 
Sbjct:   122 LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 181

Query:   155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
             L W  RM IA   A+ +E+LH++    +++ D K+SNILL+E  + KL DFG AK+G + 
Sbjct:   182 LDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTG 241

Query:   215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
                            ++ +VM  G+ GY  P Y  TG  + K+DVYSFGV+ LEL+TG +
Sbjct:   242 -----------DKSHVSTRVM--GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 288

Query:   275 AF---CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
             A     P   Q L + A  + ND       K  +L DPRL G F        L++A++C+
Sbjct:   289 AIDSEMPHGEQNLVAWARPLFND-----RRKFIKLADPRLKGRFPTRALYQALAVASMCI 343

Query:   332 RQSPILRPSATQILHTIKH 350
             ++    RP    ++  + +
Sbjct:   344 QEQAATRPLIADVVTALSY 362

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0006952 "defense response" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)]

 Score = 422 (153.6 bits), Expect = 1.4e-39, P = 1.4e-39
 Identities = 107/313 (34%), Positives = 172/313 (54%)

Query:    42 DGRSVKKYSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL- 98
             +G S+K +++ ++   T+NF Q  ++G GGF  VY   L   ST    A+K  +    L 
Sbjct:    45 EGTSLKIFTFRELATATKNFRQECLLGEGGFGRVYKGTL--KSTGQVVAVK-QLDKHGLH 101

Query:    99 -SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP- 156
              ++ F+ E+  L  L H N+VKLIGYC D D+ +L+++Y+  G+LQ+ LH  P++   P 
Sbjct:   102 GNKEFQAEVLSLGQLDHPNLVKLIGYCADGDQRLLVYDYISGGSLQDHLH-EPKADSDPM 160

Query:   157 -WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
              W  RM IA+  AQ ++YLH++    +++ D+KASNILL++  + KL DFG  K+G  + 
Sbjct:   161 DWTTRMQIAYAAAQGLDYLHDKANPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTG 220

Query:   216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                           ++ +VM  G+ GY+ P Y R G  + K+DVYSFGV+LLEL+TG  A
Sbjct:   221 ---------DKMMALSSRVM--GTYGYSAPEYTRGGNLTLKSDVYSFGVVLLELITGRRA 269

Query:   276 FC---PENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR 332
                  P + Q L S A  +  D       +  ++ DP L   F        ++IA++C++
Sbjct:   270 LDTTRPNDEQNLVSWAQPIFRD-----PKRYPDMADPVLENKFSERGLNQAVAIASMCVQ 324

Query:   333 QSPILRPSATQIL 345
             +    RP  + ++
Sbjct:   325 EEASARPLISDVM 337

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
B3LFC0	Y1332_ARATH	2, ., 7, ., 1, 1, ., 1	0.5701	0.8451	0.8911	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.1	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	368
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-33
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-23
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-21
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-10
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.001
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.001
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  161 bits (410), Expect = 1e-47
 Identities = 88/290 (30%), Positives = 125/290 (43%), Gaps = 44/290 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---ELDILLHLSHDNIVK 119
           + +GSG F  VY A+          A+KI       S+  +    E+ IL  LSH NIV+
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIV--AVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           LI   +D+D   L+ EY   G L + L    R   L       IA Q+ + +EYLH    
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSN-- 117

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
             I+H D+K  NILL+E+   K+ DFG AK    S+    +                +G+
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF---------------VGT 161

Query: 240 PGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           P Y  P  L  G     K DV+S GVIL EL+TG   F  EN          +L+ +   
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGEN----------ILDQLQ-- 209

Query: 299 EATKVNELVDPRLAGDFDL--DEARAMLSIAALCLRQSPILRPSATQILH 346
               +  ++ P L  D       +     +   CL + P  RP+A +IL 
Sbjct: 210 ---LIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  159 bits (404), Expect = 4e-47
 Identities = 72/209 (34%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G GGF  VYLAR  +  T    AIKI     S  L +   +E++IL  L+H NIVKL G
Sbjct: 1   LGEGGFGTVYLAR--DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
             +D +   L+ EY   G+L++ L       KL     + I  Q+ + +EYLH      I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 183 VHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           +H D+K  NILL  ++   KL DFG +K          +   S  ++        +G+P 
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSK--------LLTSDKSLLKTI-------VGTPA 158

Query: 242 YTDPHYLRTGM-ASTKTDVYSFGVILLEL 269
           Y  P  L      S K+D++S GVIL EL
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  153 bits (388), Expect = 2e-44
 Identities = 81/286 (28%), Positives = 117/286 (40%), Gaps = 42/286 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           + +G G F  VYLAR     T    AIK+       +  +   +E+ IL  L H NIV+L
Sbjct: 5   EKLGEGSFGKVYLARDKK--TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
               +D D+  L+ EY   G L + L    +  +L          Q+  A+EYLH +   
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSK--- 116

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            IVH D+K  NILL+E  + KL DFG A+               P     T     +G+P
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQL------------DPGEKLTT----FVGTP 160

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA 300
            Y  P  L         D++S GVIL EL+TG   F  ++  L       +   I     
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLE------LFKKIGKP-- 212

Query: 301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
               +   P    D    EA+ ++      L + P  R +A + L 
Sbjct: 213 ----KPPFPPPEWDIS-PEAKDLIR---KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  144 bits (365), Expect = 6e-41
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 22/215 (10%)

Query: 61  FSQVIGSGGFSNVYLARLIN--DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDN 116
             + +G G F  VY   L    D      A+K      S++  + F +E  I+  L H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IVKL+G C + +  +++ EY+P G L + L    R  +L   + ++ A Q+A+ +EYL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +   + +H D+ A N L+ E+L  K+ DFG ++  +            P R         
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR--------- 169

Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +  P  L+ G  ++K+DV+SFGV+L E+ T
Sbjct: 170 -----WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  142 bits (360), Expect = 4e-40
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 61  FSQVIGSGGFSNVYLARLI--NDSTSTNGAIK-IHVGSDRLSQV--FKQELDILLHLSHD 115
             + +G G F  VY  +L           A+K +   +    Q+  F +E  I+  L H 
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASE-QQIEEFLREARIMRKLDHP 61

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           N+VKL+G C + +   ++ EY+  G L   L       KL   + ++ A Q+A+ +EYL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE 119

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
            +   + +H D+ A N L+ E+L  K+ DFG ++  +            P R        
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-------- 168

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                 +  P  L+ G  ++K+DV+SFGV+L E+ T
Sbjct: 169 ------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  141 bits (357), Expect = 9e-40
 Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 61/301 (20%)

Query: 64  VIGSGGFSNVYLARLI-NDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHDNIVKL 120
            +G G F  VY  +L   D  +T  A+K         +   F +E  ++  L H N+V+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKL------HGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +G C + +   L+ EY+  G L + L        +P  S L  ++ ++ A Q+A+ +EYL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
             +     VH D+ A N L+ E L  K+ DFG                   SR       
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDFG------------------LSRDVYDDDY 160

Query: 235 MMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
               + G     +  P  L+ G+ ++K+DV+SFGV+L E+ T               L  
Sbjct: 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT---------------LGA 205

Query: 290 SMLNDIADCE-ATKVNE---LVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
           +    +++ E    + +   L  P    D        +  +   C +  P  RP+ ++++
Sbjct: 206 TPYPGLSNEEVLEYLRKGYRLPKPEYCPD-------ELYELMLSCWQLDPEDRPTFSELV 258

Query: 346 H 346
            
Sbjct: 259 E 259

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  138 bits (350), Expect = 1e-38
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNG--AIKI--HVGSDRLSQVFKQELDILLHLSHDN 116
             + +G G F  VY   L  D   T    A+K      S+   + F +E  I+  LSH N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IV+L+G C   +   ++ EY+P G L + L       KL  ++ + +A Q+A+ +EYL  
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +   + VH D+ A N L+ E+L  K+ DFG ++  +                   K+   
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-------------DYYRKRGGG 164

Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                +  P  L+ G  ++K+DV+SFGV+L E+ T 
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (350), Expect = 1e-38
 Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 48/294 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV--FKQELDILLHLSHDNIVK 119
           +++G G F +VYLA  ++  T    A+K + +  D   ++   ++E+ IL  L H NIV+
Sbjct: 6   ELLGRGSFGSVYLA--LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63

Query: 120 LIGYCDDRDEGVL-LF-EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             G   D ++  L +F EYV  G+L   L    +  KLP         Q+ + + YLH  
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               IVH DIK +NIL++     KL DFG AK          + S             + 
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-------------VR 164

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD 297
           G+P +  P  +R        D++S G  ++E+ TG   +      +      + L  I  
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKIG- 217

Query: 298 CEATKVNELVDPRLAGDFDL-DEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
             + +  E+ +        L +EA+  L     CLR+ P  RP+A ++L   +H
Sbjct: 218 -SSGEPPEIPE-------HLSEEAKDFLR---KCLRRDPKKRPTADELL---QH 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  126 bits (319), Expect = 3e-34
 Identities = 80/289 (27%), Positives = 124/289 (42%), Gaps = 51/289 (17%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
            IG GGF  VY AR  +  T    AIK+      ++  ++   E+ IL    H NIVK  
Sbjct: 7   KIGKGGFGEVYKAR--HKRTGKEVAIKVIKLESKEKKEKII-NEIQILKKCKHPNIVKYY 63

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF---QLAQAIEYLHERC 178
           G    +DE  ++ E+   G+L++ L  T ++          IA+   +L + +EYLH   
Sbjct: 64  GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS-- 116

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
              I+H DIKA+NILL      KL DFG SA++             S +++R T    M+
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-------------SDTKARNT----MV 158

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD 297
           G+P +  P  +       K D++S G+  +EL  G   +       L  +          
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE-----LPPMKALFKIATNG 213

Query: 298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
               +  E            DE +  L     CL+++P  RP+A Q+L 
Sbjct: 214 PPGLRNPEKWS---------DEFKDFLK---KCLQKNPEKRPTAEQLLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (315), Expect = 7e-33
 Identities = 89/317 (28%), Positives = 132/317 (41%), Gaps = 34/317 (10%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSH- 114
              + +G G F  VYLAR          A+K+         +  + F +E+ IL  L+H 
Sbjct: 3   RILRKLGEGSFGEVYLARDRKLV-----ALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            NIVKL  +  D     L+ EYV  G+L++ L    R   L     + I  Q+  A+EYL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 175 HERCTLHIVHGDIKASNILLEEHLN-CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           H +    I+H DIK  NILL+      KL DFG AK      +LP   S S   +  +  
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAK------LLPDPGSTSSIPALPSTS 168

Query: 234 VMMIGSPGYTDP---HYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS 290
           V   G+PGY  P     L    AS+ +D++S G+ L EL+TG+  F  E     TS    
Sbjct: 169 V---GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225

Query: 291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL-HTIK 349
           ++              +   L+       ++A   +    L + P  R S++  L H + 
Sbjct: 226 IIL-------ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Query: 350 HQISSISFLFSPQKDPS 366
             +       S    P 
Sbjct: 279 AHLKLKESDLSDLLKPD 295

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  115 bits (291), Expect = 7e-30
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 30/228 (13%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLS-HD 115
           F ++IG G FS V LA+     T+   AIKI     +  ++  +  K E ++L  L+ H 
Sbjct: 5   FGKIIGEGSFSTVVLAKEK--ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            I+KL     D +    + EY PNG L + +    +   L  +     A ++  A+EYLH
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLH 119

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
            +    I+H D+K  NILL++ ++ K+ DFG+AK      VL P+ SP  ++   T    
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAK------VLDPNSSPESNKGDATNIDS 170

Query: 236 MI-----------GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
            I           G+  Y  P  L    A   +D+++ G I+ +++TG
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (288), Expect = 9e-30
 Identities = 78/291 (26%), Positives = 115/291 (39%), Gaps = 51/291 (17%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFK--QELDILLHLSHDNIVK 119
           + IG G F  VYL R    S      +K I + +    +      E+ IL  L+H NI+K
Sbjct: 6   KQIGKGSFGKVYLVR--RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 120 LIGYCDDRDEGVLLF---EYVPNGTLQEKLH-GTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
              Y +  +E   L    EY   G L +K+          P    +    QL  A++YLH
Sbjct: 64  ---YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
            R    I+H DIK  NI L  +   KL DFG +K+  S+  L  +               
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--------------- 162

Query: 236 MIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND 294
           ++G+P Y  P   +     + K+D++S G +L EL T    F  EN      L    L  
Sbjct: 163 VVGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALK- 214

Query: 295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
           I   +   +       L             ++ +  L++ P  RPS  QIL
Sbjct: 215 ILKGQYPPIPSQYSSELR------------NLVSSLLQKDPEERPSIAQIL 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  113 bits (285), Expect = 3e-29
 Identities = 78/286 (27%), Positives = 119/286 (41%), Gaps = 43/286 (15%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRL--SQVFKQELDILLHLSHDNIVKL 120
           V+G G    VY  R  +  T    A+K IHV  D     Q+  +EL  L       +VK 
Sbjct: 8   VLGQGSSGVVYKVR--HKPTGKIYALKKIHVDGDEEFRKQL-LRELKTLRSCESPYVVKC 64

Query: 121 IG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
            G +  + +  ++L EY+  G+L + L    +  K+P      IA Q+ + ++YLH    
Sbjct: 65  YGAFYKEGEISIVL-EYMDGGSLADLLK---KVGKIPEPVLAYIARQILKGLDYLHT--K 118

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
            HI+H DIK SN+L+      K+ DFG       S VL  +     +          +G+
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFG------ISKVLENTLDQCNT---------FVGT 163

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             Y  P  ++    S   D++S G+ LLE   G     P       S    ++  I D  
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGK---FPFLPPGQPSFF-ELMQAICDGP 219

Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                    P L  +    E R  +S    CL++ P  RPSA ++L
Sbjct: 220 P--------PSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (283), Expect = 7e-29
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 39/231 (16%)

Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDN 116
           F + +G G F  V L R   + D+T    A+K   H G ++    F++E++IL  L H+N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 117 IVKLIGYCDD--RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           IVK  G C+        L+ EY+P+G+L++ L       ++  +  +  + Q+ + ++YL
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYL 125

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP--------SPSPSPS 226
             +     +H D+ A NIL+E     K+ DFG AK      VLP          P  SP 
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAK------VLPEDKDYYYVKEPGESPI 176

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                          +  P  LRT   S+ +DV+SFGV L EL T  +   
Sbjct: 177 F--------------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 3e-28
 Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 28/216 (12%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV--FKQELDILLHLSHDNI 117
              +IG G F  VY    +N  T    AIK I +   +   +    QE+D+L +L H NI
Sbjct: 4   LGDLIGRGAFGVVYKG--LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI-AFQLAQAIEYLHE 176
           VK IG  +  D   ++ EY  NG+L++ +    +    P  + +A+  +Q+ Q + YLHE
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQIIK---KFGPFP-ESLVAVYVYQVLQGLAYLHE 117

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +    ++H DIKA+NIL  +    KL DFG A             +     S+    V  
Sbjct: 118 Q---GVIHRDIKAANILTTKDGVVKLADFGVA-------------TKLNDVSKDDASV-- 159

Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           +G+P +  P  +    AST +D++S G  ++EL+TG
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (262), Expect = 6e-26
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 37/242 (15%)

Query: 61  FSQVIGSGGFSNVYLARLI---NDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD 115
           F + +G G F  VY   L       ++T+ AIK        ++ Q F+QE +++  L H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-------------HGTPRSSKLPWRNRMA 162
           NIV L+G C       +LFEY+ +G L E L                   S L   + + 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP-PSP 221
           IA Q+A  +EYL      H VH D+ A N L+ E L  K+ DFG ++  +S+      S 
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPEN 280
           S  P R              +  P  +  G  +T++D++SFGV+L E+ + G++ +   +
Sbjct: 186 SLLPVR--------------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231

Query: 281 GQ 282
            Q
Sbjct: 232 NQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 8e-24
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 32/212 (15%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
               IG G F +V L            A+K        +Q F  E  ++  L H N+V+L
Sbjct: 10  LGATIGKGEFGDVMLGDYRGQKV----AVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL 65

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           +G     +   ++ EY+  G+L + L    R+  +    ++  A  + + +EYL E+   
Sbjct: 66  LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK--- 121

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAK---MGFSSAVLPPSPSPSPSRSRITKQVMMI 237
           + VH D+ A N+L+ E L  K+ DFG AK    G  S  LP                   
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK----------------- 164

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
               +T P  LR    STK+DV+SFG++L E+
Sbjct: 165 ----WTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 5e-23
 Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 29/213 (13%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V L R  +  T    A+K+     +   +  +    E +IL  ++H  IVKL
Sbjct: 1   LGKGSFGKVLLVRKKD--TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP-WRNRMAIAFQLAQAIEYLHERCT 179
                  ++  L+ EY P G L   L    +  +    R R   A ++  A+EYLH    
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAA-EIVLALEYLHS--- 111

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
           L I++ D+K  NILL+   + KL DFG AK   S      +                 G+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT---------------FCGT 156

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           P Y  P  L         D +S GV+L E++TG
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 96.3 bits (240), Expect = 5e-23
 Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 27/215 (12%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGA---IKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           IG G F  VY A  +N  T    A   I+I     +  +    E+ +L  L H N+VK  
Sbjct: 8   IGGGTFGKVYTA--VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 122 GYCDDRDEGVLLF-EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           G    R++ V +F EY   GTL+E L        L          QL + + YLH     
Sbjct: 66  GVEVHREK-VYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            IVH DIK +NI L+ +   KL DFG A               + + +   +   + G+P
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----------LKNNTTTMGEEVQSLAGTP 167

Query: 241 GYTDPHYLRTGMASTK---TDVYSFGVILLELVTG 272
            Y  P  +  G         D++S G ++LE+ TG
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 93.9 bits (234), Expect = 4e-22
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 35/224 (15%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLSQVFKQELDILLHLSHDNIVK 119
           I  G +  V+LA+    ST    AIK+      +  +++ QV   E DIL       +VK
Sbjct: 1   ISKGAYGRVFLAK--KKSTGDIYAIKVIKKADMIRKNQVDQVLT-ERDILSQAQSPYVVK 57

Query: 120 LIGYCDDRDEGVLLF--EYVPNGTLQEKLH--GTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           L  Y   + +  L    EY+P G L   L   G+     L          ++  A+EYLH
Sbjct: 58  L--YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVLALEYLH 110

Query: 176 ERCTLHIVHGDIKASNILL--EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
                 I+H D+K  NIL+    HL  KL DFG +K+G     +  +      + RI   
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHL--KLTDFGLSKVGLVRRQINLNDDEKEDK-RI--- 161

Query: 234 VMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAF 276
              +G+P Y  P  +  G   +KT D +S G IL E + G+  F
Sbjct: 162 ---VGTPDYIAPEVI-LGQGHSKTVDWWSLGCILYEFLVGIPPF 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.1 bits (232), Expect = 7e-22
 Identities = 78/290 (26%), Positives = 115/290 (39%), Gaps = 48/290 (16%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ---ELDILLHLSHDNIVK 119
            +G+G    V         T    A+K I +  +    + KQ   ELDIL   +   IV 
Sbjct: 8   ELGAGNSGVVSKVLHR--PTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVG 63

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYLHERC 178
             G   +  +  +  EY+  G+L + L         +P R    IA  + + + YLHE  
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHE-- 118

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
              I+H D+K SNIL+      KLCDFG S ++  S A                     +
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA------------------KTFV 160

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD 297
           G+  Y  P  ++    S K+D++S G+ L+EL TG   + PEN          +L  I +
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF--ELLQYIVN 218

Query: 298 CEATKVNELVDPRLAGD-FDLDEARAMLSIAALCLRQSPILRPSATQILH 346
                      PRL    F  D          LCL + P  RPS  ++L 
Sbjct: 219 EPP--------PRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G+G F  V++        +T  A+K         + F QE  I+  L HD +V+L   C
Sbjct: 14  LGAGQFGEVWMGTWNG---TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
            + +   ++ EY+  G+L + L  +    KL     + +A Q+A+ + YL  R   + +H
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 185 GDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTD 244
            D+ A NIL+ E+L CK+ DFG A++           +  P +              +T 
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK--------------WTA 172

Query: 245 PHYLRTGMASTKTDVYSFGVILLELVT 271
           P     G  + K+DV+SFG++L E+VT
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 89/311 (28%), Positives = 126/311 (40%), Gaps = 62/311 (19%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---QELDILLHLSHDNIVKL 120
           V+G G +  V   R  N +T    AIK    S+    V K   +E+ +L  L H+NIV L
Sbjct: 8   VVGEGAYGVVLKCR--NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                 +    L+FEYV   TL E L  +P    LP     +  +QL QAI Y H     
Sbjct: 66  KEAFRRKGRLYLVFEYVER-TLLELLEASPGG--LPPDAVRSYIWQLLQAIAYCHS---H 119

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV------ 234
           +I+H DIK  NIL+ E    KLCDFG A+              +   S +T  V      
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-----------ALRARPASPLTDYVATRWYR 168

Query: 235 ---MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN--GQLLTSLAG 289
              +++G   Y  P            DV++ G I+ EL+ G   F  ++   QL   L  
Sbjct: 169 APELLVGDTNYGKP-----------VDVWAIGCIMAELLDGEPLFPGDSDIDQL--YLIQ 215

Query: 290 SMLNDIADCEATKVNELVDPRLAG-------DFDLDEAR--AMLSIAAL-----CLRQSP 335
             L  +    + +     +PR AG         +  E R    +S  AL     CLR  P
Sbjct: 216 KCLGPLP--PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDP 273

Query: 336 ILRPSATQILH 346
             R +  ++L 
Sbjct: 274 KERLTCDELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 75/246 (30%), Positives = 117/246 (47%), Gaps = 45/246 (18%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDI 108
           W+D++     F  VIG G F  V  A +  D    N AIK+     S+   + F  EL++
Sbjct: 1   WEDIK-----FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV 55

Query: 109 LLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL---------------HGTPRS 152
           L  L  H NI+ L+G C++R    +  EY P G L + L               HGT  +
Sbjct: 56  LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT--A 113

Query: 153 SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF 212
           S L  +  +  A  +A  ++YL E+     +H D+ A N+L+ E+L  K+ DFG ++ G 
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-GE 169

Query: 213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT- 271
              V         +  R+  + M I S  Y+        + +TK+DV+SFGV+L E+V+ 
Sbjct: 170 EVYV-------KKTMGRLPVRWMAIESLNYS--------VYTTKSDVWSFGVLLWEIVSL 214

Query: 272 GMEAFC 277
           G   +C
Sbjct: 215 GGTPYC 220

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 55/293 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSD-----RLSQVFKQELDILLHLSHDN 116
           +++GSG F +VY    +N       A+K + +  D        +  +QE+ +L  L H N
Sbjct: 6   ELLGSGSFGSVYEG--LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IV+ +G   + D   +  E VP G+L  KL    +    P         Q+   +EYLH+
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSL-AKLLK--KYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM- 235
           R   + VH DIK +NIL++ +   KL DFG AK                   ++ +    
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK-------------------QVVEFSFA 158

Query: 236 --MIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
               GSP +  P  + + G      D++S G  +LE+ TG     P   QL      ++ 
Sbjct: 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK----PPWSQL--EGVAAVF 212

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             I     +K    +   L+     DEA+  +     CL++ P LRP+A ++L
Sbjct: 213 K-IGR---SKELPPIPDHLS-----DEAKDFIL---KCLQRDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 45/223 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR------LSQVFKQELDILLHLSHDN 116
           + IG G F +VY   L        G  ++ V + R      L + F QE +IL    H N
Sbjct: 1   EKIGKGNFGDVYKGVL-------KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPN 53

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IVKLIG C  +    ++ E VP G+L   L    + ++L  +  + ++   A  +EYL  
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +     +H D+ A N L+ E+   K+ DFG                     SR  +  + 
Sbjct: 112 KNC---IHRDLAARNCLVGENNVLKISDFG--------------------MSREEEGGIY 148

Query: 237 IGSPG-------YTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             S G       +T P  L  G  ++++DV+S+G++L E  + 
Sbjct: 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 90.2 bits (224), Expect = 8e-21
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ-VFKQELDILLHLSHDNIVKLIGY 123
           +GSG F  V+             AIKI    D L Q  F++E+  L  L H +++ L   
Sbjct: 14  LGSGYFGEVWEGLW---KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
           C   +   ++ E +  G+L   L  +P    LP  + + +A Q+A+ + YL E+   + +
Sbjct: 71  CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126

Query: 184 HGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYT 243
           H D+ A NIL+ E L CK+ DFG A+       L        S  +I  +        +T
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLAR-------LIKEDVYLSSDKKIPYK--------WT 171

Query: 244 DPHYLRTGMASTKTDVYSFGVILLELVT 271
            P     G  STK+DV+SFG++L E+ T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 73/314 (23%), Positives = 113/314 (35%), Gaps = 73/314 (23%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ----ELDILLHLSHDNIVKL 120
           IG G +  VY AR  +  T    AIK  +     S+   +    E+ +L  L+H NI+KL
Sbjct: 7   IGEGTYGVVYKAR--DKLTGEIVAIK-KIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           +     + +  L+FE++     +       R   LP     +  +QL Q + + H     
Sbjct: 64  LDVFRHKGDLYLVFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH--- 117

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV------ 234
            I+H D+K  N+L+      KL DFG A+             P       T  V      
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLAR------SFGSPVRP------YTHYVVTRWYR 165

Query: 235 ---MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF--------------- 276
              +++G  GY+           T  D++S G I  EL++    F               
Sbjct: 166 APELLLGDKGYS-----------TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214

Query: 277 ----CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR 332
                PE     TSLA +            + +L  P  +      +A  +LS     L 
Sbjct: 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF-PNAS-----PQALDLLS---QMLH 265

Query: 333 QSPILRPSATQILH 346
             P  R +A Q L 
Sbjct: 266 YDPHKRITAEQALA 279

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 48/242 (19%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKI--HVGSDRLSQVFKQELDI 108
           V+R T    + +G G F  V+L     L  ++     A+K      S+   + F++E ++
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL--HG-------TPRSSK--LPW 157
           L +  H+NIVK  G C + D  +++FEY+ +G L + L  HG       +P S    L  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS---- 213
              + IA Q+A  + YL    + H VH D+   N L+   L  K+ DFG ++  ++    
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 214 ----SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                 +LP    P                     P  +     +T++DV+SFGV+L E+
Sbjct: 179 RVGGHTMLPIRWMP---------------------PESIMYRKFTTESDVWSFGVVLWEI 217

Query: 270 VT 271
            T
Sbjct: 218 FT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 87.3 bits (216), Expect = 8e-20
 Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 48/292 (16%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             Q IGSG F  V+L   +        AIK         + F +E  +++ LSH  +V+L
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEK---RKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G C +R    L+FE++ +G L + L    +  K      + +   + + + YL      
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            ++H D+ A N L+ E+   K+ DFG  +          + +  P +             
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------------- 166

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP----ENGQLLTSLAGSMLNDIA 296
            ++ P        S+K+DV+SFGV++ E+ +  E   P     N +++ ++         
Sbjct: 167 -WSSPEVFSFSKYSSKSDVWSFGVLMWEVFS--EGKTPYENRSNSEVVETINAGF----- 218

Query: 297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
                    L  PRLA       ++++  +   C ++ P  RPS + +LH +
Sbjct: 219 --------RLYKPRLA-------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 86.7 bits (214), Expect = 2e-19
 Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 40/233 (17%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD-NIVKL 120
           VIG G F  V  AR+  D    + AIK      S    + F  EL++L  L H  NI+ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKL---------------HGTPRSSKLPWRNRMAIAF 165
           +G C+ R    L  EY P+G L + L               + T  +S L  +  +  A 
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST--ASTLSSQQLLHFAA 119

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
            +A+ ++YL ++     +H D+ A NIL+ E+   K+ DFG ++ G    V         
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV-------KK 168

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFC 277
           +  R+  + M I S  Y+        + +T +DV+S+GV+L E+V+ G   +C
Sbjct: 169 TMGRLPVRWMAIESLNYS--------VYTTNSDVWSYGVLLWEIVSLGGTPYC 213

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 74/223 (33%), Positives = 105/223 (47%), Gaps = 36/223 (16%)

Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDN 116
           F Q +G G F +V L R   + D+T    A+K   H  ++ L + F++E++IL  L HDN
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL-RDFEREIEILKSLQHDN 66

Query: 117 IVKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           IVK  G C    R    L+ EY+P G+L++ L       +L  R  +  A Q+ + +EYL
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYL 124

Query: 175 HE-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
              R     VH D+   NIL+E     K+ DFG  K      VLP             K+
Sbjct: 125 GSKRY----VHRDLATRNILVESENRVKIGDFGLTK------VLPQD-----------KE 163

Query: 234 VMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              +  PG     +  P  L     S  +DV+SFGV+L EL T
Sbjct: 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 86/314 (27%), Positives = 135/314 (42%), Gaps = 64/314 (20%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK--IHVGSDRLSQVFKQELDI 108
           W+D++     F  VIG G F  V  AR+  D    + AIK      S    + F  EL++
Sbjct: 6   WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 109 LLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-------------PRSSK 154
           L  L  H NI+ L+G C+ R    L  EY P+G L + L  +               +S 
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L  +  +  A  +A+ ++YL ++     +H D+ A NIL+ E+   K+ DFG ++ G   
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEV 176

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GM 273
            V         +  R+  + M I S  Y+        + +T +DV+S+GV+L E+V+ G 
Sbjct: 177 YV-------KKTMGRLPVRWMAIESLNYS--------VYTTNSDVWSYGVLLWEIVSLGG 221

Query: 274 EAFCPEN-GQLLTSLA-GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
             +C     +L   L  G  L    +C+                  DE   ++     C 
Sbjct: 222 TPYCGMTCAELYEKLPQGYRLEKPLNCD------------------DEVYDLMR---QCW 260

Query: 332 RQSPILRPSATQIL 345
           R+ P  RPS  QIL
Sbjct: 261 REKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 69/288 (23%), Positives = 122/288 (42%), Gaps = 38/288 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIH----VGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+G G +  VY              +++     + +++  +  ++E+D+L  L H NIV
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           + +G C D +   +  E+VP G++   L+   R   LP         Q+   + YLH  C
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
              +VH DIK +N++L  +   KL DFG A ++ +             + S + K   M 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL--------HGTHSNMLKS--MH 169

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD 297
           G+P +  P  +       K+D++S G  + E+ TG                 + ++ +A 
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL-------------ASMDRLAA 216

Query: 298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                 +  + PRL   F    + A +     CL +    RPSA Q+L
Sbjct: 217 MFYIGAHRGLMPRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 82.6 bits (204), Expect = 5e-18
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 28/219 (12%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           V+G G +  VY AR  + ST    AIK I     R  Q   +E+ +  +L H NIV+ +G
Sbjct: 15  VLGKGTYGIVYAAR--DLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR-NRMAIAF---QLAQAIEYLHERC 178
              +     +  E VP G+L   L    RS   P + N   I F   Q+ + ++YLH+  
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKYLHD-- 126

Query: 179 TLHIVHGDIKASNILLEEHLN-CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
              IVH DIK  N+L+  +    K+ DFG++K    + + P + + + +   +  +V+  
Sbjct: 127 -NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMAPEVIDK 183

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G  GY  P            D++S G  ++E+ TG   F
Sbjct: 184 GPRGYGAP-----------ADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.5 bits (204), Expect = 6e-18
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 28/219 (12%)

Query: 64  VIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIV 118
            +G G F  V+LA+      +   T   +K       + L   F++ELD+   LSH N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRN-----RMAIAFQLAQAIE 172
           +L+G C + +   ++ EY   G L++ L  T  +  KL         ++A+  Q+A  ++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           +L        VH D+ A N L+      K+     +K  ++S       +  P R     
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----- 183

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  P  ++    STK+DV+SFGV++ E+ T
Sbjct: 184 ---------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.7 bits (204), Expect = 6e-18
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 35/225 (15%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V+LA   N S  T   + + V + +   +     F++E ++L +L H++IVK
Sbjct: 13  LGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLH-----------GTPRSSK--LPWRNRMAIAFQ 166
             G C D D  +++FEY+ +G L + L            G PR +K  L     + IA Q
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           +A  + YL  +   H VH D+   N L+  +L  K+ DFG ++  +S+            
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-----------D 177

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             R+    M+     +  P  +     +T++DV+SFGVIL E+ T
Sbjct: 178 YYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 6e-18
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 30/231 (12%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHV--------GSDR---LSQVFKQELDILLHL 112
           +IGSG F +VYL   +N S+    A+K  V          DR   +     +E+ +L  L
Sbjct: 7   LIGSGSFGSVYLG--MNASSGELMAVK-QVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+NIV+ +G   D D   +  EYVP G++   L+      +   RN +    Q+ + + 
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLN 120

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YLH R    I+H DIK +NIL++     K+ DF     G S  +   S S   + +R + 
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDF-----GISKKLEANSLSTKTNGARPSL 172

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
           Q    GS  +  P  ++    + K D++S G +++E++TG   F P+  QL
Sbjct: 173 Q----GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-PDCTQL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 81/298 (27%), Positives = 123/298 (41%), Gaps = 61/298 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDNIVK 119
           + IG G F  VY A  I+  T+   AIK+       D +  + +QE+  L       I K
Sbjct: 7   ECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDI-QQEIQFLSQCRSPYITK 63

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF---QLAQAIEYLHE 176
             G      +  ++ EY   G+  + L    +  KL   +   IAF   ++   +EYLHE
Sbjct: 64  YYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKL---DETYIAFILREVLLGLEYLHE 116

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
                 +H DIKA+NILL E  + KL DFG S ++                 S ++K+  
Sbjct: 117 EGK---IHRDIKAANILLSEEGDVKLADFGVSGQL----------------TSTMSKRNT 157

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM--LN 293
            +G+P +  P  ++      K D++S G+  +EL  G     P    L       M  L 
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE----PPLSDL-----HPMRVLF 208

Query: 294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ 351
            I             P L G+      +  +S   LCL + P  RPSA ++L   KH+
Sbjct: 209 LIPKNNP--------PSLEGNKFSKPFKDFVS---LCLNKDPKERPSAKELL---KHK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 63/238 (26%), Positives = 92/238 (38%), Gaps = 52/238 (21%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK---IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           IG G +  VY AR  N  T    A+K   +    +       +E+ +L  L H NIV+L 
Sbjct: 7   IGEGTYGQVYKAR--NKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 122 GYCDDRDEG--VLLFEYVP---NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
                + +G   ++FEY+     G L           K           QL + ++YLH 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSP------EVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV-- 234
                I+H DIK SNIL+      KL DFG A+           P    + +  T +V  
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLAR-----------PYTKRNSADYTNRVIT 164

Query: 235 -------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC--PENGQL 283
                  +++G+  Y             + D++S G IL EL  G   F    E  QL
Sbjct: 165 LWYRPPELLLGATRYG-----------PEVDMWSVGCILAELFLGKPIFQGSTELEQL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 28/216 (12%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G GGF  V L ++ + + +   A+K     H+      +    E +IL   +H  IVKL
Sbjct: 1   LGVGGFGRVELVKVKSKNRTF--ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                D+    +L EY   G L   L       +  +  R  IA  +  A EYLH R   
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARFYIA-CVVLAFEYLHNR--- 112

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            I++ D+K  N+LL+ +   KL DFG AK                      K     G+P
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK----------------KLKSGQKTWTFCGTP 156

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            Y  P  +         D +S G++L EL+TG   F
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 82.2 bits (203), Expect = 7e-18
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 23/221 (10%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILL 110
           W+ V R T    + +G+G F  V++         T  AIK         + F  E +++ 
Sbjct: 1   WE-VPRETLKLVKKLGAGQFGEVWMGYYNG---HTKVAIKSLKQGSMSPEAFLAEANLMK 56

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
            L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL     + +A Q+A+ 
Sbjct: 57  QLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPEGIKLTINKLIDMAAQIAEG 114

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
           + ++  +   + +H D++A+NIL+ E L CK+ DFG A++   +       +  P +   
Sbjct: 115 MAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK--- 168

Query: 231 TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 169 -----------WTAPEAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           Q IGSG + +VY AR I   T    AIK+      D    + +QE+ +L    H NIV  
Sbjct: 9   QRIGSGTYGDVYKARDIA--TGELVAIKVIKLEPGDDFEII-QQEISMLKECRHPNIVAY 65

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G    RD+  ++ EY   G+LQ+    T     L       +  +  + + YLHE    
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYLHET--- 120

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
             +H DIK +NILL E  + KL DFG       SA L  +         I K+   IG+P
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFG------VSAQLTAT---------IAKRKSFIGTP 165

Query: 241 GYTDPHYL---RTGMASTKTDVYSFGVILLEL 269
            +  P      R G    K D+++ G+  +EL
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.3 bits (203), Expect = 9e-18
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 25/215 (11%)

Query: 63  QVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+G G F  V L      ND T    A+K        + +  +K+E++IL  L H+NIV
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 119 KLIGYCDDR-DEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           K  G C ++  +G+ L  EYVP G+L++ L   P+  KL     +  A Q+ + + YLH 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PK-HKLNLAQLLLFAQQICEGMAYLHS 125

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +   H +H D+ A N+LL+     K+ DFG AK       +P        R      V  
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAK------AVPEGHEYYRVREDGDSPVF- 175

Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +     L+    S  +DV+SFGV L EL+T
Sbjct: 176 -----WYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 36/228 (15%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILL 110
           W+ ++R +    + +G+G F  V+   L N++T    A+K         + F  E  I+ 
Sbjct: 1   WE-IDRTSIQLLRKLGAGQFGEVW-EGLWNNTTPV--AVKTLKPGTMDPKDFLAEAQIMK 56

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMAIAFQLAQ 169
            L H  +++L   C   +   ++ E +  G+L E L G   R+ KLP    + +A Q+A 
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLP--QLIDMAAQVAS 114

Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
            + YL  +   + +H D+ A N+L+ E+  CK+ DFG A                    R
Sbjct: 115 GMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA--------------------R 151

Query: 230 ITKQVMMIGSPG------YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           + K+ +     G      +T P        S K+DV+SFG++L E+VT
Sbjct: 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 67/251 (26%), Positives = 106/251 (42%), Gaps = 40/251 (15%)

Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L H NIVKLIG C       L+ EY+    L E L        L W  R  IA  +A+A+
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKAL 793

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
            +LH RC+  +V G++    I+++      L             +  P          + 
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR------------LSLPGL--------LC 833

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
                  S  Y  P    T   + K+D+Y FG+IL+EL+TG      E G     + GS+
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-----VHGSI 888

Query: 292 LN----DIADCEATKVNELVDPRLAGDFDLDEARAM--LSIAALCLRQSPILRPSATQIL 345
           +       +DC    ++  +DP + GD  +++   +  +++A  C    P  RP A  +L
Sbjct: 889 VEWARYCYSDCH---LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945

Query: 346 HTIKHQISSIS 356
            T++    S S
Sbjct: 946 KTLESASRSSS 956

Length = 968

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 58/219 (26%), Positives = 84/219 (38%), Gaps = 38/219 (17%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLSQVFKQELDILLHLSHDNI 117
           +VIG G F  V + +   D T    A+K       V    +  V   E  IL  L+H  +
Sbjct: 6   RVIGKGAFGKVCIVQK-RD-TKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNHPFL 62

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           V L     D +   L+ + +  G L     +K+  +    K           ++  A+EY
Sbjct: 63  VNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLALEY 115

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH +    I+H DIK  NILL+E  +  + DF  A        + P           T  
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK------VTPD----------TLT 156

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
               G+PGY  P  L     S   D +S GV   E + G
Sbjct: 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 65/285 (22%), Positives = 109/285 (38%), Gaps = 45/285 (15%)

Query: 65  IGSGGFSNVYLA-RLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           IG G F  V+   R  +        I +   + R  +    E  +L  L    I++    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 124 CDDRDEGVLLFEYVPNGTLQEKLH---GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             D+ +  ++ EY  NG L + L    G P      WR       Q+   + +LH +   
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAHLHSK--- 120

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            I+H DIK+ N+ L+ + N K+ D G AK+   +     +               ++G+P
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT---------------IVGTP 165

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA 300
            Y  P        + K+DV++ GV+L E  TG   F   N        G+++  I     
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-------QGALILKIIRGVF 218

Query: 301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             V+++   +LA             +   CL +    RP   Q+L
Sbjct: 219 PPVSQMYSQQLA------------QLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 32/223 (14%)

Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V+LA    L+ +      A+K +   S+   Q F++E ++L  L H +IV+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRS----------SKLPWRNRMAIAFQLA 168
            G C +    +++FEY+ +G L   L  HG               +L     +AIA Q+A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
             + YL    +LH VH D+   N L+ + L  K+ DFG ++  +S+              
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-----------DYY 178

Query: 229 RITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           R+  + M+     +  P  +     +T++D++SFGV+L E+ T
Sbjct: 179 RVGGRTML--PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 52/304 (17%)

Query: 61  FSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLS--QVFKQELDILLHL-SH 114
           F + +G+G F  V  A    L         A+K+   +   S  +    EL I+ HL +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +NIV L+G C      +++ EY   G L   L    R S L   + ++ ++Q+A+ + +L
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--MGFSSAVLPPSPSPSPSRSRITK 232
             +   + +H D+ A N+LL      K+CDFG A+  M  S+ V           +R+  
Sbjct: 158 ASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV-------VKGNARLPV 207

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           + M         P  +   + + ++DV+S+G++L E+                SL  +  
Sbjct: 208 KWMA--------PESIFNCVYTFESDVWSYGILLWEIF---------------SLGSNPY 244

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDE----ARAMLSIAALCLRQSPILRPSATQILHTI 348
             +       V+      +   + + +       +  I   C    P+ RP+  QI+  I
Sbjct: 245 PGMP------VDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298

Query: 349 KHQI 352
             Q+
Sbjct: 299 GKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 73/304 (24%), Positives = 113/304 (37%), Gaps = 84/304 (27%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
            +G G + +VY A  I+  T    AIK+ V  +   Q   +E+ IL       IVK  G 
Sbjct: 10  KLGEGSYGSVYKA--IHKETGQVVAIKV-VPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
                +  ++ EY   G++ + +  T ++  L      AI +Q  + +EYLH       +
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHSN---KKI 121

Query: 184 HGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           H DIKA NILL E    KL DFG S ++  + A                K+  +IG+P +
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA----------------KRNTVIGTPFW 165

Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATK 302
             P  ++    + K D++S G+  +E+                                 
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMA-------------------------------- 193

Query: 303 VNELVDPRLAGDFDLDEARAMLSI---------------------AALCLRQSPILRPSA 341
             E   P      D+   RA+  I                        CL + P  RPSA
Sbjct: 194 --EGKPPY----SDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSA 247

Query: 342 TQIL 345
            Q+L
Sbjct: 248 IQLL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 66/241 (27%), Positives = 99/241 (41%), Gaps = 59/241 (24%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-HVGSDRLSQVFKQELDILLHLS-HDNIVKL 120
           +VIG G +  VY AR  +  T    AIKI  +  D   ++ K+E +IL   S H NI   
Sbjct: 12  EVIGEGTYGKVYKAR--HKKTGQLVAIKIMDIIEDEEEEI-KEEYNILRKYSNHPNIATF 68

Query: 121 IG------YCDDRDEGVLLFEYVPNGT---LQEKLHGTPRSSKLPWRNRMAIAF---QLA 168
            G         + D+  L+ E    G+   L + L    +  K  W     IA+   +  
Sbjct: 69  YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETL 123

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSR 227
           + + YLHE     ++H DIK  NILL ++   KL DFG SA++                 
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----------------D 164

Query: 228 SRITKQVMMIGSP-----------GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           S + ++   IG+P              D  Y        ++DV+S G+  +EL  G    
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASY------DARSDVWSLGITAIELADGKPPL 218

Query: 277 C 277
           C
Sbjct: 219 C 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 19/176 (10%)

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
           F +E  ++  + H N+V+L+G C       ++ E++  G L + L    R   +     +
Sbjct: 49  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLL 107

Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP 221
            +A Q++ A+EYL ++   + +H D+ A N L+ E+   K+ DFG +++         + 
Sbjct: 108 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164

Query: 222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
           +  P +              +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 165 AKFPIK--------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 63/296 (21%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ----ELDILLHLSHDNIV 118
           +V+G G F    L R   D +      K  V   RLS+  ++    E+ IL  L H NI 
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLV--VWK-EVNLTRLSEKERRDALNEIVILSLLQHPNI- 61

Query: 119 KLIGYCDD-RDEGVLL--FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA--FQLAQAIEY 173
             I Y +   D+  LL   EY   GTL +K+    R     +   M +   FQ+  A+ Y
Sbjct: 62  --IAYYNHFMDDNTLLIEMEYANGGTLYDKIV---RQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK-MGFSSAVLPPSPSPSPSRSRITK 232
           +H+     I+H DIK  NI L +    KL DFG +K +G                S  + 
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG----------------SEYSM 157

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
              ++G+P Y  P   +    + K+D+++ G +L EL+T    F                
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF---------------- 201

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEAR---AMLSIAALCLRQSPILRPSATQIL 345
                 +AT    LV   + G++    +     ++S+    L+Q P  RP+A ++L
Sbjct: 202 ------DATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 37/289 (12%)

Query: 65  IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIG 122
           IG G FS VY A  L++        ++I    D +  Q   +E+D+L  L H N++K + 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL-PWRNRMAIAFQLAQAIEYLHERCTLH 181
              + +E  ++ E    G L   +    +  +L P R       QL  A+E++H +    
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           I+H DIK +N+ +      KL D G  +  FS              S+ T    ++G+P 
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRF-FS--------------SKTTAAHSLVGTPY 171

Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEAT 301
           Y  P  +     + K+D++S G +L E+      F  +   L      S+   I  C+  
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKKIEKCDY- 225

Query: 302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
                  P L  D   +E R    + + C+   P  RP  + +L   K 
Sbjct: 226 -------PPLPADHYSEELR---DLVSRCINPDPEKRPDISYVLQVAKE 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 57/296 (19%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSDRLSQVFKQELDILLHLSHDN 116
              + IG G    VY A       +T    AIK + +       +   E+ I+    H N
Sbjct: 22  KNLEKIGEGASGEVYKAT----DRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA-IAFQLAQAIEYLH 175
           IV         DE  ++ EY+  G+L + +         P   ++A +  ++ Q +EYLH
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP---QIAYVCREVLQGLEYLH 133

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
              + +++H DIK+ NILL +  + KL DFG A      A L      +  +S   K+  
Sbjct: 134 ---SQNVIHRDIKSDNILLSKDGSVKLADFGFA------AQL------TKEKS---KRNS 175

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG----MEAFCPENGQLLTSLAGSM 291
           ++G+P +  P  ++      K D++S G++ +E+  G    +    P     L +  G  
Sbjct: 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKG-- 232

Query: 292 LNDIADCEATKVNELVDP-RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
                      +  L +P + + +F              CL + P  RPSA ++L 
Sbjct: 233 -----------IPPLKNPEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 51/179 (28%), Positives = 73/179 (40%), Gaps = 42/179 (23%)

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN--GTLQEKLHGTPRSSKLPWRNRMA 162
           E+ +L  L H NIVKL+       +  L+FEY         +K     R   L      +
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDK-----RPGPLSPNLIKS 102

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           I +QL + + Y H      I+H D+K  NIL+      KL DFG A+  F          
Sbjct: 103 IMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR-AFG--------- 149

Query: 223 PSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             P R   T +V+         ++GS  Y           ST  D++S G I  E++TG
Sbjct: 150 -IPLR-TYTHEVVTLWYRAPEILLGSKHY-----------STAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 23/213 (10%)

Query: 63  QVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNIVK 119
           +VIG G F  V   RL +      + AIK +  G SD+    F  E  I+    H NI++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G        +++ EY+ NG+L + L       K      + +   +A  ++YL E   
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
              VH D+ A NIL+  +L CK+ DFG S ++  S A         P R           
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----------- 173

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              +T P  +     ++ +DV+SFG+++ E+++
Sbjct: 174 ---WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 34/219 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-------QVFKQELDILLHLSHD 115
           +++G G F  VYL    +  T    A+K  V  D  S          + E+ +L +L H+
Sbjct: 8   KLLGQGAFGRVYLC--YDVDTGRELAVK-QVPFDPDSPETKKEVNALECEIQLLKNLQHE 64

Query: 116 NIVKLIGYCDDRDEGVLLF-EYVPNGTLQE--KLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            IV+  G C   DE + +F EY+P G++++  K +G    +      R     Q+ + +E
Sbjct: 65  RIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVE 118

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YLH      IVH DIK +NIL +   N KL DFG++K                  S  T 
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK------------RLQTICSSGTG 163

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              + G+P +  P  +       K DV+S G  ++E++T
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 21/207 (10%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G+G F  V++    N   ST  A+K         Q F +E +++  L HD +V+L    
Sbjct: 14  LGAGQFGEVWMGYYNN---STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
              +   ++ EY+  G+L + L  +    K+     +  + Q+A+ + Y+  +   + +H
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIH 126

Query: 185 GDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTD 244
            D++A+N+L+ E L CK+ DFG A++   +       +  P +              +T 
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK--------------WTA 172

Query: 245 PHYLRTGMASTKTDVYSFGVILLELVT 271
           P  +  G  + K+DV+SFG++L E+VT
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 32/213 (15%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI-G 122
           +G G F  VY A+  +  T    A K I + S+   + F  E+DIL    H NIV L   
Sbjct: 13  LGDGAFGKVYKAQ--HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y  +    +L+ E+   G L   +    R    P      +  Q+ +A+ +LH      +
Sbjct: 71  YFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIR--YVCRQMLEALNFLHSH---KV 124

Query: 183 VHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           +H D+KA NILL    + KL DFG SAK                ++S + K+   IG+P 
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAK----------------NKSTLQKRDTFIGTPY 168

Query: 242 YTDPHYLRTGMAST-----KTDVYSFGVILLEL 269
           +  P  +            K D++S G+ L+EL
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 73/296 (24%), Positives = 126/296 (42%), Gaps = 58/296 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHD---N 116
           ++IG G +  VY  R  +  T    A+KI       D +S + + E+ +L  L      N
Sbjct: 7   ELIGRGAYGAVY--RGKHVPTGRVVALKIINLDTPDDDVSDIQR-EVALLSQLRQSQPPN 63

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I K  G         ++ EY   G+++  +    ++  +  +    I  ++  A++Y+H+
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHK 119

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
              + ++H DIKA+NIL+    N KLCDFG A      A+L        S  R T     
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVA------ALL-----NQNSSKRST----F 161

Query: 237 IGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
           +G+P +  P  +  G    TK D++S G+ + E+ TG   +                   
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS------------------ 203

Query: 296 ADCEATKVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
            D +A +   L+     PRL  +     ++ +    A CL + P  R SA ++L +
Sbjct: 204 -DVDAFRAMMLIPKSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 68/260 (26%), Positives = 102/260 (39%), Gaps = 38/260 (14%)

Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPW 157
           Q+ + EL+I        IVK  G   D     +    EY   G+L + ++   +      
Sbjct: 45  QILR-ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRI 102

Query: 158 RNRMA--IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSS 214
             ++   IA  + + + YLH R    I+H DIK SNILL      KLCDFG S ++  S 
Sbjct: 103 GEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
           A                      G+  Y  P  ++    S  +DV+S G+ LLE+     
Sbjct: 160 A------------------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF 201

Query: 275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQS 334
            F PE    L  +   +L+ I +       EL D        +  +         CL + 
Sbjct: 202 PFPPEGEPPLGPI--ELLSYIVN---MPNPELKDEP---GNGIKWSEEFKDFIKQCLEKD 253

Query: 335 PILRPSATQIL-HT-IKHQI 352
           P  RP+   +L H  IK Q+
Sbjct: 254 PTRRPTPWDMLEHPWIKAQM 273

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 76.3 bits (188), Expect = 5e-16
 Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 63/294 (21%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ----ELDILLHLSHDNIVK 119
           +G G + +VY  + ++D+     A+K + +GS  +SQ  ++    E+ IL  ++H NI  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFY--ALKEVDLGS--MSQKEREDAVNEIRILASVNHPNI-- 61

Query: 120 LIGYCD---DRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
            I Y +   D ++  ++ EY P G L     + K        +  WR    I  QL + +
Sbjct: 62  -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
           + LHE+    I+H D+K++NILL  +   K+ D G +K+                +  + 
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV---------------LKKNMA 158

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
           K    IG+P Y  P   +    S K+D++S G +L E+ T    F     + +  L    
Sbjct: 159 KTQ--IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF---EARSMQDL---- 209

Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                     KV     P +   +  D    + +     L+  P LRP+  +IL
Sbjct: 210 --------RYKVQRGKYPPIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.2 bits (187), Expect = 6e-16
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 34/211 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IG G F +V    ++ D      A+K  + +D  +Q F  E  ++  L H N+V+L+G
Sbjct: 12  QTIGKGEFGDV----MLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 123 YCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +   G+ ++ EY+  G+L + L    RS  L     +  +  + +A+EYL      +
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---N 122

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFS---SAVLPPSPSPSPSRSRITKQVMMIG 238
            VH D+ A N+L+ E    K+ DFG  K   S   +  LP                    
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------------------ 164

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
              +T P  LR    STK+DV+SFG++L E+
Sbjct: 165 ---WTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.9 bits (189), Expect = 7e-16
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 25/220 (11%)

Query: 65  IGSGGFSNVYLARLI--NDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHDNIVKL 120
           +G G F  V L R     D+T    A+K        + +   K+E++IL +L H+NIVK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 121 IGYC-DDRDEGV-LLFEYVPNGTLQEKLHGTPRS-SKLPWRNRMAIAFQLAQAIEYLHER 177
            G C +D   G+ L+ E++P+G+L+E L   PR+ +K+  + ++  A Q+ + ++YL  R
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
                VH D+ A N+L+E     K+ DFG  K            +    +   T +  + 
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTK------------AIETDKEYYTVKDDLD 173

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
               +  P  L        +DV+SFGV L EL+T  ++  
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 32/233 (13%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG---AIK-IHVGSDRLSQVFKQELDIL 109
           ++R      + +G G F  V+LA   N     +    A+K +   SD   + F +E ++L
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-----------HGTPRSSKLPWR 158
            +L H++IVK  G C + D  +++FEY+ +G L + L            G    ++L   
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR-PAELTQS 120

Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP 218
             + IA Q+A  + YL  +   H VH D+   N L+ E+L  K+ DFG ++  +S+    
Sbjct: 121 QMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST---- 173

Query: 219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     R+    M+     +  P  +     +T++DV+S GV+L E+ T
Sbjct: 174 -------DYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 76/300 (25%), Positives = 114/300 (38%), Gaps = 64/300 (21%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAI----KIHVGSDRLSQVFKQ----ELDILLHLSHD 115
            IG G F  V   R  +D     G I    +I  G+  +++  KQ    E++IL  L H 
Sbjct: 7   TIGKGSFGTVRKVRRKSD-----GKILVWKEIDYGN--MTEKEKQQLVSEVNILRELKHP 59

Query: 116 NIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKL-HGTPRSSKLP----WRNRMAIAFQLA 168
           NIV+      DR    L  + EY   G L + +         +     WR    I  QL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLL 115

Query: 169 QAIEYLHERCTLH--IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
            A+   H R      ++H D+K +NI L+ + N KL DFG AK+                
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-------------LGH 162

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN-GQLLT 285
            S   K    +G+P Y  P  L       K+D++S G ++ EL      F   N  QL +
Sbjct: 163 DSSFAKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS 220

Query: 286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
            +       I    ++++NE++                       L   P  RPS  ++L
Sbjct: 221 KIKEGKFRRIPYRYSSELNEVI--------------------KSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 51/227 (22%), Positives = 104/227 (45%), Gaps = 45/227 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-------IHVGSDRLSQVFKQELDILLHLSHD 115
           Q +G+G FS+ Y AR +   T T  A+K            + + +  ++E+ ++  L+H 
Sbjct: 6   QQLGTGAFSSCYQARDV--KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQAIEY 173
           +I++++G   +     L  E++  G++   L          ++  + I +  QL + + Y
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSY 118

Query: 174 LHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSR 229
           LHE     I+H D+K +N+L++   + L  ++ DFG+A ++                 ++
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLA----------------AK 157

Query: 230 ITK----QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
            T     Q  ++G+  +  P  LR        DV+S G +++E+ T 
Sbjct: 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 43/237 (18%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQV--FKQELD 107
           DD+ER      + +G+G F  V+L R  +  +    A+K+    +  RL Q      E  
Sbjct: 1   DDLER-----IKTVGTGTFGRVHLVR--DRISEHYYALKVMAIPEVIRLKQEQHVHNEKR 53

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
           +L  +SH  I++L  +  + D+  L  L EYVP G L   L  + R S     N   + +
Sbjct: 54  VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS-----NSTGLFY 106

Query: 166 --QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
             ++  A+EYLH   +  IV+ D+K  NILL++  + KL DFG AK              
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-------------- 149

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                   +   + G+P Y  P  +++   +   D ++ G+++ E++ G   F  +N
Sbjct: 150 ----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 43/238 (18%)

Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVK 119
           IG G F  V+ AR   L+     T  A+K+     S  +   F++E  ++    H NIVK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKL-----HGTPRSSKLPWRNR-------------- 160
           L+G C       LLFEY+  G L E L           S      R              
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           + IA Q+A  + YL ER     VH D+   N L+ E++  K+ DFG ++  +S+     S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 221 PSPS-PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
            + + P R              +  P  +     +T++DV+++GV+L E+ + GM+ +
Sbjct: 190 ENDAIPIR--------------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 62/249 (24%), Positives = 110/249 (44%), Gaps = 25/249 (10%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +V+G G F  V+L R   D        I +   +       + E  +L  LSH NI++  
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 122 -GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             + +D+   +++ EY P GTL E +     +S L     +    Q+  A+ ++H +   
Sbjct: 66  ENFLEDKALMIVM-EYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK--- 120

Query: 181 HIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
            I+H D+K  NILL++H    K+ DFG +K+  S                 +K   ++G+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK----------------SKAYTVVGT 164

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN-GQLLTSLAGSMLNDIADC 298
           P Y  P        + K+D+++ G +L EL +   AF   N   L+  +       I+D 
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR 224

Query: 299 EATKVNELV 307
            +  + +L+
Sbjct: 225 YSPDLRQLI 233

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 28/201 (13%)

Query: 83  TSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKLI--GYCDDRDEGVL--LF 134
           T    AIK+        +     F++E  +   L H NIV L+  G       G+L  +F
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP---GLLFAVF 58

Query: 135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL 194
           EYVP  TL+E L        LP      +  Q+  A+   H +    IVH D+K  NI++
Sbjct: 59  EYVPGRTLREVLAA---DGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112

Query: 195 EE---HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG 251
            +     + K+ DFG         +LP         + +T+   ++G+P Y  P  LR  
Sbjct: 113 SQTGVRPHAKVLDFGI------GTLLPGVRDAD--VATLTRTTEVLGTPTYCAPEQLRGE 164

Query: 252 MASTKTDVYSFGVILLELVTG 272
             +  +D+Y++G+I LE +TG
Sbjct: 165 PVTPNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 24/220 (10%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ R +    + +G+G F  V++      + +T  A+K         + F +E  I+  L
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTW---NGNTKVAVKTLKPGTMSPESFLEEAQIMKKL 58

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-GTPRSSKLPWRNRMAIAFQLAQAI 171
            HD +V+L     +    ++  EY+  G+L + L  G  R+ KLP  N + +A Q+A  +
Sbjct: 59  RHDKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGM 115

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
            Y+ ER  ++ +H D++++NIL+ + L CK+ DFG A++   +       +  P +    
Sbjct: 116 AYI-ER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK---- 168

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     +T P     G  + K+DV+SFG++L ELVT
Sbjct: 169 ----------WTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 41/291 (14%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ----ELDILLHLSHDNIVKL 120
           IG G FS VY A  + D      A+K     D +    +     E+D+L  L+H N++K 
Sbjct: 10  IGRGQFSEVYRATCLLDGVPV--ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL-PWRNRMAIAFQLAQAIEYLHERCT 179
                + +E  ++ E    G L   +    +  +L P +       QL  A+E++H R  
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-- 125

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
             ++H DIK +N+ +      KL D G  +  FSS              + T    ++G+
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSS--------------KTTAAHSLVGT 169

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
           P Y  P  +     + K+D++S G +L E+             L +   G  +N  + C+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-----------LQSPFYGDKMNLYSLCK 218

Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
             K+ +   P L  D   +E R +++   +C+   P  RP  T +    K 
Sbjct: 219 --KIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKR 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 32/221 (14%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSHDNIVK 119
           +G GG+  V+LA+     T    A+K    S     + +  V   E DIL     + +VK
Sbjct: 9   VGQGGYGQVFLAK--KKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTTTKSEWLVK 65

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L+    D +   L  EYVP G  +  L+     S+   R  MA   ++ +A++ LHE   
Sbjct: 66  LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA---EMFEAVDALHE--- 119

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
           L  +H D+K  N L++   + KL DFG +K                    +T    ++GS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGI------------------VTYANSVVGS 161

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
           P Y  P  LR        D +S G +L E + G   F    
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 38/224 (16%)

Query: 63  QVIGSGGFSNVYLARLI---NDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNI 117
           + +G G F  VY         D+     A+K      S++    F  E  I+   +H NI
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKL-HGTPR---SSKLPWRNRMAIAFQLAQAIEY 173
           V+LIG   +R    +L E +  G L+  L    PR    S L  ++ +  A  +A+  +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNC-------KLCDFGSAKMGFSSAVLPPSPSPSPS 226
           L E    H +H DI A N L    L C       K+ DFG A+  + +           S
Sbjct: 132 LEEN---HFIHRDIAARNCL----LTCKGPGRVAKIADFGMARDIYRA-----------S 173

Query: 227 RSRITKQVMMIGSP-GYTDPHYLRTGMASTKTDVYSFGVILLEL 269
             R   + M+   P  +  P     G+ ++KTDV+SFGV+L E+
Sbjct: 174 YYRKGGRAML---PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 54/188 (28%), Positives = 86/188 (45%), Gaps = 37/188 (19%)

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-------------GTPR 151
           E ++L  ++H +++KL G C      +L+ EY   G+L+  L              G   
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 152 SSKL------PWRNRMAIAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC 203
           SS L             I+F  Q+++ ++YL E   + +VH D+ A N+L+ E    K+ 
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKIS 169

Query: 204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFG 263
           DF     G S  V         S+ RI  + M I S        L   + +T++DV+SFG
Sbjct: 170 DF-----GLSRDVYEEDSYVKRSKGRIPVKWMAIES--------LFDHIYTTQSDVWSFG 216

Query: 264 VILLELVT 271
           V+L E+VT
Sbjct: 217 VLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 69/259 (26%), Positives = 105/259 (40%), Gaps = 38/259 (14%)

Query: 91  IHVGSDRLSQVFKQ---ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH 147
           +H+G+   S V KQ   EL I+       IV   G   + +   +  E++  G+L     
Sbjct: 38  VHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK 95

Query: 148 GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG- 206
              +   +P      IA  + + + YL+      I+H DIK SNIL+      KLCDFG 
Sbjct: 96  ---KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGV 150

Query: 207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVIL 266
           S ++  S A                     +G+  Y  P  ++ G  + K+DV+S G+ +
Sbjct: 151 SGELINSIA------------------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISI 192

Query: 267 LELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRL-AGDFDLDEARAMLS 325
           +EL  G   F   +          M   I D     V E   PRL + DF  D  R  + 
Sbjct: 193 IELALGKFPF-AFSNIDDDGQDDPM--GILDLLQQIVQE-PPPRLPSSDFPED-LRDFVD 247

Query: 326 IAALCLRQSPILRPSATQI 344
               CL + P  RP+  Q+
Sbjct: 248 A---CLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 30/210 (14%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR------LSQVFKQELDILLHLSHDNIV 118
           IG G F  V+  RL  D+T       + V S R      L   F QE  IL   SH NIV
Sbjct: 3   IGRGNFGEVFSGRLRADNTP------VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +LIG C  +    ++ E V  G     L       +L  +  + +    A  +EYL  + 
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESK- 113

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
             H +H D+ A N L+ E    K+ DFG ++                + +   KQ+ +  
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY---------ASTGGMKQIPV-- 160

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
              +T P  L  G  S+++DV+SFG++L E
Sbjct: 161 --KWTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.3 bits (180), Expect = 7e-15
 Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 42/222 (18%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGA--------IKIHVGSDRLSQVFKQELDILLHLSHDN 116
           +G G F+N+Y   L   S              +K+     R S  F +   ++  LSH +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VKL G C  RDE +++ EYV  G L   LH    +  L W  ++ +A QLA A+ YL +
Sbjct: 63  LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 177 RCTLHIVHGDIKASNILLEEH-------LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
           +    +VHG++   NIL+  +          KL D G   +   S        P      
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-ITVLSREERVERIP------ 169

Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKT--DVYSFGVILLEL 269
                       +  P  +R G AS     D +SFG  LLE+
Sbjct: 170 ------------WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 33/221 (14%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQEL---DILL--HLSHDNIVK 119
           IG G    VY A  I+ +T    AIK       L Q  K+EL   +IL+     H NIV 
Sbjct: 27  IGQGASGTVYTA--IDVATGQEVAIK----QMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
            +      DE  ++ EY+  G+L + +  T     +      A+  +  QA+E+LH    
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN-- 134

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
             ++H DIK+ NILL    + KL DFG     F + + P            +K+  M+G+
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPEQ----------SKRSTMVGT 178

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
           P +  P  +       K D++S G++ +E+V G   +  EN
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 32/221 (14%)

Query: 65  IGSGGFSNVY---LARLINDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHDNIVK 119
           +G G F  VY      ++     T  AIK    +  + +   F  E  ++   +  ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI--------AFQLAQAI 171
           L+G        +++ E +  G L+  L    R                    A ++A  +
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
            YL  +     VH D+ A N ++ E L  K+ DFG  +  + +              R  
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET-----------DYYRKG 178

Query: 232 KQVMMIGSP-GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            + ++   P  +  P  L+ G+ +TK+DV+SFGV+L E+ T
Sbjct: 179 GKGLL---PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 65/239 (27%), Positives = 95/239 (39%), Gaps = 32/239 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGSDRL----SQVFKQELDILLHLSHDNI 117
           +VIG G F  V+L R   D  +    A+K+   SD +        + E DIL       I
Sbjct: 7   KVIGRGAFGEVWLVR---DKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI 63

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VKL     D +   L+ EY+P G L   L               R  IA +L  A++ +H
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA----RFYIA-ELVLALDSVH 118

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--------MGFSSAVLPPSPSPSPSR 227
           +   L  +H DIK  NIL++   + KL DFG  K          + +         +   
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 228 SRITKQVMM------IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            R   +         +G+P Y  P  LR      + D +S GVIL E++ G   F  + 
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 54/219 (24%), Positives = 107/219 (48%), Gaps = 22/219 (10%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ R +    + +G+G F  V++A     +  T  A+K         + F  E +++  L
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL 58

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            HD +VKL      ++   ++ E++  G+L + L  +   SK P    +  + Q+A+ + 
Sbjct: 59  QHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           ++ +R   + +H D++A+NIL+   L CK+ DFG A++   +       +  P +     
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----- 168

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +T P  +  G  + K+DV+SFG++L+E+VT
Sbjct: 169 ---------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 78/294 (26%), Positives = 122/294 (41%), Gaps = 62/294 (21%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIG 122
           IGSG    VY  ++I+  T    A+K+  G+  D + +   +E++IL  ++H N+VK   
Sbjct: 82  IGSGAGGTVY--KVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
             D   E  +L E++  G+L+    GT  + +    +   +A Q+   I YLH R   HI
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLAD---VARQILSGIAYLHRR---HI 189

Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM-----MI 237
           VH DIK SN+L+    N K+ DFG                     SRI  Q M      +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGV--------------------SRILAQTMDPCNSSV 229

Query: 238 GSPGYTDPHYLRTGMASTK-----TDVYSFGVILLELVTGMEAF-CPENGQLLTSLAGSM 291
           G+  Y  P  + T +          D++S GV +LE   G   F     G   + +    
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC 289

Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
           ++   +  AT                  +R      + CL++ P  R SA Q+L
Sbjct: 290 MSQPPEAPATA-----------------SREFRHFISCCLQREPAKRWSAMQLL 326

Length = 353

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 37/289 (12%)

Query: 65  IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIG 122
           IG G FS VY A  L++        ++I    D +  Q   +E+D+L  L+H N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL-PWRNRMAIAFQLAQAIEYLHERCTLH 181
              + +E  ++ E    G L + +    +  +L P R       QL  A+E++H R    
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           ++H DIK +N+ +      KL D G  +  FSS              + T    ++G+P 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRF-FSS--------------KTTAAHSLVGTPY 171

Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEAT 301
           Y  P  +     + K+D++S G +L E+      F  +   L      S+   I  C+  
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-----SLCQKIEQCDY- 225

Query: 302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
                  P L  +   ++ R ++S   +C+   P  RP    +    K 
Sbjct: 226 -------PPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 59/303 (19%)

Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ----ELDILLHLSHDNI 117
           S+V+GSG    V  A+ ++D      A+K+ V  + +S+  K     E+  LL+    +I
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPF--AVKV-VDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 118 VKL---IGYCDDRDEG-----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA--IAFQL 167
           VK        D R+        L+ +Y   G L++++    ++++  +R   A  +  Q+
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR-TFREHEAGLLFIQV 152

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
             A+ ++H +   H++H DIK++NILL  +   KL DFG +KM +++ V     S    R
Sbjct: 153 LLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATV-----SDDVGR 203

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
           +         G+P Y  P   R    S K D++S GV+L EL+T    F  EN       
Sbjct: 204 T-------FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------- 249

Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDL---DEARAMLSIAALCLRQSPILRPSATQI 344
                          + E++   LAG +D      +  M  I    L   P  RPS++++
Sbjct: 250 ---------------MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294

Query: 345 LHT 347
           L+ 
Sbjct: 295 LNM 297

Length = 496

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 42/222 (18%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QV--FKQELDILLHLSH-DNIVK 119
           I  G F +VYLA+    ST    AIK+   SD ++  QV   K E  I++       + K
Sbjct: 4   ISKGAFGSVYLAK--KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 120 LIGYCDDRDEGVLLFEYVPNG---TLQEKLHGTPRSSKLPW-RNRMAIAFQLAQAIEYLH 175
           L      +D   L+ EY+  G   +L + L G P      W +  +A   ++   +E LH
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP----EDWAKQYIA---EVVLGVEDLH 114

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
           +R    I+H DIK  N+L+++  + KL DFG ++ G                        
Sbjct: 115 QR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL----ENKK--------------- 152

Query: 236 MIGSPGYTDPHYLRTGMASTK-TDVYSFGVILLELVTGMEAF 276
            +G+P Y  P  +  G+   K +D +S G ++ E + G   F
Sbjct: 153 FVGTPDYLAPETI-LGVGDDKMSDWWSLGCVIFEFLFGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 32/219 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH 114
           +VIG G F  VY   LI      +   KIH     L+++        F +E  I+   SH
Sbjct: 1   RVIGKGHFGCVYHGTLI-----DSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55

Query: 115 DNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            N++ L+G C    EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+ +E
Sbjct: 56  PNVLSLLGICLP-SEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGME 112

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YL  +     VH D+ A N +L+E    K+ DFG A+  +           + + +++  
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH---NHTGAKLPV 166

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 167 KWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 36/211 (17%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           ++IG G F  V    L  + T    A+K  +  D  +Q F +E  ++  L H N+V+L+G
Sbjct: 12  EIIGEGEFGAV----LQGEYTGQKVAVKN-IKCDVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 123 YCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                  G+ ++ E +  G L   L    R+  +     +  +  +A+ +EYL  +    
Sbjct: 67  VI--LHNGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---K 120

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAK---MGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
           +VH D+ A NIL+ E    K+ DFG A+   MG  ++ LP                    
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------------------ 162

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
              +T P  L+    S+K+DV+S+GV+L E+
Sbjct: 163 ---WTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 26/209 (12%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G F  V++      + +T  AIK       + + F QE  I+  L HD +V L  Y 
Sbjct: 14  LGQGCFGEVWMGTW---NGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YA 68

Query: 125 DDRDEGV-LLFEYVPNGTLQEKL-HGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
              +E + ++ E++  G+L + L  G  +  KLP    + +A Q+A  + Y+ ER  ++ 
Sbjct: 69  VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP--QLVDMAAQIADGMAYI-ER--MNY 123

Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           +H D++A+NIL+ ++L CK+ DFG A++   +       +  P +              +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK--------------W 169

Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVT 271
           T P     G  + K+DV+SFG++L ELVT
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 75/292 (25%), Positives = 120/292 (41%), Gaps = 51/292 (17%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGA-----IKIHVGSDRLSQVFK--QELDILLHLSHD 115
           Q +G G F  VYL   + D  +          +I VG    ++  +  QE  +L  L H 
Sbjct: 6   QRLGKGSFGTVYL---VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF-QLAQAIEYL 174
            IVK      +RD   ++ EY     L  KL     + K    N++   F QL   + Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H+R    I+H D+KA NI L+ +L  K+ DFG +++   S  L  +              
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-------------- 164

Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG-QLLTSLAGSMLN 293
              G+P Y  P  L+     +K+D++S G IL E+     AF  +N   ++  +      
Sbjct: 165 -FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223

Query: 294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
            + +  + ++N ++   L  D                    P LRPSA +IL
Sbjct: 224 SLPETYSRQLNSIMQSMLNKD--------------------PSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 26/209 (12%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G F  V++      + +T  AIK         + F QE  ++  L H+ +V+L  Y 
Sbjct: 14  LGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 68

Query: 125 DDRDEGV-LLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
              +E + ++ EY+  G+L + L G   +  +LP    + +A Q+A  + Y+ ER  ++ 
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYV-ER--MNY 123

Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           VH D++A+NIL+ E+L CK+ DFG A++   +       +  P +              +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------------W 169

Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVT 271
           T P     G  + K+DV+SFG++L EL T
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDNIVK 119
           Q +GSG + +VY AR  N  T    A+KI     G D    + +QE+ ++    H NIV 
Sbjct: 15  QRVGSGTYGDVYKAR--NLHTGELAAVKIIKLEPGDD--FSLIQQEIFMVKECKHCNIVA 70

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF---QLAQAIEYLHE 176
             G    R++  +  EY   G+LQ+  H T   S+L       IA+   +  Q + YLH 
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL------QIAYVCRETLQGLAYLHS 124

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +  +H    DIK +NILL ++ + KL DFG A               +   + I K+   
Sbjct: 125 KGKMH---RDIKGANILLTDNGDVKLADFGVA---------------AKITATIAKRKSF 166

Query: 237 IGSPGYTDPHYL---RTGMASTKTDVYSFGVILLEL 269
           IG+P +  P      + G  +   D+++ G+  +EL
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 29/222 (13%)

Query: 64  VIGSGGFSNVYLAR--LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++G G F  V + R     D  +     K  + +      F++E DIL   +   I +L 
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
               D+D   L+ EY P G L   L+      +  +   MA  F LA+ +  +H    + 
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLN----RYEDQFDEDMA-QFYLAELVLAIHSVHQMG 122

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGS-AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            VH DIK  N+L++   + KL DFGS A++  +  V    P               +G+P
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP---------------VGTP 167

Query: 241 GYTDPHYLRT------GMASTKTDVYSFGVILLELVTGMEAF 276
            Y  P  L T      G    + D +S GVI  E++ G   F
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 7e-14
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV-FKQELDILLHLSHDNIV 118
           F + +GSG F  V+L +        + AIK I  G+  +S+  F +E  +++ LSH N+V
Sbjct: 8   FLKELGSGQFGVVHLGKWRG---KIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLV 62

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L G C  +    ++ EY+ NG L   L          W   M     + +A+EYL    
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS--DVCEAMEYLESNG 120

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
               +H D+ A N L+ E    K+ DFG A+            +  P +           
Sbjct: 121 ---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK----------- 166

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
              +  P        S+K+DV+SFGV++ E+ + 
Sbjct: 167 ---WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 73/260 (28%), Positives = 104/260 (40%), Gaps = 63/260 (24%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL--SQV--FKQELDILLHLSHDNIVK 119
           VIG G F  V L +  +  T    A+K    S+ L   QV   + E DIL    +  +VK
Sbjct: 8   VIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 120 LIGYCDDRDEG--VLLFEYVPNG----------TLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           L  Y   +DE    L+ EY+P G          T  E+              R  IA + 
Sbjct: 66  L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE------------ETRFYIA-ET 110

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP--------- 218
             AI+ +H    L  +H DIK  N+LL+   + KL DFG    G   +            
Sbjct: 111 ILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHA 166

Query: 219 -PSPSPSPS--------------RSRITKQVMMIGSPGYTDPH-YLRTGMASTKTDVYSF 262
            PS                    R+R       +G+P Y  P  +L+TG  + + D +S 
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSL 225

Query: 263 GVILLELVTGMEAFCPENGQ 282
           GVI+ E++ G   FC +N Q
Sbjct: 226 GVIMYEMLVGYPPFCSDNPQ 245

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 35/192 (18%)

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL--------------- 146
           F+QE  ++  L H NIV L+G         +LFEY+  G L E L               
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 147 HGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG 206
            GT +SS L   + + IA Q+A  +EYL        VH D+ A NIL+ E L+ K+ D G
Sbjct: 114 DGTVKSS-LDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLG 169

Query: 207 SAKMGFSSAVLPPSP-SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVI 265
            ++  +S+      P S  P R              +  P  +  G  S+ +D++SFGV+
Sbjct: 170 LSREIYSADYYRVQPKSLLPIR--------------WMPPEAIMYGKFSSDSDIWSFGVV 215

Query: 266 LLELVT-GMEAF 276
           L E+ + G++ +
Sbjct: 216 LWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 8e-14
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 44/224 (19%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNG---AIKIHVGSD--RLSQV--FKQELDILLHL 112
            F + +G+G F  V L R        +G   A+KI   +   +L QV     E  IL  +
Sbjct: 4   EFIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H  +V L G   D     L+ EYVP G L   L    +S + P       A Q+  A+E
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALE 115

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YLH   +L IV+ D+K  N+LL+     K+ DFG AK                   R+  
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-------------------RVKG 153

Query: 233 QVMMI-GSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTG 272
           +   + G+P Y  P  + +   G A    D ++ G+++ E++ G
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.5 bits (172), Expect = 8e-14
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 35/215 (16%)

Query: 63  QVIGSGGFSNVYLARLINDST-STNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           Q IGSG + +VY AR +N    +    IK+  G D    V +QE+ ++    H NIV   
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED--FAVVQQEIIMMKDCKHSNIVAYF 72

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF---QLAQAIEYLHERC 178
           G    RD+  +  E+   G+LQ+  H T   S+        IA+   +  Q + YLH + 
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES------QIAYVSRETLQGLYYLHSKG 126

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
            +H    DIK +NILL ++ + KL DFG SA++                 + I K+   I
Sbjct: 127 KMH---RDIKGANILLTDNGHVKLADFGVSAQIT----------------ATIAKRKSFI 167

Query: 238 GSPGYTDPHYL---RTGMASTKTDVYSFGVILLEL 269
           G+P +  P      R G  +   D+++ G+  +EL
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 34/223 (15%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           +IG+G F  VY A  I+  TS   AIK  V  D   Q   +EL I+ +L+H NI+ L  Y
Sbjct: 73  IIGNGSFGVVYEAICID--TSEKVAIK-KVLQD--PQYKNRELLIMKNLNHINIIFLKDY 127

Query: 124 ----CDDRDEGVLLF----EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
               C  ++E  +      E++P    +   H    +  LP       ++QL +A+ Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
            +    I H D+K  N+L++ + +  KLCDFGSAK      +L    S S   SR  +  
Sbjct: 188 SK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----NLLAGQRSVSYICSRFYRAP 239

Query: 235 -MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +M+G+  YT           T  D++S G I+ E++ G   F
Sbjct: 240 ELMLGATNYT-----------THIDLWSLGCIIAEMILGYPIF 271

Length = 440

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 50/238 (21%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHV--------GSDRLSQV--FKQELDILLH 111
           ++IG G +  VYLA  +N +T    A+K + +         S +   V   + E++ L  
Sbjct: 7   ELIGKGTYGRVYLA--LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QL 167
           L H NIV+ +G+    +   +  EYVP G++   L  +G        +  ++   F  Q+
Sbjct: 65  LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-------RFEEQLVRFFTEQV 117

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + + YLH +    I+H D+KA N+L++    CK+ DFG +K   S  +     + S   
Sbjct: 118 LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMS--- 169

Query: 228 SRITKQVMMIGSPGYTDP---HYLRTGMASTKTDVYSFGVILLELVTG------MEAF 276
                   M GS  +  P   H    G  S K D++S G ++LE+  G       EA 
Sbjct: 170 --------MQGSVFWMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 68/287 (23%), Positives = 121/287 (42%), Gaps = 45/287 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTS-TNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           + IG G F    L +   D        I I   S +  +  ++E+ +L ++ H NIV+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              ++     ++ +Y   G L +K++   R    P    +    Q+  A++++H+R    
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---K 121

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           I+H DIK+ NI L +    KL DFG A++  S+  L        +R+        IG+P 
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--------ART-------CIGTPY 166

Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEAT 301
           Y  P        + K+D+++ G +L E+ T   AF           AG+M N        
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF----------EAGNMKN-------- 208

Query: 302 KVNELVDPRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQIL 345
               LV   + G +       +  + ++ +   +++P  RPS   IL
Sbjct: 209 ----LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 15/167 (8%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR----LSQVFKQELDILLHLSHDNIVKL 120
           IG G +  VY A+  N       AIK   G       +SQ   +E+ +L  L H+N+V L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 121 IGYC-DDRDEGV-LLFEYVPNGTLQE-KLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           +    +  D+ V LLF+Y  +   Q  K H   +   +P     ++ +Q+   + YLH  
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127

Query: 178 CTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLPPS 220
               ++H D+K +NIL+     E    K+ D G A++ F++ + P +
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLA 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 90/307 (29%), Positives = 126/307 (41%), Gaps = 59/307 (19%)

Query: 49  YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---- 104
           +S DD E+   +  + IG G F  VY AR  +  T+   AIK    S + S    Q    
Sbjct: 8   FSKDDPEKLFTDLRE-IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGV-LLFEYVPNGTLQEKL--HGTPRSSKLPWRNRM 161
           E+  L  L H N ++  G C  R+    L+ EY   G+  + L  H  P    L      
Sbjct: 65  EVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKKP----LQEVEIA 118

Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP 221
           AI     Q + YLH       +H DIKA NILL E    KL DFGSA +           
Sbjct: 119 AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL----------- 164

Query: 222 SPSPSRSRITKQVMMIGSPGYTDPHY---LRTGMASTKTDVYSFGVILLELVTGMEAFCP 278
             SP+ S        +G+P +  P     +  G    K DV+S G+  +EL    E   P
Sbjct: 165 -VSPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA---ERKPP 213

Query: 279 ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR 338
               L    A S L  IA  ++        P L+ +   D +    +    CL++ P  R
Sbjct: 214 ----LFNMNAMSALYHIAQNDS--------PTLSSN---DWSDYFRNFVDSCLQKIPQDR 258

Query: 339 PSATQIL 345
           PS+ ++L
Sbjct: 259 PSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 34/225 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +++G G F  V+   L + +       K  +  + L   F  E  IL    H NIVKLIG
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKLIG 59

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL--AQAIEYLHERCTL 180
            C  R    ++ E VP G     L    R  K   + +  + F L  A  + YL  +   
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLESK--- 112

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMG----FSSAVLPPSPSPSPSRSRITKQVMM 236
           + +H D+ A N L+ E+   K+ DFG ++      +SS+ L              KQ+ +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL--------------KQIPI 158

Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG 281
                +T P  L  G  S+++DV+S+G++L E  T     CP  G
Sbjct: 159 ----KWTAPEALNYGRYSSESDVWSYGILLWE--TFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 76/310 (24%), Positives = 126/310 (40%), Gaps = 66/310 (21%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDI 108
           D  E FT+   + IG G F  V+  + I++ T    AIKI       D +  + +QE+ +
Sbjct: 1   DPEELFTK--LERIGKGSFGEVF--KGIDNRTQQVVAIKIIDLEEAEDEIEDI-QQEITV 55

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           L       + K  G      +  ++ EY+  G+  + L   P        +   IA  L 
Sbjct: 56  LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF-------DEFQIATMLK 108

Query: 169 Q---AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
           +    ++YLH       +H DIKA+N+LL E  + KL DFG A     + +         
Sbjct: 109 EILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--------- 156

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT 285
                 K+   +G+P +  P  ++     +K D++S G+  +EL  G     P N     
Sbjct: 157 ------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE----PPN----- 201

Query: 286 SLAGSMLNDIADCEATKVNELVD----PRLAGDFDLDEARAMLSIAALCLRQSPILRPSA 341
                     +D    +V  L+     P L G+F    ++        CL + P  RP+A
Sbjct: 202 ----------SDMHPMRVLFLIPKNNPPTLTGEF----SKPFKEFIDACLNKDPSFRPTA 247

Query: 342 TQILHTIKHQ 351
            ++L   KH+
Sbjct: 248 KELL---KHK 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 82/322 (25%), Positives = 131/322 (40%), Gaps = 86/322 (26%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---QELDILLHLSHDNIVKL 120
           ++G G +  V   +  +  T    AIK  + S+    V K   +E+ +L  L H+N+V L
Sbjct: 8   LVGEGSYGMVMKCK--HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           I     +    L+FE+V +  L + L   P    L         FQ+ + IE+ H     
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNG--LDESRVRKYLFQILRGIEFCHSH--- 119

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           +I+H DIK  NIL+ +    KLCDFG A+                           + +P
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR--------------------------TLAAP 153

Query: 241 G--YTDPHYLRTG--------MASTK----TDVYSFGVILLELVTGMEAF---------- 276
           G  YTD  Y+ T         +  TK     D+++ G ++ E++TG   F          
Sbjct: 154 GEVYTD--YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211

Query: 277 ---------CPENGQLLTS---LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAML 324
                     P + ++       AG  L ++ + E     E   P+L+G         +L
Sbjct: 212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPL---EKRFPKLSG--------LVL 260

Query: 325 SIAALCLRQSPILRPSATQILH 346
            +A  CLR  P  RPS++Q+LH
Sbjct: 261 DLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 30/227 (13%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IH---VGSDRLSQVFKQELDILLHLSHDNIVKL 120
           IG GG   VYLA   +   S   A+K I      +  L + F +E  I   L H  IV +
Sbjct: 10  IGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP--------WRNRMAIAFQLAQAIE 172
              C D D       Y+   TL+  L    +   L             ++I  ++   IE
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM--------GFSSAVLPPSPSPS 224
           Y+H +    ++H D+K  NILL       + D+G+A                       +
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV-----DERN 179

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              S +T    ++G+P Y  P  L    AS  TD+Y+ GVIL +++T
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 77/308 (25%), Positives = 129/308 (41%), Gaps = 62/308 (20%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDI 108
           D  E FT+   + IG G F  V+  + I++ T    AIKI       D +  + +QE+ +
Sbjct: 1   DPEELFTK--LEKIGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITV 55

Query: 109 LLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           L       + K  G Y  D    +++ EY+  G+  + L   P    L       I  ++
Sbjct: 56  LSQCDSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLLEPGP----LDETQIATILREI 110

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + ++YLH       +H DIKA+N+LL EH   KL DFG A     + +           
Sbjct: 111 LKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----------- 156

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
               K+   +G+P +  P  ++     +K D++S G+  +EL  G     P + +L    
Sbjct: 157 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE----PPHSEL---- 204

Query: 288 AGSMLNDIADCEATKVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
                         KV  L+     P L G++    ++ +      CL + P  RP+A +
Sbjct: 205 -----------HPMKVLFLIPKNNPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAKE 249

Query: 344 ILHTIKHQ 351
           +L   KH+
Sbjct: 250 LL---KHK 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 36/232 (15%)

Query: 65  IGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQV---FKQELDILLHLSHDNIVKL 120
           +G G F  V               A+K  + SD+LS +   F +E  I+  L H+N+++L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKC-LKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G        +++ E  P G+L ++L                 A Q+A  + YL  +   
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
             +H D+ A NILL      K+ DFG                    R+    +   +   
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGL------------------MRALPQNEDHYVMEE 158

Query: 241 ------GYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLL 284
                  +  P  LRT   S  +DV+ FGV L E+ T G E +   +G Q+L
Sbjct: 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL 210

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 36/219 (16%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQV--FKQELDILLHLSHDNIVKL 120
           +G+G F  V +A+     T    AIK     +  ++ QV    QE  IL+ LSH  IV +
Sbjct: 26  LGTGSFGRVRIAKH--KGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQAIEYLHERC 178
           +    D +    L E+V  G L   L    ++ + P  N +A  +  +L  A EYLH   
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHLR---KAGRFP--NDVAKFYHAELVLAFEYLHS-- 136

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI- 237
              I++ D+K  N+LL+   + K+ DFG AK                   ++  +   + 
Sbjct: 137 -KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-------------------KVPDRTFTLC 176

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  +++       D ++ GV+L E + G   F
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 75/289 (25%), Positives = 117/289 (40%), Gaps = 42/289 (14%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTS-TNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           F +V+G G +  V L R   D        + +   S R  +  +QE  +L  L H NIV 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 120 LIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
                +  D G+L  +  +   G L  KL    +   LP    +    Q+A A++YLHE+
Sbjct: 64  YRESWEGED-GLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
              HI+H D+K  N+ L      K+ D G A+      VL          ++      +I
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIAR------VL---------ENQCDMASTLI 163

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD 297
           G+P Y  P        + K+DV++ G  + E+ T   AF   N + + SL    +  I +
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF---NAKDMNSL----VYRIIE 216

Query: 298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
            +   + +   P L      +    MLS       + P  RPS   IL 
Sbjct: 217 GKLPPMPKDYSPELG-----ELIATMLS-------KRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 61/230 (26%), Positives = 90/230 (39%), Gaps = 61/230 (26%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK--------QELDILLHL-S 113
           + +G G F +VYLAR  N  T    AIK      ++ + F         +E+  L  L  
Sbjct: 5   KQLGDGTFGSVYLAR--NKETGELVAIK------KMKKKFYSWEECMNLREVKSLRKLNE 56

Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H NIVKL     + DE   +FEY+     Q  L    +          +I +Q+ Q + +
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           +H        H D+K  N+L+      K+ DFG A+                 RSR    
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---------------EIRSR---- 152

Query: 234 VMMIGSPGYTDPHY------------LRTGMASTKTDVYSFGVILLELVT 271
                 P YTD  Y            LR+   S+  D+++ G I+ EL T
Sbjct: 153 ------PPYTD--YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.4 bits (165), Expect = 8e-13
 Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 9/148 (6%)

Query: 62  SQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIV 118
            + IG G F +VY    ++ ++     A+K   +  S  + + F QE  I+    H +IV
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KLIG   + +   ++ E  P G L+  L        L   + +  ++QL+ A+ YL  + 
Sbjct: 71  KLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLESK- 126

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG 206
               VH DI A N+L+      KL DFG
Sbjct: 127 --RFVHRDIAARNVLVSSPDCVKLGDFG 152

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 72/296 (24%), Positives = 118/296 (39%), Gaps = 47/296 (15%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---QELDILLHLSHDN 116
              +VIG G  + VY A  +    +   AIK  +  ++         +E+  +   +H N
Sbjct: 4   ELIEVIGVGATAVVYAAICL--PNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA---QAIEY 173
           +VK        DE  L+  Y+  G+L + +  +     L       IA  L    + +EY
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEY 117

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH      I H DIKA NILL E  + K+ DFG +                  + R T  
Sbjct: 118 LHSNG--QI-HRDIKAGNILLGEDGSVKIADFGVSASLA-------DGGDRTRKVRKT-- 165

Query: 234 VMMIGSPGYTDPHYLRTGMAST-KTDVYSFGVILLELVTGMEAFC--PENGQLLTSLAGS 290
              +G+P +  P  +        K D++SFG+  +EL TG   +   P    L+ +L   
Sbjct: 166 --FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND 223

Query: 291 MLNDIADCEATKVNELVDPRLAGDFDLDE-ARAMLSIAALCLRQSPILRPSATQIL 345
                             P L    D  + +++   + +LCL++ P  RP+A ++L
Sbjct: 224 -----------------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           +G G F  VY A+  N  T    A K I   S+   + +  E++IL   +H  IVKL+G 
Sbjct: 20  LGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
                +  ++ E+ P G +   +    R    P      I  Q+ +A++YLH   ++ I+
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP--QIQVICRQMLEALQYLH---SMKII 132

Query: 184 HGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           H D+KA N+LL    + KL DFG SAK                +   + ++   IG+P +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAK----------------NVKTLQRRDSFIGTPYW 176

Query: 243 TDPHYLRTGMAST--------KTDVYSFGVILLEL 269
             P  +   M  T        K D++S G+ L+E+
Sbjct: 177 MAPEVV---MCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 72/319 (22%), Positives = 130/319 (40%), Gaps = 66/319 (20%)

Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +    +  
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG              
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM------------- 165

Query: 221 PSPSPSRSRITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                +R          G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 166 -----TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 220

Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 221 --PYQGMSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 257

Query: 331 LRQSPILRPSATQILHTIK 349
            + +P +RPS  +I+ +IK
Sbjct: 258 WQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 52/219 (23%), Positives = 85/219 (38%), Gaps = 24/219 (10%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVG--SDRLSQVFKQELDILLHLSHDNIVKLI 121
           IG G    V+ A+     T    A+K + +      +     +E+  L    H  +VKL+
Sbjct: 8   IGEGAHGIVFKAKDR--ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                    VL+ EY+P   L E L    R   LP     +    L + + Y+H      
Sbjct: 66  DVFPHGSGFVLVMEYMP-SDLSEVLRDEERP--LPEAQVKSYMRMLLKGVAYMHA---NG 119

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           I+H D+K +N+L+      K+ DFG A++         S   +    R  +  ++ G+  
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE--LLYGARK 177

Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
           Y               D+++ G I  EL+ G   F  EN
Sbjct: 178 YD-----------PGVDLWAVGCIFAELLNGSPLFPGEN 205

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 70/246 (28%), Positives = 99/246 (40%), Gaps = 44/246 (17%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL--SQV--FKQELDILLHLSHDNIVKL 120
           IG G F  V L R ++  T+   A+K    +D L  +Q    K E DIL    ++ +VKL
Sbjct: 9   IGIGAFGEVCLVRKVD--TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR-NRMAIAFQLAQAIEYLHERCT 179
                D+D    + +Y+P G +   L    R         R  IA +L  AIE +H+   
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIA-ELTCAIESVHK--- 119

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFG---------------------SAKMGFSSAVLP 218
           +  +H DIK  NIL++   + KL DFG                        M  S     
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 219 PSPSP-SPSRSRITKQVM------MIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELV 270
                  P   R  +Q        ++G+P Y  P  L RTG      D +S GVIL E++
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEML 238

Query: 271 TGMEAF 276
            G   F
Sbjct: 239 VGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 64/229 (27%)

Query: 65  IGSGGFSNVYLARLINDSTSTNG--AIK-IHVGS-----DRLSQVFKQELDILLHLSHDN 116
           +G G ++ VY AR       T    AIK I +G      D ++    +E+ +L  L H N
Sbjct: 8   LGEGTYAVVYKAR----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM---------AIAFQL 167
           I+ L+     +    L+FE++   T  EK+           +++          +     
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME--TDLEKV----------IKDKSIVLTPADIKSYMLMT 111

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + +EYLH      I+H D+K +N+L+      KL DFG A+  F           SP+R
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS-F----------GSPNR 157

Query: 228 SRITKQVMMIGSPGYTDP-------HYLRTGMASTKTDVYSFGVILLEL 269
            ++T QV+   +  Y  P       HY          D++S G I  EL
Sbjct: 158 -KMTHQVV---TRWYRAPELLFGARHY------GVGVDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 31/222 (13%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV------FKQELDILLHLSHDNIV 118
           +GSG F  VY     +     +G I++ V + R          F +E  ++ + +H NIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----TPRSSKLPWRNRMAIAFQLAQAIEYL 174
           KL+G C   +   ++ E +  G L   L            L  +  + I   +A+   YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 175 HERCTLHIVHGDIKASNILLEEHLN-----CKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
            +   +H +H D+ A N L+ E         K+ DFG A+  + S              R
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS-----------DYYR 168

Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              + ++     +  P  L  G  +T++DV+SFGV++ E++T
Sbjct: 169 KEGEGLL--PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 63  QVIGSGGFSNVYLARLI--NDSTSTNGAIK-IHVGSDRLSQV-FKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I   +      AIK +   +   +      E  ++  + H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLH---GTPRS-SKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C    +  L+ + +P G L + +        S   L W        Q+A+ + YL
Sbjct: 73  RLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP-SPSPSPSRSRITKQ 233
            E+    +VH D+ A N+L++   + K+ DFG AK+      L            ++  +
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL------LDVDEKEYHAEGGKVPIK 176

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            M + S        +   + + K+DV+S+GV + EL+T
Sbjct: 177 WMALES--------ILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.1 bits (158), Expect = 6e-12
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----RLSQVFKQELDILLHLSHDNI 117
           +++G G F  VYL   + D+     A ++    +     +     + E+ +L +L H+ I
Sbjct: 8   KLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 118 VKLIGYCDDRDEGVL--LFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           V+  G   DR E  L    EY+P G+++++L  +G    S      R     Q+ + + Y
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-----QILEGMSY 121

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH      IVH DIK +NIL +   N KL DFG++K   +  +     S +  RS     
Sbjct: 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM-----SGTGIRS----- 168

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             + G+P +  P  +       K DV+S G  ++E++T
Sbjct: 169 --VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 25/217 (11%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           IG G    V+ A  +  +T    AIK I++      ++   E+ ++  L + NIV  +  
Sbjct: 27  IGQGASGTVFTAIDV--ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
               DE  ++ EY+  G+L + +  T            A+  +  QA+E+LH      ++
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTETCMDEA----QIAAVCRECLQALEFLHAN---QVI 137

Query: 184 HGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYT 243
           H DIK+ N+LL    + KL DFG     F + + P            +K+  M+G+P + 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFG-----FCAQITPEQ----------SKRSTMVGTPYWM 182

Query: 244 DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            P  +       K D++S G++ +E+V G   +  EN
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 44/292 (15%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
            + ++G    +  ++A   +D      A  + +  +R +   + EL  L    H  IVK 
Sbjct: 71  LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKH 130

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA--IAFQLAQAIEYLHERC 178
                  D+ +L+ EY   G L +++    +   LP++      + +Q+  A++ +H R 
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHSRK 189

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
              ++H D+K++NI L      KL DFG +K    S  L  + S               G
Sbjct: 190 ---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS-------------FCG 233

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           +P Y  P        S K D++S GVIL EL+T    F                      
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---------------------- 271

Query: 299 EATKVNELVDPRLAGDFD---LDEARAMLSIAALCLRQSPILRPSATQILHT 347
           +     E++   L G +D      +  M ++    L ++P LRP+  Q+LHT
Sbjct: 272 KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323

Length = 478

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTS-TNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           + IG G F  +YLA+  +DS       I +     +  +  K+E+ +L  + H NIV   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKL---HGTPRSSK--LPWRNRMAIAFQLAQAIEYLHE 176
               +     ++ EY   G L +++    G   S    L W        Q++  ++++H+
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHD 119

Query: 177 RCTLHIVHGDIKASNILLEEH-LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
           R    I+H DIK+ NI L ++ +  KL DFG A+    S  L  +               
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--------------- 161

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +G+P Y  P   +    + KTD++S G +L EL T
Sbjct: 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 1e-11
 Identities = 67/243 (27%), Positives = 107/243 (44%), Gaps = 43/243 (17%)

Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G   KKY+     RF +     IG G    VY A  I+ +T    AIK       L Q  
Sbjct: 15  GDPKKKYT-----RFEK-----IGQGASGTVYTA--IDIATGQEVAIK----QMNLQQQP 58

Query: 103 KQELDI--LLHLSHDNIVKLIGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           K+EL I  +L +  +    ++ Y D     DE  ++ EY+  G+L + +  T        
Sbjct: 59  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 115

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
               A+  +  QA+++LH      ++H DIK+ NILL    + KL DFG     F + + 
Sbjct: 116 -QIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQIT 166

Query: 218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           P            +K+  M+G+P +  P  +       K D++S G++ +E+V G   + 
Sbjct: 167 PEQ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Query: 278 PEN 280
            EN
Sbjct: 217 NEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 43/243 (17%)

Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G   KKY+     RF +     IG G    VY A  ++ +T    AI+       L Q  
Sbjct: 16  GDPKKKYT-----RFEK-----IGQGASGTVYTA--MDVATGQEVAIR----QMNLQQQP 59

Query: 103 KQELDI--LLHLSHDNIVKLIGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           K+EL I  +L +  +    ++ Y D     DE  ++ EY+  G+L + +  T        
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 116

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
               A+  +  QA+E+LH      ++H DIK+ NILL    + KL DFG     F + + 
Sbjct: 117 -QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQIT 167

Query: 218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           P            +K+  M+G+P +  P  +       K D++S G++ +E++ G   + 
Sbjct: 168 PEQ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217

Query: 278 PEN 280
            EN
Sbjct: 218 NEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 41/187 (21%)

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL------ 155
           F +E+ I+  L + NI++L+G C   D   ++ EY+ NG L + L      S        
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 156 ---PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF 212
                 N + +A Q+A  ++YL    +L+ VH D+   N L+  H   K+ DFG ++  +
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180

Query: 213 SS--------AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGV 264
           S         AVL       P R    + +++              G  +T +DV++FGV
Sbjct: 181 SGDYYRIQGRAVL-------PIRWMAWESILL--------------GKFTTASDVWAFGV 219

Query: 265 ILLELVT 271
            L E+ T
Sbjct: 220 TLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 63  QVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNIVK 119
           +VIG+G F  V+   L +        AIK +  G +++  Q F  E  I+   SH NI++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLH---GTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           L G        +++ EY+ NG L + L    G   S +L     + +   +A  ++YL +
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYLSD 125

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM--GFSSAVLPPSPSPSPSRSRITKQV 234
              ++ VH D+ A NIL+  +L CK+ DFG +++           S    P R       
Sbjct: 126 ---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR------- 175

Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  +T P  +     ++ +DV+SFG+++ E+++
Sbjct: 176 -------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 37/245 (15%)

Query: 58  TQNFSQVIGSGGFSNVYLARLINDST-STNGAIKIHVGSDR----LSQVFKQELDILLHL 112
           T  F + +G   F  VY   L   +      A+ I    D+    L + FK E  +   L
Sbjct: 6   TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-HGTPRS------------SKLPWRN 159
            H NIV L+G         ++F Y  +  L E L   +P S            S L   +
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP- 218
            + I  Q+A  +E+L      H+VH D+   N+L+ + LN K+ D G  +  +++     
Sbjct: 126 FVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFC 277
              S  P R              +  P  +  G  S  +D++S+GV+L E+ + G++ +C
Sbjct: 183 MGNSLLPIR--------------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228

Query: 278 PENGQ 282
             + Q
Sbjct: 229 GYSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 11/149 (7%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---QELDILLHLSHDNIVKLI 121
           IG G +  V+  R  N  T    AIK  V S+    + K   +E+ +L  L H N+V LI
Sbjct: 9   IGEGSYGVVFKCR--NRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                + +  L+FEY  +  L E L   PR   +P      I +Q  QA+ + H+    +
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNE-LEKNPR--GVPEHLIKKIIWQTLQAVNFCHK---HN 120

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +H D+K  NIL+ +    KLCDFG A++
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 64/250 (25%)

Query: 61  FSQVIGSGGFSNVYLARLIN--DSTSTNGAIKIHVGSDRLSQV--------------FKQ 104
           F + +G G F  V+L  ++N  D  +      +  G   L  V              F +
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-------------HGTPR 151
           E+ IL  L   NI++L+G C D D   ++ EY+ NG L + L                P 
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 152 SSKLP---WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
           +  LP   + + + +A Q+A  ++YL    +L+ VH D+   N L+ E+L  K+ DFG +
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 209 KMGFSS--------AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVY 260
           +  ++         AVL       P R    + ++M              G  +T +DV+
Sbjct: 186 RNLYAGDYYRIQGRAVL-------PIRWMAWECILM--------------GKFTTASDVW 224

Query: 261 SFGVILLELV 270
           +FGV L E++
Sbjct: 225 AFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 69/227 (30%), Positives = 96/227 (42%), Gaps = 27/227 (11%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---QELDILLHLSHDNIVKL 120
           V+G G +  V   R  +  T    AIK    S+   +V +   +EL +L  L  +NIV+L
Sbjct: 8   VVGEGAYGVVLKCR--HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                 R +  L+FEYV    L E L   P     P + R  I +QL +AI + H+    
Sbjct: 66  KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGV-PPEKVRSYI-YQLIKAIHWCHKN--- 119

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            IVH DIK  N+L+  +   KLCDFG A+              + S          + + 
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFAR--------------NLSEGSNANYTEYVATR 165

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN--GQLLT 285
            Y  P  L         D++S G IL EL  G   F  E+   QL T
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 60  NFSQV--IGSGGFSNVYLARLINDSTSTNGA---IKIHVGSDRLSQVFKQELDILLHLSH 114
           NF +V  IG G +  VY AR  N  T    A   I++   ++ +     +E+ +L  L+H
Sbjct: 1   NFQKVEKIGEGTYGVVYKAR--NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            NIVKL+      ++  L+FE++ +  L++ +  +P S  +P     +  FQL Q + + 
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFC 116

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H      ++H D+K  N+L+      KL DFG A+  F            P R+  T +V
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG----------VPVRT-YTHEV 161

Query: 235 MMIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVT 271
           + +    Y  P   L     ST  D++S G I  E+VT
Sbjct: 162 VTL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 81/302 (26%), Positives = 117/302 (38%), Gaps = 55/302 (18%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELD 107
           DD E       + IG G F  VY A   N  T+   A+K    S + +    Q   +E+ 
Sbjct: 17  DDPEEIFVGLHE-IGHGSFGAVYFA--TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            L  L H N ++  G         L+ EY + + +   ++H  P    L      AI   
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHG 129

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
             Q + YLH      ++H DIKA NILL E    KL DFGSA               SP+
Sbjct: 130 ALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS------------SPA 174

Query: 227 RSRITKQVMMIGSPGYTDPHY---LRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
            S        +G+P +  P     +  G    K DV+S G+  +EL          N   
Sbjct: 175 NS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--- 224

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
               A S L  IA  ++        P L  +   D  R  +     CL++ P  RP++ +
Sbjct: 225 ----AMSALYHIAQNDS--------PTLQSNEWTDSFRGFVD---YCLQKIPQERPASAE 269

Query: 344 IL 345
           +L
Sbjct: 270 LL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 58/188 (30%), Positives = 88/188 (46%), Gaps = 44/188 (23%)

Query: 101 VFKQELDILLHLSHDNIVKL---IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           +F QEL       H NIVKL   I   +D+D   L+FEY     ++  LH   R++ L  
Sbjct: 58  MFLQELG-----DHPNIVKLLNVIKAENDKDI-YLVFEY-----METDLHAVIRANILED 106

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            ++  I +QL +A++Y+H     +++H D+K SNILL      KL DFG A+   S    
Sbjct: 107 VHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS-LSEL-- 160

Query: 218 PPSPSPSPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
                 +P    +T  V         +++GS  YT       G+     D++S G IL E
Sbjct: 161 ----EENPENPVLTDYVATRWYRAPEILLGSTRYT------KGV-----DMWSVGCILGE 205

Query: 269 LVTGMEAF 276
           ++ G   F
Sbjct: 206 MLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 30/212 (14%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           +G G F  VY A+  N  T    A K I   S+   + +  E+DIL    H NIVKL+  
Sbjct: 13  LGDGAFGKVYKAQ--NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
               +   +L E+   G +   +    R    P      +  Q  +A+ YLHE     I+
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEP--QIRVVCKQTLEALNYLHEN---KII 125

Query: 184 HGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           H D+KA NIL     + KL DFG SAK                +   I ++   IG+P +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAK----------------NTRTIQRRDSFIGTPYW 169

Query: 243 TDPHYLRTGMAST-----KTDVYSFGVILLEL 269
             P  +    +       K DV+S G+ L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 58/294 (19%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           IG G F  VY  + I++ T    AIKI       D +  + +QE+ +L       I +  
Sbjct: 12  IGKGSFGEVY--KGIDNRTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYITRYY 68

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G      +  ++ EY+  G+  + L   P    L       I  ++ + ++YLH      
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---R 121

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
            +H DIKA+N+LL E  + KL DFG A     + +               K+   +G+P 
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---------------KRNTFVGTPF 166

Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEAT 301
           +  P  ++      K D++S G+  +EL  G     P N               +D    
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGE----PPN---------------SDLHPM 207

Query: 302 KVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ 351
           +V  L+     P L G +    ++        CL + P  RP+A ++L   KH+
Sbjct: 208 RVLFLIPKNSPPTLEGQY----SKPFKEFVEACLNKDPRFRPTAKELL---KHK 254

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 67/252 (26%), Positives = 106/252 (42%), Gaps = 60/252 (23%)

Query: 60  NFSQVIGSGGFSNVYLARL--INDSTSTNGAIKIHVGSDRLSQV--------------FK 103
           NF + +G G F  V+L     + D +    A   +  +  L  V              F 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-------GTPRSSK-L 155
           +E+ IL  LS  NI +L+G C       ++ EY+ NG L + L        G   +SK L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS- 214
            +   + +A Q+A  + YL     L+ VH D+   N L+ ++   K+ DFG ++  +SS 
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 215 -------AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILL 267
                  A L       P R    + V++              G  +TK+DV++FGV L 
Sbjct: 185 YYRVQGRAPL-------PIRWMAWESVLL--------------GKFTTKSDVWAFGVTLW 223

Query: 268 ELVTGMEAFCPE 279
           E++T     C E
Sbjct: 224 EILT----LCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 65/232 (28%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAI----KIHVGSDR----LSQVFKQELDILLHLSHDN 116
           IG G +  VY AR   D+TS  G I    K+ + ++R    +S +  +E+ +LL+L H N
Sbjct: 15  IGEGTYGIVYRAR---DTTS--GEIVALKKVRMDNERDGIPISSL--REITLLLNLRHPN 67

Query: 117 IVKL---------------IGYCDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNR 160
           IV+L               + YC+ +D   LL     P    Q K               
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVK--------------- 111

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
             +  QL + ++YLHE     I+H D+K SN+LL +    K+ DFG A+  +     P +
Sbjct: 112 -CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPMT 166

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           P       R  +  +++G   YT           T  D+++ G IL EL+  
Sbjct: 167 PKVVTLWYRAPE--LLLGCTTYT-----------TAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 21/210 (10%)

Query: 63  QVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +V+G G F    L + +N D       I++   S  + +  ++E  +L  + H NIV   
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV-EDSRKEAVLLAKMKHPNIVAFK 64

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +      ++ EY   G L +K+    R    P    +    Q+   ++++HE+    
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIK-LQRGKLFPEDTILQWFVQMCLGVQHIHEK---R 120

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           ++H DIK+ NI L ++   KL DFGSA+       L  SP               +G+P 
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSAR-------LLTSP--------GAYACTYVGTPY 165

Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           Y  P        + K+D++S G IL EL T
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 43/288 (14%)

Query: 65  IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           +G G + +VY         T     I++ +   + +Q+   ELDIL       IV   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDFYGA 67

Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
                   +  EY+  G+L +   G   +  +P      I + + + +++L E    +I+
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125

Query: 184 HGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYT 243
           H D+K +N+L+  +   KLCDFG       S  L  S + +            IG   Y 
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFG------VSGNLVASLAKTN-----------IGCQSYM 168

Query: 244 DPHYLRTGMA------STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD 297
            P  +++G        + ++DV+S G+ +LE+  G   + PE      +   + L+ I D
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET----YANIFAQLSAIVD 224

Query: 298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
            +         P L   +  D+A+      A CL + P  RP+  Q+L
Sbjct: 225 GDP--------PTLPSGYS-DDAQ---DFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 44/225 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ-------VFKQELDILLHLSHD 115
           +++G G F  VYL    +  T    A+K  V  D  SQ         + E+ +L +L HD
Sbjct: 8   KLLGRGAFGEVYLC--YDADTGRELAVK-QVPFDPDSQETSKEVNALECEIQLLKNLRHD 64

Query: 116 NIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
            IV+  G   D +E  L    EY+P G+++++L      ++   R       Q+ Q + Y
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR---QILQGVSY 121

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH      IVH DIK +NIL +   N KL DFG++K                   RI   
Sbjct: 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK-------------------RIQTI 159

Query: 234 VM-------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            M       + G+P +  P  +       K DV+S    ++E++T
Sbjct: 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 83/289 (28%), Positives = 125/289 (43%), Gaps = 47/289 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-------IHVGSDRLSQVFKQELDILLHLSHD 115
           ++I +G +  VYL R  +  T    A+K       I    +++ QVF  E DIL    + 
Sbjct: 7   KLISNGAYGAVYLVR--HKETRQRFAMKKINKQNLIL--RNQIQQVFV-ERDILTFAENP 61

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNG---TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            +V +    + +    ++ EYV  G   TL + +   P         RM  A +   A+E
Sbjct: 62  FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-----RMYFA-ETVLALE 115

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV--LPPSPSPSPSRSRI 230
           YLH      IVH D+K  N+L+    + KL DFG +K+G  S    L        +R  +
Sbjct: 116 YLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 231 TKQVMMIGSPGYTDPHY-LRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
            KQV   G+P Y  P   LR G      D ++ G+IL E + G   F    G     L G
Sbjct: 173 DKQV--CGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFF---GDTPEELFG 226

Query: 290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR 338
            +++D          ++  P   GD +   A A   I+ L LRQ+P+ R
Sbjct: 227 QVISD----------DIEWPE--GD-EALPADAQDLISRL-LRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 61/231 (26%), Positives = 91/231 (39%), Gaps = 59/231 (25%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV-FKQELDILLHLSH-DNIVKLI 121
           IG G F  V   ++++  + T  A+K I    D   Q     +LD+++  S    IVK  
Sbjct: 12  IGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 122 GYCDDRDEGV-------------LLFEYV---PNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
           G      EG                ++YV       + E++ G              IA 
Sbjct: 70  GAL--FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-------------KIAV 114

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPS 224
              +A+ YL E   L I+H D+K SNILL+ + N KLCDFG S ++  S A         
Sbjct: 115 ATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--------- 163

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMAS---TKTDVYSFGVILLELVTG 272
                   +    G   Y  P  +          ++DV+S G+ L E+ TG
Sbjct: 164 --------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 50/234 (21%)

Query: 60  NFSQV--IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDR-LSQVFKQELDILLHLSHD 115
           NF Q+  +G G ++ VY  R  N +T    A+K IH+ ++        +E+ ++  L H+
Sbjct: 1   NFKQLEKLGEGTYATVYKGR--NRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           NIV+L       ++ +L+FEY+ +  L++ +  HG   +  L      +  +QL + I +
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA--LDPNTVKSFTYQLLKGIAF 115

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM------GFSSAVL-----PPSPS 222
            HE     ++H D+K  N+L+ +    KL DFG A+        FS+ V+      P   
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPD-- 170

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                       +++GS  Y           ST  D++S G I+ E++TG   F
Sbjct: 171 ------------VLLGSRTY-----------STSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 36/225 (16%)

Query: 65  IGSGGFSNVYLARLINDSTSTN----GAIKIHVGSDRLSQVFKQELDILL---HLSHDNI 117
           IG G +  VY AR   D  S +     ++++    D L     +E+ +L       H NI
Sbjct: 8   IGVGAYGTVYKAR---DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64

Query: 118 VKLIGYC----DDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           V+L+  C     DR+  V L+FE+V +  L+  L   P    LP      +  Q  + ++
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLD 122

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           +LH  C   IVH D+K  NIL+      KL DFG A++      L P             
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP------------- 166

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
              ++ +  Y  P  L     +T  D++S G I  E+      FC
Sbjct: 167 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 75/306 (24%), Positives = 127/306 (41%), Gaps = 50/306 (16%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDIL 109
           + R     S ++  G F  ++   LI++       + +    D  S++      QE  +L
Sbjct: 3   ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL 62

Query: 110 LHLSHDNIVKLIGYC-DDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMAI 163
             LSH NI+ ++  C +D +   +L+ Y+  G L     Q +L        L  +  + +
Sbjct: 63  YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS-PS 222
           A Q+A  + YLH+R    ++H DI A N +++E L  K+ D  +A    S  + P     
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD--NA---LSRDLFPMDYHC 174

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
              + +R  K         +     L     S+ +DV+SFGV+L EL+T           
Sbjct: 175 LGDNENRPVK---------WMALESLVNKEYSSASDVWSFGVLLWELMT----------- 214

Query: 283 LLTSLAGSMLNDIADCEATKVNELVDP-RLAGDFDL-DEARAMLSIAALCLRQSPILRPS 340
               L  +   +I   E      L D  RLA   +  DE   + ++ A C    P  RPS
Sbjct: 215 ----LGQTPYVEIDPFEMA--AYLKDGYRLAQPINCPDE---LFAVMACCWALDPEERPS 265

Query: 341 ATQILH 346
            +Q++ 
Sbjct: 266 FSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 58/226 (25%), Positives = 88/226 (38%), Gaps = 54/226 (23%)

Query: 65  IGSGGFSNV----YLARLINDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHDNIV 118
           +G G F +V    YL +          A+K        +    F +E  ++  L H  IV
Sbjct: 3   LGHGNFGSVVKGVYLMK---SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +LIG C   +  +L+ E  P G L + L       ++P  +   +A Q+A  + YL  + 
Sbjct: 60  RLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK- 114

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
             H VH D+ A N+LL      K+ DFG S  +G                          
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA------------------------- 147

Query: 238 GSPGYTD------------PHYLRTGMASTKTDVYSFGVILLELVT 271
           GS  Y              P  +  G  S+K+DV+S+GV L E  +
Sbjct: 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 66/254 (25%), Positives = 110/254 (43%), Gaps = 37/254 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK---IHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           + +G G F +V   +L  D +    A+K   I + +    + F  E   +    H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 120 LIGYC--DDRDEG----VLLFEYVPNGTLQE-----KLHGTPRSSKLPWRNRMAIAFQLA 168
           LIG C      EG    V++  ++ +G L       +L   P+   LP +  +     +A
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY--LPTQMLVKFMTDIA 122

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
             +EYL  +     +H D+ A N +L E++N  + DFG +K  ++             + 
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY--------RQG 171

Query: 229 RITKQ-VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP--ENGQLLT 285
           RI K  V  I      D  Y      +TK+DV+SFGV + E+ T  +   P  EN ++  
Sbjct: 172 RIAKMPVKWIAIESLADRVY------TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225

Query: 286 SL-AGSMLNDIADC 298
            L  G+ L    DC
Sbjct: 226 YLRQGNRLKQPPDC 239

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 27/174 (15%)

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT----LQEKLHGTPRSSKLPW 157
           F +E  +++ LSH+ +V+L G C  +    ++ EY+ NG     L+E      + S+L  
Sbjct: 46  FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQL-- 102

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
              + +   + + + YL  +     +H D+ A N L+++    K+ DFG ++        
Sbjct: 103 ---LEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156

Query: 218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               S  P R              ++ P  L     S+K+DV++FGV++ E+ +
Sbjct: 157 SSVGSKFPVR--------------WSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           F + +GSG F  V+L +          AIK I+ G+    + F +E  +++ LSH  +V+
Sbjct: 8   FMKELGSGQFGVVHLGKW---RAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ E++ NG L   L    R  KL     +++   + + +EYL ER +
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYL-ERNS 120

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
              +H D+ A N L+      K+ DFG  +          S +  P +            
Sbjct: 121 F--IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK------------ 166

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPE-NGQLLTSLAGSMLNDIAD 297
             ++ P        S+K+DV+SFGV++ E+ T G   F  + N +++             
Sbjct: 167 --WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE------------ 212

Query: 298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
              ++   L  P+LA       +  +  +   C  + P  RP+  ++L  I
Sbjct: 213 -MISRGFRLYRPKLA-------SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 74/302 (24%), Positives = 124/302 (41%), Gaps = 61/302 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTN----GAIKIHVGSDRLSQVFKQELDILLHLSHDNIV 118
           +++G G F +V   +L  D  S        +K+ + +    + F  E   +    H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 119 KLIGYC-DDRDEG-----VLLFEYVPNGTLQE-----KLHGTPRSSKLPWRNRMAIAFQL 167
           KLIG C +          +++  ++ +G L       +L G P   KLP +  +     +
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE--KLPLQTLLKFMVDI 122

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           A  +EYL  R   + +H D+ A N +L E +   + DFG +K  +S             +
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY--------RQ 171

Query: 228 SRITKQ-VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCP--ENGQL 283
            RI K  V  I      D  Y      ++K+DV++FGV + E+ T G   + P  EN ++
Sbjct: 172 GRIAKMPVKWIAIESLADRVY------TSKSDVWAFGVTMWEIATRGQTPY-PGVENHEI 224

Query: 284 LTSL-AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
              L  G+ L    DC                  LDE   ++     C R  P  RP+ T
Sbjct: 225 YDYLRHGNRLKQPEDC------------------LDELYDLMY---SCWRADPKDRPTFT 263

Query: 343 QI 344
           ++
Sbjct: 264 KL 265

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 60/237 (25%), Positives = 87/237 (36%), Gaps = 48/237 (20%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIK---IHVGSDRLSQVFKQELDILLHLSHDN 116
                +G G F  VY AR I        A+K   +H   D       +E+ IL  L H N
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVV--ALKKILMHNEKDGFPITALREIKILKKLKHPN 68

Query: 117 IVKLI--------GYCDDRDEGVLLFEYVP---NGTLQ-EKLHGTPRSSKLPWRNRMAIA 164
           +V LI             R    ++  Y+    +G L+   +  T    K          
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC-------YM 121

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
            QL + I YLHE    HI+H DIKA+NIL++     K+ DFG A+        P      
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG-GG 177

Query: 225 PSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
               + T  V         +++G   YT           T  D++  G +  E+ T 
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYT-----------TAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 24/115 (20%)

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSP 221
           IA  + +A+EYLH +  L ++H D+K SN+L+  +   KLCDFG S  +  S A      
Sbjct: 108 IAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA------ 159

Query: 222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA----STKTDVYSFGVILLELVTG 272
                      + +  G   Y  P  +   +       K+DV+S G+ ++EL TG
Sbjct: 160 -----------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 28/219 (12%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLS-HDNI 117
           +VIG G ++ V L RL    T    A+K+     V  D      + E  +    S H  +
Sbjct: 1   RVIGRGSYAKVLLVRL--KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 58

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           V L            + EYV  G L   +    R  KLP  +    + +++ A+ YLHER
Sbjct: 59  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER 115

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               I++ D+K  N+LL+   + KL D+G  K G     L P  + S             
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-----LRPGDTTST----------FC 157

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  LR        D ++ GV++ E++ G   F
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 72/259 (27%), Positives = 112/259 (43%), Gaps = 45/259 (17%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QV--FKQELD 107
           DD E       +VIG G F  V L +     T    A+KI   +D L   QV   + E D
Sbjct: 1   DDFESL-----KVIGRGAFGEVRLVQ--KKDTGHIYAMKILRKADMLEKEQVAHIRAERD 53

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           IL+      +VK+     D+    L+ E++P G +   L      S+       A  F +
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSE------EATQFYI 107

Query: 168 AQ---AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-------SAKMGFSSAVL 217
           A+   AI+ +H+   L  +H DIK  N+LL+   + KL DFG       + +  F   + 
Sbjct: 108 AETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164

Query: 218 --PPS-----------PSPSPSRSRITKQVMMIGSPGYTDPH-YLRTGMASTKTDVYSFG 263
             PPS            + +  ++R       +G+P Y  P  +++TG  +   D +S G
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLG 223

Query: 264 VILLELVTGMEAFCPENGQ 282
           VI+ E++ G   FC E  Q
Sbjct: 224 VIMYEMLIGYPPFCSETPQ 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 35/223 (15%)

Query: 63  QVIGSGGFSNVYLAR-LINDSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSHDN 116
           +V+G G F  V+L R +         A+K+   +     DR+    K E DIL  ++H  
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT--KMERDILAEVNHPF 59

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ---AIEY 173
           IVKL        +  L+ +++  G L  +L      SK        + F LA+   A+++
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 113

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH   +L I++ D+K  NILL+E  + KL DFG +K                S     K 
Sbjct: 114 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---------------ESIDHEKKA 155

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
               G+  Y  P  +     +   D +SFGV++ E++TG   F
Sbjct: 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-------QVFKQELDILLHLSHD 115
           +++G G F  VYL    +  T    A+K  V  D  S          + E+ +L +L H+
Sbjct: 8   KLLGQGAFGRVYLC--YDADTGRELAVK-QVQFDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 116 NIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
            IV+  G   D  E  L    E++P G+++++L      ++   R       Q+ + + Y
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK---YTRQILEGVSY 121

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH   +  IVH DIK +NIL +   N KL DFG++K    +  L  +   S         
Sbjct: 122 LH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR-LQTICLSGTGMKS--------- 168

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             + G+P +  P  +       K D++S G  ++E++T
Sbjct: 169 --VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 31/248 (12%)

Query: 33  QYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH 92
           Q H   D    +  K+ +    E F  NF + +G+G F  V LA   N+        +  
Sbjct: 8   QLHKKKDSDSTKEPKRKNKMKYEDF--NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65

Query: 93  ----VGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG 148
               +   ++  VF  E  IL +++H   V L G   D     L+ E+V  G     L  
Sbjct: 66  KSKIIKQKQVDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR- 123

Query: 149 TPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
             R+ + P       A Q+    EYL    +L+IV+ D+K  N+LL++    K+ DFG A
Sbjct: 124 --RNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178

Query: 209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
           K+                    T+   + G+P Y  P  L         D ++ G+ + E
Sbjct: 179 KV------------------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220

Query: 269 LVTGMEAF 276
           ++ G   F
Sbjct: 221 ILVGCPPF 228

Length = 340

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 82/305 (26%), Positives = 123/305 (40%), Gaps = 55/305 (18%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELD 107
           +D E+   +  + IG G F  VY AR  +  T+   AIK    S + S    Q   +E+ 
Sbjct: 21  EDPEKLFTDLRE-IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            L  + H N ++  G         L+ EY + + +   ++H  P    L      AI   
Sbjct: 78  FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHG 133

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
             Q + YLH     +++H DIKA NILL E    KL DFGSA +             SP+
Sbjct: 134 ALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA------------SPA 178

Query: 227 RSRITKQVMMIGSPGYTDPHY---LRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
            S        +G+P +  P     +  G    K DV+S G+  +EL             L
Sbjct: 179 NS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-------RKPPL 224

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
               A S L  IA  E+        P L  +   D  R  +     CL++ P  RP++ +
Sbjct: 225 FNMNAMSALYHIAQNES--------PTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEE 273

Query: 344 ILHTI 348
           +L  +
Sbjct: 274 LLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 68/302 (22%), Positives = 122/302 (40%), Gaps = 63/302 (20%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLH 111
            ++ F +     IG G    V +A     ST    A+K + +   +  ++   E+ I+  
Sbjct: 20  YLDNFVK-----IGEGSTGIVCIATDK--STGRQVAVKKMDLRKQQRRELLFNEVVIMRD 72

Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM------AIAF 165
             H NIV++       DE  ++ E++  G L + +  T          RM       +  
Sbjct: 73  YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----------RMNEEQIATVCL 122

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
            + +A+ +LH +    ++H DIK+ +ILL      KL DF     GF + V    P    
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF-----GFCAQVSKEVP---- 170

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT 285
                 ++  ++G+P +  P  +      T+ D++S G++++E+V G   +   N   L 
Sbjct: 171 ------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF--NEPPLQ 222

Query: 286 SLAGSMLNDIADCEATKVNEL--VDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
           +     +  I D    K+  L  V PRL             S     L + P  R +A +
Sbjct: 223 A-----MKRIRDNLPPKLKNLHKVSPRLR------------SFLDRMLVRDPAQRATAAE 265

Query: 344 IL 345
           +L
Sbjct: 266 LL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 44/233 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDILLHLSHDNIV 118
           +VIG G F  V + ++ N  T    A+KI    + L +     F++E D+L++     I 
Sbjct: 7   KVIGRGAFGEVAVVKMKN--TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT 64

Query: 119 KLIGYCDDRDEGVLLFEYVPNG---TLQEKLHGTPRSSKLPWRNRMAIAFQLAQ---AIE 172
            L     D +   L+ +Y   G   TL  K        +LP    MA  F LA+   AI+
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-----EDRLP--EDMA-RFYLAEMVLAID 116

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSRIT 231
            +H+   L  VH DIK  N+LL+++ + +L DFGS  ++     V          +S + 
Sbjct: 117 SVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV----------QSNVA 163

Query: 232 KQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPE 279
                +G+P Y  P  L+      G    + D +S GV + E++ G   F  E
Sbjct: 164 -----VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 44/222 (19%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHD--NIVK 119
           IGSG    VY  R     T    A+K    +       ++   +LD++L  SHD   IVK
Sbjct: 23  IGSGTCGQVYKMRFK--KTGHVMAVKQMRRTGNKEENKRIL-MDLDVVL-KSHDCPYIVK 78

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA--IAFQLAQAIEYLHER 177
             GY     +  +  E +   T  +KL    +  + P    +   +   + +A+ YL E+
Sbjct: 79  CYGYFITDSDVFICMELM--STCLDKLL---KRIQGPIPEDILGKMTVAIVKALHYLKEK 133

Query: 178 CTLH-IVHGDIKASNILLEEHLNCKLCDFG-SAKMGFS-----SAVLPPSPSPSPSRSRI 230
              H ++H D+K SNILL+   N KLCDFG S ++  S     SA      +P     RI
Sbjct: 134 ---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAP----ERI 186

Query: 231 TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                    P   +P Y        + DV+S G+ L+EL TG
Sbjct: 187 D--------PPDPNPKY------DIRADVWSLGISLVELATG 214

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 57.0 bits (138), Expect = 6e-10
 Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 17/151 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIV--KL 120
           +++  G  + VYL    ++       +KI+  S       ++E+ IL  L+   +   K+
Sbjct: 4   KLLKGGLTNRVYLLGTKDEDY----VLKIN-PSREKGADREREVAILQLLARKGLPVPKV 58

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           +   +      LL E++   TL           ++    +  IA QLA+ +  LH+   L
Sbjct: 59  LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMG 211
            + HGD+   NIL+++     + D+  A  G
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 66/247 (26%), Positives = 100/247 (40%), Gaps = 38/247 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QV--FKQELDILLHLSHDNIV 118
           +VIG G F  V L +     T    A+KI   +D L   QV   + E DIL+      +V
Sbjct: 7   KVIGRGAFGEVRLVQ--KKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ---AIEYLH 175
           K+     D+    L+ E++P G +   L       K          F +A+   AI+ +H
Sbjct: 65  KMFYSFQDKLNLYLIMEFLPGGDMMTLL------MKKDTLTEEETQFYIAETVLAIDSIH 118

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFG-------SAKMGFSSAVLPPSPS------ 222
           +   L  +H DIK  N+LL+   + KL DFG       + +  F   +    PS      
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 223 -------PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                   +  R+R       +G+P Y  P        +   D +S GVI+ E++ G   
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 276 FCPENGQ 282
           FC E  Q
Sbjct: 236 FCSETPQ 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 37/227 (16%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-------HDNI 117
           +G G F  V  A  +    + N    + V   +     K   D++  +        H NI
Sbjct: 20  LGEGAFGQVVKAEAV-GLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-------------TPRSSKLPWRNRMAIA 164
           + L+G C       ++ EY  +G L++ L                P    L  ++ ++ A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
           +Q+A+ +E+L  +     +H D+ A N+L+ E    K+ DFG A+      +        
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRK 190

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +  R+  + M         P  L   + + ++DV+SFGV+L E+ T
Sbjct: 191 TTNGRLPVKWMA--------PEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 24/217 (11%)

Query: 63  QVIGSGGFSNVYLARLI-NDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN--IVK 119
           +VIG G ++ V L RL  ND       +K  +  D     + Q    +   +  N  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L           L+ EYV  G L   +    R  KLP  +    A ++  A+ +LHER  
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHER-- 115

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
             I++ D+K  N+LL+   + KL D+G  K G     L P  + S             G+
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG-----LGPGDTTS----------TFCGT 159

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           P Y  P  LR        D ++ GV++ E++ G   F
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 28/223 (12%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDNI 117
           +V+G G F  V LARL    +    A+K+      +  D +     ++  + L  +H  +
Sbjct: 1   RVLGKGSFGKVMLARL--KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 58

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
            +L       D    + E+V  G L   +  + R  +   R R   A ++  A+ +LH++
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA--RARFYAA-EITSALMFLHDK 115

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               I++ D+K  N+LL+   +CKL DFG  K G  +     +                 
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST---------------FC 157

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
           G+P Y  P  L+  +     D ++ GV+L E++ G   F  EN
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 39/229 (17%)

Query: 65  IGSGGFSNVYLARLIN-DSTSTNGAIKIHV------GSDRLSQVFKQELDILLHL-SHDN 116
           +G G F  V +A  I  D    N  + + V       +D+       E++++  +  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------TPRSSKLP-----WRNRMAI 163
           I+ L+G C       +L EY   G L+E L          +  + KLP     +++ ++ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 164 AFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+      V      
Sbjct: 140 AYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYY 190

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              +  R+  + M         P  L   + + ++DV+SFGV+L E+ T
Sbjct: 191 KKTTNGRLPVKWMA--------PEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-QVFKQELDILL---HLSHDNIV 118
           +++GSG F  V+    I +  S    + I    DR   Q F++  D +L    L H  IV
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ +  P G+L +  H       L  +  +    Q+A+ + YL E  
Sbjct: 73  RLLGICPGASLQ-LVTQLSPLGSLLD--HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP-SRSRITKQVMMI 237
              +VH ++ A NILL+     ++ DFG A +      L P       S  +   + M +
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADL------LYPDDKKYFYSEHKTPIKWMAL 180

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
            S        +  G  + ++DV+S+GV + E+++ G E +
Sbjct: 181 ES--------ILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 58.7 bits (143), Expect = 1e-09
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 58/233 (24%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---------QELDILLHLS 113
           + IGSG +  V  A  ++  T    AIK      ++S VF          +E+ +L HL 
Sbjct: 6   KPIGSGAYGVVCSA--VDKRTGRKVAIK------KISNVFDDLIDAKRILREIKLLRHLR 57

Query: 114 HDNIVKL--IGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSKLPWRNRMA-IAFQLA 168
           H+NI+ L  I      ++    F   Y+    ++  LH   +S +    + +    +Q+ 
Sbjct: 58  HENIIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQIL 113

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           + ++YLH   + +++H D+K SNIL+  + + K+CDFG A+      V P          
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR-----GVDPDEDEKGF--- 162

Query: 229 RITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
            +T+ V         +++ S  YT              D++S G I  EL+T 
Sbjct: 163 -LTEYVVTRWYRAPELLLSSSRYTKA-----------IDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 50/230 (21%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-------------HVGSDR--LSQVFKQELD 107
           +VIG G F  V LA+  + +     A+K+             H+ ++R  L +  K    
Sbjct: 1   KVIGKGSFGKVLLAK--HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQ-EKLHGTPRSSKLPWRNRMAIAFQ 166
           + LH S     KL    D  + G L F       LQ E+    PR+           A +
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFH------LQRERSFPEPRAR--------FYAAE 104

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           +A A+ YLH    L+I++ D+K  NILL+   +  L DFG  K G              S
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI-----------EHS 150

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++  T      G+P Y  P  LR        D +  G +L E++ G+  F
Sbjct: 151 KTTST----FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELD 107
           DD E+   +  + IG G F  VY AR + +S     AIK    S + S    Q   +E+ 
Sbjct: 11  DDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVV--AIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            L  L H N ++  G         L+ EY + + +   ++H  P    L      A+   
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHG 123

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
             Q + YLH     +++H D+KA NILL E    KL DFGSA      +++ P+      
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANX---- 170

Query: 227 RSRITKQVMMIGSPGYTDPHY---LRTGMASTKTDVYSFGVILLEL 269
                     +G+P +  P     +  G    K DV+S G+  +EL
Sbjct: 171 ---------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 63  QVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNIVK 119
           +VIG+G F  V   RL +        AIK +  G +++  + F  E  I+    H NI+ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G        +++ E++ NG L   L       +      + +   +A  ++YL E   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE--- 124

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
           ++ VH D+ A NIL+  +L CK+ DFG ++       L    S     S +  ++ +   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRF------LEDDTSDPTYTSSLGGKIPI--- 175

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             +T P  +     ++ +DV+S+G+++ E+++
Sbjct: 176 -RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 33/223 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIV 118
           +VIG G F  V L R  + S+    A+K+    + +    S  F +E DI+   +   +V
Sbjct: 49  KVIGRGAFGEVQLVR--HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L     D     ++ EY+P G L   +       K  W       F  A+ +  L    
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAK-----FYTAEVVLALDAIH 159

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
           ++ ++H D+K  N+LL++H + KL DFG+  KM                 + + +    +
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM---------------DETGMVRCDTAV 204

Query: 238 GSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  L++    G    + D +S GV L E++ G   F
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 69/228 (30%), Positives = 96/228 (42%), Gaps = 48/228 (21%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK----QELDILLHLSHDNIVK 119
            IG G +  VY AR  +  T    A+K  V  D   + F     +E+ IL  L+H NIV 
Sbjct: 14  QIGEGTYGQVYKAR--DKDTGELVALK-KVRLDNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 120 LIGYCDDRDEGV----------LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QL 167
           L     D+ + +          L+FEY+        L G   S  + +      +F  QL
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + + Y H++   + +H DIK SNILL      KL DFG A++  S    P         
Sbjct: 126 LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--------- 173

Query: 228 SRITKQVMMIGSPGYTDPHYL----RTGMASTKTDVYSFGVILLELVT 271
              T +V+ +    Y  P  L    R G A    DV+S G IL EL T
Sbjct: 174 --YTNKVITL---WYRPPELLLGEERYGPA---IDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 73/252 (28%), Positives = 103/252 (40%), Gaps = 48/252 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QV--FKQELDILLHLSHDNIV 118
           + +G G F  V LA  ++  T    A+K     D L+  QV   K E DIL    ++ +V
Sbjct: 7   KTLGIGAFGEVCLACKVD--THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVV 64

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR-NRMAIAFQLAQAIEYLHER 177
           KL     D+D    + +Y+P G +   L    R    P    R  IA +L  AIE +H+ 
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMEVFPEVLARFYIA-ELTLAIESVHK- 119

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF-----------SSAVLPPSPSPS-- 224
             +  +H DIK  NIL++   + KL DFG    GF            S +   S  PS  
Sbjct: 120 --MGFIHRDIKPDNILIDLDGHIKLTDFGLC-TGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 225 --------------PSRSRITKQVM------MIGSPGYTDPHYLRTGMASTKTDVYSFGV 264
                             R TKQ        ++G+P Y  P  L     +   D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 265 ILLELVTGMEAF 276
           IL E++ G   F
Sbjct: 237 ILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 35/241 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDILLHLSHDNIV 118
           +VIG G F  V + ++    T    A+KI    + L +     F++E ++L++     I 
Sbjct: 7   KVIGRGAFGEVAVVKM--KHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWIT 64

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            L     D +   L+ +Y   G L   L  +    +LP    MA  F +A+ +  +H   
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLP--EDMA-RFYIAEMVLAIHSIH 119

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
            LH VH DIK  N+LL+ + + +L DFGS  KM     V               +  + +
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV---------------QSSVAV 164

Query: 238 GSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           G+P Y  P  L+      G    + D +S GV + E++ G   F  E+   L    G ++
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIM 221

Query: 293 N 293
           N
Sbjct: 222 N 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 37/228 (16%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHD 115
           +  +VIG G F  V L R  + S+    A+K+    + +    S  F +E DI+ H + +
Sbjct: 46  DVIKVIGRGAFGEVQLVR--HKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103

Query: 116 NIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
            IV+L  +   +D+  L  + EY+P G L   +       K  W  R   A ++  A++ 
Sbjct: 104 WIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--W-ARFYTA-EVVLALDA 157

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSRITK 232
           +H   ++  +H D+K  N+LL++  + KL DFG+  KM  +  V          R     
Sbjct: 158 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV----------RCDTA- 203

Query: 233 QVMMIGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAF 276
               +G+P Y  P  L++    G    + D +S GV L E++ G   F
Sbjct: 204 ----VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 43/232 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD-NIVKLI 121
           +V+G+G +  VY  R +   T    AIK+   ++   +  K E+++L   SH  NI    
Sbjct: 22  EVVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYY 79

Query: 122 GYCDDR------DEGVLLFEYVPNGTLQEKLHGTPRSS-KLPWRNRMAIAF---QLAQAI 171
           G    +      D+  L+ E+   G++ + +  T  ++ K  W     IA+   ++ + +
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-----IAYICREILRGL 134

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRI 230
            +LH      ++H DIK  N+LL E+   KL DFG SA++  +                +
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT----------------V 175

Query: 231 TKQVMMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFC 277
            ++   IG+P +  P  +            ++D++S G+  +E+  G    C
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 67/271 (24%), Positives = 96/271 (35%), Gaps = 60/271 (22%)

Query: 19  PIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWD----DVERFTQNFSQVIGSGGFSNVY 74
             D V    D D D+          +   + +       V R   N    +  G    V+
Sbjct: 50  DSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVF 109

Query: 75  LARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI-GY---------- 123
           +     D       +K   G     +    E+DIL  +SH  I+ LI  Y          
Sbjct: 110 VCTKHGDEQRKKVIVKAVTGGKTPGR----EIDILKTISHRAIINLIHAYRWKSTVCMVM 165

Query: 124 ----CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
               CD       LF YV             RS  LP    + I  +L +A+ YLH R  
Sbjct: 166 PKYKCD-------LFTYVD------------RSGPLPLEQAITIQRRLLEALAYLHGR-- 204

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
             I+H D+K  NI L+E  N  L DFG+A K+       P +P          +     G
Sbjct: 205 -GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH----PDTP----------QCYGWSG 249

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
           +     P  L       KTD++S G++L E+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 42/222 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---------QELDILLHLS 113
             +GSG +  V  A   +  T    AIK      +LS+ F+         +EL +L H+ 
Sbjct: 21  SPVGSGAYGQVCSA--FDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLLKHMD 72

Query: 114 HDNIVKLIGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           H+N++ L+         +  F+  Y+    +   L+   +  KL   +   + +Q+ + +
Sbjct: 73  HENVIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGL 131

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
           +Y+H   +  I+H D+K SNI + E    K+ DFG A+                +   +T
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH---------------TDDEMT 173

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
             V    +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 GYV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 44/181 (24%)

Query: 105 ELDILLHLSHDNIVKL--IGYCDDRDEGVLLFEYVPNG--TLQEKLHGTPRSSKLPWRNR 160
           E++ILL L H NIV +  +    + D+  ++ EYV +   +L E +      S++     
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK---- 109

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
             +  QL   + +LH+     I+H D+K SN+LL      K+CDFG A+           
Sbjct: 110 -CLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR----------- 154

Query: 221 PSPSPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              SP +   T+ V         +++G+  Y+           T  D++S G I  EL+T
Sbjct: 155 EYGSPLK-PYTQLVVTLWYRAPELLLGAKEYS-----------TAIDMWSVGCIFAELLT 202

Query: 272 G 272
            
Sbjct: 203 K 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 69/251 (27%), Positives = 102/251 (40%), Gaps = 46/251 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL--SQV--FKQELDILLHLSHDNIV 118
           + +G G F  V LAR ++  T    A+K     D L  +QV   K E DIL    ++ +V
Sbjct: 7   KTLGIGAFGEVCLARKVD--TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVV 64

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L     D+D    + +Y+P G +   L    R    P         +L  A+E +H+  
Sbjct: 65  RLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCAVESVHK-- 119

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG---------------------SAKMGFSSAVL 217
            +  +H DIK  NIL++   + KL DFG                        M FS+   
Sbjct: 120 -MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 218 PPSPSP-----SPSRSRITKQVM------MIGSPGYTDPH-YLRTGMASTKTDVYSFGVI 265
            P+         P   R  +Q        ++G+P Y  P   LRTG      D +S GVI
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237

Query: 266 LLELVTGMEAF 276
           L E++ G   F
Sbjct: 238 LYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 36/221 (16%)

Query: 97  RLSQVFKQELDILLHLSHDNIVKL--------IGYCDDRDEGVLLFEYVPNGTLQEKLHG 148
           R +   + E+  L  L+H+NI+K+          Y   +     L+ ++ +     K   
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK--- 261

Query: 149 TPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 L  + R AI  QL  A+EY+H++    ++H DIK  NI L       L DFG+A
Sbjct: 262 ---DRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Query: 209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
            M F              + R       +G+     P  L        TD++S G+ILL+
Sbjct: 315 -MPFE-------------KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360

Query: 269 LVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDP 309
           +++    FCP          G  L  I D  +    E  DP
Sbjct: 361 MLS--HDFCPIGDG--GGKPGKQLLKIIDSLSVCDEEFPDP 397

Length = 501

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 33/240 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDILLHLSHDNIV 118
           +VIG G F  V + +L N       A+KI    + L +     F++E D+L++  +  I 
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVF--AMKILNKWEMLKRAETACFREERDVLVNGDNQWIT 64

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            L     D +   L+ +Y   G L   L  +    +LP         ++  AI+ +H+  
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDSVHQ-- 120

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
            LH VH DIK  NIL++ + + +L DFGS         +  S              + +G
Sbjct: 121 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS--------------VAVG 165

Query: 239 SPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN 293
           +P Y  P  L+      G    + D +S GV + E++ G   F  E+   L    G ++N
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 48/229 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-------------HVGSDR--LSQVFKQELD 107
           +VIG G F  V LA+   D      A+K+             H+ ++R  L +  K    
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCY--AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           + LH S     KL    D  + G L F       LQ +     RS   P R R   A ++
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFH------LQRE-----RSFPEP-RARFYAA-EI 105

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           A A+ YLH   +++IV+ D+K  NILL+   +  L DFG  K G + +            
Sbjct: 106 ASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS------------ 150

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                     G+P Y  P  +R        D +  G +L E++ G+  F
Sbjct: 151 ---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 28/177 (15%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E  +L  L H NIV L      ++    +FEY+     Q   +       L   N    
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRLF 108

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            FQL + + Y+H +   HI+H D+K  N+L+      KL DFG A+   + ++    PS 
Sbjct: 109 MFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR---AKSI----PSQ 158

Query: 224 SPSRSRIT----KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S   +T       +++G+  Y           S+  D++  G I +E++ G  AF
Sbjct: 159 TYSSEVVTLWYRPPDVLLGATDY-----------SSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 21/124 (16%)

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           R R   A +L  A+E LH+    ++++ D+K  NILL+   +  LCDFG  K+       
Sbjct: 94  RARFYTA-ELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-- 147

Query: 218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK-TDVYSFGVILLELVTGMEAF 276
                         K     G+P Y  P  L  G   TK  D ++ GV+L E++TG+  F
Sbjct: 148 -------------DKTNTFCGTPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPF 193

Query: 277 CPEN 280
             EN
Sbjct: 194 YDEN 197

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 56/231 (24%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQ----ELDILLHLSH 114
             IG G +  V  A   +  T    AIK      ++S    Q F Q    E+ IL    H
Sbjct: 11  SYIGEGAYGMVCSA--THKPTGVKVAIK------KISPFEHQTFCQRTLREIKILRRFKH 62

Query: 115 DNIVKL--IGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
           +NI+ +  I      +     F   Y+    ++  L+   ++  L   +     +Q+ + 
Sbjct: 63  ENIIGILDIIRPPSFES----FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRG 118

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
           ++Y+H   + +++H D+K SN+LL  + + K+CDFG A++         +         +
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI---------ADPEHDHTGFL 166

Query: 231 TKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           T+ V         +M+ S GYT              D++S G IL E+++ 
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYT-----------KAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 31/172 (18%)

Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------TPRSSKLP-----WRNR 160
           H NI+ L+G C       ++ EY   G L+E L          T   +K+P     +++ 
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 161 MAIAFQLAQAIEYLH-ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
           ++ A+Q+A+ +EYL   RC    +H D+ A N+L+ E    K+ DFG A+      V   
Sbjct: 137 VSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDI 187

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                 S  R+  + M         P  L   + + ++DV+SFG+++ E+ T
Sbjct: 188 DYYKKTSNGRLPVKWMA--------PEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 44/194 (22%)

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQE-----KLHGTPRSSKLP 156
           F +E+ I+  L   NI++L+  C   D   ++ EY+ NG L +     +       + + 
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 157 ---WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
              +   + +A Q+A  ++YL    +L+ VH D+   N L+ ++   K+ DFG ++  +S
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 214 S--------AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVI 265
                    AVL       P R    + +++              G  +T +DV++FGV 
Sbjct: 183 GDYYRIQGRAVL-------PIRWMSWESILL--------------GKFTTASDVWAFGVT 221

Query: 266 LLELVTGMEAFCPE 279
           L E++T     C E
Sbjct: 222 LWEILT----LCKE 231

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.9 bits (134), Expect = 8e-09
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 65  IGSGGFSNVYLARLINDSTSTNG---AIKIHVGSDRLSQVFK--QELDILLHLSHDNIVK 119
           +G G ++ VY  +     +  NG   A+K+    +     F   +E  +L  L H NIV 
Sbjct: 13  LGEGSYATVYKGK-----SKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L      ++   L+FEYV     Q   +       L   N     FQL + + Y+H+R  
Sbjct: 68  LHDIIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIHQR-- 122

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT----KQVM 235
            +I+H D+K  N+L+ +    KL DFG A+           PS + S   +T       +
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDV 174

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++GS  Y           ST  D++  G I +E++ G+ AF
Sbjct: 175 LLGSTEY-----------STCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.5 bits (133), Expect = 8e-09
 Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 35/228 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD-NIVKLI 121
           +++G+G +  VY  R +   T    AIK+   +    +  KQE+++L   SH  NI    
Sbjct: 12  ELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYY 69

Query: 122 GYCDDR------DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           G    +      D+  L+ E+   G++ + +  T + + L       I  ++ + + +LH
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH 128

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           +     ++H DIK  N+LL E+   KL DFG SA++  +                + ++ 
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT----------------VGRRN 169

Query: 235 MMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFC 277
             IG+P +  P  +            K+D++S G+  +E+  G    C
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 31/113 (27%), Positives = 51/113 (45%), Gaps = 19/113 (16%)

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           A Q+   +E+LH+R    IV+ D+K  N+LL++H N ++ D G A               
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA-------------VE 144

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                +I  +    G+PGY  P  L+  +     D ++ G  L E++ G   F
Sbjct: 145 LKGGKKIKGRA---GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 22/196 (11%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L     + ++P      +
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKV 108

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG       S  L  S + 
Sbjct: 109 SIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFG------VSGQLIDSMAN 160

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
           S            +G+  Y  P  L+    S ++D++S G+ L+EL  G     P + + 
Sbjct: 161 S-----------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209

Query: 284 LTSLAGSMLNDIADCE 299
           L ++ G  + D  + E
Sbjct: 210 LEAIFGRPVVDGEEGE 225

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 59/263 (22%), Positives = 110/263 (41%), Gaps = 46/263 (17%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P      I
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPENILGKI 104

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG       S  L  S + 
Sbjct: 105 SIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG------VSGQLIDSMAN 156

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
           S            +G+  Y  P  L+    + ++D++S G+ L+E+  G     P + + 
Sbjct: 157 S-----------FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205

Query: 284 LTSLAGSMLNDIADCEATK--------------VNELVD-------PRLAGDFDLDEARA 322
           L ++ G  +++    E+ +              + EL+D       P+L      DE + 
Sbjct: 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD 265

Query: 323 MLSIAALCLRQSPILRPSATQIL 345
            +     CL+++P  R    ++ 
Sbjct: 266 FVDK---CLKKNPKERADLKELT 285

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 58/239 (24%), Positives = 90/239 (37%), Gaps = 32/239 (13%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           ++G G    V+L RL    T    A+K+      +  +++ +V   E +IL  L H  + 
Sbjct: 8   LLGKGDVGRVFLVRL--KGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATLDHPFLP 64

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ---AIEYLH 175
            L           L+ +Y P G L   L   P    L         F  A+   A+EYLH
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGK-CLS---EEVARFYAAEVLLALEYLH 120

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP----PSPSPSPSRSRIT 231
               L IV+ D+K  NILL E  +  L DF  +K                S   S + I 
Sbjct: 121 ---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 232 KQVM----------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            +             +G+  Y  P  +      +  D ++ G++L E++ G   F   N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 24/214 (11%)

Query: 63  QVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNIVK 119
           +VIG+G F  V   RL +        AIK +  G +++  + F  E  I+    H NI+ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G        +++ EY+ NG+L   L       +      + +   +A  ++YL +   
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYLSD--- 124

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS--RITKQVMMI 237
           +  VH D+ A NIL+  +L CK+ DFG       S VL   P  + +    +I  +    
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFG------LSRVLEDDPEAAYTTRGGKIPIR---- 174

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +T P  +     ++ +DV+S+G+++ E+++
Sbjct: 175 ----WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 21/179 (11%)

Query: 99  SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR 158
           S+ F +   ++  LSH ++V   G C   DE +++ EYV  G+L   L        + W 
Sbjct: 43  SESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW- 101

Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM---GFSSA 215
            ++ +A QLA A+ +L ++    + HG++ A N+LL    + K  +    K+   G S  
Sbjct: 102 -KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157

Query: 216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
           VLP        +  + +++  +      +P  L     S   D +SFG  L E+ +G +
Sbjct: 158 VLP--------KEILLERIPWVPPECIENPQNL-----SLAADKWSFGTTLWEIFSGGD 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 35/224 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIV 118
           +VIG G F  V L R  + ST    A+K+    + +    S  F +E DI+   +   +V
Sbjct: 49  KVIGRGAFGEVQLVR--HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106

Query: 119 KLI-GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           +L   + DDR    ++ EY+P G L   +       K  W       F  A+ +  L   
Sbjct: 107 QLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEK--WAR-----FYTAEVVLALDAI 158

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLPPSPSPSPSRSRITKQVMM 236
            ++  +H D+K  N+LL++  + KL DFG+  KM               ++  + +    
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM---------------NKEGMVRCDTA 203

Query: 237 IGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAF 276
           +G+P Y  P  L++    G    + D +S GV L E++ G   F
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 48/183 (26%), Positives = 75/183 (40%), Gaps = 42/183 (22%)

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E  +L  L H NIV L      +    L+FEY+ +  L++ +        +   N     
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSM--HNVRLFL 109

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG------FSSAVL- 217
           FQL + + Y H+R    ++H D+K  N+L+ E    KL DFG A+        +S+ V+ 
Sbjct: 110 FQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT 166

Query: 218 ----PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
               PP               +++GS  Y           ST  D++  G I  E+ TG 
Sbjct: 167 LWYRPPD--------------VLLGSTEY-----------STSLDMWGVGCIFYEMATGR 201

Query: 274 EAF 276
             F
Sbjct: 202 PLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 28/177 (15%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ +L +L H NIV L           L+FEY+ +  L++ L      + +   N    
Sbjct: 52  REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC--GNLMSMHNVKIF 108

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            FQL + + Y H+R    I+H D+K  N+L+ E    KL DFG A+   + +V    P+ 
Sbjct: 109 MFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR---AKSV----PTK 158

Query: 224 SPSRSRIT----KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S   +T       +++GS  Y           ST  D++  G IL E+ TG   F
Sbjct: 159 TYSNEVVTLWYRPPDVLLGSTEY-----------STPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 38/223 (17%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG- 122
           V+G G F  V LA L    T    A+K+ +  D    V  Q+ D+   ++   ++ L G 
Sbjct: 2   VLGKGSFGKVLLAELKG--TDELYAVKV-LKKD----VILQDDDVECTMTEKRVLALAGK 54

Query: 123 -------YCDDRDEGVLLF--EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
                  +   + +  L F  EYV  G L   +    RS +         A ++   +++
Sbjct: 55  HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQF 111

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LHER    I++ D+K  N+LL+   + K+ DFG  K G    V                 
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---------------TT 153

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
               G+P Y  P  L         D ++ GV+L E++ G   F
Sbjct: 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 50/230 (21%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-------------HVGSDR--LSQVFKQELD 107
           +VIG G F  V LA+  +D +    A+K+             H+ ++R  L +  K    
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFY--AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQ-EKLHGTPRSSKLPWRNRMAIAFQ 166
           + LH S     KL    D  + G L F       LQ E+    PR+           A +
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFH------LQRERCFLEPRAR--------FYAAE 104

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           +A AI YLH   +L+I++ D+K  NILL+   +  L DFG  K G     + P  + S  
Sbjct: 105 VASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG-----VEPEETTS-- 154

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      G+P Y  P  LR        D +  G +L E++ G+  F
Sbjct: 155 --------TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 52/157 (33%), Positives = 76/157 (48%), Gaps = 28/157 (17%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK--------QELDILLHLS-HD 115
           IG G FS V  A+          AIK       + + FK        +E+  L  LS H 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYY--AIK------CMKKHFKSLEQVNNLREIQALRRLSPHP 58

Query: 116 NIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           NI++LI    DR  G   L+FE + +  L E + G  R   LP +   +  +QL +++++
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDH 115

Query: 174 LHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAK 209
           +H R    I H DIK  NIL+ ++ L  KL DFGS +
Sbjct: 116 MH-RNG--IFHRDIKPENILIKDDIL--KLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 39/229 (17%)

Query: 65  IGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-------HDN 116
           +G G F  V +A  I  D    N   K+ V   +     K   D++  +        H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPRS---SKLPWRNRMAI 163
           I+ L+G C       ++ EY   G L+E L             P      +L +++ ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 164 AFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+      +      
Sbjct: 146 AYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 196

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              +  R+  + M         P  L   + + ++DV+SFGV+L E+ T
Sbjct: 197 KKTTNGRLPVKWMA--------PEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 43/224 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHV---GSDRLSQVFKQELDILLHLSHDNIVK 119
           Q +G G F  V  AR  +  T  N AIK  +    +  L++   +EL +L HL H+NI+ 
Sbjct: 16  QPVGMGAFGLVCSAR--DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIIS 73

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L        E +    Y     L   LH    S  L  +      +Q+ + ++Y+H   +
Sbjct: 74  LSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---S 126

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
             +VH D+K SNIL+ E+ + K+CDFG A+                   ++T        
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLAR---------------IQDPQMT-------- 163

Query: 240 PGYTDPHYLRTG--MAS-----TKTDVYSFGVILLELVTGMEAF 276
            GY    Y R    M +      + D++S G I  E++ G   F
Sbjct: 164 -GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 40/243 (16%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IH--VGSDRLSQ 100
           + V K  W+  +R+     + +GSG +  V  A  ++  T    AIK ++    S+  ++
Sbjct: 4   QEVNKTIWEVPDRYRD--LKQVGSGAYGTVCSA--LDRRTGAKVAIKKLYRPFQSELFAK 59

Query: 101 VFKQELDILLHLSHDNIVKLIGY------CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK 154
              +EL +L H+ H+N++ L+         D   +  L+  ++  GT   KL    +  K
Sbjct: 60  RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM---KHEK 114

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L       + +Q+ + ++Y+H      I+H D+K  N+ + E    K+ DFG A+     
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---- 167

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGM 273
                      + S +T  V+   +  Y  P  +   M  T+T D++S G I+ E++TG 
Sbjct: 168 -----------TDSEMTGYVV---TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Query: 274 EAF 276
             F
Sbjct: 214 PLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 22/189 (11%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 108

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG       S  L  S + 
Sbjct: 109 SIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG------VSGQLIDSMAN 160

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
           S            +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + 
Sbjct: 161 S-----------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209

Query: 284 LTSLAGSML 292
           L  + G  +
Sbjct: 210 LELMFGCPV 218

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 66/258 (25%), Positives = 101/258 (39%), Gaps = 48/258 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSHDNI 117
           +VIG G F  V L +  +       A+K  + S     D+L+ V K E D+L       +
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIY--AMKTLLKSEMFKKDQLAHV-KAERDVLAESDSPWV 63

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           V L     D     L+ E++P G L   L      S+   R  MA   +   AIE +H+ 
Sbjct: 64  VSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA---ECVLAIEAVHK- 119

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF--------------SSAVLPPSPSP 223
             L  +H DIK  NIL++   + KL DFG +  GF                +      + 
Sbjct: 120 --LGFIHRDIKPDNILIDRGGHIKLSDFGLS-TGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 224 S-----------PSRSRI-----TKQVM---MIGSPGYTDPHYLRTGMASTKTDVYSFGV 264
           +            S+ +I      +++M    +G+P Y  P          + D +S G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 265 ILLELVTGMEAFCPENGQ 282
           I+ E + G   FC EN  
Sbjct: 237 IMFECLIGWPPFCSENSH 254

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 22/168 (13%)

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+ I+    H+N+V +       DE  ++ E++  G L + +  T    ++       + 
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVC 124

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
             + +A+ YLH      ++H DIK+ +ILL      KL DFG     F + V    P   
Sbjct: 125 LSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFG-----FCAQVSKEVP--- 173

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                  K+  ++G+P +  P  +      T+ D++S G++++E++ G
Sbjct: 174 -------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 40/231 (17%)

Query: 58  TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDN 116
           T    + IG G +  V+  +++N    +  A+KI      + +  + E +IL  LS H N
Sbjct: 19  TWEIIETIGKGTYGKVF--KVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76

Query: 117 IVKLIG--YCDDRDEG---VLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMAIAFQLAQA 170
           +VK  G  Y  D   G    L+ E    G++ + + G   R  ++       IA+ L +A
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM---EEPIIAYILHEA 133

Query: 171 I---EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPS 226
           +   ++LH   T   +H D+K +NILL      KL DFG SA++             + +
Sbjct: 134 LMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQL-------------TST 177

Query: 227 RSRITKQVMMIGSPGYTDPHYL--RTGMAST---KTDVYSFGVILLELVTG 272
           R R    V   G+P +  P  +     + ST   + DV+S G+  +EL  G
Sbjct: 178 RLRRNTSV---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 5e-08
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 19/166 (11%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK---IHVGSDRLSQVFKQELDILLHL---SHDNIV 118
           IG G +  VY AR +N       A+K   + +  + +     +E+ +L  L    H NIV
Sbjct: 7   IGEGAYGTVYKARDLNTGRFV--ALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 119 KLIGYCD--DRDEGVLL---FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           +L+  C     D  + L   FE+V +  L   L   P+    P   +  +  QL + +++
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDF 122

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM-GFSSAVLP 218
           LH      IVH D+K  NIL+      K+ DFG A++  F  A+  
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 52/126 (41%)

Query: 164 AFQLAQAIEYLHER-CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           +FQ+A+ +E+L  R C    +H D+ A NILL E+   K+CDFG A+             
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR------------- 221

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSFGVI 265
                              Y DP Y+R G        MA         +T++DV+SFGV+
Sbjct: 222 -----------------DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVL 264

Query: 266 LLELVT 271
           L E+ +
Sbjct: 265 LWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI-HVGSDR-LSQVFKQELDILLHLSHDNIVKLIG 122
           +GSG F  V            + AIK+    +++ +     +E +I+  L +  IV++IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
            C+  +  +L+ E    G L + L G  +  ++   N + +  Q++  ++YL  +   + 
Sbjct: 63  VCE-AEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGK---NF 116

Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           VH D+ A N+LL      K+ DFG +K       L    S   +RS   K  +   +P  
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK------ALGADDSYYKARS-AGKWPLKWYAPEC 169

Query: 243 TDPHYLRTGMASTKTDVYSFGVILLE 268
            +         S+++DV+S+G+ + E
Sbjct: 170 INFRKF-----SSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 42/225 (18%)

Query: 65  IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL--I 121
           IG G +  VY AR  +         I++    + +     +E+ +L  L+H NIV+L  +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
            + +++    L+FE++ +  L++ +  +P +   P   +  + +QL Q I Y H      
Sbjct: 67  VHSENKL--YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYL-YQLLQGIAYCHSH---R 119

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV------- 234
           ++H D+K  N+L++     KL DFG A+  F            P R+  T +V       
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR-AFG----------VPVRT-YTHEVVTLWYRA 167

Query: 235 --MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
             +++GS  Y           ST  D++S G I  E+V     F 
Sbjct: 168 PEILLGSRQY-----------STPVDIWSIGCIFAEMVNRRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 73/301 (24%), Positives = 118/301 (39%), Gaps = 66/301 (21%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ----------ELDILL-HLS 113
           +GSG F  VY  R  N+  +     +I+V +    +  ++          E+ I+   L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 114 HDNIVKLIGYCDDRD---------EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           H NIV+      + D         EG  L E+    +L+EK        ++ W     I 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF--NSLKEK-KQRFTEERI-W----NIF 119

Query: 165 FQLAQAIEYLH-ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            Q+  A+ YLH E+    IVH D+  +NI+L E     + DFG AK              
Sbjct: 120 VQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAK-------------- 162

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
              +   +K   ++G+  Y+ P  ++      K DV++FG IL ++ T    F   N   
Sbjct: 163 --QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--- 217

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
                  ML+      ATK+ E V   L      ++   +++    CL      RP   Q
Sbjct: 218 -------MLS-----LATKIVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQ 262

Query: 344 I 344
           +
Sbjct: 263 V 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)

Query: 65  IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL--I 121
           IG G +  VY AR  + + T     I++    + +     +E+ +L  + H NIV+L  +
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
            + + R    L+FEY+ +  L++ +  +P  +K P R      +Q+ + I Y H      
Sbjct: 70  VHSEKRL--YLVFEYL-DLDLKKHMDSSPDFAKNP-RLIKTYLYQILRGIAYCHSH---R 122

Query: 182 IVHGDIKASNILLEEHLNC-KLCDFGSAK-MGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
           ++H D+K  N+L++   N  KL DFG A+  G             P R+  T +V+ +  
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI------------PVRT-FTHEVVTL-- 167

Query: 240 PGYTDPH-YLRTGMASTKTDVYSFGVILLELVT 271
             Y  P   L +   ST  D++S G I  E+V 
Sbjct: 168 -WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 61/247 (24%), Positives = 106/247 (42%), Gaps = 48/247 (19%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V        +  T   +++ V   +LS+ F+
Sbjct: 6   QELNKTIWEVPERY-QNLSPV-GSGAYGSVC------AAFDTKTGLRVAV--KKLSRPFQ 55

Query: 104 ---------QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE----YVPNGTLQEKLHGTP 150
                    +EL +L H+ H+N+   IG  D       L E    Y+    +   L+   
Sbjct: 56  SIIHAKRTYRELRLLKHMKHENV---IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 112

Query: 151 RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
           +  KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A  
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-- 167

Query: 211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLEL 269
                           R    +    + +  Y  P  +   M   +T D++S G I+ EL
Sbjct: 168 ----------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Query: 270 VTGMEAF 276
           +TG   F
Sbjct: 212 LTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 35/217 (16%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR----LSQVFKQELDILLHLS---HDNI 117
           IG G +  V+ AR + +        ++ V +      LS +  +E+ +L HL    H N+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--REVAVLRHLETFEHPNV 66

Query: 118 VKLIGYCD----DRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           V+L   C     DR+  + L+FE+V +  L   L   P    +P      + FQL + ++
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLD 124

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           +LH      +VH D+K  NIL+      KL DFG A++      L               
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------------- 166

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
              ++ +  Y  P  L     +T  D++S G I  E+
Sbjct: 167 -TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 16/141 (11%)

Query: 65  IGSGGFSNVYLARLI------NDSTSTNGAIKI-----HVGSDRLSQVFKQELDILLHLS 113
           +G G  + +Y   L       +D  S    IK+           +S  F +   ++  +S
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H +IV L G C    E +++ E+V  G L   +H        PW  +  +A QLA A+ Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 174 LHERCTLHIVHGDIKASNILL 194
           L ++    +VHG++   NILL
Sbjct: 121 LEDK---DLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 41/242 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +V+G G F  V LA L    T    AIK+         V  Q+ D+   ++   I+ L  
Sbjct: 1   KVLGKGSFGKVMLAEL--KGTDEVYAIKV-----LKKDVILQDDDVDCTMTEKRILALAA 53

Query: 123 --------YCDDRDEGVLLF--EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
                   +C  + +  L F  EYV  G L  ++    RS K         A ++  A+ 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ---RSRKFDEPRSRFYAAEVTLALM 110

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           +LH      +++ D+K  NILL+   +CKL DFG  K G  + V   +            
Sbjct: 111 FLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT------------ 155

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
                G+P Y  P  L+        D ++ GV++ E++ G   F  +N      L  S+L
Sbjct: 156 ---FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESIL 209

Query: 293 ND 294
           +D
Sbjct: 210 HD 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 43/220 (19%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDR--LSQVFKQELDILLHLSHDNIVKLI 121
           IG G +  VY  R  N  T    A+K I + S+   +     +E+ +L  L H NIV L 
Sbjct: 8   IGEGTYGVVYKGR--NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                     L+FE++ +  L++ L   P+   +      +  +Q+ Q I + H R    
Sbjct: 66  DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI-TKQV------ 234
           ++H D+K  N+L++     KL DFG A+  F   V            R+ T +V      
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPV------------RVYTHEVVTLWYR 168

Query: 235 ---MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              +++GSP Y           ST  D++S G I  E+ T
Sbjct: 169 APEVLLGSPRY-----------STPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 39/145 (26%), Positives = 65/145 (44%), Gaps = 21/145 (14%)

Query: 132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN 191
            + E+V  G L   +    R  KLP  +    + +++ A+ +LHER    I++ D+K  N
Sbjct: 73  FVIEFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDN 126

Query: 192 ILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG 251
           +LL+   + KL D+G  K G     + P  + S             G+P Y  P  LR  
Sbjct: 127 VLLDAEGHIKLTDYGMCKEG-----IRPGDTTS----------TFCGTPNYIAPEILRGE 171

Query: 252 MASTKTDVYSFGVILLELVTGMEAF 276
                 D ++ GV++ E++ G   F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 38/152 (25%), Positives = 76/152 (50%), Gaps = 10/152 (6%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    + +  +    + I + ++    + +  F  E  I+  + H ++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ + +P+G L + +H       +  +  +    Q+A+ + YL ER 
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEER- 128

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
              +VH D+ A N+L++   + K+ DFG A++
Sbjct: 129 --RLVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 40/235 (17%)

Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL 109
           +W+ +E         IG G +  VY  ++ N    +  A+KI      + +  + E +IL
Sbjct: 23  TWEIIE--------TIGKGTYGKVY--KVTNKKDGSLAAVKILDPISDVDEEIEAEYNIL 72

Query: 110 LHLS-HDNIVKLIGYCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
             L  H N+VK  G     D+ V     L+ E    G++ E + G     +    +   I
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMI 130

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPS 222
           ++ L  A+  L       I+H D+K +NILL      KL DFG SA++  +S  L  + S
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTS 188

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-----STKTDVYSFGVILLELVTG 272
                         +G+P +  P  +            + DV+S G+  +EL  G
Sbjct: 189 --------------VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 39/229 (17%)

Query: 65  IGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-------HDN 116
           +G G F  V +A  +  D      A+ + V   +     K   D++  +        H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-----GTPRS--------SKLPWRNRMAI 163
           I+ L+G C       ++ EY   G L+E L      G   S         ++ +++ ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 164 AFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
            +Q+A+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+      V      
Sbjct: 143 TYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYY 193

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              +  R+  + M         P  L   + + ++DV+SFGV++ E+ T
Sbjct: 194 KKTTNGRLPVKWMA--------PEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 28/177 (15%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ +L  L H NIV L           L+FEY+ +  L++ L     S  +   N    
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM--HNVKLF 109

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            FQL + + Y H R    ++H D+K  N+L+ E    KL DFG A+           P+ 
Sbjct: 110 LFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA-------KSIPTK 159

Query: 224 SPSRSRIT----KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S   +T       +++GS  Y           ST+ D++  G I  E+ TG   F
Sbjct: 160 TYSNEVVTLWYRPPDILLGSTDY-----------STQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 69/293 (23%), Positives = 107/293 (36%), Gaps = 118/293 (40%)

Query: 63  QVIGSGGFSNVYLARL--INDSTSTNG-AIKIHVGSDRLSQ--VFKQELDILLHL-SHDN 116
           +V+G G F  V  A    I+  +S N  A+K+       S+      EL IL+H+ +H N
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72

Query: 117 IVKLIGYCDDRDEGVLLF--EYVPNGTLQEKLHG-----TPRSSKLP------------- 156
           +V L+G C  +  G L+   E+   G L   L       +P   K P             
Sbjct: 73  VVNLLGACT-KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131

Query: 157 -----------------------------------WRNRMAI------AFQLAQAIEYLH 175
                                              W++ + +      +FQ+A+ +E+L 
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA 191

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
            R     +H D+ A NILL E+   K+CDFG A+                          
Sbjct: 192 SR---KCIHRDLAARNILLSENNVVKICDFGLAR-------------------------- 222

Query: 236 MIGSPGYTDPHYLRTGMA-----------------STKTDVYSFGVILLELVT 271
                 Y DP Y+R G A                 +T++DV+SFGV+L E+ +
Sbjct: 223 ----DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 63/265 (23%), Positives = 106/265 (40%), Gaps = 47/265 (17%)

Query: 90  KIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY----CDDRDEGVLLFEYVPNGTLQEK 145
           K H G   L  + + E+  L  +  +NI+K+ G+     DD     L+ EY   G L+E 
Sbjct: 53  KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREV 112

Query: 146 LHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           L    +   L ++ ++ +A    + +  L++    +  + ++ + + L+ E+   K+   
Sbjct: 113 LD---KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICH 167

Query: 206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA--STKTDVYSFG 263
           G  K+  S    PP            K V  +    Y     L    +  + K D+YS G
Sbjct: 168 GLEKILSS----PPF-----------KNVNFMV---YFSYKMLNDIFSEYTIKDDIYSLG 209

Query: 264 VILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
           V+L E+ TG   F  EN   LT+       +I D    K N L          LD    +
Sbjct: 210 VVLWEIFTGKIPF--EN---LTT------KEIYDLIINKNNSL-------KLPLDCPLEI 251

Query: 324 LSIAALCLRQSPILRPSATQILHTI 348
             I   C     I RP+  +IL+ +
Sbjct: 252 KCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 19/159 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAI---KIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           Q IG+G F  V L+ +  D+      +   K +  S   ++ F Q+ D    L H NI++
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNE-FLQQGDPYRILQHPNILQ 59

Query: 120 LIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            +G C +    +L+FEY   G L     QE+ H   R+S+L    RMA   ++A  + ++
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWH--RRNSQLLLLQRMAC--EIAAGVTHM 115

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           H+    + +H D+   N  L   L  K+ D+G   +G S
Sbjct: 116 HK---HNFLHSDLALRNCFLTSDLTVKVGDYG---IGPS 148

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 63/228 (27%), Positives = 93/228 (40%), Gaps = 35/228 (15%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ------ELDILLHLSHDN-- 116
           IG G F  VY  R       T     + V S +     K+      E +IL+    D   
Sbjct: 1   IGKGTFGQVYQVR----KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 117 -IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            IV L        +  L+ +Y+  G L   L    R S+   R +  IA +L  A+E+LH
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED--RAKFYIA-ELVLALEHLH 113

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
           +     IV+ D+K  NILL+   +  LCDFG +K              + + ++ T    
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK-------------ANLTDNKTTN--T 155

Query: 236 MIGSPGYTDPHYLRTGMASTK-TDVYSFGVILLELVTGMEAFCPENGQ 282
             G+  Y  P  L      TK  D +S GV++ E+  G   F  E+ Q
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ 203

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 60/233 (25%), Positives = 92/233 (39%), Gaps = 48/233 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-------------HVGSDR--LSQVFKQELD 107
           +VIG G F  V LAR  + +     A+K+             H+ S+R  L +  K    
Sbjct: 1   KVIGKGSFGKVLLAR--HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           + LH S     KL    D  + G L +        +E+    PR+           A ++
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRAR--------FYAAEI 105

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           A A+ YLH   +L+IV+ D+K  NILL+   +  L DFG  K       +  + + S   
Sbjct: 106 ASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-----IEHNGTTS--- 154

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                     G+P Y  P  L         D +  G +L E++ G+  F   N
Sbjct: 155 -------TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 19/177 (10%)

Query: 95  SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK 154
           SD+  + F  E   L    H NIV+L G     +  +++ EY+ NG L   L       +
Sbjct: 46  SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR--KHEGQ 103

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L     M +   LA  ++YL E   +  VH  + A  +L+   L CK+  F   +   S 
Sbjct: 104 LVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           A+       SP                +  P  ++    S+ +DV+SFG+++ E+++
Sbjct: 161 AIYTTMSGKSPVL--------------WAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+ I+    H N+V++       +E  +L E++  G L + +  T    +L       + 
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVC 123

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
             + QA+ YLH +    ++H DIK+ +ILL      KL DFG     F + +    P   
Sbjct: 124 ESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG-----FCAQISKDVP--- 172

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                  K+  ++G+P +  P  +      T+ D++S G++++E+V G
Sbjct: 173 -------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 55/244 (22%), Positives = 104/244 (42%), Gaps = 42/244 (17%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN + V GSG + +V         ++ +  ++  V   +LS+ F+
Sbjct: 4   QELNKTVWEVPERY-QNLTPV-GSGAYGSV--------CSAYDTRLRQKVAVKKLSRPFQ 53

Query: 104 ---------QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE-YVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+             E Y+    +   L+   +  
Sbjct: 54  SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ 113

Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +QL + ++Y+H   +  I+H D+K SN+ + E    ++ DFG A     
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA----- 165

Query: 214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                        R    +    + +  Y  P  +   M   +T D++S G I+ EL+ G
Sbjct: 166 -------------RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Query: 273 MEAF 276
              F
Sbjct: 213 KALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 49/224 (21%), Positives = 88/224 (39%), Gaps = 35/224 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV-FKQELDILLHLSHDNIVKL 120
             IG+G F  V L       +     +K +   +    Q+ F QE+     L+H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 121 IGYCDDRDEGVLLFEYVPNGTL-------QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           +G C +    +L+ E+ P G L       +  +    +   L    RMA   ++A  + +
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL---QRMAC--EVASGLLW 115

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH+      +H D+   N  L   L+ K+ D+G   +              P    ITK 
Sbjct: 116 LHQ---ADFIHSDLALRNCQLTADLSVKIGDYG---LALEQ---------YPEDYYITKD 160

Query: 234 VMMIG----SPGYTDPHY--LRTGMASTKTDVYSFGVILLELVT 271
              +     +P   +     L     + K++++S GV + EL T
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 35/179 (19%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMA 162
           +EL +L    HDN++  +              YV    +Q  LH    S + L   +   
Sbjct: 48  RELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV 107

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
             +Q+ + ++YLH   +  I+H DIK  N+L+  +   K+CDFG A++            
Sbjct: 108 FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV----------EE 154

Query: 223 PSPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           P  S+  +T++V         +++GS  YT           +  D++S G I  EL+  
Sbjct: 155 PDESK-HMTQEVVTQYYRAPEILMGSRHYT-----------SAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 22/177 (12%)

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
           F +   ++  +SH ++  + G C    E +++ E+V +G L   L        + W+  +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120

Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP--P 219
            +A QLA A+ YL ++   ++VHG++ A NILL             A++G +    P   
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILL-------------ARLGLAEGTSPFIK 164

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEA 275
              P  S + ++++  +   P +  P  +  G + ST  D +SFG  LLE+    E 
Sbjct: 165 LSDPGVSFTALSREERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 62/233 (26%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---------QELDILLHLS 113
           + IGSG +  V  A  I+  +    AIK      ++   F          +EL IL H  
Sbjct: 11  ENIGSGAYGVVCSA--IDTRSGKKVAIK------KIPHAFDVPTLAKRTLRELKILRHFK 62

Query: 114 HDNIVKLIGYCDDRD---EGVLLFE--YVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--Q 166
           HDNI+ +      RD        F+  YV    ++  LH    S + P        F  Q
Sbjct: 63  HDNIIAI------RDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQ 115

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           L + ++Y+H      ++H D+K SN+L+ E    ++ DFG A+ G SS       SP+  
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSS-------SPTEH 164

Query: 227 RSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV 270
           +  +T+ V         +++  P YT           T  D++S G I  E++
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYT-----------TAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 57/247 (23%), Positives = 96/247 (38%), Gaps = 37/247 (14%)

Query: 55  ERFTQ--NFSQVIGSGGFSNVYLARLINDSTST------NGAIKIHVGSDR-------LS 99
           ER+ Q       +G G +  V  A                  I   V  DR       + 
Sbjct: 8   ERYIQKGAH---LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
               +EL I+  + H+NI+ L+    + D   L+ + +    L++ +    R  +L    
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVD---RKIRLTESQ 120

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLP 218
              I  Q+   +  LH+    + +H D+  +NI +     CK+ DFG + + G+      
Sbjct: 121 VKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 219 PSPSPSP-SRSRITKQVMMIGSPGYTDPHYLRTGMASTK----TDVYSFGVILLELVTGM 273
            S   +   R  +T +V+ +    Y  P  L   M + K     D++S G I  EL+TG 
Sbjct: 178 LSKDETMQRREEMTSKVVTL---WYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTGK 231

Query: 274 EAFCPEN 280
             F  EN
Sbjct: 232 PLFPGEN 238

Length = 335

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 48/220 (21%), Positives = 97/220 (44%), Gaps = 24/220 (10%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D   +  NF + IG G    V +A  +  S       K+ +   +  ++   E+ I+   
Sbjct: 17  DPRTYLDNFIK-IGEGSTGIVCIAT-VKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 74

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+N+V++       DE  ++ E++  G L + +  T    ++      A+   + +A+ 
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALS 130

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
            LH +    ++H DIK+ +ILL      KL DFG     F + V             + +
Sbjct: 131 VLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG-----FCAQV----------SKEVPR 172

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           +  ++G+P +  P  +       + D++S G++++E+V G
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 22/153 (14%)

Query: 132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN 191
           L+ +YV  G L   L+     ++     R+ IA ++  A+++LH+   L I++ DIK  N
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES--EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLEN 135

Query: 192 ILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG 251
           ILL+   +  L DFG +K       L      + S           G+  Y  P  +R G
Sbjct: 136 ILLDSEGHVVLTDFGLSKE-----FLAEEEERAYS---------FCGTIEYMAPEVIRGG 181

Query: 252 MA--STKTDVYSFGVILLELVTGMEAFCPENGQ 282
                   D +S GV+  EL+TG   F  +  Q
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 61/270 (22%), Positives = 111/270 (41%), Gaps = 43/270 (15%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQEL----DILLHLSHDNIVKL 120
           +GSG F  V         +    A+KI + +D      K EL    +++  L +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKI-LKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           IG C+  +  +L+ E    G L + L    ++  +  +N   +  Q++  ++YL E    
Sbjct: 62  IGICEA-ESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEET--- 114

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           + VH D+ A N+LL      K+ DFG +K            +     +    +       
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK------------ALGADENYYKAKTHGKWPV 162

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT-------GME----AFCPENGQLLTSLAG 289
            +  P  +     S+K+DV+SFGV++ E  +       GM+        E+G+ +     
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222

Query: 290 ---SMLNDIADCEATKVNE-----LVDPRL 311
               M + +  C    V+E     +V+ RL
Sbjct: 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRL 252

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 10/152 (6%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-QVFKQELD---ILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I    +  S +  K+ LD   ++  + + ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ + +P G L + +        +  +  +    Q+A+ + YL ER 
Sbjct: 73  RLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEER- 128

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
              +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 35/125 (28%), Positives = 53/125 (42%), Gaps = 50/125 (40%)

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           +FQ+A+ +E+L  R     +H D+ A NILL E+   K+CDFG A+              
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR-------------- 227

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYSFGVIL 266
                             Y DP Y+R G A                 + ++DV+SFGV+L
Sbjct: 228 ----------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271

Query: 267 LELVT 271
            E+ +
Sbjct: 272 WEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 77/343 (22%), Positives = 119/343 (34%), Gaps = 92/343 (26%)

Query: 64  VIGSGGFSN--VYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNI 117
           +IG        V+LA+  +  T+T  A+K         + L  +  QE+     L H NI
Sbjct: 5   LIGKCFEDLMIVHLAK--HKPTNTLVAVKKINLDSCSKEDLKLLQ-QEIITSRQLQHPNI 61

Query: 118 V----------------KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
           +                 L+ Y    D   LL  + P G              LP    +
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCED---LLKTHFPEG--------------LP---EL 101

Query: 162 AIAFQLA---QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA----KMGFSS 214
           AIAF L     A++Y+H       +H  +KAS+ILL       L     +    K G   
Sbjct: 102 AIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158

Query: 215 AVLPPSPSPSPSR-----SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
            V+   P  S          + +Q +     GY +           K+D+YS G+   EL
Sbjct: 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQ----GYNE-----------KSDIYSVGITACEL 203

Query: 270 VTGMEAF--CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIA 327
             G   F   P    LL  + G++   + D     + E    +     +    R  +   
Sbjct: 204 ANGHVPFKDMPATQMLLEKVRGTVPC-LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHP 262

Query: 328 A-------------LCLRQSPILRPSATQIL-HTIKHQISSIS 356
                         LCL++ P  RPSA+Q+L H+   Q    +
Sbjct: 263 YTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN 305

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 63/248 (25%), Positives = 113/248 (45%), Gaps = 55/248 (22%)

Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK-- 103
           V K  W+  ER+T    + +GSG + +V  A  I+  T    AIK      +LS+ F+  
Sbjct: 6   VNKTVWELPERYTS--LKQVGSGAYGSVCSA--IDKRTGEKVAIK------KLSRPFQSE 55

Query: 104 -------QELDILLHLSHDNIVKLIGY------CDDRDEGVLLFEYVPNGTLQEKLHGTP 150
                  +EL +L H+ H+N++ L+         D+  +  L+  Y+   T  +K+ G P
Sbjct: 56  IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ--TDLQKIMGHP 113

Query: 151 RSS-KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            S  K+ +     + +Q+   ++Y+H   +  I+H D+K  N+ + E    K+ DFG A+
Sbjct: 114 LSEDKVQY-----LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Query: 210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLE 268
                           + + +T  V+   +  Y  P  +   M   +T D++S G I+ E
Sbjct: 166 H---------------ADAEMTGYVV---TRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207

Query: 269 LVTGMEAF 276
           ++TG   F
Sbjct: 208 MLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 67/325 (20%), Positives = 126/325 (38%), Gaps = 72/325 (22%)

Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKIHVGSDRLSQ--VFKQELD 107
           +V R      + +G G F  VY   AR +I     T  A+K    S  L +   F  E  
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG------TPRSSKLPWRNRM 161
           ++   +  ++V+L+G        +++ E + +G L+  L               P    M
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 162 -AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS------ 214
             +A ++A  + YL+ +     VH D+ A N ++      K+ DFG  +  + +      
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 215 --AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
              +LP                       +  P  L+ G+ +T +D++SFGV+L E+ + 
Sbjct: 179 GKGLLPVR---------------------WMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217

Query: 273 MEAFCP----ENGQLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIA 327
            E   P     N Q+L   + G  L+   +C           R+              + 
Sbjct: 218 AEQ--PYQGLSNEQVLKFVMDGGYLDQPDNCP---------ERVT------------DLM 254

Query: 328 ALCLRQSPILRPSATQILHTIKHQI 352
            +C + +P +RP+  +I++ +K  +
Sbjct: 255 RMCWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 28/224 (12%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG-Y 123
           +G G + +VY A+  +       A+K  +    +S    +E+ +L  L H N++ L   +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK-QIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 124 CDDRDEGV-LLFEYVPNGTLQE-KLHGTPRSSK----LPWRNRMAIAFQLAQAIEYLHER 177
               D  V LLF+Y  +      K H   +++K    LP     ++ +Q+   I YLH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 178 CTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
             L   H D+K +NIL+     E    K+ D G A++ F+S  L P     P        
Sbjct: 128 WVL---HRDLKPANILVMGEGPERGRVKIADMGFARL-FNSP-LKPLADLDP-------- 174

Query: 234 VMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAF 276
             ++ +  Y  P  L      TK  D+++ G I  EL+T    F
Sbjct: 175 --VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 47/235 (20%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLH 111
             + +G G +  V  AR    S     AIK      +++ VF +         EL +L H
Sbjct: 4   LIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKLLRH 57

Query: 112 L-SHDNIVKLIGYCDDRD-------EGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMA 162
              H NI  L     D D         + L+E +    ++  LH   RS + L   +  +
Sbjct: 58  FRGHKNITCLY----DMDIVFPGNFNELYLYEEL----MEADLHQIIRSGQPLTDAHFQS 109

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
             +Q+   ++Y+H   + +++H D+K  N+L+      K+CDFG A+ GF       S +
Sbjct: 110 FIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-GF-------SEN 158

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAF 276
           P  +   +T+ V    +  Y  P  + +  + TK  DV+S G IL EL+     F
Sbjct: 159 PGENAGFMTEYV---ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 35/185 (18%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK----QELDILLHLSHDNIVKL 120
           IG G F  V+ AR  +  T    A+K  V  +   + F     +E+ IL  L H+N+V L
Sbjct: 20  IGQGTFGEVFKAR--HKKTKQIVALK-KVLMENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 121 IGYC------DDRDEG--VLLFEYVPN---GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
           I  C       +R +G   L+FE+  +   G L  K         L    ++     L  
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN----VKFTLSEIKKVMK--MLLN 130

Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
            + Y+H      I+H D+KA+NIL+ +    KL DFG A+          S S +   +R
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR--------AFSLSKNSKPNR 179

Query: 230 ITKQV 234
            T +V
Sbjct: 180 YTNRV 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 28/177 (15%)

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ +L  L H NIV L           L+FEY+ +  L++ +      + +   N    
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIF 109

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            +Q+ + + Y H R    ++H D+K  N+L+ E    KL DFG A+   + +V    P+ 
Sbjct: 110 LYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR---AKSV----PTK 159

Query: 224 SPSRSRIT----KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S   +T       +++GS  Y           ST+ D++  G I  E+ +G   F
Sbjct: 160 TYSNEVVTLWYRPPDVLLGSSEY-----------STQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 48/205 (23%)

Query: 105 ELDILLHLSHDNIVKL--IGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSK-LPWRN 159
           E+ +L HL H+N++ +  I     R+     F   Y+    +   LH   RSS+ L   +
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREA----FNDVYIVYELMDTDLHQIIRSSQTLSDDH 109

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
                +QL + ++Y+H   + +++H D+K SN+LL  + + K+CDFG A+          
Sbjct: 110 CQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-------- 158

Query: 220 SPSPSPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV 270
               S     +T+ V         +++    YT           T  DV+S G I  EL+
Sbjct: 159 ----SEKGDFMTEYVVTRWYRAPELLLNCSEYT-----------TAIDVWSVGCIFAELL 203

Query: 271 TGMEAF----CPENGQLLTSLAGSM 291
                F         +L+T L GS 
Sbjct: 204 GRKPLFPGKDYVHQLKLITELLGSP 228

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 53/233 (22%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRL---SQVFKQELDILLHLSHDNIVKL 120
           IG G +  V+ A+  N  T    A+K + +  D     S   + E+ +L  L H NIV+L
Sbjct: 8   IGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL 64

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQ--EKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
                   +  L+FEY      +  +  +G      +      +  FQL + + + H   
Sbjct: 65  YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV-----KSFMFQLLKGLAFCHSH- 118

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAK------MGFSSAVL-----PPSPSPSPSR 227
             +++H D+K  N+L+ ++   KL DFG A+        +S+ V+     PP        
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD------- 169

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                  ++ G+  Y           ST  D++S G I  EL        P N
Sbjct: 170 -------VLFGAKLY-----------STSIDMWSAGCIFAELANAGRPLFPGN 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 36/237 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK---IHVGSDRLSQVFKQELDILLHLSHDN-IV 118
           + IG G +  VY AR  + +T    A+K   + +  + +     +E+ +L  LS    IV
Sbjct: 7   EKIGEGTYGKVYKAR--DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 119 KLIGYCD-DRDEG----VLLFEYVPNGTLQEKLHGTPRSS--KLPWRNRMAIAFQLAQAI 171
           +L+     +   G     L+FEY+ +  L++ +    R     LP +   +  +QL + +
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLN-CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
            + H+     ++H D+K  N+L+++     K+ D G  +  FS  V              
Sbjct: 124 AHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPV-----------KSY 168

Query: 231 TKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFC--PENGQLL 284
           T +++ +    Y  P  L      ST  D++S G I  E+      F    E  QLL
Sbjct: 169 THEIVTLW---YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 33/184 (17%)

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           IA  + + + YL    +L I+H D+K SN+L+      KLCDFG +    +S        
Sbjct: 100 IAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-------- 148

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                  I K    +G+  Y  P  +        +DV+S G+  +EL  G   +      
Sbjct: 149 -------IAK--TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199

Query: 283 LLTSLAGSMLNDIADCEATKVNELVDPRL-AGDFDLDEARAMLSIAALCLRQSPILRPSA 341
             + +   +L  I D +         P L  G F    +   +     C+R+ P  RP+ 
Sbjct: 200 QGSLMPLQLLQCIVDEDP--------PVLPVGQF----SEKFVHFITQCMRKQPKERPAP 247

Query: 342 TQIL 345
             ++
Sbjct: 248 ENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIH-----VGSDRLSQVFKQELDILLHLSHDN 116
           +V+G+G +  V+L R ++   S    A+K+      V   + ++  + E  +L H+    
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 117 IVKLIGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF-QLAQAIEYL 174
            +  + Y    D  + L+ +Y+  G L   L    R  +      + I   ++  A+E+L
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H+   L I++ DIK  NILL+ + +  L DFG +K      V               +  
Sbjct: 122 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--------------ERAY 164

Query: 235 MMIGSPGYTDPHYLRTGMA--STKTDVYSFGVILLELVTGMEAF 276
              G+  Y  P  +R G        D +S GV++ EL+TG   F
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 31/111 (27%), Positives = 47/111 (42%), Gaps = 19/111 (17%)

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
           Q+   I +LH    + IV+ D+K  N+LL++  NC+L D G        AV         
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLG-------LAVELKDGKTIT 152

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            R+         G+ GY  P  L+    S   D ++ G  + E+V G   F
Sbjct: 153 QRA---------GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 7/148 (4%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV-FKQELDILLHLSHDNIVKL 120
           + IG+G F  V L  + +  T     +K + V +    Q+ F +E      L H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP--WRNRMAIAFQLAQAIEYLHERC 178
           +G C +    +L+ E+ P G L+  L    ++  +         +A ++A  + +LH+  
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG 206
             + +H D+   N LL   L  K+ D+G
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYG 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 66/242 (27%), Positives = 107/242 (44%), Gaps = 35/242 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFK--QELDILLHLSHDNIV- 118
           +VIG G +  V  A  I+  T    AIK I+   + +S   +  +E+ +L  L H +IV 
Sbjct: 6   EVIGKGSYGVVCSA--IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 63

Query: 119 -KLIGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYL 174
            K I     R E    F+  YV    ++  LH   +++  L   +     +QL +A++Y+
Sbjct: 64  IKHIMLPPSRRE----FKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H   T ++ H D+K  NIL       K+CDFG A++ F+           P+    T  V
Sbjct: 120 H---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT---------PTAIFWTDYV 167

Query: 235 MMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAFCPENG----QLLTSLA 288
               +  Y  P    +     +   D++S G I  E++TG   F  +N      L+T L 
Sbjct: 168 ---ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224

Query: 289 GS 290
           G+
Sbjct: 225 GT 226

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 45/233 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIH-----VGSDRLSQVFKQELDILLHLSHDN 116
           +V+G GG+  V+  R +  + +    A+K+      V + + +   K E +IL  + H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI------AFQLAQ- 169
           IV LI       +  L+ EY+  G L   L             R  I       F L++ 
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLE------------REGIFMEDTACFYLSEI 109

Query: 170 --AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
             A+E+LH      I++ D+K  NILL+   + KL DFG  K       +  +       
Sbjct: 110 SLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT------- 159

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                     G+  Y  P  L         D +S G ++ +++TG   F  EN
Sbjct: 160 --------FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.0 bits (111), Expect = 8e-06
 Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 28/224 (12%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG-Y 123
           +G G + +VY A+  +     + A+K  +    +S    +E+ +L  L H N++ L   +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALK-QIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 124 CDDRDEGV-LLFEYVPNGTLQE-KLHGTPRSSK----LPWRNRMAIAFQLAQAIEYLHER 177
               D  V LLF+Y  +      K H   +++K    LP     ++ +Q+   I YLH  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 178 CTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
             L   H D+K +NIL+     E    K+ D G A++ F+S  L P     P        
Sbjct: 128 WVL---HRDLKPANILVMGEGPERGRVKIADMGFARL-FNSP-LKPLADLDP-------- 174

Query: 234 VMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAF 276
             ++ +  Y  P  L      TK  D+++ G I  EL+T    F
Sbjct: 175 --VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 35/240 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-----IHVGSDRLSQVFKQELDILLHLSHDNI 117
           +V+G G F  V LA L    T+   AIK     + +  D +     +   + L   H  +
Sbjct: 1   KVLGKGSFGKVMLAEL--KGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58

Query: 118 VKLIGYCDDRDEGVLLF--EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             L  +C  + +  L F  EY+  G L   +  + R  +   R R   A ++   +++LH
Sbjct: 59  THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARFYAA-EIICGLQFLH 113

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
           ++    I++ D+K  N+LL++  + K+ DFG  K   +                  K   
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN---------------GEGKAST 155

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
             G+P Y  P  L+    +   D +SFGV+L E++ G   F   +G+    L  S+LND 
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDELFDSILNDR 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 21/114 (18%)

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           A ++   +E++H R    +V+ D+K +NILL+EH + ++ D G A   FS       P  
Sbjct: 103 ATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKK----KPHA 154

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF 276
           S            +G+ GY  P  L+ G A  +  D +S G +L +L+ G   F
Sbjct: 155 S------------VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 31/238 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDNI 117
           +++G G F  V L R    ++    A+KI      +  D ++     E  +L +  H  +
Sbjct: 1   KLLGKGTFGKVILVR--EKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFL 57

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             L      +D    + EYV  G L    H +        R R   A ++  A++YLH  
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA-EIVSALDYLH-- 112

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
            +  IV+ D+K  N++L++  + K+ DFG  K G + A    +                 
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT---------------FC 156

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
           G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L   ++ DI
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDI 212

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 40/135 (29%), Positives = 56/135 (41%), Gaps = 44/135 (32%)

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           R+   I FQ   A++Y H    LH++H D+K  NIL+E                 S  V+
Sbjct: 231 RHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMET----------------SDTVV 272

Query: 218 PPSPS----PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK----------------T 257
            P  +    P P R RI      +G  G  D  + RT + ST+                T
Sbjct: 273 DPVTNRALPPDPCRVRICD----LG--GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST 326

Query: 258 DVYSFGVILLELVTG 272
           D++S G I+ EL TG
Sbjct: 327 DMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 36/166 (21%), Positives = 73/166 (43%), Gaps = 28/166 (16%)

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           +L +++H +++++    D    G +    +P+ +     + T RS  LP    + I  Q+
Sbjct: 110 LLQNVNHPSVIRMK---DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + + YLH +    I+H D+K  NI + +     + D G+A+         P  +P    
Sbjct: 167 LEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--------PVVAP---- 211

Query: 228 SRITKQVMMIGSPGYTD---PHYLRTGMASTKTDVYSFGVILLELV 270
                    +G  G  +   P  L     ++K D++S G++L E++
Sbjct: 212 -------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 35/233 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDNI 117
           +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H  +
Sbjct: 1   KLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFL 57

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             L       D    + EY   G L    H +        R R   A ++  A+EYLH R
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHSR 114

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM- 236
               +V+ DIK  N++L++  + K+ DFG  K G                  I+    M 
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------ISDGATMK 153

Query: 237 --IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 40/256 (15%)

Query: 63  QVIGSGGFSNVYLARL-INDSTSTNGAIK-----IHVGSDRLSQVFKQELDILLHLSHDN 116
           +++G G F +V  A+L   D +    A+K     I   SD   + F +E   +    H N
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD--IEEFLREAACMKEFDHPN 62

Query: 117 IVKLIGYC-DDRDEGVL-----LFEYVPNGTLQ-----EKLHGTPRSSKLPWRNRMAIAF 165
           ++KLIG     R +G L     +  ++ +G L       ++   P +  LP +  +    
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT--LPLQTLVRFMI 120

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
            +A  +EYL  +   + +H D+ A N +L E++   + DFG +K  +S            
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG----- 172

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP--ENGQL 283
             S++  + + + S        L   + +T +DV++FGV + E++T  +      EN ++
Sbjct: 173 CASKLPVKWLALES--------LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224

Query: 284 LTSL-AGSMLNDIADC 298
              L  G+ L    DC
Sbjct: 225 YNYLIKGNRLKQPPDC 240

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 42/226 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-----IHVGSDRLSQVFKQELDILLHLSHDNI 117
           +++G G F  V+LA L    T+   AIK     + +  D +     ++  + L   H  +
Sbjct: 1   KMLGKGSFGKVFLAEL--KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 58

Query: 118 VKLIGYCDDRDEGVLLF--EYVPNGTLQEKLHGT-----PRSSKLPWRNRMAIAFQLAQA 170
             L  YC  + +  L F  EY+  G L   +        PR++          A ++   
Sbjct: 59  THL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT--------FYAAEIICG 108

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
           +++LH +    IV+ D+K  NILL+   + K+ DFG  K                     
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--------------- 150

Query: 231 TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            K     G+P Y  P  L     +T  D +SFGV+L E++ G   F
Sbjct: 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 38/231 (16%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           NF  V+G G F  V LA      T    AIKI +  D    V  Q+ D+   +    ++ 
Sbjct: 3   NFLMVLGKGSFGKVMLAE--RKGTDELYAIKI-LKKD----VVIQDDDVECTMVEKRVLA 55

Query: 120 LIG---------YC-DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
           L G          C    D    + EYV  G L  ++    R  K P  + +  A ++A 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRF-KEP--HAVFYAAEIAI 112

Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
            + +LH +    I++ D+K  N++L+   + K+ DFG  K      V             
Sbjct: 113 GLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV------------- 156

Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            TK     G+P Y  P  +         D ++FGV+L E++ G   F  E+
Sbjct: 157 TTK--TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 28/225 (12%)

Query: 63  QVIGSGGFSNVYLARLIN-DSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDN 116
           +V+G+G +  V+L R +    T    A+K+      V   +  +  + E ++L H+    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 117 IVKLIGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +  + Y    +  + L+ +YV  G +   L+     S+   R     + ++  A+E+LH
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR---FYSGEIILALEHLH 122

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
           +   L IV+ DIK  NILL+   +  L DFG +K   S                  +   
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--------------EEKERTYS 165

Query: 236 MIGSPGYTDPHYLRTGMASTK-TDVYSFGVILLELVTGMEAFCPE 279
             G+  Y  P  +R      K  D +S G+++ EL+TG   F  E
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-QVFKQELD---ILLHLSHDNIV 118
           +V+GSG F  VY    I D  +    + I V  +  S +  K+ LD   ++  +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ + +P G L +  +      ++  ++ +    Q+A+ + YL E  
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLD--YVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            + +VH D+ A N+L++   + K+ DFG A++
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 21/114 (18%)

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           A ++   +E++H R    +V+ D+K +NILL+EH + ++ D G A   FS       P  
Sbjct: 103 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKK----KPHA 154

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF 276
           S            +G+ GY  P  L+ G+A  +  D +S G +L +L+ G   F
Sbjct: 155 S------------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 28/226 (12%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH----VGSDRLSQVFKQELDILLHLSHD 115
           NF  V+G G F  V LA      T    AIKI     V  D   +    E  +L      
Sbjct: 3   NFLMVLGKGSFGKVMLAER--KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 116 NIVKLIGYC-DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  +  C    D    + EYV  G L   ++   +  K      +  A +++  + +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H R    I++ D+K  N++L+   + K+ DFG  K      V         +R+      
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--------TRT------ 160

Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
              G+P Y  P  +         D +++GV+L E++ G   F  E+
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 32/120 (26%), Positives = 60/120 (50%), Gaps = 16/120 (13%)

Query: 152 SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG 211
           S  L + + +  ++Q+A  +E+L  +   + VH D+ A N+L+ E    K+CDFG A+  
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLAR-- 287

Query: 212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               ++  S   S   + +  + M         P  +   + +T +DV+SFG++L E+ T
Sbjct: 288 ---DIMRDSNYISKGSTFLPLKWMA--------PESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 8e-05
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 7/81 (8%)

Query: 131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKAS 190
           VL+ +Y+ +G L + L    + S+   +    I  QL +A+  LH+    +I+H DIK  
Sbjct: 85  VLIMDYIKDGDLFDLLKKEGKLSEAEVKK---IIRQLVEALNDLHKH---NIIHNDIKLE 138

Query: 191 NILLEEHLN-CKLCDFGSAKM 210
           N+L +   +   LCD+G  K+
Sbjct: 139 NVLYDRAKDRIYLCDYGLCKI 159

Length = 267

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 47/183 (25%), Positives = 71/183 (38%), Gaps = 33/183 (18%)

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E  IL  ++H +I++L G           F Y     L    + T     L  +  +AI 
Sbjct: 133 EAHILRAINHPSIIQLKG----------TFTYNKFTCLILPRYKTDLYCYLAAKRNIAIC 182

Query: 165 FQLA------QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP 218
             LA      +AI+YLHE     I+H DIKA NI +    +  L DFG+A          
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-------- 231

Query: 219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP 278
                 P      K     G+     P  L         D++S G++L E+ T  ++   
Sbjct: 232 ------PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285

Query: 279 ENG 281
           ++G
Sbjct: 286 KDG 288

Length = 391

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 56/231 (24%), Positives = 84/231 (36%), Gaps = 45/231 (19%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDILLHLS-- 113
               V+G G F  V LA      T    AIK     D ++    +    E  I    +  
Sbjct: 2   RCLAVLGRGHFGKVLLAEY--KKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE 59

Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLA 168
            H  +V L       D    + EY   G L       +   PR+        +  A  + 
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA--------VFYAACVV 111

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--MGFSSAVLPPSPSPSPS 226
             ++YLHE     IV+ D+K  N+LL+     K+ DFG  K  MGF              
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD------------ 156

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAF 276
                +     G+P +  P  L T  + T+  D +  GV++ E++ G   F
Sbjct: 157 -----RTSTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 30/203 (14%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL-----SQVFKQELDILLHLSHDNIVK 119
           I  G F  VYL R  N+S     A+K+   +D +      QV + E D L       IV 
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLY--AVKVVKKADMINKNMVHQV-QAERDALALSKSPFIVH 68

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLH--GTPRSSKLPWRNRMAIAF--QLAQAIEYLH 175
           L       +   L+ EY+  G ++  LH  G        +   MA+ +  ++A A++YLH
Sbjct: 69  LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLH 121

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV-------LPPSPSPSPSRS 228
                 I+H D+K  N+L+    + KL DFG +K+  +  +        P    P    S
Sbjct: 122 RH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYS 178

Query: 229 RITKQVM-MIGSPGYTDPHYLRT 250
           R   QV+ +I S G+  P   + 
Sbjct: 179 RTPGQVLSLISSLGFNTPVGEKD 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 23/120 (19%)

Query: 164 AFQLAQAIEYLHERCT----LH---IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
            F+  +A+ Y  E C     LH   IV+ D+K  NILL++H + ++ D G        AV
Sbjct: 98  GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLG-------LAV 150

Query: 217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             P       R         +G+ GY  P  ++    +   D ++ G +L E++ G   F
Sbjct: 151 HVPEGQTIKGR---------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 27/111 (24%), Positives = 47/111 (42%), Gaps = 18/111 (16%)

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
           Q+   +E+LH+R    I++ D+K  N+LL+   N ++ D G A                 
Sbjct: 105 QIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA---------------VE 146

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +   +K     G+PG+  P  L+        D ++ GV L E++     F
Sbjct: 147 LKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 26/184 (14%)

Query: 104 QELDILLHLSHDNIVKLI-----GYCDDRDEGVLLFE----YVPNGTLQEKLHGTPRSSK 154
           +E+ I+  L HDNIVK+         D  ++   L E    Y+    ++  L        
Sbjct: 51  REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP 110

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFS 213
           L   +     +QL + ++Y+H   + +++H D+K +N+ +  E L  K+ DFG A+    
Sbjct: 111 LSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR---- 163

Query: 214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
             ++ P  S     S        + +  Y  P  L +    TK  D+++ G I  E++TG
Sbjct: 164 --IVDPHYSHKGYLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Query: 273 MEAF 276
              F
Sbjct: 216 KPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 28/111 (25%), Positives = 57/111 (51%), Gaps = 16/111 (14%)

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           ++  +Q+A+ +E+L  +   + VH D+ A N+LL +    K+CDFG A+      ++  S
Sbjct: 240 LSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDS 291

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              S   + +  + M         P  +   + +T +DV+S+G++L E+ +
Sbjct: 292 NYVSKGSTFLPVKWMA--------PESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 64/266 (24%), Positives = 93/266 (34%), Gaps = 85/266 (31%)

Query: 132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN 191
           LL  Y P G + E L G              I F   + + YLH+      +H +IKAS+
Sbjct: 89  LLKTYFPEG-MSEALIGN-------------ILFGALRGLNYLHQN---GYIHRNIKASH 131

Query: 192 ILLEE----------HLNCKLCDFGSAKM-----GFSSAVLPPSPSPSPSRSRITKQVMM 236
           IL+            HL   + +   AK+      FS++VLP                  
Sbjct: 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP------------------ 173

Query: 237 IGSPGYTDPHYLRTGMA--STKTDVYSFGVILLELVTGMEAF--CPENGQLLTSLAG--- 289
                +  P  LR  +   + K+D+YS G+   EL TG   F        LL  L G   
Sbjct: 174 -----WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY 228

Query: 290 -------------SMLNDIADCE---------ATKVNELVDPRLAGDFDLDEARAMLSIA 327
                         M N  +  +         A     +   RL        + A  ++ 
Sbjct: 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288

Query: 328 ALCLRQSPILRPSATQIL-HTIKHQI 352
            LCL+Q P  RPSA+ +L H    Q+
Sbjct: 289 ELCLQQDPEKRPSASSLLSHAFFKQV 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 39/224 (17%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDNI 117
           +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H  +
Sbjct: 1   KLLGKGTFGKVILVR--EKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFL 57

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
             L       D    + EY   G L     +E++    R+       R   A ++  A+ 
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGA-EIVSALG 109

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YLH      +V+ D+K  N++L++  + K+ DFG  K G S                  K
Sbjct: 110 YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-------------ATMK 153

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                G+P Y  P  L         D +  GV++ E++ G   F
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 22/119 (18%)

Query: 165 FQLAQAIEYLHE-RCTLHIVHG------DIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           F L +A  Y  E  C L  +H       D+K  N++L+   + K+ DFG  K        
Sbjct: 93  FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-- 150

Query: 218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         +     G+P Y  P  L+    +   D +SFGV+L E++ G   F
Sbjct: 151 -------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 46/200 (23%), Positives = 89/200 (44%), Gaps = 38/200 (19%)

Query: 91  IHVGSDRLSQVFK---------QELDILLHLSHDNIVKLIGYCDDRD-----EGVLLFEY 136
           I+V   +LS+ F+         +EL +L  ++H NI+ L+     +      + V L   
Sbjct: 47  INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106

Query: 137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE 196
           + +  L + +H      ++ +     + +Q+   I++LH   +  I+H D+K SNI+++ 
Sbjct: 107 LMDANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158

Query: 197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK 256
               K+ DFG A+   ++ ++ P        +R  +   +I   GY +            
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVV-----TRYYRAPEVILGMGYKE-----------N 202

Query: 257 TDVYSFGVILLELVTGMEAF 276
            D++S G I+ ELV G   F
Sbjct: 203 VDIWSVGCIMGELVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 29/123 (23%), Positives = 54/123 (43%), Gaps = 19/123 (15%)

Query: 166 QLAQAIEYLH-ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
           ++  A++YLH E+   ++V+ D+K  N++L++  + K+ DFG  K G        +    
Sbjct: 103 EIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---- 155

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                        G+P Y  P  L         D +  GV++ E++ G   F  ++ + L
Sbjct: 156 -----------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204

Query: 285 TSL 287
             L
Sbjct: 205 FEL 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 22/58 (37%), Positives = 30/58 (51%), Gaps = 3/58 (5%)

Query: 151 RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
           R   L      A+A QL  AI+Y+H      I+H DIK  N+L+    +  L DFG+A
Sbjct: 253 RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307

Length = 461

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 15/85 (17%)

Query: 126 DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHG 185
           D +E  ++ EY+    L++ L G P            +  ++ + +  LH+     IVHG
Sbjct: 407 DPEEKTIVMEYIGGKDLKDVLEGNPE-----------LVRKVGEIVAKLHK---AGIVHG 452

Query: 186 DIKASNILLEEHLNCKLCDFGSAKM 210
           D+  SN ++ +     L DFG  K 
Sbjct: 453 DLTTSNFIVRDD-RLYLIDFGLGKY 476

Length = 535

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 30/114 (26%), Positives = 56/114 (49%), Gaps = 20/114 (17%)

Query: 160 RMA-IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP 218
           RM+ + +Q+   I++LH   +  I+H D+K SNI+++     K+ DFG A+   +S ++ 
Sbjct: 127 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 183

Query: 219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           P        +R  +   +I   GY +             D++S G I+ E++ G
Sbjct: 184 PYVV-----TRYYRAPEVILGMGYKE-----------NVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 37/216 (17%)

Query: 139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL 198
             +  +    T  S  L   + +  + Q+AQ +++L  +   + +H D+ A N+LL +  
Sbjct: 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGR 249

Query: 199 NCKLCDFGSAK--MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK 256
             K+CDFG A+  M  S+ V+          +R+  + M         P  +   + + +
Sbjct: 250 VAKICDFGLARDIMNDSNYVV-------KGNARLPVKWMA--------PESIFDCVYTVQ 294

Query: 257 TDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFD 316
           +DV+S+G++L E+ +  ++  P  G L+ S    M+            ++  P    DF 
Sbjct: 295 SDVWSYGILLWEIFSLGKS--PYPGILVNSKFYKMVKR--------GYQMSRP----DFA 340

Query: 317 LDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI 352
             E   + SI  +C    P  RP+ +QI   I+ Q+
Sbjct: 341 PPE---IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	368
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
smart00090	237	RIO RIO-like kinase.	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
COG4248	637	Uncharacterized protein with protein kinase and he	99.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.09
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.02
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
PRK09902	216	hypothetical protein; Provisional	98.76
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.58
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.46
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.38
PF01636	239	APH: Phosphotransferase enzyme family This family	98.36
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.35
PLN02876	822	acyl-CoA dehydrogenase	98.3
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.29
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.2
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.08
PRK10593	297	hypothetical protein; Provisional	98.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.98
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.68
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.67
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.64
PRK05231	319	homoserine kinase; Provisional	97.56
KOG2270	520	consensus Serine/threonine protein kinase involved	97.42
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.41
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.36
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.27
PLN02236	344	choline kinase	97.27
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.08
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.01
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.9
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.88
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.85
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.74
PLN02756	418	S-methyl-5-thioribose kinase	96.61
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.44
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.39
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.22
PHA03111	444	Ser/Thr kinase; Provisional	96.08
PTZ00384	383	choline kinase; Provisional	96.0
PRK11768	325	serine/threonine protein kinase; Provisional	95.95
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.91
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	95.74
PTZ00296	442	choline kinase; Provisional	95.15
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.11
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.88

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-55  Score=380.26  Aligned_cols=253  Identities=32%  Similarity=0.449  Sum_probs=212.4

Q ss_pred             cCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEee--cCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec
Q 017627           49 YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH--VGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD  126 (368)
Q Consensus        49 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  126 (368)
                      .+..|+++     ...||+|..|+||++.++.  ++..+|+|++  ..++...+++.+|+++++..+||+||.+||+|..
T Consensus        76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~--t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLER-----LGVLGSGNGGTVYKVRHKP--TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhh-----hhhcccCCCcEEEEEEEcC--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            45556653     4679999999999998765  8899999987  3456778899999999999999999999999998


Q ss_pred             CC-eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          127 RD-EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       127 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      .. .++++||||++|+|..++.   ..+.+++..+.+++.+|++||.|||+ +   +||||||||+|||++..|.|||||
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecc
Confidence            88 4999999999999999998   44789999999999999999999996 6   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc--h
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG--Q  282 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~  282 (368)
                      ||.|....+..-                 .+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||...+.  .
T Consensus       223 FGVS~~lvnS~a-----------------~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~  285 (364)
T KOG0581|consen  223 FGVSGILVNSIA-----------------NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL  285 (364)
T ss_pred             ccccHHhhhhhc-----------------ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC
Confidence            999986554421                 346799999999999999999999999999999999999999987521  1


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL-DEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......               .+++... ...+. .+++++++|+..||+.||.+|||+.++++|
T Consensus       286 ~~~~Ll~---------------~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  286 DIFELLC---------------AIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CHHHHHH---------------HHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2221111               2222111 11222 467899999999999999999999999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-55  Score=396.82  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=214.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+|..+++||+|||+.||.+++.+  ++..+|+|+...    +....+.+.+|+++.+.|+|||||+++++|++.+.+||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~--tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD--TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC--CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            345678899999999999999766  788999998765    56677888999999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |+|+|..++|.++++   ..+.+++.+++.+++||+.||.|||++   +|+|||||..|+|++++.+|||+|||+|....
T Consensus        96 vLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   96 VLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence            999999999999998   567899999999999999999999999   99999999999999999999999999997544


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...               .+..+.||||.|.|||++....++..+||||+||++|.|+.|++||+..+-......+..- 
T Consensus       170 ~~~---------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-  233 (592)
T KOG0575|consen  170 YDG---------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-  233 (592)
T ss_pred             Ccc---------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-
Confidence            221               2235689999999999999999999999999999999999999999776544333222211 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ++       .++...+.++.+||..+|+.||.+|||+++||.|
T Consensus       234 ------------~Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 ------------EY-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ------------Cc-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                        11       1233456789999999999999999999999987

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-54  Score=377.43  Aligned_cols=251  Identities=30%  Similarity=0.366  Sum_probs=206.5

Q ss_pred             HHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh--------HHHHHHHHHHHHhcCCCCceeeeeEEEec
Q 017627           55 ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--------LSQVFKQELDILLHLSHDNIVKLIGYCDD  126 (368)
Q Consensus        55 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  126 (368)
                      .+..|-+.+.||+|+||.|-+|..+.  ++..+|||++.....        ......+|+++|++|+|||||+++++|+.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~--tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKK--TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcc--cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            44556678899999999999998554  889999998765421        11235699999999999999999999999


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC---CceEEe
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH---LNCKLC  203 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~---~~vkl~  203 (368)
                      .+..||||||+.||+|.+++-   .++.+.+.....+++|++.|+.|||++   ||+||||||+|||++.+   ..+||+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             CCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence            999999999999999999998   567788889999999999999999999   99999999999999866   679999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM---ASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      |||+|+.....                +.+.+.||||.|.|||++.+..   +..++|+||+||+||-+++|.+||....
T Consensus       322 DFGlAK~~g~~----------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~  385 (475)
T KOG0615|consen  322 DFGLAKVSGEG----------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY  385 (475)
T ss_pred             ccchhhccccc----------------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence            99999864322                2235578999999999997754   3457899999999999999999998766


Q ss_pred             chh-hHHHHHhhhhhhhhhhhcchhhhcCCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          281 GQL-LTSLAGSMLNDIADCEATKVNELVDPRLA--GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       281 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .+. +.+.+.                  ..++.  +......+++..+||.+||..||++|||+.++|+|
T Consensus       386 ~~~sl~eQI~------------------~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  386 TDPSLKEQIL------------------KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             CCccHHHHHh------------------cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            543 322222                  11111  11234567899999999999999999999999988

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=363.70  Aligned_cols=204  Identities=34%  Similarity=0.506  Sum_probs=178.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||+||+|+++.  ++..||||.+..+   .+..+.+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~--~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKK--SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ceehhhccCcceEEEEEeEecc--CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            3456679999999999999876  5588999965443   4566778899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC------CceEEeeccccc
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH------LNCKLCDFGSAK  209 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~------~~vkl~Dfg~s~  209 (368)
                      ||.||+|..+++   ..+.+++.++..++.||+.||++||++   +||||||||+|||++..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999998   456899999999999999999999999   99999999999999864      458999999999


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      ........                .+.+|+|.|||||++....|+.|+|+||+|+++|++++|..||...+...+..
T Consensus       164 ~L~~~~~a----------------~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~  224 (429)
T KOG0595|consen  164 FLQPGSMA----------------ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL  224 (429)
T ss_pred             hCCchhHH----------------HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            75543322                34689999999999999999999999999999999999999998776554443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-54  Score=355.00  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=208.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeec---CChhHHHHHHHHHHHHhcCCCCceeeeeE-EEecCCe-eEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV---GSDRLSQVFKQELDILLHLSHDNIVKLIG-YCDDRDE-GVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~l  132 (368)
                      .|.+.++||+|+||.||++.+..  ++..+|.|-..   .+....+....|+.+|++|+|||||++++ .+.+.+. +++
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~--~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLL--DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeecc--CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            35578899999999999998765  66777776433   34566788889999999999999999999 5555555 899


Q ss_pred             EEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCC-CeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          133 LFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTL-HIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      |||+|..|+|...++... ....+++.++|+++.|++.||..+|++... -|+||||||.||+++.+|.|||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999887543 456799999999999999999999993211 399999999999999999999999999997


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ..+.....               ...+|||.||+||.+.+.+|+.+|||||+||++|||+.-.+||.+.+-..+   ..+
T Consensus       178 l~s~~tfA---------------~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L---~~K  239 (375)
T KOG0591|consen  178 LSSKTTFA---------------HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL---CKK  239 (375)
T ss_pred             hcchhHHH---------------HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH---HHH
Confidence            65544322               346899999999999999999999999999999999999999987743222   211


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ..            +.   ..+.-.....+.++..||..|+..||+.||+.-.+++.+.+.+
T Consensus       240 I~------------qg---d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l  286 (375)
T KOG0591|consen  240 IE------------QG---DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL  286 (375)
T ss_pred             HH------------cC---CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence            11            11   1111122456789999999999999999999777776666543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-52  Score=374.62  Aligned_cols=257  Identities=32%  Similarity=0.504  Sum_probs=210.3

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-eeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-EGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~  136 (368)
                      +.+.||.|+||+||+|.+.+.   ..+|+|+.....   ...+.|.+|+.+|.+++|||||+++|++.+.. ..++||||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~---~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGT---DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCc---eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            456699999999999998542   228888776543   23668999999999999999999999999887 79999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEecCCCCCeeecCCC-ceEEeeccccccCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH-IVHGDIKASNILLEEHL-NCKLCDFGSAKMGFSS  214 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~~~~  214 (368)
                      +++|+|..++... ....++...+..++.||+.|+.|||++   + ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999854 467899999999999999999999999   8 99999999999999997 9999999999854332


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR--TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .               ...+...||+.|||||++.  ...|+.++||||||+++|||+||..||.+........      
T Consensus       198 ~---------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~------  256 (362)
T KOG0192|consen  198 K---------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS------  256 (362)
T ss_pred             c---------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH------
Confidence            1               1112246999999999999  5699999999999999999999999998765421111      


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                                  .......+...+..++..+..|+..||+.||..||++.+++..|+.+......
T Consensus       257 ------------~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  257 ------------AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             ------------HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence                        11111122223333667899999999999999999999999999988775554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-52  Score=351.11  Aligned_cols=265  Identities=25%  Similarity=0.331  Sum_probs=213.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |+...++|+|+||+||+++.++  +++.||||.+..+   +...+...+|+.+|++|+|+|+|.++++|.....+++|+|
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~--TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKD--TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             HhhhhccccCcceEEEEeccCC--cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            3445679999999999998655  8999999987765   3466778899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC-
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS-  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~-  214 (368)
                      ||+.. +.+-|...  ...++...+..+++|++.|+.|+|++   ++|||||||+||||+.+|.+||||||+|+..... 
T Consensus        82 ~~dhT-vL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHT-VLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchH-HHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99664 44445543  34689999999999999999999999   9999999999999999999999999999975421 


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ..+                +.++.|.+|+|||.+.| .+|..++||||+||++.||++|.+.|.+.++.+..-.+...+.
T Consensus       156 d~Y----------------TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  156 DNY----------------TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG  219 (396)
T ss_pred             chh----------------hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence            111                33678999999999988 6899999999999999999999999999888777766666666


Q ss_pred             hhhhhhhcc-----------hhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATK-----------VNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ++..-...-           +.+.-++...+.-.+..+.-+.+|+..||+.||.+|++-++++.|
T Consensus       220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            654321111           111111111111123445678999999999999999999999987

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-51  Score=370.20  Aligned_cols=284  Identities=40%  Similarity=0.722  Sum_probs=239.9

Q ss_pred             cccccCHHHHHHHHHHhh--hhcccccceEEEEEEEcCCCCceeEEEEeecCChhH-HHHHHHHHHHHhcCCCCceeeee
Q 017627           45 SVKKYSWDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL-SQVFKQELDILLHLSHDNIVKLI  121 (368)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~--~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~  121 (368)
                      ....|++.++.++|.+|.  ..||+|+||.||+|...+   +..+|||........ ...|.+|+.++.+++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~---~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD---GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC---CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence            677899999999999998  599999999999999754   278899966554433 55699999999999999999999


Q ss_pred             EEEecCC-eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCce
Q 017627          122 GYCDDRD-EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC  200 (368)
Q Consensus       122 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~v  200 (368)
                      |+|.+.+ ..++|+|||++|+|.++|...... .++|..+.+|+.++++||+|||..+.+.||||||||+|||+|.++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999998 599999999999999999865333 88999999999999999999999987789999999999999999999


Q ss_pred             EEeeccccccCCC-CCCCCCCCCCCCCccccccceee-ecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 017627          201 KLCDFGSAKMGFS-SAVLPPSPSPSPSRSRITKQVMM-IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP  278 (368)
Q Consensus       201 kl~Dfg~s~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  278 (368)
                      ||+|||+|+.... ....                ... .||.+|+|||.+..+..+.++||||||+++.|++||+.|...
T Consensus       217 KlsDFGLa~~~~~~~~~~----------------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSV----------------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             EccCccCcccCCccccce----------------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence            9999999965332 1110                111 599999999999989999999999999999999999988875


Q ss_pred             Cc---chhhHHHHHhhhhhhhhhhhcchhhhcCCCCC-CCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          279 EN---GQLLTSLAGSMLNDIADCEATKVNELVDPRLA-GDFDL-DEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       279 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      ..   ......|....+..      ..+.+++|+.+. ..+.. .....+..+...|++.+|.+||++.++++.|+.+..
T Consensus       281 ~~~~~~~~l~~w~~~~~~~------~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  281 SRPRGELSLVEWAKPLLEE------GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CCCcccccHHHHHHHHHHC------cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            32   23345555444444      488999999987 55554 577789999999999999999999999999966554


Q ss_pred             c
Q 017627          354 S  354 (368)
Q Consensus       354 ~  354 (368)
                      .
T Consensus       355 ~  355 (361)
T KOG1187|consen  355 L  355 (361)
T ss_pred             c
Confidence            4

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-52  Score=358.81  Aligned_cols=245  Identities=26%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.++||+|+||+||.++.++  +++.+|+|+.....    .......+|..+|..++||+||+++..|.+.+.+|+|+||
T Consensus        29 ~lkviGkG~fGkV~~Vrk~d--t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~  106 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKD--TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY  106 (357)
T ss_pred             eeeeeeccCCceEEEEEEcc--cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence            67899999999999999765  88999999866542    3345677899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.||.|...|.   +.+.+++..+..++..|+.||.|||++   |||||||||+|||+|..|+++|+|||+|+...... 
T Consensus       107 ~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-  179 (357)
T KOG0598|consen  107 LNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-  179 (357)
T ss_pred             cCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence            99999999998   567899999999999999999999999   99999999999999999999999999998422221 


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                    ....+.+||+.|||||++.+..|+.++|.||||+++|||++|.+||...+.....+.+..      
T Consensus       180 --------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~------  239 (357)
T KOG0598|consen  180 --------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK------  239 (357)
T ss_pred             --------------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc------
Confidence                          112347899999999999999999999999999999999999999988775443322211      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP----SATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~~il~~  347 (368)
                                  .+ ....+...+.++++++..+|+.||++|.    ++.+|-+|
T Consensus       240 ------------~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  240 ------------GK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             ------------Cc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                        11 0112223456899999999999999995    56666555

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-51  Score=369.29  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=220.1

Q ss_pred             HHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           53 DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        53 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ++.+....+.+.||+|.||.||+|.+.+.   ..+|+|.........+.|.+|+++|+.|+|+|||+++++|..+..++|
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~---~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGS---TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCC---CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            44455556788999999999999998653   456777666655556788899999999999999999999999889999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |||||+.|+|.++|+.. .+..+...+.+.++.|||+|++||.++   ++|||||...||||+++..|||+|||+|+...
T Consensus       279 VtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999863 567899999999999999999999999   99999999999999999999999999999544


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ++.......              ..-...|.|||.+....++.+|||||||++||||+| |+.||.+.......      
T Consensus       355 d~~Y~~~~~--------------~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~------  414 (468)
T KOG0197|consen  355 DDEYTASEG--------------GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL------  414 (468)
T ss_pred             CCceeecCC--------------CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH------
Confidence            443322211              123457999999999999999999999999999999 99999876654333      


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                   +.++...+-..+..|+..+.+++..||+.+|++|||++.+...|+.+...
T Consensus       415 -------------~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  415 -------------ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             -------------HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                         33344455556667888999999999999999999999999999887654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-49  Score=327.90  Aligned_cols=282  Identities=22%  Similarity=0.264  Sum_probs=226.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +|...++||+|.||+||+|.+..  +++.||||.+...   +.......+|++.|+.++|+||+.++++|...+.+.+|+
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~--t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTE--TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecC--CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            45667889999999999999655  7888998865544   233456778999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||| ..+|...++.  +...++...+..++.++++|++|+|++   .|+||||||.|+|++.+|.+||+|||+|+...+.
T Consensus        81 Efm-~tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFM-PTDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eec-cccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            999 5599999986  456789999999999999999999999   9999999999999999999999999999976544


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....               ...+-|.+|+|||.+.| ..|+..+|+||.|||+.||+-|.+-|.+.++.+....+.+.+.
T Consensus       155 ~~~~---------------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG  219 (318)
T KOG0659|consen  155 NRIQ---------------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG  219 (318)
T ss_pred             Cccc---------------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence            3211               11267899999999877 5799999999999999999999999999888777777777776


Q ss_pred             hhhhhhhcchhhhcC--------CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCCCC
Q 017627          294 DIADCEATKVNELVD--------PRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQKD  364 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~~~  364 (368)
                      ......+..+.++-|        +..........+.++.+|+..||..||.+|+|+.|+|+|  .-+.+.+.+..|...
T Consensus       220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~~l  296 (318)
T KOG0659|consen  220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPSKL  296 (318)
T ss_pred             CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChhhC
Confidence            655544444333222        112222344556778999999999999999999999987  233444544444443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=358.54  Aligned_cols=268  Identities=23%  Similarity=0.262  Sum_probs=214.5

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHH--HHHHHHHHHhcCC-CCceeeeeEEEecCC-eeE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLS-HDNIVKLIGYCDDRD-EGV  131 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~--~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~  131 (368)
                      -.+|.+.++||.|.||.||+|+.+.  ++..||||....+-...+  .-.+|+..|++|+ ||||+++++++.+.+ .++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~--~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecC--CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3567889999999999999998655  677799986554422222  2347999999998 999999999998888 999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||| ..+|.++++.+  +..+++..+..|+.||+.||+|+|.+   |+.|||+||+|||+..+..+||+|||+||..
T Consensus        87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            999999 56899999874  67899999999999999999999999   9999999999999998889999999999976


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .+...+                +.++.|.+|+|||++.. ..|+.++|+|++|||++|+.+-++.|.+.++.+....+-.
T Consensus       161 ~SkpPY----------------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  161 RSKPPY----------------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             ccCCCc----------------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence            555443                33678999999998854 6789999999999999999999999999887666555555


Q ss_pred             hhhhhhhhhhcc---hhhhcCCCCC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATK---VNELVDPRLA-------GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .++......+..   +...+.=.++       ...-..++.++.++|..||++||.+||||.++|+|
T Consensus       225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            554433222111   1111111111       11122367889999999999999999999999987

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-50  Score=359.87  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=212.9

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .|++.||+|+|++|++|+.+.  +...+|||+....    +...+.+..|-.+|.+| .||.|++++-.|.+...+|+|+
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~--t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKA--TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             chhheeccccceeEEEeeecC--CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            378899999999999999766  7889999986543    33445677899999999 7999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++|+|.++++   +.+.+++..++.++.+|+.||+|||++   |||||||||+|||++.++++||+|||.|+.+...
T Consensus       154 e~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  154 EYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            9999999999998   567899999999999999999999999   9999999999999999999999999999986655


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .........  ...........+||..|.+||++.....+..+|||+||||+|.|+.|.+||.+.++-.....+..+-  
T Consensus       228 ~~~~~~~~~--~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~--  303 (604)
T KOG0592|consen  228 QKSQENPVD--PNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD--  303 (604)
T ss_pred             hccccCccC--cccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc--
Confidence            433211110  0011111356789999999999999999999999999999999999999998877532222221111  


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                        -.++...++.+.+||.++|..||.+|+|+.+|.+|
T Consensus       304 ------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  304 ------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                              11233344689999999999999999999999887

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=348.07  Aligned_cols=258  Identities=28%  Similarity=0.401  Sum_probs=201.0

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC--eeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD--EGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~  136 (368)
                      ..++.||+|+||.||++...+  ++...|+|..... ....+.+.+|+.+|.+|+|||||+++|......  .++++|||
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~--~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKK--TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhccccCccceEEEEEEecC--CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            467889999999999998765  4677888865443 222667899999999999999999999854444  68999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-CCceEEeeccccccCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg~s~~~~~~~  215 (368)
                      +++|+|.+++...  ++.+++..+..+..|++.||.|||++   |||||||||+|||++. ++.+||+|||+++......
T Consensus        98 ~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   98 APGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999854  22799999999999999999999999   9999999999999999 7999999999998644311


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC-cchhhHHHHHhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPE-NGQLLTSLAGSMLN  293 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~  293 (368)
                      ..            ........||+.|||||++.. .....++|||||||++.||+||..||... .......       
T Consensus       173 ~~------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~-------  233 (313)
T KOG0198|consen  173 TK------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL-------  233 (313)
T ss_pred             cc------------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH-------
Confidence            00            011123569999999999985 33445999999999999999999999653 1111000       


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                ...... ....++...+.++.+|+..|+..||.+||||+++|+|.--....
T Consensus       234 ----------~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  234 ----------LIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ----------HHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                      000011 11134445677999999999999999999999999996654443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=326.30  Aligned_cols=239  Identities=26%  Similarity=0.385  Sum_probs=205.8

Q ss_pred             cCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEE
Q 017627           49 YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYC  124 (368)
Q Consensus        49 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~  124 (368)
                      +.+++++     +.+.||.|+||.|.+++.+.  ++..+|+|+.....    +..+...+|..+|+.+.||+++++++.|
T Consensus        41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~--~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   41 YSLQDFE-----RLKTLGTGSFGRVHLVREKH--SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             cchhhhh-----heeeeccCccceEEEEEEcc--CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            6677664     56789999999999999766  68889999876543    3345577899999999999999999999


Q ss_pred             ecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       125 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      .+.+.++|||||++||.|..+++   +.+++++..++.++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitD  187 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITD  187 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEe
Confidence            99999999999999999999998   567899999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      ||.|+......                  .+.||||.|+|||++...+|+.++|.||||+++|||+.|.+||...+....
T Consensus       188 FGFAK~v~~rT------------------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i  249 (355)
T KOG0616|consen  188 FGFAKRVSGRT------------------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI  249 (355)
T ss_pred             ccceEEecCcE------------------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence            99998654432                  678999999999999999999999999999999999999999988776433


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR  338 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  338 (368)
                      ...+                  +...+  .++...+.++++|+..+|+.|-.+|
T Consensus       250 Y~KI------------------~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  250 YEKI------------------LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHH------------------HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            3221                  11111  2444556789999999999999999

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-48  Score=345.97  Aligned_cols=285  Identities=24%  Similarity=0.263  Sum_probs=221.1

Q ss_pred             HHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--C
Q 017627           54 VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--D  128 (368)
Q Consensus        54 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~  128 (368)
                      .....|+..++||+|.||.||+|++..  ++..||+|.....   +.......+||.+|++|+||||+++.+...+.  .
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~--tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLE--TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecc--cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            334455567889999999999999765  7888999855433   45556677999999999999999999998776  6


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      .+|||+|||+. +|.-++..  ..-.+++.++..++.||+.||+|+|++   ||+|||||.+|||||++|.+||+|||+|
T Consensus       192 siYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             eEEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccce
Confidence            89999999954 88887764  345799999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ++.......              ..+..+-|.+|+|||.+.|. .|+.++|+||+||||.||++|++.|.+..+......
T Consensus       266 r~y~~~~~~--------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k  331 (560)
T KOG0600|consen  266 RFYTPSGSA--------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK  331 (560)
T ss_pred             eeccCCCCc--------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH
Confidence            864433211              12345789999999999885 799999999999999999999999999988777777


Q ss_pred             HHhhhhhhhhhhhc--chh--hhcCCCCC------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          288 AGSMLNDIADCEAT--KVN--ELVDPRLA------GDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       288 ~~~~~~~~~~~~~~--~~~--~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                      +.++.....+..+.  .+.  ..+.+...      +. ....+....+|+..+|..||.+|.||.++|++  +.+...+.
T Consensus       332 IfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF~t~p~  408 (560)
T KOG0600|consen  332 IFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYFTTEPL  408 (560)
T ss_pred             HHHHhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC--cccccCCC
Confidence            77777665554433  111  11111111      11 11234678899999999999999999998864  23333344


Q ss_pred             ccCCCC
Q 017627          358 LFSPQK  363 (368)
Q Consensus       358 ~~~~~~  363 (368)
                      +.+|+.
T Consensus       409 ~~~p~~  414 (560)
T KOG0600|consen  409 PCDPSS  414 (560)
T ss_pred             CCCccc
Confidence            444433

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.4e-49  Score=355.45  Aligned_cols=245  Identities=30%  Similarity=0.415  Sum_probs=208.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |-+.+.||+|+||.||+|+.+.  +.+.||+|.....   ++..+.+.+|+++++.|+|||||.++++|++..++|+|.|
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~--t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKY--TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             hhHHHHhcCCccceeeeccccc--ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4466789999999999998655  8899999976543   3455678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.| +|..++.   ..+.++++.+..++++++.||.|||++   +|+|||+||.|||++.+|.+|+||||+|+.+....
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9966 9999998   677899999999999999999999999   99999999999999999999999999999655433


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ..               ...+.|||.|||||.+.+.+|+..+|.|||||++||+++|.+||.......+.+.+   ..+ 
T Consensus       155 ~v---------------ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I---~~d-  215 (808)
T KOG0597|consen  155 SV---------------LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI---LKD-  215 (808)
T ss_pred             ee---------------eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH---hcC-
Confidence            22               13467999999999999999999999999999999999999999654433222211   111 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   +   ..++...+..+..|+..+|..||.+|.|..+++.|
T Consensus       216 -------------~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  216 -------------P---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -------------C---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                         1   11233567789999999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=353.90  Aligned_cols=245  Identities=27%  Similarity=0.355  Sum_probs=204.6

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      -++||+|+.|.||.|....  +...||||...... ...+.+.+|+.+|+..+|+|||.+++.|...+.+|+|||||++|
T Consensus       278 ~~kigqgaSG~vy~A~~~~--~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg  355 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKIS--TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG  355 (550)
T ss_pred             hhhhccccccceeeeeecc--CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence            3569999999999998765  66778998665443 33456789999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+.+..    ..+++.++..|+++++.||+|||.+   +|+|||||.+|||++.+|.+||+|||+|........    
T Consensus       356 sLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~----  424 (550)
T KOG0578|consen  356 SLTDVVTK----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS----  424 (550)
T ss_pred             chhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC----
Confidence            99999863    4589999999999999999999999   999999999999999999999999999875443332    


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                 ...+.+|||.|||||++....|+.++||||||++++||+-|.+||..++.-.....+            
T Consensus       425 -----------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------------  481 (550)
T KOG0578|consen  425 -----------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------  481 (550)
T ss_pred             -----------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------------
Confidence                       335578999999999999999999999999999999999999999775542111111            


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                         ..  ............+..+++|+.+||..|+++||+|.+||+|
T Consensus       482 ---a~--ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  482 ---AT--NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ---hh--cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence               00  1111122344567799999999999999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-48  Score=353.16  Aligned_cols=247  Identities=30%  Similarity=0.366  Sum_probs=205.2

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-----h-hHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----D-RLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDE  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-----~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  129 (368)
                      ..|.+++.||+|+||+|+.|....  ++..+|+|+....     . ...+.+.+|+.+++.++ ||||+++++++...+.
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~--t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRL--TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeecc--CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            455678899999999999998765  5688999965443     1 34566778999999998 9999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-CceEEeecccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-LNCKLCDFGSA  208 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~~vkl~Dfg~s  208 (368)
                      .++||||+.+|+|.+++.   ..+++.+..+..++.|++.|++|+|++   ||+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999998   456789999999999999999999999   99999999999999999 99999999999


Q ss_pred             ccCC-CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          209 KMGF-SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-AS-TKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       209 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      .... ...                ...+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||...+.....
T Consensus       169 ~~~~~~~~----------------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~  232 (370)
T KOG0583|consen  169 AISPGEDG----------------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY  232 (370)
T ss_pred             cccCCCCC----------------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence            8642 111                113467999999999999977 75 7899999999999999999999886554333


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDE-ARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+....                  +  .++... +.++.+|+.+||..||.+|+|+.+|+.|
T Consensus       233 ~ki~~~~------------------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  233 RKIRKGE------------------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             HHHhcCC------------------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            2211110                  0  112222 6789999999999999999999999966

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-48  Score=358.05  Aligned_cols=246  Identities=27%  Similarity=0.393  Sum_probs=210.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +.+++.||.|+-|.|-+|++  ..+++.+|||++...    ......+.+|+-+|+.+.||||+++|++|++..++|+|+
T Consensus        14 wkLgkTLG~Gstg~vrlakh--~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKH--AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             eeccccccCCCCceehhhhc--ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            34678899999999999975  458999999987654    233456889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++|.|.+++.   ..+++++.++..+++||+.|+.|+|..   +|+|||+||+|+|++..+++||+|||+|......
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999998   667899999999999999999999999   9999999999999999999999999999865555


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....                +.||+|.|+|||++.|.+| +.++||||.|+|||.|+||+.||.+.+...+...+.+...
T Consensus       166 klLe----------------TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f  229 (786)
T KOG0588|consen  166 KLLE----------------TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF  229 (786)
T ss_pred             cccc----------------ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc
Confidence            4433                3579999999999999988 5789999999999999999999987665444333322111


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                          ..+...+.++++||..||..||++|.|+++|++|.
T Consensus       230 --------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 --------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             --------------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                                12334567899999999999999999999999984

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-48  Score=338.05  Aligned_cols=263  Identities=27%  Similarity=0.382  Sum_probs=208.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|++.++||.|..++||+|++..  ...+||||++...  ......+.+|+..+..++||||++++..|..+..+|+||.
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p--~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIP--TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecc--cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            34567889999999999999876  5689999987543  2336789999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ||.+|++.++++... ...+++..+..|++++++||.|||++   |.||||||+.||||+.+|.|||+|||.+-.+..+.
T Consensus       105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999998663 44599999999999999999999999   99999999999999999999999999886544422


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      .           ....+....+||++|||||++..  ..|+.|+||||||++..||.+|..||.........  ...+-+
T Consensus       181 ~-----------R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn  247 (516)
T KOG0582|consen  181 D-----------RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQN  247 (516)
T ss_pred             c-----------eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcC
Confidence            0           01111144579999999999643  47999999999999999999999999765432111  111111


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+    ...    -..+..+.....+..++.++..||..||++||||+++|+|
T Consensus       248 ~pp----~~~----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  248 DPP----TLL----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCC----Ccc----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            100    000    0111122223445689999999999999999999999987

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.5e-48  Score=345.56  Aligned_cols=262  Identities=28%  Similarity=0.345  Sum_probs=204.7

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhH----HHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +...||+|+||.||+|+-++  ++..+|+|+...++..    ..-++.|-.+|....+|+||++|..|.+.+.+||||||
T Consensus       145 ~Lk~IgkGAfGeVrLarKk~--Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy  222 (550)
T KOG0605|consen  145 LLKVIGKGAFGEVRLARKKD--TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY  222 (550)
T ss_pred             hheeeccccceeEEEEEEcc--CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence            45689999999999998655  8899999998776532    34466799999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      ++||++..+|.   ....+++..+..++.+++.|+..||+.   |+|||||||+|+|||..|++||+|||+|.-......
T Consensus       223 lPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  223 LPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             cCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999998   667899999999999999999999999   999999999999999999999999999954222111


Q ss_pred             CC----------------CCCCCC---CCcc-------------ccccceeeecCCCCccchhhccCCCCcchhhHHHHH
Q 017627          217 LP----------------PSPSPS---PSRS-------------RITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGV  264 (368)
Q Consensus       217 ~~----------------~~~~~~---~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  264 (368)
                      ..                +.....   ....             +..-....+|||.|+|||++.+..|+..+|+|||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence            00                000000   0000             000112468999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---H
Q 017627          265 ILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS---A  341 (368)
Q Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~  341 (368)
                      |+|||+.|.+||.+++.......+......                +..+-....+.++.+||.+||. ||.+|.-   +
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~----------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRET----------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhh----------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            999999999999888765444322221111                1111112234789999999999 9999965   6


Q ss_pred             HHHHHH
Q 017627          342 TQILHT  347 (368)
Q Consensus       342 ~~il~~  347 (368)
                      .||.+|
T Consensus       440 ~EIK~H  445 (550)
T KOG0605|consen  440 EEIKKH  445 (550)
T ss_pred             HHHhcC
Confidence            666655

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-49  Score=344.27  Aligned_cols=244  Identities=27%  Similarity=0.379  Sum_probs=205.4

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.||+|+||.||+|.+..  +...+|+|+....  ......+..|+.+|..++++||.++|+.+..+..++++||||.|
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~--t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g   95 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNK--TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG   95 (467)
T ss_pred             chhccccccceeeeeeecc--ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence            4679999999999998755  8889999987654  34456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |++.+.+.   .+..+++..+..++++++.|+.|||.+   +.+|||||+.|||+..+|.|||+|||++-........  
T Consensus        96 Gsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--  167 (467)
T KOG0201|consen   96 GSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--  167 (467)
T ss_pred             cchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence            99999997   445558888999999999999999999   9999999999999999999999999998654333221  


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                   ..+.+|||.|||||++.+..|+.++||||||++.+||.+|.+|+.....                  
T Consensus       168 -------------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------  216 (467)
T KOG0201|consen  168 -------------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------  216 (467)
T ss_pred             -------------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------
Confidence                         1346799999999999999999999999999999999999999965433                  


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       ..+.-++....+......++..+++|+..||..||+.||||.++|+|
T Consensus       217 -mrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  217 -MRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -ceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             11111222222233333667789999999999999999999999988

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-47  Score=361.55  Aligned_cols=265  Identities=27%  Similarity=0.425  Sum_probs=222.1

Q ss_pred             HhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.+.||+|+||+||+|+..+   .+....||||..+..  ....++|++|++++..|+|||||+++|+|.+++..|+|+
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF  568 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF  568 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence            367789999999999998654   235677899976554  346789999999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCC-------CC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEe
Q 017627          135 EYVPNGTLQEKLHGTPR-------SS----KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC  203 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~-------~~----~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~  203 (368)
                      |||..|+|.+||..+..       +.    +++..+.+.|+.||+.|+.||-++   .+|||||-..|.||+++..|||+
T Consensus       569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIs  645 (774)
T KOG1026|consen  569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKIS  645 (774)
T ss_pred             EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEec
Confidence            99999999999986431       12    278889999999999999999999   99999999999999999999999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcch
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQ  282 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  282 (368)
                      |||+++..++..++.....             ..-..+|||||.+..+.++++|||||+|++|||+++ |.-||.+...+
T Consensus       646 DfGLsRdiYssDYYk~~~~-------------t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  646 DFGLSRDIYSSDYYKVRGN-------------TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             ccccchhhhhhhhhcccCC-------------ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            9999998888776653211             134678999999999999999999999999999999 99999887665


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                      ...+.+..                  ..+ -..+..++.+++.|+..||+.+|.+||++++|-..|+...++...-.
T Consensus       713 EVIe~i~~------------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~  770 (774)
T KOG1026|consen  713 EVIECIRA------------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS  770 (774)
T ss_pred             HHHHHHHc------------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence            44332221                  222 33556778899999999999999999999999999998877654433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-46  Score=344.79  Aligned_cols=265  Identities=24%  Similarity=0.397  Sum_probs=203.3

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCC-
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRD-  128 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-  128 (368)
                      +.++.+.+.||+|+||.||+|.+..   ......+|+|+....  ......+.+|+.++..+ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            3456688899999999999997532   234567899976543  23346788999999999 8999999999887644 


Q ss_pred             eeEEEEecccCCCHHHHhcCCCC---------------------------------------------------------
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPR---------------------------------------------------------  151 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  151 (368)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            58899999999999998864311                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccc
Q 017627          152 --SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR  229 (368)
Q Consensus       152 --~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~  229 (368)
                        ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++........            
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------------  230 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------  230 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch------------
Confidence              13477888999999999999999999   9999999999999999999999999999753221110            


Q ss_pred             cccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcC
Q 017627          230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVD  308 (368)
Q Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (368)
                       .......+++.|+|||++.+..++.++|||||||++|||++ |..||.........  ......       .     ..
T Consensus       231 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~~~~~-------~-----~~  295 (338)
T cd05102         231 -VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQRLKD-------G-----TR  295 (338)
T ss_pred             -hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HHHHhc-------C-----CC
Confidence             00112346788999999999999999999999999999997 99999764432110  000000       0     00


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          309 PRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      .    ..+...+..+.+|+..||+.||.+|||+.++++.|++++.+
T Consensus       296 ~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         296 M----RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            0    11123355789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=327.07  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=210.3

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeec---CChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-----CCeeEEE
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHV---GSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-----RDEGVLL  133 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv  133 (368)
                      .+.||+|+||.|+.|.+..  ++..||||...   ......++..+|+.+|+.++|+||+.+++++..     -+.+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~--t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV  104 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKR--TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLV  104 (359)
T ss_pred             cccccCcceeeEEEEEEcC--CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEe
Confidence            4679999999999998766  66889988544   345566788899999999999999999999865     3568999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      +|+| +.+|...++   .+..++...+..+++|+++||+|+|+.   +|+||||||.|+|++.+..+||+|||+|+....
T Consensus       105 ~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  105 FELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             hhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccc
Confidence            9999 779999998   455699999999999999999999999   999999999999999999999999999996543


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .             ......+..+.|.+|+|||++. ...|+.++||||+|||+.||++|++.|.+.+.......+...+
T Consensus       178 ~-------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  178 F-------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             c-------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            2             1122235578999999999874 4689999999999999999999999999988766666655555


Q ss_pred             hhhhhhhhcch-----hhhcC---CCCCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKV-----NELVD---PRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~-----~~~~~---~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +.........+     ..++.   ...+..+   ....+..+.+|+.+||..||.+|+|++++|+|
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            55433211111     11111   1111111   12445789999999999999999999999988

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.6e-46  Score=321.76  Aligned_cols=272  Identities=24%  Similarity=0.251  Sum_probs=214.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh---HHHHHHHHHHHHhcCCCCc-eeeeeEEEecCC------
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN-IVKLIGYCDDRD------  128 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~------  128 (368)
                      +...++||+|+||+||+|+.+.  ++..||+|......+   ......+|+.+++.|+|+| ||.+++++.+.+      
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~--~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKR--TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEec--CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3456679999999999999766  568889987665433   4566789999999999999 999999998777      


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRS-SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      .+++|+||+ ..+|..++...... ..++...+..+++||+.||+|||++   +|+||||||+||||+.+|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            789999999 66999999875432 4678889999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      |+...-...               ..+..++|.+|+|||++.|. .|+..+||||+|||++||+++++.|.+..+.....
T Consensus       167 Ara~~ip~~---------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~  231 (323)
T KOG0594|consen  167 ARAFSIPMR---------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF  231 (323)
T ss_pred             HHHhcCCcc---------------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            984331111               01234689999999999886 79999999999999999999999999988877766


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCC--CCCC-----CCHHH---HHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhc
Q 017627          287 LAGSMLNDIADCEATKVNELVDPR--LAGD-----FDLDE---ARAMLSIAALCLRQSPILRPSATQILHT--IKHQ  351 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~~~~~---~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~  351 (368)
                      .+.+.+.......+.......+-.  ....     .....   .....+++.+||+.+|.+|.|++.+++|  +...
T Consensus       232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            666666665443332222222111  1111     11111   2478899999999999999999999998  5544

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-47  Score=308.66  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=216.9

Q ss_pred             cccccCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeee
Q 017627           45 SVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKL  120 (368)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~  120 (368)
                      ....++++++     ++++.||+|.||.||+|+...  +...+|+|+...+.    ....++.+|+++-..|+||||+++
T Consensus        15 ~~~~~~l~df-----eigr~LgkgkFG~vYlarekk--s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrl   87 (281)
T KOG0580|consen   15 ATKTWTLDDF-----EIGRPLGKGKFGNVYLAREKK--SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRL   87 (281)
T ss_pred             cccccchhhc-----cccccccCCccccEeEeeecc--CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhh
Confidence            4456666665     388999999999999999755  78899999876543    445788999999999999999999


Q ss_pred             eEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCce
Q 017627          121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC  200 (368)
Q Consensus       121 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~v  200 (368)
                      |++|.+....|+++||...|+|...|... ....+++...+.++.|++.|+.|+|.+   +|+||||||+|+|++..|.+
T Consensus        88 Y~~fhd~~riyLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   88 YGYFHDSKRIYLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             hhheeccceeEEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCe
Confidence            99999999999999999999999999854 456789999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      ||+|||-+....                 .++..+.|||..|.+||...+..++..+|+|++|++.||++.|.+||....
T Consensus       164 kiAdfGwsV~~p-----------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  164 KIADFGWSVHAP-----------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             eccCCCceeecC-----------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            999999886422                 223356899999999999999999999999999999999999999998766


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      .......+.+.-.                    .++...+..+.++|..|+..+|.+|.+..++++|-
T Consensus       227 ~~etYkrI~k~~~--------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  227 HSETYKRIRKVDL--------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             hHHHHHHHHHccc--------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            4444333322111                    12234466899999999999999999999999884

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=341.48  Aligned_cols=261  Identities=27%  Similarity=0.435  Sum_probs=207.4

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+++.||+|.||+||+|++.+  +..+..+++....+...+.|++|+.++++-+|.||+-+.|+|.+... .||..+|.|
T Consensus       395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG  471 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG  471 (678)
T ss_pred             hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence            367889999999999999865  33333344445567788999999999999999999999999998776 999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      .+|..+++..  ...+...+...|+.|++.|+.|||.+   +|||||||..|||+.+++.|||+|||++..-..-..   
T Consensus       472 sSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g---  543 (678)
T KOG0193|consen  472 SSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG---  543 (678)
T ss_pred             chhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc---
Confidence            9999999863  36789999999999999999999999   999999999999999999999999999864221110   


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                ........|...|||||++..   .+|+..+||||||+++|||++|..||...+.+....+..+.     
T Consensus       544 ----------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG-----  608 (678)
T KOG0193|consen  544 ----------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG-----  608 (678)
T ss_pred             ----------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc-----
Confidence                      000112348889999999954   57899999999999999999999999855443332222221     


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                               ++-+.+ .....+++.++.+|+..||..++++||++.+||..|+.++.+++
T Consensus       609 ---------~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  609 ---------YLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             ---------ccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence                     000100 01123557789999999999999999999999999999888653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-46  Score=317.67  Aligned_cols=277  Identities=23%  Similarity=0.223  Sum_probs=216.1

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh---HHHHHHHHHHHHhcCCCCceeeeeEEEe--cCCeeEEEEe
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDNIVKLIGYCD--DRDEGVLLFE  135 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e  135 (368)
                      ....|++|+||.||+|+++.  +...||+|.......   ..=...+|+.+|.+++|||||.+.++..  +-+.+|+|||
T Consensus        80 ~lnrI~EGtyGiVYRakdk~--t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKK--TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HHhhcccCcceeEEEeccCC--cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            45679999999999998654  889999997665432   2224568999999999999999999875  3457999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      || ..+|..++....  .++...++..+..|+++|++|||.+   .|+||||||+|+|+++.|.+||+|||+|+...+..
T Consensus       158 ~~-EhDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  158 YV-EHDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HH-HhhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99 558999998653  6789999999999999999999999   99999999999999999999999999999655442


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ..+..+-|.+|+|||.+.|. .|++++|+||+|||+.||+++.+.|.+..+.+....+...+..
T Consensus       232 k---------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt  296 (419)
T KOG0663|consen  232 K---------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT  296 (419)
T ss_pred             c---------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence            1               11335689999999999874 7999999999999999999999999998887777777776666


Q ss_pred             hhhhhhcchhhhc-----------CCCCCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          295 IADCEATKVNELV-----------DPRLAGDFDLD-EARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       295 ~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                      .....+..+...-           -..+...+... .++.-.+|+..+|..||.+|.||++.|+|  .-+.+.+.+.+|.
T Consensus       297 Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~  374 (419)
T KOG0663|consen  297 PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPS  374 (419)
T ss_pred             CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChh
Confidence            5443322221111           01112222222 45788899999999999999999999987  3344444444443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-47  Score=347.93  Aligned_cols=238  Identities=23%  Similarity=0.344  Sum_probs=201.4

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.++||+|+||+|+++..++  +.+.+|||+....    +...+....|..|+...+ ||.++.++.+|.+.+++|+||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~--~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm  448 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKG--TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM  448 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcC--CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence            367899999999999999876  6679999987654    344566778999988885 999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.||++..+.    ....+++..+..++..|+.||.|||++   +|||||||.+|||+|.+|.+||+|||+++-.-  
T Consensus       449 ey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--  519 (694)
T KOG0694|consen  449 EYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--  519 (694)
T ss_pred             EecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC--
Confidence            999999965444    456799999999999999999999999   99999999999999999999999999998422  


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                   .......+.||||.|||||++++..|+.++|.|||||++|||+.|..||.+.+++.....+...-  
T Consensus       520 -------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--  584 (694)
T KOG0694|consen  520 -------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--  584 (694)
T ss_pred             -------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--
Confidence                         22233467899999999999999999999999999999999999999999888765443322110  


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA  341 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  341 (368)
                                        ..++...+.+...+++.+|..||++|.-+
T Consensus       585 ------------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ------------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------------------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                              12445667789999999999999999765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-47  Score=340.80  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=206.1

Q ss_pred             ccCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC
Q 017627           48 KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR  127 (368)
Q Consensus        48 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  127 (368)
                      .+++++|.+..     -||.|+.|.||+|+..    ...||||...      +.-+.+++-|++|+||||+.+.|+|...
T Consensus       120 eiPFe~IsELe-----WlGSGaQGAVF~Grl~----netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  120 EIPFEEISELE-----WLGSGAQGAVFLGRLH----NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             cCCHHHhhhhh-----hhccCcccceeeeecc----CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCC
Confidence            34566666543     4999999999999874    4556776432      2223588999999999999999999999


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      -.+|||||||..|-|.+.|+   .+..+.......|..+|+.|+.|||.+   .|||||||.-||||+.+..|||+|||-
T Consensus       185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence            99999999999999999998   566788899999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ++....                ..++....||..|||||++...+.+.++||||||++||||+||..||.+-+.....  
T Consensus       259 S~e~~~----------------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII--  320 (904)
T KOG4721|consen  259 SKELSD----------------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII--  320 (904)
T ss_pred             hHhhhh----------------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE--
Confidence            874222                23335578999999999999999999999999999999999999999664432110  


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                      -..-...+....+..+++.+.-|++.||+..|..||++.+|+.||+-.-.+
T Consensus       321 ----------------wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  321 ----------------WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             ----------------EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence                            001112233334556778899999999999999999999999999866443

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-46  Score=326.67  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=210.8

Q ss_pred             HHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC
Q 017627           53 DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD  128 (368)
Q Consensus        53 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  128 (368)
                      --.+-+|++.+.||+|.||+|-+|...  ..+..||||.+..+    +...-.+.+|+++|..|+||||+.+|++|++.+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~--~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEH--KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhc--cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            344667889999999999999999743  37888999976543    334456789999999999999999999999999


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      .+++||||..+|.|.+|+.   ..+.+++.++..+++||.+|+.|+|.+   +++|||||.+|||+|.|+++||+|||++
T Consensus       127 KIvivMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             eEEEEEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchh
Confidence            9999999999999999998   567899999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      .........                .+.||+|.|.+||++.|.+| .+.+|-||||++||.|+.|..||.+.+...+...
T Consensus       201 Nly~~~kfL----------------qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ  264 (668)
T KOG0611|consen  201 NLYADKKFL----------------QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ  264 (668)
T ss_pred             hhhccccHH----------------HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH
Confidence            754433322                34789999999999999988 5679999999999999999999988765444333


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      +..             ..+..|.        .+.++.-||++||..||++|.|+.+|..|-
T Consensus       265 Is~-------------GaYrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  265 ISR-------------GAYREPE--------TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             hhc-------------ccccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            322             1111221        133677899999999999999999999884

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-47  Score=327.19  Aligned_cols=261  Identities=29%  Similarity=0.387  Sum_probs=205.0

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-----eeEEEEec
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----EGVLLFEY  136 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~  136 (368)
                      .+++|.|+||.||+|....  +...+|||..-.+....   .+|+++|+.+.|||||++..+|....     ...+||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e--~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRE--TEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             eEEEeecccceEEEEEEcC--CCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            4689999999999999876  47888988665554432   36999999999999999998875332     34689999


Q ss_pred             ccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-CceEEeeccccccCCCC
Q 017627          137 VPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-LNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       137 ~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~~vkl~Dfg~s~~~~~~  214 (368)
                      |+. +|..+++.. ..+..++.-.+.-+.+||++||.|||+.   +|+||||||.|+|+|.+ |.+||||||.|+.....
T Consensus       104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            955 888888742 1356788889999999999999999998   99999999999999955 99999999999976554


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...                ..+..|..|+|||.+.| ..|+.+.||||.||++.||+-|++.|.+.++.+....+-+.++
T Consensus       180 epn----------------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  180 EPN----------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             CCc----------------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence            422                34678999999999877 4799999999999999999999999999887766666666665


Q ss_pred             hhhhhhhcchh----hhcCCCCC-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVN----ELVDPRLA-----GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~----~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...........    +...+.+.     .-+....+.++.+|+.++|..+|.+|.++.+++.|
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            54432221111    11112111     11334456789999999999999999999999987

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.2e-46  Score=344.96  Aligned_cols=271  Identities=27%  Similarity=0.316  Sum_probs=218.4

Q ss_pred             HHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-C-----CceeeeeEEEec
Q 017627           53 DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-H-----DNIVKLIGYCDD  126 (368)
Q Consensus        53 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~  126 (368)
                      |...++|.+.++||+|+||.|.+|.+..  +.+.||||++++......+...|+.+|..|+ |     -|+|+++++|..
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~--T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHK--TGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecC--CCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            4444577789999999999999998655  8899999999999998889999999999997 4     489999999999


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC--CCceEEee
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE--HLNCKLCD  204 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~--~~~vkl~D  204 (368)
                      .+++|||+|++ ..+|.++++.+ ...+++...++.++.||+.||.+||..   +|||+||||+|||+.+  ...|||+|
T Consensus       260 r~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence            99999999999 67999999977 456799999999999999999999999   9999999999999974  34799999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      ||.|.......                  ...+.+..|+|||++.|.+|+.+.|+||||||+.||++|.+.|.+.++.+.
T Consensus       335 FGSSc~~~q~v------------------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ  396 (586)
T KOG0667|consen  335 FGSSCFESQRV------------------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ  396 (586)
T ss_pred             cccccccCCcc------------------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence            99997533222                  346789999999999999999999999999999999999999999887666


Q ss_pred             HHHHHhhhhhhhhh---hhcchhhhcCC---------------------------------CCC---CC----CCHHHHH
Q 017627          285 TSLAGSMLNDIADC---EATKVNELVDP---------------------------------RLA---GD----FDLDEAR  321 (368)
Q Consensus       285 ~~~~~~~~~~~~~~---~~~~~~~~~~~---------------------------------~~~---~~----~~~~~~~  321 (368)
                      ...+.+.++-++..   .+......++.                                 ..+   ..    .....-.
T Consensus       397 l~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~  476 (586)
T KOG0667|consen  397 LARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDK  476 (586)
T ss_pred             HHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHH
Confidence            55554444432220   00000000000                                 001   00    1112345


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          322 AMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       322 ~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      .+.+|+..||.+||.+|+|+.++|+|-
T Consensus       477 ~F~dflk~~L~~dP~~R~tp~qal~Hp  503 (586)
T KOG0667|consen  477 LFIDFLKRCLEWDPAERITPAQALNHP  503 (586)
T ss_pred             HHHHHHHHHhccCchhcCCHHHHhcCc
Confidence            679999999999999999999999983

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.7e-46  Score=331.32  Aligned_cols=250  Identities=19%  Similarity=0.260  Sum_probs=199.1

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ...+.||+|+||.||+|.+..  ++..+|+|......    .....+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEec--CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            456789999999999998765  56788998765332    223457789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|..++... ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998887643 234689999999999999999999999   99999999999999999999999999987532211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.................. 
T Consensus       157 ~----------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-  219 (285)
T cd05631         157 T----------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-  219 (285)
T ss_pred             e----------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-
Confidence            0                01235899999999999999999999999999999999999999765542221111111000 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                                     ....++...+..+.+|+..||+.||.+||+     ++++++|
T Consensus       220 ---------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         220 ---------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                           001122234568899999999999999997     8999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.2e-46  Score=339.17  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=197.6

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.||+|+||.||+|....  ++..+|+|+....    ......+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKA--TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            358999999999998755  6778899976543    2334567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        79 ~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---  149 (323)
T cd05571          79 GGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---  149 (323)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---
Confidence            999999887   445789999999999999999999999   99999999999999999999999999987422111   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..........   .    
T Consensus       150 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~---~----  210 (323)
T cd05571         150 ------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---E----  210 (323)
T ss_pred             ------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---C----
Confidence                        011235699999999999999999999999999999999999999976543322211100   0    


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                               +.    .++...+.++.+|+..||+.||++||     ++.++++|
T Consensus       211 ---------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 ---------EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             ---------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                     00    11223356789999999999999999     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-45  Score=319.54  Aligned_cols=281  Identities=22%  Similarity=0.273  Sum_probs=218.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ++.+.||.|.-|+||+++..+  +...+|+|+....    .....++..|.+||..++||.++.+|+.|+.+...|+|||
T Consensus        80 ~llk~LG~GdiG~VyL~~l~~--t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   80 RLLKRLGCGDIGTVYLVELRG--TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHcCCCCceeEEEEEecC--CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            467889999999999999866  5688999987654    3345667789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ||+||+|..+++. +.++.+++..++.++..++.||+|||-.   |||+|||||+||||-++|++.|+||.+|.......
T Consensus       158 yCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  158 YCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             cCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999987764 4678899999999999999999999999   99999999999999999999999999987542211


Q ss_pred             CCCCCC---------------------C--CCCC------------------ccccccceeeecCCCCccchhhccCCCC
Q 017627          216 VLPPSP---------------------S--PSPS------------------RSRITKQVMMIGSPGYTDPHYLRTGMAS  254 (368)
Q Consensus       216 ~~~~~~---------------------~--~~~~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~  254 (368)
                      ......                     .  ....                  .....+....+||-+|+|||++.|...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence            100000                     0  0000                  0011122357899999999999999999


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCC
Q 017627          255 TKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQS  334 (368)
Q Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  334 (368)
                      .++|+|+||+++|||+.|.-||.+.+..                  ..+.+++-..+.-.-....+..+++||+.+|..|
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~------------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK------------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCch------------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence            9999999999999999999999887753                  2233333333322222355678999999999999


Q ss_pred             CCCCCC----HHHHHHH--HHhcccccccccCCCCC
Q 017627          335 PILRPS----ATQILHT--IKHQISSISFLFSPQKD  364 (368)
Q Consensus       335 P~~Rpt----~~~il~~--L~~~~~~~~~~~~~~~~  364 (368)
                      |.+|.-    |+||.+|  .+...=++.+...|+.-
T Consensus       376 P~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~i  411 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEI  411 (459)
T ss_pred             hhhhhccccchHHhhcCccccCCChhheeccCCCcC
Confidence            999998    9999887  33333334444444443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-46  Score=334.81  Aligned_cols=244  Identities=25%  Similarity=0.322  Sum_probs=200.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRI--SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            3466789999999999998755  56788999765432    33456888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999987   345689999999999999999999999   9999999999999999999999999998753221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........   .
T Consensus       155 ~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~---~  213 (291)
T cd05612         155 T------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA---G  213 (291)
T ss_pred             c------------------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---C
Confidence            1                  124589999999999999999999999999999999999999977554322211110   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHTI  348 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~L  348 (368)
                                     .  ..++...+..+.+|+..||+.||.+||+     +.++++|-
T Consensus       214 ---------------~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         214 ---------------K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             ---------------C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence                           0  0111223457899999999999999995     99999883

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=337.69  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=210.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe-eEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE-GVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  133 (368)
                      .|.+.+.+|+|+||.+++++.+.  ....+++|.+..   .+...+....|+.++.+++|||||.+.+.|.+++. ++||
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~--~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKS--DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhcc--CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            35678899999999999998655  555677775433   34555678899999999999999999999998888 9999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |+||+||+|.+.+... ++.-++++.+..++.|++.|+.|||++   +|+|||||+.|||++.++.|||+|||+|+....
T Consensus        83 m~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999999865 357799999999999999999999998   999999999999999999999999999997655


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               ...+.+|||.||+||.+.+.+|+.++|||||||++|||++-+++|...+-..+...+...  
T Consensus       159 ~~~---------------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~--  221 (426)
T KOG0589|consen  159 EDS---------------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG--  221 (426)
T ss_pred             chh---------------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc--
Confidence            441               114578999999999999999999999999999999999999999877754433222111  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  .     ....+...+.++..+|..||+.+|..||++.++|.+
T Consensus       222 ------------~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 ------------L-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ------------c-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                        1     122344567789999999999999999999999987

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.1e-45  Score=335.62  Aligned_cols=267  Identities=21%  Similarity=0.289  Sum_probs=204.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|++.+.||+|+||.||++.+..  ++..+++|+....  +...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKP--SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            34567789999999999998755  5677888876543  3455678999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||+++  +|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            999999999997   3456899999999999999999999862  69999999999999999999999999986432211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .                 ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...................
T Consensus       159 ~-----------------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  221 (331)
T cd06649         159 A-----------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDG  221 (331)
T ss_pred             c-----------------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence            0                 12358999999999999999999999999999999999999997655433322221110000


Q ss_pred             hhhhh------------------------c----chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEA------------------------T----KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~------------------------~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....                        .    ....+.............+.++.+|+.+||+.||++|||+.++++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000                        0    0000000000111112345689999999999999999999999998


Q ss_pred             H
Q 017627          348 I  348 (368)
Q Consensus       348 L  348 (368)
                      .
T Consensus       302 ~  302 (331)
T cd06649         302 T  302 (331)
T ss_pred             h
Confidence            4

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-46  Score=339.51  Aligned_cols=243  Identities=25%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            3467889999999999998755  56788999765432    33456889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999987   345789999999999999999999999   9999999999999999999999999998753221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..........    
T Consensus       172 ~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----  229 (329)
T PTZ00263        172 T------------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA----  229 (329)
T ss_pred             c------------------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc----
Confidence            1                  124699999999999999999999999999999999999999976543222111100    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                                    ...  .++...+..+.+|+..||+.||.+||+     +++++.|
T Consensus       230 --------------~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 --------------GRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --------------CCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                          000  011123457889999999999999997     6888877

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=328.18  Aligned_cols=256  Identities=25%  Similarity=0.302  Sum_probs=198.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhH---------------HHHHHHHHHHHhcCCCCceeeeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL---------------SQVFKQELDILLHLSHDNIVKLIG  122 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~---------------~~~~~~E~~~l~~l~h~~iv~~~~  122 (368)
                      .|.+.+.||+|.||+|-+|....  +...+|||++...+..               .+...+|+.+|++|+|||||++++
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~--~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEV--DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             heehhhhhcCCccceEEEEeecC--CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            34567789999999999998654  7889999987544321               246788999999999999999999


Q ss_pred             EEecC--CeeEEEEecccCCCHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc
Q 017627          123 YCDDR--DEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN  199 (368)
Q Consensus       123 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~  199 (368)
                      +..+.  +.+|||+|||..|.+...-    ..+. +++.+++.++.+++.||+|||.+   |||||||||+|+|++.+|.
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            99765  5799999999888764322    3344 99999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC----CCcchhhHHHHHHHHHHHhCCCC
Q 017627          200 CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM----ASTKTDVYSFGVILLELVTGMEA  275 (368)
Q Consensus       200 vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~p  275 (368)
                      |||+|||.+........          ...-......+|||.|+|||...++.    .+.+.||||+|++||+|+.|..|
T Consensus       249 VKIsDFGVs~~~~~~~~----------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P  318 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSD----------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP  318 (576)
T ss_pred             EEeeccceeeecccCCc----------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence            99999999874322210          00011112257999999999987632    36789999999999999999999


Q ss_pred             CCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      |.+.....+..                  .++...+...-..+..+.+.+||..||..||++|.+..+|..|..-
T Consensus       319 F~~~~~~~l~~------------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  319 FFDDFELELFD------------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             cccchHHHHHH------------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            97765543322                  1222222222223456789999999999999999999999888643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.4e-45  Score=326.20  Aligned_cols=260  Identities=21%  Similarity=0.300  Sum_probs=202.9

Q ss_pred             cccccCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeee
Q 017627           45 SVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKL  120 (368)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~  120 (368)
                      +.+.++..++....   ...||+|++|.||+|.+    ++..+|+|......    ...+.+.+|+.++.+++|||||++
T Consensus        11 ~~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~   83 (283)
T PHA02988         11 DIKCIESDDIDKYT---SVLIKENDQNSIYKGIF----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI   83 (283)
T ss_pred             cceecCHHHcCCCC---CeEEeeCCceEEEEEEE----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence            34444555553221   14699999999999987    45678888765432    234677899999999999999999


Q ss_pred             eEEEec----CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          121 IGYCDD----RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       121 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      ++++.+    ....++||||+.+|+|.+++..   ...+++.....++.|++.|+.|||+..  +++||||||+|||+++
T Consensus        84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~  158 (283)
T PHA02988         84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE  158 (283)
T ss_pred             eeeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence            999876    3468999999999999999973   456889999999999999999999742  7889999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGME  274 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~  274 (368)
                      ++.+||+|||+++......                  ....|+..|+|||++.+  ..++.++|||||||++|||++|..
T Consensus       159 ~~~~kl~dfg~~~~~~~~~------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~  220 (283)
T PHA02988        159 NYKLKIICHGLEKILSSPP------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI  220 (283)
T ss_pred             CCcEEEcccchHhhhcccc------------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence            9999999999987532211                  11358899999999976  688999999999999999999999


Q ss_pred             CCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ||...+..........                  .......+...+..+.+|+.+||+.||.+|||+.++++.|+...
T Consensus       221 Pf~~~~~~~~~~~i~~------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        221 PFENLTTKEIYDLIIN------------------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCHHHHHHHHHh------------------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            9976654322211110                  00011122234568999999999999999999999999998753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-45  Score=329.57  Aligned_cols=267  Identities=25%  Similarity=0.297  Sum_probs=201.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|++..  +...+++|+....   +.....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKE--TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECC--CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4567889999999999998755  5677888876543   2345667889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.++++..+..   ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            998877765543   345689999999999999999999999   99999999999999999999999999987532211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ..              ......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+...............
T Consensus       155 ~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (287)
T cd07848         155 NA--------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL  220 (287)
T ss_pred             cc--------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            10              0122458999999999999899999999999999999999999998765433222222221111


Q ss_pred             hhhhhc------chhhhcCCCCCC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEAT------KVNELVDPRLAG------DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~------~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +.....      .......+....      .+....+..+.+|+.+||+.||++|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            110000      000000010000      0111245679999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.5e-45  Score=322.46  Aligned_cols=258  Identities=21%  Similarity=0.300  Sum_probs=204.6

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ...+.+.+.||+|+||.||+|.+.. ......+++|.....  ......+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            3445678899999999999997643 235678888876654  3344678899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+++++|.+++...  ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998743  34689999999999999999999999   99999999999999999999999999875422


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .....              ......++..|+|||.+.+..++.++|||||||++||+++ |..||...............
T Consensus       159 ~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~  224 (266)
T cd05064         159 SEAIY--------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG  224 (266)
T ss_pred             ccchh--------------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence            11100              0011235678999999999999999999999999999875 99999765543322211110


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                     ...    ..+..++..+.+++..||+.+|.+|||+.+|++.|+++
T Consensus       225 ---------------~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ---------------FRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------------CCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                           000    11223456789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.8e-45  Score=328.62  Aligned_cols=266  Identities=23%  Similarity=0.351  Sum_probs=202.0

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC--------------CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND--------------STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKL  120 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~--------------~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~  120 (368)
                      ..|.+.+.||+|+||.||+|.+.+.              .....+|+|+....  ......+.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            3455778899999999999986432              23456899977653  3445678899999999999999999


Q ss_pred             eEEEecCCeeEEEEecccCCCHHHHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 017627          121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTP----------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH  184 (368)
Q Consensus       121 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  184 (368)
                      ++++.+.+..++||||+.+++|.+++....                ....+++..++.++.|++.||.|||++   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            999999999999999999999999886421                113467888999999999999999999   9999


Q ss_pred             ecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHH
Q 017627          185 GDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGV  264 (368)
Q Consensus       185 ~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  264 (368)
                      |||||+|||++.++.+||+|||+++........             .......++..|+|||++.+..++.++||||||+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  228 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-------------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV  228 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCcee-------------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence            999999999999999999999998753222110             0011234678899999998889999999999999


Q ss_pred             HHHHHHh--CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017627          265 ILLELVT--GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT  342 (368)
Q Consensus       265 il~el~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  342 (368)
                      ++|+|++  +..||..................       .....     ....+..++..+.+|+.+||+.||.+|||+.
T Consensus       229 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRD-------QGRQV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             HHHHHHHccCCCCCCcCCHHHHHHHHHHHhhh-------ccccc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            9999987  56778665443332222111110       00000     0001112345789999999999999999999


Q ss_pred             HHHHHHHh
Q 017627          343 QILHTIKH  350 (368)
Q Consensus       343 ~il~~L~~  350 (368)
                      +|.+.|++
T Consensus       297 ~i~~~l~~  304 (304)
T cd05096         297 DIHAFLTE  304 (304)
T ss_pred             HHHHHHhC
Confidence            99998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.5e-45  Score=336.73  Aligned_cols=260  Identities=23%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             HHHhhhhcccccceEEEEEEEc---CCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLI---NDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      .+.+.+.||+|+||.||+|.+.   ...+...+|+|+....  ....+.+.+|+.++..+ +||||+++++++.+.+..+
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            4567899999999999999753   2335667899987543  23446788999999999 8999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCC------------------------------------------------------------
Q 017627          132 LLFEYVPNGTLQEKLHGTPR------------------------------------------------------------  151 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~------------------------------------------------------------  151 (368)
                      +|||||++|+|.+++.....                                                            
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence            99999999999998864210                                                            


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          152 ------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       152 ------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                                  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......... 
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-  271 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-  271 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc-
Confidence                        12478888999999999999999999   99999999999999999999999999987543221100 


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh-hHHHHHhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL-LTSLAGSMLNDIAD  297 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~-~~~~~~~~~~~~~~  297 (368)
                                  ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .......       
T Consensus       272 ------------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-------  332 (375)
T cd05104         272 ------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE-------  332 (375)
T ss_pred             ------------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh-------
Confidence                        0011235678999999999999999999999999999998 889986643221 1111110       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                  ......+...+.++.+|+..||+.||.+|||+.++++.|++.+
T Consensus       333 ------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         333 ------------GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             ------------CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence                        0000011112457899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.8e-45  Score=327.66  Aligned_cols=266  Identities=23%  Similarity=0.249  Sum_probs=199.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||.|+||.||+|....  ++..+|+|+....  ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECC--CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4567789999999999998755  6678888876533  22344677899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+ +|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            964 898888642  34578999999999999999999999   999999999999999999999999999874322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......|++.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+...............
T Consensus       159 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07871         159 ---------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP  223 (288)
T ss_pred             ---------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                           0012358999999999875 568999999999999999999999998766443333222222211


Q ss_pred             hhhhhcc------hhhhcCCCCCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATK------VNELVDPRLAGDF----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~------~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....+..      ......+......    ....+.++.+|+.+||+.||.+|||++++++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1111100      0111111111000    01224578999999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-45  Score=331.04  Aligned_cols=240  Identities=25%  Similarity=0.332  Sum_probs=194.3

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ||+|+||.||+|.+..  ++..+|+|+....    ......+.+|+.++..++||||+++++++.+.+..++||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRD--TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            7999999999998755  5677899976532    233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......    
T Consensus        79 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----  148 (312)
T cd05585          79 ELFHHLQ---REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD----  148 (312)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC----
Confidence            9999987   345689999999999999999999999   999999999999999999999999999874221110    


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                 ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+......   .....      
T Consensus       149 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~---~~~~~------  208 (312)
T cd05585         149 -----------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR---KILQE------  208 (312)
T ss_pred             -----------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH---HHHcC------
Confidence                       1123469999999999999999999999999999999999999997654322211   11100      


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS---ATQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~~  347 (368)
                               .  ..++...+..+.+++..||+.||.+||+   +.+++.|
T Consensus       209 ---------~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         209 ---------P--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ---------C--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence                     0  0112234567899999999999999975   6777766

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-45  Score=335.58  Aligned_cols=244  Identities=25%  Similarity=0.303  Sum_probs=199.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+... ....+|+|.....    ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECC-CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            45678899999999999986542 3467888876432    233456788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+|+|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       111 Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        111 EFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999997   445789999999999999999999999   9999999999999999999999999998753211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........    
T Consensus       185 ~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~----  242 (340)
T PTZ00426        185 T------------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE----  242 (340)
T ss_pred             c------------------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc----
Confidence            1                  234699999999999998899999999999999999999999976543322111110    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                    ...  .++...+..+.+++..||+.||.+|+     |++++++|
T Consensus       243 --------------~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        243 --------------GII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --------------CCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                          000  01112345688999999999999995     89999988

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7e-47  Score=308.39  Aligned_cols=251  Identities=27%  Similarity=0.297  Sum_probs=204.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .|.+.+.||+|.|+.|+++..  ..+++.+++|++...   ....+.+.+|+.+.+.|+|||||++.+.+.+....|+|+
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~--~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVH--KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHh--ccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            455778899999999998864  447777777765432   345678899999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec---CCCceEEeeccccccC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMG  211 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~---~~~~vkl~Dfg~s~~~  211 (368)
                      |+|.|++|..-+-.+   ..+++..+-..+.||+.||.|.|.+   +|||||+||.|+++.   ...-+||+|||+|...
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999998766532   4578888999999999999999999   999999999999995   4456999999999865


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .+...                -....|||.|||||++...+|+.++|||+.|++||-|+.|++||.+++...+.+.+...
T Consensus       164 ~~g~~----------------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g  227 (355)
T KOG0033|consen  164 NDGEA----------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG  227 (355)
T ss_pred             CCccc----------------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence            42221                13457999999999999999999999999999999999999999887765555444332


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..+.                ....-...++++++|+++||..||.+|.|+.|.|+|-
T Consensus       228 ~yd~----------------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  228 AYDY----------------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             ccCC----------------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            2221                1112234467899999999999999999999999873

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.6e-45  Score=332.25  Aligned_cols=242  Identities=25%  Similarity=0.338  Sum_probs=196.2

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.||+|+||.||++....  ++..+|+|+....    ......+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            358999999999998654  6778899976542    2334556789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|..++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        79 ~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  150 (323)
T cd05595          79 GGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  150 (323)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--
Confidence            999998887   345789999999999999999999999   999999999999999999999999999864221110  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........        
T Consensus       151 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------  209 (323)
T cd05595         151 -------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------  209 (323)
T ss_pred             -------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------
Confidence                         01224699999999999999999999999999999999999999976543322211100        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                        .      ..    .++...+..+.+++..||+.||.+||     ++.++++|
T Consensus       210 --~------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         210 --E------EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --C------CC----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              0      00    11122356789999999999999998     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-44  Score=335.60  Aligned_cols=261  Identities=24%  Similarity=0.361  Sum_probs=202.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  130 (368)
                      ..+.+.+.||+|+||.||+|.+..   ..+...+|+|+....  ......+.+|+.+++.+ +|+|||++++++...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            345678999999999999998643   223456899977543  33456688999999999 899999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCC------------------------------------------------------------
Q 017627          131 VLLFEYVPNGTLQEKLHGTP------------------------------------------------------------  150 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~------------------------------------------------------------  150 (368)
                      ++||||+.+|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885321                                                            


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCC
Q 017627          151 -------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP  223 (368)
Q Consensus       151 -------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~  223 (368)
                             ....+++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+++........      
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~------  268 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY------  268 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce------
Confidence                   112478889999999999999999999   9999999999999999999999999998753221110      


Q ss_pred             CCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhh-HHHHHhhhhhhhhhhhc
Q 017627          224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLL-TSLAGSMLNDIADCEAT  301 (368)
Q Consensus       224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  301 (368)
                             .......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ......           
T Consensus       269 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~-----------  330 (374)
T cd05106         269 -------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR-----------  330 (374)
T ss_pred             -------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc-----------
Confidence                   00011235678999999998899999999999999999997 9999975432211 111000           


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                              ......+...+.++.+++..||+.||.+|||+.++++.|++++
T Consensus       331 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         331 --------GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             --------ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                    0000011112457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.3e-45  Score=332.41  Aligned_cols=241  Identities=25%  Similarity=0.340  Sum_probs=196.3

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .||+|+||.||++....  ++..+|+|+....    ......+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus         2 ~lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           2 LLGKGTFGKVILVREKA--SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             eeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            58999999999998754  6778899976543    23345677899999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......    
T Consensus        80 g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----  149 (328)
T cd05593          80 GELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----  149 (328)
T ss_pred             CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----
Confidence            99998887   345689999999999999999999999   99999999999999999999999999987422111    


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                 ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+........   ..      
T Consensus       150 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~---~~------  209 (328)
T cd05593         150 -----------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LM------  209 (328)
T ss_pred             -----------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh---cc------
Confidence                       0112346999999999999999999999999999999999999999765432221111   00      


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                             .+.    .++...+.++.+|+..||+.||.+||     ++.++++|
T Consensus       210 -------~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         210 -------EDI----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -------CCc----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                   000    11122355789999999999999997     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-45  Score=334.07  Aligned_cols=251  Identities=24%  Similarity=0.279  Sum_probs=202.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+....    ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKD--TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            3467789999999999999765  5678899976543    123456788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~  154 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY  154 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence            9999999999997   445689999999999999999999999   9999999999999999999999999998743220


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                        .....||+.|+|||++.+..++.++|||||||++|||++|..||...+............  
T Consensus       155 ------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--  214 (333)
T cd05600         155 ------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--  214 (333)
T ss_pred             ------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--
Confidence                              122469999999999999999999999999999999999999997665433222111100  


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ...............+.++.+++..||..+|.+||++.++++|
T Consensus       215 ----------~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 ----------ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----------ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                      0000000000012345688999999999999999999999988

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-44  Score=329.79  Aligned_cols=268  Identities=21%  Similarity=0.282  Sum_probs=202.1

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ...|++.+.||+|+||.||++.+..  ++..+++|+...  .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP--SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            3456678899999999999998754  566778886554  334456788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++.   ....+++..+..++.|++.||.|||+..  +|+|+||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999997   3456889999999999999999999742  799999999999999999999999999864322


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...                 ....|+..|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus       157 ~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  219 (333)
T cd06650         157 SMA-----------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE  219 (333)
T ss_pred             hcc-----------------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCccc
Confidence            110                 123589999999999998999999999999999999999999976543322221111000


Q ss_pred             hhhhhh-----h-----------------cch---hh-hcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCE-----A-----------------TKV---NE-LVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~-----~-----------------~~~---~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......     .                 ...   .. ..............+.++.+|+.+||+.||.+|||++++++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         220 GDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            000000     0                 000   00 000000000011134578999999999999999999999887

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.4e-44  Score=318.27  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=205.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.+.||+|+||.||+|.+.+  ....+++|+..........+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus         9 ~~~~~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           9 TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             EEeeecCCcccceEEEEEEec--CCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            456789999999999998765  567789998776665567788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++... ....+++..++.++.|++.||.|||++   +++||||||+||++++++.+||+|||++.......... 
T Consensus        87 ~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-  161 (263)
T cd05052          87 GNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-  161 (263)
T ss_pred             CcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec-
Confidence            9999998753 234689999999999999999999999   99999999999999999999999999987543221100 


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+............        
T Consensus       162 -------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--------  220 (263)
T cd05052         162 -------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------  220 (263)
T ss_pred             -------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------
Confidence                         011224667999999999999999999999999999998 9999976543322211110        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                             .    .....+...+..+.+++.+||+.||.+|||+.++++.|+.++
T Consensus       221 -------~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         221 -------G----YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             -------C----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                   0    011112223467999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-44  Score=331.30  Aligned_cols=268  Identities=22%  Similarity=0.304  Sum_probs=197.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-----Cee
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-----DEG  130 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  130 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|.....   ......+.+|+.+++.++||||+++++++...     ...
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTH--TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECC--CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            4567889999999999998754  6678899876432   23345678899999999999999999988543     247


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+ +++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELM-ESDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecC-CCCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999999 568988887   345689999999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ........            .......||+.|+|||++.+  ..++.++|||||||++|+|++|.+||.+.+........
T Consensus       153 ~~~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~  220 (338)
T cd07859         153 AFNDTPTA------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI  220 (338)
T ss_pred             cccccCcc------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence            32211100            00122468999999999876  67899999999999999999999999776543322222


Q ss_pred             Hhhhhhhhhhhhcc--------hhhhcCCCCCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATK--------VNELVDPRLAGDFD---LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..............        ....+.+.....+.   ...+..+.+++..||+.||.+|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            22111111000000        00000010100000   1124578899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.3e-45  Score=331.77  Aligned_cols=242  Identities=23%  Similarity=0.336  Sum_probs=195.7

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.||+|+||.||++.+..  ++..+|+|+....    ......+.+|+.++..++||||+++++++.+.+..++||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            358999999999998654  6778899976542    2334566789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      +++|..++.   ....+++..+..++.||+.||.|||+ +   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  151 (325)
T cd05594          79 GGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-  151 (325)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence            999998887   44578999999999999999999997 6   999999999999999999999999999864221110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........   .   
T Consensus       152 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~---~---  211 (325)
T cd05594         152 --------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---E---  211 (325)
T ss_pred             --------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc---C---
Confidence                          01234699999999999999999999999999999999999999976554322211100   0   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                ...    ++...+.++.+|+.+||+.||.+|+     ++.++++|
T Consensus       212 ----------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 ----------EIR----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ----------CCC----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                      001    1112345789999999999999996     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-44  Score=328.36  Aligned_cols=242  Identities=26%  Similarity=0.400  Sum_probs=194.7

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||.||+|++..  +...+|+|+....    ......+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE--SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            358999999999998755  6678899976532    23345567788888876 6999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 ~~g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-  151 (320)
T cd05590          79 NGGDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-  151 (320)
T ss_pred             CCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence            9999999887   345689999999999999999999999   999999999999999999999999999874221110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........   .   
T Consensus       152 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~---~---  211 (320)
T cd05590         152 --------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---D---  211 (320)
T ss_pred             --------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc---C---
Confidence                          11234699999999999999999999999999999999999999977654332221110   0   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA------TQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~  347 (368)
                                  ..  ..+...+.++.+++..||+.||.+||++      ++++.|
T Consensus       212 ------------~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         212 ------------EV--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ------------CC--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                        00  0111235578999999999999999998      777766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-43  Score=317.40  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=203.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCC---CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDS---TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~---~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.+.||+|+||.||+|......   ....+++|.....  ......+.+|+.++..++||||+++++++......+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            46788999999999999875432   3356888876543  344567889999999999999999999999889999999


Q ss_pred             ecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceE
Q 017627          135 EYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCK  201 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vk  201 (368)
                      ||+.+++|.+++.....             ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence            99999999999875321             14588899999999999999999999   999999999999999999999


Q ss_pred             EeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 017627          202 LCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPEN  280 (368)
Q Consensus       202 l~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  280 (368)
                      |+|||+++.........             ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus       165 L~dfg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         165 ISDFGLSRDIYSADYYR-------------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             ECCCcceeecccccccc-------------ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999987543221100             0112346788999999998899999999999999999998 999997655


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      .......+..                   ......+...+..+.+|+.+||+.||.+|||+.+|+++|++
T Consensus       232 ~~~~~~~i~~-------------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         232 NQEVIEMIRS-------------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHHc-------------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            4322221111                   00111223445789999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-44  Score=324.59  Aligned_cols=251  Identities=28%  Similarity=0.337  Sum_probs=209.4

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh----HHHHHHHHHHHHhcCC-CCceeeeeEEEecCCee
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR----LSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  130 (368)
                      ...|.+++.||+|.||.||++..+.  ++..+|+|+......    ....+.+|+.+|+++. |||||.++++|++.+..
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~--tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKS--TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecC--CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            4456678899999999999998765  688889987654432    3467899999999998 99999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC----CCceEEeecc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE----HLNCKLCDFG  206 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~----~~~vkl~Dfg  206 (368)
                      ++|||+|.||.|.+.+...    .+++..+..++.|++.|+.|||+.   ||+||||||+|+|+..    ++.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999998854    399999999999999999999999   9999999999999963    3579999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      +|.....                .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+........
T Consensus       185 la~~~~~----------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~  248 (382)
T KOG0032|consen  185 LAKFIKP----------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL  248 (382)
T ss_pred             CceEccC----------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence            9986443                122356789999999999999999999999999999999999999998877543332


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .+....                ...........+..+.+++..||..||..|+|+.++|+|
T Consensus       249 ~i~~~~----------------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 AILRGD----------------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHcCC----------------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            111110                012222334557889999999999999999999999997

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.3e-44  Score=323.23  Aligned_cols=266  Identities=24%  Similarity=0.270  Sum_probs=194.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....  .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKV--NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECC--CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            4567889999999999998754  56778999765432  2234567899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. ++|.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          85 VH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             CC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            95 677777764  235688999999999999999999999   999999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQ-LLTSLAGSMLND  294 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~  294 (368)
                                     ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.... ............
T Consensus       159 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (303)
T cd07869         159 ---------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT  223 (303)
T ss_pred             ---------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence                           0012358999999999876 45788999999999999999999999765431 111111111111


Q ss_pred             hhhhhhcchh---hhcCCCCC----CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVN---ELVDPRLA----GDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~---~~~~~~~~----~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..........   ........    ....     ...+..+.+|+..||+.||.+|||+.++++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0000000000   00000000    0000     0113568899999999999999999999976

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-44  Score=333.73  Aligned_cols=264  Identities=21%  Similarity=0.223  Sum_probs=196.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..|.+.+.||+|+||.||+|.+..  +...+|+|...     ...+.+|+.+++.|+||||+++++++......++|||+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~--~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNK--TCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECC--CCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            456778899999999999998755  67788998643     23467899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      + .++|..++..   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       165 ~-~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 Y-KTDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             C-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            9 4688888763   35688999999999999999999999   999999999999999999999999999864221110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-------hhHHHHH
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ-------LLTSLAG  289 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~  289 (368)
                                    .......||+.|+|||++.+..++.++|||||||++|||++|..||......       .....+.
T Consensus       238 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~  303 (391)
T PHA03212        238 --------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII  303 (391)
T ss_pred             --------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence                          0112346999999999999999999999999999999999999887543211       1111111


Q ss_pred             hhhhhhhhhh----hcchhhhc---------CCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          290 SMLNDIADCE----ATKVNELV---------DPRLAGDF--DLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       290 ~~~~~~~~~~----~~~~~~~~---------~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ......+...    ...+....         .+.....+  ....+.++.+||.+||+.||.+|||++++|+|-
T Consensus       304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence            1110000000    00000000         00000000  113456889999999999999999999999863

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-44  Score=341.75  Aligned_cols=253  Identities=26%  Similarity=0.344  Sum_probs=199.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC-ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|..... ....+++|.... .......+.+|+.+++.++|||||++++++...+..++||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~-~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSD-PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCC-CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            55778899999999999986543 245566665433 3444566788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          138 PNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       138 ~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      .+++|.+++... .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887642 1345689999999999999999999999   999999999999999999999999999975432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      .             ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+......   .....  
T Consensus       225 ~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~---~~~~~--  286 (478)
T PTZ00267        225 L-------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ---QVLYG--  286 (478)
T ss_pred             c-------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhC--
Confidence            0             01123469999999999999999999999999999999999999997654321111   11000  


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               ...     ..+...+..+.++|..||+.||.+|||+++++.+
T Consensus       287 ---------~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        287 ---------KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ---------CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                     000     1122334679999999999999999999999865

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-45  Score=332.58  Aligned_cols=258  Identities=23%  Similarity=0.386  Sum_probs=210.4

Q ss_pred             hhhhcccccceEEEEEEEcCCCC--ceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDST--STNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +.++||+|+||.||+|.+.....  ...||+|....    .......+.+|+++++.++|||||++||++....++++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            55789999999999999865433  22278887653    3566788999999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |+|.||+|.++|....  ..++..+...++.+.+.||+|||++   ++|||||-..|+|++.++.+||+|||+|+.....
T Consensus       241 El~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             EecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            9999999999998532  3699999999999999999999999   9999999999999999999999999999753311


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....               ....-...|+|||.+....++.++||||||+++||+++ |..||.+.........+.    
T Consensus       316 ~~~~---------------~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~----  376 (474)
T KOG0194|consen  316 VMKK---------------FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV----  376 (474)
T ss_pred             eecc---------------ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH----
Confidence            1000               01124568999999999999999999999999999999 889998877653332221    


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                    ....+...+...+..+..++..||..||+.|||+.++.+.|+.+.+...
T Consensus       377 --------------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 --------------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             --------------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                          1112222333456788899999999999999999999999999877654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-44  Score=327.67  Aligned_cols=244  Identities=24%  Similarity=0.342  Sum_probs=196.1

Q ss_pred             hhcccccceEEEEEEEcC-CCCceeEEEEeecCC-----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           63 QVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.||+|+||.||+++... ...+..+|+|+....     ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            469999999999998643 346778999976542     22334567899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++.   ..+.+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999987   445688899999999999999999999   999999999999999999999999999864221110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......||+.|+|||++.+..++.++||||||+++|||++|..||...+......   ....   
T Consensus       156 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~---~~~~---  214 (323)
T cd05584         156 ---------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID---KILK---  214 (323)
T ss_pred             ---------------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH---HHHc---
Confidence                           0122459999999999999889999999999999999999999997655322111   1100   


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                  ..  ...+...+..+.++|..||+.||++||     ++.++++|
T Consensus       215 ------------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         215 ------------GK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ------------CC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                        00  011122345789999999999999999     89999886

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.9e-44  Score=325.11  Aligned_cols=241  Identities=24%  Similarity=0.357  Sum_probs=191.2

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .||+|+||.||+|.+.+  +...+|+|+....    ....+.+..|..++..+ +||||+++++++...+..++||||+.
T Consensus         2 ~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           2 VLGKGSFGKVMLAELKG--TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             eeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            59999999999998755  6678899976543    22334455677777654 89999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 gg~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---  150 (316)
T cd05592          80 GGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---  150 (316)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---
Confidence            999999887   345689999999999999999999999   99999999999999999999999999987432111   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..   .    
T Consensus       151 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~----  211 (316)
T cd05592         151 ------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN---D----  211 (316)
T ss_pred             ------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---C----
Confidence                        011234699999999999999999999999999999999999999977654322211110   0    


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT-QILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~  347 (368)
                               .+    .++...+.++.+++..||+.||.+||++. ++++|
T Consensus       212 ---------~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 ---------RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             ---------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                     01    11222345788999999999999999875 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.2e-44  Score=325.65  Aligned_cols=242  Identities=21%  Similarity=0.308  Sum_probs=192.5

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||.||+|.+..  ++..+|+|+....    ......+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG--KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            359999999999998765  6678899976543    22334566788888755 8999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||+++......  
T Consensus        79 ~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  150 (316)
T cd05620          79 NGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--  150 (316)
T ss_pred             CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence            9999999887   345689999999999999999999999   99999999999999999999999999986321111  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...........      
T Consensus       151 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------  211 (316)
T cd05620         151 -------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------  211 (316)
T ss_pred             -------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Confidence                         0112356999999999999999999999999999999999999999765543222211110      


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT-QILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~  347 (368)
                                .+..    +...+.++.+++..||+.||.+||++. ++++|
T Consensus       212 ----------~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         212 ----------TPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             ----------CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                      0111    112345788999999999999999984 66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.5e-44  Score=326.35  Aligned_cols=242  Identities=27%  Similarity=0.379  Sum_probs=195.3

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ++||+|+||.||+|.+..  ++..+|+|+....    ......+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG--TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            358999999999998754  6678899976542    23345567788888876 7999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  151 (321)
T cd05591          79 NGGDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-  151 (321)
T ss_pred             CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence            9999998887   345689999999999999999999999   999999999999999999999999999874221110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........   .   
T Consensus       152 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~---~---  211 (321)
T cd05591         152 --------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH---D---  211 (321)
T ss_pred             --------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc---C---
Confidence                          01234689999999999999999999999999999999999999987654332221110   0   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-------SATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------t~~~il~~  347 (368)
                             .   .    .++...+.++.+++..||+.||.+||       ++.++++|
T Consensus       212 -------~---~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         212 -------D---V----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -------C---C----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                   0   0    01112345789999999999999999       88999877

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.4e-44  Score=333.06  Aligned_cols=264  Identities=23%  Similarity=0.256  Sum_probs=197.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||+||+|.+..  ++..+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~~~LG~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           4 VKIKTLGIGAFGEVCLACKVD--THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             eEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            456789999999999998755  6778899987543    2344568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++|+|.+++.   ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999987   345689999999999999999999999   99999999999999999999999999986421110


Q ss_pred             C---CCCCC-----C-C-----------------------CCCccccccceeeecCCCCccchhhccCCCCcchhhHHHH
Q 017627          216 V---LPPSP-----S-P-----------------------SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFG  263 (368)
Q Consensus       216 ~---~~~~~-----~-~-----------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  263 (368)
                      .   .....     . .                       .............+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0   00000     0 0                       0000000011235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhc--CCCCCCCCCH
Q 017627          264 VILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL--RQSPILRPSA  341 (368)
Q Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dP~~Rpt~  341 (368)
                      |++|||++|..||...+...........                ...+........+.++.+||.+|+  ..+|..||++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~----------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINW----------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHcc----------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            9999999999999765532211111000                000000011123457888998844  5566679999


Q ss_pred             HHHHHH
Q 017627          342 TQILHT  347 (368)
Q Consensus       342 ~~il~~  347 (368)
                      .+++.|
T Consensus       300 ~~~l~h  305 (381)
T cd05626         300 DDIKAH  305 (381)
T ss_pred             HHHhcC
Confidence            999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.3e-44  Score=327.68  Aligned_cols=244  Identities=28%  Similarity=0.378  Sum_probs=190.9

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+.||+|+||.||+|.+..  ++..+++|+....  ......+.+|+++++.++|+||+++++++...+..++||||+.
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRP--TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             hhhhccCCCCeEEEEEEECC--CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            56789999999999998754  5678899976543  3445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|....       ..++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus       156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            99886432       346778889999999999999999   999999999999999999999999999875322110  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                                   ......||..|+|||++..     ...+.++|||||||++|||++|..||.................
T Consensus       224 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  290 (353)
T PLN00034        224 -------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM  290 (353)
T ss_pred             -------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc
Confidence                         0012358999999998843     2345689999999999999999999974332222211111000


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .                .........+.++.+||..||+.||++|||+.++++|
T Consensus       291 ~----------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 S----------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             c----------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0                0011122345689999999999999999999999998

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-43  Score=316.51  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=205.7

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..+.+.+.||+|+||.||+|...+.   .....+++|+.....  ...+.+.+|+++++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            3456788999999999999986543   345778898765542  24578899999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCce
Q 017627          132 LLFEYVPNGTLQEKLHGTP-----------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC  200 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~v  200 (368)
                      +||||+++++|.+++....           ....+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999987532           134578899999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPE  279 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  279 (368)
                      +|+|||+++..........             .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       162 kl~d~g~~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRV-------------GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             EECCcccceecccCcceec-------------CCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            9999999875332221100             011236788999999999999999999999999999998 99999765


Q ss_pred             cchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      +..........                  .. ....+...+..+.+++..||+.||.+|||+.++++.|++
T Consensus       229 ~~~~~~~~~~~------------------~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         229 SNEEVIECITQ------------------GR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CHHHHHHHHHc------------------CC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            54332221110                  00 001112335678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.1e-44  Score=323.74  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=192.0

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .||+|+||.||+|.+..  +...+|+|+....    ......+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           2 MLGKGSFGKVFLAELKG--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             eeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            58999999999998755  5677899976543    22334556678888764 89999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  150 (316)
T cd05619          80 GGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---  150 (316)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---
Confidence            999999987   345688999999999999999999999   99999999999999999999999999986421111   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  .......||+.|+|||++.+..++.++||||+||++|+|++|..||...+..........        
T Consensus       151 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--------  210 (316)
T cd05619         151 ------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--------  210 (316)
T ss_pred             ------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Confidence                        011234699999999999999999999999999999999999999976553322211110        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT-QILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~  347 (368)
                              ..+.    ++...+.++.+++.+||+.||.+||++. ++++|
T Consensus       211 --------~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         211 --------DNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             --------CCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence                    0011    1112345788999999999999999997 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-43  Score=318.46  Aligned_cols=267  Identities=23%  Similarity=0.301  Sum_probs=194.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC---CCCceeeeeEEEe-----cC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL---SHDNIVKLIGYCD-----DR  127 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~  127 (368)
                      |.+.+.||+|+||.||+|++... .+..+|+|.....   ......+.+|+.+++.+   +||||+++++++.     ..
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCC-CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            45678899999999999986432 3567788865432   22234556788877766   6999999999885     24


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      ...++||||+. ++|.+++... ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            56899999995 6898888754 234589999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ++......                ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......
T Consensus       157 ~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  220 (290)
T cd07862         157 ARIYSFQM----------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  220 (290)
T ss_pred             eEeccCCc----------------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence            87532211                01224589999999999988999999999999999999999999987664333222


Q ss_pred             HHhhhhhhhhhhhcch----hhhcCCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEATKV----NELVDPRLAG---DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +...............    .....+....   ......+..+.+++.+||+.||++|||+.++++|
T Consensus       221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            2111110000000000    0000000000   0111235678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5e-44  Score=325.72  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=193.9

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHH---hcCCCCceeeeeEEEecCCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDIL---LHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+.+.||+|+||.||+|.+..  ++..+|+|+....    ....+.+.+|+.++   ..++||||+++++++.+.+..|+
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKK--TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            356789999999999998755  6778899987543    22344566676665   45679999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|..++.    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        80 v~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          80 VMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999998875    34689999999999999999999999   99999999999999999999999999986422


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...               .......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..........  
T Consensus       153 ~~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--  215 (324)
T cd05589         153 GFG---------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--  215 (324)
T ss_pred             CCC---------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Confidence            111               011234699999999999999999999999999999999999999976654322211100  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                       .             ..    .++...+..+.++|.+||+.||.+||     ++.++++|
T Consensus       216 -~-------------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         216 -D-------------EV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -C-------------CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence             0             00    01122356788999999999999999     68888876

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.2e-43  Score=311.08  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      .||+|+||.||+|.+....+...+++|+....   ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            48999999999998766667788999976543   334567889999999999999999999885 45679999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.........  
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~--  152 (257)
T cd05116          81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY--  152 (257)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee--
Confidence            9999987   345689999999999999999999999   99999999999999999999999999987543222100  


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                .......++..|+|||.+....++.++||||||+++|||++ |..||..............         
T Consensus       153 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~---------  213 (257)
T cd05116         153 ----------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES---------  213 (257)
T ss_pred             ----------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence                      00011234678999999988889999999999999999998 9999976554322222111         


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                ......+...+.++.++|.+||+.||.+||++.+|.+.|++.
T Consensus       214 ----------~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         214 ----------GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----------CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                      000111223456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-43  Score=328.59  Aligned_cols=264  Identities=23%  Similarity=0.293  Sum_probs=196.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ++.+.||+|+||+||+|....  ++..+|+|+....    ......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKD--TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            456789999999999998655  6778999987543    2334567889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++|+|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          82 FLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999997   346789999999999999999999999   99999999999999999999999999987543211


Q ss_pred             CCCCCCC-----C------CC---------CccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 017627          216 VLPPSPS-----P------SP---------SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA  275 (368)
Q Consensus       216 ~~~~~~~-----~------~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  275 (368)
                      .......     .      ..         ...........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0000000     0      00         00000011235799999999999999999999999999999999999999


Q ss_pred             CCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 017627          276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR--QSPILRPSATQILHT  347 (368)
Q Consensus       276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dP~~Rpt~~~il~~  347 (368)
                      |.+.+.......+.....           ..   ..+.  ....+.++.++|..|+.  .++..||++++|++|
T Consensus       236 f~~~~~~~~~~~i~~~~~-----------~~---~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETYKKVMNWKE-----------TL---IFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHHHHHHcCcC-----------cc---cCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            976554322211111000           00   0010  01124567888887654  233456899999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.9e-44  Score=325.23  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCC-CceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSH-DNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.+.||+|+||.||+|.+.+  +...+|+|+....    ....+.+..|+.++..++| ++|+.+++++.+.+..++||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            466789999999999998755  5678899976542    2344567789999999976 56889999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999887   345689999999999999999999999   9999999999999999999999999998632111


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+...........   
T Consensus       155 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~---  216 (324)
T cd05587         155 G---------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH---  216 (324)
T ss_pred             C---------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---
Confidence            1               0112356999999999999999999999999999999999999999765543222111110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                       ...++...+..+.+++..||..||.+|++.     .++++|
T Consensus       217 -----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 -----------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                             001112234578899999999999999986     677765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=333.65  Aligned_cols=264  Identities=26%  Similarity=0.294  Sum_probs=203.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....    .....+.+|+.++..++||||+++++++.+.+..++||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKD--TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4467889999999999998755  67788999875432    34456888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999973   36789999999999999999999999   9999999999999999999999999999754432


Q ss_pred             CCCCCCC--------------CCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          215 AVLPPSP--------------SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       215 ~~~~~~~--------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      .......              ................||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2000000              00000000111233569999999999999999999999999999999999999997765


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-ATQILHT  347 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~~  347 (368)
                      .......+....                ...........+..+.+||..||. ||.+||+ ++++++|
T Consensus       235 ~~~~~~~i~~~~----------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETYNKIINWK----------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHHhccC----------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            322211111100                000000011135688999999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.2e-44  Score=324.17  Aligned_cols=242  Identities=26%  Similarity=0.365  Sum_probs=195.4

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||+||+|.+..  +...+|+|+....    ......+..|..+++.+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG--TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            358999999999998754  5678899976543    23345567889999888 6999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 ~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  151 (318)
T cd05570          79 NGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-  151 (318)
T ss_pred             CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence            9999998887   345789999999999999999999999   999999999999999999999999999863211110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........   .   
T Consensus       152 --------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~---~---  211 (318)
T cd05570         152 --------------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE---D---  211 (318)
T ss_pred             --------------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---C---
Confidence                          01224689999999999999999999999999999999999999976553322211110   0   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                ..    .++...+..+.+||.+||+.||.+|||+     .++++|
T Consensus       212 ----------~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 ----------EV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ----------CC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                      00    1112235678999999999999999999     888876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-43  Score=329.83  Aligned_cols=263  Identities=23%  Similarity=0.338  Sum_probs=204.3

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGS--DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDE  129 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  129 (368)
                      +..+.+++.||+|+||.||+|.+...   .....+|+|+....  ....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            34556788999999999999986432   23456899977543  334567889999999996 9999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCC-----------------------------------------------------------
Q 017627          130 GVLLFEYVPNGTLQEKLHGTP-----------------------------------------------------------  150 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~-----------------------------------------------------------  150 (368)
                      .++|||||.+|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998876421                                                           


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          151 ----------------------------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       151 ----------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                                                        ....+++..+..++.|++.||.|||++   +|+|+||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                              012477888899999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEA  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  275 (368)
                      ++.+||+|||+++........             .......+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P  339 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNY-------------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP  339 (400)
T ss_pred             CCEEEEEeCCcceeccccccc-------------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999998753322110             00112346788999999999899999999999999999997 9999


Q ss_pred             CCCCcchh-hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          276 FCPENGQL-LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       276 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      |....... ......               ..    .....+...+..+.+++..||+.||.+|||+.++.+.|+++++
T Consensus       340 ~~~~~~~~~~~~~~~---------------~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         340 YPGMIVDSTFYNKIK---------------SG----YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             CcccchhHHHHHHHh---------------cC----CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            86543211 111000               00    0011122345688999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-43  Score=322.98  Aligned_cols=263  Identities=23%  Similarity=0.360  Sum_probs=203.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEec-CCe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDD-RDE  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~~  129 (368)
                      .+|++.+.||+|+||.||+|...+.   .+...+++|+....  ....+.+.+|+.++.++ +|+||+++++++.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            4567889999999999999975432   24567899976543  23345677899999999 89999999998764 456


Q ss_pred             eEEEEecccCCCHHHHhcCCCC----------------------------------------------------------
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPR----------------------------------------------------------  151 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  151 (368)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8899999999999998864211                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccc
Q 017627          152 SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT  231 (368)
Q Consensus       152 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~  231 (368)
                      ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||+++.........             
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~-------------  230 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-------------  230 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh-------------
Confidence            12678999999999999999999999   99999999999999999999999999997543221100             


Q ss_pred             cceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcch-hhHHHHHhhhhhhhhhhhcchhhhcCC
Q 017627          232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQ-LLTSLAGSMLNDIADCEATKVNELVDP  309 (368)
Q Consensus       232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (368)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... ........               .   
T Consensus       231 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~---------------~---  292 (337)
T cd05054         231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE---------------G---  292 (337)
T ss_pred             hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc---------------c---
Confidence            0112346778999999999999999999999999999998 99999764322 11111100               0   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          310 RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                       .....+...+.++.+++..||+.+|++||++.+++++|+.++.+
T Consensus       293 -~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         293 -TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             -CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             00011122345789999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.2e-44  Score=326.29  Aligned_cols=253  Identities=24%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             HHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC-----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      |.+.+.||+|+||.||+++... ..++..+|+|+....     ....+.+..|+.++..+ +||||+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            3467889999999999998643 236778899976532     23345677899999999 5999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+.+++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        82 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          82 LILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999987   345689999999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ......              ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..............
T Consensus       156 ~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  221 (332)
T cd05614         156 LSEEKE--------------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR  221 (332)
T ss_pred             cccCCC--------------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH
Confidence            221110              11234699999999999875 478899999999999999999999975433211111111


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                      ...            ..++.+    +...+..+.+++..||+.||.+||     ++.++++|
T Consensus       222 ~~~------------~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         222 RIL------------KCDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             HHh------------cCCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            000            001111    122345788999999999999999     78888877

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=309.20  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=207.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.++||+|+||.||+|.++.  .+.++|||.... +...+.+..|+.++++++.|++|++||.+.....+|+|||||..
T Consensus        36 Di~~KLGEGSYGSV~KAIH~E--sG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRE--SGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhc--cCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            467889999999999997554  888999985443 34467788899999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |+..+.++.  +++++++.++..++...++||+|||..   .-||||||..|||++.+|..||+|||.+-...+..    
T Consensus       113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM----  183 (502)
T KOG0574|consen  113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM----  183 (502)
T ss_pred             CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH----
Confidence            999999986  567899999999999999999999998   88999999999999999999999999986433222    


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                 .+..++.|||.|||||++..-.|+.++||||||++..||..|++||..--.....              
T Consensus       184 -----------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------  238 (502)
T KOG0574|consen  184 -----------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------  238 (502)
T ss_pred             -----------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------
Confidence                       2234578999999999999999999999999999999999999999542211000              


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       ..+  -..|.....-+..++.++-+|+++||-.+|++|.||.++++|
T Consensus       239 -FMI--PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  239 -FMI--PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -Eec--cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence             000  011222233456788999999999999999999999999988

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=316.72  Aligned_cols=251  Identities=20%  Similarity=0.255  Sum_probs=199.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||.||++.+..  ++..+|+|+.....    .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcC--CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            4466789999999999998654  57788998765432    22345678999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++... ....+++..+..++.|++.||.|||++   +|+||||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          80 TLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             eccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999999887643 234689999999999999999999999   9999999999999999999999999998753211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                .....|++.|+|||++.+..++.++||||+|+++|+|++|..||.+................
T Consensus       156 ~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (285)
T cd05605         156 ET----------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE  219 (285)
T ss_pred             Cc----------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh
Confidence            10                01235899999999999889999999999999999999999999765543222111111100


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                      ....++...+..+.+|+..||+.||.+||     +++++++|
T Consensus       220 ----------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 ----------------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ----------------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                            00112223456789999999999999999     89999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-43  Score=312.32  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=202.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .+.+.+.||+|+||.||+|...+   ...+++|.........+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~---~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYNN---STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEecC---CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            34567889999999999998643   346788876655555678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++... ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998753 345688999999999999999999999   9999999999999999999999999999754322110


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      .              .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...............     
T Consensus       160 ~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----  220 (261)
T cd05072         160 A--------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-----  220 (261)
T ss_pred             c--------------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----
Confidence            0              011235678999999998889999999999999999998 99999765433222111110     


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                ...    ......+.++.+++.+||..+|++|||++++++.|+.+
T Consensus       221 ----------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 ----------YRM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----------CCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                      000    01112345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=331.17  Aligned_cols=264  Identities=23%  Similarity=0.248  Sum_probs=200.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|++..  ++..+|+|+....    ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            3456789999999999999755  5678899987543    233456778999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||+++.....
T Consensus        81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999987   345689999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCCCCCCCC------------------CCCc-----cccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh
Q 017627          215 AVLPPSPSP------------------SPSR-----SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT  271 (368)
Q Consensus       215 ~~~~~~~~~------------------~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  271 (368)
                      .........                  ....     .........+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            110000000                  0000     00001112469999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS---ATQILHT  347 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~~  347 (368)
                      |..||...+........   ...         .    ..+........+..+.++|..|+. +|.+|++   +.++++|
T Consensus       235 G~~Pf~~~~~~~~~~~i---~~~---------~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQETYRKI---INW---------K----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHHHHHH---HcC---------C----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999765533221111   000         0    000000111235578899999996 9999998   9999887

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=351.92  Aligned_cols=266  Identities=26%  Similarity=0.398  Sum_probs=217.5

Q ss_pred             HHHHHHHhhhhcccccceEEEEEEEcCCCC---ceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC
Q 017627           54 VERFTQNFSQVIGSGGFSNVYLARLINDST---STNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD  128 (368)
Q Consensus        54 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  128 (368)
                      +.+..-.+.+.||+|+||.||.|.+.+...   ...||+|.....  ......|.+|+.+|..++|||||+++|++.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            333334466789999999999999876433   445777765443  556778999999999999999999999999999


Q ss_pred             eeEEEEecccCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTP----RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      ..++++|||.+|+|..||+...    ....++......++.||++|+.||+++   ++|||||...|+|++....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999998652    145688999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+|+..+...++.....             ..-...|||||.+....++.++||||||+++||++| |..||...+...
T Consensus       846 FGlArDiy~~~yyr~~~~-------------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~  912 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGE-------------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE  912 (1025)
T ss_pred             cchhHhhhhchheeccCc-------------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence            999997666655443211             123467999999999999999999999999999999 999998766432


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      .....                  +... +-+.+..|+..+.++|..||+.+|++||++..|++.+..+.+.
T Consensus       913 v~~~~------------------~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  913 VLLDV------------------LEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             HHHHH------------------HhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            22111                  1111 3344566788999999999999999999999999988887664

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-43  Score=323.98  Aligned_cols=246  Identities=23%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||.||+|.+..  ++..+|+|+....    ......+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK--TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            358999999999998755  6778899977542    23345678899999998 7999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        79 ~~g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--  150 (329)
T cd05588          79 SGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--  150 (329)
T ss_pred             CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--
Confidence            9999998886   345799999999999999999999999   99999999999999999999999999986321111  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-----hHHHHHhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL-----LTSLAGSML  292 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~  292 (368)
                                   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .......  
T Consensus       151 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--  215 (329)
T cd05588         151 -------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--  215 (329)
T ss_pred             -------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--
Confidence                         01123469999999999999999999999999999999999999996322110     0000000  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS------ATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~~il~~  347 (368)
                                  .+.....  ..+...+..+.+++..||+.||.+|||      ++++++|
T Consensus       216 ------------~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         216 ------------VILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ------------HHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                        0011100  111223457899999999999999997      6788876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=322.45  Aligned_cols=262  Identities=25%  Similarity=0.378  Sum_probs=217.3

Q ss_pred             HHHHHHHHhhhhcccccceEEEEEEEcCC--CCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC
Q 017627           53 DVERFTQNFSQVIGSGGFSNVYLARLIND--STSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD  128 (368)
Q Consensus        53 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  128 (368)
                      ++.+....+.+.||+|.||.||.|.+.+.  +..-.||||..+.  .+...+.|..|+.+|+.++||||++++|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            55566666788999999999999998764  3445577886654  34557789999999999999999999999985 6


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..|+|||+++.|.|..||..+  ...++......+++||+.||.|||++   ++|||||...||||.....|||+|||+|
T Consensus       464 P~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence            899999999999999999863  46789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  287 (368)
                      +......++..+              ...-..-|||||.+....++.++|||.||+++||++. |..||.+-...+..  
T Consensus       539 R~~ed~~yYkaS--------------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--  602 (974)
T KOG4257|consen  539 RYLEDDAYYKAS--------------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--  602 (974)
T ss_pred             hhccccchhhcc--------------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--
Confidence            987776654322              1123457999999999999999999999999999988 99999875432111  


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                                       .-+...-+...+..|+..+..|+.+||+.+|.+||++.+|...|...+.
T Consensus       603 -----------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 -----------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             -----------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                             1112222334566777899999999999999999999999998887766

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-43  Score=314.41  Aligned_cols=247  Identities=20%  Similarity=0.256  Sum_probs=195.2

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ||+|+||+||++.+..  ++..+++|......    ...+.+..|+.+++.++|+||+++.+++...+..++||||++++
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRA--TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEcc--CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            7999999999998755  56788888765332    22355678999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          141 TLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       141 ~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      +|..++... .....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++........   
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---  152 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---  152 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---
Confidence            998877532 2345789999999999999999999999   999999999999999999999999999864322111   


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                  ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............         
T Consensus       153 ------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---------  211 (280)
T cd05608         153 ------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---------  211 (280)
T ss_pred             ------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---------
Confidence                        01123589999999999999999999999999999999999999976443211110000         


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                           ......  ..++...+..+.+++..||+.||++||     |++++++|
T Consensus       212 -----~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         212 -----RILNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             -----hhcccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence                 000000  112223456789999999999999999     88999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=338.40  Aligned_cols=269  Identities=25%  Similarity=0.364  Sum_probs=209.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEE-eecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEE-ec---C---Ce
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYC-DD---R---DE  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik-~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~---~---~~  129 (368)
                      ..+.+.|.+|||+.||+|.+...  +..+|+| ++..++...+.+.+|+++|+.|+ |+|||.+++.. ..   .   -.
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~--~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKG--GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCC--CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            34567899999999999997653  3666776 45556778899999999999997 99999999932 21   1   24


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      ++|.||||.+|.|-+++..+-. ..|++.++++|++|++.|+.+||.. .+.|||||||-+||||+.+|..||||||.+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            6899999999999999986633 3499999999999999999999997 3469999999999999999999999999986


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      .......      ......-........-|+.|+|||.+   .+.+.++|+|||+|||+||-|+....||+...      
T Consensus       195 t~~~~~~------~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------  262 (738)
T KOG1989|consen  195 TKILSPT------SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------  262 (738)
T ss_pred             cccCCCc------cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence            3221110      00111111111234578999999976   67889999999999999999999999996542      


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                                      ...+++..+.-.-....+..+.+||+.||+.||.+||++.+++.++-++...-.+..
T Consensus       263 ----------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~  319 (738)
T KOG1989|consen  263 ----------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP  319 (738)
T ss_pred             ----------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence                            122333333333345678899999999999999999999999999999877655443

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.2e-44  Score=337.40  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=192.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--------Ce
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--------DE  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~  129 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|.......   ...+|+.+++.++||||+++++++...        ..
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICID--TSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECC--CCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            45677899999999999998755  567889987654432   345799999999999999999876432        24


Q ss_pred             eEEEEecccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGS  207 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~  207 (368)
                      +++||||+++ +|..++... .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence            6789999965 676665432 1456789999999999999999999999   999999999999999654 699999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      |+.......                .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+........
T Consensus       218 a~~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  281 (440)
T PTZ00036        218 AKNLLAGQR----------------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV  281 (440)
T ss_pred             chhccCCCC----------------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            975332110                1124589999999998764 68999999999999999999999998765433322


Q ss_pred             HHHhhhhhhhhhhhc----chhh-----hcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEAT----KVNE-----LVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+.........    ....     .....+...++...+.++.+||.+||+.||.+|||+.++++|
T Consensus       282 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            222211111000000    0000     000001111122335689999999999999999999999987

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.3e-44  Score=324.50  Aligned_cols=242  Identities=26%  Similarity=0.361  Sum_probs=190.3

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHH-HHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELD-ILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||+||+|.+..  ++..+++|+.....    .....+..|.. +++.++||||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA--DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            358999999999998754  67789999865431    22233444544 567899999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 ~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  151 (323)
T cd05575          79 NGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-  151 (323)
T ss_pred             CCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence            9999999887   445789999999999999999999999   999999999999999999999999999864221110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+........   ...   
T Consensus       152 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~---  211 (323)
T cd05575         152 --------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI---LNK---  211 (323)
T ss_pred             --------------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH---HcC---
Confidence                          112346999999999999999999999999999999999999999765433221111   100   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA----TQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~~il~~  347 (368)
                          .      ...    ....+..+.+++..||+.||.+||++    .++++|
T Consensus       212 ----~------~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         212 ----P------LRL----KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             ----C------CCC----CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence                0      001    11225578999999999999999998    466654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.2e-43  Score=311.78  Aligned_cols=257  Identities=22%  Similarity=0.330  Sum_probs=198.8

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------CeeE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------DEGV  131 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~  131 (368)
                      +++.||+|+||.||+|.+........+++|.....   ....+.+.+|+.+++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            56789999999999999866555557888876432   44466788999999999999999999987432      2468


Q ss_pred             EEEecccCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          132 LLFEYVPNGTLQEKLHGTP---RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ++|||+.+++|..++....   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999998874221   234589999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  287 (368)
                      +.........             ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus       160 ~~~~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  226 (272)
T cd05075         160 KKIYNGDYYR-------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY  226 (272)
T ss_pred             cccCccccee-------------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            7543222100             0012236778999999999999999999999999999999 8899966443222111


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ...          ..         ........+..+.+++..||+.||.+|||+.++++.|++++
T Consensus       227 ~~~----------~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         227 LRQ----------GN---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             HHc----------CC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            110          00         00011123457899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-43  Score=310.10  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=197.9

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.+.||+|+||.||++.+..   ...+++|...........+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~---~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRA---QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             EEeeEecCCcCceEEEEEecc---CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            456789999999999998643   34678887665555556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++...  ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||.++......... 
T Consensus        84 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-  157 (256)
T cd05114          84 GCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-  157 (256)
T ss_pred             CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec-
Confidence            9999998743  24588999999999999999999999   99999999999999999999999999987533221110 


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                   .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+............      
T Consensus       158 -------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------  218 (256)
T cd05114         158 -------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------  218 (256)
T ss_pred             -------------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------
Confidence                         011225568999999998889999999999999999999 899997665433222211100      


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                            ....       +...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus       219 ------~~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         219 ------RLYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ------CCCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                  0000       111235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-43  Score=310.83  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=204.5

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +..+++.+.||+|+||.||+|.+.+   ...+++|.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN---TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC---CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            3445677899999999999998643   3568888876655556778899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++.... ...+++..+..++.|++.|+.+||++   +++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999987542 45689999999999999999999999   99999999999999999999999999997644211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...              .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+............    
T Consensus       158 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----  219 (261)
T cd05068         158 YEA--------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ----  219 (261)
T ss_pred             ccc--------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----
Confidence            100              001123457999999998899999999999999999999 9999976543322211110    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                     ......+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       220 ---------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         220 ---------------GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---------------CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                           000011223356799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.1e-43  Score=309.96  Aligned_cols=254  Identities=27%  Similarity=0.380  Sum_probs=205.2

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ..|.+.+.||.|+||.||+|.+.+   ...+++|+...... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN---RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC---CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            345678899999999999998754   56678887665543 46678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++... .+..+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.+||+|||.+.......
T Consensus        83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999754 345689999999999999999999999   99999999999999999999999999987543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...               ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..........    
T Consensus       159 ~~~---------------~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~----  219 (261)
T cd05148         159 YLS---------------SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA----  219 (261)
T ss_pred             ccc---------------cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh----
Confidence            100               11235678999999998899999999999999999998 8999976553222211110    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                     ......+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       220 ---------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 ---------------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---------------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                           001111223456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-44  Score=331.56  Aligned_cols=265  Identities=23%  Similarity=0.257  Sum_probs=198.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|....  ++..+|+|+....    ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKD--TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3456789999999999998755  6678899976542    233466788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999987   345689999999999999999999999   9999999999999999999999999999632211


Q ss_pred             CCCC-------CCCCCCC-Cc------------------------cccccceeeecCCCCccchhhccCCCCcchhhHHH
Q 017627          215 AVLP-------PSPSPSP-SR------------------------SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSF  262 (368)
Q Consensus       215 ~~~~-------~~~~~~~-~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  262 (368)
                      ....       ....... ..                        .........+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            1000       0000000 00                        00000012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC---C
Q 017627          263 GVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR---P  339 (368)
Q Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---p  339 (368)
                      ||++|||++|..||.................           ..   .+..  ....+.++.+||..||. +|.+|   +
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------~~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWRE-----------TL---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccCC-----------cc---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            9999999999999976554322111110000           00   0000  11234578899999997 77765   5


Q ss_pred             CHHHHHHHH
Q 017627          340 SATQILHTI  348 (368)
Q Consensus       340 t~~~il~~L  348 (368)
                      |+.+++.|-
T Consensus       298 ~~~~~l~hp  306 (377)
T cd05629         298 GAHEIKSHP  306 (377)
T ss_pred             CHHHHhcCC
Confidence            999999883

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-43  Score=322.61  Aligned_cols=246  Identities=24%  Similarity=0.347  Sum_probs=192.7

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||.||+|.+..  +...+|+|+....    ......+.+|+.++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK--TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            359999999999998755  6678888876542    23445677899888877 7999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus        79 ~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-  151 (329)
T cd05618          79 NGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  151 (329)
T ss_pred             CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence            9999998886   445789999999999999999999999   999999999999999999999999999864221110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-----hHHHHHhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL-----LTSLAGSML  292 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~  292 (368)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .......  
T Consensus       152 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--  215 (329)
T cd05618         152 --------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--  215 (329)
T ss_pred             --------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH--
Confidence                          0123469999999999999999999999999999999999999995322110     0000000  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS------ATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~~il~~  347 (368)
                                  ......  ...+...+..+.+++.+||+.||.+|||      +.++++|
T Consensus       216 ------------~i~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         216 ------------VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ------------HHhcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                        000000  0112233557889999999999999998      4677776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-43  Score=327.74  Aligned_cols=271  Identities=24%  Similarity=0.287  Sum_probs=203.9

Q ss_pred             HHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           52 DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        52 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..+...+|.+.+.||+|+||.||++...+......+++|......    ...+|+.+++.++||||+++++++...+..+
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            344455677888999999999999987666677888888765432    3457999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +|||++. ++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.++|+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999994 68888885   456789999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ......             .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.............
T Consensus       236 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i  302 (392)
T PHA03207        236 DAHPDT-------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI  302 (392)
T ss_pred             Cccccc-------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH
Confidence            322111             0112346999999999999999999999999999999999999999765532211111111


Q ss_pred             hhhhhh----hh---hcc----hhhhcCCCCCCCCC-------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIAD----CE---ATK----VNELVDPRLAGDFD-------LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~----~~---~~~----~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......    ..   ...    .... .......+.       ...+.++.++|.+||..||++|||+.+++.|
T Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        303 IRCMQVHPLEFPQNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHhccCccccCCccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            111000    00   000    0000 000011000       1224578899999999999999999999988

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.3e-43  Score=319.52  Aligned_cols=269  Identities=21%  Similarity=0.288  Sum_probs=190.7

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeEEEEecccC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLLFEYVPN  139 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~  139 (368)
                      +++||+|+||.||+|...+......+|+|....... ...+.+|+.+++.++||||+++++++..  ....+++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            457999999999999977666778889997754432 3456789999999999999999998854  456899999984 


Q ss_pred             CCHHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee----cCCCceEEeeccccc
Q 017627          140 GTLQEKLHGTP------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAK  209 (368)
Q Consensus       140 ~~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv----~~~~~vkl~Dfg~s~  209 (368)
                      ++|..++....      ....+++..+..++.|++.||.|||++   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            57877765321      123589999999999999999999999   99999999999999    456789999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh----
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLL----  284 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----  284 (368)
                      ........            ........||+.|+|||++.+ ..++.++||||+||++|+|++|.+||........    
T Consensus       161 ~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~  228 (317)
T cd07868         161 LFNSPLKP------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  228 (317)
T ss_pred             ccCCCCcc------------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccccc
Confidence            54322110            011123468999999999977 4589999999999999999999999975442110    


Q ss_pred             -----HHHHHhhhhhhhhhhhcchhh----------hcCCCCCC--------CCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017627          285 -----TSLAGSMLNDIADCEATKVNE----------LVDPRLAG--------DFDLDEARAMLSIAALCLRQSPILRPSA  341 (368)
Q Consensus       285 -----~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rpt~  341 (368)
                           .......+.......+.....          ........        .........+.+||..||+.||.+|||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~  308 (317)
T cd07868         229 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  308 (317)
T ss_pred             ccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH
Confidence                 000111110000000000000          00000000        0000112467899999999999999999


Q ss_pred             HHHHHH
Q 017627          342 TQILHT  347 (368)
Q Consensus       342 ~~il~~  347 (368)
                      +++++|
T Consensus       309 ~e~l~h  314 (317)
T cd07868         309 EQAMQD  314 (317)
T ss_pred             HHHhcC
Confidence            999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8e-44  Score=331.62  Aligned_cols=264  Identities=23%  Similarity=0.245  Sum_probs=197.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +.+.+.||+|+||.||+|+...  +...+|+|+.....    .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVD--TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECC--CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            3456789999999999998755  67788999765432    33456888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||++|+|.+++..   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          81 DYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999999873   45689999999999999999999999   9999999999999999999999999997532110


Q ss_pred             CC---CCCCCCC-----------------------------CCCccccccceeeecCCCCccchhhccCCCCcchhhHHH
Q 017627          215 AV---LPPSPSP-----------------------------SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSF  262 (368)
Q Consensus       215 ~~---~~~~~~~-----------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  262 (368)
                      ..   .......                             .............+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00   0000000                             000000001123579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC--
Q 017627          263 GVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS--  340 (368)
Q Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt--  340 (368)
                      ||++|||++|..||...+..........   .             ............+.++.++|..|+ .+|.+|++  
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~---~-------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~  297 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVIN---W-------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN  297 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHc---c-------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence            9999999999999976543211111000   0             000000111123457888888876 59999997  


Q ss_pred             -HHHHHHH
Q 017627          341 -ATQILHT  347 (368)
Q Consensus       341 -~~~il~~  347 (368)
                       +.++++|
T Consensus       298 ~~~ei~~h  305 (382)
T cd05625         298 GADEIKAH  305 (382)
T ss_pred             CHHHHhcC
Confidence             8888877

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.2e-43  Score=307.23  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=196.5

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      +.||+|+||.||+|.+..  ++..+++|.....  ......+.+|+++++.++||||+++++++...+..++||||+.++
T Consensus         1 ~~lg~g~~g~vy~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA--DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEec--CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            358999999999998755  5677888865432  345567889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++..  ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..........  
T Consensus        79 ~L~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--  151 (252)
T cd05084          79 DFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS--  151 (252)
T ss_pred             cHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccc--
Confidence            99999864  234688999999999999999999999   99999999999999999999999999987432211000  


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                 ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..............         
T Consensus       152 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~---------  211 (252)
T cd05084         152 -----------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ---------  211 (252)
T ss_pred             -----------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc---------
Confidence                       0011123457999999998889999999999999999998 8889865443221111110         


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                ......+...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       212 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         212 ----------GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             ----------CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence                      00111122335678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.8e-44  Score=329.34  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=197.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .|.+.+.||+|+||.||+|+...  ++..+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKS--SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            34567789999999999998755  6778899976532    22334577899999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+++|+|.+++..    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999998863    3578899999999999999999999   999999999999999999999999999875332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG----MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ....              .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||...+.......+ 
T Consensus       195 ~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-  259 (370)
T cd05596         195 NGMV--------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-  259 (370)
T ss_pred             CCcc--------------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH-
Confidence            2110              01224699999999998653    4788999999999999999999999765543221111 


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL--RPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~  347 (368)
                        ...             ...+........+..+.+||..||+.+|.+  |+|+.++++|
T Consensus       260 --~~~-------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         260 --MDH-------------KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --HcC-------------CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence              000             000000011123568899999999999988  9999999988

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.8e-43  Score=313.58  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=206.3

Q ss_pred             HHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +.+.+.||+|+||.||++.+.+   ......+++|..... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   86 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            4467889999999999998543   234566788876543 445667899999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          135 EYVPNGTLQEKLHGTP----------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      ||+.+++|.+++....          ....+++..++.++.|++.||.|||++   +++||||||+||++++++.++|+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence            9999999999986432          123589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+++.........             ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       164 fg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~  230 (288)
T cd05093         164 FGMSRDVYSTDYYR-------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE  230 (288)
T ss_pred             CCccccccCCceee-------------cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99987543221100             0011235778999999998899999999999999999998 899996654322


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      .......   .       .     ....    +...+..+.+|+.+||+.||.+|||+.++++.|+.+.++..
T Consensus       231 ~~~~i~~---~-------~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~  284 (288)
T cd05093         231 VIECITQ---G-------R-----VLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP  284 (288)
T ss_pred             HHHHHHc---C-------C-----cCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence            2111100   0       0     0001    11234578999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-43  Score=309.80  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +.+.+.||+|+||.||+|.+... .....+++|+....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            44678899999999999987543 34567888876543  3445678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++...  ...+++..+..++.|++.|+.|||++   +|+|+||||+||+++.++.++|+|||+++......
T Consensus        86 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          86 YMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             cCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            99999999998753  34689999999999999999999999   99999999999999999999999999998643111


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..             .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...............   
T Consensus       161 ~~-------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---  224 (266)
T cd05033         161 AT-------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG---  224 (266)
T ss_pred             cc-------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---
Confidence            00             00011235678999999999899999999999999999998 99999654432221111100   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                 .     ....+...+..+.+++..||+.+|++||++.+++++|++++
T Consensus       225 -----------~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         225 -----------Y-----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             -----------C-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                       0     00011233567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.4e-43  Score=316.49  Aligned_cols=258  Identities=29%  Similarity=0.440  Sum_probs=202.1

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|...+.+....+++|....  .....+.+.+|+.++.++ +||||+++++++...+..++||||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            46778999999999999876654445567776543  334456788999999999 799999999999999999999999


Q ss_pred             ccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEe
Q 017627          137 VPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC  203 (368)
Q Consensus       137 ~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~  203 (368)
                      +++++|.+++....             ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence            99999999986432             113588999999999999999999999   99999999999999999999999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcch
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQ  282 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  282 (368)
                      |||++.......                .......+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       162 dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~  225 (297)
T cd05089         162 DFGLSRGEEVYV----------------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA  225 (297)
T ss_pred             CcCCCcccccee----------------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999986311100                0011123457999999998899999999999999999997 99999765543


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      ......   .                .......+...+..+.+|+..||+.+|.+|||++++++.|+.+..+.
T Consensus       226 ~~~~~~---~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         226 ELYEKL---P----------------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHHH---h----------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            221111   0                00011111223457899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4e-43  Score=334.81  Aligned_cols=265  Identities=20%  Similarity=0.249  Sum_probs=195.8

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCC------CceeeeeEEEecC-Ce
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH------DNIVKLIGYCDDR-DE  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~-~~  129 (368)
                      ..|.+.+.||+|+||+||+|.+..  ....+|||+..........+..|+.+++.++|      .+++++++++... ..
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRK--RKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcC--CCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            345677889999999999998755  67789999886655555566778888887754      4588999988754 57


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-----------
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-----------  198 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-----------  198 (368)
                      .|+||+++ +++|.+++.   ....+++..+..++.||+.||.|||+++  +||||||||+|||++.++           
T Consensus       207 ~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccccc
Confidence            89999988 778888886   3457899999999999999999999732  899999999999998765           


Q ss_pred             -----ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCC
Q 017627          199 -----NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM  273 (368)
Q Consensus       199 -----~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  273 (368)
                           .+||+|||.+......                  ....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~------------------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHS------------------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             CCCCceEEECCCCccccCccc------------------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence                 4999999987531111                  12356999999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHhhhhhhhhhhhcc-----hhhhc------CCCCCC-----------CCCHHHHHHHHHHHHHhc
Q 017627          274 EAFCPENGQLLTSLAGSMLNDIADCEATK-----VNELV------DPRLAG-----------DFDLDEARAMLSIAALCL  331 (368)
Q Consensus       274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~------~~~~~~-----------~~~~~~~~~l~~li~~~l  331 (368)
                      +||.+.+.......+...+..++......     ...+.      .+....           .........+.+||..||
T Consensus       343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  422 (467)
T PTZ00284        343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL  422 (467)
T ss_pred             CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence            99987665443333333332221110000     00000      000000           000112356789999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 017627          332 RQSPILRPSATQILHT  347 (368)
Q Consensus       332 ~~dP~~Rpt~~~il~~  347 (368)
                      +.||.+|||++++|+|
T Consensus       423 ~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        423 HYDRQKRLNARQMTTH  438 (467)
T ss_pred             CcChhhCCCHHHHhcC
Confidence            9999999999999986

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7e-43  Score=313.38  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=203.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCC---CceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDS---TSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~---~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ++.+.||+|+||.||+|......   ....+++|......  .....+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            46678999999999999864321   23567888665432  33467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          135 EYVPNGTLQEKLHGTP---------------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      ||+.+++|.+++....                     ....+++..++.++.|++.||.|||++   +++||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence            9999999999876421                     123578899999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-C
Q 017627          194 LEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-G  272 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g  272 (368)
                      +++++.+||+|||+++.........             ......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~-------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYV-------------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             EcCCCcEEeccccccccccCccchh-------------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            9999999999999987543221110             0011235678999999988889999999999999999999 9


Q ss_pred             CCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          273 MEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ..||.+.............                   .....+...+..+.+++..||+.+|.+||++.++++.|++++
T Consensus       227 ~~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         227 GNPYPGIAPERLFNLLKTG-------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             CCCCCCCCHHHHHHHHhCC-------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            9999765543322221110                   011111223457899999999999999999999999999987


Q ss_pred             cc
Q 017627          353 SS  354 (368)
Q Consensus       353 ~~  354 (368)
                      .+
T Consensus       288 ~~  289 (290)
T cd05045         288 VK  289 (290)
T ss_pred             hc
Confidence            64

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-43  Score=323.19  Aligned_cols=237  Identities=24%  Similarity=0.311  Sum_probs=187.2

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHH-HHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQEL-DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .||+|+||.||+|++..  +...+|+|+.....    .....+..|. .+++.++||||+++++++.+.+..++||||+.
T Consensus         2 ~lg~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           2 VIGKGSFGKVLLARHKA--EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             eeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            58999999999998755  56778999765432    1222333344 45678899999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        80 ~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          80 GGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            999999987   345688899999999999999999999   999999999999999999999999999864221110  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........   .    
T Consensus       152 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~----  211 (325)
T cd05602         152 -------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---K----  211 (325)
T ss_pred             -------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh---C----
Confidence                         11234699999999999999999999999999999999999999976554322211110   0    


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ  343 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~  343 (368)
                                 ..  ......+..+.+++..||+.||.+||++.+
T Consensus       212 -----------~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         212 -----------PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             -----------Cc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence                       00  011123457899999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=295.59  Aligned_cols=270  Identities=21%  Similarity=0.271  Sum_probs=205.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEee-cCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-----ee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-VGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----EG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  130 (368)
                      .+|.+.+.||+|||+.||+++...  +...+|+|.. ..+.+..+...+|++..++++|||+++++++...+.     ..
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s--~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLS--TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccC--cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            456678899999999999998544  6777888744 344466788889999999999999999988764333     48


Q ss_pred             EEEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      |++++|...|+|.+.+.... .+..+++.+++.|+.++++||.+||+.. +.++||||||.|||+++.+.++|+|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999887654 4457999999999999999999999982 249999999999999999999999999986


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG---MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      ...-...      .+.......+-.....|..|+|||.+.-.   ..++++|||||||+||+|+.|..||...-.+    
T Consensus       178 ~a~i~i~------~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----  247 (302)
T KOG2345|consen  178 QAPIQIE------GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----  247 (302)
T ss_pred             ccceEee------chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----
Confidence            4221111      11111122222334578899999998544   5688999999999999999999999543211    


Q ss_pred             HHHhhhhhhhhhhhcchh-hhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          287 LAGSMLNDIADCEATKVN-ELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                   ...+. ....+.+.-.-....++.+.++|.+||+.||.+||++.+++.+++.++
T Consensus       248 -------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 -------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                         01111 111112221122235778999999999999999999999999998775

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-43  Score=322.29  Aligned_cols=245  Identities=23%  Similarity=0.321  Sum_probs=195.2

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ++.+.||+|+||.||+|.+..  +...+|+|+....    ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            456789999999999998755  6678899976543    22234566788888877 5899999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999887   345689999999999999999999999   9999999999999999999999999998742211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..    
T Consensus       155 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----  215 (323)
T cd05616         155 GV---------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----  215 (323)
T ss_pred             CC---------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh----
Confidence            10               01234699999999999999999999999999999999999999977654332221111    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                    ..  ..++...+.++.+++.+||+.||.+|++.     .++++|
T Consensus       216 --------------~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         216 --------------HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             --------------CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                          00  01122345678999999999999999984     677655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-42  Score=306.43  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=197.7

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCCH
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL  142 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  142 (368)
                      ||+|+||.||+|.+........+++|+....  ....+.+.+|+.+++.++||||+++++++. ....++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            8999999999998765556667888877554  234567889999999999999999999885 4578999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCC
Q 017627          143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS  222 (368)
Q Consensus       143 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~  222 (368)
                      .+++...  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++.........    
T Consensus        82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----  152 (257)
T cd05115          82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----  152 (257)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce----
Confidence            9998742  35689999999999999999999999   99999999999999999999999999987432221100    


Q ss_pred             CCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhhhc
Q 017627          223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCEAT  301 (368)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (368)
                              .......++..|+|||.+.+..++.++||||||+++|++++ |..||..............           
T Consensus       153 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----------  213 (257)
T cd05115         153 --------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-----------  213 (257)
T ss_pred             --------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-----------
Confidence                    00011224678999999988889999999999999999996 9999976544322211111           


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                              ......+...+.++.+++..||..+|++||++.++.+.|+..
T Consensus       214 --------~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 --------GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                    001112223456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-43  Score=327.97  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=195.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .|.+.+.||+|+||.||++....  +...+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKS--SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            34456789999999999998755  6678899876432    22345677899999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+++|+|.+++..    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999863    3578999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG----MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ...              .......||+.|+|||++.+.    .++.++||||+||++|+|++|..||...+.......+ 
T Consensus       195 ~~~--------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i-  259 (370)
T cd05621         195 TGM--------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI-  259 (370)
T ss_pred             CCc--------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence            111              011234699999999999764    3788999999999999999999999765432211111 


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL--RPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~  347 (368)
                        ...             ...+........+..+.+++..||..++.+  |+|+.++++|
T Consensus       260 --~~~-------------~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         260 --MDH-------------KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --HhC-------------CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              000             000000111233567889999999865543  8999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.3e-43  Score=318.56  Aligned_cols=261  Identities=20%  Similarity=0.254  Sum_probs=202.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCC--ceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDST--STNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .|...+.||+|+||.||+|.+...+.  ...+++|+....  ....+.+.+|+.+++.++||||+++++++... ..+++
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v   86 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   86 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence            34567789999999999998754322  345788876532  34567788999999999999999999999764 57899


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      +||+.+|+|.+++...  ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          87 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999998753  34588999999999999999999999   999999999999999999999999999985432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....             ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+............  
T Consensus       162 ~~~~~-------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~--  226 (316)
T cd05108         162 DEKEY-------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--  226 (316)
T ss_pred             CCcce-------------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC--
Confidence            21100             0011224678999999999999999999999999999998 9999976543322211110  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                       ......+..++..+.+++..||..||.+|||+.+++.+|..+.....
T Consensus       227 -----------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         227 -----------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             -----------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence                             00000111233478899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=326.17  Aligned_cols=240  Identities=30%  Similarity=0.400  Sum_probs=199.1

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.||.|+||.||-|.+..  +..+||||....+    ....+.+..|+..|+.|+|||++.+.|+|......|+||||| 
T Consensus        32 rEIGHGSFGAVYfArd~~--n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-  108 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-  108 (948)
T ss_pred             HHhcCCccceeEEeeccC--ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-
Confidence            459999999999998765  7889999865433    344577889999999999999999999999999999999999 


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      -|+-.+++.-  ..+++.+.++..|+.+.+.||.|||++   +.||||||..|||+++.|.|||+|||.|.+....    
T Consensus       109 lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----  179 (948)
T KOG0577|consen  109 LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----  179 (948)
T ss_pred             hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence            5577776654  346789999999999999999999999   9999999999999999999999999998753221    


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ...+|||.|||||++.   .+.|+-++||||||++..||.-.++|+.+.+.....       ..+
T Consensus       180 ---------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------YHI  237 (948)
T KOG0577|consen  180 ---------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHI  237 (948)
T ss_pred             ---------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------HHH
Confidence                           2367999999999984   468999999999999999999999998877753211       111


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....        .|.+   ...+++..++.|+..||+.-|.+|||.++++.|
T Consensus       238 AQNe--------sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  238 AQNE--------SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HhcC--------CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1111        1111   245788899999999999999999999999987

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7e-43  Score=313.52  Aligned_cols=263  Identities=25%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             HhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||.||+|.+.+   ......+++|...... ...+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            456789999999999998643   2244567788765443 344678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEE
Q 017627          136 YVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKL  202 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl  202 (368)
                      |+++++|.+++....             ....+++..++.++.|++.|+.|||++   +|+||||||+||+++.++.++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence            999999999987532             124588999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcc
Q 017627          203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG  281 (368)
Q Consensus       203 ~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~  281 (368)
                      +|||++.........             .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       165 ~dfg~a~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         165 GDFGMSRDVYSTDYY-------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             CCCCcccccCCCcee-------------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999998753322110             00112346788999999999999999999999999999999 9999866543


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                      .........                  .. ........+..+.+++.+||+.||.+|||+.++++.|+++.+..+.
T Consensus       232 ~~~~~~~~~------------------~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~  288 (291)
T cd05094         232 TEVIECITQ------------------GR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI  288 (291)
T ss_pred             HHHHHHHhC------------------CC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence            322111100                  00 0001112355789999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.5e-43  Score=311.94  Aligned_cols=259  Identities=22%  Similarity=0.351  Sum_probs=201.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..+.+.+.||+|+||.||+|.+.+.   .....+++|.....  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            4456778899999999999986432   24567888876432  233456889999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          132 LLFEYVPNGTLQEKLHGTPR-------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      +||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence            99999999999999864321       23457788899999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+++..........             .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       163 fg~~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~  229 (277)
T cd05062         163 FGMTRDIYETDYYRK-------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ  229 (277)
T ss_pred             CCCccccCCcceeec-------------CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999875433221110             011235778999999998899999999999999999999 788987654432


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      .......   .       ..         ...+...+..+.+++.+||+.||.+|||+.+++++|++
T Consensus       230 ~~~~~~~---~-------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         230 VLRFVME---G-------GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHHc---C-------Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2221110   0       00         00112234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.2e-43  Score=312.61  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=202.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+.+.+.||+|+||.||+|...+.   .....+++|+.....  .....+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            355788899999999999987542   245678999876442  345678899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc
Q 017627          133 LFEYVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN  199 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~  199 (368)
                      ++||+.+++|.+++....             ....+++..+..++.|++.||.|||++   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999885221             123578888999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 017627          200 CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCP  278 (368)
Q Consensus       200 vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~  278 (368)
                      +||+|||+++........             .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus       163 ~kl~Dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         163 VKISDLGLFREVYAADYY-------------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             eEecccccccccccchhe-------------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999998753322110             00112346788999999988889999999999999999998 8889876


Q ss_pred             CcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          279 ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      ............                  .. ....+..++..+.+|+..||+.+|.+||++++|++.|+.
T Consensus       230 ~~~~~~~~~i~~------------------~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         230 YSNQDVIEMIRN------------------RQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCHHHHHHHHHc------------------CC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            544322211111                  00 011122345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.7e-44  Score=330.44  Aligned_cols=264  Identities=24%  Similarity=0.259  Sum_probs=198.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|+...  ++..+|+|+.....    .....+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVD--TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECC--CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3467789999999999998755  57889999875432    23456788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|.+++.   ..+.+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|......
T Consensus        81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999997   345688999999999999999999999   9999999999999999999999999997532100


Q ss_pred             CC---CCCCC-------CCCC------------------CccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHH
Q 017627          215 AV---LPPSP-------SPSP------------------SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVIL  266 (368)
Q Consensus       215 ~~---~~~~~-------~~~~------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  266 (368)
                      ..   .....       ....                  ...........+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00   00000       0000                  00000111235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC---CHHH
Q 017627          267 LELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP---SATQ  343 (368)
Q Consensus       267 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~~  343 (368)
                      |+|++|..||...+...........            .    ...........+..+.++|..|+ .+|.+|+   |+.+
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i~~~------------~----~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKVINW------------E----TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHHhcc------------C----ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            9999999999776543221111000            0    00000011123457788888876 5999999   9999


Q ss_pred             HHHH
Q 017627          344 ILHT  347 (368)
Q Consensus       344 il~~  347 (368)
                      +++|
T Consensus       298 ll~h  301 (376)
T cd05598         298 IKAH  301 (376)
T ss_pred             HhCC
Confidence            9988

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-44  Score=324.30  Aligned_cols=244  Identities=25%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             hhcccccceEEEEEEEcC-CCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           63 QVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.||+|+||.||+++... ..++..+|+|+.....   .....+.+|+++++.++||||+++++++.+.+..++||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            469999999999998642 3467888999775432   233456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---  152 (318)
T cd05582          82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---  152 (318)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---
Confidence            999999986   345689999999999999999999999   99999999999999999999999999987432211   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..........        
T Consensus       153 ------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~--------  212 (318)
T cd05582         153 ------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--------  212 (318)
T ss_pred             ------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc--------
Confidence                        011234689999999999998899999999999999999999999976543322211100        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                ..  ...+...+..+.+++..||+.||.+|||+     .++++|
T Consensus       213 ----------~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         213 ----------AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             ----------CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence                      00  01112234578899999999999999994     556554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.5e-43  Score=310.71  Aligned_cols=246  Identities=22%  Similarity=0.257  Sum_probs=191.1

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ||+|+||.||++....  ++..+++|....+.    .....+..|+++++.++||||+++++++.+.+..++||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKN--TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEcc--CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            7999999999998755  57788888764321    22344567999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|..++... ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........    
T Consensus        79 ~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----  150 (277)
T cd05607          79 DLKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----  150 (277)
T ss_pred             CHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----
Confidence            999887643 234588999999999999999999999   999999999999999999999999999875322110    


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                  .....|++.|+|||++.+..++.++||||+||++|+|++|..||..............          
T Consensus       151 ------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~----------  208 (277)
T cd05607         151 ------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR----------  208 (277)
T ss_pred             ------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH----------
Confidence                        0123589999999999998899999999999999999999999976443211111100          


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                          ......... .....+.++.+|+..||+.||.+||++++++++
T Consensus       209 ----~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         209 ----RTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             ----Hhhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence                000000000 011235578999999999999999999665533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6e-43  Score=308.13  Aligned_cols=249  Identities=22%  Similarity=0.356  Sum_probs=198.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.+.||+|+||.||+|.+.+   ...+++|...........+.+|+.+++.++||||+++++++.+.+..++||||+.+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~---~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRG---QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             EEeeEecCcccceEEEEEecC---CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            466789999999999998644   33588887665544456788999999999999999999999988999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++...  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||.++........  
T Consensus        84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05113          84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT--  156 (256)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee--
Confidence            9999998753  23689999999999999999999999   9999999999999999999999999998754322110  


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..........   .    
T Consensus       157 ------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~----  217 (256)
T cd05113         157 ------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ---G----  217 (256)
T ss_pred             ------------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc---C----
Confidence                        0011235678999999998889999999999999999999 9999976554322211110   0    


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                              ....    .....+..+.+++..||+.||.+|||+.+|++.|+
T Consensus       218 --------~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 --------LRLY----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --------CCCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                    0000    01112468899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.8e-43  Score=317.00  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=201.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|.+..++....+++|....  .......+.+|+.++.++ +||||+++++++.+.+..++||||
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   89 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   89 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence            46788999999999999976654455567765443  234456788899999999 899999999999999999999999


Q ss_pred             ccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEe
Q 017627          137 VPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC  203 (368)
Q Consensus       137 ~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~  203 (368)
                      +++++|.+++....             ....+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence            99999999986432             123588999999999999999999999   99999999999999999999999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcch
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQ  282 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  282 (368)
                      |||+++......                ......++..|+|||.+.+..++.++||||||+++|+|+| |..||...+..
T Consensus       167 dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         167 DFGLSRGQEVYV----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             ccccCcccchhh----------------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            999985311000                0011124667999999988889999999999999999998 99999765433


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      ........                   ......+...+..+.+|+.+||+.+|.+||++.+++..|+.++...
T Consensus       231 ~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         231 ELYEKLPQ-------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HHHHHHhc-------------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            22211100                   0000111123457899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-43  Score=336.82  Aligned_cols=253  Identities=26%  Similarity=0.327  Sum_probs=199.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  128 (368)
                      +|.+.+.||+|+||+||+|++..  ++..+|+|+....   ......+.+|+.++..++|+||+++++.+...+      
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVS--DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcC--CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            45577889999999999998755  5678999976543   344567888999999999999999988775432      


Q ss_pred             --eeEEEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeec
Q 017627          129 --EGVLLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       129 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                        ..++||||+.+|+|.+++.... ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence              3689999999999999887532 345789999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |+++........             ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.....
T Consensus       188 Gls~~~~~~~~~-------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~  254 (496)
T PTZ00283        188 GFSKMYAATVSD-------------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM  254 (496)
T ss_pred             ccCeeccccccc-------------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999754321110             0012346999999999999999999999999999999999999999765432211


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                         ......           ..+     ..+...+..+.+++..||+.||.+|||+.++++|
T Consensus       255 ---~~~~~~-----------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 ---HKTLAG-----------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ---HHHhcC-----------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence               111100           000     1122345679999999999999999999999986

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7e-44  Score=314.51  Aligned_cols=252  Identities=31%  Similarity=0.503  Sum_probs=195.6

Q ss_pred             hhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.+.||.|+||.||+|.+.  .......|++|+....  ....+.+.+|++.++.++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3567999999999999987  4556788899988543  34467899999999999999999999999988889999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++|+|.+++... ....+++..+..++.|++.||.|||++   +++|+||+++|||++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999999864 246789999999999999999999999   999999999999999999999999999976421111


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .             .......+...|+|||.+.+..++.++||||||+++|||++ |..||...+...........    
T Consensus       159 ~-------------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----  221 (259)
T PF07714_consen  159 Y-------------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----  221 (259)
T ss_dssp             E-------------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT----
T ss_pred             c-------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----
Confidence            0             01112346778999999999889999999999999999999 78998766543322221110    


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                 ..    ...+..++..+.+++..||+.||.+|||+.+|++.|
T Consensus       222 -----------~~----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 -----------QR----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----------EE----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----------cc----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                       00    011122355788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.6e-43  Score=312.90  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=199.9

Q ss_pred             HhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ++.+.||+|+||+||+|...  +......+++|.....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   87 (283)
T cd05090           8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE   87 (283)
T ss_pred             eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence            46788999999999999853  2235577888876532  2334678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceE
Q 017627          136 YVPNGTLQEKLHGTP--------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCK  201 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vk  201 (368)
                      |+++++|.+++....              ....+++..+..++.|++.||.|||++   +++|+||||+|||++.++.+|
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (283)
T cd05090          88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVK  164 (283)
T ss_pred             cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEE
Confidence            999999999885321              123478889999999999999999999   999999999999999999999


Q ss_pred             EeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 017627          202 LCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPEN  280 (368)
Q Consensus       202 l~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  280 (368)
                      |+|||+++.........             ......++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus       165 l~dfg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         165 ISDLGLSREIYSADYYR-------------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             eccccccccccCCccee-------------cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999997543222100             0112235678999999988889999999999999999998 999997654


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      ..........                   ......+...+..+.+++.+||+.||.+||++.+|+++|+.
T Consensus       232 ~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         232 NQEVIEMVRK-------------------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHHc-------------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            3222211111                   00001112234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=305.91  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=199.7

Q ss_pred             hhcccccceEEEEEEEcCCC-CceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           63 QVIGSGGFSNVYLARLINDS-TSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      +.||+|+||.||+|.+.... ....+++|.......  ..+.+.+|+++++.+.|+||+++++++. .+..++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            35999999999999875543 447888997765443  5567889999999999999999999876 5578999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-  152 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-  152 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc-
Confidence            999999974   34789999999999999999999999   99999999999999999999999999987543222100 


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                 .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+............      
T Consensus       153 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~------  215 (257)
T cd05060         153 -----------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------  215 (257)
T ss_pred             -----------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------
Confidence                       00011124567999999998899999999999999999998 999997665433322221100      


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                   ....+...+..+.+++.+||..+|.+|||+.++++.|+...
T Consensus       216 -------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 -------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                         00111223457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-43  Score=306.77  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.+.||+|+||.||+|.+.   ....+++|+..........+.+|+++++.++||||+++++++...+..++||||+++
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWR---GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             chhhhhccCCCceEEEeEec---CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            46788999999999999864   345678887765544455688899999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++...  ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++..........
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            9999998743  24689999999999999999999999   999999999999999999999999999875432211100


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                    ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..............        
T Consensus       159 --------------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------  216 (256)
T cd05059         159 --------------QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA--------  216 (256)
T ss_pred             --------------CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc--------
Confidence                          01124457999999999999999999999999999999 8999975443322211110        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                             ....    ..+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       217 -------~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 -------GYRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -------CCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                   0000    11112355899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=308.26  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=197.4

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      .||+|+||.||+|.+.+++....+++|....  .....+.+.+|+.++.++ +||||+++++++...+..++||||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            5899999999999986654445667776653  234556788999999999 7999999999999999999999999999


Q ss_pred             CHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          141 TLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       141 ~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      +|.+++....             ....+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            9999986432             123578999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTS  286 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  286 (368)
                      +.......                .......+..|+|||++.+..++.++||||||+++|+|++ |..||...+......
T Consensus       159 ~~~~~~~~----------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~  222 (270)
T cd05047         159 SRGQEVYV----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  222 (270)
T ss_pred             ccccchhh----------------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH
Confidence            85211000                0011124567999999988899999999999999999997 999996654322211


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ...                   ...........+..+.+++..||+.||.+|||+.+++..|++++
T Consensus       223 ~~~-------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 KLP-------------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHh-------------------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            110                   00000111123457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-43  Score=321.59  Aligned_cols=236  Identities=25%  Similarity=0.323  Sum_probs=186.6

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHH-HHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQEL-DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .||+|+||.||+|++..  ++..+++|+.....    .....+..|. .+++.++||||+++++++.+.+..++||||+.
T Consensus         2 ~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             eeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            59999999999998755  66788999765321    2233444454 46788999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|...+.   ....+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+++......   
T Consensus        80 ~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---  150 (321)
T cd05603          80 GGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---  150 (321)
T ss_pred             CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---
Confidence            999998886   345688999999999999999999999   99999999999999999999999999986421111   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+........   ..     
T Consensus       151 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~-----  210 (321)
T cd05603         151 ------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI---LH-----  210 (321)
T ss_pred             ------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH---hc-----
Confidence                        0112346899999999999999999999999999999999999999765533221111   00     


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT  342 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  342 (368)
                                ..  ...+...+..+.+++.+||+.||.+||++.
T Consensus       211 ----------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 ----------KP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----------CC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                      00  011122345788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=308.40  Aligned_cols=258  Identities=22%  Similarity=0.356  Sum_probs=200.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCC-CceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe------
Q 017627           60 NFSQVIGSGGFSNVYLARLINDS-TSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE------  129 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  129 (368)
                      .+.+.||+|+||.||+|....+. ....+++|.....   ......+.+|+..++.++||||+++++++...+.      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            35678999999999999875432 4577888876543   2345678899999999999999999998866554      


Q ss_pred             eEEEEecccCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTP---RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      .+++|||+++++|..++....   ....+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence            799999999999998885432   224689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~  285 (368)
                      +++..........             .....++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus       159 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~  225 (273)
T cd05035         159 LSKKIYSGDYYRQ-------------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY  225 (273)
T ss_pred             ceeeccccccccc-------------cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9985443221110             011225678999999998899999999999999999999 88998665433222


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      .....   .                .....+...+..+.+++.+||+.||.+|||+.+++++|++++
T Consensus       226 ~~~~~---~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         226 DYLRH---G----------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             HHHHc---C----------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            11110   0                000111233568999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-42  Score=322.93  Aligned_cols=261  Identities=24%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  130 (368)
                      ..+.+.+.||+|+||.||+|.+.+   ......+|+|+....  ....+.+.+|+.++..+. |||||++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            344577899999999999998643   234567899987644  333456889999999997 99999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCC-----------------------------------------------------------
Q 017627          131 VLLFEYVPNGTLQEKLHGTPR-----------------------------------------------------------  151 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------------  151 (368)
                      ++||||+.+|+|.+++.....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999864311                                                           


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          152 ------------------------------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       152 ------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                                                          ...+++..+..++.|++.||.|||+.   +++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence                                                12366778889999999999999998   999999999999999


Q ss_pred             CCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCC
Q 017627          196 EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GME  274 (368)
Q Consensus       196 ~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~  274 (368)
                      .++.+||+|||+++........             .......+++.|+|||.+.+..++.++||||||+++|||++ |..
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~  340 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNY-------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT  340 (401)
T ss_pred             CCCEEEEEecCcceeccccccc-------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCC
Confidence            9999999999999753221110             00012246788999999998889999999999999999998 889


Q ss_pred             CCCCCcchhh-HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          275 AFCPENGQLL-TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       275 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ||........ ......                   ......+...+.++.+|+..||..+|.+||++++|++.|+.++
T Consensus       341 P~~~~~~~~~~~~~~~~-------------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         341 PYPELPMNEQFYNAIKR-------------------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCCCchHHHHHHHHc-------------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            9865432211 110000                   0000111223568999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.7e-44  Score=326.28  Aligned_cols=251  Identities=25%  Similarity=0.308  Sum_probs=198.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|....  ++..+|+|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKA--TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            3466789999999999998755  66788999766432    24567889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999743  35689999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR------TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ...              ......||+.|+|||++.      +..++.++|||||||++|+|++|..||..........  
T Consensus       156 ~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--  219 (330)
T cd05601         156 KMV--------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN--  219 (330)
T ss_pred             Cce--------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH--
Confidence            110              012246899999999986      4567889999999999999999999997654322111  


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       .....         ...    .........+..+.+|+..||+ +|.+|||+.++++|
T Consensus       220 -~i~~~---------~~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         220 -NIMNF---------QRF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -HHHcC---------CCc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence             11000         000    0000011235678899999998 99999999999987

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-42  Score=313.05  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=203.5

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  130 (368)
                      ..+.+.+.||+|+||.||+|.+..   ......+++|.....  ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            345577899999999999997532   234567888876543  34456788999999999 799999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+.+++|.+++... ....+++.++..++.|++.||.|||++   +|+|+||||+|||++.++.++|+|||+++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999998743 233489999999999999999999999   999999999999999999999999999874


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh-hHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL-LTSLA  288 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~-~~~~~  288 (368)
                      .......             .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||....... .....
T Consensus       191 ~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~  257 (302)
T cd05055         191 IMNDSNY-------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI  257 (302)
T ss_pred             ccCCCce-------------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH
Confidence            3221100             00011236788999999998899999999999999999998 999997654321 11110


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      .                   .......+...+..+.+++.+||..+|++|||+.++++.|++++
T Consensus       258 ~-------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         258 K-------------------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             H-------------------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            0                   00000111122457999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.8e-43  Score=326.84  Aligned_cols=265  Identities=20%  Similarity=0.261  Sum_probs=197.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-----eeE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----EGV  131 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~  131 (368)
                      ++.+.||+|+||.||+|.+..  ++..+|+|.....   ....+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             cccceeeeCCCEEEEEEEECC--CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            356789999999999998654  5677899876432   234467889999999999999999999998776     789


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+. ++|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999995 57877776   345789999999999999999999999   9999999999999999999999999999753


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ......              ......+++.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.......+..
T Consensus       154 ~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  219 (372)
T cd07853         154 EPDESK--------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD  219 (372)
T ss_pred             ccCccc--------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            221100              01123578999999999874 578999999999999999999999987664433332222


Q ss_pred             hhhhhhhhhh----cchhh-hcC-CCCCC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEA----TKVNE-LVD-PRLAG------DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~----~~~~~-~~~-~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..........    ..... +.. +....      ......+.++.+||.+||+.||.+|||+.+++.|
T Consensus       220 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            2111100000    00000 000 00000      0111235678999999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.7e-43  Score=313.54  Aligned_cols=260  Identities=22%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      .+.+.+.||+|+||.||++.....   .....+++|.....  ......+.+|+.++..+ +|+||+++++++...+..+
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   92 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY   92 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence            345677899999999999987542   24467888876543  33445688899999999 7999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC
Q 017627          132 LLFEYVPNGTLQEKLHGT-------------PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL  198 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~  198 (368)
                      ++|||+.+++|..++...             .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++
T Consensus        93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~  169 (293)
T cd05053          93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDH  169 (293)
T ss_pred             EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCC
Confidence            999999999999998642             1345688999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 017627          199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFC  277 (368)
Q Consensus       199 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~  277 (368)
                      .+||+|||+++..........             .....++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRK-------------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             eEEeCccccccccccccceec-------------cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            999999999975432221000             011224677999999998899999999999999999998 999997


Q ss_pred             CCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          278 PENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      .............                   ......+...+..+.+|+..||+.||.+|||+.++++.|+.++
T Consensus       237 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         237 GIPVEELFKLLKE-------------------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCHHHHHHHHHc-------------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            6543322211110                   0001112233557899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-42  Score=306.77  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=201.6

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+|.+.+.||+|+||.||+|.+.+  . ..+++|.........+.+.+|+++++.++||||+++++++. .+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~--~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNG--T-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecC--C-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            346688899999999999998644  2 35888877655444567889999999999999999999875 4568999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++... ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||.++.......
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999743 234678999999999999999999999   999999999999999999999999999875432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .              ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..............     
T Consensus       158 ~--------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-----  218 (262)
T cd05071         158 T--------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----  218 (262)
T ss_pred             c--------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-----
Confidence            0              0011236778999999988889999999999999999999 8889866543221111000     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                    ..........+..+.+++..||+.||++|||+.++++.|+..+
T Consensus       219 --------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         219 --------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             --------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                          0001112334567899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.5e-43  Score=322.11  Aligned_cols=264  Identities=22%  Similarity=0.240  Sum_probs=194.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  128 (368)
                      .|.+.+.||+|+||.||++.+..  ++..+|+|+....   ......+.+|+.+++.++||||+++++++...+      
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTV--LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcC--CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            45567889999999999998654  6778899976432   344566778999999999999999999986443      


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++||||+.+ +|...+.     ..++...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            47999999965 5666554     2478889999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      +.......                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+........
T Consensus       171 ~~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~  234 (359)
T cd07876         171 RTACTNFM----------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV  234 (359)
T ss_pred             cccccCcc----------------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            74322110                01235899999999999999999999999999999999999999876532221111


Q ss_pred             Hhhhhhhhhh----hhcchhhhcC--CCCCC----------------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017627          289 GSMLNDIADC----EATKVNELVD--PRLAG----------------DFDLDEARAMLSIAALCLRQSPILRPSATQILH  346 (368)
Q Consensus       289 ~~~~~~~~~~----~~~~~~~~~~--~~~~~----------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  346 (368)
                      ..........    ..........  +....                ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111000000    0000000000  00000                011122457899999999999999999999999


Q ss_pred             HH
Q 017627          347 TI  348 (368)
Q Consensus       347 ~L  348 (368)
                      |-
T Consensus       315 hp  316 (359)
T cd07876         315 HP  316 (359)
T ss_pred             Cc
Confidence            84

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.8e-43  Score=316.73  Aligned_cols=266  Identities=21%  Similarity=0.259  Sum_probs=197.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|.+..  +...+++|.....  ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecC--CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            4466789999999999998754  5667888866432  22334567899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+ +|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            965 788777642  34578999999999999999999999   999999999999999999999999999874322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+...............
T Consensus       160 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  224 (309)
T cd07872         160 ---------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP  224 (309)
T ss_pred             ---------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence                           0012357899999999865 468899999999999999999999998766443333332222211


Q ss_pred             hhhhhcchh------hhcCCCCCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVN------ELVDPRLAG----DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....+..+.      ....+....    ......+.++.+|+.+||+.||.+|||+.++++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            111100000      000010000    0011235678999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.9e-42  Score=306.74  Aligned_cols=257  Identities=23%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|....    .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLL--DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeC--CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4467789999999999998755  567788886432    2344566888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998886432 234588999999999999999999999   999999999999999999999999999875332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ ......  
T Consensus       159 ~~~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~--  220 (267)
T cd08228         159 KTT---------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQKI--  220 (267)
T ss_pred             hhH---------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHHHH--
Confidence            111               00123588899999999988899999999999999999999999965432211 111110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                ...   ..........+..+.+++.+||+.+|.+|||++++++.++++
T Consensus       221 ----------~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         221 ----------EQC---DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ----------hcC---CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                      000   011111223456799999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-44  Score=295.80  Aligned_cols=259  Identities=26%  Similarity=0.368  Sum_probs=203.3

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---------hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCee
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---------DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---------~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  130 (368)
                      -.+.||.|..++|..+..+.  ++...++|+....         ....++-..|+.+|+++ -||+|+++.++++.....
T Consensus        21 pkeilgrgvss~vrRci~k~--t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~   98 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHKE--TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV   98 (411)
T ss_pred             hHHHhcccchhhhhhhhhcc--cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence            35679999999998886544  5566666654321         23445667899999999 599999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++|+|.|+.|.|.++|.   ..-.+++.....|++|++.|++|||.+   +||||||||+|||++++-++||+|||.|..
T Consensus        99 FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeec
Confidence            99999999999999998   556799999999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG------MASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      .....                +....||||+|+|||.+.+.      .|+..+|+|++|+|+|.|+.|.+||-......+
T Consensus       173 l~~Ge----------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM  236 (411)
T KOG0599|consen  173 LEPGE----------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM  236 (411)
T ss_pred             cCCch----------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH
Confidence            43332                22446899999999998654      578889999999999999999999944322211


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcccccccccC
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRL--AGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQISSISFLFS  360 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~~~~~~~~~  360 (368)
                      ..+                  +.....  ...--.+.+....+||.+||+.||.+|.|++++|.|  +.++...-.+.++
T Consensus       237 LR~------------------ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~ms  298 (411)
T KOG0599|consen  237 LRM------------------IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMS  298 (411)
T ss_pred             HHH------------------HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccC
Confidence            111                  111111  111123456789999999999999999999999988  4444444444444


Q ss_pred             C
Q 017627          361 P  361 (368)
Q Consensus       361 ~  361 (368)
                      |
T Consensus       299 P  299 (411)
T KOG0599|consen  299 P  299 (411)
T ss_pred             C
Confidence            4

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-42  Score=305.11  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=199.7

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..+++.+.||+|+||.||+|...+   ...+++|...........+.+|+.+++.++|+|++++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG---NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC---CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            345678899999999999997643   345788877665445567889999999999999999999885 4568999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++... ....+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            9999999998753 234689999999999999999999999   999999999999999999999999999975332110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .              ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..........     
T Consensus       158 ~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----  218 (260)
T cd05070         158 T--------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-----  218 (260)
T ss_pred             c--------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----
Confidence            0              0011235667999999988889999999999999999999 8999976543222211110     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                    ......+...+..+.+|+.+||..+|.+|||+.++++.|+.
T Consensus       219 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 --------------GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --------------CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                          00111122335679999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.2e-43  Score=321.57  Aligned_cols=242  Identities=25%  Similarity=0.343  Sum_probs=189.9

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHH-HHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELD-ILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||.||+|....  ++..+|+|+....    ......+..|.. +++.++||||+++++++...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL--DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            358999999999998654  6778899977543    122334445554 567789999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        79 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--  150 (325)
T cd05604          79 NGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--  150 (325)
T ss_pred             CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--
Confidence            9999998886   456789999999999999999999999   99999999999999999999999999986422111  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+........   ...   
T Consensus       151 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~---~~~---  211 (325)
T cd05604         151 -------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI---LHK---  211 (325)
T ss_pred             -------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH---HcC---
Confidence                         0112346999999999999999999999999999999999999999765433221111   100   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT----QILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----~il~~  347 (368)
                                .....    ...+..+.+++..||+.||.+||++.    ++++|
T Consensus       212 ----------~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         212 ----------PLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             ----------CccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence                      00011    12345788999999999999999885    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.8e-43  Score=318.13  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=193.1

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .||+|+||.||+|....  +...+|+|+....    ....+.+.+|+.++..+ +||||+.+++++.+.+..++||||++
T Consensus         2 ~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           2 VIGRGSYAKVLLVRLKK--NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             eeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            59999999999998755  5678889877643    23445678899999888 69999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---  150 (327)
T cd05617          80 GGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---  150 (327)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---
Confidence            999998886   345699999999999999999999999   99999999999999999999999999986421111   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||................      
T Consensus       151 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~------  212 (327)
T cd05617         151 ------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF------  212 (327)
T ss_pred             ------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH------
Confidence                        01123469999999999999999999999999999999999999996432111000000000      


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA------TQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~  347 (368)
                           .......  ...+...+..+.+++.+||+.||.+|+++      +++++|
T Consensus       213 -----~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         213 -----QVILEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -----HHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                 0000000  01122234578899999999999999984      677776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.4e-43  Score=318.64  Aligned_cols=245  Identities=24%  Similarity=0.326  Sum_probs=194.5

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ++.+.||+|+||.||+|....  ++..+|+|+....    ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            466789999999999998755  6778999976542    223455677899998885 578889999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999987   445689999999999999999999999   9999999999999999999999999998742211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               ......||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......+..   .
T Consensus       155 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~---~  216 (323)
T cd05615         155 GV---------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME---H  216 (323)
T ss_pred             Cc---------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---C
Confidence            10               01224589999999999999999999999999999999999999977654322211110   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                     .  ..++...+..+.+++.+||+.||.+|++.     .++++|
T Consensus       217 ---------------~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         217 ---------------N--VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ---------------C--CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                           0  01112234578899999999999999984     566655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-42  Score=306.50  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=203.9

Q ss_pred             HHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           54 VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        54 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      +.+..+++.++||+|+||.||+|...   .+..+++|...........+.+|+.+++.++|+||+++++++. .+..+++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC---CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            34556778899999999999999854   3466899987765555677889999999999999999999874 5678999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++... .+..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            9999999999988654 345689999999999999999999999   999999999999999999999999999875332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ....              ......++..|+|||++.+..++.++||||||+++|++++ |..||...+........... 
T Consensus       155 ~~~~--------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-  219 (260)
T cd05067         155 NEYT--------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-  219 (260)
T ss_pred             CCcc--------------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-
Confidence            1110              0012235678999999998889999999999999999999 99999765543322211110 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                    ...    ......+..+.+++.+||+.+|++|||+++++..|+.
T Consensus       220 --------------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 --------------YRM----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --------------CCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                          000    1111234579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-42  Score=311.02  Aligned_cols=266  Identities=24%  Similarity=0.283  Sum_probs=193.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC---CCCceeeeeEEEec-----C
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL---SHDNIVKLIGYCDD-----R  127 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~  127 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|.....   ......+.+|+.+++.+   +||||+++++++..     .
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPH--SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECC--CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4567789999999999998765  6778888866532   22233456677777766   69999999998854     3


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      ...++|||++. ++|.+++... ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            45799999996 5888888643 234589999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ++.......                .....||..|+|||++.+..++.++||||+||++|+|++|.+||...........
T Consensus       155 ~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~  218 (288)
T cd07863         155 ARIYSCQMA----------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK  218 (288)
T ss_pred             cccccCccc----------------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence            875322111                0123588999999999998999999999999999999999999976654332221


Q ss_pred             HHhhhhhhhhhhhcchh----hhcCCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEATKVN----ELVDPRLA---GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~----~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .................    ....+...   .......+..+.+++.+||+.||.+|||+.+++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         219 IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11111100000000000    00000000   01112335678999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-42  Score=308.27  Aligned_cols=257  Identities=26%  Similarity=0.355  Sum_probs=199.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCC---CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDS---TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~---~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      +.+.+.||+|+||.||+|.+....   ....+++|.....  ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL   87 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence            446678999999999999876422   5667888865432  33445688899999999999999999999988999999


Q ss_pred             EecccCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC---ceEEeecc
Q 017627          134 FEYVPNGTLQEKLHGTPR----SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL---NCKLCDFG  206 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~---~vkl~Dfg  206 (368)
                      |||+.+++|.+++.....    ...+++..+..++.||+.||.|||++   +++|+||||+||+++.++   .+||+|||
T Consensus        88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence            999999999999875321    23588999999999999999999999   999999999999998654   59999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~  285 (368)
                      +++..........             .....++..|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       165 ~~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~  231 (277)
T cd05036         165 MARDIYRASYYRK-------------GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM  231 (277)
T ss_pred             cccccCCccceec-------------CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9986432211000             011123567999999998899999999999999999997 99999765443222


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      .....                   ......+...+..+.+++.+||+.+|++|||+.+++++|++
T Consensus       232 ~~~~~-------------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         232 EFVTG-------------------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHHc-------------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            11110                   00011122234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-42  Score=313.65  Aligned_cols=264  Identities=23%  Similarity=0.357  Sum_probs=205.6

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCC-----CceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCC
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDS-----TSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRD  128 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~-----~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  128 (368)
                      ..|.+.+.||+|+||.||+|.+.+..     ....+++|+....  ......+.+|+.+++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            34567889999999999999864321     2356888877643  33456688899999999 7999999999999999


Q ss_pred             eeEEEEecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                      ..++||||+.+++|.+++.....             ...+++.++..++.|++.||.|||++   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999975321             13588899999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCC
Q 017627          196 EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GME  274 (368)
Q Consensus       196 ~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~  274 (368)
                      .++.+||+|||.++.........             ......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~  241 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYK-------------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS  241 (307)
T ss_pred             CCCcEEECCCcccccccccchhh-------------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence            99999999999987533211100             0011124568999999998889999999999999999998 889


Q ss_pred             CCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      ||..............                   ......+...+.++.+|+..||+.+|.+|||+.++++.|++++..
T Consensus       242 p~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         242 PYPGVPVEELFKLLKE-------------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             CCCcCCHHHHHHHHHc-------------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            9865443222211111                   001111223456889999999999999999999999999998765


Q ss_pred             c
Q 017627          355 I  355 (368)
Q Consensus       355 ~  355 (368)
                      .
T Consensus       303 ~  303 (307)
T cd05098         303 T  303 (307)
T ss_pred             h
Confidence            3

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-42  Score=312.86  Aligned_cols=264  Identities=22%  Similarity=0.362  Sum_probs=205.8

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcC-----CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIN-----DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR  127 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  127 (368)
                      ...+.+.+.||+|+||.||+|.+..     ......+++|.....  ......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            4455678899999999999997532     223457888876543  34456788999999999 899999999999999


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL  194 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv  194 (368)
                      +..++||||+.+++|.+++.....             ...+++..+..++.|++.||.|||++   +++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            999999999999999999875321             23578888999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CC
Q 017627          195 EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GM  273 (368)
Q Consensus       195 ~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~  273 (368)
                      +.++.+||+|||+++.........             ......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  237 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYK-------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  237 (304)
T ss_pred             cCCCcEEECCCccceecccccccc-------------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            999999999999997543222110             0011235678999999998889999999999999999998 78


Q ss_pred             CCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      .||..............   .                .....+...+..+.+|+..||+.+|.+|||+.++++.|++++.
T Consensus       238 ~p~~~~~~~~~~~~~~~---~----------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         238 SPYPGIPVEELFKLLKE---G----------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             CCcccCCHHHHHHHHHc---C----------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            88865543322221110   0                0001112345678999999999999999999999999998765


Q ss_pred             c
Q 017627          354 S  354 (368)
Q Consensus       354 ~  354 (368)
                      -
T Consensus       299 ~  299 (304)
T cd05101         299 L  299 (304)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-42  Score=312.61  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=201.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |++.+.||+|+||.||++.+..  ++..+++|.....  ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRP--SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcC--CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3466789999999999998655  5667888876543  34456688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+  +++|+||||+|||++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  155 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccccc
Confidence            999999999973   456899999999999999999999732  899999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                       ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+................
T Consensus       156 -----------------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  218 (308)
T cd06615         156 -----------------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGE  218 (308)
T ss_pred             -----------------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccc
Confidence                             123588999999999988899999999999999999999999976553332222211111100


Q ss_pred             hhh--------------hcc----hhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          297 DCE--------------ATK----VNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       297 ~~~--------------~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ...              ...    .................+.++.+|+.+||..||.+|||+.++++|.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            000              000    0000000000000112455789999999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-42  Score=306.57  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=197.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+.+.||+|+||.||+|....  ++..+++|+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLH--TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECC--CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45577889999999999998755  56788888765432 3345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|.+++.   ....+++..+..++.|++.|+.|||+.   +|+|+||+|+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999999886   345689999999999999999999999   999999999999999999999999999875422110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                                     ......|++.|+|||.+.   ...++.++|+||+|+++|+|++|..||...........      
T Consensus       162 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~------  220 (267)
T cd06646         162 ---------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------  220 (267)
T ss_pred             ---------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee------
Confidence                           011235889999999884   34577899999999999999999999854432110000      


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                             ........+...  .....+..+.+++..||+.+|++|||++++++||
T Consensus       221 -------~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         221 -------MSKSNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -------eecCCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                   000000111111  1123356889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-42  Score=318.03  Aligned_cols=264  Identities=17%  Similarity=0.257  Sum_probs=191.3

Q ss_pred             HHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           55 ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        55 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ....|.+.+.||+|+||.||+|....  +...+++|+....     ....|+.+++.++||||+++++++...+..++||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG--QPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC--CCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            33456778899999999999998755  5677888874432     2346999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |++ .++|..++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHY-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             Ecc-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            999 4578887764  345689999999999999999999999   9999999999999999999999999998642211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCC-CCCCcch--hhHHH----
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA-FCPENGQ--LLTSL----  287 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p-f~~~~~~--~~~~~----  287 (368)
                      .                ......||+.|+|||++.+..++.++|||||||++|||+++..| |......  .....    
T Consensus       211 ~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~  274 (357)
T PHA03209        211 P----------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH  274 (357)
T ss_pred             c----------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHH
Confidence            1                01224589999999999999999999999999999999995544 4432211  10000    


Q ss_pred             HHhhhhhhh----hhh----hcchhhhcCC--CCCCCC-------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIA----DCE----ATKVNELVDP--RLAGDF-------DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~----~~~----~~~~~~~~~~--~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........    ...    ........+.  .....+       ....+.++.+||..||+.||.+|||+.++|+|
T Consensus       275 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            000000000    000    0000000000  000000       01224466789999999999999999999987

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.5e-42  Score=307.12  Aligned_cols=258  Identities=20%  Similarity=0.264  Sum_probs=198.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCC--ceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDST--STNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||+||+|.+...+.  ...+++|.....  ......+..|+.++..++||||+++++++. ....++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence            356789999999999998754332  234677765433  233456778888999999999999999885 456789999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++...  ...+++..+..++.|++.||.|||++   +++|+||||+|||++.++.+||+|||+++......
T Consensus        89 ~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          89 LSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             eCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            99999999999742  35689999999999999999999999   99999999999999999999999999997543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...             ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+.............   
T Consensus       164 ~~~-------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---  227 (279)
T cd05111         164 KKY-------------FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG---  227 (279)
T ss_pred             ccc-------------ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---
Confidence            100             0012346778999999998899999999999999999998 99999765433222111100   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                               ..   ...    +..++..+.+++..||..||.+|||+.++++.|..+....
T Consensus       228 ---------~~---~~~----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         228 ---------ER---LAQ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             ---------Cc---CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                     00   000    0112346788999999999999999999999999877644

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.6e-43  Score=307.87  Aligned_cols=252  Identities=31%  Similarity=0.483  Sum_probs=200.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHH---HHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV---FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ++.+.||+|+||+||+++...  +...+++|+..........   ..+|+.+++.++||||+++++++.+.+..++|||+
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKK--NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETT--TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             EEeEEEEeCCCEEEEEEEECC--CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence            467889999999999999765  6778899988776543332   34599999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++.   ....++...++.++.|++.||.+||++   +++|+||||+||+++.++.++|+|||.+....... 
T Consensus        80 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-  152 (260)
T PF00069_consen   80 CPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-  152 (260)
T ss_dssp             ETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred             ccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence            99999999997   456789999999999999999999999   99999999999999999999999999987431100 


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                    .......+++.|+|||++. +..++.++||||||+++|+|++|..||...................
T Consensus       153 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~  218 (260)
T PF00069_consen  153 --------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP  218 (260)
T ss_dssp             --------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH
T ss_pred             --------------cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc
Confidence                          0112245899999999998 8889999999999999999999999998764332222222222111


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ........             ......+.+++..||+.||++|||+.++++|
T Consensus       219 ~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  219 LPSSSQQS-------------REKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHTTSH-------------TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccccccc-------------chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11000000             0002689999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=323.17  Aligned_cols=267  Identities=25%  Similarity=0.352  Sum_probs=228.9

Q ss_pred             HHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           53 DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        53 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      |.++....+..+||-|.||.||.|.|+.  ...-+|||....+......|..|+.+|+.++|||+|+++|+|+..-..||
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKk--yslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeec--cceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence            4444444466789999999999999976  77889999888888888999999999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |.|||..|+|.+||+.. ....++.-.++.++.||.+|++||..+   ++|||||...|.||+++..||++|||+++++.
T Consensus       341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999876 345677888889999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .+.+..-              ....-..-|.|||.+..+.++.++|||+||++|||+.| |..||.+-+-.         
T Consensus       417 gDTYTAH--------------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---------  473 (1157)
T KOG4278|consen  417 GDTYTAH--------------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------  473 (1157)
T ss_pred             CCceecc--------------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---------
Confidence            6654221              11123457999999999999999999999999999999 99999775543         


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL  358 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~  358 (368)
                                .+..++...++.+.+..|++.+.+|++.||+++|.+||+++++-+.++.++.+.+..
T Consensus       474 ----------qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis  530 (1157)
T KOG4278|consen  474 ----------QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS  530 (1157)
T ss_pred             ----------HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence                      333444555666667788889999999999999999999999999999998876553

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-42  Score=306.68  Aligned_cols=251  Identities=24%  Similarity=0.401  Sum_probs=196.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC------Cee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR------DEG  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~~~  130 (368)
                      .|.+.+.||+|+||.||+|....  ....+++|+..........+..|+.++..+ +|+||+++++++...      ...
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcC--CCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            45567889999999999998754  677889998766555556788899999999 699999999998653      457


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+.+++|.+++... ....+++..+..++.|++.|+.|||++   +|+|+||||+||+++.++.++|+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            9999999999999998753 345689999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      ......               ......|++.|+|||++.     +..++.++|+||+||++|+|++|..||.........
T Consensus       161 ~~~~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~  225 (272)
T cd06637         161 LDRTVG---------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL  225 (272)
T ss_pred             cccccc---------------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence            322110               112345899999999986     345788999999999999999999999654322111


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....          ..     .+..   .....+..+.+|+.+||..||.+|||+.++++|
T Consensus       226 ~~~~~----------~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         226 FLIPR----------NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HHHhc----------CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            10000          00     0000   111234578999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=304.60  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      +.+.+.||+|+||.||.|....  ++..+++|......      .....+.+|+++++.++||||+++++++.+.+..++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~--~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVD--TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             ccccceecCCCceEEEEEEEcC--CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            3467889999999999998654  56778888654321      123568889999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |+||+++++|.+++.   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999887   345688999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ......            .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.........   
T Consensus       156 ~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---  220 (263)
T cd06625         156 TICSSG------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---  220 (263)
T ss_pred             cccccc------------ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh---
Confidence            211000            00012347889999999999889999999999999999999999996543321111000   


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                     ........+...+..+.+++..||..+|.+|||+.++++|.
T Consensus       221 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         221 ---------------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ---------------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                           00011112223455789999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.8e-42  Score=307.78  Aligned_cols=249  Identities=19%  Similarity=0.254  Sum_probs=197.5

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..+.||+|+||+||+|.+..  ++..+|+|......    .....+.+|+++++.++|+||+.+.+++..++..++||||
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRA--TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             EEEEEecCCCeEEEEEEECC--CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45679999999999998755  57788998765432    2334577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|..++... ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999999888643 234689999999999999999999999   999999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                      .....|+..|+|||++.+..++.++|+||+|+++|+|++|..||..................  
T Consensus       158 ----------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~--  219 (285)
T cd05632         158 ----------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE--  219 (285)
T ss_pred             ----------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc--
Confidence                            01235899999999999889999999999999999999999999765432221111111100  


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                               . .    ..+....+..+.+|+..||+.||++||+     +.+++.|
T Consensus       220 ---------~-~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         220 ---------T-E----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---------c-c----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                     0 0    0112223457889999999999999999     8888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.5e-43  Score=324.72  Aligned_cols=263  Identities=22%  Similarity=0.284  Sum_probs=197.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ++.+.||+|+||.||+|....  ++..+|+|+....    ......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           4 ESLKVIGRGAFGEVRLVQKKD--TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             eEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            356789999999999998765  6778899977532    2334567889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||+++......
T Consensus        82 ~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          82 FLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999987   345689999999999999999999999   99999999999999999999999999987543211


Q ss_pred             CCCCC---CCCC-C----------------CccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 017627          216 VLPPS---PSPS-P----------------SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA  275 (368)
Q Consensus       216 ~~~~~---~~~~-~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  275 (368)
                      .....   .... .                ...........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00000   0000 0                00000011235799999999999999999999999999999999999999


Q ss_pred             CCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 017627          276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS---ATQILHT  347 (368)
Q Consensus       276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~~  347 (368)
                      |...........+...          . ...   ....  ....+.++.++|..|+ .||.+|++   +.++++|
T Consensus       236 f~~~~~~~~~~~i~~~----------~-~~~---~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         236 FCSETPQETYRKVMNW----------K-ETL---VFPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCHHHHHHHHHcC----------C-Cce---ecCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            9765543222111100          0 000   0000  0113457888998877 49999985   6788877

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-42  Score=316.95  Aligned_cols=265  Identities=23%  Similarity=0.379  Sum_probs=201.2

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC-C
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR-D  128 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~  128 (368)
                      ..+|.+.+.||+|+||.||+|.+.+   ..+...+|+|+....  ......+.+|+.++..+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            3456788999999999999998542   235677899987543  33445688899999999 689999999987654 4


Q ss_pred             eeEEEEecccCCCHHHHhcCCCC---------------------------------------------------------
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPR---------------------------------------------------------  151 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  151 (368)
                      ..++||||+.+|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998864210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCC
Q 017627          152 -------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS  224 (368)
Q Consensus       152 -------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~  224 (368)
                             ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.........       
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------  235 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------  235 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch-------
Confidence                   12367888899999999999999999   9999999999999999999999999998754222110       


Q ss_pred             CCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhhhcch
Q 017627          225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCEATKV  303 (368)
Q Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (368)
                            .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........  ........         
T Consensus       236 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~---------  298 (343)
T cd05103         236 ------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG---------  298 (343)
T ss_pred             ------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHHhcc---------
Confidence                  00011235678999999988899999999999999999997 9999865432211  00000000         


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          304 NELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                         .....    +...+..+.+++..||+.||.+|||+.+|+++|+.++++
T Consensus       299 ---~~~~~----~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         299 ---TRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ---CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence               00000    111234688999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=304.92  Aligned_cols=279  Identities=22%  Similarity=0.284  Sum_probs=227.6

Q ss_pred             CcccccCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC--CC----ce
Q 017627           44 RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS--HD----NI  117 (368)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~--h~----~i  117 (368)
                      .....+...|....+|.+...+|+|.||.|-.+.+..  ....+|+||........++..-|+++|+++.  .|    -+
T Consensus        76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~--~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE--TKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             CceEEEEeccccccceehhhhhcCCcccceEEEeecC--CCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            3445667778878888899999999999999998765  4889999999998888889999999999994  23    38


Q ss_pred             eeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-
Q 017627          118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-  196 (368)
Q Consensus       118 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-  196 (368)
                      |.+.++|...++.|+|+|.+ |.++.+++..+ ...+++...+..+++|++.++++||+.   +++|.||||+|||+.. 
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss  228 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS  228 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence            88899999999999999998 77999999865 456799999999999999999999999   9999999999999932 


Q ss_pred             -------------------CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcch
Q 017627          197 -------------------HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT  257 (368)
Q Consensus       197 -------------------~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  257 (368)
                                         +..++++|||.|+......                  ..++.|..|+|||++.+-+++.++
T Consensus       229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------------------s~iVsTRHYRAPEViLgLGwS~pC  290 (415)
T KOG0671|consen  229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------------------STIVSTRHYRAPEVILGLGWSQPC  290 (415)
T ss_pred             ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc------------------ceeeeccccCCchheeccCcCCcc
Confidence                               3348999999997543332                  456789999999999999999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcch----------------------hhhcCCCCC---
Q 017627          258 DVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKV----------------------NELVDPRLA---  312 (368)
Q Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~---  312 (368)
                      ||||+||||+|+.+|...|...+......++++.+..++..-....                      ....++..+   
T Consensus       291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~  370 (415)
T KOG0671|consen  291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK  370 (415)
T ss_pred             CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence            9999999999999999999987766666777777776555332222                      001111000   


Q ss_pred             -CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          313 -GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       313 -~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       ......+...|.+|+..||..||.+|+|+.|+|+|
T Consensus       371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  371 YMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence             01123445679999999999999999999999987

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-42  Score=306.89  Aligned_cols=270  Identities=26%  Similarity=0.360  Sum_probs=200.7

Q ss_pred             HhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLL  133 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  133 (368)
                      .+.+.||+|+||+||++.+.  .......+++|+....  ......+.+|+++++.++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            56778999999999987643  2235667899987653  23456788999999999999999999987653  357899


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++..    ..+++..+..++.|++.||.|||++   +|+|+||||+|||++.++.++|+|||+++....
T Consensus        87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            999999999999863    3589999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      .....            .......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..........
T Consensus       160 ~~~~~------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~  226 (283)
T cd05080         160 GHEYY------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQG  226 (283)
T ss_pred             cchhh------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhccccc
Confidence            11100            0001123566799999999888999999999999999999999998654321 1111100000


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      .   .....+....+.......+...+..+.+++..||+.+|.+|||++++++.|+++.
T Consensus       227 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         227 Q---MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             c---cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0   0001111111111111222334568999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.3e-42  Score=309.85  Aligned_cols=265  Identities=25%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCC--------------CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDS--------------TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLI  121 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~--------------~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~  121 (368)
                      .+.+.+.||+|+||.||+|......              ....+++|.....  ....+.+.+|+++++.++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            4567889999999999999865432              2345788876543  34567788999999999999999999


Q ss_pred             EEEecCCeeEEEEecccCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTP--------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       122 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      +++...+..+++||++.+++|..++....        ....+++..++.++.|++.||.|||++   +++|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil  162 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence            99999999999999999999999987532        112689999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh--
Q 017627          194 LEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT--  271 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--  271 (368)
                      ++.++.++|+|||+++.........             ......+++.|+|||.+.+..++.++||||||+++|+|++  
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYR-------------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             ecCCCceEEccccceeecccCccee-------------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence            9999999999999987543222100             0112346788999999998889999999999999999998  


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      |..||..................      .      ........+...+.++.+++..||+.||.+|||+.+|++.|++
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~------~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         230 REQPYEHLTDQQVIENAGHFFRD------D------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             CCCCCCCcChHHHHHHHHhcccc------c------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            67888654433222111111000      0      0000011122334689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-42  Score=309.65  Aligned_cols=250  Identities=20%  Similarity=0.284  Sum_probs=197.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ...+.||+|+||.||++.+..  +...+++|.....    ......+.+|+.+++.++|+||+.+++.+.+.+..++|||
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcC--CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            345779999999999998765  6678888865432    2233456789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++... ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999988643 234589999999999999999999999   99999999999999999999999999986432211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .                .....|++.|+|||++.+..++.++||||+|+++|+|++|..||.................. 
T Consensus       157 ~----------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-  219 (285)
T cd05630         157 T----------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-  219 (285)
T ss_pred             c----------------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-
Confidence            0                01235899999999999999999999999999999999999999764322111111111100 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                             .        ...+....+..+.+|+..||+.||.+|||     +.++++|
T Consensus       220 -------~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 -------V--------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -------h--------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                   0        00111223457899999999999999999     8999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.9e-43  Score=322.94  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=196.0

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ..|.+.+.||+|+||.||+|.+..  +...+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECC--CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            345567889999999999998755  6778899976432    2334557789999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+++++|.+++..    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       121 v~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         121 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            9999999999999863    3478899999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM----ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      .....              .....+||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+
T Consensus       194 ~~~~~--------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  259 (371)
T cd05622         194 KEGMV--------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  259 (371)
T ss_pred             cCCcc--------------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            21110              012346999999999997643    788999999999999999999999765532221111


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL--RPSATQILHTI  348 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~L  348 (368)
                         ...            . ...........+..+.++|..||..++.+  |++++++++|.
T Consensus       260 ---~~~------------~-~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         260 ---MNH------------K-NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---HcC------------C-CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               100            0 00000011134567899999999844433  78999999885

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.1e-42  Score=302.91  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=200.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..+.+.+.||+|+||.||+|.+...   ..+++|.........+.+.+|+.+++.++|+|++++++++. .+..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~---~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT---TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC---ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            3456778899999999999986442   34788876655555677889999999999999999999885 4568999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++... ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||.++.......
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          82 MGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999999753 334588999999999999999999999   999999999999999999999999999875432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .              ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..............   . 
T Consensus       158 ~--------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~-  219 (260)
T cd05069         158 T--------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER---G-  219 (260)
T ss_pred             c--------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C-
Confidence            0              0011235678999999998889999999999999999999 8999976543322211111   0 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                     .....+...+..+.+++.+||+.||.+||++.++++.|++
T Consensus       220 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 ---------------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                           0001122345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.8e-42  Score=307.05  Aligned_cols=257  Identities=24%  Similarity=0.357  Sum_probs=200.2

Q ss_pred             HHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecC-ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVG-SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +.+.++||+|+||.||++...+   ......+++|.... .......+.+|+++++.++|+||+++++++...+..+++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF   86 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence            3467889999999999997532   23456778886544 3445678999999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEE
Q 017627          135 EYVPNGTLQEKLHGTPR------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKL  202 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl  202 (368)
                      ||+.+++|.+++.....            ...+++..+..++.|++.|+.|||++   +++|+||||+|||+++++.+||
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence            99999999999875321            13578999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcc
Q 017627          203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG  281 (368)
Q Consensus       203 ~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~  281 (368)
                      +|||+++........             .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.....
T Consensus       164 ~dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         164 GDFGMSRDIYSTDYY-------------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             CCCCceeEcCCCcee-------------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            999998753321110             00012235788999999999999999999999999999998 9999965443


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      .........               ....    ..+...+..+.+|+.+||+.||.+||++.++++.|+.
T Consensus       231 ~~~~~~~~~---------------~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         231 TEAIECITQ---------------GREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHHHc---------------CccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            221111100               0000    0111234578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-42  Score=307.87  Aligned_cols=267  Identities=22%  Similarity=0.331  Sum_probs=201.4

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCC------------CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeee
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIND------------STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLI  121 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~------------~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~  121 (368)
                      +..|.+.+.||+|+||.||++...+.            .....+++|.....  ......+.+|++++..++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            34566788999999999999876432            12345788876543  34456788999999999999999999


Q ss_pred             EEEecCCeeEEEEecccCCCHHHHhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCe
Q 017627          122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPR---------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNI  192 (368)
Q Consensus       122 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Ni  192 (368)
                      +++...+..++||||+.+++|.+++.....         ...+++..++.++.|++.||.|||++   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999999864311         12468889999999999999999999   999999999999


Q ss_pred             eecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-
Q 017627          193 LLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-  271 (368)
Q Consensus       193 lv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-  271 (368)
                      +++.++.+||+|||++.........             .......++..|+|||++.+..++.++||||||+++|+|++ 
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYY-------------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             EEcCCCcEEecccccccccccCcce-------------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence            9999999999999998753322110             00112235778999999988889999999999999999998 


Q ss_pred             -CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          272 -GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       272 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                       |..||..................       ......     ...+...+..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus       228 ~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         228 CKEQPYSLLSDEQVIENTGEFFRN-------QGRQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             CCCCCCcccChHHHHHHHHHhhhh-------cccccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             66788665443322211111100       000000     00111234589999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.9e-42  Score=339.08  Aligned_cols=274  Identities=24%  Similarity=0.315  Sum_probs=203.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.++||+|+||.||+|.+..  ++..+|+|+....    +...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~--tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPV--CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECC--CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4567889999999999998755  5778899976532    344567889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          135 EYVPNGTLQEKLHGTPR--------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      ||+++++|.+++.....        ....+...+..++.||+.||.|||++   +|+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211        23456677889999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCC---CCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh
Q 017627          207 SAKMGFSSAVLPPSPS---PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL  283 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  283 (368)
                      +++.............   ..............+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986522111000000   0000011111223569999999999999999999999999999999999999997644321


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhcccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-SATQILHTIKHQISS  354 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~~il~~L~~~~~~  354 (368)
                      ....  ...              .++... ......+..+.+++.+||+.||.+|| +++++++.|+..+..
T Consensus       239 i~~~--~~i--------------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISYR--DVI--------------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhh--hhc--------------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            1100  000              000000 00113345788999999999999995 567777778777654

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.7e-42  Score=307.09  Aligned_cols=264  Identities=22%  Similarity=0.323  Sum_probs=206.1

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCC--CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCee
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDEG  130 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~--~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~  130 (368)
                      +.+|.+.+.||+|+||.||+|.+....  ....+++|.....  ......+.+|+.+++.++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            345567789999999999999876422  3577888876543  3445678899999999999999999998765 4678


Q ss_pred             EEEEecccCCCHHHHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeec
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRS-----SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                      +++++|+.+++|.+++......     ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998754322     5689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhh
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLL  284 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  284 (368)
                      |+++...........             ....++..|+|||++.+..++.++||||||+++|++++ |..||...+....
T Consensus       162 g~~~~~~~~~~~~~~-------------~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  228 (280)
T cd05043         162 ALSRDLFPMDYHCLG-------------DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM  228 (280)
T ss_pred             CCcccccCCceEEeC-------------CCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence            999754322111000             01235678999999998899999999999999999999 9999976544322


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      .......                   ........++..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       229 ~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 AAYLKDG-------------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHcC-------------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            2211110                   00001112345789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-42  Score=319.90  Aligned_cols=263  Identities=21%  Similarity=0.232  Sum_probs=193.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------C
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------D  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  128 (368)
                      +|.+.+.||+|+||.||+|.+..  ....+|+|.....   ......+.+|+.+++.++||||+++++++...      .
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecC--CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            44567889999999999998644  6677888876532   33456677899999999999999999988643      3


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++||||+.+ +|...+.     ..++...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence            57999999965 6666664     2478889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH-H
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS-L  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~  287 (368)
                      +.......                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...... .
T Consensus       167 ~~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (355)
T cd07874         167 RTAGTSFM----------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  230 (355)
T ss_pred             ccCCCccc----------------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            75332211                012358999999999999999999999999999999999999997765322211 1


Q ss_pred             HHhhhhhhhhhh---hcchhhhcC----------CC------C--CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017627          288 AGSMLNDIADCE---ATKVNELVD----------PR------L--AGDFDLDEARAMLSIAALCLRQSPILRPSATQILH  346 (368)
Q Consensus       288 ~~~~~~~~~~~~---~~~~~~~~~----------~~------~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  346 (368)
                      ............   ........+          +.      .  ........+..+.+||.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            111100000000   000000000          00      0  00011123457899999999999999999999999


Q ss_pred             H
Q 017627          347 T  347 (368)
Q Consensus       347 ~  347 (368)
                      |
T Consensus       311 h  311 (355)
T cd07874         311 H  311 (355)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-42  Score=302.55  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+.+.||.|+||.||+|...    +..+++|.........+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~----~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR----GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             ccceeeeecCCCceEEEEEec----CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            346788999999999999863    4668899877665556788899999999999999999999998899999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++... ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||.++......   
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            99999998743 223689999999999999999999999   99999999999999999999999999987542111   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                     ....++..|+|||.+.+..++.++||||||+++|++++ |..||..............       
T Consensus       157 ---------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------  214 (256)
T cd05039         157 ---------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-------  214 (256)
T ss_pred             ---------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-------
Confidence                           01124567999999988889999999999999999998 9999966543322111110       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                  ......+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus       215 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 ------------GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------------CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                        000111122356889999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.4e-42  Score=311.07  Aligned_cols=264  Identities=23%  Similarity=0.374  Sum_probs=204.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcC-----CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN-----DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  129 (368)
                      .+.+.+.||+|+||.||+|...+     ......+++|.....  ......+.+|+.+++.+ +||||+++++++...+.
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP   92 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence            44577899999999999997532     123456788876543  33455688899999999 69999999999998889


Q ss_pred             eEEEEecccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          130 GVLLFEYVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      .++||||+.+++|.+++....             ....+++..+..++.|++.||.|||++   +++|+||||+|||++.
T Consensus        93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~  169 (314)
T cd05099          93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE  169 (314)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcC
Confidence            999999999999999986532             124588999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEA  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  275 (368)
                      ++.+||+|||+++.........             ......++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p  236 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYK-------------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP  236 (314)
T ss_pred             CCcEEEcccccccccccccccc-------------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence            9999999999997543211100             0011124567999999998899999999999999999999 8899


Q ss_pred             CCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      |..............                   ......+...+.++.+++.+||+.||.+|||+.++++.|+++....
T Consensus       237 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         237 YPGIPVEELFKLLRE-------------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             CCCCCHHHHHHHHHc-------------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            966543322221110                   0000112233457889999999999999999999999999887644


Q ss_pred             c
Q 017627          356 S  356 (368)
Q Consensus       356 ~  356 (368)
                      .
T Consensus       298 ~  298 (314)
T cd05099         298 S  298 (314)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=325.33  Aligned_cols=245  Identities=26%  Similarity=0.381  Sum_probs=201.9

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEee-cCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCCH
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIH-VGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL  142 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  142 (368)
                      +||+|.||+||.|++.+  +....|||-+ .......+.+..|+.+.+.|+|.|||+++|.+.+++..-|.||-++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~--tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD--TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeecccc--ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            69999999999999766  7778888844 44556778899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceEEeeccccccCCCCCCCCC
Q 017627          143 QEKLHGTPRSSKL--PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       143 ~~~l~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      .++++..  =+++  .+.+...+.+||+.||.|||++   .|||||||-+||||+ -.|.+||+|||-++....-.+   
T Consensus       660 SsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP---  731 (1226)
T KOG4279|consen  660 SSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP---  731 (1226)
T ss_pred             HHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc---
Confidence            9999853  3445  7888999999999999999999   999999999999997 678999999999986543321   


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                           ++       .+..||..|||||++..  ..|..++|||||||++.||.||++||-.........+.         
T Consensus       732 -----~T-------ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---------  790 (1226)
T KOG4279|consen  732 -----CT-------ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---------  790 (1226)
T ss_pred             -----cc-------cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---------
Confidence                 11       23569999999999955  46899999999999999999999999654332211110         


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                           +. +  -+.....+.+.+.+++.||.+|+.+||..||+|.++|+.
T Consensus       791 -----VG-m--yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  791 -----VG-M--YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             -----hc-c--eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                 00 0  012344667888999999999999999999999999864

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=302.26  Aligned_cols=252  Identities=25%  Similarity=0.428  Sum_probs=203.4

Q ss_pred             hhcccccceEEEEEEEcCC-CCceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           63 QVIGSGGFSNVYLARLIND-STSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      +.||+|+||.||+|..... .....+++|+......  ..+.+.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            3589999999999997653 3367788887765533  257888999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          140 GTLQEKLHGTPR------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       140 ~~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ++|.+++.....      ...+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999985421      36789999999999999999999999   999999999999999999999999999986443


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....             ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..............  
T Consensus       158 ~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--  222 (262)
T cd00192         158 DDYYR-------------KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--  222 (262)
T ss_pred             ccccc-------------cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--
Confidence            32100             0112347889999999998889999999999999999999 6999977643322221111  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                                       ......+...+.++.+++..||+.||.+|||+.+++++|+
T Consensus       223 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -----------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----------------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                             0011112233568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.3e-42  Score=304.67  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=201.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCC-CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDS-TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ...+.||+|+||.||+|.....+ ....+++|.....  ....+.+..|+++++.++||||+++++++...+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            35678999999999999876432 3457888876543  34456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++...  ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          88 MENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            9999999998642  35689999999999999999999999   999999999999999999999999999875432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ..            ........+..|+|||++.+..++.++||||||+++|+|++ |..||...+.......+...    
T Consensus       163 ~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~----  226 (268)
T cd05063         163 GT------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG----  226 (268)
T ss_pred             cc------------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC----
Confidence            00            00001123457999999998889999999999999999998 99999655432222111100    


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                     .........+..+.+++.+||+.+|.+||++.++++.|++++
T Consensus       227 ---------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         227 ---------------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             ---------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                           000111123457899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.6e-42  Score=310.93  Aligned_cols=269  Identities=21%  Similarity=0.299  Sum_probs=189.9

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeEEEEecccC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLLFEYVPN  139 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~  139 (368)
                      +.+||+|+||.||+|...+..+...+++|....... ...+.+|+.+++.++||||+++++++..  ....++||||+. 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            357999999999999977666778889997654432 3457789999999999999999998853  457899999985 


Q ss_pred             CCHHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee----cCCCceEEeeccccc
Q 017627          140 GTLQEKLHGTP------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAK  209 (368)
Q Consensus       140 ~~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv----~~~~~vkl~Dfg~s~  209 (368)
                      ++|.+++....      ....+++..+..++.|++.||.|||++   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            57777664221      223588999999999999999999999   99999999999999    466789999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh----
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLL----  284 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----  284 (368)
                      ........            ........||+.|+|||++.+ ..++.++|||||||++|||+||.+||........    
T Consensus       161 ~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~  228 (317)
T cd07867         161 LFNSPLKP------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  228 (317)
T ss_pred             ccCCCccc------------ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccc
Confidence            54322110            011123468999999999976 4578999999999999999999999975432110    


Q ss_pred             --HHHHHhhhhhh---hhhhhcchh---------h-hcCCCCC--------CCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017627          285 --TSLAGSMLNDI---ADCEATKVN---------E-LVDPRLA--------GDFDLDEARAMLSIAALCLRQSPILRPSA  341 (368)
Q Consensus       285 --~~~~~~~~~~~---~~~~~~~~~---------~-~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  341 (368)
                        ...........   ....+....         . .......        ..........+.+|+.+||+.||.+|||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~  308 (317)
T cd07867         229 FHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS  308 (317)
T ss_pred             ccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH
Confidence              00000000000   000000000         0 0000000        00001123468889999999999999999


Q ss_pred             HHHHHH
Q 017627          342 TQILHT  347 (368)
Q Consensus       342 ~~il~~  347 (368)
                      .++++|
T Consensus       309 ~e~l~h  314 (317)
T cd07867         309 EQALQD  314 (317)
T ss_pred             HHHhcC
Confidence            999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-42  Score=306.95  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..+.+.+.||+|+||.||+|.+.+.   .....+++|......  .....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            3445678899999999999987542   245778999765442  33456788999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          132 LLFEYVPNGTLQEKLHGTPR-------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      +||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence            99999999999999864321       23478889999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+++..........             .....++..|+|||.+.+..++.++||||||+++|++++ |..||...+...
T Consensus       163 fg~~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  229 (277)
T cd05032         163 FGMTRDIYETDYYRK-------------GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE  229 (277)
T ss_pred             cccchhhccCccccc-------------CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence            999875433221100             012246788999999988889999999999999999998 999996654432


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      .......                  . .....+...+..+.+++..||+.+|.+|||+.++++.|++
T Consensus       230 ~~~~~~~------------------~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         230 VLKFVID------------------G-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHHHhc------------------C-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            2221110                  0 0001111235688999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.4e-42  Score=305.42  Aligned_cols=259  Identities=20%  Similarity=0.254  Sum_probs=200.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCC--ceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDST--STNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +.+.+.||+|+||+||+|.+..++.  ...+|+|+...  .......+.+|+.++..++||||+++++++.. ...++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~   87 (279)
T cd05109           9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT   87 (279)
T ss_pred             eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence            3466789999999999998654332  23478887653  33445678899999999999999999999875 4578999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      +++++|+|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        88 ~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          88 QLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            999999999998742  34689999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....             ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...............  
T Consensus       163 ~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--  227 (279)
T cd05109         163 ETEY-------------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG--  227 (279)
T ss_pred             ccee-------------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--
Confidence            1100             0011225678999999998899999999999999999998 89999654432222111110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                                       .....+...+..+.+++..||+.||.+||++.++++.|+.+....
T Consensus       228 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         228 -----------------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -----------------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                             000111223457889999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.1e-42  Score=302.74  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=196.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEE-ecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC-DDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~  137 (368)
                      +.+.+.||+|+||.||++...    +..+++|...... ..+.+.+|+.+++.++|+|++++++++ .+.+..++||||+
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~----~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc----CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            446788999999999999753    4567888765443 356788999999999999999999976 4556789999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++++|.+++... ....+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998754 234588999999999999999999999   99999999999999999999999999987432211  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||..............      
T Consensus       157 ----------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------  214 (256)
T cd05082         157 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------  214 (256)
T ss_pred             ----------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------
Confidence                            01124567999999998889999999999999999998 9999975543222211111      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                   ..........+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       215 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         215 -------------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -------------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                         000111123356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.5e-42  Score=307.79  Aligned_cols=263  Identities=20%  Similarity=0.346  Sum_probs=203.0

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCee
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  130 (368)
                      ..+|.+.+.||+|+||.||+|...+.   .....+++|......  .....+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            45667788999999999999976432   235578888765432  2334577899999999999999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEe
Q 017627          131 VLLFEYVPNGTLQEKLHGTPR-------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC  203 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~  203 (368)
                      ++||||+.+++|.+++.....       ...++...+..++.|++.||.|||++   +|+||||||+||+++.++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence            999999999999999974321       23456778889999999999999999   99999999999999999999999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcch
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQ  282 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  282 (368)
                      |||+++..........             .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus       162 Dfg~~~~~~~~~~~~~-------------~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~  228 (288)
T cd05061         162 DFGMTRDIYETDYYRK-------------GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE  228 (288)
T ss_pred             cCCccccccccccccc-------------cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999875432221100             011235678999999998899999999999999999999 78898664433


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      .......                  +... ...+...+..+.+++.+||+.||.+|||+.++++.|++.+.
T Consensus       229 ~~~~~~~------------------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         229 QVLKFVM------------------DGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHHHHHH------------------cCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            2221110                  0000 00111224589999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=310.89  Aligned_cols=246  Identities=26%  Similarity=0.322  Sum_probs=206.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|.|.+|-+|++.-  ++..||||++....   -....+..|+..|+.++|||||++|++..++..+|+|+|
T Consensus        20 YDLekTlG~GHFAVVKLArHVF--TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhc--ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4456779999999999998654  78999999876542   334557789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~~~~~  214 (368)
                      +-.+|+|.+|+..+  ...+.+..+.+++.||+.|+.|+|+.   .+|||||||+||.+. +-|-|||.|||++..+...
T Consensus        98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999864  45789999999999999999999999   999999999999875 6789999999998643322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAS-TKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      .                ...+.||+..|-|||++.|..|+ +++||||||+|||-|++|.+||+..+..           
T Consensus       173 ~----------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------  225 (864)
T KOG4717|consen  173 K----------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------  225 (864)
T ss_pred             c----------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------
Confidence            2                22456899999999999998886 5799999999999999999999877754           


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             ..+..++|-.+  ..+...+.++++||..||..||.+|.|.++|..+
T Consensus       226 -------ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  226 -------ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             -------hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                   22333333322  2345678899999999999999999999999865

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.7e-42  Score=318.47  Aligned_cols=263  Identities=20%  Similarity=0.198  Sum_probs=193.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------C
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------D  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  128 (368)
                      +|.+.+.||+|+||.||+|.+..  ....+++|+....   ......+.+|+.+++.++||||+++++++...      .
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECC--CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            45567889999999999998654  5677888876532   34456678899999999999999999987543      3


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++||||+.+ +|...+.     ..++...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            57999999954 6777664     2378889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      +.......                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+........
T Consensus       174 ~~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  237 (364)
T cd07875         174 RTAGTSFM----------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV  237 (364)
T ss_pred             cccCCCCc----------------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            75322111                01235899999999999999999999999999999999999999776533222111


Q ss_pred             Hhhhhhhhhh-------------------hhcchhhhcCCCC---CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017627          289 GSMLNDIADC-------------------EATKVNELVDPRL---AGDFDLDEARAMLSIAALCLRQSPILRPSATQILH  346 (368)
Q Consensus       289 ~~~~~~~~~~-------------------~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  346 (368)
                      ..........                   .............   ........+..+.+||.+||+.||.+|||+.++|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1110000000                   0000000000000   00011112457899999999999999999999999


Q ss_pred             H
Q 017627          347 T  347 (368)
Q Consensus       347 ~  347 (368)
                      |
T Consensus       318 h  318 (364)
T cd07875         318 H  318 (364)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.8e-42  Score=302.61  Aligned_cols=255  Identities=21%  Similarity=0.323  Sum_probs=192.4

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      .||+|+||.||+|.+.+..+...+++|......  .....+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            589999999999987665566778888665432  334568889999999999999999999999999999999999999


Q ss_pred             HHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          142 LQEKLHGTP--RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       142 L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |.+++....  .....++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.++........  
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~--  156 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY--  156 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence            999987432  123466778889999999999999999   9999999999999999999999999998643222110  


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-------MASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                                 .......|++.|+|||++.+.       .++.++||||||+++|||++ |..||.............  
T Consensus       157 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~--  223 (269)
T cd05087         157 -----------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV--  223 (269)
T ss_pred             -----------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh--
Confidence                       001123478889999998643       35789999999999999997 999997654332211100  


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      .        .......++...    ...+..+.+++..|| .+|.+|||+.+|+..|+
T Consensus       224 ~--------~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         224 R--------EQQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             h--------cccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0        000111111111    122446788999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.2e-42  Score=306.82  Aligned_cols=275  Identities=24%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             HHHHhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--Cee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  130 (368)
                      ..+.+.+.||+|+||.||++.+.  +......+++|.....  ......+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34567788999999999999753  2346778899976533  34456788999999999999999999998765  568


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999998642  24589999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .......            ........++..|+|||++.+..++.++||||||+++|+|++++.|+......... ....
T Consensus       159 ~~~~~~~------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~  225 (284)
T cd05079         159 IETDKEY------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGP  225 (284)
T ss_pred             cccCccc------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hccc
Confidence            4322110            00001234677899999999888999999999999999999987765332111000 0000


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ......  .........+. .........+..+.+|+.+||+.||.+|||+.++++.|+.++
T Consensus       226 ~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         226 THGQMT--VTRLVRVLEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             cccccc--HHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            000000  00000000000 011111234568999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-42  Score=318.25  Aligned_cols=262  Identities=19%  Similarity=0.246  Sum_probs=193.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecC------C
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDR------D  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  128 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|......   .....+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTR--LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECC--CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            45577889999999999998655  66788898765432   2345577899999999999999999987543      3


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..+++++++ +++|..++.    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence            468999988 788988775    34689999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      +......                  ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......
T Consensus       166 ~~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  227 (343)
T cd07878         166 RQADDEM------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR  227 (343)
T ss_pred             eecCCCc------------------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            7532211                  12358999999999977 5688999999999999999999999976553322221


Q ss_pred             HHhhhhhhhhhh-----hcchhhhcCC--CCCC-C---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCE-----ATKVNELVDP--RLAG-D---FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~-----~~~~~~~~~~--~~~~-~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ............     ..........  .... .   .....+..+.+|+.+||+.||.+|||+.++++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111111100000     0000000000  0000 0   000123467899999999999999999999988

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-41  Score=300.97  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=195.0

Q ss_pred             hhcccccceEEEEEEEcCC-CCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEe-cCCeeEEEEeccc
Q 017627           63 QVIGSGGFSNVYLARLIND-STSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCD-DRDEGVLLFEYVP  138 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  138 (368)
                      +.||+|+||.||+|.+.+. .....+++|....  .......+.+|+.+++.++||||+++++++. ..+..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            3589999999999987542 3456788887643  2344567888999999999999999999775 4556899999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++...  ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998743  23467778889999999999999999   99999999999999999999999999987533221100


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                 ........++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..........   .   
T Consensus       156 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---~---  218 (262)
T cd05058         156 -----------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---G---  218 (262)
T ss_pred             -----------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---C---
Confidence                       000112346778999999988899999999999999999999 4666755443222111100   0   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                               ..+.    .+...+..+.+++..||+.+|++||++.++++.|++++.
T Consensus       219 ---------~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 ---------RRLL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ---------CCCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                     0000    111224578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.6e-42  Score=302.23  Aligned_cols=248  Identities=24%  Similarity=0.320  Sum_probs=200.5

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|....  ++..+++|....   .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKA--DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcC--CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            355779999999999998755  566778886543   344567788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998754 345789999999999999999999999   999999999999999999999999999875432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+........   ..   
T Consensus       157 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~---  215 (256)
T cd08529         157 ---------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI---IR---  215 (256)
T ss_pred             ---------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hc---
Confidence                           012245889999999999888999999999999999999999999765532211110   00   


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                              .     .........+..+.+++.+||+.+|++||++.+++++
T Consensus       216 --------~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 --------G-----VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --------C-----CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                    0     0011122345678999999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-41  Score=301.90  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|....    .......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecC--CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4567889999999999998654  566778885543    2234467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||+.+++|.+++.... ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886432 345689999999999999999999999   999999999999999999999999999875332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....               .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+..... ......   
T Consensus       159 ~~~~---------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~---  219 (267)
T cd08229         159 KTTA---------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKK---  219 (267)
T ss_pred             CCcc---------------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhh---
Confidence            2110               012358899999999998889999999999999999999999996543221 111100   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                               +.....+..   .....+..+.+++.+||+.||.+|||+.+|++.++++.
T Consensus       220 ---------~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 ---------IEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---------hhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                     000001111   11234568999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.9e-42  Score=303.19  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCC-CceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDS-TSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +++.+.||+|+||.||+|.+...+ ....+++|+...  .+.....+..|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            457788999999999999876543 245688887654  34456789999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++...  .+.+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          86 FMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             cCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999998753  34689999999999999999999999   99999999999999999999999999987543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ....          .........+..|+|||.+.+..++.++||||+|+++||+++ |..||...+...........   
T Consensus       161 ~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~---  227 (269)
T cd05065         161 SDPT----------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD---  227 (269)
T ss_pred             cccc----------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---
Confidence            1000          000000112457999999999999999999999999999987 99999765443222211100   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                  ..    ...+...+..+.+++..||+.+|.+||++.+++..|++++
T Consensus       228 ------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         228 ------------YR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             ------------Cc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                        00    0111233457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.5e-42  Score=304.34  Aligned_cols=259  Identities=22%  Similarity=0.322  Sum_probs=203.7

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ..+.+.+.||+|+||.||+|.+.+. .....+++|.....  ....+.+.+|+.+++.++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            3455778899999999999987554 34456888876544  3455678899999999999999999999875 567899


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999743  33589999999999999999999999   999999999999999999999999999875433


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ......              ....++..|+|||.+.+..++.++||||||+++|++++ |..||..............  
T Consensus       160 ~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~--  223 (270)
T cd05056         160 ESYYKA--------------SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN--  223 (270)
T ss_pred             ccceec--------------CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--
Confidence            221100              11224568999999988889999999999999999996 9999976553322211110  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                   .....    .+...+..+.+++.+||..+|.+|||+.++++.|+.+..+
T Consensus       224 -------------~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 -------------GERLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -------------CCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                         00000    1123345799999999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.4e-42  Score=303.05  Aligned_cols=258  Identities=22%  Similarity=0.327  Sum_probs=202.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCC-CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDS-TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +.+.+.||+|+||.||+|.+.... ....+++|.....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            456788999999999999865432 3456788865432  3445678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++...  ...+++.++..++.|++.|+.|||++   +++|+||||+|||++.++.++|+|||+++......
T Consensus        86 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          86 YMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999743  34689999999999999999999999   99999999999999999999999999987543211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..            ........++..|+|||.+.+..++.++|+||||+++|++++ |..||...............   
T Consensus       161 ~~------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---  225 (267)
T cd05066         161 EA------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG---  225 (267)
T ss_pred             ce------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---
Confidence            10            000011123567999999998899999999999999999887 99999765433222111110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                  ...    ......+..+.+++.+||+.+|.+|||+.++++.|++++
T Consensus       226 ------------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         226 ------------YRL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             ------------CcC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence                        000    111223457899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.4e-42  Score=311.22  Aligned_cols=273  Identities=19%  Similarity=0.214  Sum_probs=197.4

Q ss_pred             hhhhcccc--cceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           61 FSQVIGSG--GFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        61 ~~~~iG~G--~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +.++||+|  +||+||++....  ++..+|+|.....   ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP--TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecc--cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            45779999  788999998655  7788999976543   3455678889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++++||+.+.......
T Consensus        80 ~~~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          80 FMAYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             ccCCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            99999999998643 234589999999999999999999999   99999999999999999999999998654322111


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT-SLAGSML  292 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~  292 (368)
                      ....      ....  ......++..|+|||++.+  ..++.++|||||||++|+|++|..||......... .......
T Consensus       156 ~~~~------~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  227 (327)
T cd08227         156 QRLR------VVHD--FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  227 (327)
T ss_pred             cccc------cccc--ccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCc
Confidence            0000      0000  0011246778999999976  46889999999999999999999999754432211 1111111


Q ss_pred             hhhhhhhhcchhh-------------------------hcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNE-------------------------LVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +...+.......+                         ..............+..+.+|+..||+.||++|||+.++++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0000000000000                         000000011222345689999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-41  Score=306.61  Aligned_cols=265  Identities=22%  Similarity=0.348  Sum_probs=201.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcC--------------CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN--------------DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLI  121 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~--------------~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~  121 (368)
                      .+.+.+.||+|+||.||++.+.+              ......+++|+....  ....+.+.+|+.+++.++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            35677889999999999986432              223456888877643  34456788999999999999999999


Q ss_pred             EEEecCCeeEEEEecccCCCHHHHhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPR--------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       122 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      +++...+..++||||+.+++|.+++.....        ...+++.++..++.|++.||.|||++   +++|+||||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nil  162 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEE
Confidence            999999999999999999999999875321        13477889999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh--
Q 017627          194 LEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT--  271 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--  271 (368)
                      ++.++.++|+|||+++.........             ......+++.|+|||+..+..++.++|||||||++|||++  
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~  229 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYR-------------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC  229 (296)
T ss_pred             EcCCCCEEeccCcccccccCCccee-------------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence            9999999999999987543221100             0011235678999999888889999999999999999998  


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      |..||..................       .......+     .+..++..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         230 KEQPYSQLSDEQVIENTGEFFRD-------QGRQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CCCCccccChHHHHHHHHHHHhh-------ccccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            77888655433222111111000       00000001     111234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.5e-42  Score=306.79  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+.+.+.||+|+||.||+|.+..   ......+++|+....  ......+.+|+.+++.++||||+++++++.+++..++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL   85 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence            34567789999999999998643   235677889976543  3445678899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          133 LFEYVPNGTLQEKLHGTP-------------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      ||||+++++|.+++....                   ....+++..++.++.|++.||.|||++   +++||||||+||+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil  162 (288)
T cd05050          86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL  162 (288)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence            999999999999986321                   113478889999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-C
Q 017627          194 LEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-G  272 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g  272 (368)
                      ++.++.++|+|||+++..........             .....++..|+|||.+.+..++.++|||||||++|+|++ |
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKA-------------SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             ecCCCceEECccccceecccCccccc-------------cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence            99999999999999875432221100             011224567999999998999999999999999999998 8


Q ss_pred             CCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          273 MEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      ..||.+............                  ... ...+...+..+.+|+.+||+.+|.+|||+.++++.|++
T Consensus       230 ~~p~~~~~~~~~~~~~~~------------------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         230 MQPYYGMAHEEVIYYVRD------------------GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCCCCHHHHHHHHhc------------------CCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            888865543322111100                  000 00112234678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.5e-42  Score=313.18  Aligned_cols=267  Identities=24%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             HHHHHHHhhhhcccccceEEEEEEEcCC-----CCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEe
Q 017627           54 VERFTQNFSQVIGSGGFSNVYLARLIND-----STSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCD  125 (368)
Q Consensus        54 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  125 (368)
                      +...++.+++.||+|+||.||+|.+.+.     .....+++|+....  ....+.+.+|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            3445677889999999999999986432     12346788876543  34456788999999999 7999999999999


Q ss_pred             cCCeeEEEEecccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCe
Q 017627          126 DRDEGVLLFEYVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNI  192 (368)
Q Consensus       126 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Ni  192 (368)
                      ..+..+++|||+++++|.+++....             ....+++..+..++.|++.||.|||++   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            9999999999999999999987532             123578889999999999999999999   999999999999


Q ss_pred             eecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-
Q 017627          193 LLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-  271 (368)
Q Consensus       193 lv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-  271 (368)
                      |++.++.+||+|||+++.........             ......++..|+|||++.+..++.++||||||+++|||++ 
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  232 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYK-------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL  232 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccc-------------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence            99999999999999987543221100             0011224567999999999999999999999999999998 


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      |..||...+..........                   ......+...+..+.+++..||+.+|.+|||+.+++++|+++
T Consensus       233 g~~p~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         233 GGSPYPGIPVEELFKLLKE-------------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             CCCCCCCCCHHHHHHHHHc-------------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            8899976543332221111                   000011122345788999999999999999999999999988


Q ss_pred             cccc
Q 017627          352 ISSI  355 (368)
Q Consensus       352 ~~~~  355 (368)
                      ....
T Consensus       294 ~~~~  297 (334)
T cd05100         294 LTVT  297 (334)
T ss_pred             hhhc
Confidence            7544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.1e-42  Score=301.96  Aligned_cols=249  Identities=26%  Similarity=0.365  Sum_probs=199.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||++.+..  +...+++|....  .....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVN--SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcC--CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            3467889999999999998755  567788887543  234456788899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|.+++... .+..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          80 CDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            9999999988643 345688999999999999999999999   999999999999999999999999999875332111


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      .               .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..........   .  
T Consensus       156 ~---------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~--  215 (255)
T cd08219         156 Y---------------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ---G--  215 (255)
T ss_pred             c---------------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---C--
Confidence            0               0124588999999999998999999999999999999999999976543222111100   0  


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                           .         ....+...+..+.+|+.+||+.||.+|||+.+++..
T Consensus       216 -----~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 -----S---------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----C---------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 0         001122334578999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-41  Score=301.50  Aligned_cols=255  Identities=20%  Similarity=0.330  Sum_probs=190.5

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      .||+|+||.||+|..........+++|.....  ......+.+|+.+++.++||||+++++.+.+.+..++||||+.+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999998655555667888865433  3344567889999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          142 LQEKLHGTPR--SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       142 L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |.+++.....  ....++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI-  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence            9999875421  23356788889999999999999999   99999999999999999999999999986432211100 


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-------GMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                                  ......++..|+|||++..       ..++.++|||||||++|||++ |..||............   
T Consensus       158 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---  222 (269)
T cd05042         158 ------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV---  222 (269)
T ss_pred             ------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---
Confidence                        0012235678999998743       356789999999999999999 78888655432211100   


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      ..       ........+.    .....+..+.+++..|| .||.+|||+++|++.|.
T Consensus       223 ~~-------~~~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         223 VR-------EQDIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             hh-------ccCccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            00       0000111111    12233456778899998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.8e-42  Score=307.10  Aligned_cols=267  Identities=22%  Similarity=0.216  Sum_probs=196.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|....  ++..+++|.....   ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKK--TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             eEeeEecccCceEEEEEEECC--CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            456789999999999998754  5677888875432   22345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. ++|.+++.....+..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            96 68888887554456789999999999999999999999   999999999999999999999999999874322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......+++.|+|||++.+. .++.++||||||+++|+|++|++||...................
T Consensus       157 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd07861         157 ---------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP  221 (285)
T ss_pred             ---------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                           00112478899999998764 57889999999999999999999997654322211111110000


Q ss_pred             hhhhhc---c---hhhhcCCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEAT---K---VNELVDPRLA---GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~---~---~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....+.   .   .....+....   .......+.++.++|.+||..||.+|||+.+++.|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000   0   0000000000   00011235678899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-42  Score=302.09  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +..+.+.+.||+|+||.||+|.+.+   ...+++|.........+.+.+|+.+++.++|+||+++++++......++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~---~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG---TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC---CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3445577889999999999998643   3567888877665556778999999999999999999999998889999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++... .+..+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999999754 335689999999999999999999999   99999999999999999999999999987543211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..              ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.............   
T Consensus       158 ~~--------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---  220 (261)
T cd05034         158 YT--------------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---  220 (261)
T ss_pred             hh--------------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence            00              0011224568999999998889999999999999999999 99999665432222111100   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                  ...    ..+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       221 ------------~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 ------------YRM----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------------CCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                        000    0111224578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.7e-42  Score=304.57  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=194.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ++.+.||+|+||.||+|.+..  +...+++|+....  ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLL--TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcC--CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            466789999999999998654  5677899876543  344567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++++|..+.       .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++.......  
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            999986542       367888999999999999999999   99999999999999999999999999987432111  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                     .....|+..|+|||++.+..++.++|+||||+++|+|++|..||................     
T Consensus       150 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----  209 (279)
T cd06619         150 ---------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-----  209 (279)
T ss_pred             ---------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-----
Confidence                           012458999999999999899999999999999999999999996533211100000000     


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                            ....++..........+.++.+++.+||+.||.+||++.++++|.
T Consensus       210 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         210 ------QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             ------HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence                  000000000001112345789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-41  Score=300.55  Aligned_cols=242  Identities=24%  Similarity=0.337  Sum_probs=187.9

Q ss_pred             hhcccccceEEEEEEEcCC----------CCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           63 QVIGSGGFSNVYLARLIND----------STSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~----------~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      +.||+|+||.||+|....+          .....+++|+.... ......+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            3589999999999975321          12345777765543 334457888999999999999999999999888999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc-------eEEee
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN-------CKLCD  204 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~-------vkl~D  204 (368)
                      +||||+.+++|..++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988864  235689999999999999999999999   9999999999999987654       89999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCcch
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELV-TGMEAFCPENGQ  282 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~  282 (368)
                      ||++......                   ....++..|+|||++. +..++.++|||||||++|+|+ +|..||......
T Consensus       156 ~g~~~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  216 (262)
T cd05077         156 PGIPITVLSR-------------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA  216 (262)
T ss_pred             CCCCccccCc-------------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh
Confidence            9998643211                   1134788899999987 467899999999999999998 588888654322


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      ........           .        ..  .....+.++.+|+..||+.||.+||++.+|+++|+
T Consensus       217 ~~~~~~~~-----------~--------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         217 EKERFYEG-----------Q--------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHHHHhc-----------C--------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            11110000           0        00  00112357889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.4e-41  Score=302.14  Aligned_cols=251  Identities=25%  Similarity=0.308  Sum_probs=198.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |++.+.||+|+||.||+|.+..  +...+++|..... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE--TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC--CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            5577889999999999998754  5667788876543 445667889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++..  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            99999888764  235689999999999999999999999   999999999999999999999999999864322110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                                    ......|++.|+|||++.     +..++.++||||+||++|+|++|.+||...+........... 
T Consensus       159 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-  223 (282)
T cd06643         159 --------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-  223 (282)
T ss_pred             --------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-
Confidence                          011235889999999984     345778999999999999999999999765432111111000 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                    ..+..  ..+...+..+.+||..||+.||.+|||+.++++|-
T Consensus       224 --------------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         224 --------------EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             --------------CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                          00000  11122346789999999999999999999998774

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-41  Score=299.68  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=199.7

Q ss_pred             hhcccccceEEEEEEEcC-CCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           63 QVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      +.||+|++|.||+|.+.. +.....+++|......  ...+.+.+|+.+++.++||||+++++++.. ...++||||+.+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            358999999999999765 3334568888766543  356788899999999999999999999988 889999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++..... ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++........  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--  153 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--  153 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc--
Confidence            999999975422 5689999999999999999999999   9999999999999999999999999999764322110  


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+............      
T Consensus       154 ----------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------  217 (257)
T cd05040         154 ----------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------  217 (257)
T ss_pred             ----------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------
Confidence                      000012346788999999998899999999999999999999 999997654433222111100      


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                                  .....+...+..+.+++..||+.+|.+|||+.++++.|.
T Consensus       218 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ------------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ------------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                        000011123457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=312.02  Aligned_cols=272  Identities=23%  Similarity=0.334  Sum_probs=220.2

Q ss_pred             cCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEec
Q 017627           49 YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDD  126 (368)
Q Consensus        49 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  126 (368)
                      -...|+-+....++++||+|.||.|.++...   ....||+|+.+..  ....+.|.+|+++|.+|+|||||.++|+|..
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeve---g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVE---GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEEec---CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            3455666666668999999999999999863   3688999987764  3556889999999999999999999999999


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      ++.+++|+|||.+|+|..|+..+... .+.-.....|+.||++|++||.+.   ++|||||.+.|+|++.++++||+|||
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence            99999999999999999999876322 244555667999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcchhh
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT--GMEAFCPENGQLL  284 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~  284 (368)
                      +++..++...+.-.             ...+-..+|||||.+..+.+++++|+|+||+++||+++  ...||.....+..
T Consensus       683 msR~lysg~yy~vq-------------gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v  749 (807)
T KOG1094|consen  683 MSRNLYSGDYYRVQ-------------GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV  749 (807)
T ss_pred             cccccccCCceeee-------------cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence            99977665543321             22345679999999999999999999999999999876  6789977666655


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      .+.....+.+..      ..      .....+.-++..+.+++..||+.+-.+|||++++..+|.+..
T Consensus       750 ven~~~~~~~~~------~~------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  750 VENAGEFFRDQG------RQ------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             HHhhhhhcCCCC------cc------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            554444443311      11      111223455678999999999999999999999999998753

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-41  Score=304.12  Aligned_cols=261  Identities=23%  Similarity=0.292  Sum_probs=201.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ..+++.+.||+|+||+||++....  .+..+++|+....  ......+.+|+++++.++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIP--TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcC--CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            455678899999999999998754  5677888865433  445678889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|..++.   ..+.+++..+..++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999887   3456899999999999999999999732  8999999999999999999999999998643211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                 ....|+..|+|||++.+..++.++|||||||++|++++|..||................. 
T Consensus       158 ~~-----------------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-  219 (284)
T cd06620         158 IA-----------------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-  219 (284)
T ss_pred             cc-----------------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-
Confidence            10                 123589999999999888899999999999999999999999976543211000000000 


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                            ...................+..+.+|+..||+.||.+|||+.+++++.
T Consensus       220 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         220 ------DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ------HHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                  000011110000001112456789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=294.41  Aligned_cols=259  Identities=25%  Similarity=0.325  Sum_probs=207.9

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.++||+|.||+|-+++-+  .++..+|+|+....     ++. .--..|-.+|+..+||.+..+...|...+.+|+||
T Consensus       171 dfLKvLGkGTFGKVIL~rEK--at~k~YAiKIlkKeviiakdEV-AHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREK--ATGKLYAIKILKKEVIIAKDEV-AHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             hHHHHhcCCccceEEEEeec--ccCceeehhhhhhhheeehHHh-hhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            37889999999999999854  48889999976543     222 23346889999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||..||.|.-.|.   +...+++.....+-..|+.||.|||++   +||+||||.+|+|+|++|++||+|||+++-    
T Consensus       248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE----  317 (516)
T KOG0690|consen  248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE----  317 (516)
T ss_pred             EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh----
Confidence            9999999988887   556789999999999999999999999   999999999999999999999999999983    


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                 .........+.||||.|+|||++....|+.++|.|.+|+++|||++|+.||...+...+...+--  .+
T Consensus       318 -----------~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--ed  384 (516)
T KOG0690|consen  318 -----------EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--ED  384 (516)
T ss_pred             -----------cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh--hh
Confidence                       23333444678999999999999999999999999999999999999999987665433322211  00


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH--------HhcccccccccCC
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHTI--------KHQISSISFLFSP  361 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~L--------~~~~~~~~~~~~~  361 (368)
                                        -.++...++++..|+..+|..||.+|.     .+.+|.+|-        .-..+++..|++|
T Consensus       385 ------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKP  446 (516)
T KOG0690|consen  385 ------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKP  446 (516)
T ss_pred             ------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCC
Confidence                              123445566899999999999999995     345554441        1123455666666


Q ss_pred             C
Q 017627          362 Q  362 (368)
Q Consensus       362 ~  362 (368)
                      +
T Consensus       447 q  447 (516)
T KOG0690|consen  447 Q  447 (516)
T ss_pred             C
Confidence            4

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=313.49  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=194.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+++...  +...+|+|+....    ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKN--TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4467889999999999998755  5678899986532    233456788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999864  245689999999999999999999999   9999999999999999999999999998643221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ...              ......||+.|+|||++.+     ..++.++||||+||++|+|++|..||...+......   
T Consensus       156 ~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---  218 (331)
T cd05597         156 GTV--------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---  218 (331)
T ss_pred             CCc--------------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH---
Confidence            110              0112459999999999863     457889999999999999999999997654322111   


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCC--CCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP--ILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP--~~Rpt~~~il~~  347 (368)
                      .....         .....  .. ......+..+.+++.+||..++  ..||++.++++|
T Consensus       219 ~i~~~---------~~~~~--~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         219 KIMNH---------KEHFQ--FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHcC---------CCccc--CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11000         00000  00 0011245678899999886533  347899999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-43  Score=319.45  Aligned_cols=243  Identities=24%  Similarity=0.357  Sum_probs=194.9

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEE---Ee--ecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe--eEEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAI---KI--HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE--GVLL  133 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~ai---k~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv  133 (368)
                      +.++||+|+|-+||+|.+..  ++..||-   |+  +..++...++|..|+.+|+.|+||||+++|.+|.+...  ..+|
T Consensus        44 ~~evLGrGafKtVYka~De~--~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEE--EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             hhhhcccccceeeeeccccc--cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            56679999999999998744  4555443   32  23445667899999999999999999999999987665  7789


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceEEeeccccccCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~~~  212 (368)
                      +|++..|+|..|++   +.+.++...+..|++||++||.|||++ .+.|||||||-+||||+ ..|.|||+|+|+|....
T Consensus       122 TEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  122 TELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            99999999999998   556788999999999999999999998 56899999999999998 55999999999998643


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc-chhhHH-HHHh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN-GQLLTS-LAGS  290 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~-~~~~  290 (368)
                      ....                 ..++|||.|||||... ..|+..+||||||++++||+|+..||..-. ....++ ....
T Consensus       198 ~s~a-----------------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG  259 (632)
T KOG0584|consen  198 KSHA-----------------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG  259 (632)
T ss_pred             cccc-----------------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC
Confidence            3321                 2368999999999988 889999999999999999999999996422 222222 2211


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+       ..+...-            ..++++||..||.. ..+|||+.++|++
T Consensus       260 iKP-------~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  260 IKP-------AALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CCH-------HHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            111       1222222            23789999999999 9999999999976

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-41  Score=300.63  Aligned_cols=252  Identities=26%  Similarity=0.369  Sum_probs=197.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+.+.||+|+||.||+|....  +...+++|+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVN--TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcC--CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            45577889999999999998755  56778888765442 3345677899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++.   ..+.+++.+++.++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999999987   345789999999999999999999999   999999999999999999999999999864322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                                     ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||.............    
T Consensus       162 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~----  222 (267)
T cd06645         162 ---------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT----  222 (267)
T ss_pred             ---------------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh----
Confidence                           012235899999999984   4567889999999999999999999986543211110000    


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               ......+....  ....+..+.+++.+||+.+|++|||++++++|
T Consensus       223 ---------~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         223 ---------KSNFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ---------ccCCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                     00000111110  01234578899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=317.11  Aligned_cols=241  Identities=24%  Similarity=0.303  Sum_probs=187.7

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcC---CCCceeeeeEEEecCCeeEEEEecc
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHL---SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ||+|+||+||+|++..  ++..+|+|+.....    .....+..|..++..+   .||||+++++++.+.+..++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKD--TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECC--CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            7999999999998654  67788999765322    1223344566666655   6999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.++|+|||+++....... 
T Consensus        79 ~~g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-  151 (330)
T cd05586          79 SGGELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-  151 (330)
T ss_pred             CCChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence            9999998887   456789999999999999999999999   999999999999999999999999999864222110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                    .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..........      
T Consensus       152 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~------  211 (330)
T cd05586         152 --------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF------  211 (330)
T ss_pred             --------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc------
Confidence                          01234699999999999764 578999999999999999999999976554322211110      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP----SATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~~il~~  347 (368)
                          .      ...+..   ...+..+.+++..||+.||.+||    ++.++++|
T Consensus       212 ----~------~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         212 ----G------KVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ----C------CCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                0      000000   11345788999999999999998    67787775

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-41  Score=304.72  Aligned_cols=273  Identities=28%  Similarity=0.380  Sum_probs=198.7

Q ss_pred             HHhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  133 (368)
                      +.+.+.||+|+||.||++...  +......+++|..... ....+.+.+|+++++.++||||+++++++..  ....++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            446778999999999999753  3446778889876544 3445678899999999999999999998753  3468999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          86 MEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            9999999999998642  34589999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ......            ......++..|+|||++.+..++.++||||||+++|||++|..|+........ ........
T Consensus       161 ~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~  227 (284)
T cd05081         161 DKEYYK------------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQ  227 (284)
T ss_pred             CCccee------------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccc
Confidence            211000            00011234569999999988999999999999999999998877643321110 00000000


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      .  ......+.+.+............+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       228 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         228 G--QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             c--ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0  0000001111111111111223456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.5e-42  Score=305.08  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=196.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEec------CCee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDD------RDEG  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~  130 (368)
                      .|.+.+.||.|+||.||+|.+..  ....+++|+..........+..|+.+++.+ +|+||+++++++..      .+..
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcC--CCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            45567889999999999999755  667899998776665566788899999999 69999999999853      4578


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      +++|||+.+++|.+++... ....+++..++.++.|++.|+.|||+.   +|+|+||+|+||+++.++.++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            9999999999999988754 345688989999999999999999999   999999999999999999999999999874


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      ......               ......|++.|+|||.+.     +..++.++|+||||+++|+|++|..||.........
T Consensus       171 ~~~~~~---------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         171 LDRTVG---------------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             hhcccc---------------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            321110               012245899999999986     346788999999999999999999999654321110


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..               ......+..   .....+..+.+||..||+.||.+|||+.+|++|
T Consensus       236 ~~---------------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         236 FL---------------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hh---------------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            00               000000111   112345689999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-41  Score=300.67  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=201.4

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +.++.+.+.||+|+||.||++.+..   ...+++|...........+.+|+++++.++|+||+++++++.+ ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC---CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            3455678899999999999997543   3457888776655556778899999999999999999999887 77899999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999998753 345678889999999999999999998   99999999999999999999999999987533211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...              .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...............   
T Consensus       157 ~~~--------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---  219 (260)
T cd05073         157 YTA--------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---  219 (260)
T ss_pred             ccc--------------ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---
Confidence            100              011235677999999998889999999999999999999 99999765433222211110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                      .........+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       220 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 ----------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----------------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                            0001112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-42  Score=322.77  Aligned_cols=263  Identities=19%  Similarity=0.223  Sum_probs=191.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      |.+.+.||+|+||.||+|.+..  ....+++|....     ..+.+|+.+++.|+|+|||++++++...+..++|||++ 
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~--~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-  242 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPD--YPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-  242 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECC--CCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence            4556789999999999998755  567888885322     23568999999999999999999999999999999999 


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      .++|..++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       243 ~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-  316 (461)
T PHA03211        243 RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST-  316 (461)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence            46888887642  34689999999999999999999999   9999999999999999999999999999753221110 


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc-c-------hhhHHHHHh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN-G-------QLLTSLAGS  290 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~-------~~~~~~~~~  290 (368)
                                  .......||+.|+|||++.+..++.++|||||||++|||++|..|+.... .       ......+..
T Consensus       317 ------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~  384 (461)
T PHA03211        317 ------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ  384 (461)
T ss_pred             ------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHh
Confidence                        00012469999999999999999999999999999999999876653322 1       111111111


Q ss_pred             hhhhhhhhh---hcchh-hh-------cCCCCCC-CCC--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCE---ATKVN-EL-------VDPRLAG-DFD--LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~---~~~~~-~~-------~~~~~~~-~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........   ...+. .+       ..+.... .+.  ...+..+.+||.+||+.||.+|||+.|+|+|
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            100000000   00000 00       0000000 000  0223478899999999999999999999987

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.4e-42  Score=307.99  Aligned_cols=266  Identities=23%  Similarity=0.257  Sum_probs=197.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|.+..  +...+++|.....  ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKL--TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcC--CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            4466789999999999998654  5677888876432  22334577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. ++|..++...  ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            96 5888887642  34688999999999999999999999   999999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+...............
T Consensus       160 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~  224 (301)
T cd07873         160 ---------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP  224 (301)
T ss_pred             ---------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence                           00123478899999998764 57889999999999999999999998765433332222222111


Q ss_pred             hhhhhcch------hhhcCCCCCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKV------NELVDPRLAGDF----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~------~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....+...      .....+.....+    ....+..+.+||.+||+.||.+|||++++++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11100000      000001111110    11234578899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-41  Score=301.31  Aligned_cols=247  Identities=24%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|...+.||+|+||.||+|.+..  .+..+++|+....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR--TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC--CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            45567789999999999998654  5677889976532  3445678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++..    ..+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999998852    4688999999999999999999999   99999999999999999999999999987533211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .               ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............       
T Consensus       156 ~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------  213 (277)
T cd06642         156 I---------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-------  213 (277)
T ss_pred             h---------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-------
Confidence            0               011235788999999999988999999999999999999999998654322111100       


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                              .....+    ......+..+.+++..||+.+|.+|||+.++++|
T Consensus       214 --------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         214 --------PKNSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --------hcCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                    000011    1122345678999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.9e-41  Score=297.56  Aligned_cols=258  Identities=23%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|....    .......+.+|+++++.++|+||+++++++...+..++||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLL--DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcC--CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4467789999999999998764  566788886542    2233567889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||+++++|..++.... ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 345689999999999999999999999   999999999999999999999999999875332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....               .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ........ 
T Consensus       159 ~~~~---------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-  221 (267)
T cd08224         159 KTTA---------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE-  221 (267)
T ss_pred             CCcc---------------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHHHhhhh-
Confidence            2110               012358889999999998889999999999999999999999996543211 11110000 


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                    ............+..+.++|.+||..+|.+|||+.+|++.|+++.
T Consensus       222 --------------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 --------------KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --------------cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                          000000011134567899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-41  Score=302.68  Aligned_cols=252  Identities=24%  Similarity=0.364  Sum_probs=198.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +++.+.||+|+||.||+|.+..  .+..+++|....  .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRP--TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            4578889999999999998754  567788886543  334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|..++........+++..+..++.|++.||.|||+.+  +|+|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            999999998875323447899999999999999999999632  899999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG------MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                                       ....|++.|+|||.+.+.      .++.++|+|||||++|+|++|..||..............
T Consensus       159 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  221 (286)
T cd06622         159 -----------------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA  221 (286)
T ss_pred             -----------------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH
Confidence                             113478899999998654      347899999999999999999999965443222111111


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .               ... .....+...+.++.+|+.+||+.+|.+||++.+++.|
T Consensus       222 ~---------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         222 I---------------VDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             H---------------hhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0               000 0111223356788999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4e-41  Score=295.34  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=194.6

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      +.||+|+||.||+|...   ....+++|+....  ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK---DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec---CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            35899999999999753   3567788876543  334456889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++...  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..........  
T Consensus        78 ~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--  150 (250)
T cd05085          78 DFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--  150 (250)
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc--
Confidence            999988643  34578999999999999999999999   99999999999999999999999999986432211100  


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                  .....++..|+|||++.+..++.++||||||+++|++++ |..||..............         
T Consensus       151 ------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~---------  209 (250)
T cd05085         151 ------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK---------  209 (250)
T ss_pred             ------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---------
Confidence                        011124567999999998889999999999999999998 9999976543322111110         


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                                ......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       210 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         210 ----------GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ----------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                      0000111223568999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.4e-41  Score=302.03  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=197.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|++.+.||.|+||.||+|....  ++..+++|+.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECC--CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            45578889999999999998755  5677888876544 34567788899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|..++...  ...+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            9999998877542  34689999999999999999999999   99999999999999999999999999886422211 


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                                    .......+++.|+|||.+.     ...++.++|+|||||++|+|++|..||...+........   
T Consensus       165 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---  227 (292)
T cd06644         165 --------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---  227 (292)
T ss_pred             --------------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---
Confidence                          1112345889999999984     345688999999999999999999999664432111100   


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .            ....+.  ...+...+.++.+++..||..||++||+++++++|
T Consensus       228 ~------------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         228 A------------KSEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             h------------cCCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0            000000  01122334578899999999999999999999876

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.8e-41  Score=297.78  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=200.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|...+.||.|+||.||+|.+..  ....+++|+....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc--CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            34466789999999999998654  5678889876543  3445678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++..    ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999998863    3588999999999999999999999   99999999999999999999999999987533211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .               ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............       
T Consensus       156 ~---------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------  213 (277)
T cd06640         156 I---------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------  213 (277)
T ss_pred             c---------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------
Confidence            1               001235788999999999888999999999999999999999999654432111100       


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ............+..+.+++..||+.+|.+||++.++++|
T Consensus       214 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 ------------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ------------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                        0111122334556789999999999999999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.9e-41  Score=296.30  Aligned_cols=255  Identities=20%  Similarity=0.324  Sum_probs=190.7

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      .||+|+||.||+|..........+++|.....  ....+.+.+|+.+++.++||||+++++.+.+....++||||+.+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            58999999999998665555556667755433  3445678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          142 LQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       142 L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      |.+++.... .....+...+..++.|++.||.|||++   +++||||||+|||++.++.++|+|||++.........   
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---  155 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---  155 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh---
Confidence            999987542 234567778889999999999999999   9999999999999999999999999997632211110   


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRT-------GMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                                .......|+..|+|||++..       ..++.++||||||+++|||++ |..||..........   ...
T Consensus       156 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~  222 (268)
T cd05086         156 ----------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN---HVI  222 (268)
T ss_pred             ----------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHH
Confidence                      00112457889999998853       245788999999999999997 577886544322111   111


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      .       .......++.....    .+..+.+++..|| .+|.+|||+.++++.|.
T Consensus       223 ~-------~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         223 K-------DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             h-------hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            0       11111222222222    3356788999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-41  Score=300.98  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=198.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  129 (368)
                      .++..||+|+||.||+|.+..  ....+++|......          ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNAS--SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             cccceeecCCCeEEEEEEecC--CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            456789999999999998654  56678888654321          233568899999999999999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999973   45688999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ..........         .........|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+......   
T Consensus       155 ~~~~~~~~~~---------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---  222 (267)
T cd06628         155 KLEANSLSTK---------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF---  222 (267)
T ss_pred             ccccccccCC---------ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH---
Confidence            6542211100         0011122358899999999998889999999999999999999999997654321110   


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  .......+.    .+...+..+.+++.+||+.||.+||++.++++|
T Consensus       223 ------------~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         223 ------------KIGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ------------HHhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                        000011111    122345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=306.05  Aligned_cols=265  Identities=22%  Similarity=0.247  Sum_probs=202.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||.||+|...+  +...+++|......    ...+.+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcC--CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3456789999999999998765  56788998765432    24466888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++... .+..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999998743 346789999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCCCCCCCCCC--------------CccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          215 AVLPPSPSPSP--------------SRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       215 ~~~~~~~~~~~--------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      ...........              ............||..|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11100000000              0000011123468999999999999889999999999999999999999997655


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS----ATQILHT  347 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~~il~~  347 (368)
                      ......                  ...............+..+.+++.+||..||++|||    ++++++|
T Consensus       237 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDETFS------------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHHHHH------------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            321111                  001111110111114678999999999999999999    9999986

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9e-42  Score=336.93  Aligned_cols=254  Identities=25%  Similarity=0.317  Sum_probs=194.5

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~  131 (368)
                      ..|.+.+.||+|+||+||+|.+..  ....+++|+...   .......+..|+.+++.|+|||||+++++|..  ...++
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~--tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKR--TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC--CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            345677889999999999999765  667788887653   33455678899999999999999999998854  35689


Q ss_pred             EEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEEecCCCCCeeecC----------
Q 017627          132 LLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCT----LHIVHGDIKASNILLEE----------  196 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~Dikp~Nilv~~----------  196 (368)
                      +||||+.+++|..++.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999887432 23579999999999999999999998520    15999999999999964          


Q ss_pred             -------CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHH
Q 017627          197 -------HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILL  267 (368)
Q Consensus       197 -------~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~  267 (368)
                             .+.+||+|||++........                .....||+.|+|||++.+  ..++.++|||||||++|
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~----------------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY  234 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM----------------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY  234 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc----------------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence                   34589999999975322111                012469999999999864  45889999999999999


Q ss_pred             HHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          268 ELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       268 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +|++|..||........  ........              +.+.   ....+.++.+||..||+.+|.+|||+.++|.+
T Consensus       235 ELLTGk~PF~~~~~~~q--li~~lk~~--------------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        235 ELCSGKTPFHKANNFSQ--LISELKRG--------------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHCCCCCCcCCcHHH--HHHHHhcC--------------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            99999999975443211  11110000              0000   01224578999999999999999999999965

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.4e-42  Score=312.06  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=194.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+++...  +...+++|+....    ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            3466789999999999998755  5678888876432    223345788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+|+|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999742  35689999999999999999999999   9999999999999999999999999998643221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ...              ......||+.|+|||++.     ...++.++|||||||++|||++|..||...+.......+ 
T Consensus       156 ~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i-  220 (332)
T cd05623         156 GTV--------------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-  220 (332)
T ss_pred             Ccc--------------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH-
Confidence            110              011246999999999986     346788999999999999999999999765432221111 


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI--LRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~--~Rpt~~~il~~  347 (368)
                        ...       . ..   .... ......+..+.+|+..||..++.  .|++++++++|
T Consensus       221 --~~~-------~-~~---~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         221 --MNH-------K-ER---FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --hCC-------C-cc---ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              100       0 00   0000 01123456789999998865444  47899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.3e-41  Score=304.40  Aligned_cols=249  Identities=23%  Similarity=0.300  Sum_probs=197.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +|.+.+.||+|+||.||+|....  .+..+++|..... ....+.+.+|+.+++.+.|+||+++++.+......++||||
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECC--CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            34456789999999999998644  5667888865543 23346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++..    ..+++.++..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999999863    3578899999999999999999999   999999999999999999999999999874321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.............       
T Consensus       172 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~-------  229 (296)
T cd06654         172 ---------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------  229 (296)
T ss_pred             ---------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh-------
Confidence                           0012358899999999998889999999999999999999999997654321110000       


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                .........+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       230 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         230 ----------TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ----------cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                      00000001122344678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=318.29  Aligned_cols=250  Identities=25%  Similarity=0.320  Sum_probs=200.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeec-CChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV-GSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +++...||.|+||+||+|..+.  +....|-|++. .+......+.-|++||..+.||+||++++.|...+.++|+.|||
T Consensus        34 WeIiGELGDGAFGKVyKA~nke--t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKE--TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhccc--chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            4456669999999999998653  45555556443 44556677888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .||....++..  -+..+.+.++..+++|++.||.|||++   +|||||||..|||++-+|.++|+|||.+-...     
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-----  181 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-----  181 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-----
Confidence            99999887764  356799999999999999999999999   99999999999999999999999999874311     


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                                ....+.....|||+|||||++.     ..+|+.++||||||++|.||..+.+|-...+.....-.+.+  
T Consensus       182 ----------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK--  249 (1187)
T KOG0579|consen  182 ----------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--  249 (1187)
T ss_pred             ----------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh--
Confidence                      1222234568999999999874     45899999999999999999999999765544322111111  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   .-.|  ..-.+..++..+.+|+..||..||..||+++++++|
T Consensus       250 -------------SePP--TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  250 -------------SEPP--TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -------------cCCC--cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                         0011  112345677889999999999999999999999988

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3e-41  Score=299.40  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=196.8

Q ss_pred             hcccccceEEEEEEEcCC----CCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           64 VIGSGGFSNVYLARLIND----STSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~----~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .||+|+||.||+|...+.    .....+++|......  .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            589999999999987542    133567888654432  34567889999999999999999999999989999999999


Q ss_pred             cCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-----ceEEeecccc
Q 017627          138 PNGTLQEKLHGTP----RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-----NCKLCDFGSA  208 (368)
Q Consensus       138 ~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-----~vkl~Dfg~s  208 (368)
                      ++++|.+++....    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999986431    123478899999999999999999999   999999999999999877     8999999998


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  287 (368)
                      +..........             .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......
T Consensus       159 ~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~  225 (269)
T cd05044         159 RDIYKSDYYRK-------------EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH  225 (269)
T ss_pred             ccccccccccc-------------CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence            75432221110             011235778999999999999999999999999999998 9999965543222111


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      ..                   .......+...+..+.+++.+||..+|.+||++.++++.|++
T Consensus       226 ~~-------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         226 VT-------------------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             Hh-------------------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            10                   000011122345688999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.9e-41  Score=298.82  Aligned_cols=241  Identities=25%  Similarity=0.390  Sum_probs=186.4

Q ss_pred             hcccccceEEEEEEEcC----------------------CCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCCCCceeee
Q 017627           64 VIGSGGFSNVYLARLIN----------------------DSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKL  120 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~----------------------~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~  120 (368)
                      .||+|+||.||+|....                      ......+++|+..... .....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997431                      1223457777665432 334567889999999999999999


Q ss_pred             eEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC--
Q 017627          121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL--  198 (368)
Q Consensus       121 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~--  198 (368)
                      ++++.+.+..++||||+++++|..++..  ..+.+++..+..++.|++.||.|||++   +|+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998864  245688999999999999999999999   999999999999997643  


Q ss_pred             -----ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHH-h
Q 017627          199 -----NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELV-T  271 (368)
Q Consensus       199 -----~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~-~  271 (368)
                           .+|++|||.+......                   ....++..|+|||.+.+ ..++.++||||||+++|||+ +
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~-------------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR-------------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             cCccceeeecCCccccccccc-------------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence                 3899999987532111                   11247788999998875 56899999999999999995 6


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      |..||..............                 ......    .....+.++|..||+.+|.+|||+.+++++|+
T Consensus       218 g~~p~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         218 GEVPLKERTPSEKERFYEK-----------------KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CCCCccccChHHHHHHHHh-----------------ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            9999975543222111100                 000111    11246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-41  Score=299.34  Aligned_cols=261  Identities=20%  Similarity=0.274  Sum_probs=204.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCC--ceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDST--STNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .+.+.+.||+|+||.||+|.+...+.  ...+++|.....  ......+.+|+.+++.++||||+++++++.. ...++|
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v   86 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI   86 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence            34567889999999999998765332  335788865543  2345678899999999999999999999987 788999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++...  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        87 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          87 TQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999998743  34589999999999999999999998   999999999999999999999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....             ......++..|+|||.+....++.++|+||||+++||+++ |..||............... 
T Consensus       162 ~~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-  227 (279)
T cd05057         162 DEKEY-------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-  227 (279)
T ss_pred             cccce-------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-
Confidence            21100             0011124568999999988889999999999999999999 99999765543322211110 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                        .....+..++..+.+++..||..||.+|||+.++++.|+++.+...
T Consensus       228 ------------------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         228 ------------------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence                              0001111223468899999999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.9e-42  Score=312.04  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=194.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+++...  +...+|+|+....    ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKH--TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3467789999999999998755  5677899976532    223455778999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+|+|..++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999742  35689999999999999999999999   9999999999999999999999999998753322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ...              ......||+.|+|||++.+     ..++.++||||||+++|+|++|..||...+......   
T Consensus       156 ~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---  218 (331)
T cd05624         156 GTV--------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---  218 (331)
T ss_pred             Cce--------------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH---
Confidence            110              0112469999999999876     467889999999999999999999997654322111   


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL--RPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~  347 (368)
                      .....       .    ....+.. .....+..+.+++.+||..++.+  |++++++++|
T Consensus       219 ~i~~~-------~----~~~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         219 KIMNH-------E----ERFQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHcC-------C----CcccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11000       0    0000000 11123567899999999876554  5689999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-41  Score=300.52  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=200.0

Q ss_pred             HhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.+.||+|+||.||+|+....   .....+++|.......  ..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL   87 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence            4567799999999999986532   2456688887655432  4577899999999999999999999999989999999


Q ss_pred             ecccCCCHHHHhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          135 EYVPNGTLQEKLHGTPRS------SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ||+++++|.+++......      ..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||++
T Consensus        88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccc
Confidence            999999999999754322      2689999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  287 (368)
                      +.......              .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus       165 ~~~~~~~~--------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~  230 (275)
T cd05046         165 KDVYNSEY--------------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR  230 (275)
T ss_pred             cccCcccc--------------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence            64322111              01112246778999999988888999999999999999999 8889865443222211


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                      ...          ..        .........+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       231 ~~~----------~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         231 LQA----------GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHc----------CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            110          00        0000111234578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.2e-41  Score=294.63  Aligned_cols=249  Identities=26%  Similarity=0.348  Sum_probs=200.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      |.+.+.||.|+||.||+|....  +...+++|....... .+.+.+|+++++.++||||+++++++.+....++++||+.
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKE--TGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcC--CCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            4567889999999999998755  457788887765544 6789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++..  ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        82 ~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          82 AGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            9999999864  245689999999999999999999999   999999999999999999999999999875332110  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                   ......|+..|+|||++.+..++.++||||||+++|+|++|..||............          
T Consensus       155 -------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~----------  211 (256)
T cd06612         155 -------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI----------  211 (256)
T ss_pred             -------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh----------
Confidence                         012234788999999999989999999999999999999999999754332111000          


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                           .....+  ....+...+..+.+++..||+.||.+|||+.++++|
T Consensus       212 -----~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         212 -----PNKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -----ccCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence                 000000  011122345678999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-41  Score=299.02  Aligned_cols=251  Identities=27%  Similarity=0.346  Sum_probs=199.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+.+.||.|+||.||+|.+..  +...+++|+.... ....+.+.+|+.+++.++||||+++++++......++||||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcC--CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            35678889999999999998754  5677888876544 34456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|.+++...  ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            9999999998742  34689999999999999999999999   999999999999999999999999998764322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                                     ......|++.|+|||.+.     ...++.++|+||||+++|+|++|..||..........   ..
T Consensus       159 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~---~~  220 (280)
T cd06611         159 ---------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL---KI  220 (280)
T ss_pred             ---------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH---HH
Confidence                           112346899999999985     3456789999999999999999999997654321110   00


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .            ....+.+  ..+...+..+.+++..||+.+|.+|||+.++++|
T Consensus       221 ~------------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         221 L------------KSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             h------------cCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0            0000000  1112335578899999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.8e-41  Score=296.53  Aligned_cols=249  Identities=24%  Similarity=0.438  Sum_probs=197.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.+.||+|+||.||+|.+.+   ...+++|...........+.+|+++++.++|||++++++++......++||||+.+
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~---~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLE---KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             EEEeeecCcccceEEEEEEeC---CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            356789999999999998743   34678887765554456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++...  ...+++..+..++.|++.|+.+||+.   +++|+||||+||+++.++.++|+|||+++........  
T Consensus        84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--  156 (256)
T cd05112          84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT--  156 (256)
T ss_pred             CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc--
Confidence            9999998742  34578999999999999999999999   9999999999999999999999999998753222110  


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..............        
T Consensus       157 ------------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------  216 (256)
T cd05112         157 ------------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA--------  216 (256)
T ss_pred             ------------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC--------
Confidence                        0011225678999999998899999999999999999998 9999976543322211110        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                         . .....+       ...+..+.+|+.+||+.+|.+|||+.+++++|.
T Consensus       217 ---~-~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         217 ---G-FRLYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---C-CCCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence               0 000011       112457999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-41  Score=298.78  Aligned_cols=247  Identities=28%  Similarity=0.381  Sum_probs=199.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||.|+||.||+|.+..  ++..+++|+....  ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKR--TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECC--CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            4567889999999999998755  6678899976543  23345678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++..    ..+++..++.++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999999863    2789999999999999999999999   999999999999999999999999999875433211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.........       
T Consensus       154 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------  211 (274)
T cd06609         154 ---------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-------  211 (274)
T ss_pred             ---------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------
Confidence                           0122358889999999998889999999999999999999999996554221111000       


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                              ....+.+...   ..+..+.+++..||..+|.+|||++++++|
T Consensus       212 --------~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         212 --------KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --------hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                    0011111111   135578999999999999999999999886

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-41  Score=296.36  Aligned_cols=252  Identities=27%  Similarity=0.354  Sum_probs=199.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||.|+||.||+|....  +...+++|+.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIA--TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecC--CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            4466789999999999998755  4567888876543 334577889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++...  ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            999999988742  25689999999999999999999999   999999999999999999999999999875322110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG---MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                    ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||..............    
T Consensus       157 --------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~----  218 (262)
T cd06613         157 --------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK----  218 (262)
T ss_pred             --------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----
Confidence                          11224588899999999876   788999999999999999999999976442211111000    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               .....+  ........+..+.+++.+||..+|.+|||+.+++.|
T Consensus       219 ---------~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         219 ---------SNFPPP--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ---------ccCCCc--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                     000000  011223446689999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-41  Score=304.17  Aligned_cols=266  Identities=22%  Similarity=0.253  Sum_probs=193.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|.....   ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~--~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECC--CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4466789999999999998765  5667888866432   2223457789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+. ++|.+++..  ....+++..++.++.||+.||.|||++   +|+|+||||+||+++.++.++|+|||+++......
T Consensus        80 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            996 578777753  245689999999999999999999999   99999999999999999999999999987432111


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENG-QLLTSLAGSMLN  293 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~  293 (368)
                      .               ......+++.|+|||++.+. .++.++|||||||++|+|++|..||..... ............
T Consensus       154 ~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07839         154 R---------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  218 (284)
T ss_pred             C---------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence            0               00123478899999998764 478999999999999999999888644332 222111111111


Q ss_pred             hhhhhhhcchhhhcCCC----CCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPR----LAG-----DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~----~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..............+..    ...     ......+..+.+++..||+.||.+|||++++++|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            10000000011100000    000     0111245688999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.5e-41  Score=295.62  Aligned_cols=249  Identities=27%  Similarity=0.371  Sum_probs=197.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  134 (368)
                      |.+.+.||+|++|.||++....  +...+++|.....   ....+.+.+|+++++.++|+|++++++.+.. .+.++++|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcC--CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4567889999999999998755  4567888865432   3345678889999999999999999998764 44689999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|.+++... ....+++.++..++.|++.|+.+||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            999999999998753 345689999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+......   .....
T Consensus       156 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~~  217 (257)
T cd08223         156 CD---------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY---RIIEG  217 (257)
T ss_pred             CC---------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHhc
Confidence            11               0112458899999999999999999999999999999999999997544221111   10000


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             .    .     ...+...+..+.+++.+||+.||.+|||+.++++|
T Consensus       218 -------~----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 -------K----L-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -------C----C-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   0    0     01122345679999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.7e-41  Score=296.36  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=191.4

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC------hhHHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS------DRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGV  131 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~  131 (368)
                      ...+.||+|+||.||+|....  ++..+++|.....      ......+.+|+.+++.++||||+++++++.+  ....+
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVD--TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             cccceecCCCCEEEEEEEEcC--CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            356789999999999998655  5667788865422      2334568889999999999999999998865  35788


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      ++|||+++++|.+++..   ...+++...+.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||+++..
T Consensus        83 l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          83 IFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            99999999999999873   34588999999999999999999998   9999999999999999999999999998753


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .......            .......++..|+|||.+.+..++.++||||+||++|+|++|..||.........   .. 
T Consensus       157 ~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~---~~-  220 (266)
T cd06651         157 QTICMSG------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI---FK-  220 (266)
T ss_pred             ccccccC------------CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH---HH-
Confidence            2211000            0001234888999999999988999999999999999999999999654321110   00 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                    ..........+...+..+.+++ .||..+|++||++++++.|
T Consensus       221 --------------~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         221 --------------IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --------------HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                          0000011122233455677788 6888999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-41  Score=297.12  Aligned_cols=254  Identities=22%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ...+.||+|+||.||+|....  ++..+++|+.....       ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~--~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVK--TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             cccceecCcCceEEEEEEEcC--CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            356789999999999998644  56778888765321       245678899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMG  211 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~  211 (368)
                      ||||+.+++|.+++.   ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999987   345688999999999999999999999   999999999999998765 5999999998754


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ........           .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.............. 
T Consensus       155 ~~~~~~~~-----------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-  222 (268)
T cd06630         155 AAKGTGAG-----------EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-  222 (268)
T ss_pred             ccccccCC-----------ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH-
Confidence            33211000           001224588999999999888899999999999999999999999965443221111110 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                    ..........+...+.++.+++.+||..+|.+|||+.++++|
T Consensus       223 --------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         223 --------------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --------------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                          000111122333456789999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5e-41  Score=295.77  Aligned_cols=250  Identities=26%  Similarity=0.296  Sum_probs=200.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||.|+||.||.++...  ++..+++|....   +......+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcC--CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            4567889999999999998654  566778885443   34555678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++... ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999999754 245689999999999999999999999   99999999999999999999999999987542222


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .               ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..........     
T Consensus       156 ~---------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-----  215 (256)
T cd08221         156 S---------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-----  215 (256)
T ss_pred             c---------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-----
Confidence            1               01224589999999999888889999999999999999999999976543221111100     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                   .... ......+..+.+++..||+.+|.+|||+.++++++
T Consensus       216 -------------~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         216 -------------GNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -------------CCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                         0000 01123356788999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.3e-41  Score=302.11  Aligned_cols=258  Identities=22%  Similarity=0.295  Sum_probs=199.0

Q ss_pred             hhhhcccccceEEEEEEEcCCCCc--eeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTS--TNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~--~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..+.||+|+||.||+|.+...+..  ..+++|.....  ......+.+|+.+++.++||||+++++++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            456799999999999987553332  35678866543  23344678899999999999999999998654 56799999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++|+|.+++...  ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        90 ~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          90 MPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK  164 (303)
T ss_pred             cCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence            9999999998742  34588999999999999999999999   999999999999999999999999999975432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .             .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.............    
T Consensus       165 ~-------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----  227 (303)
T cd05110         165 E-------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG----  227 (303)
T ss_pred             c-------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC----
Confidence            0             00011235678999999999999999999999999999998 89999765433222211110    


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                   ...  ..+..++..+.+++..||..+|++||+++++++.|+++.....
T Consensus       228 -------------~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         228 -------------ERL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             -------------CCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence                         000  0011224578899999999999999999999999999865543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=291.91  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=195.6

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ++||+|+||.||+|.+.+   ...+++|.....  ......+.+|+++++.++|+||+++++++.+.+..++||||+.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~---~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG---NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC---CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            358999999999998643   567788865543  234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++...  ...+++..+..++.+++.|+.|||++   +++||||||+||+++.++.++|+|||.+........... 
T Consensus        78 ~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-  151 (251)
T cd05041          78 SLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-  151 (251)
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-
Confidence            999998642  34678999999999999999999999   999999999999999999999999999875332111000 


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..............         
T Consensus       152 ------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~---------  210 (251)
T cd05041         152 ------------DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES---------  210 (251)
T ss_pred             ------------cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc---------
Confidence                        001123567999999998899999999999999999999 8888866543222211110         


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                ......+...+..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       211 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         211 ----------GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence                      00011122335579999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=265.25  Aligned_cols=264  Identities=22%  Similarity=0.241  Sum_probs=211.4

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      -.++||+|.||+||+|+..+  +.+.||+|....+   +.......+|+.+++.|+|.|||+++++...+..+.+|+|||
T Consensus         6 kmekigegtygtvfkarn~~--t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             HHHhhcCCcceeeEecccCC--ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            34679999999999998544  8889999966543   344567789999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                       ..+|..+..+  -++.++.+.+..++.|+++||.+.|++   ++.|||+||.|+||+.+|.+|++|||+++...-..  
T Consensus        84 -dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   84 -DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             -hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence             5588888775  457799999999999999999999999   99999999999999999999999999998533211  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                   .-....+-|.+|++|.++.|. -|++..|+||.||++.|+.. |++.|.+.+..+....+...+...
T Consensus       156 -------------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p  222 (292)
T KOG0662|consen  156 -------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_pred             -------------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence                         011224578999999999885 58999999999999999998 788888887777666666666665


Q ss_pred             hhhhhcchhhhcCCCCCCCCCH---------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDL---------DEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....+..+..+-|-..-.-++.         .....-++++..+|.-+|.+|.++++.++|
T Consensus       223 ~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  223 TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            5544444444444333222221         222345789999999999999999999876

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-40  Score=295.12  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=193.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC------hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS------DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGV  131 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  131 (368)
                      .+.+.||+|+||.||.|....  ++..+++|.....      ....+.+.+|+.+++.++||||+++++++.+.  ..++
T Consensus         5 ~~~~~l~~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           5 RLGKLLGQGAFGRVYLCYDAD--TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             eEeeEEecCCceEEEEEEEcC--CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            456789999999999998654  5678888865422      23346788899999999999999999998763  4678


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      ++|||+++++|.+++..   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+++..
T Consensus        83 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          83 IFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            99999999999999873   34578899999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .......            .......|+..|+|||++.+..++.++||||||+++|+|++|..||.........   .. 
T Consensus       157 ~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~-  220 (265)
T cd06652         157 QTICLSG------------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---FK-  220 (265)
T ss_pred             ccccccc------------cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---HH-
Confidence            2211000            0011235889999999999888999999999999999999999999654321110   00 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                    ..........+...+..+.+++..|| .+|.+||+++++++|
T Consensus       221 --------------~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~  261 (265)
T cd06652         221 --------------IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH  261 (265)
T ss_pred             --------------HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence                          00001111223445667889999999 499999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-42  Score=306.83  Aligned_cols=251  Identities=26%  Similarity=0.328  Sum_probs=193.8

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEE-e--ecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-I--HVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik-~--~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  132 (368)
                      -.|++.+.||.||-+.||++..-+   ...+|+| +  ...++....-+.+|+..|.+|+ |.+|++++++-..++.+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~---~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD---KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC---CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            345677889999999999997433   2333433 3  3456677888999999999995 9999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |||+- ..+|..+|...  ...++.-.++.++.|++.|+.++|.+   ||||.||||.|+|+-++ .+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcccC
Confidence            99975 67999999864  23344347889999999999999999   99999999999999864 89999999998655


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC-----------CCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-----------ASTKTDVYSFGVILLELVTGMEAFCPENG  281 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (368)
                      .+....-             ....+||+.||+||.+....           .+.++||||||||||+|+.|+.||.....
T Consensus       511 ~DTTsI~-------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n  577 (677)
T KOG0596|consen  511 PDTTSIV-------------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN  577 (677)
T ss_pred             cccccee-------------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence            4442211             12357999999999986532           45789999999999999999999954321


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLD-EARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .                 +..+..+.+|...-.|+.- ...++.++++.||++||.+|||..++|+|
T Consensus       578 ~-----------------~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 Q-----------------IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             H-----------------HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1                 1334444455332222211 12239999999999999999999999987

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-41  Score=321.25  Aligned_cols=273  Identities=21%  Similarity=0.241  Sum_probs=187.2

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCce-----------------eEEEEeecCChhHHHHHHHHHHHHhcCCCCcee
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTST-----------------NGAIKIHVGSDRLSQVFKQELDILLHLSHDNIV  118 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~-----------------~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv  118 (368)
                      ...|.+.+.||+|+||+||++.........                 .++.|...........+.+|+.+++.++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            345677889999999999998754321100                 001111222334456788999999999999999


Q ss_pred             eeeEEEecCCeeEEEEecccCCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTP--RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       119 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      ++++++...+..++|++++ .++|..++....  .........+..++.||+.||.|||++   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            9999999999999999998 456777664321  122344667788999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCC-
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA-  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p-  275 (368)
                      ++.+||+|||+++........              ......||+.|+|||++.+..++.++|||||||++|||++|..+ 
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA--------------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCEEEEeCCCceecCccccc--------------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999754322110              01224699999999999999999999999999999999998754 


Q ss_pred             CCCCcchh---hHHHHHhhh---hhhhhhhhcchhhhcCCC-C---CCCCC-----HHHHHHHHHHHHHhcCCCCCCCCC
Q 017627          276 FCPENGQL---LTSLAGSML---NDIADCEATKVNELVDPR-L---AGDFD-----LDEARAMLSIAALCLRQSPILRPS  340 (368)
Q Consensus       276 f~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~---~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt  340 (368)
                      |.......   .........   ...++.. ..+...++.. +   .....     ...+.++.++|.+||+.||.+|||
T Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps  447 (501)
T PHA03210        369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPP-CKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG  447 (501)
T ss_pred             ccCCCCCHHHHHHHHHHhcccChhhcCCcH-HHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence            43332211   111111100   0000000 0001111000 0   00000     012346788899999999999999


Q ss_pred             HHHHHHH
Q 017627          341 ATQILHT  347 (368)
Q Consensus       341 ~~~il~~  347 (368)
                      +.++|+|
T Consensus       448 a~elL~h  454 (501)
T PHA03210        448 AAELLAL  454 (501)
T ss_pred             HHHHhhC
Confidence            9999987

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.8e-41  Score=301.05  Aligned_cols=250  Identities=24%  Similarity=0.292  Sum_probs=198.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ..|.+.+.||+|+||.||+|....  ++..+++|..... ....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIA--TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECC--CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            345567889999999999998654  5677888876543 2334667889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999999853    3578899999999999999999999   99999999999999999999999999986432211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .               ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+........       
T Consensus       170 ~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------  227 (297)
T cd06656         170 S---------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------  227 (297)
T ss_pred             c---------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------
Confidence            0               001235888999999999988999999999999999999999999664431110000       


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ..........+...+..+.+++.+||+.+|.+|||++++++|
T Consensus       228 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         228 ----------ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ----------ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      000000011122345678899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.2e-41  Score=299.57  Aligned_cols=266  Identities=25%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |++.+.||+|+||.||+|.+..  ++..+++|.....   ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRE--TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECC--CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            4466789999999999998754  5677888865432   2234567889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|..++.   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999988887765   344689999999999999999999999   99999999999999999999999999987543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.+................
T Consensus       155 ~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07847         155 D---------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD  219 (286)
T ss_pred             c---------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            1               0012347889999999876 45788999999999999999999999866543222222111111


Q ss_pred             hhhhhhc--c----hhhhcCCCCCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEAT--K----VNELVDPRLAGDF-----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~--~----~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......  .    ......+......     ....+..+.+|+..||+.+|++|||+.+++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             CChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            1000000  0    0000001100000     01235678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.8e-41  Score=294.67  Aligned_cols=245  Identities=23%  Similarity=0.355  Sum_probs=194.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+.+.||+|+||.||++..    ....+++|...... ....+.+|+.+++.++||||+++++++.. +..++||||+.
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~----~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY----TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             ceeeeeeccCCCCceEeccc----CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            45778899999999999864    44567888765443 34678899999999999999999999865 45799999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++... ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998754 234688999999999999999999999   99999999999999999999999999987422110   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                     .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..............       
T Consensus       155 ---------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------  212 (254)
T cd05083         155 ---------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-------  212 (254)
T ss_pred             ---------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------
Confidence                           01124567999999998899999999999999999998 9999976543322211110       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                  ..........+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       213 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 ------------GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ------------CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                        00011112334678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-41  Score=297.63  Aligned_cols=242  Identities=22%  Similarity=0.364  Sum_probs=187.0

Q ss_pred             hhcccccceEEEEEEEcCCC-----CceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           63 QVIGSGGFSNVYLARLINDS-----TSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~-----~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.||+|+||.||+|......     ....+++|..... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            35999999999999865422     2234666665433 23456788899999999999999999999998899999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc--------eEEeecccc
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN--------CKLCDFGSA  208 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~--------vkl~Dfg~s  208 (368)
                      +.+++|..++...  ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.        ++++|||.+
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999743  33688999999999999999999999   9999999999999987665        699999987


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhhHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGM-EAFCPENGQLLTS  286 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~  286 (368)
                      ......                   ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||..........
T Consensus       156 ~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~  216 (258)
T cd05078         156 ITVLPK-------------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ  216 (258)
T ss_pred             cccCCc-------------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence            632211                   12347889999999987 45789999999999999999985 6664433221111


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      ....                 ..    ..+...+.++.+++..||+.||.+|||++++++.|+
T Consensus       217 ~~~~-----------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 FYED-----------------RH----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHc-----------------cc----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1000                 00    011122357899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-40  Score=292.86  Aligned_cols=241  Identities=28%  Similarity=0.434  Sum_probs=189.7

Q ss_pred             hhcccccceEEEEEEEcCCCC--------ceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           63 QVIGSGGFSNVYLARLINDST--------STNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~--------~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +.||+|+||.||+|.+.....        ...+++|+..........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            358999999999999865331        2456777665554446788899999999999999999999987 7789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-------ceEEeeccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-------NCKLCDFGS  207 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-------~vkl~Dfg~  207 (368)
                      ||+.+++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++       .+||+|||+
T Consensus        80 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          80 EYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999998743  22688999999999999999999999   999999999999999887       799999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhh
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--MASTKTDVYSFGVILLELVT-GMEAFCPENGQLL  284 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  284 (368)
                      +......                   ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||........
T Consensus       155 a~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~  215 (259)
T cd05037         155 PITVLSR-------------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK  215 (259)
T ss_pred             ccccccc-------------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence            8753221                   112467789999999876  78999999999999999999 5777765432211


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      ......                 ......    .....+.+++..||..+|.+|||+.++++.|+
T Consensus       216 ~~~~~~-----------------~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ERFYQD-----------------QHRLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHhc-----------------CCCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111100                 000000    01157889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.5e-41  Score=295.87  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=195.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-------hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-------DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+++.||.|+||.||+|...   ++..+++|.....       ......+.+|+++++.++|+||+++++++.+.+..++
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTN---QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             cccceEeccCCeEEEEEEEc---CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            45678999999999999752   4567788865432       1233568899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++....
T Consensus        80 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          80 FMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999973   34688999999999999999999999   99999999999999999999999999987542


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ........         ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..........  
T Consensus       154 ~~~~~~~~---------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--  222 (265)
T cd06631         154 WVGLHGTH---------SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA--  222 (265)
T ss_pred             hccccccc---------cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh--
Confidence            21111000         0001123589999999999998899999999999999999999999965432211100000  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                 .....+..    +...+..+.+++.+||+.+|.+|||+.++++|
T Consensus       223 -----------~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         223 -----------HRGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             -----------ccCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                       00001111    12235678999999999999999999999865

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.7e-41  Score=299.50  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=194.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEe-----cCCeeEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCD-----DRDEGVL  132 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~~l  132 (368)
                      |.+.+.||+|+||.||+|....  .+..+++|+..........+.+|+.+++.+ +||||+++++++.     .++..++
T Consensus        20 ~~~~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          20 WEIIETIGKGTYGKVFKVLNKK--NGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             eeeeeeeccCCCcEEEEEEECC--CCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            3466789999999999998755  567789998765555456788899999999 6999999999874     3456899


Q ss_pred             EEecccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          133 LFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      ||||+++++|.+++... .....+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||+++..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            99999999999887532 1345688999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      .....               ......|++.|+|||++..     ..++.++||||+||++|+|++|..||..........
T Consensus       175 ~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~  239 (286)
T cd06638         175 TSTRL---------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF  239 (286)
T ss_pred             ccCCC---------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence            22111               0012358999999999853     457889999999999999999999996543211110


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..               .....+..  ..+...+..+.+++.+||+.||.+|||+.++++|+
T Consensus       240 ~~---------------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KI---------------PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hc---------------cccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00               00000000  00111245789999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-40  Score=293.17  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=199.8

Q ss_pred             hhhhcccccceEEEEEEEcCCC--CceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~--~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.+.||.|+||.||++.+.+..  ....+++|+......  ..+.+..|+.++..++|+||+++++++.+.+..+++||+
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            5678999999999999976532  247788898765443  567888999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|.+++.... ...+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       83 MEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             cCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            99999999987432 12289999999999999999999999   999999999999999999999999999976543321


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ...              ....+++.|+|||.+.+..++.++||||+|+++|+|++ |.+||...+...........    
T Consensus       159 ~~~--------------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~----  220 (258)
T smart00219      159 YKK--------------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG----  220 (258)
T ss_pred             ccc--------------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----
Confidence            110              01126789999999988889999999999999999998 88888764433222211110    


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                            .         ........+..+.+++.+||..||++|||+.++++.|
T Consensus       221 ------~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 ------Y---------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------C---------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  0         0011112456799999999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-41  Score=297.63  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=198.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCC------ee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRD------EG  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~------~~  130 (368)
                      .|.+.+.||+|+||.||+|....  +...+++|+..........+.+|+.+++.+ +|+||+++++++....      ..
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKK--TGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECC--CCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            45677889999999999998754  567888998777666667889999999999 7999999999996544      48


Q ss_pred             EEEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      ++||||+.+++|.+++.... ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence            99999999999999886432 246789999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      .......               ......|+..|+|||++..     ..++.++||||||+++|+|++|..||........
T Consensus       162 ~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  226 (275)
T cd06608         162 QLDSTLG---------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA  226 (275)
T ss_pred             ecccchh---------------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH
Confidence            5332211               1122458899999998854     3467889999999999999999999965432211


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..   .....            ..+.  .......+..+.+|+.+||..||.+|||+.++++|
T Consensus       227 ~~---~~~~~------------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 LF---KIPRN------------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HH---Hhhcc------------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            10   00000            0000  11122345689999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-40  Score=298.13  Aligned_cols=273  Identities=27%  Similarity=0.369  Sum_probs=203.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcC--CCCceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN--DSTSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~--~~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~  131 (368)
                      .+.+.+.||+|+||.||+|.+..  ......+++|+......  ....+.+|+++++.++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            34567889999999999998643  34567889998765544  46789999999999999999999999877  55789


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||.+...
T Consensus        85 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            999999999999999753  23589999999999999999999999   9999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ........            ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ....
T Consensus       160 ~~~~~~~~------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~  226 (284)
T cd05038         160 PEDKDYYY------------VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM-IGIA  226 (284)
T ss_pred             ccCCccee------------ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc-cccc
Confidence            42211000            0001234567999999988899999999999999999999999986543221100 0000


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                       ..  ..........+........+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       227 -~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         227 -QG--QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             -cc--cccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence             00  0000001111111111111223346799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.4e-41  Score=300.25  Aligned_cols=243  Identities=26%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||++.+..  ....+++|+....    ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKG--SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            3456789999999999998765  5677899876543    234466888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999987   346789999999999999999999999   9999999999999999999999999998753322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.............   ..
T Consensus       155 ~------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~  213 (290)
T cd05580         155 T------------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL---EG  213 (290)
T ss_pred             C------------------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cC
Confidence            1                  12358899999999988888999999999999999999999997655221111110   00


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                   ...    .+...+..+.+++..||..||.+|+     +++++++|
T Consensus       214 -------------~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 -------------KVR----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -------------Ccc----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                         001    1112256788999999999999999     88898876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-40  Score=299.63  Aligned_cols=266  Identities=21%  Similarity=0.232  Sum_probs=198.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|......      .....+.+|+++++.++|+||+++++++.+.+..++
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKE--TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECC--CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence            3456789999999999998654  46678888765432      234567789999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+ +++|.+++....  ..+++..+..++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||+++...
T Consensus        80 v~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             EEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            99999 899999997431  3689999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .....               .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...............
T Consensus       154 ~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~  218 (298)
T cd07841         154 SPNRK---------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA  218 (298)
T ss_pred             CCCcc---------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH
Confidence            22110               011246788999999865 46788999999999999999998888765543222222111


Q ss_pred             hhhhhhhhhc---chhhhcCCCCCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEAT---KVNELVDPRLAG-----DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..........   ............     ......+..+.+++..||+.||.+|||+.++++|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1110000000   000000000000     1112335788999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.6e-40  Score=300.29  Aligned_cols=267  Identities=24%  Similarity=0.320  Sum_probs=198.5

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||.||++....  ....+++|......    .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKE--TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECC--CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            456789999999999998654  66778888765432    234567789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++..   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          82 YVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999973   45689999999999999999999999   99999999999999999999999999987422111


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ......................|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+........   ..... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~---~~~~~-  231 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG---QVISD-  231 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhc-
Confidence            11000000000000011112457889999999988889999999999999999999999997544322111   10000 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                               ....+..    ....+..+.+++.+||+.||++||+...+++.|+..
T Consensus       232 ---------~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         232 ---------DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             ---------ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence                     0000000    012355789999999999999999965555555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-40  Score=298.25  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=195.8

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ...||+|+||.||++....  +...+++|..... ....+.+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKH--TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhcccCCCCeEEEEEEECC--CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            3569999999999998654  5667888866443 344566889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++..    ..+++..+..++.|++.||.|||++   +|+||||||+||++++++.++|+|||++.......     
T Consensus       105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-----  172 (292)
T cd06658         105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-----  172 (292)
T ss_pred             cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence            99998852    3588999999999999999999999   99999999999999999999999999986432111     


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                .......|+..|+|||.+.+..++.++|+||||+++|||++|..||.............           
T Consensus       173 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-----------  231 (292)
T cd06658         173 ----------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-----------  231 (292)
T ss_pred             ----------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence                      01123458999999999998889999999999999999999999997654322111110           


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                          ....+....  ....+..+.+++..||..||.+|||++++++|
T Consensus       232 ----~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         232 ----DNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ----hcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                111111111  11234578899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.2e-41  Score=300.70  Aligned_cols=248  Identities=24%  Similarity=0.326  Sum_probs=197.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||.|+||.||+|.+..  ++..+++|..... ....+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVA--TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcC--CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3456789999999999998654  5677888865433 234567888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|..++..    ..+++.++..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999998863    3589999999999999999999999   9999999999999999999999999998743221110


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                     .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..........  ..   
T Consensus       172 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~--~~---  231 (296)
T cd06655         172 ---------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG---  231 (296)
T ss_pred             ---------------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cC---
Confidence                           0123588899999999988899999999999999999999999976543211111000  00   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                .+.  ...+...+..+.++|.+||..||.+|||+.++++|
T Consensus       232 ----------~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         232 ----------TPE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ----------Ccc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                      000  01112234578899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=279.46  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=196.2

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +...||.|+.|.|++++...  ++...|||.....  .+..+++...+.++..-+ +|+||+++|+|.....+++.||.|
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs--~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRS--TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hHHhhcCCCccceEEEEEcc--cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34569999999999999765  6788899976543  344567777888877765 999999999999999999999998


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                       +..+..+++.  ..+++++.-+-++...+++||.||..++  +|+|||+||+|||+|..|++||||||+|-+..++...
T Consensus       174 -s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  174 -STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             -HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence             4456666654  3456999999999999999999999885  9999999999999999999999999999766655533


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                ..|-+.|||||.+..   ..|+-++||||||++++||.||..||.+-+.+  ...+...+.+
T Consensus       249 tr----------------sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~  310 (391)
T KOG0983|consen  249 TR----------------SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNE  310 (391)
T ss_pred             cc----------------ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhc
Confidence            22                248899999999864   36888999999999999999999999874432  1111111111


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ..|.++  .....+.++++|+..||+.|+.+||...++|+|
T Consensus       311 ------------ePP~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 ------------EPPLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ------------CCCCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                        112222  222367789999999999999999999999987

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=342.40  Aligned_cols=247  Identities=28%  Similarity=0.379  Sum_probs=200.2

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEee---cCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIH---VGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+||.|.||.||.|...+  ++...|+|-+   ....+....+.+|..++..|+|||+|+++|+-.+++..+|.||||.
T Consensus      1240 g~~Ig~G~fG~VYtavN~~--tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLD--TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred             ccccCCcceeeeEEeecCC--ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence            3479999999999998665  6666677633   2334455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +|+|.+.+.   .+.-.++.....+..|++.|+.|||++   |||||||||.|||++.+|.+|++|||.|+....+...-
T Consensus      1318 ~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1318 GGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             cCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            999999998   556678888889999999999999999   99999999999999999999999999998765542111


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG---MASTKTDVYSFGVILLELVTGMEAFCPENGQ--LLTSLAGSMLN  293 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~  293 (368)
                                 .......+||+.|||||++.+.   ....++|||||||++.||+||+.||...+..  .++...     
T Consensus      1392 -----------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~----- 1455 (1509)
T KOG4645|consen 1392 -----------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA----- 1455 (1509)
T ss_pred             -----------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-----
Confidence                       1222346799999999999764   4667899999999999999999999765532  111111     


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                 ..-.|    .++...+.+-++||..||..||+.|.++.||++|
T Consensus      1456 -----------~gh~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 -----------AGHKP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----------ccCCC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                       11112    2333467788999999999999999999988866

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-40  Score=296.90  Aligned_cols=267  Identities=22%  Similarity=0.254  Sum_probs=199.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....   ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRE--TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECC--CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            4567889999999999998755  4667788876543   3345678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+ +++|.+++...  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 99999988643  35689999999999999999999999   99999999999999999999999999987543321


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .              .......|+..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+................
T Consensus       154 ~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07832         154 P--------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT  219 (286)
T ss_pred             C--------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCC
Confidence            1              000123589999999998654 4688999999999999999998888765543222222111111


Q ss_pred             hhhhhhcchhh------hcCCCCC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNE------LVDPRLA----GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~------~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+.....      ...+...    .....+.+..+.+++.+||+.||.+|||+++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            10000000000      0000000    00011234788999999999999999999999987

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.9e-40  Score=296.86  Aligned_cols=266  Identities=24%  Similarity=0.243  Sum_probs=196.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  133 (368)
                      |.+.+.||.|+||.||+|.+..  ++..+++|.....   ......+.+|+.+++.++||||+++++++...  +..++|
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKK--TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECC--CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            4567889999999999998754  5567788866433   22334567899999999999999999998777  889999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+. ++|.+++...  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99996 5898888643  23689999999999999999999999   999999999999999999999999999875433


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...               ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||................
T Consensus       159 ~~~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  223 (293)
T cd07843         159 PLK---------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL  223 (293)
T ss_pred             Ccc---------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            210               00123478899999998764 46889999999999999999999998765433222221111


Q ss_pred             hhhhhhhhc-----------chhhhcCCCCCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEAT-----------KVNELVDPRLAGDFDLD-EARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......+.           .........+...++.. .+..+.++|..||+.||++|||+.+++.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             CCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111100000           00000001111112211 36678999999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.5e-41  Score=325.75  Aligned_cols=259  Identities=24%  Similarity=0.331  Sum_probs=194.1

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEec-------------
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDD-------------  126 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------------  126 (368)
                      .+.||+||||.||+++.  +-+++.+|||.+...  .+....+.+|+.+|.+|+|||||+++..|.+             
T Consensus       484 L~lLGkGGFG~VvkVRN--KlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~  561 (1351)
T KOG1035|consen  484 LELLGKGGFGSVVKVRN--KLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS  561 (1351)
T ss_pred             HHHhcCCCCceEEEEee--cccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence            35799999999999984  447889999865544  5566778899999999999999999887633             


Q ss_pred             --------------------------------------------------------------------------------
Q 017627          127 --------------------------------------------------------------------------------  126 (368)
Q Consensus       127 --------------------------------------------------------------------------------  126 (368)
                                                                                                      
T Consensus       562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~  641 (1351)
T KOG1035|consen  562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI  641 (1351)
T ss_pred             chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence                                                                                            


Q ss_pred             ------------------C--------CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 017627          127 ------------------R--------DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL  180 (368)
Q Consensus       127 ------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~  180 (368)
                                        .        ..+||-||||...++.+++..+....  ....+|.++++|+.||.|+|++   
T Consensus       642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~---  716 (1351)
T KOG1035|consen  642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ---  716 (1351)
T ss_pred             cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC---
Confidence                              0        23578999998888888887542211  4678899999999999999999   


Q ss_pred             CeEEecCCCCCeeecCCCceEEeeccccccCC---CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC---CCC
Q 017627          181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGF---SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG---MAS  254 (368)
Q Consensus       181 ~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~  254 (368)
                      |||||||||.|||++.++.|||+|||+|....   .....................+..+||..|+|||++.+.   .|+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999998622   111111111222233333345677899999999999775   499


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCC--CCHHHHHHHHHHHHHhcC
Q 017627          255 TKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGD--FDLDEARAMLSIAALCLR  332 (368)
Q Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~  332 (368)
                      .|+|+||||+||+||+.   ||...-+.                 ...+..+.++.++.+  +..+....-.++|++||+
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMER-----------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMER-----------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHH-----------------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhc
Confidence            99999999999999997   46433211                 022233333333333  233334456689999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 017627          333 QSPILRPSATQILHT  347 (368)
Q Consensus       333 ~dP~~Rpt~~~il~~  347 (368)
                      .||.+||||.++|..
T Consensus       857 hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  857 HDPSKRPTATELLNS  871 (1351)
T ss_pred             CCCccCCCHHHHhhc
Confidence            999999999999863

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.4e-40  Score=292.10  Aligned_cols=258  Identities=25%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |++.+.||.|+||.||+|....  ++..+++|+....  ....+.+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcC--CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4567889999999999998755  5667888876543  23457788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++........+++..+..++.|++.||.+||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997543335689999999999999999999999   999999999999999999999999999875443221


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ...           .......|+..|+|||.+... .++.++|+||||+++|+|++|..||...+........   ... 
T Consensus       158 ~~~-----------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~---~~~-  222 (267)
T cd06610         158 RTR-----------KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT---LQN-  222 (267)
T ss_pred             ccc-----------cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH---hcC-
Confidence            100           011234588999999998776 7899999999999999999999999765432111100   000 


Q ss_pred             hhhhhcchhhhcCCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                 ..+.+.... ....+..+.+++..||+.||.+|||++++++|
T Consensus       223 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         223 -----------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -----------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                       001111111 12345678999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.8e-40  Score=292.26  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=199.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||.+....  .+..+++|....   .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcC--CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            4467789999999999998754  566788886543   23445678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++... ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999988643 234578999999999999999999999   99999999999999999999999999987532211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .               ......|++.|+|||++.+..++.++|+||||+++++|++|..||...+......   ....  
T Consensus       156 ~---------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~---~~~~--  215 (256)
T cd08218         156 E---------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL---KIIR--  215 (256)
T ss_pred             h---------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH---HHhc--
Confidence            1               0012358889999999998889999999999999999999999997544322111   1000  


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               ...     ...+...+.++.++|.+||+.+|.+||++.++++|
T Consensus       216 ---------~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         216 ---------GSY-----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ---------CCC-----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                     000     01122335678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.9e-40  Score=291.02  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=191.8

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      ..||+|+||.||+|.+.+  +...+++|..... ....+.+.+|+.+++.++|+||+++++++...+..++|+||+++++
T Consensus        14 ~~lg~g~~g~v~~~~~~~--~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          14 VVLGKGTYGIVYAARDLS--TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             EEEecCCceEEEEeEecC--CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            369999999999998655  5667888865543 3455678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-CCceEEeeccccccCCCCCCCC
Q 017627          142 LQEKLHGTPRSSKL--PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       142 L~~~l~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      |.+++...  ...+  ++..+..++.|++.||.|||++   +|+||||||+||+++. ++.++|+|||++......... 
T Consensus        92 L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-  165 (268)
T cd06624          92 LSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-  165 (268)
T ss_pred             HHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-
Confidence            99998743  1234  7888899999999999999999   9999999999999986 679999999998643221110 


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM--ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                    .....|++.|+|||.+.+..  ++.++|+||+|+++|+|++|..||................    
T Consensus       166 --------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~----  227 (268)
T cd06624         166 --------------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF----  227 (268)
T ss_pred             --------------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh----
Confidence                          01124789999999986643  7889999999999999999999996533221111100000    


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                              .     .....+...+..+.+++.+||+.+|.+|||+.+++.|
T Consensus       228 --------~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 --------K-----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --------c-----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                    0     0111222345678999999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-40  Score=292.56  Aligned_cols=246  Identities=28%  Similarity=0.400  Sum_probs=196.4

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ...+.||+|+||.||+|....  ++..+++|......      ...+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus         3 ~~~~~ig~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           3 RKGELLGSGSFGSVYEGLNLD--DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             cccceeeecCCceEEEEEEcC--CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            456789999999999998754  56678888654332      3456788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      +||+++++|.+++..   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999873   45688999999999999999999999   999999999999999999999999999875332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ..                ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||..............  
T Consensus       155 ~~----------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--  216 (258)
T cd06632         155 FS----------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--  216 (258)
T ss_pred             cc----------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--
Confidence            21                012245889999999987766 89999999999999999999999966542111100000  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       .      .         .....+...+..+.+++.+||+.+|.+|||+.+++.|
T Consensus       217 -~------~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         217 -S------K---------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -c------c---------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             0      0         0001112235678899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-40  Score=292.36  Aligned_cols=248  Identities=26%  Similarity=0.327  Sum_probs=198.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |++.+.||+|+||.||+|....  +...+++|.....   ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKA--DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcC--CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            4466789999999999998755  6677888865432   3446778899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-CceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-LNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~~vkl~Dfg~s~~~~~~  214 (368)
                      |+++++|.+++... ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.+ +.++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999999753 244589999999999999999999999   99999999999999854 46899999998754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..........    
T Consensus       156 ~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~----  215 (256)
T cd08220         156 SK----------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS----  215 (256)
T ss_pred             cc----------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh----
Confidence            11                0123588999999999988889999999999999999999999976554322211110    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                            ..         ........+..+.+++..||+.+|.+|||+.++++|
T Consensus       216 ------~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         216 ------GT---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ------cC---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                  00         000111235578999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.7e-40  Score=293.10  Aligned_cols=246  Identities=24%  Similarity=0.365  Sum_probs=197.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.+.+.||.|+||.||+|....  .+..+++|+....  ......+.+|+.++..++||||+++++++...+..++||||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECC--CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            4466789999999999998644  5678899876533  23446788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|..++..    ..+++..+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999998863    3588999999999999999999999   999999999999999999999999999875322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..............      
T Consensus       157 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------  215 (277)
T cd06641         157 ---------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK------  215 (277)
T ss_pred             ---------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc------
Confidence                           00123578899999999888889999999999999999999999965443211111100      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   ..........+..+.+++..||+.+|.+||++.++++|
T Consensus       216 -------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 -------------NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -------------CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                         00011122335678899999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.4e-40  Score=292.56  Aligned_cols=257  Identities=21%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             HhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------e
Q 017627           60 NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------E  129 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~  129 (368)
                      .+.+.||+|+||.||+|.+.. ..+...+++|+....   ....+.+.+|+.+++.++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            356789999999999998653 345678999976543   344567889999999999999999999886432      2


Q ss_pred             eEEEEecccCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTP---RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      .+++++|+.+++|..++....   ....++...+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence            478899999999988765321   123578899999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~  285 (368)
                      .++..........             .....+++.|++||.+.+..++.++||||||+++|+|++ |.+||...+.....
T Consensus       159 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~  225 (273)
T cd05074         159 LSKKIYSGDYYRQ-------------GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY  225 (273)
T ss_pred             ccccccCCcceec-------------CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH
Confidence            9875432211100             011235678999999998889999999999999999999 88998765433222


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      ......         .      ...    .....+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       226 ~~~~~~---------~------~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         226 NYLIKG---------N------RLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHcC---------C------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111100         0      000    1112345899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-40  Score=292.40  Aligned_cols=250  Identities=24%  Similarity=0.296  Sum_probs=198.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  133 (368)
                      |++.+.||.|+||.||+|.+..  ++..+++|+...   .....+.+.+|+++++.++||||+++++++..  ....+++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecC--CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            3456789999999999998655  566788886643   23445678889999999999999999997753  4567999


Q ss_pred             EecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          134 FEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLH-----ERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      |||+++++|.+++.... ....+++..++.++.|++.||.|||     +.   +++|+||+|+||+++.++.+||+|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence            99999999999986431 2467899999999999999999999     66   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      +.........               .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus       157 ~~~~~~~~~~---------------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  221 (265)
T cd08217         157 AKILGHDSSF---------------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK  221 (265)
T ss_pred             cccccCCccc---------------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH
Confidence            8754322210               1123589999999999988899999999999999999999999976553222111


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...                   ......+...+..+.+++.+||+.+|.+|||+.+|++|
T Consensus       222 ~~~-------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         222 IKE-------------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             Hhc-------------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            110                   00111223445688999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.3e-40  Score=291.77  Aligned_cols=254  Identities=27%  Similarity=0.398  Sum_probs=199.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|+.....   ...+.+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLD--TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECC--CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            4567889999999999998654  56778888765443   356788999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++..   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999999873   44578999999999999999999999   99999999999999999999999999987644332


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM---ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....           ......+++.|+|||.+.+..   ++.++||||||+++|++++|..||..............  
T Consensus       154 ~~~~~-----------~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--  220 (264)
T cd06626         154 TTMGE-----------EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--  220 (264)
T ss_pred             Ccccc-----------cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh--
Confidence            21100           011235788999999998766   88999999999999999999999975432111100000  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ....+....  ....+..+.+++..||+.+|.+|||+.+++.|
T Consensus       221 ------------~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         221 ------------AGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ------------cCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                        000111111  11235678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-40  Score=297.32  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=194.9

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ...||+|+||.||+|....  ....+++|..... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKH--SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhhcCCCCceeEEEEEEcC--CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3469999999999998654  5667888876432 233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|..++..    ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++........    
T Consensus       104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----  172 (297)
T cd06659         104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----  172 (297)
T ss_pred             CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc----
Confidence            99987752    4588999999999999999999999   999999999999999999999999999864322110    


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                 ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...............         
T Consensus       173 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------  232 (297)
T cd06659         173 -----------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---------  232 (297)
T ss_pred             -----------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---------
Confidence                       112345899999999999888999999999999999999999999755432221111100         


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       .     .+..  ......+..+.+++..||+.+|.+||+++++++|
T Consensus       233 -~-----~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         233 -P-----PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -C-----CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             0     0000  0011224578899999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=285.01  Aligned_cols=247  Identities=22%  Similarity=0.304  Sum_probs=196.8

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC----CeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR----DEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~  137 (368)
                      ++||-|-.|+|..+..+.  +++.+|+|+...+++    .++|+++.-.. .|||||.+++++++.    ..+.+|||.|
T Consensus        68 qvLG~GinGkV~~C~~k~--T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKR--TQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhccccCCceEEEEecc--chhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            689999999999887544  889999999888766    45688887666 599999999998643    4578999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec---CCCceEEeeccccccCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~---~~~~vkl~Dfg~s~~~~~~  214 (368)
                      .||.|...+... ....+++.++..|+.||+.|+.|||+.   +|.||||||+|+|.+   .|..+||+|||+|+.....
T Consensus       142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            999999999865 456799999999999999999999999   999999999999996   4566999999999853321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                      ....+.+.||.|.|||++....|+..+|+||+|+++|-|++|.+||...-+.....-.+..+..
T Consensus       218 ----------------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  218 ----------------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             ----------------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence                            1224467899999999999999999999999999999999999999765543222111111110


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             ...+     ++..--...++...++|+.+|+.+|.+|.|+.++++|
T Consensus       282 -------gqy~-----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  282 -------GQYE-----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -------cCcc-----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                   0000     0111112457889999999999999999999999987

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.5e-42  Score=288.67  Aligned_cols=276  Identities=23%  Similarity=0.288  Sum_probs=202.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCce--eEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTST--NGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~--~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~  130 (368)
                      ..|+....||+|.||.||+|...++....  .+|+|.+...   .......-+|+.+++.|+|||++.+..+|.+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            34567788999999999999776655533  6788765443   2445667789999999999999999999876 7789


Q ss_pred             EEEEecccCCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC----CceEEee
Q 017627          131 VLLFEYVPNGTLQEKLHGTP--RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCD  204 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~----~~vkl~D  204 (368)
                      ++++||. .-+|+..++.+.  ....++...+..|++||+.|+.|||++   =|+||||||.||||..+    |.|||+|
T Consensus       104 ~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            9999999 458988887543  446799999999999999999999999   79999999999999877    9999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcch-
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQ-  282 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-  282 (368)
                      ||+++...+.-.            .......++-|.+|+|||.+.|. .|+.+.|+|++|||+.||+|-.+.|.+.... 
T Consensus       180 lGlaR~~~~plk------------pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~  247 (438)
T KOG0666|consen  180 LGLARLFNNPLK------------PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKI  247 (438)
T ss_pred             ccHHHHhhcccc------------ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence            999997544321            11111235689999999999885 7899999999999999999999999775521 


Q ss_pred             --------hhHHHHHhhhhhhhhhhhcchhhhcCC-----CCC-CCCCH----H-------HHHHHHHHHHHhcCCCCCC
Q 017627          283 --------LLTSLAGSMLNDIADCEATKVNELVDP-----RLA-GDFDL----D-------EARAMLSIAALCLRQSPIL  337 (368)
Q Consensus       283 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~----~-------~~~~l~~li~~~l~~dP~~  337 (368)
                              +....+...+....+..+..+..+-+-     ..+ ..+..    .       -++...+|+..+|..||.+
T Consensus       248 ~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k  327 (438)
T KOG0666|consen  248 KTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK  327 (438)
T ss_pred             ccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence                    111222222222222222221111100     000 00000    0       1234788999999999999


Q ss_pred             CCCHHHHHHHH
Q 017627          338 RPSATQILHTI  348 (368)
Q Consensus       338 Rpt~~~il~~L  348 (368)
                      |.|++++++|.
T Consensus       328 RIta~qAleh~  338 (438)
T KOG0666|consen  328 RITAEQALEHP  338 (438)
T ss_pred             hccHHHHhccc
Confidence            99999999874

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-40  Score=292.83  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=198.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .+.+.||.|+||.||++.+..  +...+++|.....  ......+.+|+++++.++||||+++++++...+..++++||+
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRP--TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcC--CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            466789999999999998754  5677888866543  345567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      .+++|.+++....  ..+++..+..++.|++.|+.|||+ .   +++|+||||+||+++.++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999987532  678999999999999999999999 7   999999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc--hhhHHHHHhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLND  294 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~  294 (368)
                                       ....++..|+|||.+.+..++.++||||||+++|+|++|..||.....  ..........   
T Consensus       157 -----------------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---  216 (265)
T cd06605         157 -----------------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---  216 (265)
T ss_pred             -----------------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH---
Confidence                             014588899999999999999999999999999999999999965532  1111111111   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDL-DEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ..... ..... ..+..+.++|..||..||.+|||+.+++.|
T Consensus       217 ------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         217 ------------VNEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ------------hcCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                        11100 01111 146679999999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=297.86  Aligned_cols=267  Identities=27%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |++.+.||+|+||.||+|.+.+  ++..+++|.....   ....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKA--TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCC--CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            4567889999999999998755  5678888876542   3345678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.++.+..+..   ....+++..+..++.|++.||.|||++   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            998877766554   345589999999999999999999999   99999999999999999999999999987543322


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..              ......++..|+|||++.+. .++.++||||||+++|+|++|.+||..................
T Consensus       155 ~~--------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  220 (288)
T cd07833         155 AS--------------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP  220 (288)
T ss_pred             cc--------------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            10              01124578899999999887 8899999999999999999999999766543322222211111


Q ss_pred             hhhhhhcch--h------hhcCCC----CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKV--N------ELVDPR----LAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~--~------~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........  .      +..+..    ....++...+.++.+||..||..+|.+|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            110000000  0      000000    0001122236789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3e-40  Score=296.42  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC-----CeeEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR-----DEGVLL  133 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv  133 (368)
                      .+.+.||+|+||.||+|....  ++..+++|+..........+.+|+.+++.+ +|||++++++++...     +..++|
T Consensus        25 ~~~~~l~~g~~~~vy~~~~~~--~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          25 EIIETIGKGTYGKVYKVTNKK--DGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             EEEEEeecCCCeEEEEEEECC--CCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            456789999999999998654  667889998766555556778899999999 799999999998643     358999


Q ss_pred             EecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          134 FEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |||+.+++|.+++.... ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            99999999999886421 345689999999999999999999999   99999999999999999999999999987533


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-----MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      .....               .....|+..|+|||.+...     .++.++|||||||++|+|++|+.||...........
T Consensus       180 ~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~  244 (291)
T cd06639         180 STRLR---------------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK  244 (291)
T ss_pred             ccccc---------------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence            22110               0123488899999998643     367899999999999999999999975432211100


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .   ..       ...     +..  ......+..+.++|.+||+.+|++||++.++++|
T Consensus       245 ~---~~-------~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 I---PR-------NPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             H---hc-------CCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0   00       000     000  0112234578999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.3e-40  Score=296.20  Aligned_cols=245  Identities=28%  Similarity=0.341  Sum_probs=193.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|....  .+..+++|.....    ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcC--CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            5567889999999999998654  5667888866432    234456889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+. +++.+++..  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9996 577666653  234689999999999999999999999   9999999999999999999999999998643211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                                         ....|++.|+|||++.   ...++.++||||||+++|+|++|..||...+.......... 
T Consensus       169 -------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-  228 (307)
T cd06607         169 -------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-  228 (307)
T ss_pred             -------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-
Confidence                               1134788999999874   35678899999999999999999999976543221111000 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                       ..........++..+.+++..||+.||.+||++.+++.|.
T Consensus       229 -----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         229 -----------------NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -----------------CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                             0000011223566899999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=298.88  Aligned_cols=246  Identities=22%  Similarity=0.293  Sum_probs=200.0

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      ++||+|+||.||-++...  ++..+|.|....+    ........+|..+|.+++.+.||.+-.+|++.+.+|+||..|.
T Consensus       191 RvlGkGGFGEV~acqvra--TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN  268 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRA--TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN  268 (591)
T ss_pred             EEEecccccceeEEEEec--chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence            479999999999998665  6677777643322    3344567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      ||+|.-.|.+. .+..+++..+..++.+|+.||++||+.   +||+||+||+|||+|+.|+|+|+|+|+|......... 
T Consensus       269 GGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~-  343 (591)
T KOG0986|consen  269 GGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI-  343 (591)
T ss_pred             CCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence            99999888766 346899999999999999999999999   9999999999999999999999999999754443322 


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH-HHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS-LAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~  297 (368)
                                     ...+||.+|||||++.+..|+..+|.|||||++|||+.|+.||.......-.+ .-.....    
T Consensus       344 ---------------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----  404 (591)
T KOG0986|consen  344 ---------------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----  404 (591)
T ss_pred             ---------------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----
Confidence                           23479999999999999999999999999999999999999997654332221 1111111    


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                   -...++...++++.+|.+.+|+.||.+|.     .+.++-+|
T Consensus       405 -------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  405 -------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             -------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                         11234556678999999999999999995     44555554

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=303.94  Aligned_cols=280  Identities=19%  Similarity=0.262  Sum_probs=203.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-----CeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-----DEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  131 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|....  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKP--TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcC--CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4567889999999999998754  567889987643  234456678899999999999999999987544     3579


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +|+||+. ++|...+.    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          85 IVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            9999995 57877775    34689999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .......            .......|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+..........
T Consensus       157 ~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~  224 (336)
T cd07849         157 DPEHDHT------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG  224 (336)
T ss_pred             ccccccc------------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            3221110            01122458999999998754 5688999999999999999999999976543222211111


Q ss_pred             hhhhhhhhhhcchhhhcCCC---------CCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcccc
Q 017627          291 MLNDIADCEATKVNELVDPR---------LAGDF-----DLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQISS  354 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~---------~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~~~  354 (368)
                      .......   .....+....         .....     ....+..+.+++..||+.+|.+|||+.++++|  ++.....
T Consensus       225 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         225 VLGTPSQ---EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HcCCCCH---HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            1111000   0000000000         00000     01235678999999999999999999999999  7777766


Q ss_pred             cccccCCCC
Q 017627          355 ISFLFSPQK  363 (368)
Q Consensus       355 ~~~~~~~~~  363 (368)
                      ...+.+++.
T Consensus       302 ~~~~~~~~~  310 (336)
T cd07849         302 SDEPVAEEP  310 (336)
T ss_pred             CCcccCCCC
Confidence            555555443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.9e-40  Score=303.67  Aligned_cols=263  Identities=22%  Similarity=0.219  Sum_probs=195.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------C
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------D  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  128 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+++|....   .......+.+|+.+++.++||||+++++++...      .
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTV--TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECC--CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            34566789999999999998755  567889997643   233445677899999999999999999988643      3


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++||||+. ++|.+.+..     .++...+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            5799999995 578877752     278899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      +.......                .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+
T Consensus       166 ~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~  229 (353)
T cd07850         166 RTAGTSFM----------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI  229 (353)
T ss_pred             eeCCCCCC----------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            75432211                01234788999999999999999999999999999999999999766532222111


Q ss_pred             Hhhhhhhhh-------------------hhhcchhhhcCCCC----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 017627          289 GSMLNDIAD-------------------CEATKVNELVDPRL----AGDFDLDEARAMLSIAALCLRQSPILRPSATQIL  345 (368)
Q Consensus       289 ~~~~~~~~~-------------------~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il  345 (368)
                      .........                   ..............    ........+..+.++|.+||+.||.+|||+.++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL  309 (353)
T cd07850         230 IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL  309 (353)
T ss_pred             HHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence            111110000                   00000001111000    0011123456789999999999999999999999


Q ss_pred             HH
Q 017627          346 HT  347 (368)
Q Consensus       346 ~~  347 (368)
                      +|
T Consensus       310 ~~  311 (353)
T cd07850         310 QH  311 (353)
T ss_pred             cC
Confidence            87

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-40  Score=292.00  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=195.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-----------hHHHHHHHHHHHHhcCCCCceeeeeEEEecC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----------RLSQVFKQELDILLHLSHDNIVKLIGYCDDR  127 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  127 (368)
                      |...+.||.|+||.||+|....  ++..+++|......           ...+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   80 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVT--TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE   80 (272)
T ss_pred             eeecceecccCceEEEEEeecC--CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence            3456789999999999998654  56678888654211           1234678899999999999999999999999


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      +..++||||+.+++|.+++..   ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999999874   35789999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM--ASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      ++........             .......|+..|+|||.+....  ++.++|+||||+++|++++|..||.........
T Consensus       155 ~~~~~~~~~~-------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  221 (272)
T cd06629         155 SKKSDDIYDN-------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM  221 (272)
T ss_pred             cccccccccc-------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence            8743221100             0012234889999999987654  789999999999999999999999644321110


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                        . ...           .....+..........+..+.+++..||..+|.+|||+.++++|
T Consensus       222 --~-~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         222 --F-KLG-----------NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             --H-Hhh-----------ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence              0 000           00001111111222345689999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-40  Score=298.70  Aligned_cols=266  Identities=24%  Similarity=0.329  Sum_probs=197.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |++.+.||+|+||.||+|.+.+  ++..+++|.....   ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKE--TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECC--CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            4466789999999999998755  5677888865432   2235667889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|..+..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999998888765   334589999999999999999999999   99999999999999999999999999987532221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||..................
T Consensus       155 ~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07846         155 E---------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN  219 (286)
T ss_pred             c---------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCC
Confidence            0               0012357889999999876 45788999999999999999999999765432211111111111


Q ss_pred             hhhhhhc------chhhhcCCCCCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEAT------KVNELVDPRLAGD-----FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......      .......+.....     .....+..+.+|+.+||+.+|.+|||+.++++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             CchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000      0000000100000     011335679999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.4e-40  Score=292.42  Aligned_cols=242  Identities=21%  Similarity=0.265  Sum_probs=186.7

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhc---CCCCceeeeeEEEecCCeeEEEEec
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLH---LSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .||+|+||.||++....  ++..+++|......    .....+.+|..+++.   .+||||+.+++++...+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECC--CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            48999999999998754  56788888664321    222334445544443   4799999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|..++.   ....+++..+..++.|++.||.|||++   +|+|+||||+|||++.++.++|+|||++........
T Consensus        79 ~~~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          79 MNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            99999999887   345699999999999999999999999   999999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                       ....|++.|+|||.+. +..++.++||||+||++|+|++|..||................   
T Consensus       153 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---  212 (279)
T cd05633         153 -----------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---  212 (279)
T ss_pred             -----------------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---
Confidence                             1135899999999986 4568899999999999999999999997543322111110000   


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                    ......+...+..+.+++..||+.||.+||     |+.++++|
T Consensus       213 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 --------------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --------------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                          001112223456889999999999999999     69999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7e-40  Score=292.93  Aligned_cols=267  Identities=22%  Similarity=0.286  Sum_probs=198.2

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .+.+.||.|++|.||+|.+..  ++..+++|.....  ......+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRT--TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             eEeeeeccCCceEEEEEEECC--CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            456789999999999998754  5677888876543  223456778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+ +|.+++........+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            64 8888887544445689999999999999999999999   999999999999999999999999999864322110 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                    ......++..|++||++.+. .++.++||||||+++|+|++|..||.+.+................
T Consensus       156 --------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd07836         156 --------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT  221 (284)
T ss_pred             --------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence                          00123478899999998664 568899999999999999999999987664333222211111110


Q ss_pred             hhhhcchhh--hcCCCCC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNE--LVDPRLA-------GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~--~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......+..  .......       .......+..+.+++..||+.||.+||++.++++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000000000  0000000       00112335678999999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.8e-40  Score=290.02  Aligned_cols=243  Identities=26%  Similarity=0.326  Sum_probs=195.5

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ||.|+||.||+|.+..  ....+++|+....    ....+.+.+|+.+++.++||||+++++++.+++..++||||++++
T Consensus         1 lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKS--KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECC--CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            6999999999999754  5678888876543    234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++..   ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.......     
T Consensus        79 ~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----  147 (262)
T cd05572          79 ELWTILRD---RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----  147 (262)
T ss_pred             cHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----
Confidence            99999973   34589999999999999999999998   99999999999999999999999999987543221     


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                 ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ .....          
T Consensus       148 -----------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----------  205 (262)
T cd05572         148 -----------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYND----------  205 (262)
T ss_pred             -----------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHHH----------
Confidence                       01223588999999999888899999999999999999999999976553111 11111          


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                           .........++...+..+.+++..||+.||.+||+     ++++++|
T Consensus       206 -----~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         206 -----ILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             -----HhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence                 11001111122223568999999999999999999     8888874

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-39  Score=288.84  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=196.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC-----------ChhHHHHHHHHHHHHhc-CCCCceeeeeEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-----------SDRLSQVFKQELDILLH-LSHDNIVKLIGYCDD  126 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-----------~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~  126 (368)
                      |.+.+.||+|+||.||+|.+..+ ....+++|....           .......+..|+.++.. ++||||+++++++.+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNN-GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCC-CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            34667899999999999997542 356777775432           22334556778888875 799999999999999


Q ss_pred             CCeeEEEEecccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeec
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                      .+..++||||+.+++|.+++... .....+++..++.++.|++.||.|||+..  +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887532 13456899999999999999999999631  8999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |.+.......                ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus       159 g~~~~~~~~~----------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~  222 (269)
T cd08528         159 GLAKQKQPES----------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA  222 (269)
T ss_pred             cceeeccccc----------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence            9987533221                112245889999999999888999999999999999999999999654432211


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      .....              ....+..    ....+..+.+++.+||+.||.+||++.++..+++
T Consensus       223 ~~~~~--------------~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 TKIVE--------------AVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHhh--------------ccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11100              0000100    1123457899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7e-40  Score=289.59  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ++.+.||+|++|.||+|.+..  ++..+++|+.....  .....+.+|+.++..++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~--~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKP--TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcC--CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            456789999999999998765  56778888765543  45678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      ++++|.+++..   ...+++..++.++.|++.|+.|||+ .   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            99999999974   3678999999999999999999999 8   999999999999999999999999999875432221


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      .               .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.................   
T Consensus       156 ~---------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---  217 (264)
T cd06623         156 Q---------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---  217 (264)
T ss_pred             c---------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---
Confidence            1               0134588999999999988999999999999999999999999976542111111111110   


Q ss_pred             hhhhcchhhhcCCCCCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLD-EARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  . .....+.. .+..+.+++..||..+|.+|||+.+++++
T Consensus       218 ------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 ------------G-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ------------C-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                        0 00111222 45689999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.3e-39  Score=294.21  Aligned_cols=249  Identities=26%  Similarity=0.329  Sum_probs=195.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +...+.||+|+||.||+|....  ++..+++|.....    ......+.+|+++++.++|||++++++++.+.+..++||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcC--CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4567789999999999998755  5677888876432    234457888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+ +|.+.+..  ....+++..+..++.|++.|+.|||++   +|+|+||+|+||+++.++.++|+|||++......
T Consensus       105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            99964 77776653  245689999999999999999999999   9999999999999999999999999987642211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                                         ....|++.|+|||.+.   ...++.++||||||+++|+|++|..||...+.......... 
T Consensus       179 -------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-  238 (317)
T cd06635         179 -------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-  238 (317)
T ss_pred             -------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-
Confidence                               1234888999999974   45688899999999999999999999876543211111000 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                       ...........+..+.+++.+||+.+|.+||++.++++|+-...
T Consensus       239 -----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         239 -----------------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -----------------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                             00000111234557899999999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-40  Score=296.38  Aligned_cols=265  Identities=23%  Similarity=0.242  Sum_probs=194.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ++.+.||.|+||.||+|.+..  ++..+++|.....   ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             eeeeeecCCCceEEEEEEECC--CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            456779999999999998754  5667888865433   22335688899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. ++|..++... ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 6888888654 345689999999999999999999999   999999999999999999999999999864322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......+++.|+|||++.+.. ++.++||||||+++|+|+||..||...+...............
T Consensus       156 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  220 (284)
T cd07860         156 ---------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP  220 (284)
T ss_pred             ---------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                           001224688999999887644 5889999999999999999999997655322211111111110


Q ss_pred             hhhhhc----------chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEAT----------KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......          .......... .......+..+.++|.+||+.||.+|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         221 DEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             ChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000000          0000000000 00011234578899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.1e-40  Score=291.23  Aligned_cols=245  Identities=24%  Similarity=0.310  Sum_probs=192.5

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ||+|+||+||+|.+..  ++..+++|+....    ......+.+|+++++.++||||+++++++...+..|+||||+.++
T Consensus         1 lg~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKA--TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcC--CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            6999999999998655  5677888876432    223445678999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++... ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+........    
T Consensus        79 ~L~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----  150 (277)
T cd05577          79 DLKYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----  150 (277)
T ss_pred             cHHHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----
Confidence            999998743 224689999999999999999999999   999999999999999999999999999864322110    


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                  .....++..|+|||++.+..++.++||||||+++|+|++|..||................        
T Consensus       151 ------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  210 (277)
T cd05577         151 ------------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--------  210 (277)
T ss_pred             ------------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--------
Confidence                        012347889999999988889999999999999999999999997654321111110000        


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                        . .     .....+...+..+.++|..||+.||.+||     ++.+++.|
T Consensus       211 --~-~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         211 --L-E-----MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             --c-c-----ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence              0 0     00111222356789999999999999999     77878865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-40  Score=292.82  Aligned_cols=254  Identities=27%  Similarity=0.356  Sum_probs=196.2

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e  135 (368)
                      +..+.||.|++|.||++.+..  +...+++|.....  ......+.+|+++++.++||||+++++++.+.  +..++|||
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKN--TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             EEEEEeccCCceEEEEEEECC--CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            345789999999999999755  6778899876543  23456788999999999999999999988543  46899999


Q ss_pred             cccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |+++++|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            999999988765321 345688999999999999999999999   9999999999999999999999999998643211


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ--LLTSLAGSML  292 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~  292 (368)
                      ..                 ....++..|+|||.+.+..++.++||||||+++|+|++|..||......  ..........
T Consensus       159 ~~-----------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (287)
T cd06621         159 LA-----------------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV  221 (287)
T ss_pred             cc-----------------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh
Confidence            10                 1134788899999999889999999999999999999999999765321  0011110000


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDF--DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ....+.+....  ....+..+.+++.+||+.||.+|||+.++++|
T Consensus       222 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         222 ------------NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ------------cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                        00000111000  12245678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=284.26  Aligned_cols=268  Identities=22%  Similarity=0.324  Sum_probs=201.8

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEeccc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      -.+.||+|+|+.|--++...  ++..+|||++... .....+..+|++++...+ |+||++++++|++++..|+|||.|.
T Consensus        82 t~e~LGeGAyasVqtcv~i~--t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   82 TSELLGEGAYASVQTCVSIQ--TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHHhcCccceeeeeeeeec--cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            35789999999999887655  7788899987654 456778889999999995 9999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC---CceEEeeccccccCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH---LNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~---~~vkl~Dfg~s~~~~~~~  215 (368)
                      ||.|...+.   ...-+++.++..+..+|+.||.|||.+   ||.|||+||+|||-..-   .-||||||.+..-.....
T Consensus       160 GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  160 GGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             CchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            999999887   455689999999999999999999999   99999999999998654   348999999875322222


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhh---cc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL---RT--GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .        .+........+.+|+..|||||+.   .+  ..|+.++|.||||+|+|.|++|.+||.+.-+.+..+...+
T Consensus       234 ~--------~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  234 D--------CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             C--------CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            1        111122233457899999999976   22  3689999999999999999999999977554322211111


Q ss_pred             hhhhhhhhhhcchhhhcCCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRL--AGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....   +...-...+-+..+  +..--...+.+..++++.+|..++.+|.++.+++.|
T Consensus       306 ~Cr~---CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  306 VCRV---CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             ccHH---HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            1110   00011111111111  011112447789999999999999999999999985

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=294.41  Aligned_cols=266  Identities=24%  Similarity=0.275  Sum_probs=192.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|......  .....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKL--TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcC--CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            3466789999999999998654  56678999765432  2234566899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. ++|.+++...  ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LD-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CC-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            96 4898888643  34689999999999999999999999   999999999999999999999999999864221110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENG-QLLTSLAGSMLND  294 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~  294 (368)
                      .               .....++..|+|||++.+ ..++.++||||+|+++|+|++|..||..... ..........+..
T Consensus       159 ~---------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  223 (291)
T cd07844         159 T---------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT  223 (291)
T ss_pred             c---------------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence            0               011236788999999876 4578999999999999999999999976542 1111111111111


Q ss_pred             hhhhhhcchh---hhc--------CCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVN---ELV--------DPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~---~~~--------~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..........   ...        ...+.... .......+.+++..||+.+|.+|||+.+++.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000000000   000        00000000 00112577899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.7e-39  Score=296.38  Aligned_cols=271  Identities=21%  Similarity=0.230  Sum_probs=194.8

Q ss_pred             hhcccc--cceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSG--GFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G--~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ..||.|  +||+||+|.+..  .+..+|+|+....   ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP--TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC--CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            346666  999999998644  6788899986532   334577889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++... ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          82 AYGSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             cCCCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            999999988754 234589999999999999999999999   9999999999999999999999999865432211110


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--MASTKTDVYSFGVILLELVTGMEAFCPENGQLLT-SLAGSMLND  294 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~  294 (368)
                      ...        .........++..|+|||++.+.  .++.++||||+||++|+|++|..||......... .........
T Consensus       158 ~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd08226         158 AKV--------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS  229 (328)
T ss_pred             ccc--------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC
Confidence            000        00000112356779999999764  4788999999999999999999999765432111 100000000


Q ss_pred             hhh------h----------hh-----cch-----hhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IAD------C----------EA-----TKV-----NELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~------~----------~~-----~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...      .          ..     ...     .......+........+..+.+|++.||+.||.+|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            000      0          00     000     00111111122233456789999999999999999999999977

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-40  Score=292.79  Aligned_cols=248  Identities=23%  Similarity=0.288  Sum_probs=199.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||.|+||.||+|.+..  +...+++|+....    ....+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRD--TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEcc--CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            3467789999999999998754  5677899876543    244577889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|..++..   ...+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          80 DLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             eCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999873   35789999999999999999999999   9999999999999999999999999998753322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||................  
T Consensus       154 ~~----------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--  215 (258)
T cd05578         154 TL----------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--  215 (258)
T ss_pred             cc----------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--
Confidence            10                112348889999999998889999999999999999999999998765421111111100  


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA--TQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~--~~il~~  347 (368)
                                .     .....+...+..+.++|.+||+.||.+||++  .++++|
T Consensus       216 ----------~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         216 ----------T-----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             ----------c-----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence                      0     0111222334688999999999999999999  776643

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-42  Score=318.64  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=214.3

Q ss_pred             hhcccccceEEEEEEEcCC-CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           63 QVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      ++||.|.||.|++|+.+-. +....||||..+..  ++....|..|+.||-++.||||+++.|+.+....+.||.|||.+
T Consensus       635 ~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMEN  714 (996)
T KOG0196|consen  635 KVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMEN  714 (996)
T ss_pred             EEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhC
Confidence            5799999999999987643 34566899977654  56677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |+|+.||+.+  .+.+...++..++++|+.|+.||-+.   ++|||||...||||+.+-.+|++|||+||...++.... 
T Consensus       715 GsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~-  788 (996)
T KOG0196|consen  715 GSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-  788 (996)
T ss_pred             CcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCcc-
Confidence            9999999874  46689999999999999999999999   99999999999999999999999999999654443100 


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                            -.+     ....=..+|.|||.+....++.+|||||+|+++||+++ |..||-....++..+.+          
T Consensus       789 ------ytt-----~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----------  847 (996)
T KOG0196|consen  789 ------YTT-----LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----------  847 (996)
T ss_pred             ------ccc-----cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----------
Confidence                  000     00112358999999999999999999999999999988 99998776655443322          


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                               +..++...+.+++..|.+|+..||+.|=.+||++.+|+.+|++++.+
T Consensus       848 ---------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  848 ---------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ---------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                     22334445667788999999999999999999999999999999864

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=289.75  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=195.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCC---CCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLS---HDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....  ......+.+|+.+++.++   |||++++++++...+..++|
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVP--TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcC--CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            4466789999999999998754  5678899976542  344567888999999996   99999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++..    ..+++..++.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          81 MEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999998863    3689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...               ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||............    
T Consensus       154 ~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~----  214 (277)
T cd06917         154 NSS---------------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI----  214 (277)
T ss_pred             Ccc---------------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----
Confidence            221               0112358899999999865 45788999999999999999999999754432111100    


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                 .....+.+...   ..+.++.+++..||+.||.+||++.+++.+
T Consensus       215 -----------~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         215 -----------PKSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -----------ccCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                       00001111111   134578999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.8e-39  Score=290.60  Aligned_cols=249  Identities=24%  Similarity=0.323  Sum_probs=199.4

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.+.||+|+||.||+|.+..  ....+++|+..........+.+|+++++.++|+||+++++++...+..++|+||+.+
T Consensus        22 ~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          22 KNLEKIGEGASGEVYKATDRA--TGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             hHhHhccCCCCeEEEEEEEcc--CCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            355779999999999998754  566788887766554566788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++....  ..+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++........   
T Consensus       100 ~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  171 (286)
T cd06614         100 GSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---  171 (286)
T ss_pred             CcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh---
Confidence            99999998532  3789999999999999999999998   999999999999999999999999998764322110   


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..........         
T Consensus       172 ------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~---------  230 (286)
T cd06614         172 ------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT---------  230 (286)
T ss_pred             ------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Confidence                        01123478899999999988899999999999999999999999976543221111100         


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       ...       .........+..+.++|..||+.+|.+|||+.+++.+
T Consensus       231 -~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         231 -KGI-------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -cCC-------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             000       0000111245678999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-40  Score=296.67  Aligned_cols=273  Identities=21%  Similarity=0.292  Sum_probs=196.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVL  132 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l  132 (368)
                      |.+.+.||+|+||.||+|.+.....+..+++|.....    ......+.+|+.++..++||||+++++++.+.  +..++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            4466789999999999999765436788899977652    23345677899999999999999999999888  78999


Q ss_pred             EEecccCCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC----CCceEEeecc
Q 017627          133 LFEYVPNGTLQEKLHGTP--RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE----HLNCKLCDFG  206 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~----~~~vkl~Dfg  206 (368)
                      ||||+.+ +|.+++....  ....+++..++.++.|++.||.|||++   +|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999965 6766664322  223689999999999999999999999   9999999999999999    9999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh--
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQL--  283 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--  283 (368)
                      ++.........            ........++..|+|||++.+ ..++.++||||||+++|+|++|.+||.......  
T Consensus       158 ~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~  225 (316)
T cd07842         158 LARLFNAPLKP------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK  225 (316)
T ss_pred             cccccCCCccc------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence            98754332210            001122457899999998876 457899999999999999999999997655332  


Q ss_pred             ----hHHHHHhhhhhhhhhhh---------cchhhhcCCCCCCCCC-----H------HHHHHHHHHHHHhcCCCCCCCC
Q 017627          284 ----LTSLAGSMLNDIADCEA---------TKVNELVDPRLAGDFD-----L------DEARAMLSIAALCLRQSPILRP  339 (368)
Q Consensus       284 ----~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~-----~------~~~~~l~~li~~~l~~dP~~Rp  339 (368)
                          ...........+.....         .......+......++     .      ..+..+.+++.+||+.||++||
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  305 (316)
T cd07842         226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI  305 (316)
T ss_pred             cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence                00011111110000000         0000000000000011     0      2345788999999999999999


Q ss_pred             CHHHHHHH
Q 017627          340 SATQILHT  347 (368)
Q Consensus       340 t~~~il~~  347 (368)
                      |+.++++|
T Consensus       306 s~~eil~~  313 (316)
T cd07842         306 TAEEALEH  313 (316)
T ss_pred             CHHHHhcC
Confidence            99999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.9e-40  Score=292.12  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=188.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHH-HhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDI-LLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|.+..  ++..+|+|......  .....+..|+.+ ++.++||||+++++++...+..+++|||
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVP--TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcC--CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            356789999999999998754  67888999765432  223345556665 6667899999999999999999999999


Q ss_pred             ccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          137 VPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       137 ~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ++ ++|.+++... .....+++..++.++.|++.||.|||+++  +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            95 6887777542 23457899999999999999999999863  89999999999999999999999999987532211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .                .....|+..|+|||.+.+    ..++.++|+|||||++|+|++|..||....... . .....
T Consensus       159 ~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~-~~~~~  220 (283)
T cd06617         159 A----------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-Q-QLKQV  220 (283)
T ss_pred             c----------------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-H-HHHHH
Confidence            0                012347889999999865    456889999999999999999999996432210 0 00000


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..            ...+...   ....+.++.+++..||..+|.+|||+.++++|
T Consensus       221 ~~------------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         221 VE------------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             Hh------------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00            0001110   11235679999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-39  Score=292.90  Aligned_cols=264  Identities=23%  Similarity=0.251  Sum_probs=191.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|+....  ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRI--NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcC--CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            3456789999999999998755  4567888876543  22234567899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. ++|..++...  ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||+++.......
T Consensus        85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          85 MH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             cc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            95 6776666532  34578888999999999999999999   999999999999999999999999999874322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh-
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND-  294 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-  294 (368)
                      .               .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||......  .......... 
T Consensus       159 ~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~  221 (291)
T cd07870         159 T---------------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVL  221 (291)
T ss_pred             C---------------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHc
Confidence            0               0123478899999998764 5788999999999999999999999765432  1111111000 


Q ss_pred             --hhhhhh---cchh----hhcCCCCCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 --IADCEA---TKVN----ELVDPRLAGDF-----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 --~~~~~~---~~~~----~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                        ......   ....    ...........     ....+..+.+++.+||..||.+|||+.+++.|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         222 GVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             CCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence              000000   0000    00000000000     00114578899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.6e-40  Score=293.46  Aligned_cols=265  Identities=17%  Similarity=0.169  Sum_probs=184.5

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCC-ceeEEEEeecCChhH--H----------HHHHHHHHHHhcCCCCceeeeeE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDST-STNGAIKIHVGSDRL--S----------QVFKQELDILLHLSHDNIVKLIG  122 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~-~~~~aik~~~~~~~~--~----------~~~~~E~~~l~~l~h~~iv~~~~  122 (368)
                      ...|.+.+.||+|+||.||+|.+.++.. ...+++|+.......  .          .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3456678899999999999998765311 345566653322111  0          11123344556678999999998


Q ss_pred             EEecCC----eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC
Q 017627          123 YCDDRD----EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL  198 (368)
Q Consensus       123 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~  198 (368)
                      ++....    ..+++++++ ..++.+.+..   ....++..+..++.|++.||.|||++   +|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            765443    347788877 3466666652   23457888999999999999999999   999999999999999999


Q ss_pred             ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 017627          199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP  278 (368)
Q Consensus       199 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  278 (368)
                      .++|+|||+|+...........        .........||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~--------~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEY--------SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             cEEEEEcCCceeeccCCccccc--------ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999764322211100        00111224599999999999999999999999999999999999999977


Q ss_pred             Ccc-hhhHHHHH-hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          279 ENG-QLLTSLAG-SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       279 ~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      ... ........ .....           +..+...   ....+..+.+++..||+.+|++||++.++++.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        236 FGHNGNLIHAAKCDFIKR-----------LHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             cccchHHHHHhHHHHHHH-----------hhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            632 21111111 11111           1111100   0122467899999999999999999999998763

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=292.67  Aligned_cols=249  Identities=24%  Similarity=0.308  Sum_probs=197.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC-ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +|.+.+.||+|+||.||++....  ++..+++|.... .....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVA--TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcC--CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            44567889999999999998644  456688887643 233456788899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++++|.+++..    ..+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999863    3578889999999999999999999   999999999999999999999999998864322111


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......|++.|+|||.+.+..++.++|+||||+++|++++|..||...+.........       
T Consensus       171 ---------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-------  228 (293)
T cd06647         171 ---------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------  228 (293)
T ss_pred             ---------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------
Confidence                           0112358889999999988889999999999999999999999997654321110000       


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ..+..........+..+.+++..||..+|.+||++.+++.|
T Consensus       229 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         229 ----------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ----------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00000111122335578899999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=309.74  Aligned_cols=271  Identities=27%  Similarity=0.355  Sum_probs=201.5

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------eeE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------EGV  131 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~  131 (368)
                      ...+.||+|+||.||+++.  +.++..+|||.....  ....+...+|+++|++|+|+|||+++++=++..      ...
T Consensus        16 ~~~e~LG~Ga~g~V~rgrn--ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRN--KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eehhhhcCCccceeeeecc--cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3467799999999999974  458999999977652  344567789999999999999999999865543      568


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec--CCC--ceEEeeccc
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE--EHL--NCKLCDFGS  207 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~~~--~vkl~Dfg~  207 (368)
                      +|||||.+|+|...+..-.+..++++.+++.++.+++.||.|||++   ||+||||||.||++-  .+|  ..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999999877778999999999999999999999999   999999999999984  223  479999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-hH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQL-LT  285 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~  285 (368)
                      |+-...+.                ......||+.|++||.+.. ..|+..+|.|||||++|+..||..||.+..... ..
T Consensus       171 Arel~d~s----------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~  234 (732)
T KOG4250|consen  171 ARELDDNS----------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK  234 (732)
T ss_pred             cccCCCCC----------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc
Confidence            98543332                3356789999999999985 889999999999999999999999998766541 11


Q ss_pred             HHHHhhhhhhhhhhhcchh-hhcCC-------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhc
Q 017627          286 SLAGSMLNDIADCEATKVN-ELVDP-------RLAGDFDLDEARAMLSIAALCLRQSPILRP--SATQILHTIKHQ  351 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp--t~~~il~~L~~~  351 (368)
                      ...-.....-++..+.... ...+|       ..+..........+-..+..+|..+|++|-  ..-+....+..+
T Consensus       235 ~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  235 EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            1111111111111111111 11101       112222344455667788889999999998  444444443333

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=287.24  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=195.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC------hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--Cee
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS------DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEG  130 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  130 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|.....      ......+.+|+++++.++|+||+++++++.+.  ...
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDAD--TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcC--CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3467889999999999998654  5678888865321      23446788999999999999999999998664  458


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      +++|||+++++|.+++.   ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999887   334588999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .......            ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........     
T Consensus       156 ~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----  218 (264)
T cd06653         156 IQTICMS------------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI-----  218 (264)
T ss_pred             ccccccc------------CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH-----
Confidence            3221100            00011245889999999999888999999999999999999999999654321110     


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   ............+...+..+.+++..||. +|..|||+.+++.|
T Consensus       219 -------------~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         219 -------------FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -------------HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                         00111111122333455689999999999 57999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-39  Score=291.24  Aligned_cols=252  Identities=25%  Similarity=0.304  Sum_probs=191.4

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ..+.||+|+||.||++.+..  ++..+++|.....  ......+.+|+.++.++. |+||+++++++...+..+++|||+
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKP--SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             HHHHhCCCCceEEEEEEECC--CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            45679999999999998754  5678899876543  244567888999999996 999999999999888999999998


Q ss_pred             cCCCHHHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          138 PNGTLQEKLHG--TPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       138 ~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      . +++.++...  ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.++|+|||+++......
T Consensus        86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            5 455543321  112457899999999999999999999742  89999999999999999999999999987433221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG---MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ..                ....|+..|+|||++.+.   .++.++||||+|+++|+|++|..||.....  .........
T Consensus       163 ~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~  224 (288)
T cd06616         163 AK----------------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV  224 (288)
T ss_pred             cc----------------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc
Confidence            10                112488899999999876   688999999999999999999999965431  111111100


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .            ...+.+........+..+.+|+..||+.||.+|||+.+++.|
T Consensus       225 ~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         225 K------------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             C------------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0            001111112222345689999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=303.38  Aligned_cols=245  Identities=32%  Similarity=0.425  Sum_probs=204.0

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ..|.+...||+|.|++|.+|.+..  +...||||++..+   ....+.+.+|+++|..|+|||||+++.+......+|+|
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~--t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHIL--TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecC--CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            344567789999999999999766  6888999987654   23334578999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+|.+.+++.   ..+...+..+..++.|+++|++|+|++   +|+|||||++|||++.+.++||+|||++.....
T Consensus       134 ~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999998   455677789999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ....                .+.+|++.|.|||++.|..| .+.+|+||+|+++|.|+.|..||.+.+-.          
T Consensus       208 ~~~l----------------qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----------  261 (596)
T KOG0586|consen  208 GLML----------------QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----------  261 (596)
T ss_pred             cccc----------------cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----------
Confidence            3322                34679999999999999776 57899999999999999999999765432          


Q ss_pred             hhhhhhhhcchhhhcCCCCCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGD--FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ++-++.+.+.  .+...+.++.++|+.+|-.+|.+|++..++.++
T Consensus       262 ------------~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  262 ------------ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ------------cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                        1112222211  223345678899999999999999999999887

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-39  Score=289.08  Aligned_cols=263  Identities=27%  Similarity=0.305  Sum_probs=192.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecC--CeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDR--DEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~  134 (368)
                      .+.+.||+|+||.||+|....  +...+++|.....  ........+|+.+++++. |+||+++++++.+.  +..++||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRK--TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             ceEeeccccccceEEEEEEcC--CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            356789999999999998754  5677888876543  222233457899999885 99999999999877  8899999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+. ++|.+++...  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++. +.+||+|||+++.....
T Consensus        80 e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          80 ELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             ecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9996 5777777642  34689999999999999999999999   9999999999999999 99999999998754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...                ....++..|+|||.+.. ..++.++||||+||++|+|++|..||...+.............
T Consensus       153 ~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~  216 (282)
T cd07831         153 PPY----------------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG  216 (282)
T ss_pred             CCc----------------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcC
Confidence            110                11347889999997644 5678899999999999999999999987665433322222211


Q ss_pred             hhhhhhhcc-----hhhhcCCCCCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATK-----VNELVDPRLAG----DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........     ......+....    ......+..+.++|..||+.+|.+|||++++++|
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             CCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            111000000     00000000000    0012346789999999999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-39  Score=294.65  Aligned_cols=270  Identities=24%  Similarity=0.268  Sum_probs=194.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-------
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-------  128 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------  128 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|.....   ......+.+|+.+++.++||||+++++++....       
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKK--TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECC--CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            4567789999999999998655  6778888866432   222345568999999999999999999986544       


Q ss_pred             -eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          129 -EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       129 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                       ..++||||+. ++|..++..  ....+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence             3599999995 578777764  234689999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      +..........           ........++..|+|||.+.+. .++.++||||||+++|+|++|..||...+......
T Consensus       166 ~~~~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~  234 (310)
T cd07865         166 ARAFSLSKNSK-----------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT  234 (310)
T ss_pred             cccccCCcccC-----------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            97543222110           0001223578899999998765 46889999999999999999999998766543333


Q ss_pred             HHHhhhhhhhhhhhcchh--hhcC-CCCCCCC---------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVN--ELVD-PRLAGDF---------DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........+........  ...+ -......         ....+..+.+||.+||+.||.+|||++++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            333322111110000000  0000 0000000         00123467899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-39  Score=292.79  Aligned_cols=268  Identities=24%  Similarity=0.250  Sum_probs=193.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCe-----
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDE-----  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~-----  129 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|......   .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~--~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKN--TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECC--CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3456789999999999998755  56778888754432   23356778999999995 6999999999876655     


Q ss_pred             eEEEEecccCCCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-CCceEEeecc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPR--SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFG  206 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg  206 (368)
                      .++||||+.+ +|..++.....  ...+++..++.++.||+.||.|||++   +|+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999975 78887764322  35689999999999999999999999   9999999999999998 8999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      +++........               .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.....
T Consensus       157 ~~~~~~~~~~~---------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~  221 (295)
T cd07837         157 LGRAFSIPVKS---------------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL  221 (295)
T ss_pred             cceecCCCccc---------------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            98743221100               011246888999998865 45789999999999999999999999765533222


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcC----CCCC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVD----PRLA----GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......................+    +...    .......+..+.+||..||..||.+|||+.+++.|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            11111111100000000000000    0000    00011245678999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.1e-39  Score=289.98  Aligned_cols=244  Identities=22%  Similarity=0.322  Sum_probs=194.4

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      +.||+|++|.||++....  ....+++|..... ....+.+.+|+.+++.++||||+++++++...+..++++||+.+++
T Consensus        25 ~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~  102 (285)
T cd06648          25 VKIGEGSTGIVCIATDKS--TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA  102 (285)
T ss_pred             eEeccCCCeEEEEEEECC--CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence            579999999999998654  5567888865433 2344567899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCC
Q 017627          142 LQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP  221 (368)
Q Consensus       142 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~  221 (368)
                      |.+++..    ..+++..+..++.|++.||.|||++   +++||||+|+||+++.++.++|+|||.+........     
T Consensus       103 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-----  170 (285)
T cd06648         103 LTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-----  170 (285)
T ss_pred             HHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence            9999863    4588999999999999999999999   999999999999999999999999998764322110     


Q ss_pred             CCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhc
Q 017627          222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEAT  301 (368)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (368)
                                ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..........           
T Consensus       171 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~-----------  229 (285)
T cd06648         171 ----------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-----------  229 (285)
T ss_pred             ----------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh-----------
Confidence                      01223588999999999988899999999999999999999999976443211111110           


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                          ...+...  .....+..+.+++.+||+.+|.+|||+.++++|
T Consensus       230 ----~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         230 ----NLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ----cCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence                0001111  011234579999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-39  Score=294.60  Aligned_cols=279  Identities=23%  Similarity=0.257  Sum_probs=200.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  133 (368)
                      |++.+.||+|+||.||+|.+..  ++..+++|......   .....+.+|+.+++.++|+||+++++++...  +..++|
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTT--SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECC--CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            3466789999999999998754  56778888765332   2223456799999999999999999998654  568999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+. ++|.+++...  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        87 ~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          87 MEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99995 5788887643  35689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ....               .....+++.|+|||++.+ ..++.++||||||+++|+|++|.+||...+............
T Consensus       161 ~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  225 (309)
T cd07845         161 PAKP---------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL  225 (309)
T ss_pred             ccCC---------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            2100               011235788999999865 567899999999999999999999998766544333222222


Q ss_pred             hhhhhhhhcchhh------hc-CCCCCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          293 NDIADCEATKVNE------LV-DPRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       293 ~~~~~~~~~~~~~------~~-~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                      .............      .. ........   ....+..+.++|..||+.||++|||+.+++.|  ..+...+.+..|.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h--~~f~~~~~~~~~~  303 (309)
T cd07845         226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES--SYFKEKPLPCEPE  303 (309)
T ss_pred             CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC--hhhccCCCCCCCC
Confidence            1111100000000      00 00000000   01135678899999999999999999999986  3334444444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.7e-40  Score=300.68  Aligned_cols=279  Identities=20%  Similarity=0.253  Sum_probs=203.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-----Cee
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-----DEG  130 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  130 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|.....   ......+.+|+.+++.++|+||+++++++...     ...
T Consensus         7 y~~~~~lg~G~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           7 YVPIKPIGRGAYGIVCSAKNSE--TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             eeEEEEeccCCCeEEEEEEecC--CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4466789999999999998654  6778888865432   23345677899999999999999999987644     357


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++|+||+. ++|.+++.   ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            99999995 68888887   345799999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......               ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.........
T Consensus       158 ~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  222 (337)
T cd07858         158 TSEKGD---------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT  222 (337)
T ss_pred             cCCCcc---------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence            322110               0112357889999998865 468899999999999999999999997765432222222


Q ss_pred             hhhhhhhhhhh-----cchhhhcC---CCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcccccc
Q 017627          290 SMLNDIADCEA-----TKVNELVD---PRLAG---DFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQISSIS  356 (368)
Q Consensus       290 ~~~~~~~~~~~-----~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~~~~~  356 (368)
                      ...........     ........   .....   ......+..+.+++.+||+.+|.+|||++++++|  ++.......
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence            21111100000     00000000   00000   0112345678999999999999999999999999  777666555


Q ss_pred             cccCC
Q 017627          357 FLFSP  361 (368)
Q Consensus       357 ~~~~~  361 (368)
                      .+.++
T Consensus       303 ~~~~~  307 (337)
T cd07858         303 EPVCQ  307 (337)
T ss_pred             CccCC
Confidence            55444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=302.95  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=205.0

Q ss_pred             hhhhcccccceEEEEEEEcC-CCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.++||+|.||+|+.|.|.. .++...||||......  .....|.+|+.+|.+|+|||++++||+..+ ....||||++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            56789999999999999865 3456778999876653  257889999999999999999999999987 6788999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      +.|+|.+.|+. .....+....+..++.||+.|+.||.++   ++|||||...|+|+-....|||+|||+.+........
T Consensus       193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999986 3456788889999999999999999999   9999999999999999889999999999865433311


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      -            .......-...|+|||.+....++.++|+|++|+++|||++ |..||.+..+....           
T Consensus       269 Y------------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-----------  325 (1039)
T KOG0199|consen  269 Y------------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-----------  325 (1039)
T ss_pred             e------------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-----------
Confidence            0            00000112346999999999999999999999999999999 88999887664333           


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH  346 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  346 (368)
                              +.+|..-+...+..|++++++++..||..+|++|||+..|.+
T Consensus       326 --------~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  326 --------KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             --------HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence                    222333333345577899999999999999999999999973

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.8e-40  Score=288.24  Aligned_cols=249  Identities=27%  Similarity=0.382  Sum_probs=196.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||++....  .+..+++|.....   ....+.+.+|+.+++.++|+||+++++.+...+..++|+|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKS--DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcC--CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            3456789999999999998755  5566788876443   2344577899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~~~~  214 (368)
                      |+.+++|.+++... ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++ .++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999998753 234579999999999999999999999   999999999999999875 4699999988754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...               .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.....   ......
T Consensus       156 ~~~---------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~  217 (257)
T cd08225         156 MEL---------------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV---LKICQG  217 (257)
T ss_pred             ccc---------------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHhcc
Confidence            110               01234889999999998888999999999999999999999999654422111   111100


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                 ...     ......+.++.+++.+||..+|++|||+.++++|
T Consensus       218 -----------~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         218 -----------YFA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----------cCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                       000     0111234579999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=284.52  Aligned_cols=241  Identities=24%  Similarity=0.318  Sum_probs=185.8

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChh----HHHHHHHHHHHH-hcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR----LSQVFKQELDIL-LHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.||+|+||.||+|....  .+..+++|+......    ....+..|..++ ...+|+|++++++++...+..++||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS--TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecC--CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            458999999999998755  567889997754321    122334454444 4558999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++.   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++.....   
T Consensus        80 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  150 (260)
T cd05611          80 NGGDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---  150 (260)
T ss_pred             CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence            9999999997   345689999999999999999999999   9999999999999999999999999998742210   


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                      ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..........   .   
T Consensus       151 ----------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~---  208 (260)
T cd05611         151 ----------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS---R---  208 (260)
T ss_pred             ----------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---c---
Confidence                            123488899999999888889999999999999999999999976544322111100   0   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH  346 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  346 (368)
                          .      ...........+..+.+++..||+.||.+||++.++.+
T Consensus       209 ----~------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         209 ----R------INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             ----c------cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence                0      00011111133567899999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.3e-40  Score=300.04  Aligned_cols=269  Identities=22%  Similarity=0.267  Sum_probs=197.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec----CCeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD----RDEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~  131 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|.....   ......+.+|+.+++.++||||+++++++..    ....+
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTR--SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcC--CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            4466789999999999998755  5678888876543   2345667789999999999999999998753    34689


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+. ++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999995 68988886   345689999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .......           ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..........
T Consensus       158 ~~~~~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~  226 (334)
T cd07855         158 SSSPTEH-----------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS  226 (334)
T ss_pred             cccCcCC-----------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence            3222110           000122468899999999865 4688999999999999999999999977654332222222


Q ss_pred             hhhhhhhhh-----hcchhhhcCC-CCCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCE-----ATKVNELVDP-RLAGDF-----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~-----~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+...     ...+....+. ......     ....+..+.++|..||+.+|.+|||+++++.|
T Consensus       227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111111000     0001111110 000001     12236789999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.3e-39  Score=291.23  Aligned_cols=250  Identities=26%  Similarity=0.306  Sum_probs=194.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .++...+.||+|+||.||+|....  .+..+++|....    .......+.+|+++++.++|+|++++++++...+..++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcC--CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            345566789999999999998755  566788886542    23344567789999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+. +++.+++..  ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        93 v~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          93 VMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            999996 577776653  234588999999999999999999999   99999999999999999999999999986432


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ..                   ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||...+.........
T Consensus       167 ~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  227 (308)
T cd06634         167 PA-------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  227 (308)
T ss_pred             Cc-------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh
Confidence            11                   1234788999999985   3467889999999999999999999986654321111000


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      .                  ...........+..+.+||.+||+.+|.+||++.+++.|..-.
T Consensus       228 ~------------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         228 Q------------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             h------------------cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence            0                  0000011123456789999999999999999999999885433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.6e-39  Score=288.14  Aligned_cols=244  Identities=21%  Similarity=0.335  Sum_probs=195.0

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      ..||+|+||.||++....  ++..+++|..... ......+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          26 IKIGEGSTGIVCIATVKS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHcCCCCCeEEEEEEEcC--CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            569999999999998654  6678888865433 3345668899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCC
Q 017627          142 LQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP  221 (368)
Q Consensus       142 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~  221 (368)
                      |.+++..    ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.......      
T Consensus       104 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------  170 (292)
T cd06657         104 LTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------  170 (292)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc------
Confidence            9998752    3578999999999999999999999   99999999999999999999999999876432211      


Q ss_pred             CCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhc
Q 017627          222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEAT  301 (368)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  301 (368)
                               .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||................         
T Consensus       171 ---------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~---------  232 (292)
T cd06657         171 ---------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---------  232 (292)
T ss_pred             ---------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC---------
Confidence                     00122458899999999988888999999999999999999999997654432222111100         


Q ss_pred             chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                            .+....  ....+..+.+++.+||+.||.+||++++++.|
T Consensus       233 ------~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         233 ------PPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ------CcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence                  111100  11234568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=290.56  Aligned_cols=266  Identities=23%  Similarity=0.248  Sum_probs=194.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||.|++|.||+|.+..  ++..+++|+....   ......+.+|+.+++.++|||++++++++.+.+..+++|||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKL--TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             chheEecCCCCeEEEEEEEcC--CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            356789999999999998755  5677888866543   22335677899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      + +++|.+++.... ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||+++.......
T Consensus        80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 L-DLDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             c-CcCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            9 468999887432 24689999999999999999999999   999999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||...+...............
T Consensus       155 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (283)
T cd07835         155 ---------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP  219 (283)
T ss_pred             ---------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                           00112468899999988764 56889999999999999999999997654322111111111000


Q ss_pred             hhhhh---cchhhhcCC------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEA---TKVNELVDP------RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~---~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....   ....+....      ..........+..+.+++.+||+.||.+|||++++++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             ChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000   000000000      00001112234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=289.97  Aligned_cols=266  Identities=27%  Similarity=0.283  Sum_probs=198.0

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~  134 (368)
                      .+.+.||.|+||.||+|...+  .+..+++|.....   ......+.+|+.+++.++|+|++++++++...  +..++||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKK--TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECC--CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            356779999999999998765  5677888876654   33445678899999999999999999999887  7899999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+. ++|.+++...  ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9996 4888887642  25789999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...              ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.............
T Consensus       154 ~~~--------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~  219 (287)
T cd07840         154 NSA--------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG  219 (287)
T ss_pred             Ccc--------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            210              0012246788999998765 4578999999999999999999999987665433332222221


Q ss_pred             hhhhhhhcchhhh-----cCC------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNEL-----VDP------RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~-----~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ............+     ..+      .+...+...++..+.+++..||+.+|.+|||+++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         220 SPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             CCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1111110000000     000      00000111125688999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.5e-39  Score=286.32  Aligned_cols=242  Identities=21%  Similarity=0.264  Sum_probs=186.6

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHH---HHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELD---ILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~---~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .||+|+||.||+|....  ++..+|+|+.....    .....+..|..   .++...||||+.+++++...+..++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEec--CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence            38999999999998654  57788999765431    11122333443   44445799999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|..++.   ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++........
T Consensus        79 ~~g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~  152 (278)
T cd05606          79 MNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (278)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence            99999999886   345799999999999999999999999   999999999999999999999999999864321110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                       ....|+..|+|||++.+. .++.++||||+|+++|+|++|..||................   
T Consensus       153 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---  212 (278)
T cd05606         153 -----------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---  212 (278)
T ss_pred             -----------------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh---
Confidence                             123589999999999754 68899999999999999999999997653322111110000   


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                .....    .+...+..+.+++..||..+|.+||     ++.++++|
T Consensus       213 ----------~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         213 ----------TMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ----------ccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                      00111    1122356899999999999999999     99999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.4e-39  Score=295.42  Aligned_cols=279  Identities=21%  Similarity=0.217  Sum_probs=198.3

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhH---------------HHHHHHHHHHHhcCCCCceeeeeEEEe
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL---------------SQVFKQELDILLHLSHDNIVKLIGYCD  125 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~---------------~~~~~~E~~~l~~l~h~~iv~~~~~~~  125 (368)
                      +.+.||.|+||.||+|.+..  .+..+++|+.......               ...+.+|+++++.++|+||+++++++.
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   90 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTL--TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV   90 (335)
T ss_pred             hhhcccCCCceeEEEEEECC--CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence            45679999999999998654  5677888876443211               124678999999999999999999999


Q ss_pred             cCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeec
Q 017627          126 DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       126 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                      ..+..++||||+. ++|.+++.   ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         91 EGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             cCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence            9999999999995 68988886   345689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      |+++................. ..........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETM-QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             cceeecccccccccccccccc-cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999765422211110000000 000111223478899999998764 468899999999999999999999987665433


Q ss_pred             HHHHHhhhhhhhhhhhcch-----hhhcCCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          285 TSLAGSMLNDIADCEATKV-----NELVDPRLAGD---FDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      ...+...........+...     ...........   .....+..+.+++..||+.+|++|||+++++.|--
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            2222221111111000000     00000000000   01123567889999999999999999999998643

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.8e-39  Score=289.04  Aligned_cols=267  Identities=22%  Similarity=0.237  Sum_probs=192.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|++|.||+|.+..  ++..+++|.....   ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecC--CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            3456789999999999998754  5667888876433   2334567889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-CCceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg~s~~~~~~  214 (368)
                      |+. ++|.+++... ....+++..+..++.||+.||.|||++   +++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            995 5787777543 233468888999999999999999999   9999999999999985 567999999998743221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               .....+++.|+|||++.+. .++.++||||+|+++|+|++|.+||.................
T Consensus       157 ~~~---------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~  221 (294)
T PLN00009        157 VRT---------------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG  221 (294)
T ss_pred             ccc---------------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            100               0112478899999998764 578899999999999999999999976543222111111110


Q ss_pred             hhhhhhh---cchhhhc--CCCCCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEA---TKVNELV--DPRLAGD----FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~---~~~~~~~--~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......+   ..+....  -+.....    .....+..+.+++.+||+.+|++||++.++++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             CCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000   0000000  0000000    011234578999999999999999999999975

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-39  Score=284.35  Aligned_cols=248  Identities=24%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||++....  ++..+++|.....   ......+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLS--DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECC--CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            3456789999999999998654  5667788865532   3345567789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |+++++|..++.... ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999886422 235689999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                 ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.........     
T Consensus       157 ~~-----------------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----  214 (256)
T cd08530         157 MA-----------------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-----  214 (256)
T ss_pred             Cc-----------------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----
Confidence            10                 11347889999999999899999999999999999999999997655332211110     


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                    ...........+.++.+++..||+.+|.+|||+.++++|
T Consensus       215 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         215 --------------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                          011111223456789999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-38  Score=280.71  Aligned_cols=249  Identities=27%  Similarity=0.374  Sum_probs=200.8

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEEEe
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLLFE  135 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e  135 (368)
                      ..+.||+|++|.||+|....  ++..+++|+.....   ...+.+.+|+.++++++||||+++++.+...  +..++|+|
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKD--TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             eeeEeeecCceEEEEEEECC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            45789999999999998754  56778888765543   4567888999999999999999999999888  88999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ++.+++|.+++...   ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          82 YVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            99999999998743   3789999999999999999999998   99999999999999999999999999987644332


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ..             .......++..|+|||.+.+...+.++||||||+++|+|++|..||........  ....     
T Consensus       156 ~~-------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~-----  215 (260)
T cd06606         156 TG-------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYK-----  215 (260)
T ss_pred             cc-------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHh-----
Confidence            10             001223588899999999988899999999999999999999999976551110  0000     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ..........+...+..+.+++.+||..||.+||++.++++|
T Consensus       216 ----------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         216 ----------IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ----------ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                      000111112223336789999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-38  Score=287.92  Aligned_cols=242  Identities=27%  Similarity=0.371  Sum_probs=189.9

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..+.||+|+||.||+|....  ++..+++|.....    ......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus        25 ~~~~lg~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          25 GLHEIGHGSFGAVYFATNSH--TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             cceeeccCCCeEEEEEEECC--CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            34569999999999998644  5677888876432    23345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. +++.+++..  ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++......  
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            95 577777653  245689999999999999999999999   9999999999999999999999999987531110  


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                                       ....|+..|+|||++.   ...++.++||||||+++|+|++|..||...+..........   
T Consensus       175 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---  234 (313)
T cd06633         175 -----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---  234 (313)
T ss_pred             -----------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---
Confidence                             1235888999999984   35678899999999999999999999976553222111100   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             ..     .+.   ......+..+.+|+.+||+.+|.+||++.+++.|
T Consensus       235 -------~~-----~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         235 -------ND-----SPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------cC-----CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   00     000   0111234568899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-38  Score=279.22  Aligned_cols=248  Identities=29%  Similarity=0.407  Sum_probs=199.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .+.+.||+|++|.||++....  .+..+++|+...... ....+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           3 EILEKIGKGGFGEVYKARHKR--TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             eeeeeeccCCceEEEEEEECC--CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            355779999999999998754  567788887765543 56788899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++...  ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999998743  25789999999999999999999998   999999999999999999999999999875332211  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                    .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..............        
T Consensus       154 --------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------  211 (253)
T cd05122         154 --------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------  211 (253)
T ss_pred             --------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------
Confidence                          1234588999999999988899999999999999999999999976542211111110        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             ...+...  .....+..+.+++..||+.||.+|||+.++++|
T Consensus       212 -------~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         212 -------NGPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -------cCCCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   0000000  011125679999999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=287.81  Aligned_cols=265  Identities=24%  Similarity=0.231  Sum_probs=198.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||.|++|.||+|....  ++..+++|......   .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKL--TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             ccceeeecCCCceEEEEEcCC--CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            345679999999999998644  56778888654432   3356788899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+ +|..++...  ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            965 888877642  35789999999999999999999999   999999999999999999999999999875433220


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+...............
T Consensus       154 ---------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd05118         154 ---------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP  218 (283)
T ss_pred             ---------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence                           00113478889999999876 78999999999999999999999997665433322222111111


Q ss_pred             hhhhhcchhh--------hcCC--CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNE--------LVDP--RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..........        ....  ..........+..+.++|..||+.||.+||++++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0000000000        0000  00011122456789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.1e-39  Score=284.68  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=194.3

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ||.|+||.||++.+..  ++..+++|+.....    .....+.+|+++++.++||||+++++.+...+..+++|||+.++
T Consensus         1 lg~g~~~~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECC--CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            6899999999998754  56788999765432    34567888999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++..   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........... 
T Consensus        79 ~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-  151 (265)
T cd05579          79 DLASLLEN---VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL-  151 (265)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-
Confidence            99999974   34789999999999999999999999   999999999999999999999999999875332211100 


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                            ...........++..|+|||.+.+...+.++|+||||+++|++++|..||..............   .      
T Consensus       152 ------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~------  216 (265)
T cd05579         152 ------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN---G------  216 (265)
T ss_pred             ------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---C------
Confidence                  0000111234588899999999888899999999999999999999999976543222111100   0      


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                           ..  ....  ....+..+.+++..||+.+|.+|||+..+.+.|+
T Consensus       217 -----~~--~~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         217 -----KI--EWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -----Cc--CCCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                 00  0000  0012567899999999999999999944444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.4e-39  Score=287.72  Aligned_cols=261  Identities=26%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|+...+    ......+.+|+.+++.++ ||||+++++++...+..++|
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKE--TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcC--CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            3466789999999999998755  6678888876542    334467888999999998 99999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||++.+++|.+++..   ...+++..++.++.|++.||.+||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999974   44799999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCCCCCC-----CCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          214 SAVLPPSPS-----PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       214 ~~~~~~~~~-----~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      .........     ...............|+..|+|||++.+..++.++|+||||++++++++|..||............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            332111000     000001111223456889999999998888999999999999999999999999765422111110


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA----TQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~~il~~  347 (368)
                      .                  .  ....++...+..+.+++..||+.+|.+|||+    +++++|
T Consensus       235 ~------------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         235 L------------------K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             H------------------h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            0                  0  0011122235678999999999999999999    888875

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-38  Score=281.69  Aligned_cols=236  Identities=22%  Similarity=0.276  Sum_probs=183.3

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecccCCCHH
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQ  143 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  143 (368)
                      ||+|+||.||++....  ++..+++|+........    .|+.....+ +||||+++++.+...+..++||||+++++|.
T Consensus        24 lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~   97 (267)
T PHA03390         24 LIDGKFGKVSVLKHKP--TQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF   97 (267)
T ss_pred             ecCCCceEEEEEEEcC--CCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence            5999999999998655  56778888765432111    133333333 7999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccCCCCCCCCCCCC
Q 017627          144 EKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFSSAVLPPSPS  222 (368)
Q Consensus       144 ~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~~~~~~~~~~~~  222 (368)
                      +++..   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++ .++|+|||++.......       
T Consensus        98 ~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-------  164 (267)
T PHA03390         98 DLLKK---EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-------  164 (267)
T ss_pred             HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-------
Confidence            99973   34789999999999999999999999   999999999999999888 99999999987432211       


Q ss_pred             CCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcc
Q 017627          223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATK  302 (368)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (368)
                                  ...|+..|+|||++.+..++.++|+||+|+++|+|++|..||..........  ...           
T Consensus       165 ------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~-----------  219 (267)
T PHA03390        165 ------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ESL-----------  219 (267)
T ss_pred             ------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HHH-----------
Confidence                        1248899999999999899999999999999999999999997544322110  000           


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 017627          303 VNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-ATQILHT  347 (368)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~~  347 (368)
                       ......  ........+..+.++|..||+.+|.+||+ ++++++|
T Consensus       220 -~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        220 -LKRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -HHhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence             000000  00111235668999999999999999996 5999865

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=318.33  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=201.8

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .-+.+.++||+|+||.|.+++.+.  +..++|+|+...-    .....-|..|-.+|..-+.+-|+.++..|.+.+++|+
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~--t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKS--TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeec--cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            345577899999999999998755  7889999987652    2334568889999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |||||+||+|..++..   ...+|+..+..++..|+.||..||+.   |+|||||||+|||+|..|++||+|||.+-.+.
T Consensus       153 VMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             EEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            9999999999999984   34799999999999999999999999   99999999999999999999999999886544


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhc----c-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR----T-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      .+....              ....+|||.|.+||++.    + +.|+..+|.||+|+++|||+.|.-||....-.   ..
T Consensus       227 ~dG~V~--------------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---eT  289 (1317)
T KOG0612|consen  227 ADGTVR--------------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---ET  289 (1317)
T ss_pred             CCCcEE--------------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---HH
Confidence            333211              12357999999999984    2 46899999999999999999999999654422   22


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCC--HHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFD--LDEARAMLSIAALCLRQSPILRPS---ATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~~  347 (368)
                      .++.+               +-.-.-.|+  ...+..+.+||+..+ -+|+.|..   ++++-.|
T Consensus       290 Y~KIm---------------~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  290 YGKIM---------------NHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             HHHHh---------------chhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence            22222               111111222  446789999999988 57888888   8888877

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=282.73  Aligned_cols=264  Identities=22%  Similarity=0.350  Sum_probs=197.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC----eeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD----EGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e  135 (368)
                      .+.+.||+|.||.||+|.+    .+..||||++...++....-+.|+..-..|+|+||+.+++.-..++    +++||.+
T Consensus       214 ~L~e~IGkGRyGEVwrG~w----rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRW----RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             EEEEEecCccccceeeccc----cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            3557899999999999998    4578999999887765443333444444669999999999875443    6899999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-----RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-----~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      |.+.|+|.+||..    ..++.+...+++..+++||++||.     ++.+.|.|||||..||||.++|.+.|+|+|+|..
T Consensus       290 YHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  290 YHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             cccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            9999999999973    568999999999999999999994     3567899999999999999999999999999986


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC------CcchhhHHHHHHHHHHHhC----------CC
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA------STKTDVYSFGVILLELVTG----------ME  274 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwslG~il~el~~g----------~~  274 (368)
                      ..........+.           ...+||.+|||||++...-.      -..+||||||.++||+...          .+
T Consensus       366 h~~~t~~idi~~-----------N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  366 HDSDTDTIDIPP-----------NPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             ecccCCcccCCC-----------CCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            554432111111           22579999999999965321      1358999999999999763          46


Q ss_pred             CCCCCcc--hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          275 AFCPENG--QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       275 pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      ||.+.-.  +.+..+..           ....+-+.|.++..+ +......+.++++.||..||.-|-||-.|.+.|.++
T Consensus       435 Pyyd~Vp~DPs~eeMrk-----------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRK-----------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CcccCCCCCCCHHHHhc-----------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            7654321  11111111           111122233333333 345567788999999999999999999999999988


Q ss_pred             cc
Q 017627          352 IS  353 (368)
Q Consensus       352 ~~  353 (368)
                      .+
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            75

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.7e-38  Score=286.87  Aligned_cols=272  Identities=18%  Similarity=0.192  Sum_probs=193.2

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +++.+|.|+++.|+++  ..  ++..+|+|+....   ......+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         6 i~~~~~~~~~v~~~~~--~~--~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           6 IGKCFEDLMIVHLAKH--KP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhHhhcCCceEEEEEe--cC--CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            4454555555444444  33  6778888876543   445567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++++|.+++... ....+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||.+.........
T Consensus        82 ~~~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          82 AYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            999999998754 334688999999999999999999999   9999999999999999999999999988754322111


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--MASTKTDVYSFGVILLELVTGMEAFCPENGQLLT-SLAGSMLND  294 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~  294 (368)
                      ...        .........++..|+|||++.+.  .++.++|+||+|+++|+|++|..||......... .........
T Consensus       158 ~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (314)
T cd08216         158 QRV--------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC  229 (314)
T ss_pred             ccc--------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcc
Confidence            000        00001223478889999999763  5788999999999999999999999765432111 111100000


Q ss_pred             hhhh-----hhcchhh----hcCCC----CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          295 IADC-----EATKVNE----LVDPR----LAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       295 ~~~~-----~~~~~~~----~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ....     .......    ..++.    .........+.++.+|+..||+.||.+|||+.++++|-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            0000     0000000    00000    11112234467889999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-38  Score=291.53  Aligned_cols=271  Identities=21%  Similarity=0.222  Sum_probs=194.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC----Cee
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR----DEG  130 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----~~~  130 (368)
                      |.+.+.||+|+||.||++.+.....+..+++|....   .....+.+.+|+.+++.+ +||||+++++.+...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            346678999999999999986643367788887653   223356678899999999 599999999875432    457


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      +++++++. ++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||+++.
T Consensus        82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            88999984 68988886   445789999999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ........           ........|++.|+|||.+.+ ..++.++||||+|+++|+|++|.+||...+.........
T Consensus       155 ~~~~~~~~-----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~  223 (332)
T cd07857         155 FSENPGEN-----------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL  223 (332)
T ss_pred             cccccccc-----------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH
Confidence            43222110           001123468999999998765 568899999999999999999999997765332222111


Q ss_pred             hhhhhhhhhhh-----cchh---hhcCCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEA-----TKVN---ELVDPRLAGD---FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~-----~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...........     ....   ..........   .....+..+.+++.+||+.||.+|||+.+++.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         224 QVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111000000     0000   0000000000   011124678999999999999999999999877

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.7e-39  Score=281.04  Aligned_cols=250  Identities=28%  Similarity=0.395  Sum_probs=200.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||.|+||.||++.+..  +...+++|.....   ......+.+|+++++.++|||++++++.+...+..++|+|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKS--DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcC--CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            3456789999999999999754  5677888876543   2455678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ++++++|.+++.... ....+++..+..++.+++.||.+||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999987532 246789999999999999999999999   9999999999999999999999999998753222


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               ......|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+......   .....
T Consensus       157 ~~---------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~~  218 (258)
T cd08215         157 VD---------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL---KILKG  218 (258)
T ss_pred             cc---------------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH---HHhcC
Confidence            10               1122458899999999988889999999999999999999999996654221111   10000


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             .         ....+...+..+.+++.+||..+|++|||+.+++++
T Consensus       219 -------~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         219 -------Q---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -------C---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0         001111335678999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=280.11  Aligned_cols=247  Identities=29%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|++|.||++....  ....+++|......   .....+.+|++++..++|+|++++++++.+.+..+++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLE--TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcC--CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            3466789999999999998654  55678888765543   456778999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ++.+++|.+++..   ...+++..+..++.|++.|+.+||++   +|+|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999999873   36789999999999999999999999   99999999999999999999999999987543322


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ..               .....++..|+|||.+.+..++.++||||+|+++|+|++|..||.............      
T Consensus       154 ~~---------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------  212 (254)
T cd06627         154 KD---------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------  212 (254)
T ss_pred             cc---------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------
Confidence            10               112347889999999988888999999999999999999999997554211111000      


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               ..    .....+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       213 ---------~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         213 ---------QD----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ---------cc----CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                     00    0011122234678999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-38  Score=290.05  Aligned_cols=271  Identities=23%  Similarity=0.263  Sum_probs=195.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC--Cee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR--DEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~  130 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+++|....   .......+.+|+.+++.+ +||||+++++++...  ...
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRR--TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcC--CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            345678899999999999998754  567788886532   223345677899999999 999999999988643  368


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+. ++|..++..   + .+++.....++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~---~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA---N-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc---C-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999996 589888863   2 678889999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .........          ........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.............
T Consensus       157 ~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~  226 (337)
T cd07852         157 LSELEENPE----------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII  226 (337)
T ss_pred             ccccccccc----------CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            433221100          001122458999999998865 467889999999999999999999997655332221111


Q ss_pred             hhhhhhhhhh-----hcchhhhcC----CCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCE-----ATKVNELVD----PRL--AGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~-----~~~~~~~~~----~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..........     ......+++    ...  ........+..+.++|..||+.||.+|||+.++++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            1111000000     000000010    000  000111235688999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=282.25  Aligned_cols=265  Identities=25%  Similarity=0.297  Sum_probs=194.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC---CCCceeeeeEEEecCCe----
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL---SHDNIVKLIGYCDDRDE----  129 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~----  129 (368)
                      ++.+.||+|+||.||+|.+..  ++..+++|.....   ......+.+|+.+++.+   +|+||+++++++...+.    
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLN--TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             eEEEEecccCceEEEEEEECC--CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            356789999999999999754  5677888876532   22234566788877666   59999999999987776    


Q ss_pred             -eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          130 -GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       130 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                       .+++||++. ++|.+++.... ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence             899999996 47888886432 23589999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      .........                ....++..|+|||++.+..++.++|+||||+++|+|++|.+||............
T Consensus       155 ~~~~~~~~~----------------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~  218 (287)
T cd07838         155 RIYSFEMAL----------------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI  218 (287)
T ss_pred             eeccCCccc----------------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence            753222110                1124788999999999999999999999999999999999999876543322211


Q ss_pred             Hhhhhhhhhhhhcch----hhhcCCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATKV----NELVDPRLAG---DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...............    ..........   ......+..+.+++..||+.||.+||++.+++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            111100000000000    0000111111   1112345778899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2e-38  Score=286.09  Aligned_cols=268  Identities=27%  Similarity=0.312  Sum_probs=195.5

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-----
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----  128 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  128 (368)
                      ..|.+.+.||+|+||.||+|....  ++..+++|.....   ......+.+|+++++.++||||+++++++.+..     
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKD--TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECC--CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            345677889999999999999765  4567888876533   233456778999999999999999999987654     


Q ss_pred             -----eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEe
Q 017627          129 -----EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC  203 (368)
Q Consensus       129 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~  203 (368)
                           ..++|+||+.+ ++...+...  ...+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence                 78999999965 676666542  34689999999999999999999999   99999999999999999999999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQ  282 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  282 (368)
                      |||++..........              .....++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..
T Consensus       159 dfg~~~~~~~~~~~~--------------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~  224 (302)
T cd07864         159 DFGLARLYNSEESRP--------------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL  224 (302)
T ss_pred             cccccccccCCcccc--------------cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            999987543222100              011236778999998865 45788999999999999999999999766543


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhh-----cCC------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          283 LLTSLAGSMLNDIADCEATKVNEL-----VDP------RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....................+.+.     .++      .....+ ...+..+.+++..||+.||.+|||+++++.|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         225 AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            333222222111110000000000     000      000000 1125678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=285.52  Aligned_cols=297  Identities=22%  Similarity=0.271  Sum_probs=208.3

Q ss_pred             cccccCHHHHHH-HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-----C---C
Q 017627           45 SVKKYSWDDVER-FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-----H---D  115 (368)
Q Consensus        45 ~~~~~~~~~~~~-~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-----h---~  115 (368)
                      .......+|... .+|-+.++||.|.|++||+|.+..  ....||+|+.+......+...+|+.+|++++     |   .
T Consensus        65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq--~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~  142 (590)
T KOG1290|consen   65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ--NKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKK  142 (590)
T ss_pred             CCceeeccccccCceEEEEEeccccccceeEEEeecc--CCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence            344455666666 888888999999999999998654  7889999999888888888999999999984     2   4


Q ss_pred             ceeeeeEEEec----CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCC
Q 017627          116 NIVKLIGYCDD----RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN  191 (368)
Q Consensus       116 ~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N  191 (368)
                      +||++++.|..    +.++|||+|++ |.+|..++... ....++...+..|++||+.||.|||.+|  ||||.||||+|
T Consensus       143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN  218 (590)
T KOG1290|consen  143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN  218 (590)
T ss_pred             eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence            79999999964    45899999999 66787887755 4567999999999999999999999998  99999999999


Q ss_pred             eeecCCCc-----------------------------------------------------------eEEeeccccc---
Q 017627          192 ILLEEHLN-----------------------------------------------------------CKLCDFGSAK---  209 (368)
Q Consensus       192 ilv~~~~~-----------------------------------------------------------vkl~Dfg~s~---  209 (368)
                      ||+..+..                                                           ..+.+-+...   
T Consensus       219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~  298 (590)
T KOG1290|consen  219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP  298 (590)
T ss_pred             eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence            99932100                                                           0000000000   


Q ss_pred             ----------------cCCCCC---------CCCCCCCCC-------------------C------Cccc----------
Q 017627          210 ----------------MGFSSA---------VLPPSPSPS-------------------P------SRSR----------  229 (368)
Q Consensus       210 ----------------~~~~~~---------~~~~~~~~~-------------------~------~~~~----------  229 (368)
                                      ......         .........                   .      ..+.          
T Consensus       299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~  378 (590)
T KOG1290|consen  299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP  378 (590)
T ss_pred             cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence                            000000         000000000                   0      0000          


Q ss_pred             ---------c-----------------ccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc--
Q 017627          230 ---------I-----------------TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG--  281 (368)
Q Consensus       230 ---------~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--  281 (368)
                               .                 .+++.-+.|..|+|||++.|..|++.+||||++|++|||+||...|.+.++  
T Consensus       379 ~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~  458 (590)
T KOG1290|consen  379 LVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN  458 (590)
T ss_pred             ccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence                     0                 001123456789999999999999999999999999999999999987653  


Q ss_pred             ----hhhHHHHHhhhhhhhhhhhc---chhhhcCCCC-------------------CCCCCHHHHHHHHHHHHHhcCCCC
Q 017627          282 ----QLLTSLAGSMLNDIADCEAT---KVNELVDPRL-------------------AGDFDLDEARAMLSIAALCLRQSP  335 (368)
Q Consensus       282 ----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP  335 (368)
                          ++....+-.++..++.....   --+++++..-                   .-.++.+...++.+|+.-||+.+|
T Consensus       459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P  538 (590)
T KOG1290|consen  459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP  538 (590)
T ss_pred             CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence                34444455555544432111   0111111110                   013556778899999999999999


Q ss_pred             CCCCCHHHHHHH
Q 017627          336 ILRPSATQILHT  347 (368)
Q Consensus       336 ~~Rpt~~~il~~  347 (368)
                      ++||||.++|+|
T Consensus       539 eKR~tA~~cl~h  550 (590)
T KOG1290|consen  539 EKRPTAAQCLKH  550 (590)
T ss_pred             cccccHHHHhcC
Confidence            999999999988

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-38  Score=326.98  Aligned_cols=270  Identities=27%  Similarity=0.441  Sum_probs=205.6

Q ss_pred             cCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC
Q 017627           49 YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD  128 (368)
Q Consensus        49 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  128 (368)
                      +.+.++... +...+.||+|+||.||+|....  .+..+|+|........   ...|++++++++|||||++++++.+.+
T Consensus       683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        683 ITINDILSS-LKEENVISRGKKGASYKGKSIK--NGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             hhHHHHHhh-CCcccEEccCCCeeEEEEEECC--CCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            344444332 2234579999999999998754  5677888876543321   235689999999999999999999999


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++||||+++|+|.+++.      .+++..+..++.|++.|++|||..+..+|+||||||+||+++.++..++. ||.+
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence            9999999999999999995      27899999999999999999996555599999999999999998888775 6654


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc--hhhHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTS  286 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~  286 (368)
                      ......                   ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  .....
T Consensus       830 ~~~~~~-------------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~  890 (968)
T PLN00113        830 GLLCTD-------------------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE  890 (968)
T ss_pred             cccccC-------------------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHH
Confidence            321100                   112488999999999999999999999999999999999999954332  12222


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGD--FDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      +.......      .......++.+...  .......++.+++.+||+.||++|||++++++.|+++.+..+
T Consensus       891 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        891 WARYCYSD------CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             HHHHhcCc------cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            22211111      22334455554332  344566778899999999999999999999999999877554

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-39  Score=285.44  Aligned_cols=265  Identities=25%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh--HHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|...+  +...+++|.......  ......+|+..+..++ |+||+++++++...+..++||||
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             eeheeeccCCceEEEEEEECC--CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            356789999999999999755  566788886544321  2234457999999998 99999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      + +++|.+++... .+..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        80 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          80 M-EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             C-CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            9 78898888743 234789999999999999999999999   999999999999999999999999999875332211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .                ....|+..|+|||++.+ ..++.++|+||||+++|+|++|.+||...................
T Consensus       155 ~----------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd07830         155 Y----------------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP  218 (283)
T ss_pred             c----------------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCC
Confidence            0                11347889999998854 567899999999999999999999997765433322222111111


Q ss_pred             hhhhh---cchhhhcCCCCC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEA---TKVNELVDPRLA-------GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....   .......+....       .......+..+.+++..||+.||++|||+++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            10000   000000000000       00001124678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-39  Score=293.54  Aligned_cols=268  Identities=21%  Similarity=0.259  Sum_probs=200.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-----ee
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----EG  130 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  130 (368)
                      |.+.+.||.|+||.||+|....  .+..+++|.....   ....+.+.+|+.+++.++|+||+++++++...+     ..
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKR--TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCC--CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4567889999999999998654  5677888866543   334567889999999999999999999987765     78


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+. ++|..++..   ...+++..++.++.|++.||.+||++   +|+|+||||+|||++.++.++|+|||++..
T Consensus        80 ~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999996 588888873   44799999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .......            ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.........
T Consensus       153 ~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~  220 (330)
T cd07834         153 VDPDEDE------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV  220 (330)
T ss_pred             ecccccc------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            4332210            0011223578999999999887 88999999999999999999999998776543322222


Q ss_pred             hhhhhhhhh-----hhcchhhhcC---CCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADC-----EATKVNELVD---PRLAG---DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~-----~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........     ........+.   .....   ......+..+.+++..||+.+|.+|||+++++.|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111110000     0000000100   00000   0111235678999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=292.48  Aligned_cols=262  Identities=20%  Similarity=0.257  Sum_probs=192.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  128 (368)
                      +|.+.+.||+|+||.||+|....  ++..+++|.....   ......+.+|+.+++.++||||+++++++....      
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECC--CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            34466789999999999998654  5677898876432   334456789999999999999999999986554      


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++|||++ +++|..++.    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            358999999 778988875    24689999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      .......                  ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......
T Consensus       166 ~~~~~~~------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  227 (343)
T cd07880         166 RQTDSEM------------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME  227 (343)
T ss_pred             cccccCc------------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            7432211                  12347889999999876 4578899999999999999999999976553221111


Q ss_pred             HHhhhhhhhhhhh-----cchhhhcC--CCCC-C---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEA-----TKVNELVD--PRLA-G---DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~-----~~~~~~~~--~~~~-~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .............     ........  +... .   ......+..+.+++.+||+.||.+|||+.+++.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1110000000000     00000000  0000 0   0111234578899999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-38  Score=290.20  Aligned_cols=261  Identities=25%  Similarity=0.298  Sum_probs=193.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  134 (368)
                      |.+.+.||.|+||.||+|.+..  ++..+++|....   .....+.+.+|+.+++.++||||+++++++.. .+..+++|
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECC--CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            4567889999999999998655  667788886532   23345667889999999999999999999865 56789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+ +++|..++..    ..++...+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||.+......
T Consensus        90 e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          90 ELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             ehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            999 5689888752    3578888899999999999999999   9999999999999999999999999998632111


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      .                  ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...............+.
T Consensus       162 ~------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  223 (328)
T cd07856         162 M------------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG  223 (328)
T ss_pred             c------------------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            0                  12347889999998765 5789999999999999999999999976554332222222211


Q ss_pred             hhhhhhh-----cchhhhc-CCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEA-----TKVNELV-DPRLAGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~-----~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+....     ....... .-......+     ...+..+.++|..||+.+|++|||+++++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1110000     0000000 000001111     1234689999999999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-38  Score=291.48  Aligned_cols=262  Identities=20%  Similarity=0.243  Sum_probs=191.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------Ce
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------DE  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~  129 (368)
                      |.+.+.||+|+||.||+|....  ++..+++|.....   ....+.+.+|+.+++.++||||+++++++...      +.
T Consensus        19 y~~~~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          19 YQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             eEEEEEeeecCCeEEEEEEEcC--CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            4456789999999999998654  5678888876543   22345677899999999999999999988543      34


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .+++++++ +++|.+++..    ..+++..++.++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        97 ~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccc
Confidence            67888887 7899887752    3589999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ......                  ....|+..|+|||.+.+ ..++.++||||+||++|+|++|..||...+........
T Consensus       169 ~~~~~~------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         169 HTDDEM------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             cccccc------------------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            422111                  12357899999999876 56788999999999999999999999765432222111


Q ss_pred             Hhhhhhhhh--------hhhcchhhhcCCCCCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          289 GSMLNDIAD--------CEATKVNELVDPRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       289 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      .........        .................+   ....+..+.++|..||+.||.+|||+.+++.|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            111110000        000000000000000000   012355789999999999999999999999883

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.5e-38  Score=283.55  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=195.9

Q ss_pred             HhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC-----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS-----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+.+.||+|+||.||++..... .....+++|+....     ....+.+.+|++++..+ +||||+++++.+......++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            4567899999999999986532 35567888876532     23345678899999999 59999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|.+++.   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++...
T Consensus        83 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          83 ILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999999886   345688999999999999999999999   99999999999999999999999999987533


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH-HHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM--ASTKTDVYSFGVILLELVTGMEAFCPENGQLLT-SLAG  289 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~  289 (368)
                      .....              ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||......... ....
T Consensus       157 ~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~  222 (288)
T cd05583         157 AEEEE--------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR  222 (288)
T ss_pred             ccccc--------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH
Confidence            22110              011235889999999987654  788999999999999999999999644322111 1111


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      .....             .+.    .+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus       223 ~~~~~-------------~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         223 RILKS-------------KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHcc-------------CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            11000             011    1122345788999999999999999987776665554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.1e-39  Score=282.41  Aligned_cols=249  Identities=28%  Similarity=0.380  Sum_probs=191.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC------ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG------SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      |.+.+.||+|+||.||++.+...  ....++|+...      .......+..|+.+++.++||||+++++++.+.+..++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKA--VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCC--CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence            45678899999999999987553  22233333221      22233456679999999999999999999998899999


Q ss_pred             EEecccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          133 LFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      ||||+++++|.+++... .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++|+|||.++..
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence            99999999999887642 1345789999999999999999999999   9999999999999986 56999999998754


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ......               .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........   ....
T Consensus       156 ~~~~~~---------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~~~  217 (260)
T cd08222         156 MGSCDL---------------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---VLRI  217 (260)
T ss_pred             CCCccc---------------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH
Confidence            322110               0123478899999999888889999999999999999999999965432111   1111


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..            .    .....+...+.++.++|.+||+.||++||++.++++|
T Consensus       218 ~~------------~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         218 VE------------G----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             Hc------------C----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            00            0    0111223445688999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=292.45  Aligned_cols=265  Identities=20%  Similarity=0.239  Sum_probs=191.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------e
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------E  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~  129 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|.....   ......+.+|+.+++.++||||+++++++....      .
T Consensus        17 y~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          17 YTSLKQVGSGAYGSVCSAIDKR--TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             eEEEEEeeecCCeEEEEEEeCC--CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            3455789999999999998754  5677888876432   333456788999999999999999999986543      4


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .++|+||+. .+|..+..     ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||+++
T Consensus        95 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             EEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            689999985 46766542     3588999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ......                  ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+........
T Consensus       166 ~~~~~~------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~  227 (342)
T cd07879         166 HADAEM------------------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  227 (342)
T ss_pred             CCCCCC------------------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            421110                  12357889999999876 46889999999999999999999999765432211111


Q ss_pred             Hhhhhhhhhhhhc-----chhhhc---CCCCCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcc
Q 017627          289 GSMLNDIADCEAT-----KVNELV---DPRLAGDFD---LDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQI  352 (368)
Q Consensus       289 ~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~  352 (368)
                      .............     ......   .........   ...+..+.+||..||+.||.+|||+.+++.|  ++..-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            1110000000000     000000   000000000   1234578899999999999999999999987  65553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=302.95  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=208.2

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEe-----cCCeeEEEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCD-----DRDEGVLLF  134 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~  134 (368)
                      |.+.||.|.+|.||+++..+  +++.+|+||..........++.|..+|+.+ .|||++.+++++.     .++++||||
T Consensus        23 i~evig~Gtygkv~k~k~~~--~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   23 IIEVIGNGTYGKVYKGRHVK--TGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             EEEEEeeccceeEEEEeeee--cCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            66789999999999998666  677788888888877778888999999999 6999999999984     356899999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||.+|+..++++... +..+.|..+..|++.++.|+.+||++   .++|||||-.|||++.++.|||+|||++....+.
T Consensus       101 EfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             eccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            9999999999998774 78899999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-----MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .               .+..+.+|||.|||||++...     .|+..+|+||||++..||--|.+|+...-....     
T Consensus       177 ~---------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----  236 (953)
T KOG0587|consen  177 V---------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----  236 (953)
T ss_pred             c---------------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence            2               222456799999999999664     467889999999999999999999965432110     


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                        +          +.-...|......+..+++++-+||..||..|-.+||+..++|+|
T Consensus       237 --L----------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 --L----------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --h----------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence              0          011112333334567889999999999999999999999999987

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.5e-38  Score=282.88  Aligned_cols=251  Identities=23%  Similarity=0.360  Sum_probs=193.9

Q ss_pred             HhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC-----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS-----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+.+.||.|+||.||.|..... .++..+++|+....     ....+.+.+|+.++..+ +|+||+.+++++......++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            4567899999999999986432 35677899976542     22345678899999999 59999999999999899999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.+||+|||+++...
T Consensus        83 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          83 ILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            9999999999999873   45688999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-hHHHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--MASTKTDVYSFGVILLELVTGMEAFCPENGQL-LTSLAG  289 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~  289 (368)
                      ....              .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||....... ......
T Consensus       157 ~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~  222 (290)
T cd05613         157 EDEV--------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR  222 (290)
T ss_pred             cccc--------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH
Confidence            2111              011124588999999998753  46789999999999999999999996433211 111111


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                      .....             .+    .++...+..+.+++..||+.||.+||     ++.+++.|
T Consensus       223 ~~~~~-------------~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         223 RILKS-------------EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             Hhhcc-------------CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            11100             01    11222345788999999999999997     78888776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=282.27  Aligned_cols=264  Identities=25%  Similarity=0.276  Sum_probs=198.4

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.+.||+|+||.||+|....  +...+++|+....   ....+.+..|+.+++.++|+|++++++++.+.+..++|||++
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKK--TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             eehcccccCcceEEEeeecC--CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            45679999999999998755  5678888876653   334566778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      . ++|.+++...  ...+++..+..++.|++.||.+||++   +|+|+||+|+||++++++.++|+|||.++....... 
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            6 5899998743  24689999999999999999999999   999999999999999999999999999875322111 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                    ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||....................
T Consensus       154 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (282)
T cd07829         154 --------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT  219 (282)
T ss_pred             --------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCc
Confidence                          00112367789999998776 788999999999999999999999977664333322222211111


Q ss_pred             hhhhcchhhh--cCCCC----CC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNEL--VDPRL----AG---DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~--~~~~~----~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...+......  .+...    ..   ......+..+.+++..||..||++||++++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            1100000000  00000    00   0011225679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3e-38  Score=286.02  Aligned_cols=277  Identities=24%  Similarity=0.262  Sum_probs=194.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-------
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-------  128 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------  128 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|.....   ......+.+|+++++.++||||+++++++.+..       
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIK--TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECC--CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            4467789999999999998755  5566788865432   222345678999999999999999999875433       


Q ss_pred             -eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          129 -EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       129 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                       ..++||||+.+ +|...+..  ....+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||+
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence             46999999954 67666653  245699999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      ++............    ............|++.|+|||.+.+. .++.++||||||+++|+|++|.+||.+.+......
T Consensus       162 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~  237 (311)
T cd07866         162 ARPYDGPPPNPKGG----GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH  237 (311)
T ss_pred             chhccCCCcccccC----CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            97543322211100    00011112335688999999988654 57889999999999999999999998766543332


Q ss_pred             HHHhhhhhhhhhhhc---chhhhc----CCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEAT---KVNELV----DPRLAGD---FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...............   .+....    .......   ........+.+++.+||+.||.+|||+.+++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            222211111100000   000000    0000000   001123578899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=281.30  Aligned_cols=273  Identities=22%  Similarity=0.366  Sum_probs=196.1

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhc--CCCCceeeeeEEEecCC----eeEEEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH--LSHDNIVKLIGYCDDRD----EGVLLF  134 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~  134 (368)
                      +.++||+|.||.||+|.+.    .+.||||++.....  +.|.+|-++...  ++|+||++++++-...+    .++||+
T Consensus       214 l~eli~~Grfg~V~KaqL~----~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD----NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hHHHhhcCccceeehhhcc----CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            5677999999999999874    47899998865544  456666666665  58999999999876655    789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER------CTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      +|.+.|+|.++|+.    ..++|....+++..+++||+|||+.      .++.|+|||||..||||.+++.+.|+|||+|
T Consensus       288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999974    4689999999999999999999953      3568999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-C-----cchhhHHHHHHHHHHHhCCCCCCCCc-c
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-S-----TKTDVYSFGVILLELVTGMEAFCPEN-G  281 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DiwslG~il~el~~g~~pf~~~~-~  281 (368)
                      ........             .+.....+||.+|||||++.|... .     .+.||||+|.++|||++...-+.+.. .
T Consensus       364 l~~~p~~~-------------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  364 LRLEPGKP-------------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             EEecCCCC-------------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            87552221             111123679999999999987532 1     36899999999999999754443211 1


Q ss_pred             hhhHHHHHhh--hhhhhhhhhcchhhhcCCCCCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          282 QLLTSLAGSM--LNDIADCEATKVNELVDPRLAGDFD-LDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       282 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      +....+....  -+.+.+.....+..-..|.++..+- ......+++.+..||..||+-|.|+.=+-+.+.++.....
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            1111111111  1111111111122222222222111 1224678899999999999999999888888777765443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=283.91  Aligned_cols=240  Identities=24%  Similarity=0.292  Sum_probs=198.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ..++..+||+|+||+|.+|..++  +.+.+|||+...+-    ...+--..|-.+|... +-|.+++++.+|.+-+.+|+
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkg--tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ccceEEEeccCccceeeeecccC--cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            34688899999999999998655  77888998765432    1122233577788777 57899999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.||+|.-.+.   .-+.+.+..+..++..|+-||-+||++   |||+||||.+||+++.+|++||+|||+++-..
T Consensus       428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999988887   456788889999999999999999999   99999999999999999999999999998322


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                                     ....+..+.+|||.|+|||++...+|+.++|.||+|++||||+.|.+||.++++..+...+....
T Consensus       502 ---------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn  566 (683)
T KOG0696|consen  502 ---------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN  566 (683)
T ss_pred             ---------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc
Confidence                           22233356899999999999999999999999999999999999999999988765543332211


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS  340 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  340 (368)
                                          -.++...+.++..+....|...|.+|..
T Consensus       567 --------------------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 --------------------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --------------------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence                                1245566778999999999999999953

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-38  Score=292.75  Aligned_cols=268  Identities=20%  Similarity=0.230  Sum_probs=190.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC---------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR---------  127 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------  127 (368)
                      +|.+.+.||.|+||.||+|....  ++..+++|..... ....+.+.+|+++++.++||||+++++++...         
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~--~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSD--CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECC--CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            34567789999999999998754  5677888865443 34456688899999999999999999876543         


Q ss_pred             -----CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceE
Q 017627          128 -----DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCK  201 (368)
Q Consensus       128 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vk  201 (368)
                           ...++||||+. ++|.+++..    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++ .++.++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence                 35789999996 588888752    3588999999999999999999999   999999999999998 456789


Q ss_pred             EeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          202 LCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       202 l~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      |+|||+++.........            .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+
T Consensus       156 l~dfg~~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         156 IGDFGLARIVDPHYSHK------------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             ECCcccceecCCccccc------------cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999987543211100            00012347889999998754 568889999999999999999999997665


Q ss_pred             chhhHHHHHhhhhhhhhhhhc----chhh-hcCCCCCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEAT----KVNE-LVDPRLAGD-----FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ............+........    .... .........     .....+.++.+|+..||+.||.+|||+.+++.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         224 ELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            422211111100000000000    0000 000000000     011234678899999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-40  Score=269.09  Aligned_cols=268  Identities=24%  Similarity=0.300  Sum_probs=203.6

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec--------CCe
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD--------RDE  129 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~  129 (368)
                      -..+||+|.||.||+|+..+  ++..|++|....   +........+|+.+|..|+|+|++.++++|..        ...
T Consensus        21 k~~kigqGtfgeVFkAr~~n--~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   21 KLAKIGQGTFGEVFKARSKN--TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHhcCCchHHHHHHHhhcC--ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            45679999999999998765  566677775433   23333456789999999999999999887743        234


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      +++||.+| ..+|..++..  ....++..++.+++.++..||.|+|+.   .|+|||+||.|+||+.+|.+||+|||+++
T Consensus        99 ~ylVf~~c-ehDLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   99 FYLVFDFC-EHDLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeeeHHHh-hhhHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            79999999 4488888874  346789999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      .+..........           -+..+-|.+|++||.+.| ..|+++.|||..|||+.||+|+.+-+.+...+.....+
T Consensus       173 ~fs~~~n~~kpr-----------ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I  241 (376)
T KOG0669|consen  173 AFSTSKNVVKPR-----------YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI  241 (376)
T ss_pred             ceecccccCCCC-----------cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence            654443322111           133567999999998877 57999999999999999999999999888777666666


Q ss_pred             Hhhhhhhhhhhhcchh-----hhcC-CCCCCCCCH---------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATKVN-----ELVD-PRLAGDFDL---------DEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+........+....     +.+. +.+......         .-.++..+|+..+|..||.+|+++.+++.|
T Consensus       242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            6666554433222221     1121 111111100         012467899999999999999999999987

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-38  Score=293.00  Aligned_cols=261  Identities=21%  Similarity=0.261  Sum_probs=193.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe------
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE------  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  129 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....   ......+.+|+.+++.++||||+++++++...+.      
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTK--TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECC--CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            3456789999999999998755  5677888876432   3344567789999999999999999988765554      


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .++|+||+ +++|.+++..    ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.
T Consensus        95 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence            89999999 6799988863    4689999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ......                  ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+........
T Consensus       167 ~~~~~~------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i  228 (343)
T cd07851         167 HTDDEM------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI  228 (343)
T ss_pred             cccccc------------------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            432211                  12347889999999865 46788999999999999999999999765543222221


Q ss_pred             Hhhhhhhhhhhh-----cchhhhcC---CCCCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEA-----TKVNELVD---PRLAGDFD---LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ........+...     .....+..   ......+.   ...+..+.+++..||+.||.+|||+.+|+.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            111111000000     00000000   00000010   1225689999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=295.49  Aligned_cols=242  Identities=26%  Similarity=0.290  Sum_probs=193.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+...+|.|+||.|-.+....  +.+..++|++....   ....+|+.++... +||||+++.+++.+..+.|+|||.
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~--t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSP--TDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             hhccccccCCCCccceeeeeccc--cccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            34566679999999999888654  67777888776652   2234677776666 799999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee-cCCCceEEeeccccccCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv-~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      +.++.+.+.+...    +.....+..|+++|+.|+.|||++   |+|||||||+|||+ +..|+++|+|||.++......
T Consensus       398 l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~  470 (612)
T KOG0603|consen  398 LDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC  470 (612)
T ss_pred             ccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence            9999888777632    223367778999999999999999   99999999999999 688999999999997543331


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                        ...+-|..|.|||++....|+.++||||||++||+|++|+.||......  ..         
T Consensus       471 ------------------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e---------  521 (612)
T KOG0603|consen  471 ------------------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE---------  521 (612)
T ss_pred             ------------------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH---------
Confidence                              2235788999999999999999999999999999999999999765543  11         


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                                +......+.+....+..+++|+.+||+.||.+||++.+++.|--.
T Consensus       522 ----------i~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  522 ----------IHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----------HHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                      111111222335567899999999999999999999999987544

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.2e-38  Score=281.69  Aligned_cols=250  Identities=26%  Similarity=0.365  Sum_probs=188.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|.+..  ++..+++|.....  ......+..|+.++..+. ||||+++++++.+....+++|||
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKK--TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECC--CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            467889999999999999754  4677888876543  233445666777777664 99999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      + +++|..++...  ...+++..+..++.|++.|+.|||+..  +|+||||+|+||+++.++.+||+|||++........
T Consensus        96 ~-~~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          96 M-STCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             c-CcCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            8 45777766542  347899999999999999999999732  899999999999999999999999999864322110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM----ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .                ....++..|+|||.+.+..    ++.++||||||+++|+|++|..||......  ........
T Consensus       171 ~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~  232 (296)
T cd06618         171 K----------------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKIL  232 (296)
T ss_pred             c----------------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHh
Confidence            0                1123788999999987654    788999999999999999999999653221  11111111


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..       .     .+...  .....+..+.+|+.+||+.||.+|||+.+++.|.
T Consensus       233 ~~-------~-----~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         233 QE-------E-----PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             cC-------C-----CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            10       0     00000  0012345789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=288.37  Aligned_cols=245  Identities=24%  Similarity=0.349  Sum_probs=198.2

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .++||.|.||+||-|+..+  +++.||||++..   ..+....+++|+++|+.+.||.||.+.--|++.+.+++|||.+.
T Consensus       569 devLGSGQFG~VYgg~hRk--tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK--TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecc--cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            4689999999999998655  888999997654   23445788999999999999999999999999999999999995


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeeccccccCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~~~~~~  215 (368)
                      | ++.+.+... ..+++++.....++.||+.||.|||.+   +|+|+||||+|||+..   -..+||||||.|+......
T Consensus       647 G-DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  647 G-DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             c-hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            5 555555433 567899999999999999999999999   9999999999999964   3569999999999765443


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ..                ...+|||.|+|||++....|+..-|+||+|+|+|--++|..||....+..  ..+..     
T Consensus       722 FR----------------rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQN-----  778 (888)
T KOG4236|consen  722 FR----------------RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQN-----  778 (888)
T ss_pred             hh----------------hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhc-----
Confidence            22                34689999999999999999999999999999999999999995433211  00000     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             ..=+    ++...-.+.+..+.+||..+|+..-++|.|..+.|.|
T Consensus       779 -------AaFM----yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  779 -------AAFM----YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             -------cccc----cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence                   0000    1111223456789999999999999999999988876

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=274.41  Aligned_cols=240  Identities=27%  Similarity=0.335  Sum_probs=192.7

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ||.|+||.||++....  .+..+++|+.....    .....+.+|+.+++.++||||+++++.+...+..++|||++.++
T Consensus         1 lg~G~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKD--TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECC--CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            6999999999998754  56678888765432    24557889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|.+++..   ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........    
T Consensus        79 ~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----  148 (250)
T cd05123          79 ELFSHLSK---EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----  148 (250)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC----
Confidence            99999973   34689999999999999999999998   999999999999999999999999999875433210    


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                 ......++..|+|||.+.+...+.++|+||||+++|++++|..||...+..........          
T Consensus       149 -----------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------  207 (250)
T cd05123         149 -----------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------  207 (250)
T ss_pred             -----------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc----------
Confidence                       01224578899999999888889999999999999999999999965543211111100          


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA---TQILHT  347 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~~il~~  347 (368)
                              .  ...++...+..+.+++.+||..||.+|||+   +++++|
T Consensus       208 --------~--~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         208 --------D--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             --------C--CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence                    0  011122225678999999999999999999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2e-37  Score=305.78  Aligned_cols=144  Identities=28%  Similarity=0.366  Sum_probs=127.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ....+|+|+....    ......+..|+.++..++||||+++++++...+..|+||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            3467889999999999998754  6778899987543    234467888999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ||+.+++|..++..   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            99999999999873   45688999999999999999999999   999999999999999999999999999873

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.7e-38  Score=273.16  Aligned_cols=226  Identities=21%  Similarity=0.174  Sum_probs=178.3

Q ss_pred             ccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCCHHHHhc
Q 017627           68 GGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH  147 (368)
Q Consensus        68 G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  147 (368)
                      |.||.||++++..  ++..+++|.......    +.+|...+....||||+++++++.+.+..++||||+.+++|.+++.
T Consensus         4 g~~~~v~~~~~~~--~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTR--TQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEcc--CCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            8999999998755  667889997765432    2345555556679999999999999999999999999999999987


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCc
Q 017627          148 GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR  227 (368)
Q Consensus       148 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~  227 (368)
                      .   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++|||.+.......            
T Consensus        78 ~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------------  139 (237)
T cd05576          78 K---FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------------  139 (237)
T ss_pred             H---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc------------
Confidence            3   34589999999999999999999999   99999999999999999999999999875432211            


Q ss_pred             cccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhc
Q 017627          228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELV  307 (368)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (368)
                            ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......                    .... 
T Consensus       140 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------------------~~~~-  192 (237)
T cd05576         140 ------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------------------INTH-  192 (237)
T ss_pred             ------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------------------cccc-
Confidence                  1123567899999998888899999999999999999999887432110                    0000 


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          308 DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                         .....+...+..+.+++.+||+.||.+|||+     +++++|
T Consensus       193 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         193 ---TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             ---cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence               0001122235678999999999999999997     565543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=305.24  Aligned_cols=259  Identities=24%  Similarity=0.386  Sum_probs=207.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCC-----CceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDS-----TSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~-----~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      .+.+.||+|+||.|++|......     ....||+|.....  ....+.+..|+++|+.+ +|+||+.++|++...+..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            46678999999999999854322     2567888876543  34567899999999999 6999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC
Q 017627          132 LLFEYVPNGTLQEKLHGTP-----RS--------SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL  198 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~-----~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~  198 (368)
                      +|+||+..|+|..+++...     ..        ..++......++.||+.|++||++.   ++|||||-..|||++.+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence            9999999999999998654     01        1388899999999999999999999   999999999999999999


Q ss_pred             ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeec--CCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 017627          199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG--SPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEA  275 (368)
Q Consensus       199 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  275 (368)
                      .+||+|||+|+...........              ...|  ...|||||.+....|+.++||||+|++|||+++ |..|
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~--------------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTK--------------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             EEEEccccceeccCCCCceEec--------------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence            9999999999864443332210              0112  234999999999999999999999999999999 8899


Q ss_pred             CCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      |.+....                  ..+.+.+.+..+...+..++.++.++++.||+.+|++||++.++.+.++..+.
T Consensus       522 Yp~~~~~------------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  522 YPGIPPT------------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCCCcH------------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            9763211                  11112233333444455667889999999999999999999999999999654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=280.11  Aligned_cols=264  Identities=25%  Similarity=0.282  Sum_probs=200.3

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhH--------HHHHHHHHHHHhcCCCCceeeeeEEEe-c
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL--------SQVFKQELDILLHLSHDNIVKLIGYCD-D  126 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~-~  126 (368)
                      ..+|-+..+||+|||+.||+|.+..  ....||+|+.......        .+-..+|..+.+.|.||.||++|++|. +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~--EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLT--EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccc--hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            3455567789999999999999765  6788999986554322        234668999999999999999999986 4


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec---CCCceEEe
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLC  203 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~---~~~~vkl~  203 (368)
                      .+..|-|+|||+|.+|.-+|+   ....+++.++..|+.||+.||.||... ...|||-||||.|||+.   .-|.+||.
T Consensus       540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            557899999999999999998   456789999999999999999999987 45799999999999995   45789999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAFCPE  279 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~  279 (368)
                      |||+++.+.+........        ........||.+|++||++.-    ...+.++||||+|+|+|..+.|+.||+..
T Consensus       616 DFGLSKIMdddSy~~vdG--------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDG--------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ecchhhhccCCccCcccc--------eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            999999877666432211        111123469999999998843    24688999999999999999999999765


Q ss_pred             cchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+.........+.         ..+     +....-+..+.++..||++||+..-++|...-++..+
T Consensus       688 qsQQdILqeNTIlk---------AtE-----VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  688 QSQQDILQENTILK---------ATE-----VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hhHHHHHhhhchhc---------cee-----ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            54321110000000         000     1111112345688999999999999999888776554

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=269.58  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=199.2

Q ss_pred             CCCcccccCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCcee
Q 017627           42 DGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIV  118 (368)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv  118 (368)
                      +......|+-++++..     ..||.|+||+|++-.++  ..+...|||.+...  +...+++..|.++..+- ++||||
T Consensus        54 ~~~~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk--~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IV  126 (361)
T KOG1006|consen   54 DDAHLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHK--PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIV  126 (361)
T ss_pred             CcccccccccchHHHH-----HHhcCCcchhhhhhhcC--ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHH
Confidence            3344556666665543     35999999999998754  47888899865543  45667888888876665 799999


Q ss_pred             eeeEEEecCCeeEEEEecccCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT--PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       119 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      ++||++...+..|+.||+| ..+|..+.+..  -....+++.-+-.|....+.||.||-...  .|||||+||+|||++.
T Consensus       127 kfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr  203 (361)
T KOG1006|consen  127 KFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDR  203 (361)
T ss_pred             HHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEec
Confidence            9999999899999999999 55776544321  13457899988899999999999998864  8999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGME  274 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~  274 (368)
                      .|.+||||||++-....+-..                +...|-..|||||.+..  ..|+-+||+||||++|||+.||..
T Consensus       204 ~G~vKLCDFGIcGqLv~SiAk----------------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~f  267 (361)
T KOG1006|consen  204 HGDVKLCDFGICGQLVDSIAK----------------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNF  267 (361)
T ss_pred             CCCEeeecccchHhHHHHHHh----------------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCC
Confidence            999999999998654433211                22358889999999954  458999999999999999999999


Q ss_pred             CCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ||...+.. +.....-...+             .|.+..+. ....+..+..+|..||..|-..||...+++++
T Consensus       268 Pyr~w~sv-feql~~Vv~gd-------------pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  268 PYRKWDSV-FEQLCQVVIGD-------------PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CcchHHHH-HHHHHHHHcCC-------------CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            99765541 11111110000             11122111 13456789999999999999999999998865

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.1e-39  Score=287.20  Aligned_cols=280  Identities=25%  Similarity=0.257  Sum_probs=222.3

Q ss_pred             cccccCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC------CCcee
Q 017627           45 SVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------HDNIV  118 (368)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~------h~~iv  118 (368)
                      ....+.+.|+...+|.+....|+|-||+|..|.+..  .+..|||||+.+.+...+.=+.|+++|++|+      --|++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~--r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA--RGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccC--CCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            455667888888888888889999999999998755  5569999999999988888889999999996      35899


Q ss_pred             eeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-
Q 017627          119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-  197 (368)
Q Consensus       119 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-  197 (368)
                      +++..|...+++|||+|-+ ..+|.++|+....+-.+....+..++.|+.-||..|-..   ||+|.||||+||||+++ 
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            9999999999999999988 669999999887888899999999999999999999987   99999999999999964 


Q ss_pred             CceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 017627          198 LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC  277 (368)
Q Consensus       198 ~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  277 (368)
                      ..+||||||.|.....+..                 +-+.-+..|.|||++.|.+|+...|+||+||+||||.||+..|.
T Consensus       574 ~iLKLCDfGSA~~~~enei-----------------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEI-----------------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             ceeeeccCccccccccccc-----------------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            5689999999976544432                 12345678999999999999999999999999999999999999


Q ss_pred             CCcchhhHHHHHhhhhhhhhhh---------------------hcc--------hhhhcCC------CCC--CCCC---H
Q 017627          278 PENGQLLTSLAGSMLNDIADCE---------------------ATK--------VNELVDP------RLA--GDFD---L  317 (368)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~---------------------~~~--------~~~~~~~------~~~--~~~~---~  317 (368)
                      +.....+..+...+-..++.--                     ...        +...+.|      .+.  ..++   .
T Consensus       637 G~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~  716 (752)
T KOG0670|consen  637 GRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQP  716 (752)
T ss_pred             CCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhH
Confidence            8775544443333222221100                     000        0000011      000  0112   2


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          318 DEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       318 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+.+|+..||..||++|.|..++|+|
T Consensus       717 ~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  717 KIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             HHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence            345678999999999999999999999987

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=284.53  Aligned_cols=244  Identities=24%  Similarity=0.300  Sum_probs=202.3

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ...||-|+||.|-++..++..  ..+|+|+....    ....+-+..|-.+|..++.|.||++|..|.+...+|++||-|
T Consensus       425 iaTLGvGgFGRVELV~~~~~~--~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC  502 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQK--ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC  502 (732)
T ss_pred             hhhcccCccceEEEEEecccc--hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence            346999999999999875532  24566654332    233455778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      -||.|+..++   ..+.++..++..++..++.|++|||++   |||+|||||+|.+++.+|-+||.|||.|+...+..  
T Consensus       503 lGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--  574 (732)
T KOG0614|consen  503 LGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--  574 (732)
T ss_pred             cCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence            9999999998   456789999999999999999999999   99999999999999999999999999998654433  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    +..+.+|||.|.|||++.+..++.++|.||||+++|||++|.+||.+.+....+..+-+.+..   
T Consensus       575 --------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---  637 (732)
T KOG0614|consen  575 --------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---  637 (732)
T ss_pred             --------------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---
Confidence                          336789999999999999999999999999999999999999999988765554443332221   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                                     -.++........+||+.+++.+|.+|.-     ..+|-+|
T Consensus       638 ---------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  638 ---------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ---------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                           1233344567889999999999999976     6777776

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=291.41  Aligned_cols=264  Identities=21%  Similarity=0.280  Sum_probs=217.1

Q ss_pred             hhhhcccccceEEEEEEEcCCC--CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~--~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..++||+|+||+||+|.+...+  ....||+|++...  .+....+.+|+.+|..|.|||++++++++.... +-||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            4568999999999999987543  2345777876554  455788999999999999999999999998654 7899999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      |+.|+|.++++.+  ...+-....+.|..||++|+.|||.+   .++||||-..||||..-..|||.|||+++.......
T Consensus       779 mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  779 MPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             cccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999999864  45688889999999999999999999   999999999999999999999999999987544332


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .-.             .....-.+-|||-|.+....|+.++||||||+++||++| |..|+.+.........+       
T Consensus       854 ey~-------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------  913 (1177)
T KOG1025|consen  854 EYS-------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------  913 (1177)
T ss_pred             ccc-------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------
Confidence            110             011224567999999999999999999999999999999 99999876654333322       


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                                  ....+...+..++.++..++..||..|+..||+++++...+.++.....+.+.++
T Consensus       914 ------------e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~  968 (1177)
T KOG1025|consen  914 ------------EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ  968 (1177)
T ss_pred             ------------hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence                        2222334455667789999999999999999999999999999999888887776

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-35  Score=271.61  Aligned_cols=209  Identities=28%  Similarity=0.383  Sum_probs=169.0

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChhH----HHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .||-|+||.|.++.-.+  +...+|+|.....+-.    ..-.+.|-.||..-.++-||++|..|.+.+.+|+||+|++|
T Consensus       636 ~iGvGAFGeV~Lv~KvD--T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  636 TIGVGAFGEVCLVRKVD--TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             eecccccceeEEEeecc--hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence            59999999999998766  5778899876655432    22356799999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc---CCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM---GFSSAV  216 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~---~~~~~~  216 (368)
                      |++..+|-   +-+-+++..++.++..+..|+++.|..   |+|||||||+|||||.+|++||.|||++.-   ..+..+
T Consensus       714 GDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  714 GDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             ccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            99999988   456789999999999999999999999   999999999999999999999999999852   111111


Q ss_pred             CCCCCCCCCCc----ccc--------------------ccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhC
Q 017627          217 LPPSPSPSPSR----SRI--------------------TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG  272 (368)
Q Consensus       217 ~~~~~~~~~~~----~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  272 (368)
                      +..+.....+.    .++                    ......+||+.|+|||++....|+..+|.||.|+|||||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence            11100000000    000                    001246899999999999999999999999999999999999


Q ss_pred             CCCCCCCc
Q 017627          273 MEAFCPEN  280 (368)
Q Consensus       273 ~~pf~~~~  280 (368)
                      ++||-...
T Consensus       868 ~~pf~~~t  875 (1034)
T KOG0608|consen  868 QPPFLADT  875 (1034)
T ss_pred             CCCccCCC
Confidence            99996543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=238.19  Aligned_cols=199  Identities=23%  Similarity=0.325  Sum_probs=163.8

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      -...||+|++|.|-+.++..  ++...|+|-....  .+..+...+|+.+..+. .+|.+|.+||........++.||.|
T Consensus        50 ~i~elGrGayG~vekmrh~~--sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQ--SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhcCCccchhhheeecc--CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            34569999999998877654  7788888865432  45566777888887666 6999999999999999999999999


Q ss_pred             cCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          138 PNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       138 ~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                       ..+|..+.... ..+..+++..+-+|+..++.||.|||++-  .+||||+||+|||++..|.|||||||+|-...++..
T Consensus       128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence             55777654432 26788999999999999999999999984  899999999999999999999999999976554432


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      .                +...|-..|||||.+..    ..|+-++||||||+++.||.+++.||....
T Consensus       205 k----------------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  205 K----------------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             H----------------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            1                12347888999998844    378899999999999999999999997654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-36  Score=254.54  Aligned_cols=244  Identities=23%  Similarity=0.334  Sum_probs=190.1

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeec----CChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEe
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV----GSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~----~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +.++||+|+|.+|.+++.+.  +.+.+|+|+.+    +.++.......|..+..+. +||.+|.++.+|.+...+++|.|
T Consensus       254 ll~vigrgsyakvl~~~~~~--t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKK--TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             eeeeecCcchhhhhheehcc--cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            45789999999999998765  78889998754    3455566677788888777 79999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |++||+|.-.+.   ....++++.+..+...|+.||.|||+.   |||+||||.+|||++..|.+||.|+|+++...   
T Consensus       332 yv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l---  402 (593)
T KOG0695|consen  332 YVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL---  402 (593)
T ss_pred             EecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC---
Confidence            999999976655   566899999999999999999999999   99999999999999999999999999998422   


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                  .......+.+|||.|.|||++.|..|...+|.|+||++++||+.|+.||.-...+......+.     
T Consensus       403 ------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted-----  465 (593)
T KOG0695|consen  403 ------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED-----  465 (593)
T ss_pred             ------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH-----
Confidence                        222233567899999999999999999999999999999999999999963221100000000     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP  339 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  339 (368)
                           .-.+-++...++  .+...+-.+..+++..|..||.+|.
T Consensus       466 -----ylfqvilekqir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  466 -----YLFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----HHHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence                 001111111111  1122233556788899999999984

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.8e-35  Score=285.23  Aligned_cols=263  Identities=21%  Similarity=0.219  Sum_probs=163.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCC--CCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEE------EecCCee
Q 017627           59 QNFSQVIGSGGFSNVYLARLIND--STSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY------CDDRDEG  130 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~--~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~------~~~~~~~  130 (368)
                      |.+.+.||+|+||.||+|.+..+  .....+++|........ +....|  .++...+.+++.+...      .......
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence            44667899999999999997652  11667888865433221 111111  1122222222222211      2455678


Q ss_pred             EEEEecccCCCHHHHhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRS-----------------SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      ++||||+.+++|.+++......                 .......+..++.|++.||.|||++   +|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence            9999999999999988643110                 0112344667999999999999999   9999999999999


Q ss_pred             ecC-CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC--------------------
Q 017627          194 LEE-HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM--------------------  252 (368)
Q Consensus       194 v~~-~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------  252 (368)
                      ++. ++.+||+|||+|+........              ......||+.|+|||.+....                    
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~--------------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~  353 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINY--------------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ  353 (566)
T ss_pred             EeCCCCcEEEEeCCCcccccccccc--------------CCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence            985 689999999999743222111              012346899999999764322                    


Q ss_pred             --CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCC----C--CHHHHHHHH
Q 017627          253 --ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGD----F--DLDEARAML  324 (368)
Q Consensus       253 --~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~  324 (368)
                        ++.++|||||||++|||+++..|+..... .+.........+.     ........+.....    +  .........
T Consensus       354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  427 (566)
T PLN03225        354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDL-----VAWRKLVEPRASPDLRRGFEVLDLDGGAGW  427 (566)
T ss_pred             ccCCCCcccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcH-----HHHHHhhccccchhhhhhhhhccccchHHH
Confidence              33456999999999999997666432211 1111111100000     01111111111000    0  001123456


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHH
Q 017627          325 SIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       325 ~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +||.+||+.||.+|||+.++|+|
T Consensus       428 dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        428 ELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHHccCCcccCCCHHHHhCC
Confidence            89999999999999999999998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=255.02  Aligned_cols=267  Identities=21%  Similarity=0.271  Sum_probs=200.8

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-----eeEEE
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----EGVLL  133 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv  133 (368)
                      .+.||.|+||+||.+.+..  ++..+++|...+   +-...+.+.+|+++|..++|.|++..+++..-..     .+|++
T Consensus        58 DRPIGYGAFGVVWsVTDPR--dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPR--SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCcccccceeEEEeccCCC--CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3569999999999997544  677888875432   2234467789999999999999999988765432     35788


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      .|+| ..+|..++-   ....++...+.-+++||++||+|||+.   +|.||||||.|+|++.|..+||||||+++....
T Consensus       136 TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence            8988 557887776   456788899999999999999999999   999999999999999999999999999985222


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .              +...++..+-|..|+|||.+.|. .|+.++||||+|||+.|++..+..|...+......++..++
T Consensus       209 d--------------~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL  274 (449)
T KOG0664|consen  209 R--------------DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL  274 (449)
T ss_pred             h--------------hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence            1              11222334578899999999885 78999999999999999999999998888777777777666


Q ss_pred             hhhhhhhhc-----chhhhcCCCCC-CC----C----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          293 NDIADCEAT-----KVNELVDPRLA-GD----F----DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       293 ~~~~~~~~~-----~~~~~~~~~~~-~~----~----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      .........     .-.-++..... ..    +    +..-..+...++..++..||.+|.+.++.+.|+..-
T Consensus       275 GTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  275 GTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             CCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence            653321110     01111111111 11    1    112234667888999999999999999999886543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-34  Score=251.25  Aligned_cols=237  Identities=32%  Similarity=0.395  Sum_probs=189.5

Q ss_pred             cceEEEEEEEcCCCCceeEEEEeecCChhH--HHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCCHHHHh
Q 017627           69 GFSNVYLARLINDSTSTNGAIKIHVGSDRL--SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL  146 (368)
Q Consensus        69 ~~g~V~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  146 (368)
                      +||.||+|...+  ++..+++|+.......  .+.+.+|++.++.++|+||+++++++......++++|++.+++|.+++
T Consensus         1 ~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKK--TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999998754  5677888877654322  578889999999999999999999999989999999999999999998


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCC
Q 017627          147 HGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS  226 (368)
Q Consensus       147 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~  226 (368)
                      ...   ..++...++.++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.......           
T Consensus        79 ~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------  141 (244)
T smart00220       79 KKR---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------  141 (244)
T ss_pred             Hhc---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------
Confidence            743   3388999999999999999999999   99999999999999999999999999987543321           


Q ss_pred             ccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC-cchhhHHHHHhhhhhhhhhhhcchhh
Q 017627          227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE-NGQLLTSLAGSMLNDIADCEATKVNE  305 (368)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (368)
                           ......++..|++||.+.+..++.++||||+|++++++++|..||... ...........               
T Consensus       142 -----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---------------  201 (244)
T smart00220      142 -----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---------------  201 (244)
T ss_pred             -----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---------------
Confidence                 112235788999999999888899999999999999999999999663 22221111111               


Q ss_pred             hcCCCCCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          306 LVDPRLAGDFD-LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       306 ~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                         ........ ...+..+.+++.+||..+|.+||++.+++++
T Consensus       202 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      202 ---PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             ---cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence               00000000 0034578999999999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=277.54  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=183.7

Q ss_pred             hhhcccccce-EEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecccC
Q 017627           62 SQVIGSGGFS-NVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        62 ~~~iG~G~~g-~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.+|.|+.| .||+|.+    .++.||||...  ......+.+|+..|+.- +|||||++|+.-.++...|+..|+| .
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y----e~R~VAVKrll--~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY----EGREVAVKRLL--EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             HHHcccCCCCcEEEEEee----CCceehHHHHh--hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            3579999998 4699987    45677877443  33445677999999998 6999999999999999999999999 5


Q ss_pred             CCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---C--CceEEeeccccccCCC
Q 017627          140 GTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---H--LNCKLCDFGSAKMGFS  213 (368)
Q Consensus       140 ~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~--~~vkl~Dfg~s~~~~~  213 (368)
                      .+|.+++... ...........+.++.|+++||++||+.   +||||||||.||||+.   +  ..++|+|||+|+....
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            6999999863 1111111134567889999999999997   9999999999999975   2  4689999999986544


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ..            +...+.....||.+|+|||++.....+.++||||+||++|..++ |..||+..-..+..    -+.
T Consensus       664 ~~------------sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N----Il~  727 (903)
T KOG1027|consen  664 GK------------SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN----ILT  727 (903)
T ss_pred             Cc------------chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh----hhc
Confidence            33            22222345669999999999999888899999999999999999 58999654322110    000


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..      ..+..+     .  ...++  ++.+||..|++++|..||+|.++|.|
T Consensus       728 ~~------~~L~~L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 GN------YTLVHL-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             Cc------cceeee-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            00      000000     0  01112  78999999999999999999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.2e-34  Score=234.65  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=191.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCC--eeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRD--EGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~  134 (368)
                      .|++.+++|+|.|+.||.|....  +...++||+.....  .+.+.+|+.+|+.|. ||||++++++..+..  ...+|+
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~--~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINIT--NNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccC--CCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            45678899999999999998654  56777888765433  356889999999997 999999999987654  578999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~~~~  213 (368)
                      |++.+.+...+..      .++...+..++.++++||.|+|+.   ||+|||+||.|++|| ....++|+|||+|.....
T Consensus       115 E~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  115 EYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9998877765543      467778899999999999999999   999999999999999 456799999999975333


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC-c-chhhHHHHHh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPE-N-GQLLTSLAGS  290 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~-~-~~~~~~~~~~  290 (368)
                      ....                ...+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||... + .+.+.....-
T Consensus       186 ~~eY----------------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV  249 (338)
T KOG0668|consen  186 GKEY----------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV  249 (338)
T ss_pred             Ccee----------------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence            2211                23457788899999866 56899999999999999999999998643 2 3333333322


Q ss_pred             hhhhhhhhhhcchhhhcCCCC--------CCCC-------CH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRL--------AGDF-------DL-DEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~--------~~~~-------~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +-.+.....-....--++|..        +..+       +. -.++++.+|+..+|..|.++|+||.|+..|
T Consensus       250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            211110000001111111111        1110       00 114688999999999999999999999877

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=250.33  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=210.3

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCC---ceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDST---STNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDE  129 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  129 (368)
                      +.+......+-+|.||.||.|.+.+..+   .+.+.+|....  +......+..|...+..+.|||+..+.+++.+ ...
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            4444445679999999999997765322   23344454332  33445677889999999999999999998754 456


Q ss_pred             eEEEEecccCCCHHHHhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          130 GVLLFEYVPNGTLQEKLHG-----TPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      .++++.++.-|+|..|+..     ......++-.+...++.|++.|++|||++   +|||.||...|.+|++.-.|||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEecc
Confidence            7888999999999999983     22334567778889999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      =.+|+..+...+...+...+             ....||+||.+....|+.++|+||||+++|||+| |+.|+..-+...
T Consensus       440 saLSRDLFP~DYhcLGDnEn-------------RPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE  506 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNEN-------------RPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE  506 (563)
T ss_pred             chhccccCcccccccCCCCC-------------CcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence            99999877776654433222             3567999999999999999999999999999999 999986544322


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                                         ...++....+-..+.++++++..++.-||+..|++||+++++..-|.+....+++
T Consensus       507 -------------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~  561 (563)
T KOG1024|consen  507 -------------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR  561 (563)
T ss_pred             -------------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence                               2223333344455677889999999999999999999999999999987665543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-33  Score=266.05  Aligned_cols=265  Identities=18%  Similarity=0.193  Sum_probs=175.1

Q ss_pred             HHhhhhcccccceEEEEEEEcC--------------CCCceeEEEEeecCCh-hHHH--------------HHHHHHHHH
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN--------------DSTSTNGAIKIHVGSD-RLSQ--------------VFKQELDIL  109 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~--------------~~~~~~~aik~~~~~~-~~~~--------------~~~~E~~~l  109 (368)
                      +.+.++||+|+||+||+|.+..              ......||||...... ...+              ....|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            3466789999999999997532              1234568888754332 1112              233467777


Q ss_pred             hcCCCCce-----eeeeEEEec--------CCeeEEEEecccCCCHHHHhcCCCC---------------------CCCC
Q 017627          110 LHLSHDNI-----VKLIGYCDD--------RDEGVLLFEYVPNGTLQEKLHGTPR---------------------SSKL  155 (368)
Q Consensus       110 ~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~  155 (368)
                      .+++|.++     ++++++|..        .+..++||||+.+++|.+++.....                     ...+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            77766544     667776643        3568999999999999998864210                     1234


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCcccccccee
Q 017627          156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM  235 (368)
Q Consensus       156 ~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (368)
                      ++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.........              ...
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--------------~~~  369 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--------------PLY  369 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--------------ccc
Confidence            5678889999999999999999   99999999999999999999999999986432211100              011


Q ss_pred             eecCCCCccchhhccCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCCcchhhHHHHHhhh
Q 017627          236 MIGSPGYTDPHYLRTGMA----------------------STKTDVYSFGVILLELVTGME-AFCPENGQLLTSLAGSML  292 (368)
Q Consensus       236 ~~gt~~y~aPE~~~~~~~----------------------~~~~DiwslG~il~el~~g~~-pf~~~~~~~~~~~~~~~~  292 (368)
                      ..+|+.|+|||.+.....                      ..+.||||+||++|+|++|.. ||........  ......
T Consensus       370 g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~--~~~~~~  447 (507)
T PLN03224        370 GMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT--ELRQYD  447 (507)
T ss_pred             cCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh--HHhhcc
Confidence            235899999998854321                      124799999999999999875 6643221100  000000


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP---ILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rpt~~~il~~  347 (368)
                      ....     ...........-......+....+|+..||..+|   .+|+|++++|+|
T Consensus       448 ~~~~-----~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        448 NDLN-----RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             chHH-----HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0000     0000011111111122345688999999999766   789999999987

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=243.74  Aligned_cols=258  Identities=22%  Similarity=0.211  Sum_probs=190.7

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------eeEE
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------EGVL  132 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~l  132 (368)
                      .+.+|.|+- .|..|.+  .-....+++|.....   ....++..+|..++..++|+||++++.+|+-..      ..|+
T Consensus        22 L~p~~~g~~-~v~~a~D--~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~   98 (369)
T KOG0665|consen   22 LKPIGSGAQ-IVVAAFD--QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYL   98 (369)
T ss_pred             ecccCCCCc-eEEecch--hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHH
Confidence            356888887 6666654  335667777743322   233466778999999999999999999996543      4699


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |||+| ..+|...+.     -.++-.++..+++|++.|+.|||+.   +|+||||||+||++..+..+||.|||+|+...
T Consensus        99 v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   99 VMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence            99999 668888776     2467788999999999999999999   99999999999999999999999999998533


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...                ..+-++.|..|+|||++.+-.+.+.+||||+||++.||++|...|.+.+..+.....-..+
T Consensus       170 ~~~----------------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l  233 (369)
T KOG0665|consen  170 TDF----------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL  233 (369)
T ss_pred             ccc----------------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence            321                1133578899999999999889999999999999999999999998776443333332222


Q ss_pred             hhhhhhhhcc-------------------hhhhc-CCCCCC--CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATK-------------------VNELV-DPRLAG--DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~-------------------~~~~~-~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +.+.......                   ..+.+ |..++.  ..+.-.+..+++++.+||-.||++|.|+.++|.|
T Consensus       234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            2221111111                   11111 000110  0111234578899999999999999999999988

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=253.05  Aligned_cols=192  Identities=27%  Similarity=0.369  Sum_probs=163.4

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHH---------HHHHHHHHHhcCC---CCceeeeeEEEecCC
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ---------VFKQELDILLHLS---HDNIVKLIGYCDDRD  128 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~---------~~~~E~~~l~~l~---h~~iv~~~~~~~~~~  128 (368)
                      ..+.+|+|+||.|++|.++.  +...|++|.+...+-...         ..-.|+++|..|+   |+||++++++|++++
T Consensus       565 tlq~lG~GAyGkV~lai~K~--n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  565 TLQPLGEGAYGKVNLAIHKE--NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             eeeeccccccceEEEeeecc--cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            45679999999999999766  577888887665543322         2345999999997   999999999999999


Q ss_pred             eeEEEEecc-cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          129 EGVLLFEYV-PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       129 ~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      ..|++||.. ++-+|.+++.   ....+++.++..|++|++.|+++||++   +|||||||-+||.++.+|-+||+|||.
T Consensus       643 ~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence            999999985 4568999998   556799999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCC
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFC  277 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~  277 (368)
                      |....+.                 -+...+||..|.|||++.|..| ...-|||++|++||.++...-||.
T Consensus       717 aa~~ksg-----------------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSG-----------------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCC-----------------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            8642221                 1234689999999999999887 566899999999999998888874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=262.58  Aligned_cols=250  Identities=26%  Similarity=0.330  Sum_probs=198.0

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      ++.+.+|.|.||.||+|+++.  ++...|+|+.... ....+-+..|+-+++..+|||||.+++.+...+.+++.||||.
T Consensus        18 ellqrvgsgTygdvyKaRd~~--s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg   95 (829)
T KOG0576|consen   18 ELLQRVGSGTYGDVYKARDKR--SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG   95 (829)
T ss_pred             hheeeecCCcccchhhhcccc--cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence            366789999999999999766  6667777765543 2345667789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +|+|++..+   ..+.+++.++...++..+.|++|||+.   +-+|||||-.|||+++.|.+|++|||.+-....     
T Consensus        96 ggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-----  164 (829)
T KOG0576|consen   96 GGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-----  164 (829)
T ss_pred             CCcccceee---ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-----
Confidence            999999877   678899999999999999999999999   889999999999999999999999998753221     


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                ...+.....||+.|||||+-   ....|+..+|||++|++..|+---.+|-...-......+..+     
T Consensus       165 ----------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----  229 (829)
T KOG0576|consen  165 ----------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----  229 (829)
T ss_pred             ----------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----
Confidence                      12223446799999999976   446789999999999999999887777433222211111111     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               ...+|.-.. -...+++.+.+|++.+|..+|++|||++.+|+|
T Consensus       230 ---------S~~qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  230 ---------SGFQPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ---------cCCCCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence                     111221111 123556789999999999999999999998876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.4e-33  Score=244.26  Aligned_cols=278  Identities=26%  Similarity=0.352  Sum_probs=194.9

Q ss_pred             HhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           60 NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ...++||+|.|++||++.+.. ......+|+|-+..... ..++.+|+++|..+ -+.||+++.+++...+..++||||+
T Consensus        39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~  117 (418)
T KOG1167|consen   39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF  117 (418)
T ss_pred             hhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence            345689999999999998765 23567788886655544 34578899999999 4999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceEEeeccccccCCCCC-
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSA-  215 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~~~~~~-  215 (368)
                      +.....++..      .++...+..+++.++.||.++|.+   |||||||||+|+|++ ..+.-.|+|||+|....... 
T Consensus       118 ~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  118 EHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             CccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            9999988886      356888999999999999999999   999999999999998 55778999999997211000 


Q ss_pred             ----------CCCC---------C------CCCCC---CccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHH
Q 017627          216 ----------VLPP---------S------PSPSP---SRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVIL  266 (368)
Q Consensus       216 ----------~~~~---------~------~~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il  266 (368)
                                ....         .      +....   ............||++|+|||++.. ...++++||||.|+|+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                      0000         0      00000   0111122234679999999999854 5678899999999999


Q ss_pred             HHHHhCCCCCCCCcch--hhHHHH-----------Hhhhhhhhhhhhc---chh-------hh-cCCCC--------CCC
Q 017627          267 LELVTGMEAFCPENGQ--LLTSLA-----------GSMLNDIADCEAT---KVN-------EL-VDPRL--------AGD  314 (368)
Q Consensus       267 ~el~~g~~pf~~~~~~--~~~~~~-----------~~~~~~~~~~~~~---~~~-------~~-~~~~~--------~~~  314 (368)
                      ..+++++.||.....+  ......           ..+...+..+...   .+.       .. .....        ...
T Consensus       269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            9999999998754421  111110           0000000000000   000       00 00000        111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          315 FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       315 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+..+.+|+.+||..||.+|.||+++|+|
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            112224578999999999999999999999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=6.1e-31  Score=223.65  Aligned_cols=211  Identities=38%  Similarity=0.589  Sum_probs=181.4

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCCH
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL  142 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  142 (368)
                      ||+|++|.||++....  .+..+++|+......  ....+.+|+.+++.++|++|+++++++......++++|++.+++|
T Consensus         1 l~~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKK--TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecC--CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999998754  467788888776544  356788999999999999999999999998999999999998999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-CCceEEeeccccccCCCCCCCCCCC
Q 017627          143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGFSSAVLPPSP  221 (368)
Q Consensus       143 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg~s~~~~~~~~~~~~~  221 (368)
                      .+++....  ..++...+..++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........     
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----  148 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----  148 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----
Confidence            99987431  4688999999999999999999999   9999999999999999 89999999999875433221     


Q ss_pred             CCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                                ......+...|++||.+... .++.++|+|++|++++++                               
T Consensus       149 ----------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------  187 (215)
T cd00180         149 ----------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------  187 (215)
T ss_pred             ----------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence                      01223478889999999877 888999999999999999                               


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                          ..+.+++..|++.||.+||++.++++++
T Consensus       188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                2578899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=219.39  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=184.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEE-EecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGY-CDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e  135 (368)
                      .|++.+.||+|.||.+-++++..  +...+++|.....-.....|.+|...--.| .|.||+.-|++ |.+.+..++++|
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~--s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQ--SKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccC--CceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            45678899999999999998655  778889998777777788899999887777 58999988875 666778889999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec--CCCceEEeeccccccCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE--EHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~~~~vkl~Dfg~s~~~~~  213 (368)
                      |++.|+|.+-+.    ...+-+.....++.|+++|+.|+|++   ++||||||.+||||-  +.-.|||||||.++..+.
T Consensus       103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999998775    35678889999999999999999999   999999999999994  345799999999874322


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-----MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ...                  ...-+..|.+||.....     ...+.+|||.||+++|.++||++||......+..-+.
T Consensus       176 tV~------------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~  237 (378)
T KOG1345|consen  176 TVK------------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE  237 (378)
T ss_pred             eeh------------------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH
Confidence            211                  12245679999976332     2467899999999999999999999754322111100


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL  345 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il  345 (368)
                                 ......-..+.++..+. ..++.+.++.++-|..+|.+|=-..++.
T Consensus       238 -----------~~~w~~rk~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  238 -----------WEQWLKRKNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             -----------HHHHhcccCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHH
Confidence                       01111111122222222 2345788899999999999994444333

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.9e-29  Score=217.17  Aligned_cols=196  Identities=35%  Similarity=0.464  Sum_probs=167.3

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+.||.|++|.||++...+  +...+++|.......  ..+.+.+|++.++.++|+|++++++++...+..++++|++.
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKG--TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcC--CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45779999999999998754  456788887765432  46788899999999999999999999998899999999999


Q ss_pred             CCCHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      +++|.+++...   .. +++..+..++.+++.++.+||++   +++|+||+|.||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-  153 (225)
T smart00221       81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-  153 (225)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence            99999998743   23 78999999999999999999999   999999999999999999999999999876433220 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhh-ccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTGMEAFCP  278 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~  278 (368)
                                   .......++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus       154 -------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 -------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                         011224578899999998 677788899999999999999999999955

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4e-31  Score=267.03  Aligned_cols=211  Identities=20%  Similarity=0.249  Sum_probs=142.2

Q ss_pred             cCCC-CceeeeeEEE-------ecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 017627          111 HLSH-DNIVKLIGYC-------DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI  182 (368)
Q Consensus       111 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  182 (368)
                      .++| +||++++++|       .....++.+||++ +++|.+++..  ....+++.+++.++.||+.||.|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            4455 5777787776       2334567788887 6799999974  235689999999999999999999999   99


Q ss_pred             EEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC-----C--------------CC-CCCCccccccceeeecCCCC
Q 017627          183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP-----S--------------PS-PSPSRSRITKQVMMIGSPGY  242 (368)
Q Consensus       183 vH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~-----~--------------~~-~~~~~~~~~~~~~~~gt~~y  242 (368)
                      +||||||+||||+..+.+|++|||++...........     +              .. ..............+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            9999999999997666666666655543211100000     0              00 00000000111234689999


Q ss_pred             ccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHH
Q 017627          243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARA  322 (368)
Q Consensus       243 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (368)
                      ||||++.+..++.++|||||||++|||++|.+|+...... ......               ....+..     ......
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-~~~~~~---------------~~~~~~~-----~~~~~~  240 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-MSSLRH---------------RVLPPQI-----LLNWPK  240 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-HHHHHH---------------hhcChhh-----hhcCHH
Confidence            9999999999999999999999999999998887432110 000000               0011100     011234


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          323 MLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       323 l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ...++.+||+.||.+|||+.++++|-
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhhch
Confidence            56788999999999999999999873

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.9e-29  Score=208.12  Aligned_cols=170  Identities=22%  Similarity=0.264  Sum_probs=127.4

Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |+|.+++..  .+..+++..++.++.|++.||.|||++   +      ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888874  245699999999999999999999998   6      999999999999999  99987532211    


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                      ..||+.|+|||++.+..++.++|||||||++|||++|..||.......  ............  
T Consensus        64 ----------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~--  123 (176)
T smart00750       64 ----------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA--  123 (176)
T ss_pred             ----------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc--
Confidence                            148899999999999999999999999999999999999996543211  111111110000  


Q ss_pred             hcchhhhcCCCCCCCCCHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          300 ATKVNELVDPRLAGDFDLDEAR--AMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~--~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                             ..+. ..........  .+.+++..||+.||.+|||+.++++|+.....+
T Consensus       124 -------~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      124 -------DDPR-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             -------CCcc-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence                   0000 0001122233  689999999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-27  Score=215.75  Aligned_cols=269  Identities=21%  Similarity=0.254  Sum_probs=200.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-HHHHHHHHHHHHhcCCC----CceeeeeEEE-ecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-LSQVFKQELDILLHLSH----DNIVKLIGYC-DDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~~~  131 (368)
                      .|.+.+.||+|+||.||++...... ...+|+|+...... ....+..|..++..+..    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            4557889999999999999976543 45778887665422 12267789999999973    6899999988 4777899


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-----CceEEeecc
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-----LNCKLCDFG  206 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-----~~vkl~Dfg  206 (368)
                      +||+.+ |.+|.++..... ...++..++..++.|++.+|.+||+.   |++||||||+|+.++..     ..+.|.|||
T Consensus        98 iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            999998 889999886654 67899999999999999999999999   99999999999999865     469999999


Q ss_pred             ccc--cCCCCCCCC-CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh
Q 017627          207 SAK--MGFSSAVLP-PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL  283 (368)
Q Consensus       207 ~s~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  283 (368)
                      +++  ......... .....        ......||..|+++.+..+...+.+.|+||++.++.+++.|..||.......
T Consensus       173 lar~~~~~~~~~~~~~~~r~--------~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~  244 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRP--------QKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD  244 (322)
T ss_pred             CCccccccCCCCcccccCCC--------CccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence            998  322222110 00000        0123459999999999999999999999999999999999999996655322


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      ...........          .....     .....+..+.++...+-..+..++|....+...|+....+.
T Consensus       245 ~~~~~~~~~~~----------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  245 LKSKFEKDPRK----------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hHHHHHHHhhh----------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            21111111111          00000     11122345666777777799999999999999998887765

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-27  Score=201.50  Aligned_cols=270  Identities=15%  Similarity=0.202  Sum_probs=208.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.++++||+|+||++|.|+..-  +.+.||||....+.+ .-++..|....+.|. .++|...|.+..++-+..||||++
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~--nne~VAIKfEPrkS~-APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLY--NNEPVAIKFEPRKSE-APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             ceeccccccCcceeeecccccc--cCceEEEEeccccCC-cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            4578999999999999997433  688999998766554 345778999999995 799999999988888999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-----CceEEeeccccccCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-----LNCKLCDFGSAKMGF  212 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-----~~vkl~Dfg~s~~~~  212 (368)
                       |-+|.++..-.  +..++..++..++.|++.-++|+|++   .+|.|||||+|+||+.-     ..+.|+|||+|+...
T Consensus       107 -GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  107 -GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             -CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence             77998877643  45789999999999999999999999   99999999999999743     358999999998654


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      +....        .+-...+.....||.+||+--...|...+.+-|+-|||-++..++-|..||.+..........++.-
T Consensus       181 Dp~Tk--------qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  181 DPKTK--------QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             Ccccc--------ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            43321        2222334455679999999999999999999999999999999999999999877654443332221


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                      ..-..   .++..         .....+.++..-+.-.-..+-.+-|..+-+...+..++..++-
T Consensus       253 e~Kr~---T~i~~---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  253 ETKRS---TPIEV---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             ccccc---CCHHH---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            11000   11111         1223455677777777788889999998888877777665543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-27  Score=193.14  Aligned_cols=271  Identities=19%  Similarity=0.222  Sum_probs=201.2

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ...|.+.++||.|+||.+|+|....  .+..||||+......- ..+..|..+.+.|+ ...|+.+..+..+.....+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~--~ge~VAiK~Es~~a~h-pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISIT--SGEEVAIKLESSKAKH-PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeecc--CCceEEEEeecccCCC-cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3455677899999999999998766  7889999998766543 34567999999997 478888888999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeeccccccC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMG  211 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~~  211 (368)
                      +++ |-+|.+++.-.  ...++..+++-++-|++.-++|+|.+   ++|||||||+|+|.+-   -..+.|+|||+|+..
T Consensus        91 dLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            999 88999887643  34688999999999999999999999   9999999999999973   346899999999875


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .+.....        +-...+.....||.+|.+--...+...+.+.|+-|+|.++..+-.|..||.+.....-....+..
T Consensus       165 ~d~~t~~--------HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  165 RDIRTRQ--------HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             ccccccc--------cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            5443211        11122234456999999988888888889999999999999999999999886543222222111


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      .+.-..   ..+..     +.    ...+.++.-.+.-|-..--++-|...-+-+.+.-++..+
T Consensus       237 ~EkK~s---~~ie~-----LC----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  237 SEKKMS---TPIEV-----LC----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             HHhhcC---CCHHH-----Hh----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence            111000   00100     11    122446667778888888888888877766666555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=6.1e-26  Score=205.49  Aligned_cols=168  Identities=18%  Similarity=0.143  Sum_probs=123.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC------ChhHHHHHHHHHHHHhcCCCCceee-eeEEEecCCeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG------SDRLSQVFKQELDILLHLSHDNIVK-LIGYCDDRDEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~  131 (368)
                      |.+.+.||+|+||+||+|.+... ++..+|+|....      .......+.+|+++|+.++|+|++. +++    .+..+
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~   94 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGD-PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDG   94 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCC-CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcE
Confidence            55778899999999999986432 345578886542      2234567899999999999999985 443    24579


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecC-CCCCeeecCCCceEEeecccccc
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDI-KASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di-kp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      +||||+.+++|.. +.   ...      ...++.|++.||.|||++   ||+|||| ||+|||++.++.+||+|||+|+.
T Consensus        95 LVmE~~~G~~L~~-~~---~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         95 LVRGWTEGVPLHL-AR---PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             EEEEccCCCCHHH-hC---ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            9999999999963 21   111      146788999999999999   9999999 99999999999999999999986


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG  251 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  251 (368)
                      ........       ............+++.|+|||.+...
T Consensus       162 ~~~~~~~~-------~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        162 FRRRGALY-------RIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cccCcchh-------hhhhhhhhhhhhccCccCCcccCChh
Confidence            54322100       00001111346788899999998654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=9e-27  Score=224.32  Aligned_cols=255  Identities=23%  Similarity=0.232  Sum_probs=180.4

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeec----CChh---HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHV----GSDR---LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~----~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ...+|.|++|.|+.+.....  ......|...    ....   ....+..|+.+-..|+|+|++..+..+.+.....-.|
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~--~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSD--LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             cceeeecccCceEEEEecCC--CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45799999998877764332  1111222111    1111   1112556888888899999988777666555555559


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||++ +|..++.   ....+....+..++.|++.|+.|+|+.   ||.|||+||+|++++.+|.+||+|||.+....-.
T Consensus       401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999987   345688888999999999999999999   9999999999999999999999999998653222


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCc-chhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAST-KTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ..           .........+|+..|+|||++.+..|+. .+||||.|+++..|.+|+.||......+.....     
T Consensus       474 ~e-----------~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----  537 (601)
T KOG0590|consen  474 WE-----------KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----  537 (601)
T ss_pred             cc-----------hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----
Confidence            11           1112234578999999999999998875 589999999999999999999754432111000     


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                            ....................+...+.+|..||++||.+|.|+++|++.
T Consensus       538 ------~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  538 ------NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ------hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence                  000000000001111223446678899999999999999999999863

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=8.1e-24  Score=192.44  Aligned_cols=260  Identities=31%  Similarity=0.428  Sum_probs=192.1

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCC-ceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHD-NIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.+.||.|+||.||++.+.     ..+++|......    .....+.+|+.++..+.|+ +|+++++++......++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            35667999999999999865     556666544332    2467788999999999988 7999999997777789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~~~  213 (368)
                      +++.++++..++........++......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            9999999997776321113688999999999999999999999   999999999999999988 799999999874332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch----hhHH
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQ----LLTS  286 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~  286 (368)
                      ........         .......||..|+|||.+.+   ...+...|+||+|++++++++|..||......    ....
T Consensus       155 ~~~~~~~~---------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~  225 (384)
T COG0515         155 PGSTSSIP---------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK  225 (384)
T ss_pred             CCcccccc---------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence            22110000         11234579999999999988   57888999999999999999999997665431    1111


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......        .   .................+.+++..|+..+|..|.+......+
T Consensus       226 ~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 IILELPT--------P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHhcCC--------c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111000        0   000000000002223578899999999999999999988775

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-25  Score=185.54  Aligned_cols=249  Identities=20%  Similarity=0.330  Sum_probs=189.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      ++..+|.+...|..|+|++.++ +.....+++-..+......|..|.-.|+.+.||||+.+++.|....++.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3556799999999999998653 222223344444556677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE-EecCCCCCeeecCCCceEEe--eccccccCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV-HGDIKASNILLEEHLNCKLC--DFGSAKMGFSSAV  216 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iv-H~Dikp~Nilv~~~~~vkl~--Dfg~s~~~~~~~~  216 (368)
                      |+|...++.. .+-.++..++.+++.++++|++|||+..  .++ ---|....++||++.+.+|.  |--+|...     
T Consensus       272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfqe-----  343 (448)
T KOG0195|consen  272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-----  343 (448)
T ss_pred             hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeeec-----
Confidence            9999999854 4456778889999999999999999873  344 34688899999998777664  32222110     


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA---STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                                       ....-.|.||+||.++..+-   -.++|+|||++++||+.|...||.........        
T Consensus       344 -----------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------  398 (448)
T KOG0195|consen  344 -----------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------  398 (448)
T ss_pred             -----------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------
Confidence                             12346789999999987653   35799999999999999999999765432111        


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                                ..+.-..++...++..+..+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus       399 ----------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  399 ----------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                      0111122333445566778899999999999999999999999998874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=4.5e-24  Score=180.06  Aligned_cols=174  Identities=14%  Similarity=0.191  Sum_probs=131.8

Q ss_pred             HHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHH------HHHHHHHHhcCCCCceeee
Q 017627           51 WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQV------FKQELDILLHLSHDNIVKL  120 (368)
Q Consensus        51 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~------~~~E~~~l~~l~h~~iv~~  120 (368)
                      ++++.+.+|...+.||.|+||.||++..    +...+++|+.....    .....      +.+|+..+.+++|++|..+
T Consensus        25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HHHHhhCceEEEEEecCCCceEEEEEec----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            4566677788889999999999999754    24468999876432    22222      5789999999999999999


Q ss_pred             eEEEecC--------CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCe
Q 017627          121 IGYCDDR--------DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNI  192 (368)
Q Consensus       121 ~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Ni  192 (368)
                      ..++...        +..++||||++|.+|.++..       +++    ....+++.++..+|+.   |++|||+||+||
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni  166 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF  166 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence            8886533        35789999999999987642       222    2456999999999999   999999999999


Q ss_pred             eecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHH
Q 017627          193 LLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV  270 (368)
Q Consensus       193 lv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  270 (368)
                      +++.+| ++|+|||.++......                           .....+....++.++|+||||+++..+.
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~---------------------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRK---------------------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchh---------------------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            999988 9999999876321110                           0111334455678999999999887654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-23  Score=182.26  Aligned_cols=202  Identities=23%  Similarity=0.271  Sum_probs=141.6

Q ss_pred             CCCceeeeeEEEec---------------------------CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          113 SHDNIVKLIGYCDD---------------------------RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF  165 (368)
Q Consensus       113 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~  165 (368)
                      +|||||+++++|.+                           ...+|+||... ..+|..++...    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence            59999999988754                           23468999887 55899999743    356667788999


Q ss_pred             HHHHHHHHHhhCCCCCeEEecCCCCCeeec--CCC--ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCC
Q 017627          166 QLAQAIEYLHERCTLHIVHGDIKASNILLE--EHL--NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG  241 (368)
Q Consensus       166 qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~~~--~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (368)
                      |+++|+.|||.+   ||.|||+|.+|||+.  +++  .+.|+|||++-.........+..+..         ....|.-.
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~---------Vd~GGNa~  416 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDE---------VDLGGNAK  416 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccccccc---------ccCCCcce
Confidence            999999999999   999999999999994  333  36889999986543332222211111         22357788


Q ss_pred             CccchhhccCCC------CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCC
Q 017627          242 YTDPHYLRTGMA------STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDF  315 (368)
Q Consensus       242 y~aPE~~~~~~~------~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (368)
                      -||||+....+-      -.++|.|+.|.+.||+++..-||.......+.        .      ...++.--|.    .
T Consensus       417 lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--------~------r~Yqe~qLPa----l  478 (598)
T KOG4158|consen  417 LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--------T------RTYQESQLPA----L  478 (598)
T ss_pred             ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--------h------hhhhhhhCCC----C
Confidence            999999864321      24799999999999999999999763221100        0      1111111122    2


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          316 DLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       316 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      +..++..+++++..+|+.||.+|+++.-....|.
T Consensus       479 p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  479 PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            3344558899999999999999999865554443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=7.2e-23  Score=177.86  Aligned_cols=230  Identities=21%  Similarity=0.253  Sum_probs=144.1

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCC----------CceeeeeEEEe-
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSH----------DNIVKLIGYCD-  125 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~~~-  125 (368)
                      .++.||.|+++.||.+.+..  +++..++|+....    ....+.+++|.-....+.+          -.++..++... 
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~--t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVE--TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETT--TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EccccccCCceEEEEEEEcc--CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            35689999999999999765  7788899875433    2344566666655555432          12222222211 


Q ss_pred             --------cC---C-----eeEEEEecccCCCHHHHhcC---CCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEe
Q 017627          126 --------DR---D-----EGVLLFEYVPNGTLQEKLHG---TPR-SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHG  185 (368)
Q Consensus       126 --------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  185 (368)
                              ..   +     ..+++|+.+ .++|..++..   ... ...+.......+..|+++.+++||+.   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    11   1     235677777 5688776542   111 12233444456778999999999999   99999


Q ss_pred             cCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC--------CCCcch
Q 017627          186 DIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MASTKT  257 (368)
Q Consensus       186 Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~  257 (368)
                      ||+|+|++++.+|.+.|+||+.........                  .....+..|.+||.....        .++.+.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~------------------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~  231 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY------------------RCSEFPVAFTPPELESCAGQFGQNNAPYTFAT  231 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE------------------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee------------------eccCCCcccCChhhhhhhcccCcccceeeecc
Confidence            999999999999999999998776422211                  102345779999977442        468899


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 017627          258 DVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL  337 (368)
Q Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  337 (368)
                      |.|+||+++|.|++|..||..........+                       .-..+. +.++.++.||..+|+.||.+
T Consensus       232 DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~  287 (288)
T PF14531_consen  232 DAWQLGITLYSLWCGRLPFGLSSPEADPEW-----------------------DFSRCR-DMPEPVQFLIRGLLQRNPED  287 (288)
T ss_dssp             HHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----------------------GGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred             CHHHHHHHHHHHHHccCCCCCCCccccccc-----------------------cchhcC-CcCHHHHHHHHHHccCCccc
Confidence            999999999999999999975543211100                       111233 66788999999999999998


Q ss_pred             C
Q 017627          338 R  338 (368)
Q Consensus       338 R  338 (368)
                      |
T Consensus       288 R  288 (288)
T PF14531_consen  288 R  288 (288)
T ss_dssp             S
T ss_pred             C
Confidence            8

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.7e-24  Score=198.38  Aligned_cols=235  Identities=23%  Similarity=0.283  Sum_probs=181.1

Q ss_pred             hcccccceEEEEEEEcC-CCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .+|+|+||.|++++-.. ...+..+++|+.....   ........|..++...+ ||.+|++...+..++..++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999875322 2234455666543321   11114456888889886 9999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +|.|...+.   ....+.+.....+...++-|++++|+.   +|+|||+|++||+++.+|.+++.|||+++......   
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            999988776   455678888889999999999999999   99999999999999999999999999998543322   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                      ..|||..|||||++.  .+..++|.||+|+++++|+||..||.+   +.......         
T Consensus       152 ----------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~Il~---------  201 (612)
T KOG0603|consen  152 ----------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRILK---------  201 (612)
T ss_pred             ----------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHHhh---------
Confidence                            127999999999998  667889999999999999999999976   11111111         


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA--TQILHTIK  349 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~--~~il~~L~  349 (368)
                                  .....+...+..+++++..++..+|..|.-.  ..+.++.+
T Consensus       202 ------------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  202 ------------AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             ------------hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence                        0112344566788999999999999999766  34444433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=3.5e-23  Score=172.67  Aligned_cols=136  Identities=21%  Similarity=0.190  Sum_probs=104.7

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChh---H------------------------HHHHHHHHHHHhcCCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---L------------------------SQVFKQELDILLHLSHD  115 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~---~------------------------~~~~~~E~~~l~~l~h~  115 (368)
                      ..||+|+||.||+|...   ++..+|+|+......   .                        ......|+.++..+.++
T Consensus         3 ~~ig~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           3 GCISTGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CccccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            56999999999999863   577889998754311   0                        11234599999999887


Q ss_pred             ceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEecCCCCCeee
Q 017627          116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILL  194 (368)
Q Consensus       116 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dikp~Nilv  194 (368)
                      ++.....+..  ...++||||++++++.....   ....++...+..++.|++.+|.++ |+.   ||+||||||+|||+
T Consensus        80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli  151 (190)
T cd05147          80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence            7644333322  22489999998877655432   235688999999999999999999 688   99999999999999


Q ss_pred             cCCCceEEeecccccc
Q 017627          195 EEHLNCKLCDFGSAKM  210 (368)
Q Consensus       195 ~~~~~vkl~Dfg~s~~  210 (368)
                      + ++.++|+|||+|..
T Consensus       152 ~-~~~v~LiDFG~a~~  166 (190)
T cd05147         152 H-DGKLYIIDVSQSVE  166 (190)
T ss_pred             E-CCcEEEEEcccccc
Confidence            8 47899999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=204.02  Aligned_cols=249  Identities=23%  Similarity=0.283  Sum_probs=170.9

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHH---HHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF---KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      +.+.||.+.|=+|.+|++.+   +. +++|++....  -....+   ..|++ ...+++||++.+.-+.....-.|||-+
T Consensus        27 ~~~~LGstRFlKv~r~k~~e---G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDRE---GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             eecccCchhhhhhhhccCCC---ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            45779999999999998533   33 6777765543  112222   33454 566689999999877766667788888


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |. ..+|.+.+..   ..-+...+.+.|+.|++.||..+|..   ||+|||||.+||||+.-.-+.|+||..-+..+-..
T Consensus       102 yv-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YV-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HH-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            88 5589888874   34577788889999999999999999   99999999999999999999999999765322211


Q ss_pred             CCCCCCCCCCCccccc-cceeeecCCCCccchhhccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCcch
Q 017627          216 VLPPSPSPSPSRSRIT-KQVMMIGSPGYTDPHYLRTG----------M-ASTKTDVYSFGVILLELVT-GMEAFCPENGQ  282 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~el~~-g~~pf~~~~~~  282 (368)
                      .         ...+.+ -+.+...-.+|.|||.+...          + .+++-||||+||++.||++ |++||.-..  
T Consensus       175 D---------NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--  243 (1431)
T KOG1240|consen  175 D---------NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--  243 (1431)
T ss_pred             C---------CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--
Confidence            1         111110 01111233469999987431          2 4678999999999999999 788884211  


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      .+.-...    . ......-+..+-            ...++.++..|++.||.+|.+|++.|+.-.
T Consensus       244 L~aYr~~----~-~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  244 LLAYRSG----N-ADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             HHhHhcc----C-ccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            0000000    0 000000111111            125788999999999999999999998733

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.89  E-value=5.6e-24  Score=192.72  Aligned_cols=178  Identities=24%  Similarity=0.349  Sum_probs=130.7

Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      +++.|++|...+|.+|+.........++...+.++.|++.|++|   +   +.+|+|+||.||++..+..+||+|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhee
Confidence            57899999999999999877677778889999999999999999   6   89999999999999999999999999976


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......         .........+..+||.+||+||.+.+..|+.++||||||++|+|+++-   |...-..       
T Consensus       405 s~~~~~---------~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T~~er-------  465 (516)
T KOG1033|consen  405 SQDKDE---------TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FSTQFER-------  465 (516)
T ss_pred             ecccCC---------cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hccHHHH-------
Confidence            433222         011112333556899999999999999999999999999999999982   2111000       


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ  343 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~  343 (368)
                                ......+-+..+++.+-.+. +.-..|+.+++.+.|.+||++.+
T Consensus       466 ----------~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  466 ----------IATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ----------HHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence                      01111122222221111111 13457999999999999995443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=9.6e-23  Score=168.33  Aligned_cols=196  Identities=17%  Similarity=0.150  Sum_probs=136.3

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHH-----HHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ-----VFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ....|++|+||+|+.+..    ....++.+.....+....     .+.+|+++|++|+ |+++++++++    +..+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            346799999999997753    345555554544444333     5889999999995 5889999886    4469999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecC-CCCCeeecCCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDI-KASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di-kp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      +|+.|.+|...+.   .       ....++.|++.+|.++|++   ||+|||| ||+|||++.++.++|+|||+|.....
T Consensus        78 eyI~G~~L~~~~~---~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         78 SYLAGAAMYQRPP---R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             eeecCccHHhhhh---h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            9999988865432   1       1134778999999999999   9999999 79999999999999999999974332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCC-cchhhHHHHHHHHHHHhCCCCCCCC
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MAS-TKTDVYSFGVILLELVTGMEAFCPE  279 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~el~~g~~pf~~~  279 (368)
                      ...... .....+.....+ .....++.|++|+...-. ..+ ...+.++.|+-+|.++|++.|+.+.
T Consensus       145 ~~~~~r-~L~~rDl~~llk-~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        145 RARWMR-LLAREDLRHLLK-HKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             cchHHH-HHHHHHHHHHHH-HHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            110000 000000000111 123478888999865432 233 4568889999999999998886443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=1.7e-23  Score=202.54  Aligned_cols=219  Identities=26%  Similarity=0.367  Sum_probs=149.0

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ..+.|..|+||.||.++++.  +.+.+|+|+..++-...+       ++....+|.+|                     |
T Consensus        87 ~IklisngAygavylvrh~~--trqrfa~kiNkq~lilRn-------ilt~a~npfvv---------------------g  136 (1205)
T KOG0606|consen   87 TIKLISNGAYGAVYLVRHKE--TRQRFAMKINKQNLILRN-------ILTFAGNPFVV---------------------G  136 (1205)
T ss_pred             eeEeeccCCCCceeeeeccc--cccchhhcccccchhhhc-------cccccCCccee---------------------c
Confidence            45789999999999998654  677888865444322111       33333445444                     3


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +-...++   .-+.++..        ++.+++|||+.   +|+|||+||+|++|+.-|.+|+.|||+++...........
T Consensus       137 Dc~tllk---~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  137 DCATLLK---NIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             hhhhhcc---cCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            3333444   22344433        27899999999   9999999999999999999999999999875544332221


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                      ..+....+..-.....+|||.|.|||++....|...+|+|++|+|+||++.|+.||.+...+.+...   .+.+...   
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~---visd~i~---  276 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ---VISDDIE---  276 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh---hhhhhcc---
Confidence            1111111111112346899999999999999999999999999999999999999988765433221   1111000   


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS  340 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  340 (368)
                                +.+. ....+.++++++..+|+.+|..|--
T Consensus       277 ----------wpE~-dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  277 ----------WPEE-DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             ----------cccc-CcCCCHHHHHHHHHHHHhChHhhcc
Confidence                      0011 1222458999999999999999943

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.4e-22  Score=168.29  Aligned_cols=137  Identities=21%  Similarity=0.184  Sum_probs=107.1

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChh---------------------------HHHHHHHHHHHHhcCCC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---------------------------LSQVFKQELDILLHLSH  114 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~---------------------------~~~~~~~E~~~l~~l~h  114 (368)
                      ...||+|+||.||+|...   ++..+|+|+......                           ....+..|...+.++.|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05145           2 NGCISTGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE   78 (190)
T ss_pred             CceeecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence            356999999999999853   578899998664311                           01234679999999999


Q ss_pred             CceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCee
Q 017627          115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNIL  193 (368)
Q Consensus       115 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nil  193 (368)
                      +++.....+...  ..++||||++++++.....   ....++...+..++.|++.++.++|+ +   ||+||||||+||+
T Consensus        79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl  150 (190)
T cd05145          79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL  150 (190)
T ss_pred             CCCCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence            987555444333  2489999998875543322   23457788999999999999999999 8   9999999999999


Q ss_pred             ecCCCceEEeecccccc
Q 017627          194 LEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~~  210 (368)
                      ++ ++.++|+|||++..
T Consensus       151 l~-~~~~~liDFG~a~~  166 (190)
T cd05145         151 YH-DGKPYIIDVSQAVE  166 (190)
T ss_pred             EE-CCCEEEEEccccee
Confidence            99 78999999999974

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.4e-21  Score=192.47  Aligned_cols=195  Identities=23%  Similarity=0.231  Sum_probs=155.0

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC---CCceeeeeEEEecCCeeEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS---HDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l  132 (368)
                      ...+.+.+.||+|+||+||.|...+   +..+|+|+......  ..|.--.+++.+|+   -+.|..+..++.-.+.-++
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~---~~~~alK~e~P~~~--WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN---GKLVALKVEKPPNP--WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC---CcEEEEEeecCCCc--eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            3344566789999999999998543   88999998766543  23344455666666   2344455555555677889


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-------CCceEEeec
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-------HLNCKLCDF  205 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-------~~~vkl~Df  205 (368)
                      |+||.+.|+|.+++.   .++.+++..+..++.|++..++.||..   +|||+||||+|+|+..       +..++|+||
T Consensus       772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999998   667899999999999999999999999   9999999999999952       345899999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME  274 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  274 (368)
                      |.|-.+.             -....+++...++|-.+-.+|...|.+|++++|.|.|+.+++.|+.|..
T Consensus       846 G~siDm~-------------lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  846 GRSIDMK-------------LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceeee-------------EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9985311             1112245567789999999999999999999999999999999999863

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=8.7e-21  Score=159.71  Aligned_cols=132  Identities=23%  Similarity=0.288  Sum_probs=101.3

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcC-----CCCceeeeeEEEecCC---e-eEE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHL-----SHDNIVKLIGYCDDRD---E-GVL  132 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~l  132 (368)
                      +.||+|+||.||.  +..  +... +||+.... ....+.+.+|+.+++.+     .||||+++++++.+..   . ..+
T Consensus         8 ~~LG~G~~~~Vy~--hp~--~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPE--DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             ceecCCCceEEEE--CCC--CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            5699999999995  333  3333 57765543 33456789999999999     5799999999998764   3 337


Q ss_pred             EEec--ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEEecCCCCCeeecC----CCceEEeec
Q 017627          133 LFEY--VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI-EYLHERCTLHIVHGDIKASNILLEE----HLNCKLCDF  205 (368)
Q Consensus       133 v~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~Dikp~Nilv~~----~~~vkl~Df  205 (368)
                      |+||  +.+++|.+++..    ..+++.  ..++.|++.++ .|||++   +|+||||||+|||++.    ++.++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  557999999964    235555  35678888888 999999   9999999999999974    347999995


Q ss_pred             ccc
Q 017627          206 GSA  208 (368)
Q Consensus       206 g~s  208 (368)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=3.2e-20  Score=171.44  Aligned_cols=216  Identities=26%  Similarity=0.371  Sum_probs=161.1

Q ss_pred             HhcCCCCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EEecC
Q 017627          109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI-VHGDI  187 (368)
Q Consensus       109 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i-vH~Di  187 (368)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..  ....+++.-...++++++.||.|||+.   .| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            4678999999999999999999999999999999999985  355688888889999999999999997   44 99999


Q ss_pred             CCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC-------CCcchhhH
Q 017627          188 KASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-------ASTKTDVY  260 (368)
Q Consensus       188 kp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Diw  260 (368)
                      ++.|.+++....+||+|||+.........             ........-...|.|||.+.+..       .+.+.|||
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~-------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiY  142 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAE-------------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIY  142 (484)
T ss_pred             ccccceeeeeEEEEechhhhccccccccc-------------ccccchhHHHHhccCHHHhcccccccccccccccCCee
Confidence            99999999999999999999875432000             00001112345699999997742       35679999


Q ss_pred             HHHHHHHHHHhCCCCCCCCcchhh-HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCC-H-HHHHHHHHHHHHhcCCCCCC
Q 017627          261 SFGVILLELVTGMEAFCPENGQLL-TSLAGSMLNDIADCEATKVNELVDPRLAGDFD-L-DEARAMLSIAALCLRQSPIL  337 (368)
Q Consensus       261 slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~~l~~dP~~  337 (368)
                      |+|++++|+++...||........ .+.+.....            .-.+..++... . ...+.+..++..||..+|.+
T Consensus       143 s~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~------------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~  210 (484)
T KOG1023|consen  143 SFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK------------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEK  210 (484)
T ss_pred             hHHHHHHHHHhccCccccccccCChHHHHHHHHh------------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhh
Confidence            999999999999999976442211 111111100            00111111111 1 33447889999999999999


Q ss_pred             CCCHHHHHHHHHhcccc
Q 017627          338 RPSATQILHTIKHQISS  354 (368)
Q Consensus       338 Rpt~~~il~~L~~~~~~  354 (368)
                      ||+++++-..++.+...
T Consensus       211 rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  211 RPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccHHHHHhhhhhhccc
Confidence            99999999988887764

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=5.2e-20  Score=158.79  Aligned_cols=140  Identities=20%  Similarity=0.259  Sum_probs=107.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-------------------------HHHHHHHHHHHHhcCC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-------------------------LSQVFKQELDILLHLS  113 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-------------------------~~~~~~~E~~~l~~l~  113 (368)
                      |.+.+.||+|+||.||+|.+. ..++..+|+|+......                         ....+.+|+.++..+.
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~-~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDF-DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             HHhCCeeccCcceeEEEEEec-CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456788999999999999721 22577899997654321                         1134568999999997


Q ss_pred             CC--ceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEecCCCC
Q 017627          114 HD--NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH-IVHGDIKAS  190 (368)
Q Consensus       114 h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~Dikp~  190 (368)
                      +.  .++++++.    ...++||||+.+.+|.....   .........+..++.|++.++.+||++   + |+|+||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            53  34455543    23589999999888866543   223456667789999999999999999   8 999999999


Q ss_pred             CeeecCCCceEEeecccccc
Q 017627          191 NILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       191 Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ||+++ ++.++|+|||.+..
T Consensus       179 NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhc
Confidence            99999 88999999999863

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.3e-19  Score=150.07  Aligned_cols=129  Identities=23%  Similarity=0.381  Sum_probs=102.3

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCCh----h-----HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----R-----LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .||+|+||.||+|.+    .+..+++|......    .     ....+.+|++++..+.|+++.....++...+..++||
T Consensus         1 ~ig~G~~~~vy~~~~----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   76 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM   76 (199)
T ss_pred             CCCCCceEEEEEeec----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence            389999999999985    23456677543221    1     1255778999999999887665555555666789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ||++|++|.+++...   ..       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        77 e~~~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        77 EYIEGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEECCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999887531   11       7899999999999999   999999999999999 78999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=5.4e-19  Score=150.86  Aligned_cols=132  Identities=20%  Similarity=0.375  Sum_probs=108.4

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCCh---------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      +.||+|++|.||+|.+    .+..+++|+.....         .....+.+|+.++..+.|++++....++...+..++|
T Consensus         2 ~~l~~G~~~~vy~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv   77 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV   77 (211)
T ss_pred             cccccCceEEEEEEee----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence            4689999999999986    33456667543221         1124577899999999999988777777777788999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      |||++|++|.+++...   .   . ....++.+++.+|.++|+.   +++|+|++|.|||++ ++.++|+|||.+.
T Consensus        78 ~e~~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         78 MEYIEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             EEEeCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCccc
Confidence            9999999999988632   1   1 7788999999999999999   999999999999999 7889999999986

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=9.4e-19  Score=169.34  Aligned_cols=133  Identities=20%  Similarity=0.307  Sum_probs=106.4

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeec--CCh-----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV--GSD-----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~--~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ..+.||+|+||.||++.+.+..  ..+.+++..  ...     ...+.+.+|+++++.++|++++....++...+..++|
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            3577999999999999875432  222222211  111     1235678999999999999999887777777788999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      |||+++++|.+++.           ....++.+++.+|.+||+.   +++||||||+|||+ .++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999998875           3467899999999999999   99999999999999 577899999999974

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=3.5e-18  Score=144.23  Aligned_cols=132  Identities=21%  Similarity=0.251  Sum_probs=103.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-----------------------hHHHHHHHHHHHHhcCCCC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----------------------RLSQVFKQELDILLHLSHD  115 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~  115 (368)
                      +.+.+.||+|+||.||++...   ++..+++|+.....                       .....+..|..++..+.|+
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            556788999999999999753   57788999754321                       0112356789999999877


Q ss_pred             c--eeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          116 N--IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       116 ~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      +  ++..++    ....++||||+++++|......         .....++.+++.++.++|+.   +|+|+||||+||+
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil  157 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL  157 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence            4  444443    2456899999999988764320         23457889999999999999   9999999999999


Q ss_pred             ecCCCceEEeeccccc
Q 017627          194 LEEHLNCKLCDFGSAK  209 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~  209 (368)
                      +++++.++|+|||++.
T Consensus       158 l~~~~~~~liDfg~~~  173 (198)
T cd05144         158 VDDDEKIYIIDWPQMV  173 (198)
T ss_pred             EcCCCcEEEEECCccc
Confidence            9999999999999985

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=4.3e-19  Score=171.33  Aligned_cols=253  Identities=25%  Similarity=0.261  Sum_probs=183.1

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.+.||+|+|+.|-....... ....++.|.....   .........|..+-..+. |+|++.+++...+.+..++++++
T Consensus        24 ~~~~ig~gs~~~~~~~~~~~~-~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~  102 (601)
T KOG0590|consen   24 LSRSIGKGSFSSSALASNSRD-PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY  102 (601)
T ss_pred             ccccccccccchhhhhhhcCC-CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence            455699999999988764332 3444555543333   233344555888888887 99999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH-ERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFSS  214 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~~~~  214 (368)
                      ..++++.+.+... .....+...+..++.|+..++.|+| ..   ++.|+||||+|.+++.++ ..+++|||+|......
T Consensus       103 s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  103 SDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccccccccccccC-CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            9999998887311 2225666677889999999999999 77   999999999999999999 9999999999754331


Q ss_pred             CCCCCCCCCCCCccccccceeeec-CCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIG-SPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .            +........+| ++.|+|||...+. ......|+||.|+++..+++|..|+.........       
T Consensus       179 ~------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------  239 (601)
T KOG0590|consen  179 N------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------  239 (601)
T ss_pred             C------------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------
Confidence            1            11112233567 9999999999884 5567899999999999999999998655432200       


Q ss_pred             hhhhhhhhcchhhhcCCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRL--AGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ...+.....  .............+++..++..+|..|.+.+++-..
T Consensus       240 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  240 ----------YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ----------ceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                      000111100  011112234467788899999999999998887544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.7e-16  Score=137.24  Aligned_cols=133  Identities=20%  Similarity=0.237  Sum_probs=100.6

Q ss_pred             hhhcc-cccceEEEEEEEcCCCCceeEEEEeecCC--------------hhHHHHHHHHHHHHhcCCCCce--eeeeEEE
Q 017627           62 SQVIG-SGGFSNVYLARLINDSTSTNGAIKIHVGS--------------DRLSQVFKQELDILLHLSHDNI--VKLIGYC  124 (368)
Q Consensus        62 ~~~iG-~G~~g~V~~~~~~~~~~~~~~aik~~~~~--------------~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~  124 (368)
                      +..|| .|+.|+||.+...    ...+++|.+...              ......+.+|+.++..|+|++|  +..+++.
T Consensus        36 ~~~lg~~~g~gtv~~v~~~----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~  111 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR  111 (239)
T ss_pred             CceeecCCCCccEEEEEeC----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence            34688 8999999998753    345666654321              1223457789999999998775  6677764


Q ss_pred             ecCC----eeEEEEecccC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc
Q 017627          125 DDRD----EGVLLFEYVPN-GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN  199 (368)
Q Consensus       125 ~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~  199 (368)
                      ....    ..++|||++++ .+|.+++..    ..++..    .+.+++.++.+||++   ||+|+||||.|||++.++.
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGK  180 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCC
Confidence            3322    23599999987 689888753    235544    357899999999999   9999999999999999889


Q ss_pred             eEEeeccccc
Q 017627          200 CKLCDFGSAK  209 (368)
Q Consensus       200 vkl~Dfg~s~  209 (368)
                      ++|+|||.+.
T Consensus       181 v~LIDfg~~~  190 (239)
T PRK01723        181 FWLIDFDRGE  190 (239)
T ss_pred             EEEEECCCcc
Confidence            9999999986

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.6e-16  Score=127.85  Aligned_cols=133  Identities=25%  Similarity=0.328  Sum_probs=109.9

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCC--CceeeeeEEEecCCeeEEEEecccC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH--DNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.||.|.++.||++...+    ..+++|....... ...+.+|+.+++.++|  .++++++.+....+..+++|||+.+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~----~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD----EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             ceecccccccceEEEEecC----CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            3569999999999998632    5678887655443 4568889999999976  5899999988888889999999988


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      +.+..+          +......++.+++.++.+||.....+++|+|++|.||+++..+.++++|||.+.
T Consensus        78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            766533          455667789999999999998633379999999999999998999999999986

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=5.2e-17  Score=135.89  Aligned_cols=133  Identities=23%  Similarity=0.278  Sum_probs=94.3

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHH----H---------------------HHHHHHHHHhcCCCCc
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----Q---------------------VFKQELDILLHLSHDN  116 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~----~---------------------~~~~E~~~l~~l~h~~  116 (368)
                      .+.||+|+||.||+|...   ++..+++|+........    .                     ....|...+..+.+.+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   78 (187)
T cd05119           2 GGPIGTGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG   78 (187)
T ss_pred             CcccccccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence            457999999999999854   46678999765432111    1                     1134666666664432


Q ss_pred             --eeeeeEEEecCCeeEEEEecccCCCHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCe
Q 017627          117 --IVKLIGYCDDRDEGVLLFEYVPNGTLQE-KLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNI  192 (368)
Q Consensus       117 --iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Ni  192 (368)
                        +++.+++    ...++||||++++.+.. .+...    ... ..+..++.+++.++.++|. .   +|+|+||||+||
T Consensus        79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni  146 (187)
T cd05119          79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNI  146 (187)
T ss_pred             CCCCceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence              4444443    24689999998854321 11110    011 5678899999999999999 7   999999999999


Q ss_pred             eecCCCceEEeecccccc
Q 017627          193 LLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       193 lv~~~~~vkl~Dfg~s~~  210 (368)
                      +++ ++.++|+|||.+..
T Consensus       147 li~-~~~~~liDfg~a~~  163 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             EEE-CCcEEEEECccccc
Confidence            999 88999999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=5.2e-16  Score=143.77  Aligned_cols=262  Identities=21%  Similarity=0.207  Sum_probs=188.2

Q ss_pred             CHHHHHHHHHHhhhhccc--ccceEEEEEEEcCCCCceeEEEEeec---CChhHHHHHHHHHHHHhcCC-CCceeeeeEE
Q 017627           50 SWDDVERFTQNFSQVIGS--GGFSNVYLARLINDSTSTNGAIKIHV---GSDRLSQVFKQELDILLHLS-HDNIVKLIGY  123 (368)
Q Consensus        50 ~~~~~~~~~~~~~~~iG~--G~~g~V~~~~~~~~~~~~~~aik~~~---~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~  123 (368)
                      ...+..+.+.++.+.+|.  |.+|.||.+..........+++|...   ..+.....-.+|+...+.++ |+|.++.+..
T Consensus       107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            344555666667788999  99999999987445566777777422   22233333446788888884 9999999999


Q ss_pred             EecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEEecCCCCCeeecCC-C
Q 017627          124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ----AIEYLHERCTLHIVHGDIKASNILLEEH-L  198 (368)
Q Consensus       124 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~  198 (368)
                      +...+..++-+|+| +.+|..+...  ...-++...++..+.+...    |+.++|+.   +++|-|+||.||+...+ .
T Consensus       187 ~e~~~~lfiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  187 WEGSGILFIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             cccCCcceeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence            99999999999999 5788877764  3345788888999999988    99999999   99999999999999988 8


Q ss_pred             ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 017627          199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP  278 (368)
Q Consensus       199 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  278 (368)
                      .++++|||+...+..........          ......|...|++||...+ -++...||+++|.++.+..++..++..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~----------~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFK----------VSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             eeecCCcceeEEccCCcccccee----------eeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence            89999999987655444211100          0011257888999999874 557789999999999999998766543


Q ss_pred             CcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          279 ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+                ..++...   +..++...-+..+...+.+|++.+|..|+++..+..+
T Consensus       330 g~~~~W----------------~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  330 GKNSSW----------------SQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             CCCCCc----------------ccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            311111                1111111   1112222223456668999999999999998765543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=1.1e-15  Score=131.16  Aligned_cols=208  Identities=23%  Similarity=0.353  Sum_probs=144.4

Q ss_pred             HHHHhcCCCCceeeeeEEEecC-----CeeEEEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 017627          106 LDILLHLSHDNIVKLIGYCDDR-----DEGVLLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCT  179 (368)
Q Consensus       106 ~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  179 (368)
                      +..|-.+-|.|||+++.+|.+.     ....++.|||..|+|..+|+... ....+......+|+-||+.||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3345556799999999998654     34688999999999999998654 345678888889999999999999995 5


Q ss_pred             CCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhh
Q 017627          180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDV  259 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  259 (368)
                      +.|+|+++..+.|++..+|-+||+--.-....           .........+.....+-++|.|||.=.....+.++||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h-----------~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI  265 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-----------PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDI  265 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccc-----------hhhhhhhHhhhhccccCCccccCCcCcccccccchhh
Confidence            68999999999999999999998632211110           0111111112223457889999998666677789999


Q ss_pred             HHHHHHHHHHHhCCCCCCC-CcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 017627          260 YSFGVILLELVTGMEAFCP-ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR  338 (368)
Q Consensus       260 wslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  338 (368)
                      |++|+...+|..|..--.. .........+......        +.   ++            .=+.++..|++..|..|
T Consensus       266 y~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~--------le---n~------------lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  266 YKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG--------LE---NG------------LQRGSITKCLEGEPNGR  322 (458)
T ss_pred             hhhhHHHHHHHHheeccCCCcceeehhhhhhhheee--------cc---Cc------------cccCcCcccccCCCCCC
Confidence            9999999999887644222 2211111111111100        00   00            11347889999999999


Q ss_pred             CCHHHHHHHH
Q 017627          339 PSATQILHTI  348 (368)
Q Consensus       339 pt~~~il~~L  348 (368)
                      |+|+.++-|.
T Consensus       323 p~ar~llfHp  332 (458)
T KOG1266|consen  323 PDARLLLFHP  332 (458)
T ss_pred             cchhhhhcCc
Confidence            9999998874

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=1.2e-13  Score=129.65  Aligned_cols=136  Identities=21%  Similarity=0.238  Sum_probs=92.8

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChh--HH-----------------------------H----------HH
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LS-----------------------------Q----------VF  102 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~-----------------------------~----------~~  102 (368)
                      .||.|++|.||+|+..   ++..||||+....-.  ..                             +          .+
T Consensus       124 plasaSigQVh~A~l~---~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       124 PLAAASIAQVHRARLV---DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             ceeeeehhheEEEEec---CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            5999999999999875   457899998654310  00                             0          13


Q ss_pred             HHHHHHHhcCC-----CCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 017627          103 KQELDILLHLS-----HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ-AIEYLHE  176 (368)
Q Consensus       103 ~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~-~l~~LH~  176 (368)
                      .+|+..+.++.     ++++.-..-++...+..++||||++|++|.++.....  ...+   ...++..++. .+..+|.
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHh
Confidence            44565555552     3333222222233456799999999999988764211  1122   2345555555 4678898


Q ss_pred             CCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       177 ~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      .   |++|+|++|.||+++.++.++++|||++..
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            8   999999999999999999999999999864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.1e-13  Score=112.10  Aligned_cols=129  Identities=19%  Similarity=0.204  Sum_probs=94.3

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCce-eeeeEEEecCCeeEEEEecccCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNI-VKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      +.|+.|.++.||++..    .+..+++|+..........+..|+.+++.+.+.++ ++++.+..  +..++|||++++.+
T Consensus         4 ~~l~~G~~~~vy~~~~----~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEV----ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEE----CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            4588999999999975    25578889876554223346789999999865444 45555433  34589999999987


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          142 LQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC--TLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       142 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      +....        .   ....++.+++.+|..||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            75420        0   11245678999999999982  11259999999999999 6689999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.46  E-value=1.4e-13  Score=130.85  Aligned_cols=137  Identities=15%  Similarity=0.127  Sum_probs=89.2

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCCh-----------------------------------hHHHH------
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----------------------------------RLSQV------  101 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-----------------------------------~~~~~------  101 (368)
                      +.||.|++|.||+|+..+  ++..||||+....-                                   +..+.      
T Consensus       125 ~PlasaSiaQVh~A~l~~--~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD  202 (537)
T PRK04750        125 KPLASASIAQVHFARLKD--NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELD  202 (537)
T ss_pred             hhhcCCCccEEEEEEECC--CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhC
Confidence            369999999999999765  47789999876431                                   01111      


Q ss_pred             HHHHHHHHhcCC----CCceeeeeEEEe-cCCeeEEEEecccCCCHHHHhcCCCCC---CCCCHHHHHHHHHHHHHHHHH
Q 017627          102 FKQELDILLHLS----HDNIVKLIGYCD-DRDEGVLLFEYVPNGTLQEKLHGTPRS---SKLPWRNRMAIAFQLAQAIEY  173 (368)
Q Consensus       102 ~~~E~~~l~~l~----h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~  173 (368)
                      +.+|+..+.++.    +.+.+.+-.++. -.+..++||||+.|+.+.++..-...+   ..+....+..++.|++     
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-----  277 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-----  277 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence            234444444442    333343333332 245678999999999997742211011   1233334444444544     


Q ss_pred             HhhCCCCCeEEecCCCCCeeecCCC----ceEEeeccccccC
Q 017627          174 LHERCTLHIVHGDIKASNILLEEHL----NCKLCDFGSAKMG  211 (368)
Q Consensus       174 LH~~~~~~ivH~Dikp~Nilv~~~~----~vkl~Dfg~s~~~  211 (368)
                        ..   |++|+|+||.||+++.+|    .++++|||++...
T Consensus       278 --~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        278 --RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             --hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence              45   999999999999999887    9999999998653

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.44  E-value=1.7e-12  Score=107.49  Aligned_cols=135  Identities=19%  Similarity=0.238  Sum_probs=96.5

Q ss_pred             hhcccccceEEEEEEEcCCC----CceeEEEEeecCC-----------------------hhHHHH----HHHHHHHHhc
Q 017627           63 QVIGSGGFSNVYLARLINDS----TSTNGAIKIHVGS-----------------------DRLSQV----FKQELDILLH  111 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~----~~~~~aik~~~~~-----------------------~~~~~~----~~~E~~~l~~  111 (368)
                      ..||.|.-+.||.|...+..    ....+|+|+...+                       ....+.    .++|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            35899999999999743211    2467889874321                       011222    3389999999


Q ss_pred             CCC--CceeeeeEEEecCCeeEEEEecccCCCHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEecC
Q 017627          112 LSH--DNIVKLIGYCDDRDEGVLLFEYVPNGTLQE-KLHGTPRSSKLPWRNRMAIAFQLAQAIEYL-HERCTLHIVHGDI  187 (368)
Q Consensus       112 l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Di  187 (368)
                      +..  -+++..+++    ...++||||+.+..+.. .+.    ...++......+..+++.++..| |+.   ++||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            953  466666664    45789999996643322 222    22345556777889999999999 777   9999999


Q ss_pred             CCCCeeecCCCceEEeeccccc
Q 017627          188 KASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       188 kp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      +|.||++++ +.+.|+|||.|.
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav  172 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSV  172 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCce
Confidence            999999974 679999999885

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.43  E-value=5e-14  Score=137.63  Aligned_cols=255  Identities=20%  Similarity=0.264  Sum_probs=171.2

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHH----HHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .+-+-.|++|.++.+.-..  .+-..+.++....+...    +....+-.++-...+|-++.....+.-....+++++|.
T Consensus       809 ~~p~qS~sp~ss~p~~pa~--sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~  886 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAG--SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYL  886 (1205)
T ss_pred             cccccCCCCcccccCCccc--cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHh
Confidence            3468899999999886333  33223333332222211    12223333333345677776665556677889999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC-
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV-  216 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~-  216 (368)
                      .+++|...++..   +..+.+-+...+..+..++++||+.   .++|+|++|.|++...+|..++.|||......-... 
T Consensus       887 ~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  887 NGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             ccCCchhhhhcC---CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            999999988843   3566666777788889999999997   799999999999999999999999984332111100 


Q ss_pred             ---------------CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 017627          217 ---------------LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG  281 (368)
Q Consensus       217 ---------------~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (368)
                                     .....................||+.|.+||.+.+......+|+|++|++++|.++|.+||.....
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                           00000001111112234567899999999999999999999999999999999999999987665


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLA-GDFDLDEARAMLSIAALCLRQSPILRPSAT  342 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  342 (368)
                      +....                  .+...... ...+...+..+++++...+..+|.+|..+.
T Consensus      1041 q~~f~------------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQIFE------------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhh------------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            43221                  11111000 111233456788899999999999998876

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=3e-12  Score=120.32  Aligned_cols=163  Identities=19%  Similarity=0.288  Sum_probs=119.9

Q ss_pred             CceeEEEEeecCChh-HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHH
Q 017627           83 TSTNGAIKIHVGSDR-LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM  161 (368)
Q Consensus        83 ~~~~~aik~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  161 (368)
                      .+..+.+.....++. ......+-++-|+.|+||||+++++.++..+..|+|+|.+.  -|..++..      +....+.
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHH
Confidence            445555554444333 34556778889999999999999999999999999999873  56666663      2366777


Q ss_pred             HHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCC
Q 017627          162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG  241 (368)
Q Consensus       162 ~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (368)
                      ..+.||+.||.|||+.|  +++|++|.-+.|+|+..|..||++|.++.........               .....--..
T Consensus       108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~---------------~~~~~~~~s  170 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP---------------AKSLYLIES  170 (690)
T ss_pred             HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc---------------cccchhhhc
Confidence            88999999999999876  9999999999999999999999999987532211100               000111223


Q ss_pred             CccchhhccCCCCcchhhHHHHHHHHHHHhC
Q 017627          242 YTDPHYLRTGMASTKTDVYSFGVILLELVTG  272 (368)
Q Consensus       242 y~aPE~~~~~~~~~~~DiwslG~il~el~~g  272 (368)
                      |..|+.+....  -..|.|.|||+++|++.|
T Consensus       171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            55666554333  347999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=1.9e-13  Score=126.91  Aligned_cols=240  Identities=21%  Similarity=0.174  Sum_probs=169.9

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      ...||.|.|+.|+... +.......+++|-....   ......-..|+.+...+ .|.+++.++..|..-++.++-.|||
T Consensus       270 v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVS-KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             eEEccCCccccceeee-ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            4569999999999887 34346667777643322   11122234577777777 5999999999998888889999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-CceEEeeccccccCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-LNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~~vkl~Dfg~s~~~~~~~~  216 (368)
                      .++++.....   ....+++...+.+..|++.++.++|+.   .++|+|+||+||++..+ +..+++|||..........
T Consensus       349 ~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  349 EGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             cCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc
Confidence            9988876653   345678888899999999999999999   99999999999999886 7889999998863111111


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCc--cchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYT--DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                       . ..+..+++  +|.......+..++|++|||..+.+.+++.+.-.....  .          
T Consensus       423 -----------------~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--~----------  472 (524)
T KOG0601|consen  423 -----------------V-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--S----------  472 (524)
T ss_pred             -----------------c-ccccccccccchhhccccccccccccccccccccccccCcccCccccc--c----------
Confidence                             1 11233344  55555666788999999999999999998654322110  0          


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                            ..+..-.-+..    + .....+..+...++..++..||++.++..+.+
T Consensus       473 ------~~i~~~~~p~~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  473 ------LTIRSGDTPNL----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------eeeecccccCC----C-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  11111101111    1 11257788899999999999999998876654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.34  E-value=4.8e-11  Score=106.55  Aligned_cols=263  Identities=16%  Similarity=0.168  Sum_probs=159.6

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEE------EecCC-eeEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGY------CDDRD-EGVL  132 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~------~~~~~-~~~l  132 (368)
                      .++.||+|+-+.+|-.-     .....+-|++...+-..+.  .-+..|... .||-+-.-+.+      .-+.. ..-+
T Consensus        15 ~gr~LgqGgea~ly~l~-----e~~d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          15 PGRPLGQGGEADLYTLG-----EVRDQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCccccCCccceeeecc-----hhhchhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            35679999999999653     2222334555554332222  123334433 45543321111      01122 2567


Q ss_pred             EEecccCC-CHHHHhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          133 LFEYVPNG-TLQEKLH---GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       133 v~e~~~~~-~L~~~l~---~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      +|..+.+. -...+++   ++....-..|..+...++.++.+.+.||++   |.+-+|+.++|+||++++.|.|+|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            78877654 2222222   122344578999999999999999999999   9999999999999999999999986543


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcch
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTG-MEAFCPENGQ  282 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~  282 (368)
                      .....                .....+.+|.+.|.+||.-.     +..-+...|.|.||+++++++.| +.||.+-.-.
T Consensus       165 qi~~n----------------g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~  228 (637)
T COG4248         165 QINAN----------------GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI  228 (637)
T ss_pred             eeccC----------------CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence            32111                11224567999999999643     44556789999999999999885 9999764310


Q ss_pred             ----h-hH-HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHHhcccc
Q 017627          283 ----L-LT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQ--SPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       283 ----~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rpt~~~il~~L~~~~~~  354 (368)
                          . .. .........-     .....-..+........-.+.++..+..+|+..  ++.-|||++..+..|..+-.+
T Consensus       229 ~~ap~p~E~~Ia~g~f~ya-----~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         229 SDAPNPLETDIAHGRFAYA-----SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             CCCCCcchhhhhcceeeec-----hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence                0 00 1111111000     011111111111111123456788888899874  578999999988877666443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=2.5e-11  Score=97.26  Aligned_cols=129  Identities=25%  Similarity=0.404  Sum_probs=97.9

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC----hh-----HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DR-----LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+++|+-+.++.+.+.+.    .+.+|.-..+    +.     ....-.+|+.++..++--.|....=+..+.+...|+|
T Consensus         3 ~i~~GAEa~i~~~~~~g~----~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGL----PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             hhhCCcceeEEeeeccCc----ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence            578999999999976432    2444432222    11     2245567999999997666655555566677888999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ||++|..|.+.+...          ...++..+-.-+.-||..   ||+|+||.++||+++.++ +.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999999888742          135677788888899999   999999999999999875 99999999863

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=7.2e-11  Score=101.36  Aligned_cols=140  Identities=21%  Similarity=0.270  Sum_probs=104.7

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChh--HHHHHHHHHHHHhcCCC--CceeeeeEEEecCC---eeEEEEe
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LSQVFKQELDILLHLSH--DNIVKLIGYCDDRD---EGVLLFE  135 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~---~~~lv~e  135 (368)
                      +.||.|..+.||++...+   +..+++|+......  ....+..|+++++.+.+  .++++++.+.....   ..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~---g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG---GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC---CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            458999999999997532   35678887655432  35568899999999975  34677777766532   5689999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC-------------------------------------  178 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------  178 (368)
                      +++|.++...+..    ..++......++.+++.+|..||+..                                     
T Consensus        81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9999888765421    24566677777888888888887421                                     


Q ss_pred             ----------------CCCeEEecCCCCCeeecC--CCceEEeeccccc
Q 017627          179 ----------------TLHIVHGDIKASNILLEE--HLNCKLCDFGSAK  209 (368)
Q Consensus       179 ----------------~~~ivH~Dikp~Nilv~~--~~~vkl~Dfg~s~  209 (368)
                                      ...++|+|++|.||+++.  ++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                            235799999999999998  6678999999885

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=1.6e-10  Score=92.26  Aligned_cols=140  Identities=24%  Similarity=0.271  Sum_probs=100.8

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC---------hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---------DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ..|-+|+-+.|+.+.+    .++...||--..+         .-..++..+|+.+|.++.--.|.-..-++.+.+...++
T Consensus        13 ~likQGAEArv~~~~~----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSF----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             eeeeccceeeEeeecc----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            4688999999999987    3445555532211         12335667899999998755555555556667778899


Q ss_pred             EecccC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc---eEEeeccccc
Q 017627          134 FEYVPN-GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAK  209 (368)
Q Consensus       134 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~---vkl~Dfg~s~  209 (368)
                      |||+++ .++.+++....... ........++..+-..+.-||..   +|||+||..+||++..++.   +.++|||++.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            999966 47777776543332 22333367888999999999999   9999999999999965433   5899999986


Q ss_pred             c
Q 017627          210 M  210 (368)
Q Consensus       210 ~  210 (368)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            3

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.11  E-value=7.3e-10  Score=94.18  Aligned_cols=132  Identities=25%  Similarity=0.295  Sum_probs=96.2

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-----------------------hHHHHHHHHHHHHhcCCCC-
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----------------------RLSQVFKQELDILLHLSHD-  115 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~-  115 (368)
                      .++..||-|.-|.||.|.+.   .+..+++|+.....                       -.....++|.++|.+|... 
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~---~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP---KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             hhccccccCccceEEEEECC---CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            46778999999999999853   56778888743221                       1123467899999999755 


Q ss_pred             -ceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee
Q 017627          116 -NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL  194 (368)
Q Consensus       116 -~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv  194 (368)
                       .+++.+++    +..++|||++.|..|...-        ++......++..|+.-+.-+-..   ||||+|+.+-||++
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV  235 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV  235 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence             67777654    5678999999886654321        12333444555565555555555   99999999999999


Q ss_pred             cCCCceEEeeccccc
Q 017627          195 EEHLNCKLCDFGSAK  209 (368)
Q Consensus       195 ~~~~~vkl~Dfg~s~  209 (368)
                      +++|.+.++||--+.
T Consensus       236 ~~dg~~~vIDwPQ~v  250 (304)
T COG0478         236 TEDGDIVVIDWPQAV  250 (304)
T ss_pred             ecCCCEEEEeCcccc
Confidence            999999999998764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.09  E-value=2e-09  Score=94.22  Aligned_cols=139  Identities=14%  Similarity=0.147  Sum_probs=95.9

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChh--HHH----------HHHHHHHHHhcCCCCce--eeeeEEEec--
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LSQ----------VFKQELDILLHLSHDNI--VKLIGYCDD--  126 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~~----------~~~~E~~~l~~l~h~~i--v~~~~~~~~--  126 (368)
                      +.+-......|+.+..    .+..+.+|.......  ..+          .+.+|...+..|...+|  +..+++...  
T Consensus        28 e~v~~~~~rrvvr~~~----~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~  103 (268)
T PRK15123         28 EVFRELEGRRTLRFEL----AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS  103 (268)
T ss_pred             cEEecCCCceEEEEEE----CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC
Confidence            3344444444666654    234677775543321  111          36789999988853333  333444432  


Q ss_pred             ---CCeeEEEEecccCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC------
Q 017627          127 ---RDEGVLLFEYVPNG-TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE------  196 (368)
Q Consensus       127 ---~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~------  196 (368)
                         ....++|||++++. +|.+++.... ....+......++.+++..+.-||+.   ||+|+|+++.|||++.      
T Consensus       104 ~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        104 NPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             CCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCC
Confidence               23468999999875 7988875321 23456677788999999999999999   9999999999999975      


Q ss_pred             -CCceEEeeccccc
Q 017627          197 -HLNCKLCDFGSAK  209 (368)
Q Consensus       197 -~~~vkl~Dfg~s~  209 (368)
                       ++.+.|+||+.+.
T Consensus       180 ~~~~~~LIDl~r~~  193 (268)
T PRK15123        180 EDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCceEEEEECCccc
Confidence             4679999999875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=4.7e-09  Score=96.35  Aligned_cols=215  Identities=18%  Similarity=0.193  Sum_probs=144.3

Q ss_pred             eEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEec----CCeeEEEEecccC-CCHHH
Q 017627           71 SNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDD----RDEGVLLFEYVPN-GTLQE  144 (368)
Q Consensus        71 g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~  144 (368)
                      .+.|++...-  ++..+.+|..... ......-..-+++++++.|.|+|++.++|..    +..+++|++|.++ ++|.+
T Consensus       290 ~Ttyk~~s~~--DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  290 ITTYKATSNV--DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ceeEeeeecc--CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4668887533  5666777755222 1111122345889999999999999998863    3468999999865 46666


Q ss_pred             HhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          145 KLHGTP------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       145 ~l~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      +.-...            .+...+++.+|.++.|+..||.++|+.   |+.-+-|.|.+||++.+.+++|...|+.....
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            443221            233578999999999999999999999   99999999999999999899999888875433


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .+..                             |-+.+   -.+-|.=.||.+++.|.||..---..+..  ......  
T Consensus       445 ~d~~-----------------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~~s~~~--  488 (655)
T KOG3741|consen  445 EDPT-----------------------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST--QSSHLT--  488 (655)
T ss_pred             CCCC-----------------------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch--HHHHHH--
Confidence            2220                             11111   13568889999999999996432111000  000000  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                           ......+.++++++......++++ -+..+++.++
T Consensus       489 ---------------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  489 ---------------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ---------------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                                 011234567778888888888877 6777777654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=1.3e-09  Score=90.11  Aligned_cols=97  Identities=27%  Similarity=0.363  Sum_probs=64.9

Q ss_pred             HHHHHHHHHHhcCCCC--ceeeeeEEEecCCeeEEEEeccc--CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-H
Q 017627          100 QVFKQELDILLHLSHD--NIVKLIGYCDDRDEGVLLFEYVP--NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY-L  174 (368)
Q Consensus       100 ~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~-L  174 (368)
                      ....+|+..|..+..-  ++++++++.    ..++||||+.  |..+..+....     ++......++.+++..+.. +
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~  123 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKML  123 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHH
Confidence            3567899999999765  566776553    3579999998  55554433311     1123445677788875555 4


Q ss_pred             hhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       175 H~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      |..   ||+|+|+.+.||+++++ .+.|+|||.+.
T Consensus       124 ~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen  124 HKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             HCT---TEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             Hhc---CceecCCChhhEEeecc-eEEEEecCcce
Confidence            677   99999999999999988 89999999886

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=1.1e-10  Score=110.29  Aligned_cols=157  Identities=19%  Similarity=0.299  Sum_probs=105.9

Q ss_pred             HHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCcc
Q 017627          165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTD  244 (368)
Q Consensus       165 ~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (368)
                      .+++.|+.|+|+..  ++||++|.|++|.++.++..||+.|+.+........++-.      .....--....-...|.|
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~------~yd~~lp~~~~~~~~f~a  177 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFS------EYDPPLPLLLQPHLNFLA  177 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccc------cCCCCCChhhccCccccc
Confidence            34558999999985  8999999999999999999999999988654442221111      111111112234568999


Q ss_pred             chhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHH
Q 017627          245 PHYLRTGMASTKTDVYSFGVILLELVTG-MEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM  323 (368)
Q Consensus       245 PE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  323 (368)
                      ||.+.+...+.++|++|+|+.+|.+..| ..-+...+........                ...+..-...+....+.++
T Consensus       178 pE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----------------~~~~~~~~~~~s~~~p~el  241 (700)
T KOG2137|consen  178 PEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----------------RNLLNAGAFGYSNNLPSEL  241 (700)
T ss_pred             chhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----------------hcccccccccccccCcHHH
Confidence            9999998889999999999999999954 4444433322221111                1111111112234556688


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHH
Q 017627          324 LSIAALCLRQSPILRPSATQIL  345 (368)
Q Consensus       324 ~~li~~~l~~dP~~Rpt~~~il  345 (368)
                      ++=+.+++..++.-||++..++
T Consensus       242 ~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  242 RESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHHHHHHhcCCcccCcchhhhh
Confidence            8889999999999999665544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=2.8e-08  Score=84.14  Aligned_cols=106  Identities=26%  Similarity=0.355  Sum_probs=82.2

Q ss_pred             HHHHHHHHHHHhcCCCC--ceeeeeEEEecCC----eeEEEEecccCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 017627           99 SQVFKQELDILLHLSHD--NIVKLIGYCDDRD----EGVLLFEYVPNG-TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI  171 (368)
Q Consensus        99 ~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l  171 (368)
                      ...+.+|...+..|...  .++..+++.....    ..++|+|++++. +|.+++...   ...+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence            34567888888888533  3445555554432    348999999774 799988742   2256667788999999999


Q ss_pred             HHHhhCCCCCeEEecCCCCCeeecCCC---ceEEeecccccc
Q 017627          172 EYLHERCTLHIVHGDIKASNILLEEHL---NCKLCDFGSAKM  210 (368)
Q Consensus       172 ~~LH~~~~~~ivH~Dikp~Nilv~~~~---~vkl~Dfg~s~~  210 (368)
                      .-||+.   ||+|+|++|.|||++.++   .+.++||+.++.
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   999999999999999887   899999998763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.76  E-value=1.4e-07  Score=78.57  Aligned_cols=138  Identities=14%  Similarity=0.085  Sum_probs=99.0

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecC----C---hhHHHHHHHHHHHHhcCCCCc--eeeeeEEEecC----CeeE
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVG----S---DRLSQVFKQELDILLHLSHDN--IVKLIGYCDDR----DEGV  131 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~---~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~----~~~~  131 (368)
                      -|+||-+-|+.....+.    .+-+|...+    +   +.....|.+|+..+..|..-+  +++........    ...+
T Consensus        26 ~~rgG~SgV~r~~~~g~----~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~  101 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK----KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRAL  101 (216)
T ss_pred             cCCCCcceEEEEEeCCc----EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEE
Confidence            36699999998876432    455663321    0   334567899999999995322  44444221111    2357


Q ss_pred             EEEecccC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc--eEEeecccc
Q 017627          132 LLFEYVPN-GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN--CKLCDFGSA  208 (368)
Q Consensus       132 lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~--vkl~Dfg~s  208 (368)
                      ||+|-+.+ .+|.+++... .-...+......++.+++..+.-||+.   |+.|+|+.+.||+++.+|.  ++++||.-+
T Consensus       102 LVTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            99997743 5888888643 223557777789999999999999999   9999999999999986667  999999987


Q ss_pred             cc
Q 017627          209 KM  210 (368)
Q Consensus       209 ~~  210 (368)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            64

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.64  E-value=3.6e-07  Score=77.24  Aligned_cols=132  Identities=23%  Similarity=0.282  Sum_probs=92.1

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChhHH-------------------------HHHHHHHHHHhcCC--CCc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-------------------------QVFKQELDILLHLS--HDN  116 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~-------------------------~~~~~E~~~l~~l~--h~~  116 (368)
                      .|+.|.-+.||+|..   .....+|+|++.......                         .....|+..|.++.  +=.
T Consensus        55 ~istGKEA~Vy~a~~---~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          55 CISTGKEANVYLAET---GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             eecCCcceEEEeecc---CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            578888899999973   357788999865432111                         12346888888884  445


Q ss_pred             eeeeeEEEecCCeeEEEEecccCCCHH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          117 IVKLIGYCDDRDEGVLLFEYVPNGTLQ-EKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       117 iv~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                      +++.+++.    ...+|||++.....- -.|    ..-++....+..+..+++..+.-|-..+  ++||+||..-|||+.
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~  201 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH  201 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE
Confidence            55666554    347999999554111 011    1222333367778888888888888743  999999999999999


Q ss_pred             CCCceEEeeccccc
Q 017627          196 EHLNCKLCDFGSAK  209 (368)
Q Consensus       196 ~~~~vkl~Dfg~s~  209 (368)
                       ++.+.|+|||-|.
T Consensus       202 -~~~p~iID~~QaV  214 (268)
T COG1718         202 -DGEPYIIDVSQAV  214 (268)
T ss_pred             -CCeEEEEECcccc
Confidence             7799999999886

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.64  E-value=5.9e-07  Score=77.06  Aligned_cols=138  Identities=17%  Similarity=0.201  Sum_probs=82.7

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc--eeeeeEEEecCCeeEEEEecccCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN--IVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      ..||+|..+.||+..      +..+++|+..... ......+|.++++.+..-+  +++.+++....+...+|||++.|.
T Consensus         7 ~~i~~G~t~~~y~~~------~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTHK------TGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEec------CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            358999999999742      2235677665433 2345688999999986433  467788877777788999999886


Q ss_pred             C-HHHH---------------------hcCCCCCCCCCHHHHH-HHHHH----------HHH-HHHHHhhC-CCCCeEEe
Q 017627          141 T-LQEK---------------------LHGTPRSSKLPWRNRM-AIAFQ----------LAQ-AIEYLHER-CTLHIVHG  185 (368)
Q Consensus       141 ~-L~~~---------------------l~~~~~~~~~~~~~~~-~i~~q----------i~~-~l~~LH~~-~~~~ivH~  185 (368)
                      . +...                     ++.... ...+..... .+..+          +.. ...+|... ....++|+
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            3 2111                     111100 011111100 01000          001 11222211 12357899


Q ss_pred             cCCCCCeeecCCCceEEeeccccc
Q 017627          186 DIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       186 Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      |+.|.||++++++ +.++||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=3.8e-07  Score=86.70  Aligned_cols=138  Identities=17%  Similarity=0.175  Sum_probs=89.8

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhH-----------------------------------HH------H
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL-----------------------------------SQ------V  101 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~-----------------------------------~~------~  101 (368)
                      +.|+.++-|.||.|+..+   ++.||||+.+..-..                                   .+      .
T Consensus       131 ~PiAsASIaQVH~A~L~s---G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD  207 (517)
T COG0661         131 EPIASASIAQVHRAVLKS---GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD  207 (517)
T ss_pred             CchhhhhHhhheeEEecC---CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence            368899999999999864   788999986543110                                   00      1


Q ss_pred             HHHHHHHHhcCC-----CCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 017627          102 FKQELDILLHLS-----HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE  176 (368)
Q Consensus       102 ~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  176 (368)
                      +.+|+..+.++.     .+++.-..=+++-.+..+++|||++|-.+.+.....  ....+...+.....++.-  ..+-.
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~ia~~~~~~f~--~q~~~  283 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKELAELLVRAFL--RQLLR  283 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHHHHHHHHHHH--HHHHh
Confidence            334665555552     344333333344456789999999998888774321  133454433333322221  22222


Q ss_pred             CCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       177 ~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      .   |+.|.|.+|.||+++.+|.+.+.|||+...
T Consensus       284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             c---CccccCCCccceEEecCCcEEEEcCcceec
Confidence            4   899999999999999999999999999754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.58  E-value=7.9e-07  Score=74.35  Aligned_cols=67  Identities=25%  Similarity=0.383  Sum_probs=53.0

Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      ...+++|||++|..|.+...       +++    .+...+..++.-||+.   |++|+|..|.|+++++++ ++++||+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~  180 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQG  180 (229)
T ss_pred             eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcc
Confidence            44578999999988765432       222    2445677789999999   999999999999999664 99999987


Q ss_pred             cc
Q 017627          208 AK  209 (368)
Q Consensus       208 s~  209 (368)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            65

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.46  E-value=3.4e-08  Score=93.00  Aligned_cols=180  Identities=17%  Similarity=0.152  Sum_probs=125.8

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc-eeeeeEEEecCCeeEEEEecccCC-CH
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN-IVKLIGYCDDRDEGVLLFEYVPNG-TL  142 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-~L  142 (368)
                      +++|+++++++.+...  +...+ .++....    ....-++++|.+++||| .+..++-+..++..+++++++.++ +-
T Consensus       250 fvK~altknpKkRpta--eklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTA--EKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHhcCCCccCCCh--hhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            6889999999987432  22222 4444433    22345899999999999 777777777778889999999776 11


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCC
Q 017627          143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS  222 (368)
Q Consensus       143 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~  222 (368)
                      ......  ....+...+...+.+.-.++++++|+.   .=+|+|    ||+.++ +..+..||+.........       
T Consensus       323 ~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-------  385 (829)
T KOG0576|consen  323 ALEMTV--SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-------  385 (829)
T ss_pred             cccCCh--hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-------
Confidence            111110  112233444555666777899999986   457888    777666 578999999876433222       


Q ss_pred             CCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 017627          223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC  277 (368)
Q Consensus       223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  277 (368)
                               ......+++.++|||+..++.+....|.|++|.-..++.-|.+|-.
T Consensus       386 ---------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 ---------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ---------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence                     1133469999999999999999999999999987777777776643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=3e-06  Score=67.89  Aligned_cols=127  Identities=20%  Similarity=0.299  Sum_probs=87.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceee-eeEEEecCCeeEEEEeccc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK-LIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~  138 (368)
                      +..+.||+|.+|.||++.+.+    ..+++|+-..+. ....+..|+++|..++-.++-. ++.+..    ..+.|||+.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~----~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~   95 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG----GEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID   95 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC----ceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence            356789999999999998744    477888765543 3567889999999998666543 443332    235599998


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCC-CC-CeeecCCCceEEeeccccc
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIK-AS-NILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dik-p~-Nilv~~~~~vkl~Dfg~s~  209 (368)
                      |-.|.++-..      .+..    -+..++.+.--|...   ||-|+.|. |. ||++.++ .+.|+||..|+
T Consensus        96 G~~L~~~~~~------~~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At  154 (201)
T COG2112          96 GRPLGKLEIG------GDRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSAT  154 (201)
T ss_pred             Ccchhhhhhc------ccHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchh
Confidence            8888765431      1222    233455554455555   99999987 44 5555554 89999999986

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.39  E-value=4.4e-06  Score=72.83  Aligned_cols=139  Identities=22%  Similarity=0.237  Sum_probs=82.5

Q ss_pred             cccccc-eEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecccCCCH
Q 017627           65 IGSGGF-SNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTL  142 (368)
Q Consensus        65 iG~G~~-g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  142 (368)
                      |-.|.. ..||+....    .....+|+.....  ...+.+|+.+++.+. +--+++++++....+..++||++++|.++
T Consensus         6 ~~~g~~~~~v~~~~~~----~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK----NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC----CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            445555 788988631    2456777665432  334667999998884 44466778877766678999999988776


Q ss_pred             HHHh-------------------cCCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHhhC---
Q 017627          143 QEKL-------------------HGTPR-SSKLPWR--NRMAIAF--------------------QLAQAIEYLHER---  177 (368)
Q Consensus       143 ~~~l-------------------~~~~~-~~~~~~~--~~~~i~~--------------------qi~~~l~~LH~~---  177 (368)
                      ....                   +..+. ...+...  .......                    .+...+..|-..   
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            5331                   11110 0011100  0000000                    011112222111   


Q ss_pred             -CCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          178 -CTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       178 -~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                       ....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             12358999999999999998778999999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.38  E-value=2.3e-06  Score=71.06  Aligned_cols=104  Identities=25%  Similarity=0.336  Sum_probs=81.5

Q ss_pred             HHHHHHHhcCCC-CceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 017627          103 KQELDILLHLSH-DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH  181 (368)
Q Consensus       103 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~  181 (368)
                      ..|.-+++.+++ +++++++|+|-    .++|.||...+++.............+|..+.+|+.+++..+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358889999975 69999999983    3679999976655432111012234689999999999999999999864446


Q ss_pred             eEEecCCCCCeeecCCCceEEeecccccc
Q 017627          182 IVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       182 ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      +.-.|++|+|+-++++|.+|++|......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.36  E-value=4.8e-06  Score=71.86  Aligned_cols=142  Identities=19%  Similarity=0.280  Sum_probs=81.1

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCC--ceeeeeEEEec---CCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD--NIVKLIGYCDD---RDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~  137 (368)
                      +.|+.|..+.||++...+    ..+++|+.... .....+.+|+.+++.|...  .+++++.....   ....+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~----~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD----GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT----SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC----cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            458999999999997532    37788876555 5566778899999988533  35666664432   23468999999


Q ss_pred             cCCCHHH----------------Hhc---CC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHh
Q 017627          138 PNGTLQE----------------KLH---GT-PRSSKLPWRN---------RMAI------------AFQLAQ-AIEYLH  175 (368)
Q Consensus       138 ~~~~L~~----------------~l~---~~-~~~~~~~~~~---------~~~i------------~~qi~~-~l~~LH  175 (368)
                      ++..+..                .+.   .. ..........         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            8887766                111   11 0111111100         0000            011111 233333


Q ss_pred             h----CCCCCeEEecCCCCCeeec-CCCceEEeeccccc
Q 017627          176 E----RCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAK  209 (368)
Q Consensus       176 ~----~~~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~  209 (368)
                      +    .....++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    1223699999999999999 66667899999875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.35  E-value=9.4e-06  Score=67.71  Aligned_cols=129  Identities=24%  Similarity=0.322  Sum_probs=88.2

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCCh-----------------hHHHHHHHHHHHHhcCC------CCceee
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----------------RLSQVFKQELDILLHLS------HDNIVK  119 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~~iv~  119 (368)
                      ..||+|+.-.||.-  .+   .....||+.....                 ...+...+|+.....+.      +.+|.+
T Consensus         7 ~~i~~G~~R~cy~H--P~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             cccccCCCceEEEC--CC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            46999999999954  22   2334566554433                 23455667777777665      789999


Q ss_pred             eeEEEecCCeeEEEEecccC------CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          120 LIGYCDDRDEGVLLFEYVPN------GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       120 ~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      ++|+.++.-..-+|+|.+.+      -+|.+++..    +.++. .....   +-.-..||-++   +|+.+|++|.||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEE
Confidence            99999999899999998643      367788852    33555 33333   33445667777   8999999999999


Q ss_pred             ecCC--C--ceEEee-ccc
Q 017627          194 LEEH--L--NCKLCD-FGS  207 (368)
Q Consensus       194 v~~~--~--~vkl~D-fg~  207 (368)
                      +..+  +  .+.|+| ||.
T Consensus       151 ~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEecCCCceEEEEEeCCCC
Confidence            9633  2  466666 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.30  E-value=1.1e-05  Score=82.45  Aligned_cols=149  Identities=19%  Similarity=0.343  Sum_probs=89.2

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCC-CCce--eeeeEEEecC---CeeEEEE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLS-HDNI--VKLIGYCDDR---DEGVLLF  134 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~  134 (368)
                      +.++.|.++.+|+....+......+++|......  .....+.+|+.+++.|. |.++  ++++.++.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4578899999999876443222345556543221  22346789999999995 6665  7778877654   4578999


Q ss_pred             ecccCCCHHH--------------------H---hcCCCCC--------CC--CCHHHHHHHHH---------------H
Q 017627          135 EYVPNGTLQE--------------------K---LHGTPRS--------SK--LPWRNRMAIAF---------------Q  166 (368)
Q Consensus       135 e~~~~~~L~~--------------------~---l~~~~~~--------~~--~~~~~~~~i~~---------------q  166 (368)
                      |+++|..+.+                    .   |+.....        .+  ....++..+..               .
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            9998764321                    1   1111100        00  00112222111               1


Q ss_pred             HHHHHHHHhhCCC--------CCeEEecCCCCCeeecC-CCc-eEEeeccccccC
Q 017627          167 LAQAIEYLHERCT--------LHIVHGDIKASNILLEE-HLN-CKLCDFGSAKMG  211 (368)
Q Consensus       167 i~~~l~~LH~~~~--------~~ivH~Dikp~Nilv~~-~~~-vkl~Dfg~s~~~  211 (368)
                      +...+.+|..+.+        ..+||+|++|+||+++. ++. +-|.||.++...
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            2234566644321        25999999999999984 333 579999998753

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=7.9e-06  Score=77.61  Aligned_cols=136  Identities=18%  Similarity=0.153  Sum_probs=85.6

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHH--------------------------------H------HHHH
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--------------------------------Q------VFKQ  104 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~--------------------------------~------~~~~  104 (368)
                      +.||.-+.|.||+|+.++   ++.||+|+.+..-+..                                +      .|.+
T Consensus       167 ~piaaASlaQVhrA~L~~---G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN---GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             chhhhcchhheEEEEecC---CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            469999999999999765   7889999865441100                                0      1334


Q ss_pred             HHHHHhcC----CCCc------eeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 017627          105 ELDILLHL----SHDN------IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL  174 (368)
Q Consensus       105 E~~~l~~l----~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L  174 (368)
                      |++...++    .|-+      |++++-.  -....+|+||||+|..+.+.-.-  ....++...+..-+.+...  ..|
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~--~qI  317 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYL--EQI  317 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHH--HHH
Confidence            55444443    3444      4444322  23567999999999866654221  2233555544433333322  122


Q ss_pred             hhCCCCCeEEecCCCCCeeecC----CCceEEeecccccc
Q 017627          175 HERCTLHIVHGDIKASNILLEE----HLNCKLCDFGSAKM  210 (368)
Q Consensus       175 H~~~~~~ivH~Dikp~Nilv~~----~~~vkl~Dfg~s~~  210 (368)
                      =..   |++|+|=+|.||+++.    ++.+.+-|||+...
T Consensus       318 f~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  318 FKT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             Hhc---CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            223   8999999999999983    67799999999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.20  E-value=1e-05  Score=81.63  Aligned_cols=203  Identities=21%  Similarity=0.218  Sum_probs=138.4

Q ss_pred             HHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE----EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 017627           99 SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL  174 (368)
Q Consensus        99 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L  174 (368)
                      .+...-|...+..+.|+|++.++.+..+.-..-    +.-++|...++...+.   .-..++..+.+.+..++.+|+.++
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHH
Confidence            344556788888889999999998875543222    3346777778877776   556789999999999999999999


Q ss_pred             hhCCCCCeEEecCCCC---CeeecCCCceEEe--eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc
Q 017627          175 HERCTLHIVHGDIKAS---NILLEEHLNCKLC--DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR  249 (368)
Q Consensus       175 H~~~~~~ivH~Dikp~---Nilv~~~~~vkl~--Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  249 (368)
                      |+.   ...|.-+..+   +.-++..+.+.++  ||+.++........                ....-+..+.+||...
T Consensus       303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----------------~~~~~~~~~~~~e~~~  363 (1351)
T KOG1035|consen  303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----------------FSDLLAEIRNADEDLK  363 (1351)
T ss_pred             HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc----------------hhhcCccccccccccc
Confidence            998   5666655555   5555666777777  88887653332211                1123455677888877


Q ss_pred             cCCCCcc--hhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHH
Q 017627          250 TGMASTK--TDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIA  327 (368)
Q Consensus       250 ~~~~~~~--~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  327 (368)
                      .+....+  .|+|.+|..+..+..|..+-....                     ....+++.        .....+.+..
T Consensus       364 ~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~---------------------~~~~~l~~--------~~~~~~~d~~  414 (1351)
T KOG1035|consen  364 ENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA---------------------VPVSLLDV--------LSTSELLDAL  414 (1351)
T ss_pred             cccchhhhhhHHHHHHHHHhhhhhcCccccccc---------------------chhhhhcc--------ccchhhhhhh
Confidence            6655544  799999999999988754421110                     00001000        0011466788


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          328 ALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       328 ~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                      ..|+..++++|+++.+++.+.-...
T Consensus       415 ~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  415 PKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhhcchhhhhccchhhhhhchhccc
Confidence            8999999999999999998865443

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.08  E-value=4.6e-05  Score=65.98  Aligned_cols=72  Identities=11%  Similarity=0.186  Sum_probs=44.1

Q ss_pred             hcccccce-EEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCC---ceeeeeEEEecC---CeeEEEEec
Q 017627           64 VIGSGGFS-NVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD---NIVKLIGYCDDR---DEGVLLFEY  136 (368)
Q Consensus        64 ~iG~G~~g-~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~  136 (368)
                      .|+.|+.. .||+..     .  .+.+|+.... .....+.+|++++..|...   -+..+++.....   ...+++|++
T Consensus         4 ~~~~gG~~n~vy~~~-----~--~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           4 PVDSGGTDNATFRLG-----D--DMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eccCCCcccceEEcC-----C--ceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            46766666 588752     1  3556765442 2345788899999988532   344455443322   234889999


Q ss_pred             ccCCCHH
Q 017627          137 VPNGTLQ  143 (368)
Q Consensus       137 ~~~~~L~  143 (368)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9886663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.02  E-value=0.00015  Score=65.07  Aligned_cols=75  Identities=16%  Similarity=0.111  Sum_probs=53.0

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCC---CceeeeeEEEecC---CeeEEEEec
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH---DNIVKLIGYCDDR---DEGVLLFEY  136 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~---~~~~lv~e~  136 (368)
                      +.||.|..+.||.....+   . .+.+|+... ......+..|+..|+.|..   -.++++++++...   +..++|||+
T Consensus        20 ~~i~~G~~~~vy~~~~~~---~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         20 ECISEQPYAALWALYDSQ---G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eecCCccceeEEEEEcCC---C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            469999999999886322   2 345565432 1233578899999999953   3688888877543   568999999


Q ss_pred             ccCCCH
Q 017627          137 VPNGTL  142 (368)
Q Consensus       137 ~~~~~L  142 (368)
                      +.+.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            988654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.98  E-value=0.00011  Score=63.54  Aligned_cols=75  Identities=20%  Similarity=0.197  Sum_probs=45.8

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCC-ceeeeeEEEecCCeeEEEEecccCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD-NIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      +.|..|-...+|++...+. ....+.+|+........-...+|+.+++.+... -.+++++.+.    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-NQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-CCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            3467788889998863210 134667776654332222334789999988533 3445554433    248999998866


Q ss_pred             H
Q 017627          142 L  142 (368)
Q Consensus       142 L  142 (368)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.94  E-value=0.00015  Score=60.18  Aligned_cols=121  Identities=24%  Similarity=0.336  Sum_probs=84.8

Q ss_pred             Hhhhhcccccc-eEEEEEEEcCCCCceeEEEEeecC----C-----------h-------hHHHHHHHHHHHHhcCC---
Q 017627           60 NFSQVIGSGGF-SNVYLARLINDSTSTNGAIKIHVG----S-----------D-------RLSQVFKQELDILLHLS---  113 (368)
Q Consensus        60 ~~~~~iG~G~~-g~V~~~~~~~~~~~~~~aik~~~~----~-----------~-------~~~~~~~~E~~~l~~l~---  113 (368)
                      ++.+.||.|.- |.||+++.    .+..+|+|+...    .           .       .....|..|..+..+|+   
T Consensus        40 ~flefLg~g~~~~~V~kv~I----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   40 EFLEFLGHGSHDGYVFKVEI----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             eeeeecCCCCceeEEEEEEE----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            46788999999 99999997    456899998211    0           0       12245778999888885   


Q ss_pred             CCce--eeeeEEEecC------------------CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 017627          114 HDNI--VKLIGYCDDR------------------DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY  173 (368)
Q Consensus       114 h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~  173 (368)
                      +.++  |+++|+..-.                  ....||.||.+...            .+..    .-+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            4455  9999987321                  01256777764432            1222    234567777889


Q ss_pred             HhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       174 LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      +|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            9998   9999999999986     3489999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00016  Score=63.41  Aligned_cols=136  Identities=19%  Similarity=0.179  Sum_probs=76.2

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCChhHH-HHHHHHHHHHhcCCCCce-eeeeEEEecCCeeEEEEecccCCCH
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-QVFKQELDILLHLSHDNI-VKLIGYCDDRDEGVLLFEYVPNGTL  142 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L  142 (368)
                      +..|-.+.+|+...    .+..+.+|+........ -...+|..+++.+...++ ++++....    .++||||++|..+
T Consensus         4 ~~~G~tn~~y~~~~----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIEH----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEEe----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence            56688889998863    33456677654432221 134679999999864333 34444432    3689999988665


Q ss_pred             HH-----------------HhcCCCC-CCCCCHH-HHHHHHHHH---------HHHHHHHhhC-----CCCCeEEecCCC
Q 017627          143 QE-----------------KLHGTPR-SSKLPWR-NRMAIAFQL---------AQAIEYLHER-----CTLHIVHGDIKA  189 (368)
Q Consensus       143 ~~-----------------~l~~~~~-~~~~~~~-~~~~i~~qi---------~~~l~~LH~~-----~~~~ivH~Dikp  189 (368)
                      ..                 -++.... ...++.. .+..+..++         ...+..+-..     ....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            32                 1221111 1111211 111111111         1112222111     123589999999


Q ss_pred             CCeeecCCCceEEeeccccc
Q 017627          190 SNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       190 ~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .||++++++ +.|+||..|.
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcEEEeCCC-CEEEeccccC
Confidence            999999877 7899999885

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.75  E-value=0.00053  Score=63.55  Aligned_cols=75  Identities=16%  Similarity=0.155  Sum_probs=50.9

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecC------C--hhHHHHHHHHHHHHhcCC---CCceeeeeEEEecCCeeE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVG------S--DRLSQVFKQELDILLHLS---HDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~------~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  131 (368)
                      +.||.|.+..||++...+  ....+.||....      .  +....+...|.+.|+.+.   -.++++++.+.  .+..+
T Consensus        32 ~elggGn~N~VyrV~~~~--g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~  107 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE--GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAV  107 (401)
T ss_pred             eEcCCCceEEEEEEEeCC--CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCE
Confidence            358999999999998643  224567775321      1  123456677888888873   34677777763  45678


Q ss_pred             EEEecccCCC
Q 017627          132 LLFEYVPNGT  141 (368)
Q Consensus       132 lv~e~~~~~~  141 (368)
                      +|||++++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999987643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.68  E-value=0.00022  Score=63.98  Aligned_cols=141  Identities=18%  Similarity=0.203  Sum_probs=80.9

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc--eeeeeEE------EecCCeeEEEE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN--IVKLIGY------CDDRDEGVLLF  134 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~  134 (368)
                      +.|..|....+|+....+    ..+++|+...  .....+..|+.++..|.+.+  +++++..      ....+..++|+
T Consensus        20 ~~i~~G~~n~~y~v~~~~----~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          20 EGISAGIENTNYFVTTDS----GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             ecccCccccceEEEEeCC----CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            357778888999886422    2467777654  22345667888888885332  4444431      22344568999


Q ss_pred             ecccCCCHHH--------------HhcCCCCC--------CCCCHHHH----------HHHHHHHHHHHHHHhh----CC
Q 017627          135 EYVPNGTLQE--------------KLHGTPRS--------SKLPWRNR----------MAIAFQLAQAIEYLHE----RC  178 (368)
Q Consensus       135 e~~~~~~L~~--------------~l~~~~~~--------~~~~~~~~----------~~i~~qi~~~l~~LH~----~~  178 (368)
                      ++++|..+..              .++.....        ....+...          ......+..++.++.+    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998865421              01100000        00011100          0011112334444443    12


Q ss_pred             CCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       179 ~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      ..+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3379999999999999998777999999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.67  E-value=0.00037  Score=62.79  Aligned_cols=142  Identities=25%  Similarity=0.296  Sum_probs=81.3

Q ss_pred             hcccccceEEEEEEEcC----CCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc-eeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLIN----DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN-IVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .|..|-...||+....+    +.....+.+|+............+|..++..+...+ .+++++++..    .+|++|++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence            35567777899887432    112456778886654333345567999999885333 3455555532    36889988


Q ss_pred             CCCHHHH-----------------hcCCCCCC------CCC--HHHHHH--------------------------HHHHH
Q 017627          139 NGTLQEK-----------------LHGTPRSS------KLP--WRNRMA--------------------------IAFQL  167 (368)
Q Consensus       139 ~~~L~~~-----------------l~~~~~~~------~~~--~~~~~~--------------------------i~~qi  167 (368)
                      |..+...                 ++......      ..+  +.....                          +...+
T Consensus        81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (302)
T cd05156          81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE  160 (302)
T ss_pred             CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence            7665321                 11111110      011  001100                          11122


Q ss_pred             HHHHHHHhh------CCCCCeEEecCCCCCeeecCC----CceEEeeccccc
Q 017627          168 AQAIEYLHE------RCTLHIVHGDIKASNILLEEH----LNCKLCDFGSAK  209 (368)
Q Consensus       168 ~~~l~~LH~------~~~~~ivH~Dikp~Nilv~~~----~~vkl~Dfg~s~  209 (368)
                      ...+.++-.      .....++|+|+.|.||+++++    +.+.++||..|.
T Consensus       161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            222334432      134478999999999999974    889999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.64  E-value=6.5e-05  Score=66.17  Aligned_cols=131  Identities=19%  Similarity=0.218  Sum_probs=88.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhH-----------------------HHHHHHHHHHHhcCCC-
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL-----------------------SQVFKQELDILLHLSH-  114 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~-----------------------~~~~~~E~~~l~~l~h-  114 (368)
                      +.+++.||-|.-+.||.+-+.   .+...++|+.......                       .-...+|+..|+.|.. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~---~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~  170 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE---EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER  170 (465)
T ss_pred             hhhccccccccccceEEEecC---CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence            346788999999999999753   3555666653221110                       1134578999998853 


Q ss_pred             -CceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          115 -DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       115 -~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                       --+++.++    .+..++|||++.+-.|...-+      ..+..   .+...+..-+.-|..+   |+||+|..-=||+
T Consensus       171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNim  234 (465)
T KOG2268|consen  171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIM  234 (465)
T ss_pred             CCCCCCccc----ccceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHc---CceecccchheeE
Confidence             23444444    356789999998877764322      11222   3344445555667777   9999999999999


Q ss_pred             ecCCCceEEeecccc
Q 017627          194 LEEHLNCKLCDFGSA  208 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s  208 (368)
                      +++++.++++||--.
T Consensus       235 v~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  235 VKDDDKIVVIDFPQM  249 (465)
T ss_pred             EecCCCEEEeechHh
Confidence            999999999999754

>PRK05231 homoserine kinase; Provisional

Probab=97.56  E-value=0.00078  Score=61.18  Aligned_cols=31  Identities=26%  Similarity=0.309  Sum_probs=26.7

Q ss_pred             CCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       179 ~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      ..++||+|+.|+||+++++...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            3489999999999999977666899999875

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.42  E-value=0.0014  Score=59.03  Aligned_cols=135  Identities=21%  Similarity=0.221  Sum_probs=93.1

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC---------------------------hhHHHHHHHHHHHHhcCCCCc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---------------------------DRLSQVFKQELDILLHLSHDN  116 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---------------------------~~~~~~~~~E~~~l~~l~h~~  116 (368)
                      .|..|.-+-||.|.-.   .+..+||||+..+                           ....-.+..|+.-|.+|+...
T Consensus       151 CiSTGKEANVYHat~~---dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  151 CISTGKEANVYHATEE---DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccCccceeEeeecC---CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            5778888899998743   4455888874322                           112223567899999997666


Q ss_pred             eeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       117 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      |+-.--+..  ...+|||+++... =+-  .-.-....++...+..+-.|++.-+.-|-+.|  ++||.||.--|+|+-+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrd-gw~--aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRD-GWA--APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCC-CCc--CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence            543222221  2357999998432 211  11113455777788888889999999998887  9999999999999976


Q ss_pred             CCceEEeeccccc
Q 017627          197 HLNCKLCDFGSAK  209 (368)
Q Consensus       197 ~~~vkl~Dfg~s~  209 (368)
                      + .+.|+|-+-|.
T Consensus       301 G-~lyiIDVSQSV  312 (520)
T KOG2270|consen  301 G-KLYIIDVSQSV  312 (520)
T ss_pred             C-EEEEEEccccc
Confidence            4 89999988774

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.41  E-value=0.0027  Score=57.28  Aligned_cols=142  Identities=17%  Similarity=0.215  Sum_probs=78.2

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc--eeeeeEE------EecCCeeEEEE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN--IVKLIGY------CDDRDEGVLLF  134 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~  134 (368)
                      +.++.|....+|+....   .+ .+.+|+...... ...+..|++++..|...+  +++++..      ....+..++++
T Consensus        28 ~~~~~G~~n~~y~v~t~---~~-~~vLK~~~~~~~-~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTD---VG-RYILTLYEKRVK-AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             cccCCccccceEEEEeC---CC-cEEEEEecCCCC-HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45777777899988632   22 456776544211 234456778887774322  3444332      12235678999


Q ss_pred             ecccCCCHH-----------H---HhcCCCCC----C----CC-CHHHHH------------HHHHHHHHHHHHHhh---
Q 017627          135 EYVPNGTLQ-----------E---KLHGTPRS----S----KL-PWRNRM------------AIAFQLAQAIEYLHE---  176 (368)
Q Consensus       135 e~~~~~~L~-----------~---~l~~~~~~----~----~~-~~~~~~------------~i~~qi~~~l~~LH~---  176 (368)
                      ++++|..+.           .   .++....+    .    .. .+....            .....+...+.++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999875431           0   11110000    0    00 000000            001122334444532   


Q ss_pred             -CCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          177 -RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       177 -~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                       ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             223489999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.36  E-value=2.9e-05  Score=80.50  Aligned_cols=162  Identities=16%  Similarity=0.009  Sum_probs=112.5

Q ss_pred             HHHHHHHHHHhcCCCCceeeeeEEEec--CCeeEEEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 017627          100 QVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHE  176 (368)
Q Consensus       100 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~  176 (368)
                      +....|..-++...|+++...+.-...  ....+.+++++.+|.+.+.+.... +...+...-+.....+.+.+..-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            334455566666789988877654432  335688999999999999876542 22333333333333332555555554


Q ss_pred             CCCC--CeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCC
Q 017627          177 RCTL--HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAS  254 (368)
Q Consensus       177 ~~~~--~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  254 (368)
                      ..+.  -.+|+++|+-|.+|..+-++|++++|+.+......               .......+++.|++|+....-.++
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~---------------sf~Gl~l~sp~~v~qli~N~ik~t 1418 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL---------------SFFGLELCSPIYVLQLIKNEIKFT 1418 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchH---------------hhhhhhhCCHHHHHHHHHHHHhhh
Confidence            4211  26899999999999999999999999998311111               111335688899999998888888


Q ss_pred             cchhhHHHHHHHHHHHhCCCCC
Q 017627          255 TKTDVYSFGVILLELVTGMEAF  276 (368)
Q Consensus       255 ~~~DiwslG~il~el~~g~~pf  276 (368)
                      .++|+|+.|+-+|+...|..+|
T Consensus      1419 ~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1419 KRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hHHHHHHHHHHHHHHhcccHHH
Confidence            8899999999999999998887

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.27  E-value=0.0027  Score=56.32  Aligned_cols=30  Identities=37%  Similarity=0.659  Sum_probs=25.4

Q ss_pred             CeEEecCCCCCeeecCCCc-eEEeecccccc
Q 017627          181 HIVHGDIKASNILLEEHLN-CKLCDFGSAKM  210 (368)
Q Consensus       181 ~ivH~Dikp~Nilv~~~~~-vkl~Dfg~s~~  210 (368)
                      .++|+|+.|.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999997554 56999998853

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.27  E-value=0.0034  Score=57.60  Aligned_cols=141  Identities=16%  Similarity=0.209  Sum_probs=78.8

Q ss_pred             cccccceEEEEEEEcCC--CCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCce-eeeeEEEecCCeeEEEEecccCCC
Q 017627           65 IGSGGFSNVYLARLIND--STSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNI-VKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~--~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      |-.|-.-.+|++...+.  .....+.+|+........-.-.+|..+++.+...++ +++++.+..+    .|.+|+++.+
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~  119 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART  119 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence            54578888998865322  123567788766543222123579999998854333 3556665432    5788887766


Q ss_pred             HHHH-----------------hcCCC-CCC--CCCHHHHHHHHHHH-----------------HHHHHHH----hh-CCC
Q 017627          142 LQEK-----------------LHGTP-RSS--KLPWRNRMAIAFQL-----------------AQAIEYL----HE-RCT  179 (368)
Q Consensus       142 L~~~-----------------l~~~~-~~~--~~~~~~~~~i~~qi-----------------~~~l~~L----H~-~~~  179 (368)
                      +...                 +++.. ...  ...+..+..+..++                 ...+..|    .. ...
T Consensus       120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~  199 (344)
T PLN02236        120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE  199 (344)
T ss_pred             CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence            5321                 11111 011  11122222322111                 1111122    21 113


Q ss_pred             CCeEEecCCCCCeeecC-CCceEEeeccccc
Q 017627          180 LHIVHGDIKASNILLEE-HLNCKLCDFGSAK  209 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~-~~~vkl~Dfg~s~  209 (368)
                      ..++|+|+++.||++++ ++.+.++||..|.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            36899999999999986 4689999999885

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.08  E-value=0.0038  Score=56.19  Aligned_cols=74  Identities=15%  Similarity=0.219  Sum_probs=58.3

Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      ...|++|++- |+.+..       -+...++++..++++.+.-+.-+..+.  .+-|||+.-+||||+ +|+|.|+||-+
T Consensus       299 ~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             eEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence            3567788875 555532       123467888899999988888887764  789999999999999 99999999999


Q ss_pred             cccCC
Q 017627          208 AKMGF  212 (368)
Q Consensus       208 s~~~~  212 (368)
                      ||...
T Consensus       368 sRl~~  372 (488)
T COG5072         368 SRLSY  372 (488)
T ss_pred             eeccc
Confidence            98543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.01  E-value=0.0017  Score=60.81  Aligned_cols=48  Identities=17%  Similarity=0.348  Sum_probs=38.0

Q ss_pred             HHHHHHHHHhcCCCCceeeeeEEEecC-CeeEEEEecccCCCHHHHhcCC
Q 017627          101 VFKQELDILLHLSHDNIVKLIGYCDDR-DEGVLLFEYVPNGTLQEKLHGT  149 (368)
Q Consensus       101 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~  149 (368)
                      .+....++++.+.|+|...++.+.... ....+|||++ +.+|.+.+..+
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            455678899999999999999887532 3478899998 77999988743

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.90  E-value=0.0096  Score=54.30  Aligned_cols=142  Identities=15%  Similarity=0.234  Sum_probs=76.7

Q ss_pred             hcccccceEEEEEEEcCCC-CceeEEEEeecCChhHHHHHHHHHHHHhcCCCCce-eeeeEEEecCCeeEEEEecccCCC
Q 017627           64 VIGSGGFSNVYLARLINDS-TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNI-VKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      .|..|=...+|+....+.. ....+.+++........-.-.+|..+++.+..-++ +++++++..+    +|.+|+.+..
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~   96 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART   96 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence            3555777788888643321 13367788765543222223578999998864444 4556655322    5888887665


Q ss_pred             HHH-----------------HhcCCC-CC-C-CCCHHHHHHHHHHH----------------------HHHHHH---Hh-
Q 017627          142 LQE-----------------KLHGTP-RS-S-KLPWRNRMAIAFQL----------------------AQAIEY---LH-  175 (368)
Q Consensus       142 L~~-----------------~l~~~~-~~-~-~~~~~~~~~i~~qi----------------------~~~l~~---LH-  175 (368)
                      |..                 .++... .. . ...+..+..+..++                      ..-+..   +. 
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            421                 111111 00 1 11122222222221                      111111   11 


Q ss_pred             hC-CCCCeEEecCCCCCeeecC-CCceEEeeccccc
Q 017627          176 ER-CTLHIVHGDIKASNILLEE-HLNCKLCDFGSAK  209 (368)
Q Consensus       176 ~~-~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg~s~  209 (368)
                      .. .+.-++|+|+.+.|||+++ ++.++++||..|-
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            11 1123799999999999974 5789999999875

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.88  E-value=0.017  Score=51.91  Aligned_cols=31  Identities=23%  Similarity=0.444  Sum_probs=28.2

Q ss_pred             CCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ..++|+|+.+.|++++.++-+-+.||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            3589999999999999988899999999865

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.85  E-value=0.0032  Score=53.44  Aligned_cols=29  Identities=34%  Similarity=0.511  Sum_probs=21.1

Q ss_pred             CeEEecCCCCCeee-cCCCceEEeeccccc
Q 017627          181 HIVHGDIKASNILL-EEHLNCKLCDFGSAK  209 (368)
Q Consensus       181 ~ivH~Dikp~Nilv-~~~~~vkl~Dfg~s~  209 (368)
                      .++|+|+.|.|||+ +.++.++++||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58999999999999 888999999999885

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.74  E-value=0.0086  Score=53.23  Aligned_cols=72  Identities=19%  Similarity=0.354  Sum_probs=45.9

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC---CCceeeeeEEEecCCeeEEEEecccC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS---HDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      +.++.|....+|...  .  ....+.+|+..  ......|..|++-|+.|.   --.+++++++....+..++|||+++.
T Consensus        23 ~~v~GG~i~~a~~~~--~--~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD--T--DGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEE--SSSSEEEEEE--T--TS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             EecCCCChhheEEEE--C--CCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            357888889999876  2  45567777665  334456788998888883   45688899988877788999999876


Q ss_pred             C
Q 017627          140 G  140 (368)
Q Consensus       140 ~  140 (368)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            5

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.61  E-value=0.016  Score=53.86  Aligned_cols=71  Identities=15%  Similarity=0.172  Sum_probs=46.2

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeec-----CCh---hHHHHHHHHHHHHhcCC---CCceeeeeEEEecCCeeE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHV-----GSD---RLSQVFKQELDILLHLS---HDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~-----~~~---~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  131 (368)
                      +.||.|.-..||+....    ...+.||...     .+.   ....+...|+..|+.+.   ..++++++.++.  +..+
T Consensus        38 ~eiggGn~N~VyrV~~~----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             EEcCCCceeeEEEEEcC----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            35899999999998752    2236666433     111   12334445677777664   247888888876  4567


Q ss_pred             EEEecccC
Q 017627          132 LLFEYVPN  139 (368)
Q Consensus       132 lv~e~~~~  139 (368)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999966

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.44  E-value=0.048  Score=49.78  Aligned_cols=73  Identities=14%  Similarity=0.179  Sum_probs=45.2

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeec-------CC-hhHHHHHHHHHHHHhcCC--CC-ceeeeeEEEecCCeeEE
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHV-------GS-DRLSQVFKQELDILLHLS--HD-NIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~-------~~-~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~l  132 (368)
                      .||.|....||++...+  ....+.||...       .+ +-...+..-|...|+...  .| .+++++.+  +.+...+
T Consensus         2 EigdGnlN~VfrV~~~~--g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE--GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCC--CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccccee
Confidence            47999999999998532  22456666321       11 223345556888887763  34 45556544  3456679


Q ss_pred             EEecccCC
Q 017627          133 LFEYVPNG  140 (368)
Q Consensus       133 v~e~~~~~  140 (368)
                      |||+++..
T Consensus        78 vMEdL~~~   85 (370)
T TIGR01767        78 VMEDLSHH   85 (370)
T ss_pred             hHhhCccc
Confidence            99998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.39  E-value=0.048  Score=49.27  Aligned_cols=32  Identities=25%  Similarity=0.413  Sum_probs=28.5

Q ss_pred             CCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       179 ~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ..+++|+|+.++|+|+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34799999999999999999999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.22  E-value=0.056  Score=48.37  Aligned_cols=72  Identities=17%  Similarity=0.149  Sum_probs=45.9

Q ss_pred             ccccceEEEEEEEcC------CCCceeEEEEeecCChh------HHHHHHHHHHHHhcCC-------------CCceeee
Q 017627           66 GSGGFSNVYLARLIN------DSTSTNGAIKIHVGSDR------LSQVFKQELDILLHLS-------------HDNIVKL  120 (368)
Q Consensus        66 G~G~~g~V~~~~~~~------~~~~~~~aik~~~~~~~------~~~~~~~E~~~l~~l~-------------h~~iv~~  120 (368)
                      |.|-.|.+|++....      ......+.+|.......      ....+.+|+.+.+.+-             ....+++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            788899999877533      22344566776553222      2356778888887651             1245677


Q ss_pred             eEEEecCCeeEEEEecc
Q 017627          121 IGYCDDRDEGVLLFEYV  137 (368)
Q Consensus       121 ~~~~~~~~~~~lv~e~~  137 (368)
                      +....+....+||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            77665555678999865

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PHA03111 Ser/Thr kinase; Provisional

Probab=96.08  E-value=0.0085  Score=53.25  Aligned_cols=54  Identities=24%  Similarity=0.258  Sum_probs=37.5

Q ss_pred             HHHHHHHHHHHHHHHHHH-hhCCCCCeEEecCCCCCeeecCCCc------------------eEEeecccccc
Q 017627          157 WRNRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLN------------------CKLCDFGSAKM  210 (368)
Q Consensus       157 ~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dikp~Nilv~~~~~------------------vkl~Dfg~s~~  210 (368)
                      .+-+..+..||+.-.-.+ .-.|..+++|.||||+|||+-++..                  ++|.||.+|+.
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  350 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV  350 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence            445667888887655344 2223447999999999999954432                  67888888764

>PTZ00384 choline kinase; Provisional

Probab=96.00  E-value=0.061  Score=49.99  Aligned_cols=76  Identities=22%  Similarity=0.242  Sum_probs=43.9

Q ss_pred             hcccccceEEEEEEEcCCCCc----eeEEEEeecCChhHHHHHHHHHHHHhcCCCC-ceeeeeEEEecCCeeEEEEeccc
Q 017627           64 VIGSGGFSNVYLARLINDSTS----TNGAIKIHVGSDRLSQVFKQELDILLHLSHD-NIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~----~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .|..|-...+|++...+....    ..|.+++........-.-.+|+.+++.|... .-+++++.+..    ++|.||++
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIe  132 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVE  132 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEec
Confidence            355588888998864332111    1244444322222111234689999999644 44566666643    58999998


Q ss_pred             CCCHH
Q 017627          139 NGTLQ  143 (368)
Q Consensus       139 ~~~L~  143 (368)
                      |.+|.
T Consensus       133 Gr~l~  137 (383)
T PTZ00384        133 GNTMG  137 (383)
T ss_pred             cccCC
Confidence            87654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.95  E-value=0.18  Score=45.83  Aligned_cols=70  Identities=14%  Similarity=0.054  Sum_probs=40.8

Q ss_pred             cceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc--eeeee---E--EEecCCeeEEEEecccCCC
Q 017627           69 GFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN--IVKLI---G--YCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        69 ~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~---~--~~~~~~~~~lv~e~~~~~~  141 (368)
                      .-..||.....   .+..+++|+..........+..|++.+..|....  ++...   |  +...++..+.++++++|..
T Consensus        37 ~eN~vy~v~~~---~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDE---DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecC---CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34567777532   3456888887644444566777888888774221  22211   1  1222456778899887653

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.91  E-value=0.052  Score=45.71  Aligned_cols=88  Identities=16%  Similarity=0.199  Sum_probs=58.9

Q ss_pred             HHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 017627          100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT  179 (368)
Q Consensus       100 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  179 (368)
                      ..+.++..++++++  .|+++..-  +.-..-+++|+|..-..               ...-.+..+ +++|.-.|+. .
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------------~~~N~i~ag-i~~L~~fH~~-~  161 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------------NFSNFITAG-IKDLMDFHSE-N  161 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------------chhHHHHHh-HHHHHHhhcc-C
Confidence            34567888887775  56776622  23345688999843211               011122222 4677888854 2


Q ss_pred             CCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          180 LHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      .+.+|+|..|+||+-|..|.+||.|=+.-
T Consensus       162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  162 QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             CCeecCCCChhheeecCCCCEEecChhhh
Confidence            38999999999999999999999998753

The function of this family is unknown.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=95.74  E-value=0.013  Score=52.43  Aligned_cols=54  Identities=28%  Similarity=0.368  Sum_probs=35.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhhC-CCCCeEEecCCCCCeeecCCC------------------ceEEeecccccc
Q 017627          157 WRNRMAIAFQLAQAIEYLHER-CTLHIVHGDIKASNILLEEHL------------------NCKLCDFGSAKM  210 (368)
Q Consensus       157 ~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dikp~Nilv~~~~------------------~vkl~Dfg~s~~  210 (368)
                      .+-+..+..||+.-.--+-.. |..+.+|.||||+|||+-++.                  .++|.||.+|+.
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence            445667777875433213222 234799999999999995432                  278889998875

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PTZ00296 choline kinase; Provisional

Probab=95.15  E-value=0.24  Score=47.06  Aligned_cols=74  Identities=16%  Similarity=0.123  Sum_probs=42.8

Q ss_pred             cccccceEEEEEEEcCCC------CceeEEEEeecCChhHHHHHHHHHHHHhcCCCCcee-eeeEEEecCCeeEEEEecc
Q 017627           65 IGSGGFSNVYLARLINDS------TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIV-KLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~------~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~  137 (368)
                      |..|=.-.+|++...+..      ....+.+++........-.-..|..+++.+...+|- ++++.+.    .+.|.+|+
T Consensus       113 l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~efi  188 (442)
T PTZ00296        113 ILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEEWL  188 (442)
T ss_pred             ecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEEee
Confidence            555666677877643211      134677787655433222335688888888644433 4555543    34678888


Q ss_pred             cCCCH
Q 017627          138 PNGTL  142 (368)
Q Consensus       138 ~~~~L  142 (368)
                      +|.+|
T Consensus       189 ~g~~l  193 (442)
T PTZ00296        189 YGDPL  193 (442)
T ss_pred             CCccC
Confidence            77644

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.11  E-value=0.1  Score=48.11  Aligned_cols=59  Identities=19%  Similarity=0.140  Sum_probs=40.3

Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEecCCCCCeeec
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH-ERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dikp~Nilv~  195 (368)
                      ..++=+|..|-++..++..    ...++....+++.-.+.|+--+- -.   +++|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEE
Confidence            4566678888888888863    34455555555555555544332 22   799999999999995

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.88  E-value=0.06  Score=48.60  Aligned_cols=29  Identities=28%  Similarity=0.350  Sum_probs=25.6

Q ss_pred             CCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          180 LHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            37999999999999998 578999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	368
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-08
3soa_A	444	Full-Length Human Camkii Length = 444		3e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 96/314 (30%), Positives = 161/314 (51%), Gaps = 31/314 (9%)
Query: 45  SVKKYSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
            +K++S  +++  + NFS   ++G GGF  VY  RL + +      +K         Q F
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ-F 82
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRM 161
           + E++++    H N+++L G+C    E +L++ Y+ NG++   L   P S   L W  R 
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 142
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK-MGFSSAVLXXX 220
            IA   A+ + YLH+ C   I+H D+KA+NILL+E     + DFG AK M +    +   
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 202
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF---- 276
                          + G+ G+  P YL TG +S KTDV+ +GV+LLEL+TG  AF    
Sbjct: 203 ---------------VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 247
Query: 277 -CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
              ++  +L      +L +       K+  LVD  L G++  +E   ++ +A LC + SP
Sbjct: 248 LANDDDVMLLDWVKGLLKE------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 301
Query: 336 ILRPSATQILHTIK 349
           + RP  ++++  ++
Sbjct: 302 MERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 95/314 (30%), Positives = 157/314 (50%), Gaps = 31/314 (9%)
Query: 45  SVKKYSWDDVERFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
            +K++S  +++  + NF    ++G GGF  VY  RL +        +K         Q F
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ-F 74
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRM 161
           + E++++    H N+++L G+C    E +L++ Y+ NG++   L   P S   L W  R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK-MGFSSAVLXXX 220
            IA   A+ + YLH+ C   I+H D+KA+NILL+E     + DFG AK M +    +   
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 194
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF---- 276
                            G  G+  P YL TG +S KTDV+ +GV+LLEL+TG  AF    
Sbjct: 195 VR---------------GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 277 -CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
              ++  +L      +L +       K+  LVD  L G++  +E   ++ +A LC + SP
Sbjct: 240 LANDDDVMLLDWVKGLLKE------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293
Query: 336 ILRPSATQILHTIK 349
           + RP  ++++  ++
Sbjct: 294 MERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/318 (29%), Positives = 159/318 (50%), Gaps = 37/318 (11%)
Query: 49  YSWDDVERFTQNFSQ--------VIGSGGFSNVYLARLINDSTSTNG-AIKIHVGSDRLS 99
           +S+ +++  T NF +         +G GGF  VY   + N + +    A  + + ++ L 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           Q F QE+ ++    H+N+V+L+G+  D D+  L++ Y+PNG+L ++L     +  L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG--FSSAVL 217
           R  IA   A  I +LHE    H +H DIK++NILL+E    K+ DFG A+    F+  V+
Sbjct: 135 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                             ++G+  Y  P  LR G  + K+D+YSFGV+LLE++TG+ A  
Sbjct: 192 XSR---------------IVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 278 P-ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI 336
                QLL  +   + +     E   + + +D ++  D D     AM S+A+ CL +   
Sbjct: 236 EHREPQLLLDIKEEIED-----EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289
Query: 337 LRPSATQILHTIKHQISS 354
            RP   ++   ++   +S
Sbjct: 290 KRPDIKKVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 93/318 (29%), Positives = 158/318 (49%), Gaps = 37/318 (11%)
Query: 49  YSWDDVERFTQNFSQ--------VIGSGGFSNVYLARLINDSTSTNG-AIKIHVGSDRLS 99
           +S+ +++  T NF +         +G GGF  VY   + N + +    A  + + ++ L 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           Q F QE+ ++    H+N+V+L+G+  D D+  L++ Y+PNG+L ++L     +  L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG--FSSAVL 217
           R  IA   A  I +LHE    H +H DIK++NILL+E    K+ DFG A+    F+  V+
Sbjct: 135 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                             ++G+  Y  P  LR G  + K+D+YSFGV+LLE++TG+ A  
Sbjct: 192 ---------------XXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 278 P-ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI 336
                QLL  +   + +     E   + + +D ++  D D     AM S+A+ CL +   
Sbjct: 236 EHREPQLLLDIKEEIED-----EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289
Query: 337 LRPSATQILHTIKHQISS 354
            RP   ++   ++   +S
Sbjct: 290 KRPDIKKVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/318 (29%), Positives = 160/318 (50%), Gaps = 37/318 (11%)
Query: 49  YSWDDVERFTQNFSQ--------VIGSGGFSNVYLARLINDSTSTNG-AIKIHVGSDRLS 99
           +S+ +++  T NF +         +G GGF  VY   + N + +    A  + + ++ L 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           Q F QE+ ++    H+N+V+L+G+  D D+  L++ Y+PNG+L ++L     +  L W  
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG--FSSAVL 217
           R  IA   A  I +LHE    H +H DIK++NILL+E    K+ DFG A+    F+  V+
Sbjct: 129 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVM 185
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                             ++G+  Y  P  LR G  + K+D+YSFGV+LLE++TG+ A  
Sbjct: 186 XXR---------------IVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 229
Query: 278 P-ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI 336
                QLL  +   + +     E   + + +D ++  D D     AM S+A+ CL +   
Sbjct: 230 EHREPQLLLDIKEEIED-----EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 283
Query: 337 LRPSATQILHTIKHQISS 354
            RP   ++   ++   +S
Sbjct: 284 KRPDIKKVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/318 (29%), Positives = 153/318 (48%), Gaps = 37/318 (11%)
Query: 49  YSWDDVERFTQNFSQ--------VIGSGGFSNVYLARLINDSTSTNG-AIKIHVGSDRLS 99
           +S+ +++  T NF +          G GGF  VY   + N + +    A  + + ++ L 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           Q F QE+ +     H+N+V+L+G+  D D+  L++ Y PNG+L ++L     +  L W  
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG--FSSAVL 217
           R  IA   A  I +LHE    H +H DIK++NILL+E    K+ DFG A+    F+  V 
Sbjct: 126 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                             ++G+  Y  P  LR G  + K+D+YSFGV+LLE++TG+ A  
Sbjct: 183 XS---------------RIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 226
Query: 278 P-ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI 336
                QLL  +   + +     E   + + +D +   D D     A  S+A+ CL +   
Sbjct: 227 EHREPQLLLDIKEEIED-----EEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKN 280
Query: 337 LRPSATQILHTIKHQISS 354
            RP   ++   ++   +S
Sbjct: 281 KRPDIKKVQQLLQEXTAS 298

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 93/311 (29%), Positives = 149/311 (47%), Gaps = 40/311 (12%)
Query: 53  DVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGA-IKIHVGSDRLSQVFKQELDIL 109
           D+E  T NF    +IG G F  VY   L       +GA + +   +   SQ  ++    +
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVL------RDGAKVALKRRTPESSQGIEEFETEI 86
Query: 110 LHLS---HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS-KLPWRNRMAIAF 165
             LS   H ++V LIG+CD+R+E +L+++Y+ NG L+  L+G+   +  + W  R+ I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
             A+ + YLH R    I+H D+K+ NILL+E+   K+ DFG +K G              
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG-------------T 190
Query: 226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT 285
                    ++ G+ GY DP Y   G  + K+DVYSFGV+L E++    A       ++ 
Sbjct: 191 ELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA-------IVQ 243
Query: 286 SLAGSMLN----DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA 341
           SL   M+N     +      ++ ++VDP LA     +  R     A  CL  S   RPS 
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 342 TQILHTIKHQI 352
             +L  +++ +
Sbjct: 304 GDVLWKLEYAL 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 150/312 (48%), Gaps = 42/312 (13%)
Query: 53  DVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGA-IKIHVGSDRLSQVFKQELDIL 109
           D+E  T NF    +IG G F  VY   L       +GA + +   +   SQ  ++    +
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVL------RDGAKVALKRRTPESSQGIEEFETEI 86
Query: 110 LHLS---HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT--PRSSKLPWRNRMAIA 164
             LS   H ++V LIG+CD+R+E +L+++Y+ NG L+  L+G+  P  S + W  R+ I 
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEIC 145
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
              A+ + YLH R    I+H D+K+ NILL+E+   K+ DFG +K G             
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG------------- 189
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                     ++ G+ GY DP Y   G  + K+DVYSFGV+L E++    A       ++
Sbjct: 190 TELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA-------IV 242
Query: 285 TSLAGSMLN----DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS 340
            SL   M+N     +      ++ ++VDP LA     +  R     A  CL  S   RPS
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 341 ATQILHTIKHQI 352
              +L  +++ +
Sbjct: 303 MGDVLWKLEYAL 314

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 139/302 (46%), Gaps = 35/302 (11%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D+     N  + IG+G F  V+ A       +    ++    ++R+++ F +E+ I+  L
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRL 91
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H NIV  +G         ++ EY+  G+L   LH +    +L  R R+++A+ +A+ + 
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YLH R    IVH D+K+ N+L+++    K+CDFG +++  S  +                
Sbjct: 152 YLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA---------- 200
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
                G+P +  P  LR   ++ K+DVYSFGVIL EL T  + +   N   + +  G   
Sbjct: 201 -----GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--- 252
Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI 352
                C+  ++   ++P++A            +I   C    P  RPS   I+  ++  I
Sbjct: 253 ---FKCKRLEIPRNLNPQVA------------AIIEGCWTNEPWKRPSFATIMDLLRPLI 297
Query: 353 SS 354
            S
Sbjct: 298 KS 299

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 139/302 (46%), Gaps = 35/302 (11%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D+     N  + IG+G F  V+ A       +    ++    ++R+++ F +E+ I+  L
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNE-FLREVAIMKRL 91
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H NIV  +G         ++ EY+  G+L   LH +    +L  R R+++A+ +A+ + 
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YLH R    IVH ++K+ N+L+++    K+CDFG +++  S+ +                
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA---------- 200
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
                G+P +  P  LR   ++ K+DVYSFGVIL EL T  + +   N   + +  G   
Sbjct: 201 -----GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--- 252
Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI 352
                C+  ++   ++P++A            +I   C    P  RPS   I+  ++  I
Sbjct: 253 ---FKCKRLEIPRNLNPQVA------------AIIEGCWTNEPWKRPSFATIMDLLRPLI 297
Query: 353 SS 354
            S
Sbjct: 298 KS 299

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 110/247 (44%), Gaps = 36/247 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF---KQELDILLHLSHDNI 117
             ++IG GGF  VY A  I D  +   A   H   + +SQ     +QE  +   L H NI
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGDEVAVKAAR--HDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           + L G C       L+ E+   G L   L G     ++P    +  A Q+A+ + YLH+ 
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 178 CTLHIVHGDIKASNILLEEHLN--------CKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
             + I+H D+K+SNIL+ + +          K+ DFG A+                    
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---------------- 168
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
            T ++   G+  +  P  +R  M S  +DV+S+GV+L EL+TG   F   +G  L    G
Sbjct: 169 -TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--LAVAYG 225
Query: 290 SMLNDIA 296
             +N +A
Sbjct: 226 VAMNKLA 232

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 55  ERFTQNFSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILL 110
           ER  +  SQ +G G F +V L R   + D+T    A+K   H G D+  + F++E+ IL 
Sbjct: 6   ERHLKYISQ-LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILK 63
Query: 111 HLSHDNIVKLIG--YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
            L  D IVK  G  Y   R E  L+ EY+P+G L++ L      ++L     +  + Q+ 
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQIC 121
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           + +EYL  R     VH D+ A NIL+E   + K+ DFG AK+                  
Sbjct: 122 KGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-----------------L 161
Query: 229 XITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
            + K   ++  PG     +  P  L   + S ++DV+SFGV+L EL T  +  C  + + 
Sbjct: 162 PLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 221
Query: 284 L 284
           L
Sbjct: 222 L 222

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNI 117
           +  + +G G F NVYLAR        +     K  +    +    ++E++I  HL H NI
Sbjct: 15  DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF-QLAQAIEYLHE 176
           ++L GY  D     L+ EY P GT+  +L    R  +     R A    +LA A+ Y H 
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE----QRTATYITELANALSYCHS 130
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
           +    ++H DIK  N+LL  +   K+ DFG +    SS                 ++  +
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS-----------------RRTTL 170
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            G+  Y  P  +   M   K D++S GV+  E + GM  F
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 65  IGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G G F NVYLAR  N     +     K  +    +    ++E++I  HL H NI++L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y  D     L+ EY P GT+  +L    + SK   +       +LA A+ Y H +    +
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---KV 129
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H DIK  N+LL      K+ DFG +    SS                 ++  + G+  Y
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----------------RRAALCGTLDY 172
Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             P  +   M   K D++S GV+  E + G   F
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNI 117
           +  + +G G F NVYLAR        +     K  +    +    ++E++I  HL H NI
Sbjct: 15  DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF-QLAQAIEYLHE 176
           ++L GY  D     L+ EY P GT+  +L    R  +     R A    +LA A+ Y H 
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE----QRTATYITELANALSYCHS 130
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
           +    ++H DIK  N+LL  +   K+ DFG +    SS                 ++  +
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS-----------------RRDTL 170
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            G+  Y  P  +   M   K D++S GV+  E + GM  F
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 27  KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 81
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 82  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 138
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 139 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 187
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 188 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 114/241 (47%), Gaps = 35/241 (14%)
Query: 55  ERFTQNFSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILL 110
           ER  +  SQ +G G F +V L R   + D+T    A+K   H G D+  + F++E+ IL 
Sbjct: 22  ERHLKYISQ-LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILK 79
Query: 111 HLSHDNIVKLIG--YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
            L  D IVK  G  Y   R    L+ EY+P+G L++ L      ++L     +  + Q+ 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQIC 137
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           + +EYL  R     VH D+ A NIL+E   + K+ DFG AK+                  
Sbjct: 138 KGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-----------------L 177
Query: 229 XITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
            + K   ++  PG     +  P  L   + S ++DV+SFGV+L EL T  +  C  + + 
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 237
Query: 284 L 284
           L
Sbjct: 238 L 238

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 114/241 (47%), Gaps = 35/241 (14%)
Query: 55  ERFTQNFSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILL 110
           ER  +  SQ +G G F +V L R   + D+T    A+K   H G D+  + F++E+ IL 
Sbjct: 9   ERHLKYISQ-LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILK 66
Query: 111 HLSHDNIVKLIG--YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
            L  D IVK  G  Y   R    L+ EY+P+G L++ L      ++L     +  + Q+ 
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQIC 124
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           + +EYL  R     VH D+ A NIL+E   + K+ DFG AK+                  
Sbjct: 125 KGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-----------------L 164
Query: 229 XITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
            + K   ++  PG     +  P  L   + S ++DV+SFGV+L EL T  +  C  + + 
Sbjct: 165 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 224
Query: 284 L 284
           L
Sbjct: 225 L 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 114/241 (47%), Gaps = 35/241 (14%)
Query: 55  ERFTQNFSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILL 110
           ER  +  SQ +G G F +V L R   + D+T    A+K   H G D+  + F++E+ IL 
Sbjct: 10  ERHLKYISQ-LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILK 67
Query: 111 HLSHDNIVKLIG--YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
            L  D IVK  G  Y   R    L+ EY+P+G L++ L      ++L     +  + Q+ 
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQIC 125
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           + +EYL  R     VH D+ A NIL+E   + K+ DFG AK+                  
Sbjct: 126 KGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-----------------L 165
Query: 229 XITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
            + K   ++  PG     +  P  L   + S ++DV+SFGV+L EL T  +  C  + + 
Sbjct: 166 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 225
Query: 284 L 284
           L
Sbjct: 226 L 226

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 45  SVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           S ++++ +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 5   SKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 59
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 116
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 117 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 165
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 166 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 4   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 58
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 115
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 164
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 165 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 6   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 60
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 117
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 118 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 167 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 4   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 58
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 115
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 164
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 165 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 18  KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 72
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 73  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 129
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 130 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 178
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 179 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           ++++ +D E       + +G G F NVYLAR        +     K  +    +    ++
Sbjct: 3   RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYI 114
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS          
Sbjct: 115 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------- 161
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 162 -------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 6   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 60
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P G + ++L    + SK   +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTAT 117
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 118 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 167 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 65  IGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G G F NVYLAR        +     K  +    +    ++E++I  HL H NI++L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y  D     L+ EY P GT+  +L    + SK   +       +LA A+ Y H +    +
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RV 128
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H DIK  N+LL      K+ DFG +    SS                 ++  + G+  Y
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----------------RRTTLCGTLDY 171
Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             P  +   M   K D++S GV+  E + G   F
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           ++++ +D E       + +G G F NVYLAR        +     K  +    +    ++
Sbjct: 3   RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYI 114
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS          
Sbjct: 115 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------- 161
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 162 -------RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 3   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 57
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 58  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 114
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 115 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 164 ---------RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           ++++ +D E       + +G G F NVYLAR        +     K  +    +    ++
Sbjct: 6   RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYI 117
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS          
Sbjct: 118 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------- 164
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 165 -------RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           ++++ +D E       + +G G F NVYLAR        +     K  +    +    ++
Sbjct: 3   RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYI 114
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS          
Sbjct: 115 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------- 161
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 162 -------RRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 4   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 58
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 115
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 164
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 165 ---------RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           +K++ DD      +  + +G G F NVYLAR   +    +     K  +  + +    ++
Sbjct: 10  RKFTIDDF-----DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 64
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI+++  Y  DR    L+ E+ P G L ++L    R  +   +      
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFM 121
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y HER    ++H DIK  N+L+      K+ DFG +    S           
Sbjct: 122 EELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----------- 167
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  M G+  Y  P  +       K D++  GV+  E + GM  F
Sbjct: 168 ------LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           +K++ DD      +  + +G G F NVYLAR   +    +     K  +  + +    ++
Sbjct: 9   RKFTIDDF-----DIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI+++  Y  DR    L+ E+ P G L ++L    R  +   +      
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFM 120
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y HER    ++H DIK  N+L+      K+ DFG +    S           
Sbjct: 121 EELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----------- 166
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  M G+  Y  P  +       K D++  GV+  E + GM  F
Sbjct: 167 ------LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 65  IGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G G F NVYLAR        +     K  +    +    ++E++I  HL H NI++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y  D     L+ EY P GT+  +L    + SK   +       +LA A+ Y H +    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RV 129
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H DIK  N+LL      K+ DFG +    SS                 ++  + G+  Y
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----------------RRTELCGTLDY 172
Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             P  +   M   K D++S GV+  E + G   F
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 6   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 60
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P G + ++L    + SK   +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTAT 117
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 118 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 167 ---------RRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           ++++ +D E       + +G G F NVYLAR        +     K  +    +    ++
Sbjct: 3   RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYI 114
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS          
Sbjct: 115 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------- 161
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 162 -------RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 2   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 56
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 113
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 114 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 162
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 2   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 56
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 113
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 114 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS-------- 162
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 163 ---------RRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 1   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 55
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 112
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 162 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 134/323 (41%), Gaps = 64/323 (19%)
Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK--IHVGSDRLSQVFKQELDI 108
           W+D++     F  VIG G F  V  AR+  D    + AIK      S    + F  EL++
Sbjct: 24  WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 78
Query: 109 LLHLSHD-NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-------------GTPRSSK 154
           L  L H  NI+ L+G C+ R    L  EY P+G L + L                  +S 
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L  +  +  A  +A+ ++YL ++     +H D+ A NIL+ E+   K+ DFG ++     
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----- 190
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GM 273
                          +  + M I S  Y+        + +T +DV+S+GV+L E+V+ G 
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIESLNYS--------VYTTNSDVWSYGVLLWEIVSLGG 239
Query: 274 EAFCPEN-GQLLTSLA-GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
             +C     +L   L  G  L    +C+    +E+ D                 +   C 
Sbjct: 240 TPYCGMTCAELYEKLPQGYRLEKPLNCD----DEVYD-----------------LMRQCW 278
Query: 332 RQSPILRPSATQILHTIKHQISS 354
           R+ P  RPS  QIL ++   +  
Sbjct: 279 REKPYERPSFAQILVSLNRMLEE 301

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 112/259 (43%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 35  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 149
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANS 193
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    AS  +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 194 FVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 254 PEKFFPKARDLVEKLLVLD 272

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 65  IGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G G F NVYLAR        +     K  +    +    ++E++I  HL H NI++L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y  D     L+ EY P GT+  +L    + SK   +       +LA A+ Y H +    +
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RV 126
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H DIK  N+LL      K+ DFG +    SS                 ++  + G+  Y
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----------------RRTTLCGTLDY 169
Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             P  +   M   K D++S GV+  E + G   F
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 134/323 (41%), Gaps = 64/323 (19%)
Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK--IHVGSDRLSQVFKQELDI 108
           W+D++     F  VIG G F  V  AR+  D    + AIK      S    + F  EL++
Sbjct: 14  WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 68
Query: 109 LLHLSHD-NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-------------GTPRSSK 154
           L  L H  NI+ L+G C+ R    L  EY P+G L + L                  +S 
Sbjct: 69  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L  +  +  A  +A+ ++YL ++     +H D+ A NIL+ E+   K+ DFG ++     
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----- 180
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GM 273
                          +  + M I S  Y+        + +T +DV+S+GV+L E+V+ G 
Sbjct: 181 ---GQEVYVKKTMGRLPVRWMAIESLNYS--------VYTTNSDVWSYGVLLWEIVSLGG 229
Query: 274 EAFCPEN-GQLLTSLA-GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
             +C     +L   L  G  L    +C+    +E+ D                 +   C 
Sbjct: 230 TPYCGMTCAELYEKLPQGYRLEKPLNCD----DEVYD-----------------LMRQCW 268
Query: 332 RQSPILRPSATQILHTIKHQISS 354
           R+ P  RPS  QIL ++   +  
Sbjct: 269 REKPYERPSFAQILVSLNRMLEE 291

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 2   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 56
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 113
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 114 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 162
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 163 ---------RRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 6   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 60
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 117
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 118 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 167 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 65  IGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G G F NVYLAR        +     K  +    +    ++E++I  HL H NI++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y  D     L+ EY P GT+  +L    + SK   +       +LA A+ Y H +    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RV 129
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H DIK  N+LL      K+ DFG +    SS                 ++  + G+  Y
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----------------RRTDLCGTLDY 172
Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             P  +   M   K D++S GV+  E + G   F
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 10  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 124
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 125 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 168
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 169 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 228
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 229 PEKFFPKARDLVEKLLVLD 247

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 11  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 125
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 169
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 229
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 230 PEKFFPKARDLVEKLLVLD 248

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 4   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 58
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 115
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ +FG +    SS        
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS-------- 164
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 165 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 3   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 57
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 58  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 114
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ +FG +    SS        
Sbjct: 115 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS-------- 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 164 ---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 13  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 127
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 128 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 171
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 172 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 231
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 232 PEKFFPKARDLVEKLLVLD 250

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 12  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 126
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 127 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 170
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 171 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 230
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 231 PEKFFPKARDLVEKLLVLD 249

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 113/260 (43%), Gaps = 27/260 (10%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 40  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 116 NIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             VKL  +C   DE +     Y  NG L + +       +   R   A   ++  A+EYL
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYL 153
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H +    I+H D+K  NILL E ++ ++ DFG+AK+                     +  
Sbjct: 154 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARAN 197
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND 294
             +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D
Sbjct: 198 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 257
Query: 295 IADCEATKVNELVDPRLAGD 314
             +    K  +LV+  L  D
Sbjct: 258 FPEKFFPKARDLVEKLLVLD 277

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 32/234 (13%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 27  KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 81
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 82  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 138
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 139 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 187
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                    ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 188 ---------RRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 17  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 131
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 132 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 175
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 176 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 235
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 236 PEKFFPKARDLVEKLLVLD 254

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 112/259 (43%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 35  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 149
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 193
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+ +    +  D 
Sbjct: 194 FVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF 253
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 254 PEKFFPKARDLVEKLLVLD 272

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 35  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 149
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 193
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 254 PEKFFPKARDLVEKLLVLD 272

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 32  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 146
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 147 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 190
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 191 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 250
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 251 PEKFFPKARDLVEKLLVLD 269

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 33  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 147
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANA 191
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 252 PEKFFPKARDLVEKLLVLD 270

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 33  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 147
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 191
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 252 PEKFFPKARDLVEKLLVLD 270

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 33  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 147
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 191
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 252 PEKFFPKARDLVEKLLVLD 270

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 120/303 (39%), Gaps = 52/303 (17%)
Query: 47  KKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVF 102
           KK  W  +D E       + +G G F NVYLAR        +     K  +    +    
Sbjct: 6   KKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 60
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 117
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS        
Sbjct: 118 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                    ++  + G+  Y  P  +       K D++S GV+  E + G   F     Q
Sbjct: 167 ---------RRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217
Query: 283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                       I+  E T            DF  + AR ++S     L+ +P  RP   
Sbjct: 218 -------ETYKRISRVEFT----------FPDFVTEGARDLIS---RLLKHNPSQRPXLR 257
Query: 343 QIL 345
           ++L
Sbjct: 258 EVL 260

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 36  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 150
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 194
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 195 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 254
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 255 PEKFFPKARDLVEKLLVLD 273

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 32  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 146
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 147 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANS 190
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 191 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 250
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 251 PEKFFPKARDLVEKLLVLD 269

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 30/232 (12%)
Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFKQ 104
           ++++ +D E       + +G G F NVYLAR        +     K  +    +    ++
Sbjct: 6   RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYI 117
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    SS          
Sbjct: 118 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------- 164
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  ++  + G+  Y  P  +   M   K D++S GV+  E + G   F
Sbjct: 165 -------RRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 35  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 149
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 193
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 254 PEKFFPKARDLVEKLLVLD 272

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 35  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 149
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 193
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 253
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 254 PEKFFPKARDLVEKLLVLD 272

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 112/259 (43%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 35  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 149
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 193
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+ +    +  D 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF 253
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 254 PEKFFPKARDLVEKLLVLD 272

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 134/323 (41%), Gaps = 64/323 (19%)
Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK--IHVGSDRLSQVFKQELDI 108
           W+D++     F  VIG G F  V  AR+  D    + AIK      S    + F  EL++
Sbjct: 21  WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 75
Query: 109 LLHLSHD-NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-------------GTPRSSK 154
           L  L H  NI+ L+G C+ R    L  EY P+G L + L                  +S 
Sbjct: 76  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L  +  +  A  +A+ ++YL ++     +H ++ A NIL+ E+   K+ DFG ++     
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR----- 187
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GM 273
                          +  + M I S  Y+        + +T +DV+S+GV+L E+V+ G 
Sbjct: 188 ---GQEVYVKKTMGRLPVRWMAIESLNYS--------VYTTNSDVWSYGVLLWEIVSLGG 236
Query: 274 EAFCPEN-GQLLTSLA-GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
             +C     +L   L  G  L    +C+    +E+ D                 +   C 
Sbjct: 237 TPYCGMTCAELYEKLPQGYRLEKPLNCD----DEVYD-----------------LMRQCW 275
Query: 332 RQSPILRPSATQILHTIKHQISS 354
           R+ P  RPS  QIL ++   +  
Sbjct: 276 REKPYERPSFAQILVSLNRMLEE 298

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 110/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 38  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 152
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 153 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 196
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 197 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 256
Query: 296 ADCEATKVNELVDPRLAGD 314
                 K  +LV+  L  D
Sbjct: 257 PAAFFPKARDLVEKLLVLD 275

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 114/239 (47%), Gaps = 33/239 (13%)
Query: 40  GIDGRSVKKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD 96
           G   +  +K  W+D   V R T    + +G+G F  V++          NG  K+ V S 
Sbjct: 1   GSQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSL 53
Query: 97  RLSQV----FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRS 152
           +   +    F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP  
Sbjct: 54  KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSG 111
Query: 153 SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF 212
            KL     + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++  
Sbjct: 112 IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL-- 166
Query: 213 SSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                             T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 167 ------------IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS V LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 36  KFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 150
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANS 194
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 195 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 254
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 255 PEKFFPKARDLVEKLLVLD 273

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 33/232 (14%)
Query: 47  KKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-- 101
           +K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +  
Sbjct: 9   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSP 61
Query: 102 --FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL    
Sbjct: 62  DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINK 119
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++         
Sbjct: 120 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------- 167
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 168 -----IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 33/232 (14%)
Query: 47  KKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-- 101
           +K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +  
Sbjct: 2   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSP 54
Query: 102 --FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL    
Sbjct: 55  DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINK 112
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++         
Sbjct: 113 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------- 160
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 161 -----IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 33/232 (14%)
Query: 47  KKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-- 101
           +K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +  
Sbjct: 1   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSP 53
Query: 102 --FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL    
Sbjct: 54  DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINK 111
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++         
Sbjct: 112 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------- 159
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 160 -----IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F+ V LAR I   T    A+KI     + S  L ++F+ E+ I+  L+H NIV
Sbjct: 20  KTIGKGNFAKVKLARHI--LTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           KL    +      L+ EY   G + + L  HG  +  +   + R     Q+  A++Y H+
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----QIVSAVQYCHQ 131
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
           +    IVH D+KA N+LL+  +N K+ DFG S +  F +                 K   
Sbjct: 132 K---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-----------------KLDT 171
Query: 236 MIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
             GSP Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 172 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 226

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 33/232 (14%)
Query: 47  KKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-- 101
           +K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +  
Sbjct: 6   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSP 58
Query: 102 --FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL    
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINK 116
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++         
Sbjct: 117 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------- 164
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 165 -----IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 33/232 (14%)
Query: 47  KKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-- 101
           +K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +  
Sbjct: 6   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSP 58
Query: 102 --FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL    
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINK 116
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++         
Sbjct: 117 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------- 164
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 165 -----IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 108/236 (45%), Gaps = 35/236 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F+ V LAR I   T    A+KI     + S  L ++F+ E+ I+  L+H NIV
Sbjct: 20  KTIGKGNFAKVKLARHI--LTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL    +      L+ EY   G + + L    R  +   R +     Q+  A++Y H++ 
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQK- 132
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
              IVH D+KA N+LL+  +N K+ DFG S +  F +                 K     
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-----------------KLDTFC 173
Query: 238 GSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           GSP Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 226

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 33/232 (14%)
Query: 47  KKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-- 101
           +K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +  
Sbjct: 5   QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSP 57
Query: 102 --FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL    
Sbjct: 58  DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINK 115
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++         
Sbjct: 116 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------- 163
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 164 -----IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 33/232 (14%)
Query: 47  KKYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-- 101
           +K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +  
Sbjct: 10  QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSP 62
Query: 102 --FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL    
Sbjct: 63  DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINK 120
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++         
Sbjct: 121 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------- 168
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 169 -----IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 13/217 (5%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ-VFKQELDILLHLSHDNIVKL 120
            +V+G G F      ++ +  T     +K  +  D  +Q  F +E+ ++  L H N++K 
Sbjct: 15  GEVLGKGCFGQA--IKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 121 IG--YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           IG  Y D R     + EY+  GTL+  +      S+ PW  R++ A  +A  + YLH   
Sbjct: 73  IGVLYKDKRLN--FITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +++I+H D+ + N L+ E+ N  + DFG A++                     K+  ++G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR-KKRYTVVG 184
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
           +P +  P  +       K DV+SFG++L E++  + A
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F+ V LAR I   T    A+KI     + S  L ++F+ E+ I+  L+H NIV
Sbjct: 13  KTIGKGNFAKVKLARHI--LTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 69
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           KL    +      L+ EY   G + + L  HG  +  +   + R     Q+  A++Y H+
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-----QIVSAVQYCHQ 124
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
           +    IVH D+KA N+LL+  +N K+ DFG S +  F +                 K   
Sbjct: 125 K---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-----------------KLDT 164
Query: 236 MIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
             GSP Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 165 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 219

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 33/231 (14%)
Query: 48  KYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--- 101
           K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +   
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSPD 53
Query: 102 -FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
            F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL     
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKL 111
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++          
Sbjct: 112 LDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL---------- 158
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 159 ----IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 33/231 (14%)
Query: 48  KYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--- 101
           K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +   
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSPD 53
Query: 102 -FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
            F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL     
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKL 111
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++          
Sbjct: 112 LDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL---------- 158
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 159 ----IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 33/231 (14%)
Query: 48  KYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--- 101
           K  W+D   V R T    + +G+G F  V++          NG  K+ V S +   +   
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSPD 53
Query: 102 -FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
            F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL     
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKL 111
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++          
Sbjct: 112 LDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL---------- 158
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 159 ----IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 105/234 (44%), Gaps = 31/234 (13%)
Query: 63  QVIGSGGFSNVYLAR--LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           + IG G F+ V LAR  L     +     K  + S  L ++F+ E+ I+  L+H NIVKL
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
               +      L+ EY   G + + L    R  +   R +     Q+  A++Y H++   
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQK--- 132
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
            IVH D+KA N+LL+  +N K+ DFG S +  F +                 K     GS
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-----------------KLDTFCGS 175
Query: 240 PGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           P Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 25/259 (9%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +++G G FS   LAR +  +TS   AIKI    H+  +       +E D++  L H 
Sbjct: 33  KFGKILGEGSFSTTVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
             VKL     D ++      Y  NG L + +       +   R   A   ++  A+EYLH
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLH 147
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +    I+H D+K  NILL E ++ ++ DFG+AK+                     +   
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQARANX 191
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N  L+      +  D 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 296 ADCEATKVNELVDPRLAGD 314
            +    K  +LV+  L  D
Sbjct: 252 PEKFFPKARDLVEKLLVLD 270

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 136/311 (43%), Gaps = 41/311 (13%)
Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G+    Y W+ +E      S  IGSG F  VY  +   D       +K+   +    Q F
Sbjct: 23  GQRDSSYYWE-IEASEVMLSTRIGSGSFGTVYKGKWHGDVAVK--ILKVVDPTPEQFQAF 79
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           + E+ +L    H NI+  +GY   +D   ++ ++    +L + LH   + +K      + 
Sbjct: 80  RNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLID 136
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           IA Q AQ ++YLH +   +I+H D+K++NI L E L  K+ DFG A +            
Sbjct: 137 IARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV------------ 181
Query: 223 XXXXXXXITKQVMM-IGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCP 278
                   ++QV    GS  +  P  +R       S ++DVYS+G++L EL+TG      
Sbjct: 182 --KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG------ 233
Query: 279 ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR 338
                   L  S +N+              P L+  +  +  +AM  + A C+++    R
Sbjct: 234 -------ELPYSHINNRDQIIFMVGRGYASPDLSKLYK-NCPKAMKRLVADCVKKVKEER 285
Query: 339 PSATQILHTIK 349
           P   QIL +I+
Sbjct: 286 PLFPQILSSIE 296

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F+ V LAR I   T    A+KI     + S  L ++F+ E+ I+  L+H NIV
Sbjct: 20  KTIGKGNFAKVKLARHI--LTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           KL    +      L+ EY   G + + L  HG  +  +   + R     Q+  A++Y H+
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----QIVSAVQYCHQ 131
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
           +    IVH D+KA N+LL+  +N K+ DFG S +  F +                 K   
Sbjct: 132 K---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-----------------KLDA 171
Query: 236 MIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
             G+P Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 172 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 226

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 107/235 (45%), Gaps = 33/235 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F+ V LAR I   T    AIKI     +    L ++F+ E+ I+  L+H NIV
Sbjct: 18  KTIGKGNFAKVKLARHI--LTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 74
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL    +      L+ EY   G + + L    R  +   R++     Q+  A++Y H++ 
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCHQK- 130
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              IVH D+KA N+LL+  +N K+ DF     GFS+                 K     G
Sbjct: 131 --RIVHRDLKAENLLLDADMNIKIADF-----GFSNEFTVG-----------GKLDTFCG 172
Query: 239 SPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           SP Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 224

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L     + ++     +    Q+ + +EYL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA--HAERIDHIKLLQYTSQICKGMEYL- 133
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 174
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 105/234 (44%), Gaps = 31/234 (13%)
Query: 63  QVIGSGGFSNVYLAR--LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           + IG G F+ V LAR  L     +     K  + S  L ++F+ E+ I+  L+H NIVKL
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
               +      L+ EY   G + + L    R  +   R +     Q+  A++Y H++   
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQK--- 132
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
            IVH D+KA N+LL+  +N K+ DFG S +  F +                 K     GS
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-----------------KLDEFCGS 175
Query: 240 PGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           P Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 226

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDI 108
           +V R T    + +G+G F  V++          NG  K+ V S +   +    F  E ++
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSPDAFLAEANL 56
Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           +  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL     + +A Q+A
Sbjct: 57  MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIA 114
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           + + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++                  
Sbjct: 115 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL--------------IEDN 157
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 158 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 107/237 (45%), Gaps = 33/237 (13%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDN 116
             + IG G F+ V LAR +   T    A+KI     +    L ++F+ E+ I+  L+H N
Sbjct: 19  LQKTIGKGNFAKVKLARHV--LTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPN 75
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IVKL    +      L+ EY   G + + L    R  +   R +     Q+  A++Y H+
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQ 132
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
           +   +IVH D+KA N+LL+  +N K+ DF     GFS+                 K    
Sbjct: 133 K---YIVHRDLKAENLLLDGDMNIKIADF-----GFSNEFTVG-----------NKLDTF 173
Query: 237 IGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
            GSP Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 174 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 227

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEFF 171
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 49/292 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +V+G G F  V  A+      + + AIK  + S+   + F  EL  L  ++H NIVKL G
Sbjct: 14  EVVGRGAFGVVCKAKW----RAKDVAIK-QIESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW---RNRMAIAFQLAQAIEYLHERCT 179
            C   +   L+ EY   G+L   LHG   +  LP+    + M+   Q +Q + YLH    
Sbjct: 69  AC--LNPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 180 LHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
             ++H D+K  N+LL       K+CDFG+A                      T      G
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTA------------------CDIQTHMTNNKG 165
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           S  +  P        S K DV+S+G+IL E++T  + F          + G     +   
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--------DEIGGPAFRIM--- 214
Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
               V+    P L  +      + + S+   C  + P  RPS  +I+  + H
Sbjct: 215 --WAVHNGTRPPLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 49/292 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +V+G G F  V  A+      + + AIK  + S+   + F  EL  L  ++H NIVKL G
Sbjct: 15  EVVGRGAFGVVCKAKW----RAKDVAIK-QIESESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW---RNRMAIAFQLAQAIEYLHERCT 179
            C   +   L+ EY   G+L   LHG   +  LP+    + M+   Q +Q + YLH    
Sbjct: 70  AC--LNPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 180 LHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
             ++H D+K  N+LL       K+CDFG+A                      T      G
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTA------------------CDIQTHMTNNKG 166
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           S  +  P        S K DV+S+G+IL E++T  + F          + G     +   
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--------DEIGGPAFRIM--- 215
Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
               V+    P L  +      + + S+   C  + P  RPS  +I+  + H
Sbjct: 216 --WAVHNGTRPPLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 261

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 107/235 (45%), Gaps = 33/235 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F+ V LAR I   T    AIKI     +    L ++F+ E+ I+  L+H NIV
Sbjct: 21  KTIGKGNFAKVKLARHI--LTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL    +      L+ EY   G + + L    R  +   R++     Q+  A++Y H++ 
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCHQK- 133
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              IVH D+KA N+LL+  +N K+ DF     GFS+                 K     G
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADF-----GFSNEFTVG-----------GKLDAFCG 175
Query: 239 SPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           +P Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 227

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL- 129
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 130 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 170
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 171 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 214

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL- 134
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 135 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 175
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 176 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL- 161
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 202
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL- 128
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 129 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 169
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 170 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 213

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 136
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 137 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 177
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 178 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 221

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL- 130
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 171
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 174
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 135
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 136 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 176
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 177 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 220

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 137
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 138 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 178
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 179 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 222

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 171
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 33/236 (13%)
Query: 65  IGSGGFSNVYLAR--LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G GG S VYLA   ++N   +           +   + F++E+     LSH NIV +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QLAQAIEYLHERC 178
             ++ D   L+ EY+   TL E +  HG       P     AI F  Q+   I++ H+  
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHG-------PLSVDTAINFTNQILDGIKHAHD-- 129
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
            + IVH DIK  NIL++ +   K+ DFG AK    ++              +T+   ++G
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--------------LTQTNHVLG 174
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND 294
           +  Y  P   +       TD+YS G++L E++ G   F   NG+   S+A   + D
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF---NGETAVSIAIKHIQD 227

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 148
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 189
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 233

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 148
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 189
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 233

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGSDRLSQVFK 103
            + ++ DD E       + +G G F NVYLAR        +     K  +  + +    +
Sbjct: 17  TRHFTIDDFE-----IGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLR 71
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E++I  HL H NI++L  Y  DR    L+ EY P G L ++L    +S     +    I
Sbjct: 72  REIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQ---KSCTFDEQRTATI 128
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
             +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    S          
Sbjct: 129 MEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPS---------- 175
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                   ++  M G+  Y  P  +   M + K D++  GV+  EL+ G   F
Sbjct: 176 -------LRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-------QVFKQELDILLHLSHDNI 117
           +G G F  V+LA   N S + +   K+ V    L        + F++E ++L +L H++I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKD---KMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-----------GTPRSSK--LPWRNRMAIA 164
           VK  G C D D  +++FEY+ +G L + L            G PR +K  L     + IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            Q+A  + YL    + H VH D+   N L+  +L  K+ DFG ++  +S+          
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST---------- 186
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +    M+     +  P  +     +T++DV+SFGVIL E+ T
Sbjct: 187 -DYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 110/228 (48%), Gaps = 33/228 (14%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           +  +K +W+ + R +    + +G+G F  V++A     +  T  A+K         + F 
Sbjct: 170 KPWEKDAWE-IPRESLKLEKKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFL 225
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
            E +++  L HD +VKL      ++   ++ E++  G+L + L  +   SK P    +  
Sbjct: 226 AEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDF 283
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           + Q+A+ + ++ +R   + +H D++A+NIL+   L CK+ DFG A++G    +       
Sbjct: 284 SAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVGAKFPI------- 333
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                             +T P  +  G  + K+DV+SFG++L+E+VT
Sbjct: 334 -----------------KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH +   +K   +  + IA Q A+ ++YLH +    I
Sbjct: 88  YST-KPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E    K+ DFG A  K  +S +                +   + GS 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS---------------HQFEQLSGSI 186
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLA-GSMLND 294
            +  P  +R   +   S ++DVY+FG++L EL+TG   +   N   Q++  +  GS+  D
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
           ++   +                 +  + M  + A CL++    RPS  +IL  I+
Sbjct: 247 LSKVRS-----------------NCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH +   +K   +  + IA Q A+ ++YLH +    I
Sbjct: 76  YST-KPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E    K+ DFG A  K  +S +                +   + GS 
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 174
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLA-GSMLND 294
            +  P  +R   +   S ++DVY+FG++L EL+TG   +   N   Q++  +  GS+  D
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 234
Query: 295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
           ++   +                 +  + M  + A CL++    RPS  +IL  I+
Sbjct: 235 LSKVRS-----------------NCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 119/255 (46%), Gaps = 28/255 (10%)
Query: 51  WD----DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQEL 106
           WD    ++ R +    + +G+G F  V++    N   ST  A+K         Q F +E 
Sbjct: 3   WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNN---STKVAVKTLKPGTMSVQAFLEEA 59
Query: 107 DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           +++  L HD +V+L       +   ++ EY+  G+L + L  +    K+     +  + Q
Sbjct: 60  NLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQ 118
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           +A+ + Y+  +   + +H D++A+N+L+ E L CK+ DFG A++                
Sbjct: 119 IAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV--------------IE 161
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP--ENGQLL 284
               T +        +T P  +  G  + K+DV+SFG++L E+VT  +   P   N  ++
Sbjct: 162 DNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVM 221
Query: 285 TSLA-GSMLNDIADC 298
           T+L+ G  +  + +C
Sbjct: 222 TALSQGYRMPRVENC 236

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 106/236 (44%), Gaps = 35/236 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F+ V LAR I   T    A+KI     + S  L ++F+ E+ I   L+H NIV
Sbjct: 20  KTIGKGNFAKVKLARHI--LTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIV 76
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL    +      L+ EY   G + + L    R  +   R +     Q+  A++Y H++ 
Sbjct: 77  KLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQYCHQK- 132
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
              IVH D+KA N+LL+   N K+ DFG S +  F +                 K     
Sbjct: 133 --FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN-----------------KLDAFC 173
Query: 238 GSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           G+P Y  P   +       + DV+S GVIL  LV+G     P +GQ L  L   +L
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS---LPFDGQNLKELRERVL 226

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDI 108
           +V R T    + +G+G F  V++          NG  K+ V S +   +    F  E ++
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSPDAFLAEANL 57
Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           +  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL     + +A Q+A
Sbjct: 58  MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIA 115
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           + + ++ ER   + +H +++A+NIL+ + L+CK+ DFG A++                  
Sbjct: 116 EGMAFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARL--------------IEDN 158
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 159 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 33/231 (14%)
Query: 48  KYSWDD---VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--- 101
           K  W+D   V R T    + +G+G    V++          NG  K+ V S +   +   
Sbjct: 1   KPWWEDAWEVPRETLKLVERLGAGQAGEVWMGYY-------NGHTKVAVKSLKQGSMSPD 53
Query: 102 -FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
            F  E +++  L H  +V+L      ++   ++ EY+ NG+L + L  TP   KL     
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKL 111
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A Q+A+ + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++          
Sbjct: 112 LDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL---------- 158
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     T +        +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 159 ----IEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 99  YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 197
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 255
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 256 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 92  YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS---------------HQFEQLSGSI 190
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 248
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 249 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 198
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 256
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 257 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F + +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ E++P G+L+E L       ++     +    Q+ + +EYL 
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKERIDHIKLLQYTSQICKGMEYL- 133
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H D+   NIL+E     K+ DFG  K+                     K+  
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEXX 174
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 218

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 100 YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS---------------HQFEQLSGSI 198
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 256
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 257 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 170
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 228
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 229 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS---------------HQFEQLSGSI 170
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 228
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 229 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 74  YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 172
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 230
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 231 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 118 VKLIGYC--DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C    R    L+ EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL- 131
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              T   +H ++   NIL+E     K+ DFG  K+                     K+  
Sbjct: 132 --GTKRYIHRNLATRNILVENENRVKIGDFGLTKV-----------------LPQDKEYY 172
Query: 236 MIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            +  PG     +  P  L     S  +DV+SFGV+L EL T +E
Sbjct: 173 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 216

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 175
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 233
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 234 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y   + +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 175
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 233
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 234 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y     +  ++ ++    +L   LH +   +K   +  + IA Q A+ ++YLH +    I
Sbjct: 88  YST-APQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E    K+ DFG A  K  +S +                +   + GS 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS---------------HQFEQLSGSI 186
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLA-GSMLND 294
            +  P  +R   +   S ++DVY+FG++L EL+TG   +   N   Q++  +  GS+  D
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
           ++   +                 +  + M  + A CL++    RPS  +IL  I+
Sbjct: 247 LSKVRS-----------------NCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 127/294 (43%), Gaps = 46/294 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IGSG F  VY  +   D       + +   + +  Q FK E+ +L    H NI+  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVK--MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           Y     +  ++ ++    +L   LH     +K      + IA Q AQ ++YLH +    I
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA--KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +H D+K++NI L E L  K+ DFG A  K  +S +                +   + GS 
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------HQFEQLSGSI 170
Query: 241 GYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENG--QLLTSLAGSMLNDI 295
            +  P  +R       S ++DVY+FG++L EL+TG   +   N   Q++  +    L+  
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-- 228
Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            D    + N                +AM  + A CL++    RP   QIL +I+
Sbjct: 229 PDLSKVRSN--------------CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 40/289 (13%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F Q IGSG F  V+L   +N        I+    S+   + F +E ++++ LSH  +V+
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQ 69
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C ++    L+FE++ +G L + L    +         + +   + + + YL E C 
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
             ++H D+ A N L+ E+   K+ DFG  +      VL              K       
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRF-----VLDDQYTSSTGTKFPVK------- 172
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P        S+K+DV+SFGV++ E+ +  E   P   +  + +    + DI    
Sbjct: 173 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSNSEV----VEDI---- 220
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
            +    L  PRLA       +  +  I   C R+ P  RP+ +++L  +
Sbjct: 221 -STGFRLYKPRLA-------STHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           +  +K +W+ + R +    + +G+G F  V++A     +  T  A+K         + F 
Sbjct: 3   KPWEKDAWE-IPRESLKLEKKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFL 58
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
            E +++  L HD +VKL      ++   ++ E++  G+L + L      SK P    +  
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDF 116
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           + Q+A+ + ++ +R   + +H D++A+NIL+   L CK+ DFG A++             
Sbjct: 117 SAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV------------- 160
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  T +        +T P  +  G  + K+DV+SFG++L+E+VT
Sbjct: 161 -IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 32/233 (13%)
Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG---AIK-IHVGSDRLSQVFKQELDIL 109
           ++R      + +G G F  V+LA   N     +    A+K +   SD   + F +E ++L
Sbjct: 10  IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 69
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-----------HGTPRSSKLPWR 158
            +L H++IVK  G C + D  +++FEY+ +G L + L            G P  ++L   
Sbjct: 70  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP-PTELTQS 128
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
             + IA Q+A  + YL    + H VH D+   N L+ E+L  K+ DFG ++  +S+    
Sbjct: 129 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST---- 181
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      +    M+     +  P  +     +T++DV+S GV+L E+ T
Sbjct: 182 -------DYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 103/241 (42%), Gaps = 40/241 (16%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G  S VY  R     T    A+K+ +      ++ + E+ +LL LSH NI+KL    
Sbjct: 61  LGRGATSIVY--RCKQKGTQKPYALKV-LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
           +   E  L+ E V  G L +++      S+   R+      Q+ +A+ YLHE     IVH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE---RDAADAVKQILEAVAYLHEN---GIVH 171
Query: 185 GDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM---IG 238
            D+K  N+L          K+ DFG +K+                   +  QV+M    G
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKI-------------------VEHQVLMKTVCG 212
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           +PGY  P  LR      + D++S G+I   L+ G E F  E G         M   I +C
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNC 266
Query: 299 E 299
           E
Sbjct: 267 E 267

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 30/230 (13%)
Query: 53  DVERFTQNFSQVI---GSGGFSNVYLARLINDSTSTN-----GAIKIHVGSDRLSQVFKQ 104
           D   F + F + I   G G F  V L R   +  +T       ++K   G + ++ + K+
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-KK 72
Query: 105 ELDILLHLSHDNIVKLIGYC-DDRDEGV-LLFEYVPNGTLQEKLHGTPRS-SKLPWRNRM 161
           E++IL +L H+NIVK  G C +D   G+ L+ E++P+G+L+E L   P++ +K+  + ++
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQL 129
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXX 221
             A Q+ + ++YL  R     VH D+ A N+L+E     K+ DFG  K       +    
Sbjct: 130 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK------AIETDK 180
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       V       +  P  L        +DV+SFGV L EL+T
Sbjct: 181 EXXTVKDDRDSPVF------WYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 110/228 (48%), Gaps = 23/228 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           +  +K +W+ + R +    + +G+G F  V++A     +  T  A+K         + F 
Sbjct: 176 KPWEKDAWE-IPRESLKLEKKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFL 231
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
            E +++  L HD +VKL      ++   ++ E++  G+L + L  +   SK P    +  
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDF 289
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           + Q+A+ + ++ +R   + +H D++A+NIL+   L CK+ DFG A++             
Sbjct: 290 SAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV------------- 333
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  T +        +T P  +  G  + K+DV+SFG++L+E+VT
Sbjct: 334 -IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 37/288 (12%)
Query: 65  IGSGGFSNVYLARLINDSTSTN-GAIKIHVGSDRLSQV-FKQELDILLHLSHDNIVKLIG 122
           IG G FS VY A  + D        ++I    D  ++    +E+D+L  L+H N++K   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL-PWRNRMAIAFQLAQAIEYLHERCTLH 181
              + +E  ++ E    G L   +    +  +L P R       QL  A+E++H R    
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---R 156
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
           ++H DIK +N+ +      KL D G  +  FSS                T    ++G+P 
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKT--------------TAAHSLVGTPY 201
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEAT 301
           Y  P  +     + K+D++S G +L E+             L +   G  +N  + C+  
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAA-----------LQSPFYGDKMNLYSLCK-- 248
Query: 302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
           K+ +   P L  D   +E R +++   +C+   P  RP  T +    K
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAK 293

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IG G F +V    ++ D      A+K  + +D  +Q F  E  ++  L H N+V+L+G
Sbjct: 18  QTIGKGEFGDV----MLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 123 YCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +   G+ ++ EY+  G+L + L    RS  L     +  +  + +A+EYL      +
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---N 128
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+L+ E    K+ DFG  K   S+                           
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------------------ 170
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +T P  LR    STK+DV+SFG++L E+ +
Sbjct: 171 WTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 111/230 (48%), Gaps = 30/230 (13%)
Query: 53  DVERFTQNFSQVI---GSGGFSNVYLARLINDSTSTN-----GAIKIHVGSDRLSQVFKQ 104
           D   F + F + I   G G F  V L R   +  +T       ++K   G + ++ + K+
Sbjct: 2   DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-KK 60
Query: 105 ELDILLHLSHDNIVKLIGYC-DDRDEGV-LLFEYVPNGTLQEKLHGTPRS-SKLPWRNRM 161
           E++IL +L H+NIVK  G C +D   G+ L+ E++P+G+L+E L   P++ +K+  + ++
Sbjct: 61  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQL 117
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXX 221
             A Q+ + ++YL  R     VH D+ A N+L+E     K+ DFG  K       +    
Sbjct: 118 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK------AIETDK 168
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       V       +  P  L        +DV+SFGV L EL+T
Sbjct: 169 EXXTVKDDRDSPVF------WYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F Q IGSG F  V+L   +N        I+    S+   + F +E ++++ LSH  +V+
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQ 66
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C ++    L+FE++ +G L + L    +         + +   + + + YL E C 
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
             ++H D+ A N L+ E+   K+ DFG  +      VL              K       
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRF-----VLDDQYTSSTGTKFPVK------- 169
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P        S+K+DV+SFGV++ E+ +  E   P   +        ++ DI    
Sbjct: 170 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENR----SNSEVVEDI---- 217
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
            +    L  PRLA       +  +  I   C ++ P  RP+ +++L  +
Sbjct: 218 -STGFRLYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F Q IGSG F  V+L   +N        I+    S+   + F +E ++++ LSH  +V+
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQ 64
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C ++    L+FE++ +G L + L    +         + +   + + + YL E C 
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
             ++H D+ A N L+ E+   K+ DFG  +      VL              K       
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRF-----VLDDQYTSSTGTKFPVK------- 167
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P        S+K+DV+SFGV++ E+ +  E   P   +        ++ DI    
Sbjct: 168 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENR----SNSEVVEDI---- 215
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
            +    L  PRLA       +  +  I   C ++ P  RP+ +++L  +
Sbjct: 216 -STGFRLYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IG G F +V    ++ D      A+K  + +D  +Q F  E  ++  L H N+V+L+G
Sbjct: 12  QTIGKGEFGDV----MLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 123 YCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +   G+ ++ EY+  G+L + L    RS  L     +  +  + +A+EYL      +
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---N 122
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+L+ E    K+ DFG                       +TK+       G
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFG-----------------------LTKEASSTQDTG 159
Query: 242 -----YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  LR    STK+DV+SFG++L E+ +
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IG G F +V    ++ D      A+K  + +D  +Q F  E  ++  L H N+V+L+G
Sbjct: 27  QTIGKGEFGDV----MLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 123 YCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +   G+ ++ EY+  G+L + L    RS  L     +  +  + +A+EYL      +
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+L+ E    K+ DFG                       +TK+       G
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFG-----------------------LTKEASSTQDTG 174
Query: 242 -----YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  LR    STK+DV+SFG++L E+ +
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 105/222 (47%), Gaps = 22/222 (9%)
Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL 109
           +W+ + R +    + +G+G F  V++    N   ST  A+K         Q F +E +++
Sbjct: 6   AWE-IPRESIKLVKKLGAGQFGEVWMGYYNN---STKVAVKTLKPGTMSVQAFLEEANLM 61
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
             L HD +V+L       +   ++ E++  G+L + L  +    K+     +  + Q+A+
Sbjct: 62  KTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAE 120
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            + Y+  +   + +H D++A+N+L+ E L CK+ DFG A++                   
Sbjct: 121 GMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV--------------IEDNE 163
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            T +        +T P  +  G  + K++V+SFG++L E+VT
Sbjct: 164 YTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F Q IGSG F  V+L   +N        IK    S+     F +E ++++ LSH  +V+
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE---DDFIEEAEVMMKLSHPKLVQ 86
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C ++    L+FE++ +G L + L    +         + +   + + + YL E C 
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
             ++H D+ A N L+ E+   K+ DFG  +      VL              K       
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRF-----VLDDQYTSSTGTKFPVK------- 189
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P        S+K+DV+SFGV++ E+ +  E   P   +  + +    + DI    
Sbjct: 190 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSNSEV----VEDI---- 237
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
            +    L  PRLA       +  +  I   C ++ P  RP+ +++L  +
Sbjct: 238 -STGFRLYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           Q IG G F +V    ++ D      A+K  + +D  +Q F  E  ++  L H N+V+L+G
Sbjct: 199 QTIGKGEFGDV----MLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 123 YCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +   G+ ++ EY+  G+L + L    RS  L     +  +  + +A+EYL      +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+L+ E    K+ DFG  K   S+                           
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------------------ 351
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +T P  LR    STK+DV+SFG++L E+ +
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 105
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 106 FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 162
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 163 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAK 216
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 217 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 79
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 80  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 136
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 137 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAK 190
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 191 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 86
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 87  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 143
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 144 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEX---XSVHNKTGAK 197
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 198 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 87
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 88  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 144
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 145 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAK 198
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 199 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 106
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 107 FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 163
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 164 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAK 217
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 218 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 85  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 141
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 142 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAK 195
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 196 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 126/309 (40%), Gaps = 62/309 (20%)
Query: 45  SVKKYSWDDVE--RFTQNFSQVIGSGGFSNVYLA------RLINDSTSTNGAIKIHVGSD 96
           +V+   W   E  R   +F  V+G+G FS V LA      +L+        A++   GS 
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS- 62
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
                 + E+ +L  + H NIV L    +      L+ + V  G L +++      ++  
Sbjct: 63  -----MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-- 115
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL---LEEHLNCKLCDFGSAKMGFS 213
            R+   + FQ+  A++YLH+   L IVH D+K  N+L   L+E     + DFG +KM   
Sbjct: 116 -RDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
            +VL                    G+PGY  P  L     S   D +S GVI   L+ G 
Sbjct: 172 GSVLSTA----------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 274 EAFCPENG-----QLLTS---LAGSMLNDIADCEATKVNELVD---------------PR 310
             F  EN      Q+L +         +DI+D     +  L++               P 
Sbjct: 216 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275
Query: 311 LAGDFDLDE 319
           +AGD  LD+
Sbjct: 276 IAGDTALDK 284

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 126/309 (40%), Gaps = 62/309 (20%)
Query: 45  SVKKYSWDDVE--RFTQNFSQVIGSGGFSNVYLA------RLINDSTSTNGAIKIHVGSD 96
           +V+   W   E  R   +F  V+G+G FS V LA      +L+        A++   GS 
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS- 62
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
                 + E+ +L  + H NIV L    +      L+ + V  G L +++      ++  
Sbjct: 63  -----MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-- 115
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL---LEEHLNCKLCDFGSAKMGFS 213
            R+   + FQ+  A++YLH+   L IVH D+K  N+L   L+E     + DFG +KM   
Sbjct: 116 -RDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
            +VL                    G+PGY  P  L     S   D +S GVI   L+ G 
Sbjct: 172 GSVLSTA----------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 274 EAFCPENG-----QLLTS---LAGSMLNDIADCEATKVNELVD---------------PR 310
             F  EN      Q+L +         +DI+D     +  L++               P 
Sbjct: 216 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275
Query: 311 LAGDFDLDE 319
           +AGD  LD+
Sbjct: 276 IAGDTALDK 284

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 85
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 86  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 142
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 143 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAK 196
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 197 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 82
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 83  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 139
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 140 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAK 193
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 194 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 86
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 87  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 143
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 144 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAK 197
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 198 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 65  IGSGGFSNV--YLARLINDSTS---TNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           +G G F  V  Y     ND T       A+K   G    S  +KQE+DIL  L H++I+K
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG-WKQEIDILRTLYHEHIIK 80
Query: 120 LIGYCDDRDEGV--LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             G C+D+ E    L+ EYVP G+L++ L   PR S +     +  A Q+ + + YLH +
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHS-IGLAQLLLFAQQICEGMAYLHSQ 136
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
              H +H ++ A N+LL+     K+ DFG AK     AV              +      
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDGDSPVF--- 185
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +  P  L+       +DV+SFGV L EL+T
Sbjct: 186 ----WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 24/220 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ R +    + +G+G F  V++      + +T  AIK         + F +E  I+  L
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTW---NGNTKVAIKTLKPGTMSPESFLEEAQIMKKL 61
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-GTPRSSKLPWRNRMAIAFQLAQAI 171
            HD +V+L     + +   ++ EY+  G+L + L  G  R+ KLP  N + +A Q+A  +
Sbjct: 62  KHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGM 118
Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXIT 231
            Y+     ++ +H D++++NIL+   L CK+ DFG A++   +                 
Sbjct: 119 AYIER---MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK---- 171
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     +T P     G  + K+DV+SFG++L ELVT
Sbjct: 172 ----------WTAPEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 87
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 88  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 144
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 145 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAK 198
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 199 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 48  KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELD 107
           K +W+ + R +      +G G F  V++      + +T  AIK         + F QE  
Sbjct: 3   KDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFLQEAQ 58
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMAIAFQ 166
           ++  L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + +A Q
Sbjct: 59  VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQ 115
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           +A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++                
Sbjct: 116 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL--------------IE 158
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 159 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 65  IGSGGFSNV--YLARLINDSTS---TNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           +G G F  V  Y     ND T       A+K   G    S  +KQE+DIL  L H++I+K
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG-WKQEIDILRTLYHEHIIK 80
Query: 120 LIGYCDDRDEGV--LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             G C+D+ E    L+ EYVP G+L++ L   PR S +     +  A Q+ + + YLH +
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHS-IGLAQLLLFAQQICEGMAYLHAQ 136
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
              H +H ++ A N+LL+     K+ DFG AK     AV              +      
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDGDSPVF--- 185
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +  P  L+       +DV+SFGV L EL+T
Sbjct: 186 ----WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL 109
           +W+ + R +      +G G F  V++      + +T  AIK         + F QE  ++
Sbjct: 2   AWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFLQEAQVM 57
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMAIAFQLA 168
             L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + +A Q+A
Sbjct: 58  KKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIA 114
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
             + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++                  
Sbjct: 115 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL--------------IEDN 157
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 158 EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F Q IGSG F  V+L   +N        I+    S+   + F +E ++++ LSH  +V+
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQ 67
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C ++    L+ E++ +G L + L    +         + +   + + + YL E C 
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
             ++H D+ A N L+ E+   K+ DFG  +      VL              K       
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRF-----VLDDQYTSSTGTKFPVK------- 170
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P        S+K+DV+SFGV++ E+ +  E   P   +  + +    + DI    
Sbjct: 171 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSNSEV----VEDI---- 218
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
            +    L  PRLA       +  +  I   C R+ P  RP+ +++L  +
Sbjct: 219 -STGFRLYKPRLA-------STHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 126/309 (40%), Gaps = 62/309 (20%)
Query: 45  SVKKYSWDDVE--RFTQNFSQVIGSGGFSNVYLA------RLINDSTSTNGAIKIHVGSD 96
           +V+   W   E  R   +F  V+G+G FS V LA      +L+        A++   GS 
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS- 62
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
                 + E+ +L  + H NIV L    +      L+ + V  G L +++      ++  
Sbjct: 63  -----MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-- 115
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL---LEEHLNCKLCDFGSAKMGFS 213
            R+   + FQ+  A++YLH+   L IVH D+K  N+L   L+E     + DFG +KM   
Sbjct: 116 -RDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
            +VL                    G+PGY  P  L     S   D +S GVI   L+ G 
Sbjct: 172 GSVLSTA----------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 274 EAFCPENG-----QLLTS---LAGSMLNDIADCEATKVNELVD---------------PR 310
             F  EN      Q+L +         +DI+D     +  L++               P 
Sbjct: 216 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275
Query: 311 LAGDFDLDE 319
           +AGD  LD+
Sbjct: 276 IAGDTALDK 284

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 172 QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 227
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVD 284
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 285 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 329
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 330 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 65  IGSGGFSNV--YLARLINDSTSTNGAIKIHVGSDRLSQ---VFKQELDILLHLSHDNIVK 119
           +G G F  V  Y     ND T    A+K  + +D   Q    +KQE+DIL  L H++I+K
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 120 LIGYCDDRDEGV--LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             G C+D       L+ EYVP G+L++ L   PR S +     +  A Q+ + + YLH +
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHS-IGLAQLLLFAQQICEGMAYLHAQ 153
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
              H +H D+ A N+LL+     K+ DFG AK     AV              +      
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEXYRVREDGDSPVF--- 202
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +  P  L+       +DV+SFGV L EL+T
Sbjct: 203 ----WYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 172 QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 227
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVD 284
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 285 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 329
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 330 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 126/309 (40%), Gaps = 62/309 (20%)
Query: 45  SVKKYSWDDVE--RFTQNFSQVIGSGGFSNVYLA------RLINDSTSTNGAIKIHVGSD 96
           +V+   W   E  R   +F  V+G+G FS V LA      +L+        A++   GS 
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS- 62
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
                 + E+ +L  + H NIV L    +      L+ + V  G L +++      ++  
Sbjct: 63  -----MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-- 115
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL---LEEHLNCKLCDFGSAKMGFS 213
            R+   + FQ+  A++YLH+   L IVH D+K  N+L   L+E     + DFG +KM   
Sbjct: 116 -RDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
            +VL                    G+PGY  P  L     S   D +S GVI   L+ G 
Sbjct: 172 GSVLSTA----------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 274 EAFCPENG-----QLLTS---LAGSMLNDIADCEATKVNELVD---------------PR 310
             F  EN      Q+L +         +DI+D     +  L++               P 
Sbjct: 216 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275
Query: 311 LAGDFDLDE 319
           +AGD  LD+
Sbjct: 276 IAGDTALDK 284

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           IG G F  V+  RL  D+T              L   F QE  IL   SH NIV+LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
             +    ++ E V  G     L      ++L  +  + +    A  +EYL  +C    +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKCC---IH 236
Query: 185 GDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTD 244
            D+ A N L+ E    K+ DFG ++                      +QV +     +T 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG---------LRQVPV----KWTA 283
Query: 245 PHYLRTGMASTKTDVYSFGVILLE 268
           P  L  G  S+++DV+SFG++L E
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWE 307

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           IG G F  V+  RL  D+T              L   F QE  IL   SH NIV+LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
             +    ++ E V  G     L      ++L  +  + +    A  +EYL  +C    +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKCC---IH 236
Query: 185 GDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTD 244
            D+ A N L+ E    K+ DFG ++                      +QV +     +T 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGG---------LRQVPV----KWTA 283
Query: 245 PHYLRTGMASTKTDVYSFGVILLE 268
           P  L  G  S+++DV+SFG++L E
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWE 307

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 172 QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 227
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLP--QLVD 284
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 285 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 329
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 330 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 255 QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 310
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + 
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVD 367
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 368 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 412
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 413 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++   +        
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGA 175
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                              +T P     G  + K+DV+SFG++L EL T
Sbjct: 176 KFPIK--------------WTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 164 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 85
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 86  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 142
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +++L  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 143 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 196
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 197 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 3   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 58
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + 
Sbjct: 59  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVD 115
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           ++ Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 116 MSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 160
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 161 --IEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 3   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 58
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G T +  +LP    + 
Sbjct: 59  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVD 115
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           ++ Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 116 MSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 160
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 161 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 87
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 88  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 144
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +++L  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 145 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 198
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 199 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 87
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 88  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 144
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +++L  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 145 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 198
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 199 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 146
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 147 FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 203
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +++L  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 204 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 257
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 258 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 92
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 93  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 149
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +++L  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 150 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 203
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 204 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 88
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 89  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 145
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +++L  +     VH D+ A N +L+E    K+ DFG A+  +                 
Sbjct: 146 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 199
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 200 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 164 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V+LA    L+ +      A+K +   S+   Q F++E ++L  L H +IV+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR------------MAIAFQLA 168
            G C +    +++FEY+ +G L   L      +KL                 +A+A Q+A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
             + YL     LH VH D+   N L+ + L  K+ DFG ++  +S+              
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-----------DYY 191
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +  + M+     +  P  +     +T++DV+SFGV+L E+ T
Sbjct: 192 RVGGRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 51/295 (17%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDILLHLSHDN 116
           F + +GSG F +V+L      S+     IK  +  DR SQV     + E+++L  L H N
Sbjct: 26  FKRKLGSGAFGDVHLVE--ERSSGLERVIKT-INKDR-SQVPMEQIEAEIEVLKSLDHPN 81
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-HGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           I+K+    +D     ++ E    G L E++     R   L       +  Q+  A+ Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 176 ERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
            +   H+VH D+K  NIL ++   H   K+ DFG A++  S                   
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD----------------EH 182
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
                G+  Y  P   +  + + K D++S GV++  L+TG   F            G+ L
Sbjct: 183 STNAAGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLPF-----------TGTSL 230
Query: 293 NDIADCEATK-VNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
            ++      K  N  V+ R      +D  + ML+       + P  RPSA Q+LH
Sbjct: 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLT-------KDPERRPSAAQVLH 278

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 164 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 57/303 (18%)
Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           S D  E FT+   + IG G F  V+  + I++ T    AIKI     ++   +  +QE+ 
Sbjct: 2   SLDPEELFTK--LEKIGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 57
Query: 108 ILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           +L       + K  G Y  D    +++ EY+  G+  + L   P    L       I  +
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLLEPGP----LDETQIATILRE 112
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           + + ++YLH       +H DIKA+N+LL EH   KL DFG A     + +          
Sbjct: 113 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---------- 159
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
                K+   +G+P +  P  ++     +K D++S G+  +EL  G     P + +L   
Sbjct: 160 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE----PPHSEL--- 207
Query: 287 LAGSMLNDIADCEATKVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                          KV  L+     P L G++    ++ +      CL + P  RP+A 
Sbjct: 208 ------------HPMKVLFLIPKNNPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAK 251
Query: 343 QIL 345
           ++L
Sbjct: 252 ELL 254

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 57/303 (18%)
Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           S D  E FT+   + IG G F  V+  + I++ T    AIKI     ++   +  +QE+ 
Sbjct: 2   SLDPEELFTK--LEKIGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 57
Query: 108 ILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           +L       + K  G Y  D    +++ EY+  G+  + L   P    L       I  +
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLLEPGP----LDETQIATILRE 112
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           + + ++YLH       +H DIKA+N+LL EH   KL DFG A     + +          
Sbjct: 113 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---------- 159
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
                K+   +G+P +  P  ++     +K D++S G+  +EL  G     P + +L   
Sbjct: 160 -----KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE----PPHSEL--- 207
Query: 287 LAGSMLNDIADCEATKVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                          KV  L+     P L G++    ++ +      CL + P  RP+A 
Sbjct: 208 ------------HPMKVLFLIPKNNPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAK 251
Query: 343 QIL 345
           ++L
Sbjct: 252 ELL 254

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 48  KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELD 107
           K +W+ + R +      +G G F  V++      + +T  AIK         + F QE  
Sbjct: 1   KDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFLQEAQ 56
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQ 166
           ++  L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + +A Q
Sbjct: 57  VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQ 113
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           +A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++                
Sbjct: 114 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL--------------IE 156
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 157 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 57/303 (18%)
Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           S D  E FT+   + IG G F  V+  + I++ T    AIKI     ++   +  +QE+ 
Sbjct: 22  SMDPEELFTK--LEKIGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 77
Query: 108 ILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           +L       + K  G Y  D    +++ EY+  G+  + L   P    L       I  +
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLLEPGP----LDETQIATILRE 132
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           + + ++YLH       +H DIKA+N+LL EH   KL DFG A     + +          
Sbjct: 133 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---------- 179
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
                K+   +G+P +  P  ++     +K D++S G+  +EL  G     P + +L   
Sbjct: 180 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE----PPHSEL--- 227
Query: 287 LAGSMLNDIADCEATKVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                          KV  L+     P L G++    ++ +      CL + P  RP+A 
Sbjct: 228 ------------HPMKVLFLIPKNNPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAK 271
Query: 343 QIL 345
           ++L
Sbjct: 272 ELL 274

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 164 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F Q IGSG F  V+L   +N        I+    S+   + F +E ++++ LSH  +V+
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQ 66
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C ++    L+FE++ +G L + L    +         + +   + + + YL E   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
             ++H D+ A N L+ E+   K+ DFG  +      VL              K       
Sbjct: 123 -SVIHRDLAARNCLVGENQVIKVSDFGMTRF-----VLDDQYTSSTGTKFPVK------- 169
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P        S+K+DV+SFGV++ E+ +  E   P   +  + +    + DI    
Sbjct: 170 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSNSEV----VEDI---- 217
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
            +    L  PRLA       +  +  I   C ++ P  RP+ +++L  +
Sbjct: 218 -STGFRLYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V+LA    L+ +      A+K +   S+   Q F++E ++L  L H +IV+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR------------MAIAFQLA 168
            G C +    +++FEY+ +G L   L      +KL                 +A+A Q+A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
             + YL     LH VH D+   N L+ + L  K+ DFG ++  +S+              
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-----------DYY 185
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +  + M+     +  P  +     +T++DV+SFGV+L E+ T
Sbjct: 186 RVGGRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 25/223 (11%)
Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL 109
           +W+ + R +      +G G F  V++      + +T  AIK         + F QE  ++
Sbjct: 1   AWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFLQEAQVM 56
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLA 168
             L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + +A Q+A
Sbjct: 57  KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIA 113
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
             + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++                  
Sbjct: 114 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL--------------IEDN 156
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 157 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + +G G F  V LA   + +T    A+KI     +    +    ++E+  L  L H +I+
Sbjct: 14  KTLGEGSFGKVKLA--YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII 71
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL      +DE +++ EY  N    E      +  K+  +       Q+  A+EY H   
Sbjct: 72  KLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 126
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              IVH D+K  N+LL+EHLN K+ DFG + +      L                    G
Sbjct: 127 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS----------------CG 168
Query: 239 SPGYTDPHYLRTGM-ASTKTDVYSFGVIL 266
           SP Y  P  +   + A  + DV+S GVIL
Sbjct: 169 SPNYAAPEVISGKLYAGPEVDVWSCGVIL 197

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V+LA    L+ +      A+K +   S+   Q F++E ++L  L H +IV+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR------------MAIAFQLA 168
            G C +    +++FEY+ +G L   L      +KL                 +A+A Q+A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
             + YL     LH VH D+   N L+ + L  K+ DFG ++  +S+              
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-----------DYY 214
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +  + M+     +  P  +     +T++DV+SFGV+L E+ T
Sbjct: 215 RVGGRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + +G G F  V LA   + +T    A+KI     +    +    ++E+  L  L H +I+
Sbjct: 10  KTLGEGSFGKVKLA--YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII 67
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL      +DE +++ EY  N    E      +  K+  +       Q+  A+EY H   
Sbjct: 68  KLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 122
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              IVH D+K  N+LL+EHLN K+ DFG + +      L                    G
Sbjct: 123 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS----------------CG 164
Query: 239 SPGYTDPHYLRTGM-ASTKTDVYSFGVIL 266
           SP Y  P  +   + A  + DV+S GVIL
Sbjct: 165 SPNYAAPEVISGKLYAGPEVDVWSCGVIL 193

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + +G G F  V LA   + +T    A+KI     +    +    ++E+  L  L H +I+
Sbjct: 20  KTLGEGSFGKVKLA--YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII 77
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL      +DE +++ EY  N    E      +  K+  +       Q+  A+EY H   
Sbjct: 78  KLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 132
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              IVH D+K  N+LL+EHLN K+ DFG + +      L                    G
Sbjct: 133 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS----------------CG 174
Query: 239 SPGYTDPHYLRTGM-ASTKTDVYSFGVIL 266
           SP Y  P  +   + A  + DV+S GVIL
Sbjct: 175 SPNYAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--------QVFKQELDILLHL 112
           + + IG GGF  V+  RL+ D +    AIK  +  D           Q F++E+ I+ +L
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVV--AIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           +H NIVKL G   +    V+  E+VP G L  +L    ++  + W  ++ +   +A  IE
Sbjct: 81  NHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIE 136
Query: 173 YLHERCTLHIVHGDIKASNILLEE-----HLNCKLCDFGSAKMGFSSAVLXXXXXXXXXX 227
           Y+  +    IVH D+++ NI L+       +  K+ DFG+++    S             
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV----------SG 185
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                Q M   + G  +  Y      + K D YSF +IL  ++TG   F
Sbjct: 186 LLGNFQWMAPETIGAEEESY------TEKADTYSFAMILYTILTGEGPF 228

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 56  RFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHL 112
           R+  +F +  V+G G F  V  AR  N   S   AIK I    ++LS +   E+ +L  L
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASL 59
Query: 113 SHDNIVKLIGYCDDRDEGV-------------LLFEYVPNGTLQEKLHGTPRSSKLP--W 157
           +H  +V+      +R   V             +  EY  NGTL + +H    + +    W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           R    +  Q+ +A+ Y+H +    I+H D+K  NI ++E  N K+ DFG AK    S  +
Sbjct: 120 R----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELV----TG 272
                              IG+  Y     L  TG  + K D+YS G+I  E++    TG
Sbjct: 173 LKLDSQNLPGSS-DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 273 MEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR 332
           ME        +L  L                   V      DFD ++ +    I  L + 
Sbjct: 232 MERV-----NILKKLRS-----------------VSIEFPPDFDDNKMKVEKKIIRLLID 269
Query: 333 QSPILRPSATQILHT----IKHQ 351
             P  RP A  +L++    +KHQ
Sbjct: 270 HDPNKRPGARTLLNSGWLPVKHQ 292

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 79
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 180
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 79
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 180
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + +G G F  V LA   + +T    A+KI     +    +    ++E+  L  L H +I+
Sbjct: 19  KTLGEGSFGKVKLA--YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHII 76
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL      +DE +++ EY  N    E      +  K+  +       Q+  A+EY H   
Sbjct: 77  KLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH- 131
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              IVH D+K  N+LL+EHLN K+ DFG + +      L                    G
Sbjct: 132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS----------------CG 173
Query: 239 SPGYTDPHYLRTGM-ASTKTDVYSFGVIL 266
           SP Y  P  +   + A  + DV+S GVIL
Sbjct: 174 SPNYAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 87
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 148 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 188
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 189 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 236

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 80
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 141 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 181
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 182 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 98
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 159 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 199
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 200 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 247

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 79
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 180
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 123/303 (40%), Gaps = 61/303 (20%)
Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           D  E FT+   + IG G F  V+  + I++ T    AIKI     ++   +  +QE+ +L
Sbjct: 20  DPEELFTK--LERIGKGSFGEVF--KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
                  + K  G      +  ++ EY+  G+  + L   P        +   IA  L +
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF-------DEFQIATMLKE 128
Query: 170 ---AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
               ++YLH       +H DIKA+N+LL E  + KL DFG A     + +          
Sbjct: 129 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---------- 175
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
                K+   +G+P +  P  ++     +K D++S G+  +EL  G     P N      
Sbjct: 176 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE----PPN------ 220
Query: 287 LAGSMLNDIADCEATKVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                    +D    +V  L+     P L GDF     ++       CL + P  RP+A 
Sbjct: 221 ---------SDMHPMRVLFLIPKNNPPTLVGDF----TKSFKEFIDACLNKDPSFRPTAK 267
Query: 343 QIL 345
           ++L
Sbjct: 268 ELL 270

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 164 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 92
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 153 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 193
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 194 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 241

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK-QELDILLHLSHDNIVKL 120
           ++VIG+G F  VY A+L  DS       K+  G     + FK +EL I+  L H NIV+L
Sbjct: 25  TKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIVRL 78
Query: 121 IGYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 175 HERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
           H   +  I H DIK  N+LL+      KLCDFGSAK                        
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PN 179
Query: 234 VMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
           V  I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 91
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 192
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 83
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 144 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 184
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 185 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 91
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 192
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 240

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +VIG+G F  V+ A+L+    S   AIK  +   R      +EL I+  + H N+V L  
Sbjct: 46  KVIGNGSFGVVFQAKLVE---SDEVAIKKVLQDKRFKN---RELQIMRIVKHPNVVDLKA 99
Query: 123 YC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +     D +DE  L  + EYVP    +   H       +P        +QL +++ Y+H 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158
Query: 177 RCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
             ++ I H DIK  N+LL+      KL DFGSAK+  +                    V 
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----------------PNVS 200
Query: 236 MIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENG 281
            I S  Y  P  +      +T  D++S G ++ EL+ G   F  E+G
Sbjct: 201 XICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK-QELDILLHLSHDNIVKL 120
           ++VIG+G F  VY A+L  DS       K+  G     + FK +EL I+  L H NIV+L
Sbjct: 25  TKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIVRL 78
Query: 121 IGYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 175 HERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
           H   +  I H DIK  N+LL+      KLCDFGSAK                        
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PN 179
Query: 234 VMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
           V  I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 57/301 (18%)
Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           D  E FT+   + IG G F  V+  + I++ T    AIKI     ++   +  +QE+ +L
Sbjct: 19  DPEELFTK--LEKIGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 110 LHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
                  + K  G Y  D    +++ EY+  G+  + L   P    L       I  ++ 
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLLEPGP----LDETQIATILREIL 129
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           + ++YLH       +H DIKA+N+LL EH   KL DFG A     + +            
Sbjct: 130 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI------------ 174
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
              K+   +G+P +  P  ++     +K D++S G+  +EL  G     P + +L     
Sbjct: 175 ---KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE----PPHSEL----- 222
Query: 289 GSMLNDIADCEATKVNELV----DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI 344
                        KV  L+     P L G++    ++ +      CL + P  RP+A ++
Sbjct: 223 ----------HPMKVLFLIPKNNPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAKEL 268
Query: 345 L 345
           L
Sbjct: 269 L 269

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLH 111
           +F++VIG G F  VY   L++     N   KIH     L+++        F  E  I+  
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLD-----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 88
Query: 112 LSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            SH N++ L+G C  R EG  +++  Y+ +G L+  +     +  +  ++ +    Q+A+
Sbjct: 89  FSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAK 145
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +++L  +     VH D+ A N +L+E    K+ DFG A+                    
Sbjct: 146 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF---DSVHNKTGAK 199
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  + M + S        L+T   +TK+DV+SFGV+L EL+T
Sbjct: 200 LPVKWMALES--------LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 107
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 168 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 208
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 209 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 256

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  + H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG A++            
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL------------ 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 164 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 113
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 214
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 215 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 84
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 145 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 185
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 186 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 233

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 113
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 214
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK         + F 
Sbjct: 6   QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFL 61
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVD 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D+ A+NIL+ E+L CK+ DFG A++            
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARL------------ 163
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 164 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 97/228 (42%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL- 120
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 79
Query: 121 -IGYCDDRDEGV----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
              Y     + V    L+ +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 180
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K +W+ + R +      +G G F  V++      + +T  AIK     +   + F 
Sbjct: 173 QGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGNMSPEAFL 228
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMA 162
           QE  ++  L H+ +V+L     + +   ++ EY+  G+L + L G   +  +LP    + 
Sbjct: 229 QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVD 285
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +A Q+A  + Y+     ++ VH D++A+NIL+ E+L CK+ DFG  ++            
Sbjct: 286 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRL------------ 330
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                   T +        +T P     G  + K+DV+SFG++L EL T
Sbjct: 331 --IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK-QELDILLHLSHDNIVKL 120
           ++VIG+G F  VY A+L  DS       K+  G     + FK +EL I+  L H NIV+L
Sbjct: 25  TKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIVRL 78
Query: 121 IGYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 175 HERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
           H   +  I H DIK  N+LL+      KLCDFGSAK                        
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PN 179
Query: 234 VMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
           V  I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 115
Query: 122 GYC----DDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 176 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 216
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 217 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 264

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 117
Query: 122 GY----CDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 178 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 218
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 219 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 266

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           ++VIG+G F  VY A+L +       AIK  +   R      +EL I+  L H NIV+L 
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELV--AIKKVLQDKRFKN---RELQIMRKLDHCNIVRLR 158
Query: 122 GY----CDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
            +     + +DE  L  + +YVP    +   H +     LP        +QL +++ Y+H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 176 ERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
              +  I H DIK  N+LL+      KLCDFGSAK                        V
Sbjct: 219 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNV 259
Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPENG 281
             I S  Y  P  +      T + DV+S G +L EL+ G   F  ++G
Sbjct: 260 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 307

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N  + E    K+ DFG  +  + +      
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK- 183
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 184 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 226
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +L +  +C
Sbjct: 227 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LLELMRMC 263
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 264 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 299

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 43/239 (17%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVK 119
           IG G F  V+ AR   L+     T  A+K+     S  +   F++E  ++    + NIVK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG---------------------TPRSSKLPWR 158
           L+G C       LLFEY+  G L E L                       +P    L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ IA Q+A  + YL ER     VH D+   N L+ E++  K+ DFG ++  +S+    
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                                  +  P  +     +T++DV+++GV+L E+ + G++ +
Sbjct: 232 ADGNDAIPIR-------------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 122/278 (43%), Gaps = 54/278 (19%)
Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL- 112
           +FT  +   + IG G +S     R I+ +T+   A+KI    D+  +   +E++ILL   
Sbjct: 19  QFTDGYEVKEDIGVGSYS--VCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYG 73
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H NI+ L    DD     ++ E +  G L +K+    R      R   A+ F + + +E
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVE 130
Query: 173 YLHERCTLHIVHGDIKASNIL-LEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           YLH +    +VH D+K SNIL ++E  N    ++CDFG AK                   
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ------------------ 169
Query: 229 XITKQVMMIGSPGYT----DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC------P 278
            +  +  ++ +P YT     P  L         D++S GV+L  ++TG   F       P
Sbjct: 170 -LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228
Query: 279 EN-----GQLLTSLAGSMLNDIADCEATKVNEL--VDP 309
           E      G    SL+G   N ++D     V+++  VDP
Sbjct: 229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDP 266

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + +      
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 187
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 188 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 230
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 231 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 267
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 268 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 303

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--------QVFKQELDILLHL 112
           + + IG GGF  V+  RL+ D +    AIK  +  D           Q F++E+ I+ +L
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVV--AIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           +H NIVKL G   +    V+  E+VP G L  +L    ++  + W  ++ +   +A  IE
Sbjct: 81  NHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIE 136
Query: 173 YLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXIT 231
           Y+  +    IVH D+++ NI L+    N  +C    A  G S   +            + 
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCA-KVADFGLSQQSVHSVSGLLGNFQWMA 194
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            + +      YT+           K D YSF +IL  ++TG   F
Sbjct: 195 PETIGAEEESYTE-----------KADTYSFAMILYTILTGEGPF 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + +      
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 190
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 191 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 233
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 234 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 270
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 271 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 306

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + +      
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 189
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 190 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 232
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 233 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 269
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 270 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 305

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 75/336 (22%), Positives = 137/336 (40%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +           
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----------- 171
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 172 -------DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 224
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +L +  +C
Sbjct: 225 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LLELMRMC 261
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 262 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 297

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + +      
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 189
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 190 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 232
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 233 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 269
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 270 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 305

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + +      
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 183
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 184 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 226
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 227 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 263
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 264 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 299

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           V+G G +  VY  R +++      AIK I     R SQ   +E+ +  HL H NIV+ +G
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRI--AIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR-NRMAIAF---QLAQAIEYLHERC 178
              +     +  E VP G+L   L    RS   P + N   I F   Q+ + ++YLH+  
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 179 TLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
              IVH DIK  N+L+  +    K+ DFG++K    + +             +  +++  
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDK 197
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G  GY        G A+   D++S G  ++E+ TG   F
Sbjct: 198 GPRGY--------GKAA---DIWSLGCTIIEMATGKPPF 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + +      
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 196
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 197 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 240 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 276
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 277 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 312

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 138/336 (41%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + +      
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 218
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 219 -----------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 261
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 262 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 298
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 299 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 334

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTS-TNGAIKIHVGSDRLSQV--FKQELDILLH 111
           ER   +  +VIG G F  VY    I+ + +    AIK       + QV  F +E  ++  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 112 LSHDNIVKLIGYCDDRDEGV--LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
           L+H N++ LIG      EG+  +L  Y+ +G L + +    R+  +  ++ ++   Q+A+
Sbjct: 79  LNHPNVLALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVAR 135
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            +EYL E+     VH D+ A N +L+E    K+ DFG A+      +L            
Sbjct: 136 GMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR-----DILDREYYSVQQHRH 187
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               V       +T    L+T   +TK+DV+SFGV+L EL+T
Sbjct: 188 ARLPV------KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 128/325 (39%), Gaps = 60/325 (18%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---QELDILLHLSHDNIVKL 120
           ++G G +  V   R  N  T    AIK  + SD    V K   +E+ +L  L H+N+V L
Sbjct: 32  LVGEGSYGMVMKCR--NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           +  C  +    L+FE+V + T+ + L   P    L ++      FQ+   I + H     
Sbjct: 90  LEVCKKKKRWYLVFEFV-DHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH--- 143
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           +I+H DIK  NIL+ +    KLCDFG A+   +   +                   + + 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---------------VATR 188
Query: 241 GYTDPHYLRTGMASTK-TDVYSFGVILLELVTGMEAF-------------------CPEN 280
            Y  P  L   +   K  DV++ G ++ E+  G   F                    P +
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 281 GQLLTS---LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL 337
            +L       AG  L +I + E     E   P+L        +  ++ +A  CL   P  
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPL---ERRYPKL--------SEVVIDLAKKCLHIDPDK 297
Query: 338 RPSATQILHTIKHQISSISFLFSPQ 362
           RP   ++LH    Q+   +  FS +
Sbjct: 298 RPFCAELLHHDFFQMDGFAERFSQE 322

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 80/341 (23%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH------------GTPRSSKL 155
           ++   +  ++V+L+G        +++ E +  G L+  L               P  SK+
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
                + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + + 
Sbjct: 131 -----IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 182
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELV 270
                                 G  G     +  P  L+ G+ +T +DV+SFGV+L E+ 
Sbjct: 183 YYRK------------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 224
Query: 271 TGMEAFCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLS 325
           T  E   P  G    Q+L   + G +L+   +C          P +           +  
Sbjct: 225 TLAEQ--PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFE 261
Query: 326 IAALCLRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
           +  +C + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 262 LMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 302

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           V+G G +  VY  R +++      AIK I     R SQ   +E+ +  HL H NIV+ +G
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRI--AIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR-NRMAIAF---QLAQAIEYLHERC 178
              +     +  E VP G+L   L    RS   P + N   I F   Q+ + ++YLH+  
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 127
Query: 179 TLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
              IVH DIK  N+L+  +    K+ DFG++K    + +             +  +++  
Sbjct: 128 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDK 183
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G  GY        G A+   D++S G  ++E+ TG   F
Sbjct: 184 GPRGY--------GKAA---DIWSLGCTIIEMATGKPPF 211

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 47/289 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTS-TNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           Q IG G F    L +   D        I I   S +  +  ++E+ +L ++ H NIV+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF-QLAQAIEYLHERCTL 180
              ++     ++ +Y   G L ++++   +   L   +++   F Q+  A++++H+R   
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR--- 144
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            I+H DIK+ NI L +    +L DFG A++  S+  L                   IG+P
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA---------------CIGTP 189
Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEA 300
            Y  P        + K+D+++ G +L EL T   AF           AGSM N       
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF----------EAGSMKN------- 232
Query: 301 TKVNELVDPRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQILH 346
                LV   ++G F    L  +  + S+ +   +++P  RPS   IL 
Sbjct: 233 -----LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 80/341 (23%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH------------GTPRSSKL 155
           ++   +  ++V+L+G        +++ E +  G L+  L               P  SK+
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
                + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +  + + 
Sbjct: 141 -----IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELV 270
                                 G  G     +  P  L+ G+ +T +DV+SFGV+L E+ 
Sbjct: 193 YYRK------------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 271 TGMEAFCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLS 325
           T  E   P  G    Q+L   + G +L+   +C          P +           +  
Sbjct: 235 TLAEQ--PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFE 271
Query: 326 IAALCLRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
           +  +C + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 272 LMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 312

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY+   +    S   A+K         + F +E  ++  +
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 85
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ EY+P G L + L    R  ++     + +A Q++ A+E
Sbjct: 86  KHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAME 144
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 145 YLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRL--------------MTGDTYTA 187
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 188 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 109/260 (41%), Gaps = 36/260 (13%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VG 94
           GI   S  +   D+ E     F +V+G G F  V LAR+    T    A+K+      + 
Sbjct: 11  GIGVNSSNRLGIDNFE-----FIRVLGKGSFGKVMLARV--KETGDLYAVKVLKKDVILQ 63
Query: 95  SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK 154
            D +     ++  + L  +H  + +L       D    + E+V  G L   +  + R  +
Sbjct: 64  DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE 123
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
              R R   A ++  A+ +LH++    I++ D+K  N+LL+   +CKL DFG  K G  +
Sbjct: 124 A--RARFYAA-EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
            V                     G+P Y  P  L+  +     D ++ GV+L E++ G  
Sbjct: 178 GV---------------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
Query: 275 AFCPENGQLLTSLAGSMLND 294
            F  EN      L  ++LND
Sbjct: 223 PFEAENED---DLFEAILND 239

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 65  IGSGGFSNV--YLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V  Y     ND T    A+K        +L   +++E++IL  L H++IVK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 121 IGYCDDRDEGV--LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            G C+D+ E    L+ EYVP G+L++ L   PR   +     +  A Q+ + + YLH + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHC-VGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
             H +H  + A N+LL+     K+ DFG AK     AV                +V   G
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYY---------RVREDG 175
Query: 239 -SP-GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            SP  +  P  L+       +DV+SFGV L EL+T    +C  N
Sbjct: 176 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT----YCDSN 215

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/336 (22%), Positives = 136/336 (40%), Gaps = 70/336 (20%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY--LAR-LINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R     S+ +G G F  VY  +A+ ++ D   T  AIK      S R    F  E  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG-------TLQEKLHGTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G       +L+ ++   P  +       
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +           
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----------- 180
Query: 221 XXXXXXXXXITKQVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                            G  G     +  P  L+ G+ +T +DV+SFGV+L E+ T  E 
Sbjct: 181 -------DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 233
Query: 276 FCPENG----QLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
             P  G    Q+L   + G +L+   +C          P +           +  +  +C
Sbjct: 234 --PYQGLSNEQVLRFVMEGGLLDKPDNC----------PDM-----------LFELMRMC 270
Query: 331 LRQSPILRPSATQILHTIKHQIS----SISFLFSPQ 362
            + +P +RPS  +I+ +IK ++      +SF +S +
Sbjct: 271 WQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 306

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 65  IGSGGFSNV--YLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V  Y     ND T    A+K        +L   +++E++IL  L H++IVK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 121 IGYCDDRDEGV--LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            G C+D+ E    L+ EYVP G+L++ L   PR   +     +  A Q+ + + YLH + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHC-VGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
             H +H  + A N+LL+     K+ DFG AK     AV                +V   G
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYY---------RVREDG 174
Query: 239 -SP-GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            SP  +  P  L+       +DV+SFGV L EL+T    +C  N
Sbjct: 175 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT----YCDSN 214

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 32/207 (15%)
Query: 98  LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKL 155
           + QV+ QE+ IL  L H N+VKL+   DD +E    ++FE V  G + E     P S   
Sbjct: 80  IEQVY-QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS--- 135
Query: 156 PWRNRMAIAFQ-LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFS 213
              ++    FQ L + IEYLH +    I+H DIK SN+L+ E  + K+ DFG S +   S
Sbjct: 136 --EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELV 270
            A+L                   +G+P +  P  L   R   +    DV++ GV L   V
Sbjct: 191 DALLSNT----------------VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 271 TGMEAFCPENGQLLTSLAGSMLNDIAD 297
            G   F  E    L S   S   +  D
Sbjct: 235 FGQCPFMDERIMCLHSKIKSQALEFPD 261

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 112/259 (43%), Gaps = 55/259 (21%)
Query: 47  KKYSWD---DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV--------GS 95
           ++Y +D   +  R    F +V+GSG F  V  A     S  T  +I++ V         S
Sbjct: 32  REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGIS-KTGVSIQVAVKMLKEKADSS 90
Query: 96  DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTL------------ 142
           +R  +    EL ++  L SH+NIV L+G C       L+FEY   G L            
Sbjct: 91  ER--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 148
Query: 143 --------QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL 194
                   Q++L      + L + + +  A+Q+A+ +E+L  +     VH D+ A N+L+
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLV 205
Query: 195 EEHLNCKLCDFGSAK--MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGM 252
                 K+CDFG A+  M  S+ V+                        +  P  L  G+
Sbjct: 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVK---------------WMAPESLFEGI 250
Query: 253 ASTKTDVYSFGVILLELVT 271
            + K+DV+S+G++L E+ +
Sbjct: 251 YTIKSDVWSYGILLWEIFS 269

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 129/323 (39%), Gaps = 60/323 (18%)
Query: 56  RFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHL 112
           R+  +F +  V+G G F  V  AR  N   S   AIK I    ++LS +   E+ +L  L
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASL 59
Query: 113 SHDNIVKLIGYCDDRDEGV-------------LLFEYVPNGTLQEKLHGTPRSSKLP--W 157
           +H  +V+      +R   V             +  EY  N TL + +H    + +    W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           R    +  Q+ +A+ Y+H +    I+H D+K  NI ++E  N K+ DFG AK    S  +
Sbjct: 120 R----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELV----TG 272
                              IG+  Y     L  TG  + K D+YS G+I  E++    TG
Sbjct: 173 LKLDSQNLPGSS-DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 273 MEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR 332
           ME        +L  L                   V      DFD ++ +    I  L + 
Sbjct: 232 MERV-----NILKKLRS-----------------VSIEFPPDFDDNKMKVEKKIIRLLID 269
Query: 333 QSPILRPSATQILHT----IKHQ 351
             P  RP A  +L++    +KHQ
Sbjct: 270 HDPNKRPGARTLLNSGWLPVKHQ 292

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           +G G F  VY A+  N  T    A K I   S+   + +  E++IL    H  IVKL+G 
Sbjct: 27  LGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
                +  ++ E+ P G +   +    R    P      +  Q+ +A+ +LH +    I+
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP--QIQVVCRQMLEALNFLHSK---RII 139
Query: 184 HGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYT 243
           H D+KA N+L+    + +L DFG +     +               + K+   IG+P + 
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---------------LQKRDSFIGTPYWM 184
Query: 244 DPHY-----LRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
            P       ++      K D++S G+ L+E    M    P + +L       +L  IA  
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIE----MAQIEPPHHELNPM---RVLLKIAKS 237
Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL-HTIKHQISS 354
           +   +  L   + + +F     R  L IA   L ++P  RPSA Q+L H     I+S
Sbjct: 238 DPPTL--LTPSKWSVEF-----RDFLKIA---LDKNPETRPSAAQLLEHPFVSSITS 284

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 119/278 (42%), Gaps = 54/278 (19%)
Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL- 112
           +FT  +   + IG G +S     R I+ +T+   A+KI    D+  +   +E++ILL   
Sbjct: 19  QFTDGYEVKEDIGVGSYS--VCKRCIHKATNXEFAVKI---IDKSKRDPTEEIEILLRYG 73
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H NI+ L    DD     ++ E    G L +K+    R      R   A+ F + + +E
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKFFSEREASAVLFTITKTVE 130
Query: 173 YLHERCTLHIVHGDIKASNIL-LEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           YLH +    +VH D+K SNIL ++E  N    ++CDFG AK                   
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ------------------ 169
Query: 229 XITKQVMMIGSPGYT----DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC------P 278
            +  +  ++ +P YT     P  L         D++S GV+L   +TG   F       P
Sbjct: 170 -LRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTP 228
Query: 279 EN-----GQLLTSLAGSMLNDIADCEATKVNEL--VDP 309
           E      G    SL+G   N ++D     V++   VDP
Sbjct: 229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDP 266

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           +G G F  VY A+  N  T    A K I   S+   + +  E++IL    H  IVKL+G 
Sbjct: 19  LGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
                +  ++ E+ P G +   +    R    P      +  Q+ +A+ +LH +    I+
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP--QIQVVCRQMLEALNFLHSK---RII 131
Query: 184 HGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYT 243
           H D+KA N+L+    + +L DFG +     +               + K+   IG+P + 
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---------------LQKRDSFIGTPYWM 176
Query: 244 DPHY-----LRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
            P       ++      K D++S G+ L+E    M    P + +L       +L  IA  
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIE----MAQIEPPHHELNPM---RVLLKIAKS 229
Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL-HTIKHQISS 354
           +   +  L   + + +F     R  L IA   L ++P  RPSA Q+L H     I+S
Sbjct: 230 DPPTL--LTPSKWSVEF-----RDFLKIA---LDKNPETRPSAAQLLEHPFVSSITS 276

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 40/238 (16%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQV---FKQELDILLH 111
            S+ +GSG    V LA      T    AIKI       +GS R +      + E++IL  
Sbjct: 14  MSKTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L+H  I+K+  + D  D  ++L E +  G L +K+ G  R  +   +      +Q+  A+
Sbjct: 72  LNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV 127
Query: 172 EYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           +YLHE     I+H D+K  N+LL   EE    K+ DFG +K+   ++++           
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--------- 175
Query: 229 XITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                  + G+P Y  P  L    T   +   D +S GVIL   ++G   F     Q+
Sbjct: 176 -------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 40/238 (16%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQV---FKQELDILLH 111
            S+ +GSG    V LA      T    AIKI       +GS R +      + E++IL  
Sbjct: 14  MSKTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L+H  I+K+  + D  D  ++L E +  G L +K+ G  R  +   +      +Q+  A+
Sbjct: 72  LNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV 127
Query: 172 EYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           +YLHE     I+H D+K  N+LL   EE    K+ DFG +K+   ++++           
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--------- 175
Query: 229 XITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                  + G+P Y  P  L    T   +   D +S GVIL   ++G   F     Q+
Sbjct: 176 -------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 10  DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 167
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 168 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 40/238 (16%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQV---FKQELDILLH 111
            S+ +GSG    V LA      T    AIKI       +GS R +      + E++IL  
Sbjct: 14  MSKTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L+H  I+K+  + D  D  ++L E +  G L +K+ G  R  +   +      +Q+  A+
Sbjct: 72  LNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV 127
Query: 172 EYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           +YLHE     I+H D+K  N+LL   EE    K+ DFG +K+   ++++           
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--------- 175
Query: 229 XITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                  + G+P Y  P  L    T   +   D +S GVIL   ++G   F     Q+
Sbjct: 176 -------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 112/283 (39%), Gaps = 45/283 (15%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           IG G F  VY  + I++ T    AIKI     ++   +  +QE+ +L       I +  G
Sbjct: 27  IGKGSFGEVY--KGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
                 +  ++ EY+  G+  + L   P    L       I  ++ + ++YLH       
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSERK--- 137
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H DIKA+N+LL E  + KL DFG A     + +               K+   +G+P +
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---------------KRNXFVGTPFW 182
Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATK 302
             P  ++      K D++S G+  +EL  G     P N               +D    +
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKGE----PPN---------------SDLHPMR 223
Query: 303 VNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
           V  L+        +   ++        CL + P  RP+A ++L
Sbjct: 224 VLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 40/238 (16%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQV---FKQELDILLH 111
            S+ +GSG    V LA      T    AIKI       +GS R +      + E++IL  
Sbjct: 13  MSKTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 70
Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L+H  I+K+  + D  D  ++L E +  G L +K+ G  R  +   +      +Q+  A+
Sbjct: 71  LNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV 126
Query: 172 EYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           +YLHE     I+H D+K  N+LL   EE    K+ DFG +K+   ++++           
Sbjct: 127 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--------- 174
Query: 229 XITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                  + G+P Y  P  L    T   +   D +S GVIL   ++G   F     Q+
Sbjct: 175 -------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--------QVFKQELDILLHL 112
           + + IG GGF  V+  RL+ D +    AIK  +  D           Q F++E+ I+ +L
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVV--AIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           +H NIVKL G   +    V+  E+VP G L  +L    ++  + W  ++ +   +A  IE
Sbjct: 81  NHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIE 136
Query: 173 YLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXIT 231
           Y+  +    IVH D+++ NI L+    N  +C    A    S   +            + 
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCA-KVADFSLSQQSVHSVSGLLGNFQWMA 194
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            + +      YT+           K D YSF +IL  ++TG   F
Sbjct: 195 PETIGAEEESYTE-----------KADTYSFAMILYTILTGEGPF 228

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHD 115
             +++G GG S V+LAR + D      A+K+ + +D          F++E      L+H 
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDV--AVKV-LRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 116 NIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQ 169
            IV +    +          ++ EYV   TL++ +H     ++ P   + AI       Q
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQ 127
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ + H+     I+H D+K +NI++      K+ DFG A+    S               
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG------------NS 172
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           +T+   +IG+  Y  P   R      ++DVYS G +L E++TG   F 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 40/238 (16%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQV---FKQELDILLH 111
            S+ +GSG    V LA      T    AIKI       +GS R +      + E++IL  
Sbjct: 20  MSKTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 77
Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L+H  I+K+  + D  D  ++L E +  G L +K+ G  R  +   +      +Q+  A+
Sbjct: 78  LNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAV 133
Query: 172 EYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           +YLHE     I+H D+K  N+LL   EE    K+ DFG +K+   ++++           
Sbjct: 134 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--------- 181
Query: 229 XITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                  + G+P Y  P  L    T   +   D +S GVIL   ++G   F     Q+
Sbjct: 182 -------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 232

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHD 115
             +++G GG S V+LAR + D      A+K+ + +D          F++E      L+H 
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDV--AVKV-LRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 116 NIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQ 169
            IV +    +          ++ EYV   TL++ +H     ++ P   + AI       Q
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQ 127
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ + H+     I+H D+K +NI++      K+ DFG A+    S               
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG------------NS 172
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           +T+   +IG+  Y  P   R      ++DVYS G +L E++TG   F 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 59  QNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSH 114
           Q+F   + +G+G F  V+L R  ++       +       RL QV     E  +L  ++H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             I+++ G   D  +  ++ +Y+  G L   L    +S + P       A ++  A+EYL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYL 122
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H +    I++ D+K  NILL+++ + K+ DFG AK                    +T   
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY----------------VPDVT--Y 161
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            + G+P Y  P  + T   +   D +SFG+++ E++ G   F   N
Sbjct: 162 XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 102/236 (43%), Gaps = 33/236 (13%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGS---GGFSNVYLARLINDSTSTNGAIK-IHVGSDRLS 99
           +S+K+Y     +   ++F ++IG    G F  VY A+  N  TS   A K I   S+   
Sbjct: 21  QSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEEL 78
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           + +  E+DIL    H NIVKL+      +   +L E+   G +   +    R   L    
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQ 136
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLX 218
              +  Q   A+ YLH+     I+H D+KA NIL     + KL DFG SAK         
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------- 184
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMAST-----KTDVYSFGVILLEL 269
                      I ++   IG+P +  P  +    +       K DV+S G+ L+E+
Sbjct: 185 -------NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 10  DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 167
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 10  DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 167
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 8   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 165
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 33/236 (13%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGS---GGFSNVYLARLINDSTSTNGAIK-IHVGSDRLS 99
           +S+K+Y     +   ++F ++IG    G F  VY A+  N  TS   A K I   S+   
Sbjct: 21  QSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEEL 78
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           + +  E+DIL    H NIVKL+      +   +L E+   G +   +    R   L    
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQ 136
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLX 218
              +  Q   A+ YLH+     I+H D+KA NIL     + KL DFG SAK         
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------- 184
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMAST-----KTDVYSFGVILLEL 269
                      I ++   IG+P +  P  +    +       K DV+S G+ L+E+
Sbjct: 185 -------NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 102/236 (43%), Gaps = 33/236 (13%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGS---GGFSNVYLARLINDSTSTNGAIK-IHVGSDRLS 99
           +S+K+Y     +   ++F ++IG    G F  VY A+  N  TS   A K I   S+   
Sbjct: 21  QSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEEL 78
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           + +  E+DIL    H NIVKL+      +   +L E+   G +   +    R   L    
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQ 136
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLX 218
              +  Q   A+ YLH+     I+H D+KA NIL     + KL DFG SAK         
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------- 184
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMAST-----KTDVYSFGVILLEL 269
                      I ++   IG+P +  P  +    +       K DV+S G+ L+E+
Sbjct: 185 -------NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 10  DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 167
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 10  DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 167
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDNIVK 119
           Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N+VK
Sbjct: 12  QTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
             G+  + +   L  EY   G L +++        +P  +      QL   + YLH    
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---G 122
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
           + I H DIK  N+LL+E  N K+ DFG          L            + K   M G+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---MCGT 169
Query: 240 PGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
             Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 10  DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 167
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 10  DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 167
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 42/244 (17%)
Query: 51  WDDVERFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKI-HVGSDRLS-------- 99
           W   + F Q +    VIG G  S V   R ++ +T    A+KI  V ++RLS        
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVV--RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR 143
Query: 100 QVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR 158
           +  ++E  IL  ++ H +I+ LI   +      L+F+ +  G L + L        L  +
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEK 200
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
              +I   L +A+ +LH     +IVH D+K  NILL++++  +L DF     GFS  +  
Sbjct: 201 ETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDF-----GFSCHL-- 250
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMAST------KTDVYSFGVILLELVTG 272
                        K   + G+PGY  P  L+  M  T      + D+++ GVIL  L+ G
Sbjct: 251 ---------EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
Query: 273 MEAF 276
              F
Sbjct: 302 SPPF 305

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDNIVK 119
           Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N+VK
Sbjct: 13  QTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
             G+  + +   L  EY   G L +++        +P  +      QL   + YLH    
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
           + I H DIK  N+LL+E  N K+ DFG          L            + K   M G+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---MCGT 170
Query: 240 PGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
             Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 40/237 (16%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQV---FKQELDILLHL 112
           S+ +GSG    V LA      T    AI+I       +GS R +      + E++IL  L
Sbjct: 154 SKTLGSGACGEVKLA--FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 211
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           +H  I+K+  + D  D  ++L E +  G L +K+ G  R  +   +      +Q+  A++
Sbjct: 212 NHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK---LYFYQMLLAVQ 267
Query: 173 YLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           YLHE     I+H D+K  N+LL   EE    K+ DFG +K+   ++++            
Sbjct: 268 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR----------- 313
Query: 230 ITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                 + G+P Y  P  L    T   +   D +S GVIL   ++G   F     Q+
Sbjct: 314 -----TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 365

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G +  V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAYGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 40/237 (16%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQV---FKQELDILLHL 112
           S+ +GSG    V LA      T    AI+I       +GS R +      + E++IL  L
Sbjct: 140 SKTLGSGACGEVKLA--FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           +H  I+K+  + D  D  ++L E +  G L +K+ G  R  +   +      +Q+  A++
Sbjct: 198 NHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK---LYFYQMLLAVQ 253
Query: 173 YLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           YLHE     I+H D+K  N+LL   EE    K+ DFG +K+   ++++            
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR----------- 299
Query: 230 ITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                 + G+P Y  P  L    T   +   D +S GVIL   ++G   F     Q+
Sbjct: 300 -----TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGS-----DRLSQVFKQELDILLHLSHDN 116
           +V+G G F  V+L + I+ S +    A+K+   +     DR+    K E DIL+ ++H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ---AIEY 173
           IVKL        +  L+ +++  G L  +L      SK        + F LA+   A+++
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 141
Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
           LH   +L I++ D+K  NILL+E  + KL DFG +K                      K 
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---------------KKA 183
Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
               G+  Y  P  +     +   D +SFGV++ E++TG   F
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 43/243 (17%)
Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G   KKY+     RF +     IG G    VY A  ++ +T    AI+       L Q  
Sbjct: 17  GDPKKKYT-----RFEK-----IGQGASGTVYTA--MDVATGQEVAIR----QMNLQQQP 60
Query: 103 KQELDI--LLHLSHDNIVKLIGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           K+EL I  +L +  +    ++ Y D     DE  ++ EY+  G+L + +  T        
Sbjct: 61  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 117
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
               A+  +  QA+E+LH      ++H DIK+ NILL    + KL DFG     F + + 
Sbjct: 118 -QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQIT 168
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                        +K+  M+G+P +  P  +       K D++S G++ +E++ G   + 
Sbjct: 169 PEQ----------SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 218
Query: 278 PEN 280
            EN
Sbjct: 219 NEN 221

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 61  FSQVIGSGGFSNVYLA---RLINDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHD 115
             + +G G F  V  A    L   +  T  A+K+   +   S++     E ++L  ++H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT---------------------PRSSK 154
           +++KL G C      +L+ EY   G+L+  L  +                     P    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L   + ++ A+Q++Q ++YL E   + +VH D+ A NIL+ E    K+ DF     G S 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDF-----GLSR 198
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            V             I  + M I S        L   + +T++DV+SFGV+L E+VT
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIES--------LFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 34/228 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHD 115
             +++G GG S V+LAR + D      A+K+ + +D          F++E      L+H 
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDV--AVKV-LRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 116 NIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQ 169
            IV +    +          ++ EYV   TL++ +H     ++ P   + AI       Q
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQ 127
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ + H+     I+H D+K +NIL+      K+ DFG A+    S               
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSG------------NS 172
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           + +   +IG+  Y  P   R      ++DVYS G +L E++TG   F 
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 43/243 (17%)
Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G   KKY+     RF +     IG G    VY A  ++ +T    AI+       L Q  
Sbjct: 16  GDPKKKYT-----RFEK-----IGQGASGTVYTA--MDVATGQEVAIR----QMNLQQQP 59
Query: 103 KQELDI--LLHLSHDNIVKLIGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           K+EL I  +L +  +    ++ Y D     DE  ++ EY+  G+L + +  T        
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 116
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
               A+  +  QA+E+LH      ++H DIK+ NILL    + KL DFG     F + + 
Sbjct: 117 -QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQIT 167
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                        +K+  M+G+P +  P  +       K D++S G++ +E++ G   + 
Sbjct: 168 PEQ----------SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
Query: 278 PEN 280
            EN
Sbjct: 218 NEN 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 42/237 (17%)
Query: 61  FSQVIGSGGFSNVYLA---RLINDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHD 115
             + +G G F  V  A    L   +  T  A+K+   +   S++     E ++L  ++H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT---------------------PRSSK 154
           +++KL G C      +L+ EY   G+L+  L  +                     P    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L   + ++ A+Q++Q ++YL E   + +VH D+ A NIL+ E    K+ DF     G S 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDF-----GLSR 198
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            V             I  + M I S        L   + +T++DV+SFGV+L E+VT
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIES--------LFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 43/243 (17%)
Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G   KKY+     RF +     IG G    VY A  ++ +T    AI+       L Q  
Sbjct: 16  GDPKKKYT-----RFEK-----IGQGASGTVYTA--MDVATGQEVAIR----QMNLQQQP 59
Query: 103 KQELDI--LLHLSHDNIVKLIGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           K+EL I  +L +  +    ++ Y D     DE  ++ EY+  G+L + +  T        
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 116
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
               A+  +  QA+E+LH      ++H DIK+ NILL    + KL DFG     F + + 
Sbjct: 117 -QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQIT 167
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                        +K+  M+G+P +  P  +       K D++S G++ +E++ G   + 
Sbjct: 168 PEQ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
Query: 278 PEN 280
            EN
Sbjct: 218 NEN 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGS-----DRLSQVFKQELDILLHLSHDN 116
           +V+G G F  V+L + I+ S +    A+K+   +     DR+    K E DIL+ ++H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IVKL        +  L+ +++  G L  +L      ++   +  +A   +LA A+++LH 
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLH- 143
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
             +L I++ D+K  NILL+E  + KL DFG +K                      K    
Sbjct: 144 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---------------KKAYSF 186
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            G+  Y  P  +     +   D +SFGV++ E++TG   F
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGS-----DRLSQVFKQELDILLHLSHDN 116
           +V+G G F  V+L + I+ S +    A+K+   +     DR+    K E DIL+ ++H  
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 88
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IVKL        +  L+ +++  G L  +L      ++   +  +A   +LA A+++LH 
Sbjct: 89  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLH- 144
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
             +L I++ D+K  NILL+E  + KL DFG +K                      K    
Sbjct: 145 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---------------KKAYSF 187
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            G+  Y  P  +     +   D +SFGV++ E++TG   F
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 61  FSQVIGSGGFSNVYLA---RLINDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHD 115
             + +G G F  V  A    L   +  T  A+K+   +   S++     E ++L  ++H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT---------------------PRSSK 154
           +++KL G C      +L+ EY   G+L+  L  +                     P    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L   + ++ A+Q++Q ++YL E   + +VH D+ A NIL+ E    K+ DF     G S 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDF-----GLSR 198
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            V             I  + M I S        L   + +T++DV+SFGV+L E+VT
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIES--------LFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 55  ERFTQNFSQVIGSGGFSNV-----------YLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           ER+  N   ++G G F  V           Y  ++IN +++ N          + +    
Sbjct: 22  ERY--NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN----------KDTSTIL 69
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+++L  L H NI+KL    +D     ++ E    G L +++    R S+    +   I
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARI 126
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
             Q+   I Y+H+    +IVH D+K  NILLE     K CD      G S+         
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLES--KEKDCDIKIIDFGLSTCFQQN---- 177
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                  TK    IG+  Y  P  LR G    K DV+S GVIL  L++G   F  +N
Sbjct: 178 -------TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 43/243 (17%)
Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G   KKY+     RF +     IG G    VY A  ++ +T    AI+       L Q  
Sbjct: 16  GDPKKKYT-----RFEK-----IGQGASGTVYTA--MDVATGQEVAIR----QMNLQQQP 59
Query: 103 KQELDI--LLHLSHDNIVKLIGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           K+EL I  +L +  +    ++ Y D     DE  ++ EY+  G+L + +  T        
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 116
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
               A+  +  QA+E+LH      ++H DIK+ NILL    + KL DFG     F + + 
Sbjct: 117 -QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQIT 167
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                        +K+  M+G+P +  P  +       K D++S G++ +E++ G   + 
Sbjct: 168 PEQ----------SKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
Query: 278 PEN 280
            EN
Sbjct: 218 NEN 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 55  ERFTQNFSQVIGSGGFSNV-----------YLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           ER+  N   ++G G F  V           Y  ++IN +++ N          + +    
Sbjct: 22  ERY--NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN----------KDTSTIL 69
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+++L  L H NI+KL    +D     ++ E    G L +++    R S+    +   I
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARI 126
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
             Q+   I Y+H+    +IVH D+K  NILLE     K CD      G S+         
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLES--KEKDCDIKIIDFGLSTCFQQN---- 177
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                  TK    IG+  Y  P  LR G    K DV+S GVIL  L++G   F  +N
Sbjct: 178 -------TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELD------ILLHLSHDN 116
           +VIG+G F  VY   L   ++S    + + + + +     KQ +D      I+   SH N
Sbjct: 50  KVIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG L + L    +  +      + +   +A  ++YL  
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              ++ VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR------VLEDDPEATYTTSGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+SFG+++ E++T
Sbjct: 216 -----WTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
            ++G G F+ VY A  I+  T    AIK+     +    + Q  + E+ I   L H +I+
Sbjct: 17  NLLGKGSFAGVYRAESIH--TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQAIEYLHE 176
           +L  Y +D +   L+ E   NG +   L    +    P+    A  F  Q+   + YLH 
Sbjct: 75  ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHS 130
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
                I+H D+  SN+LL  ++N K+ DFG A                       K   +
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLA---------------TQLKMPHEKHYTL 172
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            G+P Y  P          ++DV+S G +   L+ G   F
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 68/246 (27%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
           N  + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWRNR----------MA 162
             N+V L+G C      ++ + E+   G L   L  + R+  +P+++           + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
            +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+             
Sbjct: 149 YSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLAR------------- 192
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYSFGVI 265
                              Y DP Y+R G A                 + ++DV+SFGV+
Sbjct: 193 -----------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 235
Query: 266 LLELVT 271
           L E+ +
Sbjct: 236 LWEIFS 241

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 100/238 (42%), Gaps = 43/238 (18%)
Query: 54  VERFTQNFSQVIGSGGFSNV-----------YLARLINDSTSTNGAIKIHVGSDRLSQVF 102
            ER+  N   ++G G F  V           Y  ++IN +++ N          + +   
Sbjct: 21  AERY--NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN----------KDTSTI 68
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
            +E+++L  L H NI+KL    +D     ++ E    G L +++    R S+    +   
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAAR 125
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           I  Q+   I Y+H+    +IVH D+K  NILLE     K CD      G S+        
Sbjct: 126 IIKQVFSGITYMHKH---NIVHRDLKPENILLES--KEKDCDIKIIDFGLSTCFQQN--- 177
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                   TK    IG+  Y  P  LR G    K DV+S GVIL  L++G   F  +N
Sbjct: 178 --------TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDILLHLSHDNIV 118
           +VIG G F  V + ++ N  T    A+KI    + L +     F++E D+L++     I 
Sbjct: 80  KVIGRGAFGEVAVVKMKN--TERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 137
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            L     D +   L+ +Y   G L   L  +    KLP         ++  AI+ +H+  
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLPEDMARFYIGEMVLAIDSIHQ-- 193
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
            LH VH DIK  N+LL+ + + +L DFGS  KM     V               +  + +
Sbjct: 194 -LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV---------------QSSVAV 237
Query: 238 GSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           G+P Y  P  L+      G    + D +S GV + E++ G   F  E+   L    G ++
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIM 294
Query: 293 N 293
           N
Sbjct: 295 N 295

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 108/247 (43%), Gaps = 37/247 (14%)
Query: 57  FTQNFSQVIGSGGFSNVYLARLINDSTSTN---GAIKIHVGSDRLSQVFKQELDILLHLS 113
           +T + ++++G G F  V+      + T+T     A  I     +  +  K E+ ++  L 
Sbjct: 89  YTVSKTEILGGGRFGQVHKC----EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD 144
Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H N+++L    + +++ VL+ EYV  G L +++     S  L   + +    Q+ + I +
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRH 202
Query: 174 LHERCTLHIVHGDIKASNILL--EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXIT 231
           +H+   ++I+H D+K  NIL    +    K+ DFG A+       L              
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK------------- 246
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
              +  G+P +  P  +     S  TD++S GVI   L++G+  F  +N           
Sbjct: 247 ---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------AET 296
Query: 292 LNDIADC 298
           LN+I  C
Sbjct: 297 LNNILAC 303

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDN 116
           +  Q +G G    V LA  +N  T    A+KI V   R     +  K+E+ I   L+H+N
Sbjct: 9   DLVQTLGEGAAGEVQLA--VNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +VK  G+  + +   L  EY   G L +++        +P  +      QL   + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              + I H DIK  N+LL+E  N K+ DFG          L            + K   M
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFG----------LATVFRYNNRERLLNK---M 166
Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
            G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 35/241 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDST-STNGAIKIHVGSDR----LSQVFKQELDILLHLSHD 115
           F + +G   F  VY   L   +      A+ I    D+    L + F+ E  +   L H 
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-HGTPRS------------SKLPWRNRMA 162
           N+V L+G         ++F Y  +G L E L   +P S            S L   + + 
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +  Q+A  +EYL    + H+VH D+   N+L+ + LN K+ D G  +  +++        
Sbjct: 150 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG 281
                  +  + +M G               S  +D++S+GV+L E+ + G++ +C  + 
Sbjct: 207 SLLPIRWMAPEAIMYGK-------------FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253
Query: 282 Q 282
           Q
Sbjct: 254 Q 254

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 35/241 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNG-AIKIHVGSDR----LSQVFKQELDILLHLSHD 115
           F + +G   F  VY   L   +      A+ I    D+    L + F+ E  +   L H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-HGTPRS------------SKLPWRNRMA 162
           N+V L+G         ++F Y  +G L E L   +P S            S L   + + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +  Q+A  +EYL    + H+VH D+   N+L+ + LN K+ D G  +  +++        
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG 281
                  +  + +M G               S  +D++S+GV+L E+ + G++ +C  + 
Sbjct: 190 SLLPIRWMAPEAIMYGK-------------FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 282 Q 282
           Q
Sbjct: 237 Q 237

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGS--------------DRLSQVFKQELDILL 110
           +GSG +  V L +  N  +    AIK+   S              ++  +    E+ +L 
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEK--AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
            L H NI+KL    +D+    L+ E+   G L E++    +  +    N M    Q+   
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---QILSG 158
Query: 171 IEYLHERCTLHIVHGDIKASNILLEEH---LNCKLCDFGSAKMGFSSAVLXXXXXXXXXX 227
           I YLH+    +IVH DIK  NILLE     LN K+ DFG +   FS              
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDY----------- 203
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
               K    +G+  Y  P  L+    + K DV+S GVI+  L+ G   F  +N Q
Sbjct: 204 ----KLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V +    +  T    A+KI     + S  +    K+E+  L    H +I+KL
Sbjct: 19  LGVGTFGKVKIGE--HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                   +  ++ EYV  G L + +    R  ++  R       Q+  A++Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCHRHM-- 131
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            +VH D+K  N+LL+ H+N K+ DFG + M      L                    GSP
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----------------CGSP 174
Query: 241 GYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCPEN 280
            Y  P  +   + A  + D++S GVIL  L+ G   F  E+
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDILLHLSHDNIV 118
           +VIG G F  V + ++ N  T    A+KI    + L +     F++E D+L++     I 
Sbjct: 96  KVIGRGAFGEVAVVKMKN--TERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 153
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            L     D +   L+ +Y   G L   L  +    KLP         ++  AI+ +H+  
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLPEDMARFYIGEMVLAIDSIHQ-- 209
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
            LH VH DIK  N+LL+ + + +L DFGS  KM     V               +  + +
Sbjct: 210 -LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV---------------QSSVAV 253
Query: 238 GSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           G+P Y  P  L+      G    + D +S GV + E++ G   F  E+   L    G ++
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIM 310
Query: 293 N 293
           N
Sbjct: 311 N 311

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 43/243 (17%)
Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVF 102
           G   KKY+     RF +     IG G    VY A  ++ +T    AI+       L Q  
Sbjct: 17  GDPKKKYT-----RFEK-----IGQGASGTVYTA--MDVATGQEVAIR----QMNLQQQP 60
Query: 103 KQELDI--LLHLSHDNIVKLIGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           K+EL I  +L +  +    ++ Y D     DE  ++ EY+  G+L + +  T        
Sbjct: 61  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 117
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
               A+  +  QA+E+LH      ++H +IK+ NILL    + KL DFG     F + + 
Sbjct: 118 -QIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFG-----FCAQIT 168
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                        +K+  M+G+P +  P  +       K D++S G++ +E++ G   + 
Sbjct: 169 PEQ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 218
Query: 278 PEN 280
            EN
Sbjct: 219 NEN 221

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHD 115
             +++G GG S V+LAR +      + A+K+ + +D          F++E      L+H 
Sbjct: 16  LGEILGFGGMSEVHLARDLR--LHRDVAVKV-LRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 116 NIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQ 169
            IV +    +          ++ EYV   TL++ +H     ++ P   + AI       Q
Sbjct: 73  AIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQ 127
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ + H+     I+H D+K +NI++      K+ DFG A+    S               
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG------------NS 172
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           +T+   +IG+  Y  P   R      ++DVYS G +L E++TG   F 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V +    +  T    A+KI     + S  +    K+E+  L    H +I+KL
Sbjct: 19  LGVGTFGKVKIGE--HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                   +  ++ EYV  G L + +    R  ++  R       Q+  A++Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCHRHM-- 131
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            +VH D+K  N+LL+ H+N K+ DFG + M      L                    GSP
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS----------------CGSP 174
Query: 241 GYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCPEN 280
            Y  P  +   + A  + D++S GVIL  L+ G   F  E+
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/311 (22%), Positives = 126/311 (40%), Gaps = 50/311 (16%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G F  VY    +    S   A+K         + F +E  ++  +
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 64
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 123
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTXTA 166
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM 291
                    +T P  L     S K+DV++FGV+L E+ T GM  +               
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 211
Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARA----MLSIAALCLRQSPILRPSATQILHT 347
                  + ++V EL    L  D+ ++        +  +   C + +P  RPS  +I   
Sbjct: 212 ----PGIDPSQVYEL----LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 263
Query: 348 IK--HQISSIS 356
            +   Q SSIS
Sbjct: 264 FETMFQESSIS 274

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/311 (22%), Positives = 126/311 (40%), Gaps = 50/311 (16%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 64
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 65  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 123
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTXTA 166
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM 291
                    +T P  L     S K+DV++FGV+L E+ T GM  +               
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 211
Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARA----MLSIAALCLRQSPILRPSATQILHT 347
                  + ++V EL    L  D+ ++        +  +   C + +P  RPS  +I   
Sbjct: 212 ----PGIDPSQVYEL----LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 263
Query: 348 IK--HQISSIS 356
            +   Q SSIS
Sbjct: 264 FETMFQESSIS 274

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+G G F  V L +  +  T    A+K+     V      +   +E+ +L  L H NI+
Sbjct: 38  RVLGKGSFGEVILCK--DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 95
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL  + +D+    L+ E    G L +++    R S++   +   I  Q+   I Y+H+  
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAARIIRQVLSGITYMHKN- 151
Query: 179 TLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              IVH D+K  N+LLE   +  N ++ DFG +    +S  +                  
Sbjct: 152 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--------------- 194
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            IG+  Y  P  L  G    K DV+S GVIL  L++G   F   N
Sbjct: 195 -IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/319 (25%), Positives = 125/319 (39%), Gaps = 52/319 (16%)
Query: 56  RFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHL 112
           R+  +F +  V+G G F  V  AR  N   S   AIK I    ++LS +   E+ +L  L
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHTEEKLSTIL-SEVXLLASL 59
Query: 113 SHDNIVKLIGYCDDRDEGV----------LLF---EYVPNGTLQEKLHGTPRSSKLP--W 157
           +H  +V+      +R   V           LF   EY  N TL + +H    + +    W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           R    +  Q+ +A+ Y+H +    I+H ++K  NI ++E  N K+ DFG AK    S  +
Sbjct: 120 R----LFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
                              IG+  Y     L  TG  + K D YS G+I  E +      
Sbjct: 173 LKLDSQNLPGSS-DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFST- 230
Query: 277 CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI 336
             E   +L  L                   V      DFD ++ +    I  L +   P 
Sbjct: 231 GXERVNILKKLRS-----------------VSIEFPPDFDDNKXKVEKKIIRLLIDHDPN 273
Query: 337 LRPSATQILHT----IKHQ 351
            RP A  +L++    +KHQ
Sbjct: 274 KRPGARTLLNSGWLPVKHQ 292

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 168
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHD 115
             +++G GG S V+LAR +      + A+K+ + +D          F++E      L+H 
Sbjct: 16  LGEILGFGGMSEVHLARDLR--LHRDVAVKV-LRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 116 NIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQ 169
            IV +    +          ++ EYV   TL++ +H     ++ P   + AI       Q
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQ 127
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ + H+     I+H D+K +NI++      K+ DFG A+    S               
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG------------NS 172
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           +T+   +IG+  Y  P   R      ++DVYS G +L E++TG   F 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 56  RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL-SQVFKQELDILLHLSH 114
           R T  F +V+GSG FS V+L +     T    A+K    S        + E+ +L  + H
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVK--QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +NIV L    +      L+ + V  G L +++      ++   ++   +  Q+  A++YL
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTE---KDASLVIQQVLSAVKYL 122
Query: 175 HERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXIT 231
           HE     IVH D+K  N+L    EE+    + DFG +KM   + ++              
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTA----------- 167
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                 G+PGY  P  L     S   D +S GVI   L+ G   F  E 
Sbjct: 168 -----CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 168
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/311 (22%), Positives = 126/311 (40%), Gaps = 50/311 (16%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 64
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 123
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTFTA 166
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM 291
                    +T P  L     S K+DV++FGV+L E+ T GM  +               
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 211
Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARA----MLSIAALCLRQSPILRPSATQILHT 347
                  + ++V EL    L  D+ ++        +  +   C + +P  RPS  +I   
Sbjct: 212 ----PGIDPSQVYEL----LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 263
Query: 348 IK--HQISSIS 356
            +   Q SSIS
Sbjct: 264 FETMFQESSIS 274

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 57  FTQNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS 113
           F +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + +
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
            H      ++H D+K  N+L+      KL DFG A+  F   V              T +
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHE 170
Query: 234 VMMIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           V+ +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 171 VVTL---WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+  L+H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 87  IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 147 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 203
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 204 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+G G F  V L +  +  T    A+K+     V      +   +E+ +L  L H NI+
Sbjct: 32  RVLGKGSFGEVILCK--DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL  + +D+    L+ E    G L +++    R S++   +   I  Q+   I Y+H+  
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAARIIRQVLSGITYMHKN- 145
Query: 179 TLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              IVH D+K  N+LLE   +  N ++ DFG +    +S  +                  
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--------------- 188
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP 278
            IG+  Y  P  L  G    K DV+S GVIL  L++G    CP
Sbjct: 189 -IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG----CP 225

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 72  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 173
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 57  FTQNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS 113
           F +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + +
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
            H      ++H D+K  N+L+      KL DFG A+  F   V              T +
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHE 170
Query: 234 VMMIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           V+ +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 171 VVTL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+  L+H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 161 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 218 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 68  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 126
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 127 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTXTA 169
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 170 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSD-RLSQVFKQELDILLHLSHDN 116
             +++G GG S V+LAR +      + A+K+    +  D      F++E      L+H  
Sbjct: 33  LGEILGFGGMSEVHLARDLR--LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 117 IVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQA 170
           IV +    +          ++ EYV   TL++ +H     ++ P   + AI       QA
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQA 145
Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXI 230
           + + H+     I+H D+K +NI++      K+ DFG A+    S               +
Sbjct: 146 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG------------NSV 190
Query: 231 TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           T+   +IG+  Y  P   R      ++DVYS G +L E++TG   F 
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 237

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ 100
           +D R++K+Y             + +G GGF+  Y    ++      G +       +  Q
Sbjct: 36  VDPRTMKRYMR----------GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ 85
Query: 101 VFKQELDILLHLSHDN--IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR 158
             K   +I +H S DN  +V   G+ +D D   ++ E     +L E LH   ++   P  
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP-- 142
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVL 217
                  Q  Q ++YLH      ++H D+K  N+ L + ++ K+ DFG A K+ F     
Sbjct: 143 EARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-- 197
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         ++  + G+P Y  P  L     S + D++S G IL  L+ G   F
Sbjct: 198 --------------RKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 130
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 173
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ 100
           +D R++K+Y             + +G GGF+  Y    ++      G +       +  Q
Sbjct: 36  VDPRTMKRYMR----------GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ 85
Query: 101 VFKQELDILLHLSHDN--IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR 158
             K   +I +H S DN  +V   G+ +D D   ++ E     +L E LH   ++   P  
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP-- 142
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVL 217
                  Q  Q ++YLH      ++H D+K  N+ L + ++ K+ DFG A K+ F     
Sbjct: 143 EARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-- 197
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         ++  + G+P Y  P  L     S + D++S G IL  L+ G   F
Sbjct: 198 --------------RKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+G G F  V L +  +  T    A+K+     V      +   +E+ +L  L H NI+
Sbjct: 55  RVLGKGSFGEVILCK--DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 112
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL  + +D+    L+ E    G L +++    R S++   +   I  Q+   I Y+H+  
Sbjct: 113 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAARIIRQVLSGITYMHKN- 168
Query: 179 TLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              IVH D+K  N+LLE   +  N ++ DFG +    +S  +                  
Sbjct: 169 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--------------- 211
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            IG+  Y  P  L  G    K DV+S GVIL  L++G   F   N
Sbjct: 212 -IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V + +  ++ T    A+KI     + S  +    ++E+  L    H +I+KL
Sbjct: 24  LGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                   +  ++ EYV  G L + +    ++ +L  +    +  Q+   ++Y H     
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            +VH D+K  N+LL+ H+N K+ DFG + M      L                    GSP
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS----------------CGSP 179
Query: 241 GYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAF 276
            Y  P  +   + A  + D++S GVIL  L+ G   F
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 168
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 168
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 58/307 (18%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---LSQVFKQELDILLHLSHDNIVKLI 121
           IG G +  V+  R  N  T    AIK  + S+    + ++  +E+ +L  L H N+V L+
Sbjct: 11  IGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                +    L+FEY  +  L E L    R   +P     +I +Q  QA+ + H+    +
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHE-LDRYQRG--VPEHLVKSITWQTLQAVNFCHKH---N 122
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            +H D+K  NIL+ +H   KLCDFG A++    +                   +++G   
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---DYYDDEVATRWYRSPELLVGDTQ 179
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF-------------------CPENGQ 282
           Y  P            DV++ G +  EL++G+  +                    P + Q
Sbjct: 180 YGPP-----------VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228
Query: 283 LLTS---LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
           + ++    +G  + D  D E     EL  P +        +   L +   CL   P  R 
Sbjct: 229 VFSTNQYFSGVKIPDPEDMEPL---ELKFPNI--------SYPALGLLKGCLHMDPTERL 277
Query: 340 SATQILH 346
           +  Q+LH
Sbjct: 278 TCEQLLH 284

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+G G F  V L +  +  T    A+K+     V      +   +E+ +L  L H NI+
Sbjct: 56  RVLGKGSFGEVILCK--DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 113
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL  + +D+    L+ E    G L +++    R S++   +   I  Q+   I Y+H+  
Sbjct: 114 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAARIIRQVLSGITYMHKN- 169
Query: 179 TLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              IVH D+K  N+LLE   +  N ++ DFG +    +S  +                  
Sbjct: 170 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--------------- 212
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            IG+  Y  P  L  G    K DV+S GVIL  L++G   F   N
Sbjct: 213 -IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 99/240 (41%), Gaps = 37/240 (15%)
Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDIL 109
           RFT ++   + +G G FS V   R +  + +   A KI + + +LS    Q  ++E  I 
Sbjct: 28  RFTDDYQLFEELGKGAFSVV--RRCVKKTPTQEYAAKI-INTKKLSARDHQKLEREARIC 84
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
             L H NIV+L     +     L+F+ V  G L E +      S+    +      Q+ +
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA---DASHCIHQILE 141
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSA--KMGFSSAVLXXXXXXX 224
           ++ ++H+     IVH D+K  N+LL         KL DFG A    G   A         
Sbjct: 142 SVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG------ 192
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                        G+PGY  P  LR        D+++ GVIL  L+ G   F  E+   L
Sbjct: 193 -----------FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKL 241

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 56  RFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDIL 109
           +F+ N+   + +G G FS V   R ++ +T    A KI + + +LS    Q  ++E  I 
Sbjct: 3   KFSDNYDVKEELGKGAFSVV--RRCVHKTTGLEFAAKI-INTKKLSARDFQKLEREARIC 59
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
             L H NIV+L     +     L+F+ V  G L E +      S+    + +    Q+ +
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILE 116
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           +I Y H      IVH ++K  N+LL         KL DFG A     S            
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG------- 166
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                      G+PGY  P  L+    S   D+++ GVIL  L+ G   F  E+   L
Sbjct: 167 ---------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 30/225 (13%)
Query: 59  QNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHL 112
           Q+F   +VIG G ++ V L RL    T    A+K+     V  D      + E  +    
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRL--KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 113 S-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           S H  +V L            + EYV  G L   +    R  KLP  +    + +++ A+
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLAL 123
Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXIT 231
            YLHER    I++ D+K  N+LL+   + KL D+G  K G                    
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------------D 165
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                 G+P Y  P  LR        D ++ GV++ E++ G   F
Sbjct: 166 TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIV 118
           +VIG G F  V L R  + ++    A+K+    + +    S  F +E DI+   +   +V
Sbjct: 81  KVIGRGAFGEVQLVR--HKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 138
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L     D     ++ EY+P G L   +       K  W       F  A+ +  L    
Sbjct: 139 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAK-----FYTAEVVLALDAIH 191
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
           ++ ++H D+K  N+LL++H + KL DFG+  KM  +  V                    +
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA---------------V 236
Query: 238 GSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  L++    G    + D +S GV L E++ G   F
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 99/240 (41%), Gaps = 34/240 (14%)
Query: 56  RFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDIL 109
           +F+ N+   + +G G FS V   R ++ +T    A KI + + +LS    Q  ++E  I 
Sbjct: 2   KFSDNYDVKEELGKGAFSVV--RRCVHKTTGLEFAAKI-INTKKLSARDFQKLEREARIC 58
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
             L H NIV+L     +     L+F+ V  G L E +      S+    +      Q+ +
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---DASHCIQQILE 115
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           +I Y H      IVH ++K  N+LL         KL DFG A     S            
Sbjct: 116 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG------- 165
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
                      G+PGY  P  L+    S   D+++ GVIL  L+ G   F  E+   L +
Sbjct: 166 ---------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 216

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 125
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 168
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 98/238 (41%), Gaps = 34/238 (14%)
Query: 56  RFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDIL 109
           +F+ N+   + +G G FS V   R ++ +T    A KI + + +LS    Q  ++E  I 
Sbjct: 3   KFSDNYDVKEELGKGAFSVV--RRCVHKTTGLEFAAKI-INTKKLSARDFQKLEREARIC 59
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
             L H NIV+L     +     L+F+ V  G L E +      S+    +      Q+ +
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---DASHCIQQILE 116
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           +I Y H      IVH ++K  N+LL         KL DFG A     S            
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG------- 166
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                      G+PGY  P  L+    S   D+++ GVIL  L+ G   F  E+   L
Sbjct: 167 ---------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 173
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 173
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 127/315 (40%), Gaps = 36/315 (11%)
Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGSDRLSQVFKQELDILLHL 112
           + R      +VIGSG  + V  A             I +      + ++ K E+  +   
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK-EIQAMSQC 70
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-----GTPRSSKLPWRNRMAIAFQL 167
            H NIV        +DE  L+ + +  G++ + +      G  +S  L       I  ++
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXX 227
            + +EYLH+      +H D+KA NILL E  + ++ DFG       SA L          
Sbjct: 131 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFG------VSAFLATGGDITRNK 181
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF--CPENGQLL 284
              T     +G+P +  P  +        K D++SFG+  +EL TG   +   P    L+
Sbjct: 182 VRKT----FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
Query: 285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI 344
            +L     ND    E    ++ +  +    F     R M+S   LCL++ P  RP+A ++
Sbjct: 238 LTLQ----NDPPSLETGVQDKEMLKKYGKSF-----RKMIS---LCLQKDPEKRPTAAEL 285
Query: 345 L-HTIKHQISSISFL 358
           L H    +  +  FL
Sbjct: 286 LRHKFFQKAKNKEFL 300

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 125
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 168
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 129
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 130 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 172
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 18  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 138 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 194
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 195 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTXTA 173
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ 100
           +D R++K+Y             + +G GGF+  Y    ++      G +       +  Q
Sbjct: 20  VDPRTMKRYMR----------GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ 69
Query: 101 VFKQELDILLHLSHDN--IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR 158
             K   +I +H S DN  +V   G+ +D D   ++ E     +L E LH   ++   P  
Sbjct: 70  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP-- 126
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVL 217
                  Q  Q ++YLH      ++H D+K  N+ L + ++ K+ DFG A K+ F     
Sbjct: 127 EARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-- 181
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         ++  + G+P Y  P  L     S + D++S G IL  L+ G   F
Sbjct: 182 --------------RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 28/219 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLS-HDNI 117
           +VIG G ++ V L RL    T    A+K+     V  D      + E  +    S H  +
Sbjct: 26  RVIGRGSYAKVLLVRL--KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 83
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           V L            + EYV  G L   +    R  KLP  +    + +++ A+ YLHER
Sbjct: 84  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER 140
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
               I++ D+K  N+LL+   + KL D+G  K G                          
Sbjct: 141 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------------DTTSXFC 182
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  LR        D ++ GV++ E++ G   F
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 127
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 128 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 170
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 171 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 30/225 (13%)
Query: 59  QNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHL 112
           Q+F   +VIG G ++ V L RL    T    A+K+     V  D      + E  +    
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRL--KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 113 S-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           S H  +V L            + EYV  G L   +    R  KLP  +    + +++ A+
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLAL 119
Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXIT 231
            YLHER    I++ D+K  N+LL+   + KL D+G  K G                    
Sbjct: 120 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------------D 161
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                 G+P Y  P  LR        D ++ GV++ E++ G   F
Sbjct: 162 TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 40/285 (14%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +GSG F  V L +        + A+K+          F QE   ++ LSH  +VK  G C
Sbjct: 16  LGSGQFGVVKLGKW---KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
                  ++ EY+ NG L   L    +   L     + + + + + + +L        +H
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 185 GDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTD 244
            D+ A N L++  L  K+ DFG  +       +             TK  +   +P    
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG---------TKFPVKWSAPEVF- 177
Query: 245 PHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVN 304
            HY +    S+K+DV++FG+++ E+ +         G++   L     N     + ++ +
Sbjct: 178 -HYFKY---SSKSDVWAFGILMWEVFS--------LGKMPYDL---YTNSEVVLKVSQGH 222
Query: 305 ELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            L  P LA D        +  I   C  + P  RP+  Q+L +I+
Sbjct: 223 RLYRPHLASD-------TIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 79
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 80  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 138
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 139 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 181
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 182 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ 100
           +D R++K+Y             + +G GGF+  Y    ++      G +       +  Q
Sbjct: 36  VDPRTMKRYMR----------GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ 85
Query: 101 VFKQELDILLHLSHDN--IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR 158
             K   +I +H S DN  +V   G+ +D D   ++ E     +L E LH   ++   P  
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP-- 142
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVL 217
                  Q  Q ++YLH      ++H D+K  N+ L + ++ K+ DFG A K+ F     
Sbjct: 143 EARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-- 197
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         ++  + G+P Y  P  L     S + D++S G IL  L+ G   F
Sbjct: 198 --------------RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 127
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                    T 
Sbjct: 128 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 170
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 171 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 203 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 96/226 (42%), Gaps = 35/226 (15%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +GSG +  V L R  +  T    AIKI     V +   S++  +E+ +L  L H NI+KL
Sbjct: 45  LGSGAYGEVLLCR--DKVTHVERAIKIIRKTSVSTSSNSKLL-EEVAVLKLLDHPNIMKL 101
Query: 121 IGYCDDRDEGVLLFEYVPNGTL-QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
             + +D+    L+ E    G L  E +H      K    +   I  Q+   + YLH+   
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-- 155
Query: 180 LHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
            +IVH D+K  N+LLE        K+ DFG       SAV               K    
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFG------LSAVFENQ----------KKMKER 198
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
           +G+  Y  P  LR      K DV+S GVIL  L+ G   F  +  Q
Sbjct: 199 LGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQ 243

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 147 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 203
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 204 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 36/245 (14%)
Query: 50  SW----DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL---SQVF 102
           SW    +D+++  + F + +G+G FS V LA     +T    A+K  +    L       
Sbjct: 12  SWKKQAEDIKKIFE-FKETLGTGAFSEVVLAE--EKATGKLFAVKC-IPKKALKGKESSI 67
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           + E+ +L  + H+NIV L    +  +   L+ + V  G L +++      ++   ++   
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE---KDAST 124
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXX 219
           +  Q+  A+ YLH    + IVH D+K  N+L    +E     + DFG +KM     V+  
Sbjct: 125 LIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST 181
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
                             G+PGY  P  L     S   D +S GVI   L+ G   F  E
Sbjct: 182 A----------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 225
Query: 280 NGQLL 284
           N   L
Sbjct: 226 NDSKL 230

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 43  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 163 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 219
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 220 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 33  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 93  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 153 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 209
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 210 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 203 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 65  IGSGGFSNVYLARLINDSTSTN----GAIKIHVGSDRLSQVFKQELDILLHLS---HDNI 117
           IG G +  VY AR   D  S +     ++++  G + L     +E+ +L  L    H N+
Sbjct: 12  IGVGAYGTVYKAR---DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 118 VKLIGYC----DDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           V+L+  C     DR+  V L+FE+V +  L+  L   P    LP      +  Q  + ++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLD 126
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           +LH  C   IVH D+K  NIL+      KL DFG A++      L               
Sbjct: 127 FLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP------------- 170
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
              ++ +  Y  P  L     +T  D++S G I  E+      FC
Sbjct: 171 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 43/240 (17%)
Query: 58  TQNFSQV--IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDR-LSQVFKQELDILLHLS 113
           +  F Q+  +G+G ++ VY  + +N +T    A+K + + S+        +E+ ++  L 
Sbjct: 4   SSQFKQLEKLGNGTYATVY--KGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQ----EKLHGTPRSSKLPWRNRMA-IAFQLA 168
           H+NIV+L       ++  L+FE++ N   +      +  TPR  +L   N +    +QL 
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLEL---NLVKYFQWQLL 118
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM------GFSSAVLXXXXX 222
           Q + + HE     I+H D+K  N+L+ +    KL DFG A+        FSS V+     
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                       +++GS  Y           ST  D++S G IL E++TG   F   N +
Sbjct: 176 APD---------VLMGSRTY-----------STSIDIWSCGCILAEMITGKPLFPGTNDE 215

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 127
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                      
Sbjct: 128 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK----- 179
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 180 ---------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 68  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 126
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H D+ A N L+ E+   K+ DFG +++                      
Sbjct: 127 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK----- 178
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 179 ---------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 35/301 (11%)
Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGSDRLSQVFKQELDILLHL 112
           + R      +VIGSG  + V  A             I +      + ++ K E+  +   
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK-EIQAMSQC 65
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-----GTPRSSKLPWRNRMAIAFQL 167
            H NIV        +DE  L+ + +  G++ + +      G  +S  L       I  ++
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXX 227
            + +EYLH+      +H D+KA NILL E  + ++ DFG       SA L          
Sbjct: 126 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFG------VSAFLATGGDITRNK 176
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF--CPENGQLL 284
              T     +G+P +  P  +        K D++SFG+  +EL TG   +   P    L+
Sbjct: 177 VRKT----FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 232
Query: 285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI 344
            +L     ND    E    ++ +  +    F     R M+S   LCL++ P  RP+A ++
Sbjct: 233 LTLQ----NDPPSLETGVQDKEMLKKYGKSF-----RKMIS---LCLQKDPEKRPTAAEL 280
Query: 345 L 345
           L
Sbjct: 281 L 281

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 161 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 218 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 44  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + +      
Sbjct: 164 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 220
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 221 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTN-GAIKIHVGS-----DRLSQVFKQELDILLHLSHDN 116
           +V+G G F  V+L R +    S +  A+K+   +     DR+    K E DIL  ++H  
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT--KMERDILADVNHPF 91
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ---AIEY 173
           +VKL        +  L+ +++  G L  +L      SK        + F LA+    +++
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALGLDH 145
Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
           LH   +L I++ D+K  NILL+E  + KL DFG +K                      K 
Sbjct: 146 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE---------------KKA 187
Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
               G+  Y  P  +     S   D +S+GV++ E++TG   F
Sbjct: 188 YSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 34/234 (14%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ--ELDILL 110
           +V R      + +G G F  VY  ++   S   N    + V    L +V+ +  ELD L+
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQV---SGMPNDPSPLQVAVKTLPEVYSEQDELDFLM 97
Query: 111 H------LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNR 160
                   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + 
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVL 217
           + +A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++  
Sbjct: 158 LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 215 RKGGCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 56  RFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDIL 109
           +F+ N+   + +G G FS V   R ++ +T    A KI + + +LS    Q  ++E  I 
Sbjct: 26  KFSDNYDVKEELGKGAFSVV--RRCVHKTTGLEFAAKI-INTKKLSARDFQKLEREARIC 82
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
             L H NIV+L     +     L+F+ V  G L E +      S+    + +    Q+ +
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILE 139
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXX 226
           +I Y H      IVH ++K  N+LL         KL DFG A     S            
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG------- 189
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                      G+PGY  P  L+    S   D+++ GVIL  L+ G   F  E+   L
Sbjct: 190 ---------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 147 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKG 203
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 204 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 85/217 (39%), Gaps = 24/217 (11%)
Query: 63  QVIGSGGFSNVYLARLIN-DSTSTNGAIKIH-VGSDRLSQVFKQELDILLHLS-HDNIVK 119
           +VIG G ++ V L RL   D       +K   V  D      + E  +    S H  +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L            + EYV  G L   +    R  KLP  +    + +++ A+ YLHER  
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG- 173
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
             I++ D+K  N+LL+   + KL D+G  K G                          G+
Sbjct: 174 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------------DTTSTFCGT 216
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           P Y  P  LR        D ++ GV++ E++ G   F
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 53  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + ++     
Sbjct: 173 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 229
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 230 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 33/240 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV----FKQELDILLHLSHDNIV 118
           +VIG G F  V + +L N       A+KI    + L +     F++E D+L++     I 
Sbjct: 80  KVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            L     D +   L+ +Y   G L   L  +    +LP         ++  AI+ +H+  
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIAIDSVHQ-- 193
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
            LH VH DIK  NIL++ + + +L DFGS         +              +  + +G
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--------------QSSVAVG 238
Query: 239 SPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN 293
           +P Y  P  L+      G    + D +S GV + E++ G   F  E+   L    G ++N
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMN 295

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 65  IGSGGFSNVYLARLINDSTSTN----GAIKIHVGSDRLSQVFKQELDILLHLS---HDNI 117
           IG G +  VY AR   D  S +     ++++  G + L     +E+ +L  L    H N+
Sbjct: 12  IGVGAYGTVYKAR---DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 118 VKLIGYC----DDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           V+L+  C     DR+  V L+FE+V +  L+  L   P    LP      +  Q  + ++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLD 126
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           +LH  C   IVH D+K  NIL+      KL DFG A++      L               
Sbjct: 127 FLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP------------- 170
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
              ++ +  Y  P  L     +T  D++S G I  E+      FC
Sbjct: 171 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 65  IGSGGFSNVYLARLINDSTSTN----GAIKIHVGSDRLSQVFKQELDILLHLS---HDNI 117
           IG G +  VY AR   D  S +     ++++  G + L     +E+ +L  L    H N+
Sbjct: 12  IGVGAYGTVYKAR---DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 118 VKLIGYC----DDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           V+L+  C     DR+  V L+FE+V +  L+  L   P    LP      +  Q  + ++
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLD 126
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           +LH  C   IVH D+K  NIL+      KL DFG A++      L               
Sbjct: 127 FLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP------------- 170
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
              ++ +  Y  P  L     +T  D++S G I  E+      FC
Sbjct: 171 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 212

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 28/231 (12%)
Query: 53  DVERFTQNFSQVIGSGGFSNVY---LARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
           +V R      + +G G F  VY   ++ + ND +    A+K    V S++    F  E  
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT-PRSSK---LPWRNRMAI 163
           I+   +H NIV+ IG         +L E +  G L+  L  T PR S+   L   + + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXX 220
           A  +A   +YL E    H +H DI A N LL         K+ DFG A+  + +      
Sbjct: 187 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  +  M              G+ ++KTD +SFGV+L E+ +
Sbjct: 244 GCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 35/231 (15%)
Query: 52  DDVERFTQNFSQV--IGSGGFSNVYLARLINDSTSTNG--AIKIHVGSDRLSQVFKQELD 107
           D + R  Q +  V  IG G +  V+ AR + +         +++  G + +     +E+ 
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 108 ILLHLS---HDNIVKLIGYC-----DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           +L HL    H N+V+L   C     D   +  L+FE+V +  L   L   P    +P   
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG-VPTET 121
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM-GFSSAVLX 218
              + FQL + +++LH      +VH D+K  NIL+      KL DFG A++  F  A   
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--- 175
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                      +T  V+ +    Y  P  L     +T  D++S G I  E+
Sbjct: 176 -----------LTSVVVTL---WYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 35/231 (15%)
Query: 52  DDVERFTQNFSQV--IGSGGFSNVYLARLINDSTSTNG--AIKIHVGSDRLSQVFKQELD 107
           D + R  Q +  V  IG G +  V+ AR + +         +++  G + +     +E+ 
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 108 ILLHLS---HDNIVKLIGYC-----DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           +L HL    H N+V+L   C     D   +  L+FE+V +  L   L   P    +P   
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG-VPTET 121
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM-GFSSAVLX 218
              + FQL + +++LH      +VH D+K  NIL+      KL DFG A++  F  A   
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--- 175
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                      +T  V+ +    Y  P  L     +T  D++S G I  E+
Sbjct: 176 -----------LTSVVVTL---WYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 35/231 (15%)
Query: 52  DDVERFTQNFSQV--IGSGGFSNVYLARLINDSTSTNG--AIKIHVGSDRLSQVFKQELD 107
           D + R  Q +  V  IG G +  V+ AR + +         +++  G + +     +E+ 
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 108 ILLHLS---HDNIVKLIGYC-----DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           +L HL    H N+V+L   C     D   +  L+FE+V +  L   L   P    +P   
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG-VPTET 121
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM-GFSSAVLX 218
              + FQL + +++LH      +VH D+K  NIL+      KL DFG A++  F  A   
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--- 175
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                      +T  V+ +    Y  P  L     +T  D++S G I  E+
Sbjct: 176 -----------LTSVVVTL---WYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 30/188 (15%)
Query: 99  SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKL-HGTPRSSKL 155
            Q+   E+++L  L H NIV+      DR    L  + EY   G L   +  GT     L
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 156 PWRNRMAIAFQLAQAIEYLHERCT--LHIVHGDIKASNILLEEHLNCKLCDFGSAKM--- 210
                + +  QL  A++  H R      ++H D+K +N+ L+   N KL DFG A++   
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 211 --GFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
              F+ A                     +G+P Y  P  +     + K+D++S G +L E
Sbjct: 169 DTSFAKA--------------------FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 269 LVTGMEAF 276
           L   M  F
Sbjct: 209 LCALMPPF 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELD--------------- 107
           Q++ S G    YLA  I     + G + I        QV  +++D               
Sbjct: 35  QLVVSPGDPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV 94
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           I+    HDN+V +       DE  ++ E++  G L + +  T    ++       +   +
Sbjct: 95  IMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSV 150
Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXX 227
            +A+ YLH +    ++H DIK+ +ILL      KL DFG     F + V           
Sbjct: 151 LRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG-----FCAQV----------S 192
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
             + K+  ++G+P +  P  +      T+ D++S G++++E++ G   +  E
Sbjct: 193 KEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 165
Query: 236 MIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P  L      ST  D++S G I  E+VT    F
Sbjct: 166 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 165
Query: 236 MIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 166 TL---WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 169
Query: 236 MIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 170 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 208

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 106/254 (41%), Gaps = 39/254 (15%)
Query: 42  DGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV 101
           D RS K+     VER         G G F  V L +    ST  + AIK  +   R    
Sbjct: 15  DERSRKEMDRFQVERMA-------GQGTFGTVQLGK--EKSTGMSVAIKKVIQDPRFRNR 65
Query: 102 FKQELDILLHLSHDNIVKL------IGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSK 154
             Q +  L  L H NIV+L      +G  D RD  + ++ EYVP+ TL        R   
Sbjct: 66  ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124
Query: 155 LPWRNRMAI-AFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGF 212
            P    + +  FQL ++I  LH   ++++ H DIK  N+L+ E     KLCDFGSAK   
Sbjct: 125 APPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 213 SSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVT 271
            S                   V  I S  Y  P  +      +T  D++S G I  E++ 
Sbjct: 184 PS----------------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 272 GMEAFCPEN--GQL 283
           G   F  +N  GQL
Sbjct: 228 GEPIFRGDNSAGQL 241

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 166
Query: 236 MIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 167 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 164
Query: 236 MIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 165 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 32/225 (14%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G+GGF   Y+ R I+  T    AIK      S +  + +  E+ I+  L+H N+V    
Sbjct: 22  LGTGGFG--YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 123 YCD------DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
             D        D  +L  EY   G L++ L+       L       +   ++ A+ YLHE
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 177 RCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
                I+H D+K  NI+L+   + L  K+ D G AK      +                 
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-------------- 182
Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP 278
              +G+  Y  P  L     +   D +SFG +  E +TG   F P
Sbjct: 183 --FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 165
Query: 236 MIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P  L      ST  D++S G I  E+VT    F
Sbjct: 166 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 32/225 (14%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G+GGF   Y+ R I+  T    AIK      S +  + +  E+ I+  L+H N+V    
Sbjct: 23  LGTGGFG--YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 123 YCD------DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
             D        D  +L  EY   G L++ L+       L       +   ++ A+ YLHE
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 177 RCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
                I+H D+K  NI+L+   + L  K+ D G AK      +                 
Sbjct: 141 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-------------- 183
Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP 278
              +G+  Y  P  L     +   D +SFG +  E +TG   F P
Sbjct: 184 --FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 164
Query: 236 MIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P  L      ST  D++S G I  E+VT    F
Sbjct: 165 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 165
Query: 236 MIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 166 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+G G F  V L +  +  T    A+K+     V      +   +E+ +L  L H NI 
Sbjct: 32  RVLGKGSFGEVILCK--DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIX 89
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL  + +D+    L+ E    G L +++    R S++   +   I  Q+   I Y H+  
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAARIIRQVLSGITYXHKN- 145
Query: 179 TLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
              IVH D+K  N+LLE   +  N ++ DFG +    +S                 K   
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----------------KXKD 187
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            IG+  Y  P  L  G    K DV+S GVIL  L++G   F   N
Sbjct: 188 KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 59  QNFSQV--IGSGGFSNVYLARLINDSTSTNGA---IKIHVGSDRLSQVFKQELDILLHLS 113
           +NF +V  IG G +  VY AR  N  T    A   I++   ++ +     +E+ +L  L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKAR--NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN 60
Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
            H      ++H D+K  N+L+      KL DFG A+  F   V              T +
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHE 163
Query: 234 VMMIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           V+ +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 164 VVTL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 59  QNFSQV--IGSGGFSNVYLARLINDSTSTNGA---IKIHVGSDRLSQVFKQELDILLHLS 113
           +NF +V  IG G +  VY AR  N  T    A   I++   ++ +     +E+ +L  L+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKAR--NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN 59
Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
            H      ++H D+K  N+L+      KL DFG A+  F   V              T +
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHE 162
Query: 234 VMMIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           V+ +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 163 VVTL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 72/250 (28%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 115 D-NIVKLIGYCDDRDEGVLLF-EYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      +++  E+   G L   L  + R+  +P++              
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+         
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--------- 187
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYS 261
                                  Y DP Y+R G A                 + ++DV+S
Sbjct: 188 ---------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 226
Query: 262 FGVILLELVT 271
           FGV+L E+ +
Sbjct: 227 FGVLLWEIFS 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 99/250 (39%), Gaps = 72/250 (28%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 32  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWRNR------------ 160
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKEAPEDLYKDFLTLE 150
Query: 161 --MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
             +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+         
Sbjct: 151 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--------- 198
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYS 261
                                  Y DP Y+R G A                 + ++DV+S
Sbjct: 199 ---------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 237
Query: 262 FGVILLELVT 271
           FGV+L E+ +
Sbjct: 238 FGVLLWEIFS 247

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 72/250 (28%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 67  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 126
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 185
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+         
Sbjct: 186 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--------- 233
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYS 261
                                  Y DP Y+R G A                 + ++DV+S
Sbjct: 234 ---------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 272
Query: 262 FGVILLELVT 271
           FGV+L E+ +
Sbjct: 273 FGVLLWEIFS 282

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 65  IGSGGFSNVYLA--RLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           I  GG   +YLA  R +N        + +H G      +   E   L  + H +IV++  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 123 YCDDRDE-----GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           + +  D      G ++ EYV   +L+       +  KLP    +A   ++  A+ YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRS-----KGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
            ++ +V+ D+K  NI+L E    KL D G+                      I     + 
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-------------------RINSFGYLY 238
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
           G+PG+  P  +RTG  +  TD+Y+ G  L  L
Sbjct: 239 GTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 72/250 (28%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 115 D-NIVKLIGYCDDRDEGVLLF-EYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      +++  E+   G L   L  + R+  +P++              
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+         
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--------- 187
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYS 261
                                  Y DP Y+R G A                 + ++DV+S
Sbjct: 188 ---------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 226
Query: 262 FGVILLELVT 271
           FGV+L E+ +
Sbjct: 227 FGVLLWEIFS 236

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 198
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 199 -DIHHIDXXKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 72/250 (28%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+         
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--------- 196
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYS 261
                                  Y DP Y+R G A                 + ++DV+S
Sbjct: 197 ---------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 262 FGVILLELVT 271
           FGV+L E+ +
Sbjct: 236 FGVLLWEIFS 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 68/246 (27%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
           N  + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWRNR----------MA 162
             N+V L+G C      ++ + E+   G L   L  + R+  +P+++           + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
            +FQ+A+ +E+L  R     +H D+ A NILL E    K+ DFG A+             
Sbjct: 149 YSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLAR------------- 192
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYSFGVI 265
                              Y DP Y+R G A                 + ++DV+SFGV+
Sbjct: 193 -----------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 235
Query: 266 LLELVT 271
           L E+ +
Sbjct: 236 LWEIFS 241

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 56/271 (20%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLI 121
           + IG G +S     R ++ +T+   A+K+    D+  +   +E++ILL    H NI+ L 
Sbjct: 33  ETIGVGSYSEC--KRCVHKATNMEYAVKV---IDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              DD     L+ E +  G L +K+    R      R    +   + + +EYLH +    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVEYLHSQG--- 141
Query: 182 IVHGDIKASNIL-LEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
           +VH D+K SNIL ++E  N    ++CDFG AK                    +  +  ++
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-------------------LRAENGLL 182
Query: 238 GSPGYT----DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC------PENGQLLT-- 285
            +P YT     P  L+        D++S G++L  ++ G   F       PE  ++LT  
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRI 240
Query: 286 -----SLAGSMLNDIADCEATKVNEL--VDP 309
                +L+G   N +++     V+++  VDP
Sbjct: 241 GSGKFTLSGGNWNTVSETAKDLVSKMLHVDP 271

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 103/232 (44%), Gaps = 43/232 (18%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD-NIVKLI 121
           +++G+G +  VY  R +   T    AIK+   +    +  KQE+++L   SH  NI    
Sbjct: 30  ELVGNGTYGQVYKGRHV--KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 122 GYCDDR------DEGVLLFEYVPNGTLQEKLHGTPRSS-KLPWRNRMAIAF---QLAQAI 171
           G    +      D+  L+ E+   G++ + +  T  ++ K  W     IA+   ++ + +
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGL 142
Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXI 230
            +LH+     ++H DIK  N+LL E+   KL DFG SA++  +                +
Sbjct: 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT----------------V 183
Query: 231 TKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFC 277
            ++   IG+P +  P  +            K+D++S G+  +E+  G    C
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 75/183 (40%), Gaps = 20/183 (10%)
Query: 99  SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKL-HGTPRSSKL 155
            Q+   E+++L  L H NIV+      DR    L  + EY   G L   +  GT     L
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 156 PWRNRMAIAFQLAQAIEYLHERCT--LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
                + +  QL  A++  H R      ++H D+K +N+ L+   N KL DFG A++   
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
                                  +G+P Y  P  +     + K+D++S G +L EL   M
Sbjct: 169 DTSFAKT---------------FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 274 EAF 276
             F
Sbjct: 214 PPF 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 56/271 (20%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLI 121
           + IG G +S     R ++ +T+   A+K+    D+  +   +E++ILL    H NI+ L 
Sbjct: 33  ETIGVGSYSEC--KRCVHKATNMEYAVKV---IDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              DD     L+ E +  G L +K+    R      R    +   + + +EYLH +    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVEYLHSQG--- 141
Query: 182 IVHGDIKASNIL-LEEHLN---CKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
           +VH D+K SNIL ++E  N    ++CDFG AK                    +  +  ++
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-------------------LRAENGLL 182
Query: 238 GSPGYT----DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC------PENGQLLT-- 285
            +P YT     P  L+        D++S G++L  ++ G   F       PE  ++LT  
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRI 240
Query: 286 -----SLAGSMLNDIADCEATKVNEL--VDP 309
                +L+G   N +++     V+++  VDP
Sbjct: 241 GSGKFTLSGGNWNTVSETAKDLVSKMLHVDP 271

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 198
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 199 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 198
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 199 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIV 118
           +VIG G F  V L R  + ST    A+K+    + +    S  F +E DI+   +   +V
Sbjct: 80  KVIGRGAFGEVQLVR--HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 119 KLI-GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           +L   + DDR    ++ EY+P G L   +       K  W       F  A+ +  L   
Sbjct: 138 QLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEK--W-----ARFYTAEVVLALDAI 189
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMM 236
            ++  +H D+K  N+LL++  + KL DFG+  KM     V               +    
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------------RCDTA 234
Query: 237 IGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAF 276
           +G+P Y  P  L++    G    + D +S GV L E++ G   F
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIV 118
           +VIG G F  V L R  + ST    A+K+    + +    S  F +E DI+   +   +V
Sbjct: 75  KVIGRGAFGEVQLVR--HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 119 KLI-GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           +L   + DDR    ++ EY+P G L   +       K  W       F  A+ +  L   
Sbjct: 133 QLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEK--W-----ARFYTAEVVLALDAI 184
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMM 236
            ++  +H D+K  N+LL++  + KL DFG+  KM     V               +    
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------------RCDTA 229
Query: 237 IGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAF 276
           +G+P Y  P  L++    G    + D +S GV L E++ G   F
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 145 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 191
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 192 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 273
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 332
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H ++ A N L+ E+   K+ DFG +++                    T 
Sbjct: 333 YLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 375
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 198
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 199 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 137 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 183
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 184 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 144 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 190
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 191 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 141 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 187
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 188 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 28/238 (11%)
Query: 44  RSVKKYSWDDVERFTQNFSQVI---GSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLS 99
           R +KK   D + +  +    V+   G G + +VY A  I+  T    AIK + V SD L 
Sbjct: 13  RQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKA--IHKETGQIVAIKQVPVESD-LQ 69
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           ++ K E+ I+      ++VK  G      +  ++ EY   G++ + +    R+  L    
Sbjct: 70  EIIK-EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDE 126
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
              I     + +EYLH    +  +H DIKA NILL    + KL DFG A           
Sbjct: 127 IATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ--------- 174
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
                     + K+  +IG+P +  P  ++    +   D++S G+  +E+  G   + 
Sbjct: 175 ------LTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE+V +  L+  +  +  +  +P     +  FQL Q + + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTG-IPLPLIKSYLFQLLQGLAFCH 119
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V              T +V+
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPV-----------RTYTHEVV 164
Query: 236 MIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +    Y  P   L     ST  D++S G I  E+VT    F
Sbjct: 165 TL---WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG A+      VL                +  
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLAR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL----SQVFKQELDILLHLSHDNIV 118
           +VIG G F  V L R  + ST    A+K+    + +    S  F +E DI+   +   +V
Sbjct: 80  KVIGRGAFGEVQLVR--HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 119 KLI-GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           +L   + DDR    ++ EY+P G L   +       K  W       F  A+ +  L   
Sbjct: 138 QLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPEK--W-----ARFYTAEVVLALDAI 189
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMM 236
            ++  +H D+K  N+LL++  + KL DFG+  KM     V               +    
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV---------------RCDTA 234
Query: 237 IGSPGYTDPHYLRT----GMASTKTDVYSFGVILLELVTGMEAF 276
           +G+P Y  P  L++    G    + D +S GV L E++ G   F
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE+V      +K       + +P     +  FQL Q + + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 177
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 178 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 207

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 37/232 (15%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
           N  + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWRNR------------ 160
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 161 -MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+      +   
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR-----DIXKD 201
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                     +  + M         P  +   + + ++DV+SFGV+L E+ +
Sbjct: 202 PDXVRKGDARLPLKWMA--------PETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNG-AIKIHVG--SDRLSQVFKQELDILLHLSHDNIVK 119
           +VIG+G F  V   RL       +  AIK   G  ++R  + F  E  I+    H NI++
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G   +    ++L E++ NG L   L       +      + +   +A  + YL E   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLN--DGQFTVIQLVGMLRGIASGMRYLAE--- 136
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
           +  VH D+ A NIL+  +L CK+ DFG ++       L            +  ++ +   
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRF------LEENSSDPTETSSLGGKIPI--- 187
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             +T P  +     ++ +D +S+G+++ E+++
Sbjct: 188 -RWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 20/183 (10%)
Query: 99  SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKL-HGTPRSSKL 155
            Q+   E+++L  L H NIV+      DR    L  + EY   G L   +  GT     L
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 156 PWRNRMAIAFQLAQAIEYLHERCT--LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
                + +  QL  A++  H R      ++H D+K +N+ L+   N KL DFG A++   
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--- 165
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
                             K+   +G+P Y  P  +     + K+D++S G +L EL   M
Sbjct: 166 ----------LNHDEDFAKE--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 274 EAF 276
             F
Sbjct: 214 PPF 216

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 71/314 (22%)
Query: 55  ERFTQNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH 111
           +RF  +F ++  IGSGGF  V+ A+  I+  T     +K +      ++  ++E+  L  
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAK 60
Query: 112 LSHDNIVKLIGYCD-------------DRDEGVLLF---EYVPNGTLQEKLHGTPRSSKL 155
           L H NIV   G  D              R +   LF   E+   GTL++ +    R  KL
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKL 119
Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
                + +  Q+ + ++Y+H +    +++ D+K SNI L +    K+ DFG         
Sbjct: 120 DKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFG--------- 167
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME- 274
                           K+    G+  Y  P  + +     + D+Y+ G+IL EL+   + 
Sbjct: 168 -------LVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
Query: 275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQS 334
           AF  E  +  T L   +++DI                   FD  E   +  +    L + 
Sbjct: 221 AF--ETSKFFTDLRDGIISDI-------------------FDKKEKTLLQKL----LSKK 255
Query: 335 PILRPSATQILHTI 348
           P  RP+ ++IL T+
Sbjct: 256 PEDRPNTSEILRTL 269

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 63/330 (19%)
Query: 51  WDDVERFTQN---FSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VF 102
           +D    F +N   F + +G+G F  V  A    LI    +   A+K+   S  L++    
Sbjct: 14  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73
Query: 103 KQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
             EL +L +L +H NIV L+G C      +++ EY   G L   L    R S +  +   
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSP 132
Query: 162 AI----------------AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           AI                ++Q+A+ + +L  +   + +H D+ A NILL      K+CDF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDF 189
Query: 206 GSAK--MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFG 263
           G A+     S+ V+                        +  P  +   + + ++DV+S+G
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVK---------------WMAPESIFNCVYTFESDVWSYG 234
Query: 264 VILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
           + L EL +   +  P  G  + S    M+ +           ++ P  A          M
Sbjct: 235 IFLWELFSLGSS--PYPGMPVDSKFYKMIKEGF--------RMLSPEHA-------PAEM 277
Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQIS 353
             I   C    P+ RP+  QI+  I+ QIS
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V LA  I  D    N   K+ V   +     K   D++  +       
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG----------TPR---SSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L             P      +L  ++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++ A+Q+A+ +EYL  ++C    +H D+ A N+L+ E    K+ DFG A+         
Sbjct: 193 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR--------- 239
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV+L E+ T
Sbjct: 240 -DIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 25/215 (11%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH--LSHDNIVKLIG 122
           +G GGF+  +     +      G I       +  Q  K  ++I +H  L+H ++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           + +D D   ++ E     +L E LH   R   L          Q+    +YLH      +
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
           +H D+K  N+ L E L  K+ DFG A K+ +                   ++ ++ G+P 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------------RKKVLCGTPN 204
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           Y  P  L     S + DV+S G I+  L+ G   F
Sbjct: 205 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 63/330 (19%)
Query: 51  WDDVERFTQN---FSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VF 102
           +D    F +N   F + +G+G F  V  A    LI    +   A+K+   S  L++    
Sbjct: 30  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 89
Query: 103 KQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
             EL +L +L +H NIV L+G C      +++ EY   G L   L    R S +  +   
Sbjct: 90  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSP 148
Query: 162 AI----------------AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           AI                ++Q+A+ + +L  +   + +H D+ A NILL      K+CDF
Sbjct: 149 AIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDF 205
Query: 206 GSAK--MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFG 263
           G A+     S+ V+                        +  P  +   + + ++DV+S+G
Sbjct: 206 GLARDIKNDSNYVVKGNARLPVK---------------WMAPESIFNCVYTFESDVWSYG 250
Query: 264 VILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
           + L EL +   +  P  G  + S    M+ +           ++ P  A          M
Sbjct: 251 IFLWELFSLGSS--PYPGMPVDSKFYKMIKEGF--------RMLSPEHA-------PAEM 293
Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQIS 353
             I   C    P+ RP+  QI+  I+ QIS
Sbjct: 294 YDIMKTCWDADPLKRPTFKQIVQLIEKQIS 323

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 22/201 (10%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L     + ++P      +
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKV 119
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 120 SIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 172
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                        +G+  Y  P  L+    S ++D++S G+ L+EL  G     P + + 
Sbjct: 173 ------------FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKE 220
Query: 284 LTSLAGSMLNDIADCEATKVN 304
           L ++ G  + D  + E   ++
Sbjct: 221 LEAIFGRPVVDGEEGEPHSIS 241

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 37/227 (16%)
Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELD 107
           DD E+   +  + IG G F  VY AR + +S     AIK    S + S    Q   +E+ 
Sbjct: 50  DDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVV--AIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            L  L H N ++  G         L+ EY + + +   ++H  P    L      A+   
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHG 162
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
             Q + YLH     +++H D+KA NILL E    KL DFGSA +                
Sbjct: 163 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------- 203
Query: 227 XXXITKQVMMIGSPGYTDPHY---LRTGMASTKTDVYSFGVILLELV 270
              +      +G+P +  P     +  G    K DV+S G+  +EL 
Sbjct: 204 ---MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNG-AIKIHVG--SDRLSQVFKQELDILLHLSHDNIVK 119
           +VIG+G F  V   RL       +  AIK   G  ++R  + F  E  I+    H NI++
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G   +    ++L E++ NG L   L       +      + +   +A  + YL E   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLN--DGQFTVIQLVGMLRGIASGMRYLAE--- 134
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
           +  VH D+ A NIL+  +L CK+ DFG ++       L            +  ++ +   
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRF------LEENSSDPTYTSSLGGKIPI--- 185
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             +T P  +     ++ +D +S+G+++ E+++
Sbjct: 186 -RWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 25/215 (11%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH--LSHDNIVKLIG 122
           +G GGF+  +     +      G I       +  Q  K  ++I +H  L+H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
           + +D D   ++ E     +L E LH   R   L          Q+    +YLH      +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
           +H D+K  N+ L E L  K+ DFG A K+ +                   ++ ++ G+P 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------------RKKVLCGTPN 206
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           Y  P  L     S + DV+S G I+  L+ G   F
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QVFKQELDILLH--LSHDNIVKL 120
           +G GGF+  +   + +  T    A KI   S  L   Q  K  ++I +H  L+H ++V  
Sbjct: 23  LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G+ +D D   ++ E     +L E LH   R   L          Q+    +YLH     
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
            ++H D+K  N+ L E L  K+ DFG A K+ +                   ++ ++ G+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------------RKKVLCGT 178
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           P Y  P  L     S + DV+S G I+  L+ G   F
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 63/330 (19%)
Query: 51  WDDVERFTQN---FSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VF 102
           +D    F +N   F + +G+G F  V  A    LI    +   A+K+   S  L++    
Sbjct: 37  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 96
Query: 103 KQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
             EL +L +L +H NIV L+G C      +++ EY   G L   L    R S +  +   
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSP 155
Query: 162 AI----------------AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           AI                ++Q+A+ + +L  +   + +H D+ A NILL      K+CDF
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDF 212
Query: 206 GSAK--MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFG 263
           G A+     S+ V+                        +  P  +   + + ++DV+S+G
Sbjct: 213 GLARDIKNDSNYVVKGNARLPVK---------------WMAPESIFNCVYTFESDVWSYG 257
Query: 264 VILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
           + L EL +   +  P  G  + S    M+ +           ++ P  A          M
Sbjct: 258 IFLWELFSLGSS--PYPGMPVDSKFYKMIKEGF--------RMLSPEHA-------PAEM 300
Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQIS 353
             I   C    P+ RP+  QI+  I+ QIS
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIVQLIEKQIS 330

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 63/330 (19%)
Query: 51  WDDVERFTQN---FSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VF 102
           +D    F +N   F + +G+G F  V  A    LI    +   A+K+   S  L++    
Sbjct: 37  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 96
Query: 103 KQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
             EL +L +L +H NIV L+G C      +++ EY   G L   L    R S +  +   
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSP 155
Query: 162 AI----------------AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           AI                ++Q+A+ + +L  +   + +H D+ A NILL      K+CDF
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDF 212
Query: 206 GSAK--MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFG 263
           G A+     S+ V+                        +  P  +   + + ++DV+S+G
Sbjct: 213 GLARHIKNDSNYVVKGNARLPVK---------------WMAPESIFNCVYTFESDVWSYG 257
Query: 264 VILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
           + L EL +   +  P  G  + S    M+ +           ++ P  A          M
Sbjct: 258 IFLWELFSLGSS--PYPGMPVDSKFYKMIKEGF--------RMLSPEHA-------PAEM 300
Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQIS 353
             I   C    P+ RP+  QI+  I+ QIS
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIVQLIEKQIS 330

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 174
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 175 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 173
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 174 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 203

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 63/330 (19%)
Query: 51  WDDVERFTQN---FSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VF 102
           +D    F +N   F + +G+G F  V  A    LI    +   A+K+   S  L++    
Sbjct: 32  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 91
Query: 103 KQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
             EL +L +L +H NIV L+G C      +++ EY   G L   L    R S +  +   
Sbjct: 92  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSP 150
Query: 162 AI----------------AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           AI                ++Q+A+ + +L  +   + +H D+ A NILL      K+CDF
Sbjct: 151 AIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDF 207
Query: 206 GSAK--MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFG 263
           G A+     S+ V+                        +  P  +   + + ++DV+S+G
Sbjct: 208 GLARDIKNDSNYVVKGNARLPVK---------------WMAPESIFNCVYTFESDVWSYG 252
Query: 264 VILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
           + L EL +   +  P  G  + S    M+ +           ++ P  A          M
Sbjct: 253 IFLWELFSLGSS--PYPGMPVDSKFYKMIKEGF--------RMLSPEHA-------PAEM 295
Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQIS 353
             I   C    P+ RP+  QI+  I+ QIS
Sbjct: 296 YDIMKTCWDADPLKRPTFKQIVQLIEKQIS 325

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           ++ER        +G G +  VY    +    S   A+K         + F +E  ++  +
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 312
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q++ A+E
Sbjct: 313 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 371
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL ++   + +H ++ A N L+ E+   K+ DFG +++                    T 
Sbjct: 372 YLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL--------------MTGDTYTA 414
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                    +T P  L     S K+DV++FGV+L E+ T GM  +
Sbjct: 415 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 174
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 175 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 174
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 175 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 173
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 174 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 203

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 36  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 95
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 153
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 154 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 203
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 204 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 166 ---MGFVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 18  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 67
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 181 --------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 273 MEAF 276
              F
Sbjct: 227 RTLF 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 18  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 67
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 181 --------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 273 MEAF 276
              F
Sbjct: 227 RTLF 230

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 177
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 178 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 207

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 176
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 177 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+   +  V                  +
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYXHEVVTLWYRAPEI 177
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 178 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 175
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 176 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 205

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 18  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 67
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 181 --------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 273 MEAF 276
              F
Sbjct: 227 RTLF 230

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+   +  V                  +
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYXHEVVTLWYRAPEI 178
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 179 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 208

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 176
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 177 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 206

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 37/226 (16%)
Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELD 107
           DD E+   +  + IG G F  VY AR + +S     AIK    S + S    Q   +E+ 
Sbjct: 11  DDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVV--AIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            L  L H N ++  G         L+ EY + + +   ++H  P    L      A+   
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHG 123
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
             Q + YLH     +++H D+KA NILL E    KL DFGSA +                
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------- 164
Query: 227 XXXITKQVMMIGSPGYTDPHY---LRTGMASTKTDVYSFGVILLEL 269
              +      +G+P +  P     +  G    K DV+S G+  +EL
Sbjct: 165 ---MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 174
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 175 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 175
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 176 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 27  TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N L+ +    K+ DF     G S  VL              ++   +GS
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDF-----GLSRYVLD------------DEETSSVGS 181
Query: 240 P---GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 123 SH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 176
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 177 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 206

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QVFKQELDILLH--LSHDNIVKL 120
           +G GGF+  +   + +  T    A KI   S  L   Q  K  ++I +H  L+H ++V  
Sbjct: 25  LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G+ +D D   ++ E     +L E LH   R   L          Q+    +YLH     
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN--- 136
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
            ++H D+K  N+ L E L  K+ DFG A K+ +                   ++  + G+
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------------RKKTLCGT 180
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           P Y  P  L     S + DV+S G I+  L+ G   F
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSMDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+   +  V                  +
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLAR---AFGVPVRTYXHEVVTLWYRAPEI 175
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 176 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 205

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QVFKQELDILLH--LSHDNIVKL 120
           +G GGF+  +   + +  T    A KI   S  L   Q  K  ++I +H  L+H ++V  
Sbjct: 25  LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G+ +D D   ++ E     +L E LH   R   L          Q+    +YLH     
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN--- 136
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
            ++H D+K  N+ L E L  K+ DFG A K+ +                   ++  + G+
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------------RKKTLCGT 180
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           P Y  P  L     S + DV+S G I+  L+ G   F
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+   +  V                  +
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYXHEVVTLWYRAPEI 175
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 176 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 205

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++      +K       + +P     +  FQL Q + + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 124 SH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 177
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 178 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 207

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--QVFKQELDILLH--LSHDNIVKL 120
           +G GGF+  +   + +  T    A KI   S  L   Q  K  ++I +H  L+H ++V  
Sbjct: 29  LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G+ +D D   ++ E     +L E LH   R   L          Q+    +YLH     
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE-LHK--RRKALTEPEARYYLRQIVLGCQYLHRN--- 140
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
            ++H D+K  N+ L E L  K+ DFG A K+ +                   ++  + G+
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------------RKKTLCGT 184
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           P Y  P  L     S + DV+S G I+  L+ G   F
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 137 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 186
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 187 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++ +  L++ +  +  +  +P     +  FQL Q + + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAFCH 120
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+   +  V                  +
Sbjct: 121 SH---RVLHRDLKPENLLINTEGAIKLADFGLAR---AFGVPVRTYXHEVVTLWYRAPEI 174
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 175 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 204

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D   +  NF + IG G    V +A  +  S       K+ +   +  ++   E+ I+   
Sbjct: 26  DPRSYLDNFIK-IGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 83
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+N+V++       DE  ++ E++  G L + +  T    ++      A+   + QA+ 
Sbjct: 84  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALS 139
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
            LH +    ++H DIK+ +ILL      KL DF     GF + V             + +
Sbjct: 140 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDF-----GFCAQV----------SKEVPR 181
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +  ++G+P +  P  +       + D++S G++++E+V G   +
Sbjct: 182 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 107/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 7   QELAKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 56
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   + +
Sbjct: 57  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCA 116
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 170 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 273 MEAF 276
              F
Sbjct: 216 RTLF 219

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++ +  L++ +  +  +  +P     +  FQL Q + + H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAFCH 123
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 177
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 178 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 207

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 7   QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 56
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 57  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 170 --------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 273 MEAF 276
              F
Sbjct: 216 RTLF 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 7   TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N L+ +    K+ DFG ++                     T  V     
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--------------TSSVGSKFP 164
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 78/334 (23%), Positives = 132/334 (39%), Gaps = 86/334 (25%)
Query: 48  KYSWDDVERFTQNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQ 104
           KY+ D  +RF  +F ++  IGSGGF  V+ A+  I+  T     +K +      ++  ++
Sbjct: 3   KYTVD--KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYN------NEKAER 54
Query: 105 ELDILLHLSHDNIVKLIGYCD--------------------------DRDEGVLLF---E 135
           E+  L  L H NIV   G  D                           R +   LF   E
Sbjct: 55  EVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQME 114
Query: 136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE 195
           +   GTL++ +    R  KL     + +  Q+ + ++Y+H +    ++H D+K SNI L 
Sbjct: 115 FCDKGTLEQWIE-KRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLV 170
Query: 196 EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMAST 255
           +    K+ DFG                         K+    G+  Y  P  + +     
Sbjct: 171 DTKQVKIGDFG----------------LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK 214
Query: 256 KTDVYSFGVILLELVTGME-AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGD 314
           + D+Y+ G+IL EL+   + AF  E  +  T L   +++DI                   
Sbjct: 215 EVDLYALGLILAELLHVCDTAF--ETSKFFTDLRDGIISDI------------------- 253
Query: 315 FDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
           FD  E   +  +    L + P  RP+ ++IL T+
Sbjct: 254 FDKKEKTLLQKL----LSKKPEDRPNTSEILRTL 283

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 11  TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 123
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N L+ +    K+ DFG ++                     T  V     
Sbjct: 124 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--------------TSSVGSKFP 168
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + +G G F  V LA   +  T    A+K      +    +    ++E+  L  L H +I+
Sbjct: 15  ETLGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL        + V++ EY   G L + +    R ++   R       Q+  AIEY H   
Sbjct: 73  KLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ---QIICAIEYCHRH- 127
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              IVH D+K  N+LL+++LN K+ DFG + +      L                    G
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----------------CG 169
Query: 239 SPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCPE 279
           SP Y  P  +   + A  + DV+S G++L  ++ G   F  E
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 12  TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N L+ +    K+ DFG      S  VL              +       
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFG-----LSRYVLDDEYTSSRGSKFPVR------- 171
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 172 --WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 27  TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N L+ +    K+ DF     G S  VL              +       
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDF-----GLSRYVLDDEYTSSVGSKFPVR------- 186
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 187 --WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/227 (22%), Positives = 99/227 (43%), Gaps = 24/227 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D   +  NF + IG G    V +A  +  S       K+ +   +  ++   E+ I+   
Sbjct: 28  DPRSYLDNFIK-IGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 85
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+N+V++       DE  ++ E++  G L + +  T    ++      A+   + QA+ 
Sbjct: 86  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALS 141
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
            LH +    ++H DIK+ +ILL      KL DF     GF + V             + +
Sbjct: 142 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDF-----GFCAQV----------SKEVPR 183
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
           +  ++G+P +  P  +       + D++S G++++E+V G   +  E
Sbjct: 184 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 230

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NIVKL+      ++  L+FE++ +  L++ +  +  +  +P     +  FQL Q + + H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAFCH 122
Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
                 ++H D+K  N+L+      KL DFG A+  F   V               +  +
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE--I 176
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           ++G   Y           ST  D++S G I  E+VT    F
Sbjct: 177 LLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 206

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 7   QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 56
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 57  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 170 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 273 MEAF 276
              F
Sbjct: 216 RTLF 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 22  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 71
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 184
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 185 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230
Query: 273 MEAF 276
              F
Sbjct: 231 RTLF 234

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/227 (22%), Positives = 99/227 (43%), Gaps = 24/227 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D   +  NF + IG G    V +A  +  S       K+ +   +  ++   E+ I+   
Sbjct: 21  DPRSYLDNFIK-IGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 78
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+N+V++       DE  ++ E++  G L + +  T    ++      A+   + QA+ 
Sbjct: 79  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALS 134
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
            LH +    ++H DIK+ +ILL      KL DF     GF + V             + +
Sbjct: 135 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDF-----GFCAQV----------SKEVPR 176
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
           +  ++G+P +  P  +       + D++S G++++E+V G   +  E
Sbjct: 177 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 8   QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 57
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 58  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 170
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 171 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216
Query: 273 MEAF 276
              F
Sbjct: 217 RTLF 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG  +      VL                +  
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLGR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D   +  NF + IG G    V +A  +  S       K+ +   +  ++   E+ I+   
Sbjct: 148 DPRSYLDNFIK-IGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+N+V++       DE  ++ E++  G L + +  T    ++      A+   + QA+ 
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALS 261
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
            LH +    ++H DIK+ +ILL      KL DF     GF + V             + +
Sbjct: 262 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDF-----GFCAQV----------SKEVPR 303
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +  ++G+P +  P  +       + D++S G++++E+V G   +
Sbjct: 304 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 30  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 79
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 193 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 273 MEAF 276
              F
Sbjct: 239 RTLF 242

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 23  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 72
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 186 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 273 MEAF 276
              F
Sbjct: 232 RTLF 235

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 8   QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 57
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 58  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 170
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 171 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216
Query: 273 MEAF 276
              F
Sbjct: 217 RTLF 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 31  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 80
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 194 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 273 MEAF 276
              F
Sbjct: 240 RTLF 243

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 46  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 105
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG+L   L      ++      + +   +A  ++YL +
Sbjct: 106 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 163
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 164 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 213
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 214 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 23  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 72
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 186 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 273 MEAF 276
              F
Sbjct: 232 RTLF 235

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/227 (22%), Positives = 99/227 (43%), Gaps = 24/227 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D   +  NF + IG G    V +A  +  S       K+ +   +  ++   E+ I+   
Sbjct: 17  DPRSYLDNFIK-IGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 74
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+N+V++       DE  ++ E++  G L + +  T    ++      A+   + QA+ 
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALS 130
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
            LH +    ++H DIK+ +ILL      KL DF     GF + V             + +
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDF-----GFCAQV----------SKEVPR 172
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
           +  ++G+P +  P  +       + D++S G++++E+V G   +  E
Sbjct: 173 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 9   QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 58
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 59  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 118
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 119 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 171
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 172 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217
Query: 273 MEAF 276
              F
Sbjct: 218 RTLF 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 94/236 (39%), Gaps = 49/236 (20%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDILLHLSHDNIVKL 120
           IG G FS V   R +   T    A KI + + +LS    Q  ++E  I   L H NIV+L
Sbjct: 12  IGKGAFSVV--RRCVKLCTGHEYAAKI-INTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                +     L+F+ V  G L E +      S+    + +    Q+ +A+ + H+   +
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ---QILEAVLHCHQ---M 122
Query: 181 HIVHGDIKASNILLEEHLN---CKLCDFG---------SAKMGFSSAVLXXXXXXXXXXX 228
            +VH D+K  N+LL         KL DFG          A  GF+               
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--------------- 167
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                    G+PGY  P  LR        D+++ GVIL  L+ G   F  E+   L
Sbjct: 168 ---------GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKL 214

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 124/265 (46%), Gaps = 34/265 (12%)
Query: 94  GSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
           G+D++  + K+E+ IL    H NI+ L    +  +E V++FE++    + E+++ +  + 
Sbjct: 42  GTDQV--LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--AF 97
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMG 211
           +L  R  ++   Q+ +A+++LH     +I H DI+  NI+ +   +   K+ +FG A+  
Sbjct: 98  ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
Query: 212 FSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                                  ++  +P Y  P   +  + ST TD++S G ++  L++
Sbjct: 155 KPGDNFR----------------LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 272 GMEAFCPE-NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
           G+  F  E N Q++ ++  +      D EA K   +          + E ++ ++ +   
Sbjct: 199 GINPFLAETNQQIIENIMNAEYT--FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256
Query: 331 LRQSPILRPS----ATQILHTIKHQ 351
             Q P L+      +T+++ T+KH+
Sbjct: 257 --QHPWLKQKIERVSTKVIRTLKHR 279

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 23  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSKPFQ 72
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 186 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 273 MEAF 276
              F
Sbjct: 232 RTLF 235

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 13  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 62
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 176 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 273 MEAF 276
              F
Sbjct: 222 RTLF 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 16  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 65
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 178
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 179 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 273 MEAF 276
              F
Sbjct: 225 RTLF 228

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 101/239 (42%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           VK   +D   R+TQ   Q IG G +  V        S++ +   K  V   ++S    Q 
Sbjct: 34  VKGQPFDVGPRYTQ--LQYIGEGAYGMV--------SSAYDHVRKTRVAIKKISPFEHQT 83
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+N++ +           +   Y+    ++  L+   +S +L  
Sbjct: 84  YCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSN 143
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+L+    + K+CDFG A++       
Sbjct: 144 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDH 200
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 201 TGFLTEXVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 248

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D   +  NF + IG G    V +A  +  S       K+ +   +  ++   E+ I+   
Sbjct: 71  DPRSYLDNFIK-IGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 128
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H+N+V++       DE  ++ E++  G L + +  T    ++      A+   + QA+ 
Sbjct: 129 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALS 184
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
            LH +    ++H DIK+ +ILL      KL DF     GF + V             + +
Sbjct: 185 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDF-----GFCAQV----------SKEVPR 226
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +  ++G+P +  P  +       + D++S G++++E+V G   +
Sbjct: 227 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 36/231 (15%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 32  KLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 91
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWRNR------------ 160
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+      +    
Sbjct: 151 IXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLAR-----DIXKDP 202
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  + M         P  +   + + ++DV+SFGV+L E+ +
Sbjct: 203 DXVRKGDARLPLKWMA--------PETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 16  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 65
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 179 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 273 MEAF 276
              F
Sbjct: 225 RTLF 228

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S  IGSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 16  QELNKTIWEVPERY-QNLSP-IGSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 65
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 179 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 273 MEAF 276
              F
Sbjct: 225 RTLF 228

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 13  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 62
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 176 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 273 MEAF 276
              F
Sbjct: 222 RTLF 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 7   QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 56
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 57  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 170 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 273 MEAF 276
              F
Sbjct: 216 RTLF 219

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 12  TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N L+ +    K+ DFG ++                     T  V     
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--------------TSSVGSKFP 169
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 13  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 62
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 176 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 273 MEAF 276
              F
Sbjct: 222 RTLF 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 16  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 65
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 178
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 179 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 273 MEAF 276
              F
Sbjct: 225 RTLF 228

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 18  TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 130
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N L+ +    K+ DF     G S  VL             T  V     
Sbjct: 131 -QFLHRDLAARNCLVNDQGVVKVSDF-----GLSRYVL---------DDEYTSSVGSKFP 175
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 10  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 59
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 60  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 119
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 120 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 172
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 173 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218
Query: 273 MEAF 276
              F
Sbjct: 219 RTLF 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 18  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 67
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 181 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 273 MEAF 276
              F
Sbjct: 227 RTLF 230

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 127/319 (39%), Gaps = 56/319 (17%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRL--SQVFKQELD 107
           +  R    F + +G+G F  V  A    L  +      A+K+   +      +    EL 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 108 ILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPR-----------SSKL 155
           I+ HL  H+NIV L+G C      +++ EY   G L   L    R           +S L
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--MGFS 213
             R+ +  + Q+AQ + +L  +   + +H D+ A N+LL      K+ DFG A+  M  S
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-G 272
           + ++                        +  P  +   + + ++DV+S+G++L E+ + G
Sbjct: 219 NYIVKGNARLPVK---------------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263
Query: 273 MEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR 332
           +    P  G L+ S    ++ D          ++  P  A        + + SI   C  
Sbjct: 264 LN---PYPGILVNSKFYKLVKD--------GYQMAQPAFA-------PKNIYSIMQACWA 305
Query: 333 QSPILRPSATQILHTIKHQ 351
             P  RP+  QI   ++ Q
Sbjct: 306 LEPTHRPTFQQICSFLQEQ 324

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 34  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 83
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 84  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 196
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 197 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242
Query: 273 MEAF 276
              F
Sbjct: 243 RTLF 246

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 17  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 66
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 180 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 273 MEAF 276
              F
Sbjct: 226 RTLF 229

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 22  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 71
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 184
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 185 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230
Query: 273 MEAF 276
              F
Sbjct: 231 RTLF 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI-HVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           IG G    V LAR     +    A+K+  +   +  ++   E+ I+    H N+V++   
Sbjct: 53  IGEGSTGIVCLAR--EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
               +E  +L E++  G L + +       +L       +   + QA+ YLH +    ++
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVI 163
Query: 184 HGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYT 243
           H DIK+ +ILL      KL DFG     F + +             + K+  ++G+P + 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFG-----FCAQI----------SKDVPKRKXLVGTPYWM 208
Query: 244 DPHYLRTGMASTKTDVYSFGVILLELVTG 272
            P  +   + +T+ D++S G++++E+V G
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 38/233 (16%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+  +      
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXV 205
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                                  +  P  +   + + ++DV+SFGV+L E+ +
Sbjct: 206 RKGDARLPLK-------------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 59  QNFSQV--IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD 115
           +NF +V  IG G +  VY AR  +         I++   ++ +     +E+ +L  L+H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL---PWRNRMAIAFQLAQAIE 172
           NIVKL+      ++  L+FE+     L + L     +S L   P     +  FQL Q + 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           + H      ++H D+K  N+L+      KL DFG A+   +  V                
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYXHEVVTLWYRA 174
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             +++G   Y           ST  D++S G I  E+VT    F
Sbjct: 175 PEILLGCKYY-----------STAVDIWSLGCIFAEMVTRRALF 207

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 30  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 79
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 193 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 273 MEAF 276
              F
Sbjct: 239 RTLF 242

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 31  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 80
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 194 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 273 MEAF 276
              F
Sbjct: 240 RTLF 243

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +GSG +  V L +  +  T    AIKI     V +   S     E+ +L  L H NI+KL
Sbjct: 29  LGSGAYGEVLLCK--DKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             + +D+    L+ E    G L +++    + S++   +   I  Q+     YLH+    
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV---DAAVIMKQVLSGTTYLHKH--- 140
Query: 181 HIVHGDIKASNILLEEHLN---CKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
           +IVH D+K  N+LLE        K+ DFG SA                       K    
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG-----------------KMKER 183
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
           +G+  Y  P  LR      K DV+S GVIL  L+ G   F  +  Q
Sbjct: 184 LGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPPFGGQTDQ 228

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 171
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 172 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 224
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + 
Sbjct: 225 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 272
Query: 284 LTSLAG 289
           L  + G
Sbjct: 273 LELMFG 278

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 136
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 137 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 189
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + 
Sbjct: 190 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
Query: 284 LTSLAG 289
           L  + G
Sbjct: 238 LELMFG 243

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 39/233 (16%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-----GTPRS--------SKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L      G   S         ++ +++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 160 RMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
            ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+         
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR--------- 205
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                       T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 -DINNIDXXKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 31  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 80
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 194 --------------HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 273 MEAF 276
              F
Sbjct: 240 RTLF 243

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 17  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 66
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 180 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 273 MEAF 276
              F
Sbjct: 226 RTLF 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 34  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 83
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 84  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH--- 197
Query: 214 SAVLXXXXXXXXXXXXITKQVMM--IGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELV 270
                            T   M   + +  Y  P  +   M   +T D++S G I+ EL+
Sbjct: 198 -----------------TDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 271 TGMEAF 276
           TG   F
Sbjct: 241 TGRTLF 246

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 109
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + 
Sbjct: 163 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 284 LTSLAG 289
           L  + G
Sbjct: 211 LELMFG 216

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 109
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + 
Sbjct: 163 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 284 LTSLAG 289
           L  + G
Sbjct: 211 LELMFG 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 17  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 66
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 180 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 273 MEAF 276
              F
Sbjct: 226 RTLF 229

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 109
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + 
Sbjct: 163 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 284 LTSLAG 289
           L  + G
Sbjct: 211 LELMFG 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      IG+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    K+ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDXXKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 95/244 (38%), Gaps = 45/244 (18%)
Query: 56  RFTQNFS--QVIGSGGFSNVY-LARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           RFT+ +   + +G G FS V    +++         I     S R  Q  ++E  I   L
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H NIV+L     +     L+F+ V  G L E +      S+    +      Q+ +A+ 
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA---DASHCIQQILEAVL 124
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFG---------SAKMGFSSAVLXXX 220
           + H+   + +VH ++K  N+LL   L     KL DFG          A  GF+       
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA------- 174
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                            G+PGY  P  LR        D+++ GVIL  L+ G   F  E+
Sbjct: 175 -----------------GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217
Query: 281 GQLL 284
              L
Sbjct: 218 QHRL 221

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 22/186 (11%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 109
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + 
Sbjct: 163 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 284 LTSLAG 289
           L  + G
Sbjct: 211 LELMFG 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 24/235 (10%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SD 96
           G  GRS  +    ++E    +  ++IGSG    V   RL +        AIK +  G ++
Sbjct: 36  GRAGRSFTR----EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
           R  + F  E  I+    H NI++L G        +++ EY+ NG+L   L       +  
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFT 149
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
               + +   +   + YL +   L  VH D+ A N+L++ +L CK+ DFG ++      V
Sbjct: 150 IMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR------V 200
Query: 217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           L                +       +T P  +     S+ +DV+SFGV++ E++ 
Sbjct: 201 LEDDPDAAXTTTGGKIPIR------WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +S 
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG  +    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 13  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 62
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR---- 175
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 176 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 273 MEAF 276
              F
Sbjct: 222 RTLF 225

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SD 96
           G  GRS  +    ++E    +  ++IGSG    V   RL +        AIK +  G ++
Sbjct: 36  GRAGRSFTR----EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
           R  + F  E  I+    H NI++L G        +++ EY+ NG+L   L       +  
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFT 149
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
               + +   +   + YL +   L  VH D+ A N+L++ +L CK+ DFG ++      V
Sbjct: 150 IMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR------V 200
Query: 217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           L                +       +T P  +     S+ +DV+SFGV++ E++ 
Sbjct: 201 LEDDPDAAYTTTGGKIPIR------WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 26/215 (12%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           IG G +  VY A+     T     I++    + +     +E+ IL  L H NIVKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 125 DDRDEGVLLFEYVPN--GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
             +   VL+FE++      L +   G   S         +   QL   I Y H+R    +
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-----TAKSFLLQLLNGIAYCHDR---RV 121
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H D+K  N+L+      K+ DFG A+  F   V              T +V+ +    Y
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR-AFGIPV-----------RKYTHEVVTL---WY 166
Query: 243 TDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
             P  L  +   ST  D++S G I  E+V G   F
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 17  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 66
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR---- 179
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 180 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 273 MEAF 276
              F
Sbjct: 226 RTLF 229

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 26/215 (12%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           IG G +  VY A+     T     I++    + +     +E+ IL  L H NIVKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 125 DDRDEGVLLFEYVPN--GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
             +   VL+FE++      L +   G   S         +   QL   I Y H+R    +
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-----TAKSFLLQLLNGIAYCHDR---RV 121
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H D+K  N+L+      K+ DFG A+  F   V              T +V+ +    Y
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR-AFGIPV-----------RKYTHEVVTL---WY 166
Query: 243 TDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
             P  L  +   ST  D++S G I  E+V G   F
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLF 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 85/215 (39%), Gaps = 26/215 (12%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           IG G +  VY A+     T     I++    + +     +E+ IL  L H NIVKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 125 DDRDEGVLLFEYVPNG--TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
             +   VL+FE++      L +   G   S         +   QL   I Y H+R    +
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-----TAKSFLLQLLNGIAYCHDR---RV 121
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGY 242
           +H D+K  N+L+      K+ DFG A+  F   V               K    I +  Y
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR-AFGIPV--------------RKYTHEIVTLWY 166
Query: 243 TDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
             P  L  +   ST  D++S G I  E+V G   F
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 20/167 (11%)
Query: 53  DVERFTQNFSQV--IGSGGFSNVYLARLINDSTSTNGAIK-IHVG-----SDRLSQVFKQ 104
           DV+   + + ++  +G G F+ VY AR  + +T+   AIK I +G      D +++   +
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+ +L  LSH NI+ L+     +    L+F++     ++  L    + + L        A
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKA 116
Query: 165 FQLA--QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
           + L   Q +EYLH+     I+H D+K +N+LL+E+   KL DFG AK
Sbjct: 117 YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 103 KQELDILLHLSHDNIVKLIG--YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
           K+E+ +L  L H N+++L+   Y +++ +  ++ EY   G +QE L   P   + P    
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK-RFPVCQA 111
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
                QL   +EYLH +    IVH DIK  N+LL      K+   G A+     A     
Sbjct: 112 HGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA---- 164
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGM---ASTKTDVYSFGVILLELVTGMEAFC 277
                     T Q    GSP +  P  +  G+   +  K D++S GV L  + TG+  F 
Sbjct: 165 -----DDTCRTSQ----GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
Query: 278 PEN 280
            +N
Sbjct: 215 GDN 217

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+      +  
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR-----DIXK 200
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      +  + M         P  +   + + ++DV+SFGV+L E+ +
Sbjct: 201 DPDXVRKGDARLPLKWMA--------PETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDYYKNTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 94/236 (39%), Gaps = 49/236 (20%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDILLHLSHDNIVKL 120
           +G G FS V   R +        A KI + + +LS    Q  ++E  I   L H NIV+L
Sbjct: 30  LGKGAFSVV--RRCVKVLAGQEYAAKI-INTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                +     L+F+ V  G L E +      S+    + +    Q+ +A+ + H+   +
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---QILEAVLHCHQ---M 140
Query: 181 HIVHGDIKASNILLEEHLN---CKLCDFG---------SAKMGFSSAVLXXXXXXXXXXX 228
            +VH D+K  N+LL   L     KL DFG          A  GF+               
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--------------- 185
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                    G+PGY  P  LR        D+++ GVIL  L+ G   F  E+   L
Sbjct: 186 ---------GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 232

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 115 D-NIVKLIGYCDDRDEGVLLF-EYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      +++  E+   G L   L  + R+  +P++              
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+      +  
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR-----DIXK 191
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      +  + M         P  +   + + ++DV+SFGV+L E+ +
Sbjct: 192 DPDXVRKGDARLPLKWMA--------PETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 39/259 (15%)
Query: 61  FSQVIGSGGFSNVY--LARLINDST---STNGAIKIHVGSDR-LSQVFKQELDILLHLSH 114
           F++ +G G F+ ++  + R + D      T   +K+   + R  S+ F +   ++  LSH
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            ++V   G C   DE +L+ E+V  G+L   L        + W  ++ +A QLA A+ +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL 129
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM---GFSSAVLXXXXXXXXXXXXIT 231
            E     ++HG++ A NILL    + K  +    K+   G S  VL            + 
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--------PKDILQ 178
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA------------FCPE 279
           +++  +      +P  L        TD +SFG  L E+ +G +             F  +
Sbjct: 179 ERIPWVPPECIENPKNLNLA-----TDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
Query: 280 NGQLLTSLAGSMLNDIADC 298
             QL    A  + N I +C
Sbjct: 234 RHQLPAPKAAELANLINNC 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 39/259 (15%)
Query: 61  FSQVIGSGGFSNVY--LARLINDST---STNGAIKIHVGSDR-LSQVFKQELDILLHLSH 114
           F++ +G G F+ ++  + R + D      T   +K+   + R  S+ F +   ++  LSH
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            ++V   G C   DE +L+ E+V  G+L   L        + W  ++ +A QLA A+ +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM---GFSSAVLXXXXXXXXXXXXIT 231
            E     ++HG++ A NILL    + K  +    K+   G S  VL            + 
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--------PKDILQ 178
Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA------------FCPE 279
           +++  +      +P  L        TD +SFG  L E+ +G +             F  +
Sbjct: 179 ERIPWVPPECIENPKNLNLA-----TDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
Query: 280 NGQLLTSLAGSMLNDIADC 298
             QL    A  + N I +C
Sbjct: 234 RHQLPAPKAAELANLINNC 252

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 60  NFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHV----GSDRLSQVFKQELDILLHLSH 114
              + +G G F  V  A     D T+T   + + +     +    +    EL IL+H+ H
Sbjct: 21  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 80
Query: 115 D-NIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWR-------------- 158
             N+V L+G C      ++ + E+   G L   L  + R+  +P++              
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLX 218
           + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+      +  
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR-----DIXK 191
Query: 219 XXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      +  + M         P  +   + + ++DV+SFGV+L E+ +
Sbjct: 192 DPDXVRKGDARLPLKWMA--------PETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVG-------SDRLSQVFKQELDILLHL 112
             + +G G F  V +A  +  D      A+ + V         + LS +  +   + +  
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIG 98
Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +GSG +  V L +  +  T    AIKI     V +   S     E+ +L  L H NI+KL
Sbjct: 12  LGSGAYGEVLLCK--DKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             + +D+    L+ E    G L +++    + S++   +   I  Q+     YLH+    
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV---DAAVIMKQVLSGTTYLHKH--- 123
Query: 181 HIVHGDIKASNILLEEHLN---CKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
           +IVH D+K  N+LLE        K+ DFG SA                       K    
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG-----------------KMKER 166
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
           +G+  Y  P  LR      K DV+S GVIL  L+ G   F  +  Q
Sbjct: 167 LGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPPFGGQTDQ 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 39/226 (17%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +V   G F  V+ A+L+N+      A+KI    D+ S   + E+  L  + H+NI++ IG
Sbjct: 30  EVKARGRFGCVWKAQLLNEYV----AVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 123 YCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             + R   V     L+  +   G+L + L    +++ + W     IA  +A+ + YLHE 
Sbjct: 86  -AEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHED 140
Query: 178 C-------TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXI 230
                      I H DIK+ N+LL+ +L   + DFG A + F +                
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA-LKFEAGKSAGDTHG------- 192
Query: 231 TKQVMMIGSPGYTDPHYLRTGM-----ASTKTDVYSFGVILLELVT 271
                 +G+  Y  P  L   +     A  + D+Y+ G++L EL +
Sbjct: 193 -----QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN + V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 21  QELNKTIWEVPERY-QNLAPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 70
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 71  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 130
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+    
Sbjct: 131 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 183
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 184 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229
Query: 273 MEAF 276
              F
Sbjct: 230 RTLF 233

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/319 (21%), Positives = 132/319 (41%), Gaps = 60/319 (18%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH D+ A N ++      K+ DFG  +  + +A                K
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG----------GK 191
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG----QLLT-SL 287
            ++ +    +  P  L+ G+ +T +D++SFGV+L E+ +  E   P  G    Q+L   +
Sbjct: 192 GLLPVR---WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQVLKFVM 246
Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
            G  L+   +C   +V +L+                     +C + +P +RP+  +I++ 
Sbjct: 247 DGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPKMRPTFLEIVNL 285
Query: 348 IKHQI----SSISFLFSPQ 362
           +K  +      +SF  S +
Sbjct: 286 LKDDLHPSFPEVSFFHSEE 304

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 106/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ D+G A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 21/187 (11%)
Query: 105 ELDILLHLSHD--NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           +LD++L  SHD   IV+  G      +  +  E +  GT  EKL    +   +P R    
Sbjct: 73  DLDVVLK-SHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGP-IPERILGK 128
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           +   + +A+ YL E+    ++H D+K SNILL+E    KLCDF     G S  ++     
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDF-----GISGRLVDDKAK 181
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF--CPEN 280
                         I  P  T P Y        + DV+S G+ L+EL TG   +  C  +
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDY------DIRADVWSLGISLVELATGQFPYKNCKTD 235
Query: 281 GQLLTSL 287
            ++LT +
Sbjct: 236 FEVLTKV 242

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 22/179 (12%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 109
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + +
Sbjct: 163 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 45/256 (17%)
Query: 40  GIDGRSVKKY----------SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTS 84
           G +  SVK++           W++  + T +  Q      IG+G F  V L + +   T 
Sbjct: 9   GXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHM--ETG 66
Query: 85  TNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG 140
            + A+KI       +L Q+     E  IL  ++   +VKL     D     ++ EY+P G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG 126
Query: 141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC 200
            +   L    R S+   R   A   Q+    EYLH   +L +++ D+K  N+L+++    
Sbjct: 127 DMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 201 KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVY 260
           K+ DFG AK                      +   + G+P Y  P  + +   +   D +
Sbjct: 181 KVADFGFAK------------------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 261 SFGVILLELVTGMEAF 276
           + GV++ E+  G   F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/315 (22%), Positives = 125/315 (39%), Gaps = 52/315 (16%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRL--SQVFKQELD 107
           +  R    F + +G+G F  V  A    L  +      A+K+   +      +    EL 
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 108 ILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS-------KLPWRN 159
           I+ HL  H+NIV L+G C      +++ EY   G L   L     +         L  R+
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--MGFSSAVL 217
            +  + Q+AQ + +L  +   + +H D+ A N+LL      K+ DFG A+  M  S+ ++
Sbjct: 154 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAF 276
                                   +  P  +   + + ++DV+S+G++L E+ + G+   
Sbjct: 211 KGNARLPVK---------------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN-- 253
Query: 277 CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPI 336
            P  G L+ S    ++ D          ++  P  A        + + SI   C    P 
Sbjct: 254 -PYPGILVNSKFYKLVKD--------GYQMAQPAFA-------PKNIYSIMQACWALEPT 297
Query: 337 LRPSATQILHTIKHQ 351
            RP+  QI   ++ Q
Sbjct: 298 HRPTFQQICSFLQEQ 312

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 27/241 (11%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSD 96
           G  G S + Y   +++R      + IG G F +V+    ++ ++ +   AIK   +  SD
Sbjct: 24  GAMGSSTRDY---EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD 80
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
            + + F QE   +    H +IVKLIG   +    +++ E    G L+  L    R   L 
Sbjct: 81  SVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKYSLD 137
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
             + +  A+QL+ A+ YL  +     VH DI A N+L+  +   KL DFG ++    S  
Sbjct: 138 LASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 194
Query: 217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEA 275
                         +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ 
Sbjct: 195 YKA-----------SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 240
Query: 276 F 276
           F
Sbjct: 241 F 241

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 27/241 (11%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSD 96
           G  G S + Y   +++R      + IG G F +V+    ++ ++ +   AIK   +  SD
Sbjct: 1   GAMGSSTRDY---EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD 57
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
            + + F QE   +    H +IVKLIG   +    +++ E    G L+  L    R   L 
Sbjct: 58  SVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLD 114
Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
             + +  A+QL+ A+ YL  +     VH DI A N+L+  +   KL DFG ++    S  
Sbjct: 115 LASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171
Query: 217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEA 275
                         +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ 
Sbjct: 172 YKA-----------SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
Query: 276 F 276
           F
Sbjct: 218 F 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 76/183 (41%), Gaps = 28/183 (15%)
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           I     +A+ +L E   L I+H DIK SNILL+   N KLCDFG +     S        
Sbjct: 130 ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG 187
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                           +P   DP   R G    ++DV+S G+ L EL TG   +      
Sbjct: 188 CRPYM-----------APERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPY------ 229
Query: 283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                     N + D + T+V +   P+L+   + + + + ++   LCL +    RP   
Sbjct: 230 -------PKWNSVFD-QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYK 281
Query: 343 QIL 345
           ++L
Sbjct: 282 ELL 284

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 58/305 (19%)
Query: 54  VERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIK---IHVGSDRLSQVFKQELDIL 109
           ++R      +++G G F +V    L   D TS   A+K   +   S R  + F  E   +
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 110 LHLSHDNIVKLIGYC-DDRDEGV----LLFEYVPNGTLQ-----EKLHGTPRSSKLPWRN 159
              SH N+++L+G C +   +G+    ++  ++  G L       +L   P+   +P + 
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK--HIPLQT 148
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            +     +A  +EYL  R   + +H D+ A N +L + +   + DFG +K  +S      
Sbjct: 149 LLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG----- 200
Query: 220 XXXXXXXXXXITKQ-VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFC 277
                     I K  V  I      D  Y      ++K+DV++FGV + E+ T GM  + 
Sbjct: 201 ---DYYRQGRIAKMPVKWIAIESLADRVY------TSKSDVWAFGVTMWEIATRGMTPYP 251
Query: 278 P-ENGQLLTSLA-GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
             +N ++   L  G  L    DC                  LDE   +  I   C R  P
Sbjct: 252 GVQNHEMYDYLLHGHRLKQPEDC------------------LDE---LYEIMYSCWRTDP 290
Query: 336 ILRPS 340
           + RP+
Sbjct: 291 LDRPT 295

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/324 (23%), Positives = 125/324 (38%), Gaps = 40/324 (12%)
Query: 40  GIDGRSVKKYSWDDVE--RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR 97
           G  GR    +    VE         +V+  GGF+ VY A+ +  S       ++    + 
Sbjct: 9   GASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLSNEEE 67
Query: 98  LSQVFKQELDILLHLS-HDNIVKLIGYC----DDRDEG---VLLFEYVPNGTLQEKLHGT 149
            ++   QE+  +  LS H NIV+         ++ D G    LL   +  G L E L   
Sbjct: 68  KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
                L     + I +Q  +A++++H R    I+H D+K  N+LL      KLCDFGSA 
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 210 MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVIL 266
              + +              + +++    +P Y  P  +          K D+++ G IL
Sbjct: 187 ---TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
Query: 267 LELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSI 326
             L      F  E+G  L  + G       D + T  + L+             RAML +
Sbjct: 244 YLLCFRQHPF--EDGAKLRIVNGKYSIPPHDTQYTVFHSLI-------------RAMLQV 288
Query: 327 AALCLRQSPILRPSATQILHTIKH 350
                  +P  R S  +++H ++ 
Sbjct: 289 -------NPEERLSIAEVVHQLQE 305

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 203
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 251
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 252 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   ++ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    + +  +    + I + ++    + +  F  E  I+  + H ++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ + +P+G L E +H       +  +  +    Q+A+ + YL ER 
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER- 159
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              +VH D+ A N+L++   + K+ DFG A++                   +  + +   
Sbjct: 160 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--- 214
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  HY +    + ++DV+S+GV + EL+T
Sbjct: 215 -------HYRK---FTHQSDVWSYGVTIWELMT 237

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 90
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 149
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 150 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 197
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 198 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      IG+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EY+P G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    K+ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 90/217 (41%), Gaps = 61/217 (28%)
Query: 104 QELDILLHLSHDNIVKLIGY--------------CDD------RDEGV------------ 131
           +ELDI+  L H NI+KL+ Y               DD      ++ GV            
Sbjct: 49  RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 132 ------LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI-AFQLAQAIEYLHERCTLHIVH 184
                 ++ EYVP+ TL + L    RS +    N ++I  +QL +A+ ++H   +L I H
Sbjct: 109 QNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICH 164
Query: 185 GDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYT 243
            DIK  N+L+    N  KLCDFGSAK    S                   V  I S  Y 
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----------------PSVAXICSRFYR 208
Query: 244 DPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPE 279
            P  +      T + D++S G +  EL+ G   F  E
Sbjct: 209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/319 (22%), Positives = 126/319 (39%), Gaps = 56/319 (17%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRL--SQVFKQELD 107
           +  R    F + +G+G F  V  A    L  +      A+K+   +      +    EL 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 108 ILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPR-----------SSKL 155
           I+ HL  H+NIV L+G C      +++ EY   G L   L    R           +S  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--MGFS 213
             R+ +  + Q+AQ + +L  +   + +H D+ A N+LL      K+ DFG A+  M  S
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-G 272
           + ++                        +  P  +   + + ++DV+S+G++L E+ + G
Sbjct: 219 NYIVKGNARLPVK---------------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263
Query: 273 MEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR 332
           +    P  G L+ S    ++ D          ++  P  A        + + SI   C  
Sbjct: 264 LN---PYPGILVNSKFYKLVKD--------GYQMAQPAFA-------PKNIYSIMQACWA 305
Query: 333 QSPILRPSATQILHTIKHQ 351
             P  RP+  QI   ++ Q
Sbjct: 306 LEPTHRPTFQQICSFLQEQ 324

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 85
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 144
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 145 DLVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLAR-------- 192
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 193 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/312 (22%), Positives = 124/312 (39%), Gaps = 52/312 (16%)
Query: 56  RFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRL--SQVFKQELDILL 110
           R    F + +G+G F  V  A    L  +      A+K+   +      +    EL I+ 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 111 HL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS-------KLPWRNRMA 162
           HL  H+NIV L+G C      +++ EY   G L   L     +         L  R+ + 
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--MGFSSAVLXXX 220
            + Q+AQ + +L  +   + +H D+ A N+LL      K+ DFG A+  M  S+ ++   
Sbjct: 165 FSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPE 279
                                +  P  +   + + ++DV+S+G++L E+ + G+    P 
Sbjct: 222 ARLPVK---------------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---PY 263
Query: 280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
            G L+ S    ++ D          ++  P  A        + + SI   C    P  RP
Sbjct: 264 PGILVNSKFYKLVKD--------GYQMAQPAFA-------PKNIYSIMQACWALEPTHRP 308
Query: 340 SATQILHTIKHQ 351
           +  QI   ++ Q
Sbjct: 309 TFQQICSFLQEQ 320

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    + +  +    + I + ++    + +  F  E  I+  + H ++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ + +P+G L E +H       +  +  +    Q+A+ + YL ER 
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER- 136
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              +VH D+ A N+L++   + K+ DFG A++                   +  + +   
Sbjct: 137 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--- 191
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  HY +    + ++DV+S+GV + EL+T
Sbjct: 192 -------HYRKF---THQSDVWSYGVTIWELMT 214

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 30/189 (15%)
Query: 104 QELDILLHLS-HDNIVKLIGYC---DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           +E+ IL  LS H+NIV L+      +DRD   L+F+Y     ++  LH   R++ L   +
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRD-VYLVFDY-----METDLHAVIRANILEPVH 110
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
           +  + +QL + I+YLH    LH    D+K SNILL    + K+ DF     G S + +  
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLH---RDMKPSNILLNAECHVKVADF-----GLSRSFVNI 162
Query: 220 XXXXXXXXXXITKQVM-----------MIGSPGYTDPHYLRTGMASTK-TDVYSFGVILL 267
                     I +               + +  Y  P  L      TK  D++S G IL 
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 268 ELVTGMEAF 276
           E++ G   F
Sbjct: 223 EILCGKPIF 231

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 91/236 (38%), Gaps = 48/236 (20%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI-------------HVGSDR--LSQVFKQ 104
           +F +VIG G F  V LAR  + +     A+K+             H+ S+R  L +  K 
Sbjct: 41  HFLKVIGKGSFGKVLLAR--HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
              + LH S     KL    D  + G L +        +E+    PR+           A
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYH-----LQRERCFLEPRAR--------FYA 145
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXX 224
            ++A A+ YLH   +L+IV+ D+K  NILL+   +  L DFG  K               
Sbjct: 146 AEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--------- 193
Query: 225 XXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                 +      G+P Y  P  L         D +  G +L E++ G+  F   N
Sbjct: 194 ------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 87
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++ EY   G L+E L                 P   ++ ++
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 146
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 147 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 194
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 195 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSH 114
           ++ +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H
Sbjct: 8   DYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRH 64
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  L       D    + EY   G L    H +        R R   A ++  A+EYL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA-EIVSALEYL 121
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H R    +V+ DIK  N++L++  + K+ DFG  K G S                     
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--------------- 163
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 26/171 (15%)
Query: 112 LSHDNIVKLIGYC----DDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
             H N+V+L+  C     DR+  V L+FE+V +  L+  L   P    LP      +  Q
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAP-PPGLPAETIKDLMRQ 128
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXX 226
             + +++LH  C   IVH D+K  NIL+      KL DFG A++                
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI-------------YSY 172
Query: 227 XXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
              +T  V+ +    Y  P  L     +T  D++S G I  E+      FC
Sbjct: 173 QMALTPVVVTL---WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSH 114
           ++ +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H
Sbjct: 8   DYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRH 64
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  L       D    + EY   G L    H +        R R   A ++  A+EYL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYL 121
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H R    +V+ DIK  N++L++  + K+ DFG  K G S                     
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--------------- 163
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSH 114
           ++ +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H
Sbjct: 11  DYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRH 67
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  L       D    + EY   G L    H +        R R   A ++  A+EYL
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYL 124
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H R    +V+ DIK  N++L++  + K+ DFG  K G S                     
Sbjct: 125 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-------------- 167
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 168 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 219

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSH 114
           ++ +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H
Sbjct: 8   DYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRH 64
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  L       D    + EY   G L    H +        R R   A ++  A+EYL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYL 121
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H R    +V+ DIK  N++L++  + K+ DFG  K G S                     
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--------------- 163
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSH 114
           ++ +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H
Sbjct: 8   DYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRH 64
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  L       D    + EY   G L    H +        R R   A ++  A+EYL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYL 121
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H R    +V+ DIK  N++L++  + K+ DFG  K G S                     
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-------------- 164
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSH 114
           ++ +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H
Sbjct: 8   DYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRH 64
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  L       D    + EY   G L    H +        R R   A ++  A+EYL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYL 121
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H R    +V+ DIK  N++L++  + K+ DFG  K G S                     
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-------------- 164
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSH 114
           ++ +++G G F  V L R    +T    A+KI      +  D ++     E  +L +  H
Sbjct: 13  DYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRH 69
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  L       D    + EY   G L    H +        R R   A ++  A+EYL
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA-EIVSALEYL 126
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H R    +V+ DIK  N++L++  + K+ DFG  K G S                     
Sbjct: 127 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--------------- 168
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              G+P Y  P  L         D +  GV++ E++ G   F  ++ + L  L
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 221

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 40  KTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 97
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYVP G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 98  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 151
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 193
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ E + NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 166 ---MGAVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L +  +  T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK--HKETGNHFAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L +  +  T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK--HKETGNHFAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ E + NG+L   L      ++      + +   +A  ++YL +
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 137 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 186
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 187 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 48  KTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYVP G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 159
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 201
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L +  +  T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK--HKETGNHFAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 24/231 (10%)
Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLS-QVFKQELDILLH 111
           R+  +F   Q +G GGF  V+ A+  N     N AIK I + +  L+ +   +E+  L  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAK--NKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 59
Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR----------- 160
           L H  IV+      +++    L    P   L  ++    + +   W N            
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 161 -MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            + I  Q+A+A+E+LH +    ++H D+K SNI        K+ DFG             
Sbjct: 120 CLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV 270
                      T QV   G+  Y  P  +     S K D++S G+IL EL+
Sbjct: 177 VLTPMPAYARHTGQV---GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 48  KTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYVP G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 159
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 201
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 48  KTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYVP G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 159
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 201
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 27/238 (11%)
Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLS 99
           G S + Y   +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + 
Sbjct: 1   GASTRDY---EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 57
Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           + F QE   +    H +IVKLIG   +    +++ E    G L+  L    R   L   +
Sbjct: 58  EKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKYSLDLAS 114
Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXX 219
            +  A+QL+ A+ YL  +     VH DI A N+L+  +   KL DFG ++    S     
Sbjct: 115 LILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 171
Query: 220 XXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
                      +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 172 -----------SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 45/256 (17%)
Query: 40  GIDGRSVKKY----------SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTS 84
           G +  SVK++           W++  + T +  Q      +G+G F  V L + +   T 
Sbjct: 9   GXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETG 66
Query: 85  TNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG 140
            + A+KI       +L Q+     E  IL  ++   +VKL     D     ++ EYVP G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 126
Query: 141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC 200
            +   L    R S+   R   A   Q+    EYLH   +L +++ D+K  N+L+++    
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 201 KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVY 260
           ++ DFG AK                      +   + G+P Y  P  + +   +   D +
Sbjct: 181 QVTDFGFAK------------------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 261 SFGVILLELVTGMEAF 276
           + GV++ E+  G   F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
           +  +V+G+G F  V   RL +      + AIK + VG +++  + F  E  I+    H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ E + NG+L   L      ++      + +   +A  ++YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRGGKIPIR- 215
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G++L E+++
Sbjct: 216 -----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 105/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+  FG A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQ----VFKQELDILLHLSHDNIV 118
           +VIG G FS V + ++    T    A+KI    D L +     F++E D+L++     I 
Sbjct: 67  KVIGRGAFSEVAVVKM--KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L     D +   L+ EY   G L   L  +    ++P         ++  AI+ +H   
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYLAEIVMAIDSVHR-- 180
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSA-KMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
            L  VH DIK  NILL+   + +L DFGS  K+     V               + ++ +
Sbjct: 181 -LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV---------------RSLVAV 224
Query: 238 GSPGYTDPHYLRT-------GMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  L+        G    + D ++ GV   E+  G   F
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 22/169 (13%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 128
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDFG +     S         
Sbjct: 129 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 181
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G
Sbjct: 182 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 68  KTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYVP G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 126 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 179
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 221
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L + +   T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 33  KTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 90
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYVP G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 91  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 144
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWTLCG 186
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLS-QVFKQELDILLHLSHDN 116
           +VIG G FS V   R IN  T    A+KI        S  LS +  K+E  I   L H +
Sbjct: 30  EVIGKGAFSVV--RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRS-SKLPWRNRMAIAF--QLAQAIEY 173
           IV+L+          ++FE++    L  ++    R+ +   +   +A  +  Q+ +A+ Y
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 174 LHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSA-KMGFSSAVLXXXXXXXXXXXX 229
            H+    +I+H D+K  N+LL    N    KL DFG A ++G S  V             
Sbjct: 146 CHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--------- 193
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  +G+P +  P  ++        DV+  GVIL  L++G   F
Sbjct: 194 -------VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 96/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++  Y   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 43/239 (17%)
Query: 57  FTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGS------DRLSQVFKQ 104
           F +N+   +++G G  S V   R I+  T    A+KI      GS        L +   +
Sbjct: 2   FYENYEPKEILGRGVSSVV--RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 59
Query: 105 ELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           E+DIL  +S H NI++L    +      L+F+ +  G L + L        L  +    I
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 116
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
              L + I  LH+   L+IVH D+K  NILL++ +N KL DF     GFS  +       
Sbjct: 117 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF-----GFSCQL------- 161
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMAST------KTDVYSFGVILLELVTGMEAF 276
                   K   + G+P Y  P  +   M         + D++S GVI+  L+ G   F
Sbjct: 162 ----DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 122
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+  +   KL DFG ++    S               
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA---------- 169
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 170 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 87
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 147
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 148 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 190
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 191 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 40/247 (16%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSD 96
           G   + V K +W+   R      Q +GSG +  V  A  ++  T    AIK       S+
Sbjct: 10  GFYRQEVTKTAWE--VRAVYRDLQPVGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSE 65
Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGY------CDDRDEGVLLFEYVPNGTLQEKLHGTP 150
             ++   +EL +L H+ H+N++ L+         DD  +  L+  ++  GT   KL    
Sbjct: 66  LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM--- 120
Query: 151 RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
           +  KL       + +Q+ + + Y+H      I+H D+K  N+ + E    K+ DFG A+ 
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 211 GFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLEL 269
             S                  +    + +  Y  P  +   M  T+T D++S G I+ E+
Sbjct: 178 ADS------------------EMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 270 VTGMEAF 276
           +TG   F
Sbjct: 220 ITGKTLF 226

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 91/237 (38%), Gaps = 51/237 (21%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDILLHLSHDNIVKL 120
           +G G FS V   R +   T    A KI + + +LS    Q  ++E  I   L H NIV+L
Sbjct: 12  LGKGAFSVV--RRCMKIPTGQEYAAKI-INTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                +     L+F+ V  G L E +      S+       A A    Q I      C L
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-------ADASHCIQQILESVNHCHL 121
Query: 181 H-IVHGDIKASNILL---EEHLNCKLCDFG---------SAKMGFSSAVLXXXXXXXXXX 227
           + IVH D+K  N+LL    +    KL DFG          A  GF+              
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-------------- 167
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                     G+PGY  P  LR        D+++ GVIL  L+ G   F  E+   L
Sbjct: 168 ----------GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL 214

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 122
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+  +   KL DFG ++    S               
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKA---------- 169
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 170 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 43/239 (17%)
Query: 57  FTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGS------DRLSQVFKQ 104
           F +N+   +++G G  S V   R I+  T    A+KI      GS        L +   +
Sbjct: 15  FYENYEPKEILGRGVSSVV--RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 105 ELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           E+DIL  +S H NI++L    +      L+F+ +  G L + L        L  +    I
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 129
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
              L + I  LH+   L+IVH D+K  NILL++ +N KL DF     GFS  +       
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF-----GFSCQL------- 174
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMAST------KTDVYSFGVILLELVTGMEAF 276
                   K   + G+P Y  P  +   M         + D++S GVI+  L+ G   F
Sbjct: 175 ----DPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 122
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+  +   KL DFG ++    S               
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA---------- 169
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 170 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 87
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R S+   R  
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY 147
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 148 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 190
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 191 -------RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 43/239 (17%)
Query: 57  FTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGS------DRLSQVFKQ 104
           F +N+   +++G G  S V   R I+  T    A+KI      GS        L +   +
Sbjct: 15  FYENYEPKEILGRGVSSVV--RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 105 ELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           E+DIL  +S H NI++L    +      L+F+ +  G L + L        L  +    I
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 129
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
              L + I  LH+   L+IVH D+K  NILL++ +N KL DF     GFS  +       
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF-----GFSCQL------- 174
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMAST------KTDVYSFGVILLELVTGMEAF 276
                   K   + G+P Y  P  +   M         + D++S GVI+  L+ G   F
Sbjct: 175 ----DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 105/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ D G A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 63  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 119
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+  +   KL DFG ++    S               
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA---------- 166
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 167 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 91/237 (38%), Gaps = 51/237 (21%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDILLHLSHDNIVKL 120
           +G G FS V   R +   T    A KI + + +LS    Q  ++E  I   L H NIV+L
Sbjct: 12  LGKGAFSVV--RRCMKIPTGQEYAAKI-INTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                +     L+F+ V  G L E +      S+       A A    Q I      C L
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-------ADASHCIQQILESVNHCHL 121
Query: 181 H-IVHGDIKASNILL---EEHLNCKLCDFG---------SAKMGFSSAVLXXXXXXXXXX 227
           + IVH D+K  N+LL    +    KL DFG          A  GF+              
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-------------- 167
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
                     G+PGY  P  LR        D+++ GVIL  L+ G   F  E+   L
Sbjct: 168 ----------GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL 214

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/319 (21%), Positives = 131/319 (41%), Gaps = 60/319 (18%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH D+ A N ++      K+ DFG  +  + +                 K
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG----------GK 191
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG----QLLT-SL 287
            ++ +    +  P  L+ G+ +T +D++SFGV+L E+ +  E   P  G    Q+L   +
Sbjct: 192 GLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQVLKFVM 246
Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
            G  L+   +C   +V +L+                     +C + +P +RP+  +I++ 
Sbjct: 247 DGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPKMRPTFLEIVNL 285
Query: 348 IKHQI----SSISFLFSPQ 362
           +K  +      +SF  S +
Sbjct: 286 LKDDLHPSFPEVSFFHSEE 304

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 13/169 (7%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSKLPWRNRM 161
           +E+ IL H  H+NI+ +      R +    F   Y+    +Q  LH    +  L   +  
Sbjct: 58  REIKILKHFKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXX 221
              +Q  +A++ LH     +++H D+K SN+L+  + + K+CDFG A++   SA      
Sbjct: 116 YFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA----- 167
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLEL 269
                    +  V  + +  Y  P  + T    ++  DV+S G IL EL
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 48  KTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EY P G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 106 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 159
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+++++    K+ DFG AK                      +   + G
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK------------------RVKGRTWXLCG 201
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 105/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ D G A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/319 (21%), Positives = 131/319 (41%), Gaps = 60/319 (18%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH D+ A N ++      K+ DFG  +  + +                 K
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG----------GK 190
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG----QLLT-SL 287
            ++ +    +  P  L+ G+ +T +D++SFGV+L E+ +  E   P  G    Q+L   +
Sbjct: 191 GLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQVLKFVM 245
Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
            G  L+   +C   +V +L+                     +C + +P +RP+  +I++ 
Sbjct: 246 DGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPKMRPTFLEIVNL 284
Query: 348 IKHQI----SSISFLFSPQ 362
           +K  +      +SF  S +
Sbjct: 285 LKDDLHPSFPEVSFFHSEE 303

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 105/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGHRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DF  A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 69  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKYSLDLASLILYAYQLST 125
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+  +   KL DFG ++    S               
Sbjct: 126 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA---------- 172
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 173 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 96/234 (41%), Gaps = 41/234 (17%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS------ 113
             + +G G F  V +A  +  D      A+ + V   +     K   D++  +       
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 114 -HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG--------------TPRSSKLPWR 158
            H NI+ L+G C       ++  Y   G L+E L                 P   ++ ++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFK 157
Query: 159 NRMAIAFQLAQAIEYL-HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           + ++  +QLA+ +EYL  ++C    +H D+ A N+L+ E+   K+ DFG A+        
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-------- 205
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                        T   + +    +  P  L   + + ++DV+SFGV++ E+ T
Sbjct: 206 --DINNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 20/222 (9%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDIL 109
           ++E       +VIG+G F  V   RL +        AIK + VG +++  + F  E  I+
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H NI+ L G        +++ EY+ NG+L   L       +      + +   ++ 
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN--DGQFTVIQLVGMLRGISA 135
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            ++YL +   +  VH D+ A NIL+  +L CK+ DFG ++      VL            
Sbjct: 136 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR------VLEDDPEAAYTTRG 186
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +       +T P  +     ++ +DV+S+G+++ E+V+
Sbjct: 187 GKIPIR------WTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 105/244 (43%), Gaps = 42/244 (17%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ QN S V GSG + +V  A   +  T    A+K      +LS+ F+
Sbjct: 11  QELNKTIWEVPERY-QNLSPV-GSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQ 60
Query: 104 ---------QELDILLHLSHDNIVKLIG-YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS 153
                    +EL +L H+ H+N++ L+  +   R        Y+    +   L+   +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ D G A+    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR---- 173
Query: 214 SAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                             +    + +  Y  P  +   M   +T D++S G I+ EL+TG
Sbjct: 174 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 273 MEAF 276
              F
Sbjct: 220 RTLF 223

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
              +VIG G F  V   RL +        AIK +  G +D+  + F  E  I+    H N
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 91
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+ L G        +++ EY+ NG+L   L       +      + +   +   ++YL +
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN--DGRFTVIQLVGMLRGIGSGMKYLSD 149
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 150 ---MSAVHRDLAARNILVNSNLVCKVSDFGMSR------VLEDDPEAAYTTRGGKIPIR- 199
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G+++ E+++
Sbjct: 200 -----WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/321 (22%), Positives = 129/321 (40%), Gaps = 58/321 (18%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRL--SQVFKQELD 107
           +  R    F + +G+G F  V  A    L  +      A+K+   +      +    EL 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 108 ILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRS--------S 153
           I+ HL  H+NIV L+G C      +++ EY   G L     +++  G   S         
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK--MG 211
           +L  R+ +  + Q+AQ + +L  +   + +H D+ A N+LL      K+ DFG A+  M 
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 212 FSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            S+ ++                        +  P  +   + + ++DV+S+G++L E+ +
Sbjct: 219 DSNYIVKGNARLPVK---------------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 263
Query: 272 -GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
            G+    P  G L+ S    ++ D          ++  P  A        + + SI   C
Sbjct: 264 LGLN---PYPGILVNSKFYKLVKD--------GYQMAQPAFA-------PKNIYSIMQAC 305
Query: 331 LRQSPILRPSATQILHTIKHQ 351
               P  RP+  QI   ++ Q
Sbjct: 306 WALEPTHRPTFQQICSFLQEQ 326

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EY P G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+++++    K+ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 137/315 (43%), Gaps = 51/315 (16%)
Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNI 117
           S+ +G G F+ V   + I+ ST    A K       G D  +++  +   + L  S   +
Sbjct: 34  SKELGRGKFAVV--RQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR-MAIAFQLAQAIEYLHE 176
           + L    ++  E +L+ EY   G +       P  +++   N  + +  Q+ + + YLH+
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 177 RCTLHIVHGDIKASNILLEEHL---NCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITK 232
               +IVH D+K  NILL       + K+ DFG S K+G +  +               +
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---------------R 191
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
           ++M  G+P Y  P  L     +T TD+++ G+I   L+T    F  E+ Q  T L  S +
Sbjct: 192 EIM--GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-ETYLNISQV 248
Query: 293 N-DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ 351
           N D ++   + V++     LA DF          I +L L ++P  RP+A   L     Q
Sbjct: 249 NVDYSEETFSSVSQ-----LATDF----------IQSL-LVKNPEKRPTAEICLSHSWLQ 292
Query: 352 ISSISFLFSPQKDPS 366
                 LF P++  S
Sbjct: 293 QWDFENLFHPEETSS 307

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +EL +L   +   IV   G      E  +  E++  G+L + L    ++ ++P +    +
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKV 112
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           +  + + + YL E+    I+H D+K SNIL+      KLCDF     G S  ++      
Sbjct: 113 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF-----GVSGQLIDEMANE 165
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                        +G+  Y  P  L+    S ++D++S G+ L+E+  G
Sbjct: 166 ------------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
              +VIG G F  V   RL +        AIK +  G +D+  + F  E  I+    H N
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+ L G        +++ EY+ NG+L   L       +      + +   +   ++YL +
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN--DGRFTVIQLVGMLRGIGSGMKYLSD 128
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
              +  VH D+ A NIL+  +L CK+ DFG ++      VL                +  
Sbjct: 129 ---MSYVHRDLAARNILVNSNLVCKVSDFGMSR------VLEDDPEAAYTTRGGKIPIR- 178
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +T P  +     ++ +DV+S+G+++ E+++
Sbjct: 179 -----WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 20/214 (9%)
Query: 61  FSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNI 117
             +VIG G F  V   RL +        AIK +  G +D+  + F  E  I+    H NI
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           + L G        +++ EY+ NG+L   L       +      + +   +   ++YL + 
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKN--DGRFTVIQLVGMLRGIGSGMKYLSD- 134
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
             +  VH D+ A NIL+  +L CK+ DFG ++      VL                +   
Sbjct: 135 --MSYVHRDLAARNILVNSNLVCKVSDFGMSR------VLEDDPEAAYTTRGGKIPIR-- 184
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +T P  +     ++ +DV+S+G+++ E+++
Sbjct: 185 ----WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 40  KTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 97
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYVP G +   L    R  +   R   A   Q+    EYLH   
Sbjct: 98  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA---QIVLTFEYLH--- 151
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 193
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-QVFKQELDILL---HLSHDNIV 118
           +V+GSG F  V+    I +  S    + I V  D+   Q F+   D +L    L H +IV
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ +Y+P G+L +  H       L  +  +    Q+A+ + YL E  
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              +VH ++ A N+LL+     ++ DFG A +     +                + M + 
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADL-----LPPDDKQLLYSEAKTPIKWMALE 205
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFC 277
           S        +  G  + ++DV+S+GV + EL+T G E + 
Sbjct: 206 S--------IHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 41/239 (17%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ 104
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI    D+   V  +
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKI---LDKQKVVKLK 83
Query: 105 ELD-------ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           E++       IL  ++   +VKL     D     ++ EY P G +   L    R S+   
Sbjct: 84  EIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           R   A   Q+    EYLH   +L +++ D+K  N+++++    K+ DFG AK        
Sbjct: 144 RFYAA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-------- 189
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-QVFKQELDILL---HLSHDNIV 118
           +V+GSG F  V+    I +  S    + I V  D+   Q F+   D +L    L H +IV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ +Y+P G+L +  H       L  +  +    Q+A+ + YL E  
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
              +VH ++ A N+LL+     ++ DFG A +     +                + M + 
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADL-----LPPDDKQLLYSEAKTPIKWMALE 187
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFC 277
           S        +  G  + ++DV+S+GV + EL+T G E + 
Sbjct: 188 S--------IHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 41/226 (18%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDNI 117
           + IG G F  V + +   + T    A+K       V  + +  VFK EL I+  L H  +
Sbjct: 21  RAIGKGSFGKVCIVQ--KNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFL 77
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           V L     D ++  ++ + +  G L    Q+ +H    + KL          +L  A++Y
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICELVMALDY 130
Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
           L  +    I+H D+K  NILL+EH +  + DF  A M                    T+ 
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM----------------LPRETQI 171
Query: 234 VMMIGSPGYTDPHYL--RTGMA-STKTDVYSFGVILLELVTGMEAF 276
             M G+  Y  P     R G   S   D +S GV   EL+ G   +
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 502
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+  +   KL DFG ++    S               
Sbjct: 503 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA---------- 549
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 550 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS 113
           V R +    ++   G F  V+ A+L+ND      A+KI    D+ S   ++E+     + 
Sbjct: 12  VPRGSLQLLEIKARGRFGCVWKAQLMNDFV----AVKIFPLQDKQSWQSEREIFSTPGMK 67
Query: 114 HDNIVKLIGYCDDRD-----EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           H+N+++ I   + R      E  L+  +   G+L + L G    + + W     +A  ++
Sbjct: 68  HENLLQFIA-AEKRGSNLEVELWLITAFHDKGSLTDYLKG----NIITWNELCHVAETMS 122
Query: 169 QAIEYLHE-----RCTLH---IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + + YLHE     R   H   I H D K+ N+LL+  L   L DFG A + F        
Sbjct: 123 RGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-VRFEPGKPPGD 181
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGM-----ASTKTDVYSFGVILLELVTGMEA 275
                           +G+  Y  P  L   +     A  + D+Y+ G++L ELV+  +A
Sbjct: 182 THG------------QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKA 229

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 66  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 122
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+      KL DFG ++    S               
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA---------- 169
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 170 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 45/256 (17%)
Query: 40  GIDGRSVKKY----------SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTS 84
           G +  SVK++           W++  + T +  Q      +G+G F  V L + +   T 
Sbjct: 9   GXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETG 66
Query: 85  TNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG 140
            + A+KI       +L Q+     E  IL  ++   +VKL     D     ++ EYVP G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 126
Query: 141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC 200
            +   L    R  +   R   A   Q+    EYLH   +L +++ D+K  N+L+++    
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 201 KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVY 260
           ++ DFG AK                      +   + G+P Y  P  + +   +   D +
Sbjct: 181 QVTDFGFAK------------------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 261 SFGVILLELVTGMEAF 276
           + GV++ E+  G   F
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 48/247 (19%)
Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
           + + K  W+  ER+ Q  S V GSG + +V        S      +KI V   +LS+ F+
Sbjct: 40  QELNKTIWEVPERY-QTLSPV-GSGAYGSV------CSSYDVKSGLKIAVK--KLSRPFQ 89
Query: 104 ---------QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE----YVPNGTLQEKLHGTP 150
                    +EL +L H+ H+N+   IG  D       L E    Y+    +   L+   
Sbjct: 90  SIIHAKRTYRELRLLKHMKHENV---IGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV 146
Query: 151 RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
           +  KL   +   + +Q+ + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+ 
Sbjct: 147 KCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR- 202
Query: 211 GFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLEL 269
                                +    + +  Y  P  +   M    T D++S G I+ EL
Sbjct: 203 -----------------HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAEL 245
Query: 270 VTGMEAF 276
           +TG   F
Sbjct: 246 LTGRTLF 252

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 68/324 (20%), Positives = 127/324 (39%), Gaps = 70/324 (21%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH D+ A N ++      K+ DFG  +                       
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------------------DIXET 183
Query: 233 QVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG----QL 283
                G  G     +  P  L+ G+ +T +D++SFGV+L E+ +  E   P  G    Q+
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQV 241
Query: 284 LT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
           L   + G  L+   +C   +V +L+                     +C + +P +RP+  
Sbjct: 242 LKFVMDGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPKMRPTFL 280
Query: 343 QILHTIKHQI----SSISFLFSPQ 362
           +I++ +K  +      +SF  S +
Sbjct: 281 EIVNLLKDDLHPSFPEVSFFHSEE 304

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R  +   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/322 (20%), Positives = 126/322 (39%), Gaps = 66/322 (20%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH D+ A N ++      K+ DFG  +                       
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------------------DIXET 180
Query: 233 QVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP--ENGQLLT 285
                G  G     +  P  L+ G+ +T +D++SFGV+L E+ +  E       N Q+L 
Sbjct: 181 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240
Query: 286 -SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI 344
             + G  L+   +C   +V +L+                     +C + +P +RP+  +I
Sbjct: 241 FVMDGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPKMRPTFLEI 279
Query: 345 LHTIKHQI----SSISFLFSPQ 362
           ++ +K  +      +SF  S +
Sbjct: 280 VNLLKDDLHPSFPEVSFFHSEE 301

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 87
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYVP G +   L    R  +   R  
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY 147
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 148 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 190
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 191 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  T  + A+KI       +L Q+     E  I   ++   +V
Sbjct: 48  RTLGTGSFGRVMLVK--HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLV 105
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EY P G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 106 KLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 159
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    K+ DFG AK                      +   + G
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAK------------------RVKGRTWXLCG 201
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 27/224 (12%)
Query: 63  QVIGSGGFSNVYLARLINDS-TSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDN 116
           +V+G GG+  V+  R +  + T    A+K+      V + + +   K E +IL  + H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IV LI       +  L+ EY+  G L  +L    R              +++ A+ +LH+
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQ 139
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
           +    I++ D+K  NI+L    + KL DFG  K       +                   
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---------------F 181
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            G+  Y  P  L     +   D +S G ++ +++TG   F  EN
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI-HVGSDRL-SQVFKQELDILLHLSHDNIVKLIG 122
           +G G F +V            + AIK+   G+++  ++   +E  I+  L +  IV+LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
            C   +  +L+ E    G L + L G  +  ++P  N   +  Q++  ++YL E+   + 
Sbjct: 78  VCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NF 131
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAK-MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
           VH D+ A N+LL      K+ DFG +K +G   +                          
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------------- 178
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  P  +     S+++DV+S+GV + E ++
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 27/224 (12%)
Query: 63  QVIGSGGFSNVYLARLINDS-TSTNGAIKIH-----VGSDRLSQVFKQELDILLHLSHDN 116
           +V+G GG+  V+  R +  + T    A+K+      V + + +   K E +IL  + H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           IV LI       +  L+ EY+  G L  +L    R              +++ A+ +LH+
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQ 139
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
           +    I++ D+K  NI+L    + KL DFG  K       +                   
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH---------------XF 181
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            G+  Y  P  L     +   D +S G ++ +++TG   F  EN
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--------SDRLSQVFKQELDILLHLSH 114
           QVIG+G F  V    L        G  +I V         +++  + F  E  I+    H
Sbjct: 39  QVIGAGEFGEVCSGHL-----KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 93
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            N++ L G        +++ E++ NG+L   L       +      + +   +A  ++YL
Sbjct: 94  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYL 151
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
            +   ++ VH D+ A NIL+  +L CK+ DFG ++       L            +  ++
Sbjct: 152 AD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF------LEDDTSDPTYTSALGGKI 202
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +     +T P  ++    ++ +DV+S+G+++ E+++
Sbjct: 203 PI----RWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/324 (20%), Positives = 127/324 (39%), Gaps = 70/324 (21%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH D+ A N ++      K+ DFG  +                       
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------------------DIXET 183
Query: 233 QVMMIGSPG-----YTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG----QL 283
                G  G     +  P  L+ G+ +T +D++SFGV+L E+ +  E   P  G    Q+
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQV 241
Query: 284 LT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
           L   + G  L+   +C   +V +L+                     +C + +P +RP+  
Sbjct: 242 LKFVMDGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPNMRPTFL 280
Query: 343 QILHTIKHQI----SSISFLFSPQ 362
           +I++ +K  +      +SF  S +
Sbjct: 281 EIVNLLKDDLHPSFPEVSFFHSEE 304

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EY P G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+++++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 103/256 (40%), Gaps = 45/256 (17%)
Query: 40  GIDGRSVKKY----------SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTS 84
           G +  SVK++           W++  + T +  Q      +G+G F  V L + +   T 
Sbjct: 10  GXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETG 67
Query: 85  TNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG 140
            + A+KI       +L Q+     E  IL  ++   + KL     D     ++ EY P G
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGG 127
Query: 141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC 200
            +   L    R S+   R   A   Q+    EYLH   +L +++ D+K  N+++++    
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 181
Query: 201 KLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVY 260
           K+ DFG AK                      +   + G+P Y  P  + +   +   D +
Sbjct: 182 KVTDFGFAK------------------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 261 SFGVILLELVTGMEAF 276
           + GV++ E+  G   F
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSKLPWRNRM 161
           +E+ IL H  H+NI+ +      R +    F   Y+    +Q  LH    +  L   +  
Sbjct: 58  REIKILKHFKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXX 221
              +Q  +A++ LH     +++H D+K SN+L+  + + K+CDFG A++   SA      
Sbjct: 116 YFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA--DNS 170
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLEL 269
                   +T+ V    +  Y  P  + T    ++  DV+S G IL EL
Sbjct: 171 EPTGQQSGMTEXV---ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE--YVPNGTLQEKLHGTPRSSKLPWRNRM 161
           +E+ IL H  H+NI+ +      R +    F   Y+    +Q  LH    +  L   +  
Sbjct: 58  REIKILKHFKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXX 221
              +Q  +A++ LH     +++H D+K SN+L+  + + K+CDFG A++   SA      
Sbjct: 116 YFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA----- 167
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLEL 269
                    +     + +  Y  P  + T    ++  DV+S G IL EL
Sbjct: 168 DNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 87
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   + KL     D     ++ EY P G +   L    R S+   R  
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY 147
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+++++    K+ DFG AK           
Sbjct: 148 AA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 190
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 191 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EY P G +   L    R  +   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+++++    K+ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 41/239 (17%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ 104
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI    D+   V  +
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKI---LDKQKVVKLK 83
Query: 105 ELD-------ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           E++       IL  ++   +VKL     D     ++ EY P G +   L    R S+   
Sbjct: 84  EIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA 143
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
           R   A   Q+    EYLH   +L +++ D+K  N+++++    ++ DFG AK        
Sbjct: 144 RFYAA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-------- 189
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 ----------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
           FKQE++I+  L H NI++L    +D  +  L+ E    G L E++       K  +R   
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-----VHKRVFRESD 107
Query: 162 A--IAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAV 216
           A  I   +  A+ Y H+   L++ H D+K  N L          KL DFG A       +
Sbjct: 108 AARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164
Query: 217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +                   +G+P Y  P  L  G+   + D +S GV++  L+ G   F
Sbjct: 165 MRTK----------------VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
           +++R      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   +    +++ E    G L+  L    R   L   + +  A+QL+ 
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ--VRKFSLDLASLILYAYQLST 502
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+ YL  +     VH DI A N+L+      KL DFG ++    S               
Sbjct: 503 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA---------- 549
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE-LVTGMEAF 276
            +K  + I    +  P  +     ++ +DV+ FGV + E L+ G++ F
Sbjct: 550 -SKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/319 (20%), Positives = 131/319 (41%), Gaps = 60/319 (18%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH ++ A N ++      K+ DFG  +  + +                 K
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG----------GK 192
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG----QLLT-SL 287
            ++ +    +  P  L+ G+ +T +D++SFGV+L E+ +  E   P  G    Q+L   +
Sbjct: 193 GLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQVLKFVM 247
Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
            G  L+   +C   +V +L+                     +C + +P +RP+  +I++ 
Sbjct: 248 DGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPNMRPTFLEIVNL 286
Query: 348 IKHQI----SSISFLFSPQ 362
           +K  +      +SF  S +
Sbjct: 287 LKDDLHPSFPEVSFFHSEE 305

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
           FKQE++I+  L H NI++L    +D  +  L+ E    G L E++       K  +R   
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-----VHKRVFRESD 124
Query: 162 A--IAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAV 216
           A  I   +  A+ Y H+   L++ H D+K  N L          KL DFG A       +
Sbjct: 125 AARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 181
Query: 217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +                   +G+P Y  P  L  G+   + D +S GV++  L+ G   F
Sbjct: 182 MRTK----------------VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/319 (20%), Positives = 131/319 (41%), Gaps = 60/319 (18%)
Query: 65  IGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRLSQ--VFKQELDILLHLSHDNIVK 119
           +G G F  VY      +I     T  A+K    S  L +   F  E  ++   +  ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHG-TPRSSKLPWR------NRMAIAFQLAQAIE 172
           L+G        +++ E + +G L+  L    P +   P R        + +A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITK 232
           YL+ +     VH ++ A N ++      K+ DFG  +  + +                 K
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG----------GK 191
Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG----QLLT-SL 287
            ++ +    +  P  L+ G+ +T +D++SFGV+L E+ +  E   P  G    Q+L   +
Sbjct: 192 GLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQVLKFVM 246
Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
            G  L+   +C   +V +L+                     +C + +P +RP+  +I++ 
Sbjct: 247 DGGYLDQPDNC-PERVTDLM--------------------RMCWQFNPNMRPTFLEIVNL 285
Query: 348 IKHQI----SSISFLFSPQ 362
           +K  +      +SF  S +
Sbjct: 286 LKDDLHPSFPEVSFFHSEE 304

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           + +G+G F  V+  R+   +T  N A K +    +   +  ++E+  +  L H  +V L 
Sbjct: 57  EELGTGAFGVVH--RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 114
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +D +E V+++E++  G L EK+      +K+     +    Q+ + + ++HE   +H
Sbjct: 115 DAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 172
Query: 182 IVHGDIKASNILL--EEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +   D+K  NI+   +     KL DFG +A +    +V                  +  G
Sbjct: 173 L---DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-----------------VTTG 212
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
           +  +  P           TD++S GV+   L++G+  F  EN
Sbjct: 213 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIV 118
           +  + +G+G F  V+  R+   +T  N A K +    +   +  ++E+  +  L H  +V
Sbjct: 160 DIHEELGTGAFGVVH--RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
            L    +D +E V+++E++  G L EK+      +K+     +    Q+ + + ++HE  
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 179 TLHIVHGDIKASNILL--EEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXXXITKQVM 235
            +H+   D+K  NI+   +     KL DFG +A +    +V                  +
Sbjct: 276 YVHL---DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-----------------V 315
Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
             G+  +  P           TD++S GV+   L++G+  F  EN
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           ++IG G +  VY   L         A+K+   ++R + + ++ +  +  + HDNI + I 
Sbjct: 19  ELIGRGRYGAVYKGSLDERPV----AVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 123 -----YCDDRDEGVLLFEYVPNGTLQE--KLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
                  D R E +L+ EY PNG+L +   LH +       W +   +A  + + + YLH
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLH 128
Query: 176 ------ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
                 +     I H D+ + N+L++    C + DFG + M  +   L            
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS-MRLTGNRLVRPGEED----- 182
Query: 230 ITKQVMMIGSPGYTDPHYLRTGM-------ASTKTDVYSFGVILLEL 269
               +  +G+  Y  P  L   +       A  + D+Y+ G+I  E+
Sbjct: 183 -NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 9/152 (5%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRL--SQVFKQELDILLHLSHDNI 117
            ++++G G F  VY     N      N A+K       L   + F  E  I+ +L H +I
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           VKLIG  ++    +++ E  P G L   L     S K+     +  + Q+ +A+ YL   
Sbjct: 88  VKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLE-- 142
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            +++ VH DI   NIL+      KL DFG ++
Sbjct: 143 -SINCVHRDIAVRNILVASPECVKLGDFGLSR 173

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 34  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 91
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 92  KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 145
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L++E    ++ DFG AK                      +   + G
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAK------------------RVKGRTWXLCG 187
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 9/152 (5%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRL--SQVFKQELDILLHLSHDNI 117
            ++++G G F  VY     N      N A+K       L   + F  E  I+ +L H +I
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           VKLIG  ++    +++ E  P G L   L     S K+     +  + Q+ +A+ YL   
Sbjct: 72  VKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLE-- 126
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            +++ VH DI   NIL+      KL DFG ++
Sbjct: 127 -SINCVHRDIAVRNILVASPECVKLGDFGLSR 157

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 9/152 (5%)
Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRL--SQVFKQELDILLHLSHDNI 117
            ++++G G F  VY     N      N A+K       L   + F  E  I+ +L H +I
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           VKLIG  ++    +++ E  P G L   L     S K+     +  + Q+ +A+ YL   
Sbjct: 76  VKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLE-- 130
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            +++ VH DI   NIL+      KL DFG ++
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSR 161

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 60  NFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
              +VIG+G F  V   RL +        AIK + VG +++  + F  E  I+    H N
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +V L G        +++ E++ NG L   L       +      + +   +A  + YL +
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLR--KHDGQFTVIQLVGMLRGIAAGMRYLAD 163
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM--GFSSAVLXXXXXXXXXXXXITKQV 234
              +  VH D+ A NIL+  +L CK+ DFG +++      AV                  
Sbjct: 164 ---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR------- 213
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  +T P  ++    ++ +DV+S+G+++ E+++
Sbjct: 214 -------WTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/253 (21%), Positives = 104/253 (41%), Gaps = 52/253 (20%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS 99
           G   + + K  W+  +R  Q    V GSG + +V         ++ +  ++  V   +LS
Sbjct: 13  GFYRQELNKTVWEVPQRL-QGLRPV-GSGAYGSV--------CSAYDARLRQKVAVKKLS 62
Query: 100 QVFK---------QELDILLHLSHDNIVKLIGY------CDDRDEGVLLFEYVPNGTLQE 144
           + F+         +EL +L HL H+N++ L+         +D  E      Y+    +  
Sbjct: 63  RPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEV-----YLVTTLMGA 117
Query: 145 KLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD 204
            L+   +S  L   +   + +QL + ++Y+H   +  I+H D+K SN+ + E    ++ D
Sbjct: 118 DLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILD 174
Query: 205 FGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFG 263
           FG A+                      +    + +  Y  P  +   M   +T D++S G
Sbjct: 175 FGLARQADE------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 264 VILLELVTGMEAF 276
            I+ EL+ G   F
Sbjct: 217 CIMAELLQGKALF 229

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 117/306 (38%), Gaps = 52/306 (16%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G F  V+  R+ +  T    A+K      RL     +EL     L+   IV L G  
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVK----KVRLEVFRAEELMACAGLTSPRIVPLYGAV 154
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
            +     +  E +  G+L + +        LP    +    Q  + +EYLH R    I+H
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEGLEYLHSR---RILH 208
Query: 185 GDIKASNILL-EEHLNCKLCDFGSAKM----GFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
           GD+KA N+LL  +  +  LCDFG A      G   ++L                  + G+
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD--------------YIPGT 254
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P  +       K DV+S   ++L ++ G   +            G +   IA  E
Sbjct: 255 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW-------TQFFRGPLCLKIAS-E 306
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAAL--CLRQSPILRPSATQILHTIKHQISSISF 357
              V E           +  + A L+  A+   LR+ PI R SA ++   +   +  +  
Sbjct: 307 PPPVRE-----------IPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGG 355
Query: 358 LFSPQK 363
           L SP +
Sbjct: 356 LKSPWR 361

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-----IHVGSDRLSQVFKQELDILLHLSHDNI 117
           +++G G F  V+LA      T+   AIK     + +  D +     ++  + L   H  +
Sbjct: 23  KMLGKGSFGKVFLAEF--KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             +      ++    + EY+  G L   ++      K         A ++   +++LH +
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
               IV+ D+K  NILL++  + K+ DFG  K                      K     
Sbjct: 138 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---------------AKTNXFC 179
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  L     +   D +SFGV+L E++ G   F
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 18  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNLNKVRVAIKKISPFEHQT 67
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L  
Sbjct: 68  YXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 22  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQT 71
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L  
Sbjct: 72  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 131
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 132 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 188
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 189 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 14  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQT 63
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L  
Sbjct: 64  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 123
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 124 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 34  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQT 83
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L  
Sbjct: 84  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 143
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 144 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 200
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 248

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 29  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 86
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   +VKL     D     ++ EYV  G +   L    R S+   R  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY 146
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+L+++    ++ DFG AK           
Sbjct: 147 AA---QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 190 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/328 (21%), Positives = 125/328 (38%), Gaps = 65/328 (19%)
Query: 53  DVERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKIHVGSDRL--SQVFKQELD 107
           +  R    F + +G+G F  V  A    L  +      A+K+   +      +    EL 
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 108 ILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL------------------HG 148
           I+ HL  H+NIV L+G C      +++ EY   G L   L                   G
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 149 TPRSSKLPWRNRMAIAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG 206
             +    P   R  + F  Q+AQ + +L  +   + +H D+ A N+LL      K+ DFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 207 SAK--MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGV 264
            A+  M  S+ ++                        +  P  +   + + ++DV+S+G+
Sbjct: 204 LARDIMNDSNYIVKGNARLPVK---------------WMAPESIFDCVYTVQSDVWSYGI 248
Query: 265 ILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
           +L E+ + G+    P  G L+ S    ++ D          ++  P  A        + +
Sbjct: 249 LLWEIFSLGLN---PYPGILVNSKFYKLVKD--------GYQMAQPAFA-------PKNI 290
Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQ 351
            SI   C    P  RP+  QI   ++ Q
Sbjct: 291 YSIMQACWALEPTHRPTFQQICSFLQEQ 318

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 16  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQT 65
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L  
Sbjct: 66  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 125
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 126 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQ----ELDILLHLSHDN 116
           IG G +  V         ++ +   K+ V   ++S    Q + Q    E+ ILL   H+N
Sbjct: 31  IGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+ +           +   Y+    ++  L+   ++  L   +     +Q+ + ++Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH- 141
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
             + +++H D+K SN+LL    + K+CDFG A++                        +M
Sbjct: 142 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S GYT              D++S G IL E+++    F
Sbjct: 200 LNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 228

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI-HVGSDRL-SQVFKQELDILLHLSHDNIVKLIG 122
           +G G F +V            + AIK+   G+++  ++   +E  I+  L +  IV+LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
            C   +  +L+ E    G L + L G  +  ++P  N   +  Q++  ++YL E+   + 
Sbjct: 404 VCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NF 457
Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAK-MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
           VH ++ A N+LL      K+ DFG +K +G   +                          
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------------- 504
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +  P  +     S+++DV+S+GV + E ++
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 13/157 (8%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIV 118
            S ++G G  +NV+  R  +  T    AIK+  ++   R   V  +E ++L  L+H NIV
Sbjct: 13  LSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 119 KLIGYCDDRD--EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           KL    ++      VL+ E+ P G+L   L     +  LP    + +   +   + +L E
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 177 RCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAK 209
                IVH +IK  NI+     +     KL DFG+A+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G +  VY A+           I++    + +     +E+ +L  L H NIV LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 125 DDRDEGVLLFEYVPNG---TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                  L+FE++       L E   G   S            +QL + + + H+     
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDENKTGLQDS------QIKIYLYQLLRGVAHCHQH---R 139
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
           I+H D+K  N+L+      KL DFG A+  F   V              T +V+ +    
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPV-----------RSYTHEVVTL---W 184
Query: 242 YTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
           Y  P  L  +   ST  D++S G I  E++TG   F
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQ----ELDILLHLSHDN 116
           IG G +  V         ++ +   K+ V   ++S    Q + Q    E+ ILL   H+N
Sbjct: 31  IGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+ +           +   Y+    ++  L+   ++  L   +     +Q+ + ++Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH- 141
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
             + +++H D+K SN+LL    + K+CDFG A++                        +M
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S GYT              D++S G IL E+++    F
Sbjct: 200 LNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 228

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 13/157 (8%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIV 118
            S ++G G  +NV+  R  +  T    AIK+  ++   R   V  +E ++L  L+H NIV
Sbjct: 13  LSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 119 KLIGYCDDRD--EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           KL    ++      VL+ E+ P G+L   L     +  LP    + +   +   + +L E
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 177 RCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAK 209
                IVH +IK  NI+     +     KL DFG+A+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 42/248 (16%)
Query: 49  YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--------Q 100
           +  +DVE   +   + +GSG F+ V   R     T    A K  +   RLS        +
Sbjct: 5   FRQEDVEDHYE-MGEELGSGQFAIVRKCR--QKGTGKEYAAKF-IKKRRLSSSRRGVSRE 60
Query: 101 VFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
             ++E++IL  + H NI+ L    +++ + VL+ E V  G L + L     + K      
Sbjct: 61  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTED 115
Query: 161 MAIAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEE----HLNCKLCDFGSAKMGFSS 214
            A  F  Q+   + YLH +    I H D+K  NI+L +    +   KL DFG A    + 
Sbjct: 116 EATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 172
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
                                + G+P +  P  +       + D++S GVI   L++G  
Sbjct: 173 NEFKN----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
Query: 275 AFCPENGQ 282
            F  E  Q
Sbjct: 217 PFLGETKQ 224

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDILLHLSHD 115
            F   IG G F  VY      D+ +T       +   +L+    Q FK+E + L  L H 
Sbjct: 29  KFDIEIGRGSFKTVYKGL---DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHP 85
Query: 116 NIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           NIV+     +   +G    VL+ E   +GTL+  L    R      +   +   Q+ + +
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLK---RFKVXKIKVLRSWCRQILKGL 142
Query: 172 EYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSA---KMGFSSAVLXXXXXXXXXX 227
           ++LH R T  I+H D+K  NI +     + K+ D G A   +  F+ AV           
Sbjct: 143 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----------- 190
Query: 228 XXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    IG+P +  P         +  DVY+FG   LE  T
Sbjct: 191 ---------IGTPEFXAPEXYEEKYDES-VDVYAFGXCXLEXAT 224

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G +  VY A+           I++    + +     +E+ +L  L H NIV LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 125 DDRDEGVLLFEYVPNG---TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                  L+FE++       L E   G   S            +QL + + + H+     
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDENKTGLQDS------QIKIYLYQLLRGVAHCHQH---R 139
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
           I+H D+K  N+L+      KL DFG A+  F   V              T +V+ +    
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPV-----------RSYTHEVVTL---W 184
Query: 242 YTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAF 276
           Y  P  L  +   ST  D++S G I  E++TG   F
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 191 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQ----ELDILLHLSHDN 116
           IG G +  V         ++ +   K+ V   ++S    Q + Q    E+ ILL   H+N
Sbjct: 31  IGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+ +           +   Y+    ++  L+   ++  L   +     +Q+ + ++Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH- 141
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
             + +++H D+K SN+LL    + K+CDFG A++                        +M
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S GYT              D++S G IL E+++    F
Sbjct: 200 LNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 135 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 191
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 192 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 76  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 135
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 136 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 192
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 193 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 67  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 126
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 127 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 183
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 184 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 191 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 232

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/248 (21%), Positives = 101/248 (40%), Gaps = 42/248 (16%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS 99
           G   + + K  W+  +R  Q    V GSG + +V         ++ +  ++  V   +LS
Sbjct: 5   GFYRQELNKTVWEVPQRL-QGLRPV-GSGAYGSV--------CSAYDARLRQKVAVKKLS 54
Query: 100 QVFK---------QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE-YVPNGTLQEKLHGT 149
           + F+         +EL +L HL H+N++ L+             E Y+    +   L+  
Sbjct: 55  RPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNI 114
Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            +   L   +   + +QL + ++Y+H   +  I+H D+K SN+ + E    ++ DFG A+
Sbjct: 115 VKCQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 171
Query: 210 MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLE 268
                                 +    + +  Y  P  +   M   +T D++S G I+ E
Sbjct: 172 QADE------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 213
Query: 269 LVTGMEAF 276
           L+ G   F
Sbjct: 214 LLQGKALF 221

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 191 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 232

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-----IHVGSDRLSQVFKQELDILLHLSHDNI 117
           +++G G F  V+LA      T+   AIK     + +  D +     ++  + L   H  +
Sbjct: 24  KMLGKGSFGKVFLAEF--KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 81
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
             +      ++    + EY+  G L   ++      K         A ++   +++LH +
Sbjct: 82  THMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 138
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
               IV+ D+K  NILL++  + K+ DFG  K                      K     
Sbjct: 139 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---------------AKTNEFC 180
Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           G+P Y  P  L     +   D +SFGV+L E++ G   F
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 128 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 185 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 74/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 128 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 185 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 16  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQT 65
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L  
Sbjct: 66  YCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 125
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 126 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 230

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFK--QELDILLHLSHDNIVK 119
           + IG+G +  V  AR     T    AIK I    D ++   +  +EL IL H  HDNI+ 
Sbjct: 60  ETIGNGAYGVVSSAR--RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 117
Query: 120 L-------IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAI 171
           +       + Y + +   V+L        ++  LH    SS+ L   +     +QL + +
Sbjct: 118 IKDILRPTVPYGEFKSVYVVL------DLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
           +Y+H   +  ++H D+K SN+L+ E+   K+ DFG A+
Sbjct: 172 KYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 190
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 191 XVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 232

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 16/111 (14%)
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           ++ +FQ+A+ +E+L  R     +H D+ A NILL E+   K+CDFG A+  + +      
Sbjct: 202 ISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                                +  P  +   + STK+DV+S+GV+L E+ +
Sbjct: 259 GDTRLPLK-------------WMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L   +    
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 135 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 191
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 192 XVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 233

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 35/236 (14%)
Query: 50  SWDDVERFTQNFSQ-----VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVF 102
            W++  + T +  Q      +G+G F  V L + +   T  + A+KI       +L Q+ 
Sbjct: 30  KWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM--ETGNHYAMKILDKQKVVKLKQIE 87
Query: 103 K--QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
               E  IL  ++   + KL     D     ++ EY P G +   L    R  +   R  
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY 147
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
            A   Q+    EYLH   +L +++ D+K  N+++++    K+ DFG AK           
Sbjct: 148 AA---QIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------- 190
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +   + G+P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 191 -------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLAG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFK--QELDILLHLSHDNIVK 119
           + IG+G +  V  AR     T    AIK I    D ++   +  +EL IL H  HDNI+ 
Sbjct: 61  ETIGNGAYGVVSSAR--RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 118
Query: 120 L-------IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAI 171
           +       + Y + +   V+L        ++  LH    SS+ L   +     +QL + +
Sbjct: 119 IKDILRPTVPYGEFKSVYVVL------DLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
           +Y+H   +  ++H D+K SN+L+ E+   K+ DFG A+
Sbjct: 173 KYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 48  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 106 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 159
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 201
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 59  QNFS--QVIGSGGFSNVYLARLIND-STSTNGAIKIH-----VGSDRLSQVFKQELDILL 110
           +NF   +V+G+G +  V+L R I+   T    A+K+      V   + ++  + E  +L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 111 HLSHDNIVKLIGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
           H+     +  + Y    +  + L+ +Y+  G L   L    R ++           ++  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE---HEVQIYVGEIVL 170
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
           A+E+LH+   L I++ DIK  NILL+ + +  L DFG +K   +                
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET------------- 214
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMAS--TKTDVYSFGVILLELVTGMEAFC 277
             +     G+  Y  P  +R G +      D +S GV++ EL+TG   F 
Sbjct: 215 -ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLXG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 116/306 (37%), Gaps = 52/306 (16%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G F  V+  R+ +  T    A+K      RL     +EL     L+   IV L G  
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVK----KVRLEVFRAEELMACAGLTSPRIVPLYGAV 135
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
            +     +  E +  G+L + +        LP    +    Q  + +EYLH R    I+H
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEGLEYLHSR---RILH 189
Query: 185 GDIKASNILL-EEHLNCKLCDFGSAKM----GFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
           GD+KA N+LL  +  +  LCDFG A      G    +L                  + G+
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD--------------YIPGT 235
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P  +       K DV+S   ++L ++ G   +            G +   IA  E
Sbjct: 236 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW-------TQFFRGPLCLKIAS-E 287
Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAAL--CLRQSPILRPSATQILHTIKHQISSISF 357
              V E           +  + A L+  A+   LR+ PI R SA ++   +   +  +  
Sbjct: 288 PPPVRE-----------IPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGG 336
Query: 358 LFSPQK 363
           L SP +
Sbjct: 337 LKSPWR 342

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 25/240 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 437 GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 489
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 537
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL--AGSMLNDIADC 298
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++   G  +   A C
Sbjct: 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 597

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 41/234 (17%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS--------QVFKQELDILLHLSH 114
           + +GSG F+ V   R     T    A K  +   RLS        +  ++E++IL  + H
Sbjct: 11  EELGSGQFAIVRKCR--QKGTGKEYAAKF-IKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQAIE 172
            NI+ L    +++ + VL+ E V  G L + L     + K       A  F  Q+   + 
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVH 122
Query: 173 YLHERCTLHIVHGDIKASNILLEE----HLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXX 228
           YLH +    I H D+K  NI+L +    +   KL DFG A    +               
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--------- 170
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                  + G+P +  P  +       + D++S GVI   L++G   F  E  Q
Sbjct: 171 -------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 25/240 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 438 GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 490
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 538
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL--AGSMLNDIADC 298
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++   G  +   A C
Sbjct: 539 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 598

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 64/145 (44%), Gaps = 13/145 (8%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G F  V+  R+ +  T    A+K      RL     +EL     LS   IV L G  
Sbjct: 66  VGRGSFGEVH--RMKDKQTGFQCAVK----KVRLEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
            +     +  E +  G+L + +    +   LP    +    Q  + +EYLH R    I+H
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RILH 173
Query: 185 GDIKASNILL-EEHLNCKLCDFGSA 208
           GD+KA N+LL  +     LCDFG A
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHA 198

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 14/173 (8%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ ILL   H+NI+ +           +   Y+    ++  L+   +   L   +    
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF 133
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++             
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +M+ S GYT              D++S G IL E+++    F
Sbjct: 191 YVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 115
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 116 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 173 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 216 FLGDTKQ 222

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 115
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 116 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 173 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 216 FLGDTKQ 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 93  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 145
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 193
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 194 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 240

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 79  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 131
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENXYKAQTHGKWPVK 179
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 226

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 64/145 (44%), Gaps = 13/145 (8%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G F  V+  R+ +  T    A+K      RL     +EL     LS   IV L G  
Sbjct: 82  VGRGSFGEVH--RMKDKQTGFQCAVK----KVRLEVFRVEELVACAGLSSPRIVPLYGAV 135
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
            +     +  E +  G+L + +    +   LP    +    Q  + +EYLH R    I+H
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RILH 189
Query: 185 GDIKASNILL-EEHLNCKLCDFGSA 208
           GD+KA N+LL  +     LCDFG A
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHA 214

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 47/244 (19%)
Query: 65  IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH--------- 114
           +G G FS V+LA+ ++N   +T+ A+KI  G    ++  + E+ +L  ++          
Sbjct: 27  LGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 115 --DNIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
             ++I+KL+ + + +       V++FE +    L   L        +P      I+ QL 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA--LIKKYEHRGIPLIYVKQISKQLL 141
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLE-----EHL-NCKLCDFGSAKMGFSSAVLXXXXX 222
             ++Y+H RC   I+H DIK  N+L+E     E+L   K+ D G+A              
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------------- 185
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                         I +  Y  P  L         D++S   ++ EL+TG   F P+ G 
Sbjct: 186 ----CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241
Query: 283 LLTS 286
             T 
Sbjct: 242 SYTK 245

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 95  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 147
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 195
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 242

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 95  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 147
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 195
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 242

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 28/226 (12%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH----VGSDRLSQVFKQELDILLHLSHD 115
           NF  V+G G F  V LA      T    AIKI     V  D   +    E  +L  L   
Sbjct: 22  NFLMVLGKGSFGKVMLAD--RKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 116 NIVKLIGYC-DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
             +  +  C    D    + EYV  G L   ++   +  K      +  A +++  + +L
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
           H+R    I++ D+K  N++L+   + K+ DFG  K      V              T++ 
Sbjct: 137 HKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-------------TTRE- 179
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
              G+P Y  P  +         D +++GV+L E++ G   F  E+
Sbjct: 180 -FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 224

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 79  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 131
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 179
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 226

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 62  SQVIGSGGFSNVYLA-RLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           S+++G G ++ V  A  L N        I+   G  R S+VF++   +     + NI++L
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSR-SRVFREVETLYQCQGNKNILEL 76
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           I + +D     L+FE +  G++   L    +      R    +   +A A+++LH   T 
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLH---TK 130
Query: 181 HIVHGDIKASNILLE--EHLN-CKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
            I H D+K  NIL E  E ++  K+CDF        S +             +T      
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDF-----DLGSGMKLNNSCTPITTPELTTPC--- 182
Query: 238 GSPGYTDPHYLR--TGMAS---TKTDVYSFGVILLELVTGMEAF 276
           GS  Y  P  +   T  A+    + D++S GV+L  +++G   F
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 16  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQT 65
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    ++  L+   ++  L  
Sbjct: 66  YCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 125
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 126 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDH 182
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 73  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 125
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 173
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 174 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 220

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 47/244 (19%)
Query: 65  IGSGGFSNVYLAR-LINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH--------- 114
           +G G FS V+LA+ ++N   +T+ A+KI  G    ++  + E+ +L  ++          
Sbjct: 27  LGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 115 --DNIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
             ++I+KL+ + + +       V++FE +    L   L        +P      I+ QL 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA--LIKKYEHRGIPLIYVKQISKQLL 141
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLE-----EHL-NCKLCDFGSAKMGFSSAVLXXXXX 222
             ++Y+H RC   I+H DIK  N+L+E     E+L   K+ D G+A              
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------------- 185
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                         I +  Y  P  L         D++S   ++ EL+TG   F P+ G 
Sbjct: 186 ----CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241
Query: 283 LLTS 286
             T 
Sbjct: 242 SYTK 245

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/248 (21%), Positives = 101/248 (40%), Gaps = 42/248 (16%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS 99
           G   + + K  W+  +R  Q    V GSG + +V         ++ +  ++  V   +LS
Sbjct: 13  GFYRQELNKTVWEVPQRL-QGLRPV-GSGAYGSV--------CSAYDARLRQKVAVKKLS 62
Query: 100 QVFK---------QELDILLHLSHDNIVKLIGYCDDRDEGVLLFE-YVPNGTLQEKLHGT 149
           + F+         +EL +L HL H+N++ L+             E Y+    +   L+  
Sbjct: 63  RPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNI 122
Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            +   L   +   + +QL + ++Y+H   +  I+H D+K SN+ + E    ++ DFG A+
Sbjct: 123 VKCQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR 179
Query: 210 MGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLE 268
                                 +    + +  Y  P  +   M   +T D++S G I+ E
Sbjct: 180 QADE------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 269 LVTGMEAF 276
           L+ G   F
Sbjct: 222 LLQGKALF 229

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 75  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 127
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 175
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 65  IGSGGFSNV---YLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           +GSG F  V   Y        T     +K       L      E +++  L +  IV++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    +
Sbjct: 85  GICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---N 137
Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPG 241
            VH D+ A N+LL      K+ DFG +K                       Q        
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPVK 185
Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSL 287
           +  P  +     S+K+DV+SFGV++ E  + G + +    G  +T++
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 20/173 (11%)
Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           +E+ +L  L H NIV L           L+FEY+ +  L++ L      + +   N    
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLF 105
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
            FQL + + Y H +    ++H D+K  N+L+ E    KL DFG A+   + ++       
Sbjct: 106 LFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDN 159
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                      +++GS  Y           ST+ D++  G I  E+ TG   F
Sbjct: 160 EVVTLWYRPPDILLGSTDY-----------STQIDMWGVGCIFYEMATGRPLF 201

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/217 (21%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--------SDRLSQVFKQELDILLHLSH 114
           QVIG+G F  V    L        G  +I V         +++  + F  E  I+    H
Sbjct: 13  QVIGAGEFGEVCSGHL-----KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 67
Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            N++ L G        +++ E++ NG+L   L       +      + +   +A  ++YL
Sbjct: 68  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYL 125
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
            +   ++ VH  + A NIL+  +L CK+ DFG ++       L            +  ++
Sbjct: 126 AD---MNYVHRALAARNILVNSNLVCKVSDFGLSRF------LEDDTSDPTYTSALGGKI 176
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +     +T P  ++    ++ +DV+S+G+++ E+++
Sbjct: 177 PI----RWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 68  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 126 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 179
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK    +                     + G
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW------------------TLCG 221
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 64/145 (44%), Gaps = 13/145 (8%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G F  V+  R+ +  T    A+K      RL     +EL     LS   IV L G  
Sbjct: 80  LGRGSFGEVH--RMKDKQTGFQCAVK----KVRLEVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 125 DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVH 184
            +     +  E +  G+L + +    +   LP    +    Q  + +EYLH R    I+H
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RILH 187
Query: 185 GDIKASNILL-EEHLNCKLCDFGSA 208
           GD+KA N+LL  +     LCDFG A
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHA 212

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R ++   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 87/191 (45%), Gaps = 26/191 (13%)
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           A ++   +E++H R    +V+ D+K +NILL+EH + ++ D G A   FS          
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSK--------- 344
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF---CPE 279
                   K    +G+ GY  P  L+ G+A  +  D +S G +L +L+ G   F     +
Sbjct: 345 -------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
Query: 280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
           +   +  +  +M  ++ D  + ++  L++  L    D++     L   A  +++SP  R 
Sbjct: 398 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR--DVNRRLGCLGRGAQEVKESPFFRS 455
Query: 340 SATQILHTIKH 350
              Q++   K+
Sbjct: 456 LDWQMVFLQKY 466

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 87/191 (45%), Gaps = 26/191 (13%)
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           A ++   +E++H R    +V+ D+K +NILL+EH + ++ D G A   FS          
Sbjct: 297 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSK--------- 343
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF---CPE 279
                   K    +G+ GY  P  L+ G+A  +  D +S G +L +L+ G   F     +
Sbjct: 344 -------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 396
Query: 280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
           +   +  +  +M  ++ D  + ++  L++  L    D++     L   A  +++SP  R 
Sbjct: 397 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR--DVNRRLGCLGRGAQEVKESPFFRS 454
Query: 340 SATQILHTIKH 350
              Q++   K+
Sbjct: 455 LDWQMVFLQKY 465

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 51/107 (47%), Gaps = 14/107 (13%)
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           IA  + +A+E+LH +  L ++H D+K SN+L+      K+CDFG +     S        
Sbjct: 158 IAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVA------ 209
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                  I        +P   +P   + G  S K+D++S G+ ++EL
Sbjct: 210 -----KTIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIEL 250

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+++++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ ++  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 30/186 (16%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++IL  + H NI+ L    +++ + VL+ E V  G L + L     + K       A
Sbjct: 77  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEA 131
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEE----HLNCKLCDFGSAKMGFSSAV 216
             F  Q+   + YLH +    I H D+K  NI+L +    +   KL DFG A    +   
Sbjct: 132 TQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188
Query: 217 LXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                              + G+P +  P  +       + D++S GVI   L++G   F
Sbjct: 189 FKN----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232
Query: 277 CPENGQ 282
             E  Q
Sbjct: 233 LGETKQ 238

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 35/239 (14%)
Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELD 107
           ++DV +  ++   V+G G  + V     IN  TS   A+KI     G  R S+VF+ E++
Sbjct: 10  FEDVYQLQED---VLGEGAHARVQTC--INLITSQEYAVKIIEKQPGHIR-SRVFR-EVE 62
Query: 108 ILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           +L     H N+++LI + ++ D   L+FE +  G++   +H     ++L       +   
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EASVVVQD 119
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLN----CKLCDFGSAKMGFSSAVLXXXXX 222
           +A A+++LH +    I H D+K  NIL  EH N     K+CDFG      S   L     
Sbjct: 120 VASALDFLHNK---GIAHRDLKPENILC-EHPNQVSPVKICDFGLG----SGIKLNGDCS 171
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYL-----RTGMASTKTDVYSFGVILLELVTGMEAF 276
                  +T      GS  Y  P  +        +   + D++S GVIL  L++G   F
Sbjct: 172 PISTPELLTP----CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 87/191 (45%), Gaps = 26/191 (13%)
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           A ++   +E++H R    +V+ D+K +NILL+EH + ++ D G A   FS          
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSK--------- 344
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF---CPE 279
                   K    +G+ GY  P  L+ G+A  +  D +S G +L +L+ G   F     +
Sbjct: 345 -------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
Query: 280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
           +   +  +  +M  ++ D  + ++  L++  L    D++     L   A  +++SP  R 
Sbjct: 398 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR--DVNRRLGCLGRGAQEVKESPFFRS 455
Query: 340 SATQILHTIKH 350
              Q++   K+
Sbjct: 456 LDWQMVFLQKY 466

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 87/191 (45%), Gaps = 26/191 (13%)
Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXX 223
           A ++   +E++H R    +V+ D+K +NILL+EH + ++ D G A   FS          
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSK--------- 344
Query: 224 XXXXXXITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAF---CPE 279
                   K    +G+ GY  P  L+ G+A  +  D +S G +L +L+ G   F     +
Sbjct: 345 -------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
Query: 280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
           +   +  +  +M  ++ D  + ++  L++  L    D++     L   A  +++SP  R 
Sbjct: 398 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR--DVNRRLGCLGRGAQEVKESPFFRS 455
Query: 340 SATQILHTIKH 350
              Q++   K+
Sbjct: 456 LDWQMVFLQKY 466

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS-QVFKQELD---ILLHLSHDNIV 118
           +V+GSG F  VY    I D  +    + I V  +  S +  K+ LD   ++  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +L+G C       L+ + +P G L +  H      +L  ++ +    Q+A+ + YL +  
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLD--HVRENRGRLGSQDLLNWCMQIAKGMSYLED-- 137
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            + +VH D+ A N+L++   + K+ DFG A++
Sbjct: 138 -VRLVHRDLAARNVLVKSPNHVKITDFGLARL 168

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R  +   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R  +   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R  +   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 42  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 99
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R  +   R   A   Q+    EYLH   
Sbjct: 100 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA---QIVLTFEYLH--- 153
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 195
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ IL  + H N++ L    +++ + +L+ E V  G L + L     + K       A
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-----AEKESLTEEEA 116
Query: 163 IAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSA-KMGFSSA 215
             F  Q+   + YLH   +L I H D+K  NI+L +        K+ DFG A K+ F + 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                               + G+P +  P  +       + D++S GVI   L++G   
Sbjct: 174 FKN-----------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 276 FCPENGQ 282
           F  +  Q
Sbjct: 217 FLGDTKQ 223

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 98/239 (41%), Gaps = 32/239 (13%)
Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QV 101
           V+   +D   R+T N S  IG G +  V         ++ +   K+ V   ++S    Q 
Sbjct: 34  VRGQVFDVGPRYT-NLS-YIGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQT 83
Query: 102 FKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPW 157
           + Q    E+ ILL   H+NI+ +           +   Y+    +   L+   ++  L  
Sbjct: 84  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN 143
Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL 217
            +     +Q+ + ++Y+H   + +++H D+K SN+LL    + K+CDFG A++       
Sbjct: 144 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 200
Query: 218 XXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                            +M+ S GYT              D++S G IL E+++    F
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 248

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 68  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R  +    +    A Q+    EYLH   
Sbjct: 126 KLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFXEPHARFYAAQIVLTFEYLH--- 179
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 221
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P Y  P  + +   +   D ++ GV++ E+  G   F
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           IG G +  V++ +   +      A+K+   ++  S   + E+   + + H+NI+  I   
Sbjct: 45  IGKGRYGEVWMGKWRGEKV----AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIA-A 99
Query: 125 DDRDEG-----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC- 178
           D +  G      L+ +Y  NG+L + L    +S+ L  ++ + +A+     + +LH    
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 179 ----TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
                  I H D+K+ NIL++++  C + D G A    S                 T +V
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD----------------TNEV 199
Query: 235 -----MMIGSPGYTDPHYLRTGM------ASTKTDVYSFGVILLEL 269
                  +G+  Y  P  L   +      +    D+YSFG+IL E+
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 50/128 (39%)
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+           
Sbjct: 201 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----------- 246
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYSFG 263
                                Y DP Y+R G A                 + ++DV+SFG
Sbjct: 247 -------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 287
Query: 264 VILLELVT 271
           V+L E+ +
Sbjct: 288 VLLWEIFS 295

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLS-QVFKQELDILLHLSHDN 116
           +VIG G FS V   R IN  T    A+KI        S  LS +  K+E  I   L H +
Sbjct: 32  EVIGKGPFSVV--RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 89
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRS-SKLPWRNRMAIAF--QLAQAIEY 173
           IV+L+          ++FE++    L  ++    R+ +   +   +A  +  Q+ +A+ Y
Sbjct: 90  IVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 174 LHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSA-KMGFSSAVLXXXXXXXXXXXX 229
            H+    +I+H D+K   +LL    N    KL  FG A ++G S  V             
Sbjct: 148 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--------- 195
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  +G+P +  P  ++        DV+  GVIL  L++G   F
Sbjct: 196 -------VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLS-QVFKQELDILLHLSHDN 116
           +VIG G FS V   R IN  T    A+KI        S  LS +  K+E  I   L H +
Sbjct: 30  EVIGKGPFSVV--RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRS-SKLPWRNRMAIAF--QLAQAIEY 173
           IV+L+          ++FE++    L  ++    R+ +   +   +A  +  Q+ +A+ Y
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 174 LHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSA-KMGFSSAVLXXXXXXXXXXXX 229
            H+    +I+H D+K   +LL    N    KL  FG A ++G S  V             
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--------- 193
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                  +G+P +  P  ++        DV+  GVIL  L++G   F
Sbjct: 194 -------VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 26/221 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           + +GSG F  V+  R +  +T      K I+          K E+ I+  L H  ++ L 
Sbjct: 57  EELGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +D+ E VL+ E++  G L +++       K+     +    Q  + ++++HE     
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 182 IVHGDIKASNILLE--EHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
           IVH DIK  NI+ E  +  + K+ DFG A       ++            +T       +
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-----------KVTTATAEFAA 218
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
           P   D            TD+++ GV+   L++G+  F  E+
Sbjct: 219 PEIVD-----REPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 50/128 (39%)
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+           
Sbjct: 203 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----------- 248
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYSFG 263
                                Y DP Y+R G A                 + ++DV+SFG
Sbjct: 249 -------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 289
Query: 264 VILLELVT 271
           V+L E+ +
Sbjct: 290 VLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 50/128 (39%)
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+           
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----------- 241
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYSFG 263
                                Y DP Y+R G A                 + ++DV+SFG
Sbjct: 242 -------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282
Query: 264 VILLELVT 271
           V+L E+ +
Sbjct: 283 VLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 50/128 (39%)
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+           
Sbjct: 194 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----------- 239
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMA-----------------STKTDVYSFG 263
                                Y DP Y+R G A                 + ++DV+SFG
Sbjct: 240 -------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 280
Query: 264 VILLELVT 271
           V+L E+ +
Sbjct: 281 VLLWEIFS 288

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
            +R    +VH D+ A N+L++   + K+ DFG AK+     +             +  + 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKL-----LGAEEKEYHAEGGKVPIKW 187
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           M + S        +   + + ++DV+S+GV + EL+T
Sbjct: 188 MALES--------ILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 85  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 137
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKL 170

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           IA  + +A+E+LH +  L ++H D+K SN+L+      K+CDFG +  G+          
Sbjct: 114 IAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS--GY---------L 160
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                  I        +P   +P   + G  S K+D++S G+ ++EL
Sbjct: 161 VDDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIEL 206

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 33/218 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK-MGFSSAVLXXXXXXXXXXXXITKQ 233
            +R    +VH D+ A N+L++   + K+ DFG AK +G                    + 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           ++          H + T     ++DV+S+GV + EL+T
Sbjct: 193 IL----------HRIYT----HQSDVWSYGVTVWELMT 216

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 41/245 (16%)
Query: 56  RFTQN---FSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELD 107
           R T N   + +++G G F  V L +    +T    A+KI      V  D ++     E  
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVK--EKATGRYYAMKILKKEVIVAKDEVAHTL-TENR 200
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMA 162
           +L +  H  +  L       D    + EY   G L     +E++    R+          
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------F 252
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              ++  A++YLH     ++V+ D+K  N++L++  + K+ DFG  K G           
Sbjct: 253 YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 308
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                          G+P Y  P  L         D +  GV++ E++ G   F  ++ +
Sbjct: 309 -------------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355
Query: 283 LLTSL 287
            L  L
Sbjct: 356 KLFEL 360

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 41/245 (16%)
Query: 56  RFTQN---FSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELD 107
           R T N   + +++G G F  V L +    +T    A+KI      V  D ++     E  
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVK--EKATGRYYAMKILKKEVIVAKDEVAHTL-TENR 203
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMA 162
           +L +  H  +  L       D    + EY   G L     +E++    R+          
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------F 255
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              ++  A++YLH     ++V+ D+K  N++L++  + K+ DFG  K G           
Sbjct: 256 YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 311
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                          G+P Y  P  L         D +  GV++ E++ G   F  ++ +
Sbjct: 312 -------------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 358
Query: 283 LLTSL 287
            L  L
Sbjct: 359 KLFEL 363

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFK--QELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI       +L Q+     E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R S+   R   A   Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH--- 158
Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIG 238
           +L +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWXLCG 200
Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           +P    P  + +   +   D ++ GV++ E+  G   F
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 61  FSQVIGSGGFSNVYLARLINDST-STNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           F Q +G GGFS V L   ++D        I  H   DR  +  ++E D+    +H NI++
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHPNILR 90
Query: 120 LIGYC----DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR-MAIAFQLAQAIEYL 174
           L+ YC      + E  LL  +   GTL  ++            ++ + +   + + +E +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGS 207
           H +      H D+K +NILL +     L D GS
Sbjct: 151 HAKG---YAHRDLKPTNILLGDEGQPVLMDLGS 180

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQ----ELDILLHLSHDN 116
           IG G +  V         ++ +   K+ V   ++S    Q + Q    E+ ILL   H+N
Sbjct: 31  IGEGAYGMV--------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+ +           +   Y+    ++  L+   ++  L   +     +Q+ + ++Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH- 141
Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM 236
             + +++H D+K SN+LL    + K+ DFG A++                        +M
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
           + S GYT              D++S G IL E+++    F
Sbjct: 200 LNSKGYT-----------KSIDIWSVGCILAEMLSNRPIF 228

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 72
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 73  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 119
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 120 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 165
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 166 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 86
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 87  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 133
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H      ++H DIK  NIL++      KL DFGS  +           
Sbjct: 134 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 179
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 180 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 86
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 87  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 133
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H      ++H DIK  NIL++      KL DFGS  +           
Sbjct: 134 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 179
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 180 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 72
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 73  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 119
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 120 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 165
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 166 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 87
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 88  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 134
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H      ++H DIK  NIL++      KL DFGS  +           
Sbjct: 135 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 180
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 181 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 100 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 146
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 147 FFWQVLEAVRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 192
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 193 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 101 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 147
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 148 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 193
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 194 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 114
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 115 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 161
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 162 FFWQVLEAVRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 207
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 208 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 87
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 88  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 134
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H      ++H DIK  NIL++      KL DFGS  +           
Sbjct: 135 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 180
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 181 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 71
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 72  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 119 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 164
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 165 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLS-- 113
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 114 HDNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 114
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H    L   H DIK  NIL++      KL DFGS  +           
Sbjct: 115 FFWQVLEAVRHCHNXGVL---HRDIKDENILIDLNRGELKLIDFGSGAL----------- 160
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 87
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 88  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 134
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H      ++H DIK  NIL++      KL DFGS  +           
Sbjct: 135 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 180
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 181 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 37/239 (15%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL-LHLSHDNIVKLIGY 123
           +G G FS   + R      S N A  + + S R+    ++E+  L L   H NIVKL   
Sbjct: 19  LGEGSFS---ICRKCVHKKS-NQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
             D+    L+ E +  G L E++      S+        I  +L  A+ ++H+   + +V
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSHMHD---VGVV 128
Query: 184 HGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
           H D+K  N+L     ++L  K+ DFG A++                          + +P
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLK-------------------PPDNQPLKTP 169
Query: 241 GYT----DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
            +T     P  L         D++S GVIL  +++G   F   +  L  + A  ++  I
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLS-- 113
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 114 HDNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 114
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 115 FFWQVLEAVRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 160
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 114
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 115 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 161
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 162 FFWQVLEAVRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 207
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 208 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 101 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 147
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 148 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 193
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 194 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLS-- 113
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 70
Query: 114 HDNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 71  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 117
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 118 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 163
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 164 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 82  RLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 134
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLS-- 113
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 71
Query: 114 HDNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 72  FSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL-------------ARS 118
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 119 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 164
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 165 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 100 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 146
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 147 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 192
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 193 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 100 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 146
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 147 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 192
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 193 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 85  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 137
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 170

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 72
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 73  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 119
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 120 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 165
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 166 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 101 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 147
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 148 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 193
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 194 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 119
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 120 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 166
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 167 FFWQVLEAVRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 212
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 213 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 84  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLS-- 113
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 94
Query: 114 HDNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 95  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 141
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 142 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 187
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 188 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 83  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
            +R    +VH D+ A N+L++   + K+ DFG AK+     +             +  + 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKL-----LGAEEKEYHAEGGKVPIKW 187
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           M + S        +   + + ++DV+S+GV + EL+T
Sbjct: 188 MALES--------ILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELD 107
           ++DV +  ++   V+G G  + V     IN  TS   A+KI     G  R S+VF+ E++
Sbjct: 10  FEDVYQLQED---VLGEGAHARVQTC--INLITSQEYAVKIIEKQPGHIR-SRVFR-EVE 62
Query: 108 ILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           +L     H N+++LI + ++ D   L+FE +  G++   +H     ++L       +   
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EASVVVQD 119
Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLN----CKLCDFGSAKMGFSSAVLXXXXX 222
           +A A+++LH +    I H D+K  NIL  EH N     K+CDF    +G S   L     
Sbjct: 120 VASALDFLHNK---GIAHRDLKPENILC-EHPNQVSPVKICDF---DLG-SGIKLNGDCS 171
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYL-----RTGMASTKTDVYSFGVILLELVTGMEAF 276
                  +T      GS  Y  P  +        +   + D++S GVIL  L++G   F
Sbjct: 172 PISTPELLTP----CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
            +R    +VH D+ A N+L++   + K+ DFG AK+     +             +  + 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKL-----LGAEEKEYHAEGGKVPIKW 185
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           M + S        +   + + ++DV+S+GV + EL+T
Sbjct: 186 MALES--------ILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 100
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 101 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 147
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 148 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 193
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 194 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 99
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 100 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 146
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 147 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 192
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 193 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLSH- 114
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 115 -DNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 153
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 154 FFWQVLEAVRHCHN-CG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 199
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 200 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 81  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 59/232 (25%)
Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--------FKQELDILLHLS-- 113
           ++GSGGF +VY    ++D+     AIK HV  DR+S             E+ +L  +S  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPV--AIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 114 HDNIVKLIGYCDDRDEGVL----------LFEYVPN-GTLQEKLHGTPRSSKLPWRNRMA 162
              +++L+ + +  D  VL          LF+++   G LQE+L               +
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------------ARS 114
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLXXXX 221
             +Q+ +A+ + H  C   ++H DIK  NIL++      KL DFGS  +           
Sbjct: 115 FFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL----------- 160
Query: 222 XXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                    T      G+  Y+ P ++R      ++  V+S G++L ++V G
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 16/213 (7%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + +G G +  V+      +S     A+KI    D  S   + E+   + L HDNI+  I 
Sbjct: 14  ECVGKGRYGEVWRGLWHGESV----AVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 123 Y-CDDRDEGVLLF---EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA-IEYLHER 177
                R+    L+    Y  +G+L + L        L  R  ++ A  LA   +E    +
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMI 237
               I H D K+ N+L++ +L C + D G A M    +               TK+ M  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVG---TKRYM-- 184
Query: 238 GSPGYTDPHYLRTGMASTK-TDVYSFGVILLEL 269
            +P   D         S K TD+++FG++L E+
Sbjct: 185 -APEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 88  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKL 173

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 41/245 (16%)
Query: 56  RFTQN---FSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELD 107
           R T N   + +++G G F  V L +    +T    A+KI      V  D ++     E  
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVK--EKATGRYYAMKILKKEVIVAKDEVAHTL-TENR 60
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMA 162
           +L +  H  +  L       D    + EY   G L     +E++    R+       R  
Sbjct: 61  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFY 113
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
            A ++  A++YLH     ++V+ D+K  N++L++  + K+ DFG  K G           
Sbjct: 114 GA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK--- 167
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                          G+P Y  P  L         D +  GV++ E++ G   F  ++ +
Sbjct: 168 ------------XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 215
Query: 283 LLTSL 287
            L  L
Sbjct: 216 KLFEL 220

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 82  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 134
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 41/245 (16%)
Query: 56  RFTQN---FSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELD 107
           R T N   + +++G G F  V L +    +T    A+KI      V  D ++     E  
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVK--EKATGRYYAMKILKKEVIVAKDEVAHTL-TENR 61
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMA 162
           +L +  H  +  L       D    + EY   G L     +E++    R+          
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------F 113
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              ++  A++YLH     ++V+ D+K  N++L++  + K+ DFG  K G           
Sbjct: 114 YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK--- 168
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                          G+P Y  P  L         D +  GV++ E++ G   F  ++ +
Sbjct: 169 ------------XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 216
Query: 283 LLTSL 287
            L  L
Sbjct: 217 KLFEL 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 41/245 (16%)
Query: 56  RFTQN---FSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQVFKQELD 107
           R T N   + +++G G F  V L +    +T    A+KI      V  D ++     E  
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVK--EKATGRYYAMKILKKEVIVAKDEVAHTL-TENR 62
Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL-----QEKLHGTPRSSKLPWRNRMA 162
           +L +  H  +  L       D    + EY   G L     +E++    R+          
Sbjct: 63  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------F 114
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
              ++  A++YLH     ++V+ D+K  N++L++  + K+ DFG  K G           
Sbjct: 115 YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK--- 169
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                          G+P Y  P  L         D +  GV++ E++ G   F  ++ +
Sbjct: 170 ------------XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 217
Query: 283 LLTSL 287
            L  L
Sbjct: 218 KLFEL 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 38/231 (16%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           NF  V+G G F  V L+      T    A+KI         V  Q+ D+   +    ++ 
Sbjct: 23  NFLMVLGKGSFGKVMLSE--RKGTDELYAVKI-----LKKDVVIQDDDVECTMVEKRVLA 75
Query: 120 LIGY---------C-DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
           L G          C    D    + EYV  G L   +    R  +    + +  A ++A 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAI 132
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            + +L  +    I++ D+K  N++L+   + K+ DFG  K      V             
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------------- 176
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
            TK     G+P Y  P  +         D ++FGV+L E++ G   F  E+
Sbjct: 177 TTK--XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS 99
           G   + V K +W+  + +       +GSG + +V  A  I+  +    AIK  +     S
Sbjct: 9   GFYKQDVNKTAWELPKTYVSPTH--VGSGAYGSVCSA--IDKRSGEKVAIK-KLSRPFQS 63
Query: 100 QVFKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFE-YVPNGTLQEKLHGTPRSSK 154
           ++F +    EL +L H+ H+N++ L+            ++ Y+    +Q  L       K
Sbjct: 64  EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI-MGLK 122
Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
                   + +Q+ + ++Y+H   +  +VH D+K  N+ + E    K+ DFG A+   + 
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 215 AVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGM 273
                          +T  V+   +  Y  P  + + M   +T D++S G I+ E++TG 
Sbjct: 180 ---------------MTGYVV---TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
Query: 274 EAF 276
             F
Sbjct: 222 TLF 224

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 108/246 (43%), Gaps = 39/246 (15%)
Query: 40  GIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS 99
           G   + V K +W+  + +       +GSG + +V  A  I+  +    AIK  +     S
Sbjct: 27  GFYKQDVNKTAWELPKTYVSPTH--VGSGAYGSVCSA--IDKRSGEKVAIK-KLSRPFQS 81
Query: 100 QVFKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFE-YVPNGTLQ---EKLHGTPR 151
           ++F +    EL +L H+ H+N++ L+            ++ Y+    +Q   +K+ G   
Sbjct: 82  EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEF 141
Query: 152 SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG 211
           S +        + +Q+ + ++Y+H   +  +VH D+K  N+ + E    K+ DFG A+  
Sbjct: 142 SEE----KIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194
Query: 212 FSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELV 270
            +                +T  V+   +  Y  P  + + M   +T D++S G I+ E++
Sbjct: 195 DAE---------------MTGYVV---TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236
Query: 271 TGMEAF 276
           TG   F
Sbjct: 237 TGKTLF 242

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 78  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYL 130
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 131 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 163

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 115 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 167
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 168 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 200

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 37/235 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---------QELDILLHLS 113
            +IG G +  VYLA   + +T  N AIK      +++++F+         +E+ IL  L 
Sbjct: 32  HLIGRGSYGYVYLA--YDKNTEKNVAIK------KVNRMFEDLIDCKRILREITILNRLK 83
Query: 114 HDNIVKLIGYC--DDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
            D I++L      DD    DE  ++ E + +  L+ KL  TP    L   +   I + L 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLK-KLFKTPIF--LTEEHIKTILYNLL 139
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA------VLXXXXX 222
               ++HE     I+H D+K +N LL +  + K+CDFG A+   S         L     
Sbjct: 140 LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 223 XXXXXXXITKQVM-MIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEA 275
                  + KQ+   + +  Y  P  +      TK+ D++S G I  EL+  +++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + +G G +  V+      +    N A+KI    D  S   + EL   + L H+NI+  I 
Sbjct: 14  ECVGKGRYGEVWRGSWQGE----NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 123 Y-CDDRDEGVLLF---EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA-IEYLHER 177
                R     L+    Y   G+L + L  T   +    R  ++IA  LA   IE    +
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM- 236
               I H D+K+ NIL++++  C + D G A M   S                T Q+ + 
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS----------------TNQLDVG 173
Query: 237 ----IGSPGYTDPHYLRTGM------ASTKTDVYSFGVILLELVTGM 273
               +G+  Y  P  L   +      +  + D+++FG++L E+   M
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V        S  T       +  D LSQ      F +E++ +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G         ++ E  P G+L ++L        L   +R A+  Q+A+ + YL  +  
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 130
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N+LL      K+ DFG  +                       Q      
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHYVMQEHRKVP 177
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLLTSL--AGSMLNDI 295
             +  P  L+T   S  +D + FGV L E+ T G E +   NG Q+L  +   G  L   
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 296 ADCEATKVNELV 307
            DC     N +V
Sbjct: 238 EDCPQDIYNVMV 249

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 75  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 127
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + +G G +  V+      +    N A+KI    D  S   + EL   + L H+NI+  I 
Sbjct: 43  ECVGKGRYGEVWRGSWQGE----NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 123 Y-CDDRDEGVLLF---EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA-IEYLHER 177
                R     L+    Y   G+L + L  T   +    R  ++IA  LA   IE    +
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM- 236
               I H D+K+ NIL++++  C + D G A M   S                T Q+ + 
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS----------------TNQLDVG 202
Query: 237 ----IGSPGYTDPHYLRTGM------ASTKTDVYSFGVILLELVTGM 273
               +G+  Y  P  L   +      +  + D+++FG++L E+   M
Sbjct: 203 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 84  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + +G G +  V+      +    N A+KI    D  S   + EL   + L H+NI+  I 
Sbjct: 14  ECVGKGRYGEVWRGSWQGE----NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 123 Y-CDDRDEGVLLF---EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA-IEYLHER 177
                R     L+    Y   G+L + L  T   +    R  ++IA  LA   IE    +
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMM- 236
               I H D+K+ NIL++++  C + D G A M   S                T Q+ + 
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS----------------TNQLDVG 173
Query: 237 ----IGSPGYTDPHYLRTGM------ASTKTDVYSFGVILLELVTGM 273
               +G+  Y  P  L   +      +  + D+++FG++L E+   M
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 88  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V        S  T       +  D LSQ      F +E++ +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G         ++ E  P G+L ++L        L   +R A+  Q+A+ + YL  +  
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 130
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N+LL      K+ DFG  +                       Q      
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHXVMQEHRKVP 177
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLLTSL--AGSMLNDI 295
             +  P  L+T   S  +D + FGV L E+ T G E +   NG Q+L  +   G  L   
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 296 ADCEATKVNELV 307
            DC     N +V
Sbjct: 238 EDCPQDIYNVMV 249

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V        S  T       +  D LSQ      F +E++ +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G         ++ E  P G+L ++L        L   +R A+  Q+A+ + YL  +  
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 130
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N+LL      K+ DFG  +                       Q      
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHYVMQEHRKVP 177
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLLTSL--AGSMLNDI 295
             +  P  L+T   S  +D + FGV L E+ T G E +   NG Q+L  +   G  L   
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 296 ADCEATKVNELV 307
            DC     N +V
Sbjct: 238 EDCPQDIYNVMV 249

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 91  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 143
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 144 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 176

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 84  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 18/111 (16%)
Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
           Q+   +E+LH+R   +I++ D+K  N+LL++  N ++ D G A                 
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA---------------VE 338
Query: 226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                TK     G+PG+  P  L         D ++ GV L E++     F
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 106 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 158
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 159 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 191

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 18/111 (16%)
Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
           Q+   +E+LH+R   +I++ D+K  N+LL++  N ++ D G A                 
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA---------------VE 338
Query: 226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                TK     G+PG+  P  L         D ++ GV L E++     F
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 45/238 (18%)
Query: 53  DVERFTQNF--SQVIGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLSQVFKQE 105
           D E F   +    ++G GGF  V+    + D      AIK+      +G   LS      
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV--AIKVIPRNRVLGWSPLSDSVTCP 82
Query: 106 LDILLHL------SHDNIVKLIGYCDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWR 158
           L++ L         H  +++L+ + + ++  +L+ E  +P   L + +     + K P  
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-----TEKGPLG 137
Query: 159 NRMAIAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSA 215
              +  F  Q+  AI++ H R    +VH DIK  NIL++    C KL DFGS  +     
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194
Query: 216 VLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
                                 G+  Y+ P ++ R    +    V+S G++L ++V G
Sbjct: 195 YTD-----------------FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V        S  T       +  D LSQ      F +E++ +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G         ++ E  P G+L ++L        L   +R A+  Q+A+ + YL  +  
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 134
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N+LL      K+ DFG  +                       Q      
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHYVMQEHRKVP 181
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLLTSL--AGSMLNDI 295
             +  P  L+T   S  +D + FGV L E+ T G E +   NG Q+L  +   G  L   
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 241
Query: 296 ADCEATKVNELV 307
            DC     N +V
Sbjct: 242 EDCPQDIYNVMV 253

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 84  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 18/111 (16%)
Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
           Q+   +E+LH+R   +I++ D+K  N+LL++  N ++ D G A                 
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA---------------VE 338
Query: 226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                TK     G+PG+  P  L         D ++ GV L E++     F
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V        S  T       +  D LSQ      F +E++ +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G         ++ E  P G+L ++L        L   +R A+  Q+A+ + YL  +  
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 140
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N+LL      K+ DFG  +                       Q      
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHYVMQEHRKVP 187
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLLTSL--AGSMLNDI 295
             +  P  L+T   S  +D + FGV L E+ T G E +   NG Q+L  +   G  L   
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 296 ADCEATKVNELV 307
            DC     N +V
Sbjct: 248 EDCPQDIYNVMV 259

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 80/195 (41%), Gaps = 29/195 (14%)
Query: 89  IKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLLFEYVPNGTLQEKL 146
           +K+   S R S+ F +E   L   SH N++ ++G C         L+  ++P G+L   L
Sbjct: 41  LKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL 100
Query: 147 H-GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           H GT  +  +     +  A  +A+ + +LH    L   H  + + +++++E +  ++   
Sbjct: 101 HEGT--NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LNSRSVMIDEDMTARIS-M 156
Query: 206 GSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTK---TDVYSF 262
              K  F S                      + +P +  P  L+     T     D++SF
Sbjct: 157 ADVKFSFQSP-------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197
Query: 263 GVILLELVTGMEAFC 277
            V+L ELVT    F 
Sbjct: 198 AVLLWELVTREVPFA 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 14/107 (13%)
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
           IA  + +A+E+LH +  L ++H D+K SN+L+      K CDFG +              
Sbjct: 141 IAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA------ 192
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                  I        +P   +P   + G  S K+D++S G+  +EL
Sbjct: 193 -----KDIDAGCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIEL 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V        S  T       +  D LSQ      F +E++ +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G         ++ E  P G+L ++L        L   +R A+  Q+A+ + YL  +  
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 140
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N+LL      K+ DFG  +                       Q      
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHXVMQEHRKVP 187
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLLTSL--AGSMLNDI 295
             +  P  L+T   S  +D + FGV L E+ T G E +   NG Q+L  +   G  L   
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 296 ADCEATKVNELV 307
            DC     N +V
Sbjct: 248 EDCPQDIYNVMV 259

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 87  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 139
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
            +R    +VH D+ A N+L++   + K+ DFG AK+     +             +  + 
Sbjct: 140 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGAEEKEYHAEGGKVPIKW 191
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           M + S        +   + + ++DV+S+GV + EL+T
Sbjct: 192 MALES--------ILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 97/252 (38%), Gaps = 27/252 (10%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-----FKQELDILLHLSHDNIVK 119
           +G G F  V        S  T       +  D LSQ      F +E++ +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G         ++ E  P G+L ++L        L   +R A+  Q+A+ + YL  +  
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 134
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
              +H D+ A N+LL      K+ DFG  +                       Q      
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMR------------ALPQNDDHYVMQEHRKVP 181
Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG-QLLTSL--AGSMLNDI 295
             +  P  L+T   S  +D + FGV L E+ T G E +   NG Q+L  +   G  L   
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 241
Query: 296 ADCEATKVNELV 307
            DC     N +V
Sbjct: 242 EDCPQDIYNVMV 253

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 38/227 (16%)
Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
           NF  V+G G F  V L+      T    A+KI         V  Q+ D+   +    ++ 
Sbjct: 344 NFLMVLGKGSFGKVMLSE--RKGTDELYAVKI-----LKKDVVIQDDDVECTMVEKRVLA 396
Query: 120 LIGY---------C-DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
           L G          C    D    + EYV  G L   +    R  +    + +  A ++A 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAI 453
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXX 229
            + +L  +    I++ D+K  N++L+   + K+ DFG  K      V             
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------------- 497
Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            TK     G+P Y  P  +         D ++FGV+L E++ G   F
Sbjct: 498 TTK--XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 18/111 (16%)
Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXX 225
           Q+   +E+LH+R   +I++ D+K  N+LL++  N ++ D G A                 
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA---------------VE 338
Query: 226 XXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                TK     G+PG+  P  L         D ++ GV L E++     F
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+GSG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 83  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 27/222 (12%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDR--LSQVFKQELDILLHLSHDNIVK 119
           + IG G +  V+ A+  N  T    A+K + +  D   +     +E+ +L  L H NIV+
Sbjct: 8   EKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L        +  L+FE+  +  L++       +  L      +  FQL + + + H R  
Sbjct: 66  LHDVLHSDKKLTLVFEFC-DQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR-- 120
Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGS 239
            +++H D+K  N+L+  +   KL DFG A+  F   V              + +V+ +  
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLADFGLAR-AFGIPV-----------RCYSAEVVTL-- 165
Query: 240 PGYTDPHYL-RTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
             Y  P  L    + ST  D++S G I  EL        P N
Sbjct: 166 -WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGN 206

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 26/223 (11%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG-Y 123
           +G G + +VY A+  +     + A+K   G+  +S    +E+ +L  L H N++ L   +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 87
Query: 124 CDDRDEGV-LLFEYVPNGTLQE-KLHGTPRSSK----LPWRNRMAIAFQLAQAIEYLHER 177
               D  V LLF+Y  +      K H   +++K    LP     ++ +Q+   I YLH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 178 CTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQ 233
             L   H D+K +NIL+     E    K+ D G A++  S                    
Sbjct: 148 WVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            +++G+  YT              D+++ G I  EL+T    F
Sbjct: 205 ELLLGARHYT-----------KAIDIWAIGCIFAELLTSEPIF 236

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 56  RFTQNFSQV--IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ--------- 104
            ++Q +S +  +GSG F  V+ A  ++   +    +K       L   + +         
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+ IL  + H NI+K++   +++    L+ E   +G+  +      R  +L       I 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
            QL  A+ YL  +    I+H DIK  NI++ E    KL DFGSA
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 24/114 (21%)
Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLXXXXXXXXXXX 228
           A+ +LH +  +H+   D+K +NI L     CKL DFG   ++G + A             
Sbjct: 169 ALAHLHSQGLVHL---DVKPANIFLGPRGRCKLGDFGLLVELGTAGA------------- 212
Query: 229 XITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                 +  G P Y  P  L+ G   T  DV+S G+ +LE+   ME   P  G+
Sbjct: 213 ----GEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNME--LPHGGE 259

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 71/337 (21%), Positives = 137/337 (40%), Gaps = 58/337 (17%)
Query: 48  KYSWDDVERFTQNFS--QVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDRLS----Q 100
           K   +DV    Q F+  +++G G F +V  A+L   D +    A+K+ + +D ++    +
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM-LKADIIASSDIE 70
Query: 101 VFKQELDILLHLSHDNIVKLIGYC-DDRDEG-----VLLFEYVPNGTLQEKLHGT---PR 151
            F +E   +    H ++ KL+G     R +G     +++  ++ +G L   L  +     
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 152 SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG 211
              LP +  +     +A  +EYL  R   + +H D+ A N +L E +   + DFG ++  
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187
Query: 212 FSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +S                +  +              L   + +  +DV++FGV + E++T
Sbjct: 188 YSGDYYRQGCASKLPVKWLALES-------------LADNLYTVHSDVWAFGVTMWEIMT 234
Query: 272 -GMEAFCP-ENGQLLTSL-AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAA 328
            G   +   EN ++   L  G+ L    +C    + E+ D                 +  
Sbjct: 235 RGQTPYAGIENAEIYNYLIGGNRLKQPPEC----MEEVYD-----------------LMY 273
Query: 329 LCLRQSPILRPSATQILHTIKHQISSISFLFSPQKDP 365
            C    P  RPS T +   +++ +  +S L S  +DP
Sbjct: 274 QCWSADPKQRPSFTCLRMELENILGHLSVL-STSQDP 309

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 17  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 75  YDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 128
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                     + K    +G+ 
Sbjct: 129 -IVHSDLKPANFLIVDGM-LKLIDFGIANQ------------MQPDTTSVVKD-SQVGTV 173
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 174 NYMPPEAIK-DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 220
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I+     K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 221 QQIINQIS-----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 20  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 77
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 78  YDY-EITDQYIYMVMECGNIDLNSWLKK--KKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 131
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                     + K    +G+ 
Sbjct: 132 -IVHSDLKPANFLIVDGM-LKLIDFGIANQ------------MQPDTTSVVKD-SQVGTV 176
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 177 NYMPPEAIK-DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 223
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I     +K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 224 QQIINQI-----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 36  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 94  YDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 147
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                     + K    +G+ 
Sbjct: 148 -IVHSDLKPANFLIVDGM-LKLIDFGIANQ------------MQPDTTSVVKDSQ-VGTV 192
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 193 NYMPPEAIK-DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 239
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I+     K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 240 QQIINQIS-----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 64  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 122 YDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 175
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                     + K    +G+ 
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQ------------MQPDTTSVVKDSQ-VGTV 220
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 221 NYMPPEAIK-DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 267
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I     +K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 268 QQIINQI-----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 16  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 73
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 74  YDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 127
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                     + K    +G+ 
Sbjct: 128 -IVHSDLKPANFLIVDGM-LKLIDFGIANQ------------MQPDTTSVVKD-SQVGTV 172
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 173 NYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 219
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I     +K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 220 QQIINQI-----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/297 (21%), Positives = 118/297 (39%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 36  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 94  YDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 147
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                            +G+ 
Sbjct: 148 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDS-------------QVGTV 192
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 193 NYMPPEAIK-DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 239
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I     +K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 240 QQIINQI-----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 94/260 (36%), Gaps = 65/260 (25%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-------FKQELDILLHLSHDNI 117
           IG G +  V +A  I + T    AIKI +  +++ Q+        K E+ ++  L H NI
Sbjct: 34  IGQGSYGVVRVA--IENQTRAIRAIKI-MNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKL------------------------------- 146
            +L    +D     L+ E    G L +KL                               
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 147 ----HGTPRSSKLPWRNRM--AIAFQLAQAIEYLHERCTLHIVHGDIKASNILL--EEHL 198
               HG   S     R ++   I  Q+  A+ YLH +    I H DIK  N L    +  
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207
Query: 199 NCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMAS--TK 256
             KL DFG +K  +                  TK     G+P +  P  L T   S   K
Sbjct: 208 EIKLVDFGLSKEFYK-------LNNGEYYGMTTKA----GTPYFVAPEVLNTTNESYGPK 256
Query: 257 TDVYSFGVILLELVTGMEAF 276
            D +S GV+L  L+ G   F
Sbjct: 257 CDAWSAGVLLHLLLMGAVPF 276

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 64  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 122 YDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 175
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                     + K    +G+ 
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQ------------MQPDTTSVVKDSQ-VGTV 220
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 221 NYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 267
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I     +K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 268 QQIINQI-----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G F  V+  +   +      A+KI    +  S   + E+   + L H+NI+  
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEEV----AVKIFSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 121 IGYCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           I   D++D G      L+ +Y  +G+L + L+    + +      + +A   A  + +LH
Sbjct: 102 IA-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLH 156
Query: 176 -----ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 +    I H D+K+ NIL++++  C + D G A
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 65  IGSGGFSNVYLARLINDSTSTNGA--IKIHVGSDRLSQVFKQELDILLHLSH--DNIVKL 120
           IGSGG S V+  +++N+         + +    ++    ++ E+  L  L    D I++L
Sbjct: 64  IGSGGSSKVF--QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
             Y +  D+ + +     N  L   L    + S  PW  R +    + +A+  +H+    
Sbjct: 122 YDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWE-RKSYWKNMLEAVHTIHQHG-- 175
Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSP 240
            IVH D+K +N L+ + +  KL DFG A                     + K    +G+ 
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQ------------MQPDTTSVVKDSQ-VGAV 220
Query: 241 GYTDPHYLRTGMASTK------------TDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            Y  P  ++  M+S++            +DV+S G IL  +  G   F            
Sbjct: 221 NYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------------ 267
Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             ++N I     +K++ ++DP    +F     + +  +   CL++ P  R S  ++L
Sbjct: 268 QQIINQI-----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 111/265 (41%), Gaps = 37/265 (13%)
Query: 53  DVERFTQNFSQV---------IGSGGFSNVYLARL-INDSTSTNGAIKIHVGSDRLSQVF 102
           D+E+  +   Q+         IG G FS+VYLA   +        A+K  + +    ++ 
Sbjct: 8   DIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIA 67
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
            +   + +    DN++  + YC  +++ V++   Y+ + +  + L+       L ++   
Sbjct: 68  AELQCLTVAGGQDNVMG-VKYCFRKNDHVVIAMPYLEHESFLDILNS------LSFQEVR 120
Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFSSAV-LXX 219
                L +A++ +H+     IVH D+K SN L    L    L DFG A+    + + L  
Sbjct: 121 EYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 220 XXXXXXXXXXITKQVMMI------------GSPGYTDPHYL-RTGMASTKTDVYSFGVIL 266
                      ++    I            G+PG+  P  L +    +T  D++S GVI 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 267 LELVTGMEAFCPENGQLLTSLAGSM 291
           L L++G   F   +   LT+LA  M
Sbjct: 238 LSLLSGRYPFYKASDD-LTALAQIM 261

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+ SG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 88  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 48  KYSWDDVERFTQN-FSQ--VIGSGGFSNVYLA--RLINDSTSTNGAIKIHVGSDRLSQVF 102
           ++ W + +  T+N F Q  V+G GGF  V     R      +     K  +   +   + 
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
             E  IL  ++   +V L    + +D   L+   +  G L+  ++   ++   P    + 
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVF 290
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
            A ++   +E LH      IV+ D+K  NILL++H + ++ D G A        +     
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-- 345
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         +G+ GY  P  ++    +   D ++ G +L E++ G   F
Sbjct: 346 --------------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 80/202 (39%), Gaps = 30/202 (14%)
Query: 82  STSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT 141
           + S N  I I    D     FK EL I+  + ++  +   G   + DE  +++EY+ N +
Sbjct: 74  TKSNNDKISIKSKYDD----FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 142 L---QEKLHGTPRSSK--LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE 196
           +    E      ++    +P +    I   +  +  Y+H     +I H D+K SNIL+++
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDK 187
Query: 197 HLNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQVMMIGSPGYTDPHYL--RTGMAS 254
           +   KL DFG ++      +                     G+  +  P +    +    
Sbjct: 188 NGRVKLSDFGESEYMVDKKIKGSR-----------------GTYEFMPPEFFSNESSYNG 230
Query: 255 TKTDVYSFGVILLELVTGMEAF 276
            K D++S G+ L  +   +  F
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPF 252

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 65  IGSGGFSNVYLA-RLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGY 123
           +G G +  VY A   + + T     I++    + +     +E+ +L  L H NI++L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV 183
                   L+FEY  N  L++ +   P  S    R   +  +QL   + + H R  L   
Sbjct: 102 IHHNHRLHLIFEYAEND-LKKYMDKNPDVSM---RVIKSFLYQLINGVNFCHSRRCL--- 154
Query: 184 HGDIKASNILL-----EEHLNCKLCDFGSAK 209
           H D+K  N+LL      E    K+ DFG A+
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXX 220
           + I  Q+A+A+E+LH +    ++H D+K SNI        K+ DFG              
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 221 XXXXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV 270
                       QV   G+  Y  P  +     S K D++S G+IL EL+
Sbjct: 224 LTPMPAYATHXGQV---GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G F  V+  +   +      A+KI    +  S   + E+   + L H+NI+  
Sbjct: 33  LQESIGKGRFGEVWRGKWRGEEV----AVKIFSSREERSWFREAEIYQTVMLRHENILGF 88
Query: 121 IGYCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           I   D++D G      L+ +Y  +G+L + L+    + +      + +A   A  + +LH
Sbjct: 89  IA-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLH 143
Query: 176 -----ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 +    I H D+K+ NIL++++  C + D G A
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 48  KYSWDDVERFTQN-FSQ--VIGSGGFSNVYLA--RLINDSTSTNGAIKIHVGSDRLSQVF 102
           ++ W + +  T+N F Q  V+G GGF  V     R      +     K  +   +   + 
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
             E  IL  ++   +V L    + +D   L+   +  G L+  ++   ++   P    + 
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVF 290
Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLXXXXX 222
            A ++   +E LH      IV+ D+K  NILL++H + ++ D G A        +     
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-- 345
Query: 223 XXXXXXXITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
                         +G+ GY  P  ++    +   D ++ G +L E++ G   F
Sbjct: 346 --------------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G F  V+  +   +      A+KI    +  S   + E+   + L H+NI+  
Sbjct: 13  LQESIGKGRFGEVWRGKWRGEEV----AVKIFSSREERSWFREAEIYQTVMLRHENILGF 68
Query: 121 IGYCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           I   D++D G      L+ +Y  +G+L + L+    + +      + +A   A  + +LH
Sbjct: 69  IA-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLH 123
Query: 176 -----ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 +    I H D+K+ NIL++++  C + D G A
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G F  V+  +   +      A+KI    +  S   + E+   + L H+NI+  
Sbjct: 10  LQESIGKGRFGEVWRGKWRGEEV----AVKIFSSREERSWFREAEIYQTVMLRHENILGF 65
Query: 121 IGYCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           I   D++D G      L+ +Y  +G+L + L+    + +      + +A   A  + +LH
Sbjct: 66  IA-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLH 120
Query: 176 -----ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 +    I H D+K+ NIL++++  C + D G A
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G F  V+  +   +      A+KI    +  S   + E+   + L H+NI+  
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEEV----AVKIFSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 121 IGYCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           I   D++D G      L+ +Y  +G+L + L+    + +      + +A   A  + +LH
Sbjct: 63  IA-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLH 117
Query: 176 -----ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 +    I H D+K+ NIL++++  C + D G A
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G F  V+  +   +      A+KI    +  S   + E+   + L H+NI+  
Sbjct: 8   LQESIGKGRFGEVWRGKWRGEEV----AVKIFSSREERSWFREAEIYQTVMLRHENILGF 63
Query: 121 IGYCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           I   D++D G      L+ +Y  +G+L + L+    + +      + +A   A  + +LH
Sbjct: 64  IA-ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLH 118
Query: 176 -----ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 +    I H D+K+ NIL++++  C + D G A
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL---SHDNIVK 119
           +VIG G F  V   +  +     + A+K+     R  +   +E+ IL HL     DN + 
Sbjct: 103 KVIGKGSFGQV--VKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 120 LIGYCDD---RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +I   ++   R+   + FE +     +       +   LP   +   A  + Q ++ LH+
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALHK 218
Query: 177 RCTLHIVHGDIKASNILLEEH--LNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
                I+H D+K  NILL++      K+ DFGS+                       +  
Sbjct: 219 N---RIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQRVY 257
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             I S  Y  P  +         D++S G IL EL+TG
Sbjct: 258 TXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+ SG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 88  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 29/161 (18%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---------QELDILLHLS 113
            +IG G +  VYLA   + + + N AIK      +++++F+         +E+ IL  L 
Sbjct: 34  HLIGRGSYGYVYLA--YDKNANKNVAIK------KVNRMFEDLIDCKRILREITILNRLK 85
Query: 114 HDNIVKL--IGYCDDR---DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
            D I++L  +   +D    DE  ++ E + +  L+ KL  TP    L  ++   I + L 
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLK-KLFKTPIF--LTEQHVKTILYNLL 141
Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
              +++HE     I+H D+K +N LL +  + K+CDFG A+
Sbjct: 142 LGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL---SHDNIVK 119
           +VIG G F  V   +  +     + A+K+     R  +   +E+ IL HL     DN + 
Sbjct: 103 KVIGKGSFGQV--VKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 120 LIGYCDD---RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +I   ++   R+   + FE +     +       +   LP   +   A  + Q ++ LH+
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALHK 218
Query: 177 RCTLHIVHGDIKASNILLEEH--LNCKLCDFGSAKMGFSSAVLXXXXXXXXXXXXITKQV 234
                I+H D+K  NILL++      K+ DFGS+                       +  
Sbjct: 219 N---RIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQRVY 257
Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             I S  Y  P  +         D++S G IL EL+TG
Sbjct: 258 TXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           +V+ SG F  VY    I +       + I       S + ++    E  ++  + + ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +L+G C       L+ + +P G L    +E          L W        Q+A+ + YL
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
            +R    +VH D+ A N+L++   + K+ DFG AK+
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	368
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-90
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-86
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-85
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-49
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-47
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-46
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-45
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-45
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-43
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-37
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-26
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-17
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-09

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  274 bits (702), Expect = 1e-90
 Identities = 93/322 (28%), Positives = 153/322 (47%), Gaps = 32/322 (9%)

Query: 39  DGIDGRSVKKYSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAIKI-HVGS 95
             +      +    D+E  T NF    +IG G F  VY   L +       A+K     S
Sbjct: 19  SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD---GAKVALKRRTPES 75

Query: 96  DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK- 154
            +  + F+ E++ L    H ++V LIG+CD+R+E +L+++Y+ NG L+  L+G+   +  
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           + W  R+ I    A+ + YLH R    I+H D+K+ NILL+E+   K+ DFG +K G   
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG--- 189

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
                       ++ ++  V   G+ GY DP Y   G  + K+DVYSFGV+L E++    
Sbjct: 190 --------TELDQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Query: 275 AFCPENGQLLTSL---AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCL 331
           A      + + +L   A    N+       ++ ++VDP LA     +  R     A  CL
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNN------GQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293

Query: 332 RQSPILRPSATQILHTIKHQIS 353
             S   RPS   +L  +++ + 
Sbjct: 294 ALSSEDRPSMGDVLWKLEYALR 315

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  263 bits (674), Expect = 2e-86
 Identities = 100/331 (30%), Positives = 165/331 (49%), Gaps = 45/331 (13%)

Query: 32  DQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQ--VIGSGGFSNVYLARLINDSTSTNGAI 89
           D   + D  +    +K++S  +++  + NFS   ++G GGF  VY  RL +    T  A+
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD---GTLVAV 59

Query: 90  KIHVGSDRLSQV--------FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT 141
           K      RL +         F+ E++++    H N+++L G+C    E +L++ Y+ NG+
Sbjct: 60  K------RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113

Query: 142 LQEKLHGTPRS-SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC 200
           +   L   P S   L W  R  IA   A+ + YLH+ C   I+H D+KA+NILL+E    
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173

Query: 201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVY 260
            + DFG AK+                 + +T  V   G+ G+  P YL TG +S KTDV+
Sbjct: 174 VVGDFGLAKLM------------DYKDTHVTTAVR--GTIGHIAPEYLSTGKSSEKTDVF 219

Query: 261 SFGVILLELVTGMEAF-----CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDF 315
            +GV+LLEL+TG  AF       ++  +L      +L      +  K+  LVD  L G++
Sbjct: 220 GYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL------KEKKLEALVDVDLQGNY 273

Query: 316 DLDEARAMLSIAALCLRQSPILRPSATQILH 346
             +E   ++ +A LC + SP+ RP  ++++ 
Sbjct: 274 KDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  260 bits (666), Expect = 2e-85
 Identities = 90/333 (27%), Positives = 163/333 (48%), Gaps = 41/333 (12%)

Query: 36  DHDDGIDGRSVKKYSWDDVERFTQNFSQ--------VIGSGGFSNVYLARLINDSTSTNG 87
           +    +       +S+ +++  T NF +         +G GGF  VY   +  ++T+   
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTV-- 57

Query: 88  AIK-----IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL 142
           A+K     + + ++ L Q F QE+ ++    H+N+V+L+G+  D D+  L++ Y+PNG+L
Sbjct: 58  AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117

Query: 143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKL 202
            ++L     +  L W  R  IA   A  I +LHE      +H DIK++NILL+E    K+
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKI 174

Query: 203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSF 262
            DFG A+                +++ +T +++  G+  Y  P  L  G  + K+D+YSF
Sbjct: 175 SDFGLARAS-----------EKFAQTVMTSRIV--GTTAYMAPEAL-RGEITPKSDIYSF 220

Query: 263 GVILLELVTGMEAFCP-ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR 321
           GV+LLE++TG+ A       QLL  +   + ++        + + +D ++  D D     
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE-----EKTIEDYIDKKM-NDADSTSVE 274

Query: 322 AMLSIAALCLRQSPILRPSATQILHTIKHQISS 354
           AM S+A+ CL +    RP   ++   ++   +S
Sbjct: 275 AMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  198 bits (506), Expect = 2e-61
 Identities = 69/336 (20%), Positives = 122/336 (36%), Gaps = 48/336 (14%)

Query: 35  HDHDDGIDGRSVKKYSWDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIH 92
           H H  G+D         +++   +      +V   G F  V+ A+L+N+      A+KI 
Sbjct: 6   HHHSSGVD------LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV----AVKIF 55

Query: 93  VGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV----LLFEYVPNGTLQEKLHG 148
              D+ S   + E+  L  + H+NI++ IG             L+  +   G+L + L  
Sbjct: 56  PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115

Query: 149 TPRSSKLPWRNRMAIAFQLAQAIEYLHE-------RCTLHIVHGDIKASNILLEEHLNCK 201
                 + W     IA  +A+ + YLHE            I H DIK+ N+LL+ +L   
Sbjct: 116 NV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171

Query: 202 LCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-----ASTK 256
           + DFG A             S   +  +       +G+  Y  P  L   +     A  +
Sbjct: 172 IADFGLAL------KFEAGKSAGDTHGQ-------VGTRRYMAPEVLEGAINFQRDAFLR 218

Query: 257 TDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATK--VNELVDPRLAGD 314
            D+Y+ G++L EL +   A      + +      +    +  +  +  V++   P L   
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY 278

Query: 315 FDLDEA-RAMLSIAALCLRQSPILRPSATQILHTIK 349
           +        +      C       R SA  +   I 
Sbjct: 279 WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  175 bits (445), Expect = 2e-52
 Identities = 78/326 (23%), Positives = 127/326 (38%), Gaps = 52/326 (15%)

Query: 45  SVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ 104
           S+    + ++E       +V+G G F  V  A+      + + AIK  + S+   + F  
Sbjct: 1   SLHMIDYKEIE-----VEEVVGRGAFGVVCKAKW----RAKDVAIKQ-IESESERKAFIV 50

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           EL  L  ++H NIVKL G C   +   L+ EY   G+L   LHG          + M+  
Sbjct: 51  ELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            Q +Q + YLH      ++H D+K  N+LL       K+CDFG+                
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT---------------- 152

Query: 224 SPSRSRITKQVMM--IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG 281
               +   +  M    GS  +  P        S K DV+S+G+IL E++T  + F     
Sbjct: 153 ----ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF----- 203

Query: 282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA 341
                     +   A      V+    P L  +      + + S+   C  + P  RPS 
Sbjct: 204 --------DEIGGPAFRIMWAVHNGTRPPLIKNLP----KPIESLMTRCWSKDPSQRPSM 251

Query: 342 TQILHTIKHQISSISFLFSPQKDPSR 367
            +I+  + H +        P + P +
Sbjct: 252 EEIVKIMTHLMRYFPGADEPLQYPCQ 277

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  167 bits (426), Expect = 1e-49
 Identities = 75/312 (24%), Positives = 126/312 (40%), Gaps = 56/312 (17%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG---AIKI---HVGSDRLSQVFKQ 104
           W D+        + IG+G F  V+ A         +G   A+KI             F +
Sbjct: 36  WCDLN-----IKEKIGAGSFGTVHRAEW-------HGSDVAVKILMEQDFHAERVNEFLR 83

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+ I+  L H NIV  +G         ++ EY+  G+L   LH +    +L  R R+++A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
           + +A+ + YLH      IVH ++K+ N+L+++    K+CDFG +++              
Sbjct: 144 YDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-------------- 188

Query: 225 PSRSRITKQVMM--IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                 T        G+P +  P  LR   ++ K+DVYSFGVIL EL T  + +      
Sbjct: 189 ---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW------ 239

Query: 283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                       +    A    +     +  + +      + +I   C    P  RPS  
Sbjct: 240 -----GNLNPAQVV---AAVGFKCKRLEIPRNLN----PQVAAIIEGCWTNEPWKRPSFA 287

Query: 343 QILHTIKHQISS 354
            I+  ++  I S
Sbjct: 288 TIMDLLRPLIKS 299

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  166 bits (423), Expect = 4e-49
 Identities = 65/309 (21%), Positives = 116/309 (37%), Gaps = 26/309 (8%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV-FKQELDILLHLSHDNIVK 119
             +V+G G F            T     +K  +  D  +Q  F +E+ ++  L H N++K
Sbjct: 14  HGEVLGKGCFGQAIKVTH--RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
            IG          + EY+  GTL+  +      S+ PW  R++ A  +A  + YLH    
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSM-- 127

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
            +I+H D+ + N L+ E+ N  + DFG A++       P          R  +   ++G+
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT-VVGN 185

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
           P +  P  +       K DV+SFG++L E++  + A                        
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD----------YLPRTMDF--- 232

Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF 359
              V   +D     +       +   I   C    P  RPS  ++ H ++     ++   
Sbjct: 233 GLNVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288

Query: 360 SPQKDPSRL 368
                  +L
Sbjct: 289 PLGPQLEQL 297

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  166 bits (423), Expect = 6e-49
 Identities = 66/335 (19%), Positives = 121/335 (36%), Gaps = 53/335 (15%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNG---AIKIHVGSDRLSQVFKQELDI--LLHLSHD 115
             ++IG G +  VY   L       +    A+K+   ++R +  F  E +I  +  + HD
Sbjct: 17  LLELIGRGRYGAVYKGSL-------DERPVAVKVFSFANRQN--FINEKNIYRVPLMEHD 67

Query: 116 NIVKLIGYC-----DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
           NI + I        D R E +L+ EY PNG+L + L          W +   +A  + + 
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRG 123

Query: 171 IEYLHE------RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
           + YLH            I H D+ + N+L++    C + DFG +     + ++ P    +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGM-------ASTKTDVYSFGVILLELVTGMEAFC 277
            + S        +G+  Y  P  L   +       A  + D+Y+ G+I  E+        
Sbjct: 184 AAISE-------VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 278 PENG----QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEA--RAMLSIAALCL 331
           P       Q+             D +     E   P+    +  +    R++      C 
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 332 RQSPILRPSATQILHTIKHQISSISFLFSPQKDPS 366
            Q    R +A          ++ +  ++   K  S
Sbjct: 297 DQDAEARLTAQXAEER----MAELMMIWERNKSVS 327

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  160 bits (407), Expect = 3e-47
 Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 42/231 (18%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV----FKQELDILLHLSHD 115
             ++IG GGF  VY A  I        A+K      D          +QE  +   L H 
Sbjct: 11  LEEIIGIGGFGKVYRAFWIG----DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NI+ L G C       L+ E+   G L   L G     ++P    +  A Q+A+ + YLH
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH 122

Query: 176 ERCTLHIVHGDIKASNILLEE--------HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           +   + I+H D+K+SNIL+ +        +   K+ DFG A+                  
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----------------- 165

Query: 228 SRITKQVMM--IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
               +   M   G+  +  P  +R  M S  +DV+S+GV+L EL+TG   F
Sbjct: 166 --WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  159 bits (403), Expect = 2e-46
 Identities = 70/317 (22%), Positives = 121/317 (38%), Gaps = 65/317 (20%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--------HVGSDRLSQVF 102
            +++E     + + IG GGF  V+  RL+ D +    AIK                 Q F
Sbjct: 18  DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVV--AIKSLILGDSEGETEMIEKFQEF 70

Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E+ I+ +L+H NIVKL G     +   ++ E+VP G L  +L    ++  + W  ++ 
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLR 126

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-----HLNCKLCDFGSAKMGFSSAVL 217
           +   +A  IEY+       IVH D+++ NI L+       +  K+ DFG           
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL---------- 175

Query: 218 PPSPSPSPSRSRITKQVMM--IGSPGYTDPHYL--RTGMASTKTDVYSFGVILLELVTGM 273
                     S+ +   +   +G+  +  P  +       + K D YSF +IL  ++TG 
Sbjct: 176 ----------SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

Query: 274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQ 333
             F                  I      +   L   R     D      + ++  LC   
Sbjct: 226 GPF-----------DEYSYGKIKFINMIREEGL---RPTIPEDCPP--RLRNVIELCWSG 269

Query: 334 SPILRPSATQILHTIKH 350
            P  RP  + I+  +  
Sbjct: 270 DPKKRPHFSYIVKELSE 286

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  159 bits (403), Expect = 4e-46
 Identities = 55/313 (17%), Positives = 107/313 (34%), Gaps = 58/313 (18%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVG--SDRLSQVFKQELD 107
           ++ +E       ++IG G F  VY  R   +      AI+ I +   ++   + FK+E+ 
Sbjct: 32  FEQLE-----IGELIGKGRFGQVYHGRWHGEV-----AIRLIDIERDNEDQLKAFKREVM 81

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
                 H+N+V  +G C       ++       TL   +        L       IA ++
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEI 139

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + + YLH +    I+H D+K+ N+  +      + DFG   +               + 
Sbjct: 140 VKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSIS----------GVLQAG 185

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMA---------STKTDVYSFGVILLELVTGMEAFCP 278
            R  K  +  G   +  P  +R             S  +DV++ G I  EL      F  
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

Query: 279 ENG-QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL 337
           +    ++  +   M  +++     K                    +  I   C       
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGK-------------------EISDILLFCWAFEQEE 286

Query: 338 RPSATQILHTIKH 350
           RP+ T+++  ++ 
Sbjct: 287 RPTFTKLMDMLEK 299

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  156 bits (396), Expect = 3e-45
 Identities = 62/307 (20%), Positives = 112/307 (36%), Gaps = 36/307 (11%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + +G G +  V+           N A+KI    D  S   + EL   + L H+NI+  
Sbjct: 12  LLECVGKGRYGEVWRGSWQG----ENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGF 67

Query: 121 IGYC----DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I           +  L+  Y   G+L + L  T     L   + + I   +A  + +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHI 123

Query: 177 RCTLH-----IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
                     I H D+K+ NIL++++  C + D G A M         S S +       
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--------HSQSTNQLDVGNN 175

Query: 232 KQVMMIGSPGYTDP------HYLRTGMASTKTDVYSFGVILLELVTGMEAFCP-ENGQLL 284
            +V   G+  Y  P        +    +  + D+++FG++L E+   M +    E+ +  
Sbjct: 176 PRV---GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

Query: 285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEA-RAMLSIAALCLRQSPILRPSATQ 343
                       D       +   P +   +  D    ++  +   C  Q+P  R +A +
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292

Query: 344 ILHTIKH 350
           I  T+  
Sbjct: 293 IKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  157 bits (398), Expect = 3e-45
 Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 36/311 (11%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G +  V++ +          A+K+   ++  S   + E+   + + H+NI+  
Sbjct: 41  MVKQIGKGRYGEVWMGKWRG----EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGF 96

Query: 121 IGYCDDRDEGV----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I              L+ +Y  NG+L + L     S+ L  ++ + +A+     + +LH 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 177 RCTLH-----IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
                     I H D+K+ NIL++++  C + D G A    S       P          
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP--------N 204

Query: 232 KQVMMIGSPGYTDP------HYLRTGMASTKTDVYSFGVILLELVTGMEAFCP-ENGQLL 284
            +V   G+  Y  P             +    D+YSFG+IL E+     +    E  QL 
Sbjct: 205 TRV---GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261

Query: 285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEA-RAMLSIAALCLRQSPILRPSATQ 343
                       D       + + P     +  DE  R M  +   C   +P  R +A +
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

Query: 344 ILHTIKHQISS 354
           +  T+     S
Sbjct: 322 VKKTLAKMSES 332

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  153 bits (389), Expect = 1e-44
 Identities = 42/225 (18%), Positives = 82/225 (36%), Gaps = 34/225 (15%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDN 116
           NF   +       ++  R        +  +K+      S R S+ F +E   L   SH N
Sbjct: 13  NFLTKLNENHSGELWKGRWQG----NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 117 IVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           ++ ++G C         L+  ++P G+L   LH    +  +     +  A  +A+ + +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H      I    + + +++++E +  ++                         S  +   
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADV------------------KFSFQSPGR 168

Query: 235 MMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAF 276
           M   +P +  P  L+           D++SF V+L ELVT    F
Sbjct: 169 M--YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  153 bits (388), Expect = 4e-44
 Identities = 74/298 (24%), Positives = 122/298 (40%), Gaps = 48/298 (16%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVG--SDRLSQVFKQELDILLHLSHDNI 117
             Q IGSG F  VY  +   D      A+K ++V   + +  Q FK E+ +L    H NI
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDV-----AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           +  +GY     +  ++ ++    +L   LH     +K   +  + IA Q A+ ++YLH +
Sbjct: 83  LLFMGYST-APQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK 139

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM- 236
               I+H D+K++NI L E    K+ DFG A                             
Sbjct: 140 ---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE---------------KSRWSGSHQFEQ 181

Query: 237 -IGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
             GS  +  P  +R   +   S ++DVY+FG++L EL+TG   +   N      +   + 
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEMVG 239

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
                 + +KV      R+              + A CL++    RPS  +IL  I+ 
Sbjct: 240 RGSLSPDLSKVRSNCPKRMK------------RLMAECLKKKRDERPSFPRILAEIEE 285

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  152 bits (385), Expect = 3e-43
 Identities = 59/306 (19%), Positives = 112/306 (36%), Gaps = 34/306 (11%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + IG G F  V+  +          A+KI    +  S   + E+   + L H+NI+  
Sbjct: 46  LQESIGKGRFGEVWRGKWRG----EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 101

Query: 121 IGYCDDRDEGV----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I   +  +       L+ +Y  +G+L + L+       +     + +A   A  + +LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHM 157

Query: 177 -----RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI- 230
                +    I H D+K+ NIL++++  C + D G A    S+              R+ 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA----TDTIDIAPNHRVG 213

Query: 231 TKQVM----MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF-CPENGQLLT 285
           TK+ M    +  S         +      + D+Y+ G++  E+          E+ QL  
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFK------RADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEA-RAMLSIAALCLRQSPILRPSATQI 344
                    + +       + + P +   +   EA R M  I   C   +   R +A +I
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

Query: 345 LHTIKH 350
             T+  
Sbjct: 328 KKTLSQ 333

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  143 bits (362), Expect = 2e-40
 Identities = 73/328 (22%), Positives = 123/328 (37%), Gaps = 50/328 (15%)

Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLH 111
           R+  +F   Q +G GGF  V+ A+   D  +   AIK       +   +   +E+  L  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNY--AIKRIRLPNRELAREKVMREVKALAK 59

Query: 112 LSHDNIVKLIGYCDDRDE---------GVLLF---EYVPNGTLQEKLHGTPRSSKLPWRN 159
           L H  IV+      +++           V L+   +      L++ ++G     +     
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
            + I  Q+A+A+E+LH +    ++H D+K SNI        K+ DFG             
Sbjct: 120 CLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
             +P P+ +R T QV   G+  Y  P  +     S K D++S G+IL EL+         
Sbjct: 177 VLTPMPAYARHTGQV---GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFST---- 229

Query: 280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP 339
                       L D+ + +   +     P             M+      L  SP+ RP
Sbjct: 230 -----QMERVRTLTDVRNLKFPPLFTQKYP---------CEYVMVQ---DMLSPSPMERP 272

Query: 340 SATQILHTIKHQISSISFLFSPQKDPSR 367
            A  I+   ++ +     L  P K   R
Sbjct: 273 EAINII---ENAV--FEDLDFPGKTVLR 295

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  142 bits (359), Expect = 1e-39
 Identities = 57/293 (19%), Positives = 99/293 (33%), Gaps = 37/293 (12%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           Q +G GGFS V L            A+K I     +  +  ++E D+    +H NI++L+
Sbjct: 35  QKLGEGGFSYVDLVE--GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 122 GYCDDRDEGV----LLFEYVPNGTLQEKL-HGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
            YC           LL  +   GTL  ++     + + L     + +   + + +E +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +      H D+K +NILL +     L D GS                S     +      
Sbjct: 153 K---GYAHRDLKPTNILLGDEGQPVLMDLGSMN------QACIHVEGSRQALTLQDWAAQ 203

Query: 237 IGSPGYTDP---HYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN 293
             +  Y  P         +   +TDV+S G +L  ++ G   +              M+ 
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-------------DMVF 250

Query: 294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
              D  A  V   +    +          +L+     +   P  RP    +L 
Sbjct: 251 QKGDSVALAVQNQLSIPQSPRHS-SALWQLLNS---MMTVDPHQRPHIPLLLS 299

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  141 bits (357), Expect = 5e-39
 Identities = 66/317 (20%), Positives = 130/317 (41%), Gaps = 45/317 (14%)

Query: 33  QYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-I 91
            +H H         +   +  +E++     Q IG G F    L +  +        IK I
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMEKYV--RLQKIGEGSFGKAILVK--STEDGRQYVIKEI 57

Query: 92  HVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGT 149
           ++   S +  +  ++E+ +L ++ H NIV+     ++     ++ +Y   G L ++++  
Sbjct: 58  NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117

Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            +         +    Q+  A++++H+R    I+H DIK+ NI L +    +L DFG A+
Sbjct: 118 -KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR 173

Query: 210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
           +  S+  L  +                IG+P Y  P        + K+D+++ G +L EL
Sbjct: 174 VLNSTVELARA---------------CIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

Query: 270 VTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL 329
            T   AF   + + L                 K+     P ++  +   + R+++S    
Sbjct: 219 CTLKHAFEAGSMKNL---------------VLKIISGSFPPVSLHYS-YDLRSLVS---Q 259

Query: 330 CLRQSPILRPSATQILH 346
             +++P  RPS   IL 
Sbjct: 260 LFKRNPRDRPSVNSILE 276

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (352), Expect = 6e-39
 Identities = 66/324 (20%), Positives = 123/324 (37%), Gaps = 52/324 (16%)

Query: 31  QDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK 90
           Q++ +   D I+    K     +  RF + F   IG G F  VY    ++  T+   A  
Sbjct: 1   QEERNQQQDDIEELETKAVGMSNDGRFLK-FDIEIGRGSFKTVYKG--LDTETTVEVAWC 57

Query: 91  I----HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLLF--EYVPNGTL 142
                 +      + FK+E ++L  L H NIV+     +   + +  ++   E + +GTL
Sbjct: 58  ELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116

Query: 143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCK 201
           +  L    R   +  +   +   Q+ + +++LH   T  I+H D+K  NI +     + K
Sbjct: 117 KTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVK 172

Query: 202 LCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYS 261
           + D G A +                  R +    +IG+P +  P            DVY+
Sbjct: 173 IGDLGLATL-----------------KRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYA 214

Query: 262 FGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR 321
           FG+ +LE+ T    +           A       +  +    +++  P         E +
Sbjct: 215 FGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVKPASFDKVAIP---------EVK 260

Query: 322 AMLSIAALCLRQSPILRPSATQIL 345
            ++     C+RQ+   R S   +L
Sbjct: 261 EIIE---GCIRQNKDERYSIKDLL 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (352), Expect = 8e-39
 Identities = 71/308 (23%), Positives = 116/308 (37%), Gaps = 46/308 (14%)

Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS 113
           R+  +F    V+G G F  V  AR  N   S   AIK    ++        E+ +L  L+
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60

Query: 114 HDNIVKLIG-YCDDRDEGVLLF------------EYVPNGTLQEKL--HGTPRSSKLPWR 158
           H  +V+    + + R+    +             EY  NGTL + +      +     WR
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP 218
               +  Q+ +A+ Y+H +    I+H D+K  NI ++E  N K+ DFG AK    S  + 
Sbjct: 121 ----LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFC 277
              S +   S        IG+  Y     L  TG  + K D+YS G+I  E++       
Sbjct: 174 KLDSQNLPGSSDNLTS-AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----- 227

Query: 278 PENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL 337
              G    ++    L  +             P    +      + ++    L +   P  
Sbjct: 228 FSTGMERVNI----LKKLRSVSIE-----FPPDFDDNKM-KVEKKIIR---LLIDHDPNK 274

Query: 338 RPSATQIL 345
           RP A  +L
Sbjct: 275 RPGARTLL 282

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (344), Expect = 7e-38
 Identities = 66/292 (22%), Positives = 111/292 (38%), Gaps = 44/292 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVG--SDRLSQVFKQELDILLHLSHDNIVK 119
             IG+G +      R  +D        K +  G  ++   Q+   E+++L  L H NIV+
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKIL--VWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69

Query: 120 LIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYLHE 176
                 DR    L  + EY   G L   +    +  + L     + +  QL  A++  H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 177 R--CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           R      ++H D+K +N+ L+   N KL DFG A++         +              
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-------------- 175

Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND 294
             +G+P Y  P  +     + K+D++S G +L EL   M  F   + + L          
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---------- 224

Query: 295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
                A K+ E    R+   +  DE   +++     L      RPS  +IL 
Sbjct: 225 -----AGKIREGKFRRIPYRYS-DELNEIIT---RMLNLKDYHRPSVEEILE 267

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  136 bits (345), Expect = 1e-37
 Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 41/294 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVG---SDRLSQVFKQELDILLHLSHDNIV 118
           + IG G FS VY A           A+K + +      +      +E+D+L  L+H N++
Sbjct: 38  KKIGRGQFSEVYRAA--CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 95

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYLHER 177
           K      + +E  ++ E    G L   +    +  + +P R       QL  A+E++H R
Sbjct: 96  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               ++H DIK +N+ +      KL D G  +   S      S               ++
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---------------LV 197

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD 297
           G+P Y  P  +     + K+D++S G +L E+      F  +   L  SL          
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL---------- 246

Query: 298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ 351
               K+ +   P L  D   +E R +++   +C+   P  RP  T +    K  
Sbjct: 247 --CKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRM 295

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  136 bits (345), Expect = 2e-37
 Identities = 72/319 (22%), Positives = 124/319 (38%), Gaps = 43/319 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLS-HDNIVKL 120
           +V+  GGF+ VY A+  +  +    A+K +    +  ++   QE+  +  LS H NIV+ 
Sbjct: 34  RVLAEGGFAFVYEAQ--DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 121 IGYCDDRDEG-------VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
                   E         LL   +  G L E L        L     + I +Q  +A+++
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP-SRSRITK 232
           +H +    I+H D+K  N+LL      KLCDFGSA    ++    P  S S   R+ + +
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA----TTISHYPDYSWSAQRRALVEE 206

Query: 233 QVMMIGSPGYTDP---HYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
           ++    +P Y  P             K D+++ G IL  L      F  E+G  L  + G
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIVNG 264

Query: 290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
                  D + T  + L+                       L+ +P  R S  +++H + 
Sbjct: 265 KYSIPPHDTQYTVFHSLI--------------------RAMLQVNPEERLSIAEVVHQL- 303

Query: 350 HQISSISFLFSPQKDPSRL 368
            +I++   +         L
Sbjct: 304 QEIAAARNVNPKSPITELL 322

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  131 bits (331), Expect = 1e-35
 Identities = 64/331 (19%), Positives = 111/331 (33%), Gaps = 60/331 (18%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQV 101
           +S   + W          S ++G G  +NV+  R  +  T    AIK+  ++   R   V
Sbjct: 4   QSTSNHLWL--------LSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRPVDV 53

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
             +E ++L  L+H NIVKL    ++      VL+ E+ P G+L   L     +  LP   
Sbjct: 54  QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSA 215
            + +   +   + +L E     IVH +IK  NI+     +     KL DFG+A+      
Sbjct: 114 FLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE----- 165

Query: 216 VLPPSPSPSPSRSRITKQVMM---IGSPGYTDPHYLRTGMAST--------KTDVYSFGV 264
                         +          G+  Y  P      +             D++S GV
Sbjct: 166 --------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

Query: 265 ILLELVTGMEAFCPEN-GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL------ 317
                 TG   F P    +    +   ++        + V +  +  +    D+      
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271

Query: 318 -DEARAML-SIAALCLRQSPILRPSATQILH 346
               + +L  + A  L           Q   
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (328), Expect = 2e-35
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 29/213 (13%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVK 119
            +G G F NVYLAR     +    A+K+     +    +    ++E++I  HL H NI++
Sbjct: 16  PLGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L GY  D     L+ EY P GT+  +L    + SK   +       +LA A+ Y H +  
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK-- 128

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
             ++H DIK  N+LL      K+ DFG +               +PS  R      + G+
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVH-------------APSSRRTD----LCGT 170

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             Y  P  +   M   K D++S GV+  E + G
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  129 bits (326), Expect = 3e-35
 Identities = 67/312 (21%), Positives = 117/312 (37%), Gaps = 69/312 (22%)

Query: 55  ERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLH 111
           +RF  +F   ++IGSGGF  V+ A+  +        IK +   +++     ++E+  L  
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAK--HRIDGKTYVIKRVKYNNEKA----EREVKALAK 60

Query: 112 LSHDNIVKLIGYCDDRDEGVLLF----------------EYVPNGTLQEKLHGTPRSSKL 155
           L H NIV   G  D  D                      E+   GTL++ +    R  KL
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKL 119

Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
                + +  Q+ + ++Y+H +    +++ D+K SNI L +    K+ DFG         
Sbjct: 120 DKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT------ 170

Query: 216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
            L           R        G+  Y  P  + +     + D+Y+ G+IL EL+     
Sbjct: 171 SL------KNDGKRTR----SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV--C 218

Query: 276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
                                        +L D  ++  FD  + + +L      L + P
Sbjct: 219 DTAFETSKF------------------FTDLRDGIISDIFD-KKEKTLLQ---KLLSKKP 256

Query: 336 ILRPSATQILHT 347
             RP+ ++IL T
Sbjct: 257 EDRPNTSEILRT 268

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (330), Expect = 8e-35
 Identities = 64/341 (18%), Positives = 113/341 (33%), Gaps = 60/341 (17%)

Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRL 98
           +  +S   + W          S ++G G  +NV+  R  +  T    AIK+  ++   R 
Sbjct: 1   MGSQSTSNHLWL--------LSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRP 50

Query: 99  SQVFKQELDILLHLSHDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSKLP 156
             V  +E ++L  L+H NIVKL    ++      VL+ E+ P G+L   L     +  LP
Sbjct: 51  VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP 110

Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGF 212
               + +   +   + +L E     IVH +IK  NI+     +     KL DFG+A+   
Sbjct: 111 ESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-- 165

Query: 213 SSAVLPPSPSPSPSRSRITKQVMM---IGSPGYTDPHYLRTGMAST--------KTDVYS 261
                            +          G+  Y  P      +             D++S
Sbjct: 166 -----------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208

Query: 262 FGVILLELVTGMEAFCPEN-GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL--- 317
            GV      TG   F P    +    +   ++        + V +  +  +    D+   
Sbjct: 209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS 268

Query: 318 ----DEARAML-SIAALCLRQSPILRPSATQILHTIKHQIS 353
                  + +L  + A  L           Q        + 
Sbjct: 269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (320), Expect = 2e-34
 Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 40/236 (16%)

Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRL 98
           G  ++ +    V          +G G F+ VY A   +  T    AIK+     +    +
Sbjct: 7   GEKIEDF---KVGNL-------LGKGSFAGVYRAE--SIHTGLEVAIKMIDKKAMYKAGM 54

Query: 99  SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP-W 157
            Q  + E+ I   L H +I++L  Y +D +   L+ E   NG +   L    +       
Sbjct: 55  VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSEN 112

Query: 158 RNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAV 216
             R  +  Q+   + YLH      I+H D+  SN+LL  ++N K+ DFG + ++      
Sbjct: 113 EARHFMH-QIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL------ 162

Query: 217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                   P     T    + G+P Y  P          ++DV+S G +   L+ G
Sbjct: 163 ------KMPHEKHYT----LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  126 bits (319), Expect = 4e-34
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 29/221 (13%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVK 119
            +G G F NVYLAR          A+K+     +  + +    ++E++I  HL H NI++
Sbjct: 21  PLGKGKFGNVYLAR--EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           +  Y  DR    L+ E+ P G L ++L    +  +   +       +LA A+ Y HER  
Sbjct: 79  MYNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHER-- 133

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
             ++H DIK  N+L+      K+ DFG +               +PS  R T    M G+
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVH-------------APSLRRRT----MCGT 175

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
             Y  P  +       K D++  GV+  E + GM  F   +
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (320), Expect = 5e-34
 Identities = 59/300 (19%), Positives = 106/300 (35%), Gaps = 57/300 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSH--DNI 117
           + IGSGG S V+      +      AIK        ++    ++ E+  L  L    D I
Sbjct: 34  KQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           ++L  Y        ++ E   N  L   L    +   +    R +    + +A+  +H+ 
Sbjct: 91  IRLYDYEITDQYIYMVMECG-NIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               IVH D+K +N L+ +    KL DFG A               + S  + +     +
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQ---------MQPDTTSVVKDS----QV 189

Query: 238 GSPGY-----------TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
           G+  Y           +  +       S K+DV+S G IL  +  G   F     Q+   
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 248

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
               +   I      +  ++ +          + + +L     CL++ P  R S  ++L 
Sbjct: 249 ----LHAIIDPNHEIEFPDIPEK---------DLQDVLK---CCLKRDPKQRISIPELLA 292

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (318), Expect = 2e-33
 Identities = 45/296 (15%), Positives = 90/296 (30%), Gaps = 43/296 (14%)

Query: 4   FSKLFRIKNLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQ 63
           +      K L    KP+               +    +     K       +        
Sbjct: 22  WDDKLIFKLLSGLSKPVSS--------YPNTFEWQCKLPAIKPKTEFQLGSKLVY--VHH 71

Query: 64  VIGSGGFSNVYLARLINDSTSTNG---AIKIHVGSDRL-SQVFKQELDILLHLSHDNIVK 119
           ++G G F+ VY A   + + + N     +K+   ++     +  Q ++ L        +K
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
                  ++  VL+ E    GTL   +  +       +P    ++ A ++   IE +H+ 
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191

Query: 178 CTLHIVHGDIKASNILL-----------EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
               I+HGDIK  N +L           +      L D G +                P 
Sbjct: 192 ---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM----------KLFPK 238

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
            +  T +     + G+     L     + + D +     +  ++ G        G 
Sbjct: 239 GTIFTAK---CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  126 bits (318), Expect = 2e-33
 Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 57/300 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSH--DNI 117
           + IGSGG S V+      +      AIK        ++    ++ E+  L  L    D I
Sbjct: 15  KQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           ++L  Y        ++ E   N  L   L    +   +    R +    + +A+  +H+ 
Sbjct: 72  IRLYDYEITDQYIYMVMECG-NIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               IVH D+K +N L+ +    KL DFG      ++ + P + S          +   +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFG-----IANQMQPDTTS--------VVKDSQV 170

Query: 238 GSPGY-----------TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
           G+  Y           +  +       S K+DV+S G IL  +  G   F     Q+   
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 229

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
               +   I      +  ++ +          + + +L     CL++ P  R S  ++L 
Sbjct: 230 ----LHAIIDPNHEIEFPDIPEK---------DLQDVLK---CCLKRDPKQRISIPELLA 273

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  123 bits (312), Expect = 5e-33
 Identities = 55/237 (23%), Positives = 92/237 (38%), Gaps = 39/237 (16%)

Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSD 96
           +D RS ++Y      RF       +G GGF+  +     +  T    A KI     +   
Sbjct: 9   VDPRSRRRY---VRGRF-------LGKGGFAKCFEIS--DADTKEVFAGKIVPKSLLLKP 56

Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
              +    E+ I   L+H ++V   G+ +D D   ++ E     +L E        ++  
Sbjct: 57  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 116

Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSA 215
            R  +    Q+    +YLH      ++H D+K  N+ L E L  K+ DFG + K+     
Sbjct: 117 ARYYLR---QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---- 166

Query: 216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                        +      + G+P Y  P  L     S + DV+S G I+  L+ G
Sbjct: 167 --------YDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  125 bits (316), Expect = 6e-33
 Identities = 59/300 (19%), Positives = 106/300 (35%), Gaps = 57/300 (19%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSH--DNI 117
           + IGSGG S V+      +      AIK        ++    ++ E+  L  L    D I
Sbjct: 62  KQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           ++L  Y        ++ E   N  L   L    +   +    R +    + +A+  +H+ 
Sbjct: 119 IRLYDYEITDQYIYMVMECG-NIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               IVH D+K +N L+ +    KL DFG A               + S  + +     +
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQ---------MQPDTTSVVKDS----QV 217

Query: 238 GSPGY-----------TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
           G+  Y           +  +       S K+DV+S G IL  +  G   F     Q+   
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 276

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
               +   I      +  ++ +          + + +L     CL++ P  R S  ++L 
Sbjct: 277 ----LHAIIDPNHEIEFPDIPEK---------DLQDVLK---CCLKRDPKQRISIPELLA 320

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (312), Expect = 1e-32
 Identities = 56/237 (23%), Positives = 90/237 (37%), Gaps = 39/237 (16%)

Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSD 96
           +D RS ++Y      RF       +G GGF+  +     +  T    A KI     +   
Sbjct: 35  VDPRSRRRY---VRGRF-------LGKGGFAKCFEIS--DADTKEVFAGKIVPKSLLLKP 82

Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
              +    E+ I   L+H ++V   G+ +D D   ++ E     +L E      R   L 
Sbjct: 83  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALT 139

Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSA 215
                    Q+    +YLH      ++H D+K  N+ L E L  K+ DFG + K+     
Sbjct: 140 EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE---- 192

Query: 216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                        +      + G+P Y  P  L     S + DV+S G I+  L+ G
Sbjct: 193 --------YDGERKKV----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  121 bits (306), Expect = 9e-32
 Identities = 52/317 (16%), Positives = 107/317 (33%), Gaps = 66/317 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI------------------HVGSDRLSQVFKQ 104
           + +  G F+ + L        +   A+K                    +        FK 
Sbjct: 37  RTLNQGKFNKIILCE----KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPR-----SSKLPWRN 159
           EL I+  + ++  +   G   + DE  +++EY+ N ++ +            +  +P + 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
              I   +  +  Y+H     +I H D+K SNIL++++   KL DFG ++          
Sbjct: 153 IKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEY--------- 201

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYL--RTGMASTKTDVYSFGVILLELVTGMEAFC 277
                  +          G+  +  P +    +     K D++S G+ L  +   +  F 
Sbjct: 202 ----MVDKKIKG----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

Query: 278 PENGQLLTSLAGSMLNDIADCE---------ATKVNELVDPRLAGDFDLDEARAMLSIAA 328
            +   +       + N+I                         + +F  +E    L    
Sbjct: 254 LKISLV------ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK--- 304

Query: 329 LCLRQSPILRPSATQIL 345
           L LR++P  R ++   L
Sbjct: 305 LFLRKNPAERITSEDAL 321

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (302), Expect = 2e-31
 Identities = 64/296 (21%), Positives = 97/296 (32%), Gaps = 52/296 (17%)

Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILL 110
            F Q+F     +G G +  V+  R  +       A+K         +       E+    
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVR--SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE 111

Query: 111 HL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
            +  H   V+L    ++     L  E     +LQ+       S  LP             
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS--LPEAQVWGYLRDTLL 168

Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
           A+ +LH +    +VH D+K +NI L     CKL DFG       +A              
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE-LGTAGAGEV--------- 215

Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
                   G P Y  P  L+     T  DV+S G+ +LE+   ME   P  G+    L  
Sbjct: 216 ------QEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACNMEL--PHGGEGWQQL-- 264

Query: 290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                            + P         E R++L    + L   P LR +A  +L
Sbjct: 265 -------------RQGYLPPEFTAGLS-SELRSVLV---MMLEPDPKLRATAEALL 303

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (313), Expect = 2e-31
 Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 43/223 (19%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNG---AIKI--HVGSDRLSQVFKQELDILLHLSHDNIV 118
            I  GG   +YLA    D  + NG    +K   H G      +   E   L  + H +IV
Sbjct: 87  CIAHGGLGWIYLAL---D-RNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 119 KL--IGYCDDRDEGVLLF---EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           ++       DR    + +   EYV   +L+          KLP    +A   ++  A+ Y
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSY 197

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH      +V+ D+K  NI+L E    KL D G+                     RI   
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-------------------RINSF 234

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
             + G+PG+  P  +RTG  +  TD+Y+ G  L  L   +   
Sbjct: 235 GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTR 276

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (301), Expect = 4e-31
 Identities = 65/344 (18%), Positives = 110/344 (31%), Gaps = 54/344 (15%)

Query: 9   RIKNLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSG 68
            + +L +T          +  + +           + V     ++V   T      +G G
Sbjct: 12  SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ--PRVGRG 69

Query: 69  GFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD 128
            F  V+     +  T    A+K  V   RL     +EL     LS   IV L G   +  
Sbjct: 70  SFGEVHRM--KDKQTGFQCAVK-KV---RLEVFRVEELVACAGLSSPRIVPLYGAVREGP 123

Query: 129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIK 188
              +  E +  G+L + +    +   LP    +    Q  + +EYLH R    I+HGD+K
Sbjct: 124 WVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVK 177

Query: 189 ASNILLEEH-LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHY 247
           A N+LL        LCDFG A        L P        +       + G+  +  P  
Sbjct: 178 ADNVLLSSDGSRAALCDFGHAL------CLQPDGLGKSLLTGDY----IPGTETHMAPEV 227

Query: 248 LRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKV---- 303
           +       K D++S   ++L ++ G    C                         +    
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG----CHPW---------------TQYFRGPLCLKI 268

Query: 304 --NELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                    +            +      LR+ P+ R SA ++ 
Sbjct: 269 ASEPPPIREIPPSCA-PLTAQAIQ---EGLRKEPVHRASAMELR 308

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  123 bits (309), Expect = 5e-31
 Identities = 55/238 (23%), Positives = 89/238 (37%), Gaps = 38/238 (15%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIV 118
             + +G+GGF  V      +  T    AIK      S +  + +  E+ I+  L+H N+V
Sbjct: 18  MKERLGTGGFGYVLRWI--HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 119 KLI------GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
                          D  +L  EY   G L++ L+       L       +   ++ A+ 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135

Query: 173 YLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
           YLHE     I+H D+K  NI+L    + L  K+ D G AK                    
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE------------------- 173

Query: 230 ITKQVMM---IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
           + +  +    +G+  Y  P  L     +   D +SFG +  E +TG   F P    + 
Sbjct: 174 LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  117 bits (295), Expect = 1e-30
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 28/215 (13%)

Query: 63  QVIGSGGFSNVYLAR-LINDSTSTNGAIKI---HVGSDRLSQV-FKQELDILLHLSHDNI 117
             +G GG S VYLA   I +      AIK           +   F++E+     LSH NI
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKV---AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           V +I   ++ D   L+ EY+   TL E +        L     +    Q+   I++ H+ 
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
               IVH DIK  NIL++ +   K+ DFG AK     A+         S + +T+   ++
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAK-----AL---------SETSLTQTNHVL 173

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           G+  Y  P   +       TD+YS G++L E++ G
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (292), Expect = 5e-30
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 32/220 (14%)

Query: 63  QVIGSGGFSNVYLAR-LINDSTSTNGAIKI---HVGSDRLSQV-FKQELDILLHLSHDNI 117
           +++G GG S V+LAR L +       A+K+    +  D    + F++E      L+H  I
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDV---AVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 118 VKL--IGYCDDRDEGVLLF---EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           V +   G   +   G L +   EYV   TL++ +H       +  +  + +     QA+ 
Sbjct: 75  VAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALN 130

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           + H+     I+H D+K +NI++      K+ DFG A+     A+       + S + +T+
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR-----AI-------ADSGNSVTQ 175

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
              +IG+  Y  P   R      ++DVYS G +L E++TG
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  115 bits (289), Expect = 7e-30
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 30/236 (12%)

Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 118 VKLIGYCDDRDEGVLL--FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C       L    EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLG 131

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP----SPSPSRSRIT 231
            +     +H D+   NIL+E     K+ DFG  K      VLP          P  S I 
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTK------VLPQDKEFFKVKEPGESPIF 182

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
                     +  P  L     S  +DV+SFGV+L EL T +E       + +  +
Sbjct: 183 ----------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  115 bits (290), Expect = 1e-29
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 30/239 (12%)

Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNI 117
           F Q +G G F +V + R   + D+T    A+K +   ++   + F++E++IL  L HDNI
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 118 VKLIGYCDDRDEGVLL--FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           VK  G C       L    EY+P G+L++ L       ++     +    Q+ + +EYL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLG 162

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP----SPSPSRSRIT 231
            +     +H D+   NIL+E     K+ DFG  K      VLP          P  S I 
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTK------VLPQDKEYYKVKEPGESPIF 213

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS 290
                     +  P  L     S  +DV+SFGV+L EL T +E       + +  +   
Sbjct: 214 ----------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  114 bits (288), Expect = 1e-29
 Identities = 72/308 (23%), Positives = 115/308 (37%), Gaps = 41/308 (13%)

Query: 42  DGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQ 100
           +G         D E        V+G G +  VY     + S     AIK I     R SQ
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQ 64

Query: 101 VFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
              +E+ +  HL H NIV+ +G   +     +  E VP G+L   L       K   +  
Sbjct: 65  PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFSSAVLPP 219
                Q+ + ++YLH+     IVH DIK  N+L+  +    K+ DFG++K    + + P 
Sbjct: 125 GFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPC 179

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM--ASTKTDVYSFGVILLELVTGMEAFC 277
           + +               G+  Y  P  +  G        D++S G  ++E+ TG     
Sbjct: 180 TET-------------FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK---- 222

Query: 278 PENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL 337
           P   +L    A +M   +   +         P +       EA+A +     C    P  
Sbjct: 223 PPFYELGEPQA-AMFK-VGMFKVH-------PEIPESMS-AEAKAFIL---KCFEPDPDK 269

Query: 338 RPSATQIL 345
           R  A  +L
Sbjct: 270 RACANDLL 277

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  114 bits (287), Expect = 1e-29
 Identities = 56/324 (17%), Positives = 101/324 (31%), Gaps = 76/324 (23%)

Query: 56  RFTQNFSQV--IGSGGFSNVYLARLINDSTSTNGAIK---IHVGSDRLSQVFKQELDILL 110
           R+T  F ++  IGSG F +V+             AIK     +      Q   +E+    
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCV--KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 65

Query: 111 HLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLA 168
            L  H ++V+      + D  ++  EY   G+L + +    R            +  Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 169 QAIEYLHERCTLHIVHGDIKASNILL-------------------EEHLNCKLCDFGSAK 209
           + + Y+H      +VH DIK SNI +                      +  K+ D G   
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLE 268
                              RI+   +  G   +     L+       K D+++  + ++ 
Sbjct: 183 -------------------RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223

Query: 269 LVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAA 328
                               G   ++I             PR+       E   +L    
Sbjct: 224 AAGAEPLPR----------NGDQWHEIRQGRL--------PRIPQVLS-QEFTELLK--- 261

Query: 329 LCLRQSPILRPSATQILHTIKHQI 352
           + +   P  RPSA  ++   KH +
Sbjct: 262 VMIHPDPERRPSAMALV---KHSV 282

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (289), Expect = 1e-29
 Identities = 67/253 (26%), Positives = 101/253 (39%), Gaps = 37/253 (14%)

Query: 33  QYHDHDDGIDGRSVKKYS--WDD--VERFTQNFSQVIGSGGFSNVYLARL--INDSTSTN 86
            +H H     G     +    D     +      + +G G F  V L      ND T   
Sbjct: 3   HHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEM 62

Query: 87  GAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC-DDRDEGVLL-FEYVPNGTL 142
            A+K        +    +KQE+DIL  L H++I+K  G C D     + L  EYVP G+L
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122

Query: 143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKL 202
           ++ L        +     +  A Q+ + + YLH +   H +H D+ A N+LL+     K+
Sbjct: 123 RDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI 175

Query: 203 CDFGSAKMGFSSAVLPPSP----SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTD 258
            DFG AK       +P             S +           +  P  L+       +D
Sbjct: 176 GDFGLAK------AVPEGHEYYRVREDGDSPVF----------WYAPECLKEYKFYYASD 219

Query: 259 VYSFGVILLELVT 271
           V+SFGV L EL+T
Sbjct: 220 VWSFGVTLYELLT 232

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (292), Expect = 2e-29
 Identities = 60/249 (24%), Positives = 94/249 (37%), Gaps = 31/249 (12%)

Query: 33  QYHDHD-DGIDGRS----VKKYSWDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTST 85
            +       +  +S     +    D      ++    + IG G F  V+  RL  D+T  
Sbjct: 83  DHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142

Query: 86  NGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQ 143
             A+K         L   F QE  IL   SH NIV+LIG C  +    ++ E V  G   
Sbjct: 143 --AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200

Query: 144 EKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC 203
             L       ++    +M      A  +EYL  +     +H D+ A N L+ E    K+ 
Sbjct: 201 TFLRTEGARLRVKTLLQMVG--DAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKIS 255

Query: 204 DFGSAKMGFSSAVLPPSPSPS-PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSF 262
           DFG ++                P +              +T P  L  G  S+++DV+SF
Sbjct: 256 DFGMSREEADGVYAASGGLRQVPVK--------------WTAPEALNYGRYSSESDVWSF 301

Query: 263 GVILLELVT 271
           G++L E  +
Sbjct: 302 GILLWETFS 310

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  113 bits (285), Expect = 4e-29
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 27/219 (12%)

Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDN 116
             + +G G F  V L R     D+T    A+K              K+E++IL +L H+N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 117 IVKLIGYC-DDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           IVK  G C +D   G+ L  E++P+G+L+E L      +K+  + ++  A Q+ + ++YL
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYL 142

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM--GFSSAVLPPSPSPSPSRSRITK 232
             R     VH D+ A N+L+E     K+ DFG  K                SP       
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----- 194

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +  P  L        +DV+SFGV L EL+T
Sbjct: 195 ---------WYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  115 bits (290), Expect = 8e-29
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 20/211 (9%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
               +G G +  VY       S +   A+K         + F +E  ++  + H N+V+L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTV--AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           +G C       ++ E++  G L + L       ++     + +A Q++ A+EYL ++   
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKK--- 337

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           + +H ++ A N L+ E+   K+ DFG +++         + +  P +             
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------------- 384

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +T P  L     S K+DV++FGV+L E+ T
Sbjct: 385 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 2e-28
 Identities = 72/326 (22%), Positives = 117/326 (35%), Gaps = 65/326 (19%)

Query: 35  HDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--- 91
           H H     GR    +     + F   F + +GSG F +V+L      S+     IK    
Sbjct: 2   HHHHHHSSGRENLYFQGTIDDLFI--FKRKLGSGAFGDVHLVEER--SSGLERVIKTINK 57

Query: 92  -HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEK-LHGT 149
                    +  + E+++L  L H NI+K+    +D     ++ E    G L E+ +   
Sbjct: 58  DRSQVPM--EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ 115

Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFG 206
            R   L       +  Q+  A+ Y H +   H+VH D+K  NIL      H   K+ DFG
Sbjct: 116 ARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFG 172

Query: 207 SAKMGFSSAVLPPSPSPSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGV 264
            A++ F S                  +      G+  Y  P   +    + K D++S GV
Sbjct: 173 LAEL-FKS-----------------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGV 213

Query: 265 ILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAML 324
           ++  L+TG   F   + +                      E+       + +       L
Sbjct: 214 VMYFLLTGCLPFTGTSLE----------------------EVQQKATYKEPNYAVECRPL 251

Query: 325 SIAA-----LCLRQSPILRPSATQIL 345
           +  A       L + P  RPSA Q+L
Sbjct: 252 TPQAVDLLKQMLTKDPERRPSAAQVL 277

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (288), Expect = 2e-28
 Identities = 68/300 (22%), Positives = 111/300 (37%), Gaps = 60/300 (20%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
              +V+G G F  V L    +  T    A+K+     V      +   +E+ +L  L H 
Sbjct: 29  KGQRVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NI+KL  + +D+    L+ E    G L +++       +    +   I  Q+   I Y+H
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMH 143

Query: 176 ERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           +     IVH D+K  N+LL    +  N ++ DFG +    +S  +               
Sbjct: 144 KN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--------------- 185

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
               IG+  Y  P  L  G    K DV+S GVIL  L++G   F   N            
Sbjct: 186 -KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEY---------- 233

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPILRPSATQILH 346
                       +++     G +  +  +   +S +A       L   P +R SA   L 
Sbjct: 234 ------------DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (286), Expect = 2e-28
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
               +G G F  V++      + +T  AIK         + F QE  ++  L H+ +V+L
Sbjct: 188 LEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244

Query: 121 IGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
                +  E + +  EY+  G+L + L        L     + +A Q+A  + Y+     
Sbjct: 245 YAVVSE--EPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM-- 299

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
            + VH D++A+NIL+ E+L CK+ DFG A++   +       +  P +            
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 346

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             +T P     G  + K+DV+SFG++L EL T
Sbjct: 347 --WTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 2e-28
 Identities = 36/330 (10%), Positives = 80/330 (24%), Gaps = 95/330 (28%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI-----------------------------HVG 94
           V+G         A   +  T  +  + +                             +  
Sbjct: 80  VLGQEDPYAYLEAT--DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137

Query: 95  SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE-GVLLFEYVPNGTLQEKL----HGT 149
             ++   F    D++       ++++     D                LQ         +
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197

Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
                L    R+ +  Q+ + +  LH      +VH  ++  +I+L++     L  F    
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL-----------RTGMASTKTD 258
                              R   +V+   S G+  P              R  + +   D
Sbjct: 255 -------------------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295

Query: 259 VYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL- 317
            ++ G+++  +         +                            +       ++ 
Sbjct: 296 AWALGLVIYWIWCADLPITKDA----------------------ALGGSEWIFRSCKNIP 333

Query: 318 DEARAMLSIAALCLRQSPILRPSATQILHT 347
              RA+L      LR     R    Q + T
Sbjct: 334 QPVRALLE---GFLRYPKEDRLLPLQAMET 360

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  114 bits (287), Expect = 3e-28
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
               +G G F  V++      + +T  AIK         + F QE  ++  L H+ +V+L
Sbjct: 271 LEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 327

Query: 121 IGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
                +  E + +  EY+  G+L + L        L     + +A Q+A  + Y+     
Sbjct: 328 YAVVSE--EPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM-- 382

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
            + VH D++A+NIL+ E+L CK+ DFG A++   +       +  P +            
Sbjct: 383 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 429

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             +T P     G  + K+DV+SFG++L EL T
Sbjct: 430 --WTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  111 bits (279), Expect = 4e-28
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 32/221 (14%)

Query: 61  FSQVIGSGGFSNVYLARL--INDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDN 116
           +   +G G F +V L R   + D+T    A+K   H G D+    F++E+ IL  L  D 
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQILKALHSDF 85

Query: 117 IVKLIGYCDDRDEGVLL--FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           IVK  G         L    EY+P+G L++ L      ++L     +  + Q+ + +EYL
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYL 143

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP----SPSPSRSRI 230
             R     VH D+ A NIL+E   + K+ DFG AK      +LP          P +S I
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAK------LLPLDKDYYVVREPGQSPI 194

Query: 231 TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                      +  P  L   + S ++DV+SFGV+L EL T
Sbjct: 195 F----------WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (285), Expect = 4e-28
 Identities = 72/299 (24%), Positives = 113/299 (37%), Gaps = 61/299 (20%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDN 116
             + +GSG +  V L    +  T    AIKI     V +   S++  +E+ +L  L H N
Sbjct: 41  RVKKLGSGAYGEVLLC--RDKVTHVERAIKIIRKTSVSTSSNSKL-LEEVAVLKLLDHPN 97

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+KL  + +D+    L+ E    G L +++       K    +   I  Q+   + YLH+
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHK 154

Query: 177 RCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
               +IVH D+K  N+LL   E+    K+ DFG + +  +   +                
Sbjct: 155 H---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---------------- 195

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN 293
              +G+  Y  P  LR      K DV+S GVIL  L+ G   F  +  Q           
Sbjct: 196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----------- 243

Query: 294 DIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPILRPSATQILH 346
                      E++     G +  D      +S  A       L+     R SA Q L 
Sbjct: 244 -----------EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (277), Expect = 7e-28
 Identities = 45/220 (20%), Positives = 84/220 (38%), Gaps = 38/220 (17%)

Query: 63  QVIGSGGFSNVYLA------RLINDSTSTNGAIKI---HVGSDRLSQV-FKQELDILLHL 112
           +++G GG  +VY A      R++        A+K+    + SD + +   ++E      L
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIV--------ALKLMSETLSSDPVFRTRMQREARTAGRL 91

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
              ++V +  + +   +  +    +    L   L    R   L     +AI  Q+  A++
Sbjct: 92  QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALD 148

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
             H        H D+K  NIL+       L DFG A                 +  ++T+
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT--------------TDEKLTQ 191

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
               +G+  Y  P       A+ + D+Y+   +L E +TG
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (276), Expect = 7e-28
 Identities = 70/308 (22%), Positives = 108/308 (35%), Gaps = 81/308 (26%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
            F +V+GSG FS V+L       T    A+K         D      + E+ +L  + H+
Sbjct: 12  IFMEVLGSGAFSEVFLV--KQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHE 66

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           NIV L    +      L+ + V  G L     E+   T + +         +  Q+  A+
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSAV 119

Query: 172 EYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           +YLHE     IVH D+K  N+L    EE+    + DFG +KM                  
Sbjct: 120 KYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------------------ 158

Query: 229 RITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
                +M    G+PGY  P  L     S   D +S GVI   L+ G   F  E       
Sbjct: 159 -EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---- 213

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDL---------DEARAMLSIAALCLRQSPIL 337
                             +L +    G ++          + A+  +      L + P  
Sbjct: 214 ------------------KLFEKIKEGYYEFESPFWDDISESAKDFIC---HLLEKDPNE 252

Query: 338 RPSATQIL 345
           R +  + L
Sbjct: 253 RYTCEKAL 260

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  110 bits (277), Expect = 8e-28
 Identities = 69/276 (25%), Positives = 108/276 (39%), Gaps = 76/276 (27%)

Query: 31  QDQYHDHDDGI--DGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGA 88
           +  +H H      D        W+D++     F  VIG G F  V  AR+  D    + A
Sbjct: 2   KKHHHHHHGKNNPDPTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAA 56

Query: 89  IKI--HVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEK 145
           IK      S    + F  EL++L  L  H NI+ L+G C+ R    L  EY P+G L + 
Sbjct: 57  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116

Query: 146 L-------------HGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNI 192
           L                  +S L  +  +  A  +A+ ++YL ++     +H D+ A NI
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 173

Query: 193 LLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG- 251
           L+ E+   K+ DFG   +               SR                   Y++   
Sbjct: 174 LVGENYVAKIADFG---L---------------SRG---------------QEVYVKKTM 200

Query: 252 -------MA---------STKTDVYSFGVILLELVT 271
                  MA         +T +DV+S+GV+L E+V+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  111 bits (278), Expect = 9e-28
 Identities = 35/320 (10%), Positives = 71/320 (22%), Gaps = 71/320 (22%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVK 119
            +  G  S V+L R  +     + A+K+       S    +   +       L  ++  +
Sbjct: 69  PLRVGDRSVVFLVR--DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 120 LIGYC-------------------------DDRDEGVLLFEYVPNGTLQEKL----HGTP 150
                                         D      LL     +  L+           
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186

Query: 151 RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM 210
                       +  QL +    L  +    +VHG     N+ +       L D  +   
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL-- 241

Query: 211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL--RTGMASTKTDVYSFGVILLE 268
                               T+         Y    +L   T   +   + +  G+ +  
Sbjct: 242 ----------------WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285

Query: 269 LVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL-DEARAMLSIA 327
           +      F          L    +       + +V             L D  + ++   
Sbjct: 286 VWCLFLPF---------GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG-- 334

Query: 328 ALCLRQSPILRPSATQILHT 347
              L      R    + + T
Sbjct: 335 -RFLNFDRRRRLLPLEAMET 353

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  109 bits (275), Expect = 1e-27
 Identities = 50/252 (19%), Positives = 90/252 (35%), Gaps = 27/252 (10%)

Query: 95  SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSK 154
           S         ++  +   S  N V  +     +    +  +      L++ ++       
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
                 + I  Q+A+A+E+LH +    ++H D+K SNI        K+ DFG        
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGME 274
                  +P P+ +  T QV   G+  Y  P  +     S K D++S G+IL EL+    
Sbjct: 218 EEEQTVLTPMPAYATHTGQV---GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274

Query: 275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQS 334
               E  +++T +       +   +  + + +V                       L  S
Sbjct: 275 TQM-ERVRIITDVRNLKFPLLFTQKYPQEHMMVQ--------------------DMLSPS 313

Query: 335 PILRPSATQILH 346
           P  RP AT I+ 
Sbjct: 314 PTERPEATDIIE 325

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  108 bits (272), Expect = 3e-27
 Identities = 72/327 (22%), Positives = 117/327 (35%), Gaps = 83/327 (25%)

Query: 50  SWDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----------HVGSDR 97
                  F +N+   +++G G  S V     I+  T    A+KI                
Sbjct: 8   GSHSTHGFYENYEPKEILGRGVSSVVRRC--IHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65

Query: 98  LSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRS 152
           L +   +E+DIL  +S H NI++L    +      L+F+ +  G L     EK+  + + 
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125

Query: 153 SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF 212
           ++        I   L + I  LH+    +IVH D+K  NILL++ +N KL DFG +    
Sbjct: 126 TR-------KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ-- 173

Query: 213 SSAVLPPSPSPSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKT------DVYSFGV 264
               L P             + +  + G+P Y  P  +   M           D++S GV
Sbjct: 174 ----LDPG------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

Query: 265 ILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AM 323
           I+  L+ G   F              ML  I               ++G++         
Sbjct: 218 IMYTLLAGSPPFWHRKQM-------LMLRMI---------------MSGNYQFGSPEWDD 255

Query: 324 LSIAAL-----CLRQSPILRPSATQIL 345
            S          L   P  R +A + L
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEAL 282

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  111 bits (279), Expect = 3e-27
 Identities = 72/308 (23%), Positives = 116/308 (37%), Gaps = 70/308 (22%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI--------------HVGSDRLSQVFKQEL 106
             + +GSG +  V L +    +  +  AIK+              +   ++  +    E+
Sbjct: 40  KVRKLGSGAYGEVLLCK--EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 107 DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            +L  L H NI+KL    +D+    L+ E+   G L E++       K    +   I  Q
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQ 154

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           +   I YLH+    +IVH DIK  NILL      LN K+ DFG +   FS          
Sbjct: 155 ILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKD-------- 202

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                ++  ++   G+  Y  P  L+    + K DV+S GVI+  L+ G   F  +N Q 
Sbjct: 203 ----YKLRDRL---GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ- 253

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPIL 337
                                +++     G +  D      +S  A     L L      
Sbjct: 254 ---------------------DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNK 292

Query: 338 RPSATQIL 345
           R +A + L
Sbjct: 293 RCTAEEAL 300

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  110 bits (277), Expect = 3e-27
 Identities = 56/315 (17%), Positives = 104/315 (33%), Gaps = 60/315 (19%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQEL 106
           ++ S   V + +     V+G G    +    +     + + A+K  +  +  S    +E+
Sbjct: 14  EETSVVIVGKISFCPKDVLGHGAEGTIVYRGM---FDNRDVAVKR-ILPECFSFA-DREV 68

Query: 107 DILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
            +L     H N+++      DR    +  E     TLQE +    +         + +  
Sbjct: 69  QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ--KDFAHLGLEPITLLQ 125

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILLEE-----HLNCKLCDFGSAKMGFSSAVLPPS 220
           Q    + +LH    L+IVH D+K  NIL+        +   + DFG  K           
Sbjct: 126 QTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK---------- 172

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM---ASTKTDVYSFGVILLELVT-GMEAF 276
              +  R   +++  + G+ G+  P  L        +   D++S G +   +++ G   F
Sbjct: 173 --LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

Query: 277 CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL-----CL 331
                +    L G                      A   D         + A       +
Sbjct: 231 GKSLQRQANILLG----------------------ACSLDCLHPEKHEDVIARELIEKMI 268

Query: 332 RQSPILRPSATQILH 346
              P  RPSA  +L 
Sbjct: 269 AMDPQKRPSAKHVLK 283

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  108 bits (273), Expect = 3e-27
 Identities = 61/300 (20%), Positives = 108/300 (36%), Gaps = 62/300 (20%)

Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKL 120
            + +G G FS       ++  ++   A+KI +     +   ++E+  L     H NIVKL
Sbjct: 16  DKPLGEGSFSICRKC--VHKKSNQAFAVKI-ISKRMEANT-QKEITALKLCEGHPNIVKL 71

Query: 121 IGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
                D+    L+ E +  G L    ++K H +   +         I  +L  A+ ++H+
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-------YIMRKLVSAVSHMHD 124

Query: 177 RCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
                +VH D+K  N+L     ++L  K+ DFG A++                      Q
Sbjct: 125 V---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-----------------KPPDNQ 164

Query: 234 VMM--IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
            +     +  Y  P  L         D++S GVIL  +++G   F   +  L  + A  +
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI 224

Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPILRPSATQIL 345
           +  I                 GDF  +      +S  A       L   P  R   + + 
Sbjct: 225 MKKI---------------KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (272), Expect = 4e-27
 Identities = 59/254 (23%), Positives = 99/254 (38%), Gaps = 76/254 (29%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD 115
             + +G G F  V  A   +    +  T  A+K+     S    +    E ++L  ++H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL---------------------HGTPRSSK 154
           +++KL G C      +L+ EY   G+L+  L                        P    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L   + ++ A+Q++Q ++YL E     +VH D+ A NIL+ E    K+ DFG   +    
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFG---L---- 196

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKT 257
                        SR            Y +  Y++          MA         +T++
Sbjct: 197 -------------SRDV----------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS 233

Query: 258 DVYSFGVILLELVT 271
           DV+SFGV+L E+VT
Sbjct: 234 DVWSFGVLLWEIVT 247

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  108 bits (271), Expect = 4e-27
 Identities = 74/363 (20%), Positives = 132/363 (36%), Gaps = 111/363 (30%)

Query: 45  SVKKYSWDD---VERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIKI----HVG 94
              +  +D      R   +F + +G+G F  V  A    LI    +   A+K+       
Sbjct: 8   DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67

Query: 95  SDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL------- 146
           ++R +     EL +L +L +H NIV L+G C      +++ EY   G L   L       
Sbjct: 68  TEREA--LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125

Query: 147 --------HGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL 198
                           L   + ++ ++Q+A+ + +L  +   + +H D+ A NILL    
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGR 182

Query: 199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG------- 251
             K+CDFG                       + + +         D +Y+  G       
Sbjct: 183 ITKICDFG-----------------------LARDI-------KNDSNYVVKGNARLPVK 212

Query: 252 -MA---------STKTDVYSFGVILLELVT-------GMEAFCPENGQLLTSL-AGSMLN 293
            MA         + ++DV+S+G+ L EL +       GM    P + +    +  G  + 
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----PVDSKFYKMIKEGFRML 268

Query: 294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS 353
                      E+        +D+     M +    C    P+ RP+  QI+  I+ QIS
Sbjct: 269 SPEHAP----AEM--------YDI-----MKT----CWDADPLKRPTFKQIVQLIEKQIS 307

Query: 354 SIS 356
             +
Sbjct: 308 EST 310

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  107 bits (270), Expect = 4e-27
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 22/226 (9%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELD 107
                    +F++VIG G F  VY   L++ D    + A+K    +        F  E  
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVL-LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           I+   SH N++ L+G C   +   L +  Y+ +G L+  +     +     ++ +    Q
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           +A+ ++YL  +     VH D+ A N +L+E    K+ DFG A+  +              
Sbjct: 137 VAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK---------EYY 184

Query: 227 RSRITKQVMMIGSP-GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                    +   P  +     L+T   +TK+DV+SFGV+L EL+T
Sbjct: 185 SVHNKTGAKL---PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  108 bits (271), Expect = 4e-27
 Identities = 74/348 (21%), Positives = 127/348 (36%), Gaps = 100/348 (28%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD 115
            S+ +G G F  VY         D   T  AIK      S R    F  E  ++   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQE-------KLHGTPRSSKLPWRNRMAIAFQLA 168
           ++V+L+G        +++ E +  G L+         +   P  +       + +A ++A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
             + YL+       VH D+ A N ++ E    K+ DFG   M                 +
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG---M-----------------T 185

Query: 229 RITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSFGVILLELVT 271
           R            Y   +Y + G        M+         +T +DV+SFGV+L E+ T
Sbjct: 186 RDI----------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

Query: 272 -------GMEAFCPENGQLLTSL-AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
                  G+      N Q+L  +  G +L+   +C            L   F+L     M
Sbjct: 236 LAEQPYQGL-----SNEQVLRFVMEGGLLDKPDNCP---------DML---FEL-----M 273

Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQISS----ISFLFSPQKDPSR 367
                 C + +P +RPS  +I+ +IK ++      +SF +S +     
Sbjct: 274 RM----CWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPE 317

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  107 bits (270), Expect = 5e-27
 Identities = 55/272 (20%), Positives = 104/272 (38%), Gaps = 66/272 (24%)

Query: 33  QYHDHDDGIDGRSVK--KYSWDDVE--RFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNG 87
            +H H  G+  R  +  +   +DV   R      +++G G F +V    L   D TS   
Sbjct: 6   HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65

Query: 88  AIK---IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----EGVLLFEYVPN 139
           A+K   +   S R  + F  E   +   SH N+++L+G C +       + +++  ++  
Sbjct: 66  AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125

Query: 140 GTLQE---KLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE 196
           G L               +P +  +     +A  +EYL  R   + +H D+ A N +L +
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182

Query: 197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG----- 251
            +   + DFG   +                 S+            Y+  +Y +       
Sbjct: 183 DMTVCVADFG---L-----------------SKKI----------YSGDYYRQGRIAKMP 212

Query: 252 ---MA---------STKTDVYSFGVILLELVT 271
              +A         ++K+DV++FGV + E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  107 bits (270), Expect = 6e-27
 Identities = 69/305 (22%), Positives = 113/305 (37%), Gaps = 51/305 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLS-HDNIV 118
            V+G G  + V     IN  TS   A+KI     G  R      +E+++L     H N++
Sbjct: 19  DVLGEGAHARVQTC--INLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVL 74

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +LI + ++ D   L+FE +  G++     ++ H     +         +   +A A+++L
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-------VVVQDVASALDFL 127

Query: 175 HERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
           H +    I H D+K  NIL E   +    K+CDF        S +         S   + 
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDF-----DLGSGIKLNGDCSPISTPELL 179

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKT-----DVYSFGVILLELVTGMEAFCPENGQLLTS 286
                 GS  Y  P  +              D++S GVIL  L++G   F    G     
Sbjct: 180 TPC---GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPILRPS 340
             G       +     +         G ++  +   A +S AA       L +    R S
Sbjct: 237 DRGEACPACQNMLFESI-------QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289

Query: 341 ATQIL 345
           A Q+L
Sbjct: 290 AAQVL 294

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  108 bits (271), Expect = 7e-27
 Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 79/297 (26%)

Query: 14  RRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKY--SWDD---VERFTQNFSQVIGSG 68
           +  +KP  QV       + +  +  +G     +      +++     R    F + +G+G
Sbjct: 5   KYKQKPKYQV-------RWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAG 57

Query: 69  GFSNVYLAR---LINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL-SHDNIVKLIG 122
            F  V  A    L  +      A+K+          +    EL I+ HL  H+NIV L+G
Sbjct: 58  AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKL-----------HGTPRSSKLPWRNRMAIAFQLAQAI 171
            C      +++ EY   G L   L                +S    R+ +  + Q+AQ +
Sbjct: 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
            +L  +   + +H D+ A N+LL      K+ DFG                       + 
Sbjct: 178 AFLASK---NCIHRDVAARNVLLTNGHVAKIGDFG-----------------------LA 211

Query: 232 KQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSFGVILLELVT 271
           + +         D +Y+  G        MA         + ++DV+S+G++L E+ +
Sbjct: 212 RDI-------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (274), Expect = 7e-27
 Identities = 72/326 (22%), Positives = 119/326 (36%), Gaps = 81/326 (24%)

Query: 52  DDVERFTQNFSQ------VIGSGGFSNVYLARLINDSTSTNGAIKI---------HVGSD 96
           DD   + +           +GSG    V LA      T    AI+I              
Sbjct: 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLA--FERKTCKKVAIRIISKRKFAIGSAREA 181

Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKL 155
             +   + E++IL  L+H  I+K+  + D  D    ++ E +  G L +K+     + +L
Sbjct: 182 DPALNVETEIEILKKLNHPCIIKIKNFFDAED--YYIVLELMEGGELFDKV---VGNKRL 236

Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGF 212
                    +Q+  A++YLHE     I+H D+K  N+LL   EE    K+ DFG +K+  
Sbjct: 237 KEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-- 291

Query: 213 SSAVLPPSPSPSPSRSRITKQVMM---IGSPGYTDPHYLRTGMA---STKTDVYSFGVIL 266
                            + +  +M    G+P Y  P  L +      +   D +S GVIL
Sbjct: 292 -----------------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

Query: 267 LELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLS 325
              ++G   F     Q+      S+ + I                +G ++      A +S
Sbjct: 335 FICLSGYPPFSEHRTQV------SLKDQI---------------TSGKYNFIPEVWAEVS 373

Query: 326 IAAL-----CLRQSPILRPSATQILH 346
             AL      L   P  R +  + L 
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALR 399

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  107 bits (269), Expect = 8e-27
 Identities = 70/341 (20%), Positives = 122/341 (35%), Gaps = 103/341 (30%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL-SH 114
             + +G G F  V  A        +T    A+K+     +    +    EL IL+H+  H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 115 DNIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKL-------------HGTPRSSKLPWRNR 160
            N+V L+G C      +++  E+   G L   L                     L   + 
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG   +          
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG---L---------- 194

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSFG 263
                  +R            Y DP Y+R G        MA         + ++DV+SFG
Sbjct: 195 -------ARDI----------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237

Query: 264 VILLELVT-------GMEAFCPENGQLLTSL-AGSMLNDIADCEATKVNELVDPRLAGDF 315
           V+L E+ +       G+      + +    L  G+ +            E+        +
Sbjct: 238 VLLWEIFSLGASPYPGV----KIDEEFCRRLKEGTRMRAPDYTT----PEM--------Y 281

Query: 316 DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS 356
                  ML     C    P  RP+ ++++  + + + + +
Sbjct: 282 QT-----MLD----CWHGEPSQRPTFSELVEHLGNLLQANA 313

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (267), Expect = 9e-27
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVK 119
             Q IG G F +V L            A+K I   +   +Q F  E  ++  L H N+V+
Sbjct: 25  LLQTIGKGEFGDVMLGDYRG----NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 78

Query: 120 LIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           L+G   +   G+ +  EY+  G+L + L  +   S L     +  +  + +A+EYL    
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 136

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI-TKQVMMI 237
             + VH D+ A N+L+ E    K+ DFG  K   S+              ++  K     
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------DTGKLPVK----- 179

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +T P  LR    STK+DV+SFG++L E+ +
Sbjct: 180 ----WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (268), Expect = 1e-26
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDILLH 111
           ER   +  +VIG G F  VY    I+        AIK    +   +  + F +E  ++  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78

Query: 112 LSHDNIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
           L+H N++ LIG     +    +   Y+ +G L + +           ++ ++   Q+A+ 
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARG 136

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
           +EYL E+     VH D+ A N +L+E    K+ DFG A+                   + 
Sbjct: 137 MEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR---------EYYSVQQ 184

Query: 231 TKQVMMIGSP-GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +   +   P  +T    L+T   +TK+DV+SFGV+L EL+T
Sbjct: 185 HRHARL---PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  108 bits (271), Expect = 1e-26
 Identities = 68/348 (19%), Positives = 122/348 (35%), Gaps = 60/348 (17%)

Query: 13  LRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQ------VIG 66
           +R +         V  +      +  D       KKY    VE    +          +G
Sbjct: 1   MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60

Query: 67  SGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCD 125
           SG F  V+    +  +T      K I+          K E+ I+  L H  ++ L    +
Sbjct: 61  SGAFGVVHRC--VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 126 DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHG 185
           D+ E VL+ E++  G L +++       K+     +    Q  + ++++HE     IVH 
Sbjct: 119 DKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHL 173

Query: 186 DIKASNILLE--EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYT 243
           DIK  NI+ E  +  + K+ DFG A        L P               +   +  + 
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATK------LNPD----------EIVKVTTATAEFA 217

Query: 244 DPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKV 303
            P  +        TD+++ GV+   L++G+  F  E+           L ++        
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNV-------- 262

Query: 304 NELVDPRLAGDFDLDEAR-AMLSIAAL-----CLRQSPILRPSATQIL 345
                     D++ DE   + +S  A       L++ P  R +    L
Sbjct: 263 -------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (274), Expect = 1e-26
 Identities = 75/325 (23%), Positives = 124/325 (38%), Gaps = 63/325 (19%)

Query: 35  HDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--- 91
           H H     GR    +     ER+      ++G G F  V      +  T    A+K+   
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYN--IVCMLGKGSFGEVLKC--KDRITQQEYAVKVINK 57

Query: 92  -HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTP 150
               +   S +  +E+++L  L H NI+KL    +D     ++ E    G L +++    
Sbjct: 58  ASAKNKDTSTI-LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---I 113

Query: 151 RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGS 207
           +  +    +   I  Q+   I Y+H+    +IVH D+K  NILL   E+  + K+ DFG 
Sbjct: 114 KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170

Query: 208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILL 267
           +                   +++  ++   G+  Y  P  LR G    K DV+S GVIL 
Sbjct: 171 STC-------------FQQNTKMKDRI---GTAYYIAPEVLR-GTYDEKCDVWSAGVILY 213

Query: 268 ELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSI 326
            L++G   F  +N                        +++     G +  D  +   +S 
Sbjct: 214 ILLSGTPPFYGKNEY----------------------DILKRVETGKYAFDLPQWRTISD 251

Query: 327 AA-----LCLRQSPILRPSATQILH 346
            A       L   P LR +ATQ L 
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLE 276

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (269), Expect = 1e-26
 Identities = 73/366 (19%), Positives = 109/366 (29%), Gaps = 93/366 (25%)

Query: 35  HDHDDGIDGRSVKKYSWDDVERFTQN--FSQVIGSGGFSNVYLARLINDSTSTNGAIKIH 92
           H H     GR    +    +    +       IG G +  V +A  I + T    AIKI 
Sbjct: 2   HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVA--IENQTRAIRAIKIM 59

Query: 93  ------VGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL 146
                   + +  +  K E+ ++  L H NI +L    +D     L+ E    G L +KL
Sbjct: 60  NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119

Query: 147 ---------------------------HGTPRSSKLPWRNRMAIAF----------QLAQ 169
                                            S   +R  +              Q+  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 170 AIEYLHERCTLHIVHGDIKASNILLE--EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           A+ YLH +    I H DIK  N L    +    KL DFG +K              +   
Sbjct: 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKE---------FYKLNNGE 227

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMAS--TKTDVYSFGVILLELVTGMEAFCPENGQLLT 285
                     G+P +  P  L T   S   K D +S GV+L  L+ G   F   N     
Sbjct: 228 YYGMTTK--AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA--- 282

Query: 286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAAL-----CLRQSPILRP 339
                              + +   L      +     +LS  A       L ++   R 
Sbjct: 283 -------------------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323

Query: 340 SATQIL 345
            A + L
Sbjct: 324 DAMRAL 329

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  105 bits (264), Expect = 2e-26
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           F Q IGSG F  V+L   +N       AIK         + F +E ++++ LSH  +V+L
Sbjct: 12  FVQEIGSGQFGLVHLGYWLN---KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G C ++    L+ E++ +G L + L    +         + +   + + + YL E    
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA--- 123

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
            ++H D+ A N L+ E+   K+ DFG  +          + +  P +             
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------------- 170

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +  P        S+K+DV+SFGV++ E+ +
Sbjct: 171 -WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (269), Expect = 2e-26
 Identities = 41/349 (11%), Positives = 91/349 (26%), Gaps = 89/349 (25%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI-----------------------------HVG 94
           V+G         A   +  T  +  + +                             +  
Sbjct: 85  VLGQEDPYAYLEAT--DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 95  SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD--EGVLLFE--YVPNGTLQEKLHGTP 150
             ++   F    D++       ++++     D        L+        T  E L    
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 151 RSSK-LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
            + K L    R+ +  Q+ + +  LH      +VH  ++  +I+L++     L  F    
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGV 264
                             S ++        P  T    L        + +   D ++ G+
Sbjct: 260 --------------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305

Query: 265 ILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL-DEARAM 323
            +  +                                      +       ++    RA+
Sbjct: 306 AIYWIWCADLPN----------------------TDDAALGGSEWIFRSCKNIPQPVRAL 343

Query: 324 LSIAALCLRQSPILRPSATQILHT-----IKHQISSISFLFSPQKDPSR 367
           L      LR     R    Q + T     ++ ++S+   L+    +P+R
Sbjct: 344 LE---GFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTR 389

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (268), Expect = 3e-26
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 54/248 (21%)

Query: 43  GRSVKKYSWDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI--------- 91
           G   +   W   + F Q +    VIG G  S V     ++ +T    A+KI         
Sbjct: 78  GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC--VHRATGHEFAVKIMEVTAERLS 135

Query: 92  HVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKL 146
               + + +  ++E  IL  ++ H +I+ LI   +      L+F+ +  G L     EK+
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV 195

Query: 147 HGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG 206
             + + ++       +I   L +A+ +LH     +IVH D+K  NILL++++  +L DFG
Sbjct: 196 ALSEKETR-------SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245

Query: 207 SAKMGFSSAVLPPSPSPSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKT------D 258
            +        L P             + +  + G+PGY  P  L+  M  T        D
Sbjct: 246 FSCH------LEPG------------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287

Query: 259 VYSFGVIL 266
           +++ GVIL
Sbjct: 288 LWACGVIL 295

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (271), Expect = 3e-26
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             Q IG G F +V L            A+K  + +D  +Q F  E  ++  L H N+V+L
Sbjct: 197 LLQTIGKGEFGDVMLGDYRG----NKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQL 251

Query: 121 IGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           +G   +   G+ +  EY+  G+L + L  +   S L     +  +  + +A+EYL     
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI-TKQVMMIG 238
            + VH D+ A N+L+ E    K+ DFG  K   S+              ++  K      
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------DTGKLPVK------ 351

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
              +T P  LR    STK+DV+SFG++L E+ +
Sbjct: 352 ---WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (267), Expect = 3e-26
 Identities = 64/311 (20%), Positives = 113/311 (36%), Gaps = 54/311 (17%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ---ELDILLHLSHDNIV 118
             +G+G    V+        +    A K IH+       +  Q   EL +L   +   IV
Sbjct: 39  SELGAGNGGVVFKVSHK--PSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIV 94

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
              G      E  +  E++  G+L + L    ++ ++P +    ++  + + + YL E+ 
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREK- 150

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
              I+H D+K SNIL+      KLCDFG       S  L  S + S            +G
Sbjct: 151 -HKIMHRDVKPSNILVNSRGEIKLCDFG------VSGQLIDSMANS-----------FVG 192

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           +  Y  P  L+    S ++D++S G+ L+E+  G     P + + L  + G  +   A  
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIA------------------------ALCLRQS 334
              +      P      D     A+  +                           CL ++
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312

Query: 335 PILRPSATQIL 345
           P  R    Q++
Sbjct: 313 PAERADLKQLM 323

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  104 bits (263), Expect = 3e-26
 Identities = 68/303 (22%), Positives = 103/303 (33%), Gaps = 71/303 (23%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV--FKQELDILLHLSHDNI 117
                IG G +  V +A      T    A K  +    +  V  FKQE++I+  L H NI
Sbjct: 12  TLENTIGRGSWGEVKIAV--QKGTRIRRAAKK-IPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           ++L    +D  +  L+ E    G L      K       +         I   +  A+ Y
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAY 121

Query: 174 LHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
            H+   L++ H D+K  N L          KL DFG A          P           
Sbjct: 122 CHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR------FKPG---------- 162

Query: 231 TKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
             ++M   +G+P Y  P  L  G+   + D +S GV++  L+ G   F            
Sbjct: 163 --KMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------ 213

Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPILRPSAT 342
                           E++     G F   E     +S  A       L +SP  R ++ 
Sbjct: 214 ----------------EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257

Query: 343 QIL 345
           Q L
Sbjct: 258 QAL 260

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  106 bits (266), Expect = 4e-26
 Identities = 72/366 (19%), Positives = 127/366 (34%), Gaps = 112/366 (30%)

Query: 45  SVKKYSWDD---VERFTQNFSQVIGSGGFSNVYLAR---LINDSTSTNGAIK-IHVG-SD 96
             ++Y +D      R    F +V+GSG F  V  A    +     S   A+K +      
Sbjct: 30  DFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 89

Query: 97  RLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQE----------- 144
              +    EL ++  L SH+NIV L+G C       L+FEY   G L             
Sbjct: 90  SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 145 ---------KLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE 195
                    +L      + L + + +  A+Q+A+ +E+L  +     VH D+ A N+L+ 
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVT 206

Query: 196 EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG---- 251
                K+CDFG                       + + +        +D +Y+  G    
Sbjct: 207 HGKVVKICDFG-----------------------LARDI-------MSDSNYVVRGNARL 236

Query: 252 ----MA---------STKTDVYSFGVILLELVT-------GMEAFCPENGQLLTSL-AGS 290
               MA         + K+DV+S+G++L E+ +       G+    P +      +  G 
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI----PVDANFYKLIQNGF 292

Query: 291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
            ++           E+        + +     M S    C       RPS   +   +  
Sbjct: 293 KMDQPFYAT----EEI--------YII-----MQS----CWAFDSRKRPSFPNLTSFLGC 331

Query: 351 QISSIS 356
           Q++   
Sbjct: 332 QLADAE 337

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (264), Expect = 4e-26
 Identities = 67/338 (19%), Positives = 113/338 (33%), Gaps = 91/338 (26%)

Query: 40  GIDGRSVKKYSW--DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSD 96
           G      ++Y    +D+E         +GSG    V+  R     T    A+K +    +
Sbjct: 11  GYLTIGGQRYQAEINDLENL-----GEMGSGTCGQVWKMRFR--KTGHVIAVKQMRRSGN 63

Query: 97  RLSQVFKQ---ELDILLHLS-HDNIVKLIG-------------YCDDRDEGVLLFEYVPN 139
              +  K+   +LD++L       IV+  G                         +    
Sbjct: 64  --KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGT---CAEKLKKRMQ 118

Query: 140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN 199
           G + E++ G              +   + +A+ YL E+    ++H D+K SNILL+E   
Sbjct: 119 GPIPERILGK-------------MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQ 163

Query: 200 CKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY-----TDPHYLRTGMA 253
            KLCDFG S ++    A                 +    G   Y      DP        
Sbjct: 164 IKLCDFGISGRLVDDKA-----------------KDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 254 STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAG 313
             + DV+S G+ L+EL TG   +              +L  +   E         P L G
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDF------EVLTKVLQEEP--------PLLPG 252

Query: 314 DFDL-DEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
                 + ++ +     CL +    RP   ++L   +H
Sbjct: 253 HMGFSGDFQSFVK---DCLTKDHRKRPKYNKLL---EH 284

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  106 bits (266), Expect = 5e-26
 Identities = 49/249 (19%), Positives = 97/249 (38%), Gaps = 71/249 (28%)

Query: 61  FSQVIGSGGFSNVYLARLIN-----DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL- 112
             + +G G F  V +A  +         +   A+K+     +++       E++++  + 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-------------HGTPRSSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L                    ++ +++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
            ++  +QLA+ +EYL  +     +H D+ A N+L+ E+   K+ DFG   +         
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG---L--------- 249

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSF 262
                   +R                +Y +T         MA         + ++DV+SF
Sbjct: 250 --------ARDI----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291

Query: 263 GVILLELVT 271
           GV++ E+ T
Sbjct: 292 GVLMWEIFT 300

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  104 bits (262), Expect = 5e-26
 Identities = 62/245 (25%), Positives = 98/245 (40%), Gaps = 67/245 (27%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDN 116
             + +G G F  V+LA   N          A+K +   +    + F++E ++L +L H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-------------HGTPRSSKLPWRNRMAI 163
           IVK  G C D D  +++FEY+ +G L + L                    +L     + I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           A Q+A  + YL  +   H VH D+   N L+  +L  K+ DFG                 
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFG----------------- 178

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSFGVIL 266
               SR            Y+  +Y   G        M          +T++DV+SFGVIL
Sbjct: 179 ---MSRDV----------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225

Query: 267 LELVT 271
            E+ T
Sbjct: 226 WEIFT 230

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  107 bits (268), Expect = 6e-26
 Identities = 53/211 (25%), Positives = 102/211 (48%), Gaps = 22/211 (10%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + +G+G F  V++A        T  A+K         + F  E +++  L HD +VKL
Sbjct: 192 LEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 248

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
                 ++   ++ E++  G+L + L  +   SK P    +  + Q+A+ + ++ +R   
Sbjct: 249 HAVVT-KEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 303

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           + +H D++A+NIL+   L CK+ DFG A++   +       +  P +             
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------------- 350

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +T P  +  G  + K+DV+SFG++L+E+VT
Sbjct: 351 -WTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  104 bits (261), Expect = 6e-26
 Identities = 73/322 (22%), Positives = 117/322 (36%), Gaps = 73/322 (22%)

Query: 44  RSVKKYSWDDVERFTQN--FSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRL 98
            S  + +      F +      ++G G F  V      +  T    A+K+       ++ 
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKD 64

Query: 99  SQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSK 154
           +    +E+++L  L H NI+KL    +D     ++ E    G L     ++   +   + 
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMG 211
                   I  Q+   I Y+H+    +IVH D+K  NILL   E+  + K+ DFG +   
Sbjct: 125 -------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC- 173

Query: 212 FSSAVLPPSPSPSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
           F                      M   IG+  Y  P  LR G    K DV+S GVIL  L
Sbjct: 174 FQQ-----------------NTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYIL 215

Query: 270 VTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA 328
           ++G   F  +N                        +++     G +  D  +   +S  A
Sbjct: 216 LSGTPPFYGKNEY----------------------DILKRVETGKYAFDLPQWRTISDDA 253

Query: 329 L-----CLRQSPILRPSATQIL 345
                  L   P LR +ATQ L
Sbjct: 254 KDLIRKMLTFHPSLRITATQCL 275

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  104 bits (261), Expect = 6e-26
 Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 20/211 (9%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
               +G G +  VY       S +   A+K         + F +E  ++  + H N+V+L
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTV--AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 74

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           +G C       ++ E++  G L + L       ++     + +A Q++ A+EYL ++   
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           + +H D+ A N L+ E+   K+ DFG +++         + +  P +             
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------------- 177

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            +T P  L     S K+DV++FGV+L E+ T
Sbjct: 178 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (263), Expect = 7e-26
 Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 55/246 (22%)

Query: 46  VKKYSWD-DVERFTQNFSQVIGSGGFSNVYLARL-INDSTSTNGAIK-IHVG-SDRLSQV 101
            + ++ + +  R      ++IGSG    V   RL +        AIK +  G ++R  + 
Sbjct: 39  GRSFTREIEASRIH--IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD 96

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
           F  E  I+    H NI++L G        +++ EY+ NG+L   L       +      +
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLV 154

Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP 221
            +   +   + YL +      VH D+ A N+L++ +L CK+ DFG               
Sbjct: 155 GMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG--------------- 196

Query: 222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTG-------MA---------STKTDVYSFGVI 265
                 SR+ +           D  Y  TG        A         S+ +DV+SFGV+
Sbjct: 197 -----LSRVLED--------DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243

Query: 266 LLELVT 271
           + E++ 
Sbjct: 244 MWEVLA 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  104 bits (262), Expect = 8e-26
 Identities = 67/339 (19%), Positives = 125/339 (36%), Gaps = 67/339 (19%)

Query: 48  KYSWDDVE--RFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIK---IHVGSDRLSQV 101
           K   +DV          +++G G F +V  A+L   D +    A+K     + +    + 
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGV------LLFEYVPNGTLQE---KLHGTPRS 152
           F +E   +    H ++ KL+G               ++  ++ +G L             
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131

Query: 153 SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF 212
             LP +  +     +A  +EYL  R   + +H D+ A N +L E +   + DFG ++  +
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

Query: 213 SSAVLPPSPSPSPSRSRITKQVMMIGSP-GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           S               R      +   P  +     L   + +  +DV++FGV + E++T
Sbjct: 189 SG-----------DYYRQGCASKL---PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

Query: 272 -------GMEAFCPENGQLLTSL-AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAM 323
                  G+     EN ++   L  G+ L    +C      E+        +DL     M
Sbjct: 235 RGQTPYAGI-----ENAEIYNYLIGGNRLKQPPECM----EEV--------YDL-----M 272

Query: 324 LSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ 362
                 C    P  RPS T +   +++ +  +S L + Q
Sbjct: 273 YQ----CWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  105 bits (265), Expect = 8e-26
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 22/224 (9%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
                  +F++VIG G F  VY   L++ D    + A+K    +        F  E  I+
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144

Query: 110 LHLSHDNIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
              SH N++ L+G C   +   L+   Y+ +G L+  +     +     ++ +    Q+A
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVA 202

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           + +++L  +     VH D+ A N +L+E    K+ DFG A+  +                
Sbjct: 203 KGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK---------EFDSV 250

Query: 229 RITKQVMMIGSP-GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  +   P  +     L+T   +TK+DV+SFGV+L EL+T
Sbjct: 251 HNKTGAKL---PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  105 bits (263), Expect = 8e-26
 Identities = 49/249 (19%), Positives = 97/249 (38%), Gaps = 71/249 (28%)

Query: 61  FSQVIGSGGFSNVYLARLIN-----DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL- 112
             + +G G F  V +A  +         +   A+K+     +++       E++++  + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-------------HGTPRSSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L                    ++ +++
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
            ++  +QLA+ +EYL  +     +H D+ A N+L+ E+   K+ DFG   +         
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG---L--------- 203

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSF 262
                   +R                +Y +T         MA         + ++DV+SF
Sbjct: 204 --------ARDI----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245

Query: 263 GVILLELVT 271
           GV++ E+ T
Sbjct: 246 GVLMWEIFT 254

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  104 bits (262), Expect = 9e-26
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 53/231 (22%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNG--AIK-IHVG-SDRLSQVFKQELDILLHLSHDN 116
             +VIG+G F  VY   L   S       AIK +  G +++    F  E  I+   SH N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I++L G        +++ EY+ NG L + L    +  +      + +   +A  ++YL  
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
               + VH D+ A NIL+  +L CK+ DFG                     SR+ +    
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFG--------------------LSRVLEDD-- 200

Query: 237 IGSPGYTDPHYLRTG-------MA---------STKTDVYSFGVILLELVT 271
                  +  Y  +G        A         ++ +DV+SFG+++ E++T
Sbjct: 201 ------PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (260), Expect = 1e-25
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 46/227 (20%)

Query: 55  ERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQELDI 108
            +F+ N+   + +G G FS V     ++ +T    A KI + + +LS    Q  ++E  I
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRC--VHKTTGLEFAAKI-INTKKLSARDFQKLEREARI 58

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIA 164
              L H NIV+L     +     L+F+ V  G L      +   +   +           
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCI 111

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSP 221
            Q+ ++I Y H      IVH ++K  N+LL    +    KL DFG A        +  S 
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI------EVNDS- 161

Query: 222 SPSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVIL 266
                      +      G+PGY  P  L+    S   D+++ GVIL
Sbjct: 162 -----------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (259), Expect = 1e-25
 Identities = 47/234 (20%), Positives = 83/234 (35%), Gaps = 55/234 (23%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNG-----AIK-IHVGSDRLSQVFKQELDILLHLSH 114
           F++ +G G F+ ++                   +K +       S+ F +   ++  LSH
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            ++V   G C   DE +L+ E+V  G+L   L        + W+  +A   QLA A+ +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK--QLAAAMHFL 129

Query: 175 HERCTLHIVHGDIKASNILLE--------EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
            E     ++HG++ A NILL              KL D G +                  
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----------------- 169

Query: 227 RSRITKQVMMIGSPGYTDP---------HYLRTGMASTKTDVYSFGVILLELVT 271
                    ++      +             +    +  TD +SFG  L E+ +
Sbjct: 170 --------TVLPKDILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICS 213

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  104 bits (261), Expect = 1e-25
 Identities = 71/315 (22%), Positives = 113/315 (35%), Gaps = 83/315 (26%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---------HVGSDRLSQVFKQELDILL 110
             S+ +GSG    V LA      T    AIKI                +   + E++IL 
Sbjct: 13  IMSKTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 111 HLSHDNIVKLIGYCDDRDEGV-LLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAF 165
            L+H  I+K+  + D  D    ++ E +  G L             + K          +
Sbjct: 71  KLNHPCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCK-------LYFY 121

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           Q+  A++YLHE     I+H D+K  N+LL   EE    K+ DFG +K+            
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI------------ 166

Query: 223 PSPSRSRITKQVMM---IGSPGYTDPHYLRTGMA---STKTDVYSFGVILLELVTGMEAF 276
                  + +  +M    G+P Y  P  L +      +   D +S GVIL   ++G   F
Sbjct: 167 -------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

Query: 277 CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAAL-----C 330
                Q+      S+ + I                +G ++      A +S  AL      
Sbjct: 220 SEHRTQV------SLKDQI---------------TSGKYNFIPEVWAEVSEKALDLVKKL 258

Query: 331 LRQSPILRPSATQIL 345
           L   P  R +  + L
Sbjct: 259 LVVDPKARFTTEEAL 273

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  105 bits (263), Expect = 1e-25
 Identities = 56/234 (23%), Positives = 105/234 (44%), Gaps = 27/234 (11%)

Query: 44  RSVKKYSWD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG-AIK-IHVG-SDRLS 99
           ++V +++ + D    +    +V+G+G F  V   RL   S      AIK + VG +++  
Sbjct: 33  QTVHEFAKELDATNIS--IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90

Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
           + F  E  I+    H NI++L G        +++ EY+ NG+L   L      ++     
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQ 148

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM--GFSSAVL 217
            + +   +A  ++YL +      VH D+ A NIL+  +L CK+ DFG  ++      A  
Sbjct: 149 LVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205

Query: 218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                  P R              +T P  +     ++ +DV+S+G++L E+++
Sbjct: 206 TTRGGKIPIR--------------WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  103 bits (258), Expect = 1e-25
 Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 22/211 (10%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+L
Sbjct: 28  FLKELGTGQFGVVKYGKWRG---QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +   
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK--- 139

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
             +H D+ A N L+ +    K+ DFG ++            S  P R             
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------------- 186

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            ++ P  L     S+K+D+++FGV++ E+ +
Sbjct: 187 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (260), Expect = 2e-25
 Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 49/239 (20%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---------HVGSDRLSQVFKQELDILL 110
           +  + +GSG F+ V        ST    A K            G  R  +  ++E+ IL 
Sbjct: 15  DIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSR--EEIEREVSILR 70

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLA 168
            + H N++ L    ++R + VL+ E V  G L + L     + K       A +F  Q+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQIL 125

Query: 169 QAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
             + YLH +    I H D+K  NI+L        + KL DFG A                
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--------------- 167

Query: 225 PSRSRITKQVMM---IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                I   V      G+P +  P  +       + D++S GVI   L++G   F  + 
Sbjct: 168 ----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/300 (23%), Positives = 110/300 (36%), Gaps = 67/300 (22%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
               +G G  S VY  +     T    A+K+ +      ++ + E+ +LL LSH NI+KL
Sbjct: 57  VESELGRGATSIVYRCK--QKGTQKPYALKV-LKKTVDKKIVRTEIGVLLRLSHPNIIKL 113

Query: 121 IGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
               +   E  L+ E V  G L     EK + + R +            Q+ +A+ YLHE
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------DAVKQILEAVAYLHE 166

Query: 177 RCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
                IVH D+K  N+L          K+ DFG +K+      +                
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI------VEHQ------------V 205

Query: 234 VM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
           +M  + G+PGY  P  LR      + D++S G+I   L+ G E F  E G          
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------- 256

Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAAL-----CLRQSPILRPSATQIL 345
                         +    L  ++         +S+ A       +   P  R +  Q L
Sbjct: 257 ------------QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  106 bits (266), Expect = 2e-25
 Identities = 62/329 (18%), Positives = 118/329 (35%), Gaps = 61/329 (18%)

Query: 29  QDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGA 88
            + D Y             +   D V     +  + +G+G F  V+       +T  N A
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDH-YDIHEELGTGAFGVVHRV--TERATGNNFA 186

Query: 89  IK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH 147
            K +    +   +  ++E+  +  L H  +V L    +D +E V+++E++  G L EK+ 
Sbjct: 187 AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV- 245

Query: 148 GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDF 205
                +K+     +    Q+ + + ++HE    + VH D+K  NI+     +   KL DF
Sbjct: 246 -ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 301

Query: 206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMM---IGSPGYTDPHYLRTGMASTKTDVYSF 262
           G                       +  +  +    G+  +  P           TD++S 
Sbjct: 302 GLTA-------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342

Query: 263 GVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLD-EAR 321
           GV+   L++G+  F  EN           L ++                + D+++D  A 
Sbjct: 343 GVLSYILLSGLSPFGGENDD-------ETLRNV---------------KSCDWNMDDSAF 380

Query: 322 AMLSIAAL-----CLRQSPILRPSATQIL 345
           + +S          L   P  R +  Q L
Sbjct: 381 SGISEDGKDFIRKLLLADPNTRMTIHQAL 409

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  105 bits (263), Expect = 3e-25
 Identities = 57/314 (18%), Positives = 102/314 (32%), Gaps = 63/314 (20%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIV 118
              +++G G    V              A+K  +  D        E+ +L     H N++
Sbjct: 18  VSEKILGYGSSGTVVFQ---GSFQGRPVAVKR-MLIDFCDIA-LMEIKLLTESDDHPNVI 72

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQE----KLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           +            +  E   N  LQ+    K             N +++  Q+A  + +L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 175 HERCTLHIVHGDIKASNILL-------------EEHLNCKLCDFGSAKMGFSSAVLPPSP 221
           H    L I+H D+K  NIL+              E+L   + DFG  K       L    
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK------LDSGQ 182

Query: 222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-------STKTDVYSFGVILLELVT-GM 273
           S   +           G+ G+  P  L            +   D++S G +   +++ G 
Sbjct: 183 SSFRTNLNN-----PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL-DEARAMLSIAALCLR 332
             F  +  +    + G                L + +   D  L  EA  ++S     + 
Sbjct: 238 HPFGDKYSRESNIIRGIF-------------SLDEMKCLHDRSLIAEATDLIS---QMID 281

Query: 333 QSPILRPSATQILH 346
             P+ RP+A ++L 
Sbjct: 282 HDPLKRPTAMKVLR 295

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (259), Expect = 3e-25
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 34/215 (15%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           IG G F+ V LAR  +  T    AIKI     +    L ++  +E+ I+  L+H NIVKL
Sbjct: 23  IGKGNFAKVKLAR--HILTGREVAIKIIDKTQLNPTSLQKL-FREVRIMKILNHPNIVKL 79

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
               +      L+ EY   G + + L  HG     ++  +   +   Q+  A++Y H++ 
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK- 133

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
              IVH D+KA N+LL+  +N K+ DF     GFS+         +             G
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADF-----GFSNEFTVGGKLDAFC-----------G 175

Query: 239 SPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTG 272
           +P Y  P   +       + DV+S GVIL  LV+G
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  104 bits (260), Expect = 3e-25
 Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 26/242 (10%)

Query: 42  DGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQ 100
           D R V          +T + ++++G G F  V+       +T    A K I     +  +
Sbjct: 74  DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC--EETATGLKLAAKIIKTRGMKDKE 131

Query: 101 VFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
             K E+ ++  L H N+++L    + +++ VL+ EYV  G L +++     S  L   + 
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDT 189

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGFSSAVLP 218
           +    Q+ + I ++H+    +I+H D+K  NIL         K+ DFG A+         
Sbjct: 190 ILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR------YK 240

Query: 219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP 278
           P            K  +  G+P +  P  +     S  TD++S GVI   L++G+  F  
Sbjct: 241 PR----------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290

Query: 279 EN 280
           +N
Sbjct: 291 DN 292

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (260), Expect = 3e-25
 Identities = 60/241 (24%), Positives = 91/241 (37%), Gaps = 49/241 (20%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---------HVGSDRLSQVFKQELDILL 110
           +  + +GSG F+ V        ST    A K            G  R  +  ++E+ IL 
Sbjct: 15  DIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVCR--EEIEREVSILR 70

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLA 168
            + H NI+ L    ++R + VL+ E V  G L + L     + K       A +F  Q+ 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQIL 125

Query: 169 QAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
             + YLH      I H D+K  NI+L        + KL DFG A                
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--------------- 167

Query: 225 PSRSRITKQVMM---IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG 281
                I   V      G+P +  P  +       + D++S GVI   L++G   F  +  
Sbjct: 168 ----EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223

Query: 282 Q 282
           Q
Sbjct: 224 Q 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  102 bits (256), Expect = 4e-25
 Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 44/221 (19%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQV-FKQELDILLHLSHDNIVKLIG 122
           +G G F +V            + AIK +  G+++       +E  I+  L +  IV+LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
            C   +  +L+ E    G L + L G  +  ++P  N   +  Q++  ++YL E+   + 
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NF 131

Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           VH D+ A N+LL      K+ DFG +K                         +      Y
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSK------------------------ALGADDSYY 167

Query: 243 ------------TDPHYLRTGMASTKTDVYSFGVILLELVT 271
                         P  +     S+++DV+S+GV + E ++
Sbjct: 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  102 bits (256), Expect = 4e-25
 Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 48/225 (21%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSD--RLSQVFKQELDILLHLSHDNIVK 119
           + +GSG F  V              A+K +   ++   L      E +++  L +  IV+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 120 LIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           +IG C+   E  +L  E    G L + L    ++  +  +N + +  Q++  ++YL E  
Sbjct: 83  MIGICEA--ESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES- 136

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
             + VH D+ A N+LL      K+ DFG +K                         +   
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSK------------------------ALRAD 170

Query: 239 SPGY------------TDPHYLRTGMASTKTDVYSFGVILLELVT 271
              Y              P  +     S+K+DV+SFGV++ E  +
Sbjct: 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (255), Expect = 4e-25
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 24/212 (11%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + +G+G F  V++         T  A+K           F  E +++  L H  +V+L
Sbjct: 17  LVERLGAGQFGEVWMGYYNG---HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 121 IGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
                   E + +  EY+ NG+L + L  TP   KL     + +A Q+A+ + ++ ER  
Sbjct: 74  YAVVTQ--EPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
            + +H D++A+NIL+ + L+CK+ DFG A++   +       +  P +            
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------------ 175

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
             +T P  +  G  + K+DV+SFG++L E+VT
Sbjct: 176 --WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  103 bits (258), Expect = 4e-25
 Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 55/231 (23%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSDRLSQV-FKQELDILLHLSHDN 116
             +V+GSG F  VY    I +        AIK +   +   +      E  ++  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           + +L+G C       L+ + +P G L + +        +  +  +    Q+A+ + YL +
Sbjct: 79  VCRLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           R    +VH D+ A N+L++   + K+ DFG AK      +L                   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAK------LLGAE---------------- 170

Query: 237 IGSPGYTDPHYLRTG-------MA---------STKTDVYSFGVILLELVT 271
                  +  Y   G       MA         + ++DV+S+GV + EL+T
Sbjct: 171 -------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  101 bits (254), Expect = 7e-25
 Identities = 55/236 (23%), Positives = 86/236 (36%), Gaps = 43/236 (18%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---------HVGSDRLSQVFKQELDILL 110
              + +GSG F+ V   R     T    A K            G  R  +  ++E++IL 
Sbjct: 8   EMGEELGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSR--EEIEREVNILR 63

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
            + H NI+ L    +++ + VL+ E V  G L + L        L          Q+   
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDG 120

Query: 171 IEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           + YLH      I H D+K  NI+L      +   KL DFG A        +         
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK------IEAG------ 165

Query: 227 RSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                      + G+P +  P  +       + D++S GVI   L++G   F  E 
Sbjct: 166 ------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  101 bits (255), Expect = 8e-25
 Identities = 61/244 (25%), Positives = 95/244 (38%), Gaps = 66/244 (27%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDN 116
               +G G F  V+LA   N   +      A+K +   S+   Q F++E ++L  L H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKL------------HGTPRSSKLPWRNRMAIA 164
           IV+  G C +    +++FEY+ +G L   L                    L     +A+A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
            Q+A  + YL      H VH D+   N L+ + L  K+ DFG   M              
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFG---M-------------- 204

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSFGVILL 267
              SR            Y+  +Y   G        M          +T++DV+SFGV+L 
Sbjct: 205 ---SRDI----------YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251

Query: 268 ELVT 271
           E+ T
Sbjct: 252 EIFT 255

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  104 bits (261), Expect = 9e-25
 Identities = 52/255 (20%), Positives = 94/255 (36%), Gaps = 44/255 (17%)

Query: 31  QDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK 90
            D         D   +K                 +G G F +V            + AIK
Sbjct: 310 MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK 369

Query: 91  -IHVGSDRLS-QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG 148
            +  G+++   +   +E  I+  L +  IV+LIG C   +  +L+ E    G L + L G
Sbjct: 370 VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG 428

Query: 149 TPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
             +  ++P  N   +  Q++  ++YL E+   + VH ++ A N+LL      K+ DFG +
Sbjct: 429 --KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS 483

Query: 209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY------------TDPHYLRTGMASTK 256
           K                         +      Y              P  +     S++
Sbjct: 484 K------------------------ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519

Query: 257 TDVYSFGVILLELVT 271
           +DV+S+GV + E ++
Sbjct: 520 SDVWSYGVTMWEALS 534

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  102 bits (257), Expect = 9e-25
 Identities = 69/327 (21%), Positives = 115/327 (35%), Gaps = 72/327 (22%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD 115
             + +G G F  VY  ++     D +    A+K    V S++    F  E  I+   +H 
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL----HGTPRSSKLPWRNRMAIAFQLAQAI 171
           NIV+ IG         +L E +  G L+  L        + S L   + + +A  +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 172 EYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           +YL E    H +H DI A N LL         K+ DFG   M               +R 
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG---M---------------ARD 233

Query: 229 RITKQVMMIGSPGY-----TDPHYLRTGMASTKTDVYSFGVILLELVT-------GMEAF 276
                    G           P     G+ ++KTD +SFGV+L E+ +            
Sbjct: 234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--- 290

Query: 277 CPENGQLLTSL-AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
              N ++L  + +G  ++   +C            +   + +     M      C +  P
Sbjct: 291 --SNQEVLEFVTSGGRMDPPKNCP---------GPV---YRI-----MTQ----CWQHQP 327

Query: 336 ILRPSATQILHTIKHQISSISFLFSPQ 362
             RP+   IL  I++       + +  
Sbjct: 328 EDRPNFAIILERIEYCTQDPDVINTAL 354

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (255), Expect = 9e-25
 Identities = 69/327 (21%), Positives = 115/327 (35%), Gaps = 72/327 (22%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD 115
             + +G G F  VY  ++     D +    A+K    V S++    F  E  I+   +H 
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL----HGTPRSSKLPWRNRMAIAFQLAQAI 171
           NIV+ IG         +L E +  G L+  L        + S L   + + +A  +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 172 EYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           +YL E    H +H DI A N LL         K+ DFG   M               +R 
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG---M---------------ARD 192

Query: 229 RITKQVMMIGSPGY-----TDPHYLRTGMASTKTDVYSFGVILLELVT-------GMEAF 276
                    G           P     G+ ++KTD +SFGV+L E+ +            
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--- 249

Query: 277 CPENGQLLTSL-AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP 335
              N ++L  + +G  ++   +C            +   + +     M      C +  P
Sbjct: 250 --SNQEVLEFVTSGGRMDPPKNCP---------GPV---YRI-----MTQ----CWQHQP 286

Query: 336 ILRPSATQILHTIKHQISSISFLFSPQ 362
             RP+   IL  I++       + +  
Sbjct: 287 EDRPNFAIILERIEYCTQDPDVINTAL 313

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (253), Expect = 1e-24
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 23/214 (10%)

Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNI 117
             + IG G F +V+    ++ ++ +   AIK      SD + + F QE   +    H +I
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           VKLIG     +   ++ E    G L+  L    R   L   + +  A+QL+ A+ YL  +
Sbjct: 79  VKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK 135

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
                VH DI A N+L+  +   KL DFG ++    S     S    P +          
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---------- 182

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +  P  +     ++ +DV+ FGV + E++ 
Sbjct: 183 ----WMAPESINFRRFTSASDVWMFGVCMWEILM 212

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (254), Expect = 1e-24
 Identities = 71/331 (21%), Positives = 120/331 (36%), Gaps = 76/331 (22%)

Query: 41  IDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLS 99
           I       ++ +D++         IG G + +V         +    A+K I    D   
Sbjct: 11  ISPEQHWDFTAEDLKDL-----GEIGRGAYGSVNKMVHK--PSGQIMAVKRIRSTVD--E 61

Query: 100 QVFKQ---ELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQE--KLHGTPRSS 153
           +  KQ   +LD+++  S    IV+  G      +  +  E + + +  +  K   +    
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGF 212
            +P      I     +A+ +L E   L I+H DIK SNILL+   N KLCDFG S ++  
Sbjct: 121 VIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178

Query: 213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-------------STKTDV 259
           S A                 +    G   Y         MA               ++DV
Sbjct: 179 SIA-----------------KTRDAGCRPY---------MAPERIDPSASRQGYDVRSDV 212

Query: 260 YSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDE 319
           +S G+ L EL TG   +   N           L  +   +         P+L+   + + 
Sbjct: 213 WSLGITLYELATGRFPYPKWNSVF------DQLTQVVKGDP--------PQLSNSEEREF 258

Query: 320 ARAMLSIAALCLRQSPILRPSATQILHTIKH 350
           + + ++   LCL +    RP   ++L   KH
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELL---KH 286

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (255), Expect = 1e-24
 Identities = 56/260 (21%), Positives = 104/260 (40%), Gaps = 39/260 (15%)

Query: 33  QYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI- 91
            +H     +   ++   S ++   F    S+ +G G F+ V     I+ ST    A K  
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQC--ISKSTGQEYAAKFL 62

Query: 92  ---HVGSDRLSQVFKQELDILLHLSHD-NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH 147
                G D  +++   E+ +L        ++ L    ++  E +L+ EY   G +     
Sbjct: 63  KKRRRGQDCRAEI-LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC- 120

Query: 148 GTPRSSKLPWRNRMAIAF--QLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKL 202
             P  +++       I    Q+ + + YLH+    +IVH D+K  NILL       + K+
Sbjct: 121 -LPELAEM-VSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175

Query: 203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVY 260
            DFG ++       +  +              +  ++G+P Y  P  L     +T TD++
Sbjct: 176 VDFGMSRK------IGHA------------CELREIMGTPEYLAPEILNYDPITTATDMW 217

Query: 261 SFGVILLELVTGMEAFCPEN 280
           + G+I   L+T    F  E+
Sbjct: 218 NIGIIAYMLLTHTSPFVGED 237

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  100 bits (251), Expect = 1e-24
 Identities = 45/211 (21%), Positives = 83/211 (39%), Gaps = 22/211 (10%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKL 120
             + +GSG F  V L +        + A+K+          F QE   ++ LSH  +VK 
Sbjct: 12  LLKELGSGQFGVVKLGKWKG---QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            G C       ++ EY+ NG L   L    +  +      M     + + + +L      
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY--DVCEGMAFLESH--- 123

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
             +H D+ A N L++  L  K+ DFG  +       +    +  P +             
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------------- 170

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
            ++ P        S+K+DV++FG+++ E+ +
Sbjct: 171 -WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (260), Expect = 2e-24
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 25/215 (11%)

Query: 61  FSQVIGSGGFSNVYLARLINDS-TSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNI 117
             + IG G F +V+    ++    +   AIK      SD + + F QE   +    H +I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 118 VKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           VKLIG   +    V +  E    G L+  L    R   L   + +  A+QL+ A+ YL  
Sbjct: 454 VKLIGVITE--NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLES 509

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +     VH DI A N+L+  +   KL DFG ++    S     S    P +         
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK--------- 557

Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                +  P  +     ++ +DV+ FGV + E++ 
Sbjct: 558 -----WMAPESINFRRFTSASDVWMFGVCMWEILM 587

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (252), Expect = 2e-24
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 47/227 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI--------HVGSDRLSQVFKQELDILLHLSH 114
            ++GSGGF +VY       S +   AIK                ++V   E+ +L  +S 
Sbjct: 49  PLLGSGGFGSVYSGI--RVSDNLPVAIKHVEKDRISDWGELPNGTRV-PMEVVLLKKVSS 105

Query: 115 D--NIVKLIGYCDDRDEGVLLFEYV-PNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QL 167
               +++L+ + +  D  VL+ E   P   L + +   G      L     +A +F  Q+
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQ--EELARSFFWQV 158

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
            +A+ + H      ++H DIK  NIL+       KL DFGS       A+L  +      
Sbjct: 159 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS------GALLKDTVYTDFD 209

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTG 272
                      G+  Y+ P ++R          V+S G++L ++V G
Sbjct: 210 -----------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (252), Expect = 2e-24
 Identities = 61/303 (20%), Positives = 120/303 (39%), Gaps = 59/303 (19%)

Query: 55  ERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           +   + +   + +G G F  V+    +  S+      K          + K+E+ IL   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRC--VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
            H NI+ L    +  +E V++FE++    + E++     + +L  R  ++   Q+ +A++
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQ 116

Query: 173 YLHERCTLHIVHGDIKASNILL--EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
           +LH     +I H DI+  NI+         K+ +FG A+       L P           
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ------LKPG---------- 157

Query: 231 TKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
                  +  +P Y  P   +  + ST TD++S G ++  L++G+  F  E  Q      
Sbjct: 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------ 209

Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAAL-----CLRQSPILRPSAT 342
             ++ +I               +  ++  DE     +SI A+      L +    R +A+
Sbjct: 210 -QIIENI---------------MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTAS 253

Query: 343 QIL 345
           + L
Sbjct: 254 EAL 256

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  101 bits (254), Expect = 2e-24
 Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 46/248 (18%)

Query: 52  DDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLS----QVFKQE 105
           +   +F+ N+   + +G G FS V     ++ +T    A KI + + +LS    Q  ++E
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRC--VHKTTGLEFAAKI-INTKKLSARDFQKLERE 78

Query: 106 LDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRM 161
             I   L H NIV+L     +     L+F+ V  G L      +   +   +        
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------- 131

Query: 162 AIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLP 218
               Q+ ++I Y H      IVH ++K  N+LL    +    KL DFG A        + 
Sbjct: 132 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VN 182

Query: 219 PSPSPSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF 276
            S            +      G+PGY  P  L+    S   D+++ GVIL  L+ G   F
Sbjct: 183 DS------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

Query: 277 CPENGQLL 284
             E+   L
Sbjct: 231 WDEDQHRL 238

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  101 bits (254), Expect = 2e-24
 Identities = 70/343 (20%), Positives = 127/343 (37%), Gaps = 105/343 (30%)

Query: 61  FSQVIGSGGFSNVYLARLIN-----DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL- 112
             + +G G F  V LA  I       +  T  A+K+     +++       E++++  + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL-------------HGTPRSSKLPWRN 159
            H NI+ L+G C       ++ EY   G L+E L                    +L  ++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
            ++ A+Q+A+ +EYL  +     +H D+ A N+L+ E    K+ DFG A+          
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD--------- 240

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSF 262
                     I           +   +Y +T         MA         + ++DV+SF
Sbjct: 241 ----------I-----------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279

Query: 263 GVILLELVT-------GMEAFCPENGQLLTSL-AGSMLNDIADCEATKVNELVDPRLAGD 314
           GV+L E+ T       G+        +L   L  G  ++  ++C     NEL        
Sbjct: 280 GVLLWEIFTLGGSPYPGV-----PVEELFKLLKEGHRMDKPSNCT----NEL-------- 322

Query: 315 FDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF 357
           + +     M      C    P  RP+  Q++  +   ++  S 
Sbjct: 323 YMM-----MRD----CWHAVPSQRPTFKQLVEDLDRIVALTSN 356

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  101 bits (253), Expect = 2e-24
 Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 76/254 (29%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD 115
           + + IG G F  V+ AR          T  A+K+     S  +   F++E  ++    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKL---------------------HGTPRSSK 154
           NIVKL+G C       LLFEY+  G L E L                       +P    
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L    ++ IA Q+A  + YL ER     VH D+   N L+ E++  K+ DFG   +    
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG---L---- 220

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKT 257
                        SR            Y+  +Y   G        M          +T++
Sbjct: 221 -------------SRNI----------YSADYYKADGNDAIPIRWMPPESIFYNRYTTES 257

Query: 258 DVYSFGVILLELVT 271
           DV+++GV+L E+ +
Sbjct: 258 DVWAYGVVLWEIFS 271

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  100 bits (251), Expect = 3e-24
 Identities = 68/306 (22%), Positives = 107/306 (34%), Gaps = 75/306 (24%)

Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKL 120
            QV+G G    V      +  T    A+K+    D      +QE+D     S   +IV +
Sbjct: 34  KQVLGLGVNGKVLEC--FHRRTGQKCALKLL--YDS--PKARQEVDHHWQASGGPHIVCI 87

Query: 121 IGYCDDRDEGV----LLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMA--IAFQLAQA 170
           +   ++   G     ++ E +  G L    QE+           +  R A  I   +  A
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-------FTEREAAEIMRDIGTA 140

Query: 171 IEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           I++LH     +I H D+K  N+L    E+    KL DFG AK                  
Sbjct: 141 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE----------------- 180

Query: 228 SRITKQVMM--IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT 285
              T+  +     +P Y  P  L         D++S GVI+  L+ G   F    GQ   
Sbjct: 181 --TTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ--- 235

Query: 286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPILRP 339
           +++  M   I                 G +       + +S  A     L L+  P  R 
Sbjct: 236 AISPGMKRRI---------------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280

Query: 340 SATQIL 345
           + TQ +
Sbjct: 281 TITQFM 286

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (251), Expect = 4e-24
 Identities = 59/241 (24%), Positives = 93/241 (38%), Gaps = 44/241 (18%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI-----HVGSDRLS-QVFKQELDILLHLSH 114
             +VIG G FS V     IN  T    A+KI        S  LS +  K+E  I   L H
Sbjct: 28  LCEVIGKGPFSVVRRC--INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAF--QLA 168
            +IV+L+          ++FE++    L     ++       S+      +A  +  Q+ 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE-----AVASHYMRQIL 140

Query: 169 QAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
           +A+ Y H+    +I+H D+K   +LL   E     KL  FG A       +         
Sbjct: 141 EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ-----LGESG----- 187

Query: 226 SRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                   V    +G+P +  P  ++        DV+  GVIL  L++G   F     +L
Sbjct: 188 -------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 240

Query: 284 L 284
            
Sbjct: 241 F 241

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (255), Expect = 4e-24
 Identities = 60/244 (24%), Positives = 91/244 (37%), Gaps = 43/244 (17%)

Query: 55  ERFTQN--FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV---GSDRLSQVFKQELDIL 109
            RFT+     + +G G FS V     +        A  I      S R  Q  ++E  I 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRC--VKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64

Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSSKLPWRNRMAIAF 165
             L H NIV+L     +     L+F+ V  G L      + + +   +            
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQ 117

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           Q+ +A+ + H+     +VH ++K  N+LL    +    KL DFG A       V      
Sbjct: 118 QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-----VEGE--- 166

Query: 223 PSPSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                    +Q      G+PGY  P  LR        D+++ GVIL  L+ G   F  E+
Sbjct: 167 ---------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217

Query: 281 GQLL 284
              L
Sbjct: 218 QHRL 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 71/310 (22%), Positives = 122/310 (39%), Gaps = 57/310 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDNIVK 119
           + IG G F  V+    I++ T    AIKI       D +  + +QE+ +L       + K
Sbjct: 28  EKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTK 84

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
             G      +  ++ EY+  G+  + L   P    L       I  ++ + ++YLH    
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE-- 138

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
              +H DIKA+N+LL EH   KL DFG + ++                     K+   +G
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQL----------------TDTQIKRNTFVG 181

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           +P +  P  ++     +K D++S G+  +EL  G       +          +L  I   
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-------PMKVLFLIPKN 234

Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL 358
                     P L G++    ++ +      CL + P  RP+A ++L   KH+     F+
Sbjct: 235 NP--------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELL---KHK-----FI 274

Query: 359 FSPQKDPSRL 368
               K  S L
Sbjct: 275 LRNAKKTSYL 284

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 23/214 (10%)

Query: 61  FSQVIGSGGFSNVYLARLIN-DSTSTNGAIK-IHVG-SDRLSQVFKQELDILLHLSHDNI 117
            ++++G G F  VY     N      N A+K      +    + F  E  I+ +L H +I
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           VKLIG  +  +   ++ E  P G L   L     S K+     +  + Q+ +A+ YL   
Sbjct: 76  VKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKAMAYLESI 132

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
              + VH DI   NIL+      KL DFG ++          S +  P +          
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK---------- 179

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
               +  P  +     +T +DV+ F V + E+++
Sbjct: 180 ----WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 98.8 bits (247), Expect = 6e-24
 Identities = 55/246 (22%), Positives = 86/246 (34%), Gaps = 68/246 (27%)

Query: 61  FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHD 115
           F + +G   F  VY   L        +   AIK         L + F+ E  +   L H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-------------GTPRSSKLPWRNRMA 162
           N+V L+G         ++F Y  +G L E L                   S L   + + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           +  Q+A  +EYL      H+VH D+   N+L+ + LN K+ D G   +            
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLG---L------------ 174

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTG--------MA---------STKTDVYSFGVI 265
                 R            Y   +Y   G        MA         S  +D++S+GV+
Sbjct: 175 -----FREV----------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219

Query: 266 LLELVT 271
           L E+ +
Sbjct: 220 LWEVFS 225

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 60/315 (19%), Positives = 104/315 (33%), Gaps = 94/315 (29%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ---ELDILLHLS-HDNI 117
             +G G +  V   R +   +    A+K I    +  SQ  K+   +LDI +        
Sbjct: 13  MELGRGAYGVVEKMRHV--PSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFT 68

Query: 118 VKLIG-------------YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           V   G               D   +           T+ E + G              IA
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK-------------IA 115

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSP 223
             + +A+E+LH +  L ++H D+K SN+L+      K+CDFG S  +    A        
Sbjct: 116 VSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-------- 165

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMA-------------STKTDVYSFGVILLELV 270
                    + +  G   Y         MA             S K+D++S G+ ++EL 
Sbjct: 166 ---------KDIDAGCKPY---------MAPERINPELNQKGYSVKSDIWSLGITMIELA 207

Query: 271 TGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
                +               L  + +  +        P+L  D    E     S    C
Sbjct: 208 ILRFPYDSWGTPF------QQLKQVVEEPS--------PQLPADKFSAEFVDFTS---QC 250

Query: 331 LRQSPILRPSATQIL 345
           L+++   RP+  +++
Sbjct: 251 LKKNSKERPTYPELM 265

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 70/327 (21%), Positives = 121/327 (37%), Gaps = 76/327 (23%)

Query: 41  IDGRSVKKYSWDDVERFTQ--NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL 98
           +   S+ +    +  +FT      + IG G +S       I+ +T+   A+KI       
Sbjct: 4   VGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRC--IHKATNMEFAVKII--DKSK 59

Query: 99  SQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTL----QEKLHGTPRSS 153
                +E++ILL    H NI+ L    DD     ++ E +  G L      +   + R +
Sbjct: 60  RDP-TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118

Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAK 209
                   A+ F + + +EYLH +    +VH D+K SNIL         + ++CDFG AK
Sbjct: 119 S-------AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 210 MGFSSAVLPPSPSPSPSRSRITKQVMM--IGSPGYTDPHYLRTGMASTKTDVYSFGVILL 267
                              R    ++M    +  +  P  L         D++S GV+L 
Sbjct: 169 Q-----------------LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211

Query: 268 ELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDL---------D 318
            ++TG   F             +  +D  +    ++        +G F L         D
Sbjct: 212 TMLTGYTPF------------ANGPDDTPEEILARI-------GSGKFSLSGGYWNSVSD 252

Query: 319 EARAMLSIAALCLRQSPILRPSATQIL 345
            A+ ++S     L   P  R +A  +L
Sbjct: 253 TAKDLVS---KMLHVDPHQRLTAALVL 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 49/229 (21%)

Query: 61  FSQVIGSGGFSNVYLARL-INDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
             + +G G F  V           + + A+K      +        F +E++ +  L H 
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 116 NIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
           N+++L G        + +  E  P G+L ++L        L   +R A+  Q+A+ + YL
Sbjct: 82  NLIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL 137

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
             +     +H D+ A N+LL      K+ DFG  +                         
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR------------------------A 170

Query: 235 MMIGSPGY------------TDPHYLRTGMASTKTDVYSFGVILLELVT 271
           +      Y              P  L+T   S  +D + FGV L E+ T
Sbjct: 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 55/238 (23%), Positives = 90/238 (37%), Gaps = 47/238 (19%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---------HVGSDRLSQVFKQELDILL 110
           +  + +GSG F+ V   R    ST    A K            G  R  +  ++E+ IL 
Sbjct: 14  DTGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSR--EDIEREVSILK 69

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLA 168
            + H N++ L    +++ + +L+ E V  G L + L     + K       A  F  Q+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQIL 124

Query: 169 QAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
             + YLH    L I H D+K  NI+L          K+ DFG A        +       
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK------IDFG---- 171

Query: 225 PSRSRITKQVM--MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                        + G+P +  P  +       + D++S GVI   L++G   F  + 
Sbjct: 172 --------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 70/259 (27%), Positives = 101/259 (38%), Gaps = 67/259 (25%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----------------------------HVGSD 96
           IG G +  V LA   N++ +T  A+K+                                 
Sbjct: 21  IGKGSYGVVKLAY--NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 97  RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSK 154
            + QV  QE+ IL  L H N+VKL+   DD +E  L  +FE V  G + E        + 
Sbjct: 79  PIEQV-YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TL 131

Query: 155 LPWRNRMAIAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMG 211
            P     A  +   L + IEYLH +    I+H DIK SN+L+ E  + K+ DFG S +  
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAS---TKTDVYSFGVILLE 268
            S A+L  +                 G+P +  P  L            DV++ GV L  
Sbjct: 189 GSDALLSNTV----------------GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232

Query: 269 LVTGMEAFCPENGQLLTSL 287
            V G    CP   + +  L
Sbjct: 233 FVFG---QCPFMDERIMCL 248

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 37/217 (17%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V +    +  T    A+KI     + S  +    K+E+  L    H +I+KL
Sbjct: 19  LGVGTFGKVKIGE--HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QLAQAIEYLHE 176
                   +  ++ EYV  G L + +  HG     ++      A     Q+  A++Y H 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHG-----RVE--EMEARRLFQQILSAVDYCHR 129

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
                +VH D+K  N+LL+ H+N K+ DFG + M      L  S                
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---------------- 170

Query: 237 IGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTG 272
            GSP Y  P  +     A  + D++S GVIL  L+ G
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 70/315 (22%), Positives = 117/315 (37%), Gaps = 74/315 (23%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDNIVK 119
           +VIGSG  + V  A           AIK          + ++  +E+  +    H NIV 
Sbjct: 21  EVIGSGATAVVQAA--YCAPKKEKVAIKRINLEKCQTSMDEL-LKEIQAMSQCHHPNIVS 77

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWR--NRMAIAF---QLAQAIEYL 174
                  +DE  L+ + +  G++ + +       +      +   IA    ++ + +EYL
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H+      +H D+KA NILL E  + ++ DFG       SA L      + ++ R T   
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFG------VSAFLATGGDITRNKVRKT--- 185

Query: 235 MMIGSPGYTDPHYLRTGMA----------STKTDVYSFGVILLELVTGMEAFCPENGQLL 284
             +G+P +         MA            K D++SFG+  +EL TG   +        
Sbjct: 186 -FVGTPCW---------MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH------- 228

Query: 285 TSLAGSMLNDIADCEATKVNELV----DPRLAGDFDLDEARAMLSIA-----ALCLRQSP 335
                            KV  L      P L       E       +     +LCL++ P
Sbjct: 229 ------------KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP 276

Query: 336 ILRPSATQILHTIKH 350
             RP+A ++L   +H
Sbjct: 277 EKRPTAAELL---RH 288

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.4 bits (243), Expect = 5e-23
 Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 28/232 (12%)

Query: 46  VKKYSWD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG--AIKI--HVGSDRLSQ 100
           +K  +             +V+GSG F  V+    I +  S      IK+       +  Q
Sbjct: 3   MKVLARIFKETELR--KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60

Query: 101 VFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
                +  +  L H +IV+L+G C       L+ +Y+P G+L + +        L  +  
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLL 117

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK-MGFSSAVLPP 219
           +    Q+A+ + YL E     +VH ++ A N+LL+     ++ DFG A  +      L  
Sbjct: 118 LNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
           S + +P +              +     +  G  + ++DV+S+GV + EL+T
Sbjct: 175 SEAKTPIK--------------WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.7 bits (239), Expect = 6e-23
 Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 34/218 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---ELDILLHLSHDNIVK 119
           Q +G G +  V LA   N  T    A+KI V   R     +    E+ I   L+H+N+VK
Sbjct: 13  QTLGEGAYGEVQLAV--NRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QLAQAIEYLH 175
             G+  + +   L  EY   G L +++          +P     A  F  QL   + YLH
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMP--EPDAQRFFHQLMAGVVYLH 122

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
                 I H DIK  N+LL+E  N K+ DFG A +             +     + K   
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMC- 168

Query: 236 MIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
             G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 169 --GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 96.7 bits (241), Expect = 7e-23
 Identities = 55/239 (23%), Positives = 85/239 (35%), Gaps = 61/239 (25%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----------HVGSDRLSQVFKQELDILLHL 112
             +GSG F  V+ A   +   +    +K            +   +L +V   E+ IL  +
Sbjct: 30  SPLGSGAFGFVWTAV--DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV-TLEIAILSRV 86

Query: 113 SHDNIVKLIGYCDDRD----------EGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNRM 161
            H NI+K++   +++            G+ LF +   +  L E L               
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL--------------- 131

Query: 162 AIAF--QLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
           A     QL  A+ YL  +    I+H DIK  NI++ E    KL DFGSA       +   
Sbjct: 132 ASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFC 277
                             G+  Y  P  L        + +++S GV L  LV     FC
Sbjct: 189 F----------------CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 55/231 (23%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSDRLSQV-FKQELDILLHLSHDN 116
             +V+GSG F  VY    I +        AIK +   +   +      E  ++  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           + +L+G C       L+ + +P G L + +        +  +  +    Q+A+ + YL +
Sbjct: 79  VCRLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           R    +VH D+ A N+L++   + K+ DFG AK      +L                   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAK------LLGAE---------------- 170

Query: 237 IGSPGYTDPHYLRTG-------MA---------STKTDVYSFGVILLELVT 271
                  +  Y   G       MA         + ++DV+S+GV + EL+T
Sbjct: 171 -------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 47/228 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-------HVGSDRLSQVFKQELDILLHLS-- 113
            ++G GGF  V+       +     AIK+              S     E+ +L  +   
Sbjct: 37  PLLGKGGFGTVFAGH--RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94

Query: 114 --HDNIVKLIGYCDDRDEGVLLFEY-VPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--Q 166
             H  +++L+ + + ++  +L+ E  +P   L + +   G      L      +  F  Q
Sbjct: 95  GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-----PLG--EGPSRCFFGQ 147

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSP 225
           +  AI++ H R    +VH DIK  NIL+       KL DFG      S A+L   P    
Sbjct: 148 VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFG------SGALLHDEPYTDF 198

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTG 272
                       G+  Y+ P ++      +    V+S G++L ++V G
Sbjct: 199 D-----------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.7 bits (238), Expect = 4e-22
 Identities = 57/333 (17%), Positives = 100/333 (30%), Gaps = 54/333 (16%)

Query: 52  DDVERFTQNFSQVIGSG--GFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQEL 106
            +   +      VIG G      V LAR     T     ++       S+ +    + EL
Sbjct: 22  PEGGCYE--LLTVIGKGFEDLMTVNLAR--YKPTGEYVTVRRINLEACSNEMVTFLQGEL 77

Query: 107 DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            +    +H NIV         +E  ++  ++  G+ ++ +        +       I   
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQG 136

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSP 225
           + +A++Y+H       VH  +KAS+IL+       L     +  M               
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM---------ISHGQR 184

Query: 226 SRSRITKQVMMIGSPGYTDPHYLRTGMA--STKTDVYSFGVILLELVTGMEAFC------ 277
            R         +    +  P  L+  +     K+D+YS G+   EL  G   F       
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244

Query: 278 -----PENG--QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIA--- 327
                       LL +              +  N  +   L             S     
Sbjct: 245 MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304

Query: 328 ----------ALCLRQSPILRPSATQILHTIKH 350
                       CL+++P  RPSA+ +L    H
Sbjct: 305 TFSPHFHHFVEQCLQRNPDARPSASTLL---NH 334

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 60/218 (27%), Positives = 88/218 (40%), Gaps = 34/218 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---ELDILLHLSHDNIVK 119
           Q +G G +  V LA   N  T    A+KI V   R     +    E+ I   L+H+N+VK
Sbjct: 13  QTLGEGAYGEVQLAV--NRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QLAQAIEYLH 175
             G+  + +   L  EY   G L +++          +P     A  F  QL   + YLH
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMP--EPDAQRFFHQLMAGVVYLH 122

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
                 I H DIK  N+LL+E  N K+ DFG       + V   +               
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGL------ATVFRYNNRERLLNKMC----- 168

Query: 236 MIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
             G+  Y  P  L R    +   DV+S G++L  ++ G
Sbjct: 169 --GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 36/241 (14%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQV- 101
           +K   +D +     F +++G G FS V LAR +  +TS   AIKI    H+   + ++V 
Sbjct: 25  RKKRPEDFK-----FGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHI--IKENKVP 75

Query: 102 -FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP-WRN 159
              +E D++  L H   VKL     D ++      Y  NG L + +    +         
Sbjct: 76  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCT 132

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
           R   A ++  A+EYLH      I+H D+K  NILL E ++ ++ DFG+AK      VL P
Sbjct: 133 RFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK------VLSP 182

Query: 220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE 279
               + + S        +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   
Sbjct: 183 ESKQARANS-------FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235

Query: 280 N 280
           N
Sbjct: 236 N 236

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.5 bits (233), Expect = 5e-22
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           + IG G    VY A   + +T    AI+ +++      ++   E+ ++    + NIV  +
Sbjct: 26  EKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                 DE  ++ EY+  G+L + +  T     +      A+  +  QA+E+LH      
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---Q 136

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           ++H DIK+ NILL    + KL DFG        A + P           +K+  M+G+P 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFG------FCAQITPE---------QSKRSTMVGTPY 181

Query: 242 YTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           +  P  +       K D++S G++ +E++ G
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 94.0 bits (234), Expect = 6e-22
 Identities = 49/212 (23%), Positives = 94/212 (44%), Gaps = 27/212 (12%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
             IG G    V LAR     +    A+K + +   +  ++   E+ I+    H N+V++ 
Sbjct: 51  VKIGEGSTGIVCLAR--EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                 +E  +L E++  G L + +        L       +   + QA+ YLH +    
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQ---G 161

Query: 182 IVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           ++H DIK+ +ILL      KL DFG  A++                   + K+  ++G+P
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS----------------KDVPKRKSLVGTP 205

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
            +  P  +   + +T+ D++S G++++E+V G
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQVFKQELDILLHLSHDN 116
            ++G G +  V      +  T    A+KI          +  + V K+E+ +L  L H N
Sbjct: 11  DLLGEGSYGKVKEVL--DSETLCRRAVKILKKKKLRRIPNGEANV-KKEIQLLRRLRHKN 67

Query: 117 IVKL--IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF--QLAQAIE 172
           +++L  + Y +++ +  ++ EY   G +QE L   P   + P     A  +  QL   +E
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK-RFP--VCQAHGYFCQLIDGLE 123

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRIT 231
           YLH +    IVH DIK  N+LL      K+   G +  +             +   +  T
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL----------HPFAADDTCRT 170

Query: 232 KQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTG 272
            Q    GSP +  P         +  K D++S GV L  + TG
Sbjct: 171 SQ----GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 62/291 (21%), Positives = 109/291 (37%), Gaps = 47/291 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + +G G + +VY A   +  T    AIK       L ++  +E+ I+      ++VK  G
Sbjct: 35  EKLGEGSYGSVYKAI--HKETGQIVAIKQVPVESDLQEI-IKEISIMQQCDSPHVVKYYG 91

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
                 +  ++ EY   G++ + +    +   L       I     + +EYLH       
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFM---RK 146

Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           +H DIKA NILL    + KL DFG       +  L  +         + K+  +IG+P +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFG------VAGQLTDT---------MAKRNTVIGTPFW 191

Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM--LNDIADCEA 300
             P  ++    +   D++S G+  +E+  G   +   +          M  +  I     
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH---------PMRAIFMIPTNPP 242

Query: 301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ 351
                   P          +         CL +SP  R +ATQ+L   +H 
Sbjct: 243 --------PTFRKPELW--SDNFTDFVKQCLVKSPEQRATATQLL---QHP 280

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 37/217 (17%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V + +  ++ T    A+KI     + S  +    ++E+  L    H +I+KL
Sbjct: 24  LGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QLAQAIEYLHE 176
                   +  ++ EYV  G L + +  +G     +L    + +     Q+   ++Y H 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNG-----RLD--EKESRRLFQQILSGVDYCHR 134

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
                +VH D+K  N+LL+ H+N K+ DFG + M      L  S                
Sbjct: 135 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---------------- 175

Query: 237 IGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTG 272
            GSP Y  P  +     A  + D++S GVIL  L+ G
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 71/323 (21%), Positives = 114/323 (35%), Gaps = 104/323 (32%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
             +G G F  VY A+  N  T    A K I   S+   + +  E++IL    H  IVKL+
Sbjct: 25  GELGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 82

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           G      +  ++ E+ P G +   +    R   L       +  Q+ +A+ +LH +    
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK---R 137

Query: 182 IVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           I+H D+KA N+L+    + +L DFG SAK                    + K+   IG+P
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKN----------------LKTLQKRDSFIGTP 181

Query: 241 -----------GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
                         D  Y        K D++S G+ L+E+                    
Sbjct: 182 YWMAPEVVMCETMKDTPY------DYKADIWSLGITLIEMAQI----------------- 218

Query: 290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIA---------------------A 328
                             +P      +L+  R +L IA                      
Sbjct: 219 ------------------EPPH---HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLK 257

Query: 329 LCLRQSPILRPSATQILHTIKHQ 351
           + L ++P  RPSA Q+L   +H 
Sbjct: 258 IALDKNPETRPSAAQLL---EHP 277

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 92.1 bits (229), Expect = 9e-21
 Identities = 73/241 (30%), Positives = 108/241 (44%), Gaps = 54/241 (22%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ-ELDILLHLSHDNIVKL 120
           +VIG+G F  VY A+L +  +    AIK +        + FK  EL I+  L H NIV+L
Sbjct: 60  KVIGNGSFGVVYQAKLCD--SGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRL 112

Query: 121 IGY----CDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEY 173
             +     + +DE  L  + +YVP  T+        R+ + LP        +QL +++ Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           +H   +  I H DIK  N+LL+      KLCDFGSAK       L       P+ S I  
Sbjct: 172 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK------QLVRGE---PNVSYI-- 217

Query: 233 QV--------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG--Q 282
                     ++ G+  YT           +  DV+S G +L EL+ G   F  ++G  Q
Sbjct: 218 -CSRYYRAPELIFGATDYT-----------SSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265

Query: 283 L 283
           L
Sbjct: 266 L 266

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 38/217 (17%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
           +G G F  V LA   +  T    A+K      +    +    ++E+  L  L H +I+KL
Sbjct: 17  LGEGSFGKVKLAT--HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QLAQAIEYLHE 176
                   + V++ EY   G L + +         ++         F  Q+  AIEY H 
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKK-----RMT--EDEGRRFFQQIICAIEYCHR 126

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
                IVH D+K  N+LL+++LN K+ DFG + +      L  S                
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---------------- 167

Query: 237 IGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTG 272
            GSP Y  P  +     A  + DV+S G++L  ++ G
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 62/307 (20%), Positives = 107/307 (34%), Gaps = 74/307 (24%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVK 119
            SQV+G G    V      N  T    A+K+    D      ++E+++    S   +IV+
Sbjct: 66  TSQVLGLGINGKVLQI--FNKRTQEKFALKML--QDC--PKARREVELHWRASQCPHIVR 119

Query: 120 LIGYCDDRDEGV----LLFEYVPNGTL----QEKLHG--TPRSSKLPWRNRMAIAFQLAQ 169
           ++   ++   G     ++ E +  G L    Q++     T R +         I   + +
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGE 172

Query: 170 AIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           AI+YLH     +I H D+K  N+L      +   KL DFG AK                 
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---------------- 213

Query: 227 RSRITKQVMM--IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL 284
               +   +     +P Y  P  L         D++S GVI+  L+ G   F   +G  +
Sbjct: 214 --TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271

Query: 285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEAR-AMLSIAA-----LCLRQSPILR 338
           +     M   I                 G ++      + +S          L+  P  R
Sbjct: 272 SP---GMKTRI---------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 313

Query: 339 PSATQIL 345
            + T+ +
Sbjct: 314 MTITEFM 320

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 69/313 (22%), Positives = 122/313 (38%), Gaps = 78/313 (24%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLS-HDNIVKL 120
           +++G+G +  VY  R  +  T    AIK + V  D   ++ KQE+++L   S H NI   
Sbjct: 30  ELVGNGTYGQVYKGR--HVKTGQLAAIKVMDVTGDEEEEI-KQEINMLKKYSHHRNIATY 86

Query: 121 IG-YCDDRDEGV-----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            G +      G+     L+ E+   G++ + +  T + + L       I  ++ + + +L
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHL 145

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFG-SAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           H+     ++H DIK  N+LL E+   KL DFG SA++                   + ++
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----------------DRTVGRR 186

Query: 234 VMMIGSP-----------GYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
              IG+P              D  Y        K+D++S G+  +E+  G    C     
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATY------DFKSDLWSLGITAIEMAEGAPPLC----- 235

Query: 283 LLTSLAGSMLNDIADCEATKVNELVD----PRLAGDFDLDEARAMLSIAALCLRQSPILR 338
                         D    +   L+     PRL        ++   S    CL ++   R
Sbjct: 236 --------------DMHPMRALFLIPRNPAPRLKSK---KWSKKFQSFIESCLVKNHSQR 278

Query: 339 PSATQILHTIKHQ 351
           P+  Q++   KH 
Sbjct: 279 PATEQLM---KHP 288

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 36/291 (12%), Positives = 76/291 (26%), Gaps = 81/291 (27%)

Query: 63  QVIGSGGFSNVYLA------RLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHL 112
              G       + A      R +        A+       V  D + Q        L  +
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQV--------ALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
               + +++     R  G+++ E++  G+LQE    +P     P    +     LA A +
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP----SPVG-AIRAMQSLAAAAD 143

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
             H      +       S + +           G   + +                    
Sbjct: 144 AAHRA---GVALSIDHPSRVRVSID--------GDVVLAY-------------------- 172

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
                  P            A+ + D+   G  L  L+           +   + A    
Sbjct: 173 -------PATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
                       + ++P        D    + ++AA  ++    +R ++T 
Sbjct: 219 AG----------QPIEPADIDR---DIPFQISAVAARSVQGDGGIRSASTL 256

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 54/217 (24%), Positives = 80/217 (36%), Gaps = 35/217 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + IGSG F    L R  +  T    A+K       + +  ++E+     L H NIV+   
Sbjct: 26  KDIGSGNFGVARLMR--DKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKL--HGTPRSSKLPWRNRMAIAF--QLAQAIEYLHERC 178
                    ++ EY   G L E++   G     +       A  F  QL   + Y H   
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAG-----RFS--EDEARFFFQQLLSGVSYCHSM- 135

Query: 179 TLHIVHGDIKASNILLEEH--LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
              I H D+K  N LL+       K+CDFG +K     +    +                
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---------------- 177

Query: 237 IGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTG 272
           +G+P Y  P  L R        DV+S GV L  ++ G
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 70/269 (26%), Positives = 110/269 (40%), Gaps = 59/269 (21%)

Query: 38  DDGIDGRSVKKYSWDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVG 94
           DD      V        E+    ++  +VIG+G F  V+ A+      S   AIK +   
Sbjct: 19  DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK---LVESDEVAIKKV--- 72

Query: 95  SDRLSQVFKQ-ELDILLHLSHDNIVKLIGY----CDDRDEGV--LLFEYVPNGTLQEKLH 147
                + FK  EL I+  + H N+V L  +     D +DE    L+ EYVP  T+     
Sbjct: 73  --LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASR 129

Query: 148 GTPRSSK-LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDF 205
              +  + +P        +QL +++ Y+H   ++ I H DIK  N+LL       KL DF
Sbjct: 130 HYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDF 186

Query: 206 GSAKMGFSSAVLPPSPSPSPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTK 256
           GSAK      ++   P+           +         ++ G+  YT           T 
Sbjct: 187 GSAK-----ILIAGEPN--------VSYICSRYYRAPELIFGATNYT-----------TN 222

Query: 257 TDVYSFGVILLELVTGMEAFCPENG--QL 283
            D++S G ++ EL+ G   F  E+G  QL
Sbjct: 223 IDIWSTGCVMAELMQGQPLFPGESGIDQL 251

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 70/257 (27%), Positives = 107/257 (41%), Gaps = 56/257 (21%)

Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFK----Q 104
           S  +++RF     ++ G G F  V L +  +  T  + AIK +          F+    Q
Sbjct: 18  SRKEMDRFQV--ERMAGQGTFGTVQLGKEKS--TGMSVAIKKV-----IQDPRFRNRELQ 68

Query: 105 ELDILLHLSHDNIVKL--IGYCDDRDEG-----VLLFEYVPNGTLQEKL-HGTPRSSKLP 156
            +  L  L H NIV+L    Y     +       ++ EYVP+ TL     +   R    P
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127

Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGFSS 214
                   FQL ++I  LH   ++++ H DIK  N+L+ E  +   KLCDFGSAK     
Sbjct: 128 PILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEA-DGTLKLCDFGSAK----- 180

Query: 215 AVLPPSPSPSPSRSR------ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
            + P  P+ +   SR      +     + G+  YT           T  D++S G I  E
Sbjct: 181 KLSPSEPNVAYICSRYYRAPEL-----IFGNQHYT-----------TAVDIWSVGCIFAE 224

Query: 269 LVTGMEAFCPENG--QL 283
           ++ G   F  +N   QL
Sbjct: 225 MMLGEPIFRGDNSAGQL 241

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 44/228 (19%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC 124
           +G G + +VY A+  +     + A+K  +    +S    +E+ +L  L H N++ L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALK-QIEGTGISMSACREIALLRELKHPNVISLQKVF 87

Query: 125 DDRDEG--VLLFEYVPN---GTLQEKLHGTPRSSKLPWRNRM--AIAFQLAQAIEYLHER 177
               +    LLF+Y  +     ++           +     M  ++ +Q+   I YLH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147

Query: 178 CTLHIVHGDIKASNILLEEHLNC----KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
               ++H D+K +NIL+          K+ D G A++ F+        SP    + +   
Sbjct: 148 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FN--------SPLKPLADLDPV 195

Query: 234 V---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           V         +++G+  YT              D+++ G I  EL+T 
Sbjct: 196 VVTFWYRAPELLLGARHYT-----------KAIDIWAIGCIFAELLTS 232

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 73/319 (22%), Positives = 108/319 (33%), Gaps = 101/319 (31%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + IG G F  VY AR  +   S   AIK        S+   Q   +E+  L  L H N +
Sbjct: 60  REIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF---QLAQAIEYLH 175
           +  G         L+ EY   G+  + L    +  +        IA       Q + YLH
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLH 171

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
                +++H D+KA NILL E    KL DFGSA                   S +     
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------------------SIMAPANS 209

Query: 236 MIGSPGYTDP---HYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
            +G+P +  P     +  G    K DV+S G+  +EL                       
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-------------------- 249

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIA--------------------ALCLR 332
                           P L   F+++   A+  IA                      CL+
Sbjct: 250 ---------------KPPL---FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291

Query: 333 QSPILRPSATQILHTIKHQ 351
           + P  RP++  +L   KH+
Sbjct: 292 KIPQDRPTSEVLL---KHR 307

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 59/256 (23%), Positives = 103/256 (40%), Gaps = 54/256 (21%)

Query: 33  QYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG--AIK 90
            +H H  G+D    +   +  +E++      ++G G +  V   R    +  T    AIK
Sbjct: 4   HHHHHSSGVDL-GTENLYFQSMEKYEN--LGLVGEGSYGMVMKCR----NKDTGRIVAIK 56

Query: 91  -IHVGSDRLSQVFKQ----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEK 145
                 D   ++ K+    E+ +L  L H+N+V L+  C  +    L+FE+V + T+ + 
Sbjct: 57  KFLESDDD--KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDD 113

Query: 146 LHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF 205
           L   P    L ++      FQ+   I + H     +I+H DIK  NIL+ +    KLCDF
Sbjct: 114 LELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDF 168

Query: 206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTK 256
           G A+   +          +P       +V          ++G   Y              
Sbjct: 169 GFART-LA----------APGEV-YDDEVATRWYRAPELLVGDVKY-----------GKA 205

Query: 257 TDVYSFGVILLELVTG 272
            DV++ G ++ E+  G
Sbjct: 206 VDVWAIGCLVTEMFMG 221

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 38/235 (16%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
              +VIG G FS V + ++    T    A+KI     +        F++E D+L++    
Sbjct: 64  EILKVIGRGAFSEVAVVKMK--QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121

Query: 116 NIVKLIGYCDDRDEGVLLF--EYVPNGTLQEKLHGTPRSSKLP-WRNRMAIAFQLAQAIE 172
            I +L  +   +DE  L    EY   G L      +    ++P    R  +A ++  AI+
Sbjct: 122 WITQL--HFAFQDENYLYLVMEYYVGGDLL--TLLSKFGERIPAEMARFYLA-EIVMAID 176

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
            +H    L  VH DIK  NILL+   + +L DFGS                        +
Sbjct: 177 SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKL--------------RADGTVR 219

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVY-------SFGVILLELVTGMEAFCPEN 280
            ++ +G+P Y  P  L+       T  Y       + GV   E+  G   F  ++
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 30/163 (18%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVK 119
            SQV+G G    V      N  T    A+K+    D      ++E+++    S   +IV+
Sbjct: 22  TSQVLGLGINGKVLQI--FNKRTQEKFALKML--QD--CPKARREVELHWRASQCPHIVR 75

Query: 120 LIGYCDDRDEGV----LLFEYVPNGTL----QEKLHG--TPRSSKLPWRNRMAIAFQLAQ 169
           ++   ++   G     ++ E +  G L    Q++     T R +         I   + +
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGE 128

Query: 170 AIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAK 209
           AI+YLH     +I H D+K  N+L      +   KL DFG AK
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 56/243 (23%), Positives = 98/243 (40%), Gaps = 61/243 (25%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSD--------RLSQ 100
               +F Q   + +G+G ++ VY       + +T    A+K + + S+        R   
Sbjct: 2   SSSSQFKQ--LEKLGNGTYATVYKGL----NKTTGVYVALKEVKLDSEEGTPSTAIR--- 52

Query: 101 VFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN--GTLQEKLHGTPRSSKLPWR 158
               E+ ++  L H+NIV+L       ++  L+FE++ N      +          L   
Sbjct: 53  ----EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108

Query: 159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP 218
                 +QL Q + + HE     I+H D+K  N+L+ +    KL DFG A+  F      
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA-FG----- 159

Query: 219 PSPSPSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
                 P  +  + +V+         ++GS  Y           ST  D++S G IL E+
Sbjct: 160 -----IPVNT-FSSEVVTLWYRAPDVLMGSRTY-----------STSIDIWSCGCILAEM 202

Query: 270 VTG 272
           +TG
Sbjct: 203 ITG 205

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 49/233 (21%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ----ELDI 108
           +E++ +     IG G +  V+  R  N  T    AIK      D    V K+    E+ +
Sbjct: 2   MEKYEK--IGKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDD--PVIKKIALREIRM 55

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           L  L H N+V L+     +    L+FEY  + T+  +L    R   +P     +I +Q  
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR--GVPEHLVKSITWQTL 112

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           QA+ + H+    + +H D+K  NIL+ +H   KLCDFG A++  +           PS  
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARL-LT----------GPSDY 158

Query: 229 RITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
               +V          ++G   Y               DV++ G +  EL++G
Sbjct: 159 -YDDEVATRWYRSPELLVGDTQY-----------GPPVDVWAIGCVFAELLSG 199

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 67/363 (18%), Positives = 117/363 (32%), Gaps = 97/363 (26%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS--------HDN 116
           +G G FS V+L+   +       A+K+   ++  ++    E+ +L  +          + 
Sbjct: 45  LGWGHFSTVWLSW--DIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 117 IVKLIGYCDDRDEGVLLFEYV-PNGT--------LQEKLHGTPRSSK---LPWRNRMAIA 164
           +V+L+            F+    NGT        L   L      S    LP      I 
Sbjct: 103 VVQLLDD----------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            Q+ Q ++YLH +C   I+H DIK  NILL       +     + +   S A  P   + 
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 224 SPSRSRITKQVMMIGSPGYTD------------------------PHYLR-----TGMA- 253
           S + +     ++    P   +                            R      G   
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270

Query: 254 STKTDVYSFGVILLELVTGMEAFCPENGQ----------LLTSLAGSM------------ 291
           +T  D++S   +  EL TG   F P +G+          L+  L G +            
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330

Query: 292 --------LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
                   L  I   +   + E++  +   ++  +EA          L   P  R +A +
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLPMLELIPEKRATAAE 388

Query: 344 ILH 346
            L 
Sbjct: 389 CLR 391

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 79.5 bits (197), Expect = 6e-17
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 48/222 (21%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDR----LSQVFKQELDILLHLSHDNIVK 119
           +G G +  VY A+   DS     A+K I + ++      + +  +E+ +L  L H NIV 
Sbjct: 29  VGEGTYGVVYKAK---DSQGRIVALKRIRLDAEDEGIPSTAI--REISLLKELHHPNIVS 83

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           LI          L+FE++    L++ L      + L         +QL + + + H+   
Sbjct: 84  LIDVIHSERCLTLVFEFMEKD-LKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH-- 138

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM---- 235
             I+H D+K  N+L+      KL DFG A+  F            P RS  T +V+    
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARA-FG----------IPVRS-YTHEVVTLWY 185

Query: 236 -----MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                ++GS  Y           ST  D++S G I  E++TG
Sbjct: 186 RAPDVLMGSKKY-----------STSVDIWSIGCIFAEMITG 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.7 bits (195), Expect = 9e-17
 Identities = 60/232 (25%), Positives = 91/232 (39%), Gaps = 58/232 (25%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSD---------RLSQVFKQELDILLHLSH 114
           IG G +  VY A+   ++     A+K I +  +         R       E+ IL  L H
Sbjct: 10  IGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIR-------EISILKELKH 59

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            NIVKL      +   VL+FE++    L++ L        L      +   QL   I Y 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H+R    ++H D+K  N+L+      K+ DFG A+  F            P R   T ++
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARA-FG----------IPVRK-YTHEI 161

Query: 235 M---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC 277
           +         ++GS  Y           ST  D++S G I  E+V G   F 
Sbjct: 162 VTLWYRAPDVLMGSKKY-----------STTIDIWSVGCIFAEMVNGTPLFP 202

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 55/244 (22%), Positives = 100/244 (40%), Gaps = 40/244 (16%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVF 102
            +   +D E       +VIG G F  V L R  + ST    A+K+     +     S  F
Sbjct: 64  LRMKAEDYE-----VVKVIGRGAFGEVQLVR--HKSTRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
            +E DI+   +   +V+L     D     ++ EY+P G L   +     +  +P   + A
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVP--EKWA 170

Query: 163 I--AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
                ++  A++ +H    +  +H D+K  N+LL++  + KL DFG+             
Sbjct: 171 RFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--------- 218

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK----TDVYSFGVILLELVTGMEAF 276
                ++  + +    +G+P Y  P  L++           D +S GV L E++ G   F
Sbjct: 219 -----NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

Query: 277 CPEN 280
             ++
Sbjct: 274 YADS 277

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 58/242 (23%)

Query: 53  DVERFTQNFSQV--IGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSDRLSQVFKQ--- 104
           DV+   + + ++  +G G F+ VY AR      +TN   AIK I +G        K    
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKAR----DKNTNQIVAIKKIKLGHRS---EAKDGIN 56

Query: 105 -----ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
                E+ +L  LSH NI+ L+     +    L+F+++    L+  +        L   +
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSL--VLTPSH 113

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP 219
             A      Q +EYLH+     I+H D+K +N+LL+E+   KL DFG AK  F       
Sbjct: 114 IKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS-FG------ 163

Query: 220 SPSPSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV 270
               SP+R+  T QV+         + G+  Y               D+++ G IL EL+
Sbjct: 164 ----SPNRA-YTHQVVTRWYRAPELLFGARMY-----------GVGVDMWAVGCILAELL 207

Query: 271 TG 272
             
Sbjct: 208 LR 209

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 56/275 (20%), Positives = 101/275 (36%), Gaps = 40/275 (14%)

Query: 12  NLRRTRKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFS 71
           N    +K  +Q  V     + +  D     +  S      D  +       + +G+G F 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAK-EDFLKKWETPSQNTAQLDQFD-----RIKTLGTGSFG 55

Query: 72  NVYLARLINDSTSTNGAIKIHVGSD--RLSQV--FKQELDILLHLSHDNIVKLIGYCDDR 127
            V L +     +  + A+KI       +L Q+     E  IL  ++   +VKL     D 
Sbjct: 56  RVMLVKHKE--SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113

Query: 128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA--IAFQLAQAIEYLHERCTLHIVHG 185
               ++ EYV  G +   L    R  +       A   A Q+    EYLH    L +++ 
Sbjct: 114 SNLYMVMEYVAGGEMFSHLR---RIGRFS--EPHARFYAAQIVLTFEYLHS---LDLIYR 165

Query: 186 DIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDP 245
           D+K  N+L+++    ++ DFG AK                      +   + G+P    P
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRV------------------KGRTWTLCGTPEALAP 207

Query: 246 HYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
             + +   +   D ++ GV++ E+  G   F  + 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 77.9 bits (193), Expect = 2e-16
 Identities = 56/247 (22%), Positives = 99/247 (40%), Gaps = 52/247 (21%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDR----LSQVFKQELDI 108
           ++++ +   + IG G +  V+ A+  N  T    A+K + +  D      S +  +E+ +
Sbjct: 1   MQKYEK--LEKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSAL--REICL 54

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           L  L H NIV+L        +  L+FE+     L++          L      +  FQL 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLL 111

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           + + + H R   +++H D+K  N+L+  +   KL +FG A+  F            P R 
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARA-FG----------IPVRC 157

Query: 229 RITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP- 278
             + +V+         + G+  Y           ST  D++S G I  EL        P 
Sbjct: 158 -YSAEVVTLWYRPPDVLFGAKLY-----------STSIDMWSAGCIFAELANAGRPLFPG 205

Query: 279 --ENGQL 283
              + QL
Sbjct: 206 NDVDDQL 212

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 47/249 (18%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVF 102
            +   +D E       +VIG G F  V + +L   +     A+KI     +     +  F
Sbjct: 69  MRLHREDFE-----ILKVIGRGAFGEVAVVKLK--NADKVFAMKILNKWEMLKRAETACF 121

Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG---TLQEKLHGTPRSSKLPWRN 159
           ++E D+L++     I  L     D +   L+ +Y   G   TL  K        +LP   
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED-----RLP--E 174

Query: 160 RMA---IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
            MA   +A ++  AI+ +H+   LH VH DIK  NIL++ + + +L DFGS         
Sbjct: 175 EMARFYLA-EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL----- 225

Query: 217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-----DVYSFGVILLELVT 271
                     +S      + +G+P Y  P  L+             D +S GV + E++ 
Sbjct: 226 ----MEDGTVQSS-----VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

Query: 272 GMEAFCPEN 280
           G   F  E+
Sbjct: 277 GETPFYAES 285

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 51/248 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS--------- 113
           + +G G FS V+LA+  +   +T+ A+KI  G    ++  + E+ +L  ++         
Sbjct: 25  RKLGWGHFSTVWLAK--DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 114 --HDNIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSK---LPWRNRMAIA 164
              ++I+KL+ + + +       V++FE      L E L    +  +   +P      I+
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC------KLCDFGSAKMGFSSAVLP 218
            QL   ++Y+H RC   I+H DIK  N+L+E   +       K+ D G+A          
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------- 185

Query: 219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP 278
                       T  +    +  Y  P  L         D++S   ++ EL+TG   F P
Sbjct: 186 -----CWYDEHYTNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

Query: 279 ENGQLLTS 286
           + G   T 
Sbjct: 238 DEGHSYTK 245

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 57/251 (22%), Positives = 94/251 (37%), Gaps = 69/251 (27%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSD---------RLS 99
             ++R+ +     +G G +  VY A      T TN   AIK I +  +         R  
Sbjct: 31  TSIDRYRR--ITKLGEGTYGEVYKAI----DTVTNETVAIKRIRLEHEEEGVPGTAIR-- 82

Query: 100 QVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRN 159
                E+ +L  L H NI++L           L+FEY  N  L++ +    ++  +  R 
Sbjct: 83  -----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRV 133

Query: 160 RMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC-----KLCDFGSAKMGFSS 214
             +  +QL   + + H R     +H D+K  N+LL           K+ DFG A+  F  
Sbjct: 134 IKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA-FG- 188

Query: 215 AVLPPSPSPSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVI 265
                     P R   T +++         ++GS  Y           ST  D++S   I
Sbjct: 189 ---------IPIRQ-FTHEIITLWYRPPEILLGSRHY-----------STSVDIWSIACI 227

Query: 266 LLELVTGMEAF 276
             E++     F
Sbjct: 228 WAEMLMKTPLF 238

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 58/237 (24%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSD--------RLSQVFKQ 104
           +E + +     +G G ++ VY  +  +  T    A+K I +  +        R       
Sbjct: 1   METYIK--LDKLGEGTYATVYKGK--SKLTDNLVALKEIRLEHEEGAPCTAIR------- 49

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E+ +L  L H NIV L           L+FEY+    L++ L      + +   N     
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG--NIINMHNVKLFL 106

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
           FQL + + Y H +    ++H D+K  N+L+ E    KL DFG A+   S           
Sbjct: 107 FQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARA-KS----------I 152

Query: 225 PSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           P+++    +V+         ++GS  Y           ST+ D++  G I  E+ TG
Sbjct: 153 PTKT-YDNEVVTLWYRPPDILLGSTDY-----------STQIDMWGVGCIFYEMATG 197

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 67/275 (24%), Positives = 105/275 (38%), Gaps = 90/275 (32%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK---QELDILLHLSHDNIVK 119
           + +G+G F  V      +  +    A+K      ++ Q  +   +ELDI+  L H NI+K
Sbjct: 13  KTLGTGSFGIVCEVF--DIESGKRFALK------KVLQDPRYKNRELDIMKVLDHVNIIK 64

Query: 120 L--IGYCDDRDEGV------------------------------------LLFEYVPNGT 141
           L    Y    +E                                      ++ EYVP+ T
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-T 123

Query: 142 LQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLN 199
           L + L    RS + +P        +QL +A+ ++H   +L I H DIK  N+L+  +   
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180

Query: 200 CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV---------MMIGSPGYTDPHYLRT 250
            KLCDFGSAK      ++P  PS           +         +M+G+  YT       
Sbjct: 181 LKLCDFGSAK-----KLIPSEPS--------VAYICSRFYRAPELMLGATEYT------- 220

Query: 251 GMASTKTDVYSFGVILLELVTGMEAFCPENG--QL 283
                  D++S G +  EL+ G   F  E    QL
Sbjct: 221 ----PSIDLWSIGCVFGELILGKPLFSGETSIDQL 251

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 59/264 (22%), Positives = 97/264 (36%), Gaps = 65/264 (24%)

Query: 33  QYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-I 91
           + +D  +      V KY     E+  +     IG G F  V+ AR  +  T    A+K +
Sbjct: 3   KQYDSVECPFCDEVSKY-----EKLAK-----IGQGTFGEVFKAR--HRKTGQKVALKKV 50

Query: 92  HVGSDRLSQVFKQ----ELDILLHLSHDNIVKLIGYCDDRDEGV--------LLFEYVPN 139
            + +++    F      E+ IL  L H+N+V LI  C  +            L+F++  +
Sbjct: 51  LMENEKEG--FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108

Query: 140 --GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH 197
               L           K        +   L   + Y+H      I+H D+KA+N+L+   
Sbjct: 109 DLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD 160

Query: 198 LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV---------MMIGSPGYTDPHYL 248
              KL DFG A+  FS        S      R T +V         +++G   Y      
Sbjct: 161 GVLKLADFGLARA-FS----LAKNSQPN---RYTNRVVTLWYRPPELLLGERDY------ 206

Query: 249 RTGMASTKTDVYSFGVILLELVTG 272
                    D++  G I+ E+ T 
Sbjct: 207 -----GPPIDLWGAGCIMAEMWTR 225

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 25/170 (14%)

Query: 48  KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQV-- 101
           KYS  D +       + +G+G F  V+L R          A+K+     V   RL QV  
Sbjct: 2   KYSLQDFQ-----ILRTLGTGSFGRVHLIRSR--HNGRYYAMKVLKKEIV--VRLKQVEH 52

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRM 161
              E  +L  ++H  I+++ G   D  +  ++ +Y+  G L   L    +S + P  N +
Sbjct: 53  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFP--NPV 107

Query: 162 AI--AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
           A   A ++  A+EYLH      I++ D+K  NILL+++ + K+ DFG AK
Sbjct: 108 AKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK 154

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 47/254 (18%), Positives = 101/254 (39%), Gaps = 59/254 (23%)

Query: 45  SVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFK 103
           S+  + +D   R+     + +G GG   V+ A  +++      AIK I +   +  +   
Sbjct: 1   SMNIHGFDLGSRYM--DLKPLGCGGNGLVFSA--VDNDCDKRVAIKKIVLTDPQSVKHAL 56

Query: 104 QELDILLHLSHDNIVKLI--------------GYCDDRDEGVLLFEYVPNGTLQEKLHGT 149
           +E+ I+  L HDNIVK+               G   + +   ++ EY     ++  L   
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANV 111

Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGS 207
                L   +     +QL + ++Y+H   + +++H D+K +N+ +    +   K+ DFG 
Sbjct: 112 LEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTE-DLVLKIGDFGL 167

Query: 208 AKMGFSSAVLPPSPSPSPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTD 258
           A++                +  +++ +         +++    YT              D
Sbjct: 168 ARI---------MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT-----------KAID 207

Query: 259 VYSFGVILLELVTG 272
           +++ G I  E++TG
Sbjct: 208 MWAAGCIFAEMLTG 221

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 50/261 (19%), Positives = 98/261 (37%), Gaps = 32/261 (12%)

Query: 30  DQDQYHDHDDGIDGRSVKKYSWDDVERFTQN---FSQVIGSGGFSNVYLARLINDSTSTN 86
            Q  + +  D +      ++ W + +   ++     +V+G GGF  V+  ++    T   
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKA--TGKL 212

Query: 87  GAIKI----HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC-DDRDEGVLLFEYVPNGT 141
            A K      +   +  Q    E  IL  +    IV L  Y  + + +  L+   +  G 
Sbjct: 213 YACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGD 271

Query: 142 LQEKLHGTPRSSKLPWRNRMAI-AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC 200
           ++  ++     +      R      Q+   +E+LH+R   +I++ D+K  N+LL++  N 
Sbjct: 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNV 328

Query: 201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DV 259
           ++ D G A    +                        G+PG+  P  L  G     + D 
Sbjct: 329 RISDLGLAVELKAGQTKTKG---------------YAGTPGFMAPELLL-GEEYDFSVDY 372

Query: 260 YSFGVILLELVTGMEAFCPEN 280
           ++ GV L E++     F    
Sbjct: 373 FALGVTLYEMIAARGPFRARG 393

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 40/235 (17%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIH-----VGSDRLSQV 101
           +  ++D    F     + IG G F  V + +     T    A+K       V  + +  V
Sbjct: 10  EDVNFDH---F--EILRAIGKGSFGKVCIVQKN--DTKKMYAMKYMNKQKCVERNEVRNV 62

Query: 102 FKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP-WRNR 160
           F +EL I+  L H  +V L     D ++  ++ + +  G L+  L    ++        +
Sbjct: 63  F-KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVK 118

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           + I  +L  A++YL       I+H D+K  NILL+EH +  + DF  A M          
Sbjct: 119 LFIC-ELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML--------- 165

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAS--TKT-DVYSFGVILLELVTG 272
                   R T+   M G+  Y  P    +   +  +   D +S GV   EL+ G
Sbjct: 166 -------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 51/255 (20%), Positives = 95/255 (37%), Gaps = 68/255 (26%)

Query: 50  SWDDVERFTQNFS--------QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQV 101
            + D E     +         + +G G +S V+ A  IN + +    +KI      L  V
Sbjct: 21  EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEA--INITNNEKVVVKI------LKPV 72

Query: 102 FKQ----ELDILLHLS-HDNIVKLIGYCDDRDEG--VLLFEYVPNGTLQEKLHGTPRSSK 154
            K+    E+ IL +L    NI+ L     D       L+FE+V N   ++        + 
Sbjct: 73  KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTD 129

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGF 212
              R  M   +++ +A++Y H      I+H D+K  N+++ +H +   +L D+G A+   
Sbjct: 130 YDIRFYM---YEILKALDYCHSM---GIMHRDVKPHNVMI-DHEHRKLRLIDWGLAEFY- 181

Query: 213 SSAVLPPSPSPSPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFG 263
                       P +     +V         +++    Y               D++S G
Sbjct: 182 -----------HPGQEY-NVRVASRYFKGPELLVDYQMYD-----------YSLDMWSLG 218

Query: 264 VILLELVTGMEAFCP 278
            +L  ++   E F  
Sbjct: 219 CMLASMIFRKEPFFH 233

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 52/236 (22%), Positives = 93/236 (39%), Gaps = 70/236 (29%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLHLS 113
           Q +GSG +  V  A  ++  T    AIK      +L + F+          EL +L H+ 
Sbjct: 31  QPVGSGAYGAVCSA--VDGRTGAKVAIK------KLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 114 HDNIVKLI------GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           H+N++ L+         DD  +  L+  +     +   L    +  KL       + +Q+
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFLVYQM 137

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGFSSAVLPPSPSPSP 225
            + + Y+H      I+H D+K  N+ + E  +C  K+ DFG A+                
Sbjct: 138 LKGLRYIH---AAGIIHRDLKPGNLAVNE--DCELKILDFGLAR---------------Q 177

Query: 226 SRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           + S +T  V+         ++    YT              D++S G I+ E++TG
Sbjct: 178 ADSEMTGYVVTRWYRAPEVILNWMRYT-----------QTVDIWSVGCIMAEMITG 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 51/248 (20%)

Query: 46  VKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ 104
            K+  ++    F      ++G G +  V  A   +  T    AIK I         +F  
Sbjct: 2   PKRIVYNISSDFQ--LKSLLGEGAYGVVCSA--THKPTGEIVAIKKIEPFDK---PLFAL 54

Query: 105 ----ELDILLHLSHDNIVKLI-----GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKL 155
               E+ IL H  H+NI+ +         ++ +E  ++ E      +Q  LH    +  L
Sbjct: 55  RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQML 109

Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGFS 213
              +     +Q  +A++ LH     +++H D+K SN+L+    NC  K+CDFG A++   
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDE 164

Query: 214 SAVLPPSPSPSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGV 264
           SA    +  P+  +S + + V          M+ S  Y+              DV+S G 
Sbjct: 165 SA--ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYS-----------RAMDVWSCGC 211

Query: 265 ILLELVTG 272
           IL EL   
Sbjct: 212 ILAELFLR 219

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 58/242 (23%), Positives = 105/242 (43%), Gaps = 61/242 (25%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLHLS 113
           + +G G +  V+ +  I+  T    A+K      ++   F+          E+ IL  LS
Sbjct: 15  KKLGKGAYGIVWKS--IDRRTGEVVAVK------KIFDAFQNSTDAQRTFREIMILTELS 66

Query: 114 -HDNIVKL--IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
            H+NIV L  +   D+  +  L+F+Y     ++  LH   R++ L   ++  + +QL + 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKV 121

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSA----KMGFSSAVLPPSPSPS 224
           I+YLH   +  ++H D+K SNILL     C  K+ DFG +     +   +  +P S + +
Sbjct: 122 IKYLH---SGGLLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 225 PSRSRITKQVM--------------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV 270
                  + ++              ++GS  YT              D++S G IL E++
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYT-----------KGIDMWSLGCILGEIL 225

Query: 271 TG 272
            G
Sbjct: 226 CG 227

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 43/238 (18%), Positives = 79/238 (33%), Gaps = 63/238 (26%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK---IHVGSDRLSQVFKQ---------ELDILL 110
           + I SG +  V       DS     AIK     V   R   +            E+ +L 
Sbjct: 28  RFISSGSYGAVCAGV---DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 111 HLSHDNIVKL----IGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA--I 163
           H  H NI+ L    + + +     + L+ E      ++  L       ++    +     
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYF 139

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
            + +   +  LH      +VH D+   NILL ++ +  +CDF  A+   + A        
Sbjct: 140 MYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK------ 190

Query: 224 SPSRSRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
                  T  V         +++   G+T              D++S G ++ E+   
Sbjct: 191 -------THYVTHRWYRAPELVMQFKGFT-----------KLVDMWSAGCVMAEMFNR 230

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 50/233 (21%), Positives = 89/233 (38%), Gaps = 64/233 (27%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLHLS 113
           + IGSG    V  A   +     N AIK      +LS+ F+          EL ++  ++
Sbjct: 68  KPIGSGAQGIVCAA--YDAVLDRNVAIK------KLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 114 HDNIVKLI------GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           H NI+ L+         ++  +  L+ E      +   L    +      R    + +Q+
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSY-LLYQM 173

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
              I++LH   +  I+H D+K SNI+++     K+ DFG A+              + + 
Sbjct: 174 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTS 217

Query: 228 SRITKQVM--------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             +T  V+        +I   GY               D++S G I+ E+V  
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYK-----------ENVDIWSVGCIMGEMVRH 259

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 54/249 (21%), Positives = 94/249 (37%), Gaps = 45/249 (18%)

Query: 43  GRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRL 98
            +   + + ++   F   + +++G G F  V L +     T    A+KI     + +   
Sbjct: 139 AKPKHRVTMNE---F--EYLKLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKDE 191

Query: 99  SQVFKQELDILLHLSHDNIVKLIGYC---DDRDEGVLLF--EYVPNGTLQEKLHGTPRSS 153
                 E  +L +  H  +  L  Y     DR    L F  EY   G L   L    R  
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALK-YSFQTHDR----LCFVMEYANGGELFFHLS---RER 243

Query: 154 KLP-WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF 212
                R R   A ++  A++YLH     ++V+ D+K  N++L++  + K+ DFG  K G 
Sbjct: 244 VFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300

Query: 213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVT 271
                  +                 G+P Y  P  L       +  D +  GV++ E++ 
Sbjct: 301 KDGATMKT---------------FCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMC 344

Query: 272 GMEAFCPEN 280
           G   F  ++
Sbjct: 345 GRLPFYNQD 353

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 66/234 (28%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLHLS 113
             +GSG + +V  A   +  T    A+K      +LS+ F+          EL +L H+ 
Sbjct: 35  SPVGSGAYGSVCAA--FDTKTGLRVAVK------KLSRPFQSIIHAKRTYRELRLLKHMK 86

Query: 114 HDNIVKLI------GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           H+N++ L+         ++ ++  L+        +   L+   +  KL   +   + +Q+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQI 141

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + ++Y+H   +  I+H D+K SN+ + E    K+ DFG A+                + 
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------------HTA 183

Query: 228 SRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             +T  V          M+    Y               D++S G I+ EL+TG
Sbjct: 184 DEMTGYVATRWYRAPEIMLNWMHYN-----------QTVDIWSVGCIMAELLTG 226

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 48/227 (21%), Positives = 89/227 (39%), Gaps = 30/227 (13%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHD 115
              +V+G GGF  V   ++    T    A K      +   +   +   E  IL  ++  
Sbjct: 187 RQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244

Query: 116 NIVKLIGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            +V L  Y  +  + + L+   +  G L+  ++   ++     R     A ++   +E L
Sbjct: 245 FVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDL 302

Query: 175 HERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           H      IV+ D+K  NILL++H + ++ D G A            P     + R     
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV---------PEGQTIKGR----- 345

Query: 235 MMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPEN 280
             +G+ GY  P  ++     T + D ++ G +L E++ G   F    
Sbjct: 346 --VGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 53/263 (20%), Positives = 101/263 (38%), Gaps = 54/263 (20%)

Query: 29  QDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGA 88
                +           V+   +D   R+T      IG G +  V  A   ++      A
Sbjct: 1   HHHHHHMAAAAAAGPEMVRGQVFDVGPRYT--NLSYIGEGAYGMVCSA--YDNLNKVRVA 56

Query: 89  IK-IHVGSDRLSQVFKQ----ELDILLHLSHDNIVKLI-----GYCDDRDEGVLLFEYVP 138
           IK I        Q + Q    E+ ILL   H+NI+ +         +   +  ++ +   
Sbjct: 57  IKKISPFEH---QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-- 111

Query: 139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL 198
              ++  L+   ++  L   +     +Q+ + ++Y+H   + +++H D+K SN+LL    
Sbjct: 112 ---METDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTC 165

Query: 199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM---------MIGSPGYTDPHYLR 249
           + K+CDFG A++         +         +T+ V          M+ S GYT      
Sbjct: 166 DLKICDFGLARV---------ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT------ 210

Query: 250 TGMASTKTDVYSFGVILLELVTG 272
                   D++S G IL E+++ 
Sbjct: 211 -----KSIDIWSVGCILAEMLSN 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 67/243 (27%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HD-----N 116
           +VIG G F  V  A   +     + A+K+     R  +   +E+ IL HL   D     N
Sbjct: 103 KVIGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 117 IVKLIGYCDDRDEGVLLFE------YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
           ++ ++     R+   + FE      Y     L +K      S  L  +     A  + Q 
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLY----ELIKKNKFQGFSLPLVRK----FAHSILQC 212

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           ++ LH+     I+H D+K  NILL++      K+ DFGS+                    
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------------------- 249

Query: 229 RITKQVMMIGSPGYTDPHYLRT----------GMA-STKTDVYSFGVILLELVTGMEAFC 277
                        YT   Y+++          G       D++S G IL EL+TG     
Sbjct: 250 ------CYEHQRVYT---YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300

Query: 278 PEN 280
            E+
Sbjct: 301 GED 303

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 48/254 (18%), Positives = 91/254 (35%), Gaps = 56/254 (22%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELD---------ILLHLS 113
            +IG+G + +V  A   +       AIK      ++ +VF+  +D         IL  L+
Sbjct: 59  HLIGTGSYGHVCEA--YDKLEKRVVAIK------KILRVFEDLIDCKRILREIAILNRLN 110

Query: 114 HDNIVKLI-----GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS-KLPWRNRMAIAFQL 167
           HD++VK++        +  DE  ++ E               R+   L   +   + + L
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNL 165

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG---SAKMGFSSAVLPPSPSPS 224
              ++Y+H      I+H D+K +N L+ +  + K+CDFG   +     +     P     
Sbjct: 166 LVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 225 PSRSRITKQVMMIGSPGYTD----------------PHYLRTGMASTKTDVYSFGVILLE 268
              + +T           T                  +Y      +   DV+S G I  E
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY------TEAIDVWSIGCIFAE 276

Query: 269 LVTGMEAFCPENGQ 282
           L+  ++     +  
Sbjct: 277 LLNMIKENVAYHAD 290

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 39/247 (15%)

Query: 50  SWDDVERFTQ----NFSQ--VIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLS 99
            W +VE        +FS   +IG GGF  VY  R  +  T    A+K      +   +  
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGE 233

Query: 100 QVFKQELDILLHLSHDN---IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLP 156
            +   E  +L  +S  +   IV +       D+   + + +  G L   L      S+  
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA- 292

Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
              R   A ++   +E++H      +V+ D+K +NILL+EH + ++ D G A        
Sbjct: 293 -DMRFYAA-EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----- 342

Query: 217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEA 275
                S     +        +G+ GY  P  L+ G+A   + D +S G +L +L+ G   
Sbjct: 343 -----SKKKPHAS-------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

Query: 276 FCPENGQ 282
           F     +
Sbjct: 391 FRQHKTK 397

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 46/234 (19%), Positives = 90/234 (38%), Gaps = 67/234 (28%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLHLS 113
             +GSG + +V  A  I+  +    AIK      +LS+ F+          EL +L H+ 
Sbjct: 30  THVGSGAYGSVCSA--IDKRSGEKVAIK------KLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 114 HDNIVKLI-----GYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           H+N++ L+                L+  +     +Q  L           + +  + +Q+
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQY-LVYQM 135

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
            + ++Y+H   +  +VH D+K  N+ + E    K+ DFG A+                + 
Sbjct: 136 LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---------------HAD 177

Query: 228 SRITKQV---------MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
           + +T  V         +++    Y               D++S G I+ E++TG
Sbjct: 178 AEMTGYVVTRWYRAPEVILSWMHYN-----------QTVDIWSVGCIMAEMLTG 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 54/254 (21%), Positives = 96/254 (37%), Gaps = 65/254 (25%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLHLS 113
            +IG G +  VYLA   + +T  N AIK      +++++F+          E+ IL  L 
Sbjct: 32  HLIGRGSYGYVYLA--YDKNTEKNVAIK------KVNRMFEDLIDCKRILREITILNRLK 83

Query: 114 HDNIVKLI-----GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS-KLPWRNRMAIAFQL 167
            D I++L            DE  ++ E          L    ++   L   +   I + L
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLTEEHIKTILYNL 138

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNC--KLCDFG----------SAKMGFSSA 215
                ++HE     I+H D+K +N LL +  +C  K+CDFG          +  +     
Sbjct: 139 LLGENFIHES---GIIHRDLKPANCLLNQ--DCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 216 VLPPSPSPSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVIL 266
              P P     + ++T  V+         ++    YT              D++S G I 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-----------KSIDIWSTGCIF 242

Query: 267 LELVTGMEAFCPEN 280
            EL+  +++   + 
Sbjct: 243 AELLNMLQSHINDP 256

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 65/245 (26%)

Query: 56  RFTQNFSQV--IGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSDR----LSQVFKQEL 106
           R  Q +  V  IG G +  V+ AR   D  +     A+K + V +      LS +  +E+
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKAR---DLKNGGRFVALKRVRVQTGEEGMPLSTI--REV 62

Query: 107 DILLHLS---HDNIVKLI----GYCDDRDEGVLL-FEYVPN--GTLQEKLHGTPRSSKLP 156
            +L HL    H N+V+L         DR+  + L FE+V     T  +K+        +P
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVP 118

Query: 157 WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV 216
                 + FQL + +++LH      +VH D+K  NIL+      KL DFG A++ +S  +
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQM 174

Query: 217 LPPSPSPSPSRSRITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILL 267
                        +T  V+         ++ S       Y      +T  D++S G I  
Sbjct: 175 ------------ALTSVVVTLWYRAPEVLLQS------SY------ATPVDLWSVGCIFA 210

Query: 268 ELVTG 272
           E+   
Sbjct: 211 EMFRR 215

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 49/277 (17%), Positives = 86/277 (31%), Gaps = 78/277 (28%)

Query: 61  FSQVIGSGGFSNVYLAR---LINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL-SH 114
             + +G G F  V  A    +   +T    A+K+     +    +    EL IL+H+  H
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 115 DNIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
            N+V L+G C      +++  E+   G L   L             R        +   +
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR----------SKRNEFVPYKTKGARF 135

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
              +  +  +  D+K     +    +      G  +    S V          +  +T +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSA--SSGFVEEKSLSDVEEEEAPEDLYKDFLTLE 193

Query: 234 -------------------------------------VMMIGSPG-----YTDPHYLRTG 251
                                                V+ I   G     Y DP Y+R G
Sbjct: 194 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 252 --------MA---------STKTDVYSFGVILLELVT 271
                   MA         + ++DV+SFGV+L E+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 59/233 (25%)

Query: 65  IGSGGFSNVYLARLINDSTSTNG--AIK-IHVGSDRLSQVFK-----QELDILLHLS--- 113
           IG G +  VY AR       +    A+K + V +             +E+ +L  L    
Sbjct: 17  IGVGAYGTVYKAR----DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72

Query: 114 HDNIVKLI----GYCDDRDEGVLL-FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           H N+V+L+        DR+  V L FE+V    L+  L   P    LP      +  Q  
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP-PPGLPAETIKDLMRQFL 130

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           + +++LH      IVH D+K  NIL+      KL DFG A++ +S  +            
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARI-YSYQM------------ 174

Query: 229 RITKQVM---------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
            +T  V+         ++ S       Y      +T  D++S G I  E+   
Sbjct: 175 ALTPVVVTLWYRAPEVLLQS------TY------ATPVDMWSVGCIFAEMFRR 215

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 65.6 bits (161), Expect = 3e-12
 Identities = 62/254 (24%), Positives = 106/254 (41%), Gaps = 56/254 (22%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDS-TSTNGAIKI----HVGSDRL 98
              +K        F     +V+G G F  V+L + I+ S      A+K+     +     
Sbjct: 16  EGHEKADPSQ---F--ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70

Query: 99  SQVFKQELDILLHLSHDNIVKLIGYC---DDRDEGVLLF---EYVPNGTL-----QEKLH 147
            +  K E DIL+ ++H  IVKL  Y    + +     L+   +++  G L     +E + 
Sbjct: 71  VRT-KMERDILVEVNHPFIVKLH-YAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMF 123

Query: 148 GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS 207
                       +  +A +LA A+++LH    L I++ D+K  NILL+E  + KL DFG 
Sbjct: 124 TEEDV-------KFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL 172

Query: 208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVIL 266
           +K          S                 G+  Y  P  +      T++ D +SFGV++
Sbjct: 173 SKESIDHEKKAYS---------------FCGTVEYMAPEVVN-RRGHTQSADWWSFGVLM 216

Query: 267 LELVTGMEAFCPEN 280
            E++TG   F  ++
Sbjct: 217 FEMLTGTLPFQGKD 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 64/233 (27%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---------ELDILLHLS 113
           + IGSG    V  A   +     N AIK      +LS+ F+          EL ++  ++
Sbjct: 31  KPIGSGAQGIVCAA--YDAILERNVAIK------KLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 114 HDNIVKLI------GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           H NI+ L+         ++  +  ++ E      +   L    +  +L       + +Q+
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-----MDANLCQVIQM-ELDHERMSYLLYQM 136

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
              I++LH   +  I+H D+K SNI+++     K+ DFG A+              + + 
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTS 180

Query: 228 SRITKQVM--------MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG 272
             +T  V+        +I   GY               D++S G I+ E++ G
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYK-----------ENVDIWSVGCIMGEMIKG 222

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 60/220 (27%), Positives = 85/220 (38%), Gaps = 35/220 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HD-----N 116
            +IG G F  V  A   +       AIKI           + E+ +L  ++ HD      
Sbjct: 60  SLIGKGSFGQVVKAY--DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 117 IVKLIGYCDDRDEGVLLFEYV-PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           IV L  +   R+   L+FE +  N  L + L  T     +        A Q+  A+ +L 
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLA 174

Query: 176 ERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
               L I+H D+K  NILL        K+ DFGS+                    RI + 
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------------CQLGQRIYQ- 217

Query: 234 VMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTG 272
              I S  Y  P  L  GM      D++S G IL+E+ TG
Sbjct: 218 --YIQSRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHTG 254

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 61.8 bits (151), Expect = 7e-11
 Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 54/254 (21%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLAR-LINDSTSTNGAIKI---HVGSDRLS 99
           R  +K   +    F     +V+G GG+  V+  R +   +T    A+K+    +      
Sbjct: 9   RGPEKIRPEC---F--ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK 63

Query: 100 QVF--KQELDILLHLSHDNIVKLIGYC---DDRDEGVLLF--EYVPNGTL-----QEKLH 147
                K E +IL  + H  IV LI Y      +    L    EY+  G L     +E + 
Sbjct: 64  DTAHTKAERNILEEVKHPFIVDLI-YAFQTGGK----LYLILEYLSGGELFMQLEREGIF 118

Query: 148 GTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS 207
               +          +A +++ A+ +LH+     I++ D+K  NI+L    + KL DFG 
Sbjct: 119 MEDTA-------CFYLA-EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167

Query: 208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVIL 266
            K       +  +                 G+  Y  P  L       +  D +S G ++
Sbjct: 168 CKESIHDGTVTHT---------------FCGTIEYMAPEILM-RSGHNRAVDWWSLGALM 211

Query: 267 LELVTGMEAFCPEN 280
            +++TG   F  EN
Sbjct: 212 YDMLTGAPPFTGEN 225

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 54/271 (19%), Positives = 94/271 (34%), Gaps = 50/271 (18%)

Query: 35  HDHDDGIDGRSVKKYSWDDV---------ERFTQNFS--QVIGSGGFSNVYLARLINDST 83
           H H     GR    +  DD                F   + +G G F  V L +  +   
Sbjct: 2   HHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQ--HIDN 59

Query: 84  STNGAIKIHVGSDRLSQVFKQELDILLHLSHD-----NIVKLIGYCDDRDEGVLLFE-YV 137
               A+K+     + ++  K E DIL  + +D     NIVK  G     D   L+FE   
Sbjct: 60  KKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLG 119

Query: 138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH 197
           P+  L E +     +      +      ++ +A+ YL +   + + H D+K  NILL++ 
Sbjct: 120 PS--LYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDD- 172

Query: 198 LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI--GSPGYTDPH---YLRT-- 250
                      +    +                +  + +I  G   +   +    + T  
Sbjct: 173 --------PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ 224

Query: 251 --------GMA-STKTDVYSFGVILLELVTG 272
                    +     +D++SFG +L EL TG
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 39/163 (23%), Positives = 60/163 (36%), Gaps = 24/163 (14%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSH-DNIVKLIG 122
           IGSGGF  +YLA     +     A   + V       +F  EL     ++  D I K I 
Sbjct: 45  IGSGGFGLIYLAF--PTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIE 101

Query: 123 YCDDRDEGVLLFEYVPNGTLQEK--------LHGTPRSSKLPWRNRMA------IAFQLA 168
                  G+ LF        + +          G                    +  ++ 
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161

Query: 169 QAIEYLHERCTLHIVHGDIKASNILL-EEHLN-CKLCDFGSAK 209
             +EY+HE      VHGDIKA+N+LL  ++ +   L D+G + 
Sbjct: 162 DVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 59/275 (21%), Positives = 108/275 (39%), Gaps = 56/275 (20%)

Query: 28  DQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLIND-STSTN 86
           +Q     H+          +K   ++   F     +V+G+G +  V+L R I+   T   
Sbjct: 30  EQLLTVKHELRTANLTGHAEKVGIEN---F--ELLKVLGTGAYGKVFLVRKISGHDTGKL 84

Query: 87  GAIKI-----HVGSDRLSQVFKQELDILLHLSHDN-IVKLIGYC---DDRDEGVLLF--- 134
            A+K+      V   + ++  + E  +L H+     +V L  Y    + +     L    
Sbjct: 85  YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETK-----LHLIL 138

Query: 135 EYVPNGTL-----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKA 189
           +Y+  G L     Q +              ++ +  ++  A+E+LH+   L I++ DIK 
Sbjct: 139 DYINGGELFTHLSQRERFTEHEV-------QIYVG-EIVLALEHLHK---LGIIYRDIKL 187

Query: 190 SNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR 249
            NILL+ + +  L DFG +K   +              +         G+  Y  P  +R
Sbjct: 188 ENILLDSNGHVVLTDFGLSKEFVADE------------TERAYD--FCGTIEYMAPDIVR 233

Query: 250 TG-MASTKT-DVYSFGVILLELVTGMEAFCPENGQ 282
            G     K  D +S GV++ EL+TG   F  +  +
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 60/248 (24%), Positives = 98/248 (39%), Gaps = 54/248 (21%)

Query: 48  KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFK 103
           K + +D   F  ++ +++G G F  V L R     T    A+KI     + +        
Sbjct: 1   KVTMND---F--DYLKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTV 53

Query: 104 QELDILLHLSHDNIVKLIGYC---DDRDEGVLLF--EYVPNGTL-----QEKLHGTPRSS 153
            E  +L +  H  +  L  Y     DR    L F  EY   G L     +E++    R+ 
Sbjct: 54  TESRVLQNTRHPFLTALK-YAFQTHDR----LCFVMEYANGGELFFHLSRERVFTEERA- 107

Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
                 R   A ++  A+EYLH R    +V+ DIK  N++L++  + K+ DFG  K G S
Sbjct: 108 ------RFYGA-EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157

Query: 214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                 +                 G+P Y  P  L       +  D +  GV++ E++ G
Sbjct: 158 DGATMKT---------------FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCG 201

Query: 273 MEAFCPEN 280
              F  ++
Sbjct: 202 RLPFYNQD 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.1 bits (147), Expect = 1e-10
 Identities = 49/283 (17%), Positives = 78/283 (27%), Gaps = 68/283 (24%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQ--------ELDILLHL--- 112
           IG G F  V+          T  AIK I +    L     Q        E+ I   L   
Sbjct: 28  IGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83

Query: 113 ------SHDNIVKLIGYC------------------------------DDRDEGVLLFEY 136
                   +  + L                                     D+  ++ E+
Sbjct: 84  SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143

Query: 137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE 196
              G   E++     S         +I  QL  ++        L   H D+   N+LL++
Sbjct: 144 EFGGIDLEQMRTKLSS----LATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKK 197

Query: 197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTD---PHYLRTGMA 253
               KL    + K    S+ +P              ++   G   + D      L TG  
Sbjct: 198 TSLKKLHYTLNGK----SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG 253

Query: 254 STKTDVYSFGVILLELVTGMEAFCPE-NGQLLTSLAGSMLNDI 295
             + D+Y    +  E       + P  N   L  L   ML  +
Sbjct: 254 DYQFDIYRL--MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM 294

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 65/280 (23%), Positives = 105/280 (37%), Gaps = 55/280 (19%)

Query: 17  RKPIDQVDVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLA 76
            +P +   +  +            +   S       D   F  +F +VIG G F  V LA
Sbjct: 3   SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD---F--HFLKVIGKGSFGKVLLA 57

Query: 77  RLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILL-HLSHDNIVKLIGYC---DDRD 128
           R          A+K+     +   +  +    E ++LL ++ H  +V L  +     D+ 
Sbjct: 58  RHKA--EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADK- 113

Query: 129 EGVLLF--EYVPNGTL-----QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              L F  +Y+  G L     +E+    PR+       R   A ++A A+ YLH    L+
Sbjct: 114 ---LYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAA-EIASALGYLHS---LN 159

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           IV+ D+K  NILL+   +  L DFG  K          +                 G+P 
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST---------------FCGTPE 204

Query: 242 YTDPHYLRTGMASTKT-DVYSFGVILLELVTGMEAFCPEN 280
           Y  P  L       +T D +  G +L E++ G+  F   N
Sbjct: 205 YLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 36/154 (23%), Positives = 61/154 (39%), Gaps = 17/154 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH-DNIVKLI 121
           + IG G F  + L    N  T+   AIK+     R  Q    E      L   D I ++ 
Sbjct: 15  KKIGCGNFGELRLG--KNLYTNEYVAIKLEPMKSRAPQ-LHLEYRFYKQLGSGDGIPQVY 71

Query: 122 GYCDDRDEGVLLFEYV-PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            +        ++ E + P+  L++      R      +  + IA QL   +EY+H +   
Sbjct: 72  YFGPCGKYNAMVLELLGPS--LEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSK--- 124

Query: 181 HIVHGDIKASNILLEEHLNCK-----LCDFGSAK 209
           ++++ D+K  N L+    N       + DF  AK
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 35/166 (21%), Positives = 62/166 (37%), Gaps = 27/166 (16%)

Query: 65  IGSGGFSNVYLARLINDSTSTNG------AIKIHVGSDRLSQVFK-----------QELD 107
                   +Y A   +  T  +G      ++K+     RL                 +  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 108 ILLHLSHDNIVKLIGYCDDRDEG-VLLFEYV-PNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
            L       I   +G+   +D+   L+   +  +  LQ  L  +P+   L  R+ + +A 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKH-VLSERSVLQVAC 166

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILL--EEHLNCKLCDFGSAK 209
           +L  A+E+LHE      VHG++ A NI +  E+     L  +G A 
Sbjct: 167 RLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 65/267 (24%), Positives = 104/267 (38%), Gaps = 47/267 (17%)

Query: 28  DQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG 87
              +++    +    G++       D   F  +  +VIG G ++ V L RL    T    
Sbjct: 28  SGIEEEKEAMNTRESGKASSSLGLQD---F--DLLRVIGRGSYAKVLLVRLKK--TDRIY 80

Query: 88  AIKI----HVGSDRLSQVFKQELDILLH-LSHDNIVKLIGYC---DDRDEGVLLF--EYV 137
           A+++     V  D      + E  +     +H  +V L   C   + R    L F  EYV
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESR----LFFVIEYV 135

Query: 138 PNGTLQEKLHGTPRSSKLP-WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE 196
             G L   +    R  KLP    R   A +++ A+ YLHER    I++ D+K  N+LL+ 
Sbjct: 136 NGGDLMFHMQ---RQRKLPEEHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDS 188

Query: 197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK 256
             + KL D+G  K G        +                 G+P Y  P  LR G     
Sbjct: 189 EGHIKLTDYGMCKEGLRPGDTTST---------------FCGTPNYIAPEILR-GEDYGF 232

Query: 257 T-DVYSFGVILLELVTGMEAFCPENGQ 282
           + D ++ GV++ E++ G   F      
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSS 259

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 69/255 (27%), Positives = 107/255 (41%), Gaps = 47/255 (18%)

Query: 38  DDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HV 93
            +GI   S  +   D+   F   F +V+G G F  V LAR+    T    A+K+     +
Sbjct: 9   GNGIGVNSSNRLGIDN---F--EFIRVLGKGSFGKVMLARVKE--TGDLYAVKVLKKDVI 61

Query: 94  GSDRLSQVFKQELDILLH-LSHDNIVKLIGYC---DDRDEGVLLF--EYVPNGTLQEKLH 147
             D   +    E  IL    +H  + +L   C    DR    L F  E+V  G L   + 
Sbjct: 62  LQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDR----LFFVMEFVNGGDLMFHIQ 116

Query: 148 GTPRSSKLP-WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG 206
              +S +    R R   A ++  A+ +LH++    I++ D+K  N+LL+   +CKL DFG
Sbjct: 117 ---KSRRFDEARARFYAA-EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG 169

Query: 207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVI 265
             K G  + V   +                 G+P Y  P  L+  M      D ++ GV+
Sbjct: 170 MCKEGICNGVTTAT---------------FCGTPDYIAPEILQ-EMLYGPAVDWWAMGVL 213

Query: 266 LLELVTGMEAFCPEN 280
           L E++ G   F  EN
Sbjct: 214 LYEMLCGHAPFEAEN 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 58.8 bits (143), Expect = 8e-10
 Identities = 65/250 (26%), Positives = 99/250 (39%), Gaps = 47/250 (18%)

Query: 45  SVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQ 100
           ++      D   F  +  +VIG G ++ V L RL    T    A+K+     V  D    
Sbjct: 2   AMDPLGLQD---F--DLLRVIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDEDID 54

Query: 101 VFKQELDILLH-LSHDNIVKLIGYC---DDRDEGVLLF--EYVPNGTLQEKLHGTPRSSK 154
             + E  +     +H  +V L   C   + R    L F  EYV  G L   +    R  K
Sbjct: 55  WVQTEKHVFEQASNHPFLVGLH-SCFQTESR----LFFVIEYVNGGDLMFHMQ---RQRK 106

Query: 155 LP-WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           LP    R   A +++ A+ YLHER    I++ D+K  N+LL+   + KL D+G  K G  
Sbjct: 107 LPEEHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162

Query: 214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTG 272
                 +                 G+P Y  P  LR G     + D ++ GV++ E++ G
Sbjct: 163 PGDTTST---------------FCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAG 206

Query: 273 MEAFCPENGQ 282
              F      
Sbjct: 207 RSPFDIVGSS 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 15/151 (9%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH-DNIVKLIGY 123
           IGSG F ++YL    + +     AIK+     +  Q+   E  I   +     I  +   
Sbjct: 17  IGSGSFGDIYLG--TDIAAGEEVAIKLECVKTKHPQL-HIESKIYKMMQGGVGIPTIRWC 73

Query: 124 CDDRDEGVLLFEYV-PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
             + D  V++ E + P+  L++  +   R  K   +  + +A Q+   IEY+H +   + 
Sbjct: 74  GAEGDYNVMVMELLGPS--LEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NF 126

Query: 183 VHGDIKASNILLEEHLNCK---LCDFGSAKM 210
           +H D+K  N L+          + DFG AK 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 45/235 (19%), Positives = 82/235 (34%), Gaps = 49/235 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNG--AIKIHVGSDRLSQVFKQELDILLHL-SHD---- 115
             +G G F  V       D  +     A+KI    DR  +  + E+ +L HL + D    
Sbjct: 20  DTLGEGAFGKVVECI---DHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 116 -NIVKLIGYCDDRDEGVLLFE-YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
              V+++ + +      ++FE    +    + +            +   +A+Q+ +++ +
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLP-FRLDHIRKMAYQICKSVNF 133

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           LH      + H D+K  NIL  +                              R+ I   
Sbjct: 134 LHS---NKLTHTDLKPENILFVQS---------------DYTEAYNPKIKRDERTLINPD 175

Query: 234 VMMI--GSPGYTDPH---YLRT----------GMA-STKTDVYSFGVILLELVTG 272
           + ++  GS  Y D H    + T           +  S   DV+S G IL+E   G
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 49/244 (20%), Positives = 76/244 (31%), Gaps = 67/244 (27%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNG--AIKIHVGSDRLSQVFKQELDILLHL-SHD---- 115
             +G G F  V       D        A+KI     +  +  + E+++L  +   D    
Sbjct: 25  GNLGEGTFGKVVECL---DHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENK 81

Query: 116 -NIVKLIGYCDDRDEGVLLFE-YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
              V +  + +      + FE    N    E L         P  +   +A+QL  A+ +
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGKN--TFEFLKENNFQP-YPLPHVRHMAYQLCHALRF 138

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNC-------------------KLCDFGSAKMGFSS 214
           LHE     + H D+K  NIL                          ++ DFGSA   F  
Sbjct: 139 LHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDH 193

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----GMA-STKTDVYSFGVILLE 268
                  +     +R                HY R       +  +   DV+S G IL E
Sbjct: 194 EHHTTIVA-----TR----------------HY-RPPEVILELGWAQPCDVWSIGCILFE 231

Query: 269 LVTG 272
              G
Sbjct: 232 YYRG 235

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 57/246 (23%), Positives = 91/246 (36%), Gaps = 47/246 (19%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVF 102
            K   +D   F     +++G G F  V+LA      T+   AIK      V  D   +  
Sbjct: 12  IKLKIED---F--ILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECT 64

Query: 103 KQELDILLH-LSHDNIVKLIGYC---DDRDEGVLLF--EYVPNGTLQEKLHGTPRSSKLP 156
             E  +L     H  +  +        +     L F  EY+  G L   +       K  
Sbjct: 65  MVEKRVLSLAWEHPFLTHMF-CTFQTKEN----LFFVMEYLNGGDLMYHIQ---SCHKFD 116

Query: 157 -WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
             R     A ++   +++LH +    IV+ D+K  NILL++  + K+ DFG  K      
Sbjct: 117 LSRATFYAA-EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

Query: 216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVTGME 274
               +                 G+P Y  P  L  G     + D +SFGV+L E++ G  
Sbjct: 173 AKTNT---------------FCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQS 216

Query: 275 AFCPEN 280
            F  ++
Sbjct: 217 PFHGQD 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 47/249 (18%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLS 99
            +  +    D   F  NF  V+G G F  V L+      T    A+KI     V  D   
Sbjct: 12  GNRDRMKLTD---F--NFLMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQDDDV 64

Query: 100 QVFKQELDILLH-LSHDNIVKLIGYC---DDRDEGVLLF--EYVPNGTLQEKLHGTPRSS 153
           +    E  +L        + +L   C    DR    L F  EYV  G L   +    +  
Sbjct: 65  ECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR----LYFVMEYVNGGDLMYHIQ---QVG 116

Query: 154 KLP-WRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF 212
           +          A ++A  + +L  +    I++ D+K  N++L+   + K+ DFG  K   
Sbjct: 117 RFKEPHAVFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172

Query: 213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT-DVYSFGVILLELVT 271
              V   +                 G+P Y  P  +       K+ D ++FGV+L E++ 
Sbjct: 173 WDGVTTKT---------------FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLA 216

Query: 272 GMEAFCPEN 280
           G   F  E+
Sbjct: 217 GQAPFEGED 225

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 33/155 (21%), Positives = 60/155 (38%), Gaps = 17/155 (10%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH-DNIVKLI 121
           + IG G F  ++     N   +   AIK         Q+ + E      L+    I  + 
Sbjct: 16  RRIGEGSFGVIFEG--TNLLNNQQVAIKFEPRRSDAPQL-RDEYRTYKLLAGCTGIPNVY 72

Query: 122 GYCDDRDEGVLLFEYV-PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
            +  +    VL+ + + P+  L++ L    R  K   +     A Q+   ++ +HE+   
Sbjct: 73  YFGQEGLHNVLVIDLLGPS--LEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK--- 125

Query: 181 HIVHGDIKASNILLEEHLNCK-----LCDFGSAKM 210
            +V+ DIK  N L+    +       + DFG  K 
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 58/263 (22%), Positives = 96/263 (36%), Gaps = 45/263 (17%)

Query: 29  QDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGA 88
            ++   +      +  +  +    D   F  NF  V+G G F  V L+      T    A
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTD---F--NFLMVLGKGSFGKVMLSERKG--TDELYA 370

Query: 89  IKI----HVGSDRLSQVFKQELDILLH-LSHDNIVKLIGYC---DDRDEGVLLF--EYVP 138
           +KI     V  D   +    E  +L        + +L   C    DR    L F  EYV 
Sbjct: 371 VKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR----LYFVMEYVN 425

Query: 139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL 198
            G L   +    R  +         A ++A  + +L  +    I++ D+K  N++L+   
Sbjct: 426 GGDLMYHIQQVGRFKEP--HAVFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 479

Query: 199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKT- 257
           + K+ DFG  K      V   +                 G+P Y  P  +       K+ 
Sbjct: 480 HIKIADFGMCKENIWDGVTTKT---------------FCGTPDYIAPEIIA-YQPYGKSV 523

Query: 258 DVYSFGVILLELVTGMEAFCPEN 280
           D ++FGV+L E++ G   F  E+
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGED 546

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 15/150 (10%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGY 123
           IGSG F  +YL    N  T+   AIK+     +  Q+   E  I   L     I  +  +
Sbjct: 15  IGSGSFGEIYLG--TNIQTNEEVAIKLENVKTKHPQL-LYESKIYRILQGGTGIPNVRWF 71

Query: 124 CDDRDEGVLLFEYV-PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
             + D  VL+ + + P+  L++  +   R  KL  +  + +A Q+   +E++H +     
Sbjct: 72  GVEGDYNVLVMDLLGPS--LEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SF 124

Query: 183 VHGDIKASNILLEEHLNCK---LCDFGSAK 209
           +H DIK  N L+          + DFG AK
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 37/166 (22%), Positives = 61/166 (36%), Gaps = 27/166 (16%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQ---ELDILLHLSH-DNIVKL 120
           IG GGF  +YLA   + ++S +                     EL      +  + I K 
Sbjct: 43  IGQGGFGCIYLA---DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLH--------GTPRSSKLPWRNR-------MAIAF 165
           I     +  GV  +          K +        G+          +       + ++ 
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLN-CKLCDFGSAK 209
           ++   +EY+HE      VHGDIKASN+LL  ++ +   L D+G A 
Sbjct: 160 RILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	368
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.85
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.15
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.01
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.76
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.42
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.38
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.22
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.22
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.93
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.67
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.07
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.08
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.19
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.74
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.33

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.5e-61  Score=433.84  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=201.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||+||+|++..  ++..||+|+....   ....+.+.+|+.+|+.|+|||||++++++.+.+.+|+|||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTE--DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             EEEEEEC------CEEEEEETT--TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5578899999999999999765  6788999987543   4456788999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ||.+|+|.+++... ....+++..++.++.||+.||.|||++   +||||||||+|||++.+|.+||+|||+|+..... 
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            99999999999743 345689999999999999999999999   9999999999999999999999999999753211 


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                    .......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.......+.   .. 
T Consensus       179 --------------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---~~-  240 (350)
T 4b9d_A          179 --------------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---SG-  240 (350)
T ss_dssp             --------------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HT-
T ss_pred             --------------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---cC-
Confidence                          111234679999999999999999999999999999999999999998766433222111   10 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                            .    . +.    .+...+.++.+||.+||+.||.+|||++++|+|
T Consensus       241 ------~----~-~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 ------S----F-PP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ------C----C-CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------C----C-CC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0    0 11    122345689999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-60  Score=429.00  Aligned_cols=263  Identities=23%  Similarity=0.264  Sum_probs=210.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.++||+|+||+||+|++..  ++..||+|+......    ..+|+.+++.|+|||||++++++.+.+.+|||||||++
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~--~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQ--TGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             EeCcEeccCCCeEEEEEEECC--CCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            356789999999999999765  678899998765432    24699999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      |+|.+++.   ..+.+++..+..++.||+.||.|||++   +||||||||+|||++.+| .+||+|||+|+.........
T Consensus       135 g~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          135 GSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999998   446799999999999999999999999   999999999999999887 59999999998644322110


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                ........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.......+....      
T Consensus       209 ----------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------  272 (336)
T 4g3f_A          209 ----------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------  272 (336)
T ss_dssp             ---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC------
T ss_pred             ----------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC------
Confidence                      0011123579999999999999999999999999999999999999998765433222111100      


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCC
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSP  361 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~  361 (368)
                        ...         ...+...+..+.+||.+||+.||.+|||+.|++++|...+.+.....+|
T Consensus       273 --~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP  324 (336)
T 4g3f_A          273 --PPI---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP  324 (336)
T ss_dssp             --CGG---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred             --CCc---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence              000         0112234568999999999999999999999999999998876654444

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-60  Score=428.22  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=207.1

Q ss_pred             hhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.+.||+|+||+||+|++.+   ..++..||||+.... ....+.|.+|+++|++|+|||||+++++|.+.+..++||||
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey  124 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY  124 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            56789999999999998753   345788999987654 45567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          137 VPNGTLQEKLHGTPR------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                      |++|+|.+++.....            ...+++.++..|+.||+.||.|||++   +||||||||+|||++.++.+||+|
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence            999999999975421            24689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+|+.........             .....+||+.|||||++.+..++.++|||||||++|||+| |+.||...+...
T Consensus       202 FGla~~~~~~~~~~-------------~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          202 FGMSRDIYSTDYYR-------------VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             CC-----------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             cccceeccCCCcce-------------ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            99998543322111             1123469999999999999999999999999999999999 899998765433


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      ....+..   .            ..+    ..+..++.++.+|+..||+.||.+|||+.+|+++|+.+.++.+
T Consensus       269 ~~~~i~~---g------------~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          269 AIDCITQ---G------------REL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             HHHHHHH---T------------CCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHc---C------------CCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence            3221111   0            011    1222345689999999999999999999999999999876543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-60  Score=420.80  Aligned_cols=256  Identities=30%  Similarity=0.448  Sum_probs=201.1

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeec---CChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV---GSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.+.||+|+||+||+|++.+     .+|||+..   ......+.|.+|+.++++++|||||++++++.+ +.+++|||||
T Consensus        40 l~~~iG~G~fG~Vy~~~~~~-----~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWHG-----DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             EEEECCCCSSSEEEEEESSS-----EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EeeEEeeCCCcEEEEEEECC-----cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            67889999999999998533     36777654   345566789999999999999999999999865 5689999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++|+|.+++..  ....+++..+..|+.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+....... 
T Consensus       114 ~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~-  187 (307)
T 3omv_A          114 EGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG-  187 (307)
T ss_dssp             SSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc-
Confidence            99999999974  345699999999999999999999999   999999999999999999999999999985432211 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH-HHHhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS-LAGSMLN  293 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~  293 (368)
                                  .......+||+.|||||++.+   ..|+.++|||||||++|||+||..||.+.+...... ....   
T Consensus       188 ------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~---  252 (307)
T 3omv_A          188 ------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR---  252 (307)
T ss_dssp             ------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT---
T ss_pred             ------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc---
Confidence                        011134579999999999964   368999999999999999999999998755432211 1111   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                                 ....|.+ ...+..++..+.+|+..||+.||.+|||+.+|+++|+.+-.++
T Consensus       253 -----------~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          253 -----------GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             -----------TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             -----------CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                       0111111 1223345668999999999999999999999999998775544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.7e-61  Score=429.04  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=209.1

Q ss_pred             HHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .++.+.||+|+||+||+|.+.+   ..+...||||+....  ....+.|.+|+.++++|+|||||+++|+|.+.+..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            3477889999999999998743   235678999987543  34457899999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCce
Q 017627          134 FEYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC  200 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~v  200 (368)
                      ||||++|+|.++|.....             ...+++..+..++.||+.||.|||++   +||||||||+|||+++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence            999999999999965321             24689999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPE  279 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  279 (368)
                      ||+|||+|+.........             .....+||+.|||||++.+..++.++|||||||++|||+| |..||.+.
T Consensus       185 Ki~DFGlar~~~~~~~~~-------------~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYK-------------LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             EECCSCCBCGGGGGGCBC-------------SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             EECCcccceeccCCCcee-------------EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            999999998643322111             1123469999999999999999999999999999999999 89999876


Q ss_pred             cchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          280 NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      +.......+..                   ......+..++..+.+|+..||+.||.+|||+++|+++|+..
T Consensus       252 ~~~~~~~~i~~-------------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          252 SNQDVVEMIRN-------------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             CHHHHHHHHHT-------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CHHHHHHHHHc-------------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            65433322211                   001112234566899999999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.5e-61  Score=426.28  Aligned_cols=263  Identities=24%  Similarity=0.379  Sum_probs=212.2

Q ss_pred             HhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||+||+|++.+   ..++..||||+.... ....+.|.+|+++|++|+|||||++++++.+.+..++|||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            467889999999999998753   235778999977543 4556789999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeec
Q 017627          136 YVPNGTLQEKLHGTP----------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                      ||++|+|.+++....          ....+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence            999999999997431          235799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhh
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLL  284 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  284 (368)
                      |+|+........             .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+....
T Consensus       173 Gla~~~~~~~~~-------------~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~  239 (299)
T 4asz_A          173 GMSRDVYSTDYY-------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  239 (299)
T ss_dssp             SCHHHHTGGGCE-------------EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ccceecCCCCce-------------eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999854322210             11123469999999999999999999999999999999999 8999987654333


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                      ...+..   .                .....+..++.++.+|+..||+.||.+|||+++|++.|+++.++.+.
T Consensus       240 ~~~i~~---~----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~  293 (299)
T 4asz_A          240 IECITQ---G----------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV  293 (299)
T ss_dssp             HHHHHH---T----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred             HHHHHc---C----------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence            222111   0                00112223456899999999999999999999999999998766543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-60  Score=425.07  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=206.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+....    ....+.+.+|+++|+.|+|||||++++++.+.+.+|+||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~--~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEecccCeEEEEEEECC--CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5678999999999999999765  6788999987532    234567889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||.+|+|.+++.   ..+.+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999997   446799999999999999999999999   9999999999999999999999999999864322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..             .......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+.......+..   .
T Consensus       186 ~~-------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~  249 (311)
T 4aw0_A          186 SK-------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK---L  249 (311)
T ss_dssp             TT-------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---T
T ss_pred             CC-------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---C
Confidence            11             1112346799999999999999999999999999999999999999987664433222211   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   +.    .++...+.++.+||.+||+.||.+|||++|++.+
T Consensus       250 -------------~~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          250 -------------EY----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             -------------CC----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             -------------CC----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                         00    1122235679999999999999999999986543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.7e-60  Score=417.94  Aligned_cols=244  Identities=26%  Similarity=0.366  Sum_probs=195.9

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec----CCeeEEE
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD----RDEGVLL  133 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  133 (368)
                      +.+.||+|+||+||+|.+..  ++..||+|+...   .....+.|.+|+.+++.|+|||||+++++|.+    .+.+++|
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            55679999999999998765  677889887643   34456779999999999999999999999864    3458999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEecCCCCCeeec-CCCceEEeecccccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH--IVHGDIKASNILLE-EHLNCKLCDFGSAKM  210 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~  210 (368)
                      ||||++|+|.+++.   ....+++..+..++.||+.||.|||++   +  |+||||||+|||++ .+|.+||+|||+|+.
T Consensus       108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            99999999999998   456799999999999999999999998   7  99999999999998 479999999999974


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ....                 .....+||+.|||||++.+ .|+.++|||||||++|||+||..||.+......  ....
T Consensus       182 ~~~~-----------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~  241 (290)
T 3fpq_A          182 KRAS-----------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR  241 (290)
T ss_dssp             CCTT-----------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH
T ss_pred             CCCC-----------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHH
Confidence            2211                 1134679999999999875 699999999999999999999999976443211  1111


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....               ..+..++...++++.+||..||+.||.+|||++++++|
T Consensus       242 i~~~---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          242 VTSG---------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HTTT---------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHcC---------------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1100               00000111223578999999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.3e-60  Score=425.82  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=205.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |++.+.||+|+||+||+|.+..  ++..||||+.... ....+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cEEeEEeecCcCeEEEEEEECC--CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            4456789999999999999765  6788999976432 233456789999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+|+|.+++..    ..+++..+..++.||+.||.|||++   +||||||||+|||++.+|.+||+|||+|+....... 
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            99999999863    4599999999999999999999999   999999999999999999999999999986433221 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+...      
T Consensus       226 --------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------  285 (346)
T 4fih_A          226 --------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------  285 (346)
T ss_dssp             --------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred             --------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------
Confidence                          113457999999999999999999999999999999999999999876544332222110      


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               ..+.  .......+.++.+||.+||+.||.+|||++|+++|
T Consensus       286 ---------~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          286 ---------LPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             ---------SCCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---------CCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                     0010  11122345689999999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-59  Score=411.90  Aligned_cols=245  Identities=26%  Similarity=0.371  Sum_probs=192.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .|.+.+.||+|+||+||+|.+..  ++..+|+|+....    ......+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTT--TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            35678899999999999998654  6788999987543    23456788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||| +|+|.+++.   ..+.+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 679999887   346799999999999999999999999   999999999999999999999999999975332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ..                .....+||+.|||||++.+..+ +.++||||+||++|+|++|..||.+.+.......+....
T Consensus       165 ~~----------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~  228 (275)
T 3hyh_A          165 GN----------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV  228 (275)
T ss_dssp             --------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CC----------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            11                1133579999999999998876 579999999999999999999998765443322211100


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                      .    .++...+.++.+||.+||+.||.+|||++|+++|
T Consensus       229 ----------------~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 ----------------Y----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ----------------C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ----------------C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                            0    1112235688999999999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.5e-59  Score=430.11  Aligned_cols=248  Identities=21%  Similarity=0.318  Sum_probs=206.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||+||+|.+..  ++..||||+.... ....+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cEeeeEeccCcCcEEEEEEECC--CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            4556789999999999999765  6788999976543 333456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+|+|.+++..    ..+++..+..++.||+.||.|||++   +||||||||+|||++.+|.+||+|||+|+....... 
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            99999999963    4599999999999999999999999   999999999999999999999999999986433221 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+...      
T Consensus       303 --------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------  362 (423)
T 4fie_A          303 --------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------  362 (423)
T ss_dssp             --------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred             --------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------
Confidence                          113467999999999999999999999999999999999999999876644332222110      


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                               ..+.+  ......+.++.+||..||+.||.+|||+.|+|+|
T Consensus       363 ---------~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          363 ---------LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             ---------CCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---------CCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                     01111  1112335689999999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-59  Score=417.81  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             HHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||+||+|+... +.++..+|+|+....   ......+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            4578899999999999998743 346788999986543   122345778999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||.+|+|.+++.   ..+.+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       106 Ey~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          106 DFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             CCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999998   456799999999999999999999999   9999999999999999999999999999853322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.......+..   .
T Consensus       180 ~~---------------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---~  241 (304)
T 3ubd_A          180 EK---------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK---A  241 (304)
T ss_dssp             -C---------------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C
T ss_pred             Cc---------------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc---C
Confidence            11               11235799999999999999999999999999999999999999987665433222211   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                   ..    .++...+.++.+||.+||+.||.+|||+     +++++|
T Consensus       242 -------------~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          242 -------------KL----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -------------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -------------CC----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                         00    1122345689999999999999999995     688876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.5e-59  Score=423.74  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=212.1

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCC-CceeeeeEEEecC-C
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSH-DNIVKLIGYCDDR-D  128 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~-~  128 (368)
                      +..+.+.+.||+|+||+||+|.+.+.   .....||+|.....  ....+.|.+|+.+|.+++| ||||+++++|.+. +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            44566788999999999999997653   24467899977543  3445678999999999965 8999999999664 5


Q ss_pred             eeEEEEecccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                      .+++|||||++|+|.++|+...             ....+++..+..++.||+.||.|||++   +||||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence            7899999999999999997432             134589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCC
Q 017627          196 EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GME  274 (368)
Q Consensus       196 ~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~  274 (368)
                      .++.+||+|||+|+.......             .......+||+.|||||++.+..|+.++|||||||++|||+| |..
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~-------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPD-------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTT-------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             CCCCEEECcchhhhhcccCCC-------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            999999999999985432221             111234579999999999999999999999999999999998 999


Q ss_pred             CCCCCcchh-hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          275 AFCPENGQL-LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       275 pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      ||.+.+... ....+..               -..+    ..+..++.++.+|+..||+.||.+|||+++|++||+++++
T Consensus       287 Pf~~~~~~~~~~~~i~~---------------g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          287 PYPGVKIDEEFCRRLKE---------------GTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             SSTTCCCSHHHHHHHHH---------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHc---------------CCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            998755322 2111111               0111    1222345689999999999999999999999999999887


Q ss_pred             cc
Q 017627          354 SI  355 (368)
Q Consensus       354 ~~  355 (368)
                      +.
T Consensus       348 ~~  349 (353)
T 4ase_A          348 AN  349 (353)
T ss_dssp             HT
T ss_pred             Hh
Confidence            54

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.8e-57  Score=404.51  Aligned_cols=269  Identities=21%  Similarity=0.287  Sum_probs=191.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC--------
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD--------  128 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------  128 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+...  .....+.+.+|+.+|+.|+|||||+++++|.+.+        
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKV--DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETT--TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             CEEeeEEecCCCeEEEEEEECC--CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4567899999999999998765  677899997643  3445577899999999999999999999986544        


Q ss_pred             ----eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          129 ----EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       129 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                          .+|+|||||.+|+|.+++.........++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                3699999999999999998654444566778899999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      ||+|+............   ............+||+.|||||++.+..|+.++|||||||++|||++   ||.+....  
T Consensus       162 FGla~~~~~~~~~~~~~---~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVL---TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--  233 (299)
T ss_dssp             CCCC-----------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             CccceecCCCccccccc---cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--
Confidence            99998654433211110   00111122345689999999999999999999999999999999996   77542211  


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccc
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL  358 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~  358 (368)
                      .......               .....+ ......++.+.+||.+||+.||.+|||+.++++|  ..++.+.++
T Consensus       234 ~~~~~~~---------------~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~~~~~p  289 (299)
T 4g31_A          234 VRTLTDV---------------RNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFEDLDFP  289 (299)
T ss_dssp             HHHHHHH---------------HTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGCCC---
T ss_pred             HHHHHHH---------------hcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCCCCCC
Confidence            1111000               000000 0112334567889999999999999999999986  234444443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.1e-57  Score=407.13  Aligned_cols=278  Identities=19%  Similarity=0.270  Sum_probs=200.5

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC----eeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD----EGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e  135 (368)
                      .+.+.||+|+||+||+|++    ++..||||+..........++.|+..+..++|||||++++++.+.+    .+++|||
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~----~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEE----TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEE----CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            3567899999999999987    3578999988665544444455677777899999999999997654    5799999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC-----TLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ||++|+|.++++.    ..+++..+..++.|++.||.|||+++     ..+||||||||+|||++.++.+||+|||+|+.
T Consensus        82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999999973    35899999999999999999999752     34899999999999999999999999999986


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG------MASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      .......           ........+||+.|||||++.+.      .++.++|||||||++|||+||.+||........
T Consensus       158 ~~~~~~~-----------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~  226 (303)
T 3hmm_A          158 HDSATDT-----------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EETTTTE-----------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             ccCCCCc-----------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence            4332210           00111235799999999999764      357799999999999999999988754332110


Q ss_pred             HH-HHHhhhhhhhhhhhcchhhhcCCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          285 TS-LAGSMLNDIADCEATKVNELVDPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       285 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      .. .....................+|.++... +.+.+..+.+|+.+||+.||.+|||+.+|++.|+++.++.+
T Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            00 00000000000000011111222222211 23566789999999999999999999999999998876543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-55  Score=406.28  Aligned_cols=270  Identities=24%  Similarity=0.288  Sum_probs=205.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec------CC
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD------RD  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~  128 (368)
                      .|.+.+.||+|+||+||+|.+..  ++..||||+....   ....+.+.+|+.+|+.|+|||||++++++..      .+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~--t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRL--TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CeEEEEEEecccCeEEEEEEECC--CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            35678899999999999999755  6789999987543   3445678899999999999999999999754      35


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      .+|+|||||. |+|.+++.   ..+.+++..+..++.||+.||.|||++   |||||||||+|||++.+|.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999995 67999987   456799999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      +.........           .......+||+.|||||++.+. .++.++||||+||++|||++|.+||.+.+.......
T Consensus       206 ~~~~~~~~~~-----------~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~  274 (398)
T 4b99_A          206 RGLCTSPAEH-----------QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL  274 (398)
T ss_dssp             BCC------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred             eecccCcccc-----------ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            8643322111           1112346799999999998875 569999999999999999999999988776555444


Q ss_pred             HHhhhhhhhhhhhcc-----hhhh---cCCCCCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEATK-----VNEL---VDPRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +..............     ....   ..+.....+   ....+.++.+||.+||..||.+|||++++|+|
T Consensus       275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            433332221111100     0000   011100000   01235688999999999999999999999997

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.2e-54  Score=393.41  Aligned_cols=280  Identities=23%  Similarity=0.290  Sum_probs=200.7

Q ss_pred             HHHhhhhcccccceEEEEEEEc-CCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLI-NDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~-~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|.+.+.||+|+||+||+|++. +..+...||+|....... ...+.+|+++|+.+ +|||||++++++.+.+.+|+|||
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            3567789999999999999864 334678899997765543 34577899999998 69999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-CceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-LNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~~vkl~Dfg~s~~~~~~  214 (368)
                      ||++++|.+++.      .+++.++..++.||+.||.|||++   ||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus       101 ~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A          101 YLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             CCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             CCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            999999999984      388999999999999999999999   99999999999999876 89999999999864433


Q ss_pred             CCCCCCCC-------------CCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          215 AVLPPSPS-------------PSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       215 ~~~~~~~~-------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      ........             ..............+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            21100000             00000111122346799999999999875 58999999999999999999999996654


Q ss_pred             ch-hhHHHHHhhhhhhhhhhh----------------cchhhh---------cCCCCC---------CCCCHHHHHHHHH
Q 017627          281 GQ-LLTSLAGSMLNDIADCEA----------------TKVNEL---------VDPRLA---------GDFDLDEARAMLS  325 (368)
Q Consensus       281 ~~-~~~~~~~~~~~~~~~~~~----------------~~~~~~---------~~~~~~---------~~~~~~~~~~l~~  325 (368)
                      .. .....+............                ......         ..+...         .......++++.+
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            32 222222111111000000                000000         000000         0011123567899


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHH
Q 017627          326 IAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       326 li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ||.+||+.||.+|||++|+|+|
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHCcCChhHCcCHHHHhcC
Confidence            9999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-53  Score=409.78  Aligned_cols=246  Identities=21%  Similarity=0.262  Sum_probs=198.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+.++||+|+||+||+|+...  ++..+|+|+.....       ........++.+++.++|||||+++++|.+.+.+|+
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~--tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEEecccCeEEEEEEECC--CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            345689999999999999765  78899999875321       112223345677778899999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |||||.||+|..++.   ..+.+++..+..++.||+.||.|||++   |||||||||+|||++.+|.+||+|||+|+...
T Consensus       270 VmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999998   456799999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ....                 .+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+.+...........
T Consensus       344 ~~~~-----------------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i  406 (689)
T 3v5w_A          344 KKKP-----------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT  406 (689)
T ss_dssp             SCCC-----------------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH
T ss_pred             CCCC-----------------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Confidence            3221                 2357999999999996 468999999999999999999999999765543332222221


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                      ...             ..    .++...+.++.+||..||+.||.+|++     +++|++|
T Consensus       407 ~~~-------------~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          407 LTM-------------AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHC-------------CC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             cCC-------------CC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            111             01    122234568999999999999999998     7899887

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-52  Score=405.80  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=207.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+.+.||+|+||+||+|.++.  ++..+|+|+.... ....+.+.+|+.+|+.|+|||||+++++|.+.+.+++||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~--tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERA--TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccEEEEEEeeccCeEEEEEEECC--CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            45678899999999999999765  6788999976554 34567788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC--CCceEEeeccccccCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE--HLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~--~~~vkl~Dfg~s~~~~~~  214 (368)
                      |.+|+|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.  .+.+||+|||+|+.....
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999864  345799999999999999999999999   9999999999999985  489999999999864322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.......+......
T Consensus       311 ~----------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~  374 (573)
T 3uto_A          311 Q----------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN  374 (573)
T ss_dssp             S----------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             C----------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC
Confidence            1                123467999999999999999999999999999999999999999877654333222211100


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                      .........+.++.+||..||+.||.+|||+.++|+|
T Consensus       375 ----------------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          375 ----------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ----------------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                            0011111235688999999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.3e-50  Score=362.63  Aligned_cols=261  Identities=29%  Similarity=0.458  Sum_probs=202.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .|.+.+.||+|+||.||+|++    .+..+|+|+....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             HceeeeEeecCCCeEEEEEEE----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            445778999999999999986    3567889876543   344567889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH--IVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||+.+++|.+++........+++..++.++.|++.||.|||++   +  |+||||||+|||++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999998543223489999999999999999999999   8  9999999999999999999999999997432


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ....               ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+........... 
T Consensus       191 ~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~-  254 (309)
T 3p86_A          191 STFL---------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-  254 (309)
T ss_dssp             --------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS-
T ss_pred             cccc---------------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-
Confidence            2111               112346999999999999999999999999999999999999999776543322211110 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL  358 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~  358 (368)
                                       ......+...+..+.+||..||+.||.+|||++++++.|+.++++...+
T Consensus       255 -----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          255 -----------------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             -----------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             -----------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence                             0011122234567899999999999999999999999999999875443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-49  Score=360.87  Aligned_cols=245  Identities=29%  Similarity=0.385  Sum_probs=203.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+...   .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHIL--TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4567889999999999998755  677899997654   34456678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           95 YASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999987   345699999999999999999999999   99999999999999999999999999997533211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAS-TKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...........   
T Consensus       169 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---  229 (328)
T 3fe3_A          169 ----------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG---  229 (328)
T ss_dssp             ----------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---
T ss_pred             ----------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Confidence                            11234699999999999988775 7899999999999999999999876644332221110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                     ..  ..+...+.++.+|+..||+.||.+|||++++++|
T Consensus       230 ---------------~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 ---------------KY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---------------CC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---------------CC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                           00  1112235678999999999999999999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.5e-49  Score=362.85  Aligned_cols=264  Identities=21%  Similarity=0.351  Sum_probs=212.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC-----CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCC
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN-----DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRD  128 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  128 (368)
                      ..|.+.+.||+|+||.||+|.+.+     ......+|+|+....  ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            345577899999999999998753     235667999987653  34456789999999999 8999999999999999


Q ss_pred             eeEEEEecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                      ..++||||+.+++|.+++.....             ...+++..++.++.||+.||.|||++   +|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence            99999999999999999975421             24589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCC
Q 017627          196 EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GME  274 (368)
Q Consensus       196 ~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~  274 (368)
                      .++.+||+|||+++..........             .....||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~  304 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKK-------------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  304 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCT-------------TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCCEEEccccCCcccCcccceec-------------ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence            999999999999985443221110             012347889999999999999999999999999999999 999


Q ss_pred             CCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      ||.+............                   ......+..++..+.++|..||+.||.+|||+.+++++|++++..
T Consensus       305 p~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          305 PYPGIPVEELFKLLKE-------------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             SSTTCCGGGHHHHHHT-------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHhc-------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            9977654332221111                   001112223456899999999999999999999999999998754


Q ss_pred             c
Q 017627          355 I  355 (368)
Q Consensus       355 ~  355 (368)
                      .
T Consensus       366 ~  366 (370)
T 2psq_A          366 T  366 (370)
T ss_dssp             H
T ss_pred             h
Confidence            3

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-49  Score=355.24  Aligned_cols=251  Identities=21%  Similarity=0.295  Sum_probs=207.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+..........+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECC--CCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            4567889999999999998755  67889999887776667788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC--CCceEEeeccccccCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE--HLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~--~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.  ++.+||+|||+++...... 
T Consensus        85 g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           85 GLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999974  234689999999999999999999999   9999999999999987  7899999999997532211 


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+................
T Consensus       159 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  223 (321)
T 1tki_A          159 ---------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD  223 (321)
T ss_dssp             ---------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             ---------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC
Confidence                           12346799999999999998899999999999999999999999987654432222111100000


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      .       .         .....+.++.+|+..||..||.+|||+.++++|-
T Consensus       224 ~-------~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          224 E-------E---------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             H-------H---------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             h-------h---------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            0       0         0002245789999999999999999999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-48  Score=358.81  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=203.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-------HHHHHHHHHHHHhcCCCCceeeeeEEEecCCee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-------LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  130 (368)
                      .|.+.+.||+|+||.||+|....  ++..+|+|+......       ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECC--CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            35577899999999999998765  677889997654321       346788999999999999999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC----ceEEeecc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL----NCKLCDFG  206 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~----~vkl~Dfg  206 (368)
                      ++||||+.+++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999997   446799999999999999999999999   999999999999998776    79999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      +++.......                ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus       165 ~a~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~  228 (361)
T 2yab_A          165 LAHEIEDGVE----------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (361)
T ss_dssp             SCEECCTTCC----------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CceEcCCCCc----------------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9976433211                123469999999999999999999999999999999999999998765443322


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .+........                .......+..+.+||..||..||.+|||+.++++|
T Consensus       229 ~i~~~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          229 NITAVSYDFD----------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HHHTTCCCCC----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCCCC----------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            2211100000                00001224578999999999999999999999976

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1e-48  Score=355.68  Aligned_cols=289  Identities=31%  Similarity=0.567  Sum_probs=229.0

Q ss_pred             CcccccCHHHHHHHH--HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceee
Q 017627           44 RSVKKYSWDDVERFT--QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVK  119 (368)
Q Consensus        44 ~~~~~~~~~~~~~~~--~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~  119 (368)
                      .....+++.++....  |.+.+.||+|+||.||+|...   ++..+|+|+......  ....+.+|+.+++.++||||++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS---SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec---CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence            345566666665443  345678999999999999743   467889997655422  2236889999999999999999


Q ss_pred             eeEEEecCCeeEEEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC
Q 017627          120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL  198 (368)
Q Consensus       120 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~  198 (368)
                      +++++.+.+..++||||+.+++|.+++.... ....+++..+..++.|++.||.|||+++..+|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            9999999999999999999999999998653 334599999999999999999999998666899999999999999999


Q ss_pred             ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 017627          199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP  278 (368)
Q Consensus       199 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  278 (368)
                      .+||+|||+++.......              .......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus       172 ~~kl~Dfg~~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDT--------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL  237 (326)
T ss_dssp             CEEECCCSSCEECCSSSS--------------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred             CEEeccCccccccCcccc--------------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence            999999999975432211              011224599999999999988999999999999999999999999952


Q ss_pred             C-----cchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          279 E-----NGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       279 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      .     .......+.......      .......+......+....+..+.+++..||+.||.+|||+.+++++|+...-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          238 ARLANDDDVMLLDWVKGLLKE------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             HHHTTTSCSBHHHHHTTTTSS------CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             cccccccchhHHHHHHHHhhc------hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            1     122222222222221      44555666667777888899999999999999999999999999999997654


Q ss_pred             cc
Q 017627          354 SI  355 (368)
Q Consensus       354 ~~  355 (368)
                      ..
T Consensus       312 ~~  313 (326)
T 3uim_A          312 AE  313 (326)
T ss_dssp             SS
T ss_pred             hh
Confidence            43

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-48  Score=352.83  Aligned_cols=272  Identities=31%  Similarity=0.556  Sum_probs=219.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      .+.+.||+|+||.||+|.+.   ++..+++|+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus        42 ~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  118 (321)
T 2qkw_B           42 DHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME  118 (321)
T ss_dssp             SCCCCSCBCSSSEEEEEECT---TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred             CccceeecCCCeeEEEEEEC---CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence            35678999999999999853   4667888876543 3456778999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          139 NGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       139 ~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      +++|.+++.... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred             CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999987543 234689999999999999999999999   9999999999999999999999999999753322110


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................   .
T Consensus       196 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---~  259 (321)
T 2qkw_B          196 -------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE---S  259 (321)
T ss_dssp             -------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH---H
T ss_pred             -------------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh---c
Confidence                         001234589999999999989999999999999999999999999976543222111110000   0


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      .....+...+++..........+..+.+++..||+.||.+|||+.+++++|+.+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            11134455566666677788899999999999999999999999999999998865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-49  Score=358.00  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=211.7

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCC-CceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDS-TSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ..+|.+.+.||+|+||.||+|.+...+ ....+|+|+...  .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            345567789999999999999976432 455689998765  34556778999999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999974  335699999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .....            ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus       203 ~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  270 (325)
T 3kul_A          203 DDPDA------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG  270 (325)
T ss_dssp             ----C------------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             cCccc------------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence            32210            011122346788999999999999999999999999999999 99999776544332221110


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                                         .....+..++..+.+|+..||+.||.+|||+.++++.|+.++.+.
T Consensus       271 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 -------------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -------------------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                               011122234568999999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.9e-49  Score=352.63  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=202.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTT--TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeeeeccCCCeEEEEEEECC--CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            4566789999999999998654  6778899976433 233567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++..    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A          100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            99999999973    3589999999999999999999999   999999999999999999999999999875432221 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+............     
T Consensus       172 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----  232 (297)
T 3fxz_A          172 --------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-----  232 (297)
T ss_dssp             --------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-----
T ss_pred             --------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----
Confidence                          1123469999999999999999999999999999999999999997765432221111100     


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                .  .....+...+..+.+|+..||+.||.+|||++++++|
T Consensus       233 ----------~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          233 ----------T--PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ----------S--CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----------C--CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                      0  0001122345678999999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.1e-49  Score=357.51  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=203.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|+...  ++..+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            3467889999999999998755  6778999987543    223456788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|..++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999999987   345789999999999999999999999   9999999999999999999999999999743221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+..   .
T Consensus       159 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~  220 (337)
T 1o6l_A          159 G---------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---E  220 (337)
T ss_dssp             T---------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C
T ss_pred             C---------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc---C
Confidence            1               111235799999999999999999999999999999999999999977654332221111   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                   ..    .++...+..+.+||..||+.||.+||     +++++++|
T Consensus       221 -------------~~----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 -------------EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------------CC----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                         00    11223356889999999999999999     99999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-49  Score=354.86  Aligned_cols=274  Identities=23%  Similarity=0.377  Sum_probs=210.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC-ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETT--TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeccceecCCCCEEEEEEEECC--CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            4467889999999999998765  567888886544 4566778999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999753  45689999999999999999999999   9999999999999999999999999999865443322


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                      ...... .............||+.|+|||++.+..++.++||||||+++|+|++|..||...........          
T Consensus       165 ~~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------  233 (310)
T 3s95_A          165 PEGLRS-LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------  233 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred             cccccc-ccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence            111000 000011111245799999999999999999999999999999999999999865432111000          


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                         .......+....    ..++..+.+++..||+.||.+|||+.++++.|+.+...+..
T Consensus       234 ---~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          234 ---LNVRGFLDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             ---BCHHHHHHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ---hhhhccccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence               000011111111    12234688999999999999999999999999998776544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-48  Score=350.42  Aligned_cols=264  Identities=24%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      +|.+.+.||+|+||.||+|.+..  .+..+|+|+...    .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTI--LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECC--CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            45577899999999999998755  677889997633    345567889999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999997   345789999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH-HHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS-LAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~  292 (368)
                      ...              .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+........ ......
T Consensus       164 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~  229 (294)
T 4eqm_A          164 TSL--------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV  229 (294)
T ss_dssp             -------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred             ccc--------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence            211              11123469999999999999999999999999999999999999997765432111 000000


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhccccccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-SATQILHTIKHQISSISFLF  359 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~~il~~L~~~~~~~~~~~  359 (368)
                              .....        ......+..+.+++.+||+.||.+|| ++.++++.|++++.+.....
T Consensus       230 --------~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~  281 (294)
T 4eqm_A          230 --------PNVTT--------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE  281 (294)
T ss_dssp             --------CCHHH--------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred             --------CCcch--------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence                    00000        01112345789999999999999998 89999999999887655433

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.9e-47  Score=344.44  Aligned_cols=283  Identities=32%  Similarity=0.572  Sum_probs=225.0

Q ss_pred             cccccCHHHHHHHHHHhh--------hhcccccceEEEEEEEcCCCCceeEEEEeecCC-----hhHHHHHHHHHHHHhc
Q 017627           45 SVKKYSWDDVERFTQNFS--------QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----DRLSQVFKQELDILLH  111 (368)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~--------~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~  111 (368)
                      ....|++.++.+.+.++.        +.||+|+||.||+|.+    ....+++|+....     ....+.+.+|+.+++.
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~   86 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK   86 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence            457788999998887775        4599999999999985    3567888876432     3456788999999999


Q ss_pred             CCCCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCC
Q 017627          112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN  191 (368)
Q Consensus       112 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N  191 (368)
                      ++||||+++++++.+.+..++||||+.+++|.+++........+++..++.++.|++.||.|||++   +|+||||||+|
T Consensus        87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N  163 (307)
T 2nru_A           87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN  163 (307)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence            999999999999999999999999999999999997654456799999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh
Q 017627          192 ILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT  271 (368)
Q Consensus       192 ilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  271 (368)
                      |+++.++.+||+|||+++........             .......||+.|+|||++.+ .++.++||||||+++|+|++
T Consensus       164 ili~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~  229 (307)
T 2nru_A          164 ILLDEAFTAKISDFGLARASEKFAQT-------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT  229 (307)
T ss_dssp             EEECTTCCEEECCCTTCEECCSCSSC-------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCcEEEeeccccccccccccc-------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH
Confidence            99999999999999998754322110             00112458999999999875 47889999999999999999


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      |..||..................    ....+...+++.. .......+..+.+++..||+.||.+|||+.+++++|+++
T Consensus       230 g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          230 GLPAVDEHREPQLLLDIKEEIED----EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             CCCSBCTTBSSSBTTHHHHHHHT----TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCcccCcchHHHHHHHHHhhh----hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            99999875543222111111111    1122334444433 335667888999999999999999999999999999987


Q ss_pred             cc
Q 017627          352 IS  353 (368)
Q Consensus       352 ~~  353 (368)
                      ..
T Consensus       305 ~~  306 (307)
T 2nru_A          305 TA  306 (307)
T ss_dssp             C-
T ss_pred             hc
Confidence            54

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.1e-48  Score=363.99  Aligned_cols=252  Identities=24%  Similarity=0.268  Sum_probs=203.7

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~--~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVL--AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETT--TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECC--CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            456678899999999999998755  67888998765442   3456788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec---CCCceEEeecccccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKM  210 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~---~~~~vkl~Dfg~s~~  210 (368)
                      |||+.+++|.+.+..   ...+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999998873   45699999999999999999999999   999999999999998   567899999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ......               ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       163 ~~~~~~---------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  227 (444)
T 3soa_A          163 VEGEQQ---------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA  227 (444)
T ss_dssp             CCTTCC---------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ecCCCc---------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence            432211               01224699999999999999999999999999999999999999987665433322221


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....                .........+..+.+||..||+.||.+|||+.++|+|
T Consensus       228 ~~~~----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          228 GAYD----------------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TCCC----------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCC----------------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1100                0000111235679999999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.1e-49  Score=347.12  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=208.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      |.+.+.||+|+||.||+|.+.+   ...+|+|+........+.+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLN---KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT---TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             ceeeheecCCCccEEEEEEecC---CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4567889999999999998753   4568999887766556788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++........ 
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  162 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  162 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence            9999999975  345689999999999999999999999   9999999999999999999999999999753322110 


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||..............       
T Consensus       163 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-------  222 (269)
T 4hcu_A          163 -------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------  222 (269)
T ss_dssp             -------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------
T ss_pred             -------------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-------
Confidence                         1112346788999999999999999999999999999999 9999977654332221111       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                              ....    ..+...+..+.+++..||+.||.+|||+.+++++|+++.++
T Consensus       223 --------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          223 --------GFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             --------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------CccC----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                    0011    11112345789999999999999999999999999988654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-48  Score=349.45  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=204.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  129 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+.....       ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cceEeceEEeeCCCeEEEEEEECC--CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            456678899999999999998755  67788999765432       135678899999999999999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC----ceEEeec
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL----NCKLCDF  205 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~----~vkl~Df  205 (368)
                      .++||||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999997   446799999999999999999999999   999999999999999887    7999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |+++.......                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......
T Consensus       163 g~a~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  226 (326)
T 2y0a_A          163 GLAHKIDFGNE----------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL  226 (326)
T ss_dssp             TTCEECCTTSC----------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             CCCeECCCCCc----------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence            99976432211                12245999999999999999999999999999999999999999776543322


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........                .........+..+.+||..||+.||.+|||+.++++|
T Consensus       227 ~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          227 ANVSAVNYE----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHHHHTCCC----------------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHhcCCC----------------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            221111000                0000001224578999999999999999999999987

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.5e-49  Score=360.51  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=200.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .|.+.+.||+|+||.||+|++..  ++..+|+|+....    ......+.+|..++..+ +||||+++++++.+.+..++
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKE--TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcC--CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            34577899999999999999765  6778999987543    23345677899999988 79999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|..++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999997   345799999999999999999999999   99999999999999999999999999997422


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...               ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..  
T Consensus       176 ~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--  238 (353)
T 3txo_A          176 CNG---------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--  238 (353)
T ss_dssp             C------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--
T ss_pred             cCC---------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--
Confidence            111               111345799999999999999999999999999999999999999987665433222211  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA------TQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~  347 (368)
                       .               .  ..++...+..+.+||..||+.||.+||++      .++++|
T Consensus       239 -~---------------~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 -D---------------E--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -C---------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -C---------------C--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence             0               0  01122235578999999999999999999      888876

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.9e-48  Score=353.80  Aligned_cols=252  Identities=27%  Similarity=0.291  Sum_probs=204.9

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ...|.+.+.||+|+||.||+|.+..  ++..+|+|+....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECC--CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456778899999999999998754  6778899987543   3445678899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC---CceEEeeccccc
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH---LNCKLCDFGSAK  209 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~---~~vkl~Dfg~s~  209 (368)
                      ||||+.+++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+   +.+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999987   345689999999999999999999999   99999999999999865   459999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .......                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       180 ~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~  243 (362)
T 2bdw_A          180 EVNDSEA----------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  243 (362)
T ss_dssp             CCTTCCS----------------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EecCCcc----------------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            5432211                122469999999999999999999999999999999999999998765433322221


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....                .........+..+.+||..||+.||.+|||+.++++|
T Consensus       244 ~~~~~----------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          244 AGAYD----------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HTCCC----------------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hCCCC----------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11000                0000011235678999999999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=346.75  Aligned_cols=274  Identities=23%  Similarity=0.306  Sum_probs=213.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCC--eeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRD--EGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....  ...+.+.+|+++++.++||||+++++++...+  ..++||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEECC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            4567889999999999999765  57789999876432  33466789999999999999999999997665  779999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee----cCCCceEEeecccccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAKM  210 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv----~~~~~vkl~Dfg~s~~  210 (368)
                      ||+.+++|.+++........+++..++.++.|++.||.|||++   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999998654445599999999999999999999999   99999999999999    7888899999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR--------TGMASTKTDVYSFGVILLELVTGMEAFCPENG-  281 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-  281 (368)
                      .......                ....||+.|+|||++.        +..++.++|||||||++|+|++|..||..... 
T Consensus       166 ~~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  229 (319)
T 4euu_A          166 LEDDEQF----------------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (319)
T ss_dssp             CCTTCCB----------------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred             cCCCCce----------------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            4332211                2245999999999986        56789999999999999999999999976443 


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhc--------CCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELV--------DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      ..............+......+....        .-..........+..+.+++..||+.||++|||++++++|......
T Consensus       230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            22222233322222111111111100        1112234567888899999999999999999999999999886543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-48  Score=350.63  Aligned_cols=243  Identities=22%  Similarity=0.332  Sum_probs=202.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|+...  ++..+|+|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRH--NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            4467889999999999998755  67789999875432    23456788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999997   345789999999999999999999999   9999999999999999999999999999753321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..   .
T Consensus       160 ~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~  218 (318)
T 1fot_A          160 T------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---A  218 (318)
T ss_dssp             B------------------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---C
T ss_pred             c------------------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---C
Confidence            1                  224699999999999999999999999999999999999999977654322211110   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                   ..    .++...+.++.++|..||+.||.+||     +++++++|
T Consensus       219 -------------~~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          219 -------------EL----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -------------CC----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------------CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                         00    11122345789999999999999999     89999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-48  Score=343.70  Aligned_cols=256  Identities=21%  Similarity=0.328  Sum_probs=208.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|.+.+.||+|+||.||+|.+.   ....+|+|+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWK---GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             heeeeeeeccCCCceEEEEEec---CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            4456788999999999999864   3456899988776655677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998742  34589999999999999999999999   9999999999999999999999999999754332211


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                    ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..............      
T Consensus       161 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------  220 (268)
T 3sxs_A          161 --------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ------  220 (268)
T ss_dssp             --------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------
T ss_pred             --------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc------
Confidence                          1112346778999999999899999999999999999999 9999976654322211111      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                               .....    .+...+..+.+++..||+.||.+|||+.+++++|+.+.++
T Consensus       221 ---------~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          221 ---------GHRLY----RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---------TCCCC----CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---------CCCCC----CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                     00000    1112245789999999999999999999999999998765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-48  Score=372.76  Aligned_cols=262  Identities=22%  Similarity=0.324  Sum_probs=216.1

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ...+.+.+.||+|+||.||+|.+..  ....||+|+........+.+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGG--GTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcC--CCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3445677899999999999999865  57889999887766567789999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999754 335689999999999999999999999   99999999999999999999999999998643221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..              ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..........    
T Consensus       373 ~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~----  434 (495)
T 1opk_A          373 YT--------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----  434 (495)
T ss_dssp             EE--------------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----
T ss_pred             ee--------------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----
Confidence            11              0112346788999999999999999999999999999999 9999987654332222111    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                     ......+..++..+.+||..||+.||.+|||+.+|++.|+.++.+..
T Consensus       435 ---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~  481 (495)
T 1opk_A          435 ---------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  481 (495)
T ss_dssp             ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred             ---------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence                           11111223345689999999999999999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-49  Score=361.50  Aligned_cols=266  Identities=26%  Similarity=0.335  Sum_probs=211.0

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..+.+.+.||+|+||.||+|.+.+   ..+...+|+|+...  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            345678899999999999998653   34667899998754  3445567889999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC---ceEEee
Q 017627          132 LLFEYVPNGTLQEKLHGTP----RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL---NCKLCD  204 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~---~vkl~D  204 (368)
                      +||||+.+++|.+++....    ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999987532    224689999999999999999999999   999999999999999555   599999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+++.........             ......||+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       228 FG~a~~~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~  294 (367)
T 3l9p_A          228 FGMARDIYRAGYYR-------------KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE  294 (367)
T ss_dssp             CHHHHHHHHHSSCT-------------TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             Cccccccccccccc-------------cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99997532221110             1123458999999999999999999999999999999998 999997765443


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                      ........                   .....+...+..+.+|+..||+.||.+|||+.+|+++|+.+......
T Consensus       295 ~~~~i~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          295 VLEFVTSG-------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             HHHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HHHHHHcC-------------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence            32221110                   00111223345789999999999999999999999999988765443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-48  Score=346.90  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=207.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|.+.+.||+|+||.||+|.+.   ....+++|+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEET---TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHhHhhcCCCCCceEEEEEEc---CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            3456788999999999999864   4566899988776655678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            999999999752  35689999999999999999999999   999999999999999999999999999975432211 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                   .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..............      
T Consensus       176 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------  236 (283)
T 3gen_A          176 -------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ------  236 (283)
T ss_dssp             -------------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------
T ss_pred             -------------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc------
Confidence                         01112346788999999999999999999999999999998 9999977654332221111      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                               .....    .+...+..+.+++..||+.||.+|||+.+++++|++++++.
T Consensus       237 ---------~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          237 ---------GLRLY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             ---------TCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---------ccCCC----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence                     00111    11122457899999999999999999999999999987654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-48  Score=356.20  Aligned_cols=265  Identities=25%  Similarity=0.382  Sum_probs=207.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  130 (368)
                      ..|.+.+.||+|+||.||+|.+..   ......+|+|+....  ....+.+.+|+.++..+ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            345577899999999999999743   345678999987643  23456788999999999 899999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCC
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRS--------------------SKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKAS  190 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~  190 (368)
                      ++||||+.+++|.+++......                    ..+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence            9999999999999999864321                    3479999999999999999999999   9999999999


Q ss_pred             CeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHH
Q 017627          191 NILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELV  270 (368)
Q Consensus       191 Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  270 (368)
                      |||++.++.+||+|||++........             ........||+.|+|||++.+..++.++||||||+++|+|+
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSN-------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTT-------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             hEEEcCCCcEEeCCCccCcccccCcc-------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            99999999999999999975432211             01112345788999999999999999999999999999999


Q ss_pred             h-CCCCCCCCcchhh-HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          271 T-GMEAFCPENGQLL-TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       271 ~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      + |..||.+...... ......                   ......+...+..+.+|+..||+.||.+|||+.+++++|
T Consensus       269 t~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          269 SLGVNPYPGIPVDANFYKLIQN-------------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TTSCCSSTTCCCSHHHHHHHHT-------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCCcccCCcHHHHHHHHhc-------------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            8 9999977553221 111110                   011111223356899999999999999999999999999


Q ss_pred             Hhcccccc
Q 017627          349 KHQISSIS  356 (368)
Q Consensus       349 ~~~~~~~~  356 (368)
                      +.++.+..
T Consensus       330 ~~~~~~~~  337 (344)
T 1rjb_A          330 GCQLADAE  337 (344)
T ss_dssp             HHHC----
T ss_pred             HHHHHHHH
Confidence            99887654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-48  Score=359.01  Aligned_cols=264  Identities=22%  Similarity=0.342  Sum_probs=209.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEc---CCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCC-e
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLI---NDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRD-E  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~  129 (368)
                      ..|.+.+.||+|+||.||+|.+.   +..+...+|+|+....  ....+.+.+|+.++..+ +||||+++++++.+.+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            34567789999999999999864   3346788999987653  34456789999999999 7999999999998755 4


Q ss_pred             eEEEEecccCCCHHHHhcCCCC----------------------------------------------------------
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPR----------------------------------------------------------  151 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  151 (368)
                      .++||||+.+++|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999999986432                                                          


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCC
Q 017627          152 -----SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS  226 (368)
Q Consensus       152 -----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~  226 (368)
                           ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......          
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----------  248 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----------  248 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT----------
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc----------
Confidence                 12289999999999999999999999   999999999999999999999999999975432211          


Q ss_pred             ccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhH-HHHHhhhhhhhhhhhcchh
Q 017627          227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLT-SLAGSMLNDIADCEATKVN  304 (368)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  304 (368)
                         ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....... .....              
T Consensus       249 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------  311 (359)
T 3vhe_A          249 ---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------  311 (359)
T ss_dssp             ---CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH--------------
T ss_pred             ---chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc--------------
Confidence               111133568999999999999999999999999999999998 99999775533211 11110              


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          305 ELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                       ....    ..+...+..+.+++..||+.||.+|||+.+++++|++++++.
T Consensus       312 -~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          312 -GTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             -TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence             0001    111223457899999999999999999999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-48  Score=358.37  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +|.+.+.||+|+||+||+|++..  ++..+|+|+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKL--TKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETT--TCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cEEEEEEeccCCCEEEEEEEECC--CCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            34577889999999999998755  6778999988766655677889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc--eEEeeccccccCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN--CKLCDFGSAKMGFSSA  215 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~--vkl~Dfg~s~~~~~~~  215 (368)
                      .+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.  +||+|||+++......
T Consensus        99 ~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           99 SGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999999987   345699999999999999999999999   9999999999999987765  9999999987322111


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK-TDVYSFGVILLELVTGMEAFCPENGQ-LLTSLAGSMLN  293 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~  293 (368)
                                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.... ...........
T Consensus       173 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~  236 (361)
T 3uc3_A          173 ----------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS  236 (361)
T ss_dssp             ------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT
T ss_pred             ----------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc
Confidence                            1123469999999999988887665 89999999999999999999765432 22222211111


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                     ...........+..+.+||.+||+.||.+|||+.++++|
T Consensus       237 ---------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          237 ---------------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---------------TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---------------CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                           111111111234578999999999999999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.5e-48  Score=359.60  Aligned_cols=266  Identities=24%  Similarity=0.321  Sum_probs=208.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-----CCceeeeeEEEecCCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-----HDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~  131 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+..........+..|+.+++.++     ||||+++++++...+..+
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHID--NKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECC--CCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            456678899999999999999765  6778999998877777778889999999996     999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---------------
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---------------  196 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---------------  196 (368)
                      +||||+ +++|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.               
T Consensus       113 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          113 LIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             EEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             EEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccc
Confidence            999999 89999999754 334689999999999999999999999   9999999999999975               


Q ss_pred             ----------CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHH
Q 017627          197 ----------HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVIL  266 (368)
Q Consensus       197 ----------~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  266 (368)
                                ++.+||+|||+++......                  ....||+.|+|||++.+..++.++|||||||++
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH------------------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSCC------------------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccccCCCCEEEEeccCceecCCCC------------------cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                      7889999999997532211                  124589999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcch-----hhhc-----CCCCCCCCC----------------HHHH
Q 017627          267 LELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKV-----NELV-----DPRLAGDFD----------------LDEA  320 (368)
Q Consensus       267 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~----------------~~~~  320 (368)
                      |+|++|..||...+...............+.......     ....     ...+.....                ...+
T Consensus       250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            9999999999877655444433333222211100000     0000     000000000                0012


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          321 RAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       321 ~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+.+||..||+.||.+|||++++|+|
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            578899999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-48  Score=349.09  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=217.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+++|+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGG--GTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cceeEEeecCCCCceeEEEeEecC--CCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            345567889999999999999765  678899998887777778899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++... ....+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++........
T Consensus        91 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           91 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            9999999999754 345689999999999999999999999   999999999999999999999999999975432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                    .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+...........    
T Consensus       167 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~----  228 (288)
T 3kfa_A          167 --------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----  228 (288)
T ss_dssp             --------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----
T ss_pred             --------------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc----
Confidence                          11122457889999999999999999999999999999999 99999776544332222110    


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                                     .....+...+..+.+|+..||+.||.+|||+.++++.|++++.+...
T Consensus       229 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~  275 (288)
T 3kfa_A          229 ---------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  275 (288)
T ss_dssp             ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                           11111223356899999999999999999999999999998876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.8e-48  Score=349.23  Aligned_cols=280  Identities=24%  Similarity=0.323  Sum_probs=207.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  131 (368)
                      ..|.+.+.||+|+||.||+|++.  +..++..+|+|+.... ....+.+.+|+.+++.++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            34567889999999999999853  3446788999977654 44557889999999999999999999998543  5689


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        90 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            999999999999999753  34589999999999999999999999   9999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .......            .......|+..|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus       165 ~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~  232 (295)
T 3ugc_A          165 PQDKEFF------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK  232 (295)
T ss_dssp             -----------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC
T ss_pred             cCCccee------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc
Confidence            3322110            0011234777899999999999999999999999999999999998654321111000000


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      ..   ..........+........+..++..+.+|+..||+.||.+|||+.++++.|+++.++++
T Consensus       233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          233 QG---QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             CT---HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cc---chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            00   000001111111111222233446689999999999999999999999999999877653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-47  Score=343.58  Aligned_cols=266  Identities=21%  Similarity=0.238  Sum_probs=199.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||+||+|.+..  ++..+|+|+....   ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceeeeEecCCCCeEEEEEEECC--CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4567889999999999998755  6778899976533   3445678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+ ++...+..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9976 55555443  346799999999999999999999999   99999999999999999999999999997543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCC-CcchhhHHHHHhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCP-ENGQLLTSLAGSMLN  293 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~  293 (368)
                      .               ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.. .+.............
T Consensus       156 ~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~  220 (292)
T 3o0g_A          156 R---------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             S---------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             c---------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            1               012245899999999998765 89999999999999999998877544 333333222222222


Q ss_pred             hhhhhhhcchhhhcC---------CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVD---------PRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..............+         ...........+..+.+|+..||+.||.+|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            111111111111100         000111122345688999999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-47  Score=349.24  Aligned_cols=270  Identities=17%  Similarity=0.228  Sum_probs=212.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+...... .+.+.+|+.+++.+ +||||+++++++.+.+..++||||+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLY--TNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETT--TTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEEeeccCCceEEEEEECC--CCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            4467889999999999998654  678899998765432 34578899999999 8999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc-----eEEeeccccccCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN-----CKLCDFGSAKMGF  212 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~-----vkl~Dfg~s~~~~  212 (368)
                       +++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.     +||+|||+++...
T Consensus        88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           88 -GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             -CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence             99999998753  45799999999999999999999999   9999999999999998887     9999999998644


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .......        ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..............
T Consensus       162 ~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~  233 (330)
T 2izr_A          162 DPETKKH--------IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG  233 (330)
T ss_dssp             CTTTCCB--------CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred             cCCCCcc--------ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence            3321110        00111134569999999999999999999999999999999999999998765443333222221


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL  358 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~  358 (368)
                      .....   ......     .    ...+ .+.+++..||+.||.+||++.+|++.|+++..+.+..
T Consensus       234 ~~~~~---~~~~~~-----~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~  286 (330)
T 2izr_A          234 DTKRA---TPIEVL-----C----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM  286 (330)
T ss_dssp             HHHHH---SCHHHH-----T----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hhhcc---CCHHHH-----h----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            11000   000000     0    0123 7999999999999999999999999999988776543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.7e-48  Score=353.73  Aligned_cols=255  Identities=23%  Similarity=0.277  Sum_probs=202.4

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  129 (368)
                      ...|.+.+.||+|+||.||+|.+..  ++..+|+|+.....      ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRE--TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467788999999999999998755  67789999764321      135678899999999999999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc---eEEeec
Q 017627          130 GVLLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDF  205 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~---vkl~Df  205 (368)
                      .++|||||.+++|.+++.... ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.   +||+||
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence            999999999999988775331 344689999999999999999999999   9999999999999986655   999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |+++........               ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......
T Consensus       178 g~a~~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  242 (351)
T 3c0i_A          178 GVAIQLGESGLV---------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE  242 (351)
T ss_dssp             TTCEECCTTSCB---------------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH
T ss_pred             cceeEecCCCee---------------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH
Confidence            999764332211               12246999999999999999999999999999999999999999765432111


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ........         .    .+..    ....+..+.+||..||+.||.+|||+.++++|
T Consensus       243 ~i~~~~~~---------~----~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          243 GIIKGKYK---------M----NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHHHTCCC---------C----CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHcCCCC---------C----Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11110000         0    0000    00124578999999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.7e-48  Score=354.09  Aligned_cols=244  Identities=20%  Similarity=0.260  Sum_probs=203.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|++..  ++..+|+|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEeecCcCcEEEEEEECC--CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            3466789999999999999765  67789999875432    23456788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999973   45689999999999999999999999   9999999999999999999999999999854321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..   .
T Consensus       195 ~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~  253 (350)
T 1rdq_E          195 T------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---G  253 (350)
T ss_dssp             B------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C
T ss_pred             c------------------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc---C
Confidence            1                  234699999999999999999999999999999999999999987654332221111   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHTI  348 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~L  348 (368)
                                   ..    .++...+..+.+||..||+.||.+||+     +++|++|-
T Consensus       254 -------------~~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          254 -------------KV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             -------------CC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             -------------CC----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence                         00    111223567999999999999999998     89998873

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=342.43  Aligned_cols=263  Identities=21%  Similarity=0.301  Sum_probs=213.5

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      .||+|+||.||+|.+........+++|+....  ....+.+.+|+.+++.++||||+++++++. .+..++||||+.+++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~   95 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGP   95 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEE
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCCC
Confidence            79999999999998766667788999987653  455678899999999999999999999994 567899999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCC
Q 017627          142 LQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP  221 (368)
Q Consensus       142 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~  221 (368)
                      |.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.........   
T Consensus        96 L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~---  167 (287)
T 1u59_A           96 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---  167 (287)
T ss_dssp             HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE---
T ss_pred             HHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCccee---
Confidence            9999964  345689999999999999999999999   99999999999999999999999999998643222110   


Q ss_pred             CCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                               .......||+.|+|||++.+..++.++||||||+++|+|++ |..||..............          
T Consensus       168 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~----------  228 (287)
T 1u59_A          168 ---------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------  228 (287)
T ss_dssp             ---------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----------
T ss_pred             ---------eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc----------
Confidence                     01122347889999999998889999999999999999998 9999977654432221111          


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCCC
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQK  363 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~~  363 (368)
                           ..    ....+...+..+.++|..||+.||.+|||+.+++++|++++.+......++.
T Consensus       229 -----~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~  282 (287)
T 1u59_A          229 -----GK----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH  282 (287)
T ss_dssp             -----TC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred             -----CC----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence                 00    0112223456899999999999999999999999999999999888777654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-48  Score=358.52  Aligned_cols=266  Identities=24%  Similarity=0.353  Sum_probs=214.0

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCC-----CCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIND-----STSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR  127 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~-----~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  127 (368)
                      ..++.+.+.||+|+||.||+|.+...     .....+|+|+....  ......+.+|+++++.+ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            34566788999999999999987532     24467899987653  34457788999999999 899999999999999


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL  194 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv  194 (368)
                      +..++||||+.+++|.+++.....             ...+++..++.++.|++.||.|||++   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            999999999999999999975421             24589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CC
Q 017627          195 EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GM  273 (368)
Q Consensus       195 ~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~  273 (368)
                      +.++.+||+|||+++..........             .....||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKK-------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCC-------------CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCCcEEEcccCccccccccccccc-------------ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            9999999999999975433221110             112347889999999999999999999999999999999 99


Q ss_pred             CCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      .||...............                   .....+...+..+.+|+..||+.||.+|||+.+++++|++++.
T Consensus       292 ~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          292 SPYPGVPVEELFKLLKEG-------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             CSSTTCCHHHHHHHHHTT-------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcC-------------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            999776543332221110                   0111112335579999999999999999999999999999976


Q ss_pred             ccc
Q 017627          354 SIS  356 (368)
Q Consensus       354 ~~~  356 (368)
                      ...
T Consensus       353 ~~~  355 (382)
T 3tt0_A          353 LTS  355 (382)
T ss_dssp             HSC
T ss_pred             HHh
Confidence            543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.5e-49  Score=363.55  Aligned_cols=258  Identities=25%  Similarity=0.346  Sum_probs=207.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.+.||+|+||.||+|.+..  ++..||+|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETT--TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEec--CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            34467889999999999999764  5678999987543  3444568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++++|.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999974  234689999999999999999999999   99999999999999999999999999997533221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...             ......+++.|+|||++.+..++.++||||||+++|||++ |..||..............    
T Consensus       268 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~----  330 (377)
T 3cbl_A          268 YAA-------------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK----  330 (377)
T ss_dssp             EEC-------------CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT----
T ss_pred             eee-------------cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----
Confidence            100             0011235778999999998899999999999999999998 9999977654332222111    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                     ......+..++..+.+|+..||+.||.+|||++++++.|+++.++
T Consensus       331 ---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          331 ---------------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                           001111223356789999999999999999999999999987543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=354.45  Aligned_cols=248  Identities=22%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....    .....+.+|+.+++.++|||||++++++.+.+..++||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKND--TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4567889999999999998755  67789999765432    23467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|..++.   ....+++..+..++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999998   456799999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ..                ....+||+.|+|||++.+   ..++.++|||||||++|+|++|..||...............
T Consensus       169 ~~----------------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~  232 (384)
T 4fr4_A          169 TQ----------------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF  232 (384)
T ss_dssp             CC----------------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred             Cc----------------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence            11                123569999999999964   46899999999999999999999999765543322222211


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-ATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~~  347 (368)
                      ...                 ...++...+..+.+||..||+.||.+||+ ++++++|
T Consensus       233 ~~~-----------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          233 ETT-----------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             HHC-----------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             hhc-----------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            111                 01122233568999999999999999999 7777764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.4e-48  Score=344.22  Aligned_cols=259  Identities=23%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .+|.+.+.||+|+||.||+|.+... .....+++|+....  ....+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            3456788999999999999987653 24567889976543  445677889999999999999999999985 5678999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999999743  34689999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ....              ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..............  
T Consensus       169 ~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~--  232 (281)
T 1mp8_A          169 STYY--------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--  232 (281)
T ss_dssp             ------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--
T ss_pred             cccc--------------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc--
Confidence            2211              1122347889999999999999999999999999999997 9999977654332221111  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                   ....    ..+...+..+.+++..||+.||.+|||+.+++++|++++++
T Consensus       233 -------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          233 -------------GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             -------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                         0001    11223456889999999999999999999999999998765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.6e-47  Score=344.74  Aligned_cols=261  Identities=21%  Similarity=0.293  Sum_probs=208.5

Q ss_pred             cccCHHHHHHHHHH------------hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCC
Q 017627           47 KKYSWDDVERFTQN------------FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLS  113 (368)
Q Consensus        47 ~~~~~~~~~~~~~~------------~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~  113 (368)
                      ..++.+++...+..            ..+.||+|+||.||+|....  ++..+|+|+.... ....+.+.+|+.+++.++
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~--~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH--SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC--CCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            34667776665532            34579999999999998754  5678999976543 334567889999999999


Q ss_pred             CCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCee
Q 017627          114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       114 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil  193 (368)
                      ||||+++++++...+..++||||+.+++|.+++..    ..+++..+..++.|++.||.|||++   +|+||||||+|||
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            99999999999999999999999999999999863    4689999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCC
Q 017627          194 LEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM  273 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  273 (368)
                      ++.++.+||+|||++.........               .....||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~  238 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVPK---------------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE  238 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSCC---------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCcEEEeeeeeeeecccCccc---------------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999998754332110               12346999999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      .||..............               ...+...  .....+..+.+++..||+.||.+|||+.++++|.
T Consensus       239 ~pf~~~~~~~~~~~~~~---------------~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          239 PPYFSDSPVQAMKRLRD---------------SPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             CTTTTSCHHHHHHHHHH---------------SSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCCCCCHHHHHHHHhc---------------CCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            99976654322211111               0001110  1112345789999999999999999999999873

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-48  Score=355.97  Aligned_cols=246  Identities=23%  Similarity=0.336  Sum_probs=201.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|++..  ++..+|+|+....    ......+..|..++..+ +||||+++++++.+.+..++|
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            4467889999999999999765  6788999987543    22345677899999877 899999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+|+|.+++..   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus        97 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            999999999999973   45689999999999999999999999   999999999999999999999999999974321


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ..               ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..   
T Consensus       171 ~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---  232 (345)
T 1xjd_A          171 GD---------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM---  232 (345)
T ss_dssp             TT---------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred             CC---------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh---
Confidence            11               011235799999999999999999999999999999999999999987654333222111   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT-QILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~  347 (368)
                      .             .+.    ++...+..+.+||..||+.||.+||++. ++++|
T Consensus       233 ~-------------~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 D-------------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             C-------------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             C-------------CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            0             011    1122356889999999999999999997 77765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.5e-47  Score=340.41  Aligned_cols=276  Identities=14%  Similarity=0.157  Sum_probs=215.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+..... ..+.+.+|+.+++.+ +|+|++++++++.+....++||||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEEEeecCCEEEEEEEECC--CCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            34567889999999999998654  67889999875443 234577899999999 799999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc-----eEEeeccccccC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN-----CKLCDFGSAKMG  211 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~-----vkl~Dfg~s~~~  211 (368)
                      + +++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.     +||+|||+++..
T Consensus        88 ~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           88 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            9 99999999753  34699999999999999999999999   9999999999999987766     999999999865


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .........        .........||+.|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus       162 ~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (298)
T 1csn_A          162 RDPVTKQHI--------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  233 (298)
T ss_dssp             BCTTTCCBC--------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ccccccccc--------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence            443221110        011123356999999999999999999999999999999999999999875433222222211


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                      ......   ......     .    ...+..+.+++..||+.||.+|||+.+|++.|+++..+.....+.+
T Consensus       234 ~~~~~~---~~~~~~-----~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~  292 (298)
T 1csn_A          234 GEKKQS---TPLREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN  292 (298)
T ss_dssp             HHHHHH---SCHHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSC
T ss_pred             HhhccC---ccHHHH-----H----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCc
Confidence            111000   111111     0    1224578999999999999999999999999999998876655443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.4e-48  Score=351.67  Aligned_cols=251  Identities=25%  Similarity=0.293  Sum_probs=199.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeeEEecCCCEEEEEEEECC--CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            4567889999999999998755  67789999875442  2346688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999987   455699999999999999999999999   999999999999999999999999999975322111


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                   ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||..............     
T Consensus       161 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----  222 (323)
T 3tki_A          161 -------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----  222 (323)
T ss_dssp             -------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-----
T ss_pred             -------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----
Confidence                         001123469999999999988765 7789999999999999999999976554211110000     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ............+..+.+|+..||+.||.+|||+.++++|
T Consensus       223 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          223 ------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------------cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                        0000000112234578899999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.7e-48  Score=340.38  Aligned_cols=250  Identities=29%  Similarity=0.439  Sum_probs=192.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|.+.    +..+++|+.....     ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             eeeeeeeccCCCeEEEEEEEc----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            446788999999999999863    5678898765432     2346788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC--------CCceEEeec
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE--------HLNCKLCDF  205 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~--------~~~vkl~Df  205 (368)
                      |||+.+++|.+++.    ...+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999985    346899999999999999999999991112999999999999986        778999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |+++.......                 ....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus       161 g~~~~~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  223 (271)
T 3dtc_A          161 GLAREWHRTTK-----------------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA  223 (271)
T ss_dssp             CC------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             Ccccccccccc-----------------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99974322111                 1245899999999999999999999999999999999999999765543221


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      ...                  .........+...+..+.+++..||+.||.+|||+.+++++|+++
T Consensus       224 ~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 YGV------------------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHH------------------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             Hhh------------------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111                  001111112233456899999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-47  Score=352.64  Aligned_cols=282  Identities=16%  Similarity=0.194  Sum_probs=210.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCC---CceeEEEEeecCChhHH------------HHHHHHHHHHhcCCCCceeeeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDS---TSTNGAIKIHVGSDRLS------------QVFKQELDILLHLSHDNIVKLIG  122 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~---~~~~~aik~~~~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~  122 (368)
                      .|.+.+.||+|+||.||+|.+..+.   ....+|+|+........            ..+..|+..+..++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            3456788999999999999876532   35788999866543210            12334666777888999999999


Q ss_pred             EEecC----CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec--C
Q 017627          123 YCDDR----DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE--E  196 (368)
Q Consensus       123 ~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~  196 (368)
                      ++...    ...++||||+ +++|.+++..  ....+++..++.++.||+.||.|||++   +|+||||||+|||++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence            98764    4589999999 9999999975  346799999999999999999999999   999999999999999  8


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF  276 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  276 (368)
                      ++.+||+|||+++...........        .........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAY--------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCS--------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             CCeEEEEECCcceecccCCccccc--------ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            899999999999865433221110        001112346999999999999999999999999999999999999999


Q ss_pred             CCCcch-hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          277 CPENGQ-LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       277 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      .+.... ...........       ..+....++.+..   ...+..+.+++..||+.||.+|||+.+|++.|++++.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          262 EDNLKDPKYVRDSKIRYR-------ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             GGGTTCHHHHHHHHHHHH-------HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccccCHHHHHHHHHHhh-------hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            753322 11111111111       1122222222211   122457899999999999999999999999999999887


Q ss_pred             ccccCCCC
Q 017627          356 SFLFSPQK  363 (368)
Q Consensus       356 ~~~~~~~~  363 (368)
                      ....+...
T Consensus       332 ~~~~~~~~  339 (364)
T 3op5_A          332 GSKDDGKL  339 (364)
T ss_dssp             TCCCCCCC
T ss_pred             CCCcCCcc
Confidence            76665444

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.7e-48  Score=356.33  Aligned_cols=262  Identities=22%  Similarity=0.326  Sum_probs=200.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .+.+.+.||+|+||.||+|++.. ......+|+|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT  125 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence            34567889999999999998652 235677999987543  445677899999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+++++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       126 e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          126 EYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             ECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999975  345689999999999999999999999   9999999999999999999999999999754332


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...            ........+++.|+|||++.+..++.++||||||+++|||++ |..||...............  
T Consensus       201 ~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~--  266 (373)
T 2qol_A          201 PEA------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG--  266 (373)
T ss_dssp             -------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT--
T ss_pred             Ccc------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--
Confidence            110            001112246788999999999999999999999999999998 99999766543322211110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                                       .....+..++..+.+++..||+.||.+|||+.++++.|++++...
T Consensus       267 -----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          267 -----------------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             -----------------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             -----------------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                             001112234567999999999999999999999999999987653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-47  Score=347.21  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=211.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .|.+.+.||+|+||.||+|.+..   ......+++|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  103 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL  103 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence            34567889999999999998743   235578999987643  3455778899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCC
Q 017627          133 LFEYVPNGTLQEKLHGTPR---------------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN  191 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N  191 (368)
                      ||||+.+++|.+++.....                     ...+++..++.++.|++.||.|||++   +|+||||||+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N  180 (314)
T 2ivs_A          104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN  180 (314)
T ss_dssp             EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence            9999999999999975422                     13488999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh
Q 017627          192 ILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT  271 (368)
Q Consensus       192 ilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  271 (368)
                      ||++.++.+||+|||+++........             .......+|+.|+|||++.+..++.++||||||+++|+|++
T Consensus       181 Ili~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          181 ILVAEGRKMKISDFGLSRDVYEEDSY-------------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             EEEETTTEEEECCCTTCEECTTTSCE-------------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCCCEEEccccccccccccccc-------------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence            99999999999999999754332211             01122347889999999999899999999999999999999


Q ss_pred             -CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          272 -GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       272 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                       |..||.+.............                   .....+...+..+.+++..||+.||.+|||+.+++++|++
T Consensus       248 ~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          248 LGGNPYPGIPPERLFNLLKTG-------------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             TSCCSSTTCCGGGHHHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHhhcC-------------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             99999776544332221110                   0111122345689999999999999999999999999999


Q ss_pred             cccc
Q 017627          351 QISS  354 (368)
Q Consensus       351 ~~~~  354 (368)
                      ++.+
T Consensus       309 ~~~~  312 (314)
T 2ivs_A          309 MMVK  312 (314)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            8764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.8e-48  Score=357.44  Aligned_cols=253  Identities=23%  Similarity=0.353  Sum_probs=198.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||+||+|+...  ++..+|+|+....    ....+.+.+|..++..+ +|||||++++++.+.+..++|
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~--~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKK--TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            4567899999999999999765  6788999986543    22334577899999887 899999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+|+|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+....
T Consensus       132 ~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999987   345799999999999999999999999   999999999999999999999999999974221


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS--LAGSM  291 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~  291 (368)
                      ..               ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........  .....
T Consensus       206 ~~---------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~  270 (396)
T 4dc2_A          206 PG---------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL  270 (396)
T ss_dssp             TT---------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred             CC---------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence            11               11133579999999999999999999999999999999999999996543211000  00000


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA------TQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~  347 (368)
                      .           ..+....  ..++...+..+.+||..||+.||.+||++      +++++|
T Consensus       271 ~-----------~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          271 F-----------QVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             H-----------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             H-----------HHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            0           0000000  01222345688999999999999999995      677776

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-48  Score=351.63  Aligned_cols=264  Identities=24%  Similarity=0.374  Sum_probs=211.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .|.+.+.||+|+||.||+|.+.+.   .+...+|+|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  127 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL  127 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence            445678899999999999997642   34588999987653  3456778999999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCC
Q 017627          133 LFEYVPNGTLQEKLHGTPR---------------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN  191 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N  191 (368)
                      ||||+.+++|.+++.....                     ...+++..++.++.||+.||.|||++   +|+||||||+|
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N  204 (343)
T 1luf_A          128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  204 (343)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence            9999999999999875321                     25789999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh
Q 017627          192 ILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT  271 (368)
Q Consensus       192 ilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  271 (368)
                      ||++.++.+||+|||+++.........             ......||+.|+|||++.+..++.++||||||+++|+|++
T Consensus       205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          205 CLVGENMVVKIADFGLSRNIYSADYYK-------------ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC-----------------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             EEECCCCeEEEeecCCCcccccCcccc-------------ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence            999999999999999997543222110             1122458899999999999999999999999999999999


Q ss_pred             -CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          272 -GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       272 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                       |..||..............          ..     .+    ..+...+..+.+++..||+.||.+|||+.+++++|++
T Consensus       272 ~g~~p~~~~~~~~~~~~~~~----------~~-----~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~  332 (343)
T 1luf_A          272 YGLQPYYGMAHEEVIYYVRD----------GN-----IL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  332 (343)
T ss_dssp             TTCCTTTTSCHHHHHHHHHT----------TC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCcCCCCChHHHHHHHhC----------CC-----cC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence             9999976654332211111          00     00    1122334579999999999999999999999999999


Q ss_pred             cccccc
Q 017627          351 QISSIS  356 (368)
Q Consensus       351 ~~~~~~  356 (368)
                      +..+..
T Consensus       333 ~~~~~~  338 (343)
T 1luf_A          333 MCERAE  338 (343)
T ss_dssp             TTC---
T ss_pred             HHhhhh
Confidence            987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.8e-48  Score=350.73  Aligned_cols=275  Identities=23%  Similarity=0.304  Sum_probs=206.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC----eeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD----EGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|++.    +..+|+|+.............|+.+++.++||||+++++++.+..    ..++||
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL----NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET----TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             chhhheecccCceEEEEEEEC----CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            457789999999999999863    578999988776666666778999999999999999999998754    369999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC-------TLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      ||+.+++|.+++..    ..+++..++.++.|++.||.|||+.+       ..+|+||||||+|||++.++.+||+|||+
T Consensus       102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            99999999999974    34899999999999999999999751       22799999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-----MASTKTDVYSFGVILLELVTGMEAFCPENGQ  282 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~  282 (368)
                      ++.........             ......||+.|+|||++.+.     .++.++|||||||++|+|++|..||.+....
T Consensus       178 a~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          178 ALKFEAGKSAG-------------DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CEEECTTSCCC-------------CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             ccccccccCcc-------------ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            97644322111             01124599999999999873     4566889999999999999999999765432


Q ss_pred             hhHHHHHhhhhh--hhhhhhcchhhhcCCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          283 LLTSLAGSMLND--IADCEATKVNELVDPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       283 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      ....+.......  ..............+.+...+ ....+..+.+||..||+.||.+|||+.++++.|+++.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            211111110000  000000001111111111111 224567799999999999999999999999999987654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.2e-48  Score=351.53  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=199.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYK--TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4567889999999999999755  6778999976542    122357889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+ +|+|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 778988886   345699999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ..                ....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........        
T Consensus       162 ~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------  217 (336)
T 3h4j_B          162 NF----------------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------  217 (336)
T ss_dssp             BT----------------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------
T ss_pred             cc----------------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------
Confidence            21                122469999999999988776 68999999999999999999999765432111        


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                ......  ....+...+..+.+||..||+.||.+|||++++++|-
T Consensus       218 ----------~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          218 ----------KKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             ----------CCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             ----------HHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence                      000000  0112223456789999999999999999999999873

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-48  Score=345.36  Aligned_cols=247  Identities=29%  Similarity=0.330  Sum_probs=193.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh---------------------------HHHHHHHHHHHHhc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---------------------------LSQVFKQELDILLH  111 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~---------------------------~~~~~~~E~~~l~~  111 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+......                           ..+.+.+|+.+++.
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNEN--DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETT--TTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             eEEEeEEeecCCEEEEEEEECC--CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            4567889999999999998755  678899998754421                           13467899999999


Q ss_pred             CCCCceeeeeEEEec--CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCC
Q 017627          112 LSHDNIVKLIGYCDD--RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKA  189 (368)
Q Consensus       112 l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp  189 (368)
                      ++||||+++++++.+  .+..++||||+.+++|.+++.    ...+++..++.++.|++.||.|||++   +|+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence            999999999999986  568899999999999987653    45799999999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC---CCcchhhHHHHHHH
Q 017627          190 SNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM---ASTKTDVYSFGVIL  266 (368)
Q Consensus       190 ~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il  266 (368)
                      +|||++.++.+||+|||+++.......               ......||+.|+|||++.+..   ++.++|||||||++
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l  230 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA---------------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL  230 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC---------------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred             HHEEECCCCCEEEecCCCccccccccc---------------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence            999999999999999999975432211               012246999999999998765   37789999999999


Q ss_pred             HHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017627          267 LELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH  346 (368)
Q Consensus       267 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  346 (368)
                      |+|++|..||...............          .    ...    ......+..+.+||.+||+.||.+|||+.++++
T Consensus       231 ~~l~~g~~pf~~~~~~~~~~~~~~~----------~----~~~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          231 YCFVFGQCPFMDERIMCLHSKIKSQ----------A----LEF----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHC----------C----CCC----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHCCCCCCCccHHHHHHHHhcc----------c----CCC----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9999999999765543222111110          0    000    001123457899999999999999999999987


Q ss_pred             H
Q 017627          347 T  347 (368)
Q Consensus       347 ~  347 (368)
                      |
T Consensus       293 h  293 (298)
T 2zv2_A          293 H  293 (298)
T ss_dssp             C
T ss_pred             C
Confidence            6

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=353.35  Aligned_cols=251  Identities=21%  Similarity=0.243  Sum_probs=204.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEEEEEecCCCEEEEEEEECC--CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            35677899999999999998755  6678899977654 33456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec--CCCceEEeeccccccCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE--EHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~~~~vkl~Dfg~s~~~~~~  214 (368)
                      +.+++|.+++..  ....+++..++.++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999874  234689999999999999999999999   999999999999997  4577999999999754321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+............  
T Consensus       205 ~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~--  266 (387)
T 1kob_A          205 E----------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--  266 (387)
T ss_dssp             S----------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--
T ss_pred             c----------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--
Confidence            1                1123469999999999999999999999999999999999999998765432222111100  


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                    ...........+..+.+||..||+.||.+|||+.++++|
T Consensus       267 --------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          267 --------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             --------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                          000111112335689999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.2e-48  Score=350.30  Aligned_cols=259  Identities=19%  Similarity=0.254  Sum_probs=202.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCC--ceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDST--STNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .|.+.+.||+|+||.||+|.+..++.  ...+++|.....  ....+.+.+|+.+++.++||||+++++++.+. ..++|
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v   94 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   94 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEE
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEE
Confidence            34567889999999999999755322  334677765432  34457788999999999999999999999875 47899


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ++++.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           95 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            9999999999998753  45689999999999999999999999   999999999999999999999999999986433


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....             ......||+.|+|||++.+..++.++||||||+++|+|++ |..||............... 
T Consensus       170 ~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-  235 (327)
T 3poz_A          170 EEKEY-------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-  235 (327)
T ss_dssp             TCC--------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred             Ccccc-------------cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-
Confidence            22110             1122347889999999999999999999999999999999 99999876544332222110 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                        .....+..++..+.+++..||+.||.+|||+.+++++|+++...
T Consensus       236 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          236 ------------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ------------------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ------------------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                              11111223455789999999999999999999999999988764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.4e-48  Score=366.79  Aligned_cols=263  Identities=23%  Similarity=0.375  Sum_probs=212.8

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ...+.+.+.||+|+||.||+|.+.+   ...+|+|+........+.+.+|+.+++.++|||||++++++. .+..++|||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT---TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECC---ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3445577899999999999998743   566899988766666788999999999999999999999986 567899999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+|+|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999999743 223688999999999999999999999   99999999999999999999999999998543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .              .......+++.|+|||++.+..++.++||||||+++|||++ |..||.+.........+...   
T Consensus       339 ~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---  401 (454)
T 1qcf_A          339 Y--------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---  401 (454)
T ss_dssp             H--------------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---
T ss_pred             e--------------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence            1              01112346788999999999999999999999999999999 99999876543322221110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                                      .....+..++..+.+||..||+.||.+|||+++|++.|+.+..+....+
T Consensus       402 ----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~  450 (454)
T 1qcf_A          402 ----------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY  450 (454)
T ss_dssp             ----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSS
T ss_pred             ----------------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccc
Confidence                            0011122345689999999999999999999999999999988765443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-47  Score=349.67  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|++..  ++..+|+|+....    ....+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            3467889999999999999755  6788999987542    34456788999999988 899999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|..++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999987   345699999999999999999999999   999999999999999999999999999974221


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS--LAGSM  291 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~  291 (368)
                      ..               ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........  .....
T Consensus       163 ~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  227 (345)
T 3a8x_A          163 PG---------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL  227 (345)
T ss_dssp             TT---------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred             CC---------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence            11               01123579999999999999999999999999999999999999996532211000  00000


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA------TQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~  347 (368)
                      ..           .+....  ..++...+..+.+||..||+.||.+||++      +++++|
T Consensus       228 ~~-----------~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          228 FQ-----------VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HH-----------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HH-----------HHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            00           000000  01122345688999999999999999996      677776

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.9e-48  Score=352.03  Aligned_cols=246  Identities=21%  Similarity=0.292  Sum_probs=201.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|+...  ++..+|+|+.....    ...+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            4567889999999999998754  67889999875432    2345677899999988 799999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+|+|.+++..   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus       100 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999973   35699999999999999999999999   999999999999999999999999999974221


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ..               ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..   
T Consensus       174 ~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---  235 (353)
T 2i0e_A          174 DG---------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---  235 (353)
T ss_dssp             TT---------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred             CC---------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh---
Confidence            11               011235699999999999999999999999999999999999999987654332221111   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                      .             ..    .++...+..+.+||..||+.||.+||+     ++++++|
T Consensus       236 ~-------------~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          236 H-------------NV----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             C-------------CC----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             C-------------CC----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0             00    112234568999999999999999995     6888877

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-47  Score=346.18  Aligned_cols=265  Identities=23%  Similarity=0.232  Sum_probs=200.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||+||+|.+.   .+..+|+|+....   ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             hHhhhhccCCCCeEEEEEEEC---CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            456788999999999999873   3677899876543   2334678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+ +|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9964 78777764  345689999999999999999999999   99999999999999999999999999997543211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       174 ~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  238 (311)
T 3niz_A          174 R---------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT  238 (311)
T ss_dssp             C------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred             c---------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence            1               0122458999999999976 56899999999999999999999999876655444333332222


Q ss_pred             hhhhhhcchhh---hcCCCC--CCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNE---LVDPRL--AGDF-----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~---~~~~~~--~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..........+   ..+...  ....     ....+.++.+||..||+.||.+|||++++++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11111111000   000000  0000     11224578999999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.2e-48  Score=350.12  Aligned_cols=264  Identities=19%  Similarity=0.309  Sum_probs=197.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCC-ceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCee---
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDST-STNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG---  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~-~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---  130 (368)
                      .|.+.+.||+|+||.||+|.+..... ...+|+|+....   ....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            45678899999999999998654322 237899977543   34567788999999999999999999999877655   


Q ss_pred             ---EEEEecccCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          131 ---VLLFEYVPNGTLQEKLHGTP---RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       131 ---~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                         ++||||+.+++|.+++....   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence               99999999999999886432   223689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+++.........             ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus       181 fg~a~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~  247 (323)
T 3qup_A          181 FGLSRKIYSGDYYR-------------QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE  247 (323)
T ss_dssp             CCC------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             cccccccccccccc-------------ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence            99997543322111             1122347889999999999999999999999999999999 999998765443


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      ........                   .....+...+..+.+|+..||+.||.+|||+.++++.|++++....
T Consensus       248 ~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          248 IYNYLIGG-------------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHHHHTT-------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHhcC-------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            32211110                   0011122334679999999999999999999999999999987653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=344.20  Aligned_cols=271  Identities=23%  Similarity=0.265  Sum_probs=201.2

Q ss_pred             HHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC------hhHHHHHHHHHHHHhcCC---CCceeeeeEEE
Q 017627           54 VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS------DRLSQVFKQELDILLHLS---HDNIVKLIGYC  124 (368)
Q Consensus        54 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~------~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~  124 (368)
                      +...+|.+.+.||+|+||+||+|.+..  ++..+|+|+....      ......+.+|+.+++.++   ||||+++++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH--SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT--TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            344566788899999999999998644  6788999976522      122345667888877774   99999999999


Q ss_pred             ecCC-----eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc
Q 017627          125 DDRD-----EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN  199 (368)
Q Consensus       125 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~  199 (368)
                      ....     ..++|||++. ++|.+++... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             EECCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             eccCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            7755     4799999995 6999999854 234599999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 017627          200 CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPE  279 (368)
Q Consensus       200 vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  279 (368)
                      +||+|||+++.......                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       159 ~kl~Dfg~a~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          159 VKLADFGLARIYSYQMA----------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             EEECSCSCTTTSTTCCC----------------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             EEEeeCccccccCCCcc----------------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999975322111                12346899999999999999999999999999999999999999877


Q ss_pred             cchhhHHHHHhhhhhhhhhhhcchhh----hcCCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          280 NGQLLTSLAGSMLNDIADCEATKVNE----LVDPRLAGD---FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +.......+...........+.....    ...+.....   .....+..+.+||..||+.||.+|||+.++++|
T Consensus       223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          223 SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            65444333322222111111000000    000000000   001234688999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-47  Score=346.64  Aligned_cols=264  Identities=24%  Similarity=0.345  Sum_probs=212.3

Q ss_pred             HHHhhhhcccccceEEEEEEEc---CCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLI---NDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      .|.+.+.||+|+||.||+|.+.   +..+...+++|+.....  ...+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  103 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence            4557789999999999999863   34467889999876542  3457788999999999 8999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          132 LLFEYVPNGTLQEKLHGTPR---------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      +||||+.+++|.+++.....               ...+++..++.++.|++.||.|||++   +|+||||||+||+++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH  180 (313)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence            99999999999999875421               12589999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEA  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  275 (368)
                      ++.+||+|||+++........             .......||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNY-------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTS-------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             CCCEEEccccccccccccccc-------------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999754332210             01122357889999999999999999999999999999999 9999


Q ss_pred             CCCCcchhh-HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          276 FCPENGQLL-TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       276 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      |........ ......               ....    ..+...+..+.+++..||+.||.+|||+.+++++|++++.+
T Consensus       248 ~~~~~~~~~~~~~~~~---------------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          248 YPGMPVDSKFYKMIKE---------------GFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             STTCCSSHHHHHHHHH---------------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCcccchhHHHHHhcc---------------CCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            976553221 111111               0011    11122346789999999999999999999999999999876


Q ss_pred             cc
Q 017627          355 IS  356 (368)
Q Consensus       355 ~~  356 (368)
                      ..
T Consensus       309 ~~  310 (313)
T 1t46_A          309 ST  310 (313)
T ss_dssp             TC
T ss_pred             hh
Confidence            54

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.8e-48  Score=365.19  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=210.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..+.+.+.||+|+||.||+|.+.+   ...+|+|+........+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hHceeeeeecCCCCeEEEEEEECC---CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            344567889999999999998754   3568999887655556788999999999999999999999976 678999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++... .+..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999642 234589999999999999999999999   999999999999999999999999999975432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                    .......+++.|+|||++.+..++.++||||||+++|||++ |..||.+............     
T Consensus       336 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-----  396 (452)
T 1fmk_A          336 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----  396 (452)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----
T ss_pred             --------------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----
Confidence                          01122347889999999999999999999999999999999 9999976654322211111     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                                    ......+..++..+.+||..||+.||.+|||++++++.|+.++.+....+.|+
T Consensus       397 --------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~  449 (452)
T 1fmk_A          397 --------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG  449 (452)
T ss_dssp             --------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred             --------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence                          01111222345689999999999999999999999999999998877666554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-47  Score=360.01  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=204.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+.....    .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHEL--TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETT--TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4567889999999999998754  67889999875432    23467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999997   456799999999999999999999999   9999999999999999999999999999864322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ..                ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..   
T Consensus       170 ~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---  230 (476)
T 2y94_A          170 EF----------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD---  230 (476)
T ss_dssp             CC----------------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT---
T ss_pred             cc----------------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc---
Confidence            11                123469999999999998765 6899999999999999999999987654433221111   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQI  352 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~  352 (368)
                      .               ..  ..+...+..+.+||..||+.||.+|||+.++++|  +.+..
T Consensus       231 ~---------------~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          231 G---------------IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             T---------------CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             C---------------Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            0               00  0111234578999999999999999999999986  44433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.8e-47  Score=344.06  Aligned_cols=265  Identities=23%  Similarity=0.300  Sum_probs=193.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKT--TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             -------------CEEEEEECSS--SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEECC--CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            34577889999999999998654  6778899976543  2334678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          136 YVPNGTLQEKLHGTP---RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |+. ++|.+++....   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            996 58988876421   224689999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ....               ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus       160 ~~~~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  224 (317)
T 2pmi_A          160 IPVN---------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI  224 (317)
T ss_dssp             SCCC---------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCcc---------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            2211               0122458999999999976 46899999999999999999999999887654444333322


Q ss_pred             hhhhhhhhhcchh------------------hhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVN------------------ELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .............                  +...+....    ..+..+.+||..||+.||.+|||+.++++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            2211111100000                  011111111    224579999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3e-47  Score=360.54  Aligned_cols=250  Identities=26%  Similarity=0.350  Sum_probs=204.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-eeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-EGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~  137 (368)
                      +.+.+.||+|+||.||+|.+.    +..+|+|+..... ..+.+.+|+.+++.++||||+++++++.+.. ..++||||+
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~~----~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEET----TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             eEEEeeecCcCCeeEEEEEec----CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            345678999999999999873    4589999877654 4577899999999999999999999987655 789999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++... ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            999999999853 233479999999999999999999999   99999999999999999999999999997432111  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                      ....+++.|+|||++.+..++.++||||||+++|||++ |..||..............      
T Consensus       344 ----------------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------  401 (450)
T 1k9a_A          344 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------  401 (450)
T ss_dssp             -------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT------
T ss_pred             ----------------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence                            11247889999999999999999999999999999998 9999977654332221111      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                   ......+..++..+.+||..||+.||.+|||+.++++.|+.+...
T Consensus       402 -------------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          402 -------------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                         011112233456899999999999999999999999999987643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-47  Score=341.05  Aligned_cols=265  Identities=26%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+.   ++..+|+|+.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             chhhhhcccCCCEEEEEEEcC---CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            456788999999999999862   46678888765432   234678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+ +|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9965 898888743  35689999999999999999999999   99999999999999999999999999997532211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..............
T Consensus       155 ~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  219 (288)
T 1ob3_A          155 R---------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT  219 (288)
T ss_dssp             ----------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             c---------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCC
Confidence            0               11224589999999999764 5899999999999999999999999876644333222222111


Q ss_pred             hhhhhhcchhh--hcCCCCC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNE--LVDPRLA-------GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~--~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+.....  ..++...       ..+....+..+.+||.+||+.||.+|||++++++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11100000000  0011100       01112235678999999999999999999999976

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=343.21  Aligned_cols=257  Identities=28%  Similarity=0.406  Sum_probs=198.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+.+.||+|+||.||+|.+.    ...+++|+.... ...+.+.+|+.+++.++||||+++++++.  +..++||||+.
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR----AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET----TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             eeeeeEeecCCCceEEEEEEC----CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            346788999999999999863    467899987654 34577889999999999999999999886  45899999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc-eEEeeccccccCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN-CKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~-vkl~Dfg~s~~~~~~~~~  217 (368)
                      +++|.+++........++...++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++.......  
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--  160 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--  160 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence            9999999986543345789999999999999999999922128999999999999998876 7999999986432111  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||..............       
T Consensus       161 ----------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------  217 (307)
T 2eva_A          161 ----------------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-------  217 (307)
T ss_dssp             --------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-------
T ss_pred             ----------------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-------
Confidence                            123589999999999999999999999999999999999999976443221111000       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                            .....+..    ....+..+.+++.+||+.||.+|||+++++++|+.+....+.
T Consensus       218 ------~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          218 ------HNGTRPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             ------HTTCCCCC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             ------hcCCCCCc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence                  00001111    122345789999999999999999999999999998765543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.9e-47  Score=336.79  Aligned_cols=249  Identities=19%  Similarity=0.302  Sum_probs=201.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|++.    +..+|+|+....   ....+.+.+|+.+++.++||||+++++++.+.  +..++|
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEET----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             hHHHHHhcCCCcceEEEEEEC----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            446788999999999999873    566888876543   34556789999999999999999999999877  778999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH--IVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      |||+.+++|.+++... ....+++..++.++.|++.||.|||++   +  |+||||||+||+++.++.++|+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999999854 234689999999999999999999998   8  999999999999999999999999887531


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAST---KTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ..                    ....||+.|+|||++.+..++.   ++||||||+++|+|++|..||............
T Consensus       164 ~~--------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  223 (271)
T 3kmu_A          164 QS--------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV  223 (271)
T ss_dssp             SC--------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred             cc--------------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence            11                    1135899999999998765544   799999999999999999999765543221111


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      .              ...    .....+...+..+.+++..||+.||.+|||++++++.|+++.+
T Consensus       224 ~--------------~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          224 A--------------LEG----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             H--------------HSC----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             H--------------hcC----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0              001    1111222345679999999999999999999999999998765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.3e-47  Score=338.78  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=199.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-----H---HHHHHHHHHHHhcCCCCceeeeeEEEecCCe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-----L---SQVFKQELDILLHLSHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-----~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  129 (368)
                      .|.+.+.||+|+||.||+|.+..  +...+|+|+......     .   .+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETT--TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             cceehhccccCCceeEEEEEEcC--CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            34567889999999999999755  677899997654321     1   167889999999999999999999996654 


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEecCCCCCeeecCCCc-----eEE
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH--IVHGDIKASNILLEEHLN-----CKL  202 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nilv~~~~~-----vkl  202 (368)
                       ++||||+.+++|.+++..  ....+++..++.++.|++.||.|||++   +  |+||||||+|||++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             799999999999988864  345799999999999999999999999   8  999999999999988776     999


Q ss_pred             eeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR--TGMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       203 ~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      +|||+++.....                  .....||+.|+|||++.  ...++.++||||||+++|+|++|..||....
T Consensus       171 ~Dfg~~~~~~~~------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          171 ADFGLSQQSVHS------------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             CCCTTCBCCSSC------------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCCCcccccccc------------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            999998732211                  12346999999999994  4567889999999999999999999997655


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      ..........                .........+...+..+.+++..||+.||.+|||++++++.|+++
T Consensus       233 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          233 YGKIKFINMI----------------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCHHHHHHHH----------------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ccHHHHHHHH----------------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            4322111100                001111122233456899999999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.1e-47  Score=353.55  Aligned_cols=276  Identities=19%  Similarity=0.213  Sum_probs=203.8

Q ss_pred             HHHhhhhcccc--cceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSG--GFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G--~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .|.+.+.||+|  +||.||+|.+..  ++..+|+|+....   ....+.+.+|+.+++.++|||||++++++.+.+..++
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcC--CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            35577899999  999999999765  6778899976543   4556778899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      |||||.+++|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998754 335699999999999999999999999   99999999999999999999999999986533


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH-HHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT-SLAG  289 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~  289 (368)
                      .........        ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.+..... ....
T Consensus       180 ~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          180 SHGQRQRVV--------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             ETTEECSCB--------CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             ccccccccc--------ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            221110000        000112368999999999987  57899999999999999999999999875543222 1111


Q ss_pred             hhhhhhhhhhhcchhh----------------hc---------CCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 017627          290 SMLNDIADCEATKVNE----------------LV---------DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQI  344 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~----------------~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i  344 (368)
                      .......+........                ..         .......+....+..+.+||.+||+.||.+|||++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            1111100000000000                00         0000011223345689999999999999999999999


Q ss_pred             HHH
Q 017627          345 LHT  347 (368)
Q Consensus       345 l~~  347 (368)
                      ++|
T Consensus       332 l~h  334 (389)
T 3gni_B          332 LNH  334 (389)
T ss_dssp             TTS
T ss_pred             hcC
Confidence            987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.5e-47  Score=346.80  Aligned_cols=265  Identities=28%  Similarity=0.427  Sum_probs=209.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..++....+++|.....  ....+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            4577899999999999999876544445688866542  33456688999999999 89999999999999999999999


Q ss_pred             cccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEE
Q 017627          136 YVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKL  202 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl  202 (368)
                      |+++++|.+++....             ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence            999999999997542             234789999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcc
Q 017627          203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENG  281 (368)
Q Consensus       203 ~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~  281 (368)
                      +|||+++......                ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus       184 ~Dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          184 ADFGLSRGQEVYV----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             CCTTCEESSCEEC----------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             cccCcCccccccc----------------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            9999987322111                1122347889999999998889999999999999999998 9999977654


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCC
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSP  361 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~  361 (368)
                      .........               .    .....+...+..+.+|+..||+.||.+|||+.+++++|++++.+.....+.
T Consensus       248 ~~~~~~~~~---------------~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  308 (327)
T 1fvr_A          248 AELYEKLPQ---------------G----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT  308 (327)
T ss_dssp             HHHHHHGGG---------------T----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred             HHHHHHhhc---------------C----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcccc
Confidence            322211110               0    011112233567999999999999999999999999999998766554443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-47  Score=344.68  Aligned_cols=275  Identities=24%  Similarity=0.336  Sum_probs=206.9

Q ss_pred             HHHhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  131 (368)
                      .|.+.+.||+|+||.||+|.+.  +..++..+|+|+.....  ...+.+.+|+.+++.++||||+++++++.+.  +..+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            4557789999999999999853  33477889999876432  3446788999999999999999999999876  6689


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+.+++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       102 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence            99999999999999954  235689999999999999999999999   9999999999999999999999999999764


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ......            ........||..|+|||++.+..++.++||||||+++|+|++|..|+........ ....  
T Consensus       177 ~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~--  241 (302)
T 4e5w_A          177 ETDKEY------------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL-KMIG--  241 (302)
T ss_dssp             CTTCCE------------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHC--
T ss_pred             cCCCcc------------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh-hccC--
Confidence            332210            0111223588889999999999999999999999999999999998743221100 0000  


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                       ..........+............+...+..+.+|+..||+.||.+|||+.++++.|+++++
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          242 -PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             -SCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -CcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence             0000000011111111111222333445689999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-47  Score=342.76  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=210.4

Q ss_pred             HHhhh-hcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQ-VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~-~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+ .||+|+||.||+|.+........+++|+....   ....+.+.+|+.+++.++||||+++++++ ..+..++||
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            33555 89999999999998766667888999987654   33467789999999999999999999999 567789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..   ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        97 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           97 EMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             ECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            99999999999984   45689999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...            ........|++.|+|||++.+..++.++||||||+++|+|++ |..||...............  
T Consensus       171 ~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--  236 (291)
T 1xbb_A          171 ENY------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--  236 (291)
T ss_dssp             CSE------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--
T ss_pred             CCc------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--
Confidence            210            011122346789999999998889999999999999999999 99999876543322221110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                                   .    ....+...+..+.+++..||+.||.+|||+.++++.|++++.+....=
T Consensus       237 -------------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  285 (291)
T 1xbb_A          237 -------------E----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  285 (291)
T ss_dssp             -------------C----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             -------------C----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence                         0    011122345689999999999999999999999999999988765443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-47  Score=348.37  Aligned_cols=261  Identities=21%  Similarity=0.240  Sum_probs=196.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-------  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------  128 (368)
                      .|.+.+.||+|+||.||+|++..  ++..+|+|+...  .....+.+.+|+.+++.++||||+++++++.+.+       
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKV--DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETT--TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcC--CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            34567899999999999999754  667899997653  3445678899999999999999999999986543       


Q ss_pred             --------------------------------------------------eeEEEEecccCCCHHHHhcCCCCCCCCCHH
Q 017627          129 --------------------------------------------------EGVLLFEYVPNGTLQEKLHGTPRSSKLPWR  158 (368)
Q Consensus       129 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  158 (368)
                                                                        ..++|||||.+++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              379999999999999999876555566777


Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeec
Q 017627          159 NRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG  238 (368)
Q Consensus       159 ~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (368)
                      .++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.............   ............|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~---~~~~~~~~~~~~g  238 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT---PMPAYATHTGQVG  238 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------------CCCSCC-
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc---cccccccccccCC
Confidence            8999999999999999999   999999999999999999999999999986544321111000   0000111233569


Q ss_pred             CCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHH
Q 017627          239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLD  318 (368)
Q Consensus       239 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (368)
                      |+.|+|||++.+..++.++||||||+++|+|++|..|+....     ......               .... .......
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~~---------------~~~~-~~~~~~~  297 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITDV---------------RNLK-FPLLFTQ  297 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHHH---------------HTTC-CCHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHHh---------------hccC-CCccccc
Confidence            999999999999999999999999999999999877652110     000000               0000 0001123


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          319 EARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       319 ~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .+..+.+|+..||+.||.+|||++++++|
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            34678899999999999999999999976

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.3e-48  Score=349.61  Aligned_cols=260  Identities=20%  Similarity=0.260  Sum_probs=202.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCC--ceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDST--STNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..++.  ...+++|+....  ....+.+.+|+.+++.++||||+++++++. .+..++||
T Consensus        15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~   93 (325)
T 3kex_A           15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT   93 (325)
T ss_dssp             EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred             ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence            3467889999999999999765332  234677765433  223345678999999999999999999986 46789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           94 QYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             ECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            999999999999753  35688999999999999999999999   9999999999999999999999999999864332


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....             ......||+.|+|||++.+..++.++||||||+++|+|++ |..||................ 
T Consensus       169 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  234 (325)
T 3kex_A          169 DKQL-------------LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-  234 (325)
T ss_dssp             TTCC-------------C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-
T ss_pred             cccc-------------cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-
Confidence            2110             1123458889999999999999999999999999999999 999998765443332221100 


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                        ....+..++..+.+++..||+.||.+|||+.+++++|+++.....
T Consensus       235 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          235 ------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             ------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             ------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                              000111123367889999999999999999999999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3e-47  Score=361.30  Aligned_cols=263  Identities=21%  Similarity=0.185  Sum_probs=197.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------C
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------D  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  128 (368)
                      +|.+.+.||+|+||+||+|.+..  ++..+|+|+...   .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CeEEEEEeecCCCeEEEEEEECC--CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35567889999999999998755  678899998754   344567788999999999999999999999654      3


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++||||+.+ +|...+..     .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            57999999965 56666642     388999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      +......                .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus       212 ~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i  275 (464)
T 3ttj_A          212 RTAGTSF----------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  275 (464)
T ss_dssp             -----CC----------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eecCCCc----------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7543221                112357999999999999999999999999999999999999999887654433333


Q ss_pred             Hhhhhhhhhhhhc----chhhhcC---------------CCCCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017627          289 GSMLNDIADCEAT----KVNELVD---------------PRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQILH  346 (368)
Q Consensus       289 ~~~~~~~~~~~~~----~~~~~~~---------------~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~  346 (368)
                      ...+.........    .......               .......   ....+.++.+||.+||+.||.+|||++++|+
T Consensus       276 ~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2222211110000    0001111               0000000   1122678999999999999999999999999


Q ss_pred             H
Q 017627          347 T  347 (368)
Q Consensus       347 ~  347 (368)
                      |
T Consensus       356 H  356 (464)
T 3ttj_A          356 H  356 (464)
T ss_dssp             S
T ss_pred             C
Confidence            8

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=349.36  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=189.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|.+.+.||+|+||.||+|.+..  +...+|+|+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKG--TQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECC--CCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            35567889999999999999755  56789999876543 3466888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeeccccccCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~~~~~  214 (368)
                      .+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       131 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          131 TGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             CCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            9999999997   445689999999999999999999999   9999999999999975   889999999998753221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........  .......
T Consensus       205 ~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~i~~~  266 (349)
T 2w4o_A          205 VL----------------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--FRRILNC  266 (349)
T ss_dssp             ------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--HHHHHTT
T ss_pred             cc----------------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--HHHHHhC
Confidence            11                12346999999999999999999999999999999999999999765543211  1111000


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             .      ...........+..+.+||..||+.||.+|||+.++++|
T Consensus       267 -------~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          267 -------E------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -------C------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------C------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0      000111112345688999999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.3e-47  Score=345.88  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC-----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      .|.+.+.||+|+||.||+|+... ..++..+|+|+....     ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            34577899999999999998742 246788999987653     223456778999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+.+++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           98 LILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999997   345689999999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .....               .....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.. 
T Consensus       172 ~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-  235 (327)
T 3a62_A          172 IHDGT---------------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-  235 (327)
T ss_dssp             ----------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-
T ss_pred             ccCCc---------------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-
Confidence            22110               01224699999999999999999999999999999999999999987654322211111 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                        .             ..    .++...+..+.+||..||+.||.+||     ++.++++|
T Consensus       236 --~-------------~~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          236 --C-------------KL----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             --T-------------CC----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             --C-------------CC----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence              0             00    11122346789999999999999999     88899887

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-47  Score=358.29  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=201.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh----HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR----LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.++||+|+||+||+|++..  ++..+|+|+......    ....+.+|+.++..++||||+++++++.+.+..++||
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEcC--CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            3456789999999999999765  678899998754221    1233788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||.+|+|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       154 Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             CCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            999999999999742  45799999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ..              ......+||+.|+|||++.     ...++.++|||||||++|||++|..||.+.+.......+.
T Consensus       229 ~~--------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  294 (437)
T 4aw2_A          229 GT--------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  294 (437)
T ss_dssp             SC--------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CC--------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence            11              0112346999999999997     4578999999999999999999999998766443332221


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL--RPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~  347 (368)
                      .....           ..-+...    ...+.++.+||..||..+|.+  ||+++++++|
T Consensus       295 ~~~~~-----------~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NHKER-----------FQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             THHHH-----------CCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hcccc-----------ccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            10000           0001110    123557899999999988888  9999999988

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=337.91  Aligned_cols=263  Identities=24%  Similarity=0.312  Sum_probs=206.6

Q ss_pred             hhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCee-EEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG-VLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~  136 (368)
                      ..+.||+|+||.||+|.+.+. .....+++|+....  ....+.+.+|+.+++.++||||+++++++.+.+.. ++||||
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            457899999999999987543 24456888876543  34557788999999999999999999999876655 999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       105 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          105 MCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             ccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            999999999975  345689999999999999999999999   999999999999999999999999999975433221


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM-EAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      ...           .......+|+.|+|||.+.+..++.++||||||+++|+|++|. +||...+...........    
T Consensus       180 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~----  244 (298)
T 3pls_A          180 YSV-----------QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG----  244 (298)
T ss_dssp             GCS-----------CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT----
T ss_pred             ccc-----------ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC----
Confidence            111           1112235789999999999999999999999999999999955 445444333222111110    


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL  358 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~  358 (368)
                                     .....+...+..+.+++..||+.||.+|||+.++++.|++++.++...
T Consensus       245 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          245 ---------------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             ---------------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence                           001112223457999999999999999999999999999998876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-47  Score=362.86  Aligned_cols=246  Identities=22%  Similarity=0.319  Sum_probs=194.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cEEeEEEeeCcCEEEEEEEEcC--CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            4567889999999999998755  6788999987532    233456778999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||+.+++|..++.   ....+++..+..++.||+.||.|||+ +   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       228 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          228 EYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             CCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             eeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999987   34578999999999999999999998 8   999999999999999999999999999974222


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...  
T Consensus       302 ~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--  364 (446)
T 4ejn_A          302 DGA---------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--  364 (446)
T ss_dssp             --------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--
T ss_pred             CCc---------------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--
Confidence            111               112356999999999999999999999999999999999999999876544332221110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                    ..    .++...+..+.+||..||+.||.+||     |++++++|
T Consensus       365 --------------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 --------------EI----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             --------------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --------------CC----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                          00    01122346789999999999999999     99999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-46  Score=339.42  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-------HHHHHHHHHHHHhcCCCCceeeeeEEEecCCe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-------LSQVFKQELDILLHLSHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  129 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+......       ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECC--CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            456688999999999999998755  667889987654321       35678899999999999999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC----ceEEeec
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL----NCKLCDF  205 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~----~vkl~Df  205 (368)
                      .++||||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999998   345789999999999999999999999   999999999999999887    7999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |+++.......                .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.......
T Consensus       164 g~~~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  227 (321)
T 2a2a_A          164 GLAHEIEDGVE----------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL  227 (321)
T ss_dssp             TTCEECCTTCC----------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             ccceecCcccc----------------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            99975433211                02245999999999999999999999999999999999999999776543322


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........        .    ++.    .....+..+.+||..||+.||.+|||+.++++|
T Consensus       228 ~~i~~~~~~--------~----~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          228 ANITSVSYD--------F----DEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHHHTTCCC--------C----CHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhcccc--------c----Chh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            221111000        0    000    001124578999999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.1e-47  Score=356.19  Aligned_cols=266  Identities=23%  Similarity=0.302  Sum_probs=207.0

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC------CCCceeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL------SHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~  130 (368)
                      .+|.+.+.||+|+||.||+|.+..  ++..||+|+..........+.+|+.+++.+      +|+||+++++++...+..
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHK--VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECC--CCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            346678899999999999998755  678999999888777777888899998887      577999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc--eEEeecccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN--CKLCDFGSA  208 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~--vkl~Dfg~s  208 (368)
                      ++||||+. ++|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.  +||+|||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999995 6898888754 334589999999999999999999999   9999999999999999887  999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      .......                  ....||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+
T Consensus       250 ~~~~~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i  311 (429)
T 3kvw_A          250 CYEHQRV------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM  311 (429)
T ss_dssp             EETTCCC------------------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eecCCcc------------------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            6532211                  1246899999999999999999999999999999999999999887654443333


Q ss_pred             Hhhhhhhhhhhh---cchhhhcCC--------------------------------CCCCC----CCHHHHHHHHHHHHH
Q 017627          289 GSMLNDIADCEA---TKVNELVDP--------------------------------RLAGD----FDLDEARAMLSIAAL  329 (368)
Q Consensus       289 ~~~~~~~~~~~~---~~~~~~~~~--------------------------------~~~~~----~~~~~~~~l~~li~~  329 (368)
                      ............   ......++.                                .....    .....+..+.+||..
T Consensus       312 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~  391 (429)
T 3kvw_A          312 IELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ  391 (429)
T ss_dssp             HHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHH
T ss_pred             HHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHH
Confidence            222211111000   000000000                                00000    000114678999999


Q ss_pred             hcCCCCCCCCCHHHHHHH
Q 017627          330 CLRQSPILRPSATQILHT  347 (368)
Q Consensus       330 ~l~~dP~~Rpt~~~il~~  347 (368)
                      ||+.||.+|||++++|+|
T Consensus       392 ~L~~dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          392 CLEWDPAVRMTPGQALRH  409 (429)
T ss_dssp             HTCSSTTTSCCHHHHHTS
T ss_pred             HCCCChhhCCCHHHHhCC
Confidence            999999999999999987

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.7e-47  Score=348.06  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=200.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+......   ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKA--TNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            346678899999999999998755  678899998765432   234688888888 79999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC----CceEEeeccccccC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSAKMG  211 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~----~~vkl~Dfg~s~~~  211 (368)
                      |+.+++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||+.+.    +.+||+|||+++..
T Consensus        97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999997   445799999999999999999999999   99999999999998533    35999999999854


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .....               .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus       171 ~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i  235 (342)
T 2qr7_A          171 RAENG---------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI  235 (342)
T ss_dssp             BCTTC---------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH
T ss_pred             cCCCC---------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH
Confidence            32211               112346899999999999888999999999999999999999999764432222222221


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ...       .      ...........+..+.+||..||+.||.+|||+.++++|-
T Consensus       236 ~~~-------~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          236 GSG-------K------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             HHC-------C------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ccC-------C------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            111       0      0011111223456899999999999999999999999873

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=346.58  Aligned_cols=247  Identities=24%  Similarity=0.328  Sum_probs=195.5

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      .+.||+|+||.||+|.+..  ++..+|+|+..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETA--TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcC--CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            4579999999999998755  67788999876543 45677899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee--cCCCceEEeeccccccCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL--EEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv--~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||+  +.++.+||+|||+++.......  
T Consensus       172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            99988864  234689999999999999999999999   99999999999999  5678899999999985432221  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......    
T Consensus       245 --------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~----  306 (373)
T 2x4f_A          245 --------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD----  306 (373)
T ss_dssp             --------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----
T ss_pred             --------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----
Confidence                          11235999999999999999999999999999999999999999876643322211110000    


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  .........+..+.+||..||+.||.+|||+.++++|
T Consensus       307 ------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          307 ------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                        0000001234589999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.6e-47  Score=339.43  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=204.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEe-cCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCD-DRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+... .....+++|.....  ....+.+.+|+.+++.++||||+++++++. ..+..++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            44668899999999999987543 34456788876543  345577889999999999999999999864 456789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       107 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          107 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             ECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             eCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999975  345689999999999999999999999   9999999999999999999999999999754332


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ....           ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+...........  
T Consensus       182 ~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~--  248 (298)
T 3f66_A          182 EYYS-----------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--  248 (298)
T ss_dssp             GGCB-----------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--
T ss_pred             chhc-----------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--
Confidence            2111           111123457889999999999999999999999999999999 66777665543322211110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                   ...    ..+...+..+.+++..||+.||.+|||+.++++.|++++.+..
T Consensus       249 -------------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          249 -------------RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -------------CCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                         000    1111234579999999999999999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-47  Score=338.86  Aligned_cols=264  Identities=23%  Similarity=0.374  Sum_probs=208.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|.+.+.||+|+||.||+|.+.   ....+++|+........+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             hhhheeeecCCCCeEEEEEEEc---CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            3456788999999999999864   3457899987766555678899999999999999999999986 45689999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++... ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            999999998642 123689999999999999999999999   9999999999999999999999999999864432211


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      .              .....+++.|+|||++.+..++.++||||||+++|+|++ |..||..............      
T Consensus       166 ~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------  225 (279)
T 1qpc_A          166 A--------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------  225 (279)
T ss_dssp             C--------------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------
T ss_pred             c--------------ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc------
Confidence            0              012347889999999998889999999999999999999 9999976554322211111      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                               ....    ..+...+..+.+++..||+.||.+|||+.++++.|++++.+......|+
T Consensus       226 ---------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~  278 (279)
T 1qpc_A          226 ---------GYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQ  278 (279)
T ss_dssp             ---------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-------
T ss_pred             ---------ccCC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCCC
Confidence                     0001    1112334689999999999999999999999999999988776655553

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-47  Score=336.76  Aligned_cols=255  Identities=23%  Similarity=0.357  Sum_probs=208.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      |.+.+.||+|+||.||+|.+.   ....+++|+........+.+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             eeeeeEecCCCceeEEEEEec---CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            446788999999999999875   34678999887766556788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +++|.+++...  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++.......  
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  159 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--  159 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH--
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc--
Confidence            99999999743  35689999999999999999999999   999999999999999999999999999875432111  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                  .......|++.|+|||++.+..++.++||||||+++|+|++ |..||..............       
T Consensus       160 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-------  220 (267)
T 3t9t_A          160 ------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------  220 (267)
T ss_dssp             ------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------
T ss_pred             ------------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-------
Confidence                        00112347788999999999999999999999999999999 8999976554322211111       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                              ....    ..+...+..+.+++..||+.||.+|||+.+++++|+++.++
T Consensus       221 --------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          221 --------GFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             --------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------CCcC----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                    0001    11112345789999999999999999999999999988653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.8e-47  Score=355.17  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=199.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||.||+|++..  ++..+|+|+.....    .....+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEcCCCEEEEEEEECC--CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            345689999999999999765  67889999875422    122347789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+++|+|.+++..    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+......
T Consensus       150 ~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          150 YMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             CCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            9999999999863    3589999999999999999999999   99999999999999999999999999997543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM----ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .              ......+||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+...
T Consensus       223 ~--------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  288 (410)
T 3v8s_A          223 M--------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH  288 (410)
T ss_dssp             E--------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             c--------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence            1              1112357999999999998765    788999999999999999999999876644333222111


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL--RPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~  347 (368)
                      ...           .   ..+  .....+..+.+||..||+.+|.+  ||++++|++|
T Consensus       289 ~~~-----------~---~~p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 KNS-----------L---TFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHH-----------C---CCC--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ccc-----------c---cCC--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            000           0   000  00123458999999999999988  9999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=351.09  Aligned_cols=263  Identities=23%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             HhhhhcccccceEEEEEEEcCC-CCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  135 (368)
                      .+.+.||+|+||.||+|.+.+. .....+|+|....  .....+.+.+|+.+++.++||||+++++++.+ .+..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            4567899999999999987543 3455688887653  23456788999999999999999999998754 457899999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       172 ~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          172 YMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             CCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999975  345688999999999999999999999   99999999999999999999999999997543222


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...           ........+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+...........   
T Consensus       247 ~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~---  312 (373)
T 3c1x_A          247 FDS-----------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---  312 (373)
T ss_dssp             ----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---
T ss_pred             ccc-----------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---
Confidence            110           011123457889999999999999999999999999999999 77888765543322111110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                                  ...    ..+..++..+.+++..||+.||.+|||+.+++++|++++.+...
T Consensus       313 ------------~~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          313 ------------RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             ------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             ------------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                        000    11122345789999999999999999999999999999876653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.2e-47  Score=342.88  Aligned_cols=258  Identities=22%  Similarity=0.325  Sum_probs=195.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe----
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE----  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  129 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+....    ......+.+|+.+++.++||||+++++++...+.    
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLR--DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECC--CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            35577899999999999998755  6788999987543    3445678899999999999999999999876543    


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .++||||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            499999999999999997   345689999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ........            ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+...........
T Consensus       165 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~  232 (311)
T 3ork_A          165 AIADSGNS------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV  232 (311)
T ss_dssp             -----------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccccccc------------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence            54322110            111123569999999999999999999999999999999999999997765432221111


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHhc
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT-IKHQ  351 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~-L~~~  351 (368)
                      .....       . ...        .....+..+.+||..||+.||.+||++.+++.+ +.+.
T Consensus       233 ~~~~~-------~-~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          233 REDPI-------P-PSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HCCCC-------C-HHH--------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCCCC-------C-ccc--------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            00000       0 000        001134578999999999999999987776655 4443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.3e-47  Score=340.98  Aligned_cols=260  Identities=28%  Similarity=0.417  Sum_probs=194.6

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ...|.+.+.||+|+||.||+|++..     .+++|+...   .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS-----EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC-----ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            3445677899999999999998532     377776543   345567889999999999999999999965 4567899


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence            9999999999999964  345689999999999999999999999   99999999999999999999999999987432


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh-HHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL-TSLA  288 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~  288 (368)
                      ....             ........||+.|+|||++.   +..++.++||||||+++|+|++|..||........ ....
T Consensus       172 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  238 (289)
T 3og7_A          172 RWSG-------------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV  238 (289)
T ss_dssp             -------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred             cccc-------------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence            2111             01112346999999999996   56788899999999999999999999976554321 1111


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      ...              ...+. .......++..+.+|+..||+.||.+|||+.++++.|+++.++
T Consensus       239 ~~~--------------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          239 GRG--------------SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             HHT--------------SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             ccc--------------ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            110              00010 0111223456899999999999999999999999999998753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4e-47  Score=345.40  Aligned_cols=282  Identities=26%  Similarity=0.324  Sum_probs=209.6

Q ss_pred             HHHhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEe--cCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCD--DRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~l  132 (368)
                      .|.+.+.||+|+||.||+|++.  +...+..+++|+.... ....+.+.+|+.+++.++||||+++++++.  +.+..++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            4457789999999999999853  3446788999977654 445567899999999999999999999886  4567899


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            99999999999998742  34589999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....            ........||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus       179 ~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  246 (327)
T 3lxl_A          179 LDKDY------------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD  246 (327)
T ss_dssp             TTCSE------------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----
T ss_pred             cCCcc------------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc
Confidence            22210            011122458888999999999999999999999999999999999986543321111100000


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccC
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFS  360 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~  360 (368)
                      .  .  ....+............+...+..+.+|+..||+.||.+|||+.+++++|+.+.........
T Consensus       247 ~--~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          247 V--P--ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             C--C--HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             c--c--cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence            0  0  00111111112222223334566899999999999999999999999999999876554443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=339.30  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=201.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            5 YEKIGKIGEGSYGVVFKCRNRD--TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEeeEEeecCCeEEEEEEeCC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            4567889999999999999755  5778899976443   3345678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999887   446689999999999999999999999   99999999999999999999999999997543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+................
T Consensus       157 ~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (311)
T 4agu_A          157 D---------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD  221 (311)
T ss_dssp             ------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             c---------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcc
Confidence            1               0122468999999999976 67899999999999999999999999887654444333332222


Q ss_pred             hhhhhhc--chhhhcC----CCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEAT--KVNELVD----PRLAGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~--~~~~~~~----~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......  .......    +.......     ...+..+.+|+..||+.||.+|||++++++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            1110000  0000000    00000000     1235678999999999999999999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.2e-47  Score=335.64  Aligned_cols=245  Identities=28%  Similarity=0.424  Sum_probs=200.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  +...+++|+.....    .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEeeEEecCCCeEEEEEEEcc--CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            4467889999999999998755  67788999765432    23456889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           89 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999987   345689999999999999999999999   9999999999999999999999999998542221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                 .....||+.|+|||++.+..++.++||||||+++|+|++|..||................  
T Consensus       163 ~-----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--  223 (279)
T 3fdn_A          163 R-----------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--  223 (279)
T ss_dssp             ----------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--
T ss_pred             c-----------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--
Confidence            1                 123468999999999999999999999999999999999999997665433322221110  


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                                    .    .++...+..+.+||..||+.||.+|||+.++++|-
T Consensus       224 --------------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          224 --------------F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             --------------C----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             --------------C----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                          0    11122345789999999999999999999999883

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.3e-47  Score=345.13  Aligned_cols=265  Identities=22%  Similarity=0.359  Sum_probs=210.5

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC-----CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCC
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN-----DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRD  128 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~-----~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  128 (368)
                      ..|.+.+.||+|+||.||+|.+.+     ......+|+|+....  ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            345678899999999999998753     135677999987653  34556788999999999 8999999999999999


Q ss_pred             eeEEEEecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                      ..++||||+.+++|.+++.....             ...+++..++.++.|++.||.|||++   +|+||||||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence            99999999999999999985431             23489999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCC
Q 017627          196 EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GME  274 (368)
Q Consensus       196 ~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~  274 (368)
                      .++.+||+|||+++........             .......+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  258 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYY-------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  258 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSE-------------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCCEEEccccccccccccccc-------------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999754332211             01122347889999999998889999999999999999999 999


Q ss_pred             CCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      ||.+.............               ...    ..+...+..+.+++..||+.||.+|||+.+++++|++++..
T Consensus       259 p~~~~~~~~~~~~~~~~---------------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          259 PYPGIPVEELFKLLKEG---------------HRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             SSTTCCHHHHHHHHHHT---------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcCcCCHHHHHHHHhcC---------------CCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99766543322211110               001    11223345789999999999999999999999999999764


Q ss_pred             cc
Q 017627          355 IS  356 (368)
Q Consensus       355 ~~  356 (368)
                      ..
T Consensus       320 ~~  321 (334)
T 2pvf_A          320 TT  321 (334)
T ss_dssp             HC
T ss_pred             cc
Confidence            43

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=341.38  Aligned_cols=251  Identities=23%  Similarity=0.262  Sum_probs=193.7

Q ss_pred             HHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC-CCCceeeeeEEEec
Q 017627           51 WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL-SHDNIVKLIGYCDD  126 (368)
Q Consensus        51 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  126 (368)
                      ..++....|.+.+.||+|+||+||+|.+..  ++..+|+|+....   .........|+..+..+ +||||+++++++.+
T Consensus        51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKE--DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             SSCHHHHHEEEEEEEEEETTEEEEEEEETT--TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccchhhhheeeeheeccCCCeEEEEEEECC--CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            344555677788899999999999999765  6778999976442   23333444555555555 89999999999999


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      .+..++||||+ +++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             CCEEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            99999999999 67888887643  45699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      ++........                .....||+.|+|||++.+ .++.++|||||||++|||++|..||......  ..
T Consensus       203 ~a~~~~~~~~----------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~  263 (311)
T 3p1a_A          203 LLVELGTAGA----------------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW--QQ  263 (311)
T ss_dssp             TCEECC----------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH--HH
T ss_pred             eeeecccCCC----------------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HH
Confidence            9875432211                122459999999999986 7899999999999999999997766432210  00


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..                   .......+....+..+.+|+..||+.||.+|||++++++|
T Consensus       264 ~~-------------------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          264 LR-------------------QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HT-------------------TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             Hh-------------------ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            00                   0000000111234689999999999999999999999976

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.3e-47  Score=354.88  Aligned_cols=275  Identities=23%  Similarity=0.299  Sum_probs=208.4

Q ss_pred             cCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC--------CCceeee
Q 017627           49 YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS--------HDNIVKL  120 (368)
Q Consensus        49 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~  120 (368)
                      +...++...+|.+.+.||+|+||+||+|.+..  ++..+|+|+........+.+.+|+.+++.++        |+||+++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ--GKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecC--CCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            33444444567788899999999999998755  6788999998877777788899999999995        7889999


Q ss_pred             eEEEe----cCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          121 IGYCD----DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       121 ~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      ++++.    +....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++  +|+||||||+|||++.
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~  182 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV  182 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence            99987    556889999999 55666655433 3356999999999999999999999964  8999999999999997


Q ss_pred             CC-------------------------------------------------ceEEeeccccccCCCCCCCCCCCCCCCCc
Q 017627          197 HL-------------------------------------------------NCKLCDFGSAKMGFSSAVLPPSPSPSPSR  227 (368)
Q Consensus       197 ~~-------------------------------------------------~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~  227 (368)
                      ++                                                 .+||+|||+++......            
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~------------  250 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF------------  250 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS------------
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC------------
Confidence            75                                                 79999999997543221            


Q ss_pred             cccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh------HHHHHhhhhhhhhhhh-
Q 017627          228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLL------TSLAGSMLNDIADCEA-  300 (368)
Q Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~-  300 (368)
                            ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....      ...........+.... 
T Consensus       251 ------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  324 (397)
T 1wak_A          251 ------TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV  324 (397)
T ss_dssp             ------CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ------ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhh
Confidence                  123589999999999999999999999999999999999999986553221      1111111111110000 


Q ss_pred             -cc-hhhhcCC----------C---------CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          301 -TK-VNELVDP----------R---------LAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       301 -~~-~~~~~~~----------~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       .. .......          .         .....+...+..+.+||.+||+.||.+|||++++|+|
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence             00 0000000          0         0112456778899999999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=344.23  Aligned_cols=241  Identities=24%  Similarity=0.306  Sum_probs=198.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh---------HHHHHHHHHHHHhcCCCCceeeeeEEEecC
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR---------LSQVFKQELDILLHLSHDNIVKLIGYCDDR  127 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  127 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+......         ..+.+.+|+.+++.++||||+++++++.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKE--KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETT--TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cceEEEeEEEecCCEEEEEEEECC--CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            456677899999999999998755  678899997765421         233567899999999999999999999999


Q ss_pred             CeeEEEEecccCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          128 DEGVLLFEYVPNG-TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       128 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      +..++||||+.+| +|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999998766 9999998   445799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      +++.......                .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......   
T Consensus       176 ~a~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---  236 (335)
T 3dls_A          176 SAAYLERGKL----------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---  236 (335)
T ss_dssp             TCEECCTTCC----------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---
T ss_pred             cceECCCCCc----------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---
Confidence            9975432211                123569999999999988876 78999999999999999999999542210   


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                       ......      .+...+..+.+||..||+.||.+|||++++++|
T Consensus       237 -----------------~~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----------------VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------------TTTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------------HhhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             000000      011134578999999999999999999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.3e-47  Score=339.50  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=195.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhc--CCCCceeeeeEEEec----CCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH--LSHDNIVKLIGYCDD----RDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~----~~~~~  131 (368)
                      .|.+.+.||+|+||.||+|.+    ++..+|+|+......  ..+..|.+++..  ++||||+++++++..    .+..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~--~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW----QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE----TTEEEEEEEECGGGH--HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE----CCEEEEEEEeccccc--hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            345678899999999999986    467799998765433  445556666666  799999999998654    34589


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEecCCCCCeeecCCCceEEe
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH--------ERCTLHIVHGDIKASNILLEEHLNCKLC  203 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dikp~Nilv~~~~~vkl~  203 (368)
                      +||||+.+++|.+++.    ...+++..++.++.|++.||.|||        ++   +|+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999995    346899999999999999999999        77   99999999999999999999999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC------CCCcchhhHHHHHHHHHHHhC-----
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG------MASTKTDVYSFGVILLELVTG-----  272 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g-----  272 (368)
                      |||+++.........           ........||+.|+|||++.+.      .++.++|||||||++|||++|     
T Consensus       156 Dfg~a~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~  224 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQL-----------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG  224 (301)
T ss_dssp             CCTTCEEEETTTTEE-----------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             eCCCeeecccccccc-----------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcc
Confidence            999997543322110           0001223699999999999876      445789999999999999999     


Q ss_pred             -----CCCCCCCcchh-hHHHHHhhhhhhhhhhhcchhhhcCCCCCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 017627          273 -----MEAFCPENGQL-LTSLAGSMLNDIADCEATKVNELVDPRLAG-DFDLDEARAMLSIAALCLRQSPILRPSATQIL  345 (368)
Q Consensus       273 -----~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il  345 (368)
                           ..||....... ..........          .....+.... ......+..+.+|+..||+.||.+|||+.+++
T Consensus       225 ~~~~~~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          225 IVEDYKPPFYDVVPNDPSFEDMRKVVC----------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHT----------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             ccccccccccccCCCCcchhhhhHHHh----------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence                 77875533211 1111111000          0001111111 12235678899999999999999999999999


Q ss_pred             HHHHhc
Q 017627          346 HTIKHQ  351 (368)
Q Consensus       346 ~~L~~~  351 (368)
                      +.|+++
T Consensus       295 ~~L~~i  300 (301)
T 3q4u_A          295 KTLTKI  300 (301)
T ss_dssp             HHHHHH
T ss_pred             HHHhcc
Confidence            999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-47  Score=348.65  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=208.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCC---CceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDS---TSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~---~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      .|.+.+.||+|+||.||+|.+...+   ....+++|+....  ....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  126 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL  126 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence            4457789999999999999976532   2357889977654  34557788999999999 8999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCce
Q 017627          132 LLFEYVPNGTLQEKLHGTP-----------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC  200 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~v  200 (368)
                      +||||+.+++|.+++....           ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+
T Consensus       127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence            9999999999999886421           134689999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPE  279 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  279 (368)
                      ||+|||+++........             .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       204 kl~Dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNY-------------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EBCCCGGGCCGGGCTTS-------------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             EECccccccccccccce-------------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999754322110             01122357889999999999999999999999999999999 99999765


Q ss_pred             cchhhH-HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          280 NGQLLT-SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       280 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      ...... .....               ...    ...+...+..+.+++..||+.||.+|||+.+++++|+++..+.
T Consensus       271 ~~~~~~~~~~~~---------------~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          271 LVNSKFYKLVKD---------------GYQ----MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             CSSHHHHHHHHH---------------TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHhc---------------CCC----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            432211 11110               000    1111122457899999999999999999999999999887653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=342.63  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             HhhhhcccccceEEEEEEEcCCC--CceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~--~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||.||+|.+....  ....+++|+....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  126 (333)
T 1mqb_A           47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE  126 (333)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence            45678999999999999876432  3456899987643  3445678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       127 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          127 YMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             CCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             CCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence            9999999999974  245789999999999999999999999   99999999999999999999999999997543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..            ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..............    
T Consensus       202 ~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~----  265 (333)
T 1mqb_A          202 EA------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----  265 (333)
T ss_dssp             ---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----
T ss_pred             cc------------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC----
Confidence            10            001112346889999999999999999999999999999999 9999976554322211111    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                 .    .....+...+..+.+++..||+.||.+|||+.+++++|++++.+..
T Consensus       266 -----------~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          266 -----------G----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             -----------T----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             -----------C----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                       0    0011122345678999999999999999999999999999876544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=367.18  Aligned_cols=259  Identities=21%  Similarity=0.310  Sum_probs=208.1

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      .||+|+||.||+|.+........||+|+....  ....+.+.+|+.+++.++|||||++++++.. +..++||||+.+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            69999999999999876667788999987653  3356788999999999999999999999976 56999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCC
Q 017627          142 LQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSP  221 (368)
Q Consensus       142 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~  221 (368)
                      |.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........    
T Consensus       422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~----  492 (613)
T 2ozo_A          422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----  492 (613)
T ss_dssp             HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce----
Confidence            9999974  345689999999999999999999999   9999999999999999999999999999854322110    


Q ss_pred             CCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhhh
Q 017627          222 SPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCEA  300 (368)
Q Consensus       222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  300 (368)
                              ........+++.|+|||++.+..++.++|||||||++|||++ |..||...+.......+..          
T Consensus       493 --------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~----------  554 (613)
T 2ozo_A          493 --------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------  554 (613)
T ss_dssp             -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT----------
T ss_pred             --------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence                    011122346789999999999999999999999999999998 9999987665433322211          


Q ss_pred             cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          301 TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                               ......+..++..+.+||..||+.||.+|||+.+|++.|+.++.++....
T Consensus       555 ---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          555 ---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             ---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence                     00111223345689999999999999999999999999999887765443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.6e-47  Score=346.47  Aligned_cols=247  Identities=27%  Similarity=0.344  Sum_probs=198.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .|...+.||+|+||.||+|.+..  ++..+|+|+....    ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEcc--CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35567789999999999998654  6788999976543    23446788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+. |+|.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99996 578777753  245689999999999999999999999   999999999999999999999999999975322


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .                   ....||+.|+|||++.   +..++.++|||||||++|||++|..||...+..........
T Consensus       207 ~-------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  267 (348)
T 1u5q_A          207 A-------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ  267 (348)
T ss_dssp             B-------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             C-------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence            1                   1235999999999985   56789999999999999999999999976653322111100


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                         .            ..+..   .....+..+.+||..||+.||.+|||++++++|.-
T Consensus       268 ---~------------~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          268 ---N------------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             ---S------------CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             ---c------------CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence               0            00111   11123457899999999999999999999998743

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-47  Score=345.20  Aligned_cols=249  Identities=21%  Similarity=0.270  Sum_probs=179.4

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      +.||+|+||.||+|.+..  ++..+|+|+....  ....+.+|+.+++.+. ||||+++++++.+.+..++||||+.+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKK--SNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             CCSEEETTEEEEEEEETT--TCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CccccCCCeEEEEEEECC--CCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            679999999999998755  6788999987543  3456778999999997 9999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC---ceEEeeccccccCCCCCCCC
Q 017627          142 LQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL---NCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       142 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~---~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      |.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++   .+||+|||+++.......  
T Consensus        93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            999998   346799999999999999999999999   999999999999998765   899999999975332211  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                   .....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+.............     
T Consensus       165 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----  226 (325)
T 3kn6_A          165 -------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-----  226 (325)
T ss_dssp             --------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-----
T ss_pred             -------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-----
Confidence                         11234689999999999999999999999999999999999999976543211000000000     


Q ss_pred             hhcchhhhcCCCCCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          299 EATKVNELVDPRLAGD--FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                            .+........  .....+..+.+||..||+.||.+|||++++++|
T Consensus       227 ------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          227 ------KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             ------HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ------HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                  0111111100  011235689999999999999999999999876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=350.86  Aligned_cols=277  Identities=23%  Similarity=0.298  Sum_probs=214.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCC--eeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRD--EGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv  133 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+.....  ...+.+.+|+++++.++||||+++++++...+  ..++|
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            34577899999999999999765  67789999876432  23466789999999999999999999998665  77999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee----cCCCceEEeeccccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAK  209 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv----~~~~~vkl~Dfg~s~  209 (368)
                      |||+.+++|.+++........+++..++.++.|++.||.|||++   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999998654444599999999999999999999999   99999999999999    778889999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--------GMASTKTDVYSFGVILLELVTGMEAFCPENG  281 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (368)
                      .......                .....||+.|+|||++.+        ..++.++|||||||++|+|++|..||.+...
T Consensus       165 ~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~  228 (396)
T 4eut_A          165 ELEDDEQ----------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG  228 (396)
T ss_dssp             ECCCGGG----------------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred             EccCCCc----------------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence            5432221                122459999999999875        4677899999999999999999999975442


Q ss_pred             -hhhHHHHHhhhhhhhhhhhcchhhhc--------CCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcc
Q 017627          282 -QLLTSLAGSMLNDIADCEATKVNELV--------DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQI  352 (368)
Q Consensus       282 -~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~  352 (368)
                       ..............+...........        +...........+..+.+++..||+.||++|||+.++++.++.++
T Consensus       229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             TTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence             22222222222221111111111100        111223455778889999999999999999999999999999988


Q ss_pred             ccc
Q 017627          353 SSI  355 (368)
Q Consensus       353 ~~~  355 (368)
                      ...
T Consensus       309 ~~~  311 (396)
T 4eut_A          309 HRM  311 (396)
T ss_dssp             TCE
T ss_pred             hce
Confidence            764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-46  Score=341.27  Aligned_cols=274  Identities=25%  Similarity=0.329  Sum_probs=209.8

Q ss_pred             HhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC--CeeEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR--DEGVLL  133 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  133 (368)
                      .+.+.||+|+||.||++.+.  +..++..+|+|+....  ....+.+.+|+.+++.++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            57788999999999998753  3346788999987654  34567789999999999999999999999874  678999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++..    ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       114 ~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             ECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            999999999999974    3489999999999999999999999   999999999999999999999999999986433


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ..... 
T Consensus       187 ~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~-  252 (318)
T 3lxp_A          187 GHE------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQ-  252 (318)
T ss_dssp             TCS------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCC-
T ss_pred             ccc------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccc-
Confidence            211            0011123458889999999999899999999999999999999999996533211100 00000 


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                        .......+...+........+...+..+.+||..||+.||.+|||+.++++.|+++.++..
T Consensus       253 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          253 --GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             --HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence              0000011112222222222333456689999999999999999999999999999877654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.6e-47  Score=343.47  Aligned_cols=259  Identities=20%  Similarity=0.253  Sum_probs=201.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCC--ceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDST--STNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~--~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+...+.  ...+++|....  .....+.+.+|+.+++.++||||+++++++...+ .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~   95 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence            4567889999999999999765432  23456675543  2345677889999999999999999999998754 88999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      +++.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        96 ~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           96 QLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             CCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            999999999998753  45689999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...             .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.............  
T Consensus       171 ~~~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--  235 (327)
T 3lzb_A          171 EKE-------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--  235 (327)
T ss_dssp             ----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--
T ss_pred             ccc-------------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--
Confidence            211             11122347889999999999999999999999999999999 99999876554333222110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                                       .....+...+..+.+|+..||+.||.+|||+.++++.|+++....
T Consensus       236 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          236 -----------------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -----------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -----------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                             111112234557899999999999999999999999999987654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-46  Score=339.42  Aligned_cols=264  Identities=21%  Similarity=0.353  Sum_probs=201.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC-----
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD-----  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  128 (368)
                      .|.+.+.||+|+||.||+|.+... .+...+|+|+....   ....+.+.+|+.+++.++||||+++++++.+.+     
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            345778899999999999987543 35668899976543   344567889999999999999999999997655     


Q ss_pred             eeEEEEecccCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeec
Q 017627          129 EGVLLFEYVPNGTLQEKLHGT---PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                      ..++||||+.+++|.+++...   .....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Df  191 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF  191 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeec
Confidence            359999999999999998432   1345799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhh
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLL  284 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  284 (368)
                      |+++.........             ......+++.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus       192 g~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          192 GLSKKIYSGDYYR-------------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             SCC-----------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             CcceecccccccC-------------cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            9997543322110             1122357889999999999999999999999999999999 8999977654332


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      .......               .    ....+...+..+.+++..||+.||.+|||+.+++++|++++.+++
T Consensus       259 ~~~~~~~---------------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          259 YDYLLHG---------------H----RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHHHHTT---------------C----CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHHHHcC---------------C----CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            2211110               0    011112334579999999999999999999999999999987764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.1e-47  Score=335.72  Aligned_cols=257  Identities=22%  Similarity=0.291  Sum_probs=204.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+.+. .....+++|+....  ....+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   92 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME   92 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence            44678899999999999987643 35567899987653  3456778999999999999999999999875 46789999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++..  ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           93 LYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             CCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred             cCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence            9999999999974  234689999999999999999999999   99999999999999999999999999997543322


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..              ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...............   
T Consensus       168 ~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~---  230 (281)
T 3cc6_A          168 YY--------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG---  230 (281)
T ss_dssp             -------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---
T ss_pred             cc--------------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---
Confidence            11              1122347889999999999999999999999999999998 99999765544332221110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                  ....    .+...+..+.+++..||+.||.+|||+.+++++|+++.+.
T Consensus       231 ------------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          231 ------------DRLP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ------------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------CCCC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                        0000    1112345789999999999999999999999999988654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=347.83  Aligned_cols=261  Identities=20%  Similarity=0.236  Sum_probs=196.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------e
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------E  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~  129 (368)
                      |.+.+.||+|+||.||+|.+..  ++..||+|+...   .....+.+.+|+.+++.++||||+++++++...+      .
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             EEEEEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             EEEeEEeeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4567889999999999998754  677899997643   3445677889999999999999999999997653      4


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .++||||+ +++|.+++..    ..+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            69999999 8899999863    4689999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ......                  ....||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+
T Consensus       177 ~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i  238 (367)
T 1cm8_A          177 QADSEM------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI  238 (367)
T ss_dssp             ECCSSC------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccccc------------------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            533211                  22468999999999987 68999999999999999999999999877654433333


Q ss_pred             Hhhhhhhhhhhhcch-----h---hhcCCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATKV-----N---ELVDPRLAG---DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~-----~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..............+     .   ..+......   ......+..+.+|+.+||+.||.+|||++++++|
T Consensus       239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            222221111000000     0   000000000   1112335689999999999999999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-46  Score=350.70  Aligned_cols=281  Identities=22%  Similarity=0.270  Sum_probs=195.6

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCC--ee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRD--EG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~  130 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+...   .....+.+.+|+.+++.+. ||||+++++++...+  ..
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRR--TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETT--TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECC--CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            345677899999999999998755  677899997643   3455667889999999997 999999999997544  68


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++|||||. ++|..++..    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999996 689988863    4689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCCCCCCC------CCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh
Q 017627          211 GFSSAVLPPSPS------PSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQL  283 (368)
Q Consensus       211 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  283 (368)
                      ............      ..............+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            543221110000      0000011112234679999999999987 678999999999999999999999998876544


Q ss_pred             hHHHHHhhhhhhhhhhhcc------------hhhhc---CCCCCCCCC------------HHHHHHHHHHHHHhcCCCCC
Q 017627          284 LTSLAGSMLNDIADCEATK------------VNELV---DPRLAGDFD------------LDEARAMLSIAALCLRQSPI  336 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~------------~~~~~---~~~~~~~~~------------~~~~~~l~~li~~~l~~dP~  336 (368)
                      ....+..............            +....   .......++            ...+..+.+|+.+||+.||.
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            3333322221111100000            00000   000000000            02245789999999999999


Q ss_pred             CCCCHHHHHHH
Q 017627          337 LRPSATQILHT  347 (368)
Q Consensus       337 ~Rpt~~~il~~  347 (368)
                      +|||++++++|
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.4e-46  Score=331.68  Aligned_cols=249  Identities=27%  Similarity=0.305  Sum_probs=202.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcC--CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4567889999999999998755  5678899876443   3455678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc---eEEeeccccccCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGF  212 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~---vkl~Dfg~s~~~~  212 (368)
                      |+.+++|.+.+.   ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.   +||+|||++....
T Consensus        86 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           86 LVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999998887   345689999999999999999999999   9999999999999986655   9999999997543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....                ....||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus       160 ~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  223 (284)
T 3kk8_A          160 DSEAW----------------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  223 (284)
T ss_dssp             SSCBC----------------CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             cCccc----------------cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc
Confidence            22211                12458999999999999999999999999999999999999997765443332221111


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..                .........+..+.+|+..||+.||.+|||+.++++|
T Consensus       224 ~~----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          224 YD----------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CC----------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cc----------------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00                0000111234578999999999999999999999987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.1e-46  Score=330.14  Aligned_cols=257  Identities=24%  Similarity=0.305  Sum_probs=203.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ..|.+.+.||+|+||.||+|.+..  +...+++|..... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCC--CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            356678899999999999998755  5667788765432 3345678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee---cCCCceEEeeccccccCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv---~~~~~vkl~Dfg~s~~~~  212 (368)
                      |+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999887   345689999999999999999999999   99999999999999   788999999999997543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....                ....||+.|+|||++.+. ++.++||||||+++|+|++|..||................
T Consensus       161 ~~~~~----------------~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (277)
T 3f3z_A          161 PGKMM----------------RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT  223 (277)
T ss_dssp             TTSCB----------------CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             Cccch----------------hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            22211                224599999999998765 8999999999999999999999998765433222211110


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQISS  354 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~~~  354 (368)
                      ...+.      ..          ....+..+.+|+..||+.||.+|||+.++++|  +++...+
T Consensus       224 ~~~~~------~~----------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          224 FTFPE------KD----------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             CCCCH------HH----------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             CCCCc------hh----------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence            00000      00          00124678999999999999999999999976  4444333

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.6e-47  Score=344.19  Aligned_cols=267  Identities=22%  Similarity=0.336  Sum_probs=211.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .|.+.+.||+|+||.||+|.+.+   ......+++|+....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  105 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  105 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence            45577899999999999998652   235677899987643  3345568899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeec
Q 017627          133 LFEYVPNGTLQEKLHGTP-------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                      ||||+.+++|.+++....       ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df  182 (322)
T 1p4o_A          106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF  182 (322)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence            999999999999986421       124578999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhh
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLL  284 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  284 (368)
                      |+++.......             ........||+.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus       183 g~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  249 (322)
T 1p4o_A          183 GMTRDIYETDY-------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV  249 (322)
T ss_dssp             TCCCGGGGGGC-------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred             ccccccccccc-------------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence            99875332211             011122357899999999999999999999999999999999 8999976654332


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                      ......          ..         ....+...+..+.+++..||+.||.+|||+.+++++|++.+.......
T Consensus       250 ~~~~~~----------~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          250 LRFVME----------GG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             HHHHHT----------TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HHHHHc----------CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            221111          00         001112335678999999999999999999999999999877554433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-46  Score=357.19  Aligned_cols=281  Identities=19%  Similarity=0.207  Sum_probs=186.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-----CCe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-----RDE  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  129 (368)
                      +|.+.+.||+|+||+||+|.+..  ++..||+|+...   .....+.+.+|+.+++.++|||||++++++..     .+.
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKL--EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TEEECCC-------CEEEEEECC----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CeEEeeEeeecCCeEEEEEEECC--CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            45678899999999999998755  678899997654   23455778899999999999999999999843     356


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .|+||||+ +++|..++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus       132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 678999887   456799999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCCCCCCC------------CCccccccceeeecCCCCccchhh-ccCCCCcchhhHHHHHHHHHHHh-----
Q 017627          210 MGFSSAVLPPSPSPS------------PSRSRITKQVMMIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVT-----  271 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~-----  271 (368)
                      ...............            ............+||+.|+|||++ .+..++.++|||||||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            654322111000000            000001123456799999999986 56679999999999999999999     


Q ss_pred             ------CCCCCCCCcch--------------------hhHHHHHhhhhhhhhhhh-----cchh---hhcCCCCCC---C
Q 017627          272 ------GMEAFCPENGQ--------------------LLTSLAGSMLNDIADCEA-----TKVN---ELVDPRLAG---D  314 (368)
Q Consensus       272 ------g~~pf~~~~~~--------------------~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~---~  314 (368)
                            |.++|.+....                    .....+...+........     ....   .........   .
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  66667554310                    001111111111000000     0000   000000000   0


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          315 FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       315 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....+.++.+||.+||..||.+|||++++|+|
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            011235688999999999999999999999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.8e-46  Score=334.84  Aligned_cols=276  Identities=18%  Similarity=0.252  Sum_probs=209.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEE-ecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC-DDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~  136 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+...... ...+.+|+.+++.++|++++..+..+ .+.+..++||||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcC--CCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            45678899999999999998655  678899997554432 34577899999999887766666554 677788999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee---cCCCceEEeeccccccCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv---~~~~~vkl~Dfg~s~~~~~  213 (368)
                      + +++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+++....
T Consensus        87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           87 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             C-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             c-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            9 99999998742  34689999999999999999999999   99999999999999   7889999999999986544


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      .......        .........||+.|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus       161 ~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 4hgt_A          161 ARTHQHI--------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTTCCBC--------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             cccCccC--------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence            3321100        01111235699999999999999999999999999999999999999986543221111111111


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                      ....   ......     .    ...+..+.+|+..||+.||.+|||+.++++.|++++.+.+...+-+
T Consensus       233 ~~~~---~~~~~~-----~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~  289 (296)
T 4hgt_A          233 KKMS---TPIEVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV  289 (296)
T ss_dssp             HHHH---SCHHHH-----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCC
T ss_pred             cccc---chhhhh-----h----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCc
Confidence            1000   000000     0    0124579999999999999999999999999999999887666543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.4e-47  Score=340.68  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=200.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCC-----ceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDST-----STNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~-----~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      .|.+.+.||+|+||.||+|.+...+.     ...+++|+.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI   88 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence            45577889999999999998765332     256888876543 345677899999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc--------eEEe
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN--------CKLC  203 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~--------vkl~  203 (368)
                      +||||+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.        +||+
T Consensus        89 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             EEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             EEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999999999753  33489999999999999999999999   9999999999999998877        9999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCcc
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGM-EAFCPENG  281 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~-~pf~~~~~  281 (368)
                      |||++......                   ....||+.|+|||++.+ ..++.++||||||+++|+|++|. +||.....
T Consensus       164 Dfg~~~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          164 DPGISITVLPK-------------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             CCCSCTTTSCH-------------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cCcccccccCc-------------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence            99998632111                   12358999999999987 67899999999999999999955 55544332


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccc
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFL  358 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~  358 (368)
                      .........                 ......    ..+..+.+|+..||+.||.+|||+.+++++|++++.....+
T Consensus       225 ~~~~~~~~~-----------------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          225 QRKLQFYED-----------------RHQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             HHHHHHHHT-----------------TCCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             HHHHHHhhc-----------------cCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence            221111110                 000111    11336889999999999999999999999999998865544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-46  Score=362.19  Aligned_cols=250  Identities=21%  Similarity=0.293  Sum_probs=202.5

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .+.+.||+|+||.||+|....  ++..+|+|+....    ......+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus       187 ~~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  264 (576)
T 2acx_A          187 RQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT  264 (576)
T ss_dssp             EEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            345689999999999998755  6788999987543    2234567889999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+|+|.+++... ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++......
T Consensus       265 y~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          265 LMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            99999999998754 234589999999999999999999999   99999999999999999999999999997543221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.................. 
T Consensus       341 ----------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-  403 (576)
T 2acx_A          341 ----------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-  403 (576)
T ss_dssp             ----------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-
T ss_pred             ----------------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-
Confidence                            112346999999999999999999999999999999999999999875432111111111110 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                 .    ...++...+..+.+||..||+.||.+||     +++++++|
T Consensus       404 -----------~----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 -----------V----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -----------c----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                       0    0112223356899999999999999999     78999987

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.9e-47  Score=349.81  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=191.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHH-HhcCCCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDI-LLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|++..  ++..+|+|+.....    .....+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKA--EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETT--TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            4577899999999999999755  67888999875432    233455667776 5678999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|..++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999987   345689999999999999999999999   999999999999999999999999999975322


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+..   
T Consensus       192 ~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---  253 (373)
T 2r5t_A          192 HNS---------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---  253 (373)
T ss_dssp             CCC---------------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH---
T ss_pred             CCC---------------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---
Confidence            110               11235799999999999999999999999999999999999999987654332221111   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT----QILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----~il~~  347 (368)
                      .               .+  .++...+..+.+||..||+.||.+||++.    ++++|
T Consensus       254 ~---------------~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          254 K---------------PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             S---------------CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             c---------------cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            0               00  01112345789999999999999999984    55554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=355.03  Aligned_cols=252  Identities=25%  Similarity=0.311  Sum_probs=199.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|+...  ++..+|+|+.....    ...+.+.+|..++..++||||+++++++.+.+..|+||
T Consensus        63 f~~~~~lG~G~fG~V~~~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           63 FEILKVIGRGAFSEVAVVKMKQ--TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3455689999999999999755  67889999875432    22345788999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+|+|.+++...  +..+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++.....
T Consensus       141 E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            999999999999742  34689999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-------TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ..              ......+||+.|+|||++.       +..++.++|||||||++|||++|..||...+.......
T Consensus       216 ~~--------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  281 (412)
T 2vd5_A          216 GT--------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK  281 (412)
T ss_dssp             SC--------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             Cc--------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            11              0112346999999999997       35689999999999999999999999987664433222


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHH
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR---PSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~~il~~  347 (368)
                      +......           ..-+.    .....+.++.+||.+||. +|.+|   |+++++++|
T Consensus       282 i~~~~~~-----------~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          282 IVHYKEH-----------LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHTHHHH-----------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHhcccC-----------cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1110000           00010    112235689999999999 99998   699999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.4e-47  Score=348.63  Aligned_cols=266  Identities=21%  Similarity=0.286  Sum_probs=203.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cceeeeeecCCCCeEEEEEEECC--CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            34566789999999999999754  6778899977643  4556788999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++..   ...+++..+..++.|++.||.|||+++  +|+||||||+|||++.++.+||+|||++.......
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999999973   456899999999999999999999832  79999999999999999999999999986432111


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                       .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...............
T Consensus       187 -----------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  249 (360)
T 3eqc_A          187 -----------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD  249 (360)
T ss_dssp             ---------------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------
T ss_pred             -----------------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence                             122469999999999999999999999999999999999999998766443322221110000


Q ss_pred             hhhh--------------------h----cchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCE--------------------A----TKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~--------------------~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....                    .    ...................+..+.+||..||+.||.+|||++++++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0000                    0    00000111111111112235679999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.3e-47  Score=341.48  Aligned_cols=264  Identities=22%  Similarity=0.343  Sum_probs=209.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCC-e
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRD-E  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~  129 (368)
                      ..|.+.+.||+|+||.||+|.+.+   ..+...+++|+....  ....+.+.+|+.++..+ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            345677899999999999998643   346788999987654  33456788999999999 7999999999987654 5


Q ss_pred             eEEEEecccCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPR-------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      .++||||+.+++|.+++.....             ...+++..++.++.|++.||.|||++   +|+||||||+||+++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  183 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence            8999999999999999985432             12388999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEA  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  275 (368)
                      ++.+||+|||+++.......             ........||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPD-------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTT-------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCEEECCCccccccccCcc-------------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999975332211             111123458899999999999999999999999999999998 9999


Q ss_pred             CCCCcchhh-HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          276 FCPENGQLL-TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       276 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      |........ ......               ....    ..+...+..+.+++..||+.||.+|||+.+++++|+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~---------------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          251 YPGVKIDEEFCRRLKE---------------GTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             STTCCCSHHHHHHHHH---------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccchhHHHHHHhcc---------------CccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            976553221 111100               0001    11112345789999999999999999999999999998765


Q ss_pred             c
Q 017627          355 I  355 (368)
Q Consensus       355 ~  355 (368)
                      .
T Consensus       312 ~  312 (316)
T 2xir_A          312 N  312 (316)
T ss_dssp             H
T ss_pred             h
Confidence            4

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.4e-47  Score=370.24  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=205.6

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      +.||+|+||.||+|.+........+|+|+....   ....+.+.+|+.+++.++|||||++++++.. +..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            369999999999998777667888999987643   3345789999999999999999999999974 568999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      ++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........  
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--  525 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--  525 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc--
Confidence            99999997   446789999999999999999999999   9999999999999999999999999999864332211  


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+...       
T Consensus       526 ----------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------  588 (635)
T 4fl3_A          526 ----------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------  588 (635)
T ss_dssp             -------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------
T ss_pred             ----------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------
Confidence                      011122347889999999999999999999999999999998 99999876654332222110       


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                                  .....+..++..+.+||..||+.||.+|||+++|++.|+.++.++
T Consensus       589 ------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          589 ------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                        111122234568999999999999999999999999999887543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.5e-47  Score=367.22  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=213.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..+.+.+.||+|+||.||+|.+.+   ...||+|+........+.+.+|+.+++.|+||||+++++++.+ +..++||||
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhheecccCCCeEEEEEEECC---CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            344567889999999999998754   3568999887655556789999999999999999999999976 678999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            9999999999642 234589999999999999999999999   999999999999999999999999999975432110


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                    .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.........+..     
T Consensus       419 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-----  479 (535)
T 2h8h_A          419 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----  479 (535)
T ss_dssp             --------------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-----
T ss_pred             --------------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----
Confidence                          01112346788999999999999999999999999999999 9999977654322221111     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                                    ......+..++..+.+||..||+.||.+|||+++|++.|+.++.+....+.|.
T Consensus       480 --------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~  532 (535)
T 2h8h_A          480 --------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG  532 (535)
T ss_dssp             --------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC-
T ss_pred             --------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCcc
Confidence                          00111222345689999999999999999999999999999998876665543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-46  Score=342.30  Aligned_cols=269  Identities=25%  Similarity=0.264  Sum_probs=199.5

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  130 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+.....      ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSS--CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             cccEEEeEEeecCCEEEEEEEECC--CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            345677899999999999998654  67789999765422      1234677899999999999999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+.+ +|..++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999965 88888864  335688899999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......               ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus       162 ~~~~~~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~  226 (346)
T 1ua2_A          162 FGSPNR---------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF  226 (346)
T ss_dssp             TTSCCC---------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCcc---------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            432211               01224589999999999764 58999999999999999999999998766543332222


Q ss_pred             hhhhhhhhhhhcchh---hhcCCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          290 SMLNDIADCEATKVN---ELVDPRLAGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..........+....   ...........+     ...+..+.+||..||+.||.+|||+.++++|-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             HHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            211111110001000   000000000011     12346899999999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-46  Score=342.48  Aligned_cols=266  Identities=23%  Similarity=0.337  Sum_probs=201.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           27 YENLGLVGEGSYGMVMKCRNKD--TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             EEEEEEGGGGTTSSEEEEEETT--TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeEEeecCCEEEEEEEECC--CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            4567889999999999998755  6778899976433   3445667899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|..++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999988876   345699999999999999999999999   99999999999999999999999999997533221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..................
T Consensus       179 ~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  243 (331)
T 4aaa_A          179 E---------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN  243 (331)
T ss_dssp             --------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             c---------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            1               01224589999999999875 7899999999999999999999999876644332222211111


Q ss_pred             hhhhhh------cchhhhcCCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEA------TKVNELVDPRLAGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~------~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......      ........+.......     ...+..+.+|+..||+.||.+|||++++++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            100000      0001111111111111     1235689999999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-47  Score=345.01  Aligned_cols=266  Identities=21%  Similarity=0.236  Sum_probs=197.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh--HHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR--LSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+......  ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKL--TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             eEEEEEEcCCCCEEEEEEEECC--CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            4567889999999999998755  667889997754322  112345799999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +. ++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            96 5888888743  45689999999999999999999999   999999999999999999999999999974322111


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus       156 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  220 (324)
T 3mtl_A          156 ---------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP  220 (324)
T ss_dssp             ----------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ---------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                           1123468999999999976 568999999999999999999999998877554444443333221


Q ss_pred             hhhhhcch------hhhcCCCCCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKV------NELVDPRLAGDF----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~------~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....+...      .....+......    ....+..+.+||..||+.||.+|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            11111000      000001000000    11234678999999999999999999999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-46  Score=341.42  Aligned_cols=259  Identities=24%  Similarity=0.215  Sum_probs=198.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC------hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS------DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  130 (368)
                      .+|.+.+.||+|+||.||+|.+..  +...+|+|+....      ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQ--TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hheeecceeeecCCeEEEEEEECC--CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            456678899999999999998754  6778899976432      34457788999999999999999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 017627          131 VLLFEYVPNGTLQEKLHGTP-------------------------------------RSSKLPWRNRMAIAFQLAQAIEY  173 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~qi~~~l~~  173 (368)
                      ++||||+.+++|.+++....                                     ....+++..++.++.|++.||.|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            99999999999999885210                                     01224677888999999999999


Q ss_pred             HhhCCCCCeEEecCCCCCeeecCCC--ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-
Q 017627          174 LHERCTLHIVHGDIKASNILLEEHL--NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-  250 (368)
Q Consensus       174 LH~~~~~~ivH~Dikp~Nilv~~~~--~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  250 (368)
                      ||++   +|+||||||+|||++.++  .+||+|||+++........           .........||+.|+|||++.+ 
T Consensus       184 LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~  249 (345)
T 3hko_A          184 LHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG-----------EYYGMTTKAGTPYFVAPEVLNTT  249 (345)
T ss_dssp             HHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------------------CCCGGGCCHHHHTCS
T ss_pred             HHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc-----------ccccccccCCCccccCchhhccC
Confidence            9999   999999999999998776  8999999999754322110           0011123469999999999975 


Q ss_pred             -CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 017627          251 -GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL  329 (368)
Q Consensus       251 -~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  329 (368)
                       ..++.++||||||+++|+|++|..||..................                .........+..+.+||..
T Consensus       250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC----------------FENPNYNVLSPLARDLLSN  313 (345)
T ss_dssp             SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------TTSGGGGGSCHHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc----------------cCCcccccCCHHHHHHHHH
Confidence             67899999999999999999999999776543322211110000                0000011234578999999


Q ss_pred             hcCCCCCCCCCHHHHHHH
Q 017627          330 CLRQSPILRPSATQILHT  347 (368)
Q Consensus       330 ~l~~dP~~Rpt~~~il~~  347 (368)
                      ||+.||.+|||+.++++|
T Consensus       314 ~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHS
T ss_pred             HcCCChhHCCCHHHHhcC
Confidence            999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-46  Score=337.24  Aligned_cols=264  Identities=17%  Similarity=0.215  Sum_probs=199.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....    ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTV--RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEcCCCCeeEEEEEEcC--CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            4567889999999999998755  6788999987543    334577889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus       114 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          114 RLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             ECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999973   45689999999999999999999999   9999999999999999999999999998753322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..              .......||+.|+|||++.+..++.++||||||+++|+|++|..||................. 
T Consensus       188 ~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-  252 (309)
T 2h34_A          188 KL--------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP-  252 (309)
T ss_dssp             -----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCC-
T ss_pred             cc--------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCC-
Confidence            11              111234689999999999999999999999999999999999999976554322211111000 


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhcccccccccCC
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-SATQILHTIKHQISSISFLFSP  361 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~~il~~L~~~~~~~~~~~~~  361 (368)
                              ...        ......+..+.++|..||+.||.+|| |++++++.|++.+........+
T Consensus       253 --------~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~  304 (309)
T 2h34_A          253 --------RPS--------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT  304 (309)
T ss_dssp             --------CGG--------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--------
T ss_pred             --------Ccc--------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchh
Confidence                    000        01112344789999999999999999 9999999999998877654433

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.1e-46  Score=355.02  Aligned_cols=250  Identities=27%  Similarity=0.336  Sum_probs=198.2

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      ..|.+.+.||+|+||+||+|.+..  ++..+|+|+....   ......+.+|+.+++.++|||||++++++.+.+..++|
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKV--THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETT--TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECC--CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            456778899999999999998755  6778899876543   23356788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC---CceEEeecccccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH---LNCKLCDFGSAKM  210 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~---~~vkl~Dfg~s~~  210 (368)
                      ||||.+++|.+.+.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++..   +.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999887   345689999999999999999999999   99999999999999764   4599999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ......                ....+||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.........+..
T Consensus       189 ~~~~~~----------------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  251 (494)
T 3lij_A          189 FENQKK----------------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK  251 (494)
T ss_dssp             CBTTBC----------------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCcc----------------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            432221                12246999999999987 4689999999999999999999999987665433322221


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......           .+.     ....+..+.+||..||+.||.+|||+.++|+|
T Consensus       252 ~~~~~~-----------~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          252 GKYTFD-----------SPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             TCCCCC-----------SGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCCCC-----------chh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            110000           000     01234578999999999999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.4e-46  Score=356.15  Aligned_cols=249  Identities=28%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--------------hHHHHHHHHHHHHhcCCCCceeeeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--------------RLSQVFKQELDILLHLSHDNIVKLIGY  123 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~~~~  123 (368)
                      .|.+.+.||+|+||+||+|.+..  ++..+|+|+.....              ...+.+.+|+.+++.++||||++++++
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKN--GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETT--TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECC--CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            45577899999999999999755  67788999765432              234678899999999999999999999


Q ss_pred             EecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC---ce
Q 017627          124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL---NC  200 (368)
Q Consensus       124 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~---~v  200 (368)
                      +.+.+..++|||||.+++|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999887   345699999999999999999999999   999999999999998775   69


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      ||+|||+++.......                .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+
T Consensus       189 kl~Dfg~a~~~~~~~~----------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK----------------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             EECCCTTCEECCTTSC----------------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEECCCCEEcCCCCc----------------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999975433211                122469999999999874 68999999999999999999999998766


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......+........      ...          ....+..+.+||..||+.||.+|||++++|+|
T Consensus       252 ~~~~~~~i~~~~~~~~------~~~----------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          252 DQDIIKKVEKGKYYFD------FND----------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHHHHHHCCCCCC------HHH----------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcCCCCCC------ccc----------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            5433322221110000      000          01124679999999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-46  Score=341.54  Aligned_cols=266  Identities=23%  Similarity=0.249  Sum_probs=195.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTV--TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETT--TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hEEEEEEEEecCCeEEEEEEECC--CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            45677899999999999998755  67889999875432   23456778999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-----CCCceEEeeccccc
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-----EHLNCKLCDFGSAK  209 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-----~~~~vkl~Dfg~s~  209 (368)
                      ||+. ++|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++     .++.+||+|||+++
T Consensus       113 e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          113 EYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             ECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             ecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9996 59999987   345689999999999999999999999   999999999999994     45569999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      .......               ......||+.|+|||++.+. .++.++|||||||++|+|++|..||............
T Consensus       186 ~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  250 (329)
T 3gbz_A          186 AFGIPIR---------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI  250 (329)
T ss_dssp             HHC--------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccCCccc---------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence            5432110               11234589999999999874 5899999999999999999999999876654333322


Q ss_pred             Hhhhhhhhhhhhcchhh---hcC--CCCCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATKVNE---LVD--PRLAGDF-----DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~---~~~--~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .................   ...  +......     ....+..+.+||..||+.||.+|||++++++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            22221111111000000   000  0000000     01134678999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.6e-46  Score=331.42  Aligned_cols=275  Identities=18%  Similarity=0.253  Sum_probs=208.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEE-ecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC-DDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+...... ...+.+|+.+++.++|++++..+..+ .+.+..++||||+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEccCCCeEEEEEEEcC--CCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            4567889999999999998754  678899998665433 34578899999999988766655554 6677889999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee---cCCCceEEeeccccccCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv---~~~~~vkl~Dfg~s~~~~~~  214 (368)
                       +++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           88 -GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             -CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence             99999998742  35689999999999999999999999   99999999999999   47889999999999865443


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ......        .........||+.|+|||++.+..++.++||||||+++|+|++|..||..................
T Consensus       162 ~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          162 RTHQHI--------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TTCCBC--------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cccccc--------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            321100        011113356999999999999999999999999999999999999999864432111111111110


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                      ...   ......     .    ...+..+.+++..||+.||.+|||+.++++.|+++..+.....+.+
T Consensus       234 ~~~---~~~~~~-----~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~  289 (296)
T 3uzp_A          234 KMS---TPIEVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV  289 (296)
T ss_dssp             HHH---SCHHHH-----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCC
T ss_pred             ccC---CchHHH-----H----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccc
Confidence            000   000000     0    1124578999999999999999999999999999998887765543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.6e-46  Score=342.32  Aligned_cols=263  Identities=20%  Similarity=0.184  Sum_probs=193.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------e
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------E  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~  129 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+...   .....+.+.+|+.+++.++||||+++++++...+      .
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             eeEeeeeEecCCEEEEEEEECC--CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            4567889999999999998754  678899997654   2345567889999999999999999999997665      7


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .++||||+. ++|.+++.     ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             eEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            899999996 47888775     2488999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......                ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       176 ~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  239 (371)
T 2xrw_A          176 TAGTSF----------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  239 (371)
T ss_dssp             ------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccc----------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            532211                0123469999999999999999999999999999999999999998766433222221


Q ss_pred             hhhhhhhhh-------------------hhcchhhhcCCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADC-------------------EATKVNELVDPRLAGD---FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~-------------------~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........                   ................   .....+..+.+||.+||+.||.+|||++++++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            111100000                   0000000010000000   112346789999999999999999999999998


Q ss_pred             H
Q 017627          348 I  348 (368)
Q Consensus       348 L  348 (368)
                      -
T Consensus       320 p  320 (371)
T 2xrw_A          320 P  320 (371)
T ss_dssp             H
T ss_pred             c
Confidence            3

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-46  Score=335.52  Aligned_cols=265  Identities=23%  Similarity=0.338  Sum_probs=198.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+...    .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETT--TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEEEeecCCCCceEEEEEEcC--CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5577899999999999998755  567889997653    3445677889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||+.+++|.+++.... ....+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999886421 245689999999999999999999999   999999999999999999999999999875332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+...... ....... 
T Consensus       189 ~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-  251 (310)
T 2wqm_A          189 KTT---------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE-  251 (310)
T ss_dssp             -------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHH-
T ss_pred             CCc---------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhh-
Confidence            211               01224589999999999999999999999999999999999999975432211 1111100 


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                                 ....+..   .....+..+.+|+..||+.||.+|||+.+++++|+++......+.
T Consensus       252 -----------~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          252 -----------QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             -----------TTCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             -----------cccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence                       0000000   112234579999999999999999999999999999977655543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=331.75  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=181.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIH--TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceeeeeecCCCceEEEEEEEcc--CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4467789999999999998754  56788999875432    22467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            999999999999752  35789999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........        
T Consensus       166 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------  222 (278)
T 3cok_A          166 HE---------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--------  222 (278)
T ss_dssp             -----------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred             CC---------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH--------
Confidence            10               0122468999999999999899999999999999999999999997654321110        


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                .......  ..+...+..+.++|.+||+.||.+|||++++++|
T Consensus       223 ----------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          223 ----------KVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -----------CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----------HHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                      0000000  1112234578999999999999999999999976

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4e-46  Score=347.47  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=188.8

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHh-cCCCCceeeeeEEEec----CCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILL-HLSHDNIVKLIGYCDD----RDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~----~~~~~lv~e~~  137 (368)
                      +.||+|+||+||+|.+..  ++..+|+|+....    ..+.+|+.++. ..+||||+++++++..    .+..++|||||
T Consensus        68 ~~LG~G~~g~V~~~~~~~--~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKR--TQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             EEEEEETTEEEEEEEETT--TCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             ceeeeccCeEEEEEEECC--CCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            679999999999998755  6788999987654    34567888874 4589999999999865    56789999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeeccccccCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~~~~~  214 (368)
                      .+|+|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       142 ~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          142 DGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             CSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            999999999853 234699999999999999999999999   9999999999999997   788999999999753321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH-HHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS-LAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~  293 (368)
                      .                .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .......
T Consensus       218 ~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          218 N----------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             -------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             C----------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            1                1123568999999999999999999999999999999999999997654322110 0000000


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      .          ..   ..........+.++.+||..||+.||.+|||+.++++|-
T Consensus       282 ~----------~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          282 G----------QY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             T----------CC---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             C----------cc---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0          00   000001123356899999999999999999999999984

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=342.05  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=193.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCC--CceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSH--DNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|.+.   +...+|+|+...   .....+.+.+|+.++..++|  |||+++++++.+.+..++|
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECT---TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEEecCCCeEEEEEEeC---CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            456788999999999999863   466789987653   33455778899999999976  9999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||+ .+++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e~-~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 MEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             ECC-CSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EeC-CCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            995 5889999998   345789999999999999999999999   999999999999997 57899999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----------GMASTKTDVYSFGVILLELVTGMEAFCPENGQ  282 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  282 (368)
                      ....             .......||+.|+|||++.+           ..++.++|||||||++|+|++|..||......
T Consensus       160 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  226 (343)
T 3dbq_A          160 DTTS-------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  226 (343)
T ss_dssp             -----------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             cccc-------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence            2110             01123469999999999965           67889999999999999999999999654322


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                      ..                 .+....++.....++...+..+.+|+..||+.||.+|||+.++++|.-
T Consensus       227 ~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          227 IS-----------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             HH-----------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HH-----------------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence            11                 111112222222222233457899999999999999999999998843

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.5e-46  Score=354.65  Aligned_cols=251  Identities=26%  Similarity=0.313  Sum_probs=201.8

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ..+|.+.+.||+|+||+||+|.+..  ++..+|+|+....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETT--TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECC--CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            3467788999999999999998754  6778999986432   2335678899999999999999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec---CCCceEEeeccccc
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAK  209 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~---~~~~vkl~Dfg~s~  209 (368)
                      |||||.+++|.+.+.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999999887   345689999999999999999999999   999999999999995   45679999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .......                .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus       173 ~~~~~~~----------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  235 (486)
T 3mwu_A          173 CFQQNTK----------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE  235 (486)
T ss_dssp             TBCCC--------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ECCCCCc----------------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5332211                122469999999999986 58999999999999999999999998766543322221


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....                .........+..+.+||..||+.||.+|||+.++|+|
T Consensus       236 ~~~~~----------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          236 TGKYA----------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HTCCC----------------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             hCCCC----------------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11000                0000011235678999999999999999999999997

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.5e-46  Score=332.18  Aligned_cols=245  Identities=26%  Similarity=0.362  Sum_probs=194.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec----CCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD----RDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l  132 (368)
                      .+.+.||+|+||.||+|.+..  +...+++|+...   .....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~~--~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEecC--CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            456789999999999998755  667788887643   34556778999999999999999999999865    356899


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEecCCCCCeeec-CCCceEEeeccccc
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH--IVHGDIKASNILLE-EHLNCKLCDFGSAK  209 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~  209 (368)
                      ||||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +  |+||||||+|||++ .++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999997   345689999999999999999999999   8  99999999999998 78999999999986


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......                 .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.........  ..
T Consensus       181 ~~~~~~-----------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~  240 (290)
T 1t4h_A          181 LKRASF-----------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR  240 (290)
T ss_dssp             GCCTTS-----------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH
T ss_pred             cccccc-----------------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HH
Confidence            432211                 123469999999998874 5899999999999999999999999764432111  11


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....               ......+...+..+.+||..||+.||.+|||++++++|
T Consensus       241 ~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          241 RVTSG---------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHTTT---------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhcc---------------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            10000               00000111123478999999999999999999999976

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-46  Score=333.86  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=203.3

Q ss_pred             HHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec------
Q 017627           53 DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD------  126 (368)
Q Consensus        53 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------  126 (368)
                      ......|.+.+.||+|+||.||+|.+..  ++..+++|+......   .+.+|+.+++.++||||+++++++..      
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRI--DGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETT--TCCEEEEEEEECCSG---GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             chhccccceeeeeccCCceEEEEEEEcC--CCeEEEEEEeccccH---HHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3344556778899999999999998754  567889998765543   46689999999999999999998854      


Q ss_pred             ----------CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          127 ----------RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       127 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                                ....++||||+.+++|.+++... ....+++..++.++.|++.||.|||++   +|+|+||||+|||++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                      34579999999999999999743 345789999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF  276 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  276 (368)
                      ++.+||+|||++........                .....||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK----------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC----------------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             CCCEEECcchhheecccccc----------------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            99999999999876433221                01235899999999999999999999999999999999999887


Q ss_pred             CCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          277 CPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      ....     ....               ..........    .+..+.+++..||+.||.+|||+.+++++|+.+.++..
T Consensus       222 ~~~~-----~~~~---------------~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          222 FETS-----KFFT---------------DLRDGIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHH-----HHHH---------------HHHTTCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             hhHH-----HHHH---------------Hhhccccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            3211     0000               0011111111    23468899999999999999999999999998877654


Q ss_pred             c
Q 017627          357 F  357 (368)
Q Consensus       357 ~  357 (368)
                      .
T Consensus       278 ~  278 (284)
T 2a19_B          278 K  278 (284)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5e-46  Score=356.68  Aligned_cols=249  Identities=20%  Similarity=0.269  Sum_probs=200.6

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .+.||+|+||.||+|++..  ++..+|+|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus       190 ~~~LG~G~fG~Vy~a~~~~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMKA--TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEEECSSSEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEeeCCCeEEEEEEECC--CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            3569999999999998755  67889999875432    23456888999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          138 PNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       138 ~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      .+++|..++.... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++.......
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            9999999987542 245799999999999999999999999   999999999999999999999999999985432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL-LTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~  295 (368)
                                     .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........... 
T Consensus       345 ---------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-  408 (543)
T 3c4z_A          345 ---------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-  408 (543)
T ss_dssp             ---------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-
T ss_pred             ---------------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-
Confidence                           0122469999999999999999999999999999999999999997754321 11111111110 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                    .  ..++...+..+.+||..||+.||.+||++     ++|++|
T Consensus       409 --------------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          409 --------------A--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             --------------C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             --------------c--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                          0  01122345688999999999999999964     778876

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.3e-46  Score=357.07  Aligned_cols=251  Identities=25%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..+|.+.+.||+|+||.||+|.+..  ++..+|+|+....    ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKI--TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECC--CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3466788899999999999998754  6778999986433    334567889999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee---cCCCceEEeecccc
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSA  208 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv---~~~~~vkl~Dfg~s  208 (368)
                      +||||+.+++|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||++
T Consensus       103 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          103 LVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999999987   445799999999999999999999999   99999999999999   56789999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      +......                ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+
T Consensus       177 ~~~~~~~----------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  239 (484)
T 3nyv_A          177 THFEASK----------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV  239 (484)
T ss_dssp             HHBCCCC----------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEccccc----------------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            7533211                1123469999999999976 6899999999999999999999999876654333222


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......                .........+..+.+||..||+.||.+|||++++++|
T Consensus       240 ~~~~~~----------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          240 EKGKYT----------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HHCCCC----------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HcCCCC----------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            111000                0000011235689999999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-46  Score=334.62  Aligned_cols=250  Identities=27%  Similarity=0.362  Sum_probs=201.6

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+++|+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRL--TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceeeeeccCCCCceEEEEEECC--CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            456678899999999999998754  66788999876543 234568899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee---cCCCceEEeeccccccCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv---~~~~~vkl~Dfg~s~~~~  212 (368)
                      |+.+++|.+++.   ....+++..+..++.|++.||.|||++   +|+||||||+||++   +.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999887   345689999999999999999999999   99999999999999   788899999999986422


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...                 .....||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus       161 ~~~-----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  223 (304)
T 2jam_A          161 NGI-----------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY  223 (304)
T ss_dssp             CBT-----------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC
T ss_pred             CCc-----------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            110                 123458999999999999999999999999999999999999997765433222111100


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .                ..........+..+.+||..||+.||.+|||+.++++|
T Consensus       224 ~----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          224 Y----------------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             C----------------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             C----------------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0                00111112335689999999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-45  Score=328.50  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=200.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  129 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+++|+.....       ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG--TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC--CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            456678899999999999999765  56788888765432       135678899999999999999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC----ceEEeec
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL----NCKLCDF  205 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~----~vkl~Df  205 (368)
                      .++||||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++    .+||+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            999999999999999997   345689999999999999999999999   999999999999998877    7999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |++........                .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus       157 g~~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  220 (283)
T 3bhy_A          157 GIAHKIEAGNE----------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL  220 (283)
T ss_dssp             TTCEECC------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             ccceeccCCCc----------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH
Confidence            99975432211                12245899999999999999999999999999999999999999876543222


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........                .........+..+.+|+..||+.||.+|||+.++++|
T Consensus       221 ~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          221 TNISAVNYD----------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHHHTTCCC----------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             HHhHhcccC----------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            211110000                0000001124578999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.8e-46  Score=332.21  Aligned_cols=244  Identities=27%  Similarity=0.406  Sum_probs=201.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  +...+++|+.....    .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQ--NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceeeheecCCCCeEEEEEEEcC--CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4567889999999999998754  67788999765432    23467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..   ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999873   35689999999999999999999999   9999999999999999999999999998653321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..                 ....|++.|+|||++.+..++.++||||||+++|+|++|..||..............    
T Consensus       168 ~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----  226 (284)
T 2vgo_A          168 RR-----------------RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN----  226 (284)
T ss_dssp             CB-----------------CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----
T ss_pred             cc-----------------ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc----
Confidence            10                 124589999999999999999999999999999999999999976554322211110    


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  .+.    .++...+..+.++|..||+.||.+|||+.++++|
T Consensus       227 ------------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          227 ------------VDL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ------------TCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ------------ccc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                        001    1112234578999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.6e-46  Score=336.97  Aligned_cols=261  Identities=21%  Similarity=0.245  Sum_probs=205.4

Q ss_pred             cCHHHHHHHHHHhh-hhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC-CCCceeeeeEE
Q 017627           49 YSWDDVERFTQNFS-QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL-SHDNIVKLIGY  123 (368)
Q Consensus        49 ~~~~~~~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  123 (368)
                      +...+.....|.+. +.||+|+||.||+|.+..  ++..+|+|+....   ......+.+|+.+++.+ +||||++++++
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKS--TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            33334444555555 789999999999998755  6778899976543   23356788999999999 56999999999


Q ss_pred             EecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCce
Q 017627          124 CDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNC  200 (368)
Q Consensus       124 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~v  200 (368)
                      +.+.+..++||||+.+++|.+++... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999998643 346799999999999999999999999   9999999999999997   7899


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      ||+|||+++.......                .....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus       174 kL~Dfg~a~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE----------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             EECCGGGCEEC-------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeeCccccccCCccc----------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999975432211                122469999999999999999999999999999999999999997765


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .............                ..........+..+.+||..||+.||.+|||++++++|
T Consensus       238 ~~~~~~~i~~~~~----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          238 NQETYLNISQVNV----------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHHHHHTCC----------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             chHHHHHHHhccc----------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            4433222211110                01111112335678999999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=343.97  Aligned_cols=290  Identities=20%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-----CCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-----RDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|+.    ++..+|+|+.............|+..+..++||||+++++.+..     ....++|
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           15 LKLLELIGRGRYGAVYKGSL----DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             EEEEEEEEECSSEEEEEEEE----TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hheeeecccCCCeEEEEEEE----CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            34678899999999999976    45789999876544333233344444556899999999986532     2357899


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC------TLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      |||+++++|.+++...    ..++..++.++.|++.||.|||+++      ..+|+||||||+|||++.++.+||+|||+
T Consensus        91 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            9999999999999642    3588999999999999999999862      22799999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-------GMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      ++............       .........||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       167 a~~~~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          167 SMRLTGNRLVRPGE-------EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             CEECSSSSCC----------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             eeecccccccCccc-------cccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            98655433211110       0111123469999999999987       355678999999999999999977765433


Q ss_pred             c-hhhHHHHHhhhhh---hhhhhhcchhhhcCCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          281 G-QLLTSLAGSMLND---IADCEATKVNELVDPRLAGDF--DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       281 ~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      . .............   ..............+.+...+  ....+..+.+||..||+.||.+|||+.++++.|++++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            2 1111000000000   000000000111112222211  234677899999999999999999999999999999877


Q ss_pred             cccccCCCC
Q 017627          355 ISFLFSPQK  363 (368)
Q Consensus       355 ~~~~~~~~~  363 (368)
                      ..+.-..++
T Consensus       320 ~~~~~~~~~  328 (336)
T 3g2f_A          320 WERNKSVSP  328 (336)
T ss_dssp             CCC------
T ss_pred             HHhcccCCC
Confidence            665554443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.2e-46  Score=340.54  Aligned_cols=264  Identities=26%  Similarity=0.344  Sum_probs=204.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEc---CCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLI---NDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..|.+.+.||+|+||.||+|.+.   +..+...+|+|+...  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            34557789999999999999854   234667899998753  3455667889999999999999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEee
Q 017627          132 LLFEYVPNGTLQEKLHGTPR----SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCD  204 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~D  204 (368)
                      +||||+.+++|.+++.....    ...+++..++.++.|++.||.|||++   +|+||||||+|||++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence            99999999999999975421    24589999999999999999999999   9999999999999984   44699999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  283 (368)
                      ||+++.........             ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       187 fg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  253 (327)
T 2yfx_A          187 FGMARDIYRASYYR-------------KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE  253 (327)
T ss_dssp             CHHHHHHHC-------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             cccccccccccccc-------------cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence            99987533222110             0122457899999999999999999999999999999998 999997665433


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      ........               ...    ..+...+..+.+++..||+.||.+|||+.+++++|+.+....
T Consensus       254 ~~~~~~~~---------------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          254 VLEFVTSG---------------GRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHHHTT---------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHhcC---------------CCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            22211110               000    111233457899999999999999999999999999886543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=339.36  Aligned_cols=270  Identities=17%  Similarity=0.186  Sum_probs=198.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCChh------------HHHHHHHHHHHHhcCCCCceeeeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGSDR------------LSQVFKQELDILLHLSHDNIVKLIGYC  124 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~~  124 (368)
                      .|.+.+.||+|+||.||+|.+.. ......+++|+......            ....+.+|+..+..++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            45577899999999999999754 22567788887765421            112356788999999999999999999


Q ss_pred             ec----CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC--
Q 017627          125 DD----RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL--  198 (368)
Q Consensus       125 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~--  198 (368)
                      ..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++  
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence            87    67899999999 9999999974   34799999999999999999999999   999999999999999877  


Q ss_pred             ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 017627          199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP  278 (368)
Q Consensus       199 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  278 (368)
                      .+||+|||+++..........        ..........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQ--------YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCC--------CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             cEEEEeCCCceeccccccccc--------chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999999999986543221110        001111234699999999999999999999999999999999999999965


Q ss_pred             Ccc--hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          279 ENG--QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       279 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      ...  ..............+.    .+.....       ....+..+.+++..||+.||.+|||+.+|++.|+++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDELPQ----SVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHTTTH----HHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cccccHHHHHHHHhhcccccH----HHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            322  1111112221111111    0111100       00234579999999999999999999999999998654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-45  Score=338.71  Aligned_cols=271  Identities=22%  Similarity=0.258  Sum_probs=202.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec--------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD--------  126 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------  126 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+....   ......+.+|+.+++.++||||+++++++.+        
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETT--TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ceeEEEEEecCCCcEEEEEEECC--CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35577889999999999999755  6778899976433   2234567789999999999999999999976        


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      .+..++||||+.+ +|...+..  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            3468999999965 77776664  335699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      +++.........           ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......
T Consensus       170 ~a~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  238 (351)
T 3mi9_A          170 LARAFSLAKNSQ-----------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL  238 (351)
T ss_dssp             TCEECCCCSSSS-----------CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             hccccccccccc-----------ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            998644222111           111123468999999999976 45899999999999999999999999887765544


Q ss_pred             HHHHhhhhhhhhhhhcchh-----hhcCCCCCCCCCHH-------HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVN-----ELVDPRLAGDFDLD-------EARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..+................     ..............       .+..+.+||..||+.||.+|||++++++|
T Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            4444333322211111110     00000000001110       13568899999999999999999999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.1e-46  Score=328.93  Aligned_cols=252  Identities=25%  Similarity=0.288  Sum_probs=200.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+++|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECC--CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            45677899999999999998754  5678899976533  3445778899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999987   445789999999999999999999999   99999999999999999999999999987533211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..             .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........  .... 
T Consensus       160 ~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~-  223 (276)
T 2yex_A          160 RE-------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DWKE-  223 (276)
T ss_dssp             EE-------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH--HHHT-
T ss_pred             ch-------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH--Hhhh-
Confidence            10             00123458999999999987765 7789999999999999999999976553211100  0000 


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                    ...........+..+.+|+..||+.||.+|||++++++|
T Consensus       224 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          224 --------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------------cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                          000000011234578899999999999999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5e-46  Score=339.29  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=203.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      +|.+.+.||+|+||.||++.+..  +...+++|+....    ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            45567889999999999998755  6678888876532    34567788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999887   345789999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               ......||+.|+|||++.+..++.++||||||+++|+|++|..||...............  
T Consensus       194 ~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--  256 (335)
T 2owb_A          194 DGE---------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--  256 (335)
T ss_dssp             TTC---------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--
T ss_pred             Ccc---------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--
Confidence            211               012245999999999999999999999999999999999999999765543222111110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                    ...+    +...+..+.+||.+||+.||.+|||++++++|
T Consensus       257 --------------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 --------------EYSI----PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             --------------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------------CCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                          0011    11234578899999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-45  Score=347.72  Aligned_cols=210  Identities=24%  Similarity=0.304  Sum_probs=163.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-----Ce
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-----DE  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  129 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..||+|+....   ....+.+.+|+.+++.++||||+++++++...     +.
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKN--TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CEEEEEEEeecCCEEEEEEEECC--CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            45578899999999999998755  6788999987542   34457788999999999999999999999766     57


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .|+||||+. ++|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999995 69999997   456799999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCCCCCCC-------CCCCccccccceeeecCCCCccchhh-ccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 017627          210 MGFSSAVLPPSPS-------PSPSRSRITKQVMMIGSPGYTDPHYL-RTGMASTKTDVYSFGVILLELVTGMEAF  276 (368)
Q Consensus       210 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf  276 (368)
                      .............       ..............+||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            6543321100000       00000000122456799999999986 5667999999999999999999854443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.6e-46  Score=332.32  Aligned_cols=246  Identities=24%  Similarity=0.328  Sum_probs=202.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....    ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           17 YVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEeecCCEEEEEEEECC--CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            4567889999999999998755  5678888876432    345677889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        95 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           95 ELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             ECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999887   345789999999999999999999999   9999999999999999999999999999754321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............   .
T Consensus       169 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~  230 (294)
T 2rku_A          169 GE---------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---N  230 (294)
T ss_dssp             TC---------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---T
T ss_pred             cc---------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh---c
Confidence            11               01224589999999999999999999999999999999999999977654322111110   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   ...    .+...+..+.+++.+||+.||.+|||++++++|
T Consensus       231 -------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          231 -------------EYS----IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -------------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -------------cCC----CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                         000    111234578899999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-45  Score=333.59  Aligned_cols=265  Identities=23%  Similarity=0.331  Sum_probs=193.0

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecccC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+.||+|+||.||+|.+..  ++..+|+|+.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+.+
T Consensus        18 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLI--TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG   95 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSS--SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             CceecCCceEEEEEEEEcC--CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence            3679999999999998654  6778999987544 33456788999999985 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc---eEEeeccccccCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~---vkl~Dfg~s~~~~~~~~  216 (368)
                      ++|.+++..   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.   +||+|||+++.......
T Consensus        96 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           96 GSILSHIHK---RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             CBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             CcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999999973   45689999999999999999999999   9999999999999998766   99999999875432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ..        ...........||+.|+|||++.+     ..++.++|||||||++|+|++|..||...............
T Consensus       170 ~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          170 CS--------PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             --------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cc--------cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            00        000111123469999999999975     45789999999999999999999999765432100000000


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCH----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDL----DEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....   ......+.....  .++.    ..+..+.+||.+||+.||.+|||++++++|
T Consensus       242 ~~~~~---~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          242 CPACQ---NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CHHHH---HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhHH---HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00000   000000000000  1111    124678999999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3e-45  Score=337.79  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---------hHHHHHHHHHHHHhcC-CCCceeeeeEEEecC
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---------RLSQVFKQELDILLHL-SHDNIVKLIGYCDDR  127 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  127 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..||+|+.....         ...+.+.+|+.+++.+ +||||+++++++...
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRA--TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hcccceEEecCCCEEEEEEEECC--CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            34456789999999999998754  56789999865432         2346688999999999 799999999999999


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      +..++||||+.+++|.+++.   ....+++..+..++.||+.||.|||++   ||+|+||||+|||++.++.+||+|||+
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCc
Confidence            99999999999999999997   345689999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG------MASTKTDVYSFGVILLELVTGMEAFCPENG  281 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (368)
                      +........                .....||+.|+|||++.+.      .++.++|||||||++|+|++|..||.....
T Consensus       247 ~~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  310 (365)
T 2y7j_A          247 SCHLEPGEK----------------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ  310 (365)
T ss_dssp             CEECCTTCC----------------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccCCCcc----------------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence            875432211                1224699999999998643      578899999999999999999999976554


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..............      .....          ...+..+.+||..||+.||.+|||++++++|
T Consensus       311 ~~~~~~i~~~~~~~------~~~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          311 ILMLRMIMEGQYQF------SSPEW----------DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHHHHHHTCCCC------CHHHH----------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhCCCCC------CCccc----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            32222111100000      00000          0124578999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6e-46  Score=345.27  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=193.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCC--CCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLS--HDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|.+.   .+..+|+|+....   ....+.+.+|+.+++.++  ||||+++++++...+..++|
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEccCCCeEEEEEEcC---CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            557789999999999999853   3677899976433   445677899999999996  59999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||+++....
T Consensus       135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 558899999984   45789999999999999999999999   999999999999996 57999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----------GMASTKTDVYSFGVILLELVTGMEAFCPENGQ  282 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  282 (368)
                      ....             ......+||+.|+|||++.+           ..++.++|||||||++|+|++|..||......
T Consensus       207 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  273 (390)
T 2zmd_A          207 DTTS-------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  273 (390)
T ss_dssp             --------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             CCcc-------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence            2110             00123469999999999975           36889999999999999999999999754322


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..                 .+...+++.....++...+..+.+||..||+.||.+|||+.++++|.
T Consensus       274 ~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          274 IS-----------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HH-----------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HH-----------------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            10                 01111122111122222245789999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.2e-46  Score=330.93  Aligned_cols=249  Identities=26%  Similarity=0.361  Sum_probs=196.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-CeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-DEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|.+    .+..+++|+..... ..+.+.+|+.+++.++||||+++++++.+. +..++||||+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEE----TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             ceEEeEEecCCCceEEEEEE----cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            45678899999999999986    35678999876544 456788999999999999999999997554 4789999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++... ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.......  
T Consensus        98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999998742 122378999999999999999999999   99999999999999999999999999987432211  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                      ....+++.|+|||++.+..++.++||||||+++|+|++ |..||..............      
T Consensus       172 ----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~------  229 (278)
T 1byg_A          172 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------  229 (278)
T ss_dssp             --------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------
T ss_pred             ----------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------
Confidence                            12347889999999999999999999999999999998 9999976554322211110      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                                   ......+...+..+.+++..||+.||.+|||+.++++.|+++..
T Consensus       230 -------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          230 -------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             -------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                         01111222345689999999999999999999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-45  Score=335.51  Aligned_cols=266  Identities=20%  Similarity=0.305  Sum_probs=208.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCC------ceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD------NIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~  131 (368)
                      +|.+.+.||+|+||.||+|.+.. ..+..+|+|+........+.+.+|+.+++.++|+      +++++++++.+.+..+
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHK-AGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEecC-CCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            45677899999999999998632 3578899999887777778889999999998655      4999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---------------
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---------------  196 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---------------  196 (368)
                      +||||+ +++|.+++... ....+++..+..++.|++.||.|||++   +|+||||||+|||++.               
T Consensus        94 lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            999999 88999988754 234689999999999999999999999   9999999999999987               


Q ss_pred             ----CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhC
Q 017627          197 ----HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG  272 (368)
Q Consensus       197 ----~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  272 (368)
                          ++.+||+|||+++......                  ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  230 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEHH------------------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG  230 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSCC------------------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCCceEeeCcccccCcccc------------------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence                6689999999997532211                  123589999999999999999999999999999999999


Q ss_pred             CCCCCCCcchhhHHHHHhhhhhhhhhhhcc-----------------------hhhhcCCC-CCCCCCHHHHHHHHHHHH
Q 017627          273 MEAFCPENGQLLTSLAGSMLNDIADCEATK-----------------------VNELVDPR-LAGDFDLDEARAMLSIAA  328 (368)
Q Consensus       273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~-~~~~~~~~~~~~l~~li~  328 (368)
                      ..||...+...............+......                       ......+. .........+..+.+||.
T Consensus       231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            999987765544443333332211110000                       00000000 001123355788999999


Q ss_pred             HhcCCCCCCCCCHHHHHHH
Q 017627          329 LCLRQSPILRPSATQILHT  347 (368)
Q Consensus       329 ~~l~~dP~~Rpt~~~il~~  347 (368)
                      .||+.||.+|||+.++++|
T Consensus       311 ~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          311 KMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTTS
T ss_pred             HHhCcCcccccCHHHHhcC
Confidence            9999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.8e-46  Score=344.63  Aligned_cols=262  Identities=19%  Similarity=0.250  Sum_probs=186.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------C
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------D  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  128 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|+....   ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETT--TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            34567889999999999998655  6788999987542   34556788999999999999999999999654      5


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..++|||++ +++|.+++..    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 7899888853    4699999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      +.....                  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......
T Consensus       180 ~~~~~~------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  241 (367)
T 2fst_X          180 RHTADE------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  241 (367)
T ss_dssp             -----------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccc------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            753211                  123469999999999987 6789999999999999999999999988765444333


Q ss_pred             HHhhhhhhhhhhhc-----chhhhcCCCC-CCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEAT-----KVNELVDPRL-AGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~-----~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +.............     ....++.... .....     ...+..+.+||.+||+.||.+|||+.++|+|
T Consensus       242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            33322221110000     0001110000 00011     1224678999999999999999999999987

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=335.39  Aligned_cols=274  Identities=20%  Similarity=0.306  Sum_probs=201.5

Q ss_pred             HHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhc--CCCCceeeeeEEEecC--
Q 017627           52 DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH--LSHDNIVKLIGYCDDR--  127 (368)
Q Consensus        52 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~--  127 (368)
                      .......|.+.+.||+|+||.||+|++.    +..+|+|+.......  .+..|.+++..  ++||||+++++++...  
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~--~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR----GEKVAVKVFFTTEEA--SWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET----TEEEEEEEEEGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC----CceEEEEEEeccccc--hhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3444556778899999999999999863    678999987655443  33445555555  4899999999999877  


Q ss_pred             --CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEecCCCCCeeecCCCce
Q 017627          128 --DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC-----TLHIVHGDIKASNILLEEHLNC  200 (368)
Q Consensus       128 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dikp~Nilv~~~~~v  200 (368)
                        ...++||||+.+++|.+++..    ..+++..++.++.|++.||.|||+++     ..+|+||||||+|||++.++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence              688999999999999999963    35899999999999999999999751     2379999999999999999999


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcc------hhhHHHHHHHHHHHhC--
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTK------TDVYSFGVILLELVTG--  272 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~el~~g--  272 (368)
                      ||+|||+++..........           .......||+.|+|||++.+..++..      +|||||||++|||++|  
T Consensus       182 kl~Dfg~a~~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVD-----------IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             EECCCTTCEECC--------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             EEEeCCCceeecccccccc-----------CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            9999999975433221110           00112469999999999988776665      9999999999999999  


Q ss_pred             --------CCCCCCCcchh-hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017627          273 --------MEAFCPENGQL-LTSLAGSMLNDIADCEATKVNELVDPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSAT  342 (368)
Q Consensus       273 --------~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~  342 (368)
                              ..||....... .........          ......+.....+ ...++..+.+|+..||+.||.+|||+.
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  320 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDPSYEDMREIV----------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL  320 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHHHHHH----------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cccccccccccHhhhcCCCCchhhhHHHH----------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence                    55554322110 000000000          0001111111111 126778899999999999999999999


Q ss_pred             HHHHHHHhcccccc
Q 017627          343 QILHTIKHQISSIS  356 (368)
Q Consensus       343 ~il~~L~~~~~~~~  356 (368)
                      +++++|+++..+..
T Consensus       321 ell~~L~~l~~~~~  334 (337)
T 3mdy_A          321 RVKKTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHhhcc
Confidence            99999999887654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.7e-46  Score=367.05  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=202.6

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |++.+.||+|+||.||+|++..  ++..+|+|+....    ....+.+..|..++..+ +||||+.+++++.+.+.+|+|
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESS--SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECC--CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            4456789999999999999765  6778999986542    22345677899999988 799999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+|+|..++..   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+....
T Consensus       421 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999983   45699999999999999999999999   999999999999999999999999999985322


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               .....+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+.......+..   
T Consensus       495 ~~~---------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---  556 (674)
T 3pfq_A          495 DGV---------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---  556 (674)
T ss_dssp             TTC---------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS---
T ss_pred             CCc---------------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh---
Confidence            111               11335799999999999999999999999999999999999999987665433222111   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA-----TQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~  347 (368)
                                     ..  ..++...+.++.+||..||+.||.+||++     ++|++|
T Consensus       557 ---------------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          557 ---------------HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ---------------SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ---------------CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                           00  11222345689999999999999999998     888876

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-45  Score=342.57  Aligned_cols=265  Identities=26%  Similarity=0.350  Sum_probs=196.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-----------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-----------  126 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----------  126 (368)
                      +|.+.+.||+|+||+||+|.+..  ++..+|+|+.......   ..+|+.+++.++||||+++++++..           
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIE--SGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETT--TCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             eEEEEEEEEeccCEEEEEEEECC--CCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            45677899999999999998755  6788999977654332   3479999999999999999999843           


Q ss_pred             ---------------------------CCeeEEEEecccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 017627          127 ---------------------------RDEGVLLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERC  178 (368)
Q Consensus       127 ---------------------------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  178 (368)
                                                 ....++||||++ ++|.+.+... ..+..+++..++.++.||+.||.|||++ 
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-  160 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-  160 (383)
T ss_dssp             ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence                                       334889999997 5776665431 1456799999999999999999999999 


Q ss_pred             CCCeEEecCCCCCeeec-CCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcc
Q 017627          179 TLHIVHGDIKASNILLE-EHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTK  256 (368)
Q Consensus       179 ~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  256 (368)
                        +|+||||||+|||++ .++.+||+|||+++........                ....||+.|+|||++.+. .++.+
T Consensus       161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS----------------VAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC----------------CCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC----------------cCcccCCCccCHHHhcCCCCCCcc
Confidence              999999999999998 6889999999999854332211                224589999999998875 58999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchh----hhcCCCCC-----CCCCHHHHHHHHHHH
Q 017627          257 TDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVN----ELVDPRLA-----GDFDLDEARAMLSIA  327 (368)
Q Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-----~~~~~~~~~~l~~li  327 (368)
                      +||||+||++|+|++|..||.+.........+................    ...-+...     ..++...+..+.+|+
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  302 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL  302 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence            999999999999999999998876544333332222211110000000    00000000     001222456799999


Q ss_pred             HHhcCCCCCCCCCHHHHHHH
Q 017627          328 ALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       328 ~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..||+.||.+|||+.++++|
T Consensus       303 ~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          303 EQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHccCChhhCCCHHHHhcC
Confidence            99999999999999999976

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.6e-46  Score=347.44  Aligned_cols=252  Identities=26%  Similarity=0.350  Sum_probs=190.9

Q ss_pred             HHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---------hHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q 017627           55 ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---------RLSQVFKQELDILLHLSHDNIVKLIGYCD  125 (368)
Q Consensus        55 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  125 (368)
                      ....|.+.+.||+|+||.||+|.+..  +...+|+|+.....         .....+.+|+.+++.++||||+++++++.
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERK--TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECC--CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34456778899999999999998755  67789999865432         11234778999999999999999999986


Q ss_pred             cCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC---ceEE
Q 017627          126 DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL---NCKL  202 (368)
Q Consensus       126 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~---~vkl  202 (368)
                      . +..++||||+.+++|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++   .+||
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             c-CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence            4 56899999999999999887   456799999999999999999999999   999999999999997544   5999


Q ss_pred             eeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 017627          203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPE  279 (368)
Q Consensus       203 ~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~  279 (368)
                      +|||+++......                .....+||+.|+|||++.+   ..++.++|||||||++|+|++|..||...
T Consensus       284 ~DFG~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          284 TDFGHSKILGETS----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             CCSSTTTSCC---------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             eecccceecCCCc----------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            9999997543211                1123569999999999854   56788999999999999999999999765


Q ss_pred             cchh-hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          280 NGQL-LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       280 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .... ...........       .....         ....+..+.+||..||+.||.+|||++++++|
T Consensus       348 ~~~~~~~~~i~~~~~~-------~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          348 RTQVSLKDQITSGKYN-------FIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             SSSCCHHHHHHTTCCC-------CCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cchHHHHHHHhcCCCC-------CCchh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            4321 11111110000       00000         01124678999999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.8e-45  Score=338.16  Aligned_cols=267  Identities=24%  Similarity=0.216  Sum_probs=204.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CC-----ceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HD-----NIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~  131 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..||+|+..........+..|+.+++.++ |+     +|+++++++...+..+
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRV--EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcC--CCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            45577899999999999998754  6788999998877777778888999999885 54     4999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec--CCCceEEeeccccc
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE--EHLNCKLCDFGSAK  209 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~~~~vkl~Dfg~s~  209 (368)
                      +||||+. ++|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       133 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            9999995 5999988754 234689999999999999999999952 12899999999999995  47889999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......                  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       210 ~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~  271 (382)
T 2vx3_A          210 QLGQRI------------------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV  271 (382)
T ss_dssp             ETTCCC------------------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eccccc------------------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            543211                  12458999999999999999999999999999999999999998876544333322


Q ss_pred             hhhhhhhhhhh---cchhhhcCC-----------------------------------------CCCCCCCHHHHHHHHH
Q 017627          290 SMLNDIADCEA---TKVNELVDP-----------------------------------------RLAGDFDLDEARAMLS  325 (368)
Q Consensus       290 ~~~~~~~~~~~---~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~l~~  325 (368)
                      ......+....   ......++.                                         .............+.+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  351 (382)
T 2vx3_A          272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD  351 (382)
T ss_dssp             HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred             HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence            22211111000   000000000                                         0001122344568999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHH
Q 017627          326 IAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       326 li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ||.+||+.||.+|||++++|+|
T Consensus       352 li~~mL~~dP~~Rpta~e~L~h  373 (382)
T 2vx3_A          352 LILRMLDYDPKTRIQPYYALQH  373 (382)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHhcCCChhhCCCHHHHhcC
Confidence            9999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=340.14  Aligned_cols=271  Identities=23%  Similarity=0.314  Sum_probs=189.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC-ChhHHHHHHHHHHHHhcCC-CCceeeeeEEEe--------cC
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-SDRLSQVFKQELDILLHLS-HDNIVKLIGYCD--------DR  127 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--------~~  127 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+... .....+.+.+|+.++..+. ||||+++++++.        ..
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVG--SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             eEEEEEEEccCCceEEEEEEECC--CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45677899999999999999755  667889996543 4455677889999999996 999999999984        33


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEecCCCCCeeecCCCceEEeec
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH--IVHGDIKASNILLEEHLNCKLCDF  205 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nilv~~~~~vkl~Df  205 (368)
                      ...++||||+. |+|.+++........+++..++.++.||+.||.|||++   +  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence            45799999995 78988886533456799999999999999999999999   8  999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL---RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ  282 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  282 (368)
                      |+++............   .............||+.|+|||++   .+..++.++||||||+++|+|++|..||......
T Consensus       183 g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          183 GSATTISHYPDYSWSA---QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             TTCBCCSSCC----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccceeccccCcccccc---cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9998654332211000   000001111245699999999998   5667899999999999999999999999654321


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                      ...                      ............+..+.+|+..||+.||.+|||+.+++++|+.+..+.....
T Consensus       260 ~~~----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~  314 (337)
T 3ll6_A          260 RIV----------------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP  314 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred             Hhh----------------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence            110                      0000000111122358889999999999999999999999999977654433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-45  Score=332.10  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=202.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHhhhhcccCCeEEEEEEECC--CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4467889999999999998654  6778899987543  34457789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++.    ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++........
T Consensus       102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999986    34689999999999999999999999   999999999999999999999999999975433221


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............      
T Consensus       175 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------  233 (303)
T 3a7i_A          175 ---------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------  233 (303)
T ss_dssp             ---------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------
T ss_pred             ---------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc------
Confidence                           01224589999999999999999999999999999999999999976543322211110      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                               ...+....    ..+..+.+|+..||+.||.+|||+.++++|.
T Consensus       234 ---------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          234 ---------NNPPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             ---------SCCCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ---------CCCCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence                     01111112    2345789999999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-45  Score=341.07  Aligned_cols=268  Identities=19%  Similarity=0.228  Sum_probs=202.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-----Cee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-----DEG  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  130 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+....  ....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cEEEEEEeecCCCeEEEEEEECC--CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            34567889999999999998754  6788999987543  34457788999999999999999999999654     368


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++|||++. ++|.+++..    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999996 589998863    3589999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ........            .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus       178 ~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  245 (364)
T 3qyz_A          178 ADPDHDHT------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL  245 (364)
T ss_dssp             CCGGGCBC------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred             cCCCCCcc------------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            43322111            01123469999999998755 458999999999999999999999998876554443333


Q ss_pred             hhhhhhhhhhhcc-----hhhhcCC-CCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATK-----VNELVDP-RLAGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .............     ....... ......+     ...+..+.+||..||+.||.+|||++++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            2222211100000     0000000 0000111     1234678999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.2e-46  Score=332.34  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=198.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .|.+.+.||+|+||.||+|.+.. .+....+++|+....    ....+.+.+|+.+++.++||||+++++++.+.+ .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            34577889999999999998643 334456889876542    345678889999999999999999999998754 899


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|.+++...  ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++....
T Consensus        98 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            99999999999998742  34689999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ....            .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......... 
T Consensus       173 ~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-  239 (291)
T 1u46_A          173 QNDD------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-  239 (291)
T ss_dssp             C-CC------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-
T ss_pred             cccc------------chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc-
Confidence            2211            0111123457889999999998889999999999999999999 9999977654322211111 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                                       .......+...+..+.+++..||+.||.+|||+.+++++|+++....
T Consensus       240 -----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          240 -----------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             -----------------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -----------------cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                             00011112234568999999999999999999999999999887644

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-45  Score=328.62  Aligned_cols=252  Identities=26%  Similarity=0.360  Sum_probs=197.1

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+++|+....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERS--SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEcc--CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            356678899999999999998755  5677888876543  234577889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee---cCCCceEEeecccccc
Q 017627          135 EYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKM  210 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv---~~~~~vkl~Dfg~s~~  210 (368)
                      ||+.+++|.+++.... ....+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999999885321 346799999999999999999999999   99999999999999   4567899999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ......                .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+............
T Consensus       177 ~~~~~~----------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~  239 (285)
T 3is5_A          177 FKSDEH----------------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY  239 (285)
T ss_dssp             --------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cCCccc----------------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence            332111                12345999999999986 4688999999999999999999999987654332221111


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..                +..... ....+..+.+|+..||+.||.+|||+.++++|
T Consensus       240 ~~----------------~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          240 KE----------------PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CC----------------CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CC----------------cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00                000000 00124578899999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=339.01  Aligned_cols=277  Identities=14%  Similarity=0.160  Sum_probs=208.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCC------CceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceee------------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDS------TSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK------------  119 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~------~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~------------  119 (368)
                      .|.+.+.||+|+||.||+|.+..+.      ....+|+|+....    +.+.+|+.+++.++||||++            
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            3457788999999999999976532      3678999987654    35778999999999999887            


Q ss_pred             ---eeEEEec-CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          120 ---LIGYCDD-RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       120 ---~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                         +++++.. .+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++   +|+||||||+|||++
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence               6777765 67889999999 99999999843 236799999999999999999999999   999999999999999


Q ss_pred             CCC--ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCC
Q 017627          196 EHL--NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM  273 (368)
Q Consensus       196 ~~~--~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  273 (368)
                      .++  .+||+|||+++...........        .........||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  265 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAY--------VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCC--------CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CCCCceEEEecCcceeeccCCCccccc--------cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            998  8999999999865433211110        000112236999999999999999999999999999999999999


Q ss_pred             CCCCCCcc--hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          274 EAFCPENG--QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       274 ~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      .||.....  .............        .....+....   ....+..+.+|+..||+.||.+|||++++++.|+++
T Consensus       266 ~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          266 LPWTNCLPNTEDIMKQKQKFVDK--------PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             CTTGGGTTCHHHHHHHHHHHHHS--------CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CCcccCCcCHHHHHHHHHhccCC--------hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            99976531  1111111111110        1111111000   011245799999999999999999999999999999


Q ss_pred             ccccccccCCC
Q 017627          352 ISSISFLFSPQ  362 (368)
Q Consensus       352 ~~~~~~~~~~~  362 (368)
                      +++.....+.+
T Consensus       335 ~~~~~~~~~~~  345 (352)
T 2jii_A          335 LQDLRVSPYDP  345 (352)
T ss_dssp             HHHTTCCTTSC
T ss_pred             HHhcCCCcCcc
Confidence            98877664443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-45  Score=326.92  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=196.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQL--TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEeeecCCCCeEEEEEEECC--CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            4567889999999999998754  56788999865432    23457889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+++|.+++..   ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999973   35689999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ..                .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||................ 
T Consensus       165 ~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-  227 (276)
T 2h6d_A          165 EF----------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-  227 (276)
T ss_dssp             ----------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred             cc----------------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-
Confidence            11                122458999999999988765 689999999999999999999997655433222111100 


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQISS  354 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~~~  354 (368)
                                     ..    .+...+..+.+++..||+.||.+|||++++++|  +++.+.+
T Consensus       228 ---------------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  271 (276)
T 2h6d_A          228 ---------------FY----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS  271 (276)
T ss_dssp             ---------------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred             ---------------cc----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence                           00    111224578999999999999999999999997  5444433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-45  Score=340.34  Aligned_cols=275  Identities=27%  Similarity=0.306  Sum_probs=192.2

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe-------
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE-------  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------  129 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+............+++..+..++||||+++++++...+.       
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKS--TGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             TTEEEC----------CEEEEETT--TCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            345567899999999999998755  67789999876665555567788889999999999999999865433       


Q ss_pred             eEEEEecccCCCHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEEecCCCCCeeecC-CCceEEeec
Q 017627          130 GVLLFEYVPNGTLQEKLHG-TPRSSKLPWRNRMAIAFQLAQAIEYLH--ERCTLHIVHGDIKASNILLEE-HLNCKLCDF  205 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Df  205 (368)
                      .++||||+.++ |...+.. ......+++..+..++.|++.||.|||  ++   +|+||||||+|||++. ++.+||+||
T Consensus       101 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A          101 LNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             EEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             EEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeC
Confidence            78999999764 4433321 124567899999999999999999999  88   9999999999999996 899999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      |+++........                ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....
T Consensus       177 g~a~~~~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  240 (360)
T 3e3p_A          177 GSAKKLSPSEPN----------------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ  240 (360)
T ss_dssp             TTCBCCCTTSCC----------------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCceecCCCCCc----------------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence            999754332211                123589999999999765 489999999999999999999999988765444


Q ss_pred             HHHHHhhhhhhhhhhhcchh------hhcCC------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHh
Q 017627          285 TSLAGSMLNDIADCEATKVN------ELVDP------RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKH  350 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~------~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~  350 (368)
                      ....................      ...+.      ..........+..+.+||..||+.||.+|||+.++++|  +++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence            33332222111110000000      00000      00011122246789999999999999999999999987  554


Q ss_pred             ccc
Q 017627          351 QIS  353 (368)
Q Consensus       351 ~~~  353 (368)
                      ...
T Consensus       321 ~~~  323 (360)
T 3e3p_A          321 LHD  323 (360)
T ss_dssp             GGC
T ss_pred             cCC
Confidence            443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-46  Score=332.44  Aligned_cols=254  Identities=23%  Similarity=0.285  Sum_probs=201.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEe--cCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCD--DRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+...   .....+.+.+|+.+++.++||||+++++++.  ..+..++|
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECC--CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            4567889999999999998755  667888887654   3445677899999999999999999999874  45688999


Q ss_pred             EecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEEecCCCCCeeecCCCceEEeeccc
Q 017627          134 FEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLH-----IVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      |||+.+++|.+++.... ....+++..++.++.|++.||.|||++   +     |+||||||+||+++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            99999999999987432 234589999999999999999999998   7     99999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ++......               .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......
T Consensus       163 ~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  227 (279)
T 2w5a_A          163 ARILNHDT---------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK  227 (279)
T ss_dssp             HHHC---C---------------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             heeecccc---------------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH
Confidence            87532211               001224689999999999999999999999999999999999999987654322211


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      ...          ..     .+.    .+...+..+.+++..||+.||.+|||+.++++++...
T Consensus       228 i~~----------~~-----~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          228 IRE----------GK-----FRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             HHH----------TC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             Hhh----------cc-----ccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            111          00     011    1123356899999999999999999999999877543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.7e-46  Score=344.47  Aligned_cols=265  Identities=26%  Similarity=0.343  Sum_probs=192.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------eeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------EGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~  131 (368)
                      +|.+.+.||+|+||+||+|++..  +.. +++|........   ..+|+.+++.++||||+++++++...+      ..+
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~--~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVE--SDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT--TEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECC--CCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            35577899999999999998754  344 566654433222   236999999999999999999985443      378


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceEEeecccccc
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDFGSAKM  210 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~~  210 (368)
                      +||||+.++.+............+++..++.++.||+.||.|||++   +|+||||||+|||++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999997654443332111356799999999999999999999999   999999999999999 799999999999986


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .......                ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       192 ~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~  255 (394)
T 4e7w_A          192 LIAGEPN----------------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII  255 (394)
T ss_dssp             CCTTCCC----------------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCCCC----------------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            4322211                124589999999999765 58999999999999999999999998877544333322


Q ss_pred             hhhhhhhhhhhcch-hhhcCCCCC---C-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKV-NELVDPRLA---G-----DFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~-~~~~~~~~~---~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .............. .........   .     .+....+.++.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            22211111000000 001111000   0     0111245689999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=336.55  Aligned_cols=278  Identities=25%  Similarity=0.335  Sum_probs=208.0

Q ss_pred             HHHhhhhcccccceEEEEEEEc--CCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC--eeEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLI--NDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD--EGVL  132 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~--~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l  132 (368)
                      .+.+.+.||+|+||.||+|.+.  +..++..+++|+.... ....+.+.+|+.+++.++||||+++++++...+  ..++
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  121 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL  121 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence            3457789999999999999853  2346788999987553 455678899999999999999999999986654  7899


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       122 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          122 IMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            99999999999999753  34689999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      .....            ........++..|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus       197 ~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~-~~~~~~~  263 (326)
T 2w1i_A          197 QDKEY------------YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDK  263 (326)
T ss_dssp             SSCSE------------EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH-HHHCTTC
T ss_pred             ccccc------------cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH-Hhhcccc
Confidence            32210            0001123477889999999988899999999999999999999999854321110 0000000


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI  355 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~  355 (368)
                      .  .......+.+.+........+..++..+.++|..||+.||.+|||+.++++.|+++..++
T Consensus       264 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          264 Q--GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             C--THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             c--hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            0  000000111111111111122334568999999999999999999999999999886543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1e-45  Score=347.03  Aligned_cols=265  Identities=27%  Similarity=0.349  Sum_probs=193.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------CeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------DEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~  131 (368)
                      .|.+.+.||+|+||.||+|++..  ++..||+|+......   ...+|+++++.++|||||++++++...      ...+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECC--CCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35567889999999999999765  567899997755432   234799999999999999999988432      2367


Q ss_pred             EEEecccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-CceEEeeccccc
Q 017627          132 LLFEYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-LNCKLCDFGSAK  209 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~~vkl~Dfg~s~  209 (368)
                      +||||+.+ +|...+... .....+++..++.++.||+.||.|||++   +|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999965 565554321 1356799999999999999999999999   99999999999999954 678999999998


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      .......                .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+
T Consensus       206 ~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i  269 (420)
T 1j1b_A          206 QLVRGEP----------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI  269 (420)
T ss_dssp             ECCTTCC----------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hcccCCC----------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            5432211                0224689999999999764 7899999999999999999999999887654333222


Q ss_pred             Hhhhhhhhhhhh----cchhhhcCCCCCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEA----TKVNELVDPRLAGD-----FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~----~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...+........    .......-+.....     +....+.++.+||.+||+.||.+|||+.++++|
T Consensus       270 ~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            222111110000    00001101111000     112235689999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.9e-47  Score=350.09  Aligned_cols=240  Identities=14%  Similarity=0.132  Sum_probs=184.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeec----CChhHHHHHHHHHHH---HhcCCCCceeeee-------EEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHV----GSDRLSQVFKQELDI---LLHLSHDNIVKLI-------GYC  124 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~----~~~~~~~~~~~E~~~---l~~l~h~~iv~~~-------~~~  124 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+..    ......+.+.+|+.+   ++.++|||||+++       +++
T Consensus        75 y~~~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           75 LVRGTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEC-C--CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             EEEcceeecCCCEEEEEEEECC--CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            3456789999999999998654  57789999864    234456788899954   5555799999998       776


Q ss_pred             ecCCe-----------------eEEEEecccCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 017627          125 DDRDE-----------------GVLLFEYVPNGTLQEKLHGTPR----SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIV  183 (368)
Q Consensus       125 ~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iv  183 (368)
                      .+.+.                 .++||||+ +|+|.+++.....    ...+++..++.++.||+.||.|||++   +|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            65542                 78999999 6899999874211    12233578888999999999999999   999


Q ss_pred             EecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-----------C
Q 017627          184 HGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-----------M  252 (368)
Q Consensus       184 H~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~  252 (368)
                      ||||||+|||++.++.+||+|||+|+.....                  .....| +.|+|||++.+.           .
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  289 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR------------------VVSSVS-RGFEPPELEARRATISYHRDRRTL  289 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTCE------------------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEE
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCCc------------------ccCCCC-cCccChhhhccccccccccccccc
Confidence            9999999999999999999999999742211                  123457 999999999887           8


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcC
Q 017627          253 ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLR  332 (368)
Q Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  332 (368)
                      ++.++|||||||++|||++|..||.........                  ...... . .    ..+..+.+||..||+
T Consensus       290 ~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~------------------~~~~~~-~-~----~~~~~~~~li~~~L~  345 (377)
T 3byv_A          290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGS------------------EWIFRS-C-K----NIPQPVRALLEGFLR  345 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCCC------CCS------------------GGGGSS-C-C----CCCHHHHHHHHHHTC
T ss_pred             CChhhhHHHHHHHHHHHHHCCCCCcccccccch------------------hhhhhh-c-c----CCCHHHHHHHHHHcC
Confidence            999999999999999999999999654432111                  011110 0 1    224578999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 017627          333 QSPILRPSATQILHT  347 (368)
Q Consensus       333 ~dP~~Rpt~~~il~~  347 (368)
                      .||.+|||+.++++|
T Consensus       346 ~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          346 YPKEDRLLPLQAMET  360 (377)
T ss_dssp             SSGGGCCCHHHHHTS
T ss_pred             CCchhCCCHHHHhhC
Confidence            999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-46  Score=336.83  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=195.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEec------CCeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDD------RDEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~  131 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+..........+.+|+.+++.+ +||||+++++++..      .+..+
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECC--CCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            4467889999999999999755  567899998776655567888999999999 79999999999976      46789


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+.+++|.+++... ....+++..++.++.||+.||.|||++   +|+|+||||+|||++.++.+||+|||++...
T Consensus       104 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            999999999999999754 235689999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      .....               ......||+.|+|||++.     +..++.++|||||||++|+|++|..||..........
T Consensus       180 ~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  244 (326)
T 2x7f_A          180 DRTVG---------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  244 (326)
T ss_dssp             --------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             CcCcc---------------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            22110               112346899999999997     5678899999999999999999999997655322211


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ....          ...     +..   .....+..+.+||..||+.||.+|||+.++++|
T Consensus       245 ~~~~----------~~~-----~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          245 LIPR----------NPA-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHH----------SCC-----CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             Hhhc----------Ccc-----ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1100          000     000   011224578999999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-46  Score=341.18  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=199.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC-----hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  130 (368)
                      .|.+.+.||+|+||.||+|+... ..++..+|+|+....     ......+.+|+.+++.+ +||||+++++++.+.+..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            35577899999999999998743 346788999976532     12334567899999999 699999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ++||||+.+++|.+++..   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       135 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            999999999999999973   45689999999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhh-HHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAFCPENGQLL-TSL  287 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~  287 (368)
                      .....              ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||........ ...
T Consensus       209 ~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  274 (355)
T 1vzo_A          209 FVADE--------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  274 (355)
T ss_dssp             CCGGG--------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             cccCC--------------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH
Confidence            32211              111123469999999999986  3578899999999999999999999975443211 111


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHTI  348 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~L  348 (368)
                      .......             .+.    ++...+..+.+||..||+.||.+||     |+.++++|.
T Consensus       275 ~~~~~~~-------------~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          275 SRRILKS-------------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHHHC-------------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHHhcc-------------CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1111110             111    1223345789999999999999999     999999885

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=341.03  Aligned_cols=269  Identities=21%  Similarity=0.283  Sum_probs=184.6

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEe--cCCeeEEEEecccC
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCD--DRDEGVLLFEYVPN  139 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~  139 (368)
                      +++||+|+||.||+|.+.+..+...+|+|+...... ...+.+|+.+++.++||||+++++++.  .....++||||+. 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            557999999999999987666788899998765432 346778999999999999999999995  4678999999995 


Q ss_pred             CCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee----cCCCceEEeeccccc
Q 017627          140 GTLQEKLHGT------PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----EEHLNCKLCDFGSAK  209 (368)
Q Consensus       140 ~~L~~~l~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv----~~~~~vkl~Dfg~s~  209 (368)
                      ++|.+++...      .....+++..++.++.||+.||.|||++   +|+||||||+|||+    +.++.+||+|||+|+
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            5777776521      1223589999999999999999999999   99999999999999    677899999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcch------
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQ------  282 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~------  282 (368)
                      .......            ........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....      
T Consensus       181 ~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          181 LFNSPLK------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             ----------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             ecCCCCc------------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            5432211            01111335799999999999874 5899999999999999999999999765432      


Q ss_pred             ---hhHHHHHhhhhhhhhhhhcchh----------hhcCCCCCCCCC---------HHHHHHHHHHHHHhcCCCCCCCCC
Q 017627          283 ---LLTSLAGSMLNDIADCEATKVN----------ELVDPRLAGDFD---------LDEARAMLSIAALCLRQSPILRPS  340 (368)
Q Consensus       283 ---~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt  340 (368)
                         .....+...+.......+..+.          ........ ...         ...+..+.+||..||+.||.+|||
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT-TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC-cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               1111111111110000000000          00000000 000         011457889999999999999999


Q ss_pred             HHHHHHHH
Q 017627          341 ATQILHTI  348 (368)
Q Consensus       341 ~~~il~~L  348 (368)
                      ++++|+|-
T Consensus       328 a~e~L~hp  335 (405)
T 3rgf_A          328 SEQAMQDP  335 (405)
T ss_dssp             HHHHHTSG
T ss_pred             HHHHhcCh
Confidence            99999983

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=329.80  Aligned_cols=251  Identities=24%  Similarity=0.291  Sum_probs=198.9

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+++|+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKE--TGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETT--TCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhheeeccCCCeEEEEEEECC--CCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            345577889999999999998754  57789999876543 346688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +.+++|.+++..  ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++........
T Consensus       106 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          106 CGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             CTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            999999999863  245689999999999999999999999   999999999999999999999999999975432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......||+.|+|||++.+..++.++||||||+++|+|++|..||...............     
T Consensus       181 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----  240 (314)
T 3com_A          181 ---------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-----  240 (314)
T ss_dssp             ---------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----
T ss_pred             ---------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-----
Confidence                           012245899999999999999999999999999999999999999765432221111000     


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ..+  ....+...+..+.+|+..||+.||.+|||+.++++|
T Consensus       241 ----------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          241 ----------PPP--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ----------CCC--CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----------CCc--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                      000  001112234678999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-44  Score=344.24  Aligned_cols=272  Identities=19%  Similarity=0.249  Sum_probs=209.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCC-CceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH-DNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|.+..  ++..||||+...... ...+.+|+.+++.|+| ++|+.+..++.+.+..++||||+
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETT--TCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEeeCCCEEEEEEEECC--CCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            4567889999999999998755  677899997654433 2347789999999976 66667777778888999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee---cCCCceEEeeccccccCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL---EEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv---~~~~~vkl~Dfg~s~~~~~~  214 (368)
                       +++|.+++...  ...+++..++.++.||+.||.|||++   +|+||||||+||||   +.++.+||+|||+++.....
T Consensus        86 -g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           86 -GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             -CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence             99999999742  45699999999999999999999999   99999999999999   58899999999999865433


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .....        ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+................
T Consensus       160 ~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (483)
T 3sv0_A          160 STHQH--------IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK  231 (483)
T ss_dssp             TTCCB--------CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred             ccccc--------cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence            22110        0011112456999999999999999999999999999999999999999876543322222221111


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccccc
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLF  359 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~  359 (368)
                      ...   ..+..+.     .    .++.++.+|+..||+.||.+||++.+|++.|+.++......+
T Consensus       232 ~~~---~~~~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~  284 (483)
T 3sv0_A          232 KVA---TSIEALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF  284 (483)
T ss_dssp             HHH---SCHHHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             ccc---ccHHHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence            100   1111110     0    124578999999999999999999999999999987665443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-44  Score=329.63  Aligned_cols=261  Identities=20%  Similarity=0.288  Sum_probs=197.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEec--CCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDD--RDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~  134 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+.....  .+.+.+|+.+++.++ ||||+++++++.+  ....++||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECC--CCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            34567899999999999998755  67789999876443  456889999999997 9999999999987  56789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~~~  213 (368)
                      ||+.+++|..++.      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++ .+||+|||+++....
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999885      378999999999999999999999   999999999999999766 899999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQ-LLTSLAGSM  291 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~  291 (368)
                      ....                ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .........
T Consensus       184 ~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~  247 (330)
T 3nsz_A          184 GQEY----------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  247 (330)
T ss_dssp             TCCC----------------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             CCcc----------------ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence            2211                22358999999999987 67899999999999999999999999654322 111111111


Q ss_pred             hhhhhhhh---------hcchhhhcCC--------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADCE---------ATKVNELVDP--------RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~~---------~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ........         ..........        ..........+..+.+||..||+.||.+|||++++++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11000000         0000000000        01111112245689999999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.4e-45  Score=324.13  Aligned_cols=245  Identities=19%  Similarity=0.225  Sum_probs=195.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+++|+....   ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRL--DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcC--CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            445677899999999999998754  5678899976542   34456788899999999 89999999999999999999


Q ss_pred             EEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC--------------
Q 017627          133 LFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH--------------  197 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~--------------  197 (368)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999987431 125689999999999999999999999   99999999999999844              


Q ss_pred             -----CceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHh
Q 017627          198 -----LNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVT  271 (368)
Q Consensus       198 -----~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~  271 (368)
                           ..+||+|||.+.......                   ...||+.|+|||++.+. .++.++||||||+++|+|++
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-------------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-------------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG  226 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-------------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCceEEEEcccccccccCCcc-------------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence                 479999999987543221                   12489999999999876 56689999999999999999


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      |.+|+.....  .....                ....+...    ...+..+.+|+..||+.||.+|||+.++++|
T Consensus       227 ~~~~~~~~~~--~~~~~----------------~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          227 AEPLPRNGDQ--WHEIR----------------QGRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             CCCCCSSSHH--HHHHH----------------TTCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCCCcchhH--HHHHH----------------cCCCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            9887744321  11100                00011111    1234578999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=333.84  Aligned_cols=270  Identities=20%  Similarity=0.284  Sum_probs=202.2

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC-ChhHHHHHHHHHHHHhcCCCCceeeeeEEEe----cCCeeE
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-SDRLSQVFKQELDILLHLSHDNIVKLIGYCD----DRDEGV  131 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~  131 (368)
                      ..|.+.+.||+|+||.||+|....  ++..+|+|+... .....+.+.+|+.+++.++||||+++++++.    .....+
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLH--DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETT--TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecC--CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            345678899999999999998755  667889996543 4456678899999999999999999999986    334789


Q ss_pred             EEEecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          132 LLFEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      +||||+.+++|.+++.... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999887421 246789999999999999999999999   999999999999999999999999999864


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcc--hhhH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM---ASTKTDVYSFGVILLELVTGMEAFCPENG--QLLT  285 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~  285 (368)
                      ........      .............||+.|+|||++.+..   ++.++||||||+++|+|++|..||.....  ....
T Consensus       184 ~~~~~~~~------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  257 (317)
T 2buj_A          184 ACIHVEGS------RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA  257 (317)
T ss_dssp             SCEEEESH------HHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred             cccccccc------cccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence            32111000      0000000112345799999999997654   68899999999999999999999943110  0000


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      ..               ...    ..........+..+.++|..||+.||.+|||+.+++++|+.+....+
T Consensus       258 ~~---------------~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          258 LA---------------VQN----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             HH---------------HHC----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             HH---------------hhc----cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            00               000    00111112334679999999999999999999999999998765443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.4e-46  Score=332.81  Aligned_cols=265  Identities=23%  Similarity=0.334  Sum_probs=184.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+++|+....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAP--KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhheeccccceEEEEEEECC--CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            34567889999999999998644  5678999976543  2345678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          136 YVPNGTLQEKLHGT-----PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       136 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      |+.+++|.+++...     .....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999988631     1245689999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .........          ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.............
T Consensus       171 ~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  240 (303)
T 2vwi_A          171 LATGGDITR----------NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL  240 (303)
T ss_dssp             CC-------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             eccCCCccc----------hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh
Confidence            433211100          011123469999999999976 578999999999999999999999997755432221110


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .  ....    .......++....    ..+..+.+++..||+.||.+|||+.++++|
T Consensus       241 ~--~~~~----~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          241 Q--NDPP----SLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             T--SSCC----CTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             c--cCCC----ccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0  0000    0000011111111    224578999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=326.62  Aligned_cols=249  Identities=25%  Similarity=0.304  Sum_probs=195.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-----hhHHHHHHHHHHHHhcCCCCceeeeeEEEe--cCCeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSHDNIVKLIGYCD--DRDEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~  131 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+....     ......+.+|+.+++.++||||+++++++.  +.+..+
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSE--TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTT--TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             eeEeeEEecCCCeEEEEEEECC--CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            4567889999999999998654  6778899987543     234567889999999999999999999984  456789


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+.++ |.+++... ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999999766 76766643 345799999999999999999999999   9999999999999999999999999999754


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC--CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA--STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......             .......||+.|+|||++.+...  +.++||||||+++|+|++|..||...+.........
T Consensus       160 ~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  226 (305)
T 2wtk_C          160 HPFAAD-------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG  226 (305)
T ss_dssp             CTTCSS-------------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             Cccccc-------------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh
Confidence            321110             01123458999999999986543  779999999999999999999998765432222111


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..                ...    .+...+..+.+|+.+||+.||.+|||++++++|
T Consensus       227 ~~----------------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 KG----------------SYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HC----------------CCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cC----------------CCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10                001    111234578899999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-45  Score=335.40  Aligned_cols=267  Identities=21%  Similarity=0.291  Sum_probs=206.4

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc------eeeeeEEEecCCee
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN------IVKLIGYCDDRDEG  130 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~  130 (368)
                      ..|.+.+.||+|+||.||+|.+... ....+|+|+........+.+.+|+.+++.++|++      ++.+++++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTT-TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCC-CceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            3566788999999999999987542 3478999998877777788899999999997655      99999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeee----------------
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL----------------  194 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv----------------  194 (368)
                      ++||||+ +++|.+++... ....+++..++.++.||+.||.|||++   +|+||||||+|||+                
T Consensus        98 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence            9999999 66676666543 235689999999999999999999999   99999999999999                


Q ss_pred             ---cCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh
Q 017627          195 ---EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT  271 (368)
Q Consensus       195 ---~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  271 (368)
                         +.++.+||+|||+++......                  ....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH------------------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC------------------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccCCCcEEEeecCccccccccc------------------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence               567899999999997532211                  12459999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchhhHHHHHhhhhhhhhhhhcc-----------------------hhhhcCC-CCCCCCCHHHHHHHHHHH
Q 017627          272 GMEAFCPENGQLLTSLAGSMLNDIADCEATK-----------------------VNELVDP-RLAGDFDLDEARAMLSIA  327 (368)
Q Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~-~~~~~~~~~~~~~l~~li  327 (368)
                      |..||...................+......                       ......+ ..........+..+.+||
T Consensus       235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence            9999987765444433333322211100000                       0000000 000112234567899999


Q ss_pred             HHhcCCCCCCCCCHHHHHHH
Q 017627          328 ALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       328 ~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..||+.||.+|||+.++++|
T Consensus       315 ~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          315 RRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHhcCChhhCcCHHHHhcC
Confidence            99999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.5e-45  Score=324.79  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=195.9

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      ..||+|+||.||+|.+..  ++..+++|+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++
T Consensus        28 ~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLS--NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             CEEEECSSSEEEEEEETT--TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             EEEeecCcEEEEEEEECC--CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            379999999999998755  6678899976543 3446778899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-CCceEEeeccccccCCCCCCCCCC
Q 017627          142 LQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       142 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      |.+++........+++..+..++.|++.||.|||++   +|+|+||||+||+++. ++.+||+|||+++........   
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~---  179 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---  179 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc---
Confidence            999998654445678999999999999999999999   9999999999999987 899999999999754322110   


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM--ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  .....||+.|+|||++.+..  ++.++||||||+++|+|++|..||...............       
T Consensus       180 ------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------  240 (295)
T 2clq_A          180 ------------TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-------  240 (295)
T ss_dssp             -------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-------
T ss_pred             ------------ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-------
Confidence                        01245899999999997653  789999999999999999999999654332111100000       


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                            ....+.    .+...+..+.+|+..||+.||.+|||+.++++|
T Consensus       241 ------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 ------FKVHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ------HCCCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ------cccccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  001111    222335688999999999999999999999976

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-45  Score=363.39  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=207.0

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      ...+.+.+.||+|+||.||+|.+... .....+|+|....  .....+.+.+|+.+++.++||||+++++++. .+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            34566788999999999999987643 2456788987654  3445578899999999999999999999985 467899


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+.+++|.+++...  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       468 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            99999999999999742  34689999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  291 (368)
                      .....              ......||+.|+|||++.+..++.++||||||+++|||++ |..||.+.........+.. 
T Consensus       543 ~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-  607 (656)
T 2j0j_A          543 DSTYY--------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-  607 (656)
T ss_dssp             C------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-
T ss_pred             CCcce--------------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-
Confidence            22211              1122347889999999999999999999999999999997 9999977654332221111 


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                    ....    ..+..++..+.+|+..||+.||.+|||+.++++.|++++.+
T Consensus       608 --------------~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          608 --------------GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             --------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------CCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                          0001    11223356889999999999999999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-46  Score=344.47  Aligned_cols=252  Identities=12%  Similarity=0.057  Sum_probs=178.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcC--CCCceeeee-------EEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHL--SHDNIVKLI-------GYCD  125 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~~  125 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+....    ....+.+.+|+.+++.|  +||||++++       +++.
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVE--RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeccCCCCEEEEEEEECC--CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3467789999999999999755  6788999987763    24456677885555544  699988755       5554


Q ss_pred             cC-----------------CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCe
Q 017627          126 DR-----------------DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNR------MAIAFQLAQAIEYLHERCTLHI  182 (368)
Q Consensus       126 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~~~i  182 (368)
                      ..                 ...++||||+. ++|.+++...  +..++....      ..++.||+.||.|||++   +|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence            33                 33799999997 8999999753  223344445      67779999999999999   99


Q ss_pred             EEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhH
Q 017627          183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVY  260 (368)
Q Consensus       183 vH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diw  260 (368)
                      +||||||+|||++.++.+||+|||+|+......                  ....||+.|+|||++.+  ..++.++|||
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~~~Diw  277 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG------------------PASSVPVTYAPREFLNASTATFTHALNAW  277 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE------------------EGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc------------------cCccCCcCCcChhhccCCCCCcCccccHH
Confidence            999999999999999999999999997532111                  12357799999999987  6899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 017627          261 SFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS  340 (368)
Q Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  340 (368)
                      ||||++|+|++|..||..........+.           ....................+..+.+||..||+.||.+|||
T Consensus       278 SlG~il~elltg~~Pf~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  346 (371)
T 3q60_A          278 QLGLSIYRVWCLFLPFGLVTPGIKGSWK-----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL  346 (371)
T ss_dssp             HHHHHHHHHHHSSCSTTBCCTTCTTCCC-----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred             HHHHHHHHHHhCCCCCCCcCcccccchh-----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC
Confidence            9999999999999999765422110000           00000011111111111234568999999999999999999


Q ss_pred             HHHHHHH
Q 017627          341 ATQILHT  347 (368)
Q Consensus       341 ~~~il~~  347 (368)
                      +.++++|
T Consensus       347 ~~e~l~h  353 (371)
T 3q60_A          347 PLEAMET  353 (371)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-44  Score=324.32  Aligned_cols=249  Identities=26%  Similarity=0.292  Sum_probs=200.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----------hHHHHHHHHHHHHhcCC-CCceeeeeEEEecC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----------RLSQVFKQELDILLHLS-HDNIVKLIGYCDDR  127 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----------~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  127 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+.....          ...+.+.+|+.+++.+. ||||+++++++.+.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cceeeeecCCCceEEEEEEEcC--cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            4567889999999999998755  67889999875432          33466789999999995 99999999999999


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      +..++||||+.+++|.+++..   ...+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999973   45789999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR------TGMASTKTDVYSFGVILLELVTGMEAFCPENG  281 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (368)
                      +........                .....||+.|+|||++.      ...++.++||||||+++|+|++|..||...+.
T Consensus       171 ~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  234 (298)
T 1phk_A          171 SCQLDPGEK----------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  234 (298)
T ss_dssp             CEECCTTCC----------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hhhcCCCcc----------------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence            875432211                12245899999999985      45678899999999999999999999977654


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ............                ..........+..+.+|+..||+.||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          235 MLMLRMIMSGNY----------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHHHHHHHTCC----------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhcCCc----------------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            332221111000                00001112335679999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.6e-45  Score=330.09  Aligned_cols=251  Identities=27%  Similarity=0.357  Sum_probs=195.1

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---------hHHHHHHHHHHHHhcCCCCceeeeeEEEec
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---------RLSQVFKQELDILLHLSHDNIVKLIGYCDD  126 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  126 (368)
                      ...|.+.+.||+|+||.||+|.+..  ++..+|+|+.....         .....+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERK--TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcC--CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            4567788999999999999998755  67889999875432         123457889999999999999999999976


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc---eEEe
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLC  203 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~---vkl~  203 (368)
                      .+ .++||||+.+++|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.   +||+
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             Cc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence            54 899999999999999987   456799999999999999999999999   9999999999999987654   9999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      |||+++......                ......||+.|+|||++.   ...++.++|||||||++|+|++|..||....
T Consensus       160 Dfg~~~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          160 DFGHSKILGETS----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             CCTTCEECCCCH----------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             cCccceeccccc----------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            999997532111                112346899999999974   4678899999999999999999999997654


Q ss_pred             ch-hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          281 GQ-LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       281 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .. ............       .....         ....+..+.+|+..||+.||.+|||+.++++|
T Consensus       224 ~~~~~~~~~~~~~~~-------~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          224 TQVSLKDQITSGKYN-------FIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CSSCHHHHHHHTCCC-------CCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hHHHHHHHHHhCccc-------cCchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            32 111111110000       00000         01124578999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.6e-45  Score=337.46  Aligned_cols=261  Identities=20%  Similarity=0.232  Sum_probs=197.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCee----
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG----  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----  130 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+...   .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECC--CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            34567789999999999998755  678899998764   344567788999999999999999999999877655    


Q ss_pred             --EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          131 --VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       131 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                        ++||||+. ++|.+++.     ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999996 68887774     3489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      +......                  ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......
T Consensus       192 ~~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          192 RHADAEM------------------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             --------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccCc------------------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            7432211                  22458999999999987 6889999999999999999999999987664433332


Q ss_pred             HHhhhhhhhhhhhcc--------hhhhcCCCCCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEATK--------VNELVDPRLAGDF---DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...............        ............+   ....+..+.+||..||+.||.+|||++++++|
T Consensus       254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            222111111000000        0000001011000   11235689999999999999999999999988

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-44  Score=330.29  Aligned_cols=274  Identities=20%  Similarity=0.295  Sum_probs=208.7

Q ss_pred             ccCHHHHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhc--CCCCceeeeeEEEe
Q 017627           48 KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH--LSHDNIVKLIGYCD  125 (368)
Q Consensus        48 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~  125 (368)
                      .+...+.....|.+.+.||+|+||.||+|.+    .+..+|+|+....  ....+.+|++++..  ++||||+++++++.
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE----TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE----cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            3344555566778889999999999999986    3678899987543  34567788888887  78999999999998


Q ss_pred             cCC----eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEecCCCCCee
Q 017627          126 DRD----EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH--------ERCTLHIVHGDIKASNIL  193 (368)
Q Consensus       126 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dikp~Nil  193 (368)
                      ..+    ..++||||+.+++|.+++..    ..+++..++.++.|++.||.|||        ++   +|+||||||+|||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence            776    78999999999999999963    35899999999999999999999        77   9999999999999


Q ss_pred             ecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC------CCcchhhHHHHHHHH
Q 017627          194 LEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM------ASTKTDVYSFGVILL  267 (368)
Q Consensus       194 v~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~  267 (368)
                      ++.++.+||+|||+++.........           ........||+.|+|||++.+..      ++.++||||||+++|
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~  248 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTI-----------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW  248 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEE-----------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred             ECCCCCEEEEECCCceecccccccc-----------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHH
Confidence            9999999999999997543322100           00112246999999999998763      336899999999999


Q ss_pred             HHHhC----------CCCCCCCcch--hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCC-CCHHHHHHHHHHHHHhcCCC
Q 017627          268 ELVTG----------MEAFCPENGQ--LLTSLAGSMLNDIADCEATKVNELVDPRLAGD-FDLDEARAMLSIAALCLRQS  334 (368)
Q Consensus       268 el~~g----------~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~d  334 (368)
                      +|++|          ..||......  .........           ......+.+... .....+..+.+|+..||+.|
T Consensus       249 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  317 (342)
T 1b6c_B          249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV-----------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN  317 (342)
T ss_dssp             HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH-----------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred             HHHhccCcCCcccccccCccccCcCcccHHHHHHHH-----------HHHHhCCCCcccccchhHHHHHHHHHHHHhccC
Confidence            99999          6777654321  111111110           001111111111 12356778999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcccccc
Q 017627          335 PILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       335 P~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      |.+|||+.+++++|+++.++..
T Consensus       318 p~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          318 GAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             GGGSCCHHHHHHHHHHHHHTTC
T ss_pred             hhhCCCHHHHHHHHHHHHHHhc
Confidence            9999999999999999877643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.5e-45  Score=326.81  Aligned_cols=252  Identities=17%  Similarity=0.233  Sum_probs=184.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+....   ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVP--SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             hhhhHHhcCCCCCeEEEEEEecC--CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            34567889999999999998755  6788999977543   222334455566688889999999999999999999999


Q ss_pred             ecccCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGT-PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||+. ++|.+++... .....+++..++.++.|++.||.|||+++  +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9996 5887766531 13567999999999999999999999853  899999999999999999999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL----RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ...                .....||+.|+|||++    .+..++.++||||||+++|+|++|..||.........  ..
T Consensus       163 ~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~  224 (290)
T 3fme_A          163 DVA----------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LK  224 (290)
T ss_dssp             -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HH
T ss_pred             ccc----------------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HH
Confidence            211                1223599999999996    5567899999999999999999999999754322111  00


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...               ............+..+.+|+..||+.||.+|||+.++++|
T Consensus       225 ~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          225 QVV---------------EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HHH---------------HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHh---------------ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            000               0000011111235578999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=335.70  Aligned_cols=265  Identities=21%  Similarity=0.303  Sum_probs=194.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+.+     .+++|+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~-----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG-----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS-----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             eEEeeEeccCCceEEEEEEEcC-----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3467889999999999998643     3677765432   2334557789999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++ ++.+||+|||+++......
T Consensus       110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            99999999999752  34689999999999999999999999   999999999999998 6799999999987532211


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---------GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      ...          .........||+.|+|||++.+         ..++.++||||||+++|+|++|..||..........
T Consensus       184 ~~~----------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  253 (319)
T 2y4i_B          184 AGR----------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW  253 (319)
T ss_dssp             --------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred             ccc----------cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            100          0111123458999999999975         357889999999999999999999997665433221


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCC
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQ  362 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~  362 (368)
                      ....               ...+...   ....+..+.+++..||+.||.+|||+.++++.|+++.++.....+|.
T Consensus       254 ~~~~---------------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~  311 (319)
T 2y4i_B          254 QMGT---------------GMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG  311 (319)
T ss_dssp             HHHT---------------TCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred             Hhcc---------------CCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence            1111               0011110   01123468899999999999999999999999999998877665554

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.7e-45  Score=336.62  Aligned_cols=266  Identities=24%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-----------CCceeeeeEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-----------HDNIVKLIGYCDD  126 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~  126 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+|+|+..........+.+|+.+++.++           ||||+++++++..
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecC--CCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            45678899999999999998755  6788999998877767778889999999886           8999999999876


Q ss_pred             CC----eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec------C
Q 017627          127 RD----EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE------E  196 (368)
Q Consensus       127 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~------~  196 (368)
                      .+    ..++|||++ +++|.+++... ....+++..+..++.||+.||.|||+++  +|+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence            44    789999999 88999998754 3456899999999999999999999953  899999999999994      4


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF  276 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  276 (368)
                      .+.+||+|||+++......                  ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       174 ~~~~kl~Dfg~a~~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEHY------------------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             EEEEEECCCTTCEETTBCC------------------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cceEEEcccccccccCCCC------------------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            4579999999997543211                  1235899999999999999999999999999999999999999


Q ss_pred             CCCcchhh------HHHHHhhhhhhhhhhh---cchhhhcC------C-------------CCCCCCCHHHHHHHHHHHH
Q 017627          277 CPENGQLL------TSLAGSMLNDIADCEA---TKVNELVD------P-------------RLAGDFDLDEARAMLSIAA  328 (368)
Q Consensus       277 ~~~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~------~-------------~~~~~~~~~~~~~l~~li~  328 (368)
                      .+......      ...........+....   ........      .             .....++...+..+.+||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence            86543211      1111111111110000   00000000      0             0011345677889999999


Q ss_pred             HhcCCCCCCCCCHHHHHHH
Q 017627          329 LCLRQSPILRPSATQILHT  347 (368)
Q Consensus       329 ~~l~~dP~~Rpt~~~il~~  347 (368)
                      .||+.||.+|||++++++|
T Consensus       316 ~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          316 PMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             GGGCSSTTTCBCHHHHHTC
T ss_pred             HHhccCccccCCHHHHhhC
Confidence            9999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.8e-45  Score=328.56  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=195.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETT--TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             eeecceeccCCCeEEEEEEEcC--CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            4567889999999999999755  5678889876543 334567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      .+++|.+++..  ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        99 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  171 (302)
T 2j7t_A           99 PGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--  171 (302)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred             CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence            99999998864  235689999999999999999999999   99999999999999999999999999875321110  


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhh-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYL-----RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                                   .......||+.|+|||++     .+..++.++||||||+++|+|++|..||...+..........  
T Consensus       172 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--  236 (302)
T 2j7t_A          172 -------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--  236 (302)
T ss_dssp             -------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--
T ss_pred             -------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc--
Confidence                         011224689999999998     366789999999999999999999999976654322111110  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                              ..     .+  ....+...+..+.+++..||+.||.+|||++++++|
T Consensus       237 --------~~-----~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          237 --------SD-----PP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             --------SC-----CC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             --------cC-----Cc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                    00     00  001112335678999999999999999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-44  Score=325.22  Aligned_cols=264  Identities=25%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-----------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-----------  126 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----------  126 (368)
                      .|.+.+.||+|+||.||+|.+..  ++..+++|+........+.+.+|+.+++.++||||+++++++.+           
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNAL--DSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cchhhheeccCCcEEEEEEEEcC--CCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            45577899999999999998754  67789999887666667889999999999999999999998865           


Q ss_pred             --CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEee
Q 017627          127 --RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCD  204 (368)
Q Consensus       127 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~D  204 (368)
                        .+..++||||+.+++|.+++...  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence              35679999999999999999742  34578899999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchh
Q 017627          205 FGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQL  283 (368)
Q Consensus       205 fg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  283 (368)
                      ||+++.............. .............||+.|+|||++.+. .++.++|||||||++|+|++   ||...... 
T Consensus       160 fg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQ-NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-  234 (303)
T ss_dssp             CCCCSCTTC--------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred             Ccchhhcccccchhccccc-cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence            9999764432111000000 000001112345699999999999865 68999999999999999998   55322111 


Q ss_pred             hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       ........            . ........++...+..+.+++..||+.||.+|||+.++++|
T Consensus       235 -~~~~~~~~------------~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 -VNILKKLR------------S-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             -HHHHHHHH------------S-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -HHHHHhcc------------c-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence             11111100            0 01112222333445678999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=334.60  Aligned_cols=255  Identities=17%  Similarity=0.187  Sum_probs=200.6

Q ss_pred             HHHhhhhcccccceEEEEEEEc---CCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC---CCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLI---NDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS---HDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  131 (368)
                      .|.+.+.||+|+||.||+|.+.   +......+|+|+.....  ...+..|+.++..++   |+||+++++++...+..+
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            4556788999999999999532   23467889999876543  346778888888887   999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-----------CC
Q 017627          132 LLFEYVPNGTLQEKLHGTP--RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-----------HL  198 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-----------~~  198 (368)
                      +||||+.+|+|.+++....  ....+++..++.++.||+.||.|||++   +|+||||||+|||++.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence            9999999999999986421  245699999999999999999999999   9999999999999998           89


Q ss_pred             ceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 017627          199 NCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP  278 (368)
Q Consensus       199 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  278 (368)
                      .+||+|||+|+......             ........+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       221 ~~kl~DFG~a~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFP-------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             TEEECCCTTCEEGGGSC-------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             CEEEeeCchhhhhhccC-------------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence            99999999997432111             01111335699999999999999999999999999999999999999954


Q ss_pred             CcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhcccc
Q 017627          279 ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILR-PSATQILHTIKHQISS  354 (368)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-pt~~~il~~L~~~~~~  354 (368)
                      .....                 ..+...    ....   ...+.+.+++..||+.+|.+| |++.++.+.|++.+.+
T Consensus       288 ~~~~~-----------------~~~~~~----~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          288 NEGGE-----------------CKPEGL----FRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EETTE-----------------EEECSC----CTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCc-----------------eeechh----cccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            32210                 111111    1111   124567889999999999999 6778888888877654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=330.24  Aligned_cols=260  Identities=19%  Similarity=0.216  Sum_probs=196.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe------
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE------  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  129 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+....   ....+.+.+|+.+++.++||||+++++++...+.      
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             EEEeeeEecCCCeEEEEEEECC--CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4466789999999999998755  6788999987542   3445678899999999999999999999987654      


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .++||||+. ++|.+++.     ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            499999996 58877764     2489999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA  288 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  288 (368)
                      ......                  ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+........
T Consensus       175 ~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i  236 (353)
T 3coi_A          175 HADAEM------------------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  236 (353)
T ss_dssp             C--------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred             CCCCCc------------------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            432111                  22468999999999987 67899999999999999999999999876643332222


Q ss_pred             Hhhhhhhhhhhhcc--------hhhhcCCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATK--------VNELVDPRLA---GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..............        ....+.....   .......+..+.+||.+||+.||.+|||++++++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            22111110000000        0000000001   11122446789999999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.6e-45  Score=334.07  Aligned_cols=264  Identities=19%  Similarity=0.256  Sum_probs=200.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhH------------------HHHHHHHHHHHhcCCCCceee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRL------------------SQVFKQELDILLHLSHDNIVK  119 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~------------------~~~~~~E~~~l~~l~h~~iv~  119 (368)
                      .|.+.+.||+|+||.||+|.+    ++..+|+|+.......                  .+.+.+|+.+++.++||||++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ceEEEEEEcCCCCeEEEEEEc----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            345678899999999999987    5788899976543211                  177899999999999999999


Q ss_pred             eeEEEecCCeeEEEEecccCCCHHHH------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCe
Q 017627          120 LIGYCDDRDEGVLLFEYVPNGTLQEK------LHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNI  192 (368)
Q Consensus       120 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Ni  192 (368)
                      +++++.+.+..++||||+.+++|.++      +... ....+++..++.++.|++.||.|||+ +   +|+|+||||+||
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            99999999999999999999999998      5432 25679999999999999999999999 8   999999999999


Q ss_pred             eecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCc-chhhHHHHHHHHHHH
Q 017627          193 LLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MAST-KTDVYSFGVILLELV  270 (368)
Q Consensus       193 lv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~el~  270 (368)
                      +++.++.+||+|||++.......                 .....||+.|+|||++.+. .++. ++||||||+++|+|+
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~~-----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  246 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDKK-----------------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF  246 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTTE-----------------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred             EEcCCCcEEEecccccccccccc-----------------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence            99999999999999997543221                 1224589999999999887 6666 999999999999999


Q ss_pred             hCCCCCCCCcc-hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          271 TGMEAFCPENG-QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       271 ~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +|..||..... ..............+......... ..+..........+..+.+|+..||+.||.+|||++++++|
T Consensus       247 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          247 YNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYP-LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTT-TCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhcc-ccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            99999987654 222221111100000000000000 00000000112345689999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=328.13  Aligned_cols=268  Identities=21%  Similarity=0.276  Sum_probs=192.3

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEe-----------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCD-----------  125 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----------  125 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+.... ....+.+.+|+.+++.++||||+++++++.           
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDND--CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETT--TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             ceeEEEEeccCCCeEEEEEEECC--CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            34567889999999999998755  6788999976544 455677889999999999999999999873           


Q ss_pred             ---cCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceE
Q 017627          126 ---DRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCK  201 (368)
Q Consensus       126 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vk  201 (368)
                         +.+..++||||+. ++|.+++.    ...+++..++.++.|++.||.|||++   +|+||||||+|||++ .++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence               3467899999996 69999985    34689999999999999999999999   999999999999997 567999


Q ss_pred             EeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          202 LCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       202 l~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      |+|||+++........            ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+..
T Consensus       162 l~Dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSH------------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             ECCCTTCBCC--------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EccCccccccCCCccc------------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999854322110            011122357999999998865 678999999999999999999999998766


Q ss_pred             chhhHHHHHhhhhhhhhhhhcch--------hh-hcCCCCC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEATKV--------NE-LVDPRLA-GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ............+..........        .. ...+... .......+..+.+||..||+.||.+|||++++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            43322222111111000000000        00 0000000 00011235689999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-44  Score=327.29  Aligned_cols=267  Identities=23%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcC---CCCceeeeeEEEe-----cC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHL---SHDNIVKLIGYCD-----DR  127 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~  127 (368)
                      |.+.+.||+|+||.||+|.+.. ..+..+|+|+....   ......+.+|+.+++.+   +||||+++++++.     ..
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             eeeeeeecccccEEEEEEEecC-CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            4567889999999999998742 25677888876432   22223456788777766   8999999999987     55


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      ...++||||+. ++|.+++... ....+++..++.++.|++.||.|||++   ||+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             ceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence            67899999996 6999998754 234589999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ++......                ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........
T Consensus       167 ~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  230 (326)
T 1blx_A          167 ARIYSFQM----------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  230 (326)
T ss_dssp             CCCCCGGG----------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccCCC----------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            87532211                11234689999999999999999999999999999999999999987665433322


Q ss_pred             HHhhhhhhhhhhhcch----hhhcC---CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          288 AGSMLNDIADCEATKV----NELVD---PRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      +...............    .....   ......+....+..+.+|+.+||+.||.+|||+.++++|
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2221111000000000    00000   000011122345678999999999999999999999976

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.4e-44  Score=319.36  Aligned_cols=254  Identities=26%  Similarity=0.312  Sum_probs=201.6

Q ss_pred             HHHHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe
Q 017627           53 DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        53 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  129 (368)
                      .....+|.+.+.||+|+||.||+|.+..  ++..+++|+....   ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcC--CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            4445567788999999999999998754  5678899976432   2345678899999999999999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC---CceEEeecc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH---LNCKLCDFG  206 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~---~~vkl~Dfg  206 (368)
                      .++|||++.+++|.+++..   ...+++..++.++.|++.||.|||++   +|+|+||||+||+++.+   +.+||+|||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             EEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence            9999999999999988863   35689999999999999999999999   99999999999999754   469999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      ++........                .....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+......
T Consensus       170 ~~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  232 (287)
T 2wei_A          170 LSTCFQQNTK----------------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK  232 (287)
T ss_dssp             GGGTBCCCSS----------------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cceeecCCCc----------------cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9875332211                0123589999999998764 8899999999999999999999998765443222


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ........      ...     +     .....+..+.+++..||+.||.+|||+.++++|
T Consensus       233 ~~~~~~~~------~~~-----~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          233 RVETGKYA------FDL-----P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HHHHCCCC------CCS-----G-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHcCCCC------CCc-----h-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            11110000      000     0     001224578999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-44  Score=332.39  Aligned_cols=274  Identities=21%  Similarity=0.259  Sum_probs=199.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-----CeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-----DEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  131 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+|+|+...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHKP--TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             eEEeeEEcCCCCeEEEEEEECC--CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            4467889999999999998754  678899998753  334556788999999999999999999988654     6789


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +||||+. ++|.+++..    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        91 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            9999996 689988863    4689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .........     ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..........
T Consensus       163 ~~~~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          163 DESAADNSE-----PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             C---------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccccC-----ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            433211100     0000111123468999999998765 6789999999999999999999999987764433322222


Q ss_pred             hhhhhhhhh------hcchhhhcCC--CCCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCE------ATKVNELVDP--RLAGD----FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~------~~~~~~~~~~--~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .........      .....+....  .....    .....+..+.+||..||+.||.+|||++++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            211110000      0000000000  00000    001235678999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-44  Score=333.67  Aligned_cols=265  Identities=19%  Similarity=0.223  Sum_probs=191.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC------------hhHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS------------DRLSQVFKQELDILLHLSHDNIVKLIGYCD  125 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  125 (368)
                      .|.+.+.||+|+||.||+|.+.   .+..+|+|+....            ....+.+.+|+.+++.++||||+++++++.
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ceEEeEEeccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            3445678999999999999853   3677888865331            223477899999999999999999999984


Q ss_pred             c-----CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCce
Q 017627          126 D-----RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNC  200 (368)
Q Consensus       126 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~v  200 (368)
                      .     ....++||||+. ++|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCE
Confidence            3     346899999996 688887764  345789999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 017627          201 KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPE  279 (368)
Q Consensus       201 kl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~  279 (368)
                      ||+|||+++.......                .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus       174 kl~Dfg~~~~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          174 TICDFNLAREDTADAN----------------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             EECCTTC-------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EEEecCcccccccccc----------------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999999974222111                123468999999999977 67899999999999999999999999876


Q ss_pred             cchhhHHHHHhhhhhhhhh-----hhcchhhhcCCCCCC---C----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          280 NGQLLTSLAGSMLNDIADC-----EATKVNELVDPRLAG---D----FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~---~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ...................     ...............   .    .....+..+.+||..||+.||.+|||+.++++|
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            6443333222221111100     000011111111100   0    011224678999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.1e-44  Score=326.68  Aligned_cols=252  Identities=22%  Similarity=0.272  Sum_probs=172.5

Q ss_pred             HHh-hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec----CCeeEEE
Q 017627           59 QNF-SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD----RDEGVLL  133 (368)
Q Consensus        59 ~~~-~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  133 (368)
                      |.+ .+.||+|+||.||+|.+..  ++..+|+|+........+.   ....++.++||||+++++++..    ....++|
T Consensus        30 y~i~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           30 YQLSKQVLGLGVNGKVLECFHRR--TGQKCALKLLYDSPKARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESSHHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             eEecceeeeeCCCeEEEEEEECC--CCCEEEEEEecCcHHHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            334 3569999999999998765  6788999988765443332   3334667799999999999875    4458999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeecccccc
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKM  210 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~  210 (368)
                      |||+.+++|.+++... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|||+++.
T Consensus       105 ~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          105 MECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            9999999999999854 335799999999999999999999999   9999999999999986   45599999999975


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .....                 .....||+.|+|||++.+..++.++||||||+++|+|++|..||..............
T Consensus       181 ~~~~~-----------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (336)
T 3fhr_A          181 TTQNA-----------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR  243 (336)
T ss_dssp             C---------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             ccccc-----------------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence            33211                 1224589999999999888899999999999999999999999976554322111100


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ....         .   ............+..+.+||..||+.||.+|||+.++++|-
T Consensus       244 ~~~~---------~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          244 RIRL---------G---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhhc---------c---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000         0   00001111123456899999999999999999999999963

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.3e-44  Score=321.22  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=192.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCC--CCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLS--HDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||.||+|.+.   .+..+|+|+...   .....+.+.+|+.++..++  ||||+++++++.+.+..++|
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEecCCCCEEEEEEEcC---CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            456788999999999999863   366788887643   3455678899999999997  59999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      || +.+++|.+++..   ...+++..++.++.|++.||.|||++   +|+||||||+|||+++ +.+||+|||+++....
T Consensus       107 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          107 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             Ee-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            99 558899999983   45789999999999999999999999   9999999999999975 7999999999975432


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-----------GMASTKTDVYSFGVILLELVTGMEAFCPENGQ  282 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  282 (368)
                      ....             .......||+.|+|||++.+           ..++.++||||||+++|+|++|..||......
T Consensus       179 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          179 DTTS-------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             ------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             cccc-------------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            2110             00123469999999999876           46888999999999999999999999654322


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..                 ......++.....++...+..+.+++..||+.||.+|||+.++++|.
T Consensus       246 ~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          246 IS-----------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HH-----------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HH-----------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            11                 01111111111122222245789999999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-44  Score=326.94  Aligned_cols=240  Identities=22%  Similarity=0.316  Sum_probs=194.6

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-------HHHHHHHHHHHHhcCC--CCceeeeeEEEecC
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-------LSQVFKQELDILLHLS--HDNIVKLIGYCDDR  127 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~  127 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+......       ..+.+.+|+.+++.++  |+||+++++++.+.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETT--TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CceEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            345677899999999999998755  678899997654321       2245667999999996  59999999999999


Q ss_pred             CeeEEEEecccC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceEEeec
Q 017627          128 DEGVLLFEYVPN-GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCKLCDF  205 (368)
Q Consensus       128 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vkl~Df  205 (368)
                      +..++|||++.+ ++|.+++..   ...+++..++.++.|++.||.|||++   +|+||||||+|||++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999975 899999873   45789999999999999999999999   999999999999999 7899999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhh
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLL  284 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~  284 (368)
                      |+++.......                 ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||......  
T Consensus       195 g~~~~~~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--  255 (320)
T 3a99_A          195 GSGALLKDTVY-----------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--  255 (320)
T ss_dssp             TTCEECCSSCB-----------------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--
T ss_pred             ccccccccccc-----------------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--
Confidence            99976432211                 12358999999999987765 67899999999999999999999643210  


Q ss_pred             HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          285 TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                         .    .       ..      ....    ...+..+.+||.+||+.||.+|||++++++|
T Consensus       256 ---~----~-------~~------~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          256 ---I----R-------GQ------VFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---H----H-------CC------CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---h----c-------cc------cccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0    0       00      0011    1224578999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=323.65  Aligned_cols=243  Identities=23%  Similarity=0.356  Sum_probs=190.0

Q ss_pred             HHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChh-------HHHHHHHHHHHHhcC----CCCceeeeeEE
Q 017627           55 ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDR-------LSQVFKQELDILLHL----SHDNIVKLIGY  123 (368)
Q Consensus        55 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~E~~~l~~l----~h~~iv~~~~~  123 (368)
                      ....|.+.+.||+|+||.||+|.+..  ++..+++|+......       ....+.+|+.++..+    +||||++++++
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLT--DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTT--TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEcc--CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34556788999999999999998654  677899998755421       223455799999998    89999999999


Q ss_pred             EecCCeeEEEEec-ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec-CCCceE
Q 017627          124 CDDRDEGVLLFEY-VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE-EHLNCK  201 (368)
Q Consensus       124 ~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~vk  201 (368)
                      +.+.+..++|||+ +.+++|.+++..   ...+++..++.++.|++.||.|||++   +|+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 788999999973   45689999999999999999999999   999999999999999 889999


Q ss_pred             EeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCc
Q 017627          202 LCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMAS-TKTDVYSFGVILLELVTGMEAFCPEN  280 (368)
Q Consensus       202 l~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~  280 (368)
                      |+|||+++.......                 ....||+.|+|||++.+..+. .++||||||+++|+|++|..||....
T Consensus       181 l~dfg~~~~~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  243 (312)
T 2iwi_A          181 LIDFGSGALLHDEPY-----------------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ  243 (312)
T ss_dssp             ECCCSSCEECCSSCB-----------------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred             EEEcchhhhcccCcc-----------------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence            999999976433211                 123589999999999877664 58999999999999999999996432


Q ss_pred             chhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..     .    ..             ..    .++...+..+.+||..||+.||.+|||++++++|-
T Consensus       244 ~~-----~----~~-------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          244 EI-----L----EA-------------EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             HH-----H----HT-------------CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             HH-----h----hh-------------cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            10     0    00             00    01122345789999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.2e-43  Score=320.75  Aligned_cols=253  Identities=23%  Similarity=0.294  Sum_probs=175.1

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHH-HHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELD-ILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||.||+|.+..  ++..+|+|+....  ......+..|+. +++.++||||+++++++.+.+..++||||
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~  102 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKP--SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL  102 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETT--TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hehheeccCCCEEEEEEEEcC--CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence            356789999999999998754  6788999977553  333445555665 77778999999999999999999999999


Q ss_pred             ccCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          137 VPNGTLQEKLHGT--PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       137 ~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      +.+ +|.+++...  .....+++..+..++.|++.||.|||++.  +|+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            965 777766521  12467899999999999999999999853  7999999999999999999999999999753322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL----RTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ..                .....||+.|+|||++    .+..++.++||||||+++|+|++|..||........  ..  
T Consensus       180 ~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~--  239 (327)
T 3aln_A          180 IA----------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL--  239 (327)
T ss_dssp             ------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             cc----------------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH--
Confidence            11                1223589999999998    456789999999999999999999999975432100  00  


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ........+.+........+..+.+|+..||+.||.+|||+.++++|
T Consensus       240 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          240 ----------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ----------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ----------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                      00000011111111112335689999999999999999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.1e-43  Score=328.70  Aligned_cols=252  Identities=19%  Similarity=0.244  Sum_probs=183.8

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecccC
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      ..+.||+|+||+||.+...   ++..||+|+....  ..+.+.+|+.+++.+ +|||||++++++.+.+..++|||||. 
T Consensus        19 ~~~~LG~G~~g~V~~~~~~---~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSF---QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEECSTTCEEEEEES---SSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             ccCeEeeCCCeEEEEEEEE---CCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            3467999999999865432   5678999976543  235677899999876 89999999999999999999999995 


Q ss_pred             CCHHHHhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-------------CceEE
Q 017627          140 GTLQEKLHGTPRSS----KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-------------LNCKL  202 (368)
Q Consensus       140 ~~L~~~l~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-------------~~vkl  202 (368)
                      ++|.+++.......    ..++..++.++.||+.||.|||++   +|+||||||+|||++.+             +.+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            69999998542111    112334578999999999999999   99999999999999754             47999


Q ss_pred             eeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-------CCCCcchhhHHHHHHHHHHHh-CCC
Q 017627          203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-------GMASTKTDVYSFGVILLELVT-GME  274 (368)
Q Consensus       203 ~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~~  274 (368)
                      +|||+++.........           ........||+.|+|||++.+       ..++.++|||||||++|||++ |..
T Consensus       170 ~DFG~a~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSF-----------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             CCCTTCEECCC-------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccceecCCCCccc-----------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence            9999998643322100           001123569999999999976       568999999999999999999 999


Q ss_pred             CCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          275 AFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       275 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ||........ .....              ....+..........+.++.+||..||+.||.+|||+.++++|
T Consensus       239 Pf~~~~~~~~-~i~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          239 PFGDKYSRES-NIIRG--------------IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TTCSTTTHHH-HHHHT--------------CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCchhhHH-HHhcC--------------CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            9965433211 11000              0000111122345677899999999999999999999999976

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.5e-43  Score=342.33  Aligned_cols=275  Identities=22%  Similarity=0.268  Sum_probs=204.3

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec------CC
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD------RD  128 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~  128 (368)
                      ..|.+.+.||+|+||.||+|.+..  ++..+|+|+...  .....+.+.+|+.+++.++||||+++++++..      .+
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~--tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQD--TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTT--TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            456788999999999999998644  678899998654  34556778899999999999999999998765      66


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCc---eEEeec
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLN---CKLCDF  205 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~---vkl~Df  205 (368)
                      ..++||||+.+++|.+++........+++..++.++.|++.||.|||++   +|+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999998765555789999999999999999999999   9999999999999997665   999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          206 GSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       206 g~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      |++.........                ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+...... 
T Consensus       169 G~a~~~~~~~~~----------------~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-  231 (676)
T 3qa8_A          169 GYAKELDQGELC----------------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-  231 (676)
T ss_dssp             CCCCBTTSCCCC----------------CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-
T ss_pred             cccccccccccc----------------ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-
Confidence            999754322211                224699999999999999999999999999999999999999976432110 


Q ss_pred             HHHHhhhhhhhh--hhhcchhh----hcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHhcccc
Q 017627          286 SLAGSMLNDIAD--CEATKVNE----LVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ-----ILHTIKHQISS  354 (368)
Q Consensus       286 ~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~-----il~~L~~~~~~  354 (368)
                       +..........  ........    ..............+..+.+|+..||+.||.+|||+++     ..+.++.++..
T Consensus       232 -~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          232 -WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             -SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             -hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence             00000000000  00000000    00011122344567889999999999999999999988     44555655543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=313.90  Aligned_cols=249  Identities=23%  Similarity=0.308  Sum_probs=177.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||.||+|.+..  ++..+++|+.....   ...+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRK--TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             EEEEEEC------CEEEEEETT--TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccceeeecCCeeEEEEEEec--CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            3466789999999999999755  56788999875432   223445555667888899999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |+ ++.+..+...  ....+++..++.++.|++.||.|||+ +   +|+|+||||+||+++.++.+||+|||++......
T Consensus       105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            99 5566655542  24568999999999999999999998 6   8999999999999999999999999998643321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ..                .....||+.|+|||++.     +..++.++||||||+++|+|++|..||........  ...
T Consensus       179 ~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~  240 (318)
T 2dyl_A          179 KA----------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT  240 (318)
T ss_dssp             ------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH
T ss_pred             cc----------------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH
Confidence            11                12245899999999994     45788999999999999999999999976432211  111


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .....            ..+....  ....+..+.+|+..||+.||.+|||++++++|
T Consensus       241 ~~~~~------------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          241 KVLQE------------EPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHHHS------------CCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHhcc------------CCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11110            0000110  11234578999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=325.46  Aligned_cols=249  Identities=20%  Similarity=0.263  Sum_probs=181.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.+.+.||+|+||+|+.... .  ++..||||+......  ..+.+|+.+++.+ +|||||++++++.+.+..++|||||
T Consensus        26 y~~~~~LG~G~~G~V~~~~~-~--~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVYRGM-F--DNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEECGGGCEEEEEE-S--SSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EecCCeeecCcCEEEEEEEE-e--CCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            34567899999999654322 2  567799997754322  2356799999999 7999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-----CCceEEeeccccccCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-----HLNCKLCDFGSAKMGF  212 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-----~~~vkl~Dfg~s~~~~  212 (368)
                      . ++|.+++....  ...+...+..++.||+.||.|||++   +|+||||||+|||++.     ...+||+|||+|+...
T Consensus       101 ~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            5 69999987542  3344556678999999999999999   9999999999999953     2358899999997543


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHH
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR---TGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLA  288 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~  288 (368)
                      ....            .........||+.|+|||++.   +..++.++|||||||++|+|++ |..||............
T Consensus       175 ~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~  242 (432)
T 3p23_A          175 VGRH------------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL  242 (432)
T ss_dssp             -----------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT
T ss_pred             CCCc------------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh
Confidence            2211            011123356999999999997   4567889999999999999999 99999654332211100


Q ss_pred             HhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..          ...     .  ........+..+.+||..||+.||.+|||++++++|
T Consensus       243 ~~----------~~~-----~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          243 GA----------CSL-----D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TC----------CCC-----T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc----------CCc-----c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            00          000     0  001122446678999999999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.3e-41  Score=299.59  Aligned_cols=231  Identities=15%  Similarity=0.100  Sum_probs=182.1

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      +|.+.+.||+|+||.||+|.+..  ++..+|+|+....    ....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTA--LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETT--TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecC--CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            45677899999999999998754  6788999987654    34457788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      |||+.+++|.+++..    + .....+..++.|++.||.|||++   ||+||||||+|||++.+|.+||+++|.      
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~------  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT------  175 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc------
Confidence            999999999999953    2 35567888999999999999999   999999999999999999999985442      


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                                                   ++       .++.++|||||||++|+|++|..||.+.+........     
T Consensus       176 -----------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----  214 (286)
T 3uqc_A          176 -----------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----  214 (286)
T ss_dssp             -----------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----
T ss_pred             -----------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----
Confidence                                         22       3678999999999999999999999875532100000     


Q ss_pred             hhhhhhhcchhhhcCCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          294 DIADCEATKVNELVDPRLA--GDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                .........  .......+..+.+||.+||+.||.+| |+.++++.|+++.....
T Consensus       215 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          215 ----------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             ----------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             ----------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence                      000000000  00111234679999999999999999 99999999999866543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.5e-42  Score=306.08  Aligned_cols=222  Identities=22%  Similarity=0.315  Sum_probs=174.7

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHH-hcCCCCceeeeeEEEec----CCeeEEEEecc
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL-LHLSHDNIVKLIGYCDD----RDEGVLLFEYV  137 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~  137 (368)
                      +.||+|+||.||+|.+..  ++..+|+|+....    ..+.+|+.++ +.++||||+++++++..    ....++||||+
T Consensus        24 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~   97 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKR--TQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   97 (299)
T ss_dssp             EEEEEETTEEEEEEEETT--TCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             cccccCCCeEEEEEEEcC--CCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence            679999999999998755  6788999987654    3456788888 56699999999999876    66789999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeeccccccCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~~~~~  214 (368)
                      .+++|.+++... ....+++..++.++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|||++....  
T Consensus        98 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A           98 DGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             CSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            999999999854 335699999999999999999999999   9999999999999997   7889999999986311  


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                                                         +..++.++|||||||++|+|++|..||...........       
T Consensus       172 -----------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------  209 (299)
T 3m2w_A          172 -----------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------  209 (299)
T ss_dssp             -----------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------
T ss_pred             -----------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------
Confidence                                               23467799999999999999999999976543211100       


Q ss_pred             hhhhhhcchhhhcCCCCCCCCC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFD----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                             .........  ...+    ...+..+.+|+..||+.||.+|||+.++++|
T Consensus       210 -------~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          210 -------MKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             -------SCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   000000000  0111    1235689999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-41  Score=318.63  Aligned_cols=238  Identities=16%  Similarity=0.126  Sum_probs=176.0

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCC-Cce---------ee-------
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSH-DNI---------VK-------  119 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h-~~i---------v~-------  119 (368)
                      .++.||+|+||+||+|.+..  ++..+|||+....    ....+.+.+|+.+++.++| +|.         +.       
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETT--TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EecccccCCCEEEEEEEecC--CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            45689999999999999765  5678999987632    2335678899999999976 211         11       


Q ss_pred             -----eeEEEec-----CCeeEEEEecccCCCHHHHhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEe
Q 017627          120 -----LIGYCDD-----RDEGVLLFEYVPNGTLQEKLHGT----PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHG  185 (368)
Q Consensus       120 -----~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  185 (368)
                           +..++..     ....+++|+++ +++|.+++...    .....+++..+..++.|++.||.|||++   +|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr  235 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT  235 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence                 1111111     12457777776 67999888411    1345578889999999999999999999   99999


Q ss_pred             cCCCCCeeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhh----------ccCCCCc
Q 017627          186 DIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYL----------RTGMAST  255 (368)
Q Consensus       186 Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~  255 (368)
                      ||||+|||++.++.+||+|||+++.....                  ....+| +.|+|||++          .+..++.
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS------------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE------------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc------------------cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence            99999999999999999999998753222                  123457 999999999          5556888


Q ss_pred             chhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCC
Q 017627          256 KTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSP  335 (368)
Q Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  335 (368)
                      ++|||||||++|+|++|+.||...+.....                  ...+...  .    ..+..+.+||..||+.||
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~~------------------~~~~~~~--~----~~~~~~~~li~~~l~~dP  352 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------EWIFRSC--K----NIPQPVRALLEGFLRYPK  352 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTTGGGSCS------------------GGGGSSC--C----CCCHHHHHHHHHHTCSSG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCcchhhhH------------------HHHHhhc--c----cCCHHHHHHHHHHccCCh
Confidence            999999999999999999999765432111                  1111100  0    123579999999999999


Q ss_pred             CCCCCHHHHHHH
Q 017627          336 ILRPSATQILHT  347 (368)
Q Consensus       336 ~~Rpt~~~il~~  347 (368)
                      .+|||+.++++|
T Consensus       353 ~~Rpt~~~~l~~  364 (413)
T 3dzo_A          353 EDRLLPLQAMET  364 (413)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             hhCcCHHHHHhC
Confidence            999998888654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-41  Score=334.01  Aligned_cols=242  Identities=25%  Similarity=0.335  Sum_probs=190.7

Q ss_pred             HHHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCe---
Q 017627           55 ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDE---  129 (368)
Q Consensus        55 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  129 (368)
                      ...+|.+.+.||+|+||.||+|.+... ++..|++|+....  ......+.+|+.++..++||||+++++++...+.   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGG-TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCC-CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            334667888999999999999987532 4577899976533  3455678899999999999999999999987655   


Q ss_pred             --eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          130 --GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       130 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                        .|+||||+.+++|.+++..     .+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence              6999999999999887652     689999999999999999999999   99999999999999985 899999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      ++.....                   ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+......   
T Consensus       228 a~~~~~~-------------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---  284 (681)
T 2pzi_A          228 VSRINSF-------------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---  284 (681)
T ss_dssp             CEETTCC-------------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---
T ss_pred             chhcccC-------------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---
Confidence            9754321                   1245999999999997654 8899999999999999999998864221100   


Q ss_pred             HHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHhcc
Q 017627          288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-ATQILHTIKHQI  352 (368)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~~L~~~~  352 (368)
                                             .........+..+.+||.+||+.||.+||+ ++++.+.|...+
T Consensus       285 -----------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 -----------------------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -----------------------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----------------------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                                   000011223467899999999999999996 555555566554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.4e-41  Score=310.02  Aligned_cols=243  Identities=17%  Similarity=0.147  Sum_probs=182.6

Q ss_pred             HHHHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---------hhHHHHHHHHHHHHhcCC---------CCce
Q 017627           56 RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---------DRLSQVFKQELDILLHLS---------HDNI  117 (368)
Q Consensus        56 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---------~~~~~~~~~E~~~l~~l~---------h~~i  117 (368)
                      ...|.+.+.||+|+||.||+|++    ++..+|+|+....         ....+.+.+|+.+++.++         ||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccchheeeecccCceEEEEEEe----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            45567889999999999999986    4588999976543         223367888999999886         7777


Q ss_pred             eeeeEEEe-----------------c-------------CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 017627          118 VKLIGYCD-----------------D-------------RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL  167 (368)
Q Consensus       118 v~~~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi  167 (368)
                      |++.+++.                 +             .+..++||||+.+|++.+.+..    ..+++..++.++.||
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQL  170 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHH
Confidence            77766542                 2             6789999999999977666642    468999999999999


Q ss_pred             HHHHHHHh-hCCCCCeEEecCCCCCeeecCCC--------------------ceEEeeccccccCCCCCCCCCCCCCCCC
Q 017627          168 AQAIEYLH-ERCTLHIVHGDIKASNILLEEHL--------------------NCKLCDFGSAKMGFSSAVLPPSPSPSPS  226 (368)
Q Consensus       168 ~~~l~~LH-~~~~~~ivH~Dikp~Nilv~~~~--------------------~vkl~Dfg~s~~~~~~~~~~~~~~~~~~  226 (368)
                      +.||.||| ++   +|+||||||+|||++.++                    .+||+|||+|+....             
T Consensus       171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------------  234 (336)
T 2vuw_A          171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------------  234 (336)
T ss_dssp             HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------------
T ss_pred             HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------------
Confidence            99999999 88   999999999999999887                    899999999985322             


Q ss_pred             ccccccceeeecCCCCccchhhccCCCCcchhhHHHHHH-HHHHHhCCCCCCCCcchhhHHHHHhhhhhhhhhhhcchhh
Q 017627          227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVI-LLELVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNE  305 (368)
Q Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (368)
                             ...+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.....  ...........          .
T Consensus       235 -------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~----------~  294 (336)
T 2vuw_A          235 -------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQ----------M  294 (336)
T ss_dssp             -------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHT----------C
T ss_pred             -------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhh----------h
Confidence                   1247999999999998776 889999998777 7778889999832110  00000010000          0


Q ss_pred             hcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HH
Q 017627          306 LVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL-HT  347 (368)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il-~~  347 (368)
                      ..............+.++.+||.+||+.|     |++++| +|
T Consensus       295 ~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          295 TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            00111111123457889999999999976     999999 76

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.8e-35  Score=282.23  Aligned_cols=186  Identities=15%  Similarity=0.111  Sum_probs=129.0

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC-----------hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----------DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-----------~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      ..+.|++|.+..++..-  .+..+++|++...           +...+.|.+|+++|+++ .|+||+++++++++.+..|
T Consensus       241 ~~~~~~~~~h~~~rr~~--fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYF--FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             C-C--------CCEEEE--ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             ccccCCccccccccccc--ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            35677777666554333  5667788876432           23346789999999999 7999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      |||||++|++|.+++.   ..+.++..   .|+.||+.||.|+|++   |||||||||+|||++.+|.+||+|||+|+..
T Consensus       319 LVMEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEEECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EEEecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            9999999999999998   44567665   4789999999999999   9999999999999999999999999999853


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF  276 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  276 (368)
                      ....               ......+||+.|+|||++.+. +..++|+||+|++++++.++..++
T Consensus       390 ~~~~---------------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          390 PQDC---------------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             C------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCCC---------------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            3221               112346799999999999864 567899999999988876654443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.1e-29  Score=244.36  Aligned_cols=187  Identities=15%  Similarity=0.199  Sum_probs=140.3

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEE
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVL  132 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  132 (368)
                      .+.||+|+||.||+|..    ....+++|......         ...+.+.+|+++++.++||||+++..++...+..++
T Consensus       341 ~~~LG~G~fg~Vy~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             -------CCEEEEEEEC----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCEEeeCCCEEEEEEEE----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            46799999999999954    33456666533221         123457899999999999999966666666778899


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      ||||+++++|.+++..           +..++.|++.||.|||++   +|+||||||+|||++.  .+||+|||+|+...
T Consensus       417 VmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          417 MMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            9999999999999873           458999999999999999   9999999999999999  99999999998532


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT--GMASTKTDVYSFGVILLELVTGMEAF  276 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf  276 (368)
                      .....        ............||+.|+|||++.+  ..|+..+|+||..+-..+.+.++.+|
T Consensus       481 ~~~~~--------~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDK--------AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHH--------HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             Ccccc--------ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            21100        0000001124579999999999987  67888899999999988888877766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2e-26  Score=203.98  Aligned_cols=140  Identities=17%  Similarity=0.188  Sum_probs=114.5

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-------------------hHHHHHHHHHHHHhcCCCCceeeeeE
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-------------------RLSQVFKQELDILLHLSHDNIVKLIG  122 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-------------------~~~~~~~~E~~~l~~l~h~~iv~~~~  122 (368)
                      ++.||+|+||.||+|.+ .  ++..+|+|+.....                   .....+.+|+.+++.++  | +++.+
T Consensus        95 ~~~iG~G~~g~Vy~~~~-~--~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYS-E--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             EEEEEECSSEEEEEEEE-T--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             cCEeccCCCceEEEEEe-C--CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            47899999999999997 3  67889999875432                   13456889999999999  4 66666


Q ss_pred             EEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEE
Q 017627          123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKL  202 (368)
Q Consensus       123 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl  202 (368)
                      ++.. +..++||||+++++|.+ +..         .....++.|++.||.|||++   +|+||||||+|||++ ++.+||
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred             EEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence            5543 56799999999999988 431         12447999999999999999   999999999999999 999999


Q ss_pred             eeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc
Q 017627          203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT  250 (368)
Q Consensus       203 ~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  250 (368)
                      +|||+|+                            .+..++|||.+..
T Consensus       234 ~DFG~a~----------------------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          234 IDFPQSV----------------------------EVGEEGWREILER  253 (282)
T ss_dssp             CCCTTCE----------------------------ETTSTTHHHHHHH
T ss_pred             EECCCCe----------------------------ECCCCCHHHHHHH
Confidence            9999986                            5667899998853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.2e-21  Score=171.15  Aligned_cols=133  Identities=23%  Similarity=0.252  Sum_probs=101.6

Q ss_pred             hhhhcccccceEEEEEEEcCCCCcee--EEEEeecCChh-------------------------HHHHHHHHHHHHhcCC
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTN--GAIKIHVGSDR-------------------------LSQVFKQELDILLHLS  113 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~--~aik~~~~~~~-------------------------~~~~~~~E~~~l~~l~  113 (368)
                      +.+.||+|+||.||+|.+..  ++..  +|+|+......                         ....+.+|+.++..++
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~--~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVF--DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEE--TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hCCEEeecceEEEEEEEEcC--CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45679999999999998743  4556  89997543311                         1236788999999998


Q ss_pred             CCce--eeeeEEEecCCeeEEEEecccC-C----CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEe
Q 017627          114 HDNI--VKLIGYCDDRDEGVLLFEYVPN-G----TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH-ERCTLHIVHG  185 (368)
Q Consensus       114 h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~  185 (368)
                      |+++  +.++++    +..++||||+.+ |    +|.++...      .++..+..++.|++.||.||| +.   +|+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            8754  444432    356899999942 3    67665432      224456789999999999999 88   99999


Q ss_pred             cCCCCCeeecCCCceEEeecccccc
Q 017627          186 DIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       186 Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ||||+|||++.  .++|+|||+|..
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEE
T ss_pred             CCCHHHEEEcC--cEEEEECccccc
Confidence            99999999998  899999999963

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=4.7e-18  Score=154.47  Aligned_cols=134  Identities=16%  Similarity=0.178  Sum_probs=95.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-----------------h------HHHHHHHHHHHHhcCCCC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-----------------R------LSQVFKQELDILLHLSHD  115 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-----------------~------~~~~~~~E~~~l~~l~h~  115 (368)
                      |.++..||.|+||.||+|...   .+..+|||+.....                 .      ..-....|...|.+|.+.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~---~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE---KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT---TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEecCEeeeCCceEEEEEECC---CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            345668999999999999853   46789999854220                 0      011234577777777555


Q ss_pred             ceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec
Q 017627          116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE  195 (368)
Q Consensus       116 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~  195 (368)
                      ++.-..-+..  +..++||||+.+++|..+..       .  .....++.|++.+|.+||++   |||||||||.|||++
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence            4432211111  22479999999888865432       1  12356889999999999999   999999999999998


Q ss_pred             CCC----------ceEEeeccccc
Q 017627          196 EHL----------NCKLCDFGSAK  209 (368)
Q Consensus       196 ~~~----------~vkl~Dfg~s~  209 (368)
                      ++|          .+.|+||+-+.
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCE
T ss_pred             CCCCcccccccccceEEEEeCCcc
Confidence            776          38999999875

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=8e-13  Score=115.37  Aligned_cols=137  Identities=18%  Similarity=0.159  Sum_probs=104.2

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-hHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEeccc
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-RLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +...+|.|+.+.||++..    .+..+++|+..... .....+.+|+.+++.|. +..++++++++.+.+..++|||+++
T Consensus        18 ~~~~~~g~s~~~v~~~~~----~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   93 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             EEECCSCCSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             eEeeccCCCCCeEEEEEC----CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence            445678888899999863    24567888765421 12235788999999984 6778899999988889999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC----------------------------------------  178 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  178 (368)
                      |.+|.+.+..        ......++.+++.++..||+..                                        
T Consensus        94 G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           94 GVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             SEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             CeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            9999876321        1123467889999999999810                                        


Q ss_pred             ----------------CCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          179 ----------------TLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       179 ----------------~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                                      ...++|+|++|.||++++++.+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                            0258999999999999877667899999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=3e-11  Score=110.40  Aligned_cols=138  Identities=16%  Similarity=0.259  Sum_probs=101.9

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeec--CCh--hHHHHHHHHHHHHhcCC--CCceeeeeEEEecC---CeeEEEE
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHV--GSD--RLSQVFKQELDILLHLS--HDNIVKLIGYCDDR---DEGVLLF  134 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~--~~~--~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~  134 (368)
                      .|+.|.++.||++...    ...+++|+..  ...  .....+.+|+.+++.|.  +..+++++.++.+.   +..++||
T Consensus        45 ~l~~G~sn~~y~v~~~----~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           45 QFKGGQSNPTFKLVTP----GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             ECCC-CCSCEEEEECS----SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EcCCcccceEEEEEEC----CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            5889999999998742    2456677655  322  22356788999999997  45688899988766   3479999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC------------------------------------  178 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------  178 (368)
                      |+++|..+.+..     ...++......++.+++.+|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999987774321     224678888889999999999999721                                    


Q ss_pred             -------------------CCCeEEecCCCCCeeecCCCc--eEEeecccccc
Q 017627          179 -------------------TLHIVHGDIKASNILLEEHLN--CKLCDFGSAKM  210 (368)
Q Consensus       179 -------------------~~~ivH~Dikp~Nilv~~~~~--vkl~Dfg~s~~  210 (368)
                                         ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               136999999999999997653  68999999864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.8e-11  Score=106.39  Aligned_cols=128  Identities=19%  Similarity=0.166  Sum_probs=94.0

Q ss_pred             ccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc--eeeeeEEEecCCeeEEEEecccCCCHH
Q 017627           66 GSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN--IVKLIGYCDDRDEGVLLFEYVPNGTLQ  143 (368)
Q Consensus        66 G~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~  143 (368)
                      +.|..+.||++...   ++..+++|+....  ....+.+|+.+++.+.+.+  +++++++....+..++|||+++|.+|.
T Consensus        29 ~gg~~~~v~~~~~~---~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQ---GRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             CTTSSCEEEEEECT---TSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCCCceEEEEecC---CCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            35666999998642   3456788876554  2345778999999996444  566888888877899999999998874


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------------
Q 017627          144 EKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC---------------------------------------------  178 (368)
Q Consensus       144 ~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------------  178 (368)
                        ..   .   .+   ...++.+++..+..||+..                                             
T Consensus       104 --~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 --SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             --TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             --cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence              21   1   11   1256777888888888741                                             


Q ss_pred             ----------CCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          179 ----------TLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       179 ----------~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                                ...++|+|++|.||++++++.+.|+||+.+.
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                      1129999999999999887767899999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=5.4e-11  Score=106.06  Aligned_cols=134  Identities=22%  Similarity=0.263  Sum_probs=95.5

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCc--eeeeeEEEecCC---eeEEEEecc
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDN--IVKLIGYCDDRD---EGVLLFEYV  137 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~  137 (368)
                      .++.|....||++.       ..+++|+... ......+.+|+.+++.+. +..  +++++......+   ..|+||+++
T Consensus        27 ~~~~G~~n~v~~v~-------~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN-------RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             EEEECSSEEEEEST-------TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             ecCCCCcceEEEEC-------CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            47889999999762       2467776543 344567889999998883 332  445555443333   348899999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER----------------------------------------  177 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------------------------------------  177 (368)
                      +|.+|.....     ..++..+...++.+++..+..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865332     2356677777888888888888851                                        


Q ss_pred             ---------------CCCCeEEecCCCCCeeecC--CCceEEeecccccc
Q 017627          178 ---------------CTLHIVHGDIKASNILLEE--HLNCKLCDFGSAKM  210 (368)
Q Consensus       178 ---------------~~~~ivH~Dikp~Nilv~~--~~~vkl~Dfg~s~~  210 (368)
                                     ....++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                           0135899999999999998  56689999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=2.2e-07  Score=82.68  Aligned_cols=133  Identities=22%  Similarity=0.267  Sum_probs=90.6

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCC---ceeeeeEEEe-cCCeeEEEEecccC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD---NIVKLIGYCD-DRDEGVLLFEYVPN  139 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~  139 (368)
                      .++.|....||+.   +    ..+++|+. ........+.+|+.+|+.|.+.   .+++.+.+.. ..+..++||++++|
T Consensus        26 ~l~~G~~n~v~~v---g----~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           26 SLGEGFRNYAILV---N----GDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEECSSEEEEEE---T----TTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             ecCCCcceeEEEE---C----CEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            4788888899987   2    34566764 3334456788999999999642   3566676664 44567899999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER------------------------------------------  177 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------  177 (368)
                      ..+.....     ..++......++.++...|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88865322     1134444455555555555555532                                          


Q ss_pred             ---------------CCCCeEEecCCCCCeeecC---CCc-eEEeeccccc
Q 017627          178 ---------------CTLHIVHGDIKASNILLEE---HLN-CKLCDFGSAK  209 (368)
Q Consensus       178 ---------------~~~~ivH~Dikp~Nilv~~---~~~-vkl~Dfg~s~  209 (368)
                                     ....++|+|++|.||+++.   ++. +.|+||+.+.
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                           1225799999999999997   345 5899999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=2.4e-07  Score=80.72  Aligned_cols=134  Identities=19%  Similarity=0.154  Sum_probs=91.4

Q ss_pred             cccccce-EEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecccCCCH
Q 017627           65 IGSGGFS-NVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTL  142 (368)
Q Consensus        65 iG~G~~g-~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  142 (368)
                      +..|..| .||+.....  .+..+.+|+...  .....+.+|+.+|+.|. +--+.++++++.+.+..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~--~~~~~~lk~~~~--~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKP--NAPELFLKHGKG--SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCT--TCCCEEEEEEET--HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecC--CCeEEEEEECCC--CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            4445544 688776432  445567776543  23456788999999884 33477888899888999999999999887


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------------
Q 017627          143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER---------------------------------------------  177 (368)
Q Consensus       143 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------------------  177 (368)
                      .+.....       ......+..++...|..||+.                                             
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            6654321       112223455555555555521                                             


Q ss_pred             ----------CCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          178 ----------CTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       178 ----------~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                                ....++|+|+.|.||+++.++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      01137999999999999988777899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=2e-06  Score=78.06  Aligned_cols=81  Identities=7%  Similarity=0.098  Sum_probs=53.1

Q ss_pred             hhc-ccccceEEEEEEEc--CCC--CceeEEEEeecCChh----HHHHHHHHHHHHhcCC-C--CceeeeeEEEecC---
Q 017627           63 QVI-GSGGFSNVYLARLI--NDS--TSTNGAIKIHVGSDR----LSQVFKQELDILLHLS-H--DNIVKLIGYCDDR---  127 (368)
Q Consensus        63 ~~i-G~G~~g~V~~~~~~--~~~--~~~~~aik~~~~~~~----~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~---  127 (368)
                      +.| +.|....+|+....  ..+  .+..+++|+......    ....+.+|+.+++.|. +  -.+++++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            346 78888999987642  000  145667776543220    1245678999999884 3  3577888887655   


Q ss_pred             CeeEEEEecccCCCHH
Q 017627          128 DEGVLLFEYVPNGTLQ  143 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~  143 (368)
                      +..++|||+++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999886654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.20  E-value=4.5e-06  Score=76.95  Aligned_cols=74  Identities=18%  Similarity=0.120  Sum_probs=46.5

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCCh--------hHHHHHHHHHHHHhcCCC--C-ceeeeeEEEecCCeeE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--------RLSQVFKQELDILLHLSH--D-NIVKLIGYCDDRDEGV  131 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~E~~~l~~l~h--~-~iv~~~~~~~~~~~~~  131 (368)
                      +.||.|.++.||++....  ....+++|......        .....+..|+++++.+..  + .+++++.+  +.+..+
T Consensus        36 ~~lg~G~~n~vyrv~~~~--~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EECCSSSSEEEEEEEC------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EECCCCceEEEEEEEECC--CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            368999999999996433  34567777543221        123456779999888742  3 44566654  344568


Q ss_pred             EEEecccCC
Q 017627          132 LLFEYVPNG  140 (368)
Q Consensus       132 lv~e~~~~~  140 (368)
                      +|||++.+.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.15  E-value=9.7e-06  Score=72.91  Aligned_cols=30  Identities=23%  Similarity=0.316  Sum_probs=27.4

Q ss_pred             CCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          180 LHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      ..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            389999999999999888899999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.01  E-value=4.2e-05  Score=67.78  Aligned_cols=73  Identities=22%  Similarity=0.284  Sum_probs=56.2

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC---CCceeeeeEEEecCCeeEEEEecccCC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS---HDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      .|+.|....+|+...    ....+.+|+....  ....+..|+..|+.|.   ...+++++.+....+..++|||++++.
T Consensus        43 ~l~gG~~n~~y~v~~----~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           43 KLYSGEMNEIWLIND----EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EECCSSSSEEEEEES----SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EeCCccceeeeEEEE----CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            478899999999863    2345667776533  3567888999999884   367888998888788899999999887


Q ss_pred             CH
Q 017627          141 TL  142 (368)
Q Consensus       141 ~L  142 (368)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.99  E-value=6.3e-05  Score=61.95  Aligned_cols=100  Identities=15%  Similarity=0.111  Sum_probs=66.4

Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      .+|.++|..  .+.+++++++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.|.+.+ +.+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            478888876  5678999999999999999988773210  111223457899999999988774 2221          


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhC
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG  272 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  272 (368)
                                       .....+.|||... ...+.+.-|||||+++|.-+--
T Consensus        98 -----------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 -----------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             --------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             -----------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence                             0223466787763 3456788999999999998873

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.76  E-value=7.6e-05  Score=69.25  Aligned_cols=29  Identities=14%  Similarity=0.368  Sum_probs=26.4

Q ss_pred             CeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          181 HIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       181 ~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      .++|+|++|.|||++.++ +.++||+.+..
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            799999999999999876 99999998863

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.69  E-value=8.2e-05  Score=65.67  Aligned_cols=70  Identities=13%  Similarity=0.048  Sum_probs=42.2

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCce-eeeeEEEecCCeeEEEEecc-cCC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNI-VKLIGYCDDRDEGVLLFEYV-PNG  140 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~  140 (368)
                      +.|+.|....+|++        ..+.+|+........-...+|+.+++.+...++ ++++++.  .+..++++||+ ++.
T Consensus        24 ~~l~gG~tN~~~~~--------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           24 LERLGGLTNLVFRA--------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             EEEESCSSEEEEEE--------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eEcCCcccccccee--------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            45788999999988        246677665432211123468888887742222 4555543  34457899999 654


Q ss_pred             CH
Q 017627          141 TL  142 (368)
Q Consensus       141 ~L  142 (368)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.53  E-value=0.00015  Score=66.03  Aligned_cols=142  Identities=17%  Similarity=0.192  Sum_probs=80.9

Q ss_pred             hcccccceEEEEEEEcC-----CCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecc
Q 017627           64 VIGSGGFSNVYLARLIN-----DSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|..|-...+|++...+     ......+.+++............+|..+++.|. +.-.+++++++.+    .+||||+
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i  132 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI  132 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence            36667778899887532     112356788876442223445668999998884 3334667776653    2999999


Q ss_pred             cCCCHHH-----------------HhcCCC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHHh--
Q 017627          138 PNGTLQE-----------------KLHGTP--RSSKLP--WRNRMAIAFQLAQ-------------------AIEYLH--  175 (368)
Q Consensus       138 ~~~~L~~-----------------~l~~~~--~~~~~~--~~~~~~i~~qi~~-------------------~l~~LH--  175 (368)
                      +|.+|..                 .++...  ......  +.++..+..++..                   .+..|.  
T Consensus       133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~  212 (379)
T 3feg_A          133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL  212 (379)
T ss_dssp             SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred             cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence            8755431                 112111  111222  3455555544322                   123332  


Q ss_pred             --hC-CCCCeEEecCCCCCeeecCC----CceEEeeccccc
Q 017627          176 --ER-CTLHIVHGDIKASNILLEEH----LNCKLCDFGSAK  209 (368)
Q Consensus       176 --~~-~~~~ivH~Dikp~Nilv~~~----~~vkl~Dfg~s~  209 (368)
                        .. ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              21 12368999999999999876    789999999885

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.42  E-value=0.00021  Score=66.43  Aligned_cols=73  Identities=22%  Similarity=0.235  Sum_probs=46.8

Q ss_pred             hcccccceEEEEEEEcCC-----CCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc-eeeeeEEEecCCeeEEEEecc
Q 017627           64 VIGSGGFSNVYLARLIND-----STSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN-IVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~-----~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|+.|....||++...+.     .....+.+|+.... .....+.+|..+++.|...+ .+++++.+.+    .+|+||+
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l  154 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  154 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence            467788899999975421     12356788887442 11134457999999885333 3667776543    3899999


Q ss_pred             cCCC
Q 017627          138 PNGT  141 (368)
Q Consensus       138 ~~~~  141 (368)
                      +|.+
T Consensus       155 ~G~~  158 (429)
T 1nw1_A          155 PSRP  158 (429)
T ss_dssp             CEEE
T ss_pred             CCcc
Confidence            7643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.38  E-value=0.00038  Score=62.24  Aligned_cols=31  Identities=32%  Similarity=0.478  Sum_probs=27.1

Q ss_pred             CCeEEecCCCCCeeecCC----CceEEeecccccc
Q 017627          180 LHIVHGDIKASNILLEEH----LNCKLCDFGSAKM  210 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~~----~~vkl~Dfg~s~~  210 (368)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            379999999999999874    6899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.32  E-value=0.00069  Score=63.30  Aligned_cols=73  Identities=15%  Similarity=0.090  Sum_probs=44.3

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCce-eeeeEEEecCCeeEEEEecccCCCH
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNI-VKLIGYCDDRDEGVLLFEYVPNGTL  142 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L  142 (368)
                      .|+.|-...+|++...+  ....+.+|+........-...+|..+++.|...++ +++++++.  +  .+||||++|.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~--~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMS--KQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETT--TTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECC--CCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            46778888999987532  23567788764322111112479999999964444 56777763  2  259999977443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.27  E-value=0.00036  Score=63.39  Aligned_cols=74  Identities=16%  Similarity=0.085  Sum_probs=42.9

Q ss_pred             hcccccceEEEEEEEcCC------CCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc-eeeeeEEEecCCeeEEEEec
Q 017627           64 VIGSGGFSNVYLARLIND------STSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN-IVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~------~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|+.|....+|++...+.      .....+.+|+........-....|..+++.|...+ ++++++..  .  .++||++
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~  115 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW  115 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence            477788889999875321      01246778876554332222357888888885333 44666554  2  3689999


Q ss_pred             ccCCC
Q 017627          137 VPNGT  141 (368)
Q Consensus       137 ~~~~~  141 (368)
                      ++|..
T Consensus       116 i~G~~  120 (369)
T 3c5i_A          116 LYGDP  120 (369)
T ss_dssp             CCSEE
T ss_pred             ecCCc
Confidence            98754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.22  E-value=0.003  Score=56.15  Aligned_cols=140  Identities=16%  Similarity=0.166  Sum_probs=76.1

Q ss_pred             cccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCC--ceeeeeEE-----EecCCeeEEEEecc
Q 017627           65 IGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHD--NIVKLIGY-----CDDRDEGVLLFEYV  137 (368)
Q Consensus        65 iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv~e~~  137 (368)
                      ++ |....||++...   .+..+++|+..........+..|..+++.|...  .+++++..     ....+..+++|+++
T Consensus        34 l~-g~~n~~y~v~~~---~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           34 LN-SYENRVYQFQDE---DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EC-CSSSEEEEECCT---TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             ec-CcccceEEEEcC---CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            55 777789987532   334578887754322345566788888887422  23444433     12244567899999


Q ss_pred             cCCCHH-----H------H---hc----CCCC--CCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 017627          138 PNGTLQ-----E------K---LH----GTPR--SSKLPWRNR----------------------MAIAFQLAQAIEYLH  175 (368)
Q Consensus       138 ~~~~L~-----~------~---l~----~~~~--~~~~~~~~~----------------------~~i~~qi~~~l~~LH  175 (368)
                      +|..+.     .      .   ++    ....  ....+....                      ...+..++..+..+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            774331     0      0   11    0000  011121110                      111112222222221


Q ss_pred             h-CCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          176 E-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       176 ~-~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      . .....++|+|++|.||+++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1123689999999999999 4 899999998753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.22  E-value=0.003  Score=55.94  Aligned_cols=141  Identities=16%  Similarity=0.180  Sum_probs=74.6

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc--eeeeeEE------EecCCeeEEEEe
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN--IVKLIGY------CDDRDEGVLLFE  135 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e  135 (368)
                      .|+.|....+|+....+    ..+++|+.... .....+..|+.+++.|...+  +++++..      ....+..+++|+
T Consensus        29 ~i~~G~~n~~~~v~~~~----g~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTK----DPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EECC---EEEEEEEESS----CCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             ccCCCcccceEEEEeCC----ccEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            46678888899887532    24677776542 12234556888887774212  2333321      122356789999


Q ss_pred             cccCCCHHH--------------Hhc----CCCCC--CCCC---HHHHHH------------HHHHHHHHHHHHhhC---
Q 017627          136 YVPNGTLQE--------------KLH----GTPRS--SKLP---WRNRMA------------IAFQLAQAIEYLHER---  177 (368)
Q Consensus       136 ~~~~~~L~~--------------~l~----~~~~~--~~~~---~~~~~~------------i~~qi~~~l~~LH~~---  177 (368)
                      +++|..+..              .++    .....  ....   +.....            +...+...+..+.+.   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            998764311              011    10000  0011   111000            001133344455421   


Q ss_pred             -CCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          178 -CTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       178 -~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                       ...+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             12379999999999999987666899999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.93  E-value=0.0038  Score=54.46  Aligned_cols=71  Identities=20%  Similarity=0.206  Sum_probs=48.3

Q ss_pred             hcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCC---CceeeeeEEEecCCeeEEEEecccC
Q 017627           64 VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSH---DNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      .+|.|..+.||+....   ++..+.+|+.... ......+..|+..|+.|..   --+++++++.    ..++|||++.+
T Consensus        22 ~~g~G~~~~vyrv~l~---DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~   94 (288)
T 3f7w_A           22 ERGHSHRWHLYRVELA---DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEETTEEEEEEEET---TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred             ecCCCCCeEEEEEEEC---CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence            5899999999999864   3456778875433 2233567889999998842   2345555542    24789999876


Q ss_pred             CC
Q 017627          140 GT  141 (368)
Q Consensus       140 ~~  141 (368)
                      +.
T Consensus        95 ~~   96 (288)
T 3f7w_A           95 RP   96 (288)
T ss_dssp             CC
T ss_pred             cC
Confidence            54

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.67  E-value=0.0097  Score=53.24  Aligned_cols=31  Identities=23%  Similarity=0.425  Sum_probs=27.5

Q ss_pred             CCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       180 ~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888899999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.07  E-value=0.0076  Score=55.60  Aligned_cols=75  Identities=20%  Similarity=0.134  Sum_probs=45.7

Q ss_pred             hcccccceEEEEEEEcCCCC-----ceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecc
Q 017627           64 VIGSGGFSNVYLARLINDST-----STNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~~~-----~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|..|-...+|+....+...     ...+.+++........-...+|..+++.|. +.-.+++++.+.    .++||+|+
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~efI  152 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEFI  152 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEECC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEEe
Confidence            46678888899887642111     466778876543222112357888888884 323455665442    37899999


Q ss_pred             cCCCH
Q 017627          138 PNGTL  142 (368)
Q Consensus       138 ~~~~L  142 (368)
                      +|..|
T Consensus       153 ~G~~l  157 (424)
T 3mes_A          153 DGEPL  157 (424)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            88654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.08  E-value=0.23  Score=40.69  Aligned_cols=83  Identities=7%  Similarity=0.051  Sum_probs=60.3

Q ss_pred             CCCceeeeeEEEecCCeeEEEEecccCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCC
Q 017627          113 SHDNIVKLIGYCDDRDEGVLLFEYVPNG-TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN  191 (368)
Q Consensus       113 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N  191 (368)
                      .||+.+.. .+-.+.+.+.+.++.-..+ ++.. +.      ..+....++++..|+....+++..     +|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            58888866 5666666666666654322 2222 32      467888899999999887666654     788999999


Q ss_pred             eeecCCCceEEeecccc
Q 017627          192 ILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       192 ilv~~~~~vkl~Dfg~s  208 (368)
                      |+++.++.+++.--|+-
T Consensus       110 L~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             EEECTTSCEEESCCEET
T ss_pred             EEEcCCCCEEEEEccCc
Confidence            99999999999877763

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.19  E-value=0.55  Score=38.64  Aligned_cols=83  Identities=12%  Similarity=0.051  Sum_probs=58.9

Q ss_pred             CCCceeeeeEEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEEecCCCCC
Q 017627          113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE-YLHERCTLHIVHGDIKASN  191 (368)
Q Consensus       113 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~Dikp~N  191 (368)
                      .||++  -..+-.+.+.+.+.++.-.++.=...++      ..+....++++..|+.... +++.     -+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57777  4444466677777776543332223343      3678888899888887666 5554     4788999999


Q ss_pred             eeecCCCceEEeecccc
Q 017627          192 ILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       192 ilv~~~~~vkl~Dfg~s  208 (368)
                      |+++.++.++|.-.|+-
T Consensus       115 L~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EEECTTCCEEESCCEET
T ss_pred             EEEeCCCcEEEEEcCCc
Confidence            99999999999977763

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.74  E-value=0.32  Score=44.35  Aligned_cols=30  Identities=33%  Similarity=0.449  Sum_probs=25.2

Q ss_pred             CeEEecCCCCCeee------cCCCceEEeecccccc
Q 017627          181 HIVHGDIKASNILL------EEHLNCKLCDFGSAKM  210 (368)
Q Consensus       181 ~ivH~Dikp~Nilv------~~~~~vkl~Dfg~s~~  210 (368)
                      .++|+|+.+.|||+      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      3466799999998853

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.33  E-value=0.084  Score=49.26  Aligned_cols=59  Identities=5%  Similarity=-0.021  Sum_probs=15.6

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEE------EeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEe
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAI------KIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCD  125 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~ai------k~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  125 (368)
                      .+.||   ||.||+|.+.++  ...||+      |....   .......+.+|..+++.++|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~--~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKK--HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC-----------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhccccccc--CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            34666   999999988552  234555      43222   1223346778999999999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	368
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-44
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 3e-59
 Identities = 83/312 (26%), Positives = 134/312 (42%), Gaps = 47/312 (15%)

Query: 51  WD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQEL 106
           W+    + T    Q IGSG F  VY  +   D      A+K+      + +  Q FK E+
Sbjct: 3   WEIPDGQIT--VGQRIGSGSFGTVYKGKWHGDV-----AVKMLNVTAPTPQQLQAFKNEV 55

Query: 107 DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            +L    H NI+  +GY     +  ++ ++    +L   LH     +K      + IA Q
Sbjct: 56  GVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQ 112

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
            AQ ++YLH +    I+H D+K++NI L E L  K+ DFG A +               S
Sbjct: 113 TAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV-----------KSRWS 158

Query: 227 RSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
            S   +Q+   GS  +  P  +R       S ++DVY+FG++L EL+TG   +       
Sbjct: 159 GSHQFEQLS--GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------- 209

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
                 S +N+            + P L+     +  +AM  + A CL++    RP   Q
Sbjct: 210 ------SNINNRDQIIFMVGRGYLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQ 262

Query: 344 ILHTIKHQISSI 355
           IL +I+    S+
Sbjct: 263 ILASIELLARSL 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 4e-56
 Identities = 63/305 (20%), Positives = 127/305 (41%), Gaps = 43/305 (14%)

Query: 51  WD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL 109
           W+   E       + +G+G F  V++      +  T  A+K           F  E +++
Sbjct: 8   WEVPRETLK--LVERLGAGQFGEVWMGYY---NGHTKVAVKSLKQGSMSPDAFLAEANLM 62

Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
             L H  +V+L       +   ++ EY+ NG+L + L  TP   KL     + +A Q+A+
Sbjct: 63  KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAE 120

Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
            + ++ ER   + +H D++A+NIL+ + L+CK+ DFG A++      +  +   +   ++
Sbjct: 121 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL------IEDNEYTAREGAK 171

Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
                       +T P  +  G  + K+DV+SFG++L E+VT      P           
Sbjct: 172 --------FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------ 217

Query: 290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            ++ ++         +     L              +  LC ++ P  RP+   +   ++
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELY------------QLMRLCWKERPEDRPTFDYLRSVLE 265

Query: 350 HQISS 354
              ++
Sbjct: 266 DFFTA 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 8e-56
 Identities = 58/317 (18%), Positives = 112/317 (35%), Gaps = 52/317 (16%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL 112
           + F       +G+G    V+     +  +    A K+        +     +EL +L   
Sbjct: 6   DDFE--KISELGAGNGGVVFKVS--HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           +   IV   G      E  +  E++  G+L + L    ++ ++P +    ++  + + + 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLT 118

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YL E+    I+H D+K SNIL+      KLCDFG +                      + 
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----------------SM 159

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
               +G+  Y  P  L+    S ++D++S G+ L+E+  G     P + + L  + G  +
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL----------------------- 329
              A     +      P  +   D     A+  +                          
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279

Query: 330 -CLRQSPILRPSATQIL 345
            CL ++P  R    Q++
Sbjct: 280 KCLIKNPAERADLKQLM 296

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 7e-54
 Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 54/303 (17%)

Query: 47  KKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVF 102
           ++++ +D E       + +G G F NVYLAR     +    A+K+     +    +    
Sbjct: 1   RQWALEDFE-----IGRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQL 53

Query: 103 KQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           ++E++I  HL H NI++L GY  D     L+ EY P GT+  +L    + SK   +    
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTAT 110

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
              +LA A+ Y H +    ++H DIK  N+LL      K+ DFG +    S         
Sbjct: 111 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--------- 158

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ 282
                   +++  + G+  Y  P  +   M   K D++S GV+  E + G   F     Q
Sbjct: 159 --------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210

Query: 283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT 342
                       I+  E T   + V                  + +  L+ +P  RP   
Sbjct: 211 -------ETYKRISRVEFT-FPDFVTEGAR------------DLISRLLKHNPSQRPMLR 250

Query: 343 QIL 345
           ++L
Sbjct: 251 EVL 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-54
 Identities = 69/302 (22%), Positives = 117/302 (38%), Gaps = 49/302 (16%)

Query: 51  WD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDIL 109
           W  +++       Q IG G F +V L            A+K  + +D  +Q F  E  ++
Sbjct: 2   WALNMKELK--LLQTIGKGEFGDVMLGDY----RGNKVAVKC-IKNDATAQAFLAEASVM 54

Query: 110 LHLSHDNIVKLIGYCDDRDEGV-LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
             L H N+V+L+G   +   G+ ++ EY+  G+L + L    R S L     +  +  + 
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVC 113

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           +A+EYL      + VH D+ A N+L+ E    K+ DFG  K   S+              
Sbjct: 114 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-------------- 156

Query: 229 RITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
               Q        +T P  LR    STK+DV+SFG++L E+ +      P          
Sbjct: 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----- 207

Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
             ++  +         +   P +              +   C      +RPS  Q+   +
Sbjct: 208 -DVVPRVEKGYKMDAPDGCPPAVY------------EVMKNCWHLDAAMRPSFLQLREQL 254

Query: 349 KH 350
           +H
Sbjct: 255 EH 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 61/324 (18%), Positives = 123/324 (37%), Gaps = 49/324 (15%)

Query: 46  VKKYSWDDVERFTQNFS-----------QVIGSGGFSNVYLARL-INDSTSTNGAIKI-- 91
           +  ++++D     + F+           QVIG+G F  V    L +        AIK   
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 92  HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPR 151
              +++  + F  E  I+    H N++ L G        +++ E++ NG+L         
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQN 121

Query: 152 SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG 211
             +      + +   +A  ++YL +      VH D+ A NIL+  +L CK+ DFG ++  
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT 271
                         S    T  +       +T P  ++    ++ +DV+S+G+++ E+++
Sbjct: 179 ----------EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228

Query: 272 -GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALC 330
            G   +     Q                    V   ++        +D   A+  +   C
Sbjct: 229 YGERPYWDMTNQ-------------------DVINAIEQDYRLPPPMDCPSALHQLMLDC 269

Query: 331 LRQSPILRPSATQILHTIKHQISS 354
            ++    RP   QI++T+   I +
Sbjct: 270 WQKDRNHRPKFGQIVNTLDKMIRN 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (446), Expect = 2e-53
 Identities = 67/311 (21%), Positives = 125/311 (40%), Gaps = 42/311 (13%)

Query: 50  SWDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELD 107
           ++D  E    + +    +G G +  VY         S   A+K         + F +E  
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAA 65

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           ++  + H N+V+L+G C       ++ E++  G L + L    R  ++     + +A Q+
Sbjct: 66  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQI 124

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           + A+EYL ++   + +H D+ A N L+ E+   K+ DFG +++               + 
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--------------MTG 167

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
              T          +T P  L     S K+DV++FGV+L E+ T   +  P         
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------- 220

Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT 347
                      + ++V EL++     +        +  +   C + +P  RPS  +I   
Sbjct: 221 -----------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269

Query: 348 IKH--QISSIS 356
            +   Q SSIS
Sbjct: 270 FETMFQESSIS 280

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 4e-53
 Identities = 58/305 (19%), Positives = 111/305 (36%), Gaps = 36/305 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + IG G F  V+  +          A+KI    +  S   + E+   + L H+NI+  I 
Sbjct: 9   ESIGKGRFGEVWRGKW----RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 64

Query: 123 YCDDRDEGV----LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
             +  +       L+ +Y  +G+L + L+       +     + +A   A  + +LH   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 179 TLH-----IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
                   I H D+K+ NIL++++  C + D G A               S + +     
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-----------HDSATDTIDIAP 169

Query: 234 VMMIGSPGYTDPHYLRTGM------ASTKTDVYSFGVILLELVTGMEAFCP-ENGQLLTS 286
              +G+  Y  P  L   +      +  + D+Y+ G++  E+          E+ QL   
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEA-RAMLSIAALCLRQSPILRPSATQIL 345
                   + +       + + P +   +   EA R M  I   C   +   R +A +I 
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

Query: 346 HTIKH 350
            T+  
Sbjct: 290 KTLSQ 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 5e-53
 Identities = 70/328 (21%), Positives = 122/328 (37%), Gaps = 57/328 (17%)

Query: 51  WD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG---AIKIHVGSDRLSQV--FKQ 104
           W+    R +  F + +G+G F  V  A       S      A+K+   S  L++      
Sbjct: 18  WEFPRNRLS--FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 105 ELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS---------- 153
           EL +L +L  H NIV L+G C      +++ EY   G L   L     S           
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 154 -----KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
                 L   + ++ ++Q+A+ + +L  +   + +H D+ A NILL      K+CDFG A
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
           +                + S    +        +  P  +   + + ++DV+S+G+ L E
Sbjct: 193 RD-------------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239

Query: 269 LVTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAA 328
           L +   +  P                      +K  +++               M  I  
Sbjct: 240 LFSLGSSPYPG-----------------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK 282

Query: 329 LCLRQSPILRPSATQILHTIKHQISSIS 356
            C    P+ RP+  QI+  I+ QIS  +
Sbjct: 283 TCWDADPLKRPTFKQIVQLIEKQISEST 310

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 6e-53
 Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 42/297 (14%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHL 112
           D       F Q IGSG F  V+L   +N       AIK         + F +E ++++ L
Sbjct: 3   DPSEL--TFVQEIGSGQFGLVHLGYWLN---KDKVAIKTIREGAMSEEDFIEEAEVMMKL 57

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           SH  +V+L G C ++    L+FE++ +G L +  +   +         + +   + + + 
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMA 115

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YL E C   ++H D+ A N L+ E+   K+ DFG  +                   + T 
Sbjct: 116 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV--------------LDDQYTS 158

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
                    +  P        S+K+DV+SFGV++ E+ +  +                ++
Sbjct: 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVV 212

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            DI+         L  PRLA          +  I   C ++ P  RP+ +++L  + 
Sbjct: 213 EDIS-----TGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-52
 Identities = 67/321 (20%), Positives = 123/321 (38%), Gaps = 43/321 (13%)

Query: 45  SVKKYSWD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFK 103
            + K +W+   E         +G G F  V++      +     AIK         + F 
Sbjct: 6   GLAKDAWEIPRESLR--LEVKLGQGCFGEVWMGTWNGTTRV---AIKTLKPGTMSPEAFL 60

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           QE  ++  L H+ +V+L       +   ++ EY+  G+L + L G      L     + +
Sbjct: 61  QEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDM 118

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
           A Q+A  + Y+        VH D++A+NIL+ E+L CK+ DFG A++             
Sbjct: 119 AAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI------------ 163

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
               +  T +        +T P     G  + K+DV+SFG++L EL T      P     
Sbjct: 164 --EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN- 220

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
                             +V + V+         +   ++  +   C R+ P  RP+   
Sbjct: 221 -----------------REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEY 263

Query: 344 ILHTIKHQISSISFLFSPQKD 364
           +   ++   +S    + P ++
Sbjct: 264 LQAFLEDYFTSTEPQYQPGEN 284

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (439), Expect = 5e-52
 Identities = 78/326 (23%), Positives = 112/326 (34%), Gaps = 58/326 (17%)

Query: 55  ERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDI 108
           +   + FS  + IG G F  VY AR  +   S   AIK        S+   Q   +E+  
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           L  L H N ++  G         L+ EY                  L      A+     
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGAL 125

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           Q + YLH     +++H D+KA NILL E    KL DFGSA +                  
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------ 164

Query: 229 RITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT 285
            +      +G+P +  P  +     G    K DV+S G+  +EL          N     
Sbjct: 165 -MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--- 220

Query: 286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
               S L  IA  E         P L      +  R  +     CL++ P  RP++  +L
Sbjct: 221 ----SALYHIAQNE--------SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265

Query: 346 H----TIKHQISSISFLFSPQKDPSR 367
                  +   + I  L    KD  R
Sbjct: 266 KHRFVLRERPPTVIMDLIQRTKDAVR 291

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 6e-52
 Identities = 62/306 (20%), Positives = 111/306 (36%), Gaps = 38/306 (12%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLI-NDSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
                  +F++VIG G F  VY   L+ ND    + A+K    +        F  E  I+
Sbjct: 23  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 110 LHLSHDNIVKLIGYC-DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
              SH N++ L+G C       +++  Y+ +G L+        +     ++ +    Q+A
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVA 140

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           +    +    +   VH D+ A N +L+E    K+ DFG A+                   
Sbjct: 141 KG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-----------MYDKEFD 186

Query: 229 RITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
            +  +        +     L+T   +TK+DV+SFGV+L EL+T      P+         
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----- 241

Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI 348
             +   +         E     L              +   C      +RPS ++++  I
Sbjct: 242 -DITVYLLQGRRLLQPEYCPDPLY------------EVMLKCWHPKAEMRPSFSELVSRI 288

Query: 349 KHQISS 354
               S+
Sbjct: 289 SAIFST 294

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 7e-52
 Identities = 72/291 (24%), Positives = 109/291 (37%), Gaps = 47/291 (16%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
             +G G F  VY A+  N  TS   A K I   S+   + +  E+DIL    H NIVKL+
Sbjct: 18  GELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
                 +   +L E+   G +   +    R   L       +  Q   A+ YLH+     
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---K 130

Query: 182 IVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPG 241
           I+H D+KA NIL     + KL DFG +     +               I ++   IG+P 
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---------------IQRRDSFIGTPY 175

Query: 242 YTDPHYLRTGMA-----STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA 296
           +  P  +    +       K DV+S G+ L+E+          N          +L  IA
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-------RVLLKIA 228

Query: 297 DCEATKVNELVDPRLAGDFDL-DEARAMLSIAALCLRQSPILRPSATQILH 346
             E         P LA         +  L     CL ++   R + +Q+L 
Sbjct: 229 KSE--------PPTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 1e-51
 Identities = 61/291 (20%), Positives = 103/291 (35%), Gaps = 44/291 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDNIVK 119
             IG+G +      R    S       K       ++   Q+   E+++L  L H NIV+
Sbjct: 10  YTIGTGSYGRCQKIR--RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 120 LIGYCDDRDEGVL--LFEYVPNGTLQEKLHGTPRSSK-LPWRNRMAIAFQLAQAIEYLHE 176
                 DR    L  + EY   G L   +    +  + L     + +  QL  A++  H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 177 R--CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQV 234
           R      ++H D+K +N+ L+   N KL DFG A++                 +   K  
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-------------LNHDTSFAKAF 174

Query: 235 MMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND 294
           +   +P Y  P  +     + K+D++S G +L EL   M  F   + +        +   
Sbjct: 175 VG--TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGK 225

Query: 295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
           I + +  ++       L              I    L      RPS  +IL
Sbjct: 226 IREGKFRRIPYRYSDELN------------EIITRMLNLKDYHRPSVEEIL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-51
 Identities = 56/290 (19%), Positives = 107/290 (36%), Gaps = 40/290 (13%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVK 119
            F + +G+G F  V   +        + AIK+          F +E  ++++LSH+ +V+
Sbjct: 7   TFLKELGTGQFGVVKYGKW---RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 120 LIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCT 179
           L G C  +    ++ EY+ NG L   L       +   +  + +   + +A+EYL  +  
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 119

Query: 180 LHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
              +H D+ A N L+ +    K+ DFG ++                     T  V     
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--------------DEYTSSVGSKFP 164

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             ++ P  L     S+K+D+++FGV++ E+ +  +                    IA   
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGL 218

Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
                 L   ++             +I   C  +    RP+   +L  I 
Sbjct: 219 RLYRPHLASEKVY------------TIMYSCWHEKADERPTFKILLSNIL 256

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 4e-51
 Identities = 59/295 (20%), Positives = 111/295 (37%), Gaps = 40/295 (13%)

Query: 65  IGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           +G G F +V            + AIK+         ++   +E  I+  L +  IV+LIG
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 123 YCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHI 182
            C      +L+ E    G L + L G  +  ++P  N   +  Q++  ++YL E+   + 
Sbjct: 77  VCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NF 130

Query: 183 VHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGY 242
           VH D+ A N+LL      K+ DFG +K                  S  T +        +
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKA------------LGADDSYYTARSAGKWPLKW 178

Query: 243 TDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCEAT 301
             P  +     S+++DV+S+GV + E ++ G + +    G         ++  I   +  
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRM 231

Query: 302 KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS 356
           +      P L             ++ + C       RP    +   ++    S++
Sbjct: 232 ECPPECPPELY------------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-50
 Identities = 58/296 (19%), Positives = 108/296 (36%), Gaps = 42/296 (14%)

Query: 64  VIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHLSHDNIVKL 120
            +GSG F  V              A+KI         L      E +++  L +  IV++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 121 IGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTL 180
           IG C+  +  +L+ E    G L + L    ++  +  +N + +  Q++  ++YL E    
Sbjct: 74  IGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES--- 126

Query: 181 HIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSP 240
           + VH D+ A N+LL      K+ DFG +K            +     +    Q       
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSK------------ALRADENYYKAQTHGKWPV 174

Query: 241 GYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCE 299
            +  P  +     S+K+DV+SFGV++ E  + G + +    G                  
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------- 217

Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI 355
             +V  +++            R M  +  LC       RP    +   +++    +
Sbjct: 218 --EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 69/325 (21%), Positives = 114/325 (35%), Gaps = 63/325 (19%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG---AIKI--HVGSDRLSQVFKQELDIL 109
           E     F +V+GSG F  V  A     S +      A+K+          +    EL ++
Sbjct: 37  ENLE--FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 110 LHL-SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-------------------- 148
             L SH+NIV L+G C       L+FEY   G L   L                      
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 149 TPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA 208
               + L + + +  A+Q+A+ +E+L  +     VH D+ A N+L+      K+CDFG A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLE 268
           +                S S    +        +  P  L  G+ + K+DV+S+G++L E
Sbjct: 212 R-------------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258

Query: 269 LVT-GMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIA 327
           + + G+  +                            +L+      D        +  I 
Sbjct: 259 IFSLGVNPYPGIPVDAN------------------FYKLIQNGFKMDQPFYATEEIYIIM 300

Query: 328 ALCLRQSPILRPSATQILHTIKHQI 352
             C       RPS   +   +  Q+
Sbjct: 301 QSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-50
 Identities = 75/317 (23%), Positives = 124/317 (39%), Gaps = 58/317 (18%)

Query: 50  SWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELD 107
            W+D++     F  VIG G F  V  AR+  D    + AIK      S    + F  EL+
Sbjct: 8   DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62

Query: 108 ILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG-------------TPRSS 153
           +L  L  H NI+ L+G C+ R    L  EY P+G L + L                  +S
Sbjct: 63  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122

Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
            L  +  +  A  +A+ ++YL ++     +H D+ A NIL+ E+   K+ DFG ++    
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179

Query: 214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
                             K+ M      +     L   + +T +DV+S+GV+L E+V+  
Sbjct: 180 Y----------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223

Query: 274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQ 333
                                       ++ E +      +  L+    +  +   C R+
Sbjct: 224 GTPYCGM------------------TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 265

Query: 334 SPILRPSATQILHTIKH 350
            P  RPS  QIL ++  
Sbjct: 266 KPYERPSFAQILVSLNR 282

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 1e-49
 Identities = 69/299 (23%), Positives = 111/299 (37%), Gaps = 50/299 (16%)

Query: 56  RFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLHL 112
           RF + F   IG G F  VY     +  T+   A         +    Q FK+E ++L  L
Sbjct: 9   RFLK-FDIEIGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 113 SHDNIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
            H NIV+     +   +G    VL+ E + +GTL+  L    R   +  +   +   Q+ 
Sbjct: 66  QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQIL 122

Query: 169 QAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSR 227
           + +++LH R    I+H D+K  NI +     + K+ D G A +                R
Sbjct: 123 KGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------------KR 166

Query: 228 SRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
           +   K V  IG+P +  P            DVY+FG+ +LE+ T    +           
Sbjct: 167 ASFAKAV--IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPY----------- 212

Query: 288 AGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
                       A     +        FD      +  I   C+RQ+   R S   +L+
Sbjct: 213 ------SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 3e-48
 Identities = 62/299 (20%), Positives = 111/299 (37%), Gaps = 39/299 (13%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNG--AIKI--HVGSDRLSQVFKQELDILLHLSHD 115
              +VIG+G F  VY   L   S       AIK      +++    F  E  I+   SH 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           NI++L G        +++ EY+ NG L +      +  +      + +   +A  ++YL 
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYLA 127

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
                  VH D+ A NIL+  +L CK+ DFG +++                         
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL------------EDDPEATYTTSG 172

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
                 +T P  +     ++ +DV+SFG+++ E++T  E    E                
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--------------- 217

Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS 354
                 +V + ++        +D   A+  +   C +Q    RP    I+  +   I +
Sbjct: 218 ---SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 5e-48
 Identities = 68/320 (21%), Positives = 125/320 (39%), Gaps = 48/320 (15%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILL 110
           D  +++T    + IG G    VY A   + +T    AI+ +++      ++   E+ ++ 
Sbjct: 17  DPKKKYT--RFEKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
              + NIV  +      DE  ++ EY+  G+L + +  T            A+  +  QA
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQA 128

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
           +E+LH      ++H DIK+ NILL    + KL DFG                        
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ---------------ITPEQ 170

Query: 231 TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS 290
           +K+  M+G+P +  P  +       K D++S G++ +E++ G   +  E           
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----------- 219

Query: 291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH---- 346
             N +        N   + +          R  L+    CL      R SA ++L     
Sbjct: 220 --NPLRALYLIATNGTPELQNPEKLS-AIFRDFLN---RCLDMDVEKRGSAKELLQHQFL 273

Query: 347 TIKHQISSISFLFSPQKDPS 366
            I   +SS++ L +  K+ +
Sbjct: 274 KIAKPLSSLTPLIAAAKEAT 293

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 6e-48
 Identities = 65/294 (22%), Positives = 115/294 (39%), Gaps = 43/294 (14%)

Query: 57  FTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDILLHL 112
           F +++   Q +G G +  V LA   N  T    A+KI     +    +  K+E+ I   L
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60

Query: 113 SHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIE 172
           +H+N+VK  G+  + +   L  EY   G L +++        +P  +      QL   + 
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 117

Query: 173 YLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           YLH      I H DIK  N+LL+E  N K+ DFG A +               +R R+  
Sbjct: 118 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV-----------FRYNNRERLLN 163

Query: 233 QVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
           ++   G+  Y  P  L+     +   DV+S G++L  ++ G   +   +           
Sbjct: 164 KM--CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------ 215

Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                       ++  + +   +       A L++    L ++P  R +   I 
Sbjct: 216 -----------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (412), Expect = 1e-47
 Identities = 56/294 (19%), Positives = 109/294 (37%), Gaps = 44/294 (14%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLS 113
           + +     + +G+G F  V+       +T  N A K +    +   +  ++E+  +  L 
Sbjct: 26  DHYD--IHEELGTGAFGVVHRVT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 81

Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
           H  +V L    +D +E V+++E++  G L EK+      +K+     +    Q+ + + +
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCH 139

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNC--KLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
           +HE    + VH D+K  NI+     +   KL DFG                         
Sbjct: 140 MHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA----------------HLDPKQ 180

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
              +  G+  +  P           TD++S GV+   L++G+  F  EN           
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ET 233

Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
           L ++  C+       +D         ++ +  +      L   P  R +  Q L
Sbjct: 234 LRNVKSCDWN-----MDDSAFSGIS-EDGKDFIR---KLLLADPNTRMTIHQAL 278

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 1e-47
 Identities = 67/317 (21%), Positives = 111/317 (35%), Gaps = 60/317 (18%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNG---AIKI--HVGSDRLSQVFKQELDILLHLSH 114
            + + IG G F  V+ AR             A+K+     S  +   F++E  ++    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHG---------------------TPRSS 153
            NIVKL+G C       LLFEY+  G L E L                       +P   
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
            L    ++ IA Q+A  + YL ER     VH D+   N L+ E++  K+ DFG ++    
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN--- 189

Query: 214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
                       S               +  P  +     +T++DV+++GV+L E+ +  
Sbjct: 190 ----------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQ 333
                            ++  + D       E     L             ++  LC  +
Sbjct: 240 LQPYYGMAHE------EVIYYVRDGNILACPENCPLELY------------NLMRLCWSK 281

Query: 334 SPILRPSATQILHTIKH 350
            P  RPS   I   ++ 
Sbjct: 282 LPADRPSFCSIHRILQR 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 9e-47
 Identities = 60/293 (20%), Positives = 118/293 (40%), Gaps = 43/293 (14%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH 114
           E++    ++ +G G F  V+       S+      K          + K+E+ IL    H
Sbjct: 5   EKYM--IAEDLGRGEFGIVHRCV--ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 115 DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYL 174
            NI+ L    +  +E V++FE++    + E+++    + +L  R  ++   Q+ +A+++L
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFL 118

Query: 175 HERCTLHIVHGDIKASNILL--EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
           H     +I H DI+  NI+         K+ +FG A+                       
Sbjct: 119 HSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------LKPGDN 159

Query: 233 QVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
             ++  +P Y  P   +  + ST TD++S G ++  L++G+  F  E  Q        ++
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QII 212

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
            +I + E T      D     +    EA   +      L +    R +A++ L
Sbjct: 213 ENIMNAEYT-----FDEEAFKEIS-IEAMDFVD---RLLVKERKSRMTASEAL 256

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 2e-46
 Identities = 75/322 (23%), Positives = 123/322 (38%), Gaps = 51/322 (15%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILL 110
           E F   F +++G G FS V LAR    +TS   AIKI    H+  +       +E D++ 
Sbjct: 8   EDFK--FGKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 111 HLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQA 170
            L H   VKL     D ++      Y  NG L + +    +              ++  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSA 120

Query: 171 IEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRI 230
           +EYLH +    I+H D+K  NILL E ++ ++ DFG+AK+                 S+ 
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-------------LSPESKQ 164

Query: 231 TKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS 290
            +    +G+  Y  P  L    A   +D+++ G I+ +LV G+  F   N          
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------L 217

Query: 291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTI-- 348
           +   I   E               F   +AR ++      L      R    ++      
Sbjct: 218 IFQKIIKLE---------YDFPEKFF-PKARDLVE---KLLVLDATKRLGCEEMEGYGPL 264

Query: 349 -KHQ-ISSISFLFSPQKDPSRL 368
             H    S+++    Q+ P +L
Sbjct: 265 KAHPFFESVTWENLHQQTPPKL 286

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-46
 Identities = 65/326 (19%), Positives = 118/326 (36%), Gaps = 52/326 (15%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG---AIKI--HVGSDRLSQVFKQELD 107
             E+ T   S+ +G G F  VY                AIK      S R    F  E  
Sbjct: 18  AREKIT--MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLH-------GTPRSSKLPWRNR 160
           ++   +  ++V+L+G        +++ E +  G L+  L          P  +       
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
           + +A ++A  + YL+       VH D+ A N ++ E    K+ DFG  +           
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD---------- 182

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                      K    +    +  P  L+ G+ +T +DV+SFGV+L E+ T  E      
Sbjct: 183 ---IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239

Query: 281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS 340
                     +L  + +       +     L              +  +C + +P +RPS
Sbjct: 240 SNE------QVLRFVMEGGLLDKPDNCPDMLF------------ELMRMCWQYNPKMRPS 281

Query: 341 ATQILHTIKHQI----SSISFLFSPQ 362
             +I+ +IK ++      +SF +S +
Sbjct: 282 FLEIISSIKEEMEPGFREVSFYYSEE 307

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 4e-45
 Identities = 54/293 (18%), Positives = 100/293 (34%), Gaps = 42/293 (14%)

Query: 63  QVIGSGGFSNVYLARL-INDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNI 117
           + +G G F  V           + + A+K      +        F +E++ +  L H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 118 VKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHER 177
           ++L G         ++ E  P G+L ++L                 A Q+A+ + YL  +
Sbjct: 74  IRLYGVVLTPPM-KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK 130

Query: 178 CTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMI 237
                +H D+ A N+LL      K+ DFG  +                +      Q    
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRAL------------PQNDDHYVMQEHRK 175

Query: 238 GSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA 296
               +  P  L+T   S  +D + FGV L E+ T G E +   NG  +            
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------------ 223

Query: 297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
                 ++++           D  + + ++   C    P  RP+   +   + 
Sbjct: 224 ------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (391), Expect = 5e-45
 Identities = 67/300 (22%), Positives = 102/300 (34%), Gaps = 41/300 (13%)

Query: 51  WDDVERFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQEL 106
           W   E     +    V+G+G FS V LA   +  T    AIK       +      + E+
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKKALEGKEGSMENEI 58

Query: 107 DILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            +L  + H NIV L    +      L+ + V  G L +++           R+   + FQ
Sbjct: 59  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQ 115

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           +  A++YLH+   +H            L+E     + DFG +KM                
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--------------- 160

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
               +      G+PGY  P  L     S   D +S GVI   L+ G   F  EN      
Sbjct: 161 -DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---- 215

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
               +   I   E        D     D   D A+  +      + + P  R +  Q L 
Sbjct: 216 ---KLFEQILKAEYE-----FDSPYWDDIS-DSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-44
 Identities = 64/300 (21%), Positives = 110/300 (36%), Gaps = 43/300 (14%)

Query: 53  DVERFTQNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKI--HVGSDRLSQVFKQELDIL 109
             ER      + IG G F +V+    ++ ++ +   AIK   +  SD + + F QE   +
Sbjct: 5   QRERIE--LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62

Query: 110 LHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
               H +IVKLIG   + +   ++ E    G L+       R   L   + +  A+QL+ 
Sbjct: 63  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLST 119

Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSR 229
           A+ YL  +     VH DI A N+L+  +   KL DFG ++                  S 
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------MEDST 162

Query: 230 ITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG 289
             K         +  P  +     ++ +DV+ FGV + E++                   
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------ 216

Query: 290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK 349
            ++  I + E   +     P L             S+   C    P  RP  T++   + 
Sbjct: 217 DVIGRIENGERLPMPPNCPPTLY------------SLMTKCWAYDPSRRPRFTELKAQLS 264

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (389), Expect = 3e-44
 Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 42/286 (14%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIK-IHVGSDRLSQVFKQELDILLHLSHDNIVKLI 121
           + +GSG F  V+       +T      K I+          K E+ I+  L H  ++ L 
Sbjct: 35  EELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
              +D+ E VL+ E++  G L +++       K+     +    Q  + ++++HE     
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---S 147

Query: 182 IVHGDIKASNILLEEHLNC--KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGS 239
           IVH DIK  NI+ E       K+ DFG A                   +      +   +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLAT----------------KLNPDEIVKVTTAT 191

Query: 240 PGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADCE 299
             +  P  +        TD+++ GV+   L++G+  F  E             +D+   +
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-------------DDLETLQ 238

Query: 300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
             K  +      A      EA+  +      L++ P  R +    L
Sbjct: 239 NVKRCDWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDAL 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 52/311 (16%), Positives = 109/311 (35%), Gaps = 41/311 (13%)

Query: 60  NFSQVIGSGGFSNVYLARLINDSTSTNG--AIKI--HVGSDRLSQVFKQELDILLHLSHD 115
              +V+GSG F  VY    I +        AIK      S + ++    E  ++  + + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 116 NIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLH 175
           ++ +L+G C       L+ + +P G L + +        +  +  +    Q+A+ + YL 
Sbjct: 72  HVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 176 ERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVM 235
           +R    +VH D+ A N+L++   + K+ DFG AK+               +  +      
Sbjct: 129 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-------------LGAEEKEYHAEG 172

Query: 236 MIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
                 +     +   + + ++DV+S+GV + EL+T                        
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------------- 217

Query: 296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSI 355
               A++++ +++              +  I   C       RP   +++          
Sbjct: 218 ---PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

Query: 356 SFLFSPQKDPS 366
                 Q D  
Sbjct: 275 QRYLVIQGDER 285

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-42
 Identities = 61/320 (19%), Positives = 117/320 (36%), Gaps = 57/320 (17%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG-----AIKI--HVGSDRLSQVFKQELD 107
           +R      + +G G F  V LA  I             A+K+     +++       E++
Sbjct: 13  DRLV--LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 108 ILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSS------------- 153
           ++  +  H NI+ L+G C       ++ EY   G L+E L                    
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 154 KLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS 213
           +L  ++ ++ A+Q+A+ +EYL  +     +H D+ A N+L+ E    K+ DFG A+    
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD--- 184

Query: 214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM 273
                             K         +  P  L   + + ++DV+SFGV+L E+ T  
Sbjct: 185 ----------IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234

Query: 274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQ 333
            +  P                       ++ +L+      D   +    +  +   C   
Sbjct: 235 GSPYP------------------GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHA 276

Query: 334 SPILRPSATQILHTIKHQIS 353
            P  RP+  Q++  +   ++
Sbjct: 277 VPSQRPTFKQLVEDLDRIVA 296

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 9e-42
 Identities = 76/312 (24%), Positives = 118/312 (37%), Gaps = 41/312 (13%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH 111
           D  +  +   ++VIG+G F  VY A+L +  +    AIK  +   R      +EL I+  
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQDKRF---KNRELQIMRK 69

Query: 112 LSHDNIVKLIGYCDDRDEG------VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAF 165
           L H NIV+L  +     E        L+ +YVP    +   H +     LP        +
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 166 QLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
           QL +++ Y+H      I H DIK  N+LL  +    KLCDFGSAK               
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------- 171

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENG-- 281
               R    V  I S  Y  P  +      ++  DV+S G +L EL+ G   F  ++G  
Sbjct: 172 -QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230

Query: 282 --QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL-----CLRQS 334
               +  + G+   +          E   P++         R      A+      L  +
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290

Query: 335 PILRPSATQILH 346
           P  R +  +   
Sbjct: 291 PTARLTPLEACA 302

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  145 bits (366), Expect = 1e-41
 Identities = 60/301 (19%), Positives = 120/301 (39%), Gaps = 47/301 (15%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILL 110
           +R+     +++G GG S V+LAR  +     + A+K+              F++E     
Sbjct: 7   DRYE--LGEILGFGGMSEVHLAR--DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 111 HLSHDNIVKLIGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
            L+H  IV +    +          ++ EYV   TL++ +H       +  +  + +   
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIAD 119

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
             QA+ + H+     I+H D+K +NI++      K+ DFG A+              + S
Sbjct: 120 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA------------IADS 164

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS 286
            + +T+   +IG+  Y  P   R      ++DVYS G +L E++TG   F  +       
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------- 217

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-SATQIL 345
                 + ++        + + P    +    +  A++      L ++P  R  +A ++ 
Sbjct: 218 ------SPVSVAYQHVREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMR 268

Query: 346 H 346
            
Sbjct: 269 A 269

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 69/308 (22%), Positives = 112/308 (36%), Gaps = 59/308 (19%)

Query: 57  FTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI----------HVGSDRLSQVFKQ 104
           F +N+   +++G G  S V      +  T    A+KI                L +   +
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCI--HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58

Query: 105 ELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
           E+DIL  +S H NI++L    +      L+F+ +  G L + L        L  +    I
Sbjct: 59  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKI 115

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
              L + I  LH+    +IVH D+K  NILL++ +N KL DFG +               
Sbjct: 116 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--------- 163

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMA------STKTDVYSFGVILLELVTGMEAFC 277
                   K   + G+P Y  P  +   M         + D++S GVI+  L+ G   F 
Sbjct: 164 -------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216

Query: 278 PENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPIL 337
                        ML  I            + +       D +  +  + +  L   P  
Sbjct: 217 HRKQM-------LMLRMIMSG---------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260

Query: 338 RPSATQIL 345
           R +A + L
Sbjct: 261 RYTAEEAL 268

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 5e-41
 Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 38/299 (12%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI------HVGSDRLSQVFKQELDILLHLSHDN 116
             +G G F+ VY AR  N  T+   AIK           D +++   +E+ +L  LSH N
Sbjct: 4   DFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 117 IVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           I+ L+     +    L+F+++              S  L   +  A      Q +EYLH+
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 177 RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
                I+H D+K +N+LL+E+   KL DFG AK                  S        
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKS---------------FGSPNRAYTHQ 160

Query: 237 IGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI 295
           + +  Y  P  L          D+++ G IL EL+  +     ++     +     L   
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220

Query: 296 ADCEATKVNELVDPRLAGDF---DLDEARAMLSIAAL-----CLRQSPILRPSATQILH 346
            + +   +  L D      F    L    +      L         +P  R +ATQ L 
Sbjct: 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 8e-41
 Identities = 67/310 (21%), Positives = 107/310 (34%), Gaps = 42/310 (13%)

Query: 56  RFTQNFS--QVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILL 110
           R  Q +     IG G +  V+ AR + +      A+K      G + +     +E+ +L 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 111 HLS---HDNIVKLIGYC-----DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMA 162
           HL    H N+V+L   C     D   +  L+FE+V                 +P      
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKD 120

Query: 163 IAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPS 222
           + FQL + +++LH      +VH D+K  NIL+      KL DFG A++            
Sbjct: 121 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----------- 166

Query: 223 PSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN-- 280
                S       ++ +  Y  P  L     +T  D++S G I  E+      F   +  
Sbjct: 167 -----SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221

Query: 281 GQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL-----CLRQSP 335
            QL   L    L    D                   +++    +          CL  +P
Sbjct: 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 281

Query: 336 ILRPSATQIL 345
             R SA   L
Sbjct: 282 AKRISAYSAL 291

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 46/293 (15%)

Query: 62  SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKL 120
           SQV+G G    V      N  T    A+K+     +     ++E+++    S   +IV++
Sbjct: 17  SQVLGLGINGKVLQIF--NKRTQEKFALKML----QDCPKARREVELHWRASQCPHIVRI 70

Query: 121 IGYCDDRDEG----VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE 176
           +   ++   G    +++ E +  G L  ++           R    I   + +AI+YLH 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS 129

Query: 177 RCTLHIVHGDIKASNILLEEHLN---CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
               +I H D+K  N+L          KL DFG AK   S                    
Sbjct: 130 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----------------NSL 170

Query: 234 VMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN 293
                +P Y  P  L         D++S GVI+  L+ G   F   +G    +++  M  
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKT 227

Query: 294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILH 346
            I      ++ +   P        +E + ++      L+  P  R + T+ ++
Sbjct: 228 RI------RMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-40
 Identities = 60/297 (20%), Positives = 104/297 (35%), Gaps = 50/297 (16%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDIL 109
           +E F     +++G G F  V+LA      T+   AIK      V  D   +    E  +L
Sbjct: 1   IEDFI--LHKMLGKGSFGKVFLAE--FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 56

Query: 110 LH-LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
                H  +  +      ++    + EY+  G L   +       K         A ++ 
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEII 113

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
             +++LH +    IV+ D+K  NILL++  + K+ DFG  K                +  
Sbjct: 114 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE---------------NML 155

Query: 229 RITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
              K     G+P Y  P  L     +   D +SFGV+L E++ G   F  ++ +      
Sbjct: 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ 209

Query: 289 GSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                     E      + +P      +  EA+ +L        + P  R      +
Sbjct: 210 ----------ELFHSIRMDNPFYPRWLE-KEAKDLLV---KLFVREPEKRLGVRGDI 252

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 6e-40
 Identities = 56/325 (17%), Positives = 112/325 (34%), Gaps = 56/325 (17%)

Query: 51  WD-DVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNG---AIKI---HVGSDRLSQVFK 103
           W+   +R      + +G G F  V  A       +      A+K+            +  
Sbjct: 8   WEFPRDRLK--LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLL-FEYVPNGTLQEKLHG-------------T 149
           +   ++    H N+V L+G C      +++  E+   G L   L                
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 150 PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
                L   + +  +FQ+A+ +E+L  R     +H D+ A NILL E    K+CDFG A+
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 182

Query: 210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLEL 269
             +                   ++        +  P  +   + + ++DV+SFGV+L E+
Sbjct: 183 DIYKD-------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229

Query: 270 VTGMEAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL 329
            +   +  P        +       + +    +  +   P             M      
Sbjct: 230 FSLGASPYPG-----VKIDEEFCRRLKEGTRMRAPDYTTPE------------MYQTMLD 272

Query: 330 CLRQSPILRPSATQILHTIKHQISS 354
           C    P  RP+ ++++  + + + +
Sbjct: 273 CWHGEPSQRPTFSELVEHLGNLLQA 297

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 9e-39
 Identities = 59/309 (19%), Positives = 109/309 (35%), Gaps = 33/309 (10%)

Query: 51  WDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI--HVGSDRLSQVFKQELDI 108
           +D   R+T      IG G +  V  A   ++      AIK           Q   +E+ I
Sbjct: 4   FDVGPRYT--NLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 109 LLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLA 168
           LL   H+NI+ +           +   Y+    +   L+   ++  L   +     +Q+ 
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119

Query: 169 QAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
           + ++Y+H     +++H D+K SN+LL    + K+CDFG A++              P   
Sbjct: 120 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA------------DPDHD 164

Query: 229 RITKQVMMIGSPGYTDPHYLRTGMAST-KTDVYSFGVILLELVTGMEAFCPENGQLLTSL 287
                   + +  Y  P  +      T   D++S G IL E+++    F  ++     + 
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224

Query: 288 AGSMLNDIADCEATKV------NELVDPRLAGDFDLDEARAMLSIAAL-----CLRQSPI 336
              +L   +  +   +      N L+          +         AL      L  +P 
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284

Query: 337 LRPSATQIL 345
            R    Q L
Sbjct: 285 KRIEVEQAL 293

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (342), Expect = 5e-38
 Identities = 49/292 (16%), Positives = 92/292 (31%), Gaps = 33/292 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIG 122
           + IGSG F ++YL    + +     AIK+     +  Q    E  I   +     +  I 
Sbjct: 13  RKIGSGSFGDIYLGT--DIAAGEEVAIKLECVKTKHPQ-LHIESKIYKMMQGGVGIPTIR 69

Query: 123 YC-DDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
           +C  + D  V++ E +              S K   +  + +A Q+   IEY+H +   +
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---N 123

Query: 182 IVHGDIKASNILLEEHLNCKLC---DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
            +H D+K  N L+       L    DFG AK            + +       +   + G
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK--------YRDARTHQHIPYRENKNLTG 175

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIADC 298
           +  Y   +       S + D+ S G +L+    G   +                      
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----------TKRQKY 225

Query: 299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH 350
           E     ++  P               +    C       +P  + +    ++
Sbjct: 226 ERISEKKMSTPIEVLCKGYPS--EFATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (338), Expect = 3e-37
 Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 35/236 (14%)

Query: 49  YSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQ 104
           YS  D +       + +G+G F  V+L R  +       A+K+     V   +  +    
Sbjct: 1   YSLQDFQ-----ILRTLGTGSFGRVHLIR--SRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 105 ELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIA 164
           E  +L  ++H  I+++ G   D  +  ++ +Y+  G L   L  + R      +   A  
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-- 111

Query: 165 FQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPS 224
               +    L    +  I++ D+K  NILL+++ + K+ DFG AK               
Sbjct: 112 ----EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----------- 156

Query: 225 PSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                      + G+P Y  P  + T   +   D +SFG+++ E++ G   F   N
Sbjct: 157 -------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 59/299 (19%), Positives = 105/299 (35%), Gaps = 55/299 (18%)

Query: 61  FSQVIGSGGFSNVYLARLINDSTSTNGAIKI-------HVGSDRLSQVFKQELDILLHLS 113
             ++IG GGF  VY  R  +  T    A+K            + L+   +  L ++    
Sbjct: 8   VHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
              IV +       D+   + + +  G L   L    +       +    A ++   +E+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEH 122

Query: 174 LHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQ 233
           +H R    +V+ D+K +NILL+EH + ++ D G A                       K 
Sbjct: 123 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD-----------------FSKKKP 162

Query: 234 VMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML 292
              +G+ GY  P  L+ G+A  +  D +S G +L +L+ G   F     +    +    L
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222

Query: 293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILH 346
                             L   F   E R++L      L++    R       A ++  
Sbjct: 223 TM-------------AVELPDSFS-PELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-37
 Identities = 64/322 (19%), Positives = 108/322 (33%), Gaps = 51/322 (15%)

Query: 52  DDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDI 108
           D+V ++       IG G F  V+ AR  +  T    A+K        +       +E+ I
Sbjct: 7   DEVSKYE--KLAKIGQGTFGEVFKAR--HRKTGQKVALKKVLMENEKEGFPITALREIKI 62

Query: 109 LLHLSHDNIVKLIGYCDDRDEGV--------LLFEYVPNGTLQEKLHGTPRSSKLPWRNR 160
           L  L H+N+V LI  C  +            L+F++  +       +      K      
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEI 119

Query: 161 MAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS 220
             +   L   + Y+H      I+H D+KA+N+L+      KL DFG A+           
Sbjct: 120 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA---------- 166

Query: 221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPE 279
                  S+  +    + +  Y  P  L          D++  G I+ E+ T        
Sbjct: 167 -FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225

Query: 280 NG--------QLLTSLAGSMLNDIADCEATKVNELVDP-------RLAGDFDLDEARAML 324
                     QL  S+   +  ++ + E  +  ELV         RL        A  ++
Sbjct: 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 285

Query: 325 SIAALCLRQSPILRPSATQILH 346
                 L   P  R  +   L+
Sbjct: 286 D---KLLVLDPAQRIDSDDALN 304

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  131 bits (331), Expect = 2e-36
 Identities = 67/304 (22%), Positives = 108/304 (35%), Gaps = 39/304 (12%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLH 111
           E++     + IG G +  VY A+   ++     A+K        + +     +E+ IL  
Sbjct: 2   EKYH--GLEKIGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIREISILKE 56

Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L H NIVKL      +   VL+FE++     +           L      +   QL   I
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGI 113

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
            Y H+R    ++H D+K  N+L+      K+ DFG A+                    + 
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARA---------------FGIPVR 155

Query: 232 KQVMMIGSPGYTDPHYLR-TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS 290
           K    I +  Y  P  L  +   ST  D++S G I  E+V G   F   +          
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

Query: 291 MLNDIADCEATKVNEL---------VDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSA 341
           +L          V EL          +P     F      + + + +  L+  P  R +A
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

Query: 342 TQIL 345
            Q L
Sbjct: 276 KQAL 279

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-36
 Identities = 57/303 (18%), Positives = 103/303 (33%), Gaps = 53/303 (17%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI-------HVGSDRLSQVFKQELD 107
           + +     + +GSG F+ V   R    ST    A K                +  ++E+ 
Sbjct: 10  DYYD--TGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 108 ILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQL 167
           IL  + H N++ L    +++ + +L+ E V  G L + L        L          Q+
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQI 122

Query: 168 AQAIEYLHERCTLHIVHGDIKASNILLEEH----LNCKLCDFGSAKMGFSSAVLPPSPSP 223
              + YLH      I H D+K  NI+L +        K+ DFG A               
Sbjct: 123 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--------- 170

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQL 283
                   +   + G+P +  P  +       + D++S GVI   L++G   F  +  Q 
Sbjct: 171 -------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ- 222

Query: 284 LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQ 343
                   L +++          V+     ++  + +          L + P  R +   
Sbjct: 223 ------ETLANVSA---------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267

Query: 344 ILH 346
            L 
Sbjct: 268 SLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 8e-36
 Identities = 64/305 (20%), Positives = 105/305 (34%), Gaps = 37/305 (12%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLH 111
           E F     + IG G +  VY AR  N  T    A+K       ++ +     +E+ +L  
Sbjct: 2   ENFQ--KVEKIGEGTYGVVYKAR--NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57

Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L+H NIVKL+      ++  L+FE++     +           +P     +  FQL Q +
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGL 115

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
            + H      ++H D+K  N+L+      KL DFG A+                    + 
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA---------------FGVPVR 157

Query: 232 KQVMMIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ----LLTS 286
                + +  Y  P   L     ST  D++S G I  E+VT    F  ++       +  
Sbjct: 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL-----CLRQSPILRPSA 341
             G+    +     +  +           D  +    L           L   P  R SA
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

Query: 342 TQILH 346
              L 
Sbjct: 278 KAALA 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  128 bits (323), Expect = 3e-35
 Identities = 38/312 (12%), Positives = 85/312 (27%), Gaps = 35/312 (11%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH-DNIVKLI 121
           + IG G F  ++     N   +   AIK        +   + E      L+    I  + 
Sbjct: 11  RRIGEGSFGVIFEGT--NLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH 181
            +  +    VL+ + +                K   +     A Q+   ++ +HE+    
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---S 121

Query: 182 IVHGDIKASNILLEEHLNC-----KLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMM 236
           +V+ DIK  N L+    +       + DFG  K              +       ++  +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY--------RDPVTKQHIPYREKKNL 173

Query: 237 IGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA 296
            G+  Y   +       S + D+ + G + +  + G   +             +      
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------TNKQKYE 226

Query: 297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS 356
                ++ E        +                   +    P    +       +  ++
Sbjct: 227 -----RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281

Query: 357 FLFSPQKDPSRL 368
                  D + L
Sbjct: 282 TTEDENFDWNLL 293

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-35
 Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 61/294 (20%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI-------HVGSDRLSQVFKQELDILLHLS-- 113
            ++GSGGF +VY       S +   AIK          G          E+ +L  +S  
Sbjct: 10  PLLGSGGFGSVYSGI--RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 114 HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEY 173
              +++L+ + +  D  VL+ E                   L      +  +Q+ +A+ +
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRH 125

Query: 174 LHERCTLHIVHGDIKASNILL-EEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITK 232
            H      ++H DIK  NIL+       KL DFGS  +                  + T 
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL-----------------LKDTV 165

Query: 233 QVMMIGSPGYTDPHYLRTGMASTK-TDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM 291
                G+  Y+ P ++R      +   V+S G++L ++V G   F  +            
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 214

Query: 292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQIL 345
                  E  +       R++      E + ++     CL   P  RP+  +I 
Sbjct: 215 -------EIIRGQVFFRQRVS-----SECQHLIR---WCLALRPSDRPTFEEIQ 253

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (323), Expect = 5e-35
 Identities = 66/345 (19%), Positives = 127/345 (36%), Gaps = 62/345 (17%)

Query: 24  DVVVDQDQDQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDST 83
           DV   + ++ +      ++        W + + +     + +G G +S V+ A   N + 
Sbjct: 12  DVNTHRPREYWDYESHVVE--------WGNQDDYQ--LVRKLGRGKYSEVFEAI--NITN 59

Query: 84  STNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEG--VLLFEYVPNG 140
           +    +KI     +  +  K+E+ IL +L    NI+ L     D       L+FE+V N 
Sbjct: 60  NEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117

Query: 141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILL-EEHLN 199
             ++          L   +     +++ +A++Y H      I+H D+K  N+++  EH  
Sbjct: 118 DFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRK 168

Query: 200 CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTD 258
            +L D+G A+                      +  + + S  +  P  L          D
Sbjct: 169 LRLIDWGLAEFYHPG----------------QEYNVRVASRYFKGPELLVDYQMYDYSLD 212

Query: 259 VYSFGVILLELVTGMEAFCP--ENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAG--- 313
           ++S G +L  ++   E F    +N   L  +A  +  +       K N  +DPR      
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272

Query: 314 --------DFDLDEARAMLSIAAL-----CLRQSPILRPSATQIL 345
                    F   E + ++S  AL      LR     R +A + +
Sbjct: 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-34
 Identities = 58/305 (19%), Positives = 109/305 (35%), Gaps = 37/305 (12%)

Query: 55  ERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQVFKQELDILLH 111
           +++     + IG G +  V+ A+  N  T    A+K        + +     +E+ +L  
Sbjct: 2   QKYE--KLEKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKE 57

Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
           L H NIV+L        +  L+FE+      +   +    +  L      +  FQL + +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRIT 231
            + H R   +++H D+K  N+L+  +   KL +FG A+            +        +
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR------------AFGIPVRCYS 159

Query: 232 KQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENG-----QLLTS 286
            +V+ +              + ST  D++S G I  EL        P N      + +  
Sbjct: 160 AEVVTL--WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217

Query: 287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAAL-----CLRQSPILRPSA 341
           L G+   +         +    P       L      L+          L+ +P+ R SA
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

Query: 342 TQILH 346
            + L 
Sbjct: 278 EEALQ 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 1e-34
 Identities = 53/237 (22%), Positives = 87/237 (36%), Gaps = 32/237 (13%)

Query: 48  KYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFK 103
           K + +D +     + +++G G F  V L R    +T    A+KI     + +        
Sbjct: 1   KVTMNDFD-----YLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTV 53

Query: 104 QELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAI 163
            E  +L +  H  +  L       D    + EY   G L   L    R            
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFY 110

Query: 164 AFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSP 223
             ++  A+EYLH R    +V+ DIK  N++L++  + K+ DFG  K G S          
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------- 159

Query: 224 SPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
                         G+P Y  P  L         D +  GV++ E++ G   F  ++
Sbjct: 160 -------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-34
 Identities = 60/324 (18%), Positives = 110/324 (33%), Gaps = 51/324 (15%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQ 100
           + V K +W+    +     Q +GSG +  V  A   +  T    AIK       S+  ++
Sbjct: 7   QEVTKTAWEVRAVYR--DLQPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAK 62

Query: 101 VFKQELDILLHLSHDNIVKLIGYC------DDRDEGVLLFEYVPNGTLQEKLHGTPRSSK 154
              +EL +L H+ H+N++ L+         DD  +  L+  ++     +   H      K
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----K 117

Query: 155 LPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS 214
           L       + +Q+ + + Y+H      I+H D+K  N+ + E    K+ DFG A+   S 
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173

Query: 215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPH-YLRTGMASTKTDVYSFGVILLELVTGM 273
                            +    + +  Y  P   L     +   D++S G I+ E++TG 
Sbjct: 174 -----------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

Query: 274 EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDF------DLDEARAMLSIA 327
             F   +          +          ++                  D        S  
Sbjct: 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 276

Query: 328 AL-----CLRQSPILRPSATQILH 346
           A+      L      R +A + L 
Sbjct: 277 AVNLLEKMLVLDAEQRVTAGEALA 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (304), Expect = 4e-32
 Identities = 46/222 (20%), Positives = 87/222 (39%), Gaps = 30/222 (13%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKI----HVGSDRLSQVFKQELDILLHLSHDNIV 118
           + +G+G F  V L +  +  +  + A+KI     V   +  +    E  IL  ++   +V
Sbjct: 47  KTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 119 KLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC 178
           KL     D     ++ EYV  G +   L    R  +    +    A Q+    EYLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL- 160

Query: 179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIG 238
              +++ D+K  N+L+++    ++ DFG AK                      +   + G
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------RVKGRTWTLCG 200

Query: 239 SPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPEN 280
           +P    P  + +   +   D ++ GV++ E+  G   F  + 
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 58/322 (18%), Positives = 109/322 (33%), Gaps = 47/322 (14%)

Query: 44  RSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI---HVGSDRLSQ 100
           + + K  W+  ER+       +GSG + +V  A   +  T    A+K       S   ++
Sbjct: 7   QELNKTIWEVPERYQ--NLSPVGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 101 VFKQELDILLHLSHDNIVKLIGYCDDRD-----EGVLLFEYVPNGTLQEKLHGTPRSSKL 155
              +EL +L H+ H+N++ L+              V L  ++    L        +  KL
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKL 118

Query: 156 PWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA 215
              +   + +Q+ + ++Y+H      I+H D+K SN+ + E    K+ DFG A+      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH----- 170

Query: 216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEA 275
                       +       +           L     +   D++S G I+ EL+TG   
Sbjct: 171 ------------TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

Query: 276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDF------DLDEARAMLSIAAL 329
           F   +      L   ++         K++                 +        +  A+
Sbjct: 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278

Query: 330 -----CLRQSPILRPSATQILH 346
                 L      R +A Q L 
Sbjct: 279 DLLEKMLVLDSDKRITAAQALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 3e-29
 Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 31/236 (13%)

Query: 54  VERFTQNFSQVIGSGGFSNVYLARLIND-STSTNGAIKI-----HVGSDRLSQVFKQELD 107
           +E F     +V+G+G +  V+L R I+   T    A+K+      V   + ++  + E  
Sbjct: 23  IENFE--LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 108 ILLHLSH-DNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQ 166
           +L H+     +V L        +  L+ +Y+  G L   L    +  +           +
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGE 137

Query: 167 LAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPS 226
           +  A+E+LH+     I++ DIK  NILL+ + +  L DFG +K   +             
Sbjct: 138 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA------------- 181

Query: 227 RSRITKQVMMIGSPGYTDPHYLRTGMA--STKTDVYSFGVILLELVTGMEAFCPEN 280
                +     G+  Y  P  +R G +      D +S GV++ EL+TG   F  + 
Sbjct: 182 -DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 9e-28
 Identities = 61/345 (17%), Positives = 113/345 (32%), Gaps = 67/345 (19%)

Query: 32  DQYHDHDDGIDGRSVKKYSWDDVERFTQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKI 91
           +Q++  + G         ++  ++R+     + IGSG    V  A   +     N AIK 
Sbjct: 1   NQFYSVEVG-------DSTFTVLKRYQ--NLKPIGSGAQGIVCAAY--DAVLDRNVAIKK 49

Query: 92  ---HVGSDRLSQVFKQELDILLHLSHDNIVKLIGYC------DDRDEGVLLFEYVPNGTL 142
                 +   ++   +EL ++  ++H NI+ L+         ++  +  L+ E +     
Sbjct: 50  LSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 109

Query: 143 QEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKL 202
           Q          +L       + +Q+   I++LH      I+H D+K SNI+++     K+
Sbjct: 110 QVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160

Query: 203 CDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSF 262
            DFG A+   +S                      + +  Y  P  +         D++S 
Sbjct: 161 LDFGLARTAGTS----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204

Query: 263 GVILLELVTGMEAF-------------------CPENGQLLTSLAGSMLNDIADCEATKV 303
           G I+ E+V     F                   CPE  + L     + + +         
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264

Query: 304 NELVDPRLAGDFDLDEARAMLSIAAL---CLRQSPILRPSATQIL 345
            +L    L                 L    L   P  R S    L
Sbjct: 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (259), Expect = 8e-26
 Identities = 63/326 (19%), Positives = 114/326 (34%), Gaps = 59/326 (18%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH-------- 114
           + +G G FS V+LA+  +   +T+ A+KI  G    ++  + E+ +L  ++         
Sbjct: 19  RKLGWGHFSTVWLAK--DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 115 ---DNIVKLIGYCDDRDEGVLLFEYV--PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQ 169
              ++I+KL+ + + +    +    V    G     L        +P      I+ QL  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 170 AIEYLHERCTLHIVHGDIKASNILLEEHLNC-KLCDFGSAKMGFSSAVLPPSPSPSPSRS 228
            ++Y+H RC   I+H DIK  N+L+E   +   L     A +G              +  
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN-------------ACW 181

Query: 229 RITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLA 288
                   I +  Y  P  L         D++S   ++ EL+TG   F P+ G   T   
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241

Query: 289 GSMLNDIADCEATKVNELVDPRLAGD----------------------------FDLDEA 320
             +   I          L + +                                F  DEA
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

Query: 321 RAMLSIAALCLRQSPILRPSATQILH 346
           + +    +  L+  P  R  A  +++
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.9 bits (191), Expect = 1e-17
 Identities = 25/158 (15%), Positives = 45/158 (28%), Gaps = 24/158 (15%)

Query: 63  QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-----------DRLSQVFKQELDILLH 111
           +++G G  S V+              +K H              D     F         
Sbjct: 6   KLMGEGKESAVFNCY---SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 112 LSHDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAI 171
                + KL G    +      + +  N  L E +                +   + + +
Sbjct: 63  NEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116

Query: 172 EYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK 209
              + R    IVHGD+   N+L+ E     + DF  + 
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	368
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.21
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.94

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-59  Score=406.49  Aligned_cols=244  Identities=28%  Similarity=0.438  Sum_probs=205.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||+||+|++..  ++..+|+|+....    ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEecCCCcEEEEEEECC--CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4578899999999999999765  6788999976532    234567889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||++|+|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999997   445799999999999999999999999   9999999999999999999999999999753221


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                 .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...   
T Consensus       160 ~-----------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---  219 (263)
T d2j4za1         160 R-----------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---  219 (263)
T ss_dssp             C-----------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---
T ss_pred             c-----------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC---
Confidence            1                 13356999999999999999999999999999999999999999876544332221110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   +.    .++...++++.+||.+||+.||.+|||++++++|
T Consensus       220 -------------~~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 -------------EF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             -------------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -------------CC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                         00    1122345689999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-59  Score=413.02  Aligned_cols=261  Identities=22%  Similarity=0.309  Sum_probs=214.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .+.+.+.||+|+||+||+|.+..  ++..||+|+...+....+.+.+|+.+++.++|||||++++++.+.+..++|||||
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGG--GTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HeEEeeEEeeCCCeEEEEEEECC--CCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            34567889999999999999865  6788999987766666778999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++|+|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        96 ~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-  170 (287)
T d1opja_          96 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  170 (287)
T ss_dssp             TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred             cCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence            999999998754 346789999999999999999999999   999999999999999999999999999985433221 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC-CcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCP-ENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~  296 (368)
                                   .......||+.|+|||++.+..++.++|||||||++|||++|..||.. .+.......+.       
T Consensus       171 -------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-------  230 (287)
T d1opja_         171 -------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------  230 (287)
T ss_dssp             -------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------
T ss_pred             -------------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-------
Confidence                         111234589999999999999999999999999999999997666543 33222211111       


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                                  .......+...+..+.+|+..||+.||.+|||++++++.|+.+.++.+.
T Consensus       231 ------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~  279 (287)
T d1opja_         231 ------------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  279 (287)
T ss_dssp             ------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred             ------------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence                        1111122333456899999999999999999999999999998776543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-58  Score=409.85  Aligned_cols=260  Identities=23%  Similarity=0.350  Sum_probs=200.6

Q ss_pred             hhhhcccccceEEEEEEEcCCC-CceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQVIGSGGFSNVYLARLINDS-TSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.+.||+|+||+||+|.+..++ ....+|||....  .....+.|.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus        30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~  109 (299)
T d1jpaa_          30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM  109 (299)
T ss_dssp             EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence            4568999999999999976432 345678887543  3455678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++|+|.+++..  ....+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+........
T Consensus       110 ~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         110 ENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             TTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence            99999998874  345689999999999999999999999   9999999999999999999999999999865433211


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      ..          ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.........+..      
T Consensus       185 ~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~------  248 (299)
T d1jpaa_         185 PT----------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------  248 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------
T ss_pred             ce----------eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence            10          111123458999999999999999999999999999999998 8999977654433222111      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                   ......+..++..+.+|+.+||+.||.+|||+.+|++.|++++++
T Consensus       249 -------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 -------------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                         011112233456899999999999999999999999999998764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-59  Score=407.02  Aligned_cols=251  Identities=25%  Similarity=0.293  Sum_probs=200.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh--hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD--RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+.....  ...+.+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            4567899999999999999765  67889999865432  3345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      |.+|+|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999997   456799999999999999999999999   999999999999999999999999999986432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                      .             ......+||+.|+|||++.+..+ +.++|||||||++|||++|..||..............     
T Consensus       159 ~-------------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-----  220 (271)
T d1nvra_         159 E-------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----  220 (271)
T ss_dssp             E-------------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-----
T ss_pred             c-------------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-----
Confidence            0             11123579999999999988876 5789999999999999999999976543221111100     


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  ............+.++.+|+.+||+.||.+|||++++++|
T Consensus       221 ------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         221 ------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------------cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                        0000001112235678899999999999999999999876

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-57  Score=404.08  Aligned_cols=248  Identities=23%  Similarity=0.303  Sum_probs=204.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |.+.+.||+|+||+||+|.+..  ++..||+|+.... ....+.+.+|+.+++.++|||||++++++.+.+..|+|||||
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTT--TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEecCcCcEEEEEEECC--CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4567789999999999998655  6778999976533 234567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++|+|.+++..    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||+|+....... 
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            99999998863    3589999999999999999999999   999999999999999999999999999986432221 


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..........   .   
T Consensus       172 --------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~---  231 (293)
T d1yhwa1         172 --------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---N---  231 (293)
T ss_dssp             --------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---H---
T ss_pred             --------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---C---
Confidence                          11234699999999999999999999999999999999999999977654322211110   0   


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                 .......+...+..+.+||.+||+.||.+|||+.++++|
T Consensus       232 -----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         232 -----------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             -----------CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             -----------CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       000011122345689999999999999999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=401.24  Aligned_cols=253  Identities=23%  Similarity=0.367  Sum_probs=199.7

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      ++.+.||+|+||+||+|.+.+   ...||||+........+.+.+|+++++.++|||||++++++.+.+..++|||||++
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~---~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLN---KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETT---TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EEEEEEeeCCCeEEEEEEECC---CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            467789999999999999753   45689998877666667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |+|.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+........  
T Consensus        85 g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~--  157 (263)
T d1sm2a_          85 GCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--  157 (263)
T ss_dssp             CBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce--
Confidence            999999875  345689999999999999999999999   9999999999999999999999999999754332211  


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                                  ......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.......+..        
T Consensus       158 ------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~--------  217 (263)
T d1sm2a_         158 ------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--------  217 (263)
T ss_dssp             -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH--------
T ss_pred             ------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh--------
Confidence                        1123468999999999999999999999999999999999 5666655443322221111        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                             ...    ...+..++.++.+|+..||+.||.+|||+++|+++|+++.+
T Consensus       218 -------~~~----~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         218 -------GFR----LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -------TCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------cCC----CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                   000    11122334678999999999999999999999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=415.32  Aligned_cols=265  Identities=22%  Similarity=0.306  Sum_probs=204.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|++.+.||+|+||+||+|++..  ++..+|+|+...  .+...+.+.+|+.+|+.++|||||+++++|.+.+..++|||
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETT--TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35567889999999999998755  678999998654  34456788999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||.+|+|.+++.   ..+.+++..+..++.|++.||.|||+ +   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999997   34579999999999999999999996 5   8999999999999999999999999999853321


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh-
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN-  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-  293 (368)
                      .                 ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+............. 
T Consensus       159 ~-----------------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~  221 (322)
T d1s9ja_         159 M-----------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG  221 (322)
T ss_dssp             T-----------------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------
T ss_pred             c-----------------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcC
Confidence            1                 1235799999999999999999999999999999999999999987664332211111000 


Q ss_pred             hhhhhh-------------------hc----chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCE-------------------AT----KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~-------------------~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......                   ..    ..................+.++.+||.+||+.||.+|||++|+|+|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            000000                   00    0000000000011111234678999999999999999999999997

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=401.12  Aligned_cols=258  Identities=30%  Similarity=0.438  Sum_probs=201.6

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .+.+.||+|+||+||+|++.+     .||||+...   .....+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESSS-----EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEEEeeCCCcEEEEEEECC-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            467889999999999997532     478887643   34556789999999999999999999998764 568999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      |++|+|.+++..  ....+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+.......
T Consensus        85 ~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          85 CEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999974  335699999999999999999999999   999999999999999999999999999975432211


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLT-SLAGSML  292 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~  292 (368)
                                   ........||+.|+|||++.+   ..++.++|||||||++|||+||..||.+.+..... ...... 
T Consensus       160 -------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~-  225 (276)
T d1uwha_         160 -------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG-  225 (276)
T ss_dssp             -------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT-
T ss_pred             -------------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-
Confidence                         011133569999999999965   35789999999999999999999999875543221 111110 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                                   ...+.. ...+..+++.+.+|+.+||+.||.+|||+++|+++|+.+.++++
T Consensus       226 -------------~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         226 -------------YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             -------------SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -------------CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence                         000100 11122345689999999999999999999999999999877654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=402.95  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=193.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec--CCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD--RDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  133 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+....   +...+.+.+|++++++++|||||++++++.+  .+.+++|
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            4567889999999999999765  6778999976443   4455778899999999999999999999864  4568999


Q ss_pred             EecccCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          134 FEYVPNGTLQEKLHGTP-RSSKLPWRNRMAIAFQLAQAIEYLHERC--TLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      ||||++|+|.+++.... ....+++..++.++.||+.||.|||+++  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999886421 3467999999999999999999999861  11399999999999999999999999999986


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ......               ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..
T Consensus       164 ~~~~~~---------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~  228 (269)
T d2java1         164 LNHDTS---------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE  228 (269)
T ss_dssp             C--------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccCCC---------------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence            433221               11235699999999999999999999999999999999999999987654433221111


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                ..     .+.    .+...++++.+||.+||+.||.+|||++++++|
T Consensus       229 ----------~~-----~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 ----------GK-----FRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ----------TC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------CC-----CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                      00     011    122335689999999999999999999999976

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-57  Score=397.54  Aligned_cols=245  Identities=26%  Similarity=0.374  Sum_probs=195.2

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec----CCeeEE
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD----RDEGVL  132 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l  132 (368)
                      ++.+.||+|+||+||+|.+..  ++..+|+|....   .....+.+.+|++++++++|||||++++++.+    ...+++
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~--~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            355679999999999999765  667788886543   34456678999999999999999999999864    346799


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEecCCCCCeeec-CCCceEEeeccccc
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLH--IVHGDIKASNILLE-EHLNCKLCDFGSAK  209 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nilv~-~~~~vkl~Dfg~s~  209 (368)
                      |||||++|+|.+++.   ....+++..+..++.||+.||.|||++   +  |+||||||+|||++ .++.+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999997   446799999999999999999999998   7  99999999999997 57899999999997


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......                 ....+||+.|+|||++.+ .++.++|||||||++|||++|..||........  ...
T Consensus       164 ~~~~~~-----------------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~  223 (270)
T d1t4ha_         164 LKRASF-----------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR  223 (270)
T ss_dssp             GCCTTS-----------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH
T ss_pred             eccCCc-----------------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH
Confidence            522211                 134579999999999875 599999999999999999999999975443211  111


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......               ....++...++++.+||.+||+.||++|||++|+++|
T Consensus       224 ~i~~~~---------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         224 RVTSGV---------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             HHTTTC---------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHcCC---------------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            111100               0001111224578999999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=402.42  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=203.5

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC-ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+... .....+.+.+|+++++.++|||||++++++.+.+..++|||||
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKE--TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEeeCCCcEEEEEEECC--CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4567889999999999999765  677899997654 3455577889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++|+|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....   
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---  163 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---  163 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH---
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC---
Confidence            99999998764  245699999999999999999999999   9999999999999999999999999998743211   


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLR-----TGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                                  ........||+.|+|||++.     +..|+.++|||||||++|||++|..||.+.+..........  
T Consensus       164 ------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~--  229 (288)
T d2jfla1         164 ------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--  229 (288)
T ss_dssp             ------------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH--
T ss_pred             ------------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--
Confidence                        11112356999999999984     45688999999999999999999999987654332211111  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       .              .......+...+.++.+||.+||+.||.+|||++++++|
T Consensus       230 -~--------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         230 -S--------------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -S--------------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -C--------------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0              000111122345689999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-57  Score=399.76  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=205.4

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccC
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPN  139 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  139 (368)
                      +.||+|+||+||+|.+..+.....||+|+....   +...+.+.+|+.++++++|||||++++++.+ +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            369999999999999877667788999986532   3445779999999999999999999999965 467899999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCC
Q 017627          140 GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPP  219 (368)
Q Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~  219 (368)
                      |+|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.......   
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---  162 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---  162 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS---
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc---
Confidence            99999998   456799999999999999999999999   999999999999999999999999999986433221   


Q ss_pred             CCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhh
Q 017627          220 SPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADC  298 (368)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  298 (368)
                               .........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.......+..        
T Consensus       163 ---------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~--------  225 (277)
T d1xbba_         163 ---------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------  225 (277)
T ss_dssp             ---------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------
T ss_pred             ---------ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--------
Confidence                     1111233568999999999999999999999999999999998 8999987654333222111        


Q ss_pred             hhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          299 EATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                                 ..+...+..++.++.+|+.+||+.||.+|||+++|++.|+..+.
T Consensus       226 -----------~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         226 -----------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence                       01111223345689999999999999999999999998887654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-57  Score=398.37  Aligned_cols=259  Identities=21%  Similarity=0.315  Sum_probs=208.4

Q ss_pred             hhh-hcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           61 FSQ-VIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        61 ~~~-~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      +.+ +||+|+||+||+|.+........||||+....  ....+.|.+|+++|++++|||||++++++.+ +..++|||||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~   90 (285)
T d1u59a_          12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA   90 (285)
T ss_dssp             EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence            344 39999999999998876667778999986543  4456789999999999999999999999975 5689999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVL  217 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~  217 (368)
                      ++|+|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        91 ~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          91 GGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             TTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence            99999998864  345799999999999999999999999   9999999999999999999999999999865433211


Q ss_pred             CCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          218 PPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                      .            .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.......+..      
T Consensus       166 ~------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~------  227 (285)
T d1u59a_         166 Y------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------  227 (285)
T ss_dssp             E------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT------
T ss_pred             c------------ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence            1            11123458999999999999999999999999999999998 9999987654433222111      


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                               .    .+...+..++.++.+||..||+.||.+|||+.+|++.|+....++.
T Consensus       228 ---------~----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         228 ---------G----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             ---------T----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---------C----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence                     0    0111223345689999999999999999999999999998776543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-57  Score=403.24  Aligned_cols=250  Identities=27%  Similarity=0.373  Sum_probs=192.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .|++.+.||+|+||+||+|++..  ++..+|+|+....  ......+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKR--TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETT--TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeccCeEEEEEEECC--CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35678899999999999998765  6778999986543  2334567899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec---CCCceEEeeccccccCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE---EHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~---~~~~vkl~Dfg~s~~~~  212 (368)
                      ||++|+|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999997   456799999999999999999999999   999999999999995   57899999999997533


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ....                ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+... 
T Consensus       162 ~~~~----------------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-  224 (307)
T d1a06a_         162 PGSV----------------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-  224 (307)
T ss_dssp             ---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT-
T ss_pred             CCCe----------------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc-
Confidence            2211                12356999999999999999999999999999999999999999876544332221110 


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                     +...........+.++.+||.+||+.||.+|||++|+++|
T Consensus       225 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         225 ---------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ---------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                           0011111222345689999999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-57  Score=403.74  Aligned_cols=245  Identities=27%  Similarity=0.329  Sum_probs=200.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      .|...+.||+|+||+||+|++..  ++..||+|+....    ....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC--CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            45667889999999999998765  6788999976543    23456788999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||||.+|+|..++.   ....+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|+....
T Consensus        94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999999987766   346799999999999999999999999   999999999999999999999999999975322


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT---GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .                   ....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+.+........  
T Consensus       168 ~-------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--  226 (309)
T d1u5ra_         168 A-------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--  226 (309)
T ss_dssp             B-------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--
T ss_pred             C-------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--
Confidence            1                   12469999999999964   45899999999999999999999999765543221111  


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                       ...            ..+.+   .+...++.+.+||.+||+.||.+|||++++|+|
T Consensus       227 -~~~------------~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         227 -AQN------------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -HHS------------CCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -HhC------------CCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence             000            00111   112335689999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=401.60  Aligned_cols=248  Identities=26%  Similarity=0.368  Sum_probs=202.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |.+.+.||+|+||+||+|++..  ++..+|+|+....    ....+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4578899999999999999765  6778999986532    233467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||++|+|.+++.   ..+.+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999887   456799999999999999999999999   9999999999999999999999999999864322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ...             ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..   .
T Consensus       162 ~~~-------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---~  225 (288)
T d1uu3a_         162 SKQ-------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK---L  225 (288)
T ss_dssp             ---------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---T
T ss_pred             Ccc-------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc---C
Confidence            211             111235699999999999999999999999999999999999999987654332221111   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                   ..    .++...+.++.+||.+||+.||.+|||++|++++
T Consensus       226 -------------~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 -------------EY----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -------------CC----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -------------CC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                         00    1122335678999999999999999999987554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-57  Score=396.53  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=205.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+.+.||+|+||.||+|.+.   +...||||+........+.+.+|+.++++++|||||++++++.+ +..++|||||+
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             eEEeEEEecCCCcEEEEEEEC---CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            456788999999999999974   35678999887766667789999999999999999999998864 56799999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +|+|.+++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.........
T Consensus        91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            99999987643 234689999999999999999999999   99999999999999999999999999998654322111


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM-EAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                    .....||+.|+|||++.+..++.++|||||||++|||+||. +||...........+.        
T Consensus       167 --------------~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~--------  224 (272)
T d1qpca_         167 --------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE--------  224 (272)
T ss_dssp             --------------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------
T ss_pred             --------------ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------
Confidence                          12245899999999999999999999999999999999955 4554443322221111        


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                             ....+    ..+...+.++.+|+..||+.||.+|||+++|++.|+..+.+
T Consensus       225 -------~~~~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         225 -------RGYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -------TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------hcCCC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                   11111    11223456799999999999999999999999999987654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=404.93  Aligned_cols=259  Identities=26%  Similarity=0.389  Sum_probs=205.6

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCC---CceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDS---TSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~---~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      .+.+.+.||+|+||+||+|++....   ....||+|.....  ......+.+|+.++.++ +|||||++++++.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            3457889999999999999976432   3456888876433  34456788999999998 8999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCC
Q 017627          132 LLFEYVPNGTLQEKLHGTPR--------------------SSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASN  191 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~N  191 (368)
                      +|||||++|+|.+++.....                    ...+++..++.++.||+.||.|||++   +|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence            99999999999999975421                    23589999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh
Q 017627          192 ILLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT  271 (368)
Q Consensus       192 ilv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  271 (368)
                      ||++.++.+||+|||+|+.......             ........||+.|+|||++.+..++.++|||||||++|||+|
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSN-------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTT-------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             cccccCCeEEEeeccccccccCCCc-------------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence            9999999999999999975433221             111123568999999999999999999999999999999998


Q ss_pred             -CCCCCCCCcchh-hHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017627          272 -GMEAFCPENGQL-LTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIK  349 (368)
Q Consensus       272 -g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~  349 (368)
                       |..||.+.+... ......                   .......+..+++++.+||..||+.||.+|||+++|+++|.
T Consensus       262 ~g~~Pf~~~~~~~~~~~~~~-------------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         262 LGVNPYPGIPVDANFYKLIQ-------------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TSCCSSTTCCCSHHHHHHHH-------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHh-------------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence             899997755432 221111                   11111223344568999999999999999999999999997


Q ss_pred             hc
Q 017627          350 HQ  351 (368)
Q Consensus       350 ~~  351 (368)
                      -.
T Consensus       323 ~~  324 (325)
T d1rjba_         323 CQ  324 (325)
T ss_dssp             HH
T ss_pred             CC
Confidence            43

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=388.75  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=208.1

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecccCC
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVPNG  140 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  140 (368)
                      +.+.||+|+||+||+|++.   +...||||+........+.+.+|+.++++++|||||++++++.+.+..++||||+.+|
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG   84 (258)
T ss_dssp             CCCCCCEETTEEEEEEEET---TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred             EeEEEecCCCeEEEEEEEC---CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence            6788999999999999974   4567899988776666778999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCCCC
Q 017627          141 TLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLPPS  220 (368)
Q Consensus       141 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~~~  220 (368)
                      +|..++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.........  
T Consensus        85 ~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--  157 (258)
T d1k2pa_          85 CLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--  157 (258)
T ss_dssp             EHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC--
T ss_pred             cHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee--
Confidence            99998764  345688999999999999999999999   99999999999999999999999999997544332211  


Q ss_pred             CCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhhhh
Q 017627          221 PSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIADCE  299 (368)
Q Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  299 (368)
                                  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+.......+..         
T Consensus       158 ------------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~---------  216 (258)
T d1k2pa_         158 ------------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------  216 (258)
T ss_dssp             ------------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---------
T ss_pred             ------------ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh---------
Confidence                        122458999999999999999999999999999999998 8999987765433322211         


Q ss_pred             hcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017627          300 ATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKH  350 (368)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~  350 (368)
                            .    .....+...+..+.+||..||+.||.+|||+++|++||..
T Consensus       217 ------~----~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 ------G----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ------T----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------C----CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                  0    0111122334689999999999999999999999999965

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-55  Score=400.38  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=207.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      .|.+.+.||+|+||.||+|++..  ++..+|+|+.... ....+.+.+|+.+|+.|+|||||++++++.+.+..++||||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERA--TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35678899999999999998755  6788999977554 34457788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec--CCCceEEeeccccccCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE--EHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |.+|+|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+|+.....
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999864  345699999999999999999999999   999999999999996  4678999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus       180 ~----------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~  243 (350)
T d1koaa2         180 Q----------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN  243 (350)
T ss_dssp             S----------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             c----------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            1                123467999999999999999999999999999999999999999876654333222111100


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                      .........+.++.+||.+||+.||.+|||++++|+|
T Consensus       244 ----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 ----------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----------------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                            0111112235689999999999999999999999997

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-56  Score=392.69  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=199.5

Q ss_pred             hhhhcccccceEEEEEEEcCCC--CceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~--~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +.++||+|+||.||+|.+....  ....||||....  .+.....|.+|+.+++.++|||||++++++.+.+..++||||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            5678999999999999876532  235689997644  344456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      |.++++.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        91 ~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          91 MENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             CTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             cccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            999999988764  345799999999999999999999999   999999999999999999999999999986433221


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCC-CCcchhhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC-PENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~  295 (368)
                      .            ........||+.|+|||++.+..++.++|||||||++|||++|..||. ..+.......+.      
T Consensus       166 ~------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~------  227 (283)
T d1mqba_         166 A------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN------  227 (283)
T ss_dssp             --------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------
T ss_pred             c------------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh------
Confidence            1            011123458999999999999999999999999999999999655543 333222211111      


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                   .......+..++..+.+||.+||+.||.+|||+.+|++.|++++++
T Consensus       228 -------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         228 -------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -------------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------------ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                         1111122333456899999999999999999999999999988764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-55  Score=400.93  Aligned_cols=250  Identities=21%  Similarity=0.258  Sum_probs=207.0

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEecc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      |++.+.||+|+||+||+|.+..  ++..+|+|+.... ......+.+|+.+|+.|+|||||++++++.+.+.+++|||||
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eEEEEEEecCCCeEEEEEEECC--CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5678899999999999998755  6788999976554 344567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeec--CCCceEEeeccccccCCCCC
Q 017627          138 PNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLE--EHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~--~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ++|+|.+++..  ....+++..++.++.||+.||.|||++   ||+||||||+|||++  .++.+||+|||+|+......
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999987764  345699999999999999999999999   999999999999998  67899999999998643221


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDI  295 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  295 (368)
                                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...    
T Consensus       184 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----  243 (352)
T d1koba_         184 ----------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----  243 (352)
T ss_dssp             ----------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC----
T ss_pred             ----------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----
Confidence                            123467999999999999999999999999999999999999999876654332221110    


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                  +...........+.++.+||..||+.||.+|||+.++|+|
T Consensus       244 ------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 ------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ------------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                        0111111222345688999999999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=390.18  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=204.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC-------hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCee
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS-------DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEG  130 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  130 (368)
                      +|++.+.||+|+||+||+|++..  ++..+|+|+....       ....+.+.+|+.+|+.++|||||++++++.+.+..
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~--~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46678899999999999999755  6778999976432       12357789999999999999999999999999999


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC----ceEEeecc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL----NCKLCDFG  206 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~----~vkl~Dfg  206 (368)
                      ++|||||.+|+|.+++.   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999997   345799999999999999999999999   999999999999998776    49999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      +|+.......                .....||+.|+|||++.+..++.++||||+||++|||++|..||.+.+......
T Consensus       163 ~a~~~~~~~~----------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~  226 (293)
T d1jksa_         163 LAHKIDFGNE----------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  226 (293)
T ss_dssp             TCEECTTSCB----------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             hhhhcCCCcc----------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9976432221                123468999999999999999999999999999999999999998766543332


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .+......                .........+..+.+||.+||+.||.+|||++++++|
T Consensus       227 ~i~~~~~~----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         227 NVSAVNYE----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHHTTCCC----------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHhcCCC----------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22111000                0000011234678999999999999999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=397.42  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=205.9

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+....    ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~--~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            4577899999999999998755  6788999987543    223466889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||.+|+|..++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999988   456789999999999999999999999   9999999999999999999999999999854322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...........   
T Consensus       159 ~~---------------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~---  220 (337)
T d1o6la_         159 GA---------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---  220 (337)
T ss_dssp             TC---------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---
T ss_pred             Cc---------------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC---
Confidence            11               113357999999999999999999999999999999999999999887654333222110   


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                                   ..    .++...+.++.+||..||+.||.+||+     +.++++|
T Consensus       221 -------------~~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 -------------EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------------CC----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                         00    112234567899999999999999994     8999987

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-55  Score=393.38  Aligned_cols=243  Identities=22%  Similarity=0.332  Sum_probs=204.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+....    ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRH--NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEecCcCcEEEEEEECC--CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4577899999999999999755  6788999987532    233567889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |||.+|+|..++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999888   456789999999999999999999999   9999999999999999999999999999864322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..   .
T Consensus       158 ~------------------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~  216 (316)
T d1fota_         158 T------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---A  216 (316)
T ss_dssp             B------------------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---C
T ss_pred             c------------------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc---C
Confidence            2                  235699999999999999999999999999999999999999987654332221111   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                   ..    .++...+.++.+++.+||..||.+|+     |++++++|
T Consensus       217 -------------~~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 -------------EL----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -------------CC----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------------CC----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                         00    11122345789999999999999996     99999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=389.94  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      +.+.+.||+|+||+||+|.+.+  + ..||||+........+.|.+|+.++++++|||||++++++.+ +..++|||||.
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~--~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNG--T-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--T-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             EEEeeEEeeCCCeEEEEEEECC--C-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4578899999999999998754  2 468999887666666789999999999999999999999864 56899999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +|+|..++... ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~--  168 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--  168 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc--
Confidence            99999888643 234689999999999999999999999   999999999999999999999999999975432221  


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCC-CCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAF-CPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                  .......||+.|+|||++.+..++.++|||||||++|||++|..|| ...........+..       
T Consensus       169 ------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-------  229 (285)
T d1fmka3         169 ------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------  229 (285)
T ss_dssp             -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------
T ss_pred             ------------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------
Confidence                        1113356999999999999999999999999999999999965554 44333222221111       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCC
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSP  361 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~  361 (368)
                              .    .....+..+++++.+||.+||+.||++|||+.+|++.|+..+.+....+.|
T Consensus       230 --------~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         230 --------G----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             --------T----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             --------c----CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence                    0    111122334568999999999999999999999999999998877544444

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=390.46  Aligned_cols=258  Identities=24%  Similarity=0.319  Sum_probs=200.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      .|++++.||+|+||.||+|.+... .....+|+|....  .+...+.+.+|+.+++.++|||||++++++. .+..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence            456788999999999999987643 2456688887643  3445677999999999999999999999996 46789999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+|+|..++..  ....+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        87 E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          87 ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             ECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999998764  345789999999999999999999999   9999999999999999999999999999754322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...              ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+.......+..   
T Consensus       162 ~~~--------------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~---  224 (273)
T d1mp8a_         162 TYY--------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---  224 (273)
T ss_dssp             -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---
T ss_pred             cce--------------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc---
Confidence            211              1123468999999999999999999999999999999998 8999987665433322111   


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                  ..    ....+..++..+.+||..||+.||.+|||+.+|+++|++++++
T Consensus       225 ------------~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         225 ------------GE----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ------------TC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------CC----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                        00    0112233456899999999999999999999999999988654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=388.24  Aligned_cols=250  Identities=21%  Similarity=0.293  Sum_probs=207.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEeccc
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFEYVP  138 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  138 (368)
                      |.+.+.||+|+||+||+|.+..  ++..+|+|+..........+.+|+++|+.++|||||++++++.+.+.+|+|||||.
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~--~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            5678899999999999998765  67889999887776666778899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC--CCceEEeeccccccCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE--HLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~--~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      +++|.+++..  .+..+++.+++.++.||+.||.|||++   ||+||||||+|||++.  .+.+||+|||+++...... 
T Consensus        85 gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          85 GLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            9999999974  234699999999999999999999999   9999999999999985  4579999999997532211 


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLNDIA  296 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (368)
                                     ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus       159 ---------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~  223 (321)
T d1tkia_         159 ---------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD  223 (321)
T ss_dssp             ---------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             ---------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                           12346799999999999999999999999999999999999999987765433322211110000


Q ss_pred             hhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          297 DCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                              ..        .....+.++.+||..||..||.+|||+.++++|
T Consensus       224 --------~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         224 --------EE--------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --------HH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --------hh--------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    00        000124578999999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=387.40  Aligned_cols=277  Identities=24%  Similarity=0.225  Sum_probs=205.9

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCCh------hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD------RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      .++||+|+||+||+|++..  ++..||+|+.....      ...+.+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEETTEEEEEEECSS--CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             ceEeccCcCeEEEEEEECC--CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            3679999999999998654  67889999765432      123468899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.++++..+..   .+..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        81 ~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          81 FMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            998887776654   456789999999999999999999999   99999999999999999999999999997543322


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      ..               ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+......
T Consensus       155 ~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~  219 (299)
T d1ua2a_         155 RA---------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  219 (299)
T ss_dssp             CC---------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cc---------------ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCC
Confidence            11               122469999999999865 46799999999999999999999999877655444333333222


Q ss_pred             hhhhhhcchhhhcCCC---CCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCCCC
Q 017627          295 IADCEATKVNELVDPR---LAGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSPQK  363 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~---~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~~~  363 (368)
                      ................   .....+     ...++++.+||.+||+.||++|||++|+|+|=  .+++.+.+.++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp--~f~~~p~p~~~~~  294 (299)
T d1ua2a_         220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK--YFSNRPGPTPGCQ  294 (299)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG--GGTSSSCCCCSSS
T ss_pred             CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH--hhCCCCCCCCCCC
Confidence            1111100000000000   000111     12356899999999999999999999999872  3445554444443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.8e-55  Score=394.69  Aligned_cols=243  Identities=21%  Similarity=0.265  Sum_probs=203.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||.||+|++..  ++..+|+|+....    ....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~--~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEeecCcCcEEEEEEECC--CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4577899999999999999755  6778999976532    233467889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      ||+.+|+|..++.   ..+.+++..++.++.||+.||.|||++   +||||||||+|||++.+|.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999987   445799999999999999999999999   9999999999999999999999999999864322


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .                  ....||+.|||||++.+..++.++|||||||++|+|++|..||.+.+.......+..   .
T Consensus       195 ~------------------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~  253 (350)
T d1rdqe_         195 T------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---G  253 (350)
T ss_dssp             B------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C
T ss_pred             c------------------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc---C
Confidence            1                  235699999999999999999999999999999999999999987654332222111   0


Q ss_pred             hhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          295 IADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                                   ..    ..+...+.++.+||.+||+.||.+|+     |++++++|
T Consensus       254 -------------~~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         254 -------------KV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -------------CC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------------CC----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                         00    11123356899999999999999994     99999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=389.89  Aligned_cols=263  Identities=22%  Similarity=0.328  Sum_probs=198.7

Q ss_pred             HHHHhhhhcccccceEEEEEEEcCC---CCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecC-Ce
Q 017627           57 FTQNFSQVIGSGGFSNVYLARLIND---STSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDR-DE  129 (368)
Q Consensus        57 ~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~  129 (368)
                      ..|++.+.||+|+||.||+|.+...   .+...||+|+....  ....+.+.+|..++.++ +|+|||.+++++.+. +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            3456788999999999999997643   34568999986533  34456677888888777 689999999998654 46


Q ss_pred             eEEEEecccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          130 GVLLFEYVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      .++|||||++|+|.+++....             ....+++..+..++.||+.||.|||++   +|+||||||+|||++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            899999999999999986432             124589999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhC-CCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG-MEA  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p  275 (368)
                      ++.+||+|||+|+........             .......||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~-------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p  236 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDY-------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  236 (299)
T ss_dssp             GGCEEECC------CCSCTTS-------------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCcEEEccCcchhhccccccc-------------cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence            999999999999854332211             111234699999999999999999999999999999999996 567


Q ss_pred             CCCCcchhh-HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          276 FCPENGQLL-TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       276 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      |.+...... ......               ...+    ..+...+.++.+|+.+||+.||.+|||++++++||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~---------------~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         237 YPGVKIDEEFCRRLKE---------------GTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             STTCCCSHHHHHHHHH---------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHhc---------------CCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            866543221 111110               0111    12223356799999999999999999999999999998765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=388.32  Aligned_cols=258  Identities=20%  Similarity=0.260  Sum_probs=203.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCCC--CceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDS--TSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~--~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      |++.+.||+|+||+||+|.+..++  ....||+|....  .....+.+.+|+.+++.++|||||++++++.+. ..+++|
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            456788999999999999876532  234678886543  234567899999999999999999999999865 567888


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSS  214 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~  214 (368)
                      |++.+++|.+++..  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        90 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          90 QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             ECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            99989999888765  356799999999999999999999999   9999999999999999999999999999864432


Q ss_pred             CCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhh
Q 017627          215 AVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...             .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+.......+...  
T Consensus       165 ~~~-------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--  229 (317)
T d1xkka_         165 EKE-------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--  229 (317)
T ss_dssp             CC---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT--
T ss_pred             ccc-------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--
Confidence            211             01123458999999999999999999999999999999998 88999776544333222110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                                       .....+..++..+.+|+.+||+.||.+|||+.+|+++|+++.+.
T Consensus       230 -----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         230 -----------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -----------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----------------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                             11112233456899999999999999999999999999887543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.7e-54  Score=378.39  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC----e
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD----E  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  129 (368)
                      +|++.+.||+|+||+||+|.+..  ++..+|+|+...    +......+.+|+.+++.++|||||++++++...+    .
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLR--LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECC--CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            35678899999999999999765  678899998753    2345567899999999999999999999987654    3


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .|+|||||.+++|..++.   ..+.+++.++..++.||+.||.|||++   ||+||||||+|||++.++.++|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999887   456799999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .......            ........+||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+........ 
T Consensus       160 ~~~~~~~------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~-  226 (277)
T d1o6ya_         160 AIADSGN------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-  226 (277)
T ss_dssp             ECC----------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-
T ss_pred             hhccccc------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH-
Confidence            5332221            111123457999999999999999999999999999999999999999876543222111 


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhcc
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-SATQILHTIKHQI  352 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~~il~~L~~~~  352 (368)
                        ...             ++..........+.++.+||.+||+.||.+|| |++++++.|.++.
T Consensus       227 --~~~-------------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         227 --VRE-------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --HHC-------------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --Hhc-------------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence              110             00000011112346899999999999999999 8999998887753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-55  Score=379.22  Aligned_cols=246  Identities=26%  Similarity=0.368  Sum_probs=196.1

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCeeEEEEeccc
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDEGVLLFEYVP  138 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~  138 (368)
                      .+.+.||+|+||.||+|++.    +..+|+|+...+ ...+.+.+|++++++++|||||++++++.+ .+..++||||++
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET----TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             EEeEEEecCCCeEEEEEEEC----CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            46788999999999999973    456899987654 345778999999999999999999999865 456899999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCCCC
Q 017627          139 NGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAVLP  218 (368)
Q Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~~~  218 (368)
                      +|+|.+++... ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            99999998642 223589999999999999999999999   99999999999999999999999999997533221   


Q ss_pred             CCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhhhhhhh
Q 017627          219 PSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSMLNDIAD  297 (368)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  297 (368)
                                     ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+.......+..       
T Consensus       158 ---------------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-------  215 (262)
T d1byga_         158 ---------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------  215 (262)
T ss_dssp             -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-------
T ss_pred             ---------------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------
Confidence                           22358899999999999999999999999999999998 7888876655433322211       


Q ss_pred             hhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          298 CEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                  ......+...+..+.+||.+||+.||.+|||+.+++++|+++
T Consensus       216 ------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         216 ------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                        111122333456899999999999999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=385.35  Aligned_cols=263  Identities=28%  Similarity=0.423  Sum_probs=208.8

Q ss_pred             HhhhhcccccceEEEEEEEcCCCCceeEEEEeecC--ChhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeEEEEec
Q 017627           60 NFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG--SDRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      ++.+.||+|+||+||+|.+.+++....||||....  .....+.+.+|+++|.++ +|||||++++++.+.+..++||||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            36788999999999999987765556677876543  233456789999999999 799999999999999999999999


Q ss_pred             ccCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEe
Q 017627          137 VPNGTLQEKLHGT-------------PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLC  203 (368)
Q Consensus       137 ~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~  203 (368)
                      +++|+|.+++...             .....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence            9999999998743             1346799999999999999999999999   99999999999999999999999


Q ss_pred             eccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcch
Q 017627          204 DFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGM-EAFCPENGQ  282 (368)
Q Consensus       204 Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~  282 (368)
                      |||+|+.......                .....||+.|+|||.+.+..++.++|||||||++|||++|. +||...+..
T Consensus       170 DfG~a~~~~~~~~----------------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~  233 (309)
T d1fvra_         170 DFGLSRGQEVYVK----------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  233 (309)
T ss_dssp             CTTCEESSCEECC----------------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ccccccccccccc----------------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence            9999974322111                12345899999999999999999999999999999999965 567665543


Q ss_pred             hhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccC
Q 017627          283 LLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFS  360 (368)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~  360 (368)
                      .....+..                   ......+...++++.+||.+||+.||++|||+++|+++|++++++.....+
T Consensus       234 ~~~~~i~~-------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~  292 (309)
T d1fvra_         234 ELYEKLPQ-------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  292 (309)
T ss_dssp             HHHHHGGG-------------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred             HHHHHHHh-------------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCC
Confidence            32221111                   011122233456899999999999999999999999999999876554433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.6e-54  Score=391.26  Aligned_cols=247  Identities=21%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----hHHHHH---HHHHHHHhcCCCCceeeeeEEEecCCeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----RLSQVF---KQELDILLHLSHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  131 (368)
                      |.+.+.||+|+||.||+|++..  ++..||+|+.....    .....+   .+|+.+++.++|||||++++++.+.+..|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~--t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECC--CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            4567889999999999999765  67889999864321    112223   34577788889999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      +|||||.+|+|.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999997   446789999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      .....                 ...+||+.|+|||++.+ ..++.++|||||||++|||++|..||..............
T Consensus       158 ~~~~~-----------------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~  220 (364)
T d1omwa3         158 SKKKP-----------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM  220 (364)
T ss_dssp             SSSCC-----------------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH
T ss_pred             CCCcc-----------------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            33221                 22469999999999964 5789999999999999999999999987654433222211


Q ss_pred             hhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017627          291 MLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPS-----ATQILHT  347 (368)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~  347 (368)
                      ....                 ...++...+.++.+||..||+.||.+|||     ++++++|
T Consensus       221 ~~~~-----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         221 TLTM-----------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SSSC-----------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             cccC-----------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            1110                 01112234568999999999999999999     7999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=380.82  Aligned_cols=262  Identities=23%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             hhhhcccccceEEEEEEEcCCC-CceeEEEEeecC--ChhHHHHHHHHHHHHhcCCCCceeeeeEEEec-CCeeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDS-TSTNGAIKIHVG--SDRLSQVFKQELDILLHLSHDNIVKLIGYCDD-RDEGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~-~~~~~aik~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  136 (368)
                      +.++||+|+||+||+|.+.++. +...||||....  .....+.|.+|++++++++|||||++++++.+ ++..++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            4568999999999999986542 345688887643  45556789999999999999999999999865 4688999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSAV  216 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~~  216 (368)
                      |.+++|.+++..  ....+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       111 ~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         111 MKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             CTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             eecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999875  345678888999999999999999999   999999999999999999999999999986544332


Q ss_pred             CCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHhhhhhh
Q 017627          217 LPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQ-LLTSLAGSMLNDI  295 (368)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~  295 (368)
                      ....           ......||+.|+|||.+.+..++.++||||||+++|||+||..||...... .....+   ... 
T Consensus       186 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i---~~g-  250 (311)
T d1r0pa_         186 DSVH-----------NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQG-  250 (311)
T ss_dssp             CCTT-----------CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH---HTT-
T ss_pred             ccce-----------ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcC-
Confidence            1111           112245899999999999999999999999999999999987777543321 111111   000 


Q ss_pred             hhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccccccc
Q 017627          296 ADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISF  357 (368)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~  357 (368)
                                 ..+    ..+..++..+.+||.+||+.||.+|||+.+|+++|+++.++...
T Consensus       251 -----------~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         251 -----------RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             -----------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             -----------CCC----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence                       001    11223356799999999999999999999999999999765433

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.7e-54  Score=376.19  Aligned_cols=249  Identities=26%  Similarity=0.291  Sum_probs=203.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh----------hHHHHHHHHHHHHhcCC-CCceeeeeEEEecC
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD----------RLSQVFKQELDILLHLS-HDNIVKLIGYCDDR  127 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~----------~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  127 (368)
                      |++.+.||+|+||+||+|++..  ++..+|+|+.....          ...+.+.+|+.+++.++ |||||++++++.+.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~--~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CEEceEEecCcCeEEEEEEECC--CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            4567899999999999998755  67889999865431          23456889999999997 99999999999999


Q ss_pred             CeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          128 DEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       128 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      +..|+|||||++|+|.+++.   ..+.+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997   345799999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT------GMASTKTDVYSFGVILLELVTGMEAFCPENG  281 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (368)
                      ++.......                .....||+.|+|||.+.+      ..++.++||||+||++|+|++|..||.+.+.
T Consensus       157 a~~~~~~~~----------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~  220 (277)
T d1phka_         157 SCQLDPGEK----------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  220 (277)
T ss_dssp             CEECCTTCC----------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eeEccCCCc----------------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence            986433221                123469999999999864      3468899999999999999999999987664


Q ss_pred             hhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          282 QLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ......+....                ...........++++.+|+.+||+.||.+|||++++++|
T Consensus       221 ~~~~~~i~~~~----------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         221 MLMLRMIMSGN----------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHHHHHHTC----------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhCC----------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            43322211100                001111122345689999999999999999999999887

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-54  Score=382.07  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=207.9

Q ss_pred             HHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      +++.+.||+|+||+||+|++.+   ..+...||||+....  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            4567889999999999999764   235678999986543  34467799999999999999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCe
Q 017627          134 FEYVPNGTLQEKLHGTP---------------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNI  192 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Ni  192 (368)
                      |||+.+|+|.+++....                     ....+++..+..++.|++.||+|||++   +||||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence            99999999999986421                     123488999999999999999999999   999999999999


Q ss_pred             eecCCCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhC
Q 017627          193 LLEEHLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG  272 (368)
Q Consensus       193 lv~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  272 (368)
                      |++.++.+||+|||+|+........             .......||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYY-------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCB-------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             EECCCCcEEEccchhheeccCCccc-------------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence            9999999999999999754332211             111235689999999999999999999999999999999998


Q ss_pred             C-CCCCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          273 M-EAFCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       273 ~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                      . +||...+.......+..          .     ..+    ..+...+.++.+|+..||+.||.+|||+.+|++.|+++
T Consensus       239 ~~~p~~~~~~~e~~~~v~~----------~-----~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         239 GLQPYYGMAHEEVIYYVRD----------G-----NIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TCCTTTTSCHHHHHHHHHT----------T-----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHc----------C-----CCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            5 67876654433222111          0     001    12223345789999999999999999999999999987


Q ss_pred             c
Q 017627          352 I  352 (368)
Q Consensus       352 ~  352 (368)
                      .
T Consensus       300 ~  300 (301)
T d1lufa_         300 C  300 (301)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=378.35  Aligned_cols=257  Identities=21%  Similarity=0.275  Sum_probs=198.3

Q ss_pred             HHhhhhcccccceEEEEEEEcCC-CCceeEEEEeecC----ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIND-STSTNGAIKIHVG----SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~-~~~~~~aik~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |++.+.||+|+||.||+|++... +....||||+...    .+...+.|.+|+.+++.++|||||++++++.+ ...++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence            34677899999999999987543 3445788987643    24456788999999999999999999999975 467899


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||||.++++.+++..  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          89 TELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999987764  345699999999999999999999999   999999999999999999999999999986433


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEAFCPENGQLLTSLAGSML  292 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  292 (368)
                      ...            .........|+..|+|||++.+..++.++||||||+++|||+| |..||.+.+.......+..  
T Consensus       164 ~~~------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~--  229 (273)
T d1u46a_         164 NDD------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--  229 (273)
T ss_dssp             -CC------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--
T ss_pred             CCC------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh--
Confidence            221            1111123468889999999999999999999999999999998 8999987665433322211  


Q ss_pred             hhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 017627          293 NDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQ  351 (368)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~  351 (368)
                                      .......+...+..+.+||..||+.||.+|||+.+|++.|+++
T Consensus       230 ----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 ----------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----------------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                            1111122233456899999999999999999999999998864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=385.72  Aligned_cols=246  Identities=22%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC----hhHHHHHHHHHHHHh-cCCCCceeeeeEEEecCCeeEEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS----DRLSQVFKQELDILL-HLSHDNIVKLIGYCDDRDEGVLL  133 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv  133 (368)
                      |.+.+.||+|+||+||+|++..  ++..+|+|+....    ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~--t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECC--CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4577899999999999999765  7889999987532    222344556666654 68999999999999999999999


Q ss_pred             EecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCC
Q 017627          134 FEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       134 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~  213 (368)
                      ||||.+|+|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999998   456789999999999999999999999   999999999999999999999999999975332


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...               ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...  
T Consensus       156 ~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--  218 (320)
T d1xjda_         156 GDA---------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--  218 (320)
T ss_dssp             TTC---------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--
T ss_pred             ccc---------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--
Confidence            211               112346999999999999999999999999999999999999999876654333222110  


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSAT-QILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~  347 (368)
                                    .+.    ++...+.++.+||.+||+.||.+|||+. ++++|
T Consensus       219 --------------~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 --------------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             --------------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --------------CCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                          111    1223356799999999999999999995 78765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=384.24  Aligned_cols=246  Identities=22%  Similarity=0.297  Sum_probs=194.8

Q ss_pred             hhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhc-CCCCceeeeeEEEec----CCeeEEEEec
Q 017627           62 SQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLH-LSHDNIVKLIGYCDD----RDEGVLLFEY  136 (368)
Q Consensus        62 ~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~  136 (368)
                      .+.||+|+||+||+|++..  ++..||+|+.....    .+.+|+.++.+ ++|||||+++++|.+    .+.+|+||||
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~----~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy   90 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKR--TQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   90 (335)
T ss_dssp             EEEEEECSSCEEEEEEETT--TCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             eEEeeeccCeEEEEEEECC--CCCEEEEEEECCcH----HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence            3569999999999999765  67889999876543    46679988655 589999999999865    4568999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeeccccccCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~~~~  213 (368)
                      |++|+|.+++... ....+++..++.++.||+.||.|||++   +|+||||||+|||++.   .+.+||+|||+|+....
T Consensus        91 ~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          91 LDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence            9999999999753 245799999999999999999999999   9999999999999985   56799999999986433


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      ...                .....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+..........   
T Consensus       167 ~~~----------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---  227 (335)
T d2ozaa1         167 HNS----------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---  227 (335)
T ss_dssp             CCC----------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred             CCc----------------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---
Confidence            221                1234699999999999999999999999999999999999999976553322111100   


Q ss_pred             hhhhhhhcchhhhcCCC--CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVDPR--LAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                                 ......  .........+.++.+||.+||+.||.+|||+.++++|
T Consensus       228 -----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         228 -----------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----------HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                       000011  1111123456789999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=377.96  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=205.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCC-----CceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCe
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDS-----TSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDE  129 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~-----~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  129 (368)
                      .|++++.||+|+||.||+|++....     ....||||+....  ......+.+|+..+.++ +|||||++++++.+.+.
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            4457789999999999999875432     3457899987543  34456788899999888 79999999999999999


Q ss_pred             eEEEEecccCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          130 GVLLFEYVPNGTLQEKLHGTP-------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      .++|||||.+|+|.+++....             ....+++..++.++.||+.||.|||++   +||||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence            999999999999999997542             134689999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEA  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  275 (368)
                      ++.+||+|||+++..........             .....||+.|+|||.+.+..++.++||||||+++|||++ |.+|
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKK-------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCC-------------CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCeEeccchhhccccccccccc-------------cccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence            99999999999986543332111             122458999999999999999999999999999999998 7889


Q ss_pred             CCCCcchhhHHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhccc
Q 017627          276 FCPENGQLLTSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQIS  353 (368)
Q Consensus       276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~  353 (368)
                      |...+.......+..               -    .....+...+..+.+||.+||+.||.+|||+.+|++.|++++.
T Consensus       238 ~~~~~~~~~~~~i~~---------------~----~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         238 YPGVPVEELFKLLKE---------------G----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             STTCCHHHHHHHHHT---------------T----CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHc---------------C----CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            876654433222111               0    1111222335679999999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=380.94  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=210.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcC-CCCceeeeeEEEecCCeeE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHL-SHDNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  131 (368)
                      .+.+++.||+|+||.||+|++..   ......+|||+....  ......+.+|+.++..+ +|||||++++++.+.+..+
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~  103 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence            45578899999999999998743   356788999987543  34456788999999999 6999999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC
Q 017627          132 LLFEYVPNGTLQEKLHGTP---------------RSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE  196 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~  196 (368)
                      +|||||++|+|.+++....               ....+++..+..++.||+.||.|||++   +|+||||||+|||++.
T Consensus       104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH  180 (311)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred             EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccccc
Confidence            9999999999999987432               223689999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 017627          197 HLNCKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVT-GMEA  275 (368)
Q Consensus       197 ~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  275 (368)
                      ++.+||+|||+++........             .......||+.|+|||++.+..++.++|||||||++|||+| |.+|
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNY-------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTS-------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cCcccccccchheeccCCCcc-------------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            999999999999854332211             11123579999999999999999999999999999999999 5666


Q ss_pred             CCCCcchhh-HHHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          276 FCPENGQLL-TSLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       276 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      |...+.... ......                   ......+...+..+.+||.+||+.||.+|||+++|++.|++++.+
T Consensus       248 ~~~~~~~~~~~~~i~~-------------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         248 YPGMPVDSKFYKMIKE-------------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             STTCCSSHHHHHHHHH-------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHhc-------------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            655443221 111111                   111112223456899999999999999999999999999998765


Q ss_pred             c
Q 017627          355 I  355 (368)
Q Consensus       355 ~  355 (368)
                      .
T Consensus       309 ~  309 (311)
T d1t46a_         309 S  309 (311)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-53  Score=375.71  Aligned_cols=267  Identities=24%  Similarity=0.259  Sum_probs=200.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh---hHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD---RLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||+||+|++..  ++..+|+|+.....   ...+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus         4 Y~~~~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           4 FQKVEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CEeccEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4466889999999999999765  66789999875432   235678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      |+.++.+. ++... ....+++..++.++.|++.||.|||++   +||||||||+|||++.++.+||+|||.|+......
T Consensus        82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99665444 44322 356799999999999999999999999   99999999999999999999999999997543222


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..............
T Consensus       157 ~---------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~  221 (298)
T d1gz8a_         157 R---------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT  221 (298)
T ss_dssp             B---------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             c---------------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            1               112346999999999987765 578999999999999999999999877654333222222211


Q ss_pred             hhhhhhcchhhhcC--CCC----CCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELVD--PRL----AGDF---DLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~~--~~~----~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .............+  ...    ....   ....+.++.+|+.+||+.||.+|||+.|+++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111111111000  000    0000   01234688999999999999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=375.62  Aligned_cols=277  Identities=19%  Similarity=0.283  Sum_probs=198.7

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC----eeEEEEec
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD----EGVLLFEY  136 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~  136 (368)
                      +.+.||+|+||.||+|++    .+..||||+...........+.|+..+..++|||||++++++.+.+    ..++||||
T Consensus         7 l~~~iG~G~fg~Vy~~~~----~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE----TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEeeCCCeEEEEEEE----CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            567899999999999986    4578999987655443333444555666789999999999997654    57999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERC-----TLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      |.+|+|.++++.    ..+++..+..++.|++.||.|||+.+     ..+|+||||||+||||+.++.+||+|||+++..
T Consensus        83 ~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999974    35899999999999999999999621     138999999999999999999999999999864


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM------ASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      .......           ........||+.|+|||++.+..      ++.++|||||||++|||+||..||.........
T Consensus       159 ~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         159 DSATDTI-----------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             ETTTTEE-----------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             cCCCcce-----------eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            4322110           11112357999999999987653      567899999999999999999888543321110


Q ss_pred             HH-HHhhhhhhhhhhhcchhhhcCCCCCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccc
Q 017627          286 SL-AGSMLNDIADCEATKVNELVDPRLAGDF-DLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSIS  356 (368)
Q Consensus       286 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~  356 (368)
                      .. ....................+|.+.... .......+.+|+.+||+.||.+|||+.+|+++|+++....+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            00 0000000000000111111222222211 23456779999999999999999999999999998876544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=373.50  Aligned_cols=239  Identities=22%  Similarity=0.323  Sum_probs=193.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-------hHHHHHHHHHHHHhcCC--CCceeeeeEEEecCC
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-------RLSQVFKQELDILLHLS--HDNIVKLIGYCDDRD  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  128 (368)
                      +|.+.+.||+|+||+||+|++..  ++..||+|+.....       .....+.+|+.+++.++  |||||++++++.+.+
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             eEEEeEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            45678899999999999999765  67889999764321       11233568999999996  899999999999999


Q ss_pred             eeEEEEecccC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-CCceEEeecc
Q 017627          129 EGVLLFEYVPN-GTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-HLNCKLCDFG  206 (368)
Q Consensus       129 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-~~~vkl~Dfg  206 (368)
                      ..++||||+.+ +++.+++.   ....+++..++.++.||+.||.|||++   +|+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            99999999965 57878776   446799999999999999999999999   9999999999999985 5799999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMA-STKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      +|+......                 .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..   
T Consensus       157 ~a~~~~~~~-----------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i---  216 (273)
T d1xwsa_         157 SGALLKDTV-----------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---  216 (273)
T ss_dssp             TCEECCSSC-----------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---
T ss_pred             cceeccccc-----------------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH---
Confidence            997533221                 123469999999999987765 56799999999999999999999653210   


Q ss_pred             HHHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                            ..       .      .....    ...+.++.+||.+||+.||.+|||++++++|
T Consensus       217 ------~~-------~------~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         217 ------IR-------G------QVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ------HH-------C------CCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------hh-------c------ccCCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                  00       0      00011    1234688999999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=370.69  Aligned_cols=268  Identities=22%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcC---CCCceeeeeEEEec-----
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHL---SHDNIVKLIGYCDD-----  126 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----  126 (368)
                      +|++.+.||+|+||+||+|++..+ ....||+|+...   .......+.+|+.+++.|   +||||++++++|..     
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTT-TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CEEEEEEEecccCeEEEEEEEECC-CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            456778999999999999987542 356789987543   222233456788887766   79999999999853     


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      ....+++||++.++++......  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence            3468999999988776554443  456789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTS  286 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (368)
                      +++......                ......||+.|+|||++.+..++.++||||+||++|||++|.+||.+.+......
T Consensus       162 ~~~~~~~~~----------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  225 (305)
T d1blxa_         162 LARIYSFQM----------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  225 (305)
T ss_dssp             SCCCCCGGG----------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             hhhhhcccc----------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            987432211                1234569999999999999999999999999999999999999998776544333


Q ss_pred             HHHhhhhhhhhhhhcch---h-hhc---CCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          287 LAGSMLNDIADCEATKV---N-ELV---DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~---~-~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .+...............   . ...   .......+....++.+.+||.+||+.||.+|||++|+|+|
T Consensus       226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            32222221111000000   0 000   0000111222345678999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=371.43  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=208.4

Q ss_pred             HhhhhcccccceEEEEEEEcC---CCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEE
Q 017627           60 NFSQVIGSGGFSNVYLARLIN---DSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLF  134 (368)
Q Consensus        60 ~~~~~iG~G~~g~V~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  134 (368)
                      ++.+.||+|+||+||+|.+..   ......||||+....  ......+.+|+.++++++|||||++++++...+..++||
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            467889999999999998753   224578999977543  344456889999999999999999999999999999999


Q ss_pred             ecccCCCHHHHhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccc
Q 017627          135 EYVPNGTLQEKLHGT-------PRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGS  207 (368)
Q Consensus       135 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~  207 (368)
                      |||.+|+|.+++...       .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence            999999999987532       1234578999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcchhhHH
Q 017627          208 AKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTG-MEAFCPENGQLLTS  286 (368)
Q Consensus       208 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~  286 (368)
                      |+.......             ........||+.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+......
T Consensus       180 a~~~~~~~~-------------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         180 TRDIYETDY-------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             CCGGGGGGC-------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             ceeccCCcc-------------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            975433221             1111234689999999999999999999999999999999998 47776655433222


Q ss_pred             HHHhhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccc
Q 017627          287 LAGSMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISS  354 (368)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~  354 (368)
                      .+..                  .. ....+..++..+.+||..||+.||.+|||+++|+++|++.+..
T Consensus       247 ~i~~------------------~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         247 FVME------------------GG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             HHHT------------------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHh------------------CC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1111                  00 0111223346899999999999999999999999999998763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-51  Score=365.70  Aligned_cols=265  Identities=25%  Similarity=0.249  Sum_probs=200.4

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |.+.+.||+|+||+||+|++.   ++..||+|+....   ....+.+.+|+.+|+.++|||||++++++.+.+..+++||
T Consensus         4 Y~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           4 YHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ceeccEEecCCCcEEEEEEeC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            456788999999999999874   4577999987543   2335678899999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ++.++++..+..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||.|.......
T Consensus        81 ~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            998777766665   456799999999999999999999999   99999999999999999999999999997643222


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLND  294 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  294 (368)
                      .               ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..............
T Consensus       155 ~---------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~  219 (286)
T d1ob3a_         155 R---------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT  219 (286)
T ss_dssp             ----------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             c---------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            1               11234589999999999764 5689999999999999999999999876644333222222221


Q ss_pred             hhhhhhcchhhhc---------CCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          295 IADCEATKVNELV---------DPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       295 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .............         .+..........+..+.+|+.+||+.||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111111010000         0000011122335688999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=371.56  Aligned_cols=267  Identities=19%  Similarity=0.223  Sum_probs=198.2

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecC---ChhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVG---SDRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD------  128 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  128 (368)
                      +|.+.+.||+|+||+||+|.+..  ++..+|+|+...   .....+.+.+|+++|+.++|||||+++++|...+      
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             SEEEEEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            35567889999999999998755  678899998754   3345667889999999999999999999997654      


Q ss_pred             eeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccc
Q 017627          129 EGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSA  208 (368)
Q Consensus       129 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s  208 (368)
                      ..|+||||+ +.+|..+..    ...+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence            469999999 667887775    34699999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHH
Q 017627          209 KMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSL  287 (368)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  287 (368)
                      +......                  ....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......
T Consensus       169 ~~~~~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~  230 (346)
T d1cm8a_         169 RQADSEM------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE  230 (346)
T ss_dssp             EECCSSC------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             eccCCcc------------------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH
Confidence            8543221                  23469999999999876 4578999999999999999999999987765433332


Q ss_pred             HHhhhhhhhhhhh--------cchhhhcCCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcc
Q 017627          288 AGSMLNDIADCEA--------TKVNELVDPRLA---GDFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQI  352 (368)
Q Consensus       288 ~~~~~~~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~  352 (368)
                      ........+....        ............   .......+..+.+||.+||..||.+|||+.++|+|  ++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            2222211111000        000000000000   01112335678999999999999999999999998  55543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=374.00  Aligned_cols=269  Identities=26%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCceeeeeEEEecC------CeeEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIVKLIGYCDDR------DEGVL  132 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~l  132 (368)
                      |+..++||+|+||+||+|++..  ++..||||+.......   ..+|+++|+.++|||||+++++|...      ..+++
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             cEeeeEEeeCcCeEEEEEEECC--CCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            3456789999999999999765  6788999987665432   34799999999999999999998532      35789


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCC-ceEEeeccccccC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHL-NCKLCDFGSAKMG  211 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~-~vkl~Dfg~s~~~  211 (368)
                      |||||+++++..+.........+++..++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999997664444332222456799999999999999999999999   999999999999999765 8999999999864


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGS  290 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  290 (368)
                      ......                ....||+.|+|||.+.+ ..++.++||||+||++|||++|..||...+.......+..
T Consensus       174 ~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~  237 (350)
T d1q5ka_         174 VRGEPN----------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK  237 (350)
T ss_dssp             CTTSCC----------------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred             cCCccc----------------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence            332211                22469999999998865 5789999999999999999999999987665433322222


Q ss_pred             hhhhhhhhhhc---------chhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhc
Q 017627          291 MLNDIADCEAT---------KVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQ  351 (368)
Q Consensus       291 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~  351 (368)
                      ...........         ..................+.++.+||.+||+.||.+|||+.|+|+|  ++++
T Consensus       238 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            21111110000         0000000000111122345689999999999999999999999987  4444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=362.78  Aligned_cols=272  Identities=21%  Similarity=0.226  Sum_probs=200.8

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec--------
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD--------  126 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------  126 (368)
                      +|.+.+.||+|+||+||+|++..  ++..||||+....   +.....+.+|+.+|+.++||||+++++++..        
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CEEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            34577889999999999999754  6788999976433   3345678899999999999999999998854        


Q ss_pred             CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecc
Q 017627          127 RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFG  206 (368)
Q Consensus       127 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg  206 (368)
                      .+..++|||++.++++..+..   ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            346799999998776665544   456789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhH
Q 017627          207 SAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLT  285 (368)
Q Consensus       207 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  285 (368)
                      +++.........           .......+||+.|+|||++.+. .++.++||||+||++|||++|..||.+.+.....
T Consensus       163 ~~~~~~~~~~~~-----------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~  231 (318)
T d3blha1         163 LARAFSLAKNSQ-----------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL  231 (318)
T ss_dssp             TCEECCC----------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eeeecccccccc-----------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH
Confidence            997544322111           1111234699999999999765 6899999999999999999999999877655554


Q ss_pred             HHHHhhhhhhhhhhhcch-----hhhcCCCCCCCCCH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017627          286 SLAGSMLNDIADCEATKV-----NELVDPRLAGDFDL-------DEARAMLSIAALCLRQSPILRPSATQILHTI  348 (368)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L  348 (368)
                      ..................     ..............       ..+..+.+||.+||+.||++|||++|+|+|-
T Consensus       232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence            444443333221111110     00000001111111       1145778999999999999999999999873

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-50  Score=359.97  Aligned_cols=274  Identities=18%  Similarity=0.227  Sum_probs=203.0

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCc-eeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDN-IVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +|.+.+.||+|+||+||+|++..  ++..||||+...... ...+..|+++++.++|+| |+.+..++.+.+..++||||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECC--CCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            35678899999999999999765  677899998665433 345778999999998665 55556666788899999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC---CCceEEeeccccccCCC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE---HLNCKLCDFGSAKMGFS  213 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~---~~~vkl~Dfg~s~~~~~  213 (368)
                      + +++|...+..  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..+||+|||+|+....
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 5566655543  346799999999999999999999999   9999999999999863   55799999999987554


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhhhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSMLN  293 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  293 (368)
                      .......        .........||+.|+|||++.+..++.++|||||||++|||++|..||.................
T Consensus       159 ~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~  230 (299)
T d1ckia_         159 ARTHQHI--------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  230 (299)
T ss_dssp             TTTCCBC--------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred             cccccce--------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence            3321111        11112345799999999999999999999999999999999999999987554322221111111


Q ss_pred             hhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccC
Q 017627          294 DIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFS  360 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~  360 (368)
                      ....   ......     .    ...+.++.+|+..||+.||.+||+++++.+.|++++.+.....+
T Consensus       231 ~~~~---~~~~~~-----~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~  285 (299)
T d1ckia_         231 KKMS---TPIEVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  285 (299)
T ss_dssp             HHHH---SCHHHH-----T----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCS
T ss_pred             ccCC---CChhHh-----c----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCC
Confidence            0000   001110     1    12245789999999999999999999999999988776555444

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=366.12  Aligned_cols=275  Identities=20%  Similarity=0.246  Sum_probs=199.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC--hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCC----eeEE
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS--DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRD----EGVL  132 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l  132 (368)
                      |.+.+.||+|+||+||+|.+..  ++..+|||+....  ....+.+.+|+.+|+.|+||||+++++++....    ..++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETT--TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             eEEEEEEeeccCeEEEEEEECC--CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            5577899999999999998654  6778999987543  345567889999999999999999999996543    2344


Q ss_pred             EEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCC
Q 017627          133 LFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGF  212 (368)
Q Consensus       133 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~  212 (368)
                      +++++.+++|.+++..    ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            5556669999999963    3589999999999999999999999   99999999999999999999999999998644


Q ss_pred             CCCCCCCCCCCCCCccccccceeeecCCCCccchhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          213 SSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRT-GMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ......            ......+||+.|+|||++.. ..++.++||||+||++|+|++|..||.+.+...........
T Consensus       161 ~~~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~  228 (345)
T d1pmea_         161 PDHDHT------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI  228 (345)
T ss_dssp             GGGCBC------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCCccc------------eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence            332111            11123569999999999844 56789999999999999999999999877654333322222


Q ss_pred             hhhhhhhhhc-----chhh-hcCCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhcccc
Q 017627          292 LNDIADCEAT-----KVNE-LVDPRLAGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT--IKHQISS  354 (368)
Q Consensus       292 ~~~~~~~~~~-----~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~--L~~~~~~  354 (368)
                      ..........     .... ..........+     ...+.++.+|+..||+.||.+|||++++|+|  +++....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence            2111110000     0000 00000000111     1224578999999999999999999999998  6655443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-49  Score=353.03  Aligned_cols=275  Identities=14%  Similarity=0.158  Sum_probs=212.7

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCC-CceeeeeEEEecCCeeEEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH-DNIVKLIGYCDDRDEGVLLFEY  136 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~  136 (368)
                      +|.+.+.||+|+||+||+|++..  ++..+|+|+...... ...+.+|+++++.|+| +|++.+++++.+....++||||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            45678899999999999999765  678899998654432 3456789999999965 8999999999999999999999


Q ss_pred             ccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecC-----CCceEEeeccccccC
Q 017627          137 VPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEE-----HLNCKLCDFGSAKMG  211 (368)
Q Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~-----~~~vkl~Dfg~s~~~  211 (368)
                      + +++|.+++..  .+..++..++..++.|++.||.|||++   ||+||||||+|||++.     ++.+||+|||+|+..
T Consensus        83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9 7899888864  345689999999999999999999999   9999999999999974     578999999999875


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHHhh
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAGSM  291 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  291 (368)
                      ........        .........+||+.|||||++.+..++.++||||||+++|||++|..||.+.............
T Consensus       157 ~~~~~~~~--------~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         157 RDPVTKQH--------IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             BCTTTCCB--------CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ccCccccc--------eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            44322111        1111123457999999999999999999999999999999999999999865543322222211


Q ss_pred             hhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcccccccccCC
Q 017627          292 LNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHTIKHQISSISFLFSP  361 (368)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~L~~~~~~~~~~~~~  361 (368)
                      ......   ....++     ..    ..++++.+++..|++.+|.+||+++.+.+.|++++.+.....+.
T Consensus       229 ~~~~~~---~~~~~l-----~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~  286 (293)
T d1csna_         229 GEKKQS---TPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE  286 (293)
T ss_dssp             HHHHHH---SCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCS
T ss_pred             HhccCC---CChHHh-----cC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCC
Confidence            111000   111111     11    12357899999999999999999999999999988776655443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=362.28  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             HHhhhhcccccceEEEEEEEcC-CCCceeEEEEeecCC-----hhHHHHHHHHHHHHhcCCC-CceeeeeEEEecCCeeE
Q 017627           59 QNFSQVIGSGGFSNVYLARLIN-DSTSTNGAIKIHVGS-----DRLSQVFKQELDILLHLSH-DNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~-~~~~~~~aik~~~~~-----~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~  131 (368)
                      |.+.+.||+|+||+||+|++.. ..++..+|+|+....     ....+.+.+|++++++++| |||+++++++.+.+..+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            4578899999999999998754 446789999976432     2345667889999999966 89999999999999999


Q ss_pred             EEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccC
Q 017627          132 LLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMG  211 (368)
Q Consensus       132 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~  211 (368)
                      ++|||+.+++|.+++.   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       106 ~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         106 LILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999997   455678999999999999999999999   9999999999999999999999999999753


Q ss_pred             CCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          212 FSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG--MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ....              ........|++.|+|||.+.+.  .++.++|||||||++|+|++|..||...+.......+.
T Consensus       180 ~~~~--------------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         180 VADE--------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             CGGG--------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             cccc--------------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3221              1122345699999999999764  46889999999999999999999998766433322221


Q ss_pred             hhhhhhhhhhhcchhhhcCCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017627          290 SMLNDIADCEATKVNELVDPRLAGDFDLDEARAMLSIAALCLRQSPILRP-----SATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~  347 (368)
                      .....              .  ...++...+.++.+|+.+||+.||.+||     |++|+++|
T Consensus       246 ~~~~~--------------~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         246 RRILK--------------S--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHHHH--------------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             Hhccc--------------C--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            11110              0  0112223466899999999999999999     58999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=352.17  Aligned_cols=266  Identities=21%  Similarity=0.218  Sum_probs=204.2

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecCCeeEEEEe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDRDEGVLLFE  135 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  135 (368)
                      |++.+.||+|+||+||+|++..  ++..||+|+....   ......+.+|+.+++.++||||+++++++.+.+..++|++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEeeeEEecCcCeEEEEEEECC--CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5567889999999999999765  6778999986432   3456788999999999999999999999999999999999


Q ss_pred             cccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccccCCCCC
Q 017627          136 YVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKMGFSSA  215 (368)
Q Consensus       136 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~~~~~~  215 (368)
                      ++.+++|..++.   ..+.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.|+......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999888877   456789999999999999999999999   99999999999999999999999999998644322


Q ss_pred             CCCCCCCCCCCccccccceeeecCCCCccchhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHhhhh
Q 017627          216 VLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGM-ASTKTDVYSFGVILLELVTGMEAFCPENG-QLLTSLAGSMLN  293 (368)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~  293 (368)
                      ...               ....+++.|+|||++.+.. ++.++||||+||++|||++|+.||..... ............
T Consensus       156 ~~~---------------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  220 (292)
T d1unla_         156 RCY---------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             SCC---------------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccc---------------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC
Confidence            111               1234788899999987664 68999999999999999999998754432 222222222221


Q ss_pred             hhhhhhhcchhhhcC---------CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          294 DIADCEATKVNELVD---------PRLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       294 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ..............+         ...........+..+.+|+.+||+.||.+||||+|+|+|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111110000111000         001111223445688999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.2e-49  Score=356.94  Aligned_cols=261  Identities=20%  Similarity=0.278  Sum_probs=196.4

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEec--CCeeEEEE
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDD--RDEGVLLF  134 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~  134 (368)
                      .|.+.+.||+|+||+||+|++..  ++..||+|+.....  .+.+.+|+++|+.++ ||||+++++++..  ....++||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECC--CCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            45678899999999999998755  77899999875433  456789999999995 9999999999974  35689999


Q ss_pred             ecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCC-CceEEeeccccccCCC
Q 017627          135 EYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEH-LNCKLCDFGSAKMGFS  213 (368)
Q Consensus       135 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~-~~vkl~Dfg~s~~~~~  213 (368)
                      |||.+++|..+.      ..+++..+..++.||+.||.|||++   ||+||||||+|||++.+ +.+||+|||+|+....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987654      3589999999999999999999999   99999999999999865 4699999999986433


Q ss_pred             CCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHhh
Q 017627          214 SAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQL-LTSLAGSM  291 (368)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~  291 (368)
                      ...                .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ........
T Consensus       183 ~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~  246 (328)
T d3bqca1         183 GQE----------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  246 (328)
T ss_dssp             TCC----------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             CCc----------------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence            221                1234689999999998775 57999999999999999999999997655322 11111111


Q ss_pred             hhhhhhh---------hhcchhhhcCC--------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          292 LNDIADC---------EATKVNELVDP--------RLAGDFDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       292 ~~~~~~~---------~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      .......         ...........        ..........+.++.+||.+||+.||.+|||++|+|+|
T Consensus       247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1110000         00000011100        01111112345688999999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=360.40  Aligned_cols=262  Identities=21%  Similarity=0.181  Sum_probs=192.1

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEec------CCe
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDD------RDE  129 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~  129 (368)
                      |++.++||+|+||+||+|.+..  ++..+|+|+....   ......+.+|+.+++.++|||||+++++|..      .+.
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~--t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETT--TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             eEEEEEeecCcCeEEEEEEECC--CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            4567889999999999998755  6788999987543   3445678899999999999999999999963      367


Q ss_pred             eEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          130 GVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       130 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      .|+|||||.++++ ..+.     ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence            8999999966544 4443     3479999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          210 MGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      ......                ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.........
T Consensus       168 ~~~~~~----------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~  231 (355)
T d2b1pa1         168 TAGTSF----------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI  231 (355)
T ss_dssp             -----------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccc----------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            433211                1134569999999999999999999999999999999999999998766433322221


Q ss_pred             hhhhhhhh-------------------hhhcchhhhcCCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIAD-------------------CEATKVNELVDPRLAGD---FDLDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~-------------------~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ........                   .................   .....+.++.+||.+||..||++||||+|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11111000                   00000011111111111   123457789999999999999999999999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=358.40  Aligned_cols=262  Identities=20%  Similarity=0.244  Sum_probs=195.8

Q ss_pred             HHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCC---hhHHHHHHHHHHHHhcCCCCceeeeeEEEecC-----Cee
Q 017627           59 QNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGS---DRLSQVFKQELDILLHLSHDNIVKLIGYCDDR-----DEG  130 (368)
Q Consensus        59 ~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  130 (368)
                      |++.+.||+|+||+||+|++..  ++..||+|+....   ....+.+.+|+.+|+.++|||||++++++...     ...
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETT--TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECC--CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            5677889999999999998755  7889999987543   34456788999999999999999999998643     334


Q ss_pred             EEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceEEeecccccc
Q 017627          131 VLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCKLCDFGSAKM  210 (368)
Q Consensus       131 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~~  210 (368)
                      +++|+++.+++|.+++.    ...+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+|++|||+|..
T Consensus        98 ~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence            66677777999999985    34699999999999999999999999   999999999999999999999999999864


Q ss_pred             CCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Q 017627          211 GFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTG-MASTKTDVYSFGVILLELVTGMEAFCPENGQLLTSLAG  289 (368)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  289 (368)
                      .....                  ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus       171 ~~~~~------------------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~  232 (348)
T d2gfsa1         171 TDDEM------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  232 (348)
T ss_dssp             CTGGG------------------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCccc------------------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            32211                  234589999999987765 56889999999999999999999998876544443332


Q ss_pred             hhhhhhhhhhhc-----chhhhcCCCC-CCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017627          290 SMLNDIADCEAT-----KVNELVDPRL-AGDFD-----LDEARAMLSIAALCLRQSPILRPSATQILHT  347 (368)
Q Consensus       290 ~~~~~~~~~~~~-----~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~  347 (368)
                      ............     .......... .....     ...+..+.+||.+||+.||.+|||++|+|+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            222211110000     0000000000 00001     1234678999999999999999999999997

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-45  Score=332.04  Aligned_cols=272  Identities=22%  Similarity=0.308  Sum_probs=195.9

Q ss_pred             HHHhhhhcccccceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCC-----------CCceeeeeEEEec
Q 017627           58 TQNFSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLS-----------HDNIVKLIGYCDD  126 (368)
Q Consensus        58 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~  126 (368)
                      +|.+.++||+|+||+||+|++..  ++..||||+........+.+.+|+.+++.++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~--~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46788999999999999998755  6789999998877766778889999998885           5789999998854


Q ss_pred             --CCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEecCCCCCeeecCCCc----
Q 017627          127 --RDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-RCTLHIVHGDIKASNILLEEHLN----  199 (368)
Q Consensus       127 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nilv~~~~~----  199 (368)
                        ....+++|+++..+..............+++..+..++.||+.||.|||+ .   ||+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence              34566777766444333322222255678999999999999999999998 6   9999999999999986553    


Q ss_pred             --eEEeeccccccCCCCCCCCCCCCCCCCccccccceeeecCCCCccchhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 017627          200 --CKLCDFGSAKMGFSSAVLPPSPSPSPSRSRITKQVMMIGSPGYTDPHYLRTGMASTKTDVYSFGVILLELVTGMEAFC  277 (368)
Q Consensus       200 --vkl~Dfg~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  277 (368)
                        ++++|||.|.......                  ...+||+.|+|||++.+..++.++||||+||++++|++|+.||.
T Consensus       169 ~~~kl~dfg~s~~~~~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY------------------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             EEEEECCCTTCEETTBCC------------------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             ceeeEeeccccccccccc------------------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence              9999999987432211                  22469999999999999999999999999999999999999997


Q ss_pred             CCcchhhHH------HHHhhhhhhhhhhh---cchhhhcC---------C----------CCCCCCCHHHHHHHHHHHHH
Q 017627          278 PENGQLLTS------LAGSMLNDIADCEA---TKVNELVD---------P----------RLAGDFDLDEARAMLSIAAL  329 (368)
Q Consensus       278 ~~~~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~---------~----------~~~~~~~~~~~~~l~~li~~  329 (368)
                      +........      .....+...+....   .......+         .          ..........+..+.+|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  310 (362)
T d1q8ya_         231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  310 (362)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence            654321111      01111111000000   00000000         0          00123446678899999999


Q ss_pred             hcCCCCCCCCCHHHHHHH--HHhcc
Q 017627          330 CLRQSPILRPSATQILHT--IKHQI  352 (368)
Q Consensus       330 ~l~~dP~~Rpt~~~il~~--L~~~~  352 (368)
                      ||..||.+|||++|+|+|  ++...
T Consensus       311 mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         311 MLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             GGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             HCCCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999988  55443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4.3e-26  Score=188.37  Aligned_cols=129  Identities=19%  Similarity=0.251  Sum_probs=101.5

Q ss_pred             hhhhcccccceEEEEEEEcCCCCceeEEEEeecCCh-------------------hHHHHHHHHHHHHhcCCCCceeeee
Q 017627           61 FSQVIGSGGFSNVYLARLINDSTSTNGAIKIHVGSD-------------------RLSQVFKQELDILLHLSHDNIVKLI  121 (368)
Q Consensus        61 ~~~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~~~-------------------~~~~~~~~E~~~l~~l~h~~iv~~~  121 (368)
                      +++.||+|+||+||+|.+.   ++..+|+|+.....                   .....+..|...+..+.|.+++..+
T Consensus         4 vg~~IG~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             EEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             hCCEeeeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            5788999999999999863   45789999754211                   1123345689999999999999988


Q ss_pred             EEEecCCeeEEEEecccCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEecCCCCCeeecCCCceE
Q 017627          122 GYCDDRDEGVLLFEYVPNGTLQEKLHGTPRSSKLPWRNRMAIAFQLAQAIEYLHERCTLHIVHGDIKASNILLEEHLNCK  201 (368)
Q Consensus       122 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nilv~~~~~vk  201 (368)
                      ++..    .+++|||+.+..+..          ++...+..++.|++.|+.|||++   +|+||||||+|||++++ .++
T Consensus        81 ~~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             EecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence            7642    379999997765433          23334567899999999999999   99999999999999976 489


Q ss_pred             Eeecccccc
Q 017627          202 LCDFGSAKM  210 (368)
Q Consensus       202 l~Dfg~s~~  210 (368)
                      |+|||.|+.
T Consensus       143 liDFG~a~~  151 (191)
T d1zara2         143 IIDFPQSVE  151 (191)
T ss_dssp             ECCCTTCEE
T ss_pred             EEECCCccc
Confidence            999999864

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=3.7e-07  Score=77.01  Aligned_cols=130  Identities=19%  Similarity=0.196  Sum_probs=83.1

Q ss_pred             ccceEEEEEEEcCCCCceeEEEEeecCC-hhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecccCCCHHHH
Q 017627           68 GGFSNVYLARLINDSTSTNGAIKIHVGS-DRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYVPNGTLQEK  145 (368)
Q Consensus        68 G~~g~V~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  145 (368)
                      ++.+.||+...    ....+.+|+.... ......+.+|+.+++.|. +--+.+++.+..+.+..++||++++|.++...
T Consensus        25 ~s~~~v~rv~~----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          25 MSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             CCCCcEEEEEe----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence            44568998753    2334456654332 223334677888888774 33367788888888899999999988877654


Q ss_pred             hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------------
Q 017627          146 LHGTPRSSKLPWRNRMAIAFQLAQAIEYLHE-------------------------------------------------  176 (368)
Q Consensus       146 l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-------------------------------------------------  176 (368)
                      ....     ..   ...++.++...+..||+                                                 
T Consensus       101 ~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (263)
T d1j7la_         101 YEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD  172 (263)
T ss_dssp             TTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred             cccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence            3211     11   11233344444444441                                                 


Q ss_pred             ----CC---CCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          177 ----RC---TLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       177 ----~~---~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                          ..   ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                10   1137999999999999987777899999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=6.8e-06  Score=68.59  Aligned_cols=73  Identities=15%  Similarity=0.104  Sum_probs=49.4

Q ss_pred             ccccc-ceEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCC--CceeeeeEEEecCCeeEEEEecccCCC
Q 017627           65 IGSGG-FSNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSH--DNIVKLIGYCDDRDEGVLLFEYVPNGT  141 (368)
Q Consensus        65 iG~G~-~g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~  141 (368)
                      +..|. .+.||+....   .+..+.+|......  ...+..|+..++.|..  -.+++++.+..+.+..++||++++|.+
T Consensus        18 ~~~G~s~~~v~r~~~~---~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ---GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECT---TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeC---CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            44444 3678988642   34456777655443  2346778888887743  336778888888888999999998765


Q ss_pred             H
Q 017627          142 L  142 (368)
Q Consensus       142 L  142 (368)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.90  E-value=1.1e-05  Score=71.92  Aligned_cols=75  Identities=17%  Similarity=0.122  Sum_probs=45.6

Q ss_pred             hhcccccceEEEEEEEcCCCCceeEEEEeecC-----C---hhHHHHHHHHHHHHhcCC-C--CceeeeeEEEecCCeeE
Q 017627           63 QVIGSGGFSNVYLARLINDSTSTNGAIKIHVG-----S---DRLSQVFKQELDILLHLS-H--DNIVKLIGYCDDRDEGV  131 (368)
Q Consensus        63 ~~iG~G~~g~V~~~~~~~~~~~~~~aik~~~~-----~---~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~  131 (368)
                      +.||.|....||++...+  .+..+.+|....     .   +....+...|+.+|+.+. +  ..+++++.+.  .+..+
T Consensus        32 ~eig~G~~N~vfrV~~~~--~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~  107 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV  107 (392)
T ss_dssp             EECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred             EEeCCCceEeEEEEEeCC--CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCE
Confidence            358999999999997533  344566664221     0   112234556888888773 2  3466666553  45668


Q ss_pred             EEEecccCCC
Q 017627          132 LLFEYVPNGT  141 (368)
Q Consensus       132 lv~e~~~~~~  141 (368)
                      +|||++.+..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            9999997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.21  E-value=0.00077  Score=57.96  Aligned_cols=134  Identities=16%  Similarity=0.156  Sum_probs=75.4

Q ss_pred             eEEEEEEEcCCCCceeEEEEeecCChhHHHHHHHHHHHHhcCCCCcee--eee-----EEEecCCeeEEEEecccCCCHH
Q 017627           71 SNVYLARLINDSTSTNGAIKIHVGSDRLSQVFKQELDILLHLSHDNIV--KLI-----GYCDDRDEGVLLFEYVPNGTLQ  143 (368)
Q Consensus        71 g~V~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~h~~iv--~~~-----~~~~~~~~~~lv~e~~~~~~L~  143 (368)
                      -.||++...   ++..+++|+..........+..|...+..|...++.  ...     ..+...+..+.+++++.|..+.
T Consensus        36 N~vy~v~~~---dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQDE---DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECCT---TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEcC---CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            368888642   567788999877655567788899998888532221  111     1223455678889988664321


Q ss_pred             ------------------HHhcCCC--CCCCCCH----------------------HHHHHHHHHHHHHHHHHh-hCCCC
Q 017627          144 ------------------EKLHGTP--RSSKLPW----------------------RNRMAIAFQLAQAIEYLH-ERCTL  180 (368)
Q Consensus       144 ------------------~~l~~~~--~~~~~~~----------------------~~~~~i~~qi~~~l~~LH-~~~~~  180 (368)
                                        .......  .....+.                      ......+..+...+.-.- +....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                              0111100  0011111                      112222333333332221 22244


Q ss_pred             CeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          181 HIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       181 ~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      ++||+|+.|.|||++++  ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            79999999999999743  4589999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.21  E-value=0.00041  Score=61.52  Aligned_cols=74  Identities=23%  Similarity=0.236  Sum_probs=49.8

Q ss_pred             hcccccceEEEEEEEcCC-----CCceeEEEEeecCChhHHHHHHHHHHHHhcCC-CCceeeeeEEEecCCeeEEEEecc
Q 017627           64 VIGSGGFSNVYLARLIND-----STSTNGAIKIHVGSDRLSQVFKQELDILLHLS-HDNIVKLIGYCDDRDEGVLLFEYV  137 (368)
Q Consensus        64 ~iG~G~~g~V~~~~~~~~-----~~~~~~aik~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  137 (368)
                      .|+.|-.-.+|++...+.     .....+.+++....... -...+|..+++.+. +.-.+++++++.+    .+|+||+
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            577788889999886542     12345677776644443 34567999999885 4334577887753    5899999


Q ss_pred             cCCCH
Q 017627          138 PNGTL  142 (368)
Q Consensus       138 ~~~~L  142 (368)
                      .|..+
T Consensus       124 ~g~~l  128 (395)
T d1nw1a_         124 PSRPL  128 (395)
T ss_dssp             CEEEC
T ss_pred             ccccC
Confidence            76544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.94  E-value=0.0032  Score=53.57  Aligned_cols=31  Identities=23%  Similarity=0.249  Sum_probs=27.6

Q ss_pred             CCCeEEecCCCCCeeecCCCceEEeeccccc
Q 017627          179 TLHIVHGDIKASNILLEEHLNCKLCDFGSAK  209 (368)
Q Consensus       179 ~~~ivH~Dikp~Nilv~~~~~vkl~Dfg~s~  209 (368)
                      ..++||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3479999999999999998777899999875